<?xml version="1.0" encoding="UTF-8"?>
<rdf:RDF
   xmlns:ao="http://www.w3.org/ns/oa#"
   xmlns:dailymed="http://dbmi-icode-01.dbmi.pitt.edu/linkedSPLs/vocab/resource/"
   xmlns:dct="http://purl.org/dc/terms/"
   xmlns:dikbD2R="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/"
   xmlns:domeo="http://www.w3.org/ns/domeo#"
   xmlns:foafx="http://xmlns.com/foaf/0.1/"
   xmlns:pav="http://purl.org/pav/"
   xmlns:permissions="http://vocab.deri.ie/cpo#"
   xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#"
   xmlns:rdfs="http://www.w3.org/2000/01/rdf-schema#"
   xmlns:sio="http://semanticscience.org/resource/"
>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/E529663E-F098-4A61-A526-168945DFC957">
    <rdfs:label>cimetidine</rdfs:label>
    <dct:description>Referred to the drug in the interaction.</dct:description>
    <sio:SIO_000228>dikbD2R:precipitant-drug-of-interaction</sio:SIO_000228>
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/2541</dailymed:activeMoietyRxCUI>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/active-ingredient"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:54A742F1-BC99-4080-8071-732BA171793D">
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:lastSavedOn>2014-07-24 20:07:19 -0400</pav:lastSavedOn>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812eda990003</pav:createdBy>
    <domeo:belongsToSet>urn:domeoserver:annotationset:37B2514D-1A92-45B1-8A5C-610DA6DC935A</domeo:belongsToSet>
    <pav:createdOn>2014-07-24 20:07:04 -0400</pav:createdOn>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <domeo:belongsToSet>urn:domeoclient:uuid:8D86A4AC-54BD-4BB3-8B58-AB55DEC01A88</domeo:belongsToSet>
    <domeo:belongsToSet>urn:domeoserver:annotationset:1FC172B8-8AC3-465A-AA69-B73AD9B97CBC</domeo:belongsToSet>
    <pav:lastSavedOn>2014-07-24 20:07:20 -0400</pav:lastSavedOn>
    <rdfs:label>Highlight</rdfs:label>
    <pav:lineageUri>urn:domeoserver:annotationset:4A88D0A6-E9B6-4E7F-955F-3692600C178C</pav:lineageUri>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:lineageUri>urn:domeoserver:annotation:65D9C470-4BFE-45D6-B18D-E35118C6A738</pav:lineageUri>
    <ao:context rdf:resource="urn:domeoclient:uuid:3357AB7A-4128-4D9D-8FEF-3908BC9E44F0"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:555D0A1F-632F-4953-A2D8-E08196E7CEB9">
    <ao:context rdf:resource="urn:domeoclient:uuid:2B0781B4-A013-4EA2-8F12-DEE15D23DD0E"/>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812eda990003</pav:createdBy>
    <pav:lastSavedOn>2014-09-02 12:02:18 -0400</pav:lastSavedOn>
    <pav:createdOn>2014-09-02 11:57:24 -0400</pav:createdOn>
    <rdfs:label>Highlight</rdfs:label>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <domeo:belongsToSet>urn:domeoclient:uuid:4B51141D-C8D2-45DB-8074-74F8D8323E60</domeo:belongsToSet>
    <pav:lineageUri>urn:domeoserver:annotation:0019883E-5898-4EB5-BE4B-4192267B6B23</pav:lineageUri>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:E8B9127A-D513-4699-BEA0-07E095BADF5D">
    <dikbD2R:modality>ncit:positive</dikbD2R:modality>
    <dikbD2R:statement>ncit:quantitative</dikbD2R:statement>
    <sio:SIO_000205>dikbD2R:statement</sio:SIO_000205>
    <sio:SIO_000628 rdf:resource="urn:pddi:uuid:29BA1C64-71E4-4437-B3E3-C16FF494B3CA"/>
    <rdf:type rdf:resource="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#DrugDrugInteractionStatement"/>
    <sio:SIO_000563>dikbD2R:modality</sio:SIO_000563>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:00C24F6A-259C-4CD5-BB57-3231935B23AE">
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <domeo:belongsToSet>urn:domeoserver:annotationset:392EE0FB-AC4F-4AF2-87A6-2E50A281F434</domeo:belongsToSet>
    <pav:lastSavedOn>2014-09-02 19:19:47 -0400</pav:lastSavedOn>
    <ao:context rdf:resource="urn:domeoclient:uuid:3801AFB1-E917-4E09-8201-F7DFAAAD30AC"/>
    <rdfs:label>Highlight</rdfs:label>
    <pav:createdOn>2014-09-02 19:17:56 -0400</pav:createdOn>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812eda990003</pav:createdBy>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <domeo:belongsToSet>urn:domeoclient:uuid:CB83FFC2-EA71-44EA-8F11-DE80E389C84E</domeo:belongsToSet>
    <pav:lineageUri>urn:domeoserver:annotation:9860733E-7F46-426C-ABA5-5323B0C9C01A</pav:lineageUri>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <domeo:belongsToSet>urn:domeoserver:annotationset:E32812A9-205B-4EE1-B488-A1E294EDBFB9</domeo:belongsToSet>
    <pav:lineageUri>urn:domeoserver:annotationset:C5DEBC9B-77EE-4243-88EB-DBC19737ACD2</pav:lineageUri>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:F7DD29E8-1783-4BA7-A529-9EF0B60D8F39">
    <pav:lastSavedOn>2014-09-02 11:35:33 -0400</pav:lastSavedOn>
    <ao:context rdf:resource="urn:domeoclient:uuid:34A4FD4A-1057-41A3-B555-92B00D0BD0D1"/>
    <domeo:belongsToSet>urn:domeoclient:uuid:BED41F06-565A-4622-9A88-48810E5A28DE</domeo:belongsToSet>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:lineageUri>urn:domeoserver:annotationset:D1715BD2-BD41-46FD-9454-DC7A423A29AC</pav:lineageUri>
    <domeo:belongsToSet>urn:domeoserver:annotationset:3F546823-204F-4F9B-9006-3DC526C56931</domeo:belongsToSet>
    <pav:createdOn>2014-09-02 11:35:30 -0400</pav:createdOn>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812eda990003</pav:createdBy>
    <rdfs:label>Highlight</rdfs:label>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:lineageUri>urn:domeoserver:annotation:A8AA3257-224E-41F3-96E9-1B09CA21B516</pav:lineageUri>
    <domeo:belongsToSet>urn:domeoserver:annotationset:A5DD001D-C81A-4E2E-B5E0-7A866B35E26B</domeo:belongsToSet>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <domeo:belongsToSet>urn:domeoserver:annotationset:A3F0B39A-4249-4B63-BB0D-F24A005066AC</domeo:belongsToSet>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:E456854E-5580-4BC4-A878-DCBA76DC28FA">
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812eda990003</pav:createdBy>
    <pav:lastSavedOn>2014-07-24 19:44:56 -0400</pav:lastSavedOn>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:createdOn>2014-07-24 19:44:10 -0400</pav:createdOn>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <domeo:belongsToSet>urn:domeoclient:uuid:511EDFA9-5A42-4340-9D4A-CBF6EDD9185C</domeo:belongsToSet>
    <pav:lineageUri>urn:domeoserver:annotation:AE9EE81B-F1E8-4623-B34F-44165AD48CDE</pav:lineageUri>
    <rdfs:label>Highlight</rdfs:label>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <ao:context rdf:resource="urn:domeoclient:uuid:8C807E9A-52F6-4F5A-9553-5D4EB47525AC"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:5577FA82-F64B-40B7-8542-3CEE5BC9380E">
    <ao:exact>saquinavir</ao:exact>
    <ao:prefix> 40 mg qd co-administered days 11 to 15. Dose reduction of </ao:prefix>
    <pav:createdOn>2014-09-02 19:19:18 -0400</pav:createdOn>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:5577FA82-F64B-40B7-8542-3CEE5BC9380E"/>
    <domeo:uuid>5577FA82-F64B-40B7-8542-3CEE5BC9380E</domeo:uuid>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-74.txt.html</ao:hasSource>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:suffix> should be considered from the safety perspective for individual patients. There are also some antiretroviral drugs of which unchanged serum levels have been reported when given with omeprazole.</ao:suffix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:81F0286A-7D44-49B2-9EF8-817CDCC20940">
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:lineageUri>urn:domeoserver:annotation:D08D7947-3BE2-495E-AE50-1F65AAFC0B91</pav:lineageUri>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:createdOn>2014-07-24 20:14:15 -0400</pav:createdOn>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812eda990003</pav:createdBy>
    <rdfs:label>Highlight</rdfs:label>
    <domeo:belongsToSet>urn:domeoclient:uuid:7DCD6738-9404-46BB-A758-BDDEB41B4565</domeo:belongsToSet>
    <pav:lastSavedOn>2014-07-24 20:14:01 -0400</pav:lastSavedOn>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <ao:context rdf:resource="urn:domeoclient:uuid:E65F5A7D-A02D-468C-B1BF-DA59E8B655C9"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:195005D8-3CE9-43AD-A3D8-56739DB440A4">
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:suffix>. The mean increase in ethinyl estradiol AUC was 6% (range: -47 to 108%) and levonorgestrel AUC increased 17% (range: -33 to 141%).</ao:suffix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:195005D8-3CE9-43AD-A3D8-56739DB440A4"/>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-22.txt.html</ao:hasSource>
    <pav:createdOn>2014-07-13 12:44:25 -0400</pav:createdOn>
    <ao:prefix> AUC after the administration of 50 mg of </ao:prefix>
    <domeo:uuid>195005D8-3CE9-43AD-A3D8-56739DB440A4</domeo:uuid>
    <ao:exact>fluconazole</ao:exact>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:393FB1C5-F66E-42C6-AA25-436EBF20214E">
    <ao:context rdf:resource="urn:domeoclient:uuid:07FAC59A-4DB3-40BE-8ADC-7231ECC711EF"/>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <domeo:belongsToSet>urn:domeoclient:uuid:BED41F06-565A-4622-9A88-48810E5A28DE</domeo:belongsToSet>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812eda990003</pav:createdBy>
    <pav:lineageUri>urn:domeoserver:annotation:1BD3485D-61CF-4942-BFF8-2C46C3DC94DE</pav:lineageUri>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:lastSavedOn>2014-09-02 11:35:33 -0400</pav:lastSavedOn>
    <rdfs:label>Highlight</rdfs:label>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <domeo:belongsToSet>urn:domeoserver:annotationset:3F546823-204F-4F9B-9006-3DC526C56931</domeo:belongsToSet>
    <domeo:belongsToSet>urn:domeoserver:annotationset:A5DD001D-C81A-4E2E-B5E0-7A866B35E26B</domeo:belongsToSet>
    <domeo:belongsToSet>urn:domeoserver:annotationset:A3F0B39A-4249-4B63-BB0D-F24A005066AC</domeo:belongsToSet>
    <pav:createdOn>2014-09-02 11:30:33 -0400</pav:createdOn>
    <pav:lineageUri>urn:domeoserver:annotationset:D1715BD2-BD41-46FD-9454-DC7A423A29AC</pav:lineageUri>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:01CABF7B-5601-4091-B27B-BB36CCDE1151">
    <rdfs:label>Highlight</rdfs:label>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:lastSavedOn>2014-09-02 19:11:13 -0400</pav:lastSavedOn>
    <pav:createdOn>2014-09-02 19:08:36 -0400</pav:createdOn>
    <pav:lineageUri>urn:domeoserver:annotation:61EC9BF9-7DCF-4DC4-A685-81B401973EA5</pav:lineageUri>
    <ao:context rdf:resource="urn:domeoclient:uuid:3CB57EB2-8A93-411F-AFE4-75EE6C88177B"/>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812eda990003</pav:createdBy>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <domeo:belongsToSet>urn:domeoclient:uuid:3966BCFB-CA02-4053-828D-3860558E7BE8</domeo:belongsToSet>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:C8D05CE4-8287-449A-8921-AFACBAEE2002">
    <pav:createdOn>2014-07-07 09:39:32 -0400</pav:createdOn>
    <pav:lastSavedOn>2014-07-07 09:44:19 -0400</pav:lastSavedOn>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <domeo:belongsToSet>urn:domeoserver:annotationset:22ED7220-C6F6-43C5-9DF9-89F62F0F8E27</domeo:belongsToSet>
    <domeo:belongsToSet>urn:domeoserver:annotationset:131835A3-C655-4F91-97D4-52CAFF7B7CCA</domeo:belongsToSet>
    <pav:lineageUri>urn:domeoserver:annotationset:76FD4BB5-DE2F-4FCA-B93D-302185B1A381</pav:lineageUri>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812eda990003</pav:createdBy>
    <pav:lastSavedOn>2014-07-07 09:44:18 -0400</pav:lastSavedOn>
    <domeo:belongsToSet>urn:domeoclient:uuid:FCA2BF23-0BE3-409F-9177-761812F96097</domeo:belongsToSet>
    <rdfs:label>Highlight</rdfs:label>
    <domeo:belongsToSet>urn:domeoserver:annotationset:7AACEF8D-2EBC-4F0B-94B2-190650E562F6</domeo:belongsToSet>
    <domeo:belongsToSet>urn:domeoserver:annotationset:08C0C288-6DF4-43E6-A618-71A8BB9563C3</domeo:belongsToSet>
    <ao:context rdf:resource="urn:domeoclient:uuid:52192391-30EB-46A9-93CB-47EC77CE40BC"/>
    <domeo:belongsToSet>urn:domeoserver:annotationset:8F3CF3D9-AADE-4A86-BD42-2924B3D6A406</domeo:belongsToSet>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:lineageUri>urn:domeoserver:annotation:02608C01-A84B-4FA5-B484-E8E8B6A81DF4</pav:lineageUri>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:3A2D166B-BD0B-4C2A-9E40-D07C3CE85DBC">
    <sio:SIO_000205>dikbD2R:statement</sio:SIO_000205>
    <sio:SIO_000628 rdf:resource="urn:pddi:uuid:9639DF56-3E53-4998-9064-63357AB54862"/>
    <sio:SIO_000563>dikbD2R:modality</sio:SIO_000563>
    <dikbD2R:statement>ncit:Qualitative</dikbD2R:statement>
    <dikbD2R:modality>ncit:negative</dikbD2R:modality>
    <rdf:type rdf:resource="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#DrugDrugInteractionStatement"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:E63ABC8A-4562-42F9-B5F4-6A27DEE50F44">
    <domeo:belongsToSet>urn:domeoserver:annotationset:392EE0FB-AC4F-4AF2-87A6-2E50A281F434</domeo:belongsToSet>
    <domeo:belongsToSet>urn:domeoserver:annotationset:E32812A9-205B-4EE1-B488-A1E294EDBFB9</domeo:belongsToSet>
    <pav:createdOn>2014-09-02 19:12:10 -0400</pav:createdOn>
    <pav:lastSavedOn>2014-09-02 19:19:47 -0400</pav:lastSavedOn>
    <rdfs:label>Highlight</rdfs:label>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:lineageUri>urn:domeoserver:annotation:1731D9D0-8CC7-407A-9BD0-9813B14BC52D</pav:lineageUri>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812eda990003</pav:createdBy>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <domeo:belongsToSet>urn:domeoclient:uuid:CB83FFC2-EA71-44EA-8F11-DE80E389C84E</domeo:belongsToSet>
    <ao:context rdf:resource="urn:domeoclient:uuid:DC83EF48-BF8E-4B34-9782-4DFBE01FA8AA"/>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:lineageUri>urn:domeoserver:annotationset:C5DEBC9B-77EE-4243-88EB-DBC19737ACD2</pav:lineageUri>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoserver:annotationset:F272A789-69D0-47CC-8CC9-F25C55B91261">
    <ao:item rdf:resource="urn:domeoclient:uuid:503397EF-2F88-4CC5-9295-97542C30A8DC"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:78A5F631-80CE-4FB1-974D-F82BE8D8E584"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:B6681C81-EA03-49F0-8187-EF5752C9D126"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:D693BC09-DDB8-454B-A812-E73AB798F6FA"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:BFF65D4B-C4C0-4D4B-82C1-14B60D53FB1D"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:15E1712B-2693-4DB6-A2FE-D2F158D3A823"/>
    <pav:createdOn>2014-07-22 19:08:44 -0400</pav:createdOn>
    <ao:item rdf:resource="urn:domeoclient:uuid:F8EAE386-C8C4-4874-BD9D-09F2FAF602D8"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:ECE7CA77-7E57-44B0-89AE-B78915FEC8C2"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:73B577C5-182A-4914-B557-9A6594045898"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:023B39C4-2A61-428E-9D4B-84E60C00EA1D"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:37E9FF1C-D06E-42C3-944C-482813D8E38E"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:44D9A897-A866-42BB-8DD9-A376BF8D1B3E"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:AA680547-50B2-43E1-8768-6007654CDEF9"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:0FDB999F-470E-431C-829C-F231318245D8"/>
    <rdfs:label>Default Set</rdfs:label>
    <ao:item rdf:resource="urn:domeoclient:uuid:C4558C3C-CC16-4A44-85EC-2AB4969F8A0D"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:5CE56B1D-ACF0-4124-B31E-62EF1E11FED8"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:3E33C30E-6EC7-463F-A8C1-B699338A149B"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:B28EDC18-743D-4015-956F-B084F96B3589"/>
    <pav:lineageUri>urn:domeoserver:annotationset:AB1741F1-5A5F-4416-AEAC-A544BCBB7D16</pav:lineageUri>
    <ao:item rdf:resource="urn:domeoclient:uuid:52B64BE2-7636-4E5D-B162-D84F2D892E3D"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:FF1FC131-57E9-4A89-8FBF-B786D1543F24"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:A68BF389-96D4-4F16-BF9D-C1BF35E3CE01"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:851EB41C-687B-464B-9105-16513BFE3A24"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:544614C5-3057-4129-841C-95DBCD1340A4"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:398266C6-18B2-479E-8C00-4B3F67E7DB6D"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:424F0823-B0B8-4327-8A43-69119A2195AC"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:B1EDC65E-7D2E-4E9E-9D08-0D72BD366C29"/>
    <ao:annotatesResource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-123.txt.html</ao:annotatesResource>
    <domeo:deleted>false</domeo:deleted>
    <ao:item rdf:resource="urn:domeoclient:uuid:414AB21B-E61F-45BC-90CC-D10C8E784BF6"/>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">8</pav:versionNumber>
    <ao:item rdf:resource="urn:domeoclient:uuid:BD929BB0-93FC-4E77-9CA8-72C96F88EBB3"/>
    <permissions:permissions rdf:nodeID="Ncf3ed7da0a38468dba031c79b0406f46"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:08556835-0438-4667-8B70-71388FA5E865"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:FA96F07E-C088-44C7-AC16-D0EBD7DBD41D"/>
    <domeo:agents rdf:resource="urn:person:uuid:080e143046812afe0146812eda990003"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:ED9A4881-5A44-4C07-BAFB-529340D632F3"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:5C77DFAE-836C-475E-BE78-637BCFAAA992"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:4411E759-9248-468B-B2F6-E5A5A8657C4C"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:9F788EEC-77F0-4E60-8480-F71299529EB7"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:D62F417A-98ED-4008-ADC4-F7EBC73F9F68"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:5E8A53CD-1A4A-4A56-ABAA-82D073884595"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:51F1BD01-1111-4CA2-BC77-65762E0E45AA"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:23D9C242-E097-43FB-88F0-20E20588FBFC"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:17DEFB36-51D5-4E3A-92CC-91E1F7EEAE4B"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:E50BE5A6-0C68-4839-AB64-4D7AED50EDAC"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:2506F4F5-773E-4CCD-8303-CC244D5848D1"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:BFE514C1-B428-49F6-A34E-88C9F7618ABF"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:AF177109-0D4D-4DEA-BD5C-F29B10621C02"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:585BED0D-5182-4D39-912D-F355B5BEA6BA"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:93764486-40C1-4D42-A6D0-D1FF47D6EC82"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:3077386C-E136-4431-9DB1-FC99BF18719B"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:13D07A15-03D1-462A-AFD2-4B5FC8458177"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:4E71470A-E5FA-4B06-9981-E64925A42B90"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:9D9E07C8-AA4D-4D08-897A-996E5C499CF6"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:EF32B76C-C252-4DA7-9AC6-7FCD32EE9F83"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:AF68257F-3ADB-4BA4-9BD1-247F8428319E"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:0DCFB2B8-8A03-443E-AC2D-8FA3EBDA0087"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:66A10386-3791-4236-BBA2-9E3AD59B847D"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:F895E903-9E93-41BD-BED1-2EA2CE628B45"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:7616318E-C362-4BC0-B027-F84CBEA6207C"/>
    <dct:description>The default set is created automatically by Domeo when no other set is existing.</dct:description>
    <ao:item rdf:resource="urn:domeoclient:uuid:513FF3F1-4FCE-4790-A5C9-F75162D3687B"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:6667DCF7-AA10-4999-B062-38650C90AEA5"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:15050075-436C-4668-9987-03D689AE2236"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:6A67B256-CA48-48CA-B584-DB13E0D52B58"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:5C47D157-D8A4-4053-B2C7-7ECD1B16B721"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:137CD66C-79A5-4DE2-BF83-E1E083B1F26F"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:745E9BC2-9930-4FE0-83A2-11668B70C40A"/>
    <pav:lastSavedOn>2014-07-22 20:22:37 -0400</pav:lastSavedOn>
    <ao:item rdf:resource="urn:domeoclient:uuid:FBE8BF3F-CF31-4746-AE08-52B8B70D3AA7"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:D7B822C5-ED4F-4553-B7A4-E4C2A921922B"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:82628688-78B9-45FB-8BED-8C81D7B2F03E"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:545EC8BB-0B95-4E21-B88B-BE07F31247CE"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:7015192E-CCA2-475B-8C8B-10870378056A"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:7086D655-845E-4135-B24F-75B4FFD47BD0"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:2BB40EDC-DE0E-4B5E-AEE3-DCE89148115F"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:37752019-6AF8-406B-9C87-6BCEF8ED7AAE"/>
    <pav:previousVersion>urn:domeoserver:annotationset:2914A3FD-DF43-4F78-999C-77CE7A028B19</pav:previousVersion>
    <ao:item rdf:resource="urn:domeoclient:uuid:FCDCF22B-9687-4394-9D96-2255CE012E2D"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:3D0D19A7-AA2E-4F5C-86E6-0B171A00A7B1"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:CA9B3930-3D00-45F4-81DF-D789FB3565E3"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:796FE422-C147-4AA7-A57F-067429194AA4"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:2AE98FC9-CA39-4A5E-9A97-02182489F1DE"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:2D0A6C88-E510-4AF5-8DFB-C35B1F919461"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:669918DD-5E01-4F63-9C3C-FB4172F004FB"/>
    <domeo:agents rdf:resource="urn:domeo:software:id:Domeo-2.1alpha-050"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:446F532B-903F-4B10-9F56-9CC000DF6BDF"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:CF4B56FC-1048-4C85-AD05-E8D9C4F159CF"/>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <ao:item rdf:resource="urn:domeoclient:uuid:D519A3CD-A32C-4057-9BB6-FB2AE41AF4A9"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:CE897434-B9A6-4A1A-B7D2-C1748858051B"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:F2F7D256-D331-45B3-9459-089EEB530262"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:2DBC33BA-B5CF-487A-BE2E-5C3FB9F71111"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:D1F55052-16DF-4B25-AC16-7645C8E4AD77"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:ED1540C5-0D63-4D37-A891-4B8F18792981"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:6981279A-8AEC-4DEB-BDFB-296A4FDF471C"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:84AD1907-FCD9-44ED-A2B9-CE7DA4A1A9AA"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:8C53D58B-D2A3-4A8C-9924-E26E43A59105"/>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812eda990003</pav:createdBy>
    <ao:item rdf:resource="urn:domeoclient:uuid:62F73A2A-2D49-4A1C-B836-1F3280DE6ACE"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:D555EE88-9218-4AF9-81CC-40D543746D77"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:A75B59C8-60A9-4317-B506-9477A97901ED"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:292BF8EC-0E65-4E33-A331-3D217DD6B134"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#AnnotationSet"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:E2D1A706-CE7E-4379-97CF-4EE9CA384DB2"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:23AC6809-BABB-405A-80DE-630CA211B109"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:29694BD5-41F2-4693-A623-AABDC826F754"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:0A960BCB-9A9F-4998-9418-33D622C35F7C"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:463EFB94-13AD-4945-B3D3-4B953F099775"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:6016855A-FC6C-4F50-BBD3-3126439782E9"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:BD61A2B7-5272-4F6D-A4A5-94082E805ED6"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:3E692274-1B14-40DE-8BD6-F464FE52CF01"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:71244950-C950-47EB-A32B-D2748E51EF60"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:9C9FE015-E10A-4124-9250-BA73B7E52470"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:E3C70535-C49A-4807-84DF-3951A0E27152"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:97BD942B-FE8A-49D9-A08D-AF25357CEE2D"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:67E0B291-7BEC-4E9A-AE3A-91E5111086CD">
    <ao:exact>The metabolism of propranolol is reduced by co-administration of quinidine, leading to a two-three fold increased blood concentration and greater degrees of clinical beta-blockade</ao:exact>
    <pav:createdOn>2014-07-24 19:38:56 -0400</pav:createdOn>
    <ao:prefix>xsd:String</ao:prefix>
    <domeo:uuid>67E0B291-7BEC-4E9A-AE3A-91E5111086CD</domeo:uuid>
    <ao:suffix>xsd:String</ao:suffix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:67E0B291-7BEC-4E9A-AE3A-91E5111086CD"/>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-125.txt.html</ao:hasSource>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoserver:annotationset:22ED7220-C6F6-43C5-9DF9-89F62F0F8E27">
    <ao:item rdf:resource="urn:domeoclient:uuid:F9FE917E-CAFF-4C8B-B16B-BB0606212145"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:B9E21C61-063D-4F80-8E08-85865B387669"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:FB0C633B-9063-4FD0-91E9-2810CF1C157A"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:222C9B55-A770-41C7-AF04-566E7C7A1DBC"/>
    <pav:createdOn>2014-07-07 09:34:12 -0400</pav:createdOn>
    <ao:item rdf:resource="urn:domeoclient:uuid:E0DCF362-11F8-4FF3-8C3C-EDB9DD3D53A7"/>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">5</pav:versionNumber>
    <ao:item rdf:resource="urn:domeoclient:uuid:E5DE379E-8BB3-4609-BFC6-A0E275978ADC"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:08713DDF-0935-4B63-B281-AEE56A8D7628"/>
    <pav:lastSavedOn>2014-07-07 11:36:14 -0400</pav:lastSavedOn>
    <pav:previousVersion>urn:domeoserver:annotationset:8F3CF3D9-AADE-4A86-BD42-2924B3D6A406</pav:previousVersion>
    <ao:item rdf:resource="urn:domeoclient:uuid:0B2918C2-A28D-40C3-8147-F19D09B7119C"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:02D92735-6D44-4DFA-A2E9-75A5A3D4DCF9"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:9BD9047F-C1DA-4B64-92B7-4D031972C9CF"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:6588D45E-2F4C-40CF-8AF4-0CD621F484E1"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:5D480921-AA61-499B-9C3F-3043269104B4"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:79293219-D172-4E27-A045-D16B4F539C60"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:E7907DD5-4FA4-4B5A-99D9-9D24B76931C6"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:1C02BE13-5688-4657-A7A7-6A459283AEB2"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:137A1951-AA86-4074-9581-B011801B955F"/>
    <domeo:agents rdf:resource="urn:person:uuid:080e143046812afe0146812eda990003"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:8C5BA635-EF8B-4165-A2A6-5832D61A15BF"/>
    <ao:annotatesResource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-155.txt.html</ao:annotatesResource>
    <ao:item rdf:resource="urn:domeoclient:uuid:2ABA1A35-6C77-4A0A-9EC5-109AA13136B6"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:42423629-C409-4AD4-BBE6-7C86A696F03E"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:17E64297-0A57-4C9B-94C4-18ED1956FCF7"/>
    <dct:description>The default set is created automatically by Domeo when no other set is existing.</dct:description>
    <ao:item rdf:resource="urn:domeoclient:uuid:CE16BF01-AD42-444E-9A68-FEF6AED26815"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:74FDA5BD-9C18-4F10-AC59-C5C75AA497C2"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:FA428F64-D782-46F5-B866-2FBC24D3F4F8"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:2CF891F7-2E96-4382-8EDB-5C061E8E1AFA"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:C8D05CE4-8287-449A-8921-AFACBAEE2002"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:E13140FE-59B4-45B2-A524-CAED051C4F9D"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:E76B5D64-7248-4EBD-A023-3820BFDEFD26"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:3B85AE85-A07C-4614-91F5-52EF7A4737DF"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:10BB95F9-1856-4D70-9976-235CE8AD3D39"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:DE5C582E-1F4C-478C-9DDC-DAB4C0C1ABFF"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:DC9FB0B5-1564-4BF2-A4E4-4D05B0A1AB86"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:BDA75ADA-742A-402B-AE97-4438F99C61FC"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:2F71B86E-3B80-4813-9F00-A9E3E6B30C9E"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:B8D94772-B85A-452F-91A5-C644F8298C08"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:3D22E6FA-B90D-49C2-B42F-B8122D48D82A"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:6FD9D48D-F639-4F09-ABA6-F4B259681453"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:CBB863B4-0141-4362-8357-0FD5A3909A10"/>
    <permissions:permissions rdf:nodeID="N0b4a8c0f60a84910a71e5620b4c61c1a"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:55E300CE-2A8F-42F4-9877-A49DDE4F3360"/>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <ao:item rdf:resource="urn:domeoclient:uuid:F3C4287B-36A9-48BF-8081-A39BEF5F3C51"/>
    <domeo:agents rdf:resource="urn:domeo:software:id:Domeo-2.1alpha-050"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:54B9529D-9030-4194-B66A-D7ECCBABED1F"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:DA7B78BE-B91C-4178-9AF1-7DC800EF5121"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:3ED57AC4-296D-4C8D-9873-49C193F69BBA"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:E76D782E-ADBF-42D0-9CCA-8944F07D22DA"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:697C8F03-1543-4427-9D85-7967FCEA3100"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:8ABD9FDA-0F08-474A-A9C8-437A5346F2AC"/>
    <pav:lineageUri>urn:domeoserver:annotationset:76FD4BB5-DE2F-4FCA-B93D-302185B1A381</pav:lineageUri>
    <ao:item rdf:resource="urn:domeoclient:uuid:1F12731E-6D41-4E27-83E3-C87822424FCA"/>
    <rdfs:label>Default Set</rdfs:label>
    <ao:item rdf:resource="urn:domeoclient:uuid:FA4C8A6E-17D4-47F8-A369-67AF061E9037"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:3762570C-CF43-4DB9-B163-FAA6DAE60017"/>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812eda990003</pav:createdBy>
    <ao:item rdf:resource="urn:domeoclient:uuid:B5E75366-F0BF-442F-852E-19C5EDDC84EE"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:735CA4BD-A16D-4729-BFC3-96D72BFE5B0B"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:16393981-08BF-477D-ACB9-8FB804E50D0C"/>
    <domeo:deleted>false</domeo:deleted>
    <ao:item rdf:resource="urn:domeoclient:uuid:EC416A29-1315-42C5-90FA-652412A6AD12"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:7D37CC60-618E-46B6-8C99-BA7D598E3762"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:2093FF56-689E-4246-AF69-F566860B27BF"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:57E98049-37B0-4F70-963B-F0D12C3B36C7"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#AnnotationSet"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:32B1CD5D-3CD7-4D5E-BD76-57F6F0A9480A"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoserver:annotationset:131835A3-C655-4F91-97D4-52CAFF7B7CCA">
    <ao:item rdf:resource="urn:domeoclient:uuid:735CA4BD-A16D-4729-BFC3-96D72BFE5B0B"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:1F12731E-6D41-4E27-83E3-C87822424FCA"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:3762570C-CF43-4DB9-B163-FAA6DAE60017"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:F9FE917E-CAFF-4C8B-B16B-BB0606212145"/>
    <domeo:deleted>false</domeo:deleted>
    <ao:item rdf:resource="urn:domeoclient:uuid:57E98049-37B0-4F70-963B-F0D12C3B36C7"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:79293219-D172-4E27-A045-D16B4F539C60"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:32B1CD5D-3CD7-4D5E-BD76-57F6F0A9480A"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:0B2918C2-A28D-40C3-8147-F19D09B7119C"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:2093FF56-689E-4246-AF69-F566860B27BF"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:5D480921-AA61-499B-9C3F-3043269104B4"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:CBB863B4-0141-4362-8357-0FD5A3909A10"/>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <ao:item rdf:resource="urn:domeoclient:uuid:17E64297-0A57-4C9B-94C4-18ED1956FCF7"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:02D92735-6D44-4DFA-A2E9-75A5A3D4DCF9"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:E5DE379E-8BB3-4609-BFC6-A0E275978ADC"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:C8D05CE4-8287-449A-8921-AFACBAEE2002"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:2ABA1A35-6C77-4A0A-9EC5-109AA13136B6"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:2CF891F7-2E96-4382-8EDB-5C061E8E1AFA"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:CE16BF01-AD42-444E-9A68-FEF6AED26815"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:F3C4287B-36A9-48BF-8081-A39BEF5F3C51"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:08713DDF-0935-4B63-B281-AEE56A8D7628"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:1C02BE13-5688-4657-A7A7-6A459283AEB2"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:E0DCF362-11F8-4FF3-8C3C-EDB9DD3D53A7"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:B8D94772-B85A-452F-91A5-C644F8298C08"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:8C5BA635-EF8B-4165-A2A6-5832D61A15BF"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:DE5C582E-1F4C-478C-9DDC-DAB4C0C1ABFF"/>
    <pav:previousVersion>urn:domeoserver:annotationset:22ED7220-C6F6-43C5-9DF9-89F62F0F8E27</pav:previousVersion>
    <ao:item rdf:resource="urn:domeoclient:uuid:9BD9047F-C1DA-4B64-92B7-4D031972C9CF"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:E7907DD5-4FA4-4B5A-99D9-9D24B76931C6"/>
    <dct:description>The default set is created automatically by Domeo when no other set is existing.</dct:description>
    <ao:item rdf:resource="urn:domeoclient:uuid:6588D45E-2F4C-40CF-8AF4-0CD621F484E1"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:FA428F64-D782-46F5-B866-2FBC24D3F4F8"/>
    <domeo:agents rdf:resource="urn:domeo:software:id:Domeo-2.1alpha-050"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:6FD9D48D-F639-4F09-ABA6-F4B259681453"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:9E010F58-AD7C-435C-B2DC-0F81F34B978E"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:E13140FE-59B4-45B2-A524-CAED051C4F9D"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:42423629-C409-4AD4-BBE6-7C86A696F03E"/>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812eda990003</pav:createdBy>
    <rdfs:label>Default Set</rdfs:label>
    <ao:item rdf:resource="urn:domeoclient:uuid:74FDA5BD-9C18-4F10-AC59-C5C75AA497C2"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:2F71B86E-3B80-4813-9F00-A9E3E6B30C9E"/>
    <domeo:agents rdf:resource="urn:person:uuid:080e143046812afe0146812eda990003"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:8ABD9FDA-0F08-474A-A9C8-437A5346F2AC"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:3D22E6FA-B90D-49C2-B42F-B8122D48D82A"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:697C8F03-1543-4427-9D85-7967FCEA3100"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:BDA75ADA-742A-402B-AE97-4438F99C61FC"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:E76B5D64-7248-4EBD-A023-3820BFDEFD26"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:DC9FB0B5-1564-4BF2-A4E4-4D05B0A1AB86"/>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">6</pav:versionNumber>
    <permissions:permissions rdf:nodeID="Ncbea3f977c6a49b084d5c6f125159da8"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:DA7B78BE-B91C-4178-9AF1-7DC800EF5121"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:3B85AE85-A07C-4614-91F5-52EF7A4737DF"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:7D37CC60-618E-46B6-8C99-BA7D598E3762"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#AnnotationSet"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:222C9B55-A770-41C7-AF04-566E7C7A1DBC"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:E76D782E-ADBF-42D0-9CCA-8944F07D22DA"/>
    <pav:lastSavedOn>2014-07-07 11:37:25 -0400</pav:lastSavedOn>
    <ao:item rdf:resource="urn:domeoclient:uuid:B5E75366-F0BF-442F-852E-19C5EDDC84EE"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:54B9529D-9030-4194-B66A-D7ECCBABED1F"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:137A1951-AA86-4074-9581-B011801B955F"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:55E300CE-2A8F-42F4-9877-A49DDE4F3360"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:B9E21C61-063D-4F80-8E08-85865B387669"/>
    <pav:createdOn>2014-07-07 09:34:12 -0400</pav:createdOn>
    <ao:item rdf:resource="urn:domeoclient:uuid:10BB95F9-1856-4D70-9976-235CE8AD3D39"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:FB0C633B-9063-4FD0-91E9-2810CF1C157A"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:3ED57AC4-296D-4C8D-9873-49C193F69BBA"/>
    <pav:lineageUri>urn:domeoserver:annotationset:76FD4BB5-DE2F-4FCA-B93D-302185B1A381</pav:lineageUri>
    <ao:item rdf:resource="urn:domeoclient:uuid:EC416A29-1315-42C5-90FA-652412A6AD12"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:16393981-08BF-477D-ACB9-8FB804E50D0C"/>
    <ao:annotatesResource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-155.txt.html</ao:annotatesResource>
    <ao:item rdf:resource="urn:domeoclient:uuid:FA4C8A6E-17D4-47F8-A369-67AF061E9037"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:3B85AE85-A07C-4614-91F5-52EF7A4737DF">
    <pav:lineageUri>urn:domeoserver:annotation:3BDF4B68-5BF9-4914-96AA-D5E7665E8769</pav:lineageUri>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812eda990003</pav:createdBy>
    <pav:createdOn>2014-07-07 11:22:56 -0400</pav:createdOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <domeo:belongsToSet>urn:domeoserver:annotationset:7AACEF8D-2EBC-4F0B-94B2-190650E562F6</domeo:belongsToSet>
    <domeo:belongsToSet>urn:domeoserver:annotationset:22ED7220-C6F6-43C5-9DF9-89F62F0F8E27</domeo:belongsToSet>
    <rdfs:label>Highlight</rdfs:label>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <domeo:belongsToSet>urn:domeoserver:annotationset:8F3CF3D9-AADE-4A86-BD42-2924B3D6A406</domeo:belongsToSet>
    <domeo:belongsToSet>urn:domeoserver:annotationset:131835A3-C655-4F91-97D4-52CAFF7B7CCA</domeo:belongsToSet>
    <pav:lastSavedOn>2014-07-07 11:24:52 -0400</pav:lastSavedOn>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <ao:context rdf:resource="urn:domeoclient:uuid:3E08DAB4-201F-48CD-8ACA-375750DA65B1"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:9C5170BD-B57E-4757-B143-AE7F2FE21CCC">
    <ao:suffix>and monoamine oxidase inhibitors has been observed, but caution in the use of any opioid in patients taking this class of drugs is appropriate.</ao:suffix>
    <domeo:uuid>9C5170BD-B57E-4757-B143-AE7F2FE21CCC</domeo:uuid>
    <pav:createdOn>2014-09-02 19:10:58 -0400</pav:createdOn>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:9C5170BD-B57E-4757-B143-AE7F2FE21CCC"/>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-72.txt.html</ao:hasSource>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:prefix>No specific interaction between </ao:prefix>
    <ao:exact>oxycodone </ao:exact>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:9FBD505E-822F-4348-AFE5-73B2A9104B24">
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-25.txt.html</ao:hasSource>
    <ao:exact>phenytoin </ao:exact>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <domeo:uuid>9FBD505E-822F-4348-AFE5-73B2A9104B24</domeo:uuid>
    <pav:createdOn>2014-07-21 21:26:48 -0400</pav:createdOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:suffix>dosing (200 mg daily, orally for 3 days followed by 250 mg intravenously for one dose) both with and without the administration of fluconazole (oral fluconazole 200 mg daily for 16 days) in 10 normal male volunteers. There was a significant increase in p</ao:suffix>
    <ao:prefix>AUC was determined after 4 days of </ao:prefix>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:9FBD505E-822F-4348-AFE5-73B2A9104B24"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoserver:annotationset:2914A3FD-DF43-4F78-999C-77CE7A028B19">
    <ao:item rdf:resource="urn:domeoclient:uuid:E2D1A706-CE7E-4379-97CF-4EE9CA384DB2"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:5CE56B1D-ACF0-4124-B31E-62EF1E11FED8"/>
    <pav:previousVersion>urn:domeoserver:annotationset:606A5B3F-B6FB-4279-AA42-7893CFC2D20C</pav:previousVersion>
    <ao:item rdf:resource="urn:domeoclient:uuid:D62F417A-98ED-4008-ADC4-F7EBC73F9F68"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:A75B59C8-60A9-4317-B506-9477A97901ED"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:5C77DFAE-836C-475E-BE78-637BCFAAA992"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:FF1FC131-57E9-4A89-8FBF-B786D1543F24"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:2506F4F5-773E-4CCD-8303-CC244D5848D1"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:6016855A-FC6C-4F50-BBD3-3126439782E9"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:398266C6-18B2-479E-8C00-4B3F67E7DB6D"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:9C9FE015-E10A-4124-9250-BA73B7E52470"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:52B64BE2-7636-4E5D-B162-D84F2D892E3D"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:2D0A6C88-E510-4AF5-8DFB-C35B1F919461"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:D693BC09-DDB8-454B-A812-E73AB798F6FA"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:E3C70535-C49A-4807-84DF-3951A0E27152"/>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <ao:item rdf:resource="urn:domeoclient:uuid:B1EDC65E-7D2E-4E9E-9D08-0D72BD366C29"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:F2F7D256-D331-45B3-9459-089EEB530262"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:71244950-C950-47EB-A32B-D2748E51EF60"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:5E8A53CD-1A4A-4A56-ABAA-82D073884595"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:FA96F07E-C088-44C7-AC16-D0EBD7DBD41D"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:37E9FF1C-D06E-42C3-944C-482813D8E38E"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:17DEFB36-51D5-4E3A-92CC-91E1F7EEAE4B"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:ED9A4881-5A44-4C07-BAFB-529340D632F3"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:0FDB999F-470E-431C-829C-F231318245D8"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:414AB21B-E61F-45BC-90CC-D10C8E784BF6"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:3E33C30E-6EC7-463F-A8C1-B699338A149B"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:B28EDC18-743D-4015-956F-B084F96B3589"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:585BED0D-5182-4D39-912D-F355B5BEA6BA"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:3077386C-E136-4431-9DB1-FC99BF18719B"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:AA680547-50B2-43E1-8768-6007654CDEF9"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:544614C5-3057-4129-841C-95DBCD1340A4"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:424F0823-B0B8-4327-8A43-69119A2195AC"/>
    <domeo:agents rdf:resource="urn:person:uuid:080e143046812afe0146812eda990003"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:44D9A897-A866-42BB-8DD9-A376BF8D1B3E"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:851EB41C-687B-464B-9105-16513BFE3A24"/>
    <pav:lineageUri>urn:domeoserver:annotationset:AB1741F1-5A5F-4416-AEAC-A544BCBB7D16</pav:lineageUri>
    <ao:item rdf:resource="urn:domeoclient:uuid:66A10386-3791-4236-BBA2-9E3AD59B847D"/>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812eda990003</pav:createdBy>
    <ao:item rdf:resource="urn:domeoclient:uuid:7616318E-C362-4BC0-B027-F84CBEA6207C"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:08556835-0438-4667-8B70-71388FA5E865"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#AnnotationSet"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:82628688-78B9-45FB-8BED-8C81D7B2F03E"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:6A67B256-CA48-48CA-B584-DB13E0D52B58"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:51F1BD01-1111-4CA2-BC77-65762E0E45AA"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:745E9BC2-9930-4FE0-83A2-11668B70C40A"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:7086D655-845E-4135-B24F-75B4FFD47BD0"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:4411E759-9248-468B-B2F6-E5A5A8657C4C"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:23AC6809-BABB-405A-80DE-630CA211B109"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:15050075-436C-4668-9987-03D689AE2236"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:C4558C3C-CC16-4A44-85EC-2AB4969F8A0D"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:E50BE5A6-0C68-4839-AB64-4D7AED50EDAC"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:D1F55052-16DF-4B25-AC16-7645C8E4AD77"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:446F532B-903F-4B10-9F56-9CC000DF6BDF"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:3D0D19A7-AA2E-4F5C-86E6-0B171A00A7B1"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:9D9E07C8-AA4D-4D08-897A-996E5C499CF6"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:CE897434-B9A6-4A1A-B7D2-C1748858051B"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:F895E903-9E93-41BD-BED1-2EA2CE628B45"/>
    <rdfs:label>Default Set</rdfs:label>
    <ao:item rdf:resource="urn:domeoclient:uuid:EF32B76C-C252-4DA7-9AC6-7FCD32EE9F83"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:AF68257F-3ADB-4BA4-9BD1-247F8428319E"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:6981279A-8AEC-4DEB-BDFB-296A4FDF471C"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:5C47D157-D8A4-4053-B2C7-7ECD1B16B721"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:D555EE88-9218-4AF9-81CC-40D543746D77"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:513FF3F1-4FCE-4790-A5C9-F75162D3687B"/>
    <domeo:agents rdf:resource="urn:domeo:software:id:Domeo-2.1alpha-050"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:292BF8EC-0E65-4E33-A331-3D217DD6B134"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:7015192E-CCA2-475B-8C8B-10870378056A"/>
    <pav:lastSavedOn>2014-07-22 19:54:59 -0400</pav:lastSavedOn>
    <pav:createdOn>2014-07-22 19:08:44 -0400</pav:createdOn>
    <ao:item rdf:resource="urn:domeoclient:uuid:669918DD-5E01-4F63-9C3C-FB4172F004FB"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:FBE8BF3F-CF31-4746-AE08-52B8B70D3AA7"/>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">7</pav:versionNumber>
    <ao:item rdf:resource="urn:domeoclient:uuid:37752019-6AF8-406B-9C87-6BCEF8ED7AAE"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:29694BD5-41F2-4693-A623-AABDC826F754"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:796FE422-C147-4AA7-A57F-067429194AA4"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:D519A3CD-A32C-4057-9BB6-FB2AE41AF4A9"/>
    <permissions:permissions rdf:nodeID="Ne8aaca3863a84ef5965d29d88f1e8ead"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:62F73A2A-2D49-4A1C-B836-1F3280DE6ACE"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:78A5F631-80CE-4FB1-974D-F82BE8D8E584"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:B6681C81-EA03-49F0-8187-EF5752C9D126"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:CF4B56FC-1048-4C85-AD05-E8D9C4F159CF"/>
    <dct:description>The default set is created automatically by Domeo when no other set is existing.</dct:description>
    <ao:item rdf:resource="urn:domeoclient:uuid:ECE7CA77-7E57-44B0-89AE-B78915FEC8C2"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:A68BF389-96D4-4F16-BF9D-C1BF35E3CE01"/>
    <domeo:deleted>false</domeo:deleted>
    <ao:item rdf:resource="urn:domeoclient:uuid:0A960BCB-9A9F-4998-9418-33D622C35F7C"/>
    <ao:annotatesResource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-123.txt.html</ao:annotatesResource>
    <ao:item rdf:resource="urn:domeoclient:uuid:6667DCF7-AA10-4999-B062-38650C90AEA5"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:15E1712B-2693-4DB6-A2FE-D2F158D3A823"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:8C53D58B-D2A3-4A8C-9924-E26E43A59105"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:2BB40EDC-DE0E-4B5E-AEE3-DCE89148115F"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:B61CCD79-538E-42B4-8232-5A3A92F4AC3F">
    <pav:previousVersion>urn:domeoclient:uuid:BED41F06-565A-4622-9A88-48810E5A28DE</pav:previousVersion>
    <pav:lineageUri>urn:domeoserver:annotationset:D1715BD2-BD41-46FD-9454-DC7A423A29AC</pav:lineageUri>
    <domeo:belongsToSet>urn:domeoserver:annotationset:A3F0B39A-4249-4B63-BB0D-F24A005066AC</domeo:belongsToSet>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812eda990003</pav:createdBy>
    <pav:lineageUri>urn:domeoserver:annotation:2F99BC00-D4C7-4AB3-979C-5498A7DFF5F8</pav:lineageUri>
    <pav:createdOn>2014-09-02 11:38:56 -0400</pav:createdOn>
    <ao:context rdf:resource="urn:domeoclient:uuid:A97D0542-D1E0-45E8-A59A-491B0F6B5ABF"/>
    <domeo:belongsToSet>urn:domeoserver:annotationset:3F546823-204F-4F9B-9006-3DC526C56931</domeo:belongsToSet>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">2</pav:versionNumber>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <rdfs:label>Highlight</rdfs:label>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <domeo:belongsToSet>urn:domeoserver:annotationset:A5DD001D-C81A-4E2E-B5E0-7A866B35E26B</domeo:belongsToSet>
    <pav:lastSavedOn>2014-09-02 11:46:58 -0400</pav:lastSavedOn>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:4F554D87-2148-4927-B2EE-B016ECABC1C6">
    <pav:lastSavedOn>2014-07-28 17:02:28 -0400</pav:lastSavedOn>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <ao:context rdf:resource="urn:domeoclient:uuid:46ACA9D3-9DB9-4318-BFF9-15A57F3153D1"/>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812eda990003</pav:createdBy>
    <pav:createdOn>2014-07-28 17:02:30 -0400</pav:createdOn>
    <rdfs:label>Highlight</rdfs:label>
    <domeo:belongsToSet>urn:domeoclient:uuid:A0E3203A-2AD3-4045-BAB8-27B340F81B0E</domeo:belongsToSet>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <pav:lineageUri>urn:domeoserver:annotation:BE32957F-9AE2-489B-96B6-1B02D0F5DB9A</pav:lineageUri>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:2F010F0A-45BC-4132-A685-857F72A4DCEC">
    <domeo:belongsToSet>urn:domeoserver:annotationset:3F546823-204F-4F9B-9006-3DC526C56931</domeo:belongsToSet>
    <pav:createdOn>2014-09-02 11:46:26 -0400</pav:createdOn>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <domeo:belongsToSet>urn:domeoserver:annotationset:A5DD001D-C81A-4E2E-B5E0-7A866B35E26B</domeo:belongsToSet>
    <ao:context rdf:resource="urn:domeoclient:uuid:9B40D027-2C99-4AA7-A143-A35EFB743189"/>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">2</pav:versionNumber>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812eda990003</pav:createdBy>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:previousVersion>urn:domeoclient:uuid:BED41F06-565A-4622-9A88-48810E5A28DE</pav:previousVersion>
    <pav:lastSavedOn>2014-09-02 11:46:59 -0400</pav:lastSavedOn>
    <pav:lineageUri>urn:domeoserver:annotation:EC260D90-6F67-4EA5-8C9A-944C0A5DCEFA</pav:lineageUri>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <rdfs:label>Highlight</rdfs:label>
    <pav:lastSavedOn>2014-09-02 11:46:58 -0400</pav:lastSavedOn>
    <pav:lineageUri>urn:domeoserver:annotationset:D1715BD2-BD41-46FD-9454-DC7A423A29AC</pav:lineageUri>
    <domeo:belongsToSet>urn:domeoserver:annotationset:A3F0B39A-4249-4B63-BB0D-F24A005066AC</domeo:belongsToSet>
    <pav:previousVersion>xsd:String</pav:previousVersion>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:36443C46-71EF-4792-ADF2-D6E6E248EFAA">
    <ao:exact>methotrexate</ao:exact>
    <domeo:uuid>36443C46-71EF-4792-ADF2-D6E6E248EFAA</domeo:uuid>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:36443C46-71EF-4792-ADF2-D6E6E248EFAA"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <pav:createdOn>2014-07-28 17:02:33 -0400</pav:createdOn>
    <ao:suffix> with concomitant hematologic and gastrointestinal toxicity have been observed with methotrexate. Use of methotrexate with penicillins should be carefully monitored.</ao:suffix>
    <ao:prefix>; increased serum concentrations of </ao:prefix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-166.txt.html</ao:hasSource>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:E415356D-7B99-400C-A966-58BF2ADC3FC9">
    <ao:prefix> 20 mg in patients stabilized on </ao:prefix>
    <domeo:uuid>E415356D-7B99-400C-A966-58BF2ADC3FC9</domeo:uuid>
    <pav:createdOn>2014-09-02 11:57:35 -0400</pav:createdOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:exact>risperidone</ao:exact>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:E415356D-7B99-400C-A966-58BF2ADC3FC9"/>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-47.txt.html</ao:hasSource>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:suffix> (4 to 8 mg/day) increased mean plasma concentrations of risperidone approximately 4-fold, decreased 9-hydroxyrisperidone concentrations approximately 10%, and increased concentrations of the active moiety (the sum of risperidone plus 9-hydroxyrisperidon</ao:suffix>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:74FDA5BD-9C18-4F10-AC59-C5C75AA497C2">
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812eda990003</pav:createdBy>
    <domeo:belongsToSet>urn:domeoserver:annotationset:131835A3-C655-4F91-97D4-52CAFF7B7CCA</domeo:belongsToSet>
    <ao:context rdf:resource="urn:domeoclient:uuid:F0CCA954-EB0E-4D16-9B00-C1E4BE4A989D"/>
    <pav:createdOn>2014-07-07 11:24:14 -0400</pav:createdOn>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <pav:lineageUri>urn:domeoserver:annotation:5CD942C6-D369-4ED6-B77B-FB216085FF48</pav:lineageUri>
    <domeo:belongsToSet>urn:domeoserver:annotationset:8F3CF3D9-AADE-4A86-BD42-2924B3D6A406</domeo:belongsToSet>
    <domeo:belongsToSet>urn:domeoserver:annotationset:7AACEF8D-2EBC-4F0B-94B2-190650E562F6</domeo:belongsToSet>
    <rdfs:label>Highlight</rdfs:label>
    <pav:lastSavedOn>2014-07-07 11:24:52 -0400</pav:lastSavedOn>
    <domeo:belongsToSet>urn:domeoserver:annotationset:22ED7220-C6F6-43C5-9DF9-89F62F0F8E27</domeo:belongsToSet>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
  </rdf:Description>
  <rdf:Description rdf:nodeID="Nbefeb89c55ad42fcaa10ca450e0e6e1a">
    <domeo:sets rdf:resource="urn:pddi:uuid:76B24ED1-159D-4411-BD4C-8033557FAD2B"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:5A221420-4081-46A9-839D-6DA46028DA4B">
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:suffix> may be administered with or without food.</ao:suffix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:prefix> with food resulted in no change in overall exposure (AUC), but there was an approximately 28% decrease in Cmax and a delay in Tmax (1.75 hours). These changes are not likely to be clinically significant; therefore, </ao:prefix>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:5A221420-4081-46A9-839D-6DA46028DA4B"/>
    <pav:createdOn>2014-07-22 19:25:31 -0400</pav:createdOn>
    <ao:exact>AVANDIA</ao:exact>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-123.txt.html</ao:hasSource>
    <domeo:uuid>5A221420-4081-46A9-839D-6DA46028DA4B</domeo:uuid>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:E7907DD5-4FA4-4B5A-99D9-9D24B76931C6">
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <domeo:belongsToSet>urn:domeoserver:annotationset:8F3CF3D9-AADE-4A86-BD42-2924B3D6A406</domeo:belongsToSet>
    <pav:createdOn>2014-07-07 11:22:37 -0400</pav:createdOn>
    <pav:lastSavedOn>2014-07-07 11:24:52 -0400</pav:lastSavedOn>
    <pav:lineageUri>urn:domeoserver:annotation:4A784235-A949-4FFD-9438-52955B529B7A</pav:lineageUri>
    <domeo:belongsToSet>urn:domeoserver:annotationset:131835A3-C655-4F91-97D4-52CAFF7B7CCA</domeo:belongsToSet>
    <ao:context rdf:resource="urn:domeoclient:uuid:1D92FA7B-3CB7-4C89-9E21-9980B649BC2E"/>
    <domeo:belongsToSet>urn:domeoserver:annotationset:22ED7220-C6F6-43C5-9DF9-89F62F0F8E27</domeo:belongsToSet>
    <domeo:belongsToSet>urn:domeoserver:annotationset:7AACEF8D-2EBC-4F0B-94B2-190650E562F6</domeo:belongsToSet>
    <rdfs:label>Highlight</rdfs:label>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812eda990003</pav:createdBy>
  </rdf:Description>
  <rdf:Description rdf:nodeID="Nf6efef1f45f246cf8cac6755eaf1ba48">
    <permissions:accessType>urn:domeo:access:public</permissions:accessType>
    <permissions:isLocked>false</permissions:isLocked>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:B8D94772-B85A-452F-91A5-C644F8298C08">
    <rdfs:label>Highlight</rdfs:label>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:lastSavedOn>2014-07-07 10:02:41 -0400</pav:lastSavedOn>
    <domeo:belongsToSet>urn:domeoserver:annotationset:08C0C288-6DF4-43E6-A618-71A8BB9563C3</domeo:belongsToSet>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:lineageUri>urn:domeoserver:annotation:34C83714-44E7-4047-8688-163A67040E44</pav:lineageUri>
    <domeo:belongsToSet>urn:domeoserver:annotationset:131835A3-C655-4F91-97D4-52CAFF7B7CCA</domeo:belongsToSet>
    <domeo:belongsToSet>urn:domeoserver:annotationset:7AACEF8D-2EBC-4F0B-94B2-190650E562F6</domeo:belongsToSet>
    <domeo:belongsToSet>urn:domeoserver:annotationset:8F3CF3D9-AADE-4A86-BD42-2924B3D6A406</domeo:belongsToSet>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <domeo:belongsToSet>urn:domeoserver:annotationset:22ED7220-C6F6-43C5-9DF9-89F62F0F8E27</domeo:belongsToSet>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812eda990003</pav:createdBy>
    <pav:createdOn>2014-07-07 09:58:55 -0400</pav:createdOn>
    <ao:context rdf:resource="urn:domeoclient:uuid:7E8BEB68-80C9-4767-BEC0-5810B8C956C0"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:851EB41C-687B-464B-9105-16513BFE3A24">
    <pav:previousVersion>urn:domeoserver:annotationset:467D4F28-D086-4217-9DE0-23E165F30716</pav:previousVersion>
    <pav:createdOn>2014-07-22 19:24:53 -0400</pav:createdOn>
    <pav:lineageUri>urn:domeoserver:annotationset:AB1741F1-5A5F-4416-AEAC-A544BCBB7D16</pav:lineageUri>
    <domeo:belongsToSet>urn:domeoserver:annotationset:7021B883-FD5C-4083-BD87-DF56D3C87633</domeo:belongsToSet>
    <domeo:belongsToSet>urn:domeoserver:annotationset:2914A3FD-DF43-4F78-999C-77CE7A028B19</domeo:belongsToSet>
    <rdfs:label>Highlight</rdfs:label>
    <pav:lastSavedOn>2014-07-22 19:28:02 -0400</pav:lastSavedOn>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <ao:context rdf:resource="urn:domeoclient:uuid:19DF8C99-A2F9-40E1-9BC9-0D4A0531A57A"/>
    <domeo:belongsToSet>urn:domeoserver:annotationset:514BA51B-D734-4003-A7C3-F03C0F95833A</domeo:belongsToSet>
    <domeo:belongsToSet>urn:domeoserver:annotationset:7E80543E-BF76-4514-92A9-91458DCB802B</domeo:belongsToSet>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <domeo:belongsToSet>urn:domeoserver:annotationset:F272A789-69D0-47CC-8CC9-F25C55B91261</domeo:belongsToSet>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812eda990003</pav:createdBy>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <domeo:belongsToSet>urn:domeoserver:annotationset:606A5B3F-B6FB-4279-AA42-7893CFC2D20C</domeo:belongsToSet>
    <pav:lineageUri>urn:domeoserver:annotation:1A900CEC-F807-4CCD-8663-AB49ABB282ED</pav:lineageUri>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">3</pav:versionNumber>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:BE5B91CD-CF9E-4980-B001-64C0D34FB3CE">
    <ao:prefix> (4 to 8 mg/day) increased mean plasma concentrations of </ao:prefix>
    <pav:createdOn>2014-09-02 12:03:19 -0400</pav:createdOn>
    <ao:exact>risperidone</ao:exact>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-47.txt.html</ao:hasSource>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:suffix> approximately 4-fold, decreased 9-hydroxyrisperidone concentrations approximately 10%, and increased concentrations of the active moiety (the sum of risperidone plus 9-hydroxyrisperidone) approximately 1.4-fold. The effect of paroxetine on the pharmacok</ao:suffix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <domeo:uuid>BE5B91CD-CF9E-4980-B001-64C0D34FB3CE</domeo:uuid>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:BE5B91CD-CF9E-4980-B001-64C0D34FB3CE"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:13D07A15-03D1-462A-AFD2-4B5FC8458177">
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:lastSavedOn>2014-07-22 20:22:38 -0400</pav:lastSavedOn>
    <rdfs:label>expertstudy Annotation</rdfs:label>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#expertstudyAnnotation"/>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812eda990003</pav:createdBy>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <ao:body rdf:nodeID="N7f50465193fa40bb98a3df058c623458"/>
    <pav:createdOn>2014-07-22 20:21:10 -0400</pav:createdOn>
    <domeo:belongsToSet>urn:domeoserver:annotationset:F272A789-69D0-47CC-8CC9-F25C55B91261</domeo:belongsToSet>
    <ao:context rdf:resource="urn:domeoclient:uuid:DB2B2DE0-2BB6-4F47-A9DF-A6326E16D770"/>
    <pav:lineageUri>urn:domeoserver:annotation:B65D7AE8-6335-4BF0-A6DD-B4D7C6287875</pav:lineageUri>
    <pav:previousVersion>xsd:String</pav:previousVersion>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:7B342FF2-047C-4302-8F5E-8EED89D8C32D">
    <pav:createdOn>2014-07-22 19:55:20 -0400</pav:createdOn>
    <ao:exact>Digoxin</ao:exact>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <domeo:uuid>7B342FF2-047C-4302-8F5E-8EED89D8C32D</domeo:uuid>
    <ao:suffix>xsd:String</ao:suffix>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:7B342FF2-047C-4302-8F5E-8EED89D8C32D"/>
    <ao:prefix>xsd:String</ao:prefix>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-123.txt.html</ao:hasSource>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoserver:annotationset:08C0C288-6DF4-43E6-A618-71A8BB9563C3">
    <domeo:deleted>false</domeo:deleted>
    <ao:item rdf:resource="urn:domeoclient:uuid:42423629-C409-4AD4-BBE6-7C86A696F03E"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:2093FF56-689E-4246-AF69-F566860B27BF"/>
    <dct:description>The default set is created automatically by Domeo when no other set is existing.</dct:description>
    <ao:item rdf:resource="urn:domeoclient:uuid:32B1CD5D-3CD7-4D5E-BD76-57F6F0A9480A"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:137A1951-AA86-4074-9581-B011801B955F"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:BDA75ADA-742A-402B-AE97-4438F99C61FC"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:F3C4287B-36A9-48BF-8081-A39BEF5F3C51"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:2CF891F7-2E96-4382-8EDB-5C061E8E1AFA"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:1F12731E-6D41-4E27-83E3-C87822424FCA"/>
    <rdfs:label>Default Set</rdfs:label>
    <ao:item rdf:resource="urn:domeoclient:uuid:FA4C8A6E-17D4-47F8-A369-67AF061E9037"/>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <ao:item rdf:resource="urn:domeoclient:uuid:3ED57AC4-296D-4C8D-9873-49C193F69BBA"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:FA428F64-D782-46F5-B866-2FBC24D3F4F8"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:697C8F03-1543-4427-9D85-7967FCEA3100"/>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812eda990003</pav:createdBy>
    <ao:item rdf:resource="urn:domeoclient:uuid:CE16BF01-AD42-444E-9A68-FEF6AED26815"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:E13140FE-59B4-45B2-A524-CAED051C4F9D"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:8ABD9FDA-0F08-474A-A9C8-437A5346F2AC"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:C8D05CE4-8287-449A-8921-AFACBAEE2002"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:02D92735-6D44-4DFA-A2E9-75A5A3D4DCF9"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:3762570C-CF43-4DB9-B163-FAA6DAE60017"/>
    <domeo:agents rdf:resource="urn:person:uuid:080e143046812afe0146812eda990003"/>
    <pav:lastSavedOn>2014-07-07 10:02:41 -0400</pav:lastSavedOn>
    <ao:item rdf:resource="urn:domeoclient:uuid:5D480921-AA61-499B-9C3F-3043269104B4"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:B9E21C61-063D-4F80-8E08-85865B387669"/>
    <pav:lineageUri>urn:domeoserver:annotationset:76FD4BB5-DE2F-4FCA-B93D-302185B1A381</pav:lineageUri>
    <ao:item rdf:resource="urn:domeoclient:uuid:6588D45E-2F4C-40CF-8AF4-0CD621F484E1"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:6FD9D48D-F639-4F09-ABA6-F4B259681453"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:B5E75366-F0BF-442F-852E-19C5EDDC84EE"/>
    <domeo:agents rdf:resource="urn:domeo:software:id:Domeo-2.1alpha-050"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#AnnotationSet"/>
    <permissions:permissions rdf:nodeID="N672f966abc88436087a9cc1f6f77d772"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:54B9529D-9030-4194-B66A-D7ECCBABED1F"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:DC9FB0B5-1564-4BF2-A4E4-4D05B0A1AB86"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:2F71B86E-3B80-4813-9F00-A9E3E6B30C9E"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:0B2918C2-A28D-40C3-8147-F19D09B7119C"/>
    <ao:annotatesResource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-155.txt.html</ao:annotatesResource>
    <ao:item rdf:resource="urn:domeoclient:uuid:17E64297-0A57-4C9B-94C4-18ED1956FCF7"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:E76B5D64-7248-4EBD-A023-3820BFDEFD26"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:EC416A29-1315-42C5-90FA-652412A6AD12"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:08713DDF-0935-4B63-B281-AEE56A8D7628"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:DE5C582E-1F4C-478C-9DDC-DAB4C0C1ABFF"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:2ABA1A35-6C77-4A0A-9EC5-109AA13136B6"/>
    <pav:createdOn>2014-07-07 09:34:12 -0400</pav:createdOn>
    <ao:item rdf:resource="urn:domeoclient:uuid:16393981-08BF-477D-ACB9-8FB804E50D0C"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:B8D94772-B85A-452F-91A5-C644F8298C08"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:222C9B55-A770-41C7-AF04-566E7C7A1DBC"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:F9FE917E-CAFF-4C8B-B16B-BB0606212145"/>
    <pav:previousVersion>urn:domeoclient:uuid:FCA2BF23-0BE3-409F-9177-761812F96097</pav:previousVersion>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">2</pav:versionNumber>
    <ao:item rdf:resource="urn:domeoclient:uuid:9BD9047F-C1DA-4B64-92B7-4D031972C9CF"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:FB0C633B-9063-4FD0-91E9-2810CF1C157A"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:2F0C7C89-516F-4D00-BAAB-BA2950277705">
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:2F0C7C89-516F-4D00-BAAB-BA2950277705"/>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-74.txt.html</ao:hasSource>
    <ao:prefix> is not normally required. However, in patients with Zollinger-Ellison syndrome, who may require higher doses up to 240 mg/day, dose adjustment may be considered. When </ao:prefix>
    <pav:createdOn>2014-09-02 19:16:07 -0400</pav:createdOn>
    <ao:exact>voriconazole</ao:exact>
    <ao:suffix> (400 mg Q12h x 1 day, then 200 mg x 6 days) was given with omeprazole (40 mg once daily x 7 days) to healthy subjects, it significantly increased the steady-state Cmax and AUC0-24 of omeprazole, an average of 2 times (90% CI: 1.8, 2.6) and 4 times (90% </ao:suffix>
    <domeo:uuid>2F0C7C89-516F-4D00-BAAB-BA2950277705</domeo:uuid>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:B427C906-5D72-43EE-85C9-4D7F3117059B">
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:createdOn>2014-09-02 11:39:51 -0400</pav:createdOn>
    <domeo:belongsToSet>urn:domeoserver:annotationset:3F546823-204F-4F9B-9006-3DC526C56931</domeo:belongsToSet>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812eda990003</pav:createdBy>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">2</pav:versionNumber>
    <ao:context rdf:resource="urn:domeoclient:uuid:1B45944E-9180-4FB2-9DC0-7DC156F7508B"/>
    <domeo:belongsToSet>urn:domeoserver:annotationset:A3F0B39A-4249-4B63-BB0D-F24A005066AC</domeo:belongsToSet>
    <domeo:belongsToSet>urn:domeoserver:annotationset:A5DD001D-C81A-4E2E-B5E0-7A866B35E26B</domeo:belongsToSet>
    <rdfs:label>Highlight</rdfs:label>
    <pav:previousVersion>urn:domeoclient:uuid:BED41F06-565A-4622-9A88-48810E5A28DE</pav:previousVersion>
    <pav:lastSavedOn>2014-09-02 11:46:58 -0400</pav:lastSavedOn>
    <pav:lineageUri>urn:domeoserver:annotation:47D08B75-5D1C-4A8A-BE40-8EDC0F5FE580</pav:lineageUri>
    <pav:lineageUri>urn:domeoserver:annotationset:D1715BD2-BD41-46FD-9454-DC7A423A29AC</pav:lineageUri>
    <pav:previousVersion>xsd:String</pav:previousVersion>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:14F32A7A-80E4-454D-A47D-8CEAFB294984">
    <pav:createdOn>2014-07-24 20:04:30 -0400</pav:createdOn>
    <pav:lineageUri>urn:domeoserver:annotation:4D9D276D-5B47-405C-A464-29D3E3246BAC</pav:lineageUri>
    <rdfs:label>expertstudy Annotation</rdfs:label>
    <domeo:belongsToSet>urn:domeoclient:uuid:F70AB841-7C14-48D1-B543-A45EA067C642</domeo:belongsToSet>
    <ao:body rdf:nodeID="Nf4e755f2a5f848cea2dfc20df09619d1"/>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812eda990003</pav:createdBy>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#expertstudyAnnotation"/>
    <ao:context rdf:resource="urn:domeoclient:uuid:14E49F07-F26F-4932-B80D-AB20FFEFDB12"/>
    <pav:lastSavedOn>2014-07-24 20:04:12 -0400</pav:lastSavedOn>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:8AC4DB85-84A2-4639-9224-724D4B50FC4B">
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:exact>ithium</ao:exact>
    <pav:createdOn>2014-09-02 11:39:59 -0400</pav:createdOn>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:8AC4DB85-84A2-4639-9224-724D4B50FC4B"/>
    <ao:prefix>: As with other serotonergic drugs, l</ao:prefix>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-9.txt.html</ao:hasSource>
    <domeo:uuid>8AC4DB85-84A2-4639-9224-724D4B50FC4B</domeo:uuid>
    <ao:suffix> may enhance the serotonergic effects of fluvoxamine and, therefore, the combination should be used with caution. Seizures have been reported with the coadministration of fluvoxamine maleate and lithium.</ao:suffix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:D23F4554-62F9-4BD8-A750-B7F24EF0C57E">
    <ao:prefix>xsd:String</ao:prefix>
    <domeo:uuid>D23F4554-62F9-4BD8-A750-B7F24EF0C57E</domeo:uuid>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-123.txt.html</ao:hasSource>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:D23F4554-62F9-4BD8-A750-B7F24EF0C57E"/>
    <pav:createdOn>2014-07-22 19:38:36 -0400</pav:createdOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:exact>rosiglitazone.</ao:exact>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:suffix>xsd:String</ao:suffix>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:F263AADA-7E42-4AA1-B33C-9D0E2B21A723">
    <pav:createdOn>2014-09-02 11:54:18 -0400</pav:createdOn>
    <ao:exact>In a study of 13 healthy, male volunteers, a single 40 mg dose of tacrine added to fluvoxamine 100 mg/day administered at steady-state was associated with five- and eight-fold increases in tacrine Cmax and AUC, respectively, compared to the administration of tacrine alone. Five subjects experienced nausea, vomiting, sweating, and diarrhea following coadministration, consistent with the cholinergic effects of tacrine.</ao:exact>
    <ao:suffix>xsd:String</ao:suffix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:F263AADA-7E42-4AA1-B33C-9D0E2B21A723"/>
    <ao:prefix>: </ao:prefix>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-9.txt.html</ao:hasSource>
    <domeo:uuid>F263AADA-7E42-4AA1-B33C-9D0E2B21A723</domeo:uuid>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:BED41F06-565A-4622-9A88-48810E5A28DE">
    <domeo:agents rdf:resource="urn:domeo:software:id:Domeo-2.1alpha-050"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:EAC57EB3-DF7D-46DD-AE24-159494F820F5"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:0C6D1C88-D003-4F29-8AF2-F22A03983530"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:0DC1E786-48C0-4894-B615-AFA91FDAC5BD"/>
    <pav:createdOn>2014-09-02 11:30:03 -0400</pav:createdOn>
    <domeo:deleted>false</domeo:deleted>
    <ao:annotatesResource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-9.txt.html</ao:annotatesResource>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812eda990003</pav:createdBy>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <ao:item rdf:resource="urn:domeoclient:uuid:C6F74A83-2371-401E-B276-117735065820"/>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#AnnotationSet"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:08E3A94E-69BC-45F8-943D-0AE85FC3257B"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:393FB1C5-F66E-42C6-AA25-436EBF20214E"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:1F561698-D9D5-496E-A7E9-97BDA5059FED"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:1295B95D-9BC5-45F6-8E74-F4D1E052F64C"/>
    <dct:description>The default set is created automatically by Domeo when no other set is existing.</dct:description>
    <ao:item rdf:resource="urn:domeoclient:uuid:43D41023-3393-411C-B3B2-FDFDACB25B35"/>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <rdfs:label>Default Set</rdfs:label>
    <pav:lineageUri>urn:domeoserver:annotationset:D1715BD2-BD41-46FD-9454-DC7A423A29AC</pav:lineageUri>
    <ao:item rdf:resource="urn:domeoclient:uuid:F7DD29E8-1783-4BA7-A529-9EF0B60D8F39"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:FB5478ED-0329-4EF5-88A8-06C125D68B2A"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:87135DB6-D4F3-4808-BE76-D891C704525E"/>
    <domeo:agents rdf:resource="urn:person:uuid:080e143046812afe0146812eda990003"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:53FAB419-4FF7-440E-89DD-64411826800A"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:B572D091-3712-43AD-B485-3E1311449FAA"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:2BBB51CD-8D17-4DE2-B300-ED38485DEA33"/>
    <permissions:permissions rdf:nodeID="N37626d7c9c104850ba69b8f6d816e599"/>
    <pav:lastSavedOn>2014-09-02 11:35:33 -0400</pav:lastSavedOn>
    <ao:item rdf:resource="urn:domeoclient:uuid:82B09581-5976-41FA-8F72-66B1E36C8544"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:F0A9334D-2A9F-4B70-AC7A-5A574EACCA65"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:C84DD53D-5B64-47C5-92EE-E2D0E78BD754">
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <domeo:uuid>C84DD53D-5B64-47C5-92EE-E2D0E78BD754</domeo:uuid>
    <ao:suffix> is extensively metabolized in the liver. The main metabolic pathway is through hydroxylation of risperidone to 9-hydroxyrisperidone by the enzyme, CYP 2D6. A minor metabolic pathway is through N-dealkylation. The main metabolite, 9-hydroxyrisperidone, h</ao:suffix>
    <pav:createdOn>2014-07-13 11:11:55 -0400</pav:createdOn>
    <ao:prefix>Metabolism and Drug Interactions: </ao:prefix>
    <ao:exact>Risperidone</ao:exact>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-8.txt.html</ao:hasSource>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:C84DD53D-5B64-47C5-92EE-E2D0E78BD754"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:D344866F-87DE-4A61-99C8-1624A36AC49E">
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-139.txt.html</ao:hasSource>
    <ao:exact>In healthy adult subjects, administration of 120 mg of fexofenadine hydrochloride (2 × 60 mg capsule) within 15 minutes of an aluminum and magnesium containing antacid (Maalox®1) decreased fexofenadine AUC by 41% and Cmax by 43%.</ao:exact>
    <ao:prefix> containing antacids. </ao:prefix>
    <pav:createdOn>2014-07-24 20:06:55 -0400</pav:createdOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <domeo:uuid>D344866F-87DE-4A61-99C8-1624A36AC49E</domeo:uuid>
    <ao:suffix>xsd:String</ao:suffix>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:D344866F-87DE-4A61-99C8-1624A36AC49E"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:7882D277-8513-479D-B463-EFE36E633410">
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:suffix>and voriconazole (a combined inhibitor of CYP2C19 and CYP3A4) resulted in more than doubling of the omeprazole exposure. Dose adjustment of omeprazole is not normally required. However, in patients with Zollinger-Ellison syndrome, who may require higher </ao:suffix>
    <domeo:uuid>7882D277-8513-479D-B463-EFE36E633410</domeo:uuid>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:7882D277-8513-479D-B463-EFE36E633410"/>
    <pav:createdOn>2014-09-02 19:13:48 -0400</pav:createdOn>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-74.txt.html</ao:hasSource>
    <ao:exact>omeprazole </ao:exact>
    <ao:prefix>Concomitant administration of </ao:prefix>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoserver:annotationset:A3F0B39A-4249-4B63-BB0D-F24A005066AC">
    <ao:item rdf:resource="urn:domeoclient:uuid:8786A121-1479-4E39-A0A4-280F6167DD01"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:B61CCD79-538E-42B4-8232-5A3A92F4AC3F"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:95D28FFB-FF92-495E-92BC-C2E25FBE02B1"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:CE03C8BC-514A-4589-B370-5BBCAFD1AFE7"/>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">4</pav:versionNumber>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812eda990003</pav:createdBy>
    <ao:item rdf:resource="urn:domeoclient:uuid:CFBF6FAC-1B25-458D-A6E1-4DFEB8A3FAC9"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:B837C05B-2090-4797-A3CF-E78BA29EF167"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:60DDCB17-0D44-46B0-8348-C078AAECFF80"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:CFB0CA51-827C-4CBB-9914-266A69F0AB0B"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:1236F221-49FC-4683-9E78-9A4C14E7DA9F"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:EAC57EB3-DF7D-46DD-AE24-159494F820F5"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:C6F74A83-2371-401E-B276-117735065820"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:C8AD4F27-4001-4A0B-9D27-50063C65337E"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:2F010F0A-45BC-4132-A685-857F72A4DCEC"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:A3ECFEEE-C693-4117-91FB-027FB8CFC391"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:59DF3B57-4013-45C3-9A3F-23E01D7020B8"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:00672751-8DEF-4963-8AA5-6205618296C1"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:1D1D462E-3009-4EB1-A982-ED88FF1CE34A"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:537EDFBD-E119-4A09-B40F-63E4648698FE"/>
    <dct:description>The default set is created automatically by Domeo when no other set is existing.</dct:description>
    <ao:item rdf:resource="urn:domeoclient:uuid:9A355239-7CF3-43F5-B979-1B59EE6C6121"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:B6024659-1A02-4A19-8ED3-F29F4A70681F"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:00D416DF-EC2B-4E10-8956-D09B3C52D5E6"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:0F8D75BE-6E65-4B3E-AA75-B1FF492AC889"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:140EFF4D-9D91-427D-B48B-7B1FAFA2E5CF"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:0BE2F54A-5A28-4297-82E1-2B83EE8D882C"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:74C8573C-609D-4268-8133-F0B2749E0A1E"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:53C71D4E-A625-4012-ABC4-932105C30699"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:DD921AA0-5FC8-4BE9-AAB8-13B1D92E1958"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:288BDA0B-5368-42DA-BCF5-4D9F229E72D5"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:FB5478ED-0329-4EF5-88A8-06C125D68B2A"/>
    <pav:lastSavedOn>2014-09-02 11:54:50 -0400</pav:lastSavedOn>
    <ao:item rdf:resource="urn:domeoclient:uuid:CAAFBBB8-299E-4407-AECC-19F6B511D24C"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:41AFFAD3-B330-44BA-91A6-EFE69C07C0A2"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:44246EE4-6542-429C-AE56-DA84A2FDC57F"/>
    <pav:createdOn>2014-09-02 11:30:03 -0400</pav:createdOn>
    <ao:item rdf:resource="urn:domeoclient:uuid:15142045-DA2F-4022-9FF7-3D0277BDC3FB"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:E24CDAFA-738D-436F-8EA5-33584022000D"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:3EA9FD84-7972-4F14-ACAC-44E7B91CD0C2"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:0DEE6C6F-A6F1-480F-B422-0E55E610EAAB"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:58271A45-7CE7-4B20-8F9F-82D4B6DD0D74"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:85EED099-46E9-43C2-A412-DB4141880448"/>
    <rdfs:label>Default Set</rdfs:label>
    <ao:item rdf:resource="urn:domeoclient:uuid:8EE2A094-F107-44EE-921E-0C729A88F5DB"/>
    <pav:lineageUri>urn:domeoserver:annotationset:D1715BD2-BD41-46FD-9454-DC7A423A29AC</pav:lineageUri>
    <ao:item rdf:resource="urn:domeoclient:uuid:53FAB419-4FF7-440E-89DD-64411826800A"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:E15B413C-BEDB-4A09-B61C-CC07F96666DD"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:26C8F2D4-9063-4B38-ABF2-AC4FA32AD27F"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:8A033E70-6D84-4601-985E-2D559145926B"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#AnnotationSet"/>
    <domeo:agents rdf:resource="urn:domeo:software:id:Domeo-2.1alpha-050"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:1F561698-D9D5-496E-A7E9-97BDA5059FED"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:3B664870-D5A4-43DD-8990-228B68AA60AA"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:CA91EE4A-7D39-4CC0-A25E-E5ACA358E916"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:F7DD29E8-1783-4BA7-A529-9EF0B60D8F39"/>
    <ao:annotatesResource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-9.txt.html</ao:annotatesResource>
    <domeo:agents rdf:resource="urn:person:uuid:080e143046812afe0146812eda990003"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:4A624918-A90F-4845-8DFE-C35AFD8B0B68"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:7DC48B58-6464-4FBE-B643-CA178DD552DB"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:B427C906-5D72-43EE-85C9-4D7F3117059B"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:6950FFA4-1583-4644-99BE-7BD0F0C06B95"/>
    <pav:previousVersion>urn:domeoserver:annotationset:A5DD001D-C81A-4E2E-B5E0-7A866B35E26B</pav:previousVersion>
    <ao:item rdf:resource="urn:domeoclient:uuid:1295B95D-9BC5-45F6-8E74-F4D1E052F64C"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:393FB1C5-F66E-42C6-AA25-436EBF20214E"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:8041B2EF-1040-472F-A3E7-DC65F8159B41"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:08E3A94E-69BC-45F8-943D-0AE85FC3257B"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:9BAD39B9-2A3E-47D0-84C7-BB409378B51D"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:2C5969D2-1348-44AF-8DA9-7B96D70B4770"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:87135DB6-D4F3-4808-BE76-D891C704525E"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:F282170D-9AEA-4BD9-A758-9130391568F0"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:209C377C-FE31-4FA5-9168-BD0E96D0F448"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:70EB0C27-A6B8-49A5-94CD-7CCF2755C633"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:DBA99B4F-F7DB-4460-981A-81817F4BFE98"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:2D67B7C7-76F8-4FFD-A468-49E9E07064A4"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:0DC1E786-48C0-4894-B615-AFA91FDAC5BD"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:F0A9334D-2A9F-4B70-AC7A-5A574EACCA65"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:43D41023-3393-411C-B3B2-FDFDACB25B35"/>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <ao:item rdf:resource="urn:domeoclient:uuid:6793D5D8-D5E4-4015-B012-93740E224E6E"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:A512929D-5410-4D52-AEA7-F2E68A62A9E8"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:581B1F88-8814-40C0-9F72-77FEA7E30122"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:69354CBD-D372-4AD9-A6F1-93E07CA4D048"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:5E25E6A4-046A-49AF-B686-005D1B9BE5EC"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:093D643B-E7AF-49BD-BBEA-F13CDCDAD6C4"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:82B09581-5976-41FA-8F72-66B1E36C8544"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:0C6D1C88-D003-4F29-8AF2-F22A03983530"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:B206386D-9F43-45A3-96CA-50B346B26C4D"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:8613E32B-563F-4611-BA22-4DC13243CFD4"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:2BBB51CD-8D17-4DE2-B300-ED38485DEA33"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:D4CA3DCD-82EA-464C-8F9A-1D04DCECE7B6"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:7292F6B8-8DF2-4158-91E5-6FA4A069D796"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:0D270EDF-E644-45EB-9C94-B02DA5C51002"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:643EA9F8-ED1A-479B-9B59-6A63D55F43F7"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:0F702DA3-314E-4514-A96E-ADDF64264F59"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:E4B6A541-B29F-419F-88B1-22F770341BFA"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:04AF0456-B803-4275-972A-36BD0F6352B7"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:A3DAB1A6-C48D-422B-A0D0-776352B4CC3F"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:B572D091-3712-43AD-B485-3E1311449FAA"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:50C0FDF6-70A1-4B64-8F05-01088227E5AD"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:40AC1621-7CDD-45E4-98D3-4DE403F588CE"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:7B307336-ED36-40F6-8DED-B26488A43FD4"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:31254608-CDC4-4553-A278-115226EC9264"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:A3D1E36E-124A-4042-BB9B-6A358D1F3E3B"/>
    <domeo:deleted>false</domeo:deleted>
    <ao:item rdf:resource="urn:domeoclient:uuid:EA587655-D235-49D2-9724-0AEBB3E5E13B"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:E2CEC4DC-B35C-4F1A-8ACA-017FE944131C"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:06B4510C-85BF-4E4A-AA80-BA9BF3139105"/>
    <permissions:permissions rdf:nodeID="N5e591169c55e4fee81fc72353a06ce87"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:6EAB4BAE-C8C3-48B7-AC36-EFE4C7088448"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:9E45A71F-507C-47A7-A012-D482CF4059D6"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:02AA319D-AB4A-42F1-B73D-EF0CC9D22427">
    <ao:prefix> maleate tablets, a reduction in the initial beta-blocker dose and more cautious dose titration are recommended. No dosage adjustment is required for </ao:prefix>
    <pav:createdOn>2014-09-02 11:46:12 -0400</pav:createdOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:suffix> maleate tablets.</ao:suffix>
    <domeo:uuid>02AA319D-AB4A-42F1-B73D-EF0CC9D22427</domeo:uuid>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-9.txt.html</ao:hasSource>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:02AA319D-AB4A-42F1-B73D-EF0CC9D22427"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:exact>fluvoxamine</ao:exact>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:A05ABC03-57B2-463F-8733-BF02DB5FE3A7">
    <pav:lineageUri>urn:domeoserver:annotationset:C5DEBC9B-77EE-4243-88EB-DBC19737ACD2</pav:lineageUri>
    <ao:context rdf:resource="urn:domeoclient:uuid:35CDD6FE-B2DA-45B7-836A-B05452D0DAB8"/>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <domeo:belongsToSet>urn:domeoclient:uuid:CB83FFC2-EA71-44EA-8F11-DE80E389C84E</domeo:belongsToSet>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812eda990003</pav:createdBy>
    <rdfs:label>Highlight</rdfs:label>
    <pav:createdOn>2014-09-02 19:13:49 -0400</pav:createdOn>
    <pav:lastSavedOn>2014-09-02 19:19:47 -0400</pav:lastSavedOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <domeo:belongsToSet>urn:domeoserver:annotationset:E32812A9-205B-4EE1-B488-A1E294EDBFB9</domeo:belongsToSet>
    <domeo:belongsToSet>urn:domeoserver:annotationset:392EE0FB-AC4F-4AF2-87A6-2E50A281F434</domeo:belongsToSet>
    <pav:lineageUri>urn:domeoserver:annotation:5775ADA4-BC30-4A01-8204-8E77A968FB5B</pav:lineageUri>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:BD61A2B7-5272-4F6D-A4A5-94082E805ED6">
    <rdfs:label>Highlight</rdfs:label>
    <domeo:belongsToSet>urn:domeoserver:annotationset:F272A789-69D0-47CC-8CC9-F25C55B91261</domeo:belongsToSet>
    <pav:lineageUri>urn:domeoserver:annotation:B014F564-C05F-47C1-8A49-6B6A1D8E64BF</pav:lineageUri>
    <ao:context rdf:resource="urn:domeoclient:uuid:E4F0D688-0AAC-4069-A616-725458FCDC7B"/>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:lastSavedOn>2014-07-22 20:22:38 -0400</pav:lastSavedOn>
    <pav:createdOn>2014-07-22 20:18:17 -0400</pav:createdOn>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812eda990003</pav:createdBy>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:0B2918C2-A28D-40C3-8147-F19D09B7119C">
    <pav:lastSavedOn>2014-07-07 09:44:19 -0400</pav:lastSavedOn>
    <pav:createdOn>2014-07-07 09:37:58 -0400</pav:createdOn>
    <domeo:belongsToSet>urn:domeoserver:annotationset:08C0C288-6DF4-43E6-A618-71A8BB9563C3</domeo:belongsToSet>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <domeo:belongsToSet>urn:domeoserver:annotationset:22ED7220-C6F6-43C5-9DF9-89F62F0F8E27</domeo:belongsToSet>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <domeo:belongsToSet>urn:domeoclient:uuid:FCA2BF23-0BE3-409F-9177-761812F96097</domeo:belongsToSet>
    <pav:lastSavedOn>2014-07-07 09:44:18 -0400</pav:lastSavedOn>
    <pav:lineageUri>urn:domeoserver:annotationset:76FD4BB5-DE2F-4FCA-B93D-302185B1A381</pav:lineageUri>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <ao:context rdf:resource="urn:domeoclient:uuid:A3612760-5AFD-415B-8269-F1483D859C5D"/>
    <rdfs:label>Highlight</rdfs:label>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812eda990003</pav:createdBy>
    <pav:lineageUri>urn:domeoserver:annotation:D33635C9-431B-4949-93E0-2DE8680E9651</pav:lineageUri>
    <domeo:belongsToSet>urn:domeoserver:annotationset:8F3CF3D9-AADE-4A86-BD42-2924B3D6A406</domeo:belongsToSet>
    <domeo:belongsToSet>urn:domeoserver:annotationset:7AACEF8D-2EBC-4F0B-94B2-190650E562F6</domeo:belongsToSet>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <domeo:belongsToSet>urn:domeoserver:annotationset:131835A3-C655-4F91-97D4-52CAFF7B7CCA</domeo:belongsToSet>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:8232EB8B-B7ED-4583-BE33-F0AD71DA4D1C">
    <ao:exact>Sildenafil </ao:exact>
    <ao:suffix>is only about 10-fold as potent for PDE5 compared to PDE6, an enzyme found in the retina and involved in the phototransduction pathway of the retina. This lower selectivity is thought to be the basis for abnormalities related to color vision observed wit</ao:suffix>
    <domeo:uuid>8232EB8B-B7ED-4583-BE33-F0AD71DA4D1C</domeo:uuid>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:8232EB8B-B7ED-4583-BE33-F0AD71DA4D1C"/>
    <pav:createdOn>2014-07-07 09:36:49 -0400</pav:createdOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <domeo:uuid></domeo:uuid>
    <ao:prefix>terases (10-fold for PDE6, &gt; 80-fold for PDE1, &gt; 700-fold for PDE2, PDE3, PDE4, PDE7, PDE8, PDE9, PDE10, and PDE11). The approximately 4,000-fold selectivity for PDE5 versus PDE3 is important because PDE3 is involved in control of cardiac contractility. </ao:prefix>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-155.txt.html</ao:hasSource>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:A84DE8F6-26B7-471D-8309-4E7CC2994FDF">
    <ao:annotatesResource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-16.txt.html</ao:annotatesResource>
    <ao:item rdf:resource="urn:domeoclient:uuid:1B768EBB-3E7D-4144-B911-6362101E6343"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:01D05C1E-36FA-4699-B134-4F8E31F1B1CA"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:15F23356-1BF5-4C1D-B511-6EA6E4D8AC0E"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:67D24023-38AB-4DC8-B710-B1EC8B3A147D"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:019F3E7A-E338-4B52-B537-D71474689AD1"/>
    <pav:lastSavedOn>2014-09-01 16:06:17 -0400</pav:lastSavedOn>
    <pav:lineageUri>urn:domeoserver:annotationset:0C1C2EB5-51AF-456E-A1C2-1ED9CDDC6C3B</pav:lineageUri>
    <domeo:agents rdf:resource="urn:domeo:software:id:Domeo-2.1alpha-050"/>
    <permissions:permissions rdf:nodeID="N8fe5ef43f5504515b80ec3dc6104d9b9"/>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <ao:item rdf:resource="urn:domeoclient:uuid:F888C6E8-7F16-450A-A3B5-0E20C026DA2A"/>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812eda990003</pav:createdBy>
    <rdfs:label>Default Set</rdfs:label>
    <dct:description>The default set is created automatically by Domeo when no other set is existing.</dct:description>
    <ao:item rdf:resource="urn:domeoclient:uuid:EC7897DF-F240-4C01-A8E7-BD5189815B10"/>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <domeo:deleted>false</domeo:deleted>
    <ao:item rdf:resource="urn:domeoclient:uuid:0A2D6969-9724-41E9-BCD8-E35100958761"/>
    <domeo:agents rdf:resource="urn:person:uuid:080e143046812afe0146812eda990003"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:DC193B15-53DF-4479-BA9B-BCE880C4232C"/>
    <pav:createdOn>2014-09-01 16:05:52 -0400</pav:createdOn>
    <ao:item rdf:resource="urn:domeoclient:uuid:03ABEF2C-055A-4C30-91E7-3717F41B4C84"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#AnnotationSet"/>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <ao:item rdf:resource="urn:domeoclient:uuid:5442793D-CF1E-40C2-8779-648AB7BD1967"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoserver:annotationset:A5DD001D-C81A-4E2E-B5E0-7A866B35E26B">
    <ao:item rdf:resource="urn:domeoclient:uuid:85EED099-46E9-43C2-A412-DB4141880448"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:E15B413C-BEDB-4A09-B61C-CC07F96666DD"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:6950FFA4-1583-4644-99BE-7BD0F0C06B95"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:4A624918-A90F-4845-8DFE-C35AFD8B0B68"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:8EE2A094-F107-44EE-921E-0C729A88F5DB"/>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">3</pav:versionNumber>
    <ao:item rdf:resource="urn:domeoclient:uuid:31254608-CDC4-4553-A278-115226EC9264"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:58271A45-7CE7-4B20-8F9F-82D4B6DD0D74"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:F7DD29E8-1783-4BA7-A529-9EF0B60D8F39"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:A512929D-5410-4D52-AEA7-F2E68A62A9E8"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:9E45A71F-507C-47A7-A012-D482CF4059D6"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:B427C906-5D72-43EE-85C9-4D7F3117059B"/>
    <domeo:agents rdf:resource="urn:domeo:software:id:Domeo-2.1alpha-050"/>
    <pav:previousVersion>urn:domeoserver:annotationset:3F546823-204F-4F9B-9006-3DC526C56931</pav:previousVersion>
    <ao:item rdf:resource="urn:domeoclient:uuid:53FAB419-4FF7-440E-89DD-64411826800A"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:DD921AA0-5FC8-4BE9-AAB8-13B1D92E1958"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:288BDA0B-5368-42DA-BCF5-4D9F229E72D5"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:3EA9FD84-7972-4F14-ACAC-44E7B91CD0C2"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:0BE2F54A-5A28-4297-82E1-2B83EE8D882C"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:140EFF4D-9D91-427D-B48B-7B1FAFA2E5CF"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:15142045-DA2F-4022-9FF7-3D0277BDC3FB"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:0DEE6C6F-A6F1-480F-B422-0E55E610EAAB"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:87135DB6-D4F3-4808-BE76-D891C704525E"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:B6024659-1A02-4A19-8ED3-F29F4A70681F"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:41AFFAD3-B330-44BA-91A6-EFE69C07C0A2"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:00672751-8DEF-4963-8AA5-6205618296C1"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:537EDFBD-E119-4A09-B40F-63E4648698FE"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:00D416DF-EC2B-4E10-8956-D09B3C52D5E6"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:8786A121-1479-4E39-A0A4-280F6167DD01"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:C8AD4F27-4001-4A0B-9D27-50063C65337E"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:53C71D4E-A625-4012-ABC4-932105C30699"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:74C8573C-609D-4268-8133-F0B2749E0A1E"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:EAC57EB3-DF7D-46DD-AE24-159494F820F5"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:CAAFBBB8-299E-4407-AECC-19F6B511D24C"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:0F8D75BE-6E65-4B3E-AA75-B1FF492AC889"/>
    <rdfs:label>Default Set</rdfs:label>
    <ao:item rdf:resource="urn:domeoclient:uuid:9A355239-7CF3-43F5-B979-1B59EE6C6121"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:1D1D462E-3009-4EB1-A982-ED88FF1CE34A"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:643EA9F8-ED1A-479B-9B59-6A63D55F43F7"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:A3ECFEEE-C693-4117-91FB-027FB8CFC391"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:8A033E70-6D84-4601-985E-2D559145926B"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:CE03C8BC-514A-4589-B370-5BBCAFD1AFE7"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:C6F74A83-2371-401E-B276-117735065820"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:95D28FFB-FF92-495E-92BC-C2E25FBE02B1"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:B61CCD79-538E-42B4-8232-5A3A92F4AC3F"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:1236F221-49FC-4683-9E78-9A4C14E7DA9F"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:CFB0CA51-827C-4CBB-9914-266A69F0AB0B"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:6EAB4BAE-C8C3-48B7-AC36-EFE4C7088448"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#AnnotationSet"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:60DDCB17-0D44-46B0-8348-C078AAECFF80"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:06B4510C-85BF-4E4A-AA80-BA9BF3139105"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:E2CEC4DC-B35C-4F1A-8ACA-017FE944131C"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:D4CA3DCD-82EA-464C-8F9A-1D04DCECE7B6"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:B837C05B-2090-4797-A3CF-E78BA29EF167"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:EA587655-D235-49D2-9724-0AEBB3E5E13B"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:F0A9334D-2A9F-4B70-AC7A-5A574EACCA65"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:7B307336-ED36-40F6-8DED-B26488A43FD4"/>
    <ao:annotatesResource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-9.txt.html</ao:annotatesResource>
    <ao:item rdf:resource="urn:domeoclient:uuid:581B1F88-8814-40C0-9F72-77FEA7E30122"/>
    <permissions:permissions rdf:nodeID="N8b00472424fb4f43b0f1dd36140a81fa"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:FB5478ED-0329-4EF5-88A8-06C125D68B2A"/>
    <dct:description>The default set is created automatically by Domeo when no other set is existing.</dct:description>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:lastSavedOn>2014-09-02 11:49:28 -0400</pav:lastSavedOn>
    <ao:item rdf:resource="urn:domeoclient:uuid:E4B6A541-B29F-419F-88B1-22F770341BFA"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:0D270EDF-E644-45EB-9C94-B02DA5C51002"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:A3D1E36E-124A-4042-BB9B-6A358D1F3E3B"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:2BBB51CD-8D17-4DE2-B300-ED38485DEA33"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:44246EE4-6542-429C-AE56-DA84A2FDC57F"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:3B664870-D5A4-43DD-8990-228B68AA60AA"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:8613E32B-563F-4611-BA22-4DC13243CFD4"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:40AC1621-7CDD-45E4-98D3-4DE403F588CE"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:50C0FDF6-70A1-4B64-8F05-01088227E5AD"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:82B09581-5976-41FA-8F72-66B1E36C8544"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:B572D091-3712-43AD-B485-3E1311449FAA"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:A3DAB1A6-C48D-422B-A0D0-776352B4CC3F"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:04AF0456-B803-4275-972A-36BD0F6352B7"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:5E25E6A4-046A-49AF-B686-005D1B9BE5EC"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:69354CBD-D372-4AD9-A6F1-93E07CA4D048"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:2F010F0A-45BC-4132-A685-857F72A4DCEC"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:6793D5D8-D5E4-4015-B012-93740E224E6E"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:0C6D1C88-D003-4F29-8AF2-F22A03983530"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:26C8F2D4-9063-4B38-ABF2-AC4FA32AD27F"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:0DC1E786-48C0-4894-B615-AFA91FDAC5BD"/>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812eda990003</pav:createdBy>
    <domeo:agents rdf:resource="urn:person:uuid:080e143046812afe0146812eda990003"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:9BAD39B9-2A3E-47D0-84C7-BB409378B51D"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:43D41023-3393-411C-B3B2-FDFDACB25B35"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:2D67B7C7-76F8-4FFD-A468-49E9E07064A4"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:DBA99B4F-F7DB-4460-981A-81817F4BFE98"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:70EB0C27-A6B8-49A5-94CD-7CCF2755C633"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:B206386D-9F43-45A3-96CA-50B346B26C4D"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:1295B95D-9BC5-45F6-8E74-F4D1E052F64C"/>
    <pav:lineageUri>urn:domeoserver:annotationset:D1715BD2-BD41-46FD-9454-DC7A423A29AC</pav:lineageUri>
    <ao:item rdf:resource="urn:domeoclient:uuid:7DC48B58-6464-4FBE-B643-CA178DD552DB"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:1F561698-D9D5-496E-A7E9-97BDA5059FED"/>
    <domeo:deleted>false</domeo:deleted>
    <ao:item rdf:resource="urn:domeoclient:uuid:2C5969D2-1348-44AF-8DA9-7B96D70B4770"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:209C377C-FE31-4FA5-9168-BD0E96D0F448"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:08E3A94E-69BC-45F8-943D-0AE85FC3257B"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:8041B2EF-1040-472F-A3E7-DC65F8159B41"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:CA91EE4A-7D39-4CC0-A25E-E5ACA358E916"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:393FB1C5-F66E-42C6-AA25-436EBF20214E"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:0F702DA3-314E-4514-A96E-ADDF64264F59"/>
    <pav:createdOn>2014-09-02 11:30:03 -0400</pav:createdOn>
    <ao:item rdf:resource="urn:domeoclient:uuid:F282170D-9AEA-4BD9-A758-9130391568F0"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:59DF3B57-4013-45C3-9A3F-23E01D7020B8"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:5F230A2C-E15E-41D9-8781-4AF5CA3E381E">
    <rdfs:label>Highlight</rdfs:label>
    <pav:createdOn>2014-07-13 12:46:27 -0400</pav:createdOn>
    <ao:context rdf:resource="urn:domeoclient:uuid:C0DCB0F4-61CC-48CE-8688-567F2327B321"/>
    <pav:lastSavedOn>2014-07-13 12:48:45 -0400</pav:lastSavedOn>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812eda990003</pav:createdBy>
    <pav:lineageUri>urn:domeoserver:annotation:6DC77E85-D03E-4E33-9B0F-4B8826F63FA7</pav:lineageUri>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <domeo:belongsToSet>urn:domeoclient:uuid:EC9B90D7-F9B5-4E51-94E2-878FAA06F611</domeo:belongsToSet>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:F45CCE04-9C17-4AB6-BF4A-23A94A70AB21">
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:createdOn>2014-09-02 19:13:24 -0400</pav:createdOn>
    <pav:lineageUri>urn:domeoserver:annotationset:C5DEBC9B-77EE-4243-88EB-DBC19737ACD2</pav:lineageUri>
    <domeo:belongsToSet>urn:domeoserver:annotationset:E32812A9-205B-4EE1-B488-A1E294EDBFB9</domeo:belongsToSet>
    <pav:lastSavedOn>2014-09-02 19:19:47 -0400</pav:lastSavedOn>
    <pav:lineageUri>urn:domeoserver:annotation:D463FB91-36C0-4C2F-AE86-FEE00719B3C2</pav:lineageUri>
    <rdfs:label>Highlight</rdfs:label>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812eda990003</pav:createdBy>
    <domeo:belongsToSet>urn:domeoserver:annotationset:392EE0FB-AC4F-4AF2-87A6-2E50A281F434</domeo:belongsToSet>
    <ao:context rdf:resource="urn:domeoclient:uuid:713FC0EF-F420-4182-BCC3-9D97A1296B91"/>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <domeo:belongsToSet>urn:domeoclient:uuid:CB83FFC2-EA71-44EA-8F11-DE80E389C84E</domeo:belongsToSet>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:57E98049-37B0-4F70-963B-F0D12C3B36C7">
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <rdfs:label>Highlight</rdfs:label>
    <pav:lineageUri>urn:domeoserver:annotation:996E26F9-829E-4D62-867F-4975211CECA5</pav:lineageUri>
    <domeo:belongsToSet>urn:domeoserver:annotationset:7AACEF8D-2EBC-4F0B-94B2-190650E562F6</domeo:belongsToSet>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <domeo:belongsToSet>urn:domeoserver:annotationset:8F3CF3D9-AADE-4A86-BD42-2924B3D6A406</domeo:belongsToSet>
    <domeo:belongsToSet>urn:domeoserver:annotationset:131835A3-C655-4F91-97D4-52CAFF7B7CCA</domeo:belongsToSet>
    <domeo:belongsToSet>urn:domeoserver:annotationset:22ED7220-C6F6-43C5-9DF9-89F62F0F8E27</domeo:belongsToSet>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812eda990003</pav:createdBy>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <pav:lastSavedOn>2014-07-07 11:24:52 -0400</pav:lastSavedOn>
    <pav:createdOn>2014-07-07 11:22:43 -0400</pav:createdOn>
    <ao:context rdf:resource="urn:domeoclient:uuid:EFE95BF7-1349-414E-B68F-6C5149A03072"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:6279850D-A32F-4EDB-A281-0BC6CBECE7F7">
    <ao:exact>fluvoxamine</ao:exact>
    <pav:createdOn>2014-09-02 11:39:16 -0400</pav:createdOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:6279850D-A32F-4EDB-A281-0BC6CBECE7F7"/>
    <domeo:uuid>6279850D-A32F-4EDB-A281-0BC6CBECE7F7</domeo:uuid>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-9.txt.html</ao:hasSource>
    <ao:suffix> maleate tablets.</ao:suffix>
    <ao:prefix> maleate (50 mg b.i.d.) revealed no effect of either drug on the pharmacokinetics or pharmacodynamics of the other. As with other psychotropic medications, patients should be advised to avoid alcohol while taking </ao:prefix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:CF4B56FC-1048-4C85-AD05-E8D9C4F159CF">
    <domeo:belongsToSet>urn:domeoserver:annotationset:606A5B3F-B6FB-4279-AA42-7893CFC2D20C</domeo:belongsToSet>
    <pav:previousVersion>urn:domeoserver:annotationset:514BA51B-D734-4003-A7C3-F03C0F95833A</pav:previousVersion>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <rdfs:label>Highlight</rdfs:label>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:createdOn>2014-07-22 19:43:42 -0400</pav:createdOn>
    <domeo:belongsToSet>urn:domeoserver:annotationset:2914A3FD-DF43-4F78-999C-77CE7A028B19</domeo:belongsToSet>
    <pav:lastSavedOn>2014-07-22 19:44:46 -0400</pav:lastSavedOn>
    <domeo:belongsToSet>urn:domeoserver:annotationset:F272A789-69D0-47CC-8CC9-F25C55B91261</domeo:belongsToSet>
    <ao:context rdf:resource="urn:domeoclient:uuid:F6644A5F-920F-4CAA-86BD-086A69F19FA5"/>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">6</pav:versionNumber>
    <pav:lineageUri>urn:domeoserver:annotation:FDA83A8F-959E-43AD-931D-CFBF31F4822E</pav:lineageUri>
    <pav:lineageUri>urn:domeoserver:annotationset:AB1741F1-5A5F-4416-AEAC-A544BCBB7D16</pav:lineageUri>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812eda990003</pav:createdBy>
    <pav:previousVersion>xsd:String</pav:previousVersion>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/F044222C-AB83-4B62-B72A-FD9B65C89DD6">
    <dct:description>Referred to the drug in the interaction.</dct:description>
    <rdfs:label>AVANDIA</rdfs:label>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/drug-product"/>
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/261455</dailymed:activeMoietyRxCUI>
    <sio:SIO_000228>dikbD2R:object-drug-of-interaction</sio:SIO_000228>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoserver:annotationset:3F546823-204F-4F9B-9006-3DC526C56931">
    <ao:item rdf:resource="urn:domeoclient:uuid:B61CCD79-538E-42B4-8232-5A3A92F4AC3F"/>
    <pav:createdOn>2014-09-02 11:30:03 -0400</pav:createdOn>
    <ao:item rdf:resource="urn:domeoclient:uuid:E4B6A541-B29F-419F-88B1-22F770341BFA"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:F7DD29E8-1783-4BA7-A529-9EF0B60D8F39"/>
    <domeo:agents rdf:resource="urn:domeo:software:id:Domeo-2.1alpha-050"/>
    <dct:description>The default set is created automatically by Domeo when no other set is existing.</dct:description>
    <ao:item rdf:resource="urn:domeoclient:uuid:50C0FDF6-70A1-4B64-8F05-01088227E5AD"/>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812eda990003</pav:createdBy>
    <ao:item rdf:resource="urn:domeoclient:uuid:B572D091-3712-43AD-B485-3E1311449FAA"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:A3D1E36E-124A-4042-BB9B-6A358D1F3E3B"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:A512929D-5410-4D52-AEA7-F2E68A62A9E8"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:40AC1621-7CDD-45E4-98D3-4DE403F588CE"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:7B307336-ED36-40F6-8DED-B26488A43FD4"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:537EDFBD-E119-4A09-B40F-63E4648698FE"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:3EA9FD84-7972-4F14-ACAC-44E7B91CD0C2"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:26C8F2D4-9063-4B38-ABF2-AC4FA32AD27F"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:58271A45-7CE7-4B20-8F9F-82D4B6DD0D74"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:59DF3B57-4013-45C3-9A3F-23E01D7020B8"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:B6024659-1A02-4A19-8ED3-F29F4A70681F"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:74C8573C-609D-4268-8133-F0B2749E0A1E"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:00672751-8DEF-4963-8AA5-6205618296C1"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:0F8D75BE-6E65-4B3E-AA75-B1FF492AC889"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:140EFF4D-9D91-427D-B48B-7B1FAFA2E5CF"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:00D416DF-EC2B-4E10-8956-D09B3C52D5E6"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:53C71D4E-A625-4012-ABC4-932105C30699"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:41AFFAD3-B330-44BA-91A6-EFE69C07C0A2"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:288BDA0B-5368-42DA-BCF5-4D9F229E72D5"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:643EA9F8-ED1A-479B-9B59-6A63D55F43F7"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:0BE2F54A-5A28-4297-82E1-2B83EE8D882C"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:15142045-DA2F-4022-9FF7-3D0277BDC3FB"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:9BAD39B9-2A3E-47D0-84C7-BB409378B51D"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:1236F221-49FC-4683-9E78-9A4C14E7DA9F"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:F282170D-9AEA-4BD9-A758-9130391568F0"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:08E3A94E-69BC-45F8-943D-0AE85FC3257B"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:31254608-CDC4-4553-A278-115226EC9264"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:1D1D462E-3009-4EB1-A982-ED88FF1CE34A"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:EAC57EB3-DF7D-46DD-AE24-159494F820F5"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:DBA99B4F-F7DB-4460-981A-81817F4BFE98"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:A3ECFEEE-C693-4117-91FB-027FB8CFC391"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:E15B413C-BEDB-4A09-B61C-CC07F96666DD"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:0DEE6C6F-A6F1-480F-B422-0E55E610EAAB"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:8786A121-1479-4E39-A0A4-280F6167DD01"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:4A624918-A90F-4845-8DFE-C35AFD8B0B68"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:1F561698-D9D5-496E-A7E9-97BDA5059FED"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:7DC48B58-6464-4FBE-B643-CA178DD552DB"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:2D67B7C7-76F8-4FFD-A468-49E9E07064A4"/>
    <ao:annotatesResource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-9.txt.html</ao:annotatesResource>
    <domeo:deleted>false</domeo:deleted>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#AnnotationSet"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:CA91EE4A-7D39-4CC0-A25E-E5ACA358E916"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:1295B95D-9BC5-45F6-8E74-F4D1E052F64C"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:6950FFA4-1583-4644-99BE-7BD0F0C06B95"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:8041B2EF-1040-472F-A3E7-DC65F8159B41"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:393FB1C5-F66E-42C6-AA25-436EBF20214E"/>
    <rdfs:label>Default Set</rdfs:label>
    <ao:item rdf:resource="urn:domeoclient:uuid:0D270EDF-E644-45EB-9C94-B02DA5C51002"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:53FAB419-4FF7-440E-89DD-64411826800A"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:A3DAB1A6-C48D-422B-A0D0-776352B4CC3F"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:44246EE4-6542-429C-AE56-DA84A2FDC57F"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:85EED099-46E9-43C2-A412-DB4141880448"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:9E45A71F-507C-47A7-A012-D482CF4059D6"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:CAAFBBB8-299E-4407-AECC-19F6B511D24C"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:6793D5D8-D5E4-4015-B012-93740E224E6E"/>
    <permissions:permissions rdf:nodeID="N2ec233fed53345eaba2278fea73088e8"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:0DC1E786-48C0-4894-B615-AFA91FDAC5BD"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:209C377C-FE31-4FA5-9168-BD0E96D0F448"/>
    <pav:previousVersion>urn:domeoclient:uuid:BED41F06-565A-4622-9A88-48810E5A28DE</pav:previousVersion>
    <ao:item rdf:resource="urn:domeoclient:uuid:FB5478ED-0329-4EF5-88A8-06C125D68B2A"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:0C6D1C88-D003-4F29-8AF2-F22A03983530"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:69354CBD-D372-4AD9-A6F1-93E07CA4D048"/>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <ao:item rdf:resource="urn:domeoclient:uuid:B837C05B-2090-4797-A3CF-E78BA29EF167"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:F0A9334D-2A9F-4B70-AC7A-5A574EACCA65"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:82B09581-5976-41FA-8F72-66B1E36C8544"/>
    <domeo:agents rdf:resource="urn:person:uuid:080e143046812afe0146812eda990003"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:2BBB51CD-8D17-4DE2-B300-ED38485DEA33"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:8A033E70-6D84-4601-985E-2D559145926B"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:5E25E6A4-046A-49AF-B686-005D1B9BE5EC"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:8613E32B-563F-4611-BA22-4DC13243CFD4"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:D4CA3DCD-82EA-464C-8F9A-1D04DCECE7B6"/>
    <pav:lastSavedOn>2014-09-02 11:46:58 -0400</pav:lastSavedOn>
    <ao:item rdf:resource="urn:domeoclient:uuid:B206386D-9F43-45A3-96CA-50B346B26C4D"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:04AF0456-B803-4275-972A-36BD0F6352B7"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:95D28FFB-FF92-495E-92BC-C2E25FBE02B1"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:0F702DA3-314E-4514-A96E-ADDF64264F59"/>
    <pav:lineageUri>urn:domeoserver:annotationset:D1715BD2-BD41-46FD-9454-DC7A423A29AC</pav:lineageUri>
    <ao:item rdf:resource="urn:domeoclient:uuid:60DDCB17-0D44-46B0-8348-C078AAECFF80"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:CFB0CA51-827C-4CBB-9914-266A69F0AB0B"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:3B664870-D5A4-43DD-8990-228B68AA60AA"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:2C5969D2-1348-44AF-8DA9-7B96D70B4770"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:70EB0C27-A6B8-49A5-94CD-7CCF2755C633"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:8EE2A094-F107-44EE-921E-0C729A88F5DB"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:C8AD4F27-4001-4A0B-9D27-50063C65337E"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:43D41023-3393-411C-B3B2-FDFDACB25B35"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:2F010F0A-45BC-4132-A685-857F72A4DCEC"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:E2CEC4DC-B35C-4F1A-8ACA-017FE944131C"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:DD921AA0-5FC8-4BE9-AAB8-13B1D92E1958"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:EA587655-D235-49D2-9724-0AEBB3E5E13B"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:C6F74A83-2371-401E-B276-117735065820"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:9A355239-7CF3-43F5-B979-1B59EE6C6121"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:B427C906-5D72-43EE-85C9-4D7F3117059B"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:06B4510C-85BF-4E4A-AA80-BA9BF3139105"/>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">2</pav:versionNumber>
    <ao:item rdf:resource="urn:domeoclient:uuid:87135DB6-D4F3-4808-BE76-D891C704525E"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:6EAB4BAE-C8C3-48B7-AC36-EFE4C7088448"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:2ABA1A35-6C77-4A0A-9EC5-109AA13136B6">
    <pav:createdOn>2014-07-07 09:58:59 -0400</pav:createdOn>
    <rdfs:label>Highlight</rdfs:label>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812eda990003</pav:createdBy>
    <pav:lastSavedOn>2014-07-07 10:02:41 -0400</pav:lastSavedOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:lineageUri>urn:domeoserver:annotation:6129321F-FF20-473A-89DA-A79D75F63074</pav:lineageUri>
    <domeo:belongsToSet>urn:domeoserver:annotationset:131835A3-C655-4F91-97D4-52CAFF7B7CCA</domeo:belongsToSet>
    <domeo:belongsToSet>urn:domeoserver:annotationset:08C0C288-6DF4-43E6-A618-71A8BB9563C3</domeo:belongsToSet>
    <domeo:belongsToSet>urn:domeoserver:annotationset:22ED7220-C6F6-43C5-9DF9-89F62F0F8E27</domeo:belongsToSet>
    <ao:context rdf:resource="urn:domeoclient:uuid:D3737933-330F-487F-B41C-CDB0FF5C6F1C"/>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <domeo:belongsToSet>urn:domeoserver:annotationset:7AACEF8D-2EBC-4F0B-94B2-190650E562F6</domeo:belongsToSet>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <domeo:belongsToSet>urn:domeoserver:annotationset:8F3CF3D9-AADE-4A86-BD42-2924B3D6A406</domeo:belongsToSet>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:55E92945-9B4A-406D-8BFF-54471B2E432E">
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-8.txt.html</ao:hasSource>
    <ao:exact>9-hydroxyrisperidone</ao:exact>
    <ao:suffix> was about 21 hours (CV=20%) in extensive metabolizers and 30 hours (CV=25%) in poor metabolizers. The pharmacokinetics of risperidone and 9-hydroxyrisperidone combined, after single and multiple doses, were similar in extensive and poor metabolizers, wi</ao:suffix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <pav:createdOn>2014-07-13 11:17:02 -0400</pav:createdOn>
    <domeo:uuid>55E92945-9B4A-406D-8BFF-54471B2E432E</domeo:uuid>
    <ao:prefix> was 3 hours (CV=30%) in extensive metabolizers and 20 hours (CV=40%) in poor metabolizers. The apparent half-life of </ao:prefix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:55E92945-9B4A-406D-8BFF-54471B2E432E"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:D19C185B-AB58-4956-9871-777E207AC825">
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:D19C185B-AB58-4956-9871-777E207AC825"/>
    <pav:createdOn>2014-09-02 11:44:09 -0400</pav:createdOn>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-9.txt.html</ao:hasSource>
    <ao:exact>Tryptophan</ao:exact>
    <ao:prefix>xsd:String</ao:prefix>
    <ao:suffix> </ao:suffix>
    <domeo:uuid>D19C185B-AB58-4956-9871-777E207AC825</domeo:uuid>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoserver:annotationset:D52DFD7B-BDDF-488F-B339-B1BC641E50E9">
    <pav:previousVersion>urn:domeoclient:uuid:379CD8C1-F4B4-42B7-8F87-70776866DB1F</pav:previousVersion>
    <domeo:agents rdf:resource="urn:domeo:software:id:Domeo-2.1alpha-050"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:047EE665-B8C6-4153-96F1-5D2C3C08A276"/>
    <ao:annotatesResource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-47.txt.html</ao:annotatesResource>
    <ao:item rdf:resource="urn:domeoclient:uuid:160236BC-C839-4CD6-8648-FE98F4F6BC3F"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:17C13D4B-C4FD-4F4C-8B4F-969B0D63CD46"/>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <rdfs:label>Default Set</rdfs:label>
    <ao:item rdf:resource="urn:domeoclient:uuid:4E7D289E-0E68-4A95-9CAF-BA6B4026295E"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:4BC86345-8DEB-4D78-A90E-121B217F37B6"/>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812eda990003</pav:createdBy>
    <ao:item rdf:resource="urn:domeoclient:uuid:E07974BC-9D8F-4D5E-A1B2-C28141CD86ED"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:AB1F4800-7A8C-48DD-A103-ADE54191154D"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:5CFC30D6-1C24-402D-845E-93F7BF5F0922"/>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">2</pav:versionNumber>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#AnnotationSet"/>
    <pav:createdOn>2014-09-02 12:02:37 -0400</pav:createdOn>
    <domeo:agents rdf:resource="urn:person:uuid:080e143046812afe0146812eda990003"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:4746991B-1E22-4518-B0DA-6C25E8605F5D"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:04DF851F-404D-44D4-A74D-22017210AF9A"/>
    <pav:lineageUri>urn:domeoserver:annotationset:166C20E9-1B4C-47D1-982D-922E2E5ACFF2</pav:lineageUri>
    <ao:item rdf:resource="urn:domeoclient:uuid:64531818-53F3-4463-8017-8AD63F5904C3"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:C1594E9A-1D6B-476C-8DD6-9BADB6C707A8"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:9E2FD166-718B-4FDB-8465-F19A84DE1BB4"/>
    <dct:description>The default set is created automatically by Domeo when no other set is existing.</dct:description>
    <ao:item rdf:resource="urn:domeoclient:uuid:852CFA91-85F8-4EF7-A64F-D2A63BC3A6B5"/>
    <pav:lastSavedOn>2014-09-02 12:05:00 -0400</pav:lastSavedOn>
    <ao:item rdf:resource="urn:domeoclient:uuid:3C076A6A-DF94-4E44-AAAE-9F07C1FE0946"/>
    <permissions:permissions rdf:nodeID="Ne5e0ceaa5c9f4dce916c24355e0ac8af"/>
    <domeo:deleted>false</domeo:deleted>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/10A838C4-49F6-43A9-A4D2-77899C57569E">
    <rdfs:label>AVANDIA</rdfs:label>
    <dct:description>Referred to the drug in the interaction.</dct:description>
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/261455</dailymed:activeMoietyRxCUI>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/drug-product"/>
    <sio:SIO_000228>dikbD2R:object-drug-of-interaction</sio:SIO_000228>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoserver:annotationset:606A5B3F-B6FB-4279-AA42-7893CFC2D20C">
    <ao:item rdf:resource="urn:domeoclient:uuid:15E1712B-2693-4DB6-A2FE-D2F158D3A823"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:2BB40EDC-DE0E-4B5E-AEE3-DCE89148115F"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:B6681C81-EA03-49F0-8187-EF5752C9D126"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:9C9FE015-E10A-4124-9250-BA73B7E52470"/>
    <domeo:deleted>false</domeo:deleted>
    <ao:item rdf:resource="urn:domeoclient:uuid:ECE7CA77-7E57-44B0-89AE-B78915FEC8C2"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:FF1FC131-57E9-4A89-8FBF-B786D1543F24"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:5CE56B1D-ACF0-4124-B31E-62EF1E11FED8"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:5C47D157-D8A4-4053-B2C7-7ECD1B16B721"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:37E9FF1C-D06E-42C3-944C-482813D8E38E"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:44D9A897-A866-42BB-8DD9-A376BF8D1B3E"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:513FF3F1-4FCE-4790-A5C9-F75162D3687B"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:2D0A6C88-E510-4AF5-8DFB-C35B1F919461"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:CF4B56FC-1048-4C85-AD05-E8D9C4F159CF"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:7086D655-845E-4135-B24F-75B4FFD47BD0"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:0A960BCB-9A9F-4998-9418-33D622C35F7C"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:796FE422-C147-4AA7-A57F-067429194AA4"/>
    <permissions:permissions rdf:nodeID="Nbb9efdfbe41245aebe2673a73a96d42f"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:6667DCF7-AA10-4999-B062-38650C90AEA5"/>
    <domeo:agents rdf:resource="urn:person:uuid:080e143046812afe0146812eda990003"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:CE897434-B9A6-4A1A-B7D2-C1748858051B"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:D555EE88-9218-4AF9-81CC-40D543746D77"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:4411E759-9248-468B-B2F6-E5A5A8657C4C"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:D1F55052-16DF-4B25-AC16-7645C8E4AD77"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:6981279A-8AEC-4DEB-BDFB-296A4FDF471C"/>
    <pav:createdOn>2014-07-22 19:08:44 -0400</pav:createdOn>
    <pav:lastSavedOn>2014-07-22 19:44:46 -0400</pav:lastSavedOn>
    <ao:item rdf:resource="urn:domeoclient:uuid:292BF8EC-0E65-4E33-A331-3D217DD6B134"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:F895E903-9E93-41BD-BED1-2EA2CE628B45"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:15050075-436C-4668-9987-03D689AE2236"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:EF32B76C-C252-4DA7-9AC6-7FCD32EE9F83"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:51F1BD01-1111-4CA2-BC77-65762E0E45AA"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:2506F4F5-773E-4CCD-8303-CC244D5848D1"/>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">6</pav:versionNumber>
    <dct:description>The default set is created automatically by Domeo when no other set is existing.</dct:description>
    <ao:item rdf:resource="urn:domeoclient:uuid:585BED0D-5182-4D39-912D-F355B5BEA6BA"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:6A67B256-CA48-48CA-B584-DB13E0D52B58"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:A68BF389-96D4-4F16-BF9D-C1BF35E3CE01"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:5E8A53CD-1A4A-4A56-ABAA-82D073884595"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:23AC6809-BABB-405A-80DE-630CA211B109"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:AF68257F-3ADB-4BA4-9BD1-247F8428319E"/>
    <pav:previousVersion>urn:domeoserver:annotationset:514BA51B-D734-4003-A7C3-F03C0F95833A</pav:previousVersion>
    <ao:item rdf:resource="urn:domeoclient:uuid:66A10386-3791-4236-BBA2-9E3AD59B847D"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:745E9BC2-9930-4FE0-83A2-11668B70C40A"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:544614C5-3057-4129-841C-95DBCD1340A4"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:3D0D19A7-AA2E-4F5C-86E6-0B171A00A7B1"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:B28EDC18-743D-4015-956F-B084F96B3589"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:7616318E-C362-4BC0-B027-F84CBEA6207C"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:C4558C3C-CC16-4A44-85EC-2AB4969F8A0D"/>
    <rdfs:label>Default Set</rdfs:label>
    <ao:item rdf:resource="urn:domeoclient:uuid:82628688-78B9-45FB-8BED-8C81D7B2F03E"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:424F0823-B0B8-4327-8A43-69119A2195AC"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:F2F7D256-D331-45B3-9459-089EEB530262"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:B1EDC65E-7D2E-4E9E-9D08-0D72BD366C29"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:ED9A4881-5A44-4C07-BAFB-529340D632F3"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#AnnotationSet"/>
    <domeo:agents rdf:resource="urn:domeo:software:id:Domeo-2.1alpha-050"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:3E33C30E-6EC7-463F-A8C1-B699338A149B"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:08556835-0438-4667-8B70-71388FA5E865"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:52B64BE2-7636-4E5D-B162-D84F2D892E3D"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:FA96F07E-C088-44C7-AC16-D0EBD7DBD41D"/>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <ao:item rdf:resource="urn:domeoclient:uuid:AA680547-50B2-43E1-8768-6007654CDEF9"/>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812eda990003</pav:createdBy>
    <ao:item rdf:resource="urn:domeoclient:uuid:71244950-C950-47EB-A32B-D2748E51EF60"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:3077386C-E136-4431-9DB1-FC99BF18719B"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:6016855A-FC6C-4F50-BBD3-3126439782E9"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:8C53D58B-D2A3-4A8C-9924-E26E43A59105"/>
    <pav:lineageUri>urn:domeoserver:annotationset:AB1741F1-5A5F-4416-AEAC-A544BCBB7D16</pav:lineageUri>
    <ao:item rdf:resource="urn:domeoclient:uuid:E2D1A706-CE7E-4379-97CF-4EE9CA384DB2"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:78A5F631-80CE-4FB1-974D-F82BE8D8E584"/>
    <ao:annotatesResource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-123.txt.html</ao:annotatesResource>
    <ao:item rdf:resource="urn:domeoclient:uuid:A75B59C8-60A9-4317-B506-9477A97901ED"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:414AB21B-E61F-45BC-90CC-D10C8E784BF6"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:851EB41C-687B-464B-9105-16513BFE3A24"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:D693BC09-DDB8-454B-A812-E73AB798F6FA"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:8CBD941C-1C97-4CE2-A53E-A70EEF76055C">
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:suffix>, a CYP3A4 inhibitor, significantly increased the plasma concentrations of oxycodone. Inhibition of CYP3A4 activity by its inhibitors, such as macrolide antibiotics (e.g., erythromycin), azole-antifungal agents (e.g., ketoconazole), and protease inhibito</ao:suffix>
    <ao:prefix>A published study showed that the co-administration with </ao:prefix>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-72.txt.html</ao:hasSource>
    <ao:exact>voriconazole</ao:exact>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:8CBD941C-1C97-4CE2-A53E-A70EEF76055C"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <pav:createdOn>2014-09-02 19:09:08 -0400</pav:createdOn>
    <domeo:uuid>8CBD941C-1C97-4CE2-A53E-A70EEF76055C</domeo:uuid>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:1285AF18-3541-4E0D-9BAA-DDBC5E9C152C">
    <pav:lastSavedOn>2014-09-02 19:46:58 -0400</pav:lastSavedOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#AnnotationSet"/>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <domeo:agents rdf:resource="urn:domeo:software:id:Domeo-2.1alpha-050"/>
    <dct:description>The default set is created automatically by Domeo when no other set is existing.</dct:description>
    <ao:item rdf:resource="urn:domeoclient:uuid:58F2142F-5F2A-4136-AB4F-944FA95FB01D"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:2632D1DD-2AAF-40EA-9A99-DCA6352518F5"/>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <ao:item rdf:resource="urn:domeoclient:uuid:0D11B975-10D6-42DD-93CA-9D9026AA5279"/>
    <permissions:permissions rdf:nodeID="N8d5d337888f54793a3bf9be12fa2ed6c"/>
    <domeo:agents rdf:resource="urn:person:uuid:080e143046812afe0146812eda990003"/>
    <pav:createdOn>2014-09-02 19:46:24 -0400</pav:createdOn>
    <domeo:deleted>false</domeo:deleted>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812eda990003</pav:createdBy>
    <pav:lineageUri>urn:domeoserver:annotationset:76C3B05B-36AE-4506-907E-7AB96328F926</pav:lineageUri>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <rdfs:label>Default Set</rdfs:label>
    <ao:annotatesResource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-117.txt.html</ao:annotatesResource>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:53840DD5-460C-4E7F-BA1C-65662E771309">
    <ao:exact>maleate </ao:exact>
    <pav:createdOn>2014-09-02 11:44:26 -0400</pav:createdOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-9.txt.html</ao:hasSource>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:53840DD5-460C-4E7F-BA1C-65662E771309"/>
    <ao:prefix>xsd:String</ao:prefix>
    <ao:suffix>and tryptophan (see WARNINGS AND PRECAUTIONS [5.3]).</ao:suffix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <domeo:uuid>53840DD5-460C-4E7F-BA1C-65662E771309</domeo:uuid>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:E8525C10-3E49-4039-8E81-69ACBAC8A16F">
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:exact>Metronidazole has been reported to potentiate the anticoagulant effect of warfarin and other oral coumarin anticoagulants, resulting in a prolongation of prothrombin time. This possible drug interaction should be considered when FLAGYL (metronidazole) is prescribed for patients on this type of anticoagulant therapy.</ao:exact>
    <pav:createdOn>2014-07-22 18:59:42 -0400</pav:createdOn>
    <domeo:uuid>E8525C10-3E49-4039-8E81-69ACBAC8A16F</domeo:uuid>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-120.txt.html</ao:hasSource>
    <ao:prefix>xsd:String</ao:prefix>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:E8525C10-3E49-4039-8E81-69ACBAC8A16F"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:suffix>xsd:String</ao:suffix>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:8EAC93E7-05D8-439B-86B4-7B47CB07E8D8">
    <pav:lineageUri>urn:domeoserver:annotation:12670ED8-C472-4DF9-A553-567C7F4720E9</pav:lineageUri>
    <domeo:belongsToSet>urn:domeoclient:uuid:71191E51-53CB-4FDE-88D0-33C6818E2232</domeo:belongsToSet>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <pav:lastSavedOn>2014-07-13 11:32:29 -0400</pav:lastSavedOn>
    <rdfs:label>Highlight</rdfs:label>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812eda990003</pav:createdBy>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <ao:context rdf:resource="urn:domeoclient:uuid:70B9E8E9-06ED-4420-9CDE-4E0F36F57CC9"/>
    <pav:createdOn>2014-07-13 11:17:15 -0400</pav:createdOn>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/5A962BFF-E73B-4290-B642-C49A7EBCD1B8">
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/active-ingredient"/>
    <sio:SIO_000228>dikbD2R:precipitant-drug-of-interaction</sio:SIO_000228>
    <rdfs:label>serotonin</rdfs:label>
    <dct:description>Referred to the drug in the interaction.</dct:description>
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/1311214</dailymed:activeMoietyRxCUI>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:BFF92609-A328-4612-927E-6F35023B6FC8">
    <ao:exact>fluvoxamine</ao:exact>
    <pav:createdOn>2014-09-02 11:43:30 -0400</pav:createdOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:suffix> with a triptan is clinically warranted, careful observation of the patient is advised, particularly during treatment initiation and dose increases (see WARNINGS AND PRECAUTIONS [5.3]).</ao:suffix>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:BFF92609-A328-4612-927E-6F35023B6FC8"/>
    <ao:prefix>. If concomitant treatment of </ao:prefix>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-9.txt.html</ao:hasSource>
    <domeo:uuid>BFF92609-A328-4612-927E-6F35023B6FC8</domeo:uuid>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/504D9B65-0BA3-47AC-BD1D-5D353F912A60">
    <dct:description>Referred to the drug in the interaction.</dct:description>
    <sio:SIO_000228>dikbD2R:object-drug-of-interaction</sio:SIO_000228>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/active-ingredient"/>
    <rdfs:label>nifedipine</rdfs:label>
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/7417</dailymed:activeMoietyRxCUI>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:964473A2-5981-4815-94A0-CEAF4A357060">
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <pav:lastSavedOn>2014-07-24 20:04:50 -0400</pav:lastSavedOn>
    <ao:context rdf:resource="urn:domeoclient:uuid:67B51F20-AA33-44F4-AC6E-1115C0BA7889"/>
    <rdfs:label>Highlight</rdfs:label>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812eda990003</pav:createdBy>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <domeo:belongsToSet>urn:domeoclient:uuid:07539CCF-9ED2-4C02-AC53-CD1CF6713CB3</domeo:belongsToSet>
    <pav:createdOn>2014-07-24 20:05:09 -0400</pav:createdOn>
    <pav:lineageUri>urn:domeoserver:annotation:71B5C396-7FC2-4A48-9DD6-D8F541D4B553</pav:lineageUri>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:1B45944E-9180-4FB2-9DC0-7DC156F7508B">
    <domeo:uuid>1B45944E-9180-4FB2-9DC0-7DC156F7508B</domeo:uuid>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:1B45944E-9180-4FB2-9DC0-7DC156F7508B"/>
    <ao:exact>Lithium</ao:exact>
    <ao:prefix>xsd:String</ao:prefix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <pav:createdOn>2014-09-02 11:39:51 -0400</pav:createdOn>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-9.txt.html</ao:hasSource>
    <ao:suffix>: As with other serotonergic drugs, lithium may enhance the serotonergic effects of fluvoxamine and, therefore, the combination should be used with caution. Seizures have been reported with the coadministration of fluvoxamine maleate and lithium.</ao:suffix>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:F6D8B558-463C-428A-82F9-861E7A7AA7AC">
    <domeo:belongsToSet>urn:domeoclient:uuid:189A8E0E-67D6-4C53-A96E-CB48A3B4B2E9</domeo:belongsToSet>
    <pav:createdOn>2014-07-24 20:02:07 -0400</pav:createdOn>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812eda990003</pav:createdBy>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:lineageUri>urn:domeoserver:annotation:73DB93B0-36EA-401A-A4D9-8296CC5688CC</pav:lineageUri>
    <pav:lastSavedOn>2014-07-24 20:02:49 -0400</pav:lastSavedOn>
    <ao:context rdf:resource="urn:domeoclient:uuid:EACE427F-1066-4C2C-B450-F3CF99633404"/>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <rdfs:label>Highlight</rdfs:label>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:previousVersion>xsd:String</pav:previousVersion>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:3801AFB1-E917-4E09-8201-F7DFAAAD30AC">
    <ao:prefix>and </ao:prefix>
    <ao:exact>nelfinavir</ao:exact>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-74.txt.html</ao:hasSource>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:suffix>, decreased serum levels have been reported when given together with omeprazole. Following multiple doses of nelfinavir (1250 mg, bid) and omeprazole (40 mg, qd), AUC was decreased by 36% and 92%, Cmax by 37% and 89% and Cmin by 39% and 75% respectively </ao:suffix>
    <domeo:uuid>3801AFB1-E917-4E09-8201-F7DFAAAD30AC</domeo:uuid>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:3801AFB1-E917-4E09-8201-F7DFAAAD30AC"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <pav:createdOn>2014-09-02 19:17:56 -0400</pav:createdOn>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:5E25E6A4-046A-49AF-B686-005D1B9BE5EC">
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:lineageUri>urn:domeoserver:annotationset:D1715BD2-BD41-46FD-9454-DC7A423A29AC</pav:lineageUri>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">2</pav:versionNumber>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812eda990003</pav:createdBy>
    <domeo:belongsToSet>urn:domeoserver:annotationset:A3F0B39A-4249-4B63-BB0D-F24A005066AC</domeo:belongsToSet>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:lastSavedOn>2014-09-02 11:46:58 -0400</pav:lastSavedOn>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <domeo:belongsToSet>urn:domeoserver:annotationset:3F546823-204F-4F9B-9006-3DC526C56931</domeo:belongsToSet>
    <pav:createdOn>2014-09-02 11:35:42 -0400</pav:createdOn>
    <ao:context rdf:resource="urn:domeoclient:uuid:09E68084-B057-4315-B5D2-BAB13980BCAE"/>
    <pav:previousVersion>urn:domeoclient:uuid:BED41F06-565A-4622-9A88-48810E5A28DE</pav:previousVersion>
    <domeo:belongsToSet>urn:domeoserver:annotationset:A5DD001D-C81A-4E2E-B5E0-7A866B35E26B</domeo:belongsToSet>
    <rdfs:label>Highlight</rdfs:label>
    <pav:lineageUri>urn:domeoserver:annotation:5974BAE1-193C-4ACE-B2AD-0DE900204D54</pav:lineageUri>
    <pav:previousVersion>xsd:String</pav:previousVersion>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:544614C5-3057-4129-841C-95DBCD1340A4">
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812eda990003</pav:createdBy>
    <domeo:belongsToSet>urn:domeoserver:annotationset:F272A789-69D0-47CC-8CC9-F25C55B91261</domeo:belongsToSet>
    <pav:createdOn>2014-07-22 19:31:19 -0400</pav:createdOn>
    <rdfs:label>Highlight</rdfs:label>
    <pav:lineageUri>urn:domeoserver:annotation:03374931-4123-406E-A090-2211DCC555E1</pav:lineageUri>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">4</pav:versionNumber>
    <domeo:belongsToSet>urn:domeoserver:annotationset:514BA51B-D734-4003-A7C3-F03C0F95833A</domeo:belongsToSet>
    <pav:lastSavedOn>2014-07-22 19:35:16 -0400</pav:lastSavedOn>
    <ao:context rdf:resource="urn:domeoclient:uuid:EB4F72BF-4A36-4030-AF78-3FD9D5E4FE15"/>
    <pav:lineageUri>urn:domeoserver:annotationset:AB1741F1-5A5F-4416-AEAC-A544BCBB7D16</pav:lineageUri>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <domeo:belongsToSet>urn:domeoserver:annotationset:2914A3FD-DF43-4F78-999C-77CE7A028B19</domeo:belongsToSet>
    <pav:previousVersion>urn:domeoserver:annotationset:7E80543E-BF76-4514-92A9-91458DCB802B</pav:previousVersion>
    <domeo:belongsToSet>urn:domeoserver:annotationset:7021B883-FD5C-4083-BD87-DF56D3C87633</domeo:belongsToSet>
    <domeo:belongsToSet>urn:domeoserver:annotationset:606A5B3F-B6FB-4279-AA42-7893CFC2D20C</domeo:belongsToSet>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:C8D072B3-4844-4132-96FD-1E44EFE7C281">
    <sio:SIO_000205>dikbD2R:statement</sio:SIO_000205>
    <sio:SIO_000563>dikbD2R:modality</sio:SIO_000563>
    <dikbD2R:statement>ncit:quantitative</dikbD2R:statement>
    <rdf:type rdf:resource="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#DrugDrugInteractionStatement"/>
    <sio:SIO_000628 rdf:resource="urn:pddi:uuid:5A5F8C7B-9705-4277-87C9-38037CFFC534"/>
    <dikbD2R:modality>ncit:positive</dikbD2R:modality>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:28F8F8B3-4AAE-49BF-945F-3B91F3DE3958">
    <ao:prefix>xsd:String</ao:prefix>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-123.txt.html</ao:hasSource>
    <ao:suffix>xsd:String</ao:suffix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <domeo:uuid>28F8F8B3-4AAE-49BF-945F-3B91F3DE3958</domeo:uuid>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <pav:createdOn>2014-07-22 19:55:24 -0400</pav:createdOn>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:28F8F8B3-4AAE-49BF-945F-3B91F3DE3958"/>
    <ao:exact>Ranitidine</ao:exact>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:1E6C968E-32AF-45A2-96F3-10B3A640C99F">
    <pav:createdOn>2014-07-13 11:13:53 -0400</pav:createdOn>
    <ao:exact>Risperidone</ao:exact>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <domeo:uuid>1E6C968E-32AF-45A2-96F3-10B3A640C99F</domeo:uuid>
    <ao:prefix>xsd:String</ao:prefix>
    <ao:suffix> could be subject to two kinds of drug-drug interactions. First, inhibitors of CYP 2D6 interfere with conversion of risperidone to 9-hydroxyrisperidone [see 7 DRUG INTERACTIONS]. This occurs with quinidine, giving essentially all recipients a risperidone</ao:suffix>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:1E6C968E-32AF-45A2-96F3-10B3A640C99F"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-8.txt.html</ao:hasSource>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:9011E52E-6FAE-42BF-913B-D3EF952E8A2B">
    <rdfs:label>Highlight</rdfs:label>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <domeo:belongsToSet>urn:domeoclient:uuid:71191E51-53CB-4FDE-88D0-33C6818E2232</domeo:belongsToSet>
    <ao:context rdf:resource="urn:domeoclient:uuid:F3D2A83E-9B62-495D-A7E7-A17FEF5E2561"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:lastSavedOn>2014-07-13 11:32:29 -0400</pav:lastSavedOn>
    <pav:createdOn>2014-07-13 11:04:07 -0400</pav:createdOn>
    <pav:lineageUri>urn:domeoserver:annotation:B9422143-55C7-4DC9-89FD-1C96FFB68383</pav:lineageUri>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812eda990003</pav:createdBy>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:CB138E02-5A43-4D20-A598-828A1F13AC26">
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-139.txt.html</ao:hasSource>
    <ao:exact>ketoconazole</ao:exact>
    <ao:suffix> 400 mg once daily under steady-state conditions to healthy adult subjects (n = 24, each study). No differences in adverse events or QTc interval were observed when subjects were administered fexofenadine hydrochloride alone or in combination with either</ao:suffix>
    <pav:createdOn>2014-07-24 20:07:52 -0400</pav:createdOn>
    <domeo:uuid>CB138E02-5A43-4D20-A598-828A1F13AC26</domeo:uuid>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:CB138E02-5A43-4D20-A598-828A1F13AC26"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:prefix> 500 mg every 8 hours or </ao:prefix>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:8613E32B-563F-4611-BA22-4DC13243CFD4">
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <pav:lineageUri>urn:domeoserver:annotationset:D1715BD2-BD41-46FD-9454-DC7A423A29AC</pav:lineageUri>
    <domeo:belongsToSet>urn:domeoserver:annotationset:A3F0B39A-4249-4B63-BB0D-F24A005066AC</domeo:belongsToSet>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812eda990003</pav:createdBy>
    <domeo:belongsToSet>urn:domeoserver:annotationset:3F546823-204F-4F9B-9006-3DC526C56931</domeo:belongsToSet>
    <pav:createdOn>2014-09-02 11:43:24 -0400</pav:createdOn>
    <ao:context rdf:resource="urn:domeoclient:uuid:C624C116-E8F0-4A10-B8B2-BC8AA88D6B11"/>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:previousVersion>urn:domeoclient:uuid:BED41F06-565A-4622-9A88-48810E5A28DE</pav:previousVersion>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">2</pav:versionNumber>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <rdfs:label>Highlight</rdfs:label>
    <pav:lineageUri>urn:domeoserver:annotation:EEBFF786-73B3-478E-9260-C89FA839745A</pav:lineageUri>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <domeo:belongsToSet>urn:domeoserver:annotationset:A5DD001D-C81A-4E2E-B5E0-7A866B35E26B</domeo:belongsToSet>
    <pav:lastSavedOn>2014-09-02 11:46:58 -0400</pav:lastSavedOn>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:1A2265F0-B7D6-4A47-834F-F540E39BE257">
    <domeo:uuid>1A2265F0-B7D6-4A47-834F-F540E39BE257</domeo:uuid>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-161.txt.html</ao:hasSource>
    <ao:prefix> serum concentrations. Although a dose adjustment of </ao:prefix>
    <ao:exact>azithromycin</ao:exact>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:1A2265F0-B7D6-4A47-834F-F540E39BE257"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:suffix> is not recommended when administered in combination with nelfinavir, close monitoring for known side effects of azithromycin, such as liver enzyme abnormalities and hearing impairment, is warranted (see ADVERSE REACTIONS).</ao:suffix>
    <pav:createdOn>2014-07-24 20:14:49 -0400</pav:createdOn>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:E4B6A541-B29F-419F-88B1-22F770341BFA">
    <ao:context rdf:resource="urn:domeoclient:uuid:265209EB-0CE8-478A-9C0E-59E0095E0A6B"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <rdfs:label>Highlight</rdfs:label>
    <pav:lastSavedOn>2014-09-02 11:46:58 -0400</pav:lastSavedOn>
    <domeo:belongsToSet>urn:domeoserver:annotationset:A3F0B39A-4249-4B63-BB0D-F24A005066AC</domeo:belongsToSet>
    <pav:lineageUri>urn:domeoserver:annotation:595F5141-C2F6-4437-B065-843285C36702</pav:lineageUri>
    <domeo:belongsToSet>urn:domeoserver:annotationset:3F546823-204F-4F9B-9006-3DC526C56931</domeo:belongsToSet>
    <pav:createdOn>2014-09-02 11:41:26 -0400</pav:createdOn>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <domeo:belongsToSet>urn:domeoserver:annotationset:A5DD001D-C81A-4E2E-B5E0-7A866B35E26B</domeo:belongsToSet>
    <pav:lineageUri>urn:domeoserver:annotationset:D1715BD2-BD41-46FD-9454-DC7A423A29AC</pav:lineageUri>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">2</pav:versionNumber>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812eda990003</pav:createdBy>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:previousVersion>urn:domeoclient:uuid:BED41F06-565A-4622-9A88-48810E5A28DE</pav:previousVersion>
    <pav:previousVersion>xsd:String</pav:previousVersion>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:07539CCF-9ED2-4C02-AC53-CD1CF6713CB3">
    <ao:item rdf:resource="urn:domeoclient:uuid:35CD1CDB-7257-43BB-BB56-7A444AAF4BA3"/>
    <ao:annotatesResource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-138.txt.html</ao:annotatesResource>
    <domeo:deleted>false</domeo:deleted>
    <dct:description>The default set is created automatically by Domeo when no other set is existing.</dct:description>
    <ao:item rdf:resource="urn:domeoclient:uuid:964473A2-5981-4815-94A0-CEAF4A357060"/>
    <domeo:agents rdf:resource="urn:person:uuid:080e143046812afe0146812eda990003"/>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#AnnotationSet"/>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812eda990003</pav:createdBy>
    <rdfs:label>Default Set</rdfs:label>
    <permissions:permissions rdf:nodeID="Nacfb48ddb4644f188db24def45011806"/>
    <pav:lineageUri>urn:domeoserver:annotationset:73DB6DC7-9F44-4798-8BE5-917866542E6C</pav:lineageUri>
    <pav:lastSavedOn>2014-07-24 20:04:50 -0400</pav:lastSavedOn>
    <domeo:agents rdf:resource="urn:domeo:software:id:Domeo-2.1alpha-050"/>
    <pav:createdOn>2014-07-24 20:05:02 -0400</pav:createdOn>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:BCA04010-E0E5-4D69-A2B7-6AB2C8D2081F">
    <rdfs:label>Highlight</rdfs:label>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:lineageUri>urn:domeoserver:annotation:90C2BA9F-2F4E-451B-B00D-D47BECA00268</pav:lineageUri>
    <ao:context rdf:resource="urn:domeoclient:uuid:E0476DD8-15DF-4D2C-ADC4-C5C80BA1F15B"/>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:lastSavedOn>2014-07-24 19:51:13 -0400</pav:lastSavedOn>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <pav:createdOn>2014-07-24 19:47:39 -0400</pav:createdOn>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812eda990003</pav:createdBy>
    <domeo:belongsToSet>urn:domeoclient:uuid:6C727003-BB8F-45A8-BBAC-ACBE1D4D132E</domeo:belongsToSet>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:7A5583BB-B797-401F-B398-564C65590C7B">
    <pav:createdOn>2014-07-21 21:53:30 -0400</pav:createdOn>
    <domeo:uuid>7A5583BB-B797-401F-B398-564C65590C7B</domeo:uuid>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:suffix> </ao:suffix>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-56.txt.html</ao:hasSource>
    <ao:exact>Zonisamide</ao:exact>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:7A5583BB-B797-401F-B398-564C65590C7B"/>
    <ao:prefix>xsd:String</ao:prefix>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:86768360-42DE-4CD0-A167-0F5E6C6CAE55">
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812eda990003</pav:createdBy>
    <pav:createdOn>2014-07-22 18:51:22 -0400</pav:createdOn>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <rdfs:label>Highlight</rdfs:label>
    <pav:lastSavedOn>2014-07-22 18:54:35 -0400</pav:lastSavedOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:lineageUri>urn:domeoserver:annotation:FD0778DC-BD38-42CF-98CE-AFBBDCFDFFB7</pav:lineageUri>
    <ao:context rdf:resource="urn:domeoclient:uuid:92AF00E3-613A-4E27-ACAC-A744AA15CCB8"/>
    <domeo:belongsToSet>urn:domeoclient:uuid:3D195979-3E82-427D-95B8-F50F48DB4AA7</domeo:belongsToSet>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:70E63C27-77CA-4EFB-9B3F-9125C608F260">
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <pav:createdOn>2014-09-02 11:38:37 -0400</pav:createdOn>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:70E63C27-77CA-4EFB-9B3F-9125C608F260"/>
    <domeo:uuid>70E63C27-77CA-4EFB-9B3F-9125C608F260</domeo:uuid>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-9.txt.html</ao:hasSource>
    <ao:exact>fluvoxamine</ao:exact>
    <ao:prefix> produced substantial decrements in cognitive functioning; however, the coadministration of </ao:prefix>
    <ao:suffix> and lorazepam did not produce larger mean decrements compared to lorazepam alone.</ao:suffix>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:30903A1B-437C-4ABA-B24D-6148F07F178D">
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:prefix>, its major metabolite, 9-hydroxyrisperidone, and </ao:prefix>
    <pav:createdOn>2014-07-13 11:09:35 -0400</pav:createdOn>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-8.txt.html</ao:hasSource>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:30903A1B-437C-4ABA-B24D-6148F07F178D"/>
    <ao:exact>risperidone</ao:exact>
    <ao:suffix> plus 9-hydroxyrisperidone are dose proportional over the dosing range of 1 to 16 mg daily (0.5 to 8 mg twice daily). Following oral administration of solution or tablet, mean peak plasma concentrations of risperidone occurred at about 1 hour. Peak conce</ao:suffix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <domeo:uuid>30903A1B-437C-4ABA-B24D-6148F07F178D</domeo:uuid>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:709146DB-F43F-4A5F-B3FB-C395469E387B">
    <ao:exact>AVANDIA</ao:exact>
    <ao:prefix> </ao:prefix>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:709146DB-F43F-4A5F-B3FB-C395469E387B"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:suffix>xsd:String</ao:suffix>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-123.txt.html</ao:hasSource>
    <pav:createdOn>2014-07-22 19:12:50 -0400</pav:createdOn>
    <domeo:uuid>709146DB-F43F-4A5F-B3FB-C395469E387B</domeo:uuid>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:3347F4AE-F668-4910-8729-7775D7697AD7">
    <pav:createdOn>2014-09-01 16:07:51 -0400</pav:createdOn>
    <pav:lineageUri>urn:domeoserver:annotation:1B6E2F8D-4A01-45E3-957A-F3F5793AA559</pav:lineageUri>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:lastSavedOn>2014-09-01 16:07:52 -0400</pav:lastSavedOn>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812eda990003</pav:createdBy>
    <rdfs:label>Highlight</rdfs:label>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <ao:context rdf:resource="urn:domeoclient:uuid:15DA0901-8237-4923-B2A0-A784328F0684"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <domeo:belongsToSet>urn:domeoclient:uuid:1DA34422-734D-46B1-AB2C-C1CABCA4C26C</domeo:belongsToSet>
    <pav:previousVersion>xsd:String</pav:previousVersion>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:F6EB60C9-CEEF-414F-8B0A-9C1AF0091872">
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812eda990003</pav:createdBy>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <pav:lineageUri>urn:domeoserver:annotation:5FAF681B-8EF3-4A88-B5CE-244A3255305E</pav:lineageUri>
    <pav:lastSavedOn>2014-09-02 15:04:32 -0400</pav:lastSavedOn>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:createdOn>2014-09-02 15:03:58 -0400</pav:createdOn>
    <domeo:belongsToSet>urn:domeoclient:uuid:C4B80A95-F569-4ED4-84D1-6796B53A580C</domeo:belongsToSet>
    <rdfs:label>Highlight</rdfs:label>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <ao:context rdf:resource="urn:domeoclient:uuid:985C3233-0D87-48CA-9DDA-A1D83B9FCA6D"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:AA4737DB-0EF5-4431-A3C1-AB7A8F5E730A">
    <domeo:uuid>AA4737DB-0EF5-4431-A3C1-AB7A8F5E730A</domeo:uuid>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-123.txt.html</ao:hasSource>
    <ao:prefix>Coadministration of </ao:prefix>
    <ao:suffix> (100 mg three times daily) for 7 days in healthy volunteers had no clinically relevant effect on the pharmacokinetics of a single oral dose of AVANDIA.</ao:suffix>
    <pav:createdOn>2014-07-22 19:56:13 -0400</pav:createdOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:exact>acarbose</ao:exact>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:AA4737DB-0EF5-4431-A3C1-AB7A8F5E730A"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:38CE57C6-582D-4AE5-90CF-F2966A431DF6">
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <pav:createdOn>2014-07-22 18:37:22 -0400</pav:createdOn>
    <domeo:belongsToSet>urn:domeoclient:uuid:9FA29E53-6B1B-4856-B5BD-22A93164E58E</domeo:belongsToSet>
    <rdfs:label>Highlight</rdfs:label>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:lastSavedOn>2014-07-22 18:37:42 -0400</pav:lastSavedOn>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812eda990003</pav:createdBy>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:lineageUri>urn:domeoserver:annotation:5A027EDF-83FE-475F-9F74-63D2D35751F4</pav:lineageUri>
    <ao:context rdf:resource="urn:domeoclient:uuid:8156B623-1ED5-4672-8474-3E892FC84DF5"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:797E523C-94FC-4569-A544-1F1C2179E9C1">
    <ao:suffix> AUC and Cmax slightly increased following coadministration of AVANDIA.</ao:suffix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <domeo:uuid>797E523C-94FC-4569-A544-1F1C2179E9C1</domeo:uuid>
    <pav:createdOn>2014-07-22 19:49:34 -0400</pav:createdOn>
    <ao:exact>glyburide</ao:exact>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:797E523C-94FC-4569-A544-1F1C2179E9C1"/>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-123.txt.html</ao:hasSource>
    <ao:prefix> (8 mg once daily) for 8 days in healthy adult Caucasian subjects caused a decrease in glyburide AUC and Cmax of approximately 30%. In Japanese subjects, </ao:prefix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:32AF5202-FB01-4507-AD10-D10F0C16E37A">
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <pav:createdOn>2014-07-21 21:28:32 -0400</pav:createdOn>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:32AF5202-FB01-4507-AD10-D10F0C16E37A"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:exact>cyclosporine </ao:exact>
    <domeo:uuid>32AF5202-FB01-4507-AD10-D10F0C16E37A</domeo:uuid>
    <ao:suffix>therapy for at least 6 months and on a stable cyclosporine dose for at least 6 weeks. There was a significant increase in cyclosporine AUC, Cmax, Cmin (24-hour concentration), and a significant reduction in apparent oral clearance following the administr</ao:suffix>
    <ao:prefix>200 mg daily for 14 days in eight renal transplant patients who had been on </ao:prefix>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-26.txt.html</ao:hasSource>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:B5E75366-F0BF-442F-852E-19C5EDDC84EE">
    <pav:lastSavedOn>2014-07-07 09:44:19 -0400</pav:lastSavedOn>
    <domeo:belongsToSet>urn:domeoserver:annotationset:22ED7220-C6F6-43C5-9DF9-89F62F0F8E27</domeo:belongsToSet>
    <ao:context rdf:resource="urn:domeoclient:uuid:C4441B5B-C18F-4F66-90A8-3A3306CD1C90"/>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <domeo:belongsToSet>urn:domeoserver:annotationset:131835A3-C655-4F91-97D4-52CAFF7B7CCA</domeo:belongsToSet>
    <pav:createdOn>2014-07-07 09:42:24 -0400</pav:createdOn>
    <pav:lineageUri>urn:domeoserver:annotationset:76FD4BB5-DE2F-4FCA-B93D-302185B1A381</pav:lineageUri>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812eda990003</pav:createdBy>
    <pav:lastSavedOn>2014-07-07 09:44:18 -0400</pav:lastSavedOn>
    <domeo:belongsToSet>urn:domeoclient:uuid:FCA2BF23-0BE3-409F-9177-761812F96097</domeo:belongsToSet>
    <rdfs:label>Highlight</rdfs:label>
    <domeo:belongsToSet>urn:domeoserver:annotationset:7AACEF8D-2EBC-4F0B-94B2-190650E562F6</domeo:belongsToSet>
    <domeo:belongsToSet>urn:domeoserver:annotationset:08C0C288-6DF4-43E6-A618-71A8BB9563C3</domeo:belongsToSet>
    <domeo:belongsToSet>urn:domeoserver:annotationset:8F3CF3D9-AADE-4A86-BD42-2924B3D6A406</domeo:belongsToSet>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:lineageUri>urn:domeoserver:annotation:3190AAB5-A173-4B55-B90B-ADA3F02C967F</pav:lineageUri>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:EC4F7D99-8435-471D-98FA-12D2364884E1">
    <ao:prefix>xsd:String</ao:prefix>
    <pav:createdOn>2014-07-22 18:46:07 -0400</pav:createdOn>
    <ao:suffix>xsd:String</ao:suffix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-118.txt.html</ao:hasSource>
    <domeo:uuid>EC4F7D99-8435-471D-98FA-12D2364884E1</domeo:uuid>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:exact>Concomitant administration of Synercid and nifedipine (repeated oral doses) and midazolam (intravenous bolus dose) in healthy volunteers led to elevated plasma concentrations of these drugs. The Cmax increased by 18% and 14% (median values) and the AUC increased by 44% and 33% for nifedipine and midazolam, respectively.</ao:exact>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:EC4F7D99-8435-471D-98FA-12D2364884E1"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:3EE823B0-79E2-43AF-B47E-C72BE189895E">
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812eda990003</pav:createdBy>
    <rdfs:label>Highlight</rdfs:label>
    <domeo:belongsToSet>urn:domeoclient:uuid:B61F1A9B-4696-4ED0-80AA-4FE2E9016966</domeo:belongsToSet>
    <pav:createdOn>2014-07-21 21:33:53 -0400</pav:createdOn>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <pav:lineageUri>urn:domeoserver:annotation:6055A20F-073A-4F5E-A069-540422439AFA</pav:lineageUri>
    <ao:context rdf:resource="urn:domeoclient:uuid:FCB07677-3685-4C25-935B-67786B32E56B"/>
    <pav:lastSavedOn>2014-07-21 21:35:10 -0400</pav:lastSavedOn>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:8D86A4AC-54BD-4BB3-8B58-AB55DEC01A88">
    <ao:item rdf:resource="urn:domeoclient:uuid:2D1425A6-04BE-4372-9798-B6059B7EFF83"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:C1707DB4-5B7C-4588-BAE0-034F66A1800B"/>
    <ao:annotatesResource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-139.txt.html</ao:annotatesResource>
    <pav:lastSavedOn>2014-07-24 20:07:19 -0400</pav:lastSavedOn>
    <ao:item rdf:resource="urn:domeoclient:uuid:5846C0A3-8519-4160-91FD-DFD71E2DCC95"/>
    <domeo:agents rdf:resource="urn:domeo:software:id:Domeo-2.1alpha-050"/>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <ao:item rdf:resource="urn:domeoclient:uuid:E74FD429-7BE1-4BBF-BDBE-DA9A73D330DA"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:875A1582-88A4-40A2-9290-112578B609F1"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:7359157D-6F7C-43D2-9127-08D4CCFA7E1A"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:9273B7AD-9357-4702-9126-48471F347ED0"/>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <ao:item rdf:resource="urn:domeoclient:uuid:54A742F1-BC99-4080-8071-732BA171793D"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:19746D22-D232-4FCB-B5B2-64CA519A479E"/>
    <pav:createdOn>2014-07-24 20:05:33 -0400</pav:createdOn>
    <rdfs:label>Default Set</rdfs:label>
    <ao:item rdf:resource="urn:domeoclient:uuid:0208A9D0-4889-4F9D-A5F0-C1CBBBE42EE0"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:BE69196D-B8BA-4576-AC08-BEA775939851"/>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812eda990003</pav:createdBy>
    <ao:item rdf:resource="urn:domeoclient:uuid:B60D6EE8-97E8-426E-9A95-B877100EC48A"/>
    <domeo:deleted>false</domeo:deleted>
    <domeo:agents rdf:resource="urn:person:uuid:080e143046812afe0146812eda990003"/>
    <dct:description>The default set is created automatically by Domeo when no other set is existing.</dct:description>
    <ao:item rdf:resource="urn:domeoclient:uuid:DF3B3F8F-7CB0-4DA2-B24E-32B9E66603BF"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:0EEDF160-BB48-4F3A-8FC7-D52C908CAECC"/>
    <pav:lineageUri>urn:domeoserver:annotationset:4A88D0A6-E9B6-4E7F-955F-3692600C178C</pav:lineageUri>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#AnnotationSet"/>
    <permissions:permissions rdf:nodeID="N729962a69d5e4d598616d395d5a64342"/>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <ao:item rdf:resource="urn:domeoclient:uuid:CDDA5AD1-5495-41C1-821C-109A7D029580"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:3F0937C0-5C7C-49F4-A929-655D47825AE9">
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <pav:lineageUri>urn:domeoserver:annotation:03305D4D-6511-4CBA-867A-2D6364F265B8</pav:lineageUri>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812eda990003</pav:createdBy>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:lastSavedOn>2014-07-24 19:44:56 -0400</pav:lastSavedOn>
    <ao:context rdf:resource="urn:domeoclient:uuid:F8116D96-F5B7-4381-AFCF-C48903001E05"/>
    <rdfs:label>Highlight</rdfs:label>
    <pav:createdOn>2014-07-24 19:44:04 -0400</pav:createdOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <domeo:belongsToSet>urn:domeoclient:uuid:511EDFA9-5A42-4340-9D4A-CBF6EDD9185C</domeo:belongsToSet>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:8C53D58B-D2A3-4A8C-9924-E26E43A59105">
    <rdfs:label>Highlight</rdfs:label>
    <pav:createdOn>2014-07-22 19:35:05 -0400</pav:createdOn>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:previousVersion>urn:domeoserver:annotationset:7E80543E-BF76-4514-92A9-91458DCB802B</pav:previousVersion>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <pav:lineageUri>urn:domeoserver:annotation:E81BBD86-D7EE-47A7-9C84-44D5A2732720</pav:lineageUri>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">4</pav:versionNumber>
    <domeo:belongsToSet>urn:domeoserver:annotationset:7021B883-FD5C-4083-BD87-DF56D3C87633</domeo:belongsToSet>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:lastSavedOn>2014-07-22 19:35:16 -0400</pav:lastSavedOn>
    <domeo:belongsToSet>urn:domeoserver:annotationset:2914A3FD-DF43-4F78-999C-77CE7A028B19</domeo:belongsToSet>
    <domeo:belongsToSet>urn:domeoserver:annotationset:514BA51B-D734-4003-A7C3-F03C0F95833A</domeo:belongsToSet>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:lineageUri>urn:domeoserver:annotationset:AB1741F1-5A5F-4416-AEAC-A544BCBB7D16</pav:lineageUri>
    <domeo:belongsToSet>urn:domeoserver:annotationset:F272A789-69D0-47CC-8CC9-F25C55B91261</domeo:belongsToSet>
    <ao:context rdf:resource="urn:domeoclient:uuid:5C74E3FF-0F23-47DF-BFE0-C6FFA3577DFE"/>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812eda990003</pav:createdBy>
    <domeo:belongsToSet>urn:domeoserver:annotationset:606A5B3F-B6FB-4279-AA42-7893CFC2D20C</domeo:belongsToSet>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:CE0574D5-7BB9-4BA6-A291-C37F1314832B">
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:lineageUri>urn:domeoserver:annotation:B1FA2934-6D08-45C1-9A5C-A76136C211CF</pav:lineageUri>
    <domeo:belongsToSet>urn:domeoclient:uuid:4B51141D-C8D2-45DB-8074-74F8D8323E60</domeo:belongsToSet>
    <rdfs:label>Highlight</rdfs:label>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812eda990003</pav:createdBy>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <pav:lastSavedOn>2014-09-02 12:02:18 -0400</pav:lastSavedOn>
    <pav:createdOn>2014-09-02 11:57:27 -0400</pav:createdOn>
    <ao:context rdf:resource="urn:domeoclient:uuid:C42C067D-4201-4F47-96EA-FFFFA5B4C4AB"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:ACA8DFD4-1166-4984-97D0-E4E251EA94F3">
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:createdOn>2014-07-22 19:06:46 -0400</pav:createdOn>
    <pav:lineageUri>urn:domeoserver:annotationset:32C325B9-09DD-4A0B-A270-BAA0C42956A1</pav:lineageUri>
    <pav:lastSavedOn>2014-07-22 19:06:49 -0400</pav:lastSavedOn>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812eda990003</pav:createdBy>
    <domeo:belongsToSet>urn:domeoclient:uuid:0819E6B8-B8E8-4EB2-9248-CA54623D1BB2</domeo:belongsToSet>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <domeo:belongsToSet>urn:domeoserver:annotationset:2B18F6B1-59F7-4EA0-9386-55A934108055</domeo:belongsToSet>
    <rdfs:label>Highlight</rdfs:label>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <ao:context rdf:resource="urn:domeoclient:uuid:E578ADE6-9B8F-4EBF-937E-7BA566587314"/>
    <pav:lastSavedOn>2014-07-22 19:06:48 -0400</pav:lastSavedOn>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <pav:lineageUri>urn:domeoserver:annotation:D8EE5F81-07A7-4972-9521-0A5A0232AD58</pav:lineageUri>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:AA5EEC38-13CE-4D77-8996-A3CFF229A32F">
    <ao:exact>-</ao:exact>
    <ao:prefix>xsd:String</ao:prefix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <domeo:uuid>AA5EEC38-13CE-4D77-8996-A3CFF229A32F</domeo:uuid>
    <pav:createdOn>2014-07-07 09:34:23 -0400</pav:createdOn>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:AA5EEC38-13CE-4D77-8996-A3CFF229A32F"/>
    <ao:suffix>5 (PDE5) in the smooth muscle of the pulmonary vasculature, where PDE5 is responsible for degradation of cGMP. Sildenafil, therefore, increases cGMP within pulmonary vascular smooth muscle cells resulting in relaxation. In patients with pulmonary hyperte</ao:suffix>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-155.txt.html</ao:hasSource>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:C15235C1-3B10-4949-B8E4-1D7FCCD3AC4B">
    <pav:lineageUri>urn:domeoserver:annotation:89484DAB-0EA9-4ACB-BC2F-9FEC34383940</pav:lineageUri>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812eda990003</pav:createdBy>
    <pav:lastSavedOn>2014-07-13 11:32:29 -0400</pav:lastSavedOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:createdOn>2014-07-13 11:07:49 -0400</pav:createdOn>
    <domeo:belongsToSet>urn:domeoclient:uuid:71191E51-53CB-4FDE-88D0-33C6818E2232</domeo:belongsToSet>
    <ao:context rdf:resource="urn:domeoclient:uuid:1230CFBE-6F41-4107-8D50-5F5A730D40C5"/>
    <rdfs:label>Highlight</rdfs:label>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:previousVersion>xsd:String</pav:previousVersion>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:9E86ADEB-E76E-4255-8364-3D0CF7C52E24">
    <domeo:uuid>9E86ADEB-E76E-4255-8364-3D0CF7C52E24</domeo:uuid>
    <ao:suffix> is predominantly metabolized by CYP2C8, and to a lesser extent, 2C9. AVANDIA (4 mg twice daily) was shown to have no clinically relevant effect on the pharmacokinetics of nifedipine and oral contraceptives (ethinyl estradiol and norethindrone), which ar</ao:suffix>
    <pav:createdOn>2014-07-22 19:39:44 -0400</pav:createdOn>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:9E86ADEB-E76E-4255-8364-3D0CF7C52E24"/>
    <ao:prefix>rate that </ao:prefix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:exact>rosiglitazone</ao:exact>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-123.txt.html</ao:hasSource>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/F52690C8-04C0-4A9E-B719-C8C7578F5CA8">
    <dct:description>Referred to the drug in the interaction.</dct:description>
    <sio:SIO_000228>dikbD2R:object-drug-of-interaction</sio:SIO_000228>
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/10438</dailymed:activeMoietyRxCUI>
    <rdfs:label>theophylline</rdfs:label>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/active-ingredient"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:799D7550-4333-4600-A69B-DE23093443A4">
    <rdf:type rdf:resource="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#DrugDrugInteractionStatement"/>
    <sio:SIO_000628 rdf:resource="urn:pddi:uuid:F049BA4A-8DAF-49C1-ABA1-6E76A2F6DA6B"/>
    <sio:SIO_000563>dikbD2R:modality</sio:SIO_000563>
    <dikbD2R:statement>ncit:Qualitative</dikbD2R:statement>
    <dikbD2R:modality>ncit:negative</dikbD2R:modality>
    <sio:SIO_000205>dikbD2R:statement</sio:SIO_000205>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:A46A827E-4936-4BBC-8078-913DD6DAA84E">
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <rdfs:label>Highlight</rdfs:label>
    <ao:context rdf:resource="urn:domeoclient:uuid:CC8C2FEA-C8BE-4A4F-98E3-3E4C44B65C83"/>
    <pav:lastSavedOn>2014-07-13 11:32:29 -0400</pav:lastSavedOn>
    <pav:lineageUri>urn:domeoserver:annotation:5B70F474-288C-4C1B-AF18-E0EF9B5EE27B</pav:lineageUri>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812eda990003</pav:createdBy>
    <pav:createdOn>2014-07-13 11:14:00 -0400</pav:createdOn>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <domeo:belongsToSet>urn:domeoclient:uuid:71191E51-53CB-4FDE-88D0-33C6818E2232</domeo:belongsToSet>
    <pav:previousVersion>xsd:String</pav:previousVersion>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:6BD06504-E85C-4ECF-9079-FE0363DD8508">
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <pav:createdOn>2014-09-02 19:28:25 -0400</pav:createdOn>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">2</pav:versionNumber>
    <domeo:belongsToSet>urn:domeoserver:annotationset:392EE0FB-AC4F-4AF2-87A6-2E50A281F434</domeo:belongsToSet>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <rdfs:label>Highlight</rdfs:label>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:lineageUri>urn:domeoserver:annotation:808D2D56-AB87-4904-BBE9-49B23FA4746D</pav:lineageUri>
    <ao:context rdf:resource="urn:domeoclient:uuid:0ED57E86-1291-4DDA-9436-EC8F43B4A452"/>
    <pav:lastSavedOn>2014-09-02 19:32:13 -0400</pav:lastSavedOn>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812eda990003</pav:createdBy>
    <pav:lineageUri>urn:domeoserver:annotationset:C5DEBC9B-77EE-4243-88EB-DBC19737ACD2</pav:lineageUri>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <domeo:belongsToSet>urn:domeoserver:annotationset:E32812A9-205B-4EE1-B488-A1E294EDBFB9</domeo:belongsToSet>
    <pav:previousVersion>urn:domeoclient:uuid:CB83FFC2-EA71-44EA-8F11-DE80E389C84E</pav:previousVersion>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:5B622988-60A1-49F1-966B-8460BBF1DD4D">
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812eda990003</pav:createdBy>
    <pav:lastSavedOn>2014-07-13 11:32:29 -0400</pav:lastSavedOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:lineageUri>urn:domeoserver:annotation:18FCF895-E37C-47DC-9D3E-92CD602023DD</pav:lineageUri>
    <rdfs:label>Highlight</rdfs:label>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <ao:context rdf:resource="urn:domeoclient:uuid:F3967C16-EC04-423B-908A-CF2BC1EC4011"/>
    <domeo:belongsToSet>urn:domeoclient:uuid:71191E51-53CB-4FDE-88D0-33C6818E2232</domeo:belongsToSet>
    <pav:createdOn>2014-07-13 11:04:27 -0400</pav:createdOn>
    <pav:previousVersion>xsd:String</pav:previousVersion>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:06B4510C-85BF-4E4A-AA80-BA9BF3139105">
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <ao:context rdf:resource="urn:domeoclient:uuid:98C6E110-7293-43BC-967C-E828D967CC54"/>
    <domeo:belongsToSet>urn:domeoserver:annotationset:A5DD001D-C81A-4E2E-B5E0-7A866B35E26B</domeo:belongsToSet>
    <pav:lineageUri>urn:domeoserver:annotation:E443DF7E-2C50-4C6B-9521-401D004F018D</pav:lineageUri>
    <rdfs:label>Highlight</rdfs:label>
    <pav:previousVersion>urn:domeoclient:uuid:BED41F06-565A-4622-9A88-48810E5A28DE</pav:previousVersion>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812eda990003</pav:createdBy>
    <domeo:belongsToSet>urn:domeoserver:annotationset:A3F0B39A-4249-4B63-BB0D-F24A005066AC</domeo:belongsToSet>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">2</pav:versionNumber>
    <pav:createdOn>2014-09-02 11:39:37 -0400</pav:createdOn>
    <pav:lineageUri>urn:domeoserver:annotationset:D1715BD2-BD41-46FD-9454-DC7A423A29AC</pav:lineageUri>
    <pav:lastSavedOn>2014-09-02 11:46:58 -0400</pav:lastSavedOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <domeo:belongsToSet>urn:domeoserver:annotationset:3F546823-204F-4F9B-9006-3DC526C56931</domeo:belongsToSet>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:FCA2BF23-0BE3-409F-9177-761812F96097">
    <ao:item rdf:resource="urn:domeoclient:uuid:697C8F03-1543-4427-9D85-7967FCEA3100"/>
    <dct:description>The default set is created automatically by Domeo when no other set is existing.</dct:description>
    <ao:item rdf:resource="urn:domeoclient:uuid:9BD9047F-C1DA-4B64-92B7-4D031972C9CF"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:D5736B17-7DDF-4532-8056-6627EB5A439A"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:C8D05CE4-8287-449A-8921-AFACBAEE2002"/>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <ao:item rdf:resource="urn:domeoclient:uuid:3762570C-CF43-4DB9-B163-FAA6DAE60017"/>
    <rdfs:label>Default Set</rdfs:label>
    <ao:item rdf:resource="urn:domeoclient:uuid:3ED57AC4-296D-4C8D-9873-49C193F69BBA"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:2CF891F7-2E96-4382-8EDB-5C061E8E1AFA"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:F3C4287B-36A9-48BF-8081-A39BEF5F3C51"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:B5E75366-F0BF-442F-852E-19C5EDDC84EE"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:8ABD9FDA-0F08-474A-A9C8-437A5346F2AC"/>
    <domeo:deleted>false</domeo:deleted>
    <ao:item rdf:resource="urn:domeoclient:uuid:E13140FE-59B4-45B2-A524-CAED051C4F9D"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:CE16BF01-AD42-444E-9A68-FEF6AED26815"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:D4374CEB-BF68-487B-B5EE-5AF06DB14203"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:2093FF56-689E-4246-AF69-F566860B27BF"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:42423629-C409-4AD4-BBE6-7C86A696F03E"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:AE1A087B-7CF8-4549-978E-17FEC965A2FF"/>
    <domeo:agents rdf:resource="urn:person:uuid:080e143046812afe0146812eda990003"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:3C500E90-E946-4B1B-B3D2-27B11967A625"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:EC416A29-1315-42C5-90FA-652412A6AD12"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:DC9FB0B5-1564-4BF2-A4E4-4D05B0A1AB86"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:BDA75ADA-742A-402B-AE97-4438F99C61FC"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:222C9B55-A770-41C7-AF04-566E7C7A1DBC"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#AnnotationSet"/>
    <pav:createdOn>2014-07-07 09:34:12 -0400</pav:createdOn>
    <ao:item rdf:resource="urn:domeoclient:uuid:32B1CD5D-3CD7-4D5E-BD76-57F6F0A9480A"/>
    <domeo:agents rdf:resource="urn:domeo:software:id:Domeo-2.1alpha-050"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:4B5E4470-CD28-4DCB-9009-8377503D5E57"/>
    <permissions:permissions rdf:nodeID="Nf2408aefedbd436294109f70281787da"/>
    <ao:annotatesResource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-155.txt.html</ao:annotatesResource>
    <ao:item rdf:resource="urn:domeoclient:uuid:FB0C633B-9063-4FD0-91E9-2810CF1C157A"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:F9FE917E-CAFF-4C8B-B16B-BB0606212145"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:EE5A4249-D765-40E0-B39A-F0725082F558"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:E76B5D64-7248-4EBD-A023-3820BFDEFD26"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:B9E21C61-063D-4F80-8E08-85865B387669"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:54B9529D-9030-4194-B66A-D7ECCBABED1F"/>
    <pav:lastSavedOn>2014-07-07 09:44:18 -0400</pav:lastSavedOn>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812eda990003</pav:createdBy>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:lineageUri>urn:domeoserver:annotationset:76FD4BB5-DE2F-4FCA-B93D-302185B1A381</pav:lineageUri>
    <ao:item rdf:resource="urn:domeoclient:uuid:5D480921-AA61-499B-9C3F-3043269104B4"/>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <ao:item rdf:resource="urn:domeoclient:uuid:7FFFFE5E-7DBF-4B33-A8EC-B5E58DEE590D"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:0B2918C2-A28D-40C3-8147-F19D09B7119C"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:02D92735-6D44-4DFA-A2E9-75A5A3D4DCF9"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:584394EB-71B4-485C-B5DE-CECED70A1339"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:FA4C8A6E-17D4-47F8-A369-67AF061E9037"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:2F71B86E-3B80-4813-9F00-A9E3E6B30C9E"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:137A1951-AA86-4074-9581-B011801B955F"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:4B51141D-C8D2-45DB-8074-74F8D8323E60">
    <ao:item rdf:resource="urn:domeoclient:uuid:657DCEFF-DA71-40A0-8E23-F90A79E8F3B2"/>
    <domeo:agents rdf:resource="urn:domeo:software:id:Domeo-2.1alpha-050"/>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <ao:item rdf:resource="urn:domeoclient:uuid:4599F40B-EE74-4C90-A4C8-716EBE52CAA7"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:9D275C93-4567-4FDB-902A-6385CDBFA809"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#AnnotationSet"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:A676ABAB-01BC-4D19-9DA7-5CF8687711A8"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:06439E07-6402-42CF-99AD-58333426FE52"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:28EC9E22-4FF4-4D9B-93F4-C03F41FBC1BB"/>
    <permissions:permissions rdf:nodeID="Neca3071258a94b6eb31ff51e56358b36"/>
    <rdfs:label>Default Set</rdfs:label>
    <ao:item rdf:resource="urn:domeoclient:uuid:270BC940-6C4E-4F0E-91AB-DAC2FC78E847"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:BC0DA7A3-93CD-44F0-B862-95BDA351400D"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:CE0574D5-7BB9-4BA6-A291-C37F1314832B"/>
    <dct:description>The default set is created automatically by Domeo when no other set is existing.</dct:description>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <ao:item rdf:resource="urn:domeoclient:uuid:0A617D2E-816A-496B-B5FC-091514B75E33"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:95BF8C06-515D-4690-B616-64E06F6C0C8D"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:6522F182-C5C2-4066-893C-355B3A906EBE"/>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <ao:item rdf:resource="urn:domeoclient:uuid:01B5F725-B643-43F6-B470-6409EC7AE08D"/>
    <domeo:deleted>false</domeo:deleted>
    <pav:lastSavedOn>2014-09-02 12:02:18 -0400</pav:lastSavedOn>
    <pav:lineageUri>urn:domeoserver:annotationset:B915360D-1136-4865-9637-DFBCBDB0B73D</pav:lineageUri>
    <ao:annotatesResource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-47.txt.html</ao:annotatesResource>
    <domeo:agents rdf:resource="urn:person:uuid:080e143046812afe0146812eda990003"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:F3272B85-6D67-4686-901C-B1617D8FE66B"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:1DCA5297-1C05-4654-AADE-90A7C81DD992"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:1338CA36-AF29-4D2A-AAA6-13857E4D14F2"/>
    <pav:createdOn>2014-09-02 11:55:53 -0400</pav:createdOn>
    <ao:item rdf:resource="urn:domeoclient:uuid:555D0A1F-632F-4953-A2D8-E08196E7CEB9"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:8AEAC215-292C-4E6F-9305-D62BECCA32B2"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:16C89EA1-7173-40AF-99E3-B5CF422C3FBB"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:02B52C58-6F51-4B2E-9D66-4E523227806E"/>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812eda990003</pav:createdBy>
    <ao:item rdf:resource="urn:domeoclient:uuid:BA8C16C4-EEEA-4E22-BEA7-98D738176A08"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:338E8B18-C7D9-423A-ACA5-3E11D88F42E9">
    <ao:exact>terfenadine</ao:exact>
    <domeo:uuid>338E8B18-C7D9-423A-ACA5-3E11D88F42E9</domeo:uuid>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <pav:createdOn>2014-09-02 15:04:01 -0400</pav:createdOn>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:338E8B18-C7D9-423A-ACA5-3E11D88F42E9"/>
    <ao:prefix> and </ao:prefix>
    <ao:suffix>, a substrate for  CYP3A4, revealed no effect of paroxetine on terfenadine pharmacokinetics. In addition, in vitro studies have shown ketoconazole, a potent inhibitor of CYP3A4 activity, to be at least 100 times more potent than paroxetine as an inhibito</ao:suffix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-48.txt.html</ao:hasSource>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:DDF76582-7387-4F32-A252-95E7B69F65AE">
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <domeo:belongsToSet>urn:domeoserver:annotationset:1FC172B8-8AC3-465A-AA69-B73AD9B97CBC</domeo:belongsToSet>
    <rdfs:label>Highlight</rdfs:label>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812eda990003</pav:createdBy>
    <ao:context rdf:resource="urn:domeoclient:uuid:7FD7602A-D05F-4BEA-AC56-67DE4BF0AB32"/>
    <pav:lineageUri>urn:domeoserver:annotation:59EB0B7E-46DA-479E-89E3-A19A0E7DD3A2</pav:lineageUri>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <pav:lastSavedOn>2014-07-24 20:12:49 -0400</pav:lastSavedOn>
    <pav:createdOn>2014-07-24 20:11:57 -0400</pav:createdOn>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:F282170D-9AEA-4BD9-A758-9130391568F0">
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <rdfs:label>Highlight</rdfs:label>
    <domeo:belongsToSet>urn:domeoserver:annotationset:A5DD001D-C81A-4E2E-B5E0-7A866B35E26B</domeo:belongsToSet>
    <domeo:belongsToSet>urn:domeoserver:annotationset:A3F0B39A-4249-4B63-BB0D-F24A005066AC</domeo:belongsToSet>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">2</pav:versionNumber>
    <pav:lineageUri>urn:domeoserver:annotationset:D1715BD2-BD41-46FD-9454-DC7A423A29AC</pav:lineageUri>
    <pav:lastSavedOn>2014-09-02 11:46:58 -0400</pav:lastSavedOn>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812eda990003</pav:createdBy>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:previousVersion>urn:domeoclient:uuid:BED41F06-565A-4622-9A88-48810E5A28DE</pav:previousVersion>
    <ao:context rdf:resource="urn:domeoclient:uuid:99838144-4399-4843-860D-C565071F0347"/>
    <domeo:belongsToSet>urn:domeoserver:annotationset:3F546823-204F-4F9B-9006-3DC526C56931</domeo:belongsToSet>
    <pav:lineageUri>urn:domeoserver:annotation:80B7BA80-91B6-42C5-8D0A-A2D81C004968</pav:lineageUri>
    <pav:createdOn>2014-09-02 11:39:30 -0400</pav:createdOn>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:9BAD39B9-2A3E-47D0-84C7-BB409378B51D">
    <ao:context rdf:resource="urn:domeoclient:uuid:C970223A-AA7A-4283-8B0C-B1F7B0A1261F"/>
    <domeo:belongsToSet>urn:domeoserver:annotationset:A5DD001D-C81A-4E2E-B5E0-7A866B35E26B</domeo:belongsToSet>
    <pav:previousVersion>urn:domeoclient:uuid:BED41F06-565A-4622-9A88-48810E5A28DE</pav:previousVersion>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:lineageUri>urn:domeoserver:annotationset:D1715BD2-BD41-46FD-9454-DC7A423A29AC</pav:lineageUri>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812eda990003</pav:createdBy>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">2</pav:versionNumber>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <rdfs:label>Highlight</rdfs:label>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:createdOn>2014-09-02 11:44:36 -0400</pav:createdOn>
    <pav:lastSavedOn>2014-09-02 11:46:58 -0400</pav:lastSavedOn>
    <pav:lineageUri>urn:domeoserver:annotation:5059329F-D9CA-47AE-8A1C-8B19B050BC3C</pav:lineageUri>
    <pav:lastSavedOn>2014-09-02 11:46:59 -0400</pav:lastSavedOn>
    <domeo:belongsToSet>urn:domeoserver:annotationset:A3F0B39A-4249-4B63-BB0D-F24A005066AC</domeo:belongsToSet>
    <domeo:belongsToSet>urn:domeoserver:annotationset:3F546823-204F-4F9B-9006-3DC526C56931</domeo:belongsToSet>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:F0AC105E-C659-4D3F-9F13-4104BCC29CDE">
    <pav:lineageUri>urn:domeoserver:annotation:6A3A3F06-7277-4FF9-9E27-EBB7510D87E7</pav:lineageUri>
    <pav:createdOn>2014-07-13 11:13:36 -0400</pav:createdOn>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812eda990003</pav:createdBy>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <ao:context rdf:resource="urn:domeoclient:uuid:65044E3B-BE66-455E-B576-1B8DF996B6B4"/>
    <pav:lastSavedOn>2014-07-13 11:32:29 -0400</pav:lastSavedOn>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <domeo:belongsToSet>urn:domeoclient:uuid:71191E51-53CB-4FDE-88D0-33C6818E2232</domeo:belongsToSet>
    <rdfs:label>Highlight</rdfs:label>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:previousVersion>xsd:String</pav:previousVersion>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:6CB1CEB5-788B-4E3B-9578-C8DF02D212D9">
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <ao:body rdf:nodeID="N80f08c6ada294f36974b6afcb7c03d3f"/>
    <pav:createdOn>2014-07-21 21:32:58 -0400</pav:createdOn>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <domeo:belongsToSet>urn:domeoserver:annotationset:40007BD9-0869-48CF-A8F2-BAD26AE3E6E1</domeo:belongsToSet>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#expertstudyAnnotation"/>
    <ao:context rdf:resource="urn:domeoclient:uuid:F79885A8-4CEA-4ACB-9EC1-9EB939A385DE"/>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:lineageUri>urn:domeoserver:annotation:0A3416DB-DA64-4D76-8C16-2E801A8153AF</pav:lineageUri>
    <rdfs:label>expertstudy Annotation</rdfs:label>
    <pav:lastSavedOn>2014-07-21 21:32:45 -0400</pav:lastSavedOn>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812eda990003</pav:createdBy>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:D0CD8B93-AF6F-43D3-99AB-2252325772E9">
    <pav:createdOn>2014-09-02 15:05:52 -0400</pav:createdOn>
    <ao:prefix> hydroxide should be avoided because it may result in a reduction in Cmax and AUC of 26% and 20%, respectively and consequently in a 25% reduction in the bradycardic effect at rest. Administration of the </ao:prefix>
    <ao:suffix> two hours after sotalol has no effect on the pharmacokinetics or pharmacodynamics of </ao:suffix>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-70.txt.html</ao:hasSource>
    <domeo:uuid>D0CD8B93-AF6F-43D3-99AB-2252325772E9</domeo:uuid>
    <ao:exact>antacid</ao:exact>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:D0CD8B93-AF6F-43D3-99AB-2252325772E9"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:0A4B6E36-A9AC-4581-A4CD-969904241345">
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <domeo:uuid>0A4B6E36-A9AC-4581-A4CD-969904241345</domeo:uuid>
    <pav:createdOn>2014-09-02 11:42:05 -0400</pav:createdOn>
    <ao:suffix>: See CONTRAINDICATIONS (4) and WARNINGS AND PRECAUTIONS (5.4).</ao:suffix>
    <ao:exact>Thioridazine</ao:exact>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:0A4B6E36-A9AC-4581-A4CD-969904241345"/>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-9.txt.html</ao:hasSource>
    <ao:prefix>xsd:String</ao:prefix>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:82B09581-5976-41FA-8F72-66B1E36C8544">
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812eda990003</pav:createdBy>
    <pav:createdOn>2014-09-02 11:30:48 -0400</pav:createdOn>
    <pav:lastSavedOn>2014-09-02 11:35:33 -0400</pav:lastSavedOn>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:lineageUri>urn:domeoserver:annotation:7F199C96-5F97-4551-B197-4A684F80607A</pav:lineageUri>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <pav:lineageUri>urn:domeoserver:annotationset:D1715BD2-BD41-46FD-9454-DC7A423A29AC</pav:lineageUri>
    <ao:context rdf:resource="urn:domeoclient:uuid:F0919B6C-E254-4D92-89B8-6C9E487C9A1E"/>
    <domeo:belongsToSet>urn:domeoserver:annotationset:A3F0B39A-4249-4B63-BB0D-F24A005066AC</domeo:belongsToSet>
    <domeo:belongsToSet>urn:domeoserver:annotationset:A5DD001D-C81A-4E2E-B5E0-7A866B35E26B</domeo:belongsToSet>
    <domeo:belongsToSet>urn:domeoserver:annotationset:3F546823-204F-4F9B-9006-3DC526C56931</domeo:belongsToSet>
    <domeo:belongsToSet>urn:domeoclient:uuid:BED41F06-565A-4622-9A88-48810E5A28DE</domeo:belongsToSet>
    <rdfs:label>Highlight</rdfs:label>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:9BA34B2D-02C3-4A53-9C4E-833C005A5CBE">
    <pav:createdOn>2014-09-01 16:06:01 -0400</pav:createdOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <domeo:uuid>9BA34B2D-02C3-4A53-9C4E-833C005A5CBE</domeo:uuid>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-16.txt.html</ao:hasSource>
    <ao:suffix>, carbamazepine, or cisapride. These data indicate that sertraline’s extent of inhibition of P450 3A4 activity is not likely to be of clinical significance. Results of the interaction study with cisapride indicate that sertraline 200 mg (q.d.) induces th</ao:suffix>
    <ao:prefix>did not increase plasma concentrations of </ao:prefix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:exact>terfenadine</ao:exact>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:9BA34B2D-02C3-4A53-9C4E-833C005A5CBE"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:92F50FB9-2DDF-4D9E-B8BE-97306CD17D51">
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-16.txt.html</ao:hasSource>
    <domeo:uuid>92F50FB9-2DDF-4D9E-B8BE-97306CD17D51</domeo:uuid>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:92F50FB9-2DDF-4D9E-B8BE-97306CD17D51"/>
    <pav:createdOn>2014-09-01 15:57:26 -0400</pav:createdOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:suffix>, carbamazepine, or cisapride under steady-state conditions. The results of these studies indicated that sertraline did not increase plasma concentrations of terfenadine, carbamazepine, or cisapride. These data indicate that sertraline’s extent of inhibi</ao:suffix>
    <ao:exact>terfenadine</ao:exact>
    <ao:prefix>In three separate in vivo interaction studies, sertraline was co-administered with cytochrome P450 3A4 substrates, </ao:prefix>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:68010F53-B903-4110-B73F-5CE843CA2E18">
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <domeo:uuid>68010F53-B903-4110-B73F-5CE843CA2E18</domeo:uuid>
    <ao:suffix>and its major circulating N-desmethyl metabolite are both approximately 96% bound to plasma proteins. Protein binding is independent of total drug concentrations.</ao:suffix>
    <ao:exact>Sildenafil </ao:exact>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:68010F53-B903-4110-B73F-5CE843CA2E18"/>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-155.txt.html</ao:hasSource>
    <domeo:uuid></domeo:uuid>
    <pav:createdOn>2014-07-07 09:42:08 -0400</pav:createdOn>
    <ao:prefix>is 105 L, indicating distribution into the tissues. </ao:prefix>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:04984965-B2D0-4ECE-8862-143E95A2279E">
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:suffix>. These data indicate that sertraline’s extent of inhibition of P450 3A4 activity is not likely to be of clinical significance. Results of the interaction study with cisapride indicate that sertraline 200 mg (q.d.) induces the metabolism of cisapride (ci</ao:suffix>
    <pav:createdOn>2014-09-01 16:06:03 -0400</pav:createdOn>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-16.txt.html</ao:hasSource>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:04984965-B2D0-4ECE-8862-143E95A2279E"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:prefix>, or </ao:prefix>
    <domeo:uuid>04984965-B2D0-4ECE-8862-143E95A2279E</domeo:uuid>
    <ao:exact>cisapride</ao:exact>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:08E3A94E-69BC-45F8-943D-0AE85FC3257B">
    <domeo:belongsToSet>urn:domeoserver:annotationset:A3F0B39A-4249-4B63-BB0D-F24A005066AC</domeo:belongsToSet>
    <pav:lineageUri>urn:domeoserver:annotation:A5FE03BA-4315-4734-81C0-05DCF805F305</pav:lineageUri>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <domeo:belongsToSet>urn:domeoclient:uuid:BED41F06-565A-4622-9A88-48810E5A28DE</domeo:belongsToSet>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <pav:createdOn>2014-09-02 11:34:59 -0400</pav:createdOn>
    <pav:lineageUri>urn:domeoserver:annotationset:D1715BD2-BD41-46FD-9454-DC7A423A29AC</pav:lineageUri>
    <rdfs:label>Highlight</rdfs:label>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812eda990003</pav:createdBy>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <domeo:belongsToSet>urn:domeoserver:annotationset:3F546823-204F-4F9B-9006-3DC526C56931</domeo:belongsToSet>
    <domeo:belongsToSet>urn:domeoserver:annotationset:A5DD001D-C81A-4E2E-B5E0-7A866B35E26B</domeo:belongsToSet>
    <ao:context rdf:resource="urn:domeoclient:uuid:A05276D6-1557-4F87-90F3-A0B48D17A341"/>
    <pav:lastSavedOn>2014-09-02 11:35:33 -0400</pav:lastSavedOn>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:20DF2C21-448E-4857-BAE0-83C2A6124710">
    <ao:suffix> did not have a significant effect on propranolol’s pharmacokinetics.</ao:suffix>
    <pav:createdOn>2014-07-24 19:47:04 -0400</pav:createdOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:exact>propranolol</ao:exact>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <domeo:uuid>20DF2C21-448E-4857-BAE0-83C2A6124710</domeo:uuid>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-130.txt.html</ao:hasSource>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:20DF2C21-448E-4857-BAE0-83C2A6124710"/>
    <ao:prefix> with the long-acting </ao:prefix>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/8AB4378A-0391-4B0C-86C1-A8941D0249CB">
    <dct:description>Referred to the drug in the interaction.</dct:description>
    <sio:SIO_000228>dikbD2R:precipitant-drug-of-interaction</sio:SIO_000228>
    <rdfs:label>paroxetine</rdfs:label>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/active-ingredient"/>
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/32937</dailymed:activeMoietyRxCUI>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:E0050ED6-BE4F-4871-9847-FC4493F22447">
    <ao:annotatesResource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-135.txt.html</ao:annotatesResource>
    <rdfs:label>Default Set</rdfs:label>
    <ao:item rdf:resource="urn:domeoclient:uuid:838A3F9E-0F12-46F7-B6B3-FFABDE022693"/>
    <pav:lastSavedOn>2014-07-24 20:00:43 -0400</pav:lastSavedOn>
    <pav:lineageUri>urn:domeoserver:annotationset:A11B8A91-953F-44CE-8F20-52A8EFBAA088</pav:lineageUri>
    <domeo:agents rdf:resource="urn:person:uuid:080e143046812afe0146812eda990003"/>
    <domeo:agents rdf:resource="urn:domeo:software:id:Domeo-2.1alpha-050"/>
    <pav:createdOn>2014-07-24 20:00:35 -0400</pav:createdOn>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <dct:description>The default set is created automatically by Domeo when no other set is existing.</dct:description>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <permissions:permissions rdf:nodeID="N64fcf5e4115d4b7ba4cdf2b5e3e63044"/>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812eda990003</pav:createdBy>
    <domeo:deleted>false</domeo:deleted>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#AnnotationSet"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:7CF400AE-CD72-49D9-9780-049736D11E6D"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:1262FCE3-53B9-497A-AB5D-DA122BFC8786"/>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:71244950-C950-47EB-A32B-D2748E51EF60">
    <pav:lineageUri>urn:domeoserver:annotationset:AB1741F1-5A5F-4416-AEAC-A544BCBB7D16</pav:lineageUri>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">5</pav:versionNumber>
    <domeo:belongsToSet>urn:domeoserver:annotationset:2914A3FD-DF43-4F78-999C-77CE7A028B19</domeo:belongsToSet>
    <rdfs:label>Highlight</rdfs:label>
    <pav:lineageUri>urn:domeoserver:annotation:2A0E60C6-F690-4CE9-9CCB-D6FA3712EC52</pav:lineageUri>
    <domeo:belongsToSet>urn:domeoserver:annotationset:F272A789-69D0-47CC-8CC9-F25C55B91261</domeo:belongsToSet>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <domeo:belongsToSet>urn:domeoserver:annotationset:514BA51B-D734-4003-A7C3-F03C0F95833A</domeo:belongsToSet>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:lastSavedOn>2014-07-22 19:40:31 -0400</pav:lastSavedOn>
    <pav:createdOn>2014-07-22 19:39:28 -0400</pav:createdOn>
    <pav:previousVersion>urn:domeoserver:annotationset:7021B883-FD5C-4083-BD87-DF56D3C87633</pav:previousVersion>
    <ao:context rdf:resource="urn:domeoclient:uuid:1504073B-965A-43C5-A889-0D6EA22F08A0"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812eda990003</pav:createdBy>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:lastSavedOn>2014-07-22 19:40:32 -0400</pav:lastSavedOn>
    <domeo:belongsToSet>urn:domeoserver:annotationset:606A5B3F-B6FB-4279-AA42-7893CFC2D20C</domeo:belongsToSet>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:52192391-30EB-46A9-93CB-47EC77CE40BC">
    <domeo:uuid>52192391-30EB-46A9-93CB-47EC77CE40BC</domeo:uuid>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:prefix>After chronic dosing of 80 mg </ao:prefix>
    <ao:suffix>xsd:String</ao:suffix>
    <domeo:uuid></domeo:uuid>
    <ao:exact>TID </ao:exact>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:52192391-30EB-46A9-93CB-47EC77CE40BC"/>
    <pav:createdOn>2014-07-07 09:39:32 -0400</pav:createdOn>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-155.txt.html</ao:hasSource>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:EC9B90D7-F9B5-4E51-94E2-878FAA06F611">
    <domeo:deleted>false</domeo:deleted>
    <dct:description>The default set is created automatically by Domeo when no other set is existing.</dct:description>
    <ao:item rdf:resource="urn:domeoclient:uuid:B4ADFA01-70C2-42CC-87CC-869B81E3104E"/>
    <pav:lineageUri>urn:domeoserver:annotationset:37727E88-1331-4D52-A885-1D4C9745A521</pav:lineageUri>
    <ao:item rdf:resource="urn:domeoclient:uuid:1B6D964C-5C7B-4A8B-91D1-71E48BED6297"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:60E67B22-5DBF-4F42-9120-BC7E0F398FA0"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:D2F70BCB-D9EC-44EA-93E7-C33A22842BF2"/>
    <permissions:permissions rdf:nodeID="Ne0c3e53a72ed4027892719db68739fa5"/>
    <domeo:agents rdf:resource="urn:person:uuid:080e143046812afe0146812eda990003"/>
    <pav:lastSavedOn>2014-07-13 12:48:45 -0400</pav:lastSavedOn>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <ao:item rdf:resource="urn:domeoclient:uuid:8F4C5D67-B302-4D5E-86D3-E308EE0C607E"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:5F230A2C-E15E-41D9-8781-4AF5CA3E381E"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:EB66F52A-826A-4B19-9DAB-4F305456531E"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#AnnotationSet"/>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812eda990003</pav:createdBy>
    <ao:item rdf:resource="urn:domeoclient:uuid:DE4A37C3-330E-406A-8B07-E596729011D4"/>
    <pav:createdOn>2014-07-13 12:46:12 -0400</pav:createdOn>
    <ao:item rdf:resource="urn:domeoclient:uuid:190DDFDA-8456-4B27-972C-5E815FA29EBD"/>
    <rdfs:label>Default Set</rdfs:label>
    <ao:item rdf:resource="urn:domeoclient:uuid:0569E8E5-928F-4D8D-93AE-056F350503EF"/>
    <domeo:agents rdf:resource="urn:domeo:software:id:Domeo-2.1alpha-050"/>
    <ao:annotatesResource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-23.txt.html</ao:annotatesResource>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:CB83FFC2-EA71-44EA-8F11-DE80E389C84E">
    <ao:item rdf:resource="urn:domeoclient:uuid:31C3D8BC-BEE5-4732-B113-5F04341D26EC"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:A30DCF7F-AD5F-403E-9FF6-A1CEC51B4252"/>
    <domeo:agents rdf:resource="urn:domeo:software:id:Domeo-2.1alpha-050"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:42F3EB55-6A92-4EE6-9472-03CDC6E02D69"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:E68B19A2-98CC-4D01-88C9-2BCC8709D27A"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:DC13A4FA-8B30-458B-9343-4B48CC945EBF"/>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812eda990003</pav:createdBy>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <ao:item rdf:resource="urn:domeoclient:uuid:0A3EAA6A-641B-48C1-A03F-CCA1FF890D64"/>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <ao:annotatesResource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-74.txt.html</ao:annotatesResource>
    <ao:item rdf:resource="urn:domeoclient:uuid:812A1777-BC32-4760-9024-CF9758CF804E"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:ED46D326-5EE0-47F9-A0D2-97252A43CE9D"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:B188771E-D938-4A6E-AA65-8D511119CA92"/>
    <domeo:deleted>false</domeo:deleted>
    <ao:item rdf:resource="urn:domeoclient:uuid:820A8921-32D8-4CA7-991C-5585C1088203"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:E63ABC8A-4562-42F9-B5F4-6A27DEE50F44"/>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:createdOn>2014-09-02 19:12:09 -0400</pav:createdOn>
    <ao:item rdf:resource="urn:domeoclient:uuid:2DE3872D-3935-4824-AF9D-DBFF26D2588F"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:939BD222-0159-44F2-9E01-3D674AEF5EFE"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:50CB810E-E5CE-4D21-8703-B10F04053C7D"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:00C24F6A-259C-4CD5-BB57-3231935B23AE"/>
    <rdfs:label>Default Set</rdfs:label>
    <dct:description>The default set is created automatically by Domeo when no other set is existing.</dct:description>
    <ao:item rdf:resource="urn:domeoclient:uuid:70CC18BE-600E-4B98-B2C6-E5920EB63D79"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#AnnotationSet"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:F45CCE04-9C17-4AB6-BF4A-23A94A70AB21"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:DC77541A-190C-4C62-930E-9CF52E6C4A67"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:85752833-4F1F-4395-A378-9451755A600C"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:25474B79-791D-49D5-B5D1-858E90C62BB2"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:F989B861-2D11-4383-83FA-D6724A4DE400"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:50AA7124-5304-4E5F-8D20-3405C75223FB"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:16D91D82-D12B-41E8-A218-F336224CF507"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:94E71C50-311F-485B-9C5A-D703BD0E29D1"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:A05ABC03-57B2-463F-8733-BF02DB5FE3A7"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:4B8A305B-D42C-40FD-B384-05FE89B4ACA4"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:B1D53EEF-8BCA-4B91-B107-30A073406F41"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:62793798-1CBD-4B4E-97DB-09E6DED152F0"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:0E2360A5-44FC-4633-8B3E-758DB777C4E6"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:EA6549D1-9142-4B02-863B-C31046392662"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:5EA1A12E-999D-4F07-B3EF-67CFE143F274"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:D5B6732B-67A7-4A25-9BC2-70185A35217F"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:53200B7D-3B88-4C24-827A-DE552ED1B23F"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:F9653C29-A4D2-424D-A8FE-3DDBAC24C18C"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:8621DC71-D1C0-4E5B-97BA-B7275B47A413"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:F0FFC655-44BB-402B-B7C7-6EB6CD49035C"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:F64BA1C3-4615-428E-A209-D304847D4A08"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:807433B2-EB3F-4CEF-824C-1D71920A4C22"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:883BB188-A483-4C32-85F5-63D2C4B33561"/>
    <pav:lineageUri>urn:domeoserver:annotationset:C5DEBC9B-77EE-4243-88EB-DBC19737ACD2</pav:lineageUri>
    <ao:item rdf:resource="urn:domeoclient:uuid:FF4B8408-EC34-4E9C-A970-D7F98CF2EEE1"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:0B3096F2-9B83-424A-BCB8-CF996BA224AC"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:46890B26-242B-40DA-BF4E-E7B90E54E678"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:56E0618F-C2A8-4B2E-868E-D415AEE3E3EF"/>
    <domeo:agents rdf:resource="urn:person:uuid:080e143046812afe0146812eda990003"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:0772E366-3DDD-4D99-A1E7-B6F12EFF65DC"/>
    <pav:lastSavedOn>2014-09-02 19:19:47 -0400</pav:lastSavedOn>
    <permissions:permissions rdf:nodeID="Ne5c97be6b2a0427582efb6162e81fd0c"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:DC959F62-91AD-411B-AC17-FFBBEE22EAF0"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:95404334-796F-4A07-A18A-42601A802CDF"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:968E2714-CEBF-4C37-913F-C2DF10947AB8"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:F5B0ED12-45EB-48BE-B664-DDC78E05AA4A"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:2FAF656F-18DD-448F-84DF-6CC1FD701820"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:8BAAA01E-8AC9-466E-B388-3972354A4BAB">
    <dikbD2R:statement>ncit:Qualitative</dikbD2R:statement>
    <rdf:type rdf:resource="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#DrugDrugInteractionStatement"/>
    <dikbD2R:modality>ncit:positive</dikbD2R:modality>
    <sio:SIO_000628 rdf:resource="urn:pddi:uuid:3CF71FFB-73DC-483D-B743-8D191F63D01D"/>
    <sio:SIO_000205>dikbD2R:statement</sio:SIO_000205>
    <sio:SIO_000563>dikbD2R:modality</sio:SIO_000563>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:4EED7C96-E04B-4187-8077-DF5C7020A789">
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:exact>fexofenadine</ao:exact>
    <pav:createdOn>2014-07-24 20:12:55 -0400</pav:createdOn>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-139.txt.html</ao:hasSource>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:suffix> was reduced by 36%. Therefore, to maximize the effects of fexofenadine, it is recommended that fexofenadine hydrochloride tablets should be taken with water [see Clinical Pharmacology (12.3) and Dosage and Administration (2.1)].</ao:suffix>
    <ao:prefix>. The clinical significance of these observations is unknown. In addition, based on the population pharmacokinetics analysis of the combined data from grapefruit and orange juices studies with the data from a bioequivalence study, the bioavailability of </ao:prefix>
    <domeo:uuid>4EED7C96-E04B-4187-8077-DF5C7020A789</domeo:uuid>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:4EED7C96-E04B-4187-8077-DF5C7020A789"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:77415BA5-F65C-46BF-B1E8-F58D8F285BE2">
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-123.txt.html</ao:hasSource>
    <ao:prefix> (8 mg once daily) for 8 days in healthy adult Caucasian subjects caused a decrease in </ao:prefix>
    <ao:suffix> AUC and Cmax of approximately 30%. In Japanese subjects, </ao:suffix>
    <pav:createdOn>2014-07-22 19:51:04 -0400</pav:createdOn>
    <domeo:uuid>77415BA5-F65C-46BF-B1E8-F58D8F285BE2</domeo:uuid>
    <ao:exact>glyburide</ao:exact>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:77415BA5-F65C-46BF-B1E8-F58D8F285BE2"/>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/83E9958D-5BAA-415C-B14A-C204CC3ED68C">
    <rdfs:label>risperidone</rdfs:label>
    <sio:SIO_000228>dikbD2R:object-drug-of-interaction</sio:SIO_000228>
    <dct:description>Referred to the drug in the interaction.</dct:description>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/active-ingredient"/>
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/35636</dailymed:activeMoietyRxCUI>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:DDADE3A5-763E-4A5F-A9E8-79A393BF0629">
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812eda990003</pav:createdBy>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <pav:lineageUri>urn:domeoserver:annotation:B8506D6D-BA0C-452E-BC7D-21D250B32240</pav:lineageUri>
    <pav:lastSavedOn>2014-07-21 21:35:10 -0400</pav:lastSavedOn>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:createdOn>2014-07-21 21:33:41 -0400</pav:createdOn>
    <rdfs:label>Highlight</rdfs:label>
    <domeo:belongsToSet>urn:domeoclient:uuid:B61F1A9B-4696-4ED0-80AA-4FE2E9016966</domeo:belongsToSet>
    <ao:context rdf:resource="urn:domeoclient:uuid:E0926D3D-98EA-4A7F-A9B4-EC238004514E"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:E2EC2236-F4B5-4F35-8112-88B3BB4A33EA">
    <pav:createdOn>2014-07-24 19:51:31 -0400</pav:createdOn>
    <pav:lineageUri>urn:domeoserver:annotation:CD8D2B2B-6FC9-4E6A-AD9D-9F49C2EE67EE</pav:lineageUri>
    <domeo:belongsToSet>urn:domeoclient:uuid:6C727003-BB8F-45A8-BBAC-ACBE1D4D132E</domeo:belongsToSet>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812eda990003</pav:createdBy>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:lastSavedOn>2014-07-24 19:51:13 -0400</pav:lastSavedOn>
    <rdfs:label>Highlight</rdfs:label>
    <ao:context rdf:resource="urn:domeoclient:uuid:97DC09C5-358C-425D-918D-34D9317DC89F"/>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:4FC315CC-8F6D-4166-AEB6-FBF9CF2FA510">
    <pav:lastSavedOn>2014-07-28 17:00:28 -0400</pav:lastSavedOn>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <rdfs:label>Default Set</rdfs:label>
    <dct:description>The default set is created automatically by Domeo when no other set is existing.</dct:description>
    <permissions:permissions rdf:nodeID="N18967e1edbe24429a8e76b4f205a3993"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:7EDEC592-2359-4661-BE34-B3BD50D59548"/>
    <domeo:agents rdf:resource="urn:person:uuid:080e143046812afe0146812eda990003"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#AnnotationSet"/>
    <domeo:agents rdf:resource="urn:domeo:software:id:Domeo-2.1alpha-050"/>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <pav:createdOn>2014-07-28 17:00:46 -0400</pav:createdOn>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812eda990003</pav:createdBy>
    <ao:item rdf:resource="urn:domeoclient:uuid:F9B083BB-350D-424C-ABD3-5F63B771A9A9"/>
    <pav:lineageUri>urn:domeoserver:annotationset:8C6600A6-A090-4115-A07E-5151544DB3F1</pav:lineageUri>
    <domeo:deleted>false</domeo:deleted>
    <ao:annotatesResource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-164.txt.html</ao:annotatesResource>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <ao:item rdf:resource="urn:domeoclient:uuid:95E14AD2-785D-44CE-B25D-C8A915ADD717"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:364EB4BF-76FF-46DE-8F92-5E5F5D0222E7"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:F5A4FF79-C22B-475D-8775-B7CA929DA67C">
    <domeo:uuid>F5A4FF79-C22B-475D-8775-B7CA929DA67C</domeo:uuid>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-21.txt.html</ao:hasSource>
    <pav:createdOn>2014-07-13 12:38:47 -0400</pav:createdOn>
    <ao:suffix> AUC of any individual subject in this study compared to placebo dosing. The individual AUC values of norethindrone decreased very slightly (&lt;5%) in 3 of the 21 subjects after fluconazole treatment.</ao:suffix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:exact>ethinyl estradiol</ao:exact>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:prefix> treatment did not cause a decrease in the </ao:prefix>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:F5A4FF79-C22B-475D-8775-B7CA929DA67C"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:E0BA7513-EC9D-435D-8BE2-617311ADA2D8">
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:exact>lovastatin</ao:exact>
    <ao:suffix>xsd:String</ao:suffix>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-132.txt.html</ao:hasSource>
    <ao:prefix> </ao:prefix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:E0BA7513-EC9D-435D-8BE2-617311ADA2D8"/>
    <pav:createdOn>2014-07-24 19:53:06 -0400</pav:createdOn>
    <domeo:uuid>E0BA7513-EC9D-435D-8BE2-617311ADA2D8</domeo:uuid>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoserver:annotationset:1FC172B8-8AC3-465A-AA69-B73AD9B97CBC">
    <ao:annotatesResource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-139.txt.html</ao:annotatesResource>
    <ao:item rdf:resource="urn:domeoclient:uuid:19746D22-D232-4FCB-B5B2-64CA519A479E"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:236BB8FF-931E-44E4-8D12-9F1FB83D8082"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:84BD0311-11DD-4CCD-B082-CEE1C8BAAD37"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:DE707944-9AAF-45E4-85A6-2EA10D365226"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:3DC39945-7562-466B-9B45-B860249B5C62"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:183649A8-AEE3-4F6E-9CCA-10E240E419C8"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:875A1582-88A4-40A2-9290-112578B609F1"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:24143967-8568-40EB-838F-056E2F0B075C"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:CDDA5AD1-5495-41C1-821C-109A7D029580"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:54A742F1-BC99-4080-8071-732BA171793D"/>
    <pav:createdOn>2014-07-24 20:05:33 -0400</pav:createdOn>
    <ao:item rdf:resource="urn:domeoclient:uuid:5846C0A3-8519-4160-91FD-DFD71E2DCC95"/>
    <pav:lineageUri>urn:domeoserver:annotationset:4A88D0A6-E9B6-4E7F-955F-3692600C178C</pav:lineageUri>
    <pav:previousVersion>urn:domeoserver:annotationset:37B2514D-1A92-45B1-8A5C-610DA6DC935A</pav:previousVersion>
    <ao:item rdf:resource="urn:domeoclient:uuid:6A4B6F3D-5923-4FB1-A369-D9FE1BF7FD5C"/>
    <permissions:permissions rdf:nodeID="Na838bc0083a74d209cd0d61f1de80f7f"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#AnnotationSet"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:DDEC112C-9331-4573-8A13-ED3D4798FE89"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:B60D6EE8-97E8-426E-9A95-B877100EC48A"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:DDF76582-7387-4F32-A252-95E7B69F65AE"/>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812eda990003</pav:createdBy>
    <ao:item rdf:resource="urn:domeoclient:uuid:0EEDF160-BB48-4F3A-8FC7-D52C908CAECC"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:4AF71C9F-3EB8-4736-9C47-FEDEAC296DAB"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:1C538CF6-5CD8-48ED-96FC-B9B3546A66F8"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:9273B7AD-9357-4702-9126-48471F347ED0"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:7359157D-6F7C-43D2-9127-08D4CCFA7E1A"/>
    <pav:lastSavedOn>2014-07-24 20:12:49 -0400</pav:lastSavedOn>
    <ao:item rdf:resource="urn:domeoclient:uuid:0208A9D0-4889-4F9D-A5F0-C1CBBBE42EE0"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:E74FD429-7BE1-4BBF-BDBE-DA9A73D330DA"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:A9F0C45F-A9FD-47B4-BBF0-2D2F2CBAD8B9"/>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <ao:item rdf:resource="urn:domeoclient:uuid:986D80D9-D47C-41ED-95FE-F55B1AE2AC9D"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:BE69196D-B8BA-4576-AC08-BEA775939851"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:C1707DB4-5B7C-4588-BAE0-034F66A1800B"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:A533EC0D-DA36-41E1-8BF3-3650517EB300"/>
    <domeo:deleted>false</domeo:deleted>
    <dct:description>The default set is created automatically by Domeo when no other set is existing.</dct:description>
    <ao:item rdf:resource="urn:domeoclient:uuid:97C469A7-A5FD-4636-8744-4240B805D2D0"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:6DF7A5F7-A5AA-4B80-A495-D1E04A24A471"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:432A7650-30CD-4BF8-8B03-ECC3935769BA"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:326CE5A9-3567-4645-9375-940B32F01216"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:31F715F6-A269-43C4-9AA2-9270BCFEF7C0"/>
    <domeo:agents rdf:resource="urn:domeo:software:id:Domeo-2.1alpha-050"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:DF3B3F8F-7CB0-4DA2-B24E-32B9E66603BF"/>
    <rdfs:label>Default Set</rdfs:label>
    <ao:item rdf:resource="urn:domeoclient:uuid:2D1425A6-04BE-4372-9798-B6059B7EFF83"/>
    <domeo:agents rdf:resource="urn:person:uuid:080e143046812afe0146812eda990003"/>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">3</pav:versionNumber>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:AA9BE1F2-854A-4E7D-8C64-DCE1158C5D96">
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-155.txt.html</ao:hasSource>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <pav:createdOn>2014-07-07 09:58:57 -0400</pav:createdOn>
    <domeo:uuid>AA9BE1F2-854A-4E7D-8C64-DCE1158C5D96</domeo:uuid>
    <ao:exact>N</ao:exact>
    <domeo:uuid></domeo:uuid>
    <ao:suffix>-</ao:suffix>
    <ao:prefix>Injection is predicted to provide a pharmacological effect of sildenafil and its </ao:prefix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:AA9BE1F2-854A-4E7D-8C64-DCE1158C5D96"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:A52F0287-AD68-4755-8E11-75217CD4FED8">
    <domeo:agents rdf:resource="urn:domeo:software:id:Domeo-2.1alpha-050"/>
    <pav:lineageUri>urn:domeoserver:annotationset:F3F491C1-68D8-4886-B2FC-D5550636F035</pav:lineageUri>
    <pav:createdOn>2014-07-21 21:38:40 -0400</pav:createdOn>
    <ao:item rdf:resource="urn:domeoclient:uuid:BA5DA7BD-C00F-4D3B-B057-830BB357C412"/>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <rdfs:label>Default Set</rdfs:label>
    <permissions:permissions rdf:nodeID="N1fc69d89f9db4e15b51906db9cc8ed0b"/>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812eda990003</pav:createdBy>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#AnnotationSet"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:BBA25E8B-C9EC-4761-85B9-71DE456EB881"/>
    <domeo:agents rdf:resource="urn:person:uuid:080e143046812afe0146812eda990003"/>
    <ao:annotatesResource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-29.txt.html</ao:annotatesResource>
    <pav:lastSavedOn>2014-07-21 21:38:45 -0400</pav:lastSavedOn>
    <ao:item rdf:resource="urn:domeoclient:uuid:833A5FDE-B0F0-4E66-B232-68839CFE44D9"/>
    <dct:description>The default set is created automatically by Domeo when no other set is existing.</dct:description>
    <domeo:deleted>false</domeo:deleted>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:7DCD6738-9404-46BB-A758-BDDEB41B4565">
    <ao:annotatesResource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-160.txt.html</ao:annotatesResource>
    <permissions:permissions rdf:nodeID="Nef5cd4ad855b4351b1ae1fe0205cfa0c"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:81F0286A-7D44-49B2-9EF8-817CDCC20940"/>
    <pav:lastSavedOn>2014-07-24 20:14:00 -0400</pav:lastSavedOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#AnnotationSet"/>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <domeo:agents rdf:resource="urn:domeo:software:id:Domeo-2.1alpha-050"/>
    <dct:description>The default set is created automatically by Domeo when no other set is existing.</dct:description>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <ao:item rdf:resource="urn:domeoclient:uuid:A6FD6D5D-B7A2-423B-8A6B-8CCFD72983C1"/>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <domeo:agents rdf:resource="urn:person:uuid:080e143046812afe0146812eda990003"/>
    <pav:createdOn>2014-07-24 20:13:52 -0400</pav:createdOn>
    <rdfs:label>Default Set</rdfs:label>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812eda990003</pav:createdBy>
    <ao:item rdf:resource="urn:domeoclient:uuid:60DE0286-3CA3-49E7-8170-0F036F3F13E2"/>
    <pav:lineageUri>urn:domeoserver:annotationset:D2CDA065-14B9-49F3-B117-09FCBF86485A</pav:lineageUri>
    <domeo:deleted>false</domeo:deleted>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:A6BFB4F6-55F6-4660-A8CF-B7A01D2650C1">
    <domeo:belongsToSet>urn:domeoclient:uuid:7DEB6848-E3C6-4761-8965-41F19EE5D781</domeo:belongsToSet>
    <pav:createdOn>2014-07-24 19:42:43 -0400</pav:createdOn>
    <pav:lineageUri>urn:domeoserver:annotation:794FFC2B-AC60-4181-8773-B24EE98EB4EB</pav:lineageUri>
    <rdfs:label>Highlight</rdfs:label>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812eda990003</pav:createdBy>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <ao:context rdf:resource="urn:domeoclient:uuid:D0643518-055A-42DE-BA98-B5C01760828C"/>
    <pav:lastSavedOn>2014-07-24 19:43:34 -0400</pav:lastSavedOn>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:B803E851-5AD5-4741-B1B9-1CBAED597E18">
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <rdfs:label>Default Set</rdfs:label>
    <ao:item rdf:resource="urn:domeoclient:uuid:905FFDFF-C273-410A-BE8E-A56C8BC94629"/>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <ao:annotatesResource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-54.txt.html</ao:annotatesResource>
    <domeo:agents rdf:resource="urn:domeo:software:id:Domeo-2.1alpha-050"/>
    <pav:lineageUri>urn:domeoserver:annotationset:B796714B-4414-4CA1-8F35-70E7AD530AE1</pav:lineageUri>
    <domeo:agents rdf:resource="urn:person:uuid:080e143046812afe0146812eda990003"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:1FE8E158-755A-4E57-81FB-928873E93B12"/>
    <domeo:deleted>false</domeo:deleted>
    <ao:item rdf:resource="urn:domeoclient:uuid:E60C908C-8168-4614-80BA-973B0DEE03B0"/>
    <dct:description>The default set is created automatically by Domeo when no other set is existing.</dct:description>
    <pav:createdOn>2014-07-21 21:47:18 -0400</pav:createdOn>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812eda990003</pav:createdBy>
    <permissions:permissions rdf:nodeID="Nde8cf1713a904f2f8ec50fd4d3db4095"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:F1EC2D5D-E8AA-4BAB-8BCE-D86C722E5855"/>
    <pav:lastSavedOn>2014-07-21 21:49:33 -0400</pav:lastSavedOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#AnnotationSet"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:EDF86F62-D99C-4656-9677-171A5B522535"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:FE17741D-F10F-4662-94F4-BB9A69F3D7F4"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:B2987A9F-B765-4C33-B2FF-1E55869E162F">
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <domeo:uuid>B2987A9F-B765-4C33-B2FF-1E55869E162F</domeo:uuid>
    <ao:exact>metformin</ao:exact>
    <ao:prefix>. Since </ao:prefix>
    <pav:createdOn>2014-07-22 19:37:19 -0400</pav:createdOn>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-123.txt.html</ao:hasSource>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:B2987A9F-B765-4C33-B2FF-1E55869E162F"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:suffix> is contraindicated in patients with renal impairment, coadministration of metformin with AVANDIA is contraindicated in these patients.</ao:suffix>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:E0476DD8-15DF-4D2C-ADC4-C5C80BA1F15B">
    <ao:exact>cholestyramine</ao:exact>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-131.txt.html</ao:hasSource>
    <ao:suffix> or colestipol with propranolol resulted in up to 50% decrease in propranolol concentrations.</ao:suffix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:E0476DD8-15DF-4D2C-ADC4-C5C80BA1F15B"/>
    <domeo:uuid>E0476DD8-15DF-4D2C-ADC4-C5C80BA1F15B</domeo:uuid>
    <ao:prefix>Co-administration of </ao:prefix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <pav:createdOn>2014-07-24 19:47:39 -0400</pav:createdOn>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:FB09B648-AD4B-44C2-AE1F-42FAB75A314E">
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:lineageUri>urn:domeoserver:annotation:2E93B705-88F1-45AA-8E94-53BE72B4DA55</pav:lineageUri>
    <pav:createdOn>2014-09-01 16:22:02 -0400</pav:createdOn>
    <ao:context rdf:resource="urn:domeoclient:uuid:034AD896-FB93-4F64-9796-CB98DF23644B"/>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <rdfs:label>Highlight</rdfs:label>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812eda990003</pav:createdBy>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <domeo:belongsToSet>urn:domeoclient:uuid:215CE713-9F50-45C2-808D-0725CC11DF6D</domeo:belongsToSet>
    <pav:lastSavedOn>2014-09-01 16:22:41 -0400</pav:lastSavedOn>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:42423629-C409-4AD4-BBE6-7C86A696F03E">
    <domeo:belongsToSet>urn:domeoclient:uuid:FCA2BF23-0BE3-409F-9177-761812F96097</domeo:belongsToSet>
    <pav:lastSavedOn>2014-07-07 09:44:19 -0400</pav:lastSavedOn>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812eda990003</pav:createdBy>
    <pav:createdOn>2014-07-07 09:41:41 -0400</pav:createdOn>
    <pav:lineageUri>urn:domeoserver:annotationset:76FD4BB5-DE2F-4FCA-B93D-302185B1A381</pav:lineageUri>
    <domeo:belongsToSet>urn:domeoserver:annotationset:22ED7220-C6F6-43C5-9DF9-89F62F0F8E27</domeo:belongsToSet>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:lastSavedOn>2014-07-07 09:44:18 -0400</pav:lastSavedOn>
    <domeo:belongsToSet>urn:domeoserver:annotationset:8F3CF3D9-AADE-4A86-BD42-2924B3D6A406</domeo:belongsToSet>
    <ao:context rdf:resource="urn:domeoclient:uuid:6791DC23-BC40-4E62-815B-0DA5CCA7BD4F"/>
    <domeo:belongsToSet>urn:domeoserver:annotationset:7AACEF8D-2EBC-4F0B-94B2-190650E562F6</domeo:belongsToSet>
    <pav:lineageUri>urn:domeoserver:annotation:219B0F32-F586-4381-AC89-B73DA847B68D</pav:lineageUri>
    <rdfs:label>Highlight</rdfs:label>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <domeo:belongsToSet>urn:domeoserver:annotationset:131835A3-C655-4F91-97D4-52CAFF7B7CCA</domeo:belongsToSet>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <domeo:belongsToSet>urn:domeoserver:annotationset:08C0C288-6DF4-43E6-A618-71A8BB9563C3</domeo:belongsToSet>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:62CFF353-D9DB-4975-A77C-87D5AE3C0CCA">
    <ao:suffix> are not influenced by age, race, smoking, or alcohol consumption. Both oral clearance (CL/F) and oral steady-state volume of distribution (Vss/F) were shown to increase with increases in body weight. Over the weight range observed in these analyses (50 </ao:suffix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <pav:createdOn>2014-07-22 19:28:40 -0400</pav:createdOn>
    <domeo:uuid>62CFF353-D9DB-4975-A77C-87D5AE3C0CCA</domeo:uuid>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:62CFF353-D9DB-4975-A77C-87D5AE3C0CCA"/>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-123.txt.html</ao:hasSource>
    <ao:exact>rosiglitazone</ao:exact>
    <ao:prefix>Population pharmacokinetic analyses from 3 large clinical trials including 642 men and 405 women with type 2 diabetes (aged 35 to 80 years) showed that the pharmacokinetics of </ao:prefix>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:9A220CC1-B0E4-46E3-92ED-BA102CB9A99F">
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/PK_DDI"/>
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/E2F95CEA-24A5-407F-856C-8C142EEA5626"/>
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/D17A3686-1703-468A-9054-837449C245F1"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:BF575835-131F-4DD9-876A-6D2B6D7A7744">
    <ao:suffix> every 12 hours. This resulted in increases in steady state atomoxetine AUC values that were 6- to 8-fold greater and in atomoxetine Cmax values that were 3- to 4-fold greater than when atomoxetine was given alone. Dosage adjustment of atomoxetine may be</ao:suffix>
    <ao:exact>atomoxetine</ao:exact>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-47.txt.html</ao:hasSource>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:BF575835-131F-4DD9-876A-6D2B6D7A7744"/>
    <ao:prefix> 20 mg daily was given in combination with 20 mg </ao:prefix>
    <pav:createdOn>2014-09-02 11:58:31 -0400</pav:createdOn>
    <domeo:uuid>BF575835-131F-4DD9-876A-6D2B6D7A7744</domeo:uuid>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:74381157-1392-49DE-BD6B-8C71824715BF">
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-123.txt.html</ao:hasSource>
    <ao:prefix>, </ao:prefix>
    <pav:createdOn>2014-07-22 19:31:30 -0400</pav:createdOn>
    <ao:exact>AVANDIA</ao:exact>
    <domeo:uuid>74381157-1392-49DE-BD6B-8C71824715BF</domeo:uuid>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:suffix> improved glycemic control in both males and females. In metformin combination studies, efficacy was demonstrated with no gender differences in glycemic response.</ao:suffix>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:74381157-1392-49DE-BD6B-8C71824715BF"/>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/DA01DC4D-57B2-4142-A8DB-72DB578A27AD">
    <rdfs:label>fexofenadine hydrochloride</rdfs:label>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/active-ingredient"/>
    <dct:description>Referred to the drug in the interaction.</dct:description>
    <sio:SIO_000228>dikbD2R:object-drug-of-interaction</sio:SIO_000228>
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/236474</dailymed:activeMoietyRxCUI>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:140EFF4D-9D91-427D-B48B-7B1FAFA2E5CF">
    <pav:createdOn>2014-09-02 11:44:39 -0400</pav:createdOn>
    <pav:lastSavedOn>2014-09-02 11:46:59 -0400</pav:lastSavedOn>
    <pav:lineageUri>urn:domeoserver:annotation:C39C3AE8-54D3-494B-AC04-67C45DEF42CC</pav:lineageUri>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:lineageUri>urn:domeoserver:annotationset:D1715BD2-BD41-46FD-9454-DC7A423A29AC</pav:lineageUri>
    <ao:context rdf:resource="urn:domeoclient:uuid:5841BCC9-42A5-4486-AA8B-635392DB4438"/>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">2</pav:versionNumber>
    <rdfs:label>Highlight</rdfs:label>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812eda990003</pav:createdBy>
    <pav:previousVersion>urn:domeoclient:uuid:BED41F06-565A-4622-9A88-48810E5A28DE</pav:previousVersion>
    <pav:lastSavedOn>2014-09-02 11:46:58 -0400</pav:lastSavedOn>
    <domeo:belongsToSet>urn:domeoserver:annotationset:A3F0B39A-4249-4B63-BB0D-F24A005066AC</domeo:belongsToSet>
    <domeo:belongsToSet>urn:domeoserver:annotationset:A5DD001D-C81A-4E2E-B5E0-7A866B35E26B</domeo:belongsToSet>
    <domeo:belongsToSet>urn:domeoserver:annotationset:3F546823-204F-4F9B-9006-3DC526C56931</domeo:belongsToSet>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:F5A32BEB-91E7-4E38-9495-09168C9EA7B8">
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#expertstudyAnnotation"/>
    <rdfs:label>expertstudy Annotation</rdfs:label>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:createdOn>2014-07-22 18:36:48 -0400</pav:createdOn>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812eda990003</pav:createdBy>
    <ao:context rdf:resource="urn:domeoclient:uuid:CDDC5F6F-E40F-4F4A-BB7A-C77A3A968B0B"/>
    <pav:lastSavedOn>2014-07-22 18:36:37 -0400</pav:lastSavedOn>
    <domeo:belongsToSet>urn:domeoclient:uuid:040380DC-30D6-454D-ACD7-489B2130A9CC</domeo:belongsToSet>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <ao:body rdf:nodeID="N4d885807613045c1b8c2bf4351085fa7"/>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <pav:lineageUri>urn:domeoserver:annotation:72EBC805-5C38-43F6-B5A7-655F7D1D8C4C</pav:lineageUri>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:5A444D2E-FB37-4D42-8D22-19CAC1F671D0">
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <domeo:uuid>5A444D2E-FB37-4D42-8D22-19CAC1F671D0</domeo:uuid>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-47.txt.html</ao:hasSource>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:5A444D2E-FB37-4D42-8D22-19CAC1F671D0"/>
    <pav:createdOn>2014-09-02 12:02:51 -0400</pav:createdOn>
    <ao:suffix> (100 mg) Cmax, AUC, and T½ by an average of approximately 2-, 5-, and 3-fold, respectively. Concomitant use of paroxetine with risperidone, a CYP2D6 substrate has also been evaluated. In 1 study, daily dosing of paroxetine 20 mg in patients stabilized o</ao:suffix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:prefix>  (20 mg once daily) under steady-state conditions increased single-dose </ao:prefix>
    <ao:exact>desipramine</ao:exact>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:B6681C81-EA03-49F0-8187-EF5752C9D126">
    <domeo:belongsToSet>urn:domeoclient:uuid:BE4B86AC-FE5F-4543-A713-EC5B852A5A2A</domeo:belongsToSet>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:lastSavedOn>2014-07-22 19:11:40 -0400</pav:lastSavedOn>
    <pav:lineageUri>urn:domeoserver:annotation:24F88180-EA99-461B-9796-C5E98B1CB3C9</pav:lineageUri>
    <pav:lastSavedOn>2014-07-22 19:11:41 -0400</pav:lastSavedOn>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812eda990003</pav:createdBy>
    <domeo:belongsToSet>urn:domeoserver:annotationset:606A5B3F-B6FB-4279-AA42-7893CFC2D20C</domeo:belongsToSet>
    <domeo:belongsToSet>urn:domeoserver:annotationset:7021B883-FD5C-4083-BD87-DF56D3C87633</domeo:belongsToSet>
    <domeo:belongsToSet>urn:domeoserver:annotationset:7E80543E-BF76-4514-92A9-91458DCB802B</domeo:belongsToSet>
    <domeo:belongsToSet>urn:domeoserver:annotationset:514BA51B-D734-4003-A7C3-F03C0F95833A</domeo:belongsToSet>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <ao:context rdf:resource="urn:domeoclient:uuid:9ED864DE-C2BC-4B14-881F-AFD561FC58D1"/>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <pav:createdOn>2014-07-22 19:11:40 -0400</pav:createdOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <domeo:belongsToSet>urn:domeoserver:annotationset:2914A3FD-DF43-4F78-999C-77CE7A028B19</domeo:belongsToSet>
    <rdfs:label>Highlight</rdfs:label>
    <domeo:belongsToSet>urn:domeoserver:annotationset:F272A789-69D0-47CC-8CC9-F25C55B91261</domeo:belongsToSet>
    <pav:lineageUri>urn:domeoserver:annotationset:AB1741F1-5A5F-4416-AEAC-A544BCBB7D16</pav:lineageUri>
    <domeo:belongsToSet>urn:domeoserver:annotationset:467D4F28-D086-4217-9DE0-23E165F30716</domeo:belongsToSet>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:3E33C30E-6EC7-463F-A8C1-B699338A149B">
    <pav:lastSavedOn>2014-07-22 19:40:31 -0400</pav:lastSavedOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#expertstudyAnnotation"/>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">5</pav:versionNumber>
    <domeo:belongsToSet>urn:domeoserver:annotationset:F272A789-69D0-47CC-8CC9-F25C55B91261</domeo:belongsToSet>
    <ao:context rdf:resource="urn:domeoclient:uuid:A788721A-520C-402D-95A4-65EC994B3F25"/>
    <ao:body rdf:nodeID="Na443844cba664ce7bec9cb7102024110"/>
    <ao:body rdf:nodeID="N8e07f133bf774d7397e9bf67b9759e19"/>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812eda990003</pav:createdBy>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <rdfs:label>expertstudy Annotation</rdfs:label>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <domeo:belongsToSet>urn:domeoserver:annotationset:606A5B3F-B6FB-4279-AA42-7893CFC2D20C</domeo:belongsToSet>
    <ao:body rdf:nodeID="N8d9f93872ec744fdb315e073c71343eb"/>
    <pav:lastSavedOn>2014-07-22 19:40:32 -0400</pav:lastSavedOn>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <pav:lineageUri>urn:domeoserver:annotation:E4C9BC85-6205-4191-8217-044D31C9ABE4</pav:lineageUri>
    <domeo:belongsToSet>urn:domeoserver:annotationset:514BA51B-D734-4003-A7C3-F03C0F95833A</domeo:belongsToSet>
    <domeo:belongsToSet>urn:domeoserver:annotationset:2914A3FD-DF43-4F78-999C-77CE7A028B19</domeo:belongsToSet>
    <pav:createdOn>2014-07-22 19:40:41 -0400</pav:createdOn>
    <pav:lineageUri>urn:domeoserver:annotationset:AB1741F1-5A5F-4416-AEAC-A544BCBB7D16</pav:lineageUri>
    <pav:previousVersion>urn:domeoserver:annotationset:7021B883-FD5C-4083-BD87-DF56D3C87633</pav:previousVersion>
    <ao:body rdf:nodeID="Nc7bf281fc5664d4cb1298129cce93627"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:B1EDC65E-7D2E-4E9E-9D08-0D72BD366C29">
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <domeo:belongsToSet>urn:domeoserver:annotationset:7E80543E-BF76-4514-92A9-91458DCB802B</domeo:belongsToSet>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">3</pav:versionNumber>
    <pav:createdOn>2014-07-22 19:26:15 -0400</pav:createdOn>
    <domeo:belongsToSet>urn:domeoserver:annotationset:606A5B3F-B6FB-4279-AA42-7893CFC2D20C</domeo:belongsToSet>
    <pav:previousVersion>urn:domeoserver:annotationset:467D4F28-D086-4217-9DE0-23E165F30716</pav:previousVersion>
    <domeo:belongsToSet>urn:domeoserver:annotationset:F272A789-69D0-47CC-8CC9-F25C55B91261</domeo:belongsToSet>
    <pav:lastSavedOn>2014-07-22 19:28:02 -0400</pav:lastSavedOn>
    <domeo:belongsToSet>urn:domeoserver:annotationset:2914A3FD-DF43-4F78-999C-77CE7A028B19</domeo:belongsToSet>
    <domeo:belongsToSet>urn:domeoserver:annotationset:514BA51B-D734-4003-A7C3-F03C0F95833A</domeo:belongsToSet>
    <pav:lineageUri>urn:domeoserver:annotation:37DF83DB-1EA2-4D02-960E-F0B97D97CBD0</pav:lineageUri>
    <ao:context rdf:resource="urn:domeoclient:uuid:97B4DA35-A3A0-41E4-9927-06388A15995F"/>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <domeo:belongsToSet>urn:domeoserver:annotationset:7021B883-FD5C-4083-BD87-DF56D3C87633</domeo:belongsToSet>
    <pav:lineageUri>urn:domeoserver:annotationset:AB1741F1-5A5F-4416-AEAC-A544BCBB7D16</pav:lineageUri>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812eda990003</pav:createdBy>
    <rdfs:label>Highlight</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:09BC9686-C635-41F7-85A0-6560EB1B0E1B">
    <pav:lineageUri>urn:domeoserver:annotation:335F50B9-E22A-4E09-99C0-34C4EF941E22</pav:lineageUri>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812eda990003</pav:createdBy>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <pav:createdOn>2014-09-01 16:12:00 -0400</pav:createdOn>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <domeo:belongsToSet>urn:domeoclient:uuid:5D381360-05CD-407C-BAB9-6496A42C73E4</domeo:belongsToSet>
    <pav:lastSavedOn>2014-09-01 16:12:36 -0400</pav:lastSavedOn>
    <ao:context rdf:resource="urn:domeoclient:uuid:1E61DE2D-66C2-4CB4-9D74-6D8DC468ABA3"/>
    <rdfs:label>Highlight</rdfs:label>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:05DDDFF9-6ACB-4806-8A4D-37A221046E18">
    <ao:prefix> and </ao:prefix>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-9.txt.html</ao:hasSource>
    <domeo:uuid>05DDDFF9-6ACB-4806-8A4D-37A221046E18</domeo:uuid>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:05DDDFF9-6ACB-4806-8A4D-37A221046E18"/>
    <pav:createdOn>2014-09-02 11:40:15 -0400</pav:createdOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:exact>lithium</ao:exact>
    <ao:suffix>.</ao:suffix>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:DC83EF48-BF8E-4B34-9782-4DFBE01FA8AA">
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:exact>ampicillin </ao:exact>
    <ao:suffix>esters, and iron salts). In the clinical trials, antacids were used concomitantly with the administration of omeprazole delayed-release capsules USP.</ao:suffix>
    <ao:prefix>, </ao:prefix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:DC83EF48-BF8E-4B34-9782-4DFBE01FA8AA"/>
    <pav:createdOn>2014-09-02 19:12:10 -0400</pav:createdOn>
    <domeo:uuid>DC83EF48-BF8E-4B34-9782-4DFBE01FA8AA</domeo:uuid>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-74.txt.html</ao:hasSource>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:C08A8D30-A040-45EF-9873-91013299399D">
    <pav:createdOn>2014-09-02 11:30:17 -0400</pav:createdOn>
    <ao:prefix> and the cytochrome P450 isoenzyme system has been obtained mostly from pharmacokinetic interaction studies conducted in healthy volunteers, but some preliminary in vitro data are also available. Based on a finding of substantial interactions of </ao:prefix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:suffix> with certain of these drugs (see later parts of this section and also WARNINGS AND PRECAUTIONS [5]) and limited in vitro data for CYP3A4, it appears that fluvoxamine inhibits several cytochrome P450 isoenzymes that are known to be involved in the metabo</ao:suffix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:C08A8D30-A040-45EF-9873-91013299399D"/>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-9.txt.html</ao:hasSource>
    <domeo:uuid>C08A8D30-A040-45EF-9873-91013299399D</domeo:uuid>
    <ao:exact>fluvoxamine</ao:exact>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/49D3BE30-05A4-4698-AD40-671451F49C7C">
    <rdfs:label>fluconazole</rdfs:label>
    <sio:SIO_000228>dikbD2R:precipitant-drug-of-interaction</sio:SIO_000228>
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/4450</dailymed:activeMoietyRxCUI>
    <dct:description>Referred to the drug in the interaction.</dct:description>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/active-ingredient"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:2FC7CD9D-9CBA-4723-8996-9E721AB52D4A">
    <pav:createdOn>2014-07-22 19:07:10 -0400</pav:createdOn>
    <rdfs:label>Highlight</rdfs:label>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <domeo:belongsToSet>urn:domeoserver:annotationset:2B18F6B1-59F7-4EA0-9386-55A934108055</domeo:belongsToSet>
    <ao:context rdf:resource="urn:domeoclient:uuid:2C00A54D-2DAC-4CE9-9A86-5591EF7E3323"/>
    <pav:lastSavedOn>2014-07-22 19:08:05 -0400</pav:lastSavedOn>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812eda990003</pav:createdBy>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:lineageUri>urn:domeoserver:annotation:9A8A293B-262D-43EF-8C00-7D4DBC75FC6D</pav:lineageUri>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:FD9D4BD5-A390-4CD6-8FF4-21ABE76D596A">
    <pav:lineageUri>urn:domeoserver:annotation:4B02B1E0-9F20-40AA-9E20-12AD253C4462</pav:lineageUri>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <rdfs:label>Highlight</rdfs:label>
    <pav:lastSavedOn>2014-07-13 11:32:29 -0400</pav:lastSavedOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:createdOn>2014-07-13 11:17:12 -0400</pav:createdOn>
    <domeo:belongsToSet>urn:domeoclient:uuid:71191E51-53CB-4FDE-88D0-33C6818E2232</domeo:belongsToSet>
    <ao:context rdf:resource="urn:domeoclient:uuid:CB01A892-8D67-4A38-8CA4-2D230875A1F6"/>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812eda990003</pav:createdBy>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:AF3F948A-978C-448B-972C-FC7423B8770D">
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:prefix> with </ao:prefix>
    <ao:suffix> resulted in up to 50% decrease in propranolol concentrations.</ao:suffix>
    <pav:createdOn>2014-07-24 19:51:25 -0400</pav:createdOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:AF3F948A-978C-448B-972C-FC7423B8770D"/>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-131.txt.html</ao:hasSource>
    <domeo:uuid>AF3F948A-978C-448B-972C-FC7423B8770D</domeo:uuid>
    <ao:exact>propranolol</ao:exact>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:62793798-1CBD-4B4E-97DB-09E6DED152F0">
    <pav:createdOn>2014-09-02 19:12:43 -0400</pav:createdOn>
    <pav:lineageUri>urn:domeoserver:annotationset:C5DEBC9B-77EE-4243-88EB-DBC19737ACD2</pav:lineageUri>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812eda990003</pav:createdBy>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:lastSavedOn>2014-09-02 19:19:47 -0400</pav:lastSavedOn>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:lineageUri>urn:domeoserver:annotation:1F9BE1C1-D852-4A55-8413-A79523ED1FBB</pav:lineageUri>
    <rdfs:label>Highlight</rdfs:label>
    <domeo:belongsToSet>urn:domeoserver:annotationset:392EE0FB-AC4F-4AF2-87A6-2E50A281F434</domeo:belongsToSet>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <domeo:belongsToSet>urn:domeoserver:annotationset:E32812A9-205B-4EE1-B488-A1E294EDBFB9</domeo:belongsToSet>
    <ao:context rdf:resource="urn:domeoclient:uuid:9802981C-E3CC-427F-9464-29E20B17C0CD"/>
    <domeo:belongsToSet>urn:domeoclient:uuid:CB83FFC2-EA71-44EA-8F11-DE80E389C84E</domeo:belongsToSet>
    <pav:previousVersion>xsd:String</pav:previousVersion>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:745E9BC2-9930-4FE0-83A2-11668B70C40A">
    <pav:lineageUri>urn:domeoserver:annotationset:AB1741F1-5A5F-4416-AEAC-A544BCBB7D16</pav:lineageUri>
    <pav:createdOn>2014-07-22 19:41:54 -0400</pav:createdOn>
    <domeo:belongsToSet>urn:domeoserver:annotationset:F272A789-69D0-47CC-8CC9-F25C55B91261</domeo:belongsToSet>
    <rdfs:label>Highlight</rdfs:label>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <domeo:belongsToSet>urn:domeoserver:annotationset:2914A3FD-DF43-4F78-999C-77CE7A028B19</domeo:belongsToSet>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">6</pav:versionNumber>
    <ao:context rdf:resource="urn:domeoclient:uuid:0A0256F1-F31A-4A0C-BA59-EC817B22A85D"/>
    <domeo:belongsToSet>urn:domeoserver:annotationset:606A5B3F-B6FB-4279-AA42-7893CFC2D20C</domeo:belongsToSet>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812eda990003</pav:createdBy>
    <pav:lineageUri>urn:domeoserver:annotation:F3496B6B-271D-4B20-ABDB-6DF59B584316</pav:lineageUri>
    <pav:previousVersion>urn:domeoserver:annotationset:514BA51B-D734-4003-A7C3-F03C0F95833A</pav:previousVersion>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:lastSavedOn>2014-07-22 19:44:46 -0400</pav:lastSavedOn>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:E15B413C-BEDB-4A09-B61C-CC07F96666DD">
    <rdfs:label>Highlight</rdfs:label>
    <domeo:belongsToSet>urn:domeoserver:annotationset:A3F0B39A-4249-4B63-BB0D-F24A005066AC</domeo:belongsToSet>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">2</pav:versionNumber>
    <pav:lastSavedOn>2014-09-02 11:46:58 -0400</pav:lastSavedOn>
    <pav:lineageUri>urn:domeoserver:annotation:B090E480-D181-4410-A655-783F2B6C4AB7</pav:lineageUri>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:createdOn>2014-09-02 11:46:29 -0400</pav:createdOn>
    <domeo:belongsToSet>urn:domeoserver:annotationset:3F546823-204F-4F9B-9006-3DC526C56931</domeo:belongsToSet>
    <domeo:belongsToSet>urn:domeoserver:annotationset:A5DD001D-C81A-4E2E-B5E0-7A866B35E26B</domeo:belongsToSet>
    <pav:lastSavedOn>2014-09-02 11:46:59 -0400</pav:lastSavedOn>
    <pav:previousVersion>urn:domeoclient:uuid:BED41F06-565A-4622-9A88-48810E5A28DE</pav:previousVersion>
    <ao:context rdf:resource="urn:domeoclient:uuid:C91687BB-8074-4878-8273-7F14FC861404"/>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812eda990003</pav:createdBy>
    <pav:lineageUri>urn:domeoserver:annotationset:D1715BD2-BD41-46FD-9454-DC7A423A29AC</pav:lineageUri>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:8E221E79-602A-4812-8488-538D6506C879">
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <domeo:belongsToSet>urn:domeoclient:uuid:71191E51-53CB-4FDE-88D0-33C6818E2232</domeo:belongsToSet>
    <pav:createdOn>2014-07-13 11:17:48 -0400</pav:createdOn>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812eda990003</pav:createdBy>
    <pav:lastSavedOn>2014-07-13 11:32:29 -0400</pav:lastSavedOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <ao:context rdf:resource="urn:domeoclient:uuid:AD57239D-3225-4F0C-8054-FBD32976EE0C"/>
    <pav:lineageUri>urn:domeoserver:annotation:99FCA5E3-D174-4EE6-A00A-E8CEB0ED9FB4</pav:lineageUri>
    <rdfs:label>Highlight</rdfs:label>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:previousVersion>xsd:String</pav:previousVersion>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:4411E759-9248-468B-B2F6-E5A5A8657C4C">
    <pav:lineageUri>urn:domeoserver:annotation:DF844E38-9CBB-4BB8-AACB-E91F5B0E4767</pav:lineageUri>
    <pav:previousVersion>urn:domeoserver:annotationset:467D4F28-D086-4217-9DE0-23E165F30716</pav:previousVersion>
    <rdfs:label>Highlight</rdfs:label>
    <domeo:belongsToSet>urn:domeoserver:annotationset:F272A789-69D0-47CC-8CC9-F25C55B91261</domeo:belongsToSet>
    <domeo:belongsToSet>urn:domeoserver:annotationset:7E80543E-BF76-4514-92A9-91458DCB802B</domeo:belongsToSet>
    <domeo:belongsToSet>urn:domeoserver:annotationset:606A5B3F-B6FB-4279-AA42-7893CFC2D20C</domeo:belongsToSet>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:lastSavedOn>2014-07-22 19:28:02 -0400</pav:lastSavedOn>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">3</pav:versionNumber>
    <domeo:belongsToSet>urn:domeoserver:annotationset:2914A3FD-DF43-4F78-999C-77CE7A028B19</domeo:belongsToSet>
    <pav:createdOn>2014-07-22 19:28:08 -0400</pav:createdOn>
    <domeo:belongsToSet>urn:domeoserver:annotationset:514BA51B-D734-4003-A7C3-F03C0F95833A</domeo:belongsToSet>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <domeo:belongsToSet>urn:domeoserver:annotationset:7021B883-FD5C-4083-BD87-DF56D3C87633</domeo:belongsToSet>
    <pav:lineageUri>urn:domeoserver:annotationset:AB1741F1-5A5F-4416-AEAC-A544BCBB7D16</pav:lineageUri>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812eda990003</pav:createdBy>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <ao:context rdf:resource="urn:domeoclient:uuid:643A5ED0-8507-40E4-BF8F-798721470D41"/>
    <pav:previousVersion>xsd:String</pav:previousVersion>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:3D22E6FA-B90D-49C2-B42F-B8122D48D82A">
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812eda990003</pav:createdBy>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <domeo:belongsToSet>urn:domeoserver:annotationset:22ED7220-C6F6-43C5-9DF9-89F62F0F8E27</domeo:belongsToSet>
    <rdfs:label>Highlight</rdfs:label>
    <domeo:belongsToSet>urn:domeoserver:annotationset:7AACEF8D-2EBC-4F0B-94B2-190650E562F6</domeo:belongsToSet>
    <domeo:belongsToSet>urn:domeoserver:annotationset:8F3CF3D9-AADE-4A86-BD42-2924B3D6A406</domeo:belongsToSet>
    <ao:context rdf:resource="urn:domeoclient:uuid:62F3C932-C305-4581-AA4E-BB34C6D0F7D4"/>
    <pav:lineageUri>urn:domeoserver:annotation:462DD4AC-A4D5-481B-AE25-173C924C4620</pav:lineageUri>
    <pav:createdOn>2014-07-07 11:22:45 -0400</pav:createdOn>
    <domeo:belongsToSet>urn:domeoserver:annotationset:131835A3-C655-4F91-97D4-52CAFF7B7CCA</domeo:belongsToSet>
    <pav:lastSavedOn>2014-07-07 11:24:52 -0400</pav:lastSavedOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:DC13A4FA-8B30-458B-9343-4B48CC945EBF">
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812eda990003</pav:createdBy>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <domeo:belongsToSet>urn:domeoclient:uuid:CB83FFC2-EA71-44EA-8F11-DE80E389C84E</domeo:belongsToSet>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:lineageUri>urn:domeoserver:annotationset:C5DEBC9B-77EE-4243-88EB-DBC19737ACD2</pav:lineageUri>
    <pav:lineageUri>urn:domeoserver:annotation:55446F64-5506-47A7-B57B-B769A09C51E4</pav:lineageUri>
    <pav:createdOn>2014-09-02 19:13:14 -0400</pav:createdOn>
    <domeo:belongsToSet>urn:domeoserver:annotationset:E32812A9-205B-4EE1-B488-A1E294EDBFB9</domeo:belongsToSet>
    <pav:lastSavedOn>2014-09-02 19:19:47 -0400</pav:lastSavedOn>
    <rdfs:label>Highlight</rdfs:label>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <ao:context rdf:resource="urn:domeoclient:uuid:25585F8F-7F91-467C-B8DE-9153331081D5"/>
    <domeo:belongsToSet>urn:domeoserver:annotationset:392EE0FB-AC4F-4AF2-87A6-2E50A281F434</domeo:belongsToSet>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
  </rdf:Description>
  <rdf:Description rdf:nodeID="Nb30e482b535a4cbfa38da60936fb469b">
    <domeo:sets rdf:resource="urn:pddi:uuid:799D7550-4333-4600-A69B-DE23093443A4"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:DF3B3F8F-7CB0-4DA2-B24E-32B9E66603BF">
    <ao:context rdf:resource="urn:domeoclient:uuid:4989A785-0867-4672-982C-3FCFF8AB4F7A"/>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <domeo:belongsToSet>urn:domeoclient:uuid:8D86A4AC-54BD-4BB3-8B58-AB55DEC01A88</domeo:belongsToSet>
    <pav:createdOn>2014-07-24 20:05:33 -0400</pav:createdOn>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <domeo:belongsToSet>urn:domeoserver:annotationset:1FC172B8-8AC3-465A-AA69-B73AD9B97CBC</domeo:belongsToSet>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:lastSavedOn>2014-07-24 20:07:19 -0400</pav:lastSavedOn>
    <pav:lastSavedOn>2014-07-24 20:07:20 -0400</pav:lastSavedOn>
    <domeo:belongsToSet>urn:domeoserver:annotationset:37B2514D-1A92-45B1-8A5C-610DA6DC935A</domeo:belongsToSet>
    <pav:lineageUri>urn:domeoserver:annotation:749E55D3-D439-4C34-8142-4475E1D52C79</pav:lineageUri>
    <pav:lineageUri>urn:domeoserver:annotationset:4A88D0A6-E9B6-4E7F-955F-3692600C178C</pav:lineageUri>
    <rdfs:label>Highlight</rdfs:label>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812eda990003</pav:createdBy>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:752D3341-6554-481E-A205-06C244A6CD0A">
    <pav:lineageUri>urn:domeoserver:annotation:632B82EF-22AD-4B0E-97DC-A03C1CE546AB</pav:lineageUri>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812eda990003</pav:createdBy>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <ao:context rdf:resource="urn:domeoclient:uuid:AFC067D9-3DC4-4FB0-B028-1D222EE28907"/>
    <pav:lastSavedOn>2014-09-02 15:04:32 -0400</pav:lastSavedOn>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:createdOn>2014-09-02 15:04:18 -0400</pav:createdOn>
    <domeo:belongsToSet>urn:domeoclient:uuid:C4B80A95-F569-4ED4-84D1-6796B53A580C</domeo:belongsToSet>
    <rdfs:label>Highlight</rdfs:label>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:A0645479-B3CA-4505-B451-B003C3B19554">
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:lineageUri>urn:domeoserver:annotation:EABDAFD6-3CCF-4D2C-BD80-C1DB3A591C0B</pav:lineageUri>
    <pav:createdOn>2014-07-13 12:44:25 -0400</pav:createdOn>
    <pav:lastSavedOn>2014-07-13 12:45:54 -0400</pav:lastSavedOn>
    <domeo:belongsToSet>urn:domeoclient:uuid:23567EF7-7482-444A-B1F6-5AAA9D43E54A</domeo:belongsToSet>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <ao:context rdf:resource="urn:domeoclient:uuid:195005D8-3CE9-43AD-A3D8-56739DB440A4"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812eda990003</pav:createdBy>
    <rdfs:label>Highlight</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:CAAFBBB8-299E-4407-AECC-19F6B511D24C">
    <domeo:belongsToSet>urn:domeoserver:annotationset:A5DD001D-C81A-4E2E-B5E0-7A866B35E26B</domeo:belongsToSet>
    <pav:lastSavedOn>2014-09-02 11:46:58 -0400</pav:lastSavedOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:createdOn>2014-09-02 11:42:13 -0400</pav:createdOn>
    <domeo:belongsToSet>urn:domeoserver:annotationset:3F546823-204F-4F9B-9006-3DC526C56931</domeo:belongsToSet>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812eda990003</pav:createdBy>
    <ao:context rdf:resource="urn:domeoclient:uuid:76579336-5224-465A-A966-852EF8B65F10"/>
    <pav:lineageUri>urn:domeoserver:annotationset:D1715BD2-BD41-46FD-9454-DC7A423A29AC</pav:lineageUri>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <rdfs:label>Highlight</rdfs:label>
    <pav:previousVersion>urn:domeoclient:uuid:BED41F06-565A-4622-9A88-48810E5A28DE</pav:previousVersion>
    <domeo:belongsToSet>urn:domeoserver:annotationset:A3F0B39A-4249-4B63-BB0D-F24A005066AC</domeo:belongsToSet>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">2</pav:versionNumber>
    <pav:lineageUri>urn:domeoserver:annotation:6CA3CE4B-C0B6-463D-9DA7-0DC6DABCFBF9</pav:lineageUri>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:E0054F81-6A9B-4AF0-9DCB-962A6FC1C418">
    <permissions:permissions rdf:nodeID="Nf432dfe594e94869b2991605e242e024"/>
    <pav:lastSavedOn>2014-07-22 18:46:51 -0400</pav:lastSavedOn>
    <ao:item rdf:resource="urn:domeoclient:uuid:9E3F8352-2C14-46DC-9E50-892286D5905F"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#AnnotationSet"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:8B3FBAFB-BA3F-4404-86D8-EB3FEBC44D50"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:FFD8A436-5516-4F50-8C7E-7512116C24BA"/>
    <ao:annotatesResource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-118.txt.html</ao:annotatesResource>
    <dct:description>The default set is created automatically by Domeo when no other set is existing.</dct:description>
    <ao:item rdf:resource="urn:domeoclient:uuid:53D686B6-4D2E-4EA7-922E-FFE9A54F0AFC"/>
    <pav:createdOn>2014-07-22 18:44:30 -0400</pav:createdOn>
    <ao:item rdf:resource="urn:domeoclient:uuid:1DBDA3FA-5F1C-4CC1-9712-91AF1D9421C6"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:7BB31731-2995-4E32-A961-91EF24F0EEE7"/>
    <domeo:agents rdf:resource="urn:domeo:software:id:Domeo-2.1alpha-050"/>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <domeo:agents rdf:resource="urn:person:uuid:080e143046812afe0146812eda990003"/>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812eda990003</pav:createdBy>
    <ao:item rdf:resource="urn:domeoclient:uuid:170D0DFA-5641-4603-80E1-C79ED18CB7D8"/>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <ao:item rdf:resource="urn:domeoclient:uuid:5D477356-49DE-4F65-97BE-07989E4A1B92"/>
    <rdfs:label>Default Set</rdfs:label>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <domeo:deleted>false</domeo:deleted>
    <ao:item rdf:resource="urn:domeoclient:uuid:532BC8DC-5349-4E14-AC6A-60B992104491"/>
    <pav:lineageUri>urn:domeoserver:annotationset:BDA938F7-92DA-40E1-8207-1B5ED3889ECC</pav:lineageUri>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:C1707DB4-5B7C-4588-BAE0-034F66A1800B">
    <pav:lastSavedOn>2014-07-24 20:07:19 -0400</pav:lastSavedOn>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812eda990003</pav:createdBy>
    <domeo:belongsToSet>urn:domeoclient:uuid:8D86A4AC-54BD-4BB3-8B58-AB55DEC01A88</domeo:belongsToSet>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:lastSavedOn>2014-07-24 20:07:20 -0400</pav:lastSavedOn>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <domeo:belongsToSet>urn:domeoserver:annotationset:37B2514D-1A92-45B1-8A5C-610DA6DC935A</domeo:belongsToSet>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <domeo:belongsToSet>urn:domeoserver:annotationset:1FC172B8-8AC3-465A-AA69-B73AD9B97CBC</domeo:belongsToSet>
    <rdfs:label>Highlight</rdfs:label>
    <pav:lineageUri>urn:domeoserver:annotationset:4A88D0A6-E9B6-4E7F-955F-3692600C178C</pav:lineageUri>
    <pav:lineageUri>urn:domeoserver:annotation:054FFC45-F2BD-4E8C-B7A1-929D480AF27E</pav:lineageUri>
    <pav:createdOn>2014-07-24 20:07:29 -0400</pav:createdOn>
    <ao:context rdf:resource="urn:domeoclient:uuid:EFB91CD1-48E1-4F2E-9E33-D718A3D8D087"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:6E7448AD-8A84-4C38-A84C-AA12E07DD681">
    <pav:createdOn>2014-07-24 19:42:58 -0400</pav:createdOn>
    <domeo:uuid>6E7448AD-8A84-4C38-A84C-AA12E07DD681</domeo:uuid>
    <ao:exact>Verapamil</ao:exact>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-127.txt.html</ao:hasSource>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:prefix>. </ao:prefix>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:6E7448AD-8A84-4C38-A84C-AA12E07DD681"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:suffix> does not affect the pharmacokinetics of propranolol.</ao:suffix>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:5034993F-95BA-483B-9B77-F3B8E9E3CFC5">
    <ao:exact>Sertraline </ao:exact>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:prefix>xsd:String</ao:prefix>
    <ao:suffix>(100 mg) when administered to 10 healthy male subjects had no effect on the beta-adrenergic blocking ability of atenolol.</ao:suffix>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-18.txt.html</ao:hasSource>
    <pav:createdOn>2014-09-01 16:02:32 -0400</pav:createdOn>
    <domeo:uuid>5034993F-95BA-483B-9B77-F3B8E9E3CFC5</domeo:uuid>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:5034993F-95BA-483B-9B77-F3B8E9E3CFC5"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:6B6560EB-DD3A-4FD9-ACE8-690CA260DD8B">
    <domeo:belongsToSet>urn:domeoclient:uuid:71191E51-53CB-4FDE-88D0-33C6818E2232</domeo:belongsToSet>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <rdfs:label>Highlight</rdfs:label>
    <ao:context rdf:resource="urn:domeoclient:uuid:76258D2D-1630-4254-82ED-C3434163EAE3"/>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812eda990003</pav:createdBy>
    <pav:lastSavedOn>2014-07-13 11:32:29 -0400</pav:lastSavedOn>
    <pav:createdOn>2014-07-13 11:15:09 -0400</pav:createdOn>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:lineageUri>urn:domeoserver:annotation:45DFA268-E20B-41A7-BE0C-703868597D0E</pav:lineageUri>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:6EF1F67B-32D0-48C5-BEB7-6F545D96A5AA">
    <domeo:uuid>6EF1F67B-32D0-48C5-BEB7-6F545D96A5AA</domeo:uuid>
    <ao:exact>ritonavir</ao:exact>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:prefix>increased by 34%, the AUC increased 2.4 fold, the half-life increased by 2.2 fold, and the clearance decreased by 52%. Adverse effects including nausea, hypotension, and syncope were observed when </ao:prefix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:6EF1F67B-32D0-48C5-BEB7-6F545D96A5AA"/>
    <ao:suffix> and trazodone were coadministered.</ao:suffix>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-136.txt.html</ao:hasSource>
    <pav:createdOn>2014-07-24 20:02:30 -0400</pav:createdOn>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/AB6125AD-8476-408C-A170-B40BE6A511E4">
    <sio:SIO_000228>dikbD2R:precipitant-drug-of-interaction</sio:SIO_000228>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/active-ingredient"/>
    <rdfs:label>glyburide</rdfs:label>
    <dct:description>Referred to the drug in the interaction.</dct:description>
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/4815</dailymed:activeMoietyRxCUI>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:5488F065-12C7-4BC6-B53E-99FE4483B13A">
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-47.txt.html</ao:hasSource>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:exact>atomoxetine</ao:exact>
    <domeo:uuid>5488F065-12C7-4BC6-B53E-99FE4483B13A</domeo:uuid>
    <ao:prefix> AUC values that were 6- to 8-fold greater and in </ao:prefix>
    <pav:createdOn>2014-09-02 11:58:39 -0400</pav:createdOn>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:5488F065-12C7-4BC6-B53E-99FE4483B13A"/>
    <ao:suffix> Cmax values that were 3- to 4-fold greater than when atomoxetine was given alone. Dosage adjustment of atomoxetine may be necessary and it is recommended that atomoxetine be initiated at a reduced dose when given with paroxetine.</ao:suffix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:54B9529D-9030-4194-B66A-D7ECCBABED1F">
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812eda990003</pav:createdBy>
    <pav:createdOn>2014-07-07 09:37:41 -0400</pav:createdOn>
    <domeo:belongsToSet>urn:domeoclient:uuid:FCA2BF23-0BE3-409F-9177-761812F96097</domeo:belongsToSet>
    <pav:lineageUri>urn:domeoserver:annotationset:76FD4BB5-DE2F-4FCA-B93D-302185B1A381</pav:lineageUri>
    <domeo:belongsToSet>urn:domeoserver:annotationset:8F3CF3D9-AADE-4A86-BD42-2924B3D6A406</domeo:belongsToSet>
    <domeo:belongsToSet>urn:domeoserver:annotationset:7AACEF8D-2EBC-4F0B-94B2-190650E562F6</domeo:belongsToSet>
    <ao:context rdf:resource="urn:domeoclient:uuid:DBBBE91C-3E2F-469A-9254-58328E372FEA"/>
    <pav:lastSavedOn>2014-07-07 09:44:18 -0400</pav:lastSavedOn>
    <pav:lastSavedOn>2014-07-07 09:44:19 -0400</pav:lastSavedOn>
    <domeo:belongsToSet>urn:domeoserver:annotationset:22ED7220-C6F6-43C5-9DF9-89F62F0F8E27</domeo:belongsToSet>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <domeo:belongsToSet>urn:domeoserver:annotationset:08C0C288-6DF4-43E6-A618-71A8BB9563C3</domeo:belongsToSet>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <rdfs:label>Highlight</rdfs:label>
    <pav:lineageUri>urn:domeoserver:annotation:97175F26-BD6F-4CA9-819A-E5E6892969B4</pav:lineageUri>
    <domeo:belongsToSet>urn:domeoserver:annotationset:131835A3-C655-4F91-97D4-52CAFF7B7CCA</domeo:belongsToSet>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:4CEC1749-9AA0-4FDA-B649-6B3CDED4298A">
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <domeo:uuid>4CEC1749-9AA0-4FDA-B649-6B3CDED4298A</domeo:uuid>
    <ao:exact>fluconazole</ao:exact>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:4CEC1749-9AA0-4FDA-B649-6B3CDED4298A"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <pav:createdOn>2014-07-13 12:56:07 -0400</pav:createdOn>
    <ao:suffix>. There was a mean ± SD reduction in fluconazole AUC of 23% ± 9% (range: -13 to -42%). Apparent oral clearance of fluconazole increased 32% ± 17% (range: 16 to 72%). Fluconazole half-life decreased from 33.4 ± 4.4 hours to 26.8 ± 3.9 hours. (See PRECAUTI</ao:suffix>
    <ao:prefix> AUC and a significant increase in apparent oral clearance of </ao:prefix>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-24.txt.html</ao:hasSource>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:AD52F407-3F2E-43FA-A8DA-659510309A62">
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:createdOn>2014-09-01 16:22:20 -0400</pav:createdOn>
    <domeo:belongsToSet>urn:domeoclient:uuid:215CE713-9F50-45C2-808D-0725CC11DF6D</domeo:belongsToSet>
    <pav:lineageUri>urn:domeoserver:annotation:778C0BF9-5A4D-40AD-B741-BA2E9EEA8CD8</pav:lineageUri>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <rdfs:label>Highlight</rdfs:label>
    <pav:lastSavedOn>2014-09-01 16:22:41 -0400</pav:lastSavedOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812eda990003</pav:createdBy>
    <ao:context rdf:resource="urn:domeoclient:uuid:A4CCAADB-C549-4258-8D06-8971C53D94D8"/>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/B959D351-8EA8-4A27-AEBB-7E2C63519031">
    <sio:SIO_000228>dikbD2R:object-drug-of-interaction</sio:SIO_000228>
    <rdfs:label>ethanol</rdfs:label>
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/448</dailymed:activeMoietyRxCUI>
    <dct:description>Referred to the drug in the interaction.</dct:description>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/active-ingredient"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:F3B66F49-9D04-482E-BF7F-722441E81595">
    <pav:createdOn>2014-09-02 11:30:35 -0400</pav:createdOn>
    <ao:prefix>, </ao:prefix>
    <ao:exact>propranolol</ao:exact>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-9.txt.html</ao:hasSource>
    <domeo:uuid>F3B66F49-9D04-482E-BF7F-722441E81595</domeo:uuid>
    <ao:suffix>, tizanidine), CYP2C9 (e.g., warfarin), CYP3A4 (e.g., alprazolam), and CYP2C19 (e.g., omeprazole).</ao:suffix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:F3B66F49-9D04-482E-BF7F-722441E81595"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoserver:annotationset:37B2514D-1A92-45B1-8A5C-610DA6DC935A">
    <pav:previousVersion>urn:domeoclient:uuid:8D86A4AC-54BD-4BB3-8B58-AB55DEC01A88</pav:previousVersion>
    <ao:item rdf:resource="urn:domeoclient:uuid:C1707DB4-5B7C-4588-BAE0-034F66A1800B"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:2D1425A6-04BE-4372-9798-B6059B7EFF83"/>
    <domeo:agents rdf:resource="urn:person:uuid:080e143046812afe0146812eda990003"/>
    <permissions:permissions rdf:nodeID="Nc332bcd7d43c4208845b6dd3ed9bf9a2"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:7359157D-6F7C-43D2-9127-08D4CCFA7E1A"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:3DC39945-7562-466B-9B45-B860249B5C62"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:97C469A7-A5FD-4636-8744-4240B805D2D0"/>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <ao:item rdf:resource="urn:domeoclient:uuid:DDEC112C-9331-4573-8A13-ED3D4798FE89"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:CDDA5AD1-5495-41C1-821C-109A7D029580"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:DE707944-9AAF-45E4-85A6-2EA10D365226"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:9273B7AD-9357-4702-9126-48471F347ED0"/>
    <rdfs:label>Default Set</rdfs:label>
    <ao:item rdf:resource="urn:domeoclient:uuid:B60D6EE8-97E8-426E-9A95-B877100EC48A"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:5846C0A3-8519-4160-91FD-DFD71E2DCC95"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:0208A9D0-4889-4F9D-A5F0-C1CBBBE42EE0"/>
    <domeo:deleted>false</domeo:deleted>
    <ao:item rdf:resource="urn:domeoclient:uuid:875A1582-88A4-40A2-9290-112578B609F1"/>
    <pav:createdOn>2014-07-24 20:05:33 -0400</pav:createdOn>
    <ao:item rdf:resource="urn:domeoclient:uuid:0EEDF160-BB48-4F3A-8FC7-D52C908CAECC"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:E74FD429-7BE1-4BBF-BDBE-DA9A73D330DA"/>
    <domeo:agents rdf:resource="urn:domeo:software:id:Domeo-2.1alpha-050"/>
    <dct:description>The default set is created automatically by Domeo when no other set is existing.</dct:description>
    <ao:annotatesResource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-139.txt.html</ao:annotatesResource>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812eda990003</pav:createdBy>
    <pav:lastSavedOn>2014-07-24 20:10:48 -0400</pav:lastSavedOn>
    <ao:item rdf:resource="urn:domeoclient:uuid:236BB8FF-931E-44E4-8D12-9F1FB83D8082"/>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">2</pav:versionNumber>
    <ao:item rdf:resource="urn:domeoclient:uuid:BE69196D-B8BA-4576-AC08-BEA775939851"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:1C538CF6-5CD8-48ED-96FC-B9B3546A66F8"/>
    <pav:lineageUri>urn:domeoserver:annotationset:4A88D0A6-E9B6-4E7F-955F-3692600C178C</pav:lineageUri>
    <ao:item rdf:resource="urn:domeoclient:uuid:54A742F1-BC99-4080-8071-732BA171793D"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:19746D22-D232-4FCB-B5B2-64CA519A479E"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:6A4B6F3D-5923-4FB1-A369-D9FE1BF7FD5C"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#AnnotationSet"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:84BD0311-11DD-4CCD-B082-CEE1C8BAAD37"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:DF3B3F8F-7CB0-4DA2-B24E-32B9E66603BF"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:996C494E-48A6-41DB-B582-CC68851B64C1">
    <pav:lastSavedOn>2014-07-22 18:54:35 -0400</pav:lastSavedOn>
    <pav:lineageUri>urn:domeoserver:annotation:E5528993-F0D4-4378-B175-B901EA18D750</pav:lineageUri>
    <pav:createdOn>2014-07-22 18:51:41 -0400</pav:createdOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <rdfs:label>Highlight</rdfs:label>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <ao:context rdf:resource="urn:domeoclient:uuid:EB4D6CAD-8800-44E1-9856-C0585E6A6B61"/>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <domeo:belongsToSet>urn:domeoclient:uuid:3D195979-3E82-427D-95B8-F50F48DB4AA7</domeo:belongsToSet>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812eda990003</pav:createdBy>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:AF68257F-3ADB-4BA4-9BD1-247F8428319E">
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:previousVersion>urn:domeoserver:annotationset:467D4F28-D086-4217-9DE0-23E165F30716</pav:previousVersion>
    <pav:createdOn>2014-07-22 19:22:27 -0400</pav:createdOn>
    <pav:lineageUri>urn:domeoserver:annotationset:AB1741F1-5A5F-4416-AEAC-A544BCBB7D16</pav:lineageUri>
    <domeo:belongsToSet>urn:domeoserver:annotationset:606A5B3F-B6FB-4279-AA42-7893CFC2D20C</domeo:belongsToSet>
    <domeo:belongsToSet>urn:domeoserver:annotationset:7E80543E-BF76-4514-92A9-91458DCB802B</domeo:belongsToSet>
    <pav:lastSavedOn>2014-07-22 19:28:02 -0400</pav:lastSavedOn>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">3</pav:versionNumber>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812eda990003</pav:createdBy>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <rdfs:label>Highlight</rdfs:label>
    <domeo:belongsToSet>urn:domeoserver:annotationset:F272A789-69D0-47CC-8CC9-F25C55B91261</domeo:belongsToSet>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <domeo:belongsToSet>urn:domeoserver:annotationset:7021B883-FD5C-4083-BD87-DF56D3C87633</domeo:belongsToSet>
    <domeo:belongsToSet>urn:domeoserver:annotationset:2914A3FD-DF43-4F78-999C-77CE7A028B19</domeo:belongsToSet>
    <ao:context rdf:resource="urn:domeoclient:uuid:90498C00-BE72-46BA-94D5-04F8265DDA63"/>
    <pav:lineageUri>urn:domeoserver:annotation:056D380F-7A12-4AFC-AFF9-D253A14D689C</pav:lineageUri>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <domeo:belongsToSet>urn:domeoserver:annotationset:514BA51B-D734-4003-A7C3-F03C0F95833A</domeo:belongsToSet>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:DB9F8CF3-932C-4B62-8B9D-7E4C3E1A4FF6">
    <ao:suffix> with risperidone, a CYP2D6 substrate has also been evaluated. In 1 study, daily dosing of paroxetine 20 mg in patients stabilized on risperidone (4 to 8 mg/day) increased mean plasma concentrations of risperidone approximately 4-fold, decreased 9-hydrox</ao:suffix>
    <ao:exact>paroxetine</ao:exact>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-47.txt.html</ao:hasSource>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <domeo:uuid>DB9F8CF3-932C-4B62-8B9D-7E4C3E1A4FF6</domeo:uuid>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:DB9F8CF3-932C-4B62-8B9D-7E4C3E1A4FF6"/>
    <pav:createdOn>2014-09-02 12:03:00 -0400</pav:createdOn>
    <ao:prefix> (100 mg) Cmax, AUC, and T½ by an average of approximately 2-, 5-, and 3-fold, respectively. Concomitant use of </ao:prefix>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:B28EDC18-743D-4015-956F-B084F96B3589">
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">3</pav:versionNumber>
    <domeo:belongsToSet>urn:domeoserver:annotationset:7E80543E-BF76-4514-92A9-91458DCB802B</domeo:belongsToSet>
    <domeo:belongsToSet>urn:domeoserver:annotationset:514BA51B-D734-4003-A7C3-F03C0F95833A</domeo:belongsToSet>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <rdfs:label>Highlight</rdfs:label>
    <domeo:belongsToSet>urn:domeoserver:annotationset:2914A3FD-DF43-4F78-999C-77CE7A028B19</domeo:belongsToSet>
    <domeo:belongsToSet>urn:domeoserver:annotationset:7021B883-FD5C-4083-BD87-DF56D3C87633</domeo:belongsToSet>
    <pav:createdOn>2014-07-22 19:22:52 -0400</pav:createdOn>
    <ao:context rdf:resource="urn:domeoclient:uuid:C0EC2FB2-F825-49D1-A3E4-EA98B976BFED"/>
    <pav:previousVersion>urn:domeoserver:annotationset:467D4F28-D086-4217-9DE0-23E165F30716</pav:previousVersion>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:lastSavedOn>2014-07-22 19:28:02 -0400</pav:lastSavedOn>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812eda990003</pav:createdBy>
    <pav:lineageUri>urn:domeoserver:annotationset:AB1741F1-5A5F-4416-AEAC-A544BCBB7D16</pav:lineageUri>
    <pav:lineageUri>urn:domeoserver:annotation:858940A9-7A41-417F-A86C-ECDF1B6FF2E7</pav:lineageUri>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <domeo:belongsToSet>urn:domeoserver:annotationset:F272A789-69D0-47CC-8CC9-F25C55B91261</domeo:belongsToSet>
    <domeo:belongsToSet>urn:domeoserver:annotationset:606A5B3F-B6FB-4279-AA42-7893CFC2D20C</domeo:belongsToSet>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:3BF96FBC-622D-4EC3-80A1-339B20EFCD2C">
    <ao:context rdf:resource="urn:domeoclient:uuid:16E9C8A9-8DAA-4EB9-8859-7C353FD7C273"/>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:lastSavedOn>2014-07-21 21:55:00 -0400</pav:lastSavedOn>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812eda990003</pav:createdBy>
    <pav:lineageUri>urn:domeoserver:annotation:98C00EB4-0531-430D-AC33-58A40A3AE2BB</pav:lineageUri>
    <rdfs:label>Highlight</rdfs:label>
    <pav:createdOn>2014-07-21 21:53:44 -0400</pav:createdOn>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <domeo:belongsToSet>urn:domeoclient:uuid:C988D053-7CF3-4C50-BDB6-7C2B20B837B9</domeo:belongsToSet>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:C8BC97FA-A136-4744-ADD4-4988FBBA6CCB">
    <ao:exact>rosiglitazone</ao:exact>
    <domeo:uuid>C8BC97FA-A136-4744-ADD4-4988FBBA6CCB</domeo:uuid>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-123.txt.html</ao:hasSource>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:C8BC97FA-A136-4744-ADD4-4988FBBA6CCB"/>
    <pav:createdOn>2014-07-22 19:41:41 -0400</pav:createdOn>
    <ao:prefix>l (600 mg twice daily), an inhibitor of CYP2C8, and </ao:prefix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:suffix> (4 mg once daily) for 7 days increased rosiglitazone AUC by 127%, compared to the administration of rosiglitazone (4 mg once daily) alone. Given the potential for dose-related adverse events with rosiglitazone, a decrease in the dose of rosiglitazone ma</ao:suffix>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:2BAA59CB-3862-4A98-8A6C-AA14E82983DC">
    <ao:item rdf:resource="urn:domeoclient:uuid:5B604E28-4F1B-4B10-A878-DE6620893CDB"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:09CCA90F-F1D9-49A6-A47E-B693A373A03E"/>
    <domeo:agents rdf:resource="urn:person:uuid:080e143046812afe0146812eda990003"/>
    <rdfs:label>Default Set</rdfs:label>
    <ao:item rdf:resource="urn:domeoclient:uuid:A59202ED-7ABE-4A45-97C0-8272FAD7DF90"/>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <ao:item rdf:resource="urn:domeoclient:uuid:787692CD-0BB7-4EBC-B1EB-B839CB0674FF"/>
    <pav:lastSavedOn>2014-07-24 20:14:42 -0400</pav:lastSavedOn>
    <dct:description>The default set is created automatically by Domeo when no other set is existing.</dct:description>
    <pav:createdOn>2014-07-24 20:14:32 -0400</pav:createdOn>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812eda990003</pav:createdBy>
    <domeo:agents rdf:resource="urn:domeo:software:id:Domeo-2.1alpha-050"/>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <ao:annotatesResource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-161.txt.html</ao:annotatesResource>
    <permissions:permissions rdf:nodeID="Nb193dcf35a6a452d98488c4ed0e0f508"/>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <ao:item rdf:resource="urn:domeoclient:uuid:4D592D1B-7B6F-448B-9149-4BBF0B36A730"/>
    <domeo:deleted>false</domeo:deleted>
    <ao:item rdf:resource="urn:domeoclient:uuid:4FEEF689-2803-4ABA-A0A9-56F6C3A923F0"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#AnnotationSet"/>
    <pav:lineageUri>urn:domeoserver:annotationset:8B64B96E-071B-44E9-B07F-4E24C15D39AF</pav:lineageUri>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:08713DDF-0935-4B63-B281-AEE56A8D7628">
    <domeo:belongsToSet>urn:domeoserver:annotationset:22ED7220-C6F6-43C5-9DF9-89F62F0F8E27</domeo:belongsToSet>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812eda990003</pav:createdBy>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <domeo:belongsToSet>urn:domeoserver:annotationset:08C0C288-6DF4-43E6-A618-71A8BB9563C3</domeo:belongsToSet>
    <ao:context rdf:resource="urn:domeoclient:uuid:6BF6E19B-3833-4401-A589-B16E9522C485"/>
    <domeo:belongsToSet>urn:domeoserver:annotationset:8F3CF3D9-AADE-4A86-BD42-2924B3D6A406</domeo:belongsToSet>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:createdOn>2014-07-07 09:58:53 -0400</pav:createdOn>
    <pav:lastSavedOn>2014-07-07 10:02:41 -0400</pav:lastSavedOn>
    <domeo:belongsToSet>urn:domeoserver:annotationset:7AACEF8D-2EBC-4F0B-94B2-190650E562F6</domeo:belongsToSet>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <domeo:belongsToSet>urn:domeoserver:annotationset:131835A3-C655-4F91-97D4-52CAFF7B7CCA</domeo:belongsToSet>
    <rdfs:label>Highlight</rdfs:label>
    <pav:lineageUri>urn:domeoserver:annotation:A6C1D994-FD1E-4778-8CFC-8AF61A3DA42E</pav:lineageUri>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:A788721A-520C-402D-95A4-65EC994B3F25">
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <pav:createdOn>2014-07-22 19:40:41 -0400</pav:createdOn>
    <domeo:uuid>A788721A-520C-402D-95A4-65EC994B3F25</domeo:uuid>
    <ao:prefix> does not inhibit any of the major P450 enzymes at clinically relevant concentrations. </ao:prefix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:exact>In vitro data demonstrate that rosiglitazone is predominantly metabolized by CYP2C8, and to a lesser extent, 2C9. AVANDIA (4 mg twice daily) was shown to have no clinically relevant effect on the pharmacokinetics of nifedipine and oral contraceptives (ethinyl estradiol and norethindrone), which are predominantly metabolized by CYP3A4.</ao:exact>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-123.txt.html</ao:hasSource>
    <ao:suffix>xsd:String</ao:suffix>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:A788721A-520C-402D-95A4-65EC994B3F25"/>
  </rdf:Description>
  <rdf:Description rdf:nodeID="Nf432dfe594e94869b2991605e242e024">
    <permissions:accessType>urn:domeo:access:public</permissions:accessType>
    <permissions:isLocked>false</permissions:isLocked>
  </rdf:Description>
  <rdf:Description rdf:nodeID="N6a302775c3b24d7c9f997c0789b4078e">
    <permissions:accessType>urn:domeo:access:public</permissions:accessType>
    <permissions:isLocked>false</permissions:isLocked>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:D2F70BCB-D9EC-44EA-93E7-C33A22842BF2">
    <pav:lineageUri>urn:domeoserver:annotation:F4CD88A4-5CEC-433F-9DFF-C429C94CCEA2</pav:lineageUri>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:lastSavedOn>2014-07-13 12:48:45 -0400</pav:lastSavedOn>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <rdfs:label>Highlight</rdfs:label>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <domeo:belongsToSet>urn:domeoclient:uuid:EC9B90D7-F9B5-4E51-94E2-878FAA06F611</domeo:belongsToSet>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812eda990003</pav:createdBy>
    <pav:createdOn>2014-07-13 12:46:37 -0400</pav:createdOn>
    <ao:context rdf:resource="urn:domeoclient:uuid:57242808-9748-4ED3-908E-E0054E0C8BBE"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:E67991C8-7BD1-474A-98AE-6F58A72C0A35">
    <ao:suffix>AUC, Cmax, Cmin (24-hour concentration), and a significant reduction in apparent oral clearance following the administration of fluconazole. The mean ± SD increase in AUC was 92% ± 43% (range: 18 to 147%). The Cmax increased 60% ± 48% (range: -5 to 133%)</ao:suffix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:exact>cyclosporine </ao:exact>
    <ao:prefix>dose for at least 6 weeks. There was a significant increase in </ao:prefix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <domeo:uuid>E67991C8-7BD1-474A-98AE-6F58A72C0A35</domeo:uuid>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-26.txt.html</ao:hasSource>
    <pav:createdOn>2014-07-21 21:28:38 -0400</pav:createdOn>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:E67991C8-7BD1-474A-98AE-6F58A72C0A35"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:35FBCEB9-D10F-4DB4-8F8D-DB121D785B9B">
    <pav:createdOn>2014-07-21 21:50:34 -0400</pav:createdOn>
    <ao:suffix> Extended-release Tablet contains 300 mg of quinidine sulfate (249 mg of quinidine base) in a formulation to provide extended release; the inactive ingredients are: fumaric acid, hypromellose, lactose monohydrate, magnesium stearate, polydextrose, polyet</ao:suffix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:35FBCEB9-D10F-4DB4-8F8D-DB121D785B9B"/>
    <ao:exact>Quinidine Sulfate</ao:exact>
    <ao:prefix>Each </ao:prefix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-55.txt.html</ao:hasSource>
    <domeo:uuid>35FBCEB9-D10F-4DB4-8F8D-DB121D785B9B</domeo:uuid>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:0F702DA3-314E-4514-A96E-ADDF64264F59">
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812eda990003</pav:createdBy>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:lastSavedOn>2014-09-02 11:46:58 -0400</pav:lastSavedOn>
    <pav:lineageUri>urn:domeoserver:annotation:C4E2D502-319B-4543-AB98-387C5FD4661E</pav:lineageUri>
    <domeo:belongsToSet>urn:domeoserver:annotationset:3F546823-204F-4F9B-9006-3DC526C56931</domeo:belongsToSet>
    <domeo:belongsToSet>urn:domeoserver:annotationset:A5DD001D-C81A-4E2E-B5E0-7A866B35E26B</domeo:belongsToSet>
    <domeo:belongsToSet>urn:domeoserver:annotationset:A3F0B39A-4249-4B63-BB0D-F24A005066AC</domeo:belongsToSet>
    <pav:lineageUri>urn:domeoserver:annotationset:D1715BD2-BD41-46FD-9454-DC7A423A29AC</pav:lineageUri>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">2</pav:versionNumber>
    <ao:context rdf:resource="urn:domeoclient:uuid:A3A7600E-EE05-47D1-8823-CA504866B3BD"/>
    <pav:previousVersion>urn:domeoclient:uuid:BED41F06-565A-4622-9A88-48810E5A28DE</pav:previousVersion>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <rdfs:label>Highlight</rdfs:label>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <pav:createdOn>2014-09-02 11:36:37 -0400</pav:createdOn>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:2FAF656F-18DD-448F-84DF-6CC1FD701820">
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812eda990003</pav:createdBy>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <domeo:belongsToSet>urn:domeoclient:uuid:CB83FFC2-EA71-44EA-8F11-DE80E389C84E</domeo:belongsToSet>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <domeo:belongsToSet>urn:domeoserver:annotationset:E32812A9-205B-4EE1-B488-A1E294EDBFB9</domeo:belongsToSet>
    <rdfs:label>Highlight</rdfs:label>
    <pav:lineageUri>urn:domeoserver:annotation:E4BB33BE-C724-4884-A06C-C1D4457CEB13</pav:lineageUri>
    <pav:lineageUri>urn:domeoserver:annotationset:C5DEBC9B-77EE-4243-88EB-DBC19737ACD2</pav:lineageUri>
    <pav:createdOn>2014-09-02 19:19:46 -0400</pav:createdOn>
    <domeo:belongsToSet>urn:domeoserver:annotationset:392EE0FB-AC4F-4AF2-87A6-2E50A281F434</domeo:belongsToSet>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <ao:context rdf:resource="urn:domeoclient:uuid:7A374628-9340-4980-A329-4E957642EBA7"/>
    <pav:lastSavedOn>2014-09-02 19:19:47 -0400</pav:lastSavedOn>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:78BBB6BD-543C-42F3-B5F5-431ADE5F4D72">
    <pav:createdOn>2014-07-13 11:12:09 -0400</pav:createdOn>
    <ao:suffix> by the enzyme, CYP 2D6. A minor metabolic pathway is through N-dealkylation. The main metabolite, 9-hydroxyrisperidone, has similar pharmacological activity as risperidone. Consequently, the clinical effect of the drug results from the combined concentr</ao:suffix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:exact>9-hydroxyrisperidone</ao:exact>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:78BBB6BD-543C-42F3-B5F5-431ADE5F4D72"/>
    <domeo:uuid>78BBB6BD-543C-42F3-B5F5-431ADE5F4D72</domeo:uuid>
    <ao:prefix> to </ao:prefix>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-8.txt.html</ao:hasSource>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:6F5EB55C-E7E1-447C-B54E-5F02D52FA3AE">
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <domeo:uuid>6F5EB55C-E7E1-447C-B54E-5F02D52FA3AE</domeo:uuid>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:6F5EB55C-E7E1-447C-B54E-5F02D52FA3AE"/>
    <ao:suffix>xsd:String</ao:suffix>
    <ao:exact>Pretreatment with ranitidine (150 mg twice daily for 4 days) did not alter the pharmacokinetics of either single oral or intravenous doses of rosiglitazone in healthy volunteers. These results suggest that the absorption of oral rosiglitazone is not altered in conditions accompanied by increases in gastrointestinal pH</ao:exact>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:prefix>xsd:String</ao:prefix>
    <pav:createdOn>2014-07-22 20:22:47 -0400</pav:createdOn>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-123.txt.html</ao:hasSource>
  </rdf:Description>
  <rdf:Description rdf:nodeID="N57b3d2e5ec5f4f43b7db2ac62e331f70">
    <domeo:sets rdf:resource="urn:pddi:uuid:7A7954C3-5D7A-42B7-A218-ECC19277FC3A"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:D39A9499-CCA7-4666-A0EC-BE7D45405E91">
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-201.txt.html</ao:hasSource>
    <ao:prefix> administration (250 mg b.i.d. initially for 1 day followed by 300 mg QD for 3 to 4 days) resulted in an approximately 50% reduction in </ao:prefix>
    <ao:suffix> exposure and withdrawal symptoms occurred concurrently. Upon discontinuation of phenytoin, the incidence of withdrawal symptoms decreased and methadone exposure increased to a level comparable to that prior to phenytoin administration.</ao:suffix>
    <ao:exact>methadone</ao:exact>
    <domeo:uuid>D39A9499-CCA7-4666-A0EC-BE7D45405E91</domeo:uuid>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:D39A9499-CCA7-4666-A0EC-BE7D45405E91"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <pav:createdOn>2014-07-28 17:04:35 -0400</pav:createdOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:EB4F72BF-4A36-4030-AF78-3FD9D5E4FE15">
    <ao:exact>rosiglitazone</ao:exact>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <pav:createdOn>2014-07-22 19:31:19 -0400</pav:createdOn>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-123.txt.html</ao:hasSource>
    <domeo:uuid>EB4F72BF-4A36-4030-AF78-3FD9D5E4FE15</domeo:uuid>
    <ao:suffix> in female patients (n = 405) was approximately 6% lower compared to male patients of the same body weight (n = 642).</ao:suffix>
    <ao:prefix>Results of the population pharmacokinetics analysis showed that the mean oral clearance of </ao:prefix>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:EB4F72BF-4A36-4030-AF78-3FD9D5E4FE15"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:846B6C02-30BD-4750-BAD3-4CC242462EE4">
    <ao:suffix>significantly decreased plasma levels of paroxetine. Any dose adjustment should be guided by clinical effect (tolerability and efficacy). </ao:suffix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <domeo:uuid>846B6C02-30BD-4750-BAD3-4CC242462EE4</domeo:uuid>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-51.txt.html</ao:hasSource>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:846B6C02-30BD-4750-BAD3-4CC242462EE4"/>
    <ao:prefix>with </ao:prefix>
    <ao:exact>paroxetine </ao:exact>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <pav:createdOn>2014-07-21 21:43:20 -0400</pav:createdOn>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:0819E6B8-B8E8-4EB2-9248-CA54623D1BB2">
    <rdfs:label>Default Set</rdfs:label>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#AnnotationSet"/>
    <pav:lineageUri>urn:domeoserver:annotationset:32C325B9-09DD-4A0B-A270-BAA0C42956A1</pav:lineageUri>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <ao:annotatesResource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-122.txt.html</ao:annotatesResource>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812eda990003</pav:createdBy>
    <pav:createdOn>2014-07-22 19:06:46 -0400</pav:createdOn>
    <domeo:deleted>false</domeo:deleted>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <ao:item rdf:resource="urn:domeoclient:uuid:605A1706-1C67-4FBD-9A42-21DF312E4339"/>
    <permissions:permissions rdf:nodeID="Nf34060c5ea7740afa9db91c1b9ddec16"/>
    <pav:lastSavedOn>2014-07-22 19:06:48 -0400</pav:lastSavedOn>
    <dct:description>The default set is created automatically by Domeo when no other set is existing.</dct:description>
    <ao:item rdf:resource="urn:domeoclient:uuid:525D9A2A-57D7-4B82-AAC2-92BA3D298032"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:ACA8DFD4-1166-4984-97D0-E4E251EA94F3"/>
    <domeo:agents rdf:resource="urn:domeo:software:id:Domeo-2.1alpha-050"/>
    <domeo:agents rdf:resource="urn:person:uuid:080e143046812afe0146812eda990003"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:5F8E4E79-C59A-410E-ACD6-41B9C532F968">
    <rdfs:label>Highlight</rdfs:label>
    <pav:lineageUri>urn:domeoserver:annotation:FDE2CC52-F5FC-4C63-AEAD-C53C36960021</pav:lineageUri>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:createdOn>2014-07-13 11:14:57 -0400</pav:createdOn>
    <ao:context rdf:resource="urn:domeoclient:uuid:806597EC-5BAB-46E0-96D6-B25563A80A8C"/>
    <domeo:belongsToSet>urn:domeoclient:uuid:71191E51-53CB-4FDE-88D0-33C6818E2232</domeo:belongsToSet>
    <pav:lastSavedOn>2014-07-13 11:32:29 -0400</pav:lastSavedOn>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812eda990003</pav:createdBy>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:6C2A60D1-56A3-4C14-A2B0-4A75D2CDBF72">
    <pav:createdOn>2014-07-22 19:39:49 -0400</pav:createdOn>
    <ao:exact>AVANDIA</ao:exact>
    <ao:prefix> is predominantly metabolized by CYP2C8, and to a lesser extent, 2C9. </ao:prefix>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-123.txt.html</ao:hasSource>
    <domeo:uuid>6C2A60D1-56A3-4C14-A2B0-4A75D2CDBF72</domeo:uuid>
    <ao:suffix> (4 mg twice daily) was shown to have no clinically relevant effect on the pharmacokinetics of nifedipine and oral contraceptives (ethinyl estradiol and norethindrone), which are predominantly metabolized by CYP3A4.</ao:suffix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:6C2A60D1-56A3-4C14-A2B0-4A75D2CDBF72"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:50C0FDF6-70A1-4B64-8F05-01088227E5AD">
    <pav:lineageUri>urn:domeoserver:annotationset:D1715BD2-BD41-46FD-9454-DC7A423A29AC</pav:lineageUri>
    <pav:lineageUri>urn:domeoserver:annotation:48B6E90B-BCFF-4E31-B9D6-90262C75BAF5</pav:lineageUri>
    <pav:createdOn>2014-09-02 11:43:52 -0400</pav:createdOn>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <domeo:belongsToSet>urn:domeoserver:annotationset:A5DD001D-C81A-4E2E-B5E0-7A866B35E26B</domeo:belongsToSet>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812eda990003</pav:createdBy>
    <domeo:belongsToSet>urn:domeoserver:annotationset:3F546823-204F-4F9B-9006-3DC526C56931</domeo:belongsToSet>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <rdfs:label>Highlight</rdfs:label>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <domeo:belongsToSet>urn:domeoserver:annotationset:A3F0B39A-4249-4B63-BB0D-F24A005066AC</domeo:belongsToSet>
    <pav:lastSavedOn>2014-09-02 11:46:58 -0400</pav:lastSavedOn>
    <ao:context rdf:resource="urn:domeoclient:uuid:CFAB29CD-3C49-4713-BDAE-478181F5EB8F"/>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">2</pav:versionNumber>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:previousVersion>urn:domeoclient:uuid:BED41F06-565A-4622-9A88-48810E5A28DE</pav:previousVersion>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:BF2D2BC3-6C22-44A4-8021-D0C2308687B9">
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#AnnotationSet"/>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812eda990003</pav:createdBy>
    <dct:description>The default set is created automatically by Domeo when no other set is existing.</dct:description>
    <pav:createdOn>2014-07-21 21:44:28 -0400</pav:createdOn>
    <ao:annotatesResource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-52.txt.html</ao:annotatesResource>
    <domeo:agents rdf:resource="urn:domeo:software:id:Domeo-2.1alpha-050"/>
    <domeo:agents rdf:resource="urn:person:uuid:080e143046812afe0146812eda990003"/>
    <pav:lineageUri>urn:domeoserver:annotationset:A3FC309E-D0BF-44B0-9FA1-EE2A55F76369</pav:lineageUri>
    <pav:lastSavedOn>2014-07-21 21:44:21 -0400</pav:lastSavedOn>
    <rdfs:label>Default Set</rdfs:label>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <permissions:permissions rdf:nodeID="N7ffc8cb50878452ba52294e3ede3067e"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:AC96215A-123C-49AB-9A1D-9FE75BE48E10"/>
    <domeo:deleted>false</domeo:deleted>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:2490C71A-5328-4CD0-A630-7A3E5DC56DAB">
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-123.txt.html</ao:hasSource>
    <ao:prefix>xsd:String</ao:prefix>
    <pav:createdOn>2014-07-22 19:44:51 -0400</pav:createdOn>
    <ao:exact>Concomitant administration of gemfibrozil (600 mg twice daily), an inhibitor of CYP2C8, and rosiglitazone (4 mg once daily) for 7 days increased rosiglitazone AUC by 127%, compared to the administration of rosiglitazone (4 mg once daily) alone. Given the potential for dose-related adverse events with rosiglitazone, a decrease in the dose of rosiglitazone may be needed when gemfibrozil is introduced</ao:exact>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:suffix>xsd:String</ao:suffix>
    <domeo:uuid>2490C71A-5328-4CD0-A630-7A3E5DC56DAB</domeo:uuid>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:2490C71A-5328-4CD0-A630-7A3E5DC56DAB"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:6950FFA4-1583-4644-99BE-7BD0F0C06B95">
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <domeo:belongsToSet>urn:domeoserver:annotationset:3F546823-204F-4F9B-9006-3DC526C56931</domeo:belongsToSet>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">2</pav:versionNumber>
    <domeo:belongsToSet>urn:domeoserver:annotationset:A3F0B39A-4249-4B63-BB0D-F24A005066AC</domeo:belongsToSet>
    <pav:previousVersion>urn:domeoclient:uuid:BED41F06-565A-4622-9A88-48810E5A28DE</pav:previousVersion>
    <rdfs:label>Highlight</rdfs:label>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812eda990003</pav:createdBy>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:lineageUri>urn:domeoserver:annotation:53F8FAD2-51E4-4DC2-BE55-DFC06AB7180B</pav:lineageUri>
    <domeo:belongsToSet>urn:domeoserver:annotationset:A5DD001D-C81A-4E2E-B5E0-7A866B35E26B</domeo:belongsToSet>
    <ao:context rdf:resource="urn:domeoclient:uuid:0A4B6E36-A9AC-4581-A4CD-969904241345"/>
    <pav:lineageUri>urn:domeoserver:annotationset:D1715BD2-BD41-46FD-9454-DC7A423A29AC</pav:lineageUri>
    <pav:lastSavedOn>2014-09-02 11:46:58 -0400</pav:lastSavedOn>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <pav:createdOn>2014-09-02 11:42:05 -0400</pav:createdOn>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:7616318E-C362-4BC0-B027-F84CBEA6207C">
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812eda990003</pav:createdBy>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <pav:lastSavedOn>2014-07-22 19:40:32 -0400</pav:lastSavedOn>
    <ao:context rdf:resource="urn:domeoclient:uuid:4588D04A-4EE6-4AEB-8E31-47ECEB3BF1E4"/>
    <pav:lineageUri>urn:domeoserver:annotation:7F8BD394-39FE-44E9-8EC8-2CE04FAEFE1D</pav:lineageUri>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:createdOn>2014-07-22 19:35:38 -0400</pav:createdOn>
    <pav:previousVersion>urn:domeoserver:annotationset:7021B883-FD5C-4083-BD87-DF56D3C87633</pav:previousVersion>
    <domeo:belongsToSet>urn:domeoserver:annotationset:2914A3FD-DF43-4F78-999C-77CE7A028B19</domeo:belongsToSet>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">5</pav:versionNumber>
    <domeo:belongsToSet>urn:domeoserver:annotationset:514BA51B-D734-4003-A7C3-F03C0F95833A</domeo:belongsToSet>
    <pav:lastSavedOn>2014-07-22 19:40:31 -0400</pav:lastSavedOn>
    <domeo:belongsToSet>urn:domeoserver:annotationset:606A5B3F-B6FB-4279-AA42-7893CFC2D20C</domeo:belongsToSet>
    <pav:lineageUri>urn:domeoserver:annotationset:AB1741F1-5A5F-4416-AEAC-A544BCBB7D16</pav:lineageUri>
    <domeo:belongsToSet>urn:domeoserver:annotationset:F272A789-69D0-47CC-8CC9-F25C55B91261</domeo:belongsToSet>
    <rdfs:label>Highlight</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:12FA04F1-54A6-4C48-9FDA-8E372C8A648A">
    <rdfs:label>Highlight</rdfs:label>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:createdOn>2014-07-13 12:38:23 -0400</pav:createdOn>
    <domeo:belongsToSet>urn:domeoclient:uuid:4F872953-6D19-4809-9285-FCCF2FF54315</domeo:belongsToSet>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812eda990003</pav:createdBy>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <pav:lineageUri>urn:domeoserver:annotation:13CBA444-A83A-48E8-AC3C-79379FB9E6F7</pav:lineageUri>
    <pav:lastSavedOn>2014-07-13 12:41:10 -0400</pav:lastSavedOn>
    <ao:context rdf:resource="urn:domeoclient:uuid:A810EBBA-9C6C-4A0D-9FD2-AFA2874096F5"/>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:804C4BF7-B45B-4CC2-BD44-707AAD50F219">
    <ao:prefix>, is 77%. Neither </ao:prefix>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:804C4BF7-B45B-4CC2-BD44-707AAD50F219"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:suffix> nor 9-hydroxyrisperidone displaces each other from plasma binding sites. High therapeutic concentrations of sulfamethazine (100 mcg/mL), warfarin (10 mcg/mL), and carbamazepine (10 mcg/mL) caused only a slight increase in the free fraction of risperidon</ao:suffix>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-8.txt.html</ao:hasSource>
    <pav:createdOn>2014-07-13 11:11:13 -0400</pav:createdOn>
    <ao:exact>risperidone</ao:exact>
    <domeo:uuid>804C4BF7-B45B-4CC2-BD44-707AAD50F219</domeo:uuid>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:78A5F631-80CE-4FB1-974D-F82BE8D8E584">
    <domeo:belongsToSet>urn:domeoserver:annotationset:606A5B3F-B6FB-4279-AA42-7893CFC2D20C</domeo:belongsToSet>
    <domeo:belongsToSet>urn:domeoserver:annotationset:7021B883-FD5C-4083-BD87-DF56D3C87633</domeo:belongsToSet>
    <domeo:belongsToSet>urn:domeoserver:annotationset:467D4F28-D086-4217-9DE0-23E165F30716</domeo:belongsToSet>
    <pav:createdOn>2014-07-22 19:11:48 -0400</pav:createdOn>
    <rdfs:label>Highlight</rdfs:label>
    <ao:context rdf:resource="urn:domeoclient:uuid:CCA3540C-4A74-4782-9325-18A999F61C75"/>
    <pav:lineageUri>urn:domeoserver:annotation:D46206C0-40D0-4FB6-9137-329AF9D772DE</pav:lineageUri>
    <pav:lastSavedOn>2014-07-22 19:11:41 -0400</pav:lastSavedOn>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812eda990003</pav:createdBy>
    <pav:lineageUri>urn:domeoserver:annotationset:AB1741F1-5A5F-4416-AEAC-A544BCBB7D16</pav:lineageUri>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:lastSavedOn>2014-07-22 19:11:40 -0400</pav:lastSavedOn>
    <domeo:belongsToSet>urn:domeoserver:annotationset:7E80543E-BF76-4514-92A9-91458DCB802B</domeo:belongsToSet>
    <domeo:belongsToSet>urn:domeoserver:annotationset:F272A789-69D0-47CC-8CC9-F25C55B91261</domeo:belongsToSet>
    <domeo:belongsToSet>urn:domeoclient:uuid:BE4B86AC-FE5F-4543-A713-EC5B852A5A2A</domeo:belongsToSet>
    <domeo:belongsToSet>urn:domeoserver:annotationset:2914A3FD-DF43-4F78-999C-77CE7A028B19</domeo:belongsToSet>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <domeo:belongsToSet>urn:domeoserver:annotationset:514BA51B-D734-4003-A7C3-F03C0F95833A</domeo:belongsToSet>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/78B277CF-FACC-42EA-9594-CD77F7E3193A">
    <rdfs:label>erythromycin</rdfs:label>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/active-ingredient"/>
    <dct:description>Referred to the drug in the interaction.</dct:description>
    <sio:SIO_000228>dikbD2R:precipitant-drug-of-interaction</sio:SIO_000228>
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/4053</dailymed:activeMoietyRxCUI>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:BA5DA7BD-C00F-4D3B-B057-830BB357C412">
    <pav:lastSavedOn>2014-07-21 21:38:46 -0400</pav:lastSavedOn>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:lineageUri>urn:domeoserver:annotation:24FDF5F9-D6C5-4622-91F8-981D96C742C1</pav:lineageUri>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812eda990003</pav:createdBy>
    <pav:createdOn>2014-07-21 21:38:46 -0400</pav:createdOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <ao:context rdf:resource="urn:domeoclient:uuid:B4B52B26-239D-47C5-8E82-702E109CC247"/>
    <rdfs:label>Highlight</rdfs:label>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <domeo:belongsToSet>urn:domeoclient:uuid:A52F0287-AD68-4755-8E11-75217CD4FED8</domeo:belongsToSet>
    <pav:previousVersion>xsd:String</pav:previousVersion>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:2EF11BBD-DFCE-4A86-A72C-0BCC80E7E152">
    <rdf:type rdf:resource="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#DrugDrugInteractionStatement"/>
    <sio:SIO_000563>dikbD2R:modality</sio:SIO_000563>
    <sio:SIO_000205>dikbD2R:statement</sio:SIO_000205>
    <dikbD2R:modality>ncit:positive</dikbD2R:modality>
    <sio:SIO_000628 rdf:resource="urn:pddi:uuid:9B609E45-9C17-43F3-B813-24BD2E69F02B"/>
    <dikbD2R:statement>ncit:quantitative</dikbD2R:statement>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:0546F8AF-C9DB-4EB6-A2C6-2FB5CABD510D">
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-29.txt.html</ao:hasSource>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:0546F8AF-C9DB-4EB6-A2C6-2FB5CABD510D"/>
    <domeo:uuid>0546F8AF-C9DB-4EB6-A2C6-2FB5CABD510D</domeo:uuid>
    <ao:suffix>(500 mg single dose) AUC and Cmax following the administration of fluconazole. There was a mean ± SD increase in tolbutamide AUC of 26% ± 9% (range: 12 to 39%). Tolbutamide Cmax increased 11% ± 9% (range: -6 to 27%). (See PRECAUTIONS.)</ao:suffix>
    <pav:createdOn>2014-07-21 21:38:40 -0400</pav:createdOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:prefix>In 13 normal male volunteers, there was significant increase in </ao:prefix>
    <ao:exact>tolbutamide </ao:exact>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:0DC4E7B3-91DD-45B9-9175-1936730AC49F">
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-9.txt.html</ao:hasSource>
    <pav:createdOn>2014-09-02 11:43:26 -0400</pav:createdOn>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:0DC4E7B3-91DD-45B9-9175-1936730AC49F"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:suffix>: There have been rare postmarketing reports of </ao:suffix>
    <ao:exact>Triptans</ao:exact>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <domeo:uuid>0DC4E7B3-91DD-45B9-9175-1936730AC49F</domeo:uuid>
    <ao:prefix>xsd:String</ao:prefix>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:D5B6732B-67A7-4A25-9BC2-70185A35217F">
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:createdOn>2014-09-02 19:13:08 -0400</pav:createdOn>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <domeo:belongsToSet>urn:domeoclient:uuid:CB83FFC2-EA71-44EA-8F11-DE80E389C84E</domeo:belongsToSet>
    <ao:context rdf:resource="urn:domeoclient:uuid:601A10D5-2B9E-4942-8107-15DFA9C70ACF"/>
    <domeo:belongsToSet>urn:domeoserver:annotationset:392EE0FB-AC4F-4AF2-87A6-2E50A281F434</domeo:belongsToSet>
    <pav:lastSavedOn>2014-09-02 19:19:47 -0400</pav:lastSavedOn>
    <pav:lineageUri>urn:domeoserver:annotation:3CE715A4-63BE-4097-B9E7-CCAFB6F6F310</pav:lineageUri>
    <rdfs:label>Highlight</rdfs:label>
    <domeo:belongsToSet>urn:domeoserver:annotationset:E32812A9-205B-4EE1-B488-A1E294EDBFB9</domeo:belongsToSet>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812eda990003</pav:createdBy>
    <pav:lineageUri>urn:domeoserver:annotationset:C5DEBC9B-77EE-4243-88EB-DBC19737ACD2</pav:lineageUri>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:C9F22978-089A-4215-9421-19B4E3E4358A">
    <ao:suffix>xsd:String</ao:suffix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-125.txt.html</ao:hasSource>
    <ao:exact>propranolol</ao:exact>
    <domeo:uuid>C9F22978-089A-4215-9421-19B4E3E4358A</domeo:uuid>
    <pav:createdOn>2014-07-24 19:38:18 -0400</pav:createdOn>
    <ao:prefix>The metabolism of </ao:prefix>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:C9F22978-089A-4215-9421-19B4E3E4358A"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:F87D2273-7E05-4F58-B46E-DA5B9D8816DE">
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#AnnotationSet"/>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812eda990003</pav:createdBy>
    <pav:lineageUri>urn:domeoserver:annotationset:450319D6-0B1D-4008-A222-CF6FE648CCD6</pav:lineageUri>
    <ao:item rdf:resource="urn:domeoclient:uuid:BB5170BC-470C-4927-94E9-76D8F5299B74"/>
    <ao:annotatesResource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-134.txt.html</ao:annotatesResource>
    <dct:description>The default set is created automatically by Domeo when no other set is existing.</dct:description>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <ao:item rdf:resource="urn:domeoclient:uuid:18F9EC5C-6A37-4A41-85DF-87BCEB900110"/>
    <domeo:agents rdf:resource="urn:person:uuid:080e143046812afe0146812eda990003"/>
    <domeo:agents rdf:resource="urn:domeo:software:id:Domeo-2.1alpha-050"/>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <rdfs:label>Default Set</rdfs:label>
    <permissions:permissions rdf:nodeID="N6d7109c3144743b0b145f59b9b892212"/>
    <pav:createdOn>2014-07-24 19:55:03 -0400</pav:createdOn>
    <domeo:deleted>false</domeo:deleted>
    <pav:lastSavedOn>2014-07-24 19:54:44 -0400</pav:lastSavedOn>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:E13140FE-59B4-45B2-A524-CAED051C4F9D">
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:createdOn>2014-07-07 09:42:08 -0400</pav:createdOn>
    <pav:lastSavedOn>2014-07-07 09:44:19 -0400</pav:lastSavedOn>
    <pav:lastSavedOn>2014-07-07 09:44:18 -0400</pav:lastSavedOn>
    <domeo:belongsToSet>urn:domeoserver:annotationset:131835A3-C655-4F91-97D4-52CAFF7B7CCA</domeo:belongsToSet>
    <pav:lineageUri>urn:domeoserver:annotationset:76FD4BB5-DE2F-4FCA-B93D-302185B1A381</pav:lineageUri>
    <domeo:belongsToSet>urn:domeoserver:annotationset:7AACEF8D-2EBC-4F0B-94B2-190650E562F6</domeo:belongsToSet>
    <domeo:belongsToSet>urn:domeoserver:annotationset:8F3CF3D9-AADE-4A86-BD42-2924B3D6A406</domeo:belongsToSet>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812eda990003</pav:createdBy>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <rdfs:label>Highlight</rdfs:label>
    <pav:lineageUri>urn:domeoserver:annotation:54480EEE-DF3F-4931-84CB-D1B1770AE31E</pav:lineageUri>
    <domeo:belongsToSet>urn:domeoserver:annotationset:08C0C288-6DF4-43E6-A618-71A8BB9563C3</domeo:belongsToSet>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <domeo:belongsToSet>urn:domeoserver:annotationset:22ED7220-C6F6-43C5-9DF9-89F62F0F8E27</domeo:belongsToSet>
    <domeo:belongsToSet>urn:domeoclient:uuid:FCA2BF23-0BE3-409F-9177-761812F96097</domeo:belongsToSet>
    <ao:context rdf:resource="urn:domeoclient:uuid:68010F53-B903-4110-B73F-5CE843CA2E18"/>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/C8697DBE-189E-49C7-A34D-563280FA497C">
    <rdfs:label>fexofenadine hydrochloride</rdfs:label>
    <sio:SIO_000228>dikbD2R:object-drug-of-interaction</sio:SIO_000228>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/active-ingredient"/>
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/236474</dailymed:activeMoietyRxCUI>
    <dct:description>Referred to the drug in the interaction.</dct:description>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:08556835-0438-4667-8B70-71388FA5E865">
    <pav:lastSavedOn>2014-07-22 19:40:31 -0400</pav:lastSavedOn>
    <pav:createdOn>2014-07-22 19:36:20 -0400</pav:createdOn>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812eda990003</pav:createdBy>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:lineageUri>urn:domeoserver:annotationset:AB1741F1-5A5F-4416-AEAC-A544BCBB7D16</pav:lineageUri>
    <domeo:belongsToSet>urn:domeoserver:annotationset:F272A789-69D0-47CC-8CC9-F25C55B91261</domeo:belongsToSet>
    <pav:lastSavedOn>2014-07-22 19:40:32 -0400</pav:lastSavedOn>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <domeo:belongsToSet>urn:domeoserver:annotationset:2914A3FD-DF43-4F78-999C-77CE7A028B19</domeo:belongsToSet>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">5</pav:versionNumber>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <domeo:belongsToSet>urn:domeoserver:annotationset:606A5B3F-B6FB-4279-AA42-7893CFC2D20C</domeo:belongsToSet>
    <domeo:belongsToSet>urn:domeoserver:annotationset:514BA51B-D734-4003-A7C3-F03C0F95833A</domeo:belongsToSet>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <rdfs:label>Highlight</rdfs:label>
    <ao:context rdf:resource="urn:domeoclient:uuid:38A0F3BF-9F6A-4A3D-89AB-BD75B2AC4CE8"/>
    <pav:previousVersion>urn:domeoserver:annotationset:7021B883-FD5C-4083-BD87-DF56D3C87633</pav:previousVersion>
    <pav:lineageUri>urn:domeoserver:annotation:5F4D4F8A-ADBB-430E-B540-4AA0ED411C21</pav:lineageUri>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:3CA31561-312B-4AE9-A654-27502AE41947">
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812eda990003</pav:createdBy>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <rdfs:label>Highlight</rdfs:label>
    <pav:lastSavedOn>2014-07-21 21:50:30 -0400</pav:lastSavedOn>
    <pav:createdOn>2014-07-21 21:50:40 -0400</pav:createdOn>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <ao:context rdf:resource="urn:domeoclient:uuid:E8450D63-C063-4E83-BCD1-4BE5A8F6FF5C"/>
    <pav:lineageUri>urn:domeoserver:annotation:07D0E09D-1B95-4EA5-944E-2F63A43629C1</pav:lineageUri>
    <domeo:belongsToSet>urn:domeoclient:uuid:404B1852-88F6-45BB-8C18-358B3A408485</domeo:belongsToSet>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:71191E51-53CB-4FDE-88D0-33C6818E2232">
    <ao:item rdf:resource="urn:domeoclient:uuid:454E7688-A4B1-42BF-86B5-6E1A3C88986A"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:2532730F-81C6-4CC5-93B2-FC3A19B98EC5"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#AnnotationSet"/>
    <domeo:agents rdf:resource="urn:domeo:software:id:Domeo-2.1alpha-050"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:B9C5564E-F653-404D-B333-299E63141AF5"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:04EFF21D-F5C9-468D-BFA5-057DD08ABD00"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:EEC761C8-1050-4E1A-A450-D460F8514160"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:2537CEFB-4053-4AC9-8731-C65B1AC5D0F9"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:7AF3A49F-90C3-4D03-97CB-74AE03BF7C86"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:3B743E18-8323-4761-B0A4-3B200C16F9BE"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:6ECE2E9A-54C4-4507-95A6-2F4053719529"/>
    <ao:annotatesResource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-8.txt.html</ao:annotatesResource>
    <ao:item rdf:resource="urn:domeoclient:uuid:89155DC0-3493-4590-8DD7-44717F141C27"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:A361190A-A611-4162-AA47-4014AAEBA0B2"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:90F5AA7B-F35E-4B00-A666-C6FE8F1B0324"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:97C1D6A3-E462-4C1F-8DD6-513D5AD2268A"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:518CD4C6-1719-48AB-B300-84A10DEACB68"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:3B18CF78-48CD-4D32-B4F4-88F8072C8185"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:9AF0B949-C133-4703-9F65-362D4B5B4494"/>
    <permissions:permissions rdf:nodeID="N8fb4f1f2fd2e4c6b98aa7794dd80f966"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:8E221E79-602A-4812-8488-538D6506C879"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:A151EB77-7400-49F2-9673-BFAD2171D5CD"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:E728D92E-FEA6-4EE6-9E40-E59051DEB8E3"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:9BD1E279-39ED-4853-AF2E-BE56BEB4AF03"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:92DB5361-BE2B-4C69-B141-FB431E8EFC22"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:464ED203-77EC-4EFC-873A-7853A308DCA5"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:4E77E45D-0BB8-4168-8CAF-9D1591E37A36"/>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <ao:item rdf:resource="urn:domeoclient:uuid:C5594C9A-8B88-4CF6-B5AA-3F081580D92D"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:05BFBD66-D24D-4F61-89C5-4EDDE7B6040C"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:F0AC105E-C659-4D3F-9F13-4104BCC29CDE"/>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <ao:item rdf:resource="urn:domeoclient:uuid:E8680340-7715-4656-A160-A6F608AD7CE9"/>
    <pav:createdOn>2014-07-13 11:04:07 -0400</pav:createdOn>
    <ao:item rdf:resource="urn:domeoclient:uuid:651C0626-4BF6-4B96-A66A-7385C6456D51"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:A6F0B480-ABD4-436B-8A6F-A4BD34827F73"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:CAC294B3-5790-4488-B65C-CB3269F765C6"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:FD9D4BD5-A390-4CD6-8FF4-21ABE76D596A"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:E2A93D3C-935C-417F-BE1B-282EDBEB8D85"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:95AEC430-A2F4-4B0D-B623-70050D7B891E"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:3805F006-2423-4B51-87AB-CAE85C6B4E21"/>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812eda990003</pav:createdBy>
    <ao:item rdf:resource="urn:domeoclient:uuid:4019A76A-1D16-4F04-8CBF-FF855DD2A7A2"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:1E597BBC-9857-4D08-953B-5CBE831F5884"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:B088F7FA-8870-4336-965B-4A558E3F08B0"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:5F8E4E79-C59A-410E-ACD6-41B9C532F968"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:8EAC93E7-05D8-439B-86B4-7B47CB07E8D8"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:5B622988-60A1-49F1-966B-8460BBF1DD4D"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:6B6560EB-DD3A-4FD9-ACE8-690CA260DD8B"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:56F428F6-CAF7-4343-B57C-103B1BA935EB"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:64792593-BEAB-4B65-88FB-A2254663F469"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:DFCBEAF2-DEEA-4C46-A167-B2B6F5C56C00"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:017A9836-D985-4347-BFF0-9EBED8DB5CD1"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:FE717566-90D0-4B59-B00F-B053CAE639C4"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:0C4061A3-979D-486B-9CDA-1CFF771CCB5B"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:94239CD6-2883-459B-A125-FF55B9791833"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:F94384BA-7A08-4E0D-A89C-A73959BAA203"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:EFBA3663-4C52-45BA-895B-7EB3C0A4DA3A"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:72843AE3-90CC-43FD-BCEC-E83B4E3A7EDF"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:2EC8E075-F7E3-4259-A656-99D292E9F0A4"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:CA230F0A-406C-43AE-88DE-A7FD67CF4D61"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:E73E8FF7-7FA2-47F3-B0B1-14D1640DDBF7"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:5BA6BC8B-1F30-4288-9D03-060F552BAA12"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:14556CC1-0C55-47A6-8175-973C292639CC"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:9F3CA373-B79A-4B2D-8C96-BFB67CB4B175"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:F46BEE2C-B82E-4386-96D7-C74221898C04"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:72584FCC-E5F1-4130-993B-ED469AE3E810"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:23E5F3F5-E089-460E-A736-58E2FC44ADC6"/>
    <pav:lastSavedOn>2014-07-13 11:32:29 -0400</pav:lastSavedOn>
    <domeo:deleted>false</domeo:deleted>
    <ao:item rdf:resource="urn:domeoclient:uuid:97FF727B-70F7-4A8F-9355-6D53C2602A7E"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:539264FC-F626-408A-BB71-03BC387083CB"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:34472B29-EA4E-45E5-84B2-2EEE556610B6"/>
    <pav:lineageUri>urn:domeoserver:annotationset:90C0A4CD-5288-4960-B31A-195D0159FE45</pav:lineageUri>
    <ao:item rdf:resource="urn:domeoclient:uuid:8B475492-95FE-4CDD-81AE-94DFEEB91E11"/>
    <dct:description>The default set is created automatically by Domeo when no other set is existing.</dct:description>
    <ao:item rdf:resource="urn:domeoclient:uuid:0D7139F9-BDC3-437F-A5A1-D75EDAC972B0"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:1C446162-FA92-4715-9095-A116DC12F4C8"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:6DDA4ED5-743F-4C12-93A8-37B2366FF364"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:CBE541BF-AED9-48E5-ACA0-9309C45B20F5"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:5FF2B43E-5E15-4C21-BFDD-C97D4C18B3B1"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:C15235C1-3B10-4949-B8E4-1D7FCCD3AC4B"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:92436D94-1FB4-49B2-B20D-385CA961A940"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:420B9B73-0394-4975-8634-61202EA8F217"/>
    <domeo:agents rdf:resource="urn:person:uuid:080e143046812afe0146812eda990003"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:9011E52E-6FAE-42BF-913B-D3EF952E8A2B"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:BA2C0A64-143A-46D5-A408-01FC3EC62525"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:420A77EC-3CAE-4EA3-B428-B635FA4A9F5D"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:A46A827E-4936-4BBC-8078-913DD6DAA84E"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:71E5047C-5690-4D45-9A6E-FB1384C14928"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:934B866B-AFCB-4F4A-A5CA-1B312B3088E1"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:99E97745-423E-4818-BFC6-3F67C8BF2A87"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:0025BED1-B4CA-4D8F-9C43-B2F10841CCF4"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:7CC41192-004E-44F9-8E3D-0FF7CECF1DC2"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:6EC654F2-7C5C-4C0B-9973-518245983B18"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:E202AAE6-7DCA-486D-9C29-8CB3B82CFECF"/>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <rdfs:label>Default Set</rdfs:label>
    <ao:item rdf:resource="urn:domeoclient:uuid:E6A5356C-B181-4F61-AEF2-74464A340D7F"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:265209EB-0CE8-478A-9C0E-59E0095E0A6B">
    <ao:suffix>.</ao:suffix>
    <pav:createdOn>2014-09-02 11:41:26 -0400</pav:createdOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:prefix>e- and eight-fold increases in tacrine Cmax and AUC, respectively, compared to the administration of tacrine alone. Five subjects experienced nausea, vomiting, sweating, and diarrhea following coadministration, consistent with the cholinergic effects of </ao:prefix>
    <domeo:uuid>265209EB-0CE8-478A-9C0E-59E0095E0A6B</domeo:uuid>
    <ao:exact>tacrine</ao:exact>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-9.txt.html</ao:hasSource>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:265209EB-0CE8-478A-9C0E-59E0095E0A6B"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:E0ECD29D-DAB1-4D63-85F1-1839E3B04BF6">
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <domeo:uuid>E0ECD29D-DAB1-4D63-85F1-1839E3B04BF6</domeo:uuid>
    <ao:prefix> nor </ao:prefix>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:E0ECD29D-DAB1-4D63-85F1-1839E3B04BF6"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:suffix> displaces each other from plasma binding sites. High therapeutic concentrations of sulfamethazine (100 mcg/mL), warfarin (10 mcg/mL), and carbamazepine (10 mcg/mL) caused only a slight increase in the free fraction of risperidone at 10 ng/mL and 9-hydro</ao:suffix>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-8.txt.html</ao:hasSource>
    <pav:createdOn>2014-07-13 11:11:19 -0400</pav:createdOn>
    <ao:exact>9-hydroxyrisperidone</ao:exact>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:F3272B85-6D67-4686-901C-B1617D8FE66B">
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812eda990003</pav:createdBy>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <pav:createdOn>2014-09-02 11:58:50 -0400</pav:createdOn>
    <pav:lastSavedOn>2014-09-02 12:02:18 -0400</pav:lastSavedOn>
    <rdfs:label>Highlight</rdfs:label>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:lineageUri>urn:domeoserver:annotation:170ACB73-F2AA-42BF-B064-7D7B43660DBF</pav:lineageUri>
    <domeo:belongsToSet>urn:domeoclient:uuid:4B51141D-C8D2-45DB-8074-74F8D8323E60</domeo:belongsToSet>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <ao:context rdf:resource="urn:domeoclient:uuid:F57938E2-AD63-45EA-B996-C0C893D21182"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:C889EF0F-E8A2-4563-BA94-C8364D653756">
    <pav:lineageUri>urn:domeoserver:annotation:B51D6A91-C630-44CC-96EE-901F0B00549B</pav:lineageUri>
    <ao:context rdf:resource="urn:domeoclient:uuid:D888862A-48F7-478F-BD96-42A7D5B21693"/>
    <pav:createdOn>2014-07-28 17:04:48 -0400</pav:createdOn>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812eda990003</pav:createdBy>
    <rdfs:label>Highlight</rdfs:label>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <domeo:belongsToSet>urn:domeoclient:uuid:48D839E5-6B0A-4EC3-B64A-E3E20E06246A</domeo:belongsToSet>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <pav:lastSavedOn>2014-07-28 17:08:37 -0400</pav:lastSavedOn>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:F989B861-2D11-4383-83FA-D6724A4DE400">
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812eda990003</pav:createdBy>
    <pav:lineageUri>urn:domeoserver:annotation:DBB25016-BFD9-41FA-A42B-EADA54610DC2</pav:lineageUri>
    <domeo:belongsToSet>urn:domeoserver:annotationset:E32812A9-205B-4EE1-B488-A1E294EDBFB9</domeo:belongsToSet>
    <pav:createdOn>2014-09-02 19:12:54 -0400</pav:createdOn>
    <ao:context rdf:resource="urn:domeoclient:uuid:BCC3E44B-0E96-41D5-AB03-A4CC9A1EB653"/>
    <pav:lineageUri>urn:domeoserver:annotationset:C5DEBC9B-77EE-4243-88EB-DBC19737ACD2</pav:lineageUri>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <domeo:belongsToSet>urn:domeoclient:uuid:CB83FFC2-EA71-44EA-8F11-DE80E389C84E</domeo:belongsToSet>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <domeo:belongsToSet>urn:domeoserver:annotationset:392EE0FB-AC4F-4AF2-87A6-2E50A281F434</domeo:belongsToSet>
    <rdfs:label>Highlight</rdfs:label>
    <pav:lastSavedOn>2014-09-02 19:19:47 -0400</pav:lastSavedOn>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:28EC9E22-4FF4-4D9B-93F4-C03F41FBC1BB">
    <pav:createdOn>2014-09-02 11:57:44 -0400</pav:createdOn>
    <ao:context rdf:resource="urn:domeoclient:uuid:5D96071F-E598-4A67-BE46-D1F8D7E04E18"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812eda990003</pav:createdBy>
    <rdfs:label>Highlight</rdfs:label>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <domeo:belongsToSet>urn:domeoclient:uuid:4B51141D-C8D2-45DB-8074-74F8D8323E60</domeo:belongsToSet>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <pav:lineageUri>urn:domeoserver:annotation:2D98FBF3-6C37-4A7C-8FC6-315ACC460D3B</pav:lineageUri>
    <pav:lastSavedOn>2014-09-02 12:02:18 -0400</pav:lastSavedOn>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:7CF400AE-CD72-49D9-9780-049736D11E6D">
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:lineageUri>urn:domeoserver:annotation:9FD13A04-F6A6-4702-A660-AD94950EF574</pav:lineageUri>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812eda990003</pav:createdBy>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <ao:context rdf:resource="urn:domeoclient:uuid:74981A52-DA21-4061-9DF7-E2A73DB55601"/>
    <rdfs:label>Highlight</rdfs:label>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <domeo:belongsToSet>urn:domeoclient:uuid:E0050ED6-BE4F-4871-9847-FC4493F22447</domeo:belongsToSet>
    <pav:createdOn>2014-07-24 20:00:56 -0400</pav:createdOn>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <pav:lastSavedOn>2014-07-24 20:00:43 -0400</pav:lastSavedOn>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:3762570C-CF43-4DB9-B163-FAA6DAE60017">
    <rdfs:label>Highlight</rdfs:label>
    <domeo:belongsToSet>urn:domeoserver:annotationset:131835A3-C655-4F91-97D4-52CAFF7B7CCA</domeo:belongsToSet>
    <domeo:belongsToSet>urn:domeoserver:annotationset:7AACEF8D-2EBC-4F0B-94B2-190650E562F6</domeo:belongsToSet>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:createdOn>2014-07-07 09:39:29 -0400</pav:createdOn>
    <domeo:belongsToSet>urn:domeoclient:uuid:FCA2BF23-0BE3-409F-9177-761812F96097</domeo:belongsToSet>
    <pav:lineageUri>urn:domeoserver:annotationset:76FD4BB5-DE2F-4FCA-B93D-302185B1A381</pav:lineageUri>
    <pav:lastSavedOn>2014-07-07 09:44:19 -0400</pav:lastSavedOn>
    <pav:lineageUri>urn:domeoserver:annotation:65E1DF4C-ED97-45AE-A88B-0EE9DF979CD2</pav:lineageUri>
    <domeo:belongsToSet>urn:domeoserver:annotationset:8F3CF3D9-AADE-4A86-BD42-2924B3D6A406</domeo:belongsToSet>
    <domeo:belongsToSet>urn:domeoserver:annotationset:08C0C288-6DF4-43E6-A618-71A8BB9563C3</domeo:belongsToSet>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <domeo:belongsToSet>urn:domeoserver:annotationset:22ED7220-C6F6-43C5-9DF9-89F62F0F8E27</domeo:belongsToSet>
    <ao:context rdf:resource="urn:domeoclient:uuid:28EA3105-DAE4-4248-8C5A-EACDF44B4680"/>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812eda990003</pav:createdBy>
    <pav:lastSavedOn>2014-07-07 09:44:18 -0400</pav:lastSavedOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:3E08DAB4-201F-48CD-8ACA-375750DA65B1">
    <ao:exact>sildenafil </ao:exact>
    <ao:prefix>concentrations when co-administered with </ao:prefix>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:3E08DAB4-201F-48CD-8ACA-375750DA65B1"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <pav:createdOn>2014-07-07 11:22:56 -0400</pav:createdOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-155.txt.html</ao:hasSource>
    <domeo:uuid>3E08DAB4-201F-48CD-8ACA-375750DA65B1</domeo:uuid>
    <ao:suffix>(50 mg) to healthy volunteers.</ao:suffix>
    <domeo:uuid></domeo:uuid>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:D3F1A48F-9525-4CA3-8022-C7885849CBC2">
    <pav:lineageUri>urn:domeoserver:annotation:0EB4AE1F-6DB3-497B-AAE0-DD8E03C51D30</pav:lineageUri>
    <rdfs:label>Highlight</rdfs:label>
    <domeo:belongsToSet>urn:domeoclient:uuid:6A05795B-B1AB-4DB3-A12F-2765CBCC2FED</domeo:belongsToSet>
    <ao:context rdf:resource="urn:domeoclient:uuid:4FCA7E7B-CC82-4455-94C0-73C09ED070C1"/>
    <pav:createdOn>2014-07-13 12:34:41 -0400</pav:createdOn>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:lastSavedOn>2014-07-13 12:34:42 -0400</pav:lastSavedOn>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812eda990003</pav:createdBy>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:35CD1CDB-7257-43BB-BB56-7A444AAF4BA3">
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812eda990003</pav:createdBy>
    <domeo:belongsToSet>urn:domeoclient:uuid:07539CCF-9ED2-4C02-AC53-CD1CF6713CB3</domeo:belongsToSet>
    <ao:context rdf:resource="urn:domeoclient:uuid:CC1D209A-F362-4FEA-ABD5-96B660CE4A7A"/>
    <pav:lastSavedOn>2014-07-24 20:04:50 -0400</pav:lastSavedOn>
    <pav:lineageUri>urn:domeoserver:annotation:CB9DE49D-2EBB-4CA3-BC80-5D2A9373C00A</pav:lineageUri>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:createdOn>2014-07-24 20:05:02 -0400</pav:createdOn>
    <rdfs:label>Highlight</rdfs:label>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:9BD1E279-39ED-4853-AF2E-BE56BEB4AF03">
    <rdfs:label>Highlight</rdfs:label>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <domeo:belongsToSet>urn:domeoclient:uuid:71191E51-53CB-4FDE-88D0-33C6818E2232</domeo:belongsToSet>
    <pav:lineageUri>urn:domeoserver:annotation:7687B2A2-948F-4E07-9BC1-43216AD31878</pav:lineageUri>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:createdOn>2014-07-13 11:11:31 -0400</pav:createdOn>
    <ao:context rdf:resource="urn:domeoclient:uuid:159DCA30-3727-4241-9440-301E40381956"/>
    <pav:lastSavedOn>2014-07-13 11:32:29 -0400</pav:lastSavedOn>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812eda990003</pav:createdBy>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:A3802033-7DB0-4AE2-833F-5EF306928ABF">
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:prefix>Co-administration of long-acting </ao:prefix>
    <pav:createdOn>2014-07-24 19:54:37 -0400</pav:createdOn>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:A3802033-7DB0-4AE2-833F-5EF306928ABF"/>
    <domeo:uuid>A3802033-7DB0-4AE2-833F-5EF306928ABF</domeo:uuid>
    <ao:exact>propranolol</ao:exact>
    <ao:suffix> at doses greater than or equal to 160 mg/day resulted in increased thioridazine plasma concentrations ranging from 55% to 369% and increased thioridazine metabolite (mesoridazine) concentrations ranging from 33% to 209%.</ao:suffix>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-133.txt.html</ao:hasSource>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/FD1E05D2-DBCD-40D9-A3EB-92B46960D6B9">
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/261455</dailymed:activeMoietyRxCUI>
    <rdfs:label>AVANDIA</rdfs:label>
    <dct:description>Referred to the drug in the interaction.</dct:description>
    <sio:SIO_000228>dikbD2R:object-drug-of-interaction</sio:SIO_000228>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/drug-product"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:C29885C9-C34F-446F-88D0-5C6DE9D91033">
    <ao:prefix>s metabolite has a phosphodiesterase selectivity profile similar to sildenafil and an in vitro potency for PDE5 approximately 50% of the parent drug. In healthy volunteers, plasma concentrations of this metabolite are approximately 40% of those seen for </ao:prefix>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-155.txt.html</ao:hasSource>
    <pav:createdOn>2014-07-07 09:43:59 -0400</pav:createdOn>
    <ao:exact>sildenafil</ao:exact>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:C29885C9-C34F-446F-88D0-5C6DE9D91033"/>
    <ao:suffix>, so that the metabolite accounts for about 20% of sildenafil's pharmacologic effects. In patients with pulmonary arterial hypertension, however, the ratio of the metabolite to sildenafil is higher. Both sildenafil and the active metabolite have terminal</ao:suffix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <domeo:uuid></domeo:uuid>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <domeo:uuid>C29885C9-C34F-446F-88D0-5C6DE9D91033</domeo:uuid>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoserver:annotationset:7E80543E-BF76-4514-92A9-91458DCB802B">
    <ao:item rdf:resource="urn:domeoclient:uuid:FF1FC131-57E9-4A89-8FBF-B786D1543F24"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:5CE56B1D-ACF0-4124-B31E-62EF1E11FED8"/>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <ao:item rdf:resource="urn:domeoclient:uuid:78A5F631-80CE-4FB1-974D-F82BE8D8E584"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:51F1BD01-1111-4CA2-BC77-65762E0E45AA"/>
    <permissions:permissions rdf:nodeID="Nb0ce8ef3d8e3495baf70e3f4f30f0fb1"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:15E1712B-2693-4DB6-A2FE-D2F158D3A823"/>
    <ao:annotatesResource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-123.txt.html</ao:annotatesResource>
    <pav:lineageUri>urn:domeoserver:annotationset:AB1741F1-5A5F-4416-AEAC-A544BCBB7D16</pav:lineageUri>
    <ao:item rdf:resource="urn:domeoclient:uuid:0A960BCB-9A9F-4998-9418-33D622C35F7C"/>
    <domeo:deleted>false</domeo:deleted>
    <ao:item rdf:resource="urn:domeoclient:uuid:585BED0D-5182-4D39-912D-F355B5BEA6BA"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:AF68257F-3ADB-4BA4-9BD1-247F8428319E"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:A68BF389-96D4-4F16-BF9D-C1BF35E3CE01"/>
    <dct:description>The default set is created automatically by Domeo when no other set is existing.</dct:description>
    <ao:item rdf:resource="urn:domeoclient:uuid:B6681C81-EA03-49F0-8187-EF5752C9D126"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:23AC6809-BABB-405A-80DE-630CA211B109"/>
    <pav:lastSavedOn>2014-07-22 19:28:02 -0400</pav:lastSavedOn>
    <ao:item rdf:resource="urn:domeoclient:uuid:851EB41C-687B-464B-9105-16513BFE3A24"/>
    <domeo:agents rdf:resource="urn:domeo:software:id:Domeo-2.1alpha-050"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:513FF3F1-4FCE-4790-A5C9-F75162D3687B"/>
    <domeo:agents rdf:resource="urn:person:uuid:080e143046812afe0146812eda990003"/>
    <rdfs:label>Default Set</rdfs:label>
    <ao:item rdf:resource="urn:domeoclient:uuid:D555EE88-9218-4AF9-81CC-40D543746D77"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:5C47D157-D8A4-4053-B2C7-7ECD1B16B721"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:B28EDC18-743D-4015-956F-B084F96B3589"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:B1EDC65E-7D2E-4E9E-9D08-0D72BD366C29"/>
    <pav:previousVersion>urn:domeoserver:annotationset:467D4F28-D086-4217-9DE0-23E165F30716</pav:previousVersion>
    <pav:createdOn>2014-07-22 19:08:44 -0400</pav:createdOn>
    <ao:item rdf:resource="urn:domeoclient:uuid:ED9A4881-5A44-4C07-BAFB-529340D632F3"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:F895E903-9E93-41BD-BED1-2EA2CE628B45"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:37E9FF1C-D06E-42C3-944C-482813D8E38E"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:2506F4F5-773E-4CCD-8303-CC244D5848D1"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#AnnotationSet"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:4411E759-9248-468B-B2F6-E5A5A8657C4C"/>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812eda990003</pav:createdBy>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">3</pav:versionNumber>
    <ao:item rdf:resource="urn:domeoclient:uuid:D1F55052-16DF-4B25-AC16-7645C8E4AD77"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:874E727F-4FC5-466C-9B3D-C17154D3C2D1">
    <domeo:uuid>874E727F-4FC5-466C-9B3D-C17154D3C2D1</domeo:uuid>
    <pav:createdOn>2014-07-28 17:07:56 -0400</pav:createdOn>
    <ao:prefix>xsd:String</ao:prefix>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-201.txt.html</ao:hasSource>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:exact>In a pharmacokinetic study with patients on methadone maintenance therapy, phenytoin administration (250 mg b.i.d. initially for 1 day followed by 300 mg QD for 3 to 4 days) resulted in an approximately 50% reduction in methadone exposure and withdrawal symptoms occurred concurrently. Upon discontinuation of phenytoin, the incidence of withdrawal symptoms decreased and methadone exposure increased to a level comparable to that prior to phenytoin administration.</ao:exact>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:874E727F-4FC5-466C-9B3D-C17154D3C2D1"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:suffix>xsd:String</ao:suffix>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:876DAFB7-BB08-4119-BA16-59187031D7BB">
    <ao:item rdf:resource="urn:domeoclient:uuid:C5974F18-7052-426D-A45F-D129E2BC7FB8"/>
    <rdfs:label>Default Set</rdfs:label>
    <pav:createdOn>2014-07-21 21:45:44 -0400</pav:createdOn>
    <ao:item rdf:resource="urn:domeoclient:uuid:6BC9135A-65A9-4BB2-A462-DD73D14C286B"/>
    <pav:lineageUri>urn:domeoserver:annotationset:F60474E5-A763-40B4-B547-A0BB4FA6BDEF</pav:lineageUri>
    <domeo:agents rdf:resource="urn:person:uuid:080e143046812afe0146812eda990003"/>
    <permissions:permissions rdf:nodeID="Nba115080b5364b22ab22abf0490e9926"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:6E8F08BA-7079-4216-9618-95A54B886D84"/>
    <ao:annotatesResource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-53.txt.html</ao:annotatesResource>
    <domeo:agents rdf:resource="urn:domeo:software:id:Domeo-2.1alpha-050"/>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812eda990003</pav:createdBy>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <dct:description>The default set is created automatically by Domeo when no other set is existing.</dct:description>
    <domeo:deleted>false</domeo:deleted>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#AnnotationSet"/>
    <pav:lastSavedOn>2014-07-21 21:46:47 -0400</pav:lastSavedOn>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:0DC1E786-48C0-4894-B615-AFA91FDAC5BD">
    <domeo:belongsToSet>urn:domeoserver:annotationset:A3F0B39A-4249-4B63-BB0D-F24A005066AC</domeo:belongsToSet>
    <pav:createdOn>2014-09-02 11:30:42 -0400</pav:createdOn>
    <domeo:belongsToSet>urn:domeoserver:annotationset:3F546823-204F-4F9B-9006-3DC526C56931</domeo:belongsToSet>
    <ao:context rdf:resource="urn:domeoclient:uuid:181AEA3C-635D-4DE0-8CD4-D795EB36DD79"/>
    <domeo:belongsToSet>urn:domeoserver:annotationset:A5DD001D-C81A-4E2E-B5E0-7A866B35E26B</domeo:belongsToSet>
    <rdfs:label>Highlight</rdfs:label>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:lineageUri>urn:domeoserver:annotation:A16E6CEA-F544-47F5-B3AC-5AC66CBD408C</pav:lineageUri>
    <pav:lastSavedOn>2014-09-02 11:35:33 -0400</pav:lastSavedOn>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812eda990003</pav:createdBy>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <domeo:belongsToSet>urn:domeoclient:uuid:BED41F06-565A-4622-9A88-48810E5A28DE</domeo:belongsToSet>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:lineageUri>urn:domeoserver:annotationset:D1715BD2-BD41-46FD-9454-DC7A423A29AC</pav:lineageUri>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:EAE18A28-D547-4A0F-951B-598FF59A2D26">
    <ao:context rdf:resource="urn:domeoclient:uuid:856ADB71-F8FC-4B9D-8651-B139286C3B33"/>
    <rdfs:label>expertstudy Annotation</rdfs:label>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:lastSavedOn>2014-07-22 18:54:35 -0400</pav:lastSavedOn>
    <ao:body rdf:nodeID="Ne8c75e56ecff40c8bb7a31fda7cad1e4"/>
    <pav:createdOn>2014-07-22 18:54:36 -0400</pav:createdOn>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812eda990003</pav:createdBy>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#expertstudyAnnotation"/>
    <domeo:belongsToSet>urn:domeoclient:uuid:3D195979-3E82-427D-95B8-F50F48DB4AA7</domeo:belongsToSet>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:lineageUri>urn:domeoserver:annotation:D2959471-DB15-4D27-9C9C-2AEF6BC7E79F</pav:lineageUri>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:DC200567-4E8F-495B-9D13-A2A04A7A47EC">
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/83E9958D-5BAA-415C-B14A-C204CC3ED68C"/>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/PK_DDI"/>
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/F1504F1A-B189-4B6A-9973-4A17775240C5"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:8BB0D7D8-E6FC-43D6-A047-53DA7C4A005E">
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-28.txt.html</ao:hasSource>
    <ao:prefix>xsd:String</ao:prefix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:exact>The pharmacokinetics of theophylline were determined from a single intravenous dose of aminophylline (6 mg/kg) before and after the oral administration of fluconazole 200 mg daily for 14 days in 16 normal male volunteers. There were significant increases in theophylline AUC, Cmax, and half-life with a corresponding decrease in clearance. The mean ± SD theophylline AUC increased 21% ± 16% (range: -5 to 48%). The Cmax increased 13% ± 17% (range: -13 to 40%). Theophylline clearance decreased 16% ± 11 % (range: -32 to 5%). The half-life of theophylline increased from 6.6 ± 1.7 hours to 7.9 ± 1.5 hours. (See PRECAUTIONS.)</ao:exact>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:8BB0D7D8-E6FC-43D6-A047-53DA7C4A005E"/>
    <domeo:uuid>8BB0D7D8-E6FC-43D6-A047-53DA7C4A005E</domeo:uuid>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <pav:createdOn>2014-07-21 21:34:52 -0400</pav:createdOn>
    <ao:suffix>xsd:String</ao:suffix>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:75244705-D763-4A47-A23E-5C4CAE8A90B5">
    <domeo:belongsToSet>urn:domeoclient:uuid:1DA34422-734D-46B1-AB2C-C1CABCA4C26C</domeo:belongsToSet>
    <pav:lineageUri>urn:domeoserver:annotation:2B6ECB24-F92D-4CD5-ABD6-C88B1D218116</pav:lineageUri>
    <rdfs:label>Highlight</rdfs:label>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:createdOn>2014-09-01 16:07:25 -0400</pav:createdOn>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812eda990003</pav:createdBy>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <ao:context rdf:resource="urn:domeoclient:uuid:5B31DBDC-7235-4CB3-937C-37BEC560A1C4"/>
    <pav:lastSavedOn>2014-09-01 16:07:52 -0400</pav:lastSavedOn>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:DE725ECB-6E8C-4D1C-9EE0-A969014D8035">
    <domeo:uuid>DE725ECB-6E8C-4D1C-9EE0-A969014D8035</domeo:uuid>
    <pav:createdOn>2014-09-02 19:09:57 -0400</pav:createdOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:suffix>, and phenytoin, may lead to a lack of efficacy or, possibly, development of an abstinence syndrome in a patient who had developed physical dependence to oxycodone. If co-administration is necessary, caution is advised when initiating therapy with, curre</ao:suffix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:prefix>, </ao:prefix>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-72.txt.html</ao:hasSource>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:DE725ECB-6E8C-4D1C-9EE0-A969014D8035"/>
    <ao:exact>carbamazepine</ao:exact>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:9C2359BE-4DCE-4088-A5EE-19EA356FF32D">
    <sio:SIO_000563>dikbD2R:modality</sio:SIO_000563>
    <dikbD2R:statement>ncit:quantitative</dikbD2R:statement>
    <sio:SIO_000628 rdf:resource="urn:pddi:uuid:36209E50-DEE4-4172-A9EA-98FA4D4477D3"/>
    <rdf:type rdf:resource="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#DrugDrugInteractionStatement"/>
    <sio:SIO_000205>dikbD2R:statement</sio:SIO_000205>
    <dikbD2R:modality>ncit:positive</dikbD2R:modality>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/CA0AE675-8281-46D4-AD74-54B4F3150E52">
    <rdfs:label>sildenafil</rdfs:label>
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/136411</dailymed:activeMoietyRxCUI>
    <sio:SIO_000228>dikbD2R:object-drug-of-interaction</sio:SIO_000228>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/active-ingredient"/>
    <dct:description>Referred to the drug in the interaction.</dct:description>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:875A1582-88A4-40A2-9290-112578B609F1">
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812eda990003</pav:createdBy>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:lastSavedOn>2014-07-24 20:07:19 -0400</pav:lastSavedOn>
    <domeo:belongsToSet>urn:domeoserver:annotationset:1FC172B8-8AC3-465A-AA69-B73AD9B97CBC</domeo:belongsToSet>
    <pav:createdOn>2014-07-24 20:07:18 -0400</pav:createdOn>
    <pav:lastSavedOn>2014-07-24 20:07:20 -0400</pav:lastSavedOn>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <domeo:belongsToSet>urn:domeoclient:uuid:8D86A4AC-54BD-4BB3-8B58-AB55DEC01A88</domeo:belongsToSet>
    <pav:lineageUri>urn:domeoserver:annotation:7D1D26BE-A2DC-448B-B435-F7E5D3300F00</pav:lineageUri>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <rdfs:label>Highlight</rdfs:label>
    <pav:lineageUri>urn:domeoserver:annotationset:4A88D0A6-E9B6-4E7F-955F-3692600C178C</pav:lineageUri>
    <domeo:belongsToSet>urn:domeoserver:annotationset:37B2514D-1A92-45B1-8A5C-610DA6DC935A</domeo:belongsToSet>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <ao:context rdf:resource="urn:domeoclient:uuid:C4DA9FCE-B7DB-4AB2-8187-C60945E96A8D"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:25474B79-791D-49D5-B5D1-858E90C62BB2">
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812eda990003</pav:createdBy>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <domeo:belongsToSet>urn:domeoclient:uuid:CB83FFC2-EA71-44EA-8F11-DE80E389C84E</domeo:belongsToSet>
    <pav:createdOn>2014-09-02 19:12:34 -0400</pav:createdOn>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <pav:lineageUri>urn:domeoserver:annotation:D53DB470-0450-40F6-9E72-52FEDD380C14</pav:lineageUri>
    <pav:lineageUri>urn:domeoserver:annotationset:C5DEBC9B-77EE-4243-88EB-DBC19737ACD2</pav:lineageUri>
    <domeo:belongsToSet>urn:domeoserver:annotationset:392EE0FB-AC4F-4AF2-87A6-2E50A281F434</domeo:belongsToSet>
    <pav:lastSavedOn>2014-09-02 19:19:47 -0400</pav:lastSavedOn>
    <rdfs:label>Highlight</rdfs:label>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <ao:context rdf:resource="urn:domeoclient:uuid:5F397631-58CE-4AAD-85E7-C4D90E5C8F78"/>
    <domeo:belongsToSet>urn:domeoserver:annotationset:E32812A9-205B-4EE1-B488-A1E294EDBFB9</domeo:belongsToSet>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:F652E827-5625-4F3B-BD53-6EF8860F2CDE">
    <ao:exact>AVANDIA</ao:exact>
    <pav:createdOn>2014-07-22 19:35:22 -0400</pav:createdOn>
    <ao:prefix>Therapy with </ao:prefix>
    <ao:suffix> should not be initiated if the patient exhibits clinical evidence of active liver disease or increased serum transaminase levels (ALT &gt;2.5X upper limit of normal) at baseline [see Warnings and Precautions (5.6)].</ao:suffix>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-123.txt.html</ao:hasSource>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:F652E827-5625-4F3B-BD53-6EF8860F2CDE"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <domeo:uuid>F652E827-5625-4F3B-BD53-6EF8860F2CDE</domeo:uuid>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:017A9836-D985-4347-BFF0-9EBED8DB5CD1">
    <domeo:belongsToSet>urn:domeoclient:uuid:71191E51-53CB-4FDE-88D0-33C6818E2232</domeo:belongsToSet>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812eda990003</pav:createdBy>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:lineageUri>urn:domeoserver:annotation:489A8473-952A-4034-A912-302A2847F038</pav:lineageUri>
    <pav:lastSavedOn>2014-07-13 11:32:29 -0400</pav:lastSavedOn>
    <rdfs:label>Highlight</rdfs:label>
    <pav:createdOn>2014-07-13 11:17:02 -0400</pav:createdOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <ao:context rdf:resource="urn:domeoclient:uuid:55E92945-9B4A-406D-8BFF-54471B2E432E"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:819F1E61-50CC-41FC-9596-57CE5DC96A2C">
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-25.txt.html</ao:hasSource>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <domeo:uuid>819F1E61-50CC-41FC-9596-57CE5DC96A2C</domeo:uuid>
    <pav:createdOn>2014-07-21 21:26:46 -0400</pav:createdOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:819F1E61-50CC-41FC-9596-57CE5DC96A2C"/>
    <ao:suffix>AUC was determined after 4 days of phenytoin dosing (200 mg daily, orally for 3 days followed by 250 mg intravenously for one dose) both with and without the administration of fluconazole (oral fluconazole 200 mg daily for 16 days) in 10 normal male volu</ao:suffix>
    <ao:prefix>xsd:String</ao:prefix>
    <ao:exact>Phenytoin </ao:exact>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/F1ACE0D3-FA23-46EC-ACAA-40836B0D32A9">
    <dct:description>Referred to the drug in the interaction.</dct:description>
    <sio:SIO_000228>dikbD2R:object-drug-of-interaction</sio:SIO_000228>
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/261455</dailymed:activeMoietyRxCUI>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/drug-product"/>
    <rdfs:label>AVANDIA</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:17C13D4B-C4FD-4F4C-8B4F-969B0D63CD46">
    <pav:createdOn>2014-09-02 12:03:06 -0400</pav:createdOn>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812eda990003</pav:createdBy>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <domeo:belongsToSet>urn:domeoserver:annotationset:D52DFD7B-BDDF-488F-B339-B1BC641E50E9</domeo:belongsToSet>
    <pav:lineageUri>urn:domeoserver:annotation:9A24307B-6226-4EA8-94BA-34FF3C6A694E</pav:lineageUri>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <rdfs:label>Highlight</rdfs:label>
    <domeo:belongsToSet>urn:domeoclient:uuid:379CD8C1-F4B4-42B7-8F87-70776866DB1F</domeo:belongsToSet>
    <pav:lastSavedOn>2014-09-02 12:03:47 -0400</pav:lastSavedOn>
    <pav:lineageUri>urn:domeoserver:annotationset:166C20E9-1B4C-47D1-982D-922E2E5ACFF2</pav:lineageUri>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <ao:context rdf:resource="urn:domeoclient:uuid:109B3973-618F-4814-8D01-1C468E7A80F2"/>
    <pav:previousVersion>xsd:String</pav:previousVersion>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:F41B0D87-B434-42EF-90F7-E87825A6741D">
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <pav:createdOn>2014-07-21 21:31:17 -0400</pav:createdOn>
    <ao:exact>fluconazole</ao:exact>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-27.txt.html</ao:hasSource>
    <ao:prefix>AUC following the administration of </ao:prefix>
    <ao:suffix>. The mean ± SD increase in AUC was 20% ± 32% (range: -27 to 104%). The metabolite, GZDV, to parent drug ratio significantly decreased after the administration of fluconazole, from 7.6 ± 3.6 to 5.7 ± 2.2.</ao:suffix>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:F41B0D87-B434-42EF-90F7-E87825A6741D"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <domeo:uuid>F41B0D87-B434-42EF-90F7-E87825A6741D</domeo:uuid>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:B77653C9-A978-4DDF-BFD4-9627754056FA">
    <dikbD2R:statement>ncit:quantitative</dikbD2R:statement>
    <sio:SIO_000628 rdf:resource="urn:pddi:uuid:B6DF21E9-E88D-43B6-BC67-2BA93CF4CFEF"/>
    <dikbD2R:modality>ncit:positive</dikbD2R:modality>
    <sio:SIO_000205>dikbD2R:statement</sio:SIO_000205>
    <rdf:type rdf:resource="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#DrugDrugInteractionStatement"/>
    <sio:SIO_000563>dikbD2R:modality</sio:SIO_000563>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:856ADB71-F8FC-4B9D-8651-B139286C3B33">
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <pav:createdOn>2014-07-22 18:54:36 -0400</pav:createdOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:suffix>xsd:String</ao:suffix>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-119.txt.html</ao:hasSource>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:856ADB71-F8FC-4B9D-8651-B139286C3B33"/>
    <domeo:uuid>856ADB71-F8FC-4B9D-8651-B139286C3B33</domeo:uuid>
    <ao:exact>Two randomized, open-label, controlled clinical trials of Synercid (7.5 mg/kg q12h intravenously [iv]) in the treatment of complicated skin and skin structure infections were performed. The comparator drug was oxacillin (2g q6h iv) in the first study (JRV 304) and cefazolin (1g q8h iv) in the second study (JRV 305); however, in both studies vancomycin (1g q12h iv) could be substituted for the specified comparator if the causative pathogen was suspected or confirmed methicillin-resistant staphylococcus or if the patient was allergic to penicillins, cephalosporins or carbapenems. Study JRV 304 enrolled 450 patients (n = 229 Synercid; n= 221 Comparator) and Study JRV 305 enrolled 443 patients (n = 221 Synercid; n = 222 Comparator)</ao:exact>
    <ao:prefix>xsd:String</ao:prefix>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/60730FAE-AD66-492F-8E58-7FE659B7159F">
    <rdfs:label>Propranolol</rdfs:label>
    <sio:SIO_000228>dikbD2R:object-drug-of-interaction</sio:SIO_000228>
    <dct:description>Referred to the drug in the interaction.</dct:description>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/active-ingredient"/>
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/8787</dailymed:activeMoietyRxCUI>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:1F41B5CD-E2A4-46BE-9B88-1BCA05A1A5EE">
    <pav:createdOn>2014-09-02 15:04:25 -0400</pav:createdOn>
    <domeo:belongsToSet>urn:domeoclient:uuid:C4B80A95-F569-4ED4-84D1-6796B53A580C</domeo:belongsToSet>
    <rdfs:label>Highlight</rdfs:label>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:lastSavedOn>2014-09-02 15:04:32 -0400</pav:lastSavedOn>
    <pav:lineageUri>urn:domeoserver:annotation:EEE12379-F146-461E-9F7D-3F5DEEF5991C</pav:lineageUri>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812eda990003</pav:createdBy>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <ao:context rdf:resource="urn:domeoclient:uuid:2E73BB40-870E-4E49-B189-491A7CC6CA08"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:952FDCF1-252C-42FC-BE9F-40622C26F85D">
    <ao:exact>nitrates </ao:exact>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-155.txt.html</ao:hasSource>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <pav:createdOn>2014-07-07 09:38:21 -0400</pav:createdOn>
    <ao:prefix>xsd:String</ao:prefix>
    <ao:suffix>[see Contraindications (4)].</ao:suffix>
    <domeo:uuid>952FDCF1-252C-42FC-BE9F-40622C26F85D</domeo:uuid>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:952FDCF1-252C-42FC-BE9F-40622C26F85D"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:E578ADE6-9B8F-4EBF-937E-7BA566587314">
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <domeo:uuid>E578ADE6-9B8F-4EBF-937E-7BA566587314</domeo:uuid>
    <pav:createdOn>2014-07-22 19:06:46 -0400</pav:createdOn>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:E578ADE6-9B8F-4EBF-937E-7BA566587314"/>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-122.txt.html</ao:hasSource>
    <ao:suffix> and an inducer of CYP2C8 (e.g., rifampin) may decrease the AUC of rosiglitazone. Therefore, if an inhibitor or an inducer of CYP2C8 is started or stopped during treatment with rosiglitazone, changes in diabetes treatment may be needed based upon clinica</ao:suffix>
    <ao:prefix>An inhibitor of CYP2C8 (e.g., gemfibrozil) may increase the AUC of </ao:prefix>
    <ao:exact>rosiglitazone</ao:exact>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:2551E950-6EBC-471F-B165-F68320BB8C62">
    <ao:context rdf:resource="urn:domeoclient:uuid:79016A6C-CD48-4680-8D24-28567975EAC5"/>
    <pav:createdOn>2014-07-28 17:04:42 -0400</pav:createdOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812eda990003</pav:createdBy>
    <rdfs:label>Highlight</rdfs:label>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <domeo:belongsToSet>urn:domeoclient:uuid:48D839E5-6B0A-4EC3-B64A-E3E20E06246A</domeo:belongsToSet>
    <pav:lastSavedOn>2014-07-28 17:08:37 -0400</pav:lastSavedOn>
    <pav:lineageUri>urn:domeoserver:annotation:F9987B02-0E12-4725-ACBA-F5330BAA49CB</pav:lineageUri>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:FE717566-90D0-4B59-B00F-B053CAE639C4">
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:lineageUri>urn:domeoserver:annotation:D7AEA2C8-0FF3-482D-BC96-255927C0D5D8</pav:lineageUri>
    <rdfs:label>Highlight</rdfs:label>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812eda990003</pav:createdBy>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <ao:context rdf:resource="urn:domeoclient:uuid:0D83441D-0916-4D83-A136-CA26588E67D0"/>
    <pav:createdOn>2014-07-13 11:13:49 -0400</pav:createdOn>
    <domeo:belongsToSet>urn:domeoclient:uuid:71191E51-53CB-4FDE-88D0-33C6818E2232</domeo:belongsToSet>
    <pav:lastSavedOn>2014-07-13 11:32:29 -0400</pav:lastSavedOn>
    <pav:previousVersion>xsd:String</pav:previousVersion>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:67CFE2D6-F2AA-4465-A433-B26BEA64FB5E">
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812eda990003</pav:createdBy>
    <pav:createdOn>2014-07-13 12:42:01 -0400</pav:createdOn>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <ao:context rdf:resource="urn:domeoclient:uuid:C5023B49-22AF-4880-9F9A-B1FCB16EAE71"/>
    <pav:lineageUri>urn:domeoserver:annotation:2B2D2409-EC63-45B4-9720-BB70CEBD3CE2</pav:lineageUri>
    <domeo:belongsToSet>urn:domeoclient:uuid:23567EF7-7482-444A-B1F6-5AAA9D43E54A</domeo:belongsToSet>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <rdfs:label>Highlight</rdfs:label>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:lastSavedOn>2014-07-13 12:45:54 -0400</pav:lastSavedOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:B61F1A9B-4696-4ED0-80AA-4FE2E9016966">
    <permissions:permissions rdf:nodeID="N0fcd4616fad649c2bfdaa906ac45fc4d"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:DDADE3A5-763E-4A5F-A9E8-79A393BF0629"/>
    <rdfs:label>Default Set</rdfs:label>
    <ao:annotatesResource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-28.txt.html</ao:annotatesResource>
    <domeo:agents rdf:resource="urn:person:uuid:080e143046812afe0146812eda990003"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:3EE823B0-79E2-43AF-B47E-C72BE189895E"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:9C4009FB-5A17-4B3C-B5E0-D9CC8275A5D7"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:93DAC455-F057-464E-B0F5-494B00341776"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:4A2643B5-4BD1-4161-8CBE-473EFB4DDFC8"/>
    <pav:lastSavedOn>2014-07-21 21:35:09 -0400</pav:lastSavedOn>
    <domeo:agents rdf:resource="urn:domeo:software:id:Domeo-2.1alpha-050"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:7990829B-F65B-4D7A-B0B9-46A365009737"/>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812eda990003</pav:createdBy>
    <pav:lineageUri>urn:domeoserver:annotationset:EAC2701C-C88D-4DBC-A889-9FDEA7C97C40</pav:lineageUri>
    <dct:description>The default set is created automatically by Domeo when no other set is existing.</dct:description>
    <domeo:deleted>false</domeo:deleted>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <ao:item rdf:resource="urn:domeoclient:uuid:F7650976-DBE7-4CD9-8158-46355CF2F821"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:9FAFF1D3-9F76-4586-93FE-52B6168FFC14"/>
    <pav:createdOn>2014-07-21 21:33:41 -0400</pav:createdOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#AnnotationSet"/>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <ao:item rdf:resource="urn:domeoclient:uuid:00F93F74-A2F5-4F4F-869B-19496B9D0B0C"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:2C30455C-E476-4155-9E8E-67570BFAB396"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:3EBDA2ED-165F-4B57-B4BE-CFA63CD5C5A6">
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-155.txt.html</ao:hasSource>
    <ao:exact>Sildenafil</ao:exact>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:prefix>(PDE5) in the smooth muscle of the pulmonary vasculature, where PDE5 is responsible for degradation of cGMP. </ao:prefix>
    <domeo:uuid>3EBDA2ED-165F-4B57-B4BE-CFA63CD5C5A6</domeo:uuid>
    <ao:suffix>, therefore, increases cGMP within pulmonary vascular smooth muscle cells resulting in relaxation. In patients with pulmonary hypertension, this can lead to vasodilation of the pulmonary vascular bed and, to a lesser degree, vasodilatation in the systemi</ao:suffix>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:3EBDA2ED-165F-4B57-B4BE-CFA63CD5C5A6"/>
    <domeo:uuid></domeo:uuid>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <pav:createdOn>2014-07-07 09:36:02 -0400</pav:createdOn>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:35E17DFA-B3B8-4521-B986-4AC98CC81C96">
    <rdfs:label>Highlight</rdfs:label>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <pav:createdOn>2014-07-21 21:53:30 -0400</pav:createdOn>
    <pav:lineageUri>urn:domeoserver:annotation:AE683DEB-803C-4D4C-BDAB-800593153F2E</pav:lineageUri>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <ao:context rdf:resource="urn:domeoclient:uuid:7A5583BB-B797-401F-B398-564C65590C7B"/>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812eda990003</pav:createdBy>
    <pav:lastSavedOn>2014-07-21 21:55:00 -0400</pav:lastSavedOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <domeo:belongsToSet>urn:domeoclient:uuid:C988D053-7CF3-4C50-BDB6-7C2B20B837B9</domeo:belongsToSet>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:BA2C0A64-143A-46D5-A408-01FC3EC62525">
    <pav:lineageUri>urn:domeoserver:annotation:A65B00D7-6AC0-4BC7-B831-3E6D23520F80</pav:lineageUri>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812eda990003</pav:createdBy>
    <ao:context rdf:resource="urn:domeoclient:uuid:5F4EA581-2F5C-4FF1-8DA3-D5101E760F69"/>
    <rdfs:label>Highlight</rdfs:label>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:createdOn>2014-07-13 11:28:14 -0400</pav:createdOn>
    <domeo:belongsToSet>urn:domeoclient:uuid:71191E51-53CB-4FDE-88D0-33C6818E2232</domeo:belongsToSet>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <pav:lastSavedOn>2014-07-13 11:32:29 -0400</pav:lastSavedOn>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:79E9E9CE-1D2A-473E-9AED-36041863A42E">
    <domeo:belongsToSet>urn:domeoclient:uuid:215CE713-9F50-45C2-808D-0725CC11DF6D</domeo:belongsToSet>
    <rdfs:label>Highlight</rdfs:label>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <ao:context rdf:resource="urn:domeoclient:uuid:FA692151-6A7E-43FA-8077-22E490457CAD"/>
    <pav:createdOn>2014-09-01 16:21:59 -0400</pav:createdOn>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812eda990003</pav:createdBy>
    <pav:lastSavedOn>2014-09-01 16:22:41 -0400</pav:lastSavedOn>
    <pav:lineageUri>urn:domeoserver:annotation:62F4BB2B-6ABB-434D-9DBF-F5176BA6325C</pav:lineageUri>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:5B7317CD-AFB7-45AB-8141-DD5FD3B899F5">
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:suffix> or erythromycin coadministration enhances fexofenadine gastrointestinal absorption. This observed increase in the bioavailability of fexofenadine may be due to transport-related effects, such as p-glycoprotein. In vivo animal studies also suggest that i</ao:suffix>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-139.txt.html</ao:hasSource>
    <ao:exact>ketoconazole</ao:exact>
    <domeo:uuid>5B7317CD-AFB7-45AB-8141-DD5FD3B899F5</domeo:uuid>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:prefix>The mechanism of these interactions has been evaluated in in vitro, in situ, and in vivo animal models. These studies indicate that </ao:prefix>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:5B7317CD-AFB7-45AB-8141-DD5FD3B899F5"/>
    <pav:createdOn>2014-07-24 20:11:39 -0400</pav:createdOn>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:F1FF7E05-1C80-4A3F-9366-A074CA5EDF15">
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <ao:body rdf:nodeID="N75f00f9999f84ff3afc8788435c7f8c2"/>
    <domeo:belongsToSet>urn:domeoserver:annotationset:E32812A9-205B-4EE1-B488-A1E294EDBFB9</domeo:belongsToSet>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">2</pav:versionNumber>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <ao:context rdf:resource="urn:domeoclient:uuid:33BB0EA3-00A7-4E9A-8406-1B489BED52FB"/>
    <pav:lastSavedOn>2014-09-02 19:32:13 -0400</pav:lastSavedOn>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812eda990003</pav:createdBy>
    <ao:body rdf:nodeID="N2e09856b11054fd1938ac7e4e4ccd332"/>
    <pav:lineageUri>urn:domeoserver:annotation:0DEF7712-EC52-4903-803B-3D8B645B4DA2</pav:lineageUri>
    <rdfs:label>expertstudy Annotation</rdfs:label>
    <pav:lineageUri>urn:domeoserver:annotationset:C5DEBC9B-77EE-4243-88EB-DBC19737ACD2</pav:lineageUri>
    <domeo:belongsToSet>urn:domeoserver:annotationset:392EE0FB-AC4F-4AF2-87A6-2E50A281F434</domeo:belongsToSet>
    <pav:previousVersion>urn:domeoclient:uuid:CB83FFC2-EA71-44EA-8F11-DE80E389C84E</pav:previousVersion>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#expertstudyAnnotation"/>
    <pav:createdOn>2014-09-02 19:32:05 -0400</pav:createdOn>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:E9C5B173-AFE1-44E0-A146-6AEBE6A982AB">
    <domeo:belongsToSet>urn:domeoclient:uuid:21C1BD16-9B1B-4BDA-B036-93523B41DFDF</domeo:belongsToSet>
    <pav:createdOn>2014-07-24 19:47:04 -0400</pav:createdOn>
    <pav:lineageUri>urn:domeoserver:annotation:AD6B5DF1-C69F-4C7D-A37D-3E0DBE84C47A</pav:lineageUri>
    <pav:lastSavedOn>2014-07-24 19:46:59 -0400</pav:lastSavedOn>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812eda990003</pav:createdBy>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <rdfs:label>Highlight</rdfs:label>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <ao:context rdf:resource="urn:domeoclient:uuid:20DF2C21-448E-4857-BAE0-83C2A6124710"/>
    <pav:previousVersion>xsd:String</pav:previousVersion>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:A16A73F6-04A0-4350-B482-E365FE1CCB81">
    <domeo:uuid>A16A73F6-04A0-4350-B482-E365FE1CCB81</domeo:uuid>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:A16A73F6-04A0-4350-B482-E365FE1CCB81"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:prefix>xsd:String</ao:prefix>
    <ao:suffix>: Tryptophan may enhance the serotonergic effects of fluvoxamine, and the combination should, therefore, be used with caution. Severe vomiting has been reported with the coadministration of fluvoxamine maleate and tryptophan (see WARNINGS AND PRECAUTIONS</ao:suffix>
    <ao:exact>Tryptophan</ao:exact>
    <pav:createdOn>2014-09-02 11:43:38 -0400</pav:createdOn>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-9.txt.html</ao:hasSource>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:97B4DA35-A3A0-41E4-9927-06388A15995F">
    <ao:exact>Rosiglitazone</ao:exact>
    <ao:suffix> is extensively metabolized with no unchanged drug excreted in the urine. The major routes of metabolism were N-demethylation and hydroxylation, followed by conjugation with sulfate and glucuronic acid. All the circulating metabolites are considerably le</ao:suffix>
    <domeo:uuid>97B4DA35-A3A0-41E4-9927-06388A15995F</domeo:uuid>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <pav:createdOn>2014-07-22 19:26:15 -0400</pav:createdOn>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:97B4DA35-A3A0-41E4-9927-06388A15995F"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:prefix>xsd:String</ao:prefix>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-123.txt.html</ao:hasSource>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:35E50D31-0B97-45CD-9519-3A5F2D6512D3">
    <pav:lastSavedOn>2014-07-21 21:44:00 -0400</pav:lastSavedOn>
    <pav:lineageUri>urn:domeoserver:annotation:3E53E10A-E533-402B-8239-6CE1B3724B6B</pav:lineageUri>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <domeo:belongsToSet>urn:domeoclient:uuid:42248733-4719-42F4-8132-866191F8E708</domeo:belongsToSet>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812eda990003</pav:createdBy>
    <rdfs:label>Highlight</rdfs:label>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <ao:context rdf:resource="urn:domeoclient:uuid:0D6AEBDD-929E-4D65-B956-E7E552F5D014"/>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <pav:createdOn>2014-07-21 21:43:18 -0400</pav:createdOn>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:507B5E29-9158-4374-B797-6175E792AA48">
    <rdfs:label>Highlight</rdfs:label>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <domeo:belongsToSet>urn:domeoclient:uuid:C4B80A95-F569-4ED4-84D1-6796B53A580C</domeo:belongsToSet>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:lastSavedOn>2014-09-02 15:04:32 -0400</pav:lastSavedOn>
    <pav:createdOn>2014-09-02 15:04:30 -0400</pav:createdOn>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <ao:context rdf:resource="urn:domeoclient:uuid:05003F42-3401-4DB3-B275-544005230F77"/>
    <pav:lineageUri>urn:domeoserver:annotation:983811FA-8F7B-417F-9FCB-1073412D65C7</pav:lineageUri>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812eda990003</pav:createdBy>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:171C7925-6F8E-4017-8743-473B0DE0C8C1">
    <sio:SIO_000563>dikbD2R:modality</sio:SIO_000563>
    <rdf:type rdf:resource="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#DrugDrugInteractionStatement"/>
    <sio:SIO_000205>dikbD2R:statement</sio:SIO_000205>
    <sio:SIO_000628 rdf:resource="urn:pddi:uuid:E1974882-EFE7-48A1-A145-232BC76F5E40"/>
    <dikbD2R:statement>ncit:Qualitative</dikbD2R:statement>
    <dikbD2R:modality>ncit:negative</dikbD2R:modality>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:E7AD1296-3138-4E05-ACC3-466E8259339A">
    <ao:exact> In 1 study, daily dosing of immediate-release paroxetine (20 mg once daily) under steady-state conditions increased single-dose desipramine (100 mg) Cmax, AUC, and T½ by an average of approximately 2-, 5-, and 3-fold, respectively. </ao:exact>
    <domeo:uuid>E7AD1296-3138-4E05-ACC3-466E8259339A</domeo:uuid>
    <ao:prefix> dosing.</ao:prefix>
    <ao:suffix> Concomitant use of</ao:suffix>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:E7AD1296-3138-4E05-ACC3-466E8259339A"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <pav:createdOn>2014-09-02 12:00:11 -0400</pav:createdOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-47.txt.html</ao:hasSource>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:2CF891F7-2E96-4382-8EDB-5C061E8E1AFA">
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <pav:lineageUri>urn:domeoserver:annotation:EEA8C6CB-C786-4D23-908D-E615652DD4F2</pav:lineageUri>
    <domeo:belongsToSet>urn:domeoserver:annotationset:7AACEF8D-2EBC-4F0B-94B2-190650E562F6</domeo:belongsToSet>
    <domeo:belongsToSet>urn:domeoserver:annotationset:8F3CF3D9-AADE-4A86-BD42-2924B3D6A406</domeo:belongsToSet>
    <ao:context rdf:resource="urn:domeoclient:uuid:8F1DD8EF-72E2-425B-B98B-233F1591A13F"/>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:lastSavedOn>2014-07-07 09:44:19 -0400</pav:lastSavedOn>
    <domeo:belongsToSet>urn:domeoserver:annotationset:131835A3-C655-4F91-97D4-52CAFF7B7CCA</domeo:belongsToSet>
    <pav:lastSavedOn>2014-07-07 09:44:18 -0400</pav:lastSavedOn>
    <pav:createdOn>2014-07-07 09:42:06 -0400</pav:createdOn>
    <domeo:belongsToSet>urn:domeoclient:uuid:FCA2BF23-0BE3-409F-9177-761812F96097</domeo:belongsToSet>
    <domeo:belongsToSet>urn:domeoserver:annotationset:08C0C288-6DF4-43E6-A618-71A8BB9563C3</domeo:belongsToSet>
    <pav:lineageUri>urn:domeoserver:annotationset:76FD4BB5-DE2F-4FCA-B93D-302185B1A381</pav:lineageUri>
    <domeo:belongsToSet>urn:domeoserver:annotationset:22ED7220-C6F6-43C5-9DF9-89F62F0F8E27</domeo:belongsToSet>
    <rdfs:label>Highlight</rdfs:label>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812eda990003</pav:createdBy>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:0A5A79F0-6C01-40CE-B775-CC68C1268935">
    <domeo:belongsToSet>urn:domeoclient:uuid:443354CF-9409-4015-81BA-17601E505BAB</domeo:belongsToSet>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812eda990003</pav:createdBy>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:lastSavedOn>2014-09-02 15:06:18 -0400</pav:lastSavedOn>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <ao:context rdf:resource="urn:domeoclient:uuid:DFF0F114-795C-4A7F-B8CF-1A970C7B1D1A"/>
    <rdfs:label>Highlight</rdfs:label>
    <pav:lineageUri>urn:domeoserver:annotation:AFC65757-0E22-4DF6-AF98-3F2A9DAE6482</pav:lineageUri>
    <pav:createdOn>2014-09-02 15:05:19 -0400</pav:createdOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:previousVersion>xsd:String</pav:previousVersion>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:0D7139F9-BDC3-437F-A5A1-D75EDAC972B0">
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:lineageUri>urn:domeoserver:annotation:18699EA6-5F06-460B-B2AD-992A44EC2FCD</pav:lineageUri>
    <pav:createdOn>2014-07-13 11:07:46 -0400</pav:createdOn>
    <rdfs:label>Highlight</rdfs:label>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812eda990003</pav:createdBy>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <domeo:belongsToSet>urn:domeoclient:uuid:71191E51-53CB-4FDE-88D0-33C6818E2232</domeo:belongsToSet>
    <pav:lastSavedOn>2014-07-13 11:32:29 -0400</pav:lastSavedOn>
    <ao:context rdf:resource="urn:domeoclient:uuid:B3435A02-DBAF-4D33-9A80-3B78037721AE"/>
    <pav:previousVersion>xsd:String</pav:previousVersion>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:53200B7D-3B88-4C24-827A-DE552ED1B23F">
    <ao:context rdf:resource="urn:domeoclient:uuid:A2B398FC-383E-4A71-A215-EA4AD0E5C9DA"/>
    <pav:lineageUri>urn:domeoserver:annotationset:C5DEBC9B-77EE-4243-88EB-DBC19737ACD2</pav:lineageUri>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812eda990003</pav:createdBy>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <domeo:belongsToSet>urn:domeoclient:uuid:CB83FFC2-EA71-44EA-8F11-DE80E389C84E</domeo:belongsToSet>
    <pav:createdOn>2014-09-02 19:13:05 -0400</pav:createdOn>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <pav:lastSavedOn>2014-09-02 19:19:47 -0400</pav:lastSavedOn>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <rdfs:label>Highlight</rdfs:label>
    <domeo:belongsToSet>urn:domeoserver:annotationset:392EE0FB-AC4F-4AF2-87A6-2E50A281F434</domeo:belongsToSet>
    <pav:lineageUri>urn:domeoserver:annotation:402BA4BD-4E7F-4040-A232-59AD93F47A42</pav:lineageUri>
    <domeo:belongsToSet>urn:domeoserver:annotationset:E32812A9-205B-4EE1-B488-A1E294EDBFB9</domeo:belongsToSet>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:CAC294B3-5790-4488-B65C-CB3269F765C6">
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812eda990003</pav:createdBy>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <domeo:belongsToSet>urn:domeoclient:uuid:71191E51-53CB-4FDE-88D0-33C6818E2232</domeo:belongsToSet>
    <pav:lineageUri>urn:domeoserver:annotation:E7F026CF-6162-4445-A7F9-6B029DDC6F96</pav:lineageUri>
    <pav:lastSavedOn>2014-07-13 11:32:29 -0400</pav:lastSavedOn>
    <pav:createdOn>2014-07-13 11:16:30 -0400</pav:createdOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <ao:context rdf:resource="urn:domeoclient:uuid:366925ED-C6A8-41CA-97EB-602399B8DB72"/>
    <rdfs:label>Highlight</rdfs:label>
    <pav:previousVersion>xsd:String</pav:previousVersion>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:40AC1621-7CDD-45E4-98D3-4DE403F588CE">
    <pav:createdOn>2014-09-02 11:41:05 -0400</pav:createdOn>
    <domeo:belongsToSet>urn:domeoserver:annotationset:3F546823-204F-4F9B-9006-3DC526C56931</domeo:belongsToSet>
    <domeo:belongsToSet>urn:domeoserver:annotationset:A3F0B39A-4249-4B63-BB0D-F24A005066AC</domeo:belongsToSet>
    <ao:context rdf:resource="urn:domeoclient:uuid:0072DC69-60A4-45F2-9EA7-C1B1D9B53CA2"/>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">2</pav:versionNumber>
    <pav:previousVersion>urn:domeoclient:uuid:BED41F06-565A-4622-9A88-48810E5A28DE</pav:previousVersion>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812eda990003</pav:createdBy>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <rdfs:label>Highlight</rdfs:label>
    <pav:lineageUri>urn:domeoserver:annotation:3AF9AABB-ADFE-4609-9D9C-47B8F7DDB732</pav:lineageUri>
    <domeo:belongsToSet>urn:domeoserver:annotationset:A5DD001D-C81A-4E2E-B5E0-7A866B35E26B</domeo:belongsToSet>
    <pav:lineageUri>urn:domeoserver:annotationset:D1715BD2-BD41-46FD-9454-DC7A423A29AC</pav:lineageUri>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:lastSavedOn>2014-09-02 11:46:58 -0400</pav:lastSavedOn>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:189A8E0E-67D6-4C53-A96E-CB48A3B4B2E9">
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812eda990003</pav:createdBy>
    <ao:item rdf:resource="urn:domeoclient:uuid:84B56A7B-030D-4746-A4B2-C5097E07099C"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:2FF3133B-3C6A-4B14-A744-B8F141C65349"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:F6D8B558-463C-428A-82F9-861E7A7AA7AC"/>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <ao:item rdf:resource="urn:domeoclient:uuid:1BB855FB-FD90-4495-85CA-4D3634124298"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:34A39B5E-1BC8-4028-8390-448D67AF41F6"/>
    <domeo:agents rdf:resource="urn:person:uuid:080e143046812afe0146812eda990003"/>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:lastSavedOn>2014-07-24 20:02:49 -0400</pav:lastSavedOn>
    <permissions:permissions rdf:nodeID="Ncc463923d5f548f5820845eea9f80a6b"/>
    <rdfs:label>Default Set</rdfs:label>
    <pav:createdOn>2014-07-24 20:01:20 -0400</pav:createdOn>
    <domeo:deleted>false</domeo:deleted>
    <ao:item rdf:resource="urn:domeoclient:uuid:3DCB5ACD-9F2E-46B4-98D0-F1D2BD3C8EE7"/>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <ao:item rdf:resource="urn:domeoclient:uuid:7EF07060-EF5D-42BC-87F0-3EFC38B56BAA"/>
    <dct:description>The default set is created automatically by Domeo when no other set is existing.</dct:description>
    <ao:annotatesResource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-136.txt.html</ao:annotatesResource>
    <ao:item rdf:resource="urn:domeoclient:uuid:40692CE2-57E3-4181-873F-BF7EE5E8B25B"/>
    <pav:lineageUri>urn:domeoserver:annotationset:9ADFC8FA-4A14-45BD-A695-CF6C015BEB43</pav:lineageUri>
    <ao:item rdf:resource="urn:domeoclient:uuid:164A1C02-147C-4620-8927-26251560C2C2"/>
    <domeo:agents rdf:resource="urn:domeo:software:id:Domeo-2.1alpha-050"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#AnnotationSet"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:89DD6C2B-2874-4E37-8852-758926B57EB7">
    <sio:SIO_000205>dikbD2R:statement</sio:SIO_000205>
    <sio:SIO_000563>dikbD2R:modality</sio:SIO_000563>
    <dikbD2R:statement>ncit:quantitative</dikbD2R:statement>
    <rdf:type rdf:resource="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#DrugDrugInteractionStatement"/>
    <sio:SIO_000628 rdf:resource="urn:pddi:uuid:E32C0683-393F-4141-AB8D-7863405CC923"/>
    <dikbD2R:modality>ncit:positive</dikbD2R:modality>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:E854201F-10EB-4992-8353-B60276384931">
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812eda990003</pav:createdBy>
    <pav:lineageUri>urn:domeoserver:annotation:5DA1738B-3B14-48F7-9099-42BBEE0E2846</pav:lineageUri>
    <ao:context rdf:resource="urn:domeoclient:uuid:BE7787BA-2717-4D64-BE0B-A188784B75CE"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:createdOn>2014-09-01 16:07:12 -0400</pav:createdOn>
    <rdfs:label>Highlight</rdfs:label>
    <domeo:belongsToSet>urn:domeoclient:uuid:1DA34422-734D-46B1-AB2C-C1CABCA4C26C</domeo:belongsToSet>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:lastSavedOn>2014-09-01 16:07:52 -0400</pav:lastSavedOn>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:079AA7B9-9BE4-4706-A20A-5848B50272B5">
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#AnnotationSet"/>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <domeo:deleted>false</domeo:deleted>
    <ao:annotatesResource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-124.txt.html</ao:annotatesResource>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812eda990003</pav:createdBy>
    <ao:item rdf:resource="urn:domeoclient:uuid:35B88B08-A82B-4D65-B565-57DA9528E578"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:E785934B-232B-456F-A0C7-F28959E09129"/>
    <domeo:agents rdf:resource="urn:domeo:software:id:Domeo-2.1alpha-050"/>
    <dct:description>The default set is created automatically by Domeo when no other set is existing.</dct:description>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <permissions:permissions rdf:nodeID="N6dbf83d8109d4a67af6bca7b2afbbf85"/>
    <rdfs:label>Default Set</rdfs:label>
    <domeo:agents rdf:resource="urn:person:uuid:080e143046812afe0146812eda990003"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:CDCD9DD7-A54D-402A-8BEE-9FE5E515E7D4"/>
    <pav:lastSavedOn>2014-07-24 19:37:33 -0400</pav:lastSavedOn>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:lineageUri>urn:domeoserver:annotationset:CF44A79E-F8B5-4F6D-B490-6D46E9586529</pav:lineageUri>
    <pav:createdOn>2014-07-24 19:36:31 -0400</pav:createdOn>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:C4B80A95-F569-4ED4-84D1-6796B53A580C">
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <domeo:agents rdf:resource="urn:domeo:software:id:Domeo-2.1alpha-050"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:507B5E29-9158-4374-B797-6175E792AA48"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:D4EC67EE-50D3-4156-87D9-A45D936232F9"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:752D3341-6554-481E-A205-06C244A6CD0A"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:8164F866-D42E-492E-9290-5B0170C62867"/>
    <domeo:deleted>false</domeo:deleted>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#AnnotationSet"/>
    <pav:lineageUri>urn:domeoserver:annotationset:3B6AC179-753D-43FC-9F87-1511C2E4BFA1</pav:lineageUri>
    <ao:item rdf:resource="urn:domeoclient:uuid:D32DB27C-3D8E-46AF-87F9-8A3307B5D13B"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:BE7465D0-1375-484E-9391-EFB42F00FC99"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:1F41B5CD-E2A4-46BE-9B88-1BCA05A1A5EE"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:C8425744-9F63-4970-8237-27D021CAD666"/>
    <domeo:agents rdf:resource="urn:person:uuid:080e143046812afe0146812eda990003"/>
    <permissions:permissions rdf:nodeID="Ndf26c159fe2a4acebe008a5a61d94409"/>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812eda990003</pav:createdBy>
    <ao:item rdf:resource="urn:domeoclient:uuid:F6EB60C9-CEEF-414F-8B0A-9C1AF0091872"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:7ACE5CBD-6F8F-4F53-8756-2657011A4A35"/>
    <ao:annotatesResource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-48.txt.html</ao:annotatesResource>
    <rdfs:label>Default Set</rdfs:label>
    <ao:item rdf:resource="urn:domeoclient:uuid:88A57962-2A3E-4D94-8F54-0A13BDB6FAD9"/>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:lastSavedOn>2014-09-02 15:04:32 -0400</pav:lastSavedOn>
    <ao:item rdf:resource="urn:domeoclient:uuid:7B017829-D9F5-484A-8F49-2CBAD935419D"/>
    <dct:description>The default set is created automatically by Domeo when no other set is existing.</dct:description>
    <pav:createdOn>2014-09-02 15:03:58 -0400</pav:createdOn>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:E2CEC4DC-B35C-4F1A-8ACA-017FE944131C">
    <domeo:belongsToSet>urn:domeoserver:annotationset:3F546823-204F-4F9B-9006-3DC526C56931</domeo:belongsToSet>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <domeo:belongsToSet>urn:domeoserver:annotationset:A5DD001D-C81A-4E2E-B5E0-7A866B35E26B</domeo:belongsToSet>
    <ao:context rdf:resource="urn:domeoclient:uuid:1AD84D60-1A25-43EF-A981-A873C4F1D40E"/>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">2</pav:versionNumber>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812eda990003</pav:createdBy>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:createdOn>2014-09-02 11:44:48 -0400</pav:createdOn>
    <pav:lastSavedOn>2014-09-02 11:46:59 -0400</pav:lastSavedOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <rdfs:label>Highlight</rdfs:label>
    <pav:lineageUri>urn:domeoserver:annotation:1A4BC19E-2CC7-45A3-B24F-70399CE5C725</pav:lineageUri>
    <pav:previousVersion>urn:domeoclient:uuid:BED41F06-565A-4622-9A88-48810E5A28DE</pav:previousVersion>
    <pav:lastSavedOn>2014-09-02 11:46:58 -0400</pav:lastSavedOn>
    <pav:lineageUri>urn:domeoserver:annotationset:D1715BD2-BD41-46FD-9454-DC7A423A29AC</pav:lineageUri>
    <domeo:belongsToSet>urn:domeoserver:annotationset:A3F0B39A-4249-4B63-BB0D-F24A005066AC</domeo:belongsToSet>
    <pav:previousVersion>xsd:String</pav:previousVersion>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:D3B6634D-5A1F-4C6F-AF5E-421854DA709D">
    <rdfs:label>Highlight</rdfs:label>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <ao:context rdf:resource="urn:domeoclient:uuid:9FBD505E-822F-4348-AFE5-73B2A9104B24"/>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <domeo:belongsToSet>urn:domeoclient:uuid:B6F745E6-5734-4636-A383-683BA4C79E38</domeo:belongsToSet>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812eda990003</pav:createdBy>
    <pav:createdOn>2014-07-21 21:26:48 -0400</pav:createdOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:lineageUri>urn:domeoserver:annotation:3D34B51E-FCA2-43A6-B868-09CC77429F93</pav:lineageUri>
    <pav:lastSavedOn>2014-07-21 21:27:51 -0400</pav:lastSavedOn>
  </rdf:Description>
  <rdf:Description rdf:nodeID="Nb0311d351487462b93a8cfede91ef33e">
    <domeo:sets rdf:resource="urn:pddi:uuid:89DD6C2B-2874-4E37-8852-758926B57EB7"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:EB4D6CAD-8800-44E1-9856-C0585E6A6B61">
    <domeo:uuid>EB4D6CAD-8800-44E1-9856-C0585E6A6B61</domeo:uuid>
    <pav:createdOn>2014-07-22 18:51:41 -0400</pav:createdOn>
    <ao:exact>vancomycin</ao:exact>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:suffix> (1g q12h iv) could be substituted for the specified comparator if the causative pathogen was suspected or confirmed methicillin-resistant staphylococcus or if the patient was allergic to penicillins, cephalosporins or carbapenems. Study JRV 304 enrolled</ao:suffix>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-119.txt.html</ao:hasSource>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:EB4D6CAD-8800-44E1-9856-C0585E6A6B61"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:prefix> (1g q8h iv) in the second study (JRV 305); however, in both studies </ao:prefix>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:5BA6BC8B-1F30-4288-9D03-060F552BAA12">
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <domeo:belongsToSet>urn:domeoclient:uuid:71191E51-53CB-4FDE-88D0-33C6818E2232</domeo:belongsToSet>
    <ao:context rdf:resource="urn:domeoclient:uuid:1BF82CCC-CD60-4AB5-8C1B-4176DC1A85F3"/>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:lineageUri>urn:domeoserver:annotation:DDA9B5AE-040F-439A-82F9-BF46844F39FC</pav:lineageUri>
    <pav:createdOn>2014-07-13 11:16:53 -0400</pav:createdOn>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <pav:lastSavedOn>2014-07-13 11:32:29 -0400</pav:lastSavedOn>
    <rdfs:label>Highlight</rdfs:label>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812eda990003</pav:createdBy>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:9C7097E9-595B-4F6E-9745-CA4FB4156079">
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/C98F4F9C-3452-4547-9D59-858A821616E1"/>
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/A3E00879-812C-4400-97F2-AF59166DF8BB"/>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/PK_DDI"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:FF4B8408-EC34-4E9C-A970-D7F98CF2EEE1">
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <domeo:belongsToSet>urn:domeoclient:uuid:CB83FFC2-EA71-44EA-8F11-DE80E389C84E</domeo:belongsToSet>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812eda990003</pav:createdBy>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:lastSavedOn>2014-09-02 19:19:47 -0400</pav:lastSavedOn>
    <pav:createdOn>2014-09-02 19:19:31 -0400</pav:createdOn>
    <pav:lineageUri>urn:domeoserver:annotationset:C5DEBC9B-77EE-4243-88EB-DBC19737ACD2</pav:lineageUri>
    <pav:lineageUri>urn:domeoserver:annotation:D21C33D7-020F-4EB8-8BCE-EDF5A3BF9789</pav:lineageUri>
    <domeo:belongsToSet>urn:domeoserver:annotationset:E32812A9-205B-4EE1-B488-A1E294EDBFB9</domeo:belongsToSet>
    <rdfs:label>Highlight</rdfs:label>
    <domeo:belongsToSet>urn:domeoserver:annotationset:392EE0FB-AC4F-4AF2-87A6-2E50A281F434</domeo:belongsToSet>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <ao:context rdf:resource="urn:domeoclient:uuid:3CDFB7B3-F366-4F19-B27E-4B00DC64BA96"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:CDDA5AD1-5495-41C1-821C-109A7D029580">
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:lastSavedOn>2014-07-24 20:07:19 -0400</pav:lastSavedOn>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812eda990003</pav:createdBy>
    <domeo:belongsToSet>urn:domeoserver:annotationset:37B2514D-1A92-45B1-8A5C-610DA6DC935A</domeo:belongsToSet>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <domeo:belongsToSet>urn:domeoclient:uuid:8D86A4AC-54BD-4BB3-8B58-AB55DEC01A88</domeo:belongsToSet>
    <domeo:belongsToSet>urn:domeoserver:annotationset:1FC172B8-8AC3-465A-AA69-B73AD9B97CBC</domeo:belongsToSet>
    <pav:lastSavedOn>2014-07-24 20:07:20 -0400</pav:lastSavedOn>
    <rdfs:label>Highlight</rdfs:label>
    <pav:lineageUri>urn:domeoserver:annotation:3C24A2D8-ED6D-4083-AE7E-457336083281</pav:lineageUri>
    <pav:lineageUri>urn:domeoserver:annotationset:4A88D0A6-E9B6-4E7F-955F-3692600C178C</pav:lineageUri>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:createdOn>2014-07-24 20:07:07 -0400</pav:createdOn>
    <ao:context rdf:resource="urn:domeoclient:uuid:A71C73E7-BDEF-430C-BE2B-73E35D00A542"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:72843AE3-90CC-43FD-BCEC-E83B4E3A7EDF">
    <pav:lastSavedOn>2014-07-13 11:32:29 -0400</pav:lastSavedOn>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <rdfs:label>Highlight</rdfs:label>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:createdOn>2014-07-13 11:10:19 -0400</pav:createdOn>
    <domeo:belongsToSet>urn:domeoclient:uuid:71191E51-53CB-4FDE-88D0-33C6818E2232</domeo:belongsToSet>
    <pav:lineageUri>urn:domeoserver:annotation:7D999E14-4D2E-4EE2-945B-2011BD864F5E</pav:lineageUri>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812eda990003</pav:createdBy>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <ao:context rdf:resource="urn:domeoclient:uuid:77F990A5-C7A6-4873-A32F-AD9607EFDE51"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:BB359BC3-6C0F-427E-B961-0838B54690D5">
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <domeo:uuid></domeo:uuid>
    <domeo:uuid>BB359BC3-6C0F-427E-B961-0838B54690D5</domeo:uuid>
    <ao:exact>sildenafil </ao:exact>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:BB359BC3-6C0F-427E-B961-0838B54690D5"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <pav:createdOn>2014-07-07 09:38:27 -0400</pav:createdOn>
    <ao:prefix>Single oral doses of </ao:prefix>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-155.txt.html</ao:hasSource>
    <ao:suffix>up to 100 mg in healthy volunteers produced no clinically relevant effects on ECG. After chronic dosing of 80 mg TID to patients with pulmonary arterial hypertension, no clinically relevant effects on ECG were reported.</ao:suffix>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:6588D45E-2F4C-40CF-8AF4-0CD621F484E1">
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <domeo:belongsToSet>urn:domeoserver:annotationset:08C0C288-6DF4-43E6-A618-71A8BB9563C3</domeo:belongsToSet>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812eda990003</pav:createdBy>
    <domeo:belongsToSet>urn:domeoserver:annotationset:131835A3-C655-4F91-97D4-52CAFF7B7CCA</domeo:belongsToSet>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <ao:context rdf:resource="urn:domeoclient:uuid:FAD17173-A1D3-4A24-A29E-5999F0DFA8F4"/>
    <domeo:belongsToSet>urn:domeoserver:annotationset:22ED7220-C6F6-43C5-9DF9-89F62F0F8E27</domeo:belongsToSet>
    <pav:lastSavedOn>2014-07-07 10:02:41 -0400</pav:lastSavedOn>
    <rdfs:label>Highlight</rdfs:label>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <domeo:belongsToSet>urn:domeoserver:annotationset:8F3CF3D9-AADE-4A86-BD42-2924B3D6A406</domeo:belongsToSet>
    <pav:createdOn>2014-07-07 09:58:43 -0400</pav:createdOn>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <pav:lineageUri>urn:domeoserver:annotation:905A65BE-2FB4-442E-92C6-EA5747341AA6</pav:lineageUri>
    <domeo:belongsToSet>urn:domeoserver:annotationset:7AACEF8D-2EBC-4F0B-94B2-190650E562F6</domeo:belongsToSet>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:16BAA0E0-EEEC-4785-9C63-DBB8909400D3">
    <ao:exact>omeprazole</ao:exact>
    <pav:createdOn>2014-09-02 19:16:32 -0400</pav:createdOn>
    <ao:suffix> was given without voriconazole.</ao:suffix>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:16BAA0E0-EEEC-4785-9C63-DBB8909400D3"/>
    <domeo:uuid>16BAA0E0-EEEC-4785-9C63-DBB8909400D3</domeo:uuid>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:prefix> (40 mg once daily x 7 days) to healthy subjects, it significantly increased the steady-state Cmax and AUC0-24 of omeprazole, an average of 2 times (90% CI: 1.8, 2.6) and 4 times (90% CI: 3.3, 4.4) respectively as compared to when </ao:prefix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-74.txt.html</ao:hasSource>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/6FD42917-DF6A-4B72-83EF-A23E155102AF">
    <rdfs:label>theophylline</rdfs:label>
    <sio:SIO_000228>dikbD2R:object-drug-of-interaction</sio:SIO_000228>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/active-ingredient"/>
    <dct:description>Referred to the drug in the interaction.</dct:description>
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/10438</dailymed:activeMoietyRxCUI>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:215CE713-9F50-45C2-808D-0725CC11DF6D">
    <rdfs:label>Default Set</rdfs:label>
    <dct:description>The default set is created automatically by Domeo when no other set is existing.</dct:description>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <ao:item rdf:resource="urn:domeoclient:uuid:AD52F407-3F2E-43FA-A8DA-659510309A62"/>
    <pav:lastSavedOn>2014-09-01 16:22:41 -0400</pav:lastSavedOn>
    <domeo:deleted>false</domeo:deleted>
    <ao:annotatesResource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-45.txt.html</ao:annotatesResource>
    <domeo:agents rdf:resource="urn:domeo:software:id:Domeo-2.1alpha-050"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#AnnotationSet"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:FB09B648-AD4B-44C2-AE1F-42FAB75A314E"/>
    <pav:lineageUri>urn:domeoserver:annotationset:28689965-00D7-4FD6-A246-BDFF4DFC6794</pav:lineageUri>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <ao:item rdf:resource="urn:domeoclient:uuid:A8053299-E5E9-402F-B927-AC23DB68E0B9"/>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812eda990003</pav:createdBy>
    <permissions:permissions rdf:nodeID="N915e02fd95714098aba133476f1afce3"/>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <domeo:agents rdf:resource="urn:person:uuid:080e143046812afe0146812eda990003"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:79E9E9CE-1D2A-473E-9AED-36041863A42E"/>
    <pav:createdOn>2014-09-01 16:21:59 -0400</pav:createdOn>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:19746D22-D232-4FCB-B5B2-64CA519A479E">
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <ao:body rdf:nodeID="Nc51dd627f9534301bba7d2b069ae1357"/>
    <domeo:belongsToSet>urn:domeoserver:annotationset:1FC172B8-8AC3-465A-AA69-B73AD9B97CBC</domeo:belongsToSet>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <domeo:belongsToSet>urn:domeoserver:annotationset:37B2514D-1A92-45B1-8A5C-610DA6DC935A</domeo:belongsToSet>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#expertstudyAnnotation"/>
    <domeo:belongsToSet>urn:domeoclient:uuid:8D86A4AC-54BD-4BB3-8B58-AB55DEC01A88</domeo:belongsToSet>
    <ao:body rdf:nodeID="Ncc0591e02c1845af940211aab3b5baae"/>
    <pav:lineageUri>urn:domeoserver:annotationset:4A88D0A6-E9B6-4E7F-955F-3692600C178C</pav:lineageUri>
    <pav:lineageUri>urn:domeoserver:annotation:308F1D42-1B46-4280-A3CE-1EDFCB4918E6</pav:lineageUri>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:createdOn>2014-07-24 20:06:55 -0400</pav:createdOn>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812eda990003</pav:createdBy>
    <pav:lastSavedOn>2014-07-24 20:07:20 -0400</pav:lastSavedOn>
    <ao:body rdf:nodeID="N57b3d2e5ec5f4f43b7db2ac62e331f70"/>
    <ao:context rdf:resource="urn:domeoclient:uuid:D344866F-87DE-4A61-99C8-1624A36AC49E"/>
    <pav:lastSavedOn>2014-07-24 20:07:19 -0400</pav:lastSavedOn>
    <rdfs:label>expertstudy Annotation</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:3ED57AC4-296D-4C8D-9873-49C193F69BBA">
    <pav:lineageUri>urn:domeoserver:annotation:EDAFE895-630D-4E68-A004-9114AFE7F495</pav:lineageUri>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:lineageUri>urn:domeoserver:annotationset:76FD4BB5-DE2F-4FCA-B93D-302185B1A381</pav:lineageUri>
    <domeo:belongsToSet>urn:domeoserver:annotationset:08C0C288-6DF4-43E6-A618-71A8BB9563C3</domeo:belongsToSet>
    <pav:lastSavedOn>2014-07-07 09:44:19 -0400</pav:lastSavedOn>
    <pav:lastSavedOn>2014-07-07 09:44:18 -0400</pav:lastSavedOn>
    <domeo:belongsToSet>urn:domeoserver:annotationset:22ED7220-C6F6-43C5-9DF9-89F62F0F8E27</domeo:belongsToSet>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812eda990003</pav:createdBy>
    <ao:context rdf:resource="urn:domeoclient:uuid:CE972F8D-C1AD-46A9-B34B-1D883FDAF1EC"/>
    <domeo:belongsToSet>urn:domeoserver:annotationset:7AACEF8D-2EBC-4F0B-94B2-190650E562F6</domeo:belongsToSet>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <pav:createdOn>2014-07-07 09:40:14 -0400</pav:createdOn>
    <domeo:belongsToSet>urn:domeoclient:uuid:FCA2BF23-0BE3-409F-9177-761812F96097</domeo:belongsToSet>
    <rdfs:label>Highlight</rdfs:label>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <domeo:belongsToSet>urn:domeoserver:annotationset:8F3CF3D9-AADE-4A86-BD42-2924B3D6A406</domeo:belongsToSet>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <domeo:belongsToSet>urn:domeoserver:annotationset:131835A3-C655-4F91-97D4-52CAFF7B7CCA</domeo:belongsToSet>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:525D9A2A-57D7-4B82-AAC2-92BA3D298032">
    <domeo:belongsToSet>urn:domeoclient:uuid:0819E6B8-B8E8-4EB2-9248-CA54623D1BB2</domeo:belongsToSet>
    <pav:lineageUri>urn:domeoserver:annotationset:32C325B9-09DD-4A0B-A270-BAA0C42956A1</pav:lineageUri>
    <ao:context rdf:resource="urn:domeoclient:uuid:F409D487-F7F1-4F27-B967-0469F9A468A8"/>
    <pav:createdOn>2014-07-22 19:06:51 -0400</pav:createdOn>
    <rdfs:label>Highlight</rdfs:label>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <domeo:belongsToSet>urn:domeoserver:annotationset:2B18F6B1-59F7-4EA0-9386-55A934108055</domeo:belongsToSet>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812eda990003</pav:createdBy>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <pav:lineageUri>urn:domeoserver:annotation:27D963CC-66ED-4E86-A7B0-01D298203BB3</pav:lineageUri>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:lastSavedOn>2014-07-22 19:06:48 -0400</pav:lastSavedOn>
    <pav:lastSavedOn>2014-07-22 19:06:49 -0400</pav:lastSavedOn>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:62CEF929-8FCC-4F3F-8B23-F0215966A438">
    <pav:createdOn>2014-07-22 19:53:07 -0400</pav:createdOn>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:62CEF929-8FCC-4F3F-8B23-F0215966A438"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:exact>Glimepiride</ao:exact>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-123.txt.html</ao:hasSource>
    <ao:prefix>xsd:String</ao:prefix>
    <ao:suffix>xsd:String</ao:suffix>
    <domeo:uuid>62CEF929-8FCC-4F3F-8B23-F0215966A438</domeo:uuid>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:D77CF944-3EF8-45F2-9976-BAD4E451F994">
    <pav:lineageUri>urn:domeoserver:annotation:7996706F-8826-48E3-A9EE-7A3F64D946D8</pav:lineageUri>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <domeo:belongsToSet>urn:domeoclient:uuid:21C1BD16-9B1B-4BDA-B036-93523B41DFDF</domeo:belongsToSet>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:lastSavedOn>2014-07-24 19:46:59 -0400</pav:lastSavedOn>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812eda990003</pav:createdBy>
    <ao:body rdf:nodeID="Nd50e98fc4cd04367ba07408a8e7e411a"/>
    <rdfs:label>expertstudy Annotation</rdfs:label>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#expertstudyAnnotation"/>
    <pav:createdOn>2014-07-24 19:47:18 -0400</pav:createdOn>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <ao:context rdf:resource="urn:domeoclient:uuid:F33CE913-7DCE-473E-810F-A9B07CED9081"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:95CC663C-8F74-4A62-BE19-7170368BDA5F">
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:suffix> maleate 100 mg per day with atenolol 100 mg per day (N = 6) did not affect the plasma concentrations of atenolol. Unlike propranolol and metoprolol which undergo hepatic metabolism, atenolol is eliminated primarily by renal excretion.</ao:suffix>
    <pav:createdOn>2014-09-02 11:46:17 -0400</pav:createdOn>
    <ao:prefix>Coadministration of </ao:prefix>
    <domeo:uuid>95CC663C-8F74-4A62-BE19-7170368BDA5F</domeo:uuid>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-9.txt.html</ao:hasSource>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:exact>fluvoxamine</ao:exact>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:95CC663C-8F74-4A62-BE19-7170368BDA5F"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:31C3D8BC-BEE5-4732-B113-5F04341D26EC">
    <domeo:belongsToSet>urn:domeoserver:annotationset:392EE0FB-AC4F-4AF2-87A6-2E50A281F434</domeo:belongsToSet>
    <pav:lineageUri>urn:domeoserver:annotation:D15877AB-1458-401C-A494-58BE10849773</pav:lineageUri>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <pav:lastSavedOn>2014-09-02 19:19:47 -0400</pav:lastSavedOn>
    <ao:context rdf:resource="urn:domeoclient:uuid:D5BCCF61-F8EE-41B5-8F8E-D5A8F239ED7F"/>
    <rdfs:label>Highlight</rdfs:label>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812eda990003</pav:createdBy>
    <domeo:belongsToSet>urn:domeoserver:annotationset:E32812A9-205B-4EE1-B488-A1E294EDBFB9</domeo:belongsToSet>
    <pav:createdOn>2014-09-02 19:12:13 -0400</pav:createdOn>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:lineageUri>urn:domeoserver:annotationset:C5DEBC9B-77EE-4243-88EB-DBC19737ACD2</pav:lineageUri>
    <domeo:belongsToSet>urn:domeoclient:uuid:CB83FFC2-EA71-44EA-8F11-DE80E389C84E</domeo:belongsToSet>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:820A8921-32D8-4CA7-991C-5585C1088203">
    <rdfs:label>Highlight</rdfs:label>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:lastSavedOn>2014-09-02 19:19:47 -0400</pav:lastSavedOn>
    <domeo:belongsToSet>urn:domeoserver:annotationset:E32812A9-205B-4EE1-B488-A1E294EDBFB9</domeo:belongsToSet>
    <ao:context rdf:resource="urn:domeoclient:uuid:8AA02101-5E16-4D28-B719-8FAC66F7E101"/>
    <pav:createdOn>2014-09-02 19:13:15 -0400</pav:createdOn>
    <domeo:belongsToSet>urn:domeoserver:annotationset:392EE0FB-AC4F-4AF2-87A6-2E50A281F434</domeo:belongsToSet>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:lineageUri>urn:domeoserver:annotationset:C5DEBC9B-77EE-4243-88EB-DBC19737ACD2</pav:lineageUri>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <domeo:belongsToSet>urn:domeoclient:uuid:CB83FFC2-EA71-44EA-8F11-DE80E389C84E</domeo:belongsToSet>
    <pav:lineageUri>urn:domeoserver:annotation:5883FF62-E476-4FDF-AFDF-2A5958DD1951</pav:lineageUri>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812eda990003</pav:createdBy>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:56FE6B9A-96B3-43BC-A4E1-A9AFE78680CE">
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <domeo:uuid>56FE6B9A-96B3-43BC-A4E1-A9AFE78680CE</domeo:uuid>
    <ao:prefix> to </ao:prefix>
    <pav:createdOn>2014-07-13 11:14:04 -0400</pav:createdOn>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-8.txt.html</ao:hasSource>
    <ao:suffix> [see 7 DRUG INTERACTIONS]. This occurs with quinidine, giving essentially all recipients a risperidone pharmacokinetic profile typical of poor metabolizers. The therapeutic benefits and adverse effects of risperidone in patients receiving quinidine have</ao:suffix>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:56FE6B9A-96B3-43BC-A4E1-A9AFE78680CE"/>
    <ao:exact>9-hydroxyrisperidone</ao:exact>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:64531818-53F3-4463-8017-8AD63F5904C3">
    <pav:lineageUri>urn:domeoserver:annotation:FC66EC25-1110-43B1-B5BC-AAE69200665F</pav:lineageUri>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <domeo:belongsToSet>urn:domeoclient:uuid:379CD8C1-F4B4-42B7-8F87-70776866DB1F</domeo:belongsToSet>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812eda990003</pav:createdBy>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:createdOn>2014-09-02 12:03:14 -0400</pav:createdOn>
    <domeo:belongsToSet>urn:domeoserver:annotationset:D52DFD7B-BDDF-488F-B339-B1BC641E50E9</domeo:belongsToSet>
    <pav:lineageUri>urn:domeoserver:annotationset:166C20E9-1B4C-47D1-982D-922E2E5ACFF2</pav:lineageUri>
    <rdfs:label>Highlight</rdfs:label>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:lastSavedOn>2014-09-02 12:03:47 -0400</pav:lastSavedOn>
    <ao:context rdf:resource="urn:domeoclient:uuid:96A8BD35-396A-4A08-9E1C-55EB39E4B7D4"/>
    <pav:previousVersion>xsd:String</pav:previousVersion>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:3077386C-E136-4431-9DB1-FC99BF18719B">
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:previousVersion>urn:domeoserver:annotationset:7E80543E-BF76-4514-92A9-91458DCB802B</pav:previousVersion>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812eda990003</pav:createdBy>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <domeo:belongsToSet>urn:domeoserver:annotationset:606A5B3F-B6FB-4279-AA42-7893CFC2D20C</domeo:belongsToSet>
    <domeo:belongsToSet>urn:domeoserver:annotationset:F272A789-69D0-47CC-8CC9-F25C55B91261</domeo:belongsToSet>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <pav:createdOn>2014-07-22 19:35:22 -0400</pav:createdOn>
    <domeo:belongsToSet>urn:domeoserver:annotationset:514BA51B-D734-4003-A7C3-F03C0F95833A</domeo:belongsToSet>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <rdfs:label>Highlight</rdfs:label>
    <domeo:belongsToSet>urn:domeoserver:annotationset:2914A3FD-DF43-4F78-999C-77CE7A028B19</domeo:belongsToSet>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">4</pav:versionNumber>
    <ao:context rdf:resource="urn:domeoclient:uuid:F652E827-5625-4F3B-BD53-6EF8860F2CDE"/>
    <pav:lastSavedOn>2014-07-22 19:35:16 -0400</pav:lastSavedOn>
    <domeo:belongsToSet>urn:domeoserver:annotationset:7021B883-FD5C-4083-BD87-DF56D3C87633</domeo:belongsToSet>
    <pav:lineageUri>urn:domeoserver:annotationset:AB1741F1-5A5F-4416-AEAC-A544BCBB7D16</pav:lineageUri>
    <pav:lineageUri>urn:domeoserver:annotation:EC923EC5-7B3C-42DB-BA56-4922EF21AE85</pav:lineageUri>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:C988D053-7CF3-4C50-BDB6-7C2B20B837B9">
    <ao:item rdf:resource="urn:domeoclient:uuid:64F7664B-0B75-443E-8A3F-3A145064071E"/>
    <pav:lineageUri>urn:domeoserver:annotationset:7E388D29-FA3D-451D-B685-893CF456C7E5</pav:lineageUri>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812eda990003</pav:createdBy>
    <domeo:deleted>false</domeo:deleted>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <ao:item rdf:resource="urn:domeoclient:uuid:FE7EF264-FC22-45A9-853D-E8804BE9EF1B"/>
    <pav:lastSavedOn>2014-07-21 21:55:00 -0400</pav:lastSavedOn>
    <ao:item rdf:resource="urn:domeoclient:uuid:3BF96FBC-622D-4EC3-80A1-339B20EFCD2C"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#AnnotationSet"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:CC05ADFA-B5BA-4A4E-BAB0-61B3D424E8F2"/>
    <pav:createdOn>2014-07-21 21:51:30 -0400</pav:createdOn>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <ao:annotatesResource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-56.txt.html</ao:annotatesResource>
    <ao:item rdf:resource="urn:domeoclient:uuid:6FF44D67-C048-4D48-95BC-9CAC7BF5E54F"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:35E17DFA-B3B8-4521-B986-4AC98CC81C96"/>
    <dct:description>The default set is created automatically by Domeo when no other set is existing.</dct:description>
    <ao:item rdf:resource="urn:domeoclient:uuid:B9805A65-BB53-4315-AF92-EC703ABB5E61"/>
    <rdfs:label>Default Set</rdfs:label>
    <domeo:agents rdf:resource="urn:person:uuid:080e143046812afe0146812eda990003"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:1D7C043D-E62F-4A5D-A912-AB586E95D811"/>
    <permissions:permissions rdf:nodeID="N842258e05292469bb2edfeff6dbf1e5e"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:D41F6EB4-7428-411F-9159-905789D6B7B0"/>
    <domeo:agents rdf:resource="urn:domeo:software:id:Domeo-2.1alpha-050"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:DBA2FBEC-FB21-4B1E-AFD1-05AF52CBAB09">
    <domeo:agents rdf:resource="urn:person:uuid:080e143046812afe0146812eda990003"/>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <pav:createdOn>2014-07-24 19:38:05 -0400</pav:createdOn>
    <permissions:permissions rdf:nodeID="N291410c6a5af42dfab7129b7962092a6"/>
    <domeo:agents rdf:resource="urn:domeo:software:id:Domeo-2.1alpha-050"/>
    <dct:description>The default set is created automatically by Domeo when no other set is existing.</dct:description>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#AnnotationSet"/>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <ao:annotatesResource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-125.txt.html</ao:annotatesResource>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812eda990003</pav:createdBy>
    <pav:lineageUri>urn:domeoserver:annotationset:5B223E53-D0BF-4E3A-9D17-4CDE219FA974</pav:lineageUri>
    <ao:item rdf:resource="urn:domeoclient:uuid:DC73A4DB-52A1-428E-A3E7-50DAC49D6A5A"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:0ABA0AC7-182A-406C-840C-4443E197D138"/>
    <rdfs:label>Default Set</rdfs:label>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:lastSavedOn>2014-07-24 19:38:40 -0400</pav:lastSavedOn>
    <ao:item rdf:resource="urn:domeoclient:uuid:56885854-DBBA-451C-B531-1D54B8C98A0B"/>
    <domeo:deleted>false</domeo:deleted>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:D05E9B7E-AE50-4FCD-BC2D-B3A39CEF8396">
    <pav:createdOn>2014-07-24 19:54:46 -0400</pav:createdOn>
    <domeo:belongsToSet>urn:domeoclient:uuid:8AA46BC0-EA66-4E73-81A9-6463BB4DE15B</domeo:belongsToSet>
    <pav:lastSavedOn>2014-07-24 19:54:28 -0400</pav:lastSavedOn>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812eda990003</pav:createdBy>
    <rdfs:label>Highlight</rdfs:label>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <ao:context rdf:resource="urn:domeoclient:uuid:E7176E11-44D4-4336-A0B0-21D16F8910C5"/>
    <pav:lineageUri>urn:domeoserver:annotation:A8E97F89-BD6B-481E-9E5B-A03025E04E7D</pav:lineageUri>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:46345058-661B-476F-9809-F885E60E0311">
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:suffix> on the pharmacokinetics of atomoxetine has been evaluated when both drugs were at steady state. In healthy volunteers who were extensive metabolizers of CYP2D6, paroxetine 20 mg daily was given in combination with 20 mg atomoxetine every 12 hours. This </ao:suffix>
    <domeo:uuid>46345058-661B-476F-9809-F885E60E0311</domeo:uuid>
    <pav:createdOn>2014-09-02 12:03:26 -0400</pav:createdOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:46345058-661B-476F-9809-F885E60E0311"/>
    <ao:exact>paroxetine</ao:exact>
    <ao:prefix> approximately 4-fold, decreased 9-hydroxyrisperidone concentrations approximately 10%, and increased concentrations of the active moiety (the sum of risperidone plus 9-hydroxyrisperidone) approximately 1.4-fold. The effect of </ao:prefix>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-47.txt.html</ao:hasSource>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:518CD4C6-1719-48AB-B300-84A10DEACB68">
    <pav:lastSavedOn>2014-07-13 11:32:29 -0400</pav:lastSavedOn>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812eda990003</pav:createdBy>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:createdOn>2014-07-13 11:10:38 -0400</pav:createdOn>
    <domeo:belongsToSet>urn:domeoclient:uuid:71191E51-53CB-4FDE-88D0-33C6818E2232</domeo:belongsToSet>
    <ao:context rdf:resource="urn:domeoclient:uuid:35CE9A7F-F23D-4EBE-B09F-02A153717FBA"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <rdfs:label>Highlight</rdfs:label>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <pav:lineageUri>urn:domeoserver:annotation:01596A5C-8D3C-4B38-BEFB-CD0AFC09802B</pav:lineageUri>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:CFBF6FAC-1B25-458D-A6E1-4DFEB8A3FAC9">
    <domeo:belongsToSet>urn:domeoserver:annotationset:A3F0B39A-4249-4B63-BB0D-F24A005066AC</domeo:belongsToSet>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812eda990003</pav:createdBy>
    <pav:lineageUri>urn:domeoserver:annotation:5DBA32DA-F1E7-4F9E-AD15-D58983A11DB9</pav:lineageUri>
    <pav:createdOn>2014-09-02 11:53:02 -0400</pav:createdOn>
    <ao:body rdf:nodeID="N20e49fc8c1d14b46bba22f77b4068d67"/>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:lastSavedOn>2014-09-02 11:54:50 -0400</pav:lastSavedOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#expertstudyAnnotation"/>
    <rdfs:label>expertstudy Annotation</rdfs:label>
    <ao:context rdf:resource="urn:domeoclient:uuid:42814771-C705-49EC-A4A8-3257DD3ADB49"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:A4CCAADB-C549-4258-8D06-8971C53D94D8">
    <pav:createdOn>2014-09-01 16:22:20 -0400</pav:createdOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:prefix> on phenobarbital pharmacokinetics was not studied. Since </ao:prefix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:A4CCAADB-C549-4258-8D06-8971C53D94D8"/>
    <ao:exact>paroxetine</ao:exact>
    <domeo:uuid>A4CCAADB-C549-4258-8D06-8971C53D94D8</domeo:uuid>
    <ao:suffix> exhibits nonlinear pharmacokinetics, the results of this study may not address the case where the 2 drugs are both being chronically dosed. No initial dosage adjustment with Paroxetine Hydrochloride Controlled-Release Tablets is considered necessary whe</ao:suffix>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-45.txt.html</ao:hasSource>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:1E597BBC-9857-4D08-953B-5CBE831F5884">
    <pav:lastSavedOn>2014-07-13 11:32:29 -0400</pav:lastSavedOn>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <ao:body rdf:nodeID="Nbddbe61709044c32874ac9cdf7b7d2df"/>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812eda990003</pav:createdBy>
    <ao:context rdf:resource="urn:domeoclient:uuid:B7CF0599-4EF7-4EA9-AA71-F3F0B7596EF6"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#expertstudyAnnotation"/>
    <pav:createdOn>2014-07-13 11:26:45 -0400</pav:createdOn>
    <domeo:belongsToSet>urn:domeoclient:uuid:71191E51-53CB-4FDE-88D0-33C6818E2232</domeo:belongsToSet>
    <rdfs:label>expertstudy Annotation</rdfs:label>
    <pav:lineageUri>urn:domeoserver:annotation:DE221D8D-564A-4ED6-8FA2-FEACF6BADD9F</pav:lineageUri>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:424F0823-B0B8-4327-8A43-69119A2195AC">
    <domeo:belongsToSet>urn:domeoserver:annotationset:606A5B3F-B6FB-4279-AA42-7893CFC2D20C</domeo:belongsToSet>
    <pav:previousVersion>urn:domeoserver:annotationset:7021B883-FD5C-4083-BD87-DF56D3C87633</pav:previousVersion>
    <rdfs:label>Highlight</rdfs:label>
    <pav:createdOn>2014-07-22 19:39:49 -0400</pav:createdOn>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <domeo:belongsToSet>urn:domeoserver:annotationset:514BA51B-D734-4003-A7C3-F03C0F95833A</domeo:belongsToSet>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:lastSavedOn>2014-07-22 19:40:31 -0400</pav:lastSavedOn>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">5</pav:versionNumber>
    <pav:lineageUri>urn:domeoserver:annotation:CE271D57-1AF8-4CAB-902C-203A0CF15B95</pav:lineageUri>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:lineageUri>urn:domeoserver:annotationset:AB1741F1-5A5F-4416-AEAC-A544BCBB7D16</pav:lineageUri>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <domeo:belongsToSet>urn:domeoserver:annotationset:F272A789-69D0-47CC-8CC9-F25C55B91261</domeo:belongsToSet>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812eda990003</pav:createdBy>
    <pav:lastSavedOn>2014-07-22 19:40:32 -0400</pav:lastSavedOn>
    <ao:context rdf:resource="urn:domeoclient:uuid:6C2A60D1-56A3-4C14-A2B0-4A75D2CDBF72"/>
    <domeo:belongsToSet>urn:domeoserver:annotationset:2914A3FD-DF43-4F78-999C-77CE7A028B19</domeo:belongsToSet>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:CBB863B4-0141-4362-8357-0FD5A3909A10">
    <domeo:belongsToSet>urn:domeoserver:annotationset:8F3CF3D9-AADE-4A86-BD42-2924B3D6A406</domeo:belongsToSet>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812eda990003</pav:createdBy>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <ao:context rdf:resource="urn:domeoclient:uuid:098AA784-6695-4935-9450-C87D502EDBCD"/>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:lineageUri>urn:domeoserver:annotation:23A67AAE-576A-4FB5-8468-E2C34B2748CB</pav:lineageUri>
    <domeo:belongsToSet>urn:domeoserver:annotationset:131835A3-C655-4F91-97D4-52CAFF7B7CCA</domeo:belongsToSet>
    <pav:createdOn>2014-07-07 11:23:07 -0400</pav:createdOn>
    <pav:lastSavedOn>2014-07-07 11:24:52 -0400</pav:lastSavedOn>
    <domeo:belongsToSet>urn:domeoserver:annotationset:7AACEF8D-2EBC-4F0B-94B2-190650E562F6</domeo:belongsToSet>
    <rdfs:label>Highlight</rdfs:label>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <domeo:belongsToSet>urn:domeoserver:annotationset:22ED7220-C6F6-43C5-9DF9-89F62F0F8E27</domeo:belongsToSet>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:31254608-CDC4-4553-A278-115226EC9264">
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:lineageUri>urn:domeoserver:annotationset:D1715BD2-BD41-46FD-9454-DC7A423A29AC</pav:lineageUri>
    <ao:context rdf:resource="urn:domeoclient:uuid:EE0F6228-C669-47FF-9D22-04B7A608D69E"/>
    <domeo:belongsToSet>urn:domeoserver:annotationset:A3F0B39A-4249-4B63-BB0D-F24A005066AC</domeo:belongsToSet>
    <rdfs:label>Highlight</rdfs:label>
    <pav:previousVersion>urn:domeoclient:uuid:BED41F06-565A-4622-9A88-48810E5A28DE</pav:previousVersion>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812eda990003</pav:createdBy>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <pav:lastSavedOn>2014-09-02 11:46:58 -0400</pav:lastSavedOn>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">2</pav:versionNumber>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <domeo:belongsToSet>urn:domeoserver:annotationset:A5DD001D-C81A-4E2E-B5E0-7A866B35E26B</domeo:belongsToSet>
    <domeo:belongsToSet>urn:domeoserver:annotationset:3F546823-204F-4F9B-9006-3DC526C56931</domeo:belongsToSet>
    <pav:createdOn>2014-09-02 11:38:12 -0400</pav:createdOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:lineageUri>urn:domeoserver:annotation:0382DB9B-E5C4-482F-9C4E-BC94C07C08D1</pav:lineageUri>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:15142045-DA2F-4022-9FF7-3D0277BDC3FB">
    <domeo:belongsToSet>urn:domeoserver:annotationset:A5DD001D-C81A-4E2E-B5E0-7A866B35E26B</domeo:belongsToSet>
    <pav:createdOn>2014-09-02 11:44:09 -0400</pav:createdOn>
    <rdfs:label>Highlight</rdfs:label>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <pav:previousVersion>urn:domeoclient:uuid:BED41F06-565A-4622-9A88-48810E5A28DE</pav:previousVersion>
    <pav:lastSavedOn>2014-09-02 11:46:58 -0400</pav:lastSavedOn>
    <ao:context rdf:resource="urn:domeoclient:uuid:D19C185B-AB58-4956-9871-777E207AC825"/>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">2</pav:versionNumber>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:lineageUri>urn:domeoserver:annotationset:D1715BD2-BD41-46FD-9454-DC7A423A29AC</pav:lineageUri>
    <domeo:belongsToSet>urn:domeoserver:annotationset:3F546823-204F-4F9B-9006-3DC526C56931</domeo:belongsToSet>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812eda990003</pav:createdBy>
    <pav:lastSavedOn>2014-09-02 11:46:59 -0400</pav:lastSavedOn>
    <pav:lineageUri>urn:domeoserver:annotation:C748FBC3-EA6F-4F6A-97B3-3BB54D6C17DD</pav:lineageUri>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <domeo:belongsToSet>urn:domeoserver:annotationset:A3F0B39A-4249-4B63-BB0D-F24A005066AC</domeo:belongsToSet>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:74CD19CE-F47D-46AD-8DBC-B02B6A6F0D87">
    <rdfs:label>Highlight</rdfs:label>
    <pav:createdOn>2014-07-24 20:03:45 -0400</pav:createdOn>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:lineageUri>urn:domeoserver:annotation:C95F2443-78FA-4BF4-A1AB-C2328E73A175</pav:lineageUri>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <domeo:belongsToSet>urn:domeoclient:uuid:F70AB841-7C14-48D1-B543-A45EA067C642</domeo:belongsToSet>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <ao:context rdf:resource="urn:domeoclient:uuid:F80BB417-0183-4007-8F4C-0705AA0B529E"/>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812eda990003</pav:createdBy>
    <pav:lastSavedOn>2014-07-24 20:04:12 -0400</pav:lastSavedOn>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:D4374CEB-BF68-487B-B5EE-5AF06DB14203">
    <pav:lineageUri>urn:domeoserver:annotation:455774FE-0093-4F4D-84D8-16C42C340D54</pav:lineageUri>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812eda990003</pav:createdBy>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <ao:context rdf:resource="urn:domeoclient:uuid:8380B817-2385-42D1-ACFB-89134B65210A"/>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <rdfs:label>Highlight</rdfs:label>
    <domeo:belongsToSet>urn:domeoclient:uuid:FCA2BF23-0BE3-409F-9177-761812F96097</domeo:belongsToSet>
    <pav:lastSavedOn>2014-07-07 09:44:19 -0400</pav:lastSavedOn>
    <pav:createdOn>2014-07-07 09:42:37 -0400</pav:createdOn>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:FD421B20-B74E-481A-8077-F6D9C42943B8">
    <sio:SIO_000205>dikbD2R:statement</sio:SIO_000205>
    <dikbD2R:modality>ncit:positive</dikbD2R:modality>
    <sio:SIO_000563>dikbD2R:modality</sio:SIO_000563>
    <dikbD2R:statement>ncit:quantitative</dikbD2R:statement>
    <sio:SIO_000628 rdf:resource="urn:pddi:uuid:861C11A2-8AEA-4CD2-AC61-355B6002E25D"/>
    <rdf:type rdf:resource="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#DrugDrugInteractionStatement"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:2E7AB2E6-7FEA-4A78-80FB-CE3FA7ABBCCB">
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/PK_DDI"/>
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/27D0B4AA-F7F1-4B7F-ADC9-3414612394E8"/>
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/78B277CF-FACC-42EA-9594-CD77F7E3193A"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:601A10D5-2B9E-4942-8107-15DFA9C70ACF">
    <ao:exact>propranolol</ao:exact>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-74.txt.html</ao:hasSource>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:601A10D5-2B9E-4942-8107-15DFA9C70ACF"/>
    <ao:suffix> was found, there have been clinical reports of interaction with other drugs metabolized via the cytochrome P450 system (e.g., cyclosporine, disulfiram, benzodiazepines). Patients should be monitored to determine if it is necessary to adjust the dosage o</ao:suffix>
    <pav:createdOn>2014-09-02 19:13:08 -0400</pav:createdOn>
    <ao:prefix> or </ao:prefix>
    <domeo:uuid>601A10D5-2B9E-4942-8107-15DFA9C70ACF</domeo:uuid>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:C45EB527-9AC4-4005-86AF-8EEB1D4B88FA">
    <pav:createdOn>2014-07-22 19:22:31 -0400</pav:createdOn>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-123.txt.html</ao:hasSource>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:prefix> in combination with other hypoglycemic agents were generally similar to those seen with </ao:prefix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:C45EB527-9AC4-4005-86AF-8EEB1D4B88FA"/>
    <ao:exact>AVANDIA</ao:exact>
    <ao:suffix> in monotherapy.</ao:suffix>
    <domeo:uuid>C45EB527-9AC4-4005-86AF-8EEB1D4B88FA</domeo:uuid>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:2025A1F1-3A58-4E3E-A4B7-739A783D52BB">
    <ao:suffix> is therefore not recommended. For other antiretroviral drugs, such as saquinavir, elevated serum levels have been reported with an increase in AUC by 82%, in Cmax by 75% and in Cmin by 106% following multiple dosing of saquinavir/ritonavir (1000/100 mg)</ao:suffix>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-74.txt.html</ao:hasSource>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:exact>nelfinavir</ao:exact>
    <ao:prefix> and </ao:prefix>
    <pav:createdOn>2014-09-02 19:18:51 -0400</pav:createdOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:2025A1F1-3A58-4E3E-A4B7-739A783D52BB"/>
    <domeo:uuid>2025A1F1-3A58-4E3E-A4B7-739A783D52BB</domeo:uuid>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:420A77EC-3CAE-4EA3-B428-B635FA4A9F5D">
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812eda990003</pav:createdBy>
    <pav:lastSavedOn>2014-07-13 11:32:29 -0400</pav:lastSavedOn>
    <domeo:belongsToSet>urn:domeoclient:uuid:71191E51-53CB-4FDE-88D0-33C6818E2232</domeo:belongsToSet>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:createdOn>2014-07-13 11:11:13 -0400</pav:createdOn>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <pav:lineageUri>urn:domeoserver:annotation:1734C6CD-F7E3-40D2-B440-4C5D8B428556</pav:lineageUri>
    <rdfs:label>Highlight</rdfs:label>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <ao:context rdf:resource="urn:domeoclient:uuid:804C4BF7-B45B-4CC2-BD44-707AAD50F219"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:8A7AE105-ADC2-416B-AD5B-0B0B1DB2A2E2">
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-21.txt.html</ao:hasSource>
    <ao:exact>fluconazole</ao:exact>
    <pav:createdOn>2014-07-13 12:38:56 -0400</pav:createdOn>
    <domeo:uuid>8A7AE105-ADC2-416B-AD5B-0B0B1DB2A2E2</domeo:uuid>
    <ao:prefix> decreased very slightly (&lt;5%) in 3 of the 21 subjects after </ao:prefix>
    <ao:suffix> treatment.</ao:suffix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:8A7AE105-ADC2-416B-AD5B-0B0B1DB2A2E2"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/2E502086-B34B-4ECF-A908-98A7B7EF6EA3">
    <rdfs:label>desipramine</rdfs:label>
    <dct:description>Referred to the drug in the interaction.</dct:description>
    <sio:SIO_000228>dikbD2R:object-drug-of-interaction</sio:SIO_000228>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/active-ingredient"/>
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/3247</dailymed:activeMoietyRxCUI>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:EFE95BF7-1349-414E-B68F-6C5149A03072">
    <domeo:uuid></domeo:uuid>
    <ao:exact>TID</ao:exact>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-155.txt.html</ao:hasSource>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:EFE95BF7-1349-414E-B68F-6C5149A03072"/>
    <domeo:uuid>EFE95BF7-1349-414E-B68F-6C5149A03072</domeo:uuid>
    <ao:prefix>exposure without concomitant medication is shown to be 5-fold higher at a dose of 80 mg TID compared to its exposure at a dose of 20 mg </ao:prefix>
    <ao:suffix>. This concentration range covers the same increased sildenafil exposure observed in specifically-designed drug interaction studies with CYP3A inhibitors (except for potent inhibitors such as ketoconazole, itraconazole, and ritonavir).</ao:suffix>
    <pav:createdOn>2014-07-07 11:22:43 -0400</pav:createdOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:4AF71C9F-3EB8-4736-9C47-FEDEAC296DAB">
    <rdfs:label>Highlight</rdfs:label>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <domeo:belongsToSet>urn:domeoserver:annotationset:1FC172B8-8AC3-465A-AA69-B73AD9B97CBC</domeo:belongsToSet>
    <ao:context rdf:resource="urn:domeoclient:uuid:12AC269E-4947-4540-A483-BE43615F8E88"/>
    <pav:lastSavedOn>2014-07-24 20:12:49 -0400</pav:lastSavedOn>
    <pav:lineageUri>urn:domeoserver:annotation:19A46F54-942B-4821-B4F0-DA4F98AAF594</pav:lineageUri>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:createdOn>2014-07-24 20:13:04 -0400</pav:createdOn>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812eda990003</pav:createdBy>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:01B5F725-B643-43F6-B470-6409EC7AE08D">
    <pav:createdOn>2014-09-02 11:58:55 -0400</pav:createdOn>
    <ao:context rdf:resource="urn:domeoclient:uuid:B4A07D2A-59AD-4845-9180-9D26F251F26E"/>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <pav:lastSavedOn>2014-09-02 12:02:18 -0400</pav:lastSavedOn>
    <domeo:belongsToSet>urn:domeoclient:uuid:4B51141D-C8D2-45DB-8074-74F8D8323E60</domeo:belongsToSet>
    <rdfs:label>Highlight</rdfs:label>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812eda990003</pav:createdBy>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:lineageUri>urn:domeoserver:annotation:60CFA2CD-757B-43D2-A98C-0ED2D3BDE041</pav:lineageUri>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:9904E394-CEF0-416A-8F6B-42179BE2B9C6">
    <pav:lastSavedOn>2014-07-24 19:43:34 -0400</pav:lastSavedOn>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <pav:lineageUri>urn:domeoserver:annotation:F9534CDE-E0E1-4B2C-8EB0-477EA628D436</pav:lineageUri>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#expertstudyAnnotation"/>
    <pav:createdOn>2014-07-24 19:43:26 -0400</pav:createdOn>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812eda990003</pav:createdBy>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <domeo:belongsToSet>urn:domeoclient:uuid:7DEB6848-E3C6-4761-8965-41F19EE5D781</domeo:belongsToSet>
    <ao:body rdf:nodeID="Ne8914da9cd8a49f1903f213ebb61fac1"/>
    <rdfs:label>expertstudy Annotation</rdfs:label>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <ao:context rdf:resource="urn:domeoclient:uuid:D630E295-F643-4F99-AB1E-8DA3F1178740"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:89138321-17A8-4CAE-B03E-6A7C0F8B6AC5">
    <ao:suffix>, carbamazepine, or cisapride. These data indicate that sertraline’s extent of inhibition of P450 3A4 activity is not likely to be of clinical significance. Results of the interaction study with cisapride indicate that sertraline 200 mg (q.d.) induces th</ao:suffix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <domeo:uuid>89138321-17A8-4CAE-B03E-6A7C0F8B6AC5</domeo:uuid>
    <ao:prefix>did not increase plasma concentrations of </ao:prefix>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:89138321-17A8-4CAE-B03E-6A7C0F8B6AC5"/>
    <ao:exact>terfenadine</ao:exact>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <pav:createdOn>2014-09-01 15:57:31 -0400</pav:createdOn>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-16.txt.html</ao:hasSource>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:93AEC1F9-3191-4D73-8BB9-21EE50636AB5">
    <pav:lineageUri>urn:domeoserver:annotation:F0A0304E-D86D-4C10-B359-4A808EF0B94F</pav:lineageUri>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812eda990003</pav:createdBy>
    <domeo:belongsToSet>urn:domeoclient:uuid:42248733-4719-42F4-8132-866191F8E708</domeo:belongsToSet>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:lastSavedOn>2014-07-21 21:44:00 -0400</pav:lastSavedOn>
    <rdfs:label>Highlight</rdfs:label>
    <ao:context rdf:resource="urn:domeoclient:uuid:056787DE-BFEB-4038-A418-CB53FF7030DC"/>
    <pav:createdOn>2014-07-21 21:43:22 -0400</pav:createdOn>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoserver:annotationset:E32812A9-205B-4EE1-B488-A1E294EDBFB9">
    <ao:annotatesResource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-74.txt.html</ao:annotatesResource>
    <ao:item rdf:resource="urn:domeoclient:uuid:9BCE3E38-7FC6-48FE-A2E7-EB618F9B1F7F"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:95404334-796F-4A07-A18A-42601A802CDF"/>
    <domeo:agents rdf:resource="urn:domeo:software:id:Domeo-2.1alpha-050"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:0772E366-3DDD-4D99-A1E7-B6F12EFF65DC"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:F64BA1C3-4615-428E-A209-D304847D4A08"/>
    <dct:description>The default set is created automatically by Domeo when no other set is existing.</dct:description>
    <ao:item rdf:resource="urn:domeoclient:uuid:B1D53EEF-8BCA-4B91-B107-30A073406F41"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:A05ABC03-57B2-463F-8733-BF02DB5FE3A7"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:0A3EAA6A-641B-48C1-A03F-CCA1FF890D64"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:DC13A4FA-8B30-458B-9343-4B48CC945EBF"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:A30DCF7F-AD5F-403E-9FF6-A1CEC51B4252"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:968E2714-CEBF-4C37-913F-C2DF10947AB8"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:56E0618F-C2A8-4B2E-868E-D415AEE3E3EF"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:8621DC71-D1C0-4E5B-97BA-B7275B47A413"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:939BD222-0159-44F2-9E01-3D674AEF5EFE"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:F1FF7E05-1C80-4A3F-9366-A074CA5EDF15"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:0E2360A5-44FC-4633-8B3E-758DB777C4E6"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:F0FFC655-44BB-402B-B7C7-6EB6CD49035C"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:62793798-1CBD-4B4E-97DB-09E6DED152F0"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:53200B7D-3B88-4C24-827A-DE552ED1B23F"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:F9653C29-A4D2-424D-A8FE-3DDBAC24C18C"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:D5B6732B-67A7-4A25-9BC2-70185A35217F"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:EA6549D1-9142-4B02-863B-C31046392662"/>
    <domeo:agents rdf:resource="urn:person:uuid:080e143046812afe0146812eda990003"/>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">3</pav:versionNumber>
    <pav:createdOn>2014-09-02 19:12:09 -0400</pav:createdOn>
    <permissions:permissions rdf:nodeID="N4d79055f10be45ae940dfb257d1b015f"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:00C24F6A-259C-4CD5-BB57-3231935B23AE"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:807433B2-EB3F-4CEF-824C-1D71920A4C22"/>
    <pav:lineageUri>urn:domeoserver:annotationset:C5DEBC9B-77EE-4243-88EB-DBC19737ACD2</pav:lineageUri>
    <ao:item rdf:resource="urn:domeoclient:uuid:0B3096F2-9B83-424A-BCB8-CF996BA224AC"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:31C3D8BC-BEE5-4732-B113-5F04341D26EC"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:16D91D82-D12B-41E8-A218-F336224CF507"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:5EA1A12E-999D-4F07-B3EF-67CFE143F274"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:94E71C50-311F-485B-9C5A-D703BD0E29D1"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:50AA7124-5304-4E5F-8D20-3405C75223FB"/>
    <rdfs:label>Default Set</rdfs:label>
    <ao:item rdf:resource="urn:domeoclient:uuid:F989B861-2D11-4383-83FA-D6724A4DE400"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:F45CCE04-9C17-4AB6-BF4A-23A94A70AB21"/>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <ao:item rdf:resource="urn:domeoclient:uuid:85752833-4F1F-4395-A378-9451755A600C"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:812A1777-BC32-4760-9024-CF9758CF804E"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:70CC18BE-600E-4B98-B2C6-E5920EB63D79"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:4B8A305B-D42C-40FD-B384-05FE89B4ACA4"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:ED46D326-5EE0-47F9-A0D2-97252A43CE9D"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:DC77541A-190C-4C62-930E-9CF52E6C4A67"/>
    <pav:previousVersion>urn:domeoserver:annotationset:392EE0FB-AC4F-4AF2-87A6-2E50A281F434</pav:previousVersion>
    <ao:item rdf:resource="urn:domeoclient:uuid:E68B19A2-98CC-4D01-88C9-2BCC8709D27A"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:2FAF656F-18DD-448F-84DF-6CC1FD701820"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:42F3EB55-6A92-4EE6-9472-03CDC6E02D69"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:2DE3872D-3935-4824-AF9D-DBFF26D2588F"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:820A8921-32D8-4CA7-991C-5585C1088203"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:50CB810E-E5CE-4D21-8703-B10F04053C7D"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:E63ABC8A-4562-42F9-B5F4-6A27DEE50F44"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:B188771E-D938-4A6E-AA65-8D511119CA92"/>
    <domeo:deleted>false</domeo:deleted>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812eda990003</pav:createdBy>
    <ao:item rdf:resource="urn:domeoclient:uuid:25474B79-791D-49D5-B5D1-858E90C62BB2"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:DC959F62-91AD-411B-AC17-FFBBEE22EAF0"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:883BB188-A483-4C32-85F5-63D2C4B33561"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:FF4B8408-EC34-4E9C-A970-D7F98CF2EEE1"/>
    <pav:lastSavedOn>2014-09-02 19:33:40 -0400</pav:lastSavedOn>
    <ao:item rdf:resource="urn:domeoclient:uuid:46890B26-242B-40DA-BF4E-E7B90E54E678"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:6BD06504-E85C-4ECF-9079-FE0363DD8508"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:66EF0F25-8A90-4498-99B4-6985AB481B18"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:19626855-8C17-4CB6-BD80-697B52F6ADC9"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:F5B0ED12-45EB-48BE-B664-DDC78E05AA4A"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#AnnotationSet"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:32B1CD5D-3CD7-4D5E-BD76-57F6F0A9480A">
    <domeo:belongsToSet>urn:domeoserver:annotationset:8F3CF3D9-AADE-4A86-BD42-2924B3D6A406</domeo:belongsToSet>
    <domeo:belongsToSet>urn:domeoserver:annotationset:131835A3-C655-4F91-97D4-52CAFF7B7CCA</domeo:belongsToSet>
    <pav:lastSavedOn>2014-07-07 09:44:19 -0400</pav:lastSavedOn>
    <pav:createdOn>2014-07-07 09:34:12 -0400</pav:createdOn>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812eda990003</pav:createdBy>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <domeo:belongsToSet>urn:domeoserver:annotationset:7AACEF8D-2EBC-4F0B-94B2-190650E562F6</domeo:belongsToSet>
    <domeo:belongsToSet>urn:domeoserver:annotationset:08C0C288-6DF4-43E6-A618-71A8BB9563C3</domeo:belongsToSet>
    <pav:lineageUri>urn:domeoserver:annotation:D39EF779-DAF5-4F97-868F-87A730F44650</pav:lineageUri>
    <pav:lastSavedOn>2014-07-07 09:44:18 -0400</pav:lastSavedOn>
    <rdfs:label>Highlight</rdfs:label>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <ao:context rdf:resource="urn:domeoclient:uuid:5672F5D0-071A-4DE9-9A98-BD20431A00C2"/>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <domeo:belongsToSet>urn:domeoclient:uuid:FCA2BF23-0BE3-409F-9177-761812F96097</domeo:belongsToSet>
    <domeo:belongsToSet>urn:domeoserver:annotationset:22ED7220-C6F6-43C5-9DF9-89F62F0F8E27</domeo:belongsToSet>
    <pav:lineageUri>urn:domeoserver:annotationset:76FD4BB5-DE2F-4FCA-B93D-302185B1A381</pav:lineageUri>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:FADFAA32-BB4A-4542-AEFD-2B7D80177234">
    <ao:prefix>Food Effect: Food does not affect either the rate or extent of absorption of </ao:prefix>
    <pav:createdOn>2014-07-13 11:10:35 -0400</pav:createdOn>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:FADFAA32-BB4A-4542-AEFD-2B7D80177234"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:exact>risperidone</ao:exact>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-8.txt.html</ao:hasSource>
    <ao:suffix>. Thus, risperidone can be given with or without meals.</ao:suffix>
    <domeo:uuid>FADFAA32-BB4A-4542-AEFD-2B7D80177234</domeo:uuid>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:DC959F62-91AD-411B-AC17-FFBBEE22EAF0">
    <rdfs:label>Highlight</rdfs:label>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <domeo:belongsToSet>urn:domeoclient:uuid:CB83FFC2-EA71-44EA-8F11-DE80E389C84E</domeo:belongsToSet>
    <pav:lineageUri>urn:domeoserver:annotation:629227D7-38B9-4A3D-A63A-9B8DC03D59F3</pav:lineageUri>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <ao:context rdf:resource="urn:domeoclient:uuid:6A404FE8-4389-4D36-A815-EE09948F4613"/>
    <domeo:belongsToSet>urn:domeoserver:annotationset:392EE0FB-AC4F-4AF2-87A6-2E50A281F434</domeo:belongsToSet>
    <pav:lastSavedOn>2014-09-02 19:19:47 -0400</pav:lastSavedOn>
    <pav:lineageUri>urn:domeoserver:annotationset:C5DEBC9B-77EE-4243-88EB-DBC19737ACD2</pav:lineageUri>
    <pav:createdOn>2014-09-02 19:18:28 -0400</pav:createdOn>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <domeo:belongsToSet>urn:domeoserver:annotationset:E32812A9-205B-4EE1-B488-A1E294EDBFB9</domeo:belongsToSet>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812eda990003</pav:createdBy>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:E2DFE50C-520B-4A09-83FE-8498F429017C">
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-160.txt.html</ao:hasSource>
    <pav:createdOn>2014-07-24 20:13:52 -0400</pav:createdOn>
    <ao:exact>mexiletine</ao:exact>
    <domeo:uuid>E2DFE50C-520B-4A09-83FE-8498F429017C</domeo:uuid>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:suffix> therapy has not been established. In addition, there have been isolated reports of drowsiness, nystagmus, ataxia, dyspepsia, hypersensitivity reaction, and exacerbation of congestive heart failure in patients with pre-existing compromised ventricular fu</ao:suffix>
    <ao:prefix>have been isolated, spontaneous reports of pulmonary changes including pulmonary infiltration and pulmonary fibrosis during mexiletine therapy with or without other drugs or diseases that are known to produce pulmonary toxicity. A causal relationship to </ao:prefix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:E2DFE50C-520B-4A09-83FE-8498F429017C"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:A3AF38F3-51D7-4A66-84B7-21A51A8CE79F">
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/6FD42917-DF6A-4B72-83EF-A23E155102AF"/>
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/6FA2E5AB-9D75-44CD-B064-73797C92A684"/>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/PK_DDI"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:B30D95E2-6A9C-41B9-A6BC-823FD4639E01">
    <domeo:uuid>B30D95E2-6A9C-41B9-A6BC-823FD4639E01</domeo:uuid>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:exact>oxycodone</ao:exact>
    <pav:createdOn>2014-09-02 19:10:13 -0400</pav:createdOn>
    <ao:suffix>. If co-administration is necessary, caution is advised when initiating therapy with, currently taking, or discontinuing CYP3A4 inducers. Evaluate these patients at frequent intervals and consider dose adjustments until stable drug effects are achieved. </ao:suffix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-72.txt.html</ao:hasSource>
    <ao:prefix>, may lead to a lack of efficacy or, possibly, development of an abstinence syndrome in a patient who had developed physical dependence to </ao:prefix>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:B30D95E2-6A9C-41B9-A6BC-823FD4639E01"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:B572D091-3712-43AD-B485-3E1311449FAA">
    <domeo:belongsToSet>urn:domeoserver:annotationset:A5DD001D-C81A-4E2E-B5E0-7A866B35E26B</domeo:belongsToSet>
    <domeo:belongsToSet>urn:domeoclient:uuid:BED41F06-565A-4622-9A88-48810E5A28DE</domeo:belongsToSet>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:lastSavedOn>2014-09-02 11:35:33 -0400</pav:lastSavedOn>
    <rdfs:label>Highlight</rdfs:label>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:lineageUri>urn:domeoserver:annotation:76B7B883-099C-4DC7-AD76-A351F93134EA</pav:lineageUri>
    <domeo:belongsToSet>urn:domeoserver:annotationset:3F546823-204F-4F9B-9006-3DC526C56931</domeo:belongsToSet>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812eda990003</pav:createdBy>
    <domeo:belongsToSet>urn:domeoserver:annotationset:A3F0B39A-4249-4B63-BB0D-F24A005066AC</domeo:belongsToSet>
    <pav:lineageUri>urn:domeoserver:annotationset:D1715BD2-BD41-46FD-9454-DC7A423A29AC</pav:lineageUri>
    <pav:createdOn>2014-09-02 11:32:43 -0400</pav:createdOn>
    <ao:context rdf:resource="urn:domeoclient:uuid:54E3B0B5-2096-41BF-BC0D-256928923869"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:F8EAE386-C8C4-4874-BD9D-09F2FAF602D8">
    <pav:createdOn>2014-07-22 20:20:26 -0400</pav:createdOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <rdfs:label>Highlight</rdfs:label>
    <pav:lastSavedOn>2014-07-22 20:22:38 -0400</pav:lastSavedOn>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812eda990003</pav:createdBy>
    <domeo:belongsToSet>urn:domeoserver:annotationset:F272A789-69D0-47CC-8CC9-F25C55B91261</domeo:belongsToSet>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <ao:context rdf:resource="urn:domeoclient:uuid:4F81F868-415D-4A79-8A62-6366850D49AA"/>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:lineageUri>urn:domeoserver:annotation:BAE27596-EB60-4361-9A9F-1417E09C1460</pav:lineageUri>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:224F94C2-6E6D-4C8D-9B6C-9E8B442425A3">
    <pav:createdOn>2014-07-24 19:43:03 -0400</pav:createdOn>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812eda990003</pav:createdBy>
    <ao:context rdf:resource="urn:domeoclient:uuid:3DFC0290-B79C-492E-A5DB-32EF23C9B433"/>
    <pav:lastSavedOn>2014-07-24 19:43:34 -0400</pav:lastSavedOn>
    <pav:lineageUri>urn:domeoserver:annotation:A1618A56-31FE-4CA0-8501-AA51FFFC9A40</pav:lineageUri>
    <domeo:belongsToSet>urn:domeoclient:uuid:7DEB6848-E3C6-4761-8965-41F19EE5D781</domeo:belongsToSet>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <rdfs:label>Highlight</rdfs:label>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:DC34C3D8-C58F-483B-80DB-B65FEBB2EC20">
    <domeo:uuid>DC34C3D8-C58F-483B-80DB-B65FEBB2EC20</domeo:uuid>
    <ao:exact>Sildenafil </ao:exact>
    <pav:createdOn>2014-07-07 09:42:51 -0400</pav:createdOn>
    <ao:suffix>is cleared predominantly by the CYP3A (major route) and cytochrome P450 2C9 (CYP2C9, minor route) hepatic microsomal isoenzymes. The major circulating metabolite results from N-desmethylation of sildenafil, and is, itself, further metabolized. This metab</ao:suffix>
    <ao:prefix>xsd:String</ao:prefix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-155.txt.html</ao:hasSource>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:DC34C3D8-C58F-483B-80DB-B65FEBB2EC20"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <domeo:uuid></domeo:uuid>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/CEF2E7CC-61D6-42FF-A861-DCF099AE1E0C">
    <rdfs:label>Maalox®1</rdfs:label>
    <sio:SIO_000228>dikbD2R:precipitant-drug-of-interaction</sio:SIO_000228>
    <dct:description>Referred to the drug in the interaction.</dct:description>
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/</dailymed:activeMoietyRxCUI>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/drug-product"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:E785934B-232B-456F-A0C7-F28959E09129">
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812eda990003</pav:createdBy>
    <pav:createdOn>2014-07-24 19:37:23 -0400</pav:createdOn>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <domeo:belongsToSet>urn:domeoclient:uuid:079AA7B9-9BE4-4706-A20A-5848B50272B5</domeo:belongsToSet>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <pav:lineageUri>urn:domeoserver:annotation:104DADA8-D487-4A8B-A0D8-CC6F4317C2AA</pav:lineageUri>
    <ao:context rdf:resource="urn:domeoclient:uuid:5B787EC6-4A3E-44EC-8288-875426F19CB3"/>
    <rdfs:label>Highlight</rdfs:label>
    <pav:lastSavedOn>2014-07-24 19:37:34 -0400</pav:lastSavedOn>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:288BDA0B-5368-42DA-BCF5-4D9F229E72D5">
    <pav:lineageUri>urn:domeoserver:annotationset:D1715BD2-BD41-46FD-9454-DC7A423A29AC</pav:lineageUri>
    <pav:lineageUri>urn:domeoserver:annotation:2EADD83F-334B-4E69-9F8C-7FE5BFC027D4</pav:lineageUri>
    <rdfs:label>Highlight</rdfs:label>
    <pav:lastSavedOn>2014-09-02 11:46:59 -0400</pav:lastSavedOn>
    <domeo:belongsToSet>urn:domeoserver:annotationset:A3F0B39A-4249-4B63-BB0D-F24A005066AC</domeo:belongsToSet>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">2</pav:versionNumber>
    <pav:previousVersion>urn:domeoclient:uuid:BED41F06-565A-4622-9A88-48810E5A28DE</pav:previousVersion>
    <ao:context rdf:resource="urn:domeoclient:uuid:53840DD5-460C-4E7F-BA1C-65662E771309"/>
    <domeo:belongsToSet>urn:domeoserver:annotationset:A5DD001D-C81A-4E2E-B5E0-7A866B35E26B</domeo:belongsToSet>
    <pav:lastSavedOn>2014-09-02 11:46:58 -0400</pav:lastSavedOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <domeo:belongsToSet>urn:domeoserver:annotationset:3F546823-204F-4F9B-9006-3DC526C56931</domeo:belongsToSet>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812eda990003</pav:createdBy>
    <pav:createdOn>2014-09-02 11:44:26 -0400</pav:createdOn>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:A412DBFC-2FE0-43FA-A538-B84D822A5BFD">
    <ao:suffix>pharmacologic effects. In patients with pulmonary arterial hypertension, however, the ratio of the metabolite to sildenafil is higher. Both sildenafil and the active metabolite have terminal half-lives of about 4 hours.</ao:suffix>
    <ao:prefix>, so that the metabolite accounts for about 20% of </ao:prefix>
    <domeo:uuid>A412DBFC-2FE0-43FA-A538-B84D822A5BFD</domeo:uuid>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-155.txt.html</ao:hasSource>
    <ao:exact>sildenafil's </ao:exact>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:A412DBFC-2FE0-43FA-A538-B84D822A5BFD"/>
    <pav:createdOn>2014-07-07 09:44:07 -0400</pav:createdOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <domeo:uuid></domeo:uuid>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:FF969EAD-2CD7-4039-AD45-C2D98B79E3B0">
    <ao:context rdf:resource="urn:domeoclient:uuid:F2BC4367-94B2-4BA7-AAA4-DA34C58B02C3"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <rdfs:label>Highlight</rdfs:label>
    <pav:lineageUri>urn:domeoserver:annotation:CFC97B98-DBD4-41F9-A8AC-EE259873DFA7</pav:lineageUri>
    <domeo:belongsToSet>urn:domeoclient:uuid:B394B422-1AAF-4ED4-A3BB-3FB13E961EEA</domeo:belongsToSet>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812eda990003</pav:createdBy>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:createdOn>2014-07-21 21:28:35 -0400</pav:createdOn>
    <pav:lastSavedOn>2014-07-21 21:30:23 -0400</pav:lastSavedOn>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:8AA46BC0-EA66-4E73-81A9-6463BB4DE15B">
    <rdfs:label>Default Set</rdfs:label>
    <permissions:permissions rdf:nodeID="Nea72ce4021ff4644963864ea46bae207"/>
    <domeo:deleted>false</domeo:deleted>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#AnnotationSet"/>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <domeo:agents rdf:resource="urn:domeo:software:id:Domeo-2.1alpha-050"/>
    <dct:description>The default set is created automatically by Domeo when no other set is existing.</dct:description>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <ao:item rdf:resource="urn:domeoclient:uuid:5B9978DD-BF7E-4B48-BA74-826CB1EA9750"/>
    <domeo:agents rdf:resource="urn:person:uuid:080e143046812afe0146812eda990003"/>
    <pav:lastSavedOn>2014-07-24 19:54:28 -0400</pav:lastSavedOn>
    <pav:lineageUri>urn:domeoserver:annotationset:441C478A-130C-4F95-BEAE-9053E4BC0B6B</pav:lineageUri>
    <pav:createdOn>2014-07-24 19:54:37 -0400</pav:createdOn>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812eda990003</pav:createdBy>
    <ao:item rdf:resource="urn:domeoclient:uuid:D05E9B7E-AE50-4FCD-BC2D-B3A39CEF8396"/>
    <ao:annotatesResource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-133.txt.html</ao:annotatesResource>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:7B307336-ED36-40F6-8DED-B26488A43FD4">
    <domeo:belongsToSet>urn:domeoserver:annotationset:A5DD001D-C81A-4E2E-B5E0-7A866B35E26B</domeo:belongsToSet>
    <pav:lastSavedOn>2014-09-02 11:46:58 -0400</pav:lastSavedOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <domeo:belongsToSet>urn:domeoserver:annotationset:3F546823-204F-4F9B-9006-3DC526C56931</domeo:belongsToSet>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812eda990003</pav:createdBy>
    <ao:context rdf:resource="urn:domeoclient:uuid:C0ABFAEB-5A08-4B49-A2D0-716AA915DFF2"/>
    <pav:lineageUri>urn:domeoserver:annotationset:D1715BD2-BD41-46FD-9454-DC7A423A29AC</pav:lineageUri>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <rdfs:label>Highlight</rdfs:label>
    <pav:previousVersion>urn:domeoclient:uuid:BED41F06-565A-4622-9A88-48810E5A28DE</pav:previousVersion>
    <domeo:belongsToSet>urn:domeoserver:annotationset:A3F0B39A-4249-4B63-BB0D-F24A005066AC</domeo:belongsToSet>
    <pav:createdOn>2014-09-02 11:36:07 -0400</pav:createdOn>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">2</pav:versionNumber>
    <pav:lineageUri>urn:domeoserver:annotation:C958E05E-D9A2-4C9B-9140-743DE28CC4DB</pav:lineageUri>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/F1504F1A-B189-4B6A-9973-4A17775240C5">
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/679314</dailymed:activeMoietyRxCUI>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/active-ingredient"/>
    <dct:description>Referred to the drug in the interaction.</dct:description>
    <sio:SIO_000228>dikbD2R:precipitant-drug-of-interaction</sio:SIO_000228>
    <rdfs:label>9-hydroxyrisperidone</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:1D7C043D-E62F-4A5D-A912-AB586E95D811">
    <ao:body rdf:nodeID="Nd63715d19f2242479033a24abc4bc590"/>
    <rdfs:label>expertstudy Annotation</rdfs:label>
    <pav:createdOn>2014-07-21 21:55:12 -0400</pav:createdOn>
    <domeo:belongsToSet>urn:domeoclient:uuid:C988D053-7CF3-4C50-BDB6-7C2B20B837B9</domeo:belongsToSet>
    <pav:lineageUri>urn:domeoserver:annotation:F4651B13-0AD9-4F9A-BF93-E7DE774DF9D5</pav:lineageUri>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812eda990003</pav:createdBy>
    <ao:context rdf:resource="urn:domeoclient:uuid:93550871-2475-42C7-82BF-66ECE7117537"/>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#expertstudyAnnotation"/>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <pav:lastSavedOn>2014-07-21 21:55:00 -0400</pav:lastSavedOn>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:CFB0CA51-827C-4CBB-9914-266A69F0AB0B">
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812eda990003</pav:createdBy>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <ao:context rdf:resource="urn:domeoclient:uuid:C3406496-29A1-41A2-B195-BAD281E72E4B"/>
    <pav:lastSavedOn>2014-09-02 11:46:58 -0400</pav:lastSavedOn>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">2</pav:versionNumber>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <domeo:belongsToSet>urn:domeoserver:annotationset:A5DD001D-C81A-4E2E-B5E0-7A866B35E26B</domeo:belongsToSet>
    <domeo:belongsToSet>urn:domeoserver:annotationset:3F546823-204F-4F9B-9006-3DC526C56931</domeo:belongsToSet>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:previousVersion>urn:domeoclient:uuid:BED41F06-565A-4622-9A88-48810E5A28DE</pav:previousVersion>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:createdOn>2014-09-02 11:40:04 -0400</pav:createdOn>
    <pav:lineageUri>urn:domeoserver:annotationset:D1715BD2-BD41-46FD-9454-DC7A423A29AC</pav:lineageUri>
    <domeo:belongsToSet>urn:domeoserver:annotationset:A3F0B39A-4249-4B63-BB0D-F24A005066AC</domeo:belongsToSet>
    <pav:lineageUri>urn:domeoserver:annotation:B2BC2926-2921-435E-8A32-C810F32FFFE5</pav:lineageUri>
    <rdfs:label>Highlight</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:05CE82A3-E1C6-497A-B0B0-31DD508C02A1">
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812eda990003</pav:createdBy>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <ao:item rdf:resource="urn:domeoclient:uuid:346C2F84-FCE8-40ED-8A94-975E020C4F44"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:7E9300CC-A667-49A8-AD8F-115AE6705100"/>
    <rdfs:label>Default Set</rdfs:label>
    <domeo:agents rdf:resource="urn:person:uuid:080e143046812afe0146812eda990003"/>
    <pav:createdOn>2014-07-28 17:01:19 -0400</pav:createdOn>
    <domeo:agents rdf:resource="urn:domeo:software:id:Domeo-2.1alpha-050"/>
    <ao:annotatesResource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-165.txt.html</ao:annotatesResource>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <domeo:deleted>false</domeo:deleted>
    <ao:item rdf:resource="urn:domeoclient:uuid:46461303-C78E-4E52-94D7-0AB13BC2A0A5"/>
    <pav:lineageUri>urn:domeoserver:annotationset:223CD894-F008-4BE2-8498-33B3CB50DC37</pav:lineageUri>
    <dct:description>The default set is created automatically by Domeo when no other set is existing.</dct:description>
    <pav:lastSavedOn>2014-07-28 17:01:38 -0400</pav:lastSavedOn>
    <permissions:permissions rdf:nodeID="Nc242a3240d214e07aeb4e0d80b8d4d15"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#AnnotationSet"/>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:6341241A-9991-4CE8-B771-4A2513B1FF21">
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-17.txt.html</ao:hasSource>
    <domeo:uuid>6341241A-9991-4CE8-B771-4A2513B1FF21</domeo:uuid>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:6341241A-9991-4CE8-B771-4A2513B1FF21"/>
    <pav:createdOn>2014-09-01 15:59:54 -0400</pav:createdOn>
    <ao:suffix>following an intravenous 1000 mg dose. Sertraline administration did not noticeably change either the plasma protein binding or the apparent volume of distribution of tolbutamide, suggesting that the decreased clearance was due to a change in the metabol</ao:suffix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:exact>tolbutamide </ao:exact>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:prefix>for 22 days (including 200 mg/day for the final 13 days) caused a statistically significant 16% decrease from baseline in the clearance of </ao:prefix>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:D519A3CD-A32C-4057-9BB6-FB2AE41AF4A9">
    <domeo:belongsToSet>urn:domeoserver:annotationset:F272A789-69D0-47CC-8CC9-F25C55B91261</domeo:belongsToSet>
    <ao:body rdf:nodeID="Na03f780a531743b3a9322c7223f7d56b"/>
    <ao:body rdf:nodeID="Nb0311d351487462b93a8cfede91ef33e"/>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:lineageUri>urn:domeoserver:annotation:22BB03C8-9C5D-4099-B844-B1E24ACB4002</pav:lineageUri>
    <pav:previousVersion>urn:domeoserver:annotationset:606A5B3F-B6FB-4279-AA42-7893CFC2D20C</pav:previousVersion>
    <pav:lineageUri>urn:domeoserver:annotationset:AB1741F1-5A5F-4416-AEAC-A544BCBB7D16</pav:lineageUri>
    <domeo:belongsToSet>urn:domeoserver:annotationset:2914A3FD-DF43-4F78-999C-77CE7A028B19</domeo:belongsToSet>
    <rdfs:label>expertstudy Annotation</rdfs:label>
    <pav:lastSavedOn>2014-07-22 19:54:59 -0400</pav:lastSavedOn>
    <ao:context rdf:resource="urn:domeoclient:uuid:EC0A22A6-E91A-4E15-A935-E1021555864A"/>
    <pav:createdOn>2014-07-22 19:53:02 -0400</pav:createdOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#expertstudyAnnotation"/>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">7</pav:versionNumber>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812eda990003</pav:createdBy>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:9C2BE5C7-01F4-4E29-A201-893A98F5268A">
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <domeo:uuid>9C2BE5C7-01F4-4E29-A201-893A98F5268A</domeo:uuid>
    <ao:prefix> and its metabolites. </ao:prefix>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-128.txt.html</ao:hasSource>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:exact>Diazepam</ao:exact>
    <pav:createdOn>2014-07-24 19:44:20 -0400</pav:createdOn>
    <ao:suffix> does not alter the pharmacokinetics of propranolol.</ao:suffix>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:9C2BE5C7-01F4-4E29-A201-893A98F5268A"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:FBE8BF3F-CF31-4746-AE08-52B8B70D3AA7">
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:lineageUri>urn:domeoserver:annotation:CDC56775-8CE3-4236-9491-8D6ED0DF41DD</pav:lineageUri>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812eda990003</pav:createdBy>
    <domeo:belongsToSet>urn:domeoserver:annotationset:2914A3FD-DF43-4F78-999C-77CE7A028B19</domeo:belongsToSet>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <ao:context rdf:resource="urn:domeoclient:uuid:97D1DB41-3631-4DF4-AC28-E9932F707785"/>
    <domeo:belongsToSet>urn:domeoserver:annotationset:F272A789-69D0-47CC-8CC9-F25C55B91261</domeo:belongsToSet>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <pav:lineageUri>urn:domeoserver:annotationset:AB1741F1-5A5F-4416-AEAC-A544BCBB7D16</pav:lineageUri>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <rdfs:label>Highlight</rdfs:label>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">7</pav:versionNumber>
    <pav:createdOn>2014-07-22 19:50:12 -0400</pav:createdOn>
    <pav:previousVersion>urn:domeoserver:annotationset:606A5B3F-B6FB-4279-AA42-7893CFC2D20C</pav:previousVersion>
    <pav:lastSavedOn>2014-07-22 19:54:59 -0400</pav:lastSavedOn>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:FCDCF22B-9687-4394-9D96-2255CE012E2D">
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:lastSavedOn>2014-07-22 20:22:38 -0400</pav:lastSavedOn>
    <pav:createdOn>2014-07-22 20:17:43 -0400</pav:createdOn>
    <pav:lineageUri>urn:domeoserver:annotation:84B7AD13-E987-4309-B765-FB5115098E4A</pav:lineageUri>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812eda990003</pav:createdBy>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <ao:context rdf:resource="urn:domeoclient:uuid:1C14E39F-8619-4318-B524-D5D59AE2A868"/>
    <domeo:belongsToSet>urn:domeoserver:annotationset:F272A789-69D0-47CC-8CC9-F25C55B91261</domeo:belongsToSet>
    <rdfs:label>Highlight</rdfs:label>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:previousVersion>xsd:String</pav:previousVersion>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:71CADA90-E1E5-4B50-9394-FDFC0B1512B0">
    <ao:item rdf:resource="urn:domeoclient:uuid:390CA5FE-7939-4F69-B612-7F5C21A06481"/>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <domeo:agents rdf:resource="urn:person:uuid:080e143046812afe0146812eda990003"/>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <ao:annotatesResource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-4.txt.html</ao:annotatesResource>
    <permissions:permissions rdf:nodeID="N6374cce4c5da4eb7bc6dcaac29aa8f8a"/>
    <rdfs:label>Default Set</rdfs:label>
    <pav:lineageUri>urn:domeoserver:annotationset:BA49274C-11BD-499C-B6F3-8E9B55B40E77</pav:lineageUri>
    <dct:description>The default set is created automatically by Domeo when no other set is existing.</dct:description>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <domeo:deleted>false</domeo:deleted>
    <pav:createdOn>2014-07-13 11:02:05 -0400</pav:createdOn>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812eda990003</pav:createdBy>
    <domeo:agents rdf:resource="urn:domeo:software:id:Domeo-2.1alpha-050"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#AnnotationSet"/>
    <pav:lastSavedOn>2014-07-13 11:02:33 -0400</pav:lastSavedOn>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:CDE42D33-6312-4DF8-AF70-310C20268892">
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-74.txt.html</ao:hasSource>
    <ao:prefix>, and </ao:prefix>
    <ao:exact>warfarin</ao:exact>
    <pav:createdOn>2014-09-02 19:12:46 -0400</pav:createdOn>
    <ao:suffix> concomitantly. Increases in INR and prothrombin time may lead to abnormal bleeding and even death. Patients treated with proton pump inhibitors and warfarin may need to be monitored for increases in INR and prothrombin time.</ao:suffix>
    <domeo:uuid>CDE42D33-6312-4DF8-AF70-310C20268892</domeo:uuid>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:CDE42D33-6312-4DF8-AF70-310C20268892"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:CA91EE4A-7D39-4CC0-A25E-E5ACA358E916">
    <pav:createdOn>2014-09-02 11:38:37 -0400</pav:createdOn>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:lineageUri>urn:domeoserver:annotationset:D1715BD2-BD41-46FD-9454-DC7A423A29AC</pav:lineageUri>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">2</pav:versionNumber>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812eda990003</pav:createdBy>
    <domeo:belongsToSet>urn:domeoserver:annotationset:A3F0B39A-4249-4B63-BB0D-F24A005066AC</domeo:belongsToSet>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:lastSavedOn>2014-09-02 11:46:58 -0400</pav:lastSavedOn>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <domeo:belongsToSet>urn:domeoserver:annotationset:3F546823-204F-4F9B-9006-3DC526C56931</domeo:belongsToSet>
    <pav:previousVersion>urn:domeoclient:uuid:BED41F06-565A-4622-9A88-48810E5A28DE</pav:previousVersion>
    <pav:lineageUri>urn:domeoserver:annotation:4A8F445A-92CD-4EC7-96C2-8B9097AFBE12</pav:lineageUri>
    <domeo:belongsToSet>urn:domeoserver:annotationset:A5DD001D-C81A-4E2E-B5E0-7A866B35E26B</domeo:belongsToSet>
    <ao:context rdf:resource="urn:domeoclient:uuid:70E63C27-77CA-4EFB-9B3F-9125C608F260"/>
    <rdfs:label>Highlight</rdfs:label>
    <pav:previousVersion>xsd:String</pav:previousVersion>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoserver:annotationset:514BA51B-D734-4003-A7C3-F03C0F95833A">
    <ao:item rdf:resource="urn:domeoclient:uuid:F895E903-9E93-41BD-BED1-2EA2CE628B45"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#AnnotationSet"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:37E9FF1C-D06E-42C3-944C-482813D8E38E"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:EF32B76C-C252-4DA7-9AC6-7FCD32EE9F83"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:AF68257F-3ADB-4BA4-9BD1-247F8428319E"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:6981279A-8AEC-4DEB-BDFB-296A4FDF471C"/>
    <pav:lastSavedOn>2014-07-22 19:40:31 -0400</pav:lastSavedOn>
    <ao:item rdf:resource="urn:domeoclient:uuid:D555EE88-9218-4AF9-81CC-40D543746D77"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:6A67B256-CA48-48CA-B584-DB13E0D52B58"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:51F1BD01-1111-4CA2-BC77-65762E0E45AA"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:4411E759-9248-468B-B2F6-E5A5A8657C4C"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:2506F4F5-773E-4CCD-8303-CC244D5848D1"/>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812eda990003</pav:createdBy>
    <ao:item rdf:resource="urn:domeoclient:uuid:292BF8EC-0E65-4E33-A331-3D217DD6B134"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:851EB41C-687B-464B-9105-16513BFE3A24"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:D1F55052-16DF-4B25-AC16-7645C8E4AD77"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:C4558C3C-CC16-4A44-85EC-2AB4969F8A0D"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:796FE422-C147-4AA7-A57F-067429194AA4"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:52B64BE2-7636-4E5D-B162-D84F2D892E3D"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:44D9A897-A866-42BB-8DD9-A376BF8D1B3E"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:5C47D157-D8A4-4053-B2C7-7ECD1B16B721"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:513FF3F1-4FCE-4790-A5C9-F75162D3687B"/>
    <domeo:agents rdf:resource="urn:person:uuid:080e143046812afe0146812eda990003"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:0A960BCB-9A9F-4998-9418-33D622C35F7C"/>
    <pav:lineageUri>urn:domeoserver:annotationset:AB1741F1-5A5F-4416-AEAC-A544BCBB7D16</pav:lineageUri>
    <pav:previousVersion>urn:domeoserver:annotationset:7021B883-FD5C-4083-BD87-DF56D3C87633</pav:previousVersion>
    <ao:item rdf:resource="urn:domeoclient:uuid:2BB40EDC-DE0E-4B5E-AEE3-DCE89148115F"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:5CE56B1D-ACF0-4124-B31E-62EF1E11FED8"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:2D0A6C88-E510-4AF5-8DFB-C35B1F919461"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:FF1FC131-57E9-4A89-8FBF-B786D1543F24"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:9C9FE015-E10A-4124-9250-BA73B7E52470"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:78A5F631-80CE-4FB1-974D-F82BE8D8E584"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:B6681C81-EA03-49F0-8187-EF5752C9D126"/>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">5</pav:versionNumber>
    <ao:item rdf:resource="urn:domeoclient:uuid:D693BC09-DDB8-454B-A812-E73AB798F6FA"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:15E1712B-2693-4DB6-A2FE-D2F158D3A823"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:8C53D58B-D2A3-4A8C-9924-E26E43A59105"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:5E8A53CD-1A4A-4A56-ABAA-82D073884595"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:E2D1A706-CE7E-4379-97CF-4EE9CA384DB2"/>
    <dct:description>The default set is created automatically by Domeo when no other set is existing.</dct:description>
    <ao:item rdf:resource="urn:domeoclient:uuid:ED9A4881-5A44-4C07-BAFB-529340D632F3"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:3E33C30E-6EC7-463F-A8C1-B699338A149B"/>
    <domeo:deleted>false</domeo:deleted>
    <ao:item rdf:resource="urn:domeoclient:uuid:3077386C-E136-4431-9DB1-FC99BF18719B"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:AA680547-50B2-43E1-8768-6007654CDEF9"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:15050075-436C-4668-9987-03D689AE2236"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:424F0823-B0B8-4327-8A43-69119A2195AC"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:71244950-C950-47EB-A32B-D2748E51EF60"/>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <ao:item rdf:resource="urn:domeoclient:uuid:B1EDC65E-7D2E-4E9E-9D08-0D72BD366C29"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:7616318E-C362-4BC0-B027-F84CBEA6207C"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:FA96F07E-C088-44C7-AC16-D0EBD7DBD41D"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:F2F7D256-D331-45B3-9459-089EEB530262"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:08556835-0438-4667-8B70-71388FA5E865"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:23AC6809-BABB-405A-80DE-630CA211B109"/>
    <permissions:permissions rdf:nodeID="Nf33676a225644d7f86722ec2a00d93d4"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:414AB21B-E61F-45BC-90CC-D10C8E784BF6"/>
    <domeo:agents rdf:resource="urn:domeo:software:id:Domeo-2.1alpha-050"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:A68BF389-96D4-4F16-BF9D-C1BF35E3CE01"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:B28EDC18-743D-4015-956F-B084F96B3589"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:585BED0D-5182-4D39-912D-F355B5BEA6BA"/>
    <rdfs:label>Default Set</rdfs:label>
    <ao:item rdf:resource="urn:domeoclient:uuid:544614C5-3057-4129-841C-95DBCD1340A4"/>
    <ao:annotatesResource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-123.txt.html</ao:annotatesResource>
    <ao:item rdf:resource="urn:domeoclient:uuid:3D0D19A7-AA2E-4F5C-86E6-0B171A00A7B1"/>
    <pav:createdOn>2014-07-22 19:08:44 -0400</pav:createdOn>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:EEA0DB9F-24A6-4283-B426-FDECA24BE603">
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-8.txt.html</ao:hasSource>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:prefix> plus </ao:prefix>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:EEA0DB9F-24A6-4283-B426-FDECA24BE603"/>
    <domeo:uuid>EEA0DB9F-24A6-4283-B426-FDECA24BE603</domeo:uuid>
    <ao:exact>9-hydroxyrisperidone</ao:exact>
    <ao:suffix>.</ao:suffix>
    <pav:createdOn>2014-07-13 11:12:34 -0400</pav:createdOn>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:82B114B4-DF8C-4358-AB9B-8EBA4957BC3F">
    <ao:prefix> AUC and Cmax slightly increased following coadministration of </ao:prefix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:82B114B4-DF8C-4358-AB9B-8EBA4957BC3F"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:exact>AVANDIA</ao:exact>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-123.txt.html</ao:hasSource>
    <domeo:uuid>82B114B4-DF8C-4358-AB9B-8EBA4957BC3F</domeo:uuid>
    <ao:suffix>.</ao:suffix>
    <pav:createdOn>2014-07-22 19:50:53 -0400</pav:createdOn>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:441651E7-B4B0-4FA2-BDD8-3B5B7B207EE2">
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <domeo:uuid>441651E7-B4B0-4FA2-BDD8-3B5B7B207EE2</domeo:uuid>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-155.txt.html</ao:hasSource>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:441651E7-B4B0-4FA2-BDD8-3B5B7B207EE2"/>
    <ao:suffix>-5 (PDE5) in the smooth muscle of the pulmonary vasculature, where PDE5 is responsible for degradation of cGMP. Sildenafil, therefore, increases cGMP within pulmonary vascular smooth muscle cells resulting in relaxation. In patients with pulmonary hypert</ao:suffix>
    <ao:exact>type</ao:exact>
    <pav:createdOn>2014-07-07 09:34:22 -0400</pav:createdOn>
    <ao:prefix>xsd:String</ao:prefix>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/B4FD0768-DC29-42AD-9E32-079005955FF6">
    <dct:description>Referred to the drug in the interaction.</dct:description>
    <sio:SIO_000228>dikbD2R:precipitant-drug-of-interaction</sio:SIO_000228>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/active-ingredient"/>
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/42355</dailymed:activeMoietyRxCUI>
    <rdfs:label>fluvoxamine</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:9E010F58-AD7C-435C-B2DC-0F81F34B978E">
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#expertstudyAnnotation"/>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812eda990003</pav:createdBy>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <ao:context rdf:resource="urn:domeoclient:uuid:CF3DBDD7-1816-4E91-BF27-7D21BEF67A06"/>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <ao:body rdf:nodeID="N4e15a828729e4ee2adbac01643ade321"/>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <domeo:belongsToSet>urn:domeoserver:annotationset:131835A3-C655-4F91-97D4-52CAFF7B7CCA</domeo:belongsToSet>
    <pav:createdOn>2014-07-07 11:37:21 -0400</pav:createdOn>
    <rdfs:label>expertstudy Annotation</rdfs:label>
    <pav:lineageUri>urn:domeoserver:annotation:6AED9017-2775-4A23-915C-FCB7842E4D54</pav:lineageUri>
    <pav:lastSavedOn>2014-07-07 11:37:25 -0400</pav:lastSavedOn>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:D6127232-F0FF-46A9-830F-67E3832E779A">
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812eda990003</pav:createdBy>
    <pav:lastSavedOn>2014-09-02 15:08:18 -0400</pav:lastSavedOn>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <ao:context rdf:resource="urn:domeoclient:uuid:41C681E8-1D19-42FD-B50F-1189BEEA2B54"/>
    <pav:lineageUri>urn:domeoserver:annotation:E40335DD-BC65-49CD-BC0F-8BBE782D757E</pav:lineageUri>
    <domeo:belongsToSet>urn:domeoclient:uuid:C4E518E3-AA88-46AF-85A6-8C02ABD7AB1D</domeo:belongsToSet>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <rdfs:label>Highlight</rdfs:label>
    <pav:createdOn>2014-09-02 15:08:17 -0400</pav:createdOn>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:643A5ED0-8507-40E4-BF8F-798721470D41">
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-123.txt.html</ao:hasSource>
    <domeo:uuid>643A5ED0-8507-40E4-BF8F-798721470D41</domeo:uuid>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <pav:createdOn>2014-07-22 19:28:08 -0400</pav:createdOn>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:643A5ED0-8507-40E4-BF8F-798721470D41"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:suffix>.</ao:suffix>
    <ao:prefix>e N-demethylation and hydroxylation, followed by conjugation with sulfate and glucuronic acid. All the circulating metabolites are considerably less potent than parent and, therefore, are not expected to contribute to the insulin-sensitizing activity of </ao:prefix>
    <ao:exact>rosiglitazone</ao:exact>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:2EC8E075-F7E3-4259-A656-99D292E9F0A4">
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812eda990003</pav:createdBy>
    <domeo:belongsToSet>urn:domeoclient:uuid:71191E51-53CB-4FDE-88D0-33C6818E2232</domeo:belongsToSet>
    <pav:lastSavedOn>2014-07-13 11:32:29 -0400</pav:lastSavedOn>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <ao:context rdf:resource="urn:domeoclient:uuid:0124DF91-B793-47E7-9547-2BF080146FA7"/>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <pav:createdOn>2014-07-13 11:12:20 -0400</pav:createdOn>
    <pav:lineageUri>urn:domeoserver:annotation:6A45E1E3-7270-4950-9185-AED9AF04A2E4</pav:lineageUri>
    <rdfs:label>Highlight</rdfs:label>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:0F95BD67-87EE-4AA9-A33E-A0BCF7921FF0">
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <domeo:uuid>0F95BD67-87EE-4AA9-A33E-A0BCF7921FF0</domeo:uuid>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:prefix> after 15 days of </ao:prefix>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-24.txt.html</ao:hasSource>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:0F95BD67-87EE-4AA9-A33E-A0BCF7921FF0"/>
    <ao:exact>rifampin</ao:exact>
    <ao:suffix> administered as 600 mg daily in eight healthy male volunteers resulted in a significant decrease in fluconazole AUC and a significant increase in apparent oral clearance of fluconazole. There was a mean ± SD reduction in fluconazole AUC of 23% ± 9% (ran</ao:suffix>
    <pav:createdOn>2014-07-13 12:56:00 -0400</pav:createdOn>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:E19B0AE6-FB85-4E0D-AC07-7E22C589DC36">
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-118.txt.html</ao:hasSource>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <domeo:uuid>E19B0AE6-FB85-4E0D-AC07-7E22C589DC36</domeo:uuid>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:E19B0AE6-FB85-4E0D-AC07-7E22C589DC36"/>
    <ao:prefix> and </ao:prefix>
    <ao:exact>midazolam</ao:exact>
    <pav:createdOn>2014-07-22 18:44:54 -0400</pav:createdOn>
    <ao:suffix>, respectively.</ao:suffix>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:9F3CA373-B79A-4B2D-8C96-BFB67CB4B175">
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812eda990003</pav:createdBy>
    <pav:lineageUri>urn:domeoserver:annotation:6784E1B8-4746-4B76-AE23-2ACB7CBA8ADF</pav:lineageUri>
    <pav:lastSavedOn>2014-07-13 11:32:29 -0400</pav:lastSavedOn>
    <domeo:belongsToSet>urn:domeoclient:uuid:71191E51-53CB-4FDE-88D0-33C6818E2232</domeo:belongsToSet>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <pav:createdOn>2014-07-13 11:16:05 -0400</pav:createdOn>
    <rdfs:label>Highlight</rdfs:label>
    <ao:context rdf:resource="urn:domeoclient:uuid:612855C1-32AF-48C7-A341-A649DD897808"/>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:67D24023-38AB-4DC8-B710-B1EC8B3A147D">
    <pav:createdOn>2014-09-01 16:06:16 -0400</pav:createdOn>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812eda990003</pav:createdBy>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <domeo:belongsToSet>urn:domeoclient:uuid:A84DE8F6-26B7-471D-8309-4E7CC2994FDF</domeo:belongsToSet>
    <pav:lineageUri>urn:domeoserver:annotation:04FACAFC-E89E-4116-BE1F-60034A71727A</pav:lineageUri>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:lastSavedOn>2014-09-01 16:06:18 -0400</pav:lastSavedOn>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <rdfs:label>Highlight</rdfs:label>
    <ao:context rdf:resource="urn:domeoclient:uuid:88D0CD7F-7AEE-47DB-9F13-A8F5D6A36CAB"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:1FEAE882-CD22-4693-8DC0-495CC155160B">
    <ao:suffix> has been reported to potentiate the anticoagulant effect of warfarin and other oral coumarin anticoagulants, resulting in a prolongation of prothrombin time. This possible drug interaction should be considered when FLAGYL (metronidazole) is prescribed f</ao:suffix>
    <pav:createdOn>2014-07-22 18:58:19 -0400</pav:createdOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:1FEAE882-CD22-4693-8DC0-495CC155160B"/>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-120.txt.html</ao:hasSource>
    <ao:exact>Metronidazole</ao:exact>
    <ao:prefix>xsd:String</ao:prefix>
    <domeo:uuid>1FEAE882-CD22-4693-8DC0-495CC155160B</domeo:uuid>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:65F441ED-AF61-4AE3-8365-8ABE9FA557A2">
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-9.txt.html</ao:hasSource>
    <domeo:uuid>65F441ED-AF61-4AE3-8365-8ABE9FA557A2</domeo:uuid>
    <pav:createdOn>2014-09-02 11:35:56 -0400</pav:createdOn>
    <ao:exact>fluvoxamine</ao:exact>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:65F441ED-AF61-4AE3-8365-8ABE9FA557A2"/>
    <ao:suffix> interaction is possible with drugs having a narrow therapeutic ratio such as pimozide, warfarin, theophylline, certain benzodiazepines, omeprazole and phenytoin. If fluvoxamine maleate tablets are to be administered together with a drug that is eliminat</ao:suffix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:prefix>A clinically significant </ao:prefix>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:52B64BE2-7636-4E5D-B162-D84F2D892E3D">
    <domeo:belongsToSet>urn:domeoserver:annotationset:2914A3FD-DF43-4F78-999C-77CE7A028B19</domeo:belongsToSet>
    <pav:lineageUri>urn:domeoserver:annotation:9AC5A3D6-30AF-4FFD-9020-3C60BDEA7CA8</pav:lineageUri>
    <domeo:belongsToSet>urn:domeoserver:annotationset:514BA51B-D734-4003-A7C3-F03C0F95833A</domeo:belongsToSet>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:lineageUri>urn:domeoserver:annotationset:AB1741F1-5A5F-4416-AEAC-A544BCBB7D16</pav:lineageUri>
    <domeo:belongsToSet>urn:domeoserver:annotationset:F272A789-69D0-47CC-8CC9-F25C55B91261</domeo:belongsToSet>
    <pav:createdOn>2014-07-22 19:31:27 -0400</pav:createdOn>
    <ao:context rdf:resource="urn:domeoclient:uuid:DCEF4B50-19DE-4DDE-ADB0-22E897CE8FC1"/>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812eda990003</pav:createdBy>
    <rdfs:label>Highlight</rdfs:label>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">4</pav:versionNumber>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:previousVersion>urn:domeoserver:annotationset:7E80543E-BF76-4514-92A9-91458DCB802B</pav:previousVersion>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <domeo:belongsToSet>urn:domeoserver:annotationset:7021B883-FD5C-4083-BD87-DF56D3C87633</domeo:belongsToSet>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:lastSavedOn>2014-07-22 19:35:16 -0400</pav:lastSavedOn>
    <domeo:belongsToSet>urn:domeoserver:annotationset:606A5B3F-B6FB-4279-AA42-7893CFC2D20C</domeo:belongsToSet>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:9D9E07C8-AA4D-4D08-897A-996E5C499CF6">
    <domeo:belongsToSet>urn:domeoserver:annotationset:F272A789-69D0-47CC-8CC9-F25C55B91261</domeo:belongsToSet>
    <ao:context rdf:resource="urn:domeoclient:uuid:797E523C-94FC-4569-A544-1F1C2179E9C1"/>
    <pav:lineageUri>urn:domeoserver:annotationset:AB1741F1-5A5F-4416-AEAC-A544BCBB7D16</pav:lineageUri>
    <rdfs:label>Highlight</rdfs:label>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:previousVersion>urn:domeoserver:annotationset:606A5B3F-B6FB-4279-AA42-7893CFC2D20C</pav:previousVersion>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <domeo:belongsToSet>urn:domeoserver:annotationset:2914A3FD-DF43-4F78-999C-77CE7A028B19</domeo:belongsToSet>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812eda990003</pav:createdBy>
    <pav:lineageUri>urn:domeoserver:annotation:E79DCBD9-C965-4A7F-9C9E-AA333D325DB3</pav:lineageUri>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">7</pav:versionNumber>
    <pav:lastSavedOn>2014-07-22 19:54:59 -0400</pav:lastSavedOn>
    <pav:createdOn>2014-07-22 19:49:34 -0400</pav:createdOn>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:43D41023-3393-411C-B3B2-FDFDACB25B35">
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <domeo:belongsToSet>urn:domeoserver:annotationset:A3F0B39A-4249-4B63-BB0D-F24A005066AC</domeo:belongsToSet>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812eda990003</pav:createdBy>
    <domeo:belongsToSet>urn:domeoclient:uuid:BED41F06-565A-4622-9A88-48810E5A28DE</domeo:belongsToSet>
    <pav:createdOn>2014-09-02 11:30:03 -0400</pav:createdOn>
    <pav:lastSavedOn>2014-09-02 11:35:33 -0400</pav:lastSavedOn>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:lineageUri>urn:domeoserver:annotation:A6CB480B-9EA3-46EC-AB2B-03C43BF4B3D7</pav:lineageUri>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <domeo:belongsToSet>urn:domeoserver:annotationset:3F546823-204F-4F9B-9006-3DC526C56931</domeo:belongsToSet>
    <pav:lineageUri>urn:domeoserver:annotationset:D1715BD2-BD41-46FD-9454-DC7A423A29AC</pav:lineageUri>
    <rdfs:label>Highlight</rdfs:label>
    <domeo:belongsToSet>urn:domeoserver:annotationset:A5DD001D-C81A-4E2E-B5E0-7A866B35E26B</domeo:belongsToSet>
    <ao:context rdf:resource="urn:domeoclient:uuid:D47C4E1D-3FAD-4BB4-842A-3B71726A722C"/>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:7D37CC60-618E-46B6-8C99-BA7D598E3762">
    <domeo:belongsToSet>urn:domeoserver:annotationset:8F3CF3D9-AADE-4A86-BD42-2924B3D6A406</domeo:belongsToSet>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:createdOn>2014-07-07 11:23:40 -0400</pav:createdOn>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <domeo:belongsToSet>urn:domeoserver:annotationset:22ED7220-C6F6-43C5-9DF9-89F62F0F8E27</domeo:belongsToSet>
    <domeo:belongsToSet>urn:domeoserver:annotationset:131835A3-C655-4F91-97D4-52CAFF7B7CCA</domeo:belongsToSet>
    <rdfs:label>Highlight</rdfs:label>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812eda990003</pav:createdBy>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <ao:context rdf:resource="urn:domeoclient:uuid:ECF8E578-9A91-41E0-91AC-502E097E5A11"/>
    <pav:lastSavedOn>2014-07-07 11:24:52 -0400</pav:lastSavedOn>
    <domeo:belongsToSet>urn:domeoserver:annotationset:7AACEF8D-2EBC-4F0B-94B2-190650E562F6</domeo:belongsToSet>
    <pav:lineageUri>urn:domeoserver:annotation:DDCCCF49-E95D-4DE0-8F83-128C04E4F1DB</pav:lineageUri>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:92530361-A562-40CE-942A-CC181EBE7AD7">
    <pav:lineageUri>urn:domeoserver:annotation:FB9B5330-BB9D-4DA0-8780-703069BE2890</pav:lineageUri>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <rdfs:label>Highlight</rdfs:label>
    <domeo:belongsToSet>urn:domeoclient:uuid:6A05795B-B1AB-4DB3-A12F-2765CBCC2FED</domeo:belongsToSet>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:lastSavedOn>2014-07-13 12:34:42 -0400</pav:lastSavedOn>
    <ao:context rdf:resource="urn:domeoclient:uuid:A22D7450-FC77-45A4-B835-3948870AD344"/>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812eda990003</pav:createdBy>
    <pav:createdOn>2014-07-13 12:34:35 -0400</pav:createdOn>
  </rdf:Description>
  <rdf:Description rdf:nodeID="Na838bc0083a74d209cd0d61f1de80f7f">
    <permissions:accessType>urn:domeo:access:public</permissions:accessType>
    <permissions:isLocked>false</permissions:isLocked>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:8EE2A094-F107-44EE-921E-0C729A88F5DB">
    <domeo:belongsToSet>urn:domeoserver:annotationset:A5DD001D-C81A-4E2E-B5E0-7A866B35E26B</domeo:belongsToSet>
    <pav:lastSavedOn>2014-09-02 11:46:58 -0400</pav:lastSavedOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <domeo:belongsToSet>urn:domeoserver:annotationset:3F546823-204F-4F9B-9006-3DC526C56931</domeo:belongsToSet>
    <pav:createdOn>2014-09-02 11:46:12 -0400</pav:createdOn>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812eda990003</pav:createdBy>
    <pav:lineageUri>urn:domeoserver:annotationset:D1715BD2-BD41-46FD-9454-DC7A423A29AC</pav:lineageUri>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <rdfs:label>Highlight</rdfs:label>
    <pav:lineageUri>urn:domeoserver:annotation:8CEFD738-FFAC-4544-ADA0-D3EA65700638</pav:lineageUri>
    <pav:previousVersion>urn:domeoclient:uuid:BED41F06-565A-4622-9A88-48810E5A28DE</pav:previousVersion>
    <domeo:belongsToSet>urn:domeoserver:annotationset:A3F0B39A-4249-4B63-BB0D-F24A005066AC</domeo:belongsToSet>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:lastSavedOn>2014-09-02 11:46:59 -0400</pav:lastSavedOn>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">2</pav:versionNumber>
    <ao:context rdf:resource="urn:domeoclient:uuid:02AA319D-AB4A-42F1-B73D-EF0CC9D22427"/>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/77D06206-6695-47A2-961A-30BA8D501FA5">
    <sio:SIO_000228>dikbD2R:object-drug-of-interaction</sio:SIO_000228>
    <dct:description>Referred to the drug in the interaction.</dct:description>
    <rdfs:label>rosiglitazone</rdfs:label>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/active-ingredient"/>
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/84108</dailymed:activeMoietyRxCUI>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:6FD9D48D-F639-4F09-ABA6-F4B259681453">
    <pav:createdOn>2014-07-07 09:59:10 -0400</pav:createdOn>
    <domeo:belongsToSet>urn:domeoserver:annotationset:7AACEF8D-2EBC-4F0B-94B2-190650E562F6</domeo:belongsToSet>
    <rdfs:label>Highlight</rdfs:label>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <domeo:belongsToSet>urn:domeoserver:annotationset:08C0C288-6DF4-43E6-A618-71A8BB9563C3</domeo:belongsToSet>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <pav:lineageUri>urn:domeoserver:annotation:BCAC0F86-EF1B-48A6-B71C-46750D478032</pav:lineageUri>
    <ao:context rdf:resource="urn:domeoclient:uuid:50649F2A-1F77-4AC3-AA05-9C465AAF3D79"/>
    <domeo:belongsToSet>urn:domeoserver:annotationset:22ED7220-C6F6-43C5-9DF9-89F62F0F8E27</domeo:belongsToSet>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812eda990003</pav:createdBy>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <domeo:belongsToSet>urn:domeoserver:annotationset:8F3CF3D9-AADE-4A86-BD42-2924B3D6A406</domeo:belongsToSet>
    <pav:lastSavedOn>2014-07-07 10:02:41 -0400</pav:lastSavedOn>
    <domeo:belongsToSet>urn:domeoserver:annotationset:131835A3-C655-4F91-97D4-52CAFF7B7CCA</domeo:belongsToSet>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:ECF8E578-9A91-41E0-91AC-502E097E5A11">
    <ao:suffix>administration.</ao:suffix>
    <domeo:uuid></domeo:uuid>
    <pav:createdOn>2014-07-07 11:23:40 -0400</pav:createdOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:exact>sildenafil </ao:exact>
    <domeo:uuid>ECF8E578-9A91-41E0-91AC-502E097E5A11</domeo:uuid>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-155.txt.html</ao:hasSource>
    <ao:prefix>Injection: Predictions based on a pharmacokinetic model suggest that drug-drug interactions with CYP3A inhibitors will be less than those observed after oral </ao:prefix>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:ECF8E578-9A91-41E0-91AC-502E097E5A11"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:D6854021-6829-4D54-8ADE-ADC84C0AF5B8">
    <ao:exact>carbamazepine</ao:exact>
    <pav:createdOn>2014-09-01 16:05:57 -0400</pav:createdOn>
    <domeo:uuid>D6854021-6829-4D54-8ADE-ADC84C0AF5B8</domeo:uuid>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:suffix>, or cisapride under steady-state conditions. The results of these studies indicated that sertraline did not increase plasma concentrations of terfenadine, carbamazepine, or cisapride. These data indicate that sertraline’s extent of inhibition of P450 3A</ao:suffix>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-16.txt.html</ao:hasSource>
    <ao:prefix>, </ao:prefix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:D6854021-6829-4D54-8ADE-ADC84C0AF5B8"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:E3C70535-C49A-4807-84DF-3951A0E27152">
    <pav:lineageUri>urn:domeoserver:annotation:10E6A863-79D8-4D43-8EE8-49854FE0771C</pav:lineageUri>
    <rdfs:label>Highlight</rdfs:label>
    <domeo:belongsToSet>urn:domeoserver:annotationset:F272A789-69D0-47CC-8CC9-F25C55B91261</domeo:belongsToSet>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:lastSavedOn>2014-07-22 19:54:59 -0400</pav:lastSavedOn>
    <pav:lineageUri>urn:domeoserver:annotationset:AB1741F1-5A5F-4416-AEAC-A544BCBB7D16</pav:lineageUri>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">7</pav:versionNumber>
    <pav:previousVersion>urn:domeoserver:annotationset:606A5B3F-B6FB-4279-AA42-7893CFC2D20C</pav:previousVersion>
    <domeo:belongsToSet>urn:domeoserver:annotationset:2914A3FD-DF43-4F78-999C-77CE7A028B19</domeo:belongsToSet>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812eda990003</pav:createdBy>
    <ao:context rdf:resource="urn:domeoclient:uuid:2D07F657-485E-493B-84FC-C20CA68F0295"/>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:createdOn>2014-07-22 19:53:12 -0400</pav:createdOn>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoserver:annotationset:7AACEF8D-2EBC-4F0B-94B2-190650E562F6">
    <ao:item rdf:resource="urn:domeoclient:uuid:FA428F64-D782-46F5-B866-2FBC24D3F4F8"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:74FDA5BD-9C18-4F10-AC59-C5C75AA497C2"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:6FD9D48D-F639-4F09-ABA6-F4B259681453"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:42423629-C409-4AD4-BBE6-7C86A696F03E"/>
    <pav:createdOn>2014-07-07 09:34:12 -0400</pav:createdOn>
    <ao:item rdf:resource="urn:domeoclient:uuid:3D22E6FA-B90D-49C2-B42F-B8122D48D82A"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:3762570C-CF43-4DB9-B163-FAA6DAE60017"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:2F71B86E-3B80-4813-9F00-A9E3E6B30C9E"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:BDA75ADA-742A-402B-AE97-4438F99C61FC"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:222C9B55-A770-41C7-AF04-566E7C7A1DBC"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:3B85AE85-A07C-4614-91F5-52EF7A4737DF"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:E76B5D64-7248-4EBD-A023-3820BFDEFD26"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:79293219-D172-4E27-A045-D16B4F539C60"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:5D480921-AA61-499B-9C3F-3043269104B4"/>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812eda990003</pav:createdBy>
    <ao:item rdf:resource="urn:domeoclient:uuid:02D92735-6D44-4DFA-A2E9-75A5A3D4DCF9"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:0B2918C2-A28D-40C3-8147-F19D09B7119C"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:C8D05CE4-8287-449A-8921-AFACBAEE2002"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#AnnotationSet"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:2CF891F7-2E96-4382-8EDB-5C061E8E1AFA"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:CE16BF01-AD42-444E-9A68-FEF6AED26815"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:17E64297-0A57-4C9B-94C4-18ED1956FCF7"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:E5DE379E-8BB3-4609-BFC6-A0E275978ADC"/>
    <pav:lastSavedOn>2014-07-07 11:24:52 -0400</pav:lastSavedOn>
    <ao:item rdf:resource="urn:domeoclient:uuid:FB0C633B-9063-4FD0-91E9-2810CF1C157A"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:137A1951-AA86-4074-9581-B011801B955F"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:1C02BE13-5688-4657-A7A7-6A459283AEB2"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:E7907DD5-4FA4-4B5A-99D9-9D24B76931C6"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:B9E21C61-063D-4F80-8E08-85865B387669"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:6588D45E-2F4C-40CF-8AF4-0CD621F484E1"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:9BD9047F-C1DA-4B64-92B7-4D031972C9CF"/>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <domeo:deleted>false</domeo:deleted>
    <ao:item rdf:resource="urn:domeoclient:uuid:2ABA1A35-6C77-4A0A-9EC5-109AA13136B6"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:EC416A29-1315-42C5-90FA-652412A6AD12"/>
    <domeo:agents rdf:resource="urn:domeo:software:id:Domeo-2.1alpha-050"/>
    <pav:previousVersion>urn:domeoserver:annotationset:08C0C288-6DF4-43E6-A618-71A8BB9563C3</pav:previousVersion>
    <ao:item rdf:resource="urn:domeoclient:uuid:16393981-08BF-477D-ACB9-8FB804E50D0C"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:735CA4BD-A16D-4729-BFC3-96D72BFE5B0B"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:E0DCF362-11F8-4FF3-8C3C-EDB9DD3D53A7"/>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">3</pav:versionNumber>
    <ao:item rdf:resource="urn:domeoclient:uuid:DC9FB0B5-1564-4BF2-A4E4-4D05B0A1AB86"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:FA4C8A6E-17D4-47F8-A369-67AF061E9037"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:1F12731E-6D41-4E27-83E3-C87822424FCA"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:F9FE917E-CAFF-4C8B-B16B-BB0606212145"/>
    <domeo:agents rdf:resource="urn:person:uuid:080e143046812afe0146812eda990003"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:8ABD9FDA-0F08-474A-A9C8-437A5346F2AC"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:32B1CD5D-3CD7-4D5E-BD76-57F6F0A9480A"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:697C8F03-1543-4427-9D85-7967FCEA3100"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:57E98049-37B0-4F70-963B-F0D12C3B36C7"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:2093FF56-689E-4246-AF69-F566860B27BF"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:7D37CC60-618E-46B6-8C99-BA7D598E3762"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:CBB863B4-0141-4362-8357-0FD5A3909A10"/>
    <dct:description>The default set is created automatically by Domeo when no other set is existing.</dct:description>
    <ao:item rdf:resource="urn:domeoclient:uuid:DA7B78BE-B91C-4178-9AF1-7DC800EF5121"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:B5E75366-F0BF-442F-852E-19C5EDDC84EE"/>
    <ao:annotatesResource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-155.txt.html</ao:annotatesResource>
    <ao:item rdf:resource="urn:domeoclient:uuid:54B9529D-9030-4194-B66A-D7ECCBABED1F"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:E76D782E-ADBF-42D0-9CCA-8944F07D22DA"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:55E300CE-2A8F-42F4-9877-A49DDE4F3360"/>
    <permissions:permissions rdf:nodeID="Nb391a10f8b6443949f426d7d2805e116"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:B8D94772-B85A-452F-91A5-C644F8298C08"/>
    <rdfs:label>Default Set</rdfs:label>
    <ao:item rdf:resource="urn:domeoclient:uuid:DE5C582E-1F4C-478C-9DDC-DAB4C0C1ABFF"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:3ED57AC4-296D-4C8D-9873-49C193F69BBA"/>
    <pav:lineageUri>urn:domeoserver:annotationset:76FD4BB5-DE2F-4FCA-B93D-302185B1A381</pav:lineageUri>
    <ao:item rdf:resource="urn:domeoclient:uuid:08713DDF-0935-4B63-B281-AEE56A8D7628"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:F3C4287B-36A9-48BF-8081-A39BEF5F3C51"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:E13140FE-59B4-45B2-A524-CAED051C4F9D"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:5D381360-05CD-407C-BAB9-6496A42C73E4">
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <ao:item rdf:resource="urn:domeoclient:uuid:DCBFA6B2-22F1-4138-ABA7-CDA3F5A19FC6"/>
    <ao:annotatesResource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-42.txt.html</ao:annotatesResource>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#AnnotationSet"/>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812eda990003</pav:createdBy>
    <dct:description>The default set is created automatically by Domeo when no other set is existing.</dct:description>
    <domeo:agents rdf:resource="urn:domeo:software:id:Domeo-2.1alpha-050"/>
    <domeo:agents rdf:resource="urn:person:uuid:080e143046812afe0146812eda990003"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:A5437FEA-0356-41EE-AA7B-C75739F23B59"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:09BC9686-C635-41F7-85A0-6560EB1B0E1B"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:3B332456-24D5-452E-8A10-14D40375ED79"/>
    <rdfs:label>Default Set</rdfs:label>
    <ao:item rdf:resource="urn:domeoclient:uuid:346B16C2-85FF-42F8-A3AB-6C7DEBB418C7"/>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <pav:lastSavedOn>2014-09-01 16:12:35 -0400</pav:lastSavedOn>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <ao:item rdf:resource="urn:domeoclient:uuid:7A41AFCF-E95D-4B06-B213-C3D7AC444FB8"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:C3BD9C2A-EDB9-42C4-8D62-372034300BF1"/>
    <pav:lineageUri>urn:domeoserver:annotationset:F5BDD98B-931D-46AD-978A-EF6B8EF58A83</pav:lineageUri>
    <domeo:deleted>false</domeo:deleted>
    <pav:createdOn>2014-09-01 16:11:59 -0400</pav:createdOn>
    <permissions:permissions rdf:nodeID="Na8a7bae9105f41b3b7169745044886c2"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:4EEAF739-3D04-465D-8AC0-35EAE4B00AE0">
    <pav:lastSavedOn>2014-07-13 12:41:10 -0400</pav:lastSavedOn>
    <pav:lineageUri>urn:domeoserver:annotation:3D8D67C2-6E18-4F0E-AEDD-1DFCE48220A1</pav:lineageUri>
    <pav:createdOn>2014-07-13 12:35:54 -0400</pav:createdOn>
    <ao:context rdf:resource="urn:domeoclient:uuid:F3FEE8D2-9817-490A-AF14-CC53E5ADFBF2"/>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812eda990003</pav:createdBy>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <domeo:belongsToSet>urn:domeoclient:uuid:4F872953-6D19-4809-9285-FCCF2FF54315</domeo:belongsToSet>
    <rdfs:label>Highlight</rdfs:label>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:02B52C58-6F51-4B2E-9D66-4E523227806E">
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:lineageUri>urn:domeoserver:annotation:91866B43-056C-4732-918F-F1A8DB5C81CC</pav:lineageUri>
    <pav:createdOn>2014-09-02 11:57:13 -0400</pav:createdOn>
    <domeo:belongsToSet>urn:domeoclient:uuid:4B51141D-C8D2-45DB-8074-74F8D8323E60</domeo:belongsToSet>
    <rdfs:label>Highlight</rdfs:label>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812eda990003</pav:createdBy>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <ao:context rdf:resource="urn:domeoclient:uuid:7D867112-B5D9-4FEA-A8A5-D8FC72239EAE"/>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <pav:lastSavedOn>2014-09-02 12:02:18 -0400</pav:lastSavedOn>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:DDEC112C-9331-4573-8A13-ED3D4798FE89">
    <domeo:belongsToSet>urn:domeoserver:annotationset:37B2514D-1A92-45B1-8A5C-610DA6DC935A</domeo:belongsToSet>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <ao:context rdf:resource="urn:domeoclient:uuid:5701D17C-4067-47BA-ACBD-ED6053F1DE96"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#expertstudyAnnotation"/>
    <pav:lastSavedOn>2014-07-24 20:10:48 -0400</pav:lastSavedOn>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">2</pav:versionNumber>
    <pav:lineageUri>urn:domeoserver:annotationset:4A88D0A6-E9B6-4E7F-955F-3692600C178C</pav:lineageUri>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:lineageUri>urn:domeoserver:annotation:6ACD33D0-B2D8-4A76-902A-A7F23C3CAB31</pav:lineageUri>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812eda990003</pav:createdBy>
    <pav:previousVersion>urn:domeoclient:uuid:8D86A4AC-54BD-4BB3-8B58-AB55DEC01A88</pav:previousVersion>
    <ao:body rdf:nodeID="N7f7756a59f0c415186455e5e0044522a"/>
    <rdfs:label>expertstudy Annotation</rdfs:label>
    <pav:createdOn>2014-07-24 20:10:51 -0400</pav:createdOn>
    <ao:body rdf:nodeID="N9395dc1455f943798fdcef107cb3fea6"/>
    <pav:lastSavedOn>2014-07-24 20:10:49 -0400</pav:lastSavedOn>
    <domeo:belongsToSet>urn:domeoserver:annotationset:1FC172B8-8AC3-465A-AA69-B73AD9B97CBC</domeo:belongsToSet>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:D1F55052-16DF-4B25-AC16-7645C8E4AD77">
    <pav:previousVersion>urn:domeoserver:annotationset:467D4F28-D086-4217-9DE0-23E165F30716</pav:previousVersion>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:lastSavedOn>2014-07-22 19:28:02 -0400</pav:lastSavedOn>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812eda990003</pav:createdBy>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">3</pav:versionNumber>
    <domeo:belongsToSet>urn:domeoserver:annotationset:7E80543E-BF76-4514-92A9-91458DCB802B</domeo:belongsToSet>
    <domeo:belongsToSet>urn:domeoserver:annotationset:606A5B3F-B6FB-4279-AA42-7893CFC2D20C</domeo:belongsToSet>
    <ao:context rdf:resource="urn:domeoclient:uuid:BFE9EAEF-FFFF-446F-B84E-D50E1FB72CA0"/>
    <pav:lineageUri>urn:domeoserver:annotation:B59E6AB4-E2FC-4345-9F1B-E23106D27CB2</pav:lineageUri>
    <rdfs:label>Highlight</rdfs:label>
    <domeo:belongsToSet>urn:domeoserver:annotationset:F272A789-69D0-47CC-8CC9-F25C55B91261</domeo:belongsToSet>
    <domeo:belongsToSet>urn:domeoserver:annotationset:514BA51B-D734-4003-A7C3-F03C0F95833A</domeo:belongsToSet>
    <pav:createdOn>2014-07-22 19:22:42 -0400</pav:createdOn>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <pav:lineageUri>urn:domeoserver:annotationset:AB1741F1-5A5F-4416-AEAC-A544BCBB7D16</pav:lineageUri>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <domeo:belongsToSet>urn:domeoserver:annotationset:2914A3FD-DF43-4F78-999C-77CE7A028B19</domeo:belongsToSet>
    <domeo:belongsToSet>urn:domeoserver:annotationset:7021B883-FD5C-4083-BD87-DF56D3C87633</domeo:belongsToSet>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:02D77FC0-6DA3-45AA-9C58-66539927EF97">
    <pav:createdOn>2014-07-21 21:31:15 -0400</pav:createdOn>
    <domeo:uuid>02D77FC0-6DA3-45AA-9C58-66539927EF97</domeo:uuid>
    <ao:prefix>dose for at least two weeks. There was a significant increase in </ao:prefix>
    <ao:exact>zidovudine </ao:exact>
    <ao:suffix>AUC following the administration of fluconazole. The mean ± SD increase in AUC was 20% ± 32% (range: -27 to 104%). The metabolite, GZDV, to parent drug ratio significantly decreased after the administration of fluconazole, from 7.6 ± 3.6 to 5.7 ± 2.2.</ao:suffix>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-27.txt.html</ao:hasSource>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:02D77FC0-6DA3-45AA-9C58-66539927EF97"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:C072F602-C93D-48EA-B6A2-EEDE4C49DC48">
    <ao:exact>ritonavir</ao:exact>
    <ao:prefix>), and protease inhibitors (e.g., </ao:prefix>
    <domeo:uuid>C072F602-C93D-48EA-B6A2-EEDE4C49DC48</domeo:uuid>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-72.txt.html</ao:hasSource>
    <ao:suffix>), may prolong opioid effects. If co-administration is necessary, caution is advised when initiating therapy with, currently taking, or discontinuing CYP3A4 inhibitors. Evaluate these patients at frequent intervals and consider dose adjustments until sta</ao:suffix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <pav:createdOn>2014-09-02 19:09:27 -0400</pav:createdOn>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:C072F602-C93D-48EA-B6A2-EEDE4C49DC48"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:5846C0A3-8519-4160-91FD-DFD71E2DCC95">
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812eda990003</pav:createdBy>
    <pav:createdOn>2014-07-24 20:05:50 -0400</pav:createdOn>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <ao:context rdf:resource="urn:domeoclient:uuid:B4B8ACAF-EC72-42B7-8537-72C0706EA026"/>
    <domeo:belongsToSet>urn:domeoclient:uuid:8D86A4AC-54BD-4BB3-8B58-AB55DEC01A88</domeo:belongsToSet>
    <pav:lastSavedOn>2014-07-24 20:07:19 -0400</pav:lastSavedOn>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:lastSavedOn>2014-07-24 20:07:20 -0400</pav:lastSavedOn>
    <pav:lineageUri>urn:domeoserver:annotation:451A702A-FF89-4D80-B07D-24152AAE1E97</pav:lineageUri>
    <domeo:belongsToSet>urn:domeoserver:annotationset:1FC172B8-8AC3-465A-AA69-B73AD9B97CBC</domeo:belongsToSet>
    <rdfs:label>Highlight</rdfs:label>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:lineageUri>urn:domeoserver:annotationset:4A88D0A6-E9B6-4E7F-955F-3692600C178C</pav:lineageUri>
    <domeo:belongsToSet>urn:domeoserver:annotationset:37B2514D-1A92-45B1-8A5C-610DA6DC935A</domeo:belongsToSet>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:E0926D3D-98EA-4A7F-A9B4-EC238004514E">
    <domeo:uuid>E0926D3D-98EA-4A7F-A9B4-EC238004514E</domeo:uuid>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-28.txt.html</ao:hasSource>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:E0926D3D-98EA-4A7F-A9B4-EC238004514E"/>
    <pav:createdOn>2014-07-21 21:33:41 -0400</pav:createdOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:prefix>The pharmacokinetics of </ao:prefix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:exact>theophylline </ao:exact>
    <ao:suffix>were determined from a single intravenous dose of aminophylline (6 mg/kg) before and after the oral administration of fluconazole 200 mg daily for 14 days in 16 normal male volunteers. There were significant increases in theophylline AUC, Cmax, and half-</ao:suffix>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:4BBBCCF7-77AF-4B32-B246-8C1032EB3DF0">
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <pav:lineageUri>urn:domeoserver:annotation:5BA69179-4C83-4FF7-804C-115EDBEB0233</pav:lineageUri>
    <rdfs:label>Highlight</rdfs:label>
    <pav:lastSavedOn>2014-07-24 19:53:55 -0400</pav:lastSavedOn>
    <domeo:belongsToSet>urn:domeoclient:uuid:E0863579-8D19-4B30-ADD6-2A5BDBC2F482</domeo:belongsToSet>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:createdOn>2014-07-24 19:52:41 -0400</pav:createdOn>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812eda990003</pav:createdBy>
    <ao:context rdf:resource="urn:domeoclient:uuid:59F56EF7-8899-4A8B-904D-B19516E60E30"/>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:6A404FE8-4389-4D36-A815-EE09948F4613">
    <ao:suffix> (40 mg, qd, 2 hr before atazanavir), AUC was decreased by 94%, Cmax by 96%, and Cmin by 95%. Concomitant administration with omeprazole and drugs such as atazanavir and nelfinavir is therefore not recommended. For other antiretroviral drugs, such as saq</ao:suffix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:exact>omeprazole</ao:exact>
    <pav:createdOn>2014-09-02 19:18:28 -0400</pav:createdOn>
    <domeo:uuid>6A404FE8-4389-4D36-A815-EE09948F4613</domeo:uuid>
    <ao:prefix> (400 mg, qd) and </ao:prefix>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:6A404FE8-4389-4D36-A815-EE09948F4613"/>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-74.txt.html</ao:hasSource>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:2537CEFB-4053-4AC9-8731-C65B1AC5D0F9">
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <ao:context rdf:resource="urn:domeoclient:uuid:D526C276-CAAE-4E9B-8038-08BB2FB8FBBD"/>
    <pav:createdOn>2014-07-13 11:15:55 -0400</pav:createdOn>
    <domeo:belongsToSet>urn:domeoclient:uuid:71191E51-53CB-4FDE-88D0-33C6818E2232</domeo:belongsToSet>
    <pav:lastSavedOn>2014-07-13 11:32:29 -0400</pav:lastSavedOn>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <pav:lineageUri>urn:domeoserver:annotation:F1E65BAF-B906-4702-93F2-2AB99EAC8EC2</pav:lineageUri>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812eda990003</pav:createdBy>
    <rdfs:label>Highlight</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:E17E51AB-6385-4BD7-89B1-ABDDA504EE2C">
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-9.txt.html</ao:hasSource>
    <ao:exact>Ramelteon</ao:exact>
    <ao:prefix>xsd:String</ao:prefix>
    <pav:createdOn>2014-09-02 11:41:00 -0400</pav:createdOn>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:E17E51AB-6385-4BD7-89B1-ABDDA504EE2C"/>
    <ao:suffix>: See WARNINGS AND PRECAUTIONS (5.8).</ao:suffix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <domeo:uuid>E17E51AB-6385-4BD7-89B1-ABDDA504EE2C</domeo:uuid>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:0A0256F1-F31A-4A0C-BA59-EC817B22A85D">
    <ao:prefix> (4 mg once daily) for 7 days increased rosiglitazone AUC by 127%, compared to the administration of </ao:prefix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:0A0256F1-F31A-4A0C-BA59-EC817B22A85D"/>
    <pav:createdOn>2014-07-22 19:41:54 -0400</pav:createdOn>
    <domeo:uuid>0A0256F1-F31A-4A0C-BA59-EC817B22A85D</domeo:uuid>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-123.txt.html</ao:hasSource>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:suffix> (4 mg once daily) alone. Given the potential for dose-related adverse events with rosiglitazone, a decrease in the dose of rosiglitazone may be needed when gemfibrozil is introduced [see Drug Interactions (7.1)].</ao:suffix>
    <ao:exact>rosiglitazone</ao:exact>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:90F5AA7B-F35E-4B00-A666-C6FE8F1B0324">
    <pav:lineageUri>urn:domeoserver:annotation:86034B03-551B-406A-BFE8-B44A1CB16857</pav:lineageUri>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <rdfs:label>Highlight</rdfs:label>
    <pav:createdOn>2014-07-13 11:10:35 -0400</pav:createdOn>
    <ao:context rdf:resource="urn:domeoclient:uuid:FADFAA32-BB4A-4542-AEFD-2B7D80177234"/>
    <pav:lastSavedOn>2014-07-13 11:32:29 -0400</pav:lastSavedOn>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812eda990003</pav:createdBy>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <domeo:belongsToSet>urn:domeoclient:uuid:71191E51-53CB-4FDE-88D0-33C6818E2232</domeo:belongsToSet>
    <pav:previousVersion>xsd:String</pav:previousVersion>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:605A1706-1C67-4FBD-9A42-21DF312E4339">
    <pav:lineageUri>urn:domeoserver:annotation:B613F797-C3F6-49D7-8CC3-5539D739B164</pav:lineageUri>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <pav:createdOn>2014-07-22 19:06:58 -0400</pav:createdOn>
    <domeo:belongsToSet>urn:domeoserver:annotationset:2B18F6B1-59F7-4EA0-9386-55A934108055</domeo:belongsToSet>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <rdfs:label>Highlight</rdfs:label>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812eda990003</pav:createdBy>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <domeo:belongsToSet>urn:domeoclient:uuid:0819E6B8-B8E8-4EB2-9248-CA54623D1BB2</domeo:belongsToSet>
    <pav:lastSavedOn>2014-07-22 19:06:48 -0400</pav:lastSavedOn>
    <pav:lineageUri>urn:domeoserver:annotationset:32C325B9-09DD-4A0B-A270-BAA0C42956A1</pav:lineageUri>
    <ao:context rdf:resource="urn:domeoclient:uuid:0AE7742B-EF74-477D-95CF-44A73986D022"/>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:lastSavedOn>2014-07-22 19:06:49 -0400</pav:lastSavedOn>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:82CD11C4-7E04-4E14-81A6-7D8B8CBC98F0">
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <domeo:uuid>82CD11C4-7E04-4E14-81A6-7D8B8CBC98F0</domeo:uuid>
    <ao:exact>fluconazole </ao:exact>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-26.txt.html</ao:hasSource>
    <ao:suffix>200 mg daily for 14 days in eight renal transplant patients who had been on cyclosporine therapy for at least 6 months and on a stable cyclosporine dose for at least 6 weeks. There was a significant increase in cyclosporine AUC, Cmax, Cmin (24-hour conce</ao:suffix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <pav:createdOn>2014-07-21 21:28:29 -0400</pav:createdOn>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:82CD11C4-7E04-4E14-81A6-7D8B8CBC98F0"/>
    <ao:prefix>AUC and Cmax were determined before and after the administration of </ao:prefix>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:03276EA7-732F-4344-8706-3960852CCE36">
    <pav:createdOn>2014-07-21 21:28:25 -0400</pav:createdOn>
    <rdfs:label>Highlight</rdfs:label>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <domeo:belongsToSet>urn:domeoclient:uuid:B394B422-1AAF-4ED4-A3BB-3FB13E961EEA</domeo:belongsToSet>
    <pav:lineageUri>urn:domeoserver:annotation:41C8DF88-B17A-4B09-986C-ED152384BD07</pav:lineageUri>
    <pav:lastSavedOn>2014-07-21 21:30:23 -0400</pav:lastSavedOn>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812eda990003</pav:createdBy>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <ao:context rdf:resource="urn:domeoclient:uuid:031F5AE1-D155-403C-AE7F-01A1DD9F84AC"/>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/20398182-F09D-4166-8536-A74DA8BDB5D5">
    <sio:SIO_000228>dikbD2R:object-drug-of-interaction</sio:SIO_000228>
    <dct:description>Referred to the drug in the interaction.</dct:description>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/active-ingredient"/>
    <rdfs:label>nifedipine</rdfs:label>
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/7417</dailymed:activeMoietyRxCUI>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:EBCFB082-4C3F-4C27-B1B4-7DE7E01178ED">
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:exact>fluconazole</ao:exact>
    <pav:createdOn>2014-07-13 12:55:59 -0400</pav:createdOn>
    <ao:prefix>Administration of a single oral 200 mg dose of </ao:prefix>
    <domeo:uuid>EBCFB082-4C3F-4C27-B1B4-7DE7E01178ED</domeo:uuid>
    <ao:suffix> after 15 days of rifampin administered as 600 mg daily in eight healthy male volunteers resulted in a significant decrease in fluconazole AUC and a significant increase in apparent oral clearance of fluconazole. There was a mean ± SD reduction in flucon</ao:suffix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-24.txt.html</ao:hasSource>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:EBCFB082-4C3F-4C27-B1B4-7DE7E01178ED"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:9E3F8352-2C14-46DC-9E50-892286D5905F">
    <pav:lastSavedOn>2014-07-22 18:46:52 -0400</pav:lastSavedOn>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:lineageUri>urn:domeoserver:annotation:B18D3A3B-241A-4AC2-8C86-EE2E51490093</pav:lineageUri>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#expertstudyAnnotation"/>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812eda990003</pav:createdBy>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <pav:createdOn>2014-07-22 18:46:46 -0400</pav:createdOn>
    <ao:body rdf:nodeID="Nd3e5f90c8929405ab99d16af856698a7"/>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <rdfs:label>expertstudy Annotation</rdfs:label>
    <domeo:belongsToSet>urn:domeoclient:uuid:E0054F81-6A9B-4AF0-9DCB-962A6FC1C418</domeo:belongsToSet>
    <ao:context rdf:resource="urn:domeoclient:uuid:CAEF4002-AC71-41B3-AB37-783C0F6D54AB"/>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/43BF860F-DF76-4336-A687-956DE41661F4">
    <rdfs:label>paroxetine</rdfs:label>
    <sio:SIO_000228>dikbD2R:precipitant-drug-of-interaction</sio:SIO_000228>
    <dct:description>Referred to the drug in the interaction.</dct:description>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/active-ingredient"/>
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/32937</dailymed:activeMoietyRxCUI>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:E72D7D03-AAE5-42A5-A83A-3C68C2C2BCB6">
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/PK_DDI"/>
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/C9B2FC03-3B32-472D-B469-B9F86400F4C6"/>
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/5A962BFF-E73B-4290-B642-C49A7EBCD1B8"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:CB40975A-75D0-432E-9BC4-38AE8661FBF6">
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:suffix>, thus caution should be used with concomitant administration.</ao:suffix>
    <domeo:uuid>CB40975A-75D0-432E-9BC4-38AE8661FBF6</domeo:uuid>
    <ao:prefix>, may be increased by </ao:prefix>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:CB40975A-75D0-432E-9BC4-38AE8661FBF6"/>
    <ao:exact>acyclovir</ao:exact>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-163.txt.html</ao:hasSource>
    <pav:createdOn>2014-07-28 17:00:25 -0400</pav:createdOn>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:5E38DB7B-2B38-491B-8686-9C2D434ACD79">
    <pav:createdOn>2014-07-13 12:40:24 -0400</pav:createdOn>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#expertstudyAnnotation"/>
    <pav:lineageUri>urn:domeoserver:annotation:B018D6F2-5667-4118-9A44-AD32984915AA</pav:lineageUri>
    <ao:context rdf:resource="urn:domeoclient:uuid:ED359A65-2894-4EE7-9430-453B2C8C6D26"/>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812eda990003</pav:createdBy>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <pav:lastSavedOn>2014-07-13 12:41:10 -0400</pav:lastSavedOn>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <ao:body rdf:nodeID="N7ab8fdf910c849bea39ab007703bb988"/>
    <domeo:belongsToSet>urn:domeoclient:uuid:4F872953-6D19-4809-9285-FCCF2FF54315</domeo:belongsToSet>
    <rdfs:label>expertstudy Annotation</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:F14E8BB4-85EC-49A7-B9E5-8976B448D19D">
    <ao:suffix>pharmacokinetics in patients with PAH. The dataset available for the population pharmacokinetic evaluation contained a wide range of demographic data and laboratory parameters associated with hepatic and renal function. None of these factors had a signif</ao:suffix>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-155.txt.html</ao:hasSource>
    <domeo:uuid>F14E8BB4-85EC-49A7-B9E5-8976B448D19D</domeo:uuid>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <domeo:uuid></domeo:uuid>
    <pav:createdOn>2014-07-07 09:59:05 -0400</pav:createdOn>
    <ao:exact>sildenafil </ao:exact>
    <ao:prefix>Age, gender, race, and renal and hepatic function were included as factors assessed in the population pharmacokinetic model to evaluate </ao:prefix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:F14E8BB4-85EC-49A7-B9E5-8976B448D19D"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:E3A608F7-C1CD-4106-B1C6-F80BB86494C0">
    <ao:prefix>In vitro data suggest that </ao:prefix>
    <ao:exact>fluvoxamine</ao:exact>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-9.txt.html</ao:hasSource>
    <domeo:uuid>E3A608F7-C1CD-4106-B1C6-F80BB86494C0</domeo:uuid>
    <pav:createdOn>2014-09-02 11:30:53 -0400</pav:createdOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:suffix> is a relatively weak inhibitor of CYP2D6.</ao:suffix>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:E3A608F7-C1CD-4106-B1C6-F80BB86494C0"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:39B82E57-92E3-4322-A8E6-A3AFF215F02C">
    <domeo:agents rdf:resource="urn:domeo:software:id:Domeo-2.1alpha-050"/>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <domeo:agents rdf:resource="urn:person:uuid:080e143046812afe0146812eda990003"/>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <ao:item rdf:resource="urn:domeoclient:uuid:86BC1F50-DBC2-4291-BD23-23F4890101B8"/>
    <pav:createdOn>2014-09-01 15:57:26 -0400</pav:createdOn>
    <rdfs:label>Default Set</rdfs:label>
    <ao:item rdf:resource="urn:domeoclient:uuid:0F6275ED-13B1-45BE-8276-90A65C4C4506"/>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <domeo:deleted>false</domeo:deleted>
    <permissions:permissions rdf:nodeID="Nc80e187ccaaa40b6b607c8ebc34e55a5"/>
    <ao:annotatesResource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-16.txt.html</ao:annotatesResource>
    <ao:item rdf:resource="urn:domeoclient:uuid:BEED566B-9689-4906-8331-FFFE92EBBEEE"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:3152AF8A-AAEB-4E0D-8A47-3405FA95E483"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:914E70FC-7296-4025-B9C4-BDAD1F572CC6"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:59CE514A-8B1A-4DA2-92CC-4703FC7215B7"/>
    <pav:lineageUri>urn:domeoserver:annotationset:39101FC3-67D7-4AD0-9EEA-6871F413979B</pav:lineageUri>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#AnnotationSet"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:C93F0A9D-FE1B-4281-BB1F-58EBF1E21173"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:C44A8620-423F-46B3-A5AA-096744C9A1FF"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:3E551BB3-088F-4A07-A523-A094DE08768F"/>
    <pav:lastSavedOn>2014-09-01 15:57:39 -0400</pav:lastSavedOn>
    <dct:description>The default set is created automatically by Domeo when no other set is existing.</dct:description>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812eda990003</pav:createdBy>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:7EBA2A42-43E7-40EC-B69A-A8622A20C1FD">
    <ao:prefix>metabolism can be inhibited by the CYP3A4 inhibitors ketoconazole, ritonavir, and indinavir.</ao:prefix>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-136.txt.html</ao:hasSource>
    <domeo:uuid>7EBA2A42-43E7-40EC-B69A-A8622A20C1FD</domeo:uuid>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:suffix> Adverse effects including nausea, hypotension, and syncope were observed when</ao:suffix>
    <pav:createdOn>2014-07-24 20:03:04 -0400</pav:createdOn>
    <ao:exact> The effect of short-term administration of ritonavir (200 mg twice daily, 4 doses) on the pharmacokinetics of a single dose of trazodone (50 mg) has been studied in 10 healthy subjects. The Cmax of trazodone increased by 34%, the AUC increased 2.4 fold, the half-life increased by 2.2 fold, and the clearance decreased by 52%.</ao:exact>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:7EBA2A42-43E7-40EC-B69A-A8622A20C1FD"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:BE7465D0-1375-484E-9391-EFB42F00FC99">
    <ao:context rdf:resource="urn:domeoclient:uuid:4AF93FFE-AF2A-4091-98AF-CE5D00B15BB0"/>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812eda990003</pav:createdBy>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <pav:createdOn>2014-09-02 15:04:25 -0400</pav:createdOn>
    <pav:lastSavedOn>2014-09-02 15:04:32 -0400</pav:lastSavedOn>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <rdfs:label>Highlight</rdfs:label>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:lineageUri>urn:domeoserver:annotation:E6F20489-F8CB-4779-81D4-E9901F37C4BA</pav:lineageUri>
    <domeo:belongsToSet>urn:domeoclient:uuid:C4B80A95-F569-4ED4-84D1-6796B53A580C</domeo:belongsToSet>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:59CE514A-8B1A-4DA2-92CC-4703FC7215B7">
    <ao:context rdf:resource="urn:domeoclient:uuid:69C094F7-F9EC-4E26-B0BB-5E321AD43538"/>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812eda990003</pav:createdBy>
    <pav:createdOn>2014-09-01 15:57:30 -0400</pav:createdOn>
    <domeo:belongsToSet>urn:domeoclient:uuid:39B82E57-92E3-4322-A8E6-A3AFF215F02C</domeo:belongsToSet>
    <rdfs:label>Highlight</rdfs:label>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <pav:lineageUri>urn:domeoserver:annotation:37F743F9-CC64-4CE3-85B6-3B8B882E4367</pav:lineageUri>
    <pav:lastSavedOn>2014-09-01 15:57:39 -0400</pav:lastSavedOn>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:1262FCE3-53B9-497A-AB5D-DA122BFC8786">
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <domeo:belongsToSet>urn:domeoclient:uuid:E0050ED6-BE4F-4871-9847-FC4493F22447</domeo:belongsToSet>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <pav:createdOn>2014-07-24 20:00:44 -0400</pav:createdOn>
    <ao:context rdf:resource="urn:domeoclient:uuid:762110B9-8FE2-4631-8D47-86C30D8D9102"/>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <rdfs:label>Highlight</rdfs:label>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:lastSavedOn>2014-07-24 20:00:43 -0400</pav:lastSavedOn>
    <pav:lineageUri>urn:domeoserver:annotation:A8719BF8-41F7-424F-A7E0-D2E9708465A5</pav:lineageUri>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812eda990003</pav:createdBy>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:ECE7CA77-7E57-44B0-89AE-B78915FEC8C2">
    <domeo:belongsToSet>urn:domeoserver:annotationset:606A5B3F-B6FB-4279-AA42-7893CFC2D20C</domeo:belongsToSet>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#expertstudyAnnotation"/>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">6</pav:versionNumber>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <ao:body rdf:nodeID="N2d513254c3ed46bdb906d08dec2b8d5c"/>
    <domeo:belongsToSet>urn:domeoserver:annotationset:2914A3FD-DF43-4F78-999C-77CE7A028B19</domeo:belongsToSet>
    <rdfs:label>expertstudy Annotation</rdfs:label>
    <pav:lineageUri>urn:domeoserver:annotationset:AB1741F1-5A5F-4416-AEAC-A544BCBB7D16</pav:lineageUri>
    <pav:createdOn>2014-07-22 19:43:29 -0400</pav:createdOn>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <ao:body rdf:nodeID="N499cfe574e01485b98190f0d8c354a4d"/>
    <pav:previousVersion>urn:domeoserver:annotationset:514BA51B-D734-4003-A7C3-F03C0F95833A</pav:previousVersion>
    <pav:lineageUri>urn:domeoserver:annotation:679CA6EF-77E4-481F-B6A6-F6BD7FE84383</pav:lineageUri>
    <ao:body rdf:nodeID="N1b3b231d098047199ffc450ddab36bb2"/>
    <pav:lastSavedOn>2014-07-22 19:44:46 -0400</pav:lastSavedOn>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812eda990003</pav:createdBy>
    <ao:context rdf:resource="urn:domeoclient:uuid:2490C71A-5328-4CD0-A630-7A3E5DC56DAB"/>
    <domeo:belongsToSet>urn:domeoserver:annotationset:F272A789-69D0-47CC-8CC9-F25C55B91261</domeo:belongsToSet>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:581B1F88-8814-40C0-9F72-77FEA7E30122">
    <rdfs:label>Highlight</rdfs:label>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:lastSavedOn>2014-09-02 11:49:28 -0400</pav:lastSavedOn>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">3</pav:versionNumber>
    <domeo:belongsToSet>urn:domeoserver:annotationset:A5DD001D-C81A-4E2E-B5E0-7A866B35E26B</domeo:belongsToSet>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <pav:lineageUri>urn:domeoserver:annotation:58F97A1E-7AEA-4278-8523-E5FFC9EAC039</pav:lineageUri>
    <pav:createdOn>2014-09-02 11:49:17 -0400</pav:createdOn>
    <pav:lineageUri>urn:domeoserver:annotationset:D1715BD2-BD41-46FD-9454-DC7A423A29AC</pav:lineageUri>
    <domeo:belongsToSet>urn:domeoserver:annotationset:A3F0B39A-4249-4B63-BB0D-F24A005066AC</domeo:belongsToSet>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812eda990003</pav:createdBy>
    <ao:context rdf:resource="urn:domeoclient:uuid:5C2CFA62-3DF2-413F-9AE0-376E0D06DC3C"/>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:previousVersion>urn:domeoserver:annotationset:3F546823-204F-4F9B-9006-3DC526C56931</pav:previousVersion>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:BE69196D-B8BA-4576-AC08-BEA775939851">
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812eda990003</pav:createdBy>
    <domeo:belongsToSet>urn:domeoclient:uuid:8D86A4AC-54BD-4BB3-8B58-AB55DEC01A88</domeo:belongsToSet>
    <pav:lineageUri>urn:domeoserver:annotation:160C2050-0C6F-4E14-AFD3-C7FB024EE9DA</pav:lineageUri>
    <ao:context rdf:resource="urn:domeoclient:uuid:EDE878E4-C5E0-46C3-B925-8B3825F4CA93"/>
    <pav:lastSavedOn>2014-07-24 20:07:20 -0400</pav:lastSavedOn>
    <domeo:belongsToSet>urn:domeoserver:annotationset:1FC172B8-8AC3-465A-AA69-B73AD9B97CBC</domeo:belongsToSet>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:lastSavedOn>2014-07-24 20:07:19 -0400</pav:lastSavedOn>
    <pav:lineageUri>urn:domeoserver:annotationset:4A88D0A6-E9B6-4E7F-955F-3692600C178C</pav:lineageUri>
    <pav:createdOn>2014-07-24 20:07:21 -0400</pav:createdOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <rdfs:label>Highlight</rdfs:label>
    <domeo:belongsToSet>urn:domeoserver:annotationset:37B2514D-1A92-45B1-8A5C-610DA6DC935A</domeo:belongsToSet>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:170D0DFA-5641-4603-80E1-C79ED18CB7D8">
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <pav:createdOn>2014-07-22 18:46:29 -0400</pav:createdOn>
    <ao:context rdf:resource="urn:domeoclient:uuid:C6A356B7-0DEE-4744-8B2D-DDF0B281AC9B"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#expertstudyAnnotation"/>
    <pav:lineageUri>urn:domeoserver:annotation:0AE29601-35D4-4744-B1F3-9C7B8DC9B20B</pav:lineageUri>
    <rdfs:label>expertstudy Annotation</rdfs:label>
    <domeo:belongsToSet>urn:domeoclient:uuid:E0054F81-6A9B-4AF0-9DCB-962A6FC1C418</domeo:belongsToSet>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812eda990003</pav:createdBy>
    <pav:lastSavedOn>2014-07-22 18:46:52 -0400</pav:lastSavedOn>
    <ao:body rdf:nodeID="Nbfc121d4b53846209962b13800c070cd"/>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:75348A1F-6A84-4B07-BE23-172E91593A8D">
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-118.txt.html</ao:hasSource>
    <domeo:uuid>75348A1F-6A84-4B07-BE23-172E91593A8D</domeo:uuid>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:75348A1F-6A84-4B07-BE23-172E91593A8D"/>
    <ao:prefix>Concomitant administration of </ao:prefix>
    <pav:createdOn>2014-07-22 18:44:30 -0400</pav:createdOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:exact>Synercid</ao:exact>
    <ao:suffix> and nifedipine (repeated oral doses) and midazolam (intravenous bolus dose) in healthy volunteers led to elevated plasma concentrations of these drugs. The Cmax increased by 18% and 14% (median values) and the AUC increased by 44% and 33% for nifedipine</ao:suffix>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:C4E518E3-AA88-46AF-85A6-8C02ABD7AB1D">
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <domeo:agents rdf:resource="urn:domeo:software:id:Domeo-2.1alpha-050"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#AnnotationSet"/>
    <pav:lineageUri>urn:domeoserver:annotationset:EEDB7AD0-3CC8-4CAE-AB61-BF30A626BE96</pav:lineageUri>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <permissions:permissions rdf:nodeID="Ne83f7a588a36426087d7dce3cf6c689d"/>
    <dct:description>The default set is created automatically by Domeo when no other set is existing.</dct:description>
    <rdfs:label>Default Set</rdfs:label>
    <ao:item rdf:resource="urn:domeoclient:uuid:D6127232-F0FF-46A9-830F-67E3832E779A"/>
    <pav:createdOn>2014-09-02 15:08:17 -0400</pav:createdOn>
    <pav:lastSavedOn>2014-09-02 15:08:18 -0400</pav:lastSavedOn>
    <domeo:agents rdf:resource="urn:person:uuid:080e143046812afe0146812eda990003"/>
    <ao:annotatesResource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-71.txt.html</ao:annotatesResource>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812eda990003</pav:createdBy>
    <domeo:deleted>false</domeo:deleted>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:D3737933-330F-487F-B41C-CDB0FF5C6F1C">
    <ao:suffix>equivalent to that of a 20 mg oral dose.</ao:suffix>
    <ao:exact>metabolite </ao:exact>
    <pav:createdOn>2014-07-07 09:58:59 -0400</pav:createdOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-155.txt.html</ao:hasSource>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <domeo:uuid></domeo:uuid>
    <domeo:uuid>D3737933-330F-487F-B41C-CDB0FF5C6F1C</domeo:uuid>
    <ao:prefix>xsd:String</ao:prefix>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:D3737933-330F-487F-B41C-CDB0FF5C6F1C"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:DAB2122F-CA41-44C2-9EB5-3469E45FCF04">
    <domeo:uuid>DAB2122F-CA41-44C2-9EB5-3469E45FCF04</domeo:uuid>
    <ao:prefix>xsd:String</ao:prefix>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-123.txt.html</ao:hasSource>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:exact>Rosiglitazone</ao:exact>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:DAB2122F-CA41-44C2-9EB5-3469E45FCF04"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <pav:createdOn>2014-07-22 19:08:44 -0400</pav:createdOn>
    <ao:suffix>, a member of the thiazolidinedione class of antidiabetic agents, improves glycemic control by improving insulin sensitivity. Rosiglitazone is a highly selective and potent agonist for the peroxisome proliferator-activated receptor-gamma (PPARγ). In huma</ao:suffix>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:5701D17C-4067-47BA-ACBD-ED6053F1DE96">
    <ao:exact>Fexofenadine had no effect on the pharmacokinetics of either erythromycin or ketoconazole</ao:exact>
    <pav:createdOn>2014-07-24 20:10:51 -0400</pav:createdOn>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-139.txt.html</ao:hasSource>
    <ao:suffix>xsd:String</ao:suffix>
    <ao:prefix>xsd:String</ao:prefix>
    <domeo:uuid>5701D17C-4067-47BA-ACBD-ED6053F1DE96</domeo:uuid>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:5701D17C-4067-47BA-ACBD-ED6053F1DE96"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:2532730F-81C6-4CC5-93B2-FC3A19B98EC5">
    <rdfs:label>Highlight</rdfs:label>
    <pav:lineageUri>urn:domeoserver:annotation:2080DF37-EAA6-443D-A391-2897A81CAD23</pav:lineageUri>
    <domeo:belongsToSet>urn:domeoclient:uuid:71191E51-53CB-4FDE-88D0-33C6818E2232</domeo:belongsToSet>
    <pav:createdOn>2014-07-13 11:09:57 -0400</pav:createdOn>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <ao:context rdf:resource="urn:domeoclient:uuid:FA839309-7C8B-4446-A5C1-08694E7B8482"/>
    <pav:lastSavedOn>2014-07-13 11:32:29 -0400</pav:lastSavedOn>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812eda990003</pav:createdBy>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:E728D92E-FEA6-4EE6-9E40-E59051DEB8E3">
    <pav:lastSavedOn>2014-07-13 11:32:29 -0400</pav:lastSavedOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <rdfs:label>Highlight</rdfs:label>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812eda990003</pav:createdBy>
    <pav:createdOn>2014-07-13 11:09:21 -0400</pav:createdOn>
    <pav:lineageUri>urn:domeoserver:annotation:DDCD9620-FC48-419B-ACE3-537915C7889C</pav:lineageUri>
    <domeo:belongsToSet>urn:domeoclient:uuid:71191E51-53CB-4FDE-88D0-33C6818E2232</domeo:belongsToSet>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <ao:context rdf:resource="urn:domeoclient:uuid:043FCC7B-7CBD-4BE5-9962-3F6CF2B132DB"/>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:40F97AE4-1A18-4FD3-B30C-9226F8465F7B">
    <ao:suffix>200 mg daily for 14 days in 16 normal male volunteers. There were significant increases in theophylline AUC, Cmax, and half-life with a corresponding decrease in clearance. The mean ± SD theophylline AUC increased 21% ± 16% (range: -5 to 48%). The Cmax i</ao:suffix>
    <pav:createdOn>2014-07-21 21:33:50 -0400</pav:createdOn>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-28.txt.html</ao:hasSource>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:exact>fluconazole </ao:exact>
    <domeo:uuid>40F97AE4-1A18-4FD3-B30C-9226F8465F7B</domeo:uuid>
    <ao:prefix>(6 mg/kg) before and after the oral administration of </ao:prefix>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:40F97AE4-1A18-4FD3-B30C-9226F8465F7B"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:7FFFFE5E-7DBF-4B33-A8EC-B5E58DEE590D">
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:createdOn>2014-07-07 09:42:34 -0400</pav:createdOn>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <rdfs:label>Highlight</rdfs:label>
    <pav:lineageUri>urn:domeoserver:annotation:1942C7AF-662B-419B-945F-EBC948BBC805</pav:lineageUri>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812eda990003</pav:createdBy>
    <pav:lastSavedOn>2014-07-07 09:44:19 -0400</pav:lastSavedOn>
    <ao:context rdf:resource="urn:domeoclient:uuid:A03AB529-B51D-495B-88D7-404C443338CF"/>
    <domeo:belongsToSet>urn:domeoclient:uuid:FCA2BF23-0BE3-409F-9177-761812F96097</domeo:belongsToSet>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:5B7BF8E5-F410-48B2-AF56-5421E6B7FF0B">
    <ao:exact>carbamazepine</ao:exact>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-8.txt.html</ao:hasSource>
    <ao:suffix>, phenytoin, rifampin, and phenobarbital) with risperidone may cause a decrease in the combined plasma concentrations of risperidone and 9-hydroxyrisperidone [see 7 DRUG INTERACTIONS]. It would also be possible for risperidone to interfere with metabolis</ao:suffix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:5B7BF8E5-F410-48B2-AF56-5421E6B7FF0B"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:prefix> do not suggest important differences between poor and extensive metabolizers. Second, co-administration of known enzyme inducers (e.g., </ao:prefix>
    <domeo:uuid>5B7BF8E5-F410-48B2-AF56-5421E6B7FF0B</domeo:uuid>
    <pav:createdOn>2014-07-13 11:15:50 -0400</pav:createdOn>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:88D0CD7F-7AEE-47DB-9F13-A8F5D6A36CAB">
    <pav:createdOn>2014-09-01 16:06:16 -0400</pav:createdOn>
    <ao:suffix>(cisapride AUC and Cmax were reduced by about 35%).</ao:suffix>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-16.txt.html</ao:hasSource>
    <domeo:uuid>88D0CD7F-7AEE-47DB-9F13-A8F5D6A36CAB</domeo:uuid>
    <ao:prefix>200 mg (q.d.) induces the metabolism of </ao:prefix>
    <ao:exact>cisapride </ao:exact>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:88D0CD7F-7AEE-47DB-9F13-A8F5D6A36CAB"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:A24D3202-33F3-42B7-9021-4CDA18CA2F7B">
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812eda990003</pav:createdBy>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:createdOn>2014-07-28 17:02:39 -0400</pav:createdOn>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <domeo:belongsToSet>urn:domeoclient:uuid:A0E3203A-2AD3-4045-BAB8-27B340F81B0E</domeo:belongsToSet>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <rdfs:label>Highlight</rdfs:label>
    <pav:lastSavedOn>2014-07-28 17:02:28 -0400</pav:lastSavedOn>
    <ao:context rdf:resource="urn:domeoclient:uuid:07EE36EA-171A-4057-95BE-E666C69DD2C3"/>
    <pav:lineageUri>urn:domeoserver:annotation:693F959A-5877-43E5-95BB-063A7AB42D5D</pav:lineageUri>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:7D618B8B-0DAF-414B-911B-81ED1815FD8C">
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:createdOn>2014-09-01 15:59:50 -0400</pav:createdOn>
    <rdfs:label>Highlight</rdfs:label>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812eda990003</pav:createdBy>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <ao:context rdf:resource="urn:domeoclient:uuid:DB79C29A-687E-46A8-AEEA-C0F67E49EB97"/>
    <pav:lastSavedOn>2014-09-01 16:00:14 -0400</pav:lastSavedOn>
    <domeo:belongsToSet>urn:domeoclient:uuid:659ED9DF-77DA-41F2-B123-6E455B4F2385</domeo:belongsToSet>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:lineageUri>urn:domeoserver:annotation:E5909B1D-7622-4164-8773-34186D306235</pav:lineageUri>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:E5DE379E-8BB3-4609-BFC6-A0E275978ADC">
    <domeo:belongsToSet>urn:domeoserver:annotationset:22ED7220-C6F6-43C5-9DF9-89F62F0F8E27</domeo:belongsToSet>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812eda990003</pav:createdBy>
    <pav:lineageUri>urn:domeoserver:annotation:C1698FA2-C1AE-4B3D-9950-C56ECC1CFB3C</pav:lineageUri>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <ao:context rdf:resource="urn:domeoclient:uuid:1A7382E8-45D1-4872-98EA-20455089A06B"/>
    <pav:createdOn>2014-07-07 11:23:45 -0400</pav:createdOn>
    <rdfs:label>Highlight</rdfs:label>
    <pav:lastSavedOn>2014-07-07 11:24:52 -0400</pav:lastSavedOn>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <domeo:belongsToSet>urn:domeoserver:annotationset:131835A3-C655-4F91-97D4-52CAFF7B7CCA</domeo:belongsToSet>
    <domeo:belongsToSet>urn:domeoserver:annotationset:8F3CF3D9-AADE-4A86-BD42-2924B3D6A406</domeo:belongsToSet>
    <domeo:belongsToSet>urn:domeoserver:annotationset:7AACEF8D-2EBC-4F0B-94B2-190650E562F6</domeo:belongsToSet>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:10BB95F9-1856-4D70-9976-235CE8AD3D39">
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812eda990003</pav:createdBy>
    <ao:body rdf:nodeID="N2a3050d2d2594b3d86b5f5fbdea7e9f1"/>
    <rdfs:label>expertstudy Annotation</rdfs:label>
    <ao:context rdf:resource="urn:domeoclient:uuid:2D04CBBE-379A-4D9F-BDD4-AA3663CD4669"/>
    <domeo:belongsToSet>urn:domeoserver:annotationset:131835A3-C655-4F91-97D4-52CAFF7B7CCA</domeo:belongsToSet>
    <pav:lastSavedOn>2014-07-07 11:36:14 -0400</pav:lastSavedOn>
    <pav:createdOn>2014-07-07 11:36:13 -0400</pav:createdOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#expertstudyAnnotation"/>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <ao:body rdf:nodeID="N777b976cbd3f4c92a82e132e0b0fd8f0"/>
    <pav:lineageUri>urn:domeoserver:annotation:58C251EE-2C78-4764-B2EC-4DBA240A5FD1</pav:lineageUri>
    <domeo:belongsToSet>urn:domeoserver:annotationset:22ED7220-C6F6-43C5-9DF9-89F62F0F8E27</domeo:belongsToSet>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <pav:previousVersion>urn:domeoserver:annotationset:8F3CF3D9-AADE-4A86-BD42-2924B3D6A406</pav:previousVersion>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">5</pav:versionNumber>
    <pav:lineageUri>urn:domeoserver:annotationset:76FD4BB5-DE2F-4FCA-B93D-302185B1A381</pav:lineageUri>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:9273B7AD-9357-4702-9126-48471F347ED0">
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <rdfs:label>Highlight</rdfs:label>
    <ao:context rdf:resource="urn:domeoclient:uuid:2342B6D8-C79F-4015-BB88-4C2608E0EBC6"/>
    <domeo:belongsToSet>urn:domeoserver:annotationset:1FC172B8-8AC3-465A-AA69-B73AD9B97CBC</domeo:belongsToSet>
    <domeo:belongsToSet>urn:domeoclient:uuid:8D86A4AC-54BD-4BB3-8B58-AB55DEC01A88</domeo:belongsToSet>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812eda990003</pav:createdBy>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:lastSavedOn>2014-07-24 20:07:19 -0400</pav:lastSavedOn>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:createdOn>2014-07-24 20:05:44 -0400</pav:createdOn>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <pav:lineageUri>urn:domeoserver:annotationset:4A88D0A6-E9B6-4E7F-955F-3692600C178C</pav:lineageUri>
    <pav:lineageUri>urn:domeoserver:annotation:6F1EEC83-A393-450E-9CAE-684DA163ED74</pav:lineageUri>
    <domeo:belongsToSet>urn:domeoserver:annotationset:37B2514D-1A92-45B1-8A5C-610DA6DC935A</domeo:belongsToSet>
    <pav:lastSavedOn>2014-07-24 20:07:20 -0400</pav:lastSavedOn>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:2D67B7C7-76F8-4FFD-A468-49E9E07064A4">
    <pav:createdOn>2014-09-02 11:42:08 -0400</pav:createdOn>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">2</pav:versionNumber>
    <domeo:belongsToSet>urn:domeoserver:annotationset:A3F0B39A-4249-4B63-BB0D-F24A005066AC</domeo:belongsToSet>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <ao:context rdf:resource="urn:domeoclient:uuid:39EB4A47-EAC7-4A2A-9B4F-05E57C8A10E3"/>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <rdfs:label>Highlight</rdfs:label>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812eda990003</pav:createdBy>
    <pav:lineageUri>urn:domeoserver:annotationset:D1715BD2-BD41-46FD-9454-DC7A423A29AC</pav:lineageUri>
    <domeo:belongsToSet>urn:domeoserver:annotationset:A5DD001D-C81A-4E2E-B5E0-7A866B35E26B</domeo:belongsToSet>
    <pav:lastSavedOn>2014-09-02 11:46:58 -0400</pav:lastSavedOn>
    <pav:previousVersion>urn:domeoclient:uuid:BED41F06-565A-4622-9A88-48810E5A28DE</pav:previousVersion>
    <pav:lineageUri>urn:domeoserver:annotation:2ED00A78-AD79-4059-8CE8-D607E076CD4F</pav:lineageUri>
    <domeo:belongsToSet>urn:domeoserver:annotationset:3F546823-204F-4F9B-9006-3DC526C56931</domeo:belongsToSet>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:8A033E70-6D84-4601-985E-2D559145926B">
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <domeo:belongsToSet>urn:domeoserver:annotationset:A5DD001D-C81A-4E2E-B5E0-7A866B35E26B</domeo:belongsToSet>
    <pav:lineageUri>urn:domeoserver:annotation:00201290-005F-4CF5-9942-78EB2B38087A</pav:lineageUri>
    <rdfs:label>Highlight</rdfs:label>
    <pav:previousVersion>urn:domeoclient:uuid:BED41F06-565A-4622-9A88-48810E5A28DE</pav:previousVersion>
    <pav:createdOn>2014-09-02 11:38:06 -0400</pav:createdOn>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812eda990003</pav:createdBy>
    <domeo:belongsToSet>urn:domeoserver:annotationset:A3F0B39A-4249-4B63-BB0D-F24A005066AC</domeo:belongsToSet>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">2</pav:versionNumber>
    <pav:lineageUri>urn:domeoserver:annotationset:D1715BD2-BD41-46FD-9454-DC7A423A29AC</pav:lineageUri>
    <pav:lastSavedOn>2014-09-02 11:46:58 -0400</pav:lastSavedOn>
    <ao:context rdf:resource="urn:domeoclient:uuid:1B51833F-74F3-4AB3-A6D0-CD524F9F3140"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <domeo:belongsToSet>urn:domeoserver:annotationset:3F546823-204F-4F9B-9006-3DC526C56931</domeo:belongsToSet>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:66762812-3E76-4815-AF5C-6E5A2D4739C3">
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-78.txt.html</ao:hasSource>
    <domeo:uuid>66762812-3E76-4815-AF5C-6E5A2D4739C3</domeo:uuid>
    <ao:prefix> did not alter the mean AUC or Cmax of </ao:prefix>
    <ao:suffix>. The mechanism of this pharmacodynamic interaction is not known.</ao:suffix>
    <pav:createdOn>2014-09-02 19:38:25 -0400</pav:createdOn>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:66762812-3E76-4815-AF5C-6E5A2D4739C3"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:exact>pimozide</ao:exact>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:44246EE4-6542-429C-AE56-DA84A2FDC57F">
    <domeo:belongsToSet>urn:domeoserver:annotationset:A3F0B39A-4249-4B63-BB0D-F24A005066AC</domeo:belongsToSet>
    <pav:createdOn>2014-09-02 11:40:12 -0400</pav:createdOn>
    <pav:previousVersion>urn:domeoclient:uuid:BED41F06-565A-4622-9A88-48810E5A28DE</pav:previousVersion>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <rdfs:label>Highlight</rdfs:label>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:lastSavedOn>2014-09-02 11:46:58 -0400</pav:lastSavedOn>
    <pav:lineageUri>urn:domeoserver:annotationset:D1715BD2-BD41-46FD-9454-DC7A423A29AC</pav:lineageUri>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">2</pav:versionNumber>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812eda990003</pav:createdBy>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <domeo:belongsToSet>urn:domeoserver:annotationset:3F546823-204F-4F9B-9006-3DC526C56931</domeo:belongsToSet>
    <ao:context rdf:resource="urn:domeoclient:uuid:26DA75B4-1584-4219-A170-BBFBF5DAB037"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:lineageUri>urn:domeoserver:annotation:80B436A9-31D5-4B64-8CA7-E1ACB485DA63</pav:lineageUri>
    <domeo:belongsToSet>urn:domeoserver:annotationset:A5DD001D-C81A-4E2E-B5E0-7A866B35E26B</domeo:belongsToSet>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:66A10386-3791-4236-BBA2-9E3AD59B847D">
    <pav:lastSavedOn>2014-07-22 19:44:46 -0400</pav:lastSavedOn>
    <domeo:belongsToSet>urn:domeoserver:annotationset:2914A3FD-DF43-4F78-999C-77CE7A028B19</domeo:belongsToSet>
    <rdfs:label>Highlight</rdfs:label>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <ao:context rdf:resource="urn:domeoclient:uuid:98363801-880A-4060-8919-70CE42916B17"/>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <domeo:belongsToSet>urn:domeoserver:annotationset:F272A789-69D0-47CC-8CC9-F25C55B91261</domeo:belongsToSet>
    <pav:createdOn>2014-07-22 19:42:09 -0400</pav:createdOn>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812eda990003</pav:createdBy>
    <domeo:belongsToSet>urn:domeoserver:annotationset:606A5B3F-B6FB-4279-AA42-7893CFC2D20C</domeo:belongsToSet>
    <pav:lineageUri>urn:domeoserver:annotation:A73A22AA-BCDF-42B3-ACD7-1CBD2F7A3D78</pav:lineageUri>
    <pav:previousVersion>urn:domeoserver:annotationset:514BA51B-D734-4003-A7C3-F03C0F95833A</pav:previousVersion>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">6</pav:versionNumber>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:lineageUri>urn:domeoserver:annotationset:AB1741F1-5A5F-4416-AEAC-A544BCBB7D16</pav:lineageUri>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:69FB098B-12F9-4F1C-AE30-F8B99226F270">
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:exact>propranolol</ao:exact>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:69FB098B-12F9-4F1C-AE30-F8B99226F270"/>
    <domeo:uuid>69FB098B-12F9-4F1C-AE30-F8B99226F270</domeo:uuid>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-129.txt.html</ao:hasSource>
    <ao:prefix>Co-administration of </ao:prefix>
    <pav:createdOn>2014-07-24 19:45:39 -0400</pav:createdOn>
    <ao:suffix> with </ao:suffix>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:0B56F971-EB28-4859-ADD4-58040927A5DF">
    <domeo:uuid>0B56F971-EB28-4859-ADD4-58040927A5DF</domeo:uuid>
    <ao:prefix>There are no clinical studies establishing the benefits or risks of combined use of ECT and </ao:prefix>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-9.txt.html</ao:hasSource>
    <pav:createdOn>2014-09-02 11:49:22 -0400</pav:createdOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:suffix> maleate.</ao:suffix>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:0B56F971-EB28-4859-ADD4-58040927A5DF"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:exact>fluvoxamine</ao:exact>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:25585F8F-7F91-467C-B8DE-9153331081D5">
    <pav:createdOn>2014-09-02 19:13:14 -0400</pav:createdOn>
    <ao:exact>benzodiazepines</ao:exact>
    <domeo:uuid>25585F8F-7F91-467C-B8DE-9153331081D5</domeo:uuid>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:suffix>). Patients should be monitored to determine if it is necessary to adjust the dosage of these drugs when taken concomitantly with omeprazole delayed-release capsules USP.</ao:suffix>
    <ao:prefix> was found, there have been clinical reports of interaction with other drugs metabolized via the cytochrome P450 system (e.g., cyclosporine, disulfiram, </ao:prefix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-74.txt.html</ao:hasSource>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:25585F8F-7F91-467C-B8DE-9153331081D5"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:EB317DCF-ED84-480E-92AF-867EFA3D6E76">
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812eda990003</pav:createdBy>
    <pav:createdOn>2014-07-21 21:42:16 -0400</pav:createdOn>
    <ao:context rdf:resource="urn:domeoclient:uuid:87DA7BB9-8F52-460F-B488-90DD6AC36EFF"/>
    <rdfs:label>Highlight</rdfs:label>
    <pav:lastSavedOn>2014-07-21 21:42:43 -0400</pav:lastSavedOn>
    <domeo:belongsToSet>urn:domeoclient:uuid:BD4B7475-BD13-46C4-932F-139564A0063D</domeo:belongsToSet>
    <pav:lineageUri>urn:domeoserver:annotation:5826AA0F-B3D5-46C2-99FF-C0761E3C5E0D</pav:lineageUri>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:0ACECEC3-3253-49CC-B7BF-D586E8F2D7A4">
    <ao:exact>AVANDIA</ao:exact>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:0ACECEC3-3253-49CC-B7BF-D586E8F2D7A4"/>
    <ao:suffix>.</ao:suffix>
    <ao:prefix> (100 mg three times daily) for 7 days in healthy volunteers had no clinically relevant effect on the pharmacokinetics of a single oral dose of </ao:prefix>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-123.txt.html</ao:hasSource>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <domeo:uuid>0ACECEC3-3253-49CC-B7BF-D586E8F2D7A4</domeo:uuid>
    <pav:createdOn>2014-07-22 20:19:56 -0400</pav:createdOn>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:A68BF389-96D4-4F16-BF9D-C1BF35E3CE01">
    <pav:lineageUri>urn:domeoserver:annotation:F4E434E1-65FE-4D50-BB8B-4B2CA1552C6E</pav:lineageUri>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812eda990003</pav:createdBy>
    <domeo:belongsToSet>urn:domeoserver:annotationset:606A5B3F-B6FB-4279-AA42-7893CFC2D20C</domeo:belongsToSet>
    <pav:lineageUri>urn:domeoserver:annotationset:AB1741F1-5A5F-4416-AEAC-A544BCBB7D16</pav:lineageUri>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:previousVersion>urn:domeoserver:annotationset:467D4F28-D086-4217-9DE0-23E165F30716</pav:previousVersion>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <domeo:belongsToSet>urn:domeoserver:annotationset:7E80543E-BF76-4514-92A9-91458DCB802B</domeo:belongsToSet>
    <domeo:belongsToSet>urn:domeoserver:annotationset:514BA51B-D734-4003-A7C3-F03C0F95833A</domeo:belongsToSet>
    <domeo:belongsToSet>urn:domeoserver:annotationset:2914A3FD-DF43-4F78-999C-77CE7A028B19</domeo:belongsToSet>
    <pav:lastSavedOn>2014-07-22 19:28:02 -0400</pav:lastSavedOn>
    <domeo:belongsToSet>urn:domeoserver:annotationset:7021B883-FD5C-4083-BD87-DF56D3C87633</domeo:belongsToSet>
    <pav:createdOn>2014-07-22 19:26:02 -0400</pav:createdOn>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">3</pav:versionNumber>
    <domeo:belongsToSet>urn:domeoserver:annotationset:F272A789-69D0-47CC-8CC9-F25C55B91261</domeo:belongsToSet>
    <rdfs:label>Highlight</rdfs:label>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <ao:context rdf:resource="urn:domeoclient:uuid:A9F3E7CF-7FCB-472F-9AC5-B1BE53CD842F"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:A6FD6D5D-B7A2-423B-8A6B-8CCFD72983C1">
    <pav:lastSavedOn>2014-07-24 20:14:01 -0400</pav:lastSavedOn>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <domeo:belongsToSet>urn:domeoclient:uuid:7DCD6738-9404-46BB-A758-BDDEB41B4565</domeo:belongsToSet>
    <rdfs:label>Highlight</rdfs:label>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812eda990003</pav:createdBy>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <ao:context rdf:resource="urn:domeoclient:uuid:E2DFE50C-520B-4A09-83FE-8498F429017C"/>
    <pav:createdOn>2014-07-24 20:13:52 -0400</pav:createdOn>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:lineageUri>urn:domeoserver:annotation:D8F80F0D-199C-4FA6-8689-BEE04574348B</pav:lineageUri>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:8DA59D18-94D7-4239-958E-D00E6CCD30E7">
    <ao:prefix>. Subsequent adjustment of doses of </ao:prefix>
    <ao:exact>mercaptopurine </ao:exact>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <pav:createdOn>2014-09-01 16:12:30 -0400</pav:createdOn>
    <ao:suffix>or azathioprine should be made on the basis of therapeutic response and the appearance of toxic effects (see PRECAUTIONS- Drug Interactions).</ao:suffix>
    <domeo:uuid>8DA59D18-94D7-4239-958E-D00E6CCD30E7</domeo:uuid>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:8DA59D18-94D7-4239-958E-D00E6CCD30E7"/>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-42.txt.html</ao:hasSource>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:DC77541A-190C-4C62-930E-9CF52E6C4A67">
    <pav:lineageUri>urn:domeoserver:annotationset:C5DEBC9B-77EE-4243-88EB-DBC19737ACD2</pav:lineageUri>
    <pav:lineageUri>urn:domeoserver:annotation:82BF60E1-FA27-433C-87E9-B7093A7EA796</pav:lineageUri>
    <pav:lastSavedOn>2014-09-02 19:19:47 -0400</pav:lastSavedOn>
    <domeo:belongsToSet>urn:domeoserver:annotationset:E32812A9-205B-4EE1-B488-A1E294EDBFB9</domeo:belongsToSet>
    <pav:createdOn>2014-09-02 19:13:16 -0400</pav:createdOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812eda990003</pav:createdBy>
    <rdfs:label>Highlight</rdfs:label>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <domeo:belongsToSet>urn:domeoclient:uuid:CB83FFC2-EA71-44EA-8F11-DE80E389C84E</domeo:belongsToSet>
    <ao:context rdf:resource="urn:domeoclient:uuid:CC3DAA6B-4FED-42FC-B83D-E1EECF33E119"/>
    <domeo:belongsToSet>urn:domeoserver:annotationset:392EE0FB-AC4F-4AF2-87A6-2E50A281F434</domeo:belongsToSet>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:120B172A-5B0A-4411-BB16-2CE6618D971C">
    <rdfs:label>Highlight</rdfs:label>
    <ao:context rdf:resource="urn:domeoclient:uuid:8CCC8C43-B443-46E4-8630-042448CA24F6"/>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:createdOn>2014-07-21 21:26:52 -0400</pav:createdOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <domeo:belongsToSet>urn:domeoclient:uuid:B6F745E6-5734-4636-A383-683BA4C79E38</domeo:belongsToSet>
    <pav:lastSavedOn>2014-07-21 21:27:51 -0400</pav:lastSavedOn>
    <pav:lineageUri>urn:domeoserver:annotation:4D5053F3-2E7B-45B1-9C0B-62DBD3C8B27C</pav:lineageUri>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812eda990003</pav:createdBy>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:71782464-053E-46F0-8930-DB2CDA0F1338">
    <ao:exact>erythromycin</ao:exact>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <pav:createdOn>2014-07-24 20:11:41 -0400</pav:createdOn>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:71782464-053E-46F0-8930-DB2CDA0F1338"/>
    <ao:suffix> coadministration enhances fexofenadine gastrointestinal absorption. This observed increase in the bioavailability of fexofenadine may be due to transport-related effects, such as p-glycoprotein. In vivo animal studies also suggest that in addition to en</ao:suffix>
    <domeo:uuid>71782464-053E-46F0-8930-DB2CDA0F1338</domeo:uuid>
    <ao:prefix> or </ao:prefix>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-139.txt.html</ao:hasSource>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:49F8A244-9291-40F9-AE95-B64DDF5E624D">
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-155.txt.html</ao:hasSource>
    <domeo:uuid>49F8A244-9291-40F9-AE95-B64DDF5E624D</domeo:uuid>
    <domeo:uuid></domeo:uuid>
    <ao:prefix>xsd:String</ao:prefix>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:49F8A244-9291-40F9-AE95-B64DDF5E624D"/>
    <ao:suffix> are both approximately 96% bound to plasma proteins. Protein binding is independent of total drug concentrations.</ao:suffix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <pav:createdOn>2014-07-07 09:57:03 -0400</pav:createdOn>
    <ao:exact>metabolite</ao:exact>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:19AF6A28-5E1F-4E38-963D-A9F4633CDDE9">
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-74.txt.html</ao:hasSource>
    <ao:suffix>/ritonavir (1000/100 mg) bid for 15 days with omeprazole 40 mg qd co-administered days 11 to 15. Dose reduction of saquinavir should be considered from the safety perspective for individual patients. There are also some antiretroviral drugs of which unch</ao:suffix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:19AF6A28-5E1F-4E38-963D-A9F4633CDDE9"/>
    <ao:prefix>, elevated serum levels have been reported with an increase in AUC by 82%, in Cmax by 75% and in Cmin by 106% following multiple dosing of </ao:prefix>
    <domeo:uuid>19AF6A28-5E1F-4E38-963D-A9F4633CDDE9</domeo:uuid>
    <pav:createdOn>2014-09-02 19:19:04 -0400</pav:createdOn>
    <ao:exact>saquinavir</ao:exact>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:F6644A5F-920F-4CAA-86BD-086A69F19FA5">
    <ao:suffix> AUC by 66%, compared to the administration of rosiglitazone (8 mg) alone [see Drug Interactions (7.1)].4</ao:suffix>
    <domeo:uuid>F6644A5F-920F-4CAA-86BD-086A69F19FA5</domeo:uuid>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:prefix> administration (600 mg once a day), an inducer of CYP2C8, for 6 days is reported to decrease </ao:prefix>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:F6644A5F-920F-4CAA-86BD-086A69F19FA5"/>
    <pav:createdOn>2014-07-22 19:43:42 -0400</pav:createdOn>
    <ao:exact>rosiglitazone</ao:exact>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-123.txt.html</ao:hasSource>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:FF9C19C8-A145-4276-833C-C3641196A24F">
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-28.txt.html</ao:hasSource>
    <ao:suffix>xsd:String</ao:suffix>
    <ao:prefix>xsd:String</ao:prefix>
    <domeo:uuid>FF9C19C8-A145-4276-833C-C3641196A24F</domeo:uuid>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:exact>The pharmacokinetics of theophylline were determined from a single intravenous dose of aminophylline (6 mg/kg) before and after the oral administration of fluconazole 200 mg daily for 14 days in 16 normal male volunteers. There were significant increases in theophylline AUC, Cmax, and half-life with a corresponding decrease in clearance. The mean ± SD theophylline AUC increased 21% ± 16% (range: -5 to 48%). The Cmax increased 13% ± 17% (range: -13 to 40%). Theophylline clearance decreased 16% ± 11 % (range: -32 to 5%). The half-life of theophylline increased from 6.6 ± 1.7 hours to 7.9 ± 1.5 hours. (See PRECAUTIONS.)</ao:exact>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:FF9C19C8-A145-4276-833C-C3641196A24F"/>
    <pav:createdOn>2014-07-21 21:35:21 -0400</pav:createdOn>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:CF43541C-6D0C-436D-805F-CCE8AF9ED52C">
    <ao:suffix> in healthy volunteers. These results suggest that the absorption of oral rosiglitazone is not altered in conditions accompanied by increases in gastrointestinal pH.</ao:suffix>
    <pav:createdOn>2014-07-22 20:18:40 -0400</pav:createdOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:CF43541C-6D0C-436D-805F-CCE8AF9ED52C"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <domeo:uuid>CF43541C-6D0C-436D-805F-CCE8AF9ED52C</domeo:uuid>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-123.txt.html</ao:hasSource>
    <ao:prefix> (150 mg twice daily for 4 days) did not alter the pharmacokinetics of either single oral or intravenous doses of </ao:prefix>
    <ao:exact>rosiglitazone</ao:exact>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:D599C322-4D76-48B0-9A8D-27A82819F5D2">
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812eda990003</pav:createdBy>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <ao:context rdf:resource="urn:domeoclient:uuid:2FC590A9-4A32-43E3-8740-436A834AADD1"/>
    <pav:lineageUri>urn:domeoserver:annotation:1DC02DA4-9C12-4D4D-BD0C-036E8049CF14</pav:lineageUri>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <pav:lastSavedOn>2014-07-22 18:37:42 -0400</pav:lastSavedOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <domeo:belongsToSet>urn:domeoclient:uuid:9FA29E53-6B1B-4856-B5BD-22A93164E58E</domeo:belongsToSet>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <rdfs:label>Highlight</rdfs:label>
    <pav:createdOn>2014-07-22 18:37:42 -0400</pav:createdOn>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:205F8706-B144-4ED0-9F00-551E6481AD6D">
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-129.txt.html</ao:hasSource>
    <ao:prefix>, a non-specific CYP450 inhibitor, increased </ao:prefix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <domeo:uuid>205F8706-B144-4ED0-9F00-551E6481AD6D</domeo:uuid>
    <pav:createdOn>2014-07-24 19:45:44 -0400</pav:createdOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:suffix> AUC and Cmax by 46% and 35%, respectively. Co-administration with aluminum hydroxide gel (1200 mg) may result in a decrease in propranolol concentrations.</ao:suffix>
    <ao:exact>propranolol</ao:exact>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:205F8706-B144-4ED0-9F00-551E6481AD6D"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:2FC590A9-4A32-43E3-8740-436A834AADD1">
    <ao:exact>zonisamide</ao:exact>
    <ao:suffix> who experienced an event on at least one occasion. All events are included except those already listed in the previous table or discussed in WARNINGS or PRECAUTIONS, trivial events, those too general to be informative, and those not reasonably associate</ao:suffix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-58.txt.html</ao:hasSource>
    <domeo:uuid>2FC590A9-4A32-43E3-8740-436A834AADD1</domeo:uuid>
    <pav:createdOn>2014-07-22 18:37:42 -0400</pav:createdOn>
    <ao:prefix>e of the proportion of individuals having adverse events, similar events have been grouped into a smaller number of standardized categories using a modified COSTART dictionary. The frequencies represent the proportion of the 1,598 individuals exposed to </ao:prefix>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:2FC590A9-4A32-43E3-8740-436A834AADD1"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:C0EC2FB2-F825-49D1-A3E4-EA98B976BFED">
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-123.txt.html</ao:hasSource>
    <ao:prefix>Maximum plasma concentration (Cmax) and the area under the curve (AUC) of </ao:prefix>
    <ao:exact>rosiglitazon</ao:exact>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <domeo:uuid>C0EC2FB2-F825-49D1-A3E4-EA98B976BFED</domeo:uuid>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <pav:createdOn>2014-07-22 19:22:52 -0400</pav:createdOn>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:C0EC2FB2-F825-49D1-A3E4-EA98B976BFED"/>
    <ao:suffix>e increase in a dose-proportional manner over the therapeutic dose range (Table 8). The elimination half-life is 3 to 4 hours and is independent of dose.</ao:suffix>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:0C4061A3-979D-486B-9CDA-1CFF771CCB5B">
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <ao:context rdf:resource="urn:domeoclient:uuid:ABF527C0-D635-49E4-BC45-911EBB72D2E8"/>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812eda990003</pav:createdBy>
    <pav:lastSavedOn>2014-07-13 11:32:29 -0400</pav:lastSavedOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:createdOn>2014-07-13 11:10:47 -0400</pav:createdOn>
    <rdfs:label>Highlight</rdfs:label>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <domeo:belongsToSet>urn:domeoclient:uuid:71191E51-53CB-4FDE-88D0-33C6818E2232</domeo:belongsToSet>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <pav:lineageUri>urn:domeoserver:annotation:67C400B9-D19B-4746-9FE2-12A58EE79507</pav:lineageUri>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:54953EDA-07BE-4F30-8DE9-32B9DFDAC13D">
    <ao:prefix>xsd:String</ao:prefix>
    <ao:suffix>xsd:String</ao:suffix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-53.txt.html</ao:hasSource>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <domeo:uuid>54953EDA-07BE-4F30-8DE9-32B9DFDAC13D</domeo:uuid>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:54953EDA-07BE-4F30-8DE9-32B9DFDAC13D"/>
    <pav:createdOn>2014-07-21 21:47:00 -0400</pav:createdOn>
    <ao:exact>Perhaps because of competition for the P450 3A4metabolic pathway, quinidine levels rise when ketoconazole is coadministered.</ao:exact>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:585BED0D-5182-4D39-912D-F355B5BEA6BA">
    <pav:lineageUri>urn:domeoserver:annotationset:AB1741F1-5A5F-4416-AEAC-A544BCBB7D16</pav:lineageUri>
    <domeo:belongsToSet>urn:domeoserver:annotationset:467D4F28-D086-4217-9DE0-23E165F30716</domeo:belongsToSet>
    <pav:lastSavedOn>2014-07-22 19:11:41 -0400</pav:lastSavedOn>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812eda990003</pav:createdBy>
    <ao:context rdf:resource="urn:domeoclient:uuid:2363FCF8-4364-4BDB-BB21-5EDBFD6F753B"/>
    <pav:lineageUri>urn:domeoserver:annotation:11E9ED0A-D5A8-4788-BFD1-B21FEFC646F1</pav:lineageUri>
    <domeo:belongsToSet>urn:domeoserver:annotationset:7021B883-FD5C-4083-BD87-DF56D3C87633</domeo:belongsToSet>
    <pav:lastSavedOn>2014-07-22 19:11:40 -0400</pav:lastSavedOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <rdfs:label>Highlight</rdfs:label>
    <domeo:belongsToSet>urn:domeoserver:annotationset:514BA51B-D734-4003-A7C3-F03C0F95833A</domeo:belongsToSet>
    <pav:createdOn>2014-07-22 19:11:19 -0400</pav:createdOn>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <domeo:belongsToSet>urn:domeoserver:annotationset:606A5B3F-B6FB-4279-AA42-7893CFC2D20C</domeo:belongsToSet>
    <domeo:belongsToSet>urn:domeoserver:annotationset:2914A3FD-DF43-4F78-999C-77CE7A028B19</domeo:belongsToSet>
    <domeo:belongsToSet>urn:domeoclient:uuid:BE4B86AC-FE5F-4543-A713-EC5B852A5A2A</domeo:belongsToSet>
    <domeo:belongsToSet>urn:domeoserver:annotationset:7E80543E-BF76-4514-92A9-91458DCB802B</domeo:belongsToSet>
    <domeo:belongsToSet>urn:domeoserver:annotationset:F272A789-69D0-47CC-8CC9-F25C55B91261</domeo:belongsToSet>
  </rdf:Description>
  <rdf:Description rdf:nodeID="Necbd12bde3994d17bd7db8a39bb1c584">
    <permissions:isLocked>false</permissions:isLocked>
    <permissions:accessType>urn:domeo:access:public</permissions:accessType>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:76B68D47-1D9C-4B2A-B9A6-CFE359C93E64">
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <domeo:uuid>76B68D47-1D9C-4B2A-B9A6-CFE359C93E64</domeo:uuid>
    <pav:createdOn>2014-07-13 12:56:09 -0400</pav:createdOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:suffix> AUC of 23% ± 9% (range: -13 to -42%). Apparent oral clearance of fluconazole increased 32% ± 17% (range: 16 to 72%). Fluconazole half-life decreased from 33.4 ± 4.4 hours to 26.8 ± 3.9 hours. (See PRECAUTIONS.)</ao:suffix>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-24.txt.html</ao:hasSource>
    <ao:prefix>. There was a mean ± SD reduction in </ao:prefix>
    <ao:exact>fluconazole</ao:exact>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:76B68D47-1D9C-4B2A-B9A6-CFE359C93E64"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:F3F94F7A-3299-4ECD-8A0C-54D9B0E17A6D">
    <ao:prefix> rapidly into </ao:prefix>
    <domeo:uuid>F3F94F7A-3299-4ECD-8A0C-54D9B0E17A6D</domeo:uuid>
    <ao:suffix>, whereas poor CYP 2D6 metabolizers convert it much more slowly. Although extensive metabolizers have lower risperidone and higher 9-hydroxyrisperidone concentrations than poor metabolizers, the pharmacokinetics of risperidone and 9-hydroxyrisperidone co</ao:suffix>
    <ao:exact>9-hydroxyrisperidone</ao:exact>
    <pav:createdOn>2014-07-13 11:13:30 -0400</pav:createdOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-8.txt.html</ao:hasSource>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:F3F94F7A-3299-4ECD-8A0C-54D9B0E17A6D"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:7C414A6F-D97C-4DE2-83B7-8EA499CCDE11">
    <domeo:uuid>7C414A6F-D97C-4DE2-83B7-8EA499CCDE11</domeo:uuid>
    <ao:prefix> in 14 healthy adult subjects had no clinically significant effect on the steady-state pharmacokinetics of </ao:prefix>
    <pav:createdOn>2014-07-22 19:53:20 -0400</pav:createdOn>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-123.txt.html</ao:hasSource>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:7C414A6F-D97C-4DE2-83B7-8EA499CCDE11"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:exact>AVANDIA</ao:exact>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:suffix>. No clinically significant reductions in glimepiride AUC and Cmax were observed after repeat doses of AVANDIA (8 mg once daily) for 8 days in healthy adult subjects.</ao:suffix>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:E50BE5A6-0C68-4839-AB64-4D7AED50EDAC">
    <pav:lastSavedOn>2014-07-22 19:54:59 -0400</pav:lastSavedOn>
    <domeo:belongsToSet>urn:domeoserver:annotationset:F272A789-69D0-47CC-8CC9-F25C55B91261</domeo:belongsToSet>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812eda990003</pav:createdBy>
    <pav:lineageUri>urn:domeoserver:annotationset:AB1741F1-5A5F-4416-AEAC-A544BCBB7D16</pav:lineageUri>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:createdOn>2014-07-22 19:49:08 -0400</pav:createdOn>
    <domeo:belongsToSet>urn:domeoserver:annotationset:2914A3FD-DF43-4F78-999C-77CE7A028B19</domeo:belongsToSet>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <rdfs:label>Highlight</rdfs:label>
    <ao:context rdf:resource="urn:domeoclient:uuid:1BD555DB-DE08-478A-98FE-8A631606CA83"/>
    <pav:lineageUri>urn:domeoserver:annotation:7B0C65E4-7AA9-443D-BB5F-2C807CD28619</pav:lineageUri>
    <pav:previousVersion>urn:domeoserver:annotationset:606A5B3F-B6FB-4279-AA42-7893CFC2D20C</pav:previousVersion>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">7</pav:versionNumber>
  </rdf:Description>
  <rdf:Description rdf:about="urn:person:uuid:080e143046812afe0146812eda990003">
    <foafx:email>nonexpert2@gmail.com</foafx:email>
    <foafx:middlename></foafx:middlename>
    <foafx:name>nonexpert2</foafx:name>
    <foafx:lastname>2</foafx:lastname>
    <foafx:title>nonexpert2</foafx:title>
    <rdfs:label>nonexpert2</rdfs:label>
    <rdf:type rdf:resource="http://xmlns.com/foaf/0.1/Person"/>
    <foafx:homepage></foafx:homepage>
    <foafx:picture>http://www.hcklab.org/images/me/paolo%20ciccarese-boston.jpg</foafx:picture>
    <foafx:firstname>nonexpert</foafx:firstname>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:BD4B7475-BD13-46C4-932F-139564A0063D">
    <ao:item rdf:resource="urn:domeoclient:uuid:0C0CF158-24A6-445D-B09F-EA2C2052959E"/>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812eda990003</pav:createdBy>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <domeo:deleted>false</domeo:deleted>
    <permissions:permissions rdf:nodeID="N338d4b4b54f1412b8351fede6a9e0c18"/>
    <domeo:agents rdf:resource="urn:domeo:software:id:Domeo-2.1alpha-050"/>
    <pav:createdOn>2014-07-21 21:42:03 -0400</pav:createdOn>
    <pav:lineageUri>urn:domeoserver:annotationset:6BA39DFC-7B82-4E59-8309-2C37AF881D40</pav:lineageUri>
    <ao:item rdf:resource="urn:domeoclient:uuid:EB317DCF-ED84-480E-92AF-867EFA3D6E76"/>
    <pav:lastSavedOn>2014-07-21 21:42:43 -0400</pav:lastSavedOn>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <rdfs:label>Default Set</rdfs:label>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <ao:item rdf:resource="urn:domeoclient:uuid:F0BD5D38-FA1E-4B14-9F0A-76765ADF5FEE"/>
    <domeo:agents rdf:resource="urn:person:uuid:080e143046812afe0146812eda990003"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#AnnotationSet"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:3E4DD9DD-ACD7-4BE1-99C4-C10C579DD83A"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:A98AC7AB-8326-46FF-A484-D9D3774E511A"/>
    <dct:description>The default set is created automatically by Domeo when no other set is existing.</dct:description>
    <ao:annotatesResource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-50.txt.html</ao:annotatesResource>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:78651239-7677-4E29-8D57-C04613A83C19">
    <ao:exact>paroxetine</ao:exact>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:suffix>.</ao:suffix>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-47.txt.html</ao:hasSource>
    <ao:prefix> be initiated at a reduced dose when given with </ao:prefix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <pav:createdOn>2014-09-02 12:03:50 -0400</pav:createdOn>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:78651239-7677-4E29-8D57-C04613A83C19"/>
    <domeo:uuid>78651239-7677-4E29-8D57-C04613A83C19</domeo:uuid>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:F2CEE4B1-2371-4B8E-B2D2-F9EED99532CB">
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:suffix> and nelfinavir is therefore not recommended. For other antiretroviral drugs, such as saquinavir, elevated serum levels have been reported with an increase in AUC by 82%, in Cmax by 75% and in Cmin by 106% following multiple dosing of saquinavir/ritonavi</ao:suffix>
    <domeo:uuid>F2CEE4B1-2371-4B8E-B2D2-F9EED99532CB</domeo:uuid>
    <ao:prefix> (40 mg, qd, 2 hr before atazanavir), AUC was decreased by 94%, Cmax by 96%, and Cmin by 95%. Concomitant administration with omeprazole and drugs such as </ao:prefix>
    <ao:exact>atazanavir</ao:exact>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:F2CEE4B1-2371-4B8E-B2D2-F9EED99532CB"/>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-74.txt.html</ao:hasSource>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <pav:createdOn>2014-09-02 19:18:40 -0400</pav:createdOn>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:2342B6D8-C79F-4015-BB88-4C2608E0EBC6">
    <ao:prefix> containing antacids. In healthy adult subjects, administration of 120 mg of </ao:prefix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <domeo:uuid>2342B6D8-C79F-4015-BB88-4C2608E0EBC6</domeo:uuid>
    <ao:exact>fexofenadine hydrochloride</ao:exact>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:2342B6D8-C79F-4015-BB88-4C2608E0EBC6"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:suffix> (2 × 60 mg capsule) within 15 minutes of an aluminum and magnesium containing antacid (Maalox®1) decreased fexofenadine AUC by 41% and Cmax by 43%.</ao:suffix>
    <pav:createdOn>2014-07-24 20:05:44 -0400</pav:createdOn>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-139.txt.html</ao:hasSource>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:BD929BB0-93FC-4E77-9CA8-72C96F88EBB3">
    <ao:context rdf:resource="urn:domeoclient:uuid:A2F4B6D6-7CF7-42D6-A019-60A8CCB4F364"/>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812eda990003</pav:createdBy>
    <pav:createdOn>2014-07-22 19:55:29 -0400</pav:createdOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <rdfs:label>Highlight</rdfs:label>
    <pav:lastSavedOn>2014-07-22 20:22:38 -0400</pav:lastSavedOn>
    <pav:lineageUri>urn:domeoserver:annotation:FBC12C20-ABFB-48FF-87DF-D79ED53A9F20</pav:lineageUri>
    <domeo:belongsToSet>urn:domeoserver:annotationset:F272A789-69D0-47CC-8CC9-F25C55B91261</domeo:belongsToSet>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:8B475492-95FE-4CDD-81AE-94DFEEB91E11">
    <domeo:belongsToSet>urn:domeoclient:uuid:71191E51-53CB-4FDE-88D0-33C6818E2232</domeo:belongsToSet>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:createdOn>2014-07-13 11:09:25 -0400</pav:createdOn>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812eda990003</pav:createdBy>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <rdfs:label>Highlight</rdfs:label>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:lineageUri>urn:domeoserver:annotation:D6AADC58-2D29-4DC9-83E4-5252DDC68D2C</pav:lineageUri>
    <pav:lastSavedOn>2014-07-13 11:32:29 -0400</pav:lastSavedOn>
    <ao:context rdf:resource="urn:domeoclient:uuid:46780EA4-462F-4B55-AB22-23CB7FC82C80"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:F895E903-9E93-41BD-BED1-2EA2CE628B45">
    <domeo:belongsToSet>urn:domeoserver:annotationset:7021B883-FD5C-4083-BD87-DF56D3C87633</domeo:belongsToSet>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">3</pav:versionNumber>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <ao:context rdf:resource="urn:domeoclient:uuid:DC75BC49-9657-4DDD-BA6E-E382607C98F8"/>
    <domeo:belongsToSet>urn:domeoserver:annotationset:F272A789-69D0-47CC-8CC9-F25C55B91261</domeo:belongsToSet>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <rdfs:label>Highlight</rdfs:label>
    <pav:lineageUri>urn:domeoserver:annotation:C62E3EE8-5C20-4F01-92D8-4BFED87F0DE9</pav:lineageUri>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812eda990003</pav:createdBy>
    <domeo:belongsToSet>urn:domeoserver:annotationset:606A5B3F-B6FB-4279-AA42-7893CFC2D20C</domeo:belongsToSet>
    <pav:lineageUri>urn:domeoserver:annotationset:AB1741F1-5A5F-4416-AEAC-A544BCBB7D16</pav:lineageUri>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:previousVersion>urn:domeoserver:annotationset:467D4F28-D086-4217-9DE0-23E165F30716</pav:previousVersion>
    <pav:createdOn>2014-07-22 19:22:19 -0400</pav:createdOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <domeo:belongsToSet>urn:domeoserver:annotationset:7E80543E-BF76-4514-92A9-91458DCB802B</domeo:belongsToSet>
    <domeo:belongsToSet>urn:domeoserver:annotationset:514BA51B-D734-4003-A7C3-F03C0F95833A</domeo:belongsToSet>
    <domeo:belongsToSet>urn:domeoserver:annotationset:2914A3FD-DF43-4F78-999C-77CE7A028B19</domeo:belongsToSet>
    <pav:lastSavedOn>2014-07-22 19:28:02 -0400</pav:lastSavedOn>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:A3ECFEEE-C693-4117-91FB-027FB8CFC391">
    <pav:previousVersion>urn:domeoclient:uuid:BED41F06-565A-4622-9A88-48810E5A28DE</pav:previousVersion>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812eda990003</pav:createdBy>
    <pav:lineageUri>urn:domeoserver:annotationset:D1715BD2-BD41-46FD-9454-DC7A423A29AC</pav:lineageUri>
    <domeo:belongsToSet>urn:domeoserver:annotationset:3F546823-204F-4F9B-9006-3DC526C56931</domeo:belongsToSet>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <domeo:belongsToSet>urn:domeoserver:annotationset:A5DD001D-C81A-4E2E-B5E0-7A866B35E26B</domeo:belongsToSet>
    <pav:lastSavedOn>2014-09-02 11:46:58 -0400</pav:lastSavedOn>
    <ao:context rdf:resource="urn:domeoclient:uuid:D3D401FD-5D13-4E47-A4E2-A367B34A8F2B"/>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:createdOn>2014-09-02 11:36:01 -0400</pav:createdOn>
    <domeo:belongsToSet>urn:domeoserver:annotationset:A3F0B39A-4249-4B63-BB0D-F24A005066AC</domeo:belongsToSet>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">2</pav:versionNumber>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:lineageUri>urn:domeoserver:annotation:DDDD1FD7-5E0D-42EA-AEC7-FE6CDD971A5F</pav:lineageUri>
    <rdfs:label>Highlight</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:1D1D462E-3009-4EB1-A982-ED88FF1CE34A">
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <ao:context rdf:resource="urn:domeoclient:uuid:D5584BFA-AB83-49EE-A2F1-68159AD3AEAC"/>
    <pav:lineageUri>urn:domeoserver:annotationset:D1715BD2-BD41-46FD-9454-DC7A423A29AC</pav:lineageUri>
    <domeo:belongsToSet>urn:domeoserver:annotationset:3F546823-204F-4F9B-9006-3DC526C56931</domeo:belongsToSet>
    <rdfs:label>Highlight</rdfs:label>
    <pav:lastSavedOn>2014-09-02 11:46:58 -0400</pav:lastSavedOn>
    <domeo:belongsToSet>urn:domeoserver:annotationset:A5DD001D-C81A-4E2E-B5E0-7A866B35E26B</domeo:belongsToSet>
    <domeo:belongsToSet>urn:domeoserver:annotationset:A3F0B39A-4249-4B63-BB0D-F24A005066AC</domeo:belongsToSet>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812eda990003</pav:createdBy>
    <pav:createdOn>2014-09-02 11:38:45 -0400</pav:createdOn>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">2</pav:versionNumber>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:previousVersion>urn:domeoclient:uuid:BED41F06-565A-4622-9A88-48810E5A28DE</pav:previousVersion>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <pav:lineageUri>urn:domeoserver:annotation:CA7D8289-16DF-49DF-85D3-F44469CC5BE5</pav:lineageUri>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:CD89FD03-D99F-41BD-9614-0F760DFF0EFC">
    <ao:prefix> has been shown to exhibit minimal (ca. 5%) metabolism. However, coadministration of </ao:prefix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <pav:createdOn>2014-07-24 20:07:14 -0400</pav:createdOn>
    <ao:exact>fexofenadine hydrochloride</ao:exact>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-139.txt.html</ao:hasSource>
    <domeo:uuid>CD89FD03-D99F-41BD-9614-0F760DFF0EFC</domeo:uuid>
    <ao:suffix> with either ketoconazole or erythromycin led to increased plasma concentrations of fexofenadine in healthy adult subjects. Fexofenadine had no effect on the pharmacokinetics of either erythromycin or ketoconazole. In two separate studies in healthy adul</ao:suffix>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:CD89FD03-D99F-41BD-9614-0F760DFF0EFC"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:DC193B15-53DF-4479-BA9B-BCE880C4232C">
    <pav:lineageUri>urn:domeoserver:annotation:98202FCE-E474-49D7-9BB0-19337824E18A</pav:lineageUri>
    <pav:lastSavedOn>2014-09-01 16:06:18 -0400</pav:lastSavedOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <rdfs:label>Highlight</rdfs:label>
    <domeo:belongsToSet>urn:domeoclient:uuid:A84DE8F6-26B7-471D-8309-4E7CC2994FDF</domeo:belongsToSet>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812eda990003</pav:createdBy>
    <ao:context rdf:resource="urn:domeoclient:uuid:04984965-B2D0-4ECE-8862-143E95A2279E"/>
    <pav:createdOn>2014-09-01 16:06:03 -0400</pav:createdOn>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:23567EF7-7482-444A-B1F6-5AAA9D43E54A">
    <ao:item rdf:resource="urn:domeoclient:uuid:1B6E9A08-C112-4656-8901-F8802CD64317"/>
    <dct:description>The default set is created automatically by Domeo when no other set is existing.</dct:description>
    <pav:lineageUri>urn:domeoserver:annotationset:CE4C4228-2925-4DF5-84E2-5A5B519C5595</pav:lineageUri>
    <domeo:agents rdf:resource="urn:domeo:software:id:Domeo-2.1alpha-050"/>
    <permissions:permissions rdf:nodeID="Na7bed5b05e634d2a9cf00a98762765c8"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:5A5707CC-D3AC-4807-9E98-6536CDC7AC55"/>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <rdfs:label>Default Set</rdfs:label>
    <ao:item rdf:resource="urn:domeoclient:uuid:67CFE2D6-F2AA-4465-A433-B26BEA64FB5E"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:BB4AA59B-BD34-4506-A617-157D639949C4"/>
    <domeo:deleted>false</domeo:deleted>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812eda990003</pav:createdBy>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#AnnotationSet"/>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <ao:item rdf:resource="urn:domeoclient:uuid:A0645479-B3CA-4505-B451-B003C3B19554"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:010AF63D-C71E-4A93-9F41-8E5764F068ED"/>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <pav:lastSavedOn>2014-07-13 12:45:54 -0400</pav:lastSavedOn>
    <domeo:agents rdf:resource="urn:person:uuid:080e143046812afe0146812eda990003"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:2EC3D9EC-E1A7-4DD1-A006-50B08564335E"/>
    <pav:createdOn>2014-07-13 12:41:59 -0400</pav:createdOn>
    <ao:item rdf:resource="urn:domeoclient:uuid:F0E54D90-28C4-48FD-B72C-21011511DD58"/>
    <ao:annotatesResource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-22.txt.html</ao:annotatesResource>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/39638090-D8E9-46BA-A5C4-A4210E7F0DCB">
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/active-ingredient"/>
    <rdfs:label>rosiglitazone</rdfs:label>
    <dct:description>Referred to the drug in the interaction.</dct:description>
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/84108</dailymed:activeMoietyRxCUI>
    <sio:SIO_000228>dikbD2R:precipitant-drug-of-interaction</sio:SIO_000228>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:8BA43995-3A5A-44A6-AEC6-73AB1675E1DE">
    <pav:createdOn>2014-09-02 19:10:44 -0400</pav:createdOn>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812eda990003</pav:createdBy>
    <domeo:belongsToSet>urn:domeoclient:uuid:3966BCFB-CA02-4053-828D-3860558E7BE8</domeo:belongsToSet>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <ao:context rdf:resource="urn:domeoclient:uuid:4B7476C3-D9FB-4C21-AF95-2B4CD2143061"/>
    <pav:lineageUri>urn:domeoserver:annotation:C91B79D0-C0A0-4540-8068-2730CADBF44E</pav:lineageUri>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <rdfs:label>Highlight</rdfs:label>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:lastSavedOn>2014-09-02 19:11:13 -0400</pav:lastSavedOn>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:93C83EDE-36D5-4436-B242-D2D391BA499C">
    <domeo:uuid>93C83EDE-36D5-4436-B242-D2D391BA499C</domeo:uuid>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:suffix>was co-administered with cytochrome P450 3A4 substrates, terfenadine, carbamazepine, or cisapride under steady-state conditions. The results of these studies indicated that sertraline did not increase plasma concentrations of terfenadine, carbamazepine, </ao:suffix>
    <ao:prefix>In three separate in vivo interaction studies, </ao:prefix>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:93C83EDE-36D5-4436-B242-D2D391BA499C"/>
    <pav:createdOn>2014-09-01 16:05:52 -0400</pav:createdOn>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-16.txt.html</ao:hasSource>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:exact>sertraline </ao:exact>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:A30DCF7F-AD5F-403E-9FF6-A1CEC51B4252">
    <ao:context rdf:resource="urn:domeoclient:uuid:16BAA0E0-EEEC-4785-9C63-DBB8909400D3"/>
    <domeo:belongsToSet>urn:domeoserver:annotationset:392EE0FB-AC4F-4AF2-87A6-2E50A281F434</domeo:belongsToSet>
    <pav:lineageUri>urn:domeoserver:annotationset:C5DEBC9B-77EE-4243-88EB-DBC19737ACD2</pav:lineageUri>
    <pav:createdOn>2014-09-02 19:16:32 -0400</pav:createdOn>
    <domeo:belongsToSet>urn:domeoclient:uuid:CB83FFC2-EA71-44EA-8F11-DE80E389C84E</domeo:belongsToSet>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <rdfs:label>Highlight</rdfs:label>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812eda990003</pav:createdBy>
    <domeo:belongsToSet>urn:domeoserver:annotationset:E32812A9-205B-4EE1-B488-A1E294EDBFB9</domeo:belongsToSet>
    <pav:lineageUri>urn:domeoserver:annotation:2C7FEF8C-D874-4B58-98B7-67ACE9FCAC07</pav:lineageUri>
    <pav:lastSavedOn>2014-09-02 19:19:47 -0400</pav:lastSavedOn>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:43D69C84-CE2E-4308-B875-6976981E58BC">
    <ao:exact>omeprazole</ao:exact>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <domeo:uuid>43D69C84-CE2E-4308-B875-6976981E58BC</domeo:uuid>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-74.txt.html</ao:hasSource>
    <pav:createdOn>2014-09-02 19:19:11 -0400</pav:createdOn>
    <ao:suffix> 40 mg qd co-administered days 11 to 15. Dose reduction of saquinavir should be considered from the safety perspective for individual patients. There are also some antiretroviral drugs of which unchanged serum levels have been reported when given with om</ao:suffix>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:43D69C84-CE2E-4308-B875-6976981E58BC"/>
    <ao:prefix> (1000/100 mg) bid for 15 days with </ao:prefix>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/BD0AC8FF-8734-4C34-ADDF-43EE98A0C2CD">
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/87636</dailymed:activeMoietyRxCUI>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/active-ingredient"/>
    <dct:description>Referred to the drug in the interaction.</dct:description>
    <sio:SIO_000228>dikbD2R:object-drug-of-interaction</sio:SIO_000228>
    <rdfs:label>Fexofenadine</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:3B8303DC-666E-48AC-A169-56BEAEB6610A">
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:exact>metoprolol</ao:exact>
    <pav:createdOn>2014-09-02 11:45:59 -0400</pav:createdOn>
    <ao:suffix> is coadministered with fluvoxamine maleate tablets, a reduction in the initial beta-blocker dose and more cautious dose titration are recommended. No dosage adjustment is required for fluvoxamine maleate tablets.</ao:suffix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:3B8303DC-666E-48AC-A169-56BEAEB6610A"/>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-9.txt.html</ao:hasSource>
    <domeo:uuid>3B8303DC-666E-48AC-A169-56BEAEB6610A</domeo:uuid>
    <ao:prefix>xsd:String</ao:prefix>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:1236F221-49FC-4683-9E78-9A4C14E7DA9F">
    <pav:lineageUri>urn:domeoserver:annotationset:D1715BD2-BD41-46FD-9454-DC7A423A29AC</pav:lineageUri>
    <pav:previousVersion>urn:domeoclient:uuid:BED41F06-565A-4622-9A88-48810E5A28DE</pav:previousVersion>
    <pav:lineageUri>urn:domeoserver:annotation:88277968-1F48-42B9-9F8E-B812166D2E03</pav:lineageUri>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <domeo:belongsToSet>urn:domeoserver:annotationset:A5DD001D-C81A-4E2E-B5E0-7A866B35E26B</domeo:belongsToSet>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812eda990003</pav:createdBy>
    <ao:context rdf:resource="urn:domeoclient:uuid:8AC4DB85-84A2-4639-9224-724D4B50FC4B"/>
    <domeo:belongsToSet>urn:domeoserver:annotationset:3F546823-204F-4F9B-9006-3DC526C56931</domeo:belongsToSet>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <rdfs:label>Highlight</rdfs:label>
    <pav:createdOn>2014-09-02 11:39:59 -0400</pav:createdOn>
    <domeo:belongsToSet>urn:domeoserver:annotationset:A3F0B39A-4249-4B63-BB0D-F24A005066AC</domeo:belongsToSet>
    <pav:lastSavedOn>2014-09-02 11:46:58 -0400</pav:lastSavedOn>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">2</pav:versionNumber>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:previousVersion>xsd:String</pav:previousVersion>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:CE897434-B9A6-4A1A-B7D2-C1748858051B">
    <domeo:belongsToSet>urn:domeoserver:annotationset:2914A3FD-DF43-4F78-999C-77CE7A028B19</domeo:belongsToSet>
    <pav:createdOn>2014-07-22 19:43:36 -0400</pav:createdOn>
    <domeo:belongsToSet>urn:domeoserver:annotationset:606A5B3F-B6FB-4279-AA42-7893CFC2D20C</domeo:belongsToSet>
    <domeo:belongsToSet>urn:domeoserver:annotationset:F272A789-69D0-47CC-8CC9-F25C55B91261</domeo:belongsToSet>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <rdfs:label>Highlight</rdfs:label>
    <pav:previousVersion>urn:domeoserver:annotationset:514BA51B-D734-4003-A7C3-F03C0F95833A</pav:previousVersion>
    <ao:context rdf:resource="urn:domeoclient:uuid:9E1B668B-C744-4EDA-8C35-67ED2D2886D7"/>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812eda990003</pav:createdBy>
    <pav:lineageUri>urn:domeoserver:annotation:3312543F-8D59-4949-8B4E-4788CC2E0CC4</pav:lineageUri>
    <pav:lineageUri>urn:domeoserver:annotationset:AB1741F1-5A5F-4416-AEAC-A544BCBB7D16</pav:lineageUri>
    <pav:lastSavedOn>2014-07-22 19:44:46 -0400</pav:lastSavedOn>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">6</pav:versionNumber>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:69C22FA1-8D50-4AA7-ACD8-8F71E69BB8AC">
    <domeo:agents rdf:resource="urn:person:uuid:080e143046812afe0146812eda990003"/>
    <permissions:permissions rdf:nodeID="Nec6db731a7ae4f9985354696d1c120cd"/>
    <pav:createdOn>2014-09-02 19:41:34 -0400</pav:createdOn>
    <ao:item rdf:resource="urn:domeoclient:uuid:EB533813-9EA9-4387-A0AA-5E6F4443AB02"/>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <pav:lastSavedOn>2014-09-02 19:42:49 -0400</pav:lastSavedOn>
    <domeo:deleted>false</domeo:deleted>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:lineageUri>urn:domeoserver:annotationset:6B16FDBC-E803-4786-93CA-6CA50C2701B9</pav:lineageUri>
    <ao:item rdf:resource="urn:domeoclient:uuid:194B637B-12E0-40F8-A961-33C50074CD18"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#AnnotationSet"/>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <ao:item rdf:resource="urn:domeoclient:uuid:BB14DC78-807E-4A6B-BCB8-D66CC1E0A2E7"/>
    <domeo:agents rdf:resource="urn:domeo:software:id:Domeo-2.1alpha-050"/>
    <ao:annotatesResource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-117.txt.html</ao:annotatesResource>
    <dct:description>The default set is created automatically by Domeo when no other set is existing.</dct:description>
    <rdfs:label>Default Set</rdfs:label>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812eda990003</pav:createdBy>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:05BFBD66-D24D-4F61-89C5-4EDDE7B6040C">
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <rdfs:label>Highlight</rdfs:label>
    <domeo:belongsToSet>urn:domeoclient:uuid:71191E51-53CB-4FDE-88D0-33C6818E2232</domeo:belongsToSet>
    <pav:lastSavedOn>2014-07-13 11:32:29 -0400</pav:lastSavedOn>
    <ao:context rdf:resource="urn:domeoclient:uuid:9BB046B1-5949-4043-9525-70D01EC3816C"/>
    <pav:createdOn>2014-07-13 11:10:51 -0400</pav:createdOn>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812eda990003</pav:createdBy>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:lineageUri>urn:domeoserver:annotation:CA7C94FF-7470-4B26-A1E1-5C8247C8F0FC</pav:lineageUri>
    <pav:previousVersion>xsd:String</pav:previousVersion>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:960E16A3-CF0E-48BD-8B23-ACD869DFB214">
    <domeo:belongsToSet>urn:domeoclient:uuid:3966BCFB-CA02-4053-828D-3860558E7BE8</domeo:belongsToSet>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812eda990003</pav:createdBy>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:createdOn>2014-09-02 19:09:44 -0400</pav:createdOn>
    <pav:lineageUri>urn:domeoserver:annotation:17DC0692-91CE-41C4-B801-A31BD19A01C7</pav:lineageUri>
    <rdfs:label>Highlight</rdfs:label>
    <ao:context rdf:resource="urn:domeoclient:uuid:3558088E-2467-4C3A-87EA-D9EA80C217D1"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:lastSavedOn>2014-09-02 19:11:13 -0400</pav:lastSavedOn>
    <pav:previousVersion>xsd:String</pav:previousVersion>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:E4F0D688-0AAC-4069-A616-725458FCDC7B">
    <pav:createdOn>2014-07-22 20:18:17 -0400</pav:createdOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:prefix>A single administration of a moderate amount of alcohol did not increase the risk of acute hypoglycemia in type 2 diabetes mellitus patients treated with </ao:prefix>
    <domeo:uuid>E4F0D688-0AAC-4069-A616-725458FCDC7B</domeo:uuid>
    <ao:suffix>.</ao:suffix>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:E4F0D688-0AAC-4069-A616-725458FCDC7B"/>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-123.txt.html</ao:hasSource>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:exact>AVANDIA</ao:exact>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:42248733-4719-42F4-8132-866191F8E708">
    <dct:description>The default set is created automatically by Domeo when no other set is existing.</dct:description>
    <ao:item rdf:resource="urn:domeoclient:uuid:9AE25ABB-CFC2-479D-B1B0-184576D49108"/>
    <domeo:deleted>false</domeo:deleted>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <ao:item rdf:resource="urn:domeoclient:uuid:35E50D31-0B97-45CD-9519-3A5F2D6512D3"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:B549CAF8-BA63-4493-B342-27702B9FC841"/>
    <pav:createdOn>2014-07-21 21:43:17 -0400</pav:createdOn>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#AnnotationSet"/>
    <domeo:agents rdf:resource="urn:person:uuid:080e143046812afe0146812eda990003"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:0EA544B7-9EBE-419C-A57B-B74B8AC3FB29"/>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <ao:item rdf:resource="urn:domeoclient:uuid:93AEC1F9-3191-4D73-8BB9-21EE50636AB5"/>
    <rdfs:label>Default Set</rdfs:label>
    <permissions:permissions rdf:nodeID="Nb594beb684ad4f3485d5101e3633fb63"/>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812eda990003</pav:createdBy>
    <pav:lastSavedOn>2014-07-21 21:43:59 -0400</pav:lastSavedOn>
    <pav:lineageUri>urn:domeoserver:annotationset:D514E533-2EAF-4DD1-ADEB-209AF96F6E59</pav:lineageUri>
    <domeo:agents rdf:resource="urn:domeo:software:id:Domeo-2.1alpha-050"/>
    <ao:annotatesResource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-51.txt.html</ao:annotatesResource>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:85043124-E686-41BA-831E-AB868FA3D3B1">
    <rdfs:label>Highlight</rdfs:label>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <domeo:belongsToSet>urn:domeoclient:uuid:3966BCFB-CA02-4053-828D-3860558E7BE8</domeo:belongsToSet>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:lineageUri>urn:domeoserver:annotation:77246EBF-67C1-4D2C-89E7-A85EBD42831E</pav:lineageUri>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <pav:lastSavedOn>2014-09-02 19:11:13 -0400</pav:lastSavedOn>
    <pav:createdOn>2014-09-02 19:09:50 -0400</pav:createdOn>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812eda990003</pav:createdBy>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <ao:context rdf:resource="urn:domeoclient:uuid:F7ED86B3-B970-41BF-B468-D38526646742"/>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/B92741C4-FB91-4395-8B40-7C9F2438DDA0">
    <sio:SIO_000228>dikbD2R:precipitant-drug-of-interaction</sio:SIO_000228>
    <rdfs:label>fluvoxamine</rdfs:label>
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/42355</dailymed:activeMoietyRxCUI>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/active-ingredient"/>
    <dct:description>Referred to the drug in the interaction.</dct:description>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:007F6835-1CAF-4F0B-8BFD-311D8BFD8926">
    <domeo:uuid></domeo:uuid>
    <ao:prefix>When a single 100 mg dose of </ao:prefix>
    <domeo:uuid>007F6835-1CAF-4F0B-8BFD-311D8BFD8926</domeo:uuid>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <pav:createdOn>2014-07-07 11:23:01 -0400</pav:createdOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-155.txt.html</ao:hasSource>
    <ao:exact>sildenafil </ao:exact>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:007F6835-1CAF-4F0B-8BFD-311D8BFD8926"/>
    <ao:suffix>was co-administered with erythromycin, a CYP3A inhibitor, at steady state (500 mg BID for 5 days), there was a 182% increase in sildenafil systemic exposure (AUC).</ao:suffix>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:8B3FBAFB-BA3F-4404-86D8-EB3FEBC44D50">
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <ao:context rdf:resource="urn:domeoclient:uuid:9C474000-EB80-4F4E-8C99-0066BDF22196"/>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:lastSavedOn>2014-07-22 18:46:52 -0400</pav:lastSavedOn>
    <domeo:belongsToSet>urn:domeoclient:uuid:E0054F81-6A9B-4AF0-9DCB-962A6FC1C418</domeo:belongsToSet>
    <pav:createdOn>2014-07-22 18:44:50 -0400</pav:createdOn>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <pav:lineageUri>urn:domeoserver:annotation:737BF383-2E27-497C-B02E-98A51537FC3A</pav:lineageUri>
    <rdfs:label>Highlight</rdfs:label>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812eda990003</pav:createdBy>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:8A0A9901-A1C2-4230-8BC1-B758AADE7F4C">
    <pav:createdOn>2014-07-22 18:44:37 -0400</pav:createdOn>
    <ao:prefix> (repeated oral doses) and </ao:prefix>
    <domeo:uuid>8A0A9901-A1C2-4230-8BC1-B758AADE7F4C</domeo:uuid>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:exact>midazolam</ao:exact>
    <ao:suffix> (intravenous bolus dose) in healthy volunteers led to elevated plasma concentrations of these drugs. The Cmax increased by 18% and 14% (median values) and the AUC increased by 44% and 33% for nifedipine and midazolam, respectively.</ao:suffix>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:8A0A9901-A1C2-4230-8BC1-B758AADE7F4C"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-118.txt.html</ao:hasSource>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:04EFF21D-F5C9-468D-BFA5-057DD08ABD00">
    <ao:context rdf:resource="urn:domeoclient:uuid:E804A110-85A5-4650-B960-F11AB9FD25A2"/>
    <pav:lineageUri>urn:domeoserver:annotation:9901869B-6CBE-4242-B8B1-1CE8B5D728FA</pav:lineageUri>
    <rdfs:label>Highlight</rdfs:label>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812eda990003</pav:createdBy>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <domeo:belongsToSet>urn:domeoclient:uuid:71191E51-53CB-4FDE-88D0-33C6818E2232</domeo:belongsToSet>
    <pav:createdOn>2014-07-13 11:11:36 -0400</pav:createdOn>
    <pav:lastSavedOn>2014-07-13 11:32:29 -0400</pav:lastSavedOn>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:7A41AFCF-E95D-4B06-B213-C3D7AC444FB8">
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812eda990003</pav:createdBy>
    <ao:context rdf:resource="urn:domeoclient:uuid:150123D0-F340-48A6-8FF1-AE43891B6007"/>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:lineageUri>urn:domeoserver:annotation:34AB49DC-0AB4-455F-A582-7E3D626DD866</pav:lineageUri>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <pav:lastSavedOn>2014-09-01 16:12:36 -0400</pav:lastSavedOn>
    <pav:createdOn>2014-09-01 16:12:22 -0400</pav:createdOn>
    <rdfs:label>Highlight</rdfs:label>
    <domeo:belongsToSet>urn:domeoclient:uuid:5D381360-05CD-407C-BAB9-6496A42C73E4</domeo:belongsToSet>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:209C377C-FE31-4FA5-9168-BD0E96D0F448">
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <ao:context rdf:resource="urn:domeoclient:uuid:84F2753B-0F8B-4975-8EFA-3A99E0B82A50"/>
    <pav:lastSavedOn>2014-09-02 11:46:59 -0400</pav:lastSavedOn>
    <pav:lineageUri>urn:domeoserver:annotation:B7DF56CE-BEBE-4385-A469-D74B35A6F4E5</pav:lineageUri>
    <pav:lineageUri>urn:domeoserver:annotationset:D1715BD2-BD41-46FD-9454-DC7A423A29AC</pav:lineageUri>
    <domeo:belongsToSet>urn:domeoserver:annotationset:3F546823-204F-4F9B-9006-3DC526C56931</domeo:belongsToSet>
    <rdfs:label>Highlight</rdfs:label>
    <pav:lastSavedOn>2014-09-02 11:46:58 -0400</pav:lastSavedOn>
    <pav:createdOn>2014-09-02 11:44:14 -0400</pav:createdOn>
    <domeo:belongsToSet>urn:domeoserver:annotationset:A5DD001D-C81A-4E2E-B5E0-7A866B35E26B</domeo:belongsToSet>
    <domeo:belongsToSet>urn:domeoserver:annotationset:A3F0B39A-4249-4B63-BB0D-F24A005066AC</domeo:belongsToSet>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812eda990003</pav:createdBy>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">2</pav:versionNumber>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:previousVersion>urn:domeoclient:uuid:BED41F06-565A-4622-9A88-48810E5A28DE</pav:previousVersion>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:70BA73C3-70D0-43D1-9E54-82E0AE865E17">
    <ao:item rdf:resource="urn:domeoclient:uuid:560D7055-0BE0-4AE4-9912-39985A237181"/>
    <ao:annotatesResource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-19.txt.html</ao:annotatesResource>
    <dct:description>The default set is created automatically by Domeo when no other set is existing.</dct:description>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:createdOn>2014-09-01 16:04:28 -0400</pav:createdOn>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812eda990003</pav:createdBy>
    <domeo:deleted>false</domeo:deleted>
    <pav:lastSavedOn>2014-09-01 16:04:28 -0400</pav:lastSavedOn>
    <permissions:permissions rdf:nodeID="Nb806b78da4d0430c85637054820d1a2a"/>
    <domeo:agents rdf:resource="urn:person:uuid:080e143046812afe0146812eda990003"/>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <domeo:agents rdf:resource="urn:domeo:software:id:Domeo-2.1alpha-050"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#AnnotationSet"/>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <pav:lineageUri>urn:domeoserver:annotationset:8E378B8C-A732-4AF9-8539-558B03C369A1</pav:lineageUri>
    <rdfs:label>Default Set</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:838A3F9E-0F12-46F7-B6B3-FFABDE022693">
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <rdfs:label>Highlight</rdfs:label>
    <ao:context rdf:resource="urn:domeoclient:uuid:D6C4080C-5AC3-402F-9359-F2135366B16E"/>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <domeo:belongsToSet>urn:domeoclient:uuid:E0050ED6-BE4F-4871-9847-FC4493F22447</domeo:belongsToSet>
    <pav:createdOn>2014-07-24 20:00:35 -0400</pav:createdOn>
    <pav:lastSavedOn>2014-07-24 20:00:43 -0400</pav:lastSavedOn>
    <pav:lineageUri>urn:domeoserver:annotation:3BA6C4A7-55CD-4101-A138-60C934E15A12</pav:lineageUri>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812eda990003</pav:createdBy>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:812A1777-BC32-4760-9024-CF9758CF804E">
    <pav:lineageUri>urn:domeoserver:annotation:B8615C36-34A3-46B6-B50B-E3D4A1AD47ED</pav:lineageUri>
    <domeo:belongsToSet>urn:domeoserver:annotationset:E32812A9-205B-4EE1-B488-A1E294EDBFB9</domeo:belongsToSet>
    <domeo:belongsToSet>urn:domeoserver:annotationset:392EE0FB-AC4F-4AF2-87A6-2E50A281F434</domeo:belongsToSet>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <rdfs:label>Highlight</rdfs:label>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <domeo:belongsToSet>urn:domeoclient:uuid:CB83FFC2-EA71-44EA-8F11-DE80E389C84E</domeo:belongsToSet>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812eda990003</pav:createdBy>
    <pav:createdOn>2014-09-02 19:12:46 -0400</pav:createdOn>
    <pav:lineageUri>urn:domeoserver:annotationset:C5DEBC9B-77EE-4243-88EB-DBC19737ACD2</pav:lineageUri>
    <pav:lastSavedOn>2014-09-02 19:19:47 -0400</pav:lastSavedOn>
    <ao:context rdf:resource="urn:domeoclient:uuid:CDE42D33-6312-4DF8-AF70-310C20268892"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:023B39C4-2A61-428E-9D4B-84E60C00EA1D">
    <rdfs:label>Highlight</rdfs:label>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:lineageUri>urn:domeoserver:annotation:403C1687-0E8E-4E45-B22A-85D8A976B2E9</pav:lineageUri>
    <pav:createdOn>2014-07-22 19:55:33 -0400</pav:createdOn>
    <domeo:belongsToSet>urn:domeoserver:annotationset:F272A789-69D0-47CC-8CC9-F25C55B91261</domeo:belongsToSet>
    <ao:context rdf:resource="urn:domeoclient:uuid:30CD6C3F-1B6D-4C66-B96F-A460B56D3480"/>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812eda990003</pav:createdBy>
    <pav:lastSavedOn>2014-07-22 20:22:38 -0400</pav:lastSavedOn>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/5224D32E-E4DE-4A9C-B197-4A0F7E4F982D">
    <sio:SIO_000228>dikbD2R:precipitant-drug-of-interaction</sio:SIO_000228>
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/85762</dailymed:activeMoietyRxCUI>
    <rdfs:label>ritonavir</rdfs:label>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/active-ingredient"/>
    <dct:description>Referred to the drug in the interaction.</dct:description>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:A0EE858B-D738-4E79-B01E-E50A3141586B">
    <ao:suffix>, giving essentially all recipients a </ao:suffix>
    <pav:createdOn>2014-07-13 11:15:01 -0400</pav:createdOn>
    <ao:prefix> [see 7 DRUG INTERACTIONS]. This occurs with </ao:prefix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:exact>quinidine</ao:exact>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:A0EE858B-D738-4E79-B01E-E50A3141586B"/>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-8.txt.html</ao:hasSource>
    <domeo:uuid>A0EE858B-D738-4E79-B01E-E50A3141586B</domeo:uuid>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:0D270EDF-E644-45EB-9C94-B02DA5C51002">
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812eda990003</pav:createdBy>
    <ao:context rdf:resource="urn:domeoclient:uuid:7562C75C-08B1-4D26-BA5E-2C77FA08B4F0"/>
    <pav:lineageUri>urn:domeoserver:annotationset:D1715BD2-BD41-46FD-9454-DC7A423A29AC</pav:lineageUri>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">2</pav:versionNumber>
    <domeo:belongsToSet>urn:domeoserver:annotationset:A3F0B39A-4249-4B63-BB0D-F24A005066AC</domeo:belongsToSet>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:lastSavedOn>2014-09-02 11:46:58 -0400</pav:lastSavedOn>
    <domeo:belongsToSet>urn:domeoserver:annotationset:A5DD001D-C81A-4E2E-B5E0-7A866B35E26B</domeo:belongsToSet>
    <pav:lineageUri>urn:domeoserver:annotation:9671DDE5-0983-46D3-A89A-BB381C19D7C3</pav:lineageUri>
    <domeo:belongsToSet>urn:domeoserver:annotationset:3F546823-204F-4F9B-9006-3DC526C56931</domeo:belongsToSet>
    <pav:createdOn>2014-09-02 11:41:11 -0400</pav:createdOn>
    <pav:previousVersion>urn:domeoclient:uuid:BED41F06-565A-4622-9A88-48810E5A28DE</pav:previousVersion>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <rdfs:label>Highlight</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:6EE25330-67E2-4BE9-AB27-EB9F40763AA3">
    <ao:exact>ketoconazole</ao:exact>
    <ao:suffix> </ao:suffix>
    <pav:createdOn>2014-07-21 21:46:40 -0400</pav:createdOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:6EE25330-67E2-4BE9-AB27-EB9F40763AA3"/>
    <ao:prefix>xsd:String</ao:prefix>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-53.txt.html</ao:hasSource>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <domeo:uuid>6EE25330-67E2-4BE9-AB27-EB9F40763AA3</domeo:uuid>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:6E817E52-FC9C-4090-86D7-ADDBC13CA122">
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:prefix>me of distribution (Vss/F) were shown to increase with increases in body weight. Over the weight range observed in these analyses (50 to 150 kg), the range of predicted CL/F and Vss/F values varied by &lt;1.7-fold and &lt;2.3-fold, respectively. Additionally, </ao:prefix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:suffix> CL/F was shown to be influenced by both weight and gender, being lower (about 15%) in female patients.</ao:suffix>
    <ao:exact>rosiglitazone</ao:exact>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-123.txt.html</ao:hasSource>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:6E817E52-FC9C-4090-86D7-ADDBC13CA122"/>
    <domeo:uuid>6E817E52-FC9C-4090-86D7-ADDBC13CA122</domeo:uuid>
    <pav:createdOn>2014-07-22 19:28:50 -0400</pav:createdOn>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:E6A5356C-B181-4F61-AEF2-74464A340D7F">
    <domeo:belongsToSet>urn:domeoclient:uuid:71191E51-53CB-4FDE-88D0-33C6818E2232</domeo:belongsToSet>
    <rdfs:label>Highlight</rdfs:label>
    <ao:context rdf:resource="urn:domeoclient:uuid:5FBE9544-4653-482C-B065-70CA3AA07309"/>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <pav:lineageUri>urn:domeoserver:annotation:C5FD329C-F801-4589-8147-439BFA776D12</pav:lineageUri>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812eda990003</pav:createdBy>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:createdOn>2014-07-13 11:15:53 -0400</pav:createdOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:lastSavedOn>2014-07-13 11:32:29 -0400</pav:lastSavedOn>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:31F715F6-A269-43C4-9AA2-9270BCFEF7C0">
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812eda990003</pav:createdBy>
    <domeo:belongsToSet>urn:domeoserver:annotationset:1FC172B8-8AC3-465A-AA69-B73AD9B97CBC</domeo:belongsToSet>
    <rdfs:label>Highlight</rdfs:label>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:lastSavedOn>2014-07-24 20:12:49 -0400</pav:lastSavedOn>
    <pav:lineageUri>urn:domeoserver:annotation:CD9F9CAF-F87E-49CF-A73B-3ED9BCBF0A03</pav:lineageUri>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:createdOn>2014-07-24 20:11:41 -0400</pav:createdOn>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <ao:context rdf:resource="urn:domeoclient:uuid:71782464-053E-46F0-8930-DB2CDA0F1338"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:28EA3105-DAE4-4248-8C5A-EACDF44B4680">
    <ao:exact>ECG </ao:exact>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:prefix>to patients with pulmonary arterial hypertension, no clinically relevant effects on </ao:prefix>
    <ao:suffix>were reported.</ao:suffix>
    <domeo:uuid>28EA3105-DAE4-4248-8C5A-EACDF44B4680</domeo:uuid>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-155.txt.html</ao:hasSource>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:28EA3105-DAE4-4248-8C5A-EACDF44B4680"/>
    <pav:createdOn>2014-07-07 09:39:29 -0400</pav:createdOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <domeo:uuid></domeo:uuid>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:2D1425A6-04BE-4372-9798-B6059B7EFF83">
    <pav:lastSavedOn>2014-07-24 20:07:20 -0400</pav:lastSavedOn>
    <pav:lineageUri>urn:domeoserver:annotation:31C345CA-4FE7-4417-83AC-2767B732A2D7</pav:lineageUri>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:lastSavedOn>2014-07-24 20:07:19 -0400</pav:lastSavedOn>
    <pav:createdOn>2014-07-24 20:06:30 -0400</pav:createdOn>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812eda990003</pav:createdBy>
    <ao:context rdf:resource="urn:domeoclient:uuid:3E13A2A1-DB0E-49CA-8B2D-2D7FD2760FEC"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <rdfs:label>Highlight</rdfs:label>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:lineageUri>urn:domeoserver:annotationset:4A88D0A6-E9B6-4E7F-955F-3692600C178C</pav:lineageUri>
    <domeo:belongsToSet>urn:domeoserver:annotationset:37B2514D-1A92-45B1-8A5C-610DA6DC935A</domeo:belongsToSet>
    <domeo:belongsToSet>urn:domeoclient:uuid:8D86A4AC-54BD-4BB3-8B58-AB55DEC01A88</domeo:belongsToSet>
    <domeo:belongsToSet>urn:domeoserver:annotationset:1FC172B8-8AC3-465A-AA69-B73AD9B97CBC</domeo:belongsToSet>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:FF1FC131-57E9-4A89-8FBF-B786D1543F24">
    <pav:previousVersion>urn:domeoserver:annotationset:467D4F28-D086-4217-9DE0-23E165F30716</pav:previousVersion>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812eda990003</pav:createdBy>
    <pav:lastSavedOn>2014-07-22 19:28:02 -0400</pav:lastSavedOn>
    <domeo:belongsToSet>urn:domeoserver:annotationset:606A5B3F-B6FB-4279-AA42-7893CFC2D20C</domeo:belongsToSet>
    <domeo:belongsToSet>urn:domeoserver:annotationset:F272A789-69D0-47CC-8CC9-F25C55B91261</domeo:belongsToSet>
    <pav:createdOn>2014-07-22 19:16:20 -0400</pav:createdOn>
    <pav:lineageUri>urn:domeoserver:annotation:F72DFB67-FA95-423F-B97B-889D46EF9E41</pav:lineageUri>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">3</pav:versionNumber>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <domeo:belongsToSet>urn:domeoserver:annotationset:7E80543E-BF76-4514-92A9-91458DCB802B</domeo:belongsToSet>
    <domeo:belongsToSet>urn:domeoserver:annotationset:514BA51B-D734-4003-A7C3-F03C0F95833A</domeo:belongsToSet>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <rdfs:label>Highlight</rdfs:label>
    <domeo:belongsToSet>urn:domeoserver:annotationset:2914A3FD-DF43-4F78-999C-77CE7A028B19</domeo:belongsToSet>
    <ao:context rdf:resource="urn:domeoclient:uuid:6C37E9D5-F4A3-4CDB-AE4B-E46CCA6F2A60"/>
    <domeo:belongsToSet>urn:domeoserver:annotationset:7021B883-FD5C-4083-BD87-DF56D3C87633</domeo:belongsToSet>
    <pav:lineageUri>urn:domeoserver:annotationset:AB1741F1-5A5F-4416-AEAC-A544BCBB7D16</pav:lineageUri>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:CC3DAA6B-4FED-42FC-B83D-E1EECF33E119">
    <ao:suffix>, </ao:suffix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:CC3DAA6B-4FED-42FC-B83D-E1EECF33E119"/>
    <ao:exact>cyclosporine</ao:exact>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-74.txt.html</ao:hasSource>
    <domeo:uuid>CC3DAA6B-4FED-42FC-B83D-E1EECF33E119</domeo:uuid>
    <pav:createdOn>2014-09-02 19:13:16 -0400</pav:createdOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:prefix> was found, there have been clinical reports of interaction with other drugs metabolized via the cytochrome P450 system (e.g., </ao:prefix>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:EA6549D1-9142-4B02-863B-C31046392662">
    <pav:createdOn>2014-09-02 19:15:59 -0400</pav:createdOn>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812eda990003</pav:createdBy>
    <ao:context rdf:resource="urn:domeoclient:uuid:F442DD1F-67E3-41D3-92CB-9048022BDFCC"/>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:lineageUri>urn:domeoserver:annotationset:C5DEBC9B-77EE-4243-88EB-DBC19737ACD2</pav:lineageUri>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <domeo:belongsToSet>urn:domeoclient:uuid:CB83FFC2-EA71-44EA-8F11-DE80E389C84E</domeo:belongsToSet>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <domeo:belongsToSet>urn:domeoserver:annotationset:392EE0FB-AC4F-4AF2-87A6-2E50A281F434</domeo:belongsToSet>
    <rdfs:label>Highlight</rdfs:label>
    <pav:lastSavedOn>2014-09-02 19:19:47 -0400</pav:lastSavedOn>
    <pav:lineageUri>urn:domeoserver:annotation:7C0FF7F0-A2A6-415E-B95F-9305F777FAF0</pav:lineageUri>
    <domeo:belongsToSet>urn:domeoserver:annotationset:E32812A9-205B-4EE1-B488-A1E294EDBFB9</domeo:belongsToSet>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/7C9742EE-BA6E-4470-AF96-757C3B8CF332">
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/87636</dailymed:activeMoietyRxCUI>
    <sio:SIO_000228>dikbD2R:object-drug-of-interaction</sio:SIO_000228>
    <rdfs:label>Fexofenadine</rdfs:label>
    <dct:description>Referred to the drug in the interaction.</dct:description>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/active-ingredient"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:2506F4F5-773E-4CCD-8303-CC244D5848D1">
    <domeo:belongsToSet>urn:domeoserver:annotationset:514BA51B-D734-4003-A7C3-F03C0F95833A</domeo:belongsToSet>
    <domeo:belongsToSet>urn:domeoserver:annotationset:F272A789-69D0-47CC-8CC9-F25C55B91261</domeo:belongsToSet>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <domeo:belongsToSet>urn:domeoserver:annotationset:2914A3FD-DF43-4F78-999C-77CE7A028B19</domeo:belongsToSet>
    <rdfs:label>Highlight</rdfs:label>
    <domeo:belongsToSet>urn:domeoserver:annotationset:606A5B3F-B6FB-4279-AA42-7893CFC2D20C</domeo:belongsToSet>
    <pav:lineageUri>urn:domeoserver:annotationset:AB1741F1-5A5F-4416-AEAC-A544BCBB7D16</pav:lineageUri>
    <pav:lineageUri>urn:domeoserver:annotation:51A280AC-67DD-4650-B90E-A5FA6E5B0FC5</pav:lineageUri>
    <pav:createdOn>2014-07-22 19:22:07 -0400</pav:createdOn>
    <domeo:belongsToSet>urn:domeoserver:annotationset:7E80543E-BF76-4514-92A9-91458DCB802B</domeo:belongsToSet>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">3</pav:versionNumber>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <ao:context rdf:resource="urn:domeoclient:uuid:72BE2161-391C-488C-B44D-F6CF16588EAC"/>
    <pav:lastSavedOn>2014-07-22 19:28:02 -0400</pav:lastSavedOn>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812eda990003</pav:createdBy>
    <domeo:belongsToSet>urn:domeoserver:annotationset:7021B883-FD5C-4083-BD87-DF56D3C87633</domeo:belongsToSet>
    <pav:previousVersion>urn:domeoserver:annotationset:467D4F28-D086-4217-9DE0-23E165F30716</pav:previousVersion>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:464ED203-77EC-4EFC-873A-7853A308DCA5">
    <domeo:belongsToSet>urn:domeoclient:uuid:71191E51-53CB-4FDE-88D0-33C6818E2232</domeo:belongsToSet>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:lineageUri>urn:domeoserver:annotation:A434E784-EF19-4D9F-9D9A-D71E320A8599</pav:lineageUri>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812eda990003</pav:createdBy>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <ao:context rdf:resource="urn:domeoclient:uuid:7F63A36F-F819-4E40-9C8A-C518B5519787"/>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <rdfs:label>Highlight</rdfs:label>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:lastSavedOn>2014-07-13 11:32:29 -0400</pav:lastSavedOn>
    <pav:createdOn>2014-07-13 11:17:56 -0400</pav:createdOn>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:A5A1F4E1-991C-4D93-AC6A-4DEDDF392601">
    <pav:createdOn>2014-07-13 12:56:07 -0400</pav:createdOn>
    <rdfs:label>Highlight</rdfs:label>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812eda990003</pav:createdBy>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <pav:lineageUri>urn:domeoserver:annotation:7920C548-5100-46DE-B19C-AFACF431A0C2</pav:lineageUri>
    <ao:context rdf:resource="urn:domeoclient:uuid:4CEC1749-9AA0-4FDA-B649-6B3CDED4298A"/>
    <domeo:belongsToSet>urn:domeoclient:uuid:E89548FF-A4A2-4B87-B1E1-B12E3E255FA1</domeo:belongsToSet>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:lastSavedOn>2014-07-13 12:56:57 -0400</pav:lastSavedOn>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:544DD6BF-DAEB-4EEF-86D9-2AD7760B51C5">
    <ao:suffix> and its metabolite, normeperidine, may be increased by acyclovir, thus caution should be used with concomitant administration.</ao:suffix>
    <pav:createdOn>2014-07-28 17:00:13 -0400</pav:createdOn>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-163.txt.html</ao:hasSource>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:exact>meperidine</ao:exact>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:prefix>Plasma concentrations of </ao:prefix>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:544DD6BF-DAEB-4EEF-86D9-2AD7760B51C5"/>
    <domeo:uuid>544DD6BF-DAEB-4EEF-86D9-2AD7760B51C5</domeo:uuid>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:FB5478ED-0329-4EF5-88A8-06C125D68B2A">
    <pav:lineageUri>urn:domeoserver:annotation:93623B08-4562-4C81-AAA3-31B8574186E1</pav:lineageUri>
    <pav:createdOn>2014-09-02 11:30:17 -0400</pav:createdOn>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <ao:context rdf:resource="urn:domeoclient:uuid:C08A8D30-A040-45EF-9873-91013299399D"/>
    <domeo:belongsToSet>urn:domeoserver:annotationset:A5DD001D-C81A-4E2E-B5E0-7A866B35E26B</domeo:belongsToSet>
    <pav:lastSavedOn>2014-09-02 11:35:33 -0400</pav:lastSavedOn>
    <domeo:belongsToSet>urn:domeoclient:uuid:BED41F06-565A-4622-9A88-48810E5A28DE</domeo:belongsToSet>
    <rdfs:label>Highlight</rdfs:label>
    <pav:lineageUri>urn:domeoserver:annotationset:D1715BD2-BD41-46FD-9454-DC7A423A29AC</pav:lineageUri>
    <domeo:belongsToSet>urn:domeoserver:annotationset:A3F0B39A-4249-4B63-BB0D-F24A005066AC</domeo:belongsToSet>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812eda990003</pav:createdBy>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <domeo:belongsToSet>urn:domeoserver:annotationset:3F546823-204F-4F9B-9006-3DC526C56931</domeo:belongsToSet>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:EEC761C8-1050-4E1A-A450-D460F8514160">
    <pav:lineageUri>urn:domeoserver:annotation:FE75629E-FE6A-4361-BE28-79148B042D27</pav:lineageUri>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:createdOn>2014-07-13 11:18:21 -0400</pav:createdOn>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812eda990003</pav:createdBy>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <rdfs:label>Highlight</rdfs:label>
    <ao:context rdf:resource="urn:domeoclient:uuid:984E4D2D-A998-4068-9BF7-F709348DD1B2"/>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <domeo:belongsToSet>urn:domeoclient:uuid:71191E51-53CB-4FDE-88D0-33C6818E2232</domeo:belongsToSet>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <pav:lastSavedOn>2014-07-13 11:32:29 -0400</pav:lastSavedOn>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:0208A9D0-4889-4F9D-A5F0-C1CBBBE42EE0">
    <ao:context rdf:resource="urn:domeoclient:uuid:8301C100-8F47-4B2E-A908-FF663A864A1E"/>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812eda990003</pav:createdBy>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:lastSavedOn>2014-07-24 20:07:19 -0400</pav:lastSavedOn>
    <pav:lineageUri>urn:domeoserver:annotationset:4A88D0A6-E9B6-4E7F-955F-3692600C178C</pav:lineageUri>
    <pav:createdOn>2014-07-24 20:07:25 -0400</pav:createdOn>
    <domeo:belongsToSet>urn:domeoserver:annotationset:37B2514D-1A92-45B1-8A5C-610DA6DC935A</domeo:belongsToSet>
    <domeo:belongsToSet>urn:domeoclient:uuid:8D86A4AC-54BD-4BB3-8B58-AB55DEC01A88</domeo:belongsToSet>
    <domeo:belongsToSet>urn:domeoserver:annotationset:1FC172B8-8AC3-465A-AA69-B73AD9B97CBC</domeo:belongsToSet>
    <pav:lastSavedOn>2014-07-24 20:07:20 -0400</pav:lastSavedOn>
    <rdfs:label>Highlight</rdfs:label>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:lineageUri>urn:domeoserver:annotation:DE65FE02-8E4E-4E39-8EBA-B6264EC4BD68</pav:lineageUri>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:A07FFEB8-13E6-4964-A170-13A6FA26AB90">
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812eda990003</pav:createdBy>
    <rdfs:label>Highlight</rdfs:label>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:createdOn>2014-09-02 19:09:08 -0400</pav:createdOn>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <pav:lineageUri>urn:domeoserver:annotation:12709F63-2474-4857-8883-0FFFA8BD82EB</pav:lineageUri>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <domeo:belongsToSet>urn:domeoclient:uuid:3966BCFB-CA02-4053-828D-3860558E7BE8</domeo:belongsToSet>
    <pav:lastSavedOn>2014-09-02 19:11:13 -0400</pav:lastSavedOn>
    <ao:context rdf:resource="urn:domeoclient:uuid:8CBD941C-1C97-4CE2-A53E-A70EEF76055C"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:CFAB29CD-3C49-4713-BDAE-478181F5EB8F">
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:prefix>, </ao:prefix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <pav:createdOn>2014-09-02 11:43:52 -0400</pav:createdOn>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:CFAB29CD-3C49-4713-BDAE-478181F5EB8F"/>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-9.txt.html</ao:hasSource>
    <ao:suffix>, paroxetine, sertraline) is clinically warranted, appropriate observation of the patient is advised.</ao:suffix>
    <ao:exact>fluvoxamine</ao:exact>
    <domeo:uuid>CFAB29CD-3C49-4713-BDAE-478181F5EB8F</domeo:uuid>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:8BCB35DD-E167-44C4-BD7A-709DC2E39765">
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:prefix> at steady-state with a single oral dose of </ao:prefix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:exact>azithromycin</ao:exact>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-161.txt.html</ao:hasSource>
    <pav:createdOn>2014-07-24 20:14:38 -0400</pav:createdOn>
    <domeo:uuid>8BCB35DD-E167-44C4-BD7A-709DC2E39765</domeo:uuid>
    <ao:suffix> resulted in increased azithromycin serum concentrations. Although a dose adjustment of azithromycin is not recommended when administered in combination with nelfinavir, close monitoring for known side effects of azithromycin, such as liver enzyme abnorm</ao:suffix>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:8BCB35DD-E167-44C4-BD7A-709DC2E39765"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:34A39B5E-1BC8-4028-8390-448D67AF41F6">
    <rdfs:label>expertstudy Annotation</rdfs:label>
    <pav:lineageUri>urn:domeoserver:annotation:57110ED0-1E32-4464-B810-CBC16353C315</pav:lineageUri>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <ao:context rdf:resource="urn:domeoclient:uuid:7EBA2A42-43E7-40EC-B69A-A8622A20C1FD"/>
    <pav:lastSavedOn>2014-07-24 20:02:49 -0400</pav:lastSavedOn>
    <pav:createdOn>2014-07-24 20:03:04 -0400</pav:createdOn>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812eda990003</pav:createdBy>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#expertstudyAnnotation"/>
    <domeo:belongsToSet>urn:domeoclient:uuid:189A8E0E-67D6-4C53-A96E-CB48A3B4B2E9</domeo:belongsToSet>
    <ao:body rdf:nodeID="N0c077dafa1b34d60ae091274c58d4cf4"/>
    <pav:previousVersion>xsd:String</pav:previousVersion>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:FAA92561-4F1F-46DE-9C0F-2783EAC09CFA">
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <pav:createdOn>2014-07-21 21:34:27 -0400</pav:createdOn>
    <ao:prefix>xsd:String</ao:prefix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:FAA92561-4F1F-46DE-9C0F-2783EAC09CFA"/>
    <ao:exact>theophylline</ao:exact>
    <domeo:uuid>FAA92561-4F1F-46DE-9C0F-2783EAC09CFA</domeo:uuid>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-28.txt.html</ao:hasSource>
    <ao:suffix> </ao:suffix>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:211F5FD6-FC29-4AC5-96E1-14E088108ABB">
    <ao:exact>Administration of a single oral 200 mg dose of fluconazole after 15 days of rifampin administered as 600 mg daily in eight healthy male volunteers resulted in a significant decrease in fluconazole AUC and a significant increase in apparent oral clearance of fluconazole. There was a mean ± SD reduction in fluconazole AUC of 23% ± 9% (range: -13 to -42%). Apparent oral clearance of fluconazole increased 32% ± 17% (range: 16 to 72%). Fluconazole half-life decreased from 33.4 ± 4.4 hours to 26.8 ± 3.9 hours.</ao:exact>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:prefix>xsd:String</ao:prefix>
    <domeo:uuid>211F5FD6-FC29-4AC5-96E1-14E088108ABB</domeo:uuid>
    <pav:createdOn>2014-07-13 12:56:54 -0400</pav:createdOn>
    <ao:suffix> (See PRECAUTIONS.</ao:suffix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-24.txt.html</ao:hasSource>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:211F5FD6-FC29-4AC5-96E1-14E088108ABB"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:D09BF05F-7BD7-4E57-A285-8CF1F5BA4395">
    <pav:createdOn>2014-07-21 21:42:10 -0400</pav:createdOn>
    <ao:prefix>(30 mg once daily) increased steady-state AUC0-24, Cmax, and Cmin values of </ao:prefix>
    <domeo:uuid>D09BF05F-7BD7-4E57-A285-8CF1F5BA4395</domeo:uuid>
    <ao:exact>procyclidine </ao:exact>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-50.txt.html</ao:hasSource>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:suffix>(5 mg oral once daily) by 35%, 37%, and 67%, respectively, compared to procyclidine alone at steady state. If anticholinergic effects are seen, the dose of procyclidine should be reduced.</ao:suffix>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:D09BF05F-7BD7-4E57-A285-8CF1F5BA4395"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:040380DC-30D6-454D-ACD7-489B2130A9CC">
    <domeo:agents rdf:resource="urn:person:uuid:080e143046812afe0146812eda990003"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:F5A32BEB-91E7-4E38-9495-09168C9EA7B8"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:7C69D717-13B9-4E6F-B20D-24925FA1E992"/>
    <pav:lineageUri>urn:domeoserver:annotationset:A1EB0824-DCE2-40B3-B3EE-D596E2049283</pav:lineageUri>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812eda990003</pav:createdBy>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:createdOn>2014-07-22 18:36:06 -0400</pav:createdOn>
    <permissions:permissions rdf:nodeID="N191340f154f546248363868794a22928"/>
    <domeo:agents rdf:resource="urn:domeo:software:id:Domeo-2.1alpha-050"/>
    <rdfs:label>Default Set</rdfs:label>
    <domeo:deleted>false</domeo:deleted>
    <dct:description>The default set is created automatically by Domeo when no other set is existing.</dct:description>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <ao:item rdf:resource="urn:domeoclient:uuid:2C536245-38D8-4238-BA9C-5A2C84CD1E14"/>
    <pav:lastSavedOn>2014-07-22 18:36:37 -0400</pav:lastSavedOn>
    <ao:annotatesResource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-57.txt.html</ao:annotatesResource>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#AnnotationSet"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:EC0A22A6-E91A-4E15-A935-E1021555864A">
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <domeo:uuid>EC0A22A6-E91A-4E15-A935-E1021555864A</domeo:uuid>
    <ao:suffix>xsd:String</ao:suffix>
    <ao:prefix>therapy. </ao:prefix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:EC0A22A6-E91A-4E15-A935-E1021555864A"/>
    <pav:createdOn>2014-07-22 19:55:11 -0400</pav:createdOn>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-123.txt.html</ao:hasSource>
    <ao:exact>Repeat doses of AVANDIA (8 mg once daily) for 8 days in healthy adult Caucasian subjects caused a decrease in glyburide AUC and Cmax of approximately 30%. In Japanese subjects, glyburide AUC and Cmax slightly increased following coadministration of AVANDIA.</ao:exact>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:8C403ABF-BCD6-4923-946F-4AF2BAAB0800">
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:createdOn>2014-07-21 21:31:24 -0400</pav:createdOn>
    <domeo:belongsToSet>urn:domeoclient:uuid:5B3EE83F-83C7-4BA8-A892-C032BE699CFA</domeo:belongsToSet>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812eda990003</pav:createdBy>
    <pav:lineageUri>urn:domeoserver:annotationset:092451F5-B0C0-430C-8896-07F81D33F9E1</pav:lineageUri>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:lastSavedOn>2014-07-21 21:31:54 -0400</pav:lastSavedOn>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <domeo:belongsToSet>urn:domeoserver:annotationset:40007BD9-0869-48CF-A8F2-BAD26AE3E6E1</domeo:belongsToSet>
    <rdfs:label>Highlight</rdfs:label>
    <ao:context rdf:resource="urn:domeoclient:uuid:2EB7D7E2-B15C-4936-A208-A041FD22D74F"/>
    <pav:lineageUri>urn:domeoserver:annotation:5FBA1925-2CB4-44AD-870F-625F1FBCE934</pav:lineageUri>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:1BC59DC6-C39B-4F32-9DCC-98000370046A">
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/PK_DDI"/>
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/E74D3AEA-33B5-4A50-A977-87798E92D401"/>
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/7C90A079-6EB4-494B-B58B-CC7428475342"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:C93F0A9D-FE1B-4281-BB1F-58EBF1E21173">
    <pav:createdOn>2014-09-01 15:57:31 -0400</pav:createdOn>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <domeo:belongsToSet>urn:domeoclient:uuid:39B82E57-92E3-4322-A8E6-A3AFF215F02C</domeo:belongsToSet>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <ao:context rdf:resource="urn:domeoclient:uuid:89138321-17A8-4CAE-B03E-6A7C0F8B6AC5"/>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <pav:lineageUri>urn:domeoserver:annotation:212DE3D9-8C0B-4C3D-9FCD-B82D6F9CF98E</pav:lineageUri>
    <pav:lastSavedOn>2014-09-01 15:57:39 -0400</pav:lastSavedOn>
    <rdfs:label>Highlight</rdfs:label>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812eda990003</pav:createdBy>
  </rdf:Description>
  <rdf:Description rdf:nodeID="Nde8cf1713a904f2f8ec50fd4d3db4095">
    <permissions:isLocked>false</permissions:isLocked>
    <permissions:accessType>urn:domeo:access:public</permissions:accessType>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:5B604E28-4F1B-4B10-A878-DE6620893CDB">
    <rdfs:label>Highlight</rdfs:label>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:lineageUri>urn:domeoserver:annotation:3843036B-6944-4AF6-BA4D-F08B2E58FE59</pav:lineageUri>
    <domeo:belongsToSet>urn:domeoclient:uuid:2BAA59CB-3862-4A98-8A6C-AA14E82983DC</domeo:belongsToSet>
    <pav:lastSavedOn>2014-07-24 20:14:43 -0400</pav:lastSavedOn>
    <pav:createdOn>2014-07-24 20:14:32 -0400</pav:createdOn>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812eda990003</pav:createdBy>
    <ao:context rdf:resource="urn:domeoclient:uuid:B57AEEF2-0F0B-4E76-9F59-DBC483D6322C"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:114406CD-55D0-459D-A4F0-CEDB09E201C6">
    <dikbD2R:modality>ncit:negative</dikbD2R:modality>
    <dikbD2R:statement>ncit:quantitative</dikbD2R:statement>
    <sio:SIO_000205>dikbD2R:statement</sio:SIO_000205>
    <rdf:type rdf:resource="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#DrugDrugInteractionStatement"/>
    <sio:SIO_000563>dikbD2R:modality</sio:SIO_000563>
    <sio:SIO_000628 rdf:resource="urn:pddi:uuid:7CBD8092-1453-4994-9F29-22622E743A15"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:9BD9047F-C1DA-4B64-92B7-4D031972C9CF">
    <pav:lineageUri>urn:domeoserver:annotationset:76FD4BB5-DE2F-4FCA-B93D-302185B1A381</pav:lineageUri>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <domeo:belongsToSet>urn:domeoserver:annotationset:08C0C288-6DF4-43E6-A618-71A8BB9563C3</domeo:belongsToSet>
    <pav:lastSavedOn>2014-07-07 09:44:19 -0400</pav:lastSavedOn>
    <pav:lastSavedOn>2014-07-07 09:44:18 -0400</pav:lastSavedOn>
    <domeo:belongsToSet>urn:domeoserver:annotationset:22ED7220-C6F6-43C5-9DF9-89F62F0F8E27</domeo:belongsToSet>
    <pav:lineageUri>urn:domeoserver:annotation:70ECE601-93F6-46C3-A2D3-93CE5E029677</pav:lineageUri>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812eda990003</pav:createdBy>
    <domeo:belongsToSet>urn:domeoserver:annotationset:7AACEF8D-2EBC-4F0B-94B2-190650E562F6</domeo:belongsToSet>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <ao:context rdf:resource="urn:domeoclient:uuid:AEC296E5-554D-42F1-BF6A-CA09B038958F"/>
    <domeo:belongsToSet>urn:domeoclient:uuid:FCA2BF23-0BE3-409F-9177-761812F96097</domeo:belongsToSet>
    <rdfs:label>Highlight</rdfs:label>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <domeo:belongsToSet>urn:domeoserver:annotationset:8F3CF3D9-AADE-4A86-BD42-2924B3D6A406</domeo:belongsToSet>
    <pav:createdOn>2014-07-07 09:39:24 -0400</pav:createdOn>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <domeo:belongsToSet>urn:domeoserver:annotationset:131835A3-C655-4F91-97D4-52CAFF7B7CCA</domeo:belongsToSet>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:A29DA787-54E3-4422-B166-2BA6676BC91D">
    <ao:prefix> at 10 ng/mL and </ao:prefix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <pav:createdOn>2014-07-13 11:11:50 -0400</pav:createdOn>
    <ao:suffix> at 50 ng/mL, changes of unknown clinical significance.</ao:suffix>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-8.txt.html</ao:hasSource>
    <domeo:uuid>A29DA787-54E3-4422-B166-2BA6676BC91D</domeo:uuid>
    <ao:exact>9-hydroxyrisperidone</ao:exact>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:A29DA787-54E3-4422-B166-2BA6676BC91D"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:CB3BF401-6553-421E-A6DD-22B0C2F0BC44">
    <pav:createdOn>2014-09-02 19:10:58 -0400</pav:createdOn>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <domeo:belongsToSet>urn:domeoclient:uuid:3966BCFB-CA02-4053-828D-3860558E7BE8</domeo:belongsToSet>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812eda990003</pav:createdBy>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <rdfs:label>Highlight</rdfs:label>
    <ao:context rdf:resource="urn:domeoclient:uuid:9C5170BD-B57E-4757-B143-AE7F2FE21CCC"/>
    <pav:lastSavedOn>2014-09-02 19:11:13 -0400</pav:lastSavedOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:lineageUri>urn:domeoserver:annotation:1E8589E4-636D-44DF-8972-8217A9E8E1C6</pav:lineageUri>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:6667DCF7-AA10-4999-B062-38650C90AEA5">
    <ao:body rdf:nodeID="Nfa1448e0e5c74a8185feb4e1e0cfccc6"/>
    <ao:context rdf:resource="urn:domeoclient:uuid:5F55A562-8BC3-4202-8F0A-0D9AD00722CD"/>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812eda990003</pav:createdBy>
    <ao:body rdf:nodeID="Nf740a826859f4224933964a512ae3b72"/>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">6</pav:versionNumber>
    <pav:previousVersion>urn:domeoserver:annotationset:514BA51B-D734-4003-A7C3-F03C0F95833A</pav:previousVersion>
    <ao:body rdf:nodeID="Na1b73923fdf94353bfac4a63980fb1ba"/>
    <pav:lineageUri>urn:domeoserver:annotation:C6EA9444-6987-4221-BA26-6310FAADE99B</pav:lineageUri>
    <pav:lineageUri>urn:domeoserver:annotationset:AB1741F1-5A5F-4416-AEAC-A544BCBB7D16</pav:lineageUri>
    <domeo:belongsToSet>urn:domeoserver:annotationset:F272A789-69D0-47CC-8CC9-F25C55B91261</domeo:belongsToSet>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#expertstudyAnnotation"/>
    <domeo:belongsToSet>urn:domeoserver:annotationset:2914A3FD-DF43-4F78-999C-77CE7A028B19</domeo:belongsToSet>
    <pav:lastSavedOn>2014-07-22 19:44:46 -0400</pav:lastSavedOn>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:createdOn>2014-07-22 19:44:10 -0400</pav:createdOn>
    <domeo:belongsToSet>urn:domeoserver:annotationset:606A5B3F-B6FB-4279-AA42-7893CFC2D20C</domeo:belongsToSet>
    <rdfs:label>expertstudy Annotation</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:EC7897DF-F240-4C01-A8E7-BD5189815B10">
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:lineageUri>urn:domeoserver:annotation:8BE98D27-B14B-4326-9CC3-87A6DD3A1F8B</pav:lineageUri>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812eda990003</pav:createdBy>
    <ao:context rdf:resource="urn:domeoclient:uuid:D4866C08-5431-4BCB-8D02-35C7E6408B74"/>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <rdfs:label>Highlight</rdfs:label>
    <domeo:belongsToSet>urn:domeoclient:uuid:A84DE8F6-26B7-471D-8309-4E7CC2994FDF</domeo:belongsToSet>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:lastSavedOn>2014-09-01 16:06:18 -0400</pav:lastSavedOn>
    <pav:createdOn>2014-09-01 16:06:02 -0400</pav:createdOn>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:18A94768-B77C-45AF-843F-894BD40CD040">
    <ao:suffix> is metabolized, at least in part, by CYP2D6. Caution is indicated in patients known to have reduced levels of CYP2D6 activity and those receiving concomitant drugs known to inhibit this cytochrome P450 isoenzyme (e.g., quinidine).</ao:suffix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <pav:createdOn>2014-09-02 11:35:13 -0400</pav:createdOn>
    <domeo:uuid>18A94768-B77C-45AF-843F-894BD40CD040</domeo:uuid>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-9.txt.html</ao:hasSource>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:exact>fluvoxamine</ao:exact>
    <ao:prefix>tics in 13 PM subjects demonstrated altered pharmacokinetic properties compared to 16 "extensive metabolizers" (EM): mean Cmax, AUC, and half-life were increased by 52%, 200%, and 62%, respectively, in the PM compared to the EM group. This suggests that </ao:prefix>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:18A94768-B77C-45AF-843F-894BD40CD040"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:F79885A8-4CEA-4ACB-9EC1-9EB939A385DE">
    <domeo:uuid>F79885A8-4CEA-4ACB-9EC1-9EB939A385DE</domeo:uuid>
    <pav:createdOn>2014-07-21 21:32:58 -0400</pav:createdOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:exact>Plasma zidovudine concentrations were determined on two occasions (before and following fluconazole 200 mg daily for 15 days) in 13 volunteers with AIDS or ARC who were on a stable zidovudine dose for at least two weeks. There was a significant increase in zidovudine AUC following the administration of fluconazole. The mean ± SD increase in AUC was 20% ± 32% (range: -27 to 104%). The metabolite, GZDV, to parent drug ratio significantly decreased after the administration of fluconazole, from 7.6 ± 3.6 to 5.7 ± 2.2</ao:exact>
    <ao:suffix>xsd:String</ao:suffix>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-27.txt.html</ao:hasSource>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:F79885A8-4CEA-4ACB-9EC1-9EB939A385DE"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:prefix>xsd:String</ao:prefix>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:CF243312-0709-454B-9D42-8D2FEDA95D55">
    <dikbD2R:statement>ncit:quantitative</dikbD2R:statement>
    <rdf:type rdf:resource="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#DrugDrugInteractionStatement"/>
    <sio:SIO_000563>dikbD2R:modality</sio:SIO_000563>
    <sio:SIO_000205>dikbD2R:statement</sio:SIO_000205>
    <dikbD2R:modality>ncit:positive</dikbD2R:modality>
    <sio:SIO_000628 rdf:resource="urn:pddi:uuid:6D31780D-83B2-4F04-8282-BA0D62D2F386"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:89155DC0-3493-4590-8DD7-44717F141C27">
    <pav:lastSavedOn>2014-07-13 11:32:29 -0400</pav:lastSavedOn>
    <pav:lineageUri>urn:domeoserver:annotation:94085E4A-F1A0-40E6-8805-C846AF27EEDD</pav:lineageUri>
    <pav:createdOn>2014-07-13 11:09:15 -0400</pav:createdOn>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <domeo:belongsToSet>urn:domeoclient:uuid:71191E51-53CB-4FDE-88D0-33C6818E2232</domeo:belongsToSet>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <ao:context rdf:resource="urn:domeoclient:uuid:0A1E742B-4ABE-40BF-84E5-2A5F57F232F2"/>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812eda990003</pav:createdBy>
    <rdfs:label>Highlight</rdfs:label>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
  </rdf:Description>
  <rdf:Description rdf:nodeID="Ne8914da9cd8a49f1903f213ebb61fac1">
    <domeo:sets rdf:resource="urn:pddi:uuid:E4C91349-DA7A-412B-B58B-E0D1EEF83781"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:A95EA236-59E2-47FB-878A-81116D82930F">
    <ao:prefix> are dose proportional over the dosing range of 1 to 16 mg daily (0.5 to 8 mg twice daily). Following oral administration of solution or tablet, mean peak plasma concentrations of </ao:prefix>
    <ao:suffix> occurred at about 1 hour. Peak concentrations of 9-hydroxyrisperidone occurred at about 3 hours in extensive metabolizers, and 17 hours in poor metabolizers. Steady-state concentrations of risperidone are reached in 1 day in extensive metabolizers and w</ao:suffix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <domeo:uuid>A95EA236-59E2-47FB-878A-81116D82930F</domeo:uuid>
    <ao:exact>risperidone</ao:exact>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:A95EA236-59E2-47FB-878A-81116D82930F"/>
    <pav:createdOn>2014-07-13 11:10:15 -0400</pav:createdOn>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-8.txt.html</ao:hasSource>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:C6F74A83-2371-401E-B276-117735065820">
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <domeo:belongsToSet>urn:domeoserver:annotationset:3F546823-204F-4F9B-9006-3DC526C56931</domeo:belongsToSet>
    <domeo:belongsToSet>urn:domeoserver:annotationset:A5DD001D-C81A-4E2E-B5E0-7A866B35E26B</domeo:belongsToSet>
    <ao:context rdf:resource="urn:domeoclient:uuid:CA1AC920-C96A-453E-A808-BB6D8038B11E"/>
    <pav:createdOn>2014-09-02 11:30:30 -0400</pav:createdOn>
    <pav:lineageUri>urn:domeoserver:annotation:5A2DA81E-6A94-43BD-AB20-F8879E709F47</pav:lineageUri>
    <domeo:belongsToSet>urn:domeoserver:annotationset:A3F0B39A-4249-4B63-BB0D-F24A005066AC</domeo:belongsToSet>
    <pav:lineageUri>urn:domeoserver:annotationset:D1715BD2-BD41-46FD-9454-DC7A423A29AC</pav:lineageUri>
    <domeo:belongsToSet>urn:domeoclient:uuid:BED41F06-565A-4622-9A88-48810E5A28DE</domeo:belongsToSet>
    <pav:lastSavedOn>2014-09-02 11:35:33 -0400</pav:lastSavedOn>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <rdfs:label>Highlight</rdfs:label>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812eda990003</pav:createdBy>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:4FEEF689-2803-4ABA-A0A9-56F6C3A923F0">
    <domeo:belongsToSet>urn:domeoclient:uuid:2BAA59CB-3862-4A98-8A6C-AA14E82983DC</domeo:belongsToSet>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <ao:context rdf:resource="urn:domeoclient:uuid:8BCB35DD-E167-44C4-BD7A-709DC2E39765"/>
    <pav:lineageUri>urn:domeoserver:annotation:D22E3AF2-1E34-4DEC-8926-B89FE6678282</pav:lineageUri>
    <pav:createdOn>2014-07-24 20:14:38 -0400</pav:createdOn>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812eda990003</pav:createdBy>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <rdfs:label>Highlight</rdfs:label>
    <pav:lastSavedOn>2014-07-24 20:14:43 -0400</pav:lastSavedOn>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:AE4E1848-BBFA-4DA4-8738-800749B0AAF2">
    <pav:createdOn>2014-07-21 21:42:56 -0400</pav:createdOn>
    <domeo:uuid>AE4E1848-BBFA-4DA4-8738-800749B0AAF2</domeo:uuid>
    <ao:prefix>xsd:String</ao:prefix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:exact>Daily oral dosing of immediate-release paroxetine (30 mg once daily) increased steady-state AUC0-24, Cmax, and Cmin values of procyclidine (5 mg oral once daily) by 35%, 37%, and 67%, respectively, compared to procyclidine alone at steady state. If anticholinergic effects are seen, the dose of procyclidine should be reduced.</ao:exact>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:suffix>xsd:String</ao:suffix>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-50.txt.html</ao:hasSource>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:AE4E1848-BBFA-4DA4-8738-800749B0AAF2"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:59F56EF7-8899-4A8B-904D-B19516E60E30">
    <domeo:uuid>59F56EF7-8899-4A8B-904D-B19516E60E30</domeo:uuid>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <pav:createdOn>2014-07-24 19:52:41 -0400</pav:createdOn>
    <ao:exact>propranolol</ao:exact>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:prefix>Co-administration of </ao:prefix>
    <ao:suffix> with lovastatin or pravastatin, decreased 18% to 23% the AUC of both, but did not alter their pharmacodynamics. Propranolol did not have an effect on the pharmacokinetics of fluvastatin.</ao:suffix>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-132.txt.html</ao:hasSource>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:59F56EF7-8899-4A8B-904D-B19516E60E30"/>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/3B9DE0DC-8223-4138-A13C-06DB166E9DEF">
    <sio:SIO_000228>dikbD2R:object-drug-of-interaction</sio:SIO_000228>
    <dct:description>Referred to the drug in the interaction.</dct:description>
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/39998</dailymed:activeMoietyRxCUI>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/active-ingredient"/>
    <rdfs:label>Zonisamide</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:60DE0286-3CA3-49E7-8170-0F036F3F13E2">
    <rdfs:label>Highlight</rdfs:label>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <ao:context rdf:resource="urn:domeoclient:uuid:B866F0DD-7DF3-4E04-804F-9A346D40E738"/>
    <pav:createdOn>2014-07-24 20:14:10 -0400</pav:createdOn>
    <domeo:belongsToSet>urn:domeoclient:uuid:7DCD6738-9404-46BB-A758-BDDEB41B4565</domeo:belongsToSet>
    <pav:lineageUri>urn:domeoserver:annotation:99DC39B5-C193-4FEC-922A-52F2BAF5AFA5</pav:lineageUri>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812eda990003</pav:createdBy>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:lastSavedOn>2014-07-24 20:14:01 -0400</pav:lastSavedOn>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:E73E8FF7-7FA2-47F3-B0B1-14D1640DDBF7">
    <pav:lastSavedOn>2014-07-13 11:32:29 -0400</pav:lastSavedOn>
    <pav:createdOn>2014-07-13 11:10:54 -0400</pav:createdOn>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <ao:context rdf:resource="urn:domeoclient:uuid:789A1E1D-CA44-4410-B654-F6392AB94EDC"/>
    <pav:lineageUri>urn:domeoserver:annotation:469138F3-F092-499E-AF0F-B2CB920DF026</pav:lineageUri>
    <domeo:belongsToSet>urn:domeoclient:uuid:71191E51-53CB-4FDE-88D0-33C6818E2232</domeo:belongsToSet>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812eda990003</pav:createdBy>
    <rdfs:label>Highlight</rdfs:label>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:DA7B78BE-B91C-4178-9AF1-7DC800EF5121">
    <pav:lineageUri>urn:domeoserver:annotation:B08B644F-5630-4DD4-870A-83EE4BFF9279</pav:lineageUri>
    <domeo:belongsToSet>urn:domeoserver:annotationset:8F3CF3D9-AADE-4A86-BD42-2924B3D6A406</domeo:belongsToSet>
    <ao:context rdf:resource="urn:domeoclient:uuid:5139C7C3-ACE5-4F03-BC84-8DD2AF187DDB"/>
    <rdfs:label>Highlight</rdfs:label>
    <domeo:belongsToSet>urn:domeoserver:annotationset:7AACEF8D-2EBC-4F0B-94B2-190650E562F6</domeo:belongsToSet>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:lastSavedOn>2014-07-07 11:24:52 -0400</pav:lastSavedOn>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <domeo:belongsToSet>urn:domeoserver:annotationset:131835A3-C655-4F91-97D4-52CAFF7B7CCA</domeo:belongsToSet>
    <pav:createdOn>2014-07-07 11:22:50 -0400</pav:createdOn>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812eda990003</pav:createdBy>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <domeo:belongsToSet>urn:domeoserver:annotationset:22ED7220-C6F6-43C5-9DF9-89F62F0F8E27</domeo:belongsToSet>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:56C7D107-DA52-4259-9BBA-41DB4C5FB13D">
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:suffix>xsd:String</ao:suffix>
    <ao:exact>rosiglitazone</ao:exact>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:56C7D107-DA52-4259-9BBA-41DB4C5FB13D"/>
    <pav:createdOn>2014-07-22 19:38:28 -0400</pav:createdOn>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-123.txt.html</ao:hasSource>
    <ao:prefix>xsd:String</ao:prefix>
    <domeo:uuid>56C7D107-DA52-4259-9BBA-41DB4C5FB13D</domeo:uuid>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:532BC8DC-5349-4E14-AC6A-60B992104491">
    <pav:lastSavedOn>2014-07-22 18:46:52 -0400</pav:lastSavedOn>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <ao:context rdf:resource="urn:domeoclient:uuid:8A0A9901-A1C2-4230-8BC1-B758AADE7F4C"/>
    <pav:createdOn>2014-07-22 18:44:37 -0400</pav:createdOn>
    <domeo:belongsToSet>urn:domeoclient:uuid:E0054F81-6A9B-4AF0-9DCB-962A6FC1C418</domeo:belongsToSet>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812eda990003</pav:createdBy>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <rdfs:label>Highlight</rdfs:label>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:lineageUri>urn:domeoserver:annotation:8192878E-B1B0-4825-8F66-9102938DC568</pav:lineageUri>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:3966BCFB-CA02-4053-828D-3860558E7BE8">
    <ao:item rdf:resource="urn:domeoclient:uuid:960E16A3-CF0E-48BD-8B23-ACD869DFB214"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:C241BBD6-7DDD-4B8E-BA29-A9A307595892"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:5BCF5967-ADD0-4798-B754-B12D230BDBFA"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:85043124-E686-41BA-831E-AB868FA3D3B1"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:C9DB2D07-ABDB-402C-AA6C-8EB7046415D4"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:01CABF7B-5601-4091-B27B-BB36CCDE1151"/>
    <domeo:agents rdf:resource="urn:person:uuid:080e143046812afe0146812eda990003"/>
    <permissions:permissions rdf:nodeID="N671a11f55a4f4168ae4ffe27f5d6b14b"/>
    <pav:createdOn>2014-09-02 19:08:19 -0400</pav:createdOn>
    <dct:description>The default set is created automatically by Domeo when no other set is existing.</dct:description>
    <pav:lineageUri>urn:domeoserver:annotationset:D37B2D57-1801-4552-AFD9-6AE31E8DC5A5</pav:lineageUri>
    <ao:item rdf:resource="urn:domeoclient:uuid:083AD66D-BAA3-4731-A45A-FB051CF3619F"/>
    <domeo:deleted>false</domeo:deleted>
    <ao:item rdf:resource="urn:domeoclient:uuid:FA208444-D170-43D4-B1EB-ED24016D3210"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:8BA43995-3A5A-44A6-AEC6-73AB1675E1DE"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:724EC70E-AD36-444C-A1EB-23C9873CB536"/>
    <ao:annotatesResource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-72.txt.html</ao:annotatesResource>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#AnnotationSet"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:4683A379-9BF3-47AD-B269-BF50998FE88B"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:3B40A6C2-C532-4FE1-9D1E-96A1576E7CC1"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:A07FFEB8-13E6-4964-A170-13A6FA26AB90"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:095C4B55-33C1-4413-83DF-963BC2158506"/>
    <rdfs:label>Default Set</rdfs:label>
    <ao:item rdf:resource="urn:domeoclient:uuid:29043652-5144-43F9-865A-114AECF87D36"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:F1AECF5B-0B80-4F34-AE54-273DA1B3D41A"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:55F0E65E-65B9-4FEF-9D48-18521D03D3DC"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:35B0C843-6298-4494-92B8-CA2A60C766FB"/>
    <domeo:agents rdf:resource="urn:domeo:software:id:Domeo-2.1alpha-050"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:B9517CDA-E201-4D75-90EA-09D040EC5F9E"/>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:lastSavedOn>2014-09-02 19:11:13 -0400</pav:lastSavedOn>
    <ao:item rdf:resource="urn:domeoclient:uuid:CE8D9855-AB1B-4B9E-97B4-6A441B8254E8"/>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <ao:item rdf:resource="urn:domeoclient:uuid:18E928D8-1D25-4E2F-BBD0-E7B1E4E45799"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:76ADDE4C-05F0-4C9D-B547-37B2AA813054"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:CB3BF401-6553-421E-A6DD-22B0C2F0BC44"/>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812eda990003</pav:createdBy>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:B4A07D2A-59AD-4845-9180-9D26F251F26E">
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-47.txt.html</ao:hasSource>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:B4A07D2A-59AD-4845-9180-9D26F251F26E"/>
    <ao:exact> paroxetine</ao:exact>
    <ao:suffix>.</ao:suffix>
    <domeo:uuid>B4A07D2A-59AD-4845-9180-9D26F251F26E</domeo:uuid>
    <ao:prefix> be initiated at a reduced dose when given with</ao:prefix>
    <pav:createdOn>2014-09-02 11:58:55 -0400</pav:createdOn>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:7A49EC3D-7C54-46A7-831E-A352B5A1B081">
    <ao:exact>glyburide</ao:exact>
    <ao:suffix> (3.75 to 10 mg/day) for 7 days did not alter the mean steady-state 24-hour plasma glucose concentrations in diabetic patients stabilized on glyburide therapy. Repeat doses of AVANDIA (8 mg once daily) for 8 days in healthy adult Caucasian subjects cause</ao:suffix>
    <ao:prefix> (2 mg twice daily) taken concomitantly with </ao:prefix>
    <domeo:uuid>7A49EC3D-7C54-46A7-831E-A352B5A1B081</domeo:uuid>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-123.txt.html</ao:hasSource>
    <pav:createdOn>2014-07-22 19:49:16 -0400</pav:createdOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:7A49EC3D-7C54-46A7-831E-A352B5A1B081"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:4519FF07-AE90-4478-8B97-B4B2C84457DC">
    <ao:item rdf:resource="urn:domeoclient:uuid:EE072CDD-1278-4505-A3C0-39DABDD38987"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:0C7DC9EA-F2B4-4F7F-BD05-8D844F135B91"/>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <rdfs:label>Default Set</rdfs:label>
    <dct:description>The default set is created automatically by Domeo when no other set is existing.</dct:description>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#AnnotationSet"/>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <domeo:agents rdf:resource="urn:person:uuid:080e143046812afe0146812eda990003"/>
    <ao:annotatesResource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-129.txt.html</ao:annotatesResource>
    <domeo:agents rdf:resource="urn:domeo:software:id:Domeo-2.1alpha-050"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:0F69928C-A74C-43BB-99CF-5CCE1F577586"/>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812eda990003</pav:createdBy>
    <pav:lastSavedOn>2014-07-24 19:46:04 -0400</pav:lastSavedOn>
    <pav:lineageUri>urn:domeoserver:annotationset:FC19467B-77EB-4025-99ED-15D0CC1ED7F6</pav:lineageUri>
    <permissions:permissions rdf:nodeID="Nf76a020971ca4e628b60dbd5707e083d"/>
    <domeo:deleted>false</domeo:deleted>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:createdOn>2014-07-24 19:45:35 -0400</pav:createdOn>
    <ao:item rdf:resource="urn:domeoclient:uuid:436A0572-7B45-4903-B1A7-9FA513872756"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:3B0F0546-41D1-46D1-95BF-CB03118C9BB8">
    <rdfs:label>Highlight</rdfs:label>
    <pav:createdOn>2014-09-01 16:07:44 -0400</pav:createdOn>
    <domeo:belongsToSet>urn:domeoclient:uuid:1DA34422-734D-46B1-AB2C-C1CABCA4C26C</domeo:belongsToSet>
    <ao:context rdf:resource="urn:domeoclient:uuid:A08092E7-4D52-4833-B9FF-4EFA3BA6D2E4"/>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:lineageUri>urn:domeoserver:annotation:A0AB1C1B-6261-4216-AAA4-093882220EF2</pav:lineageUri>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:lastSavedOn>2014-09-01 16:07:52 -0400</pav:lastSavedOn>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812eda990003</pav:createdBy>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:D32DB27C-3D8E-46AF-87F9-8A3307B5D13B">
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812eda990003</pav:createdBy>
    <ao:context rdf:resource="urn:domeoclient:uuid:2FF47DA5-4366-4BC2-AA71-7E8F63D7F2AA"/>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:lineageUri>urn:domeoserver:annotation:32CAAE58-D8E1-40B0-8139-A1D54B51BEEE</pav:lineageUri>
    <rdfs:label>Highlight</rdfs:label>
    <domeo:belongsToSet>urn:domeoclient:uuid:C4B80A95-F569-4ED4-84D1-6796B53A580C</domeo:belongsToSet>
    <pav:createdOn>2014-09-02 15:04:10 -0400</pav:createdOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:lastSavedOn>2014-09-02 15:04:32 -0400</pav:lastSavedOn>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:BF6678E7-2ECF-462C-8BF0-34D8AD9D7A8B">
    <ao:exact>nifedipine</ao:exact>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:suffix> causes arterial vasodilation and decreased peripheral vascular resistance which results in reduced arterial blood pressure.</ao:suffix>
    <pav:createdOn>2014-09-02 19:46:53 -0400</pav:createdOn>
    <ao:prefix>lts in an inhibition of calcium influx through these channels. Stores of intracellular calcium in vascular smooth muscle are limited and thus dependent upon the influx of extracellular calcium for contraction to occur. The reduction in calcium influx by </ao:prefix>
    <domeo:uuid>BF6678E7-2ECF-462C-8BF0-34D8AD9D7A8B</domeo:uuid>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-117.txt.html</ao:hasSource>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:BF6678E7-2ECF-462C-8BF0-34D8AD9D7A8B"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:BFF65D4B-C4C0-4D4B-82C1-14B60D53FB1D">
    <ao:context rdf:resource="urn:domeoclient:uuid:06416843-5F84-4886-A5D4-559FA1082541"/>
    <pav:lineageUri>urn:domeoserver:annotation:DCA20857-B042-41C0-8F2D-DFF85B6A4526</pav:lineageUri>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <rdfs:label>Highlight</rdfs:label>
    <pav:lastSavedOn>2014-07-22 20:22:38 -0400</pav:lastSavedOn>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:createdOn>2014-07-22 19:55:21 -0400</pav:createdOn>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812eda990003</pav:createdBy>
    <domeo:belongsToSet>urn:domeoserver:annotationset:F272A789-69D0-47CC-8CC9-F25C55B91261</domeo:belongsToSet>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:1504073B-965A-43C5-A889-0D6EA22F08A0">
    <domeo:uuid>1504073B-965A-43C5-A889-0D6EA22F08A0</domeo:uuid>
    <pav:createdOn>2014-07-22 19:39:28 -0400</pav:createdOn>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:1504073B-965A-43C5-A889-0D6EA22F08A0"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:suffix> does not inhibit any of the major P450 enzymes at clinically relevant concentrations. In vitro data demonst</ao:suffix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:exact>rosiglitazone</ao:exact>
    <ao:prefix>In vitro drug metabolism studies suggest that </ao:prefix>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-123.txt.html</ao:hasSource>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:E9D4D6AE-7491-4219-BCFA-453D4DA5FF99">
    <ao:prefix>. No clinically significant reductions in glimepiride AUC and Cmax were observed after repeat doses of </ao:prefix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:suffix> (8 mg once daily) for 8 days in healthy adult subjects.</ao:suffix>
    <pav:createdOn>2014-07-22 19:53:25 -0400</pav:createdOn>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:E9D4D6AE-7491-4219-BCFA-453D4DA5FF99"/>
    <ao:exact>AVANDIA</ao:exact>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-123.txt.html</ao:hasSource>
    <domeo:uuid>E9D4D6AE-7491-4219-BCFA-453D4DA5FF99</domeo:uuid>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:C1594E9A-1D6B-476C-8DD6-9BADB6C707A8">
    <pav:lineageUri>urn:domeoserver:annotation:A28BF2BE-2291-4744-A54F-D02559667C47</pav:lineageUri>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <pav:createdOn>2014-09-02 12:04:40 -0400</pav:createdOn>
    <ao:body rdf:nodeID="Neb407c1162d0489cbadf4aa85f4d56d6"/>
    <ao:context rdf:resource="urn:domeoclient:uuid:FC8952F2-7F31-41D0-BEDA-AC57C009870A"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#expertstudyAnnotation"/>
    <rdfs:label>expertstudy Annotation</rdfs:label>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <domeo:belongsToSet>urn:domeoserver:annotationset:D52DFD7B-BDDF-488F-B339-B1BC641E50E9</domeo:belongsToSet>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812eda990003</pav:createdBy>
    <pav:lastSavedOn>2014-09-02 12:05:00 -0400</pav:lastSavedOn>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:69354CBD-D372-4AD9-A6F1-93E07CA4D048">
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">2</pav:versionNumber>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <rdfs:label>Highlight</rdfs:label>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <ao:context rdf:resource="urn:domeoclient:uuid:FF8F1249-3CE1-41AF-B118-1647BE5597AF"/>
    <pav:lastSavedOn>2014-09-02 11:46:58 -0400</pav:lastSavedOn>
    <pav:lineageUri>urn:domeoserver:annotation:750A2A81-90A6-4499-83F5-A63A90E4AB4E</pav:lineageUri>
    <domeo:belongsToSet>urn:domeoserver:annotationset:A3F0B39A-4249-4B63-BB0D-F24A005066AC</domeo:belongsToSet>
    <domeo:belongsToSet>urn:domeoserver:annotationset:3F546823-204F-4F9B-9006-3DC526C56931</domeo:belongsToSet>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <pav:previousVersion>urn:domeoclient:uuid:BED41F06-565A-4622-9A88-48810E5A28DE</pav:previousVersion>
    <domeo:belongsToSet>urn:domeoserver:annotationset:A5DD001D-C81A-4E2E-B5E0-7A866B35E26B</domeo:belongsToSet>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:lineageUri>urn:domeoserver:annotationset:D1715BD2-BD41-46FD-9454-DC7A423A29AC</pav:lineageUri>
    <pav:createdOn>2014-09-02 11:45:26 -0400</pav:createdOn>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812eda990003</pav:createdBy>
    <pav:lastSavedOn>2014-09-02 11:46:59 -0400</pav:lastSavedOn>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:37752019-6AF8-406B-9C87-6BCEF8ED7AAE">
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812eda990003</pav:createdBy>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:createdOn>2014-07-22 19:53:25 -0400</pav:createdOn>
    <domeo:belongsToSet>urn:domeoserver:annotationset:F272A789-69D0-47CC-8CC9-F25C55B91261</domeo:belongsToSet>
    <pav:lineageUri>urn:domeoserver:annotation:AAF804DC-8EFB-4635-9DA3-1A55EE4A0F18</pav:lineageUri>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">7</pav:versionNumber>
    <pav:lastSavedOn>2014-07-22 19:54:59 -0400</pav:lastSavedOn>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <rdfs:label>Highlight</rdfs:label>
    <ao:context rdf:resource="urn:domeoclient:uuid:E9D4D6AE-7491-4219-BCFA-453D4DA5FF99"/>
    <pav:lineageUri>urn:domeoserver:annotationset:AB1741F1-5A5F-4416-AEAC-A544BCBB7D16</pav:lineageUri>
    <pav:previousVersion>urn:domeoserver:annotationset:606A5B3F-B6FB-4279-AA42-7893CFC2D20C</pav:previousVersion>
    <domeo:belongsToSet>urn:domeoserver:annotationset:2914A3FD-DF43-4F78-999C-77CE7A028B19</domeo:belongsToSet>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:9B40D027-2C99-4AA7-A143-A35EFB743189">
    <domeo:uuid>9B40D027-2C99-4AA7-A143-A35EFB743189</domeo:uuid>
    <ao:exact>propranolol</ao:exact>
    <ao:prefix> maleate 100 mg per day with atenolol 100 mg per day (N = 6) did not affect the plasma concentrations of atenolol. Unlike </ao:prefix>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-9.txt.html</ao:hasSource>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <pav:createdOn>2014-09-02 11:46:26 -0400</pav:createdOn>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:9B40D027-2C99-4AA7-A143-A35EFB743189"/>
    <ao:suffix> and metoprolol which undergo hepatic metabolism, atenolol is eliminated primarily by renal excretion.</ao:suffix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:CC05ADFA-B5BA-4A4E-BAB0-61B3D424E8F2">
    <pav:lineageUri>urn:domeoserver:annotation:D632D7ED-9F65-4CC8-992B-4A4753EEBBCC</pav:lineageUri>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <ao:body rdf:nodeID="Nf98d13d8337a44c2b1f1c4c6fe169164"/>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <ao:context rdf:resource="urn:domeoclient:uuid:B6E0548D-97C5-4C24-A078-F69D2D16D9FE"/>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812eda990003</pav:createdBy>
    <pav:lastSavedOn>2014-07-21 21:55:00 -0400</pav:lastSavedOn>
    <pav:createdOn>2014-07-21 21:54:13 -0400</pav:createdOn>
    <domeo:belongsToSet>urn:domeoclient:uuid:C988D053-7CF3-4C50-BDB6-7C2B20B837B9</domeo:belongsToSet>
    <rdfs:label>expertstudy Annotation</rdfs:label>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#expertstudyAnnotation"/>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:6FF44D67-C048-4D48-95BC-9CAC7BF5E54F">
    <rdfs:label>Highlight</rdfs:label>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <domeo:belongsToSet>urn:domeoclient:uuid:C988D053-7CF3-4C50-BDB6-7C2B20B837B9</domeo:belongsToSet>
    <pav:createdOn>2014-07-21 21:52:26 -0400</pav:createdOn>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <pav:lineageUri>urn:domeoserver:annotation:5D24394F-4462-424E-8BC2-BB9AC13FAFF6</pav:lineageUri>
    <pav:lastSavedOn>2014-07-21 21:55:00 -0400</pav:lastSavedOn>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812eda990003</pav:createdBy>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <ao:context rdf:resource="urn:domeoclient:uuid:58BF67B8-BDBC-4A81-816F-832DAD1FC0F8"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:D3699069-7DAD-4616-9500-2A16ADBA4010">
    <ao:exact>FLAGYL</ao:exact>
    <pav:createdOn>2014-07-22 18:58:36 -0400</pav:createdOn>
    <domeo:uuid>D3699069-7DAD-4616-9500-2A16ADBA4010</domeo:uuid>
    <ao:prefix> and other oral coumarin anticoagulants, resulting in a prolongation of prothrombin time. This possible drug interaction should be considered when </ao:prefix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:suffix> (metronidazole) is prescribed for patients on this type of anticoagulant therapy.</ao:suffix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-120.txt.html</ao:hasSource>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:D3699069-7DAD-4616-9500-2A16ADBA4010"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:48081C9F-3CDC-436C-888F-B763536ACD92">
    <ao:exact>Propranolol can inhibit the metabolism of diazepam, resulting in increased concentrations of diazepam and its metabolites. Diazepam does not alter the pharmacokinetics of propranolol</ao:exact>
    <pav:createdOn>2014-07-24 19:44:48 -0400</pav:createdOn>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-128.txt.html</ao:hasSource>
    <ao:suffix>xsd:String</ao:suffix>
    <ao:prefix>xsd:String</ao:prefix>
    <domeo:uuid>48081C9F-3CDC-436C-888F-B763536ACD92</domeo:uuid>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:48081C9F-3CDC-436C-888F-B763536ACD92"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:010AF63D-C71E-4A93-9F41-8E5764F068ED">
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <rdfs:label>Highlight</rdfs:label>
    <domeo:belongsToSet>urn:domeoclient:uuid:23567EF7-7482-444A-B1F6-5AAA9D43E54A</domeo:belongsToSet>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:lineageUri>urn:domeoserver:annotation:451E9FBF-CD25-4B95-963D-2A293790A1B4</pav:lineageUri>
    <ao:context rdf:resource="urn:domeoclient:uuid:00CDF4D6-2271-4B2A-9836-98BD00E7E952"/>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:createdOn>2014-07-13 12:42:05 -0400</pav:createdOn>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812eda990003</pav:createdBy>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <pav:lastSavedOn>2014-07-13 12:45:54 -0400</pav:lastSavedOn>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:94DCE217-B72B-4727-9783-98D7EFCB02E6">
    <ao:item rdf:resource="urn:domeoclient:uuid:08D219B2-A0EC-49C7-A943-47EE7CE4B542"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:FF3A4E4B-56B2-47CF-B174-C006C3954623"/>
    <pav:createdOn>2014-09-01 16:19:43 -0400</pav:createdOn>
    <pav:lastSavedOn>2014-09-01 16:20:01 -0400</pav:lastSavedOn>
    <rdfs:label>Default Set</rdfs:label>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <domeo:deleted>false</domeo:deleted>
    <domeo:agents rdf:resource="urn:person:uuid:080e143046812afe0146812eda990003"/>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <permissions:permissions rdf:nodeID="Nf6efef1f45f246cf8cac6755eaf1ba48"/>
    <pav:lineageUri>urn:domeoserver:annotationset:549650A1-2BE0-4AAB-87A9-51EB33F5FE79</pav:lineageUri>
    <domeo:agents rdf:resource="urn:domeo:software:id:Domeo-2.1alpha-050"/>
    <dct:description>The default set is created automatically by Domeo when no other set is existing.</dct:description>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#AnnotationSet"/>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812eda990003</pav:createdBy>
    <ao:annotatesResource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-43.txt.html</ao:annotatesResource>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:6793D5D8-D5E4-4015-B012-93740E224E6E">
    <domeo:belongsToSet>urn:domeoserver:annotationset:3F546823-204F-4F9B-9006-3DC526C56931</domeo:belongsToSet>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:createdOn>2014-09-02 11:46:17 -0400</pav:createdOn>
    <ao:context rdf:resource="urn:domeoclient:uuid:95CC663C-8F74-4A62-BE19-7170368BDA5F"/>
    <pav:lineageUri>urn:domeoserver:annotation:EBCCD5EB-B1CB-4FCA-881B-1BDF95F9CAFF</pav:lineageUri>
    <domeo:belongsToSet>urn:domeoserver:annotationset:A5DD001D-C81A-4E2E-B5E0-7A866B35E26B</domeo:belongsToSet>
    <pav:lineageUri>urn:domeoserver:annotationset:D1715BD2-BD41-46FD-9454-DC7A423A29AC</pav:lineageUri>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">2</pav:versionNumber>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812eda990003</pav:createdBy>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:lastSavedOn>2014-09-02 11:46:59 -0400</pav:lastSavedOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <rdfs:label>Highlight</rdfs:label>
    <pav:lastSavedOn>2014-09-02 11:46:58 -0400</pav:lastSavedOn>
    <domeo:belongsToSet>urn:domeoserver:annotationset:A3F0B39A-4249-4B63-BB0D-F24A005066AC</domeo:belongsToSet>
    <pav:previousVersion>urn:domeoclient:uuid:BED41F06-565A-4622-9A88-48810E5A28DE</pav:previousVersion>
    <pav:previousVersion>xsd:String</pav:previousVersion>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:92DB5361-BE2B-4C69-B141-FB431E8EFC22">
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <domeo:belongsToSet>urn:domeoclient:uuid:71191E51-53CB-4FDE-88D0-33C6818E2232</domeo:belongsToSet>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <ao:context rdf:resource="urn:domeoclient:uuid:0991F050-6152-45E8-8D40-DC901E368C9E"/>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <pav:createdOn>2014-07-13 11:17:24 -0400</pav:createdOn>
    <pav:lastSavedOn>2014-07-13 11:32:29 -0400</pav:lastSavedOn>
    <pav:lineageUri>urn:domeoserver:annotation:BF0C3C69-52C2-4462-9A48-708B80A1A097</pav:lineageUri>
    <rdfs:label>Highlight</rdfs:label>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812eda990003</pav:createdBy>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:23CAE79F-92D8-407B-BE7A-4BCA038E20F4">
    <pav:createdOn>2014-07-22 19:00:38 -0400</pav:createdOn>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:lastSavedOn>2014-07-22 19:00:28 -0400</pav:lastSavedOn>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812eda990003</pav:createdBy>
    <pav:lineageUri>urn:domeoserver:annotation:B1F452A5-D9B4-427C-B59B-814D4EF0510B</pav:lineageUri>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <ao:context rdf:resource="urn:domeoclient:uuid:319A061D-1A35-4E08-859B-F39DA704D1B4"/>
    <rdfs:label>Highlight</rdfs:label>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <domeo:belongsToSet>urn:domeoclient:uuid:4C207F47-3585-4A4F-A5A4-245A1F19DF8E</domeo:belongsToSet>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:F409D487-F7F1-4F27-B967-0469F9A468A8">
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:suffix>. Therefore, if an inhibitor or an inducer of CYP2C8 is started or stopped during treatment with rosiglitazone, changes in diabetes treatment may be needed based upon clinical response. [See Clinical Pharmacology (12.4).] </ao:suffix>
    <domeo:uuid>F409D487-F7F1-4F27-B967-0469F9A468A8</domeo:uuid>
    <pav:createdOn>2014-07-22 19:06:51 -0400</pav:createdOn>
    <ao:prefix> and an inducer of CYP2C8 (e.g., rifampin) may decrease the AUC of </ao:prefix>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:F409D487-F7F1-4F27-B967-0469F9A468A8"/>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-122.txt.html</ao:hasSource>
    <ao:exact>rosiglitazone</ao:exact>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:66EF0F25-8A90-4498-99B4-6985AB481B18">
    <ao:body rdf:nodeID="N3b4342baa5b040bbb0d1c39149bc5a02"/>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:lastSavedOn>2014-09-02 19:33:40 -0400</pav:lastSavedOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#expertstudyAnnotation"/>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812eda990003</pav:createdBy>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:createdOn>2014-09-02 19:33:36 -0400</pav:createdOn>
    <ao:context rdf:resource="urn:domeoclient:uuid:87FEE025-38F8-476B-BB04-19AD3D10B07C"/>
    <pav:lineageUri>urn:domeoserver:annotation:AD447610-C9B8-4FFF-AAC8-76E00E96A039</pav:lineageUri>
    <domeo:belongsToSet>urn:domeoserver:annotationset:E32812A9-205B-4EE1-B488-A1E294EDBFB9</domeo:belongsToSet>
    <rdfs:label>expertstudy Annotation</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:60E67B22-5DBF-4F42-9120-BC7E0F398FA0">
    <rdfs:label>expertstudy Annotation</rdfs:label>
    <domeo:belongsToSet>urn:domeoclient:uuid:EC9B90D7-F9B5-4E51-94E2-878FAA06F611</domeo:belongsToSet>
    <pav:createdOn>2014-07-13 12:48:08 -0400</pav:createdOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#expertstudyAnnotation"/>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812eda990003</pav:createdBy>
    <ao:body rdf:nodeID="Nc8427479039e45d6959dd84aa7121215"/>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:lastSavedOn>2014-07-13 12:48:45 -0400</pav:lastSavedOn>
    <ao:context rdf:resource="urn:domeoclient:uuid:AE5EBB85-C1D9-438F-B2E8-17B61D972F3D"/>
    <pav:lineageUri>urn:domeoserver:annotation:B4D55559-EA4E-4B39-A156-D764B9CB8614</pav:lineageUri>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoserver:annotationset:8F3CF3D9-AADE-4A86-BD42-2924B3D6A406">
    <ao:item rdf:resource="urn:domeoclient:uuid:9BD9047F-C1DA-4B64-92B7-4D031972C9CF"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:DC9FB0B5-1564-4BF2-A4E4-4D05B0A1AB86"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:0B2918C2-A28D-40C3-8147-F19D09B7119C"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:137A1951-AA86-4074-9581-B011801B955F"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:55E300CE-2A8F-42F4-9877-A49DDE4F3360"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:57E98049-37B0-4F70-963B-F0D12C3B36C7"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:E5DE379E-8BB3-4609-BFC6-A0E275978ADC"/>
    <pav:lineageUri>urn:domeoserver:annotationset:76FD4BB5-DE2F-4FCA-B93D-302185B1A381</pav:lineageUri>
    <ao:item rdf:resource="urn:domeoclient:uuid:54B9529D-9030-4194-B66A-D7ECCBABED1F"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:B9E21C61-063D-4F80-8E08-85865B387669"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:16393981-08BF-477D-ACB9-8FB804E50D0C"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:F9FE917E-CAFF-4C8B-B16B-BB0606212145"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:BDA75ADA-742A-402B-AE97-4438F99C61FC"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:EC416A29-1315-42C5-90FA-652412A6AD12"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:3D22E6FA-B90D-49C2-B42F-B8122D48D82A"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:FA4C8A6E-17D4-47F8-A369-67AF061E9037"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:3B85AE85-A07C-4614-91F5-52EF7A4737DF"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:E0DCF362-11F8-4FF3-8C3C-EDB9DD3D53A7"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:CE16BF01-AD42-444E-9A68-FEF6AED26815"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:E13140FE-59B4-45B2-A524-CAED051C4F9D"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:222C9B55-A770-41C7-AF04-566E7C7A1DBC"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:C8D05CE4-8287-449A-8921-AFACBAEE2002"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:1F12731E-6D41-4E27-83E3-C87822424FCA"/>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <ao:item rdf:resource="urn:domeoclient:uuid:74FDA5BD-9C18-4F10-AC59-C5C75AA497C2"/>
    <permissions:permissions rdf:nodeID="N6b4960fe8ade40debecf6a621b26c4a4"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:8ABD9FDA-0F08-474A-A9C8-437A5346F2AC"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:2CF891F7-2E96-4382-8EDB-5C061E8E1AFA"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:DA7B78BE-B91C-4178-9AF1-7DC800EF5121"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:02D92735-6D44-4DFA-A2E9-75A5A3D4DCF9"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:8C5BA635-EF8B-4165-A2A6-5832D61A15BF"/>
    <pav:createdOn>2014-07-07 09:34:12 -0400</pav:createdOn>
    <ao:item rdf:resource="urn:domeoclient:uuid:5D480921-AA61-499B-9C3F-3043269104B4"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:3ED57AC4-296D-4C8D-9873-49C193F69BBA"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:6588D45E-2F4C-40CF-8AF4-0CD621F484E1"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:697C8F03-1543-4427-9D85-7967FCEA3100"/>
    <domeo:deleted>false</domeo:deleted>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">4</pav:versionNumber>
    <ao:item rdf:resource="urn:domeoclient:uuid:E7907DD5-4FA4-4B5A-99D9-9D24B76931C6"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:2F71B86E-3B80-4813-9F00-A9E3E6B30C9E"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:08713DDF-0935-4B63-B281-AEE56A8D7628"/>
    <ao:annotatesResource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-155.txt.html</ao:annotatesResource>
    <ao:item rdf:resource="urn:domeoclient:uuid:6FD9D48D-F639-4F09-ABA6-F4B259681453"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:E76D782E-ADBF-42D0-9CCA-8944F07D22DA"/>
    <domeo:agents rdf:resource="urn:person:uuid:080e143046812afe0146812eda990003"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:E76B5D64-7248-4EBD-A023-3820BFDEFD26"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:32B1CD5D-3CD7-4D5E-BD76-57F6F0A9480A"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:B8D94772-B85A-452F-91A5-C644F8298C08"/>
    <dct:description>The default set is created automatically by Domeo when no other set is existing.</dct:description>
    <ao:item rdf:resource="urn:domeoclient:uuid:FB0C633B-9063-4FD0-91E9-2810CF1C157A"/>
    <pav:previousVersion>urn:domeoserver:annotationset:7AACEF8D-2EBC-4F0B-94B2-190650E562F6</pav:previousVersion>
    <ao:item rdf:resource="urn:domeoclient:uuid:CBB863B4-0141-4362-8357-0FD5A3909A10"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#AnnotationSet"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:2093FF56-689E-4246-AF69-F566860B27BF"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:DE5C582E-1F4C-478C-9DDC-DAB4C0C1ABFF"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:FA428F64-D782-46F5-B866-2FBC24D3F4F8"/>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812eda990003</pav:createdBy>
    <ao:item rdf:resource="urn:domeoclient:uuid:B5E75366-F0BF-442F-852E-19C5EDDC84EE"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:F3C4287B-36A9-48BF-8081-A39BEF5F3C51"/>
    <rdfs:label>Default Set</rdfs:label>
    <ao:item rdf:resource="urn:domeoclient:uuid:3762570C-CF43-4DB9-B163-FAA6DAE60017"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:42423629-C409-4AD4-BBE6-7C86A696F03E"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:79293219-D172-4E27-A045-D16B4F539C60"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:7D37CC60-618E-46B6-8C99-BA7D598E3762"/>
    <domeo:agents rdf:resource="urn:domeo:software:id:Domeo-2.1alpha-050"/>
    <pav:lastSavedOn>2014-07-07 11:35:31 -0400</pav:lastSavedOn>
    <ao:item rdf:resource="urn:domeoclient:uuid:17E64297-0A57-4C9B-94C4-18ED1956FCF7"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:735CA4BD-A16D-4729-BFC3-96D72BFE5B0B"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:1C02BE13-5688-4657-A7A7-6A459283AEB2"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:2ABA1A35-6C77-4A0A-9EC5-109AA13136B6"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:DA8337B7-4497-4F34-93E8-291B9ED278CB">
    <ao:context rdf:resource="urn:domeoclient:uuid:8214D15C-5AF1-47D0-A63C-30543353403D"/>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:lastSavedOn>2014-07-13 12:41:10 -0400</pav:lastSavedOn>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812eda990003</pav:createdBy>
    <pav:lineageUri>urn:domeoserver:annotation:6D41F524-FA45-4B72-94A7-36317513638D</pav:lineageUri>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <rdfs:label>Highlight</rdfs:label>
    <pav:createdOn>2014-07-13 12:37:44 -0400</pav:createdOn>
    <domeo:belongsToSet>urn:domeoclient:uuid:4F872953-6D19-4809-9285-FCCF2FF54315</domeo:belongsToSet>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:F1EC2D5D-E8AA-4BAB-8BCE-D86C722E5855">
    <rdfs:label>Highlight</rdfs:label>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:createdOn>2014-07-21 21:47:22 -0400</pav:createdOn>
    <domeo:belongsToSet>urn:domeoclient:uuid:B803E851-5AD5-4741-B1B9-1CBAED597E18</domeo:belongsToSet>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:lineageUri>urn:domeoserver:annotation:C0CA1D7A-A6F3-4B33-A548-FEE27A93C15D</pav:lineageUri>
    <pav:lastSavedOn>2014-07-21 21:49:33 -0400</pav:lastSavedOn>
    <ao:context rdf:resource="urn:domeoclient:uuid:805A260D-8C6D-4764-98FF-7A828A5A8A65"/>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812eda990003</pav:createdBy>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:8F4C5D67-B302-4D5E-86D3-E308EE0C607E">
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812eda990003</pav:createdBy>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <ao:context rdf:resource="urn:domeoclient:uuid:B06BD29E-2481-4EA0-885B-420749EBE703"/>
    <pav:lineageUri>urn:domeoserver:annotation:044837BF-E4FA-4C9D-8EA0-E23B27E2EC72</pav:lineageUri>
    <domeo:belongsToSet>urn:domeoclient:uuid:EC9B90D7-F9B5-4E51-94E2-878FAA06F611</domeo:belongsToSet>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:createdOn>2014-07-13 12:46:20 -0400</pav:createdOn>
    <pav:lastSavedOn>2014-07-13 12:48:45 -0400</pav:lastSavedOn>
    <rdfs:label>Highlight</rdfs:label>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:575F0CD0-2CEC-4594-9019-B1A6C8BA5D55">
    <pav:createdOn>2014-07-13 12:37:40 -0400</pav:createdOn>
    <domeo:uuid>575F0CD0-2CEC-4594-9019-B1A6C8BA5D55</domeo:uuid>
    <ao:prefix>. In this placebo-controlled, double-blind, randomized, two-way crossover study carried out over three cycles of oral contraceptive treatment, </ao:prefix>
    <ao:exact>fluconazole</ao:exact>
    <ao:suffix> dosing resulted in small increases in the mean AUCs of ethinyl estradiol and norethindrone compared to similar placebo dosing. The mean AUCs of ethinyl estradiol and norethindrone increased by 24% (95% C.I. range 18 to 31%) and 13% (95% C.I. range 8 to </ao:suffix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:575F0CD0-2CEC-4594-9019-B1A6C8BA5D55"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-21.txt.html</ao:hasSource>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:70EB0C27-A6B8-49A5-94CD-7CCF2755C633">
    <rdfs:label>Highlight</rdfs:label>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:previousVersion>urn:domeoclient:uuid:BED41F06-565A-4622-9A88-48810E5A28DE</pav:previousVersion>
    <pav:lastSavedOn>2014-09-02 11:46:58 -0400</pav:lastSavedOn>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">2</pav:versionNumber>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <domeo:belongsToSet>urn:domeoserver:annotationset:A5DD001D-C81A-4E2E-B5E0-7A866B35E26B</domeo:belongsToSet>
    <domeo:belongsToSet>urn:domeoserver:annotationset:3F546823-204F-4F9B-9006-3DC526C56931</domeo:belongsToSet>
    <pav:lastSavedOn>2014-09-02 11:46:59 -0400</pav:lastSavedOn>
    <pav:lineageUri>urn:domeoserver:annotation:331EA9C0-5A55-4AC7-BB2D-A61E9A1CDD11</pav:lineageUri>
    <pav:createdOn>2014-09-02 11:44:20 -0400</pav:createdOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <domeo:belongsToSet>urn:domeoserver:annotationset:A3F0B39A-4249-4B63-BB0D-F24A005066AC</domeo:belongsToSet>
    <ao:context rdf:resource="urn:domeoclient:uuid:0FEC326D-6B98-40B2-8D49-7B4318AEB3B8"/>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <pav:lineageUri>urn:domeoserver:annotationset:D1715BD2-BD41-46FD-9454-DC7A423A29AC</pav:lineageUri>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812eda990003</pav:createdBy>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:2F9FC4A6-CD86-434B-9237-24FD478F9ECA">
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/PK_DDI"/>
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/49D3BE30-05A4-4698-AD40-671451F49C7C"/>
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/F52690C8-04C0-4A9E-B719-C8C7578F5CA8"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:F0CCA954-EB0E-4D16-9B00-C1E4BE4A989D">
    <domeo:uuid>F0CCA954-EB0E-4D16-9B00-C1E4BE4A989D</domeo:uuid>
    <domeo:uuid></domeo:uuid>
    <pav:createdOn>2014-07-07 11:24:14 -0400</pav:createdOn>
    <ao:exact>sildenafil </ao:exact>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-155.txt.html</ao:hasSource>
    <ao:suffix>AUC.</ao:suffix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:prefix>Cmax and a 210% increase in </ao:prefix>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:F0CCA954-EB0E-4D16-9B00-C1E4BE4A989D"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:083AD66D-BAA3-4731-A45A-FB051CF3619F">
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:lineageUri>urn:domeoserver:annotation:6DB697AB-44ED-459A-BF85-DA145CBA7F25</pav:lineageUri>
    <rdfs:label>Highlight</rdfs:label>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:lastSavedOn>2014-09-02 19:11:13 -0400</pav:lastSavedOn>
    <domeo:belongsToSet>urn:domeoclient:uuid:3966BCFB-CA02-4053-828D-3860558E7BE8</domeo:belongsToSet>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812eda990003</pav:createdBy>
    <ao:context rdf:resource="urn:domeoclient:uuid:D555A94C-D1DE-4B5C-B227-8172F8605613"/>
    <pav:createdOn>2014-09-02 19:09:20 -0400</pav:createdOn>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:833A5FDE-B0F0-4E66-B232-68839CFE44D9">
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <domeo:belongsToSet>urn:domeoclient:uuid:A52F0287-AD68-4755-8E11-75217CD4FED8</domeo:belongsToSet>
    <pav:createdOn>2014-07-21 21:38:40 -0400</pav:createdOn>
    <rdfs:label>Highlight</rdfs:label>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812eda990003</pav:createdBy>
    <pav:lastSavedOn>2014-07-21 21:38:46 -0400</pav:lastSavedOn>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <ao:context rdf:resource="urn:domeoclient:uuid:0546F8AF-C9DB-4EB6-A2C6-2FB5CABD510D"/>
    <pav:lineageUri>urn:domeoserver:annotation:ADF29A86-5F3A-4560-8B26-F1E831392AF3</pav:lineageUri>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:0C0CF158-24A6-445D-B09F-EA2C2052959E">
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:lineageUri>urn:domeoserver:annotation:8FCA782E-F02D-491B-9589-8C28B1C29F7E</pav:lineageUri>
    <pav:createdOn>2014-07-21 21:42:03 -0400</pav:createdOn>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <ao:context rdf:resource="urn:domeoclient:uuid:2F209001-62CD-42DB-94B6-8505E0EB8F2E"/>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812eda990003</pav:createdBy>
    <domeo:belongsToSet>urn:domeoclient:uuid:BD4B7475-BD13-46C4-932F-139564A0063D</domeo:belongsToSet>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:lastSavedOn>2014-07-21 21:42:43 -0400</pav:lastSavedOn>
    <rdfs:label>Highlight</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:4A35ABC4-4C04-40DD-A14B-E710CC4288AE">
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/B9045C9A-4D72-42C8-90B8-EFC09CB8C259"/>
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/3C01338E-7E0D-4BD8-B48B-5D14379A445C"/>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/PK_DDI"/>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/093D1F2A-587E-4B3C-AAF4-10347561D8A9">
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/136411</dailymed:activeMoietyRxCUI>
    <rdfs:label>sildenafil</rdfs:label>
    <sio:SIO_000228>dikbD2R:object-drug-of-interaction</sio:SIO_000228>
    <dct:description>Referred to the drug in the interaction.</dct:description>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/active-ingredient"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:CE5AF44C-D211-4F33-A502-2B4C37E2ACFC">
    <pav:lastSavedOn>2014-07-24 19:39:22 -0400</pav:lastSavedOn>
    <domeo:agents rdf:resource="urn:person:uuid:080e143046812afe0146812eda990003"/>
    <ao:annotatesResource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-126.txt.html</ao:annotatesResource>
    <domeo:agents rdf:resource="urn:domeo:software:id:Domeo-2.1alpha-050"/>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <dct:description>The default set is created automatically by Domeo when no other set is existing.</dct:description>
    <domeo:deleted>false</domeo:deleted>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <ao:item rdf:resource="urn:domeoclient:uuid:7F0238CB-D573-4236-AA09-42BC8251946C"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#AnnotationSet"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:1CF0856D-0878-41B0-8A05-7007C19C91DB"/>
    <pav:lineageUri>urn:domeoserver:annotationset:6CBB0DBC-BDB3-472E-A2C0-B3E73E7BB10B</pav:lineageUri>
    <rdfs:label>Default Set</rdfs:label>
    <ao:item rdf:resource="urn:domeoclient:uuid:39262D74-39DF-473E-A61D-3DBC89E74ACA"/>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812eda990003</pav:createdBy>
    <permissions:permissions rdf:nodeID="N773370ee26bd463b9ae13d34c157680f"/>
    <pav:createdOn>2014-07-24 19:39:19 -0400</pav:createdOn>
    <pav:previousVersion>xsd:String</pav:previousVersion>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:379CD8C1-F4B4-42B7-8F87-70776866DB1F">
    <ao:item rdf:resource="urn:domeoclient:uuid:04DF851F-404D-44D4-A74D-22017210AF9A"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:AB1F4800-7A8C-48DD-A103-ADE54191154D"/>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <domeo:deleted>false</domeo:deleted>
    <dct:description>The default set is created automatically by Domeo when no other set is existing.</dct:description>
    <ao:item rdf:resource="urn:domeoclient:uuid:4BC86345-8DEB-4D78-A90E-121B217F37B6"/>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <ao:item rdf:resource="urn:domeoclient:uuid:4746991B-1E22-4518-B0DA-6C25E8605F5D"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:5CFC30D6-1C24-402D-845E-93F7BF5F0922"/>
    <pav:lineageUri>urn:domeoserver:annotationset:166C20E9-1B4C-47D1-982D-922E2E5ACFF2</pav:lineageUri>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#AnnotationSet"/>
    <domeo:agents rdf:resource="urn:domeo:software:id:Domeo-2.1alpha-050"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:047EE665-B8C6-4153-96F1-5D2C3C08A276"/>
    <domeo:agents rdf:resource="urn:person:uuid:080e143046812afe0146812eda990003"/>
    <ao:annotatesResource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-47.txt.html</ao:annotatesResource>
    <rdfs:label>Default Set</rdfs:label>
    <pav:createdOn>2014-09-02 12:02:37 -0400</pav:createdOn>
    <ao:item rdf:resource="urn:domeoclient:uuid:64531818-53F3-4463-8017-8AD63F5904C3"/>
    <permissions:permissions rdf:nodeID="N0aa099019b724c3ca0bff1a233f95591"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:9E2FD166-718B-4FDB-8465-F19A84DE1BB4"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:4E7D289E-0E68-4A95-9CAF-BA6B4026295E"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:17C13D4B-C4FD-4F4C-8B4F-969B0D63CD46"/>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812eda990003</pav:createdBy>
    <ao:item rdf:resource="urn:domeoclient:uuid:3C076A6A-DF94-4E44-AAAE-9F07C1FE0946"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:E07974BC-9D8F-4D5E-A1B2-C28141CD86ED"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:852CFA91-85F8-4EF7-A64F-D2A63BC3A6B5"/>
    <pav:lastSavedOn>2014-09-02 12:03:47 -0400</pav:lastSavedOn>
    <ao:item rdf:resource="urn:domeoclient:uuid:160236BC-C839-4CD6-8648-FE98F4F6BC3F"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:B16948AC-DC5A-471F-B39F-849EE793A353">
    <pav:createdOn>2014-07-24 19:44:25 -0400</pav:createdOn>
    <rdfs:label>Highlight</rdfs:label>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:lineageUri>urn:domeoserver:annotation:78BA69B3-6B98-43DC-BD49-8139CC471F72</pav:lineageUri>
    <ao:context rdf:resource="urn:domeoclient:uuid:A95F4FE2-696A-4769-8ED1-FC8F49B83876"/>
    <domeo:belongsToSet>urn:domeoclient:uuid:511EDFA9-5A42-4340-9D4A-CBF6EDD9185C</domeo:belongsToSet>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812eda990003</pav:createdBy>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:lastSavedOn>2014-07-24 19:44:56 -0400</pav:lastSavedOn>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/E2F95CEA-24A5-407F-856C-8C142EEA5626">
    <sio:SIO_000228>dikbD2R:object-drug-of-interaction</sio:SIO_000228>
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/4450</dailymed:activeMoietyRxCUI>
    <rdfs:label>fluconazole</rdfs:label>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/active-ingredient"/>
    <dct:description>Referred to the drug in the interaction.</dct:description>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:D6C4080C-5AC3-402F-9359-F2135366B16E">
    <ao:suffix> is extensively metabolized with most metabolites appearing in the urine. Propranolol is metabolized through three primary routes: aromatic hydroxylation (mainly 4-hydroxylation), N-dealkylation followed by further side-chain oxidation, and direct glucur</ao:suffix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:exact>Propranolol</ao:exact>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:prefix>xsd:String</ao:prefix>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-135.txt.html</ao:hasSource>
    <domeo:uuid>D6C4080C-5AC3-402F-9359-F2135366B16E</domeo:uuid>
    <pav:createdOn>2014-07-24 20:00:35 -0400</pav:createdOn>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:D6C4080C-5AC3-402F-9359-F2135366B16E"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:B06BD29E-2481-4EA0-885B-420749EBE703">
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:exact>fluconazole</ao:exact>
    <ao:suffix> AUC and Cmax. There was a mean ± SD decrease in fluconazole AUC of 13% ± 11% (range: -3.4 to -31%) and Cmax decreased 19% ± 14% (range: -5 to -40%). However, the administration of cimetidine 600 mg to 900 mg intravenously over a four-hour period (from o</ao:suffix>
    <ao:prefix>, there was a significant decrease in </ao:prefix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <domeo:uuid>B06BD29E-2481-4EA0-885B-420749EBE703</domeo:uuid>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:B06BD29E-2481-4EA0-885B-420749EBE703"/>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-23.txt.html</ao:hasSource>
    <pav:createdOn>2014-07-13 12:46:20 -0400</pav:createdOn>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:C8425744-9F63-4970-8237-27D021CAD666">
    <pav:lineageUri>urn:domeoserver:annotation:E384B2C0-0834-482B-812C-73024B30202C</pav:lineageUri>
    <rdfs:label>Highlight</rdfs:label>
    <pav:createdOn>2014-09-02 15:04:22 -0400</pav:createdOn>
    <ao:context rdf:resource="urn:domeoclient:uuid:04931205-C053-487C-8E10-4A1A8F38120C"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <domeo:belongsToSet>urn:domeoclient:uuid:C4B80A95-F569-4ED4-84D1-6796B53A580C</domeo:belongsToSet>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812eda990003</pav:createdBy>
    <pav:lastSavedOn>2014-09-02 15:04:32 -0400</pav:lastSavedOn>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:7E8BEB68-80C9-4767-BEC0-5810B8C956C0">
    <ao:exact>desmethyl </ao:exact>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:suffix>metabolite equivalent to that of a 20 mg oral dose.</ao:suffix>
    <domeo:uuid></domeo:uuid>
    <ao:prefix>Injection is predicted to provide a pharmacological effect of sildenafil and its N-</ao:prefix>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-155.txt.html</ao:hasSource>
    <pav:createdOn>2014-07-07 09:58:55 -0400</pav:createdOn>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:7E8BEB68-80C9-4767-BEC0-5810B8C956C0"/>
    <domeo:uuid>7E8BEB68-80C9-4767-BEC0-5810B8C956C0</domeo:uuid>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:A151EB77-7400-49F2-9673-BFAD2171D5CD">
    <rdfs:label>Highlight</rdfs:label>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:createdOn>2014-07-13 11:07:24 -0400</pav:createdOn>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <ao:context rdf:resource="urn:domeoclient:uuid:A3654752-C204-49F0-B3F7-87C2EE277992"/>
    <pav:lineageUri>urn:domeoserver:annotation:17F49268-30E8-4066-B9B1-4521C34B09E9</pav:lineageUri>
    <domeo:belongsToSet>urn:domeoclient:uuid:71191E51-53CB-4FDE-88D0-33C6818E2232</domeo:belongsToSet>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812eda990003</pav:createdBy>
    <pav:lastSavedOn>2014-07-13 11:32:29 -0400</pav:lastSavedOn>
    <pav:previousVersion>xsd:String</pav:previousVersion>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:319A061D-1A35-4E08-859B-F39DA704D1B4">
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <pav:createdOn>2014-07-22 19:00:38 -0400</pav:createdOn>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:319A061D-1A35-4E08-859B-F39DA704D1B4"/>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-121.txt.html</ao:hasSource>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:suffix> at high doses for extended periods of time. A cause and effect relationship has not been established. Crohn's disease is not an approved indication for FLAGYL.</ao:suffix>
    <domeo:uuid>319A061D-1A35-4E08-859B-F39DA704D1B4</domeo:uuid>
    <ao:prefix>s disease patients are known to have an increased incidence of gastrointestinal and certain extraintestinal cancers. There have been some reports in the medical literature of breast and colon cancer in Crohn's disease patients who have been treated with </ao:prefix>
    <ao:exact>metronidazole</ao:exact>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:2B0781B4-A013-4EA2-8F12-DEE15D23DD0E">
    <domeo:uuid>2B0781B4-A013-4EA2-8F12-DEE15D23DD0E</domeo:uuid>
    <pav:createdOn>2014-09-02 11:57:24 -0400</pav:createdOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-47.txt.html</ao:hasSource>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:2B0781B4-A013-4EA2-8F12-DEE15D23DD0E"/>
    <ao:suffix> with risperidone, a CYP2D6 substrate has also been evaluated. In 1 study, daily dosing of paroxetine 20 mg in patients stabilized on risperidone (4 to 8 mg/day) increased mean plasma concentrations of risperidone approximately 4-fold, decreased 9-hydrox</ao:suffix>
    <ao:exact>paroxetine</ao:exact>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:prefix> (100 mg) Cmax, AUC, and T½ by an average of approximately 2-, 5-, and 3-fold, respectively. Concomitant use of </ao:prefix>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:C91687BB-8074-4878-8273-7F14FC861404">
    <ao:exact>metoprolol</ao:exact>
    <ao:suffix> which undergo hepatic metabolism, atenolol is eliminated primarily by renal excretion.</ao:suffix>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-9.txt.html</ao:hasSource>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:C91687BB-8074-4878-8273-7F14FC861404"/>
    <domeo:uuid>C91687BB-8074-4878-8273-7F14FC861404</domeo:uuid>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:prefix> and </ao:prefix>
    <pav:createdOn>2014-09-02 11:46:29 -0400</pav:createdOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:72594949-CA92-4CEF-8CB6-0072661759A0">
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:createdOn>2014-07-13 12:38:31 -0400</pav:createdOn>
    <rdfs:label>Highlight</rdfs:label>
    <pav:lineageUri>urn:domeoserver:annotation:4A02C183-A585-4567-848A-3878478E06F5</pav:lineageUri>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <pav:lastSavedOn>2014-07-13 12:41:10 -0400</pav:lastSavedOn>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812eda990003</pav:createdBy>
    <ao:context rdf:resource="urn:domeoclient:uuid:72C81315-5D14-41CA-AEB9-E23AC335F4C3"/>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <domeo:belongsToSet>urn:domeoclient:uuid:4F872953-6D19-4809-9285-FCCF2FF54315</domeo:belongsToSet>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:7650C658-240A-439A-9275-FFBCC1902F40">
    <dikbD2R:modality>ncit:positive</dikbD2R:modality>
    <dikbD2R:statement>ncit:Qualitative</dikbD2R:statement>
    <sio:SIO_000563>dikbD2R:modality</sio:SIO_000563>
    <rdf:type rdf:resource="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#DrugDrugInteractionStatement"/>
    <sio:SIO_000205>dikbD2R:statement</sio:SIO_000205>
    <sio:SIO_000628 rdf:resource="urn:pddi:uuid:19EC0F23-10DE-4B34-BA59-B2E33CFE1030"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:C5974F18-7052-426D-A45F-D129E2BC7FB8">
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <domeo:belongsToSet>urn:domeoclient:uuid:876DAFB7-BB08-4119-BA16-59187031D7BB</domeo:belongsToSet>
    <pav:createdOn>2014-07-21 21:46:40 -0400</pav:createdOn>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812eda990003</pav:createdBy>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <ao:context rdf:resource="urn:domeoclient:uuid:6EE25330-67E2-4BE9-AB27-EB9F40763AA3"/>
    <rdfs:label>Highlight</rdfs:label>
    <pav:lastSavedOn>2014-07-21 21:46:47 -0400</pav:lastSavedOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:lineageUri>urn:domeoserver:annotation:2727C185-A674-4921-8C56-55CC92FEF648</pav:lineageUri>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:74C8573C-609D-4268-8133-F0B2749E0A1E">
    <domeo:belongsToSet>urn:domeoserver:annotationset:3F546823-204F-4F9B-9006-3DC526C56931</domeo:belongsToSet>
    <pav:previousVersion>urn:domeoclient:uuid:BED41F06-565A-4622-9A88-48810E5A28DE</pav:previousVersion>
    <rdfs:label>Highlight</rdfs:label>
    <domeo:belongsToSet>urn:domeoserver:annotationset:A3F0B39A-4249-4B63-BB0D-F24A005066AC</domeo:belongsToSet>
    <pav:lastSavedOn>2014-09-02 11:46:58 -0400</pav:lastSavedOn>
    <pav:createdOn>2014-09-02 11:46:50 -0400</pav:createdOn>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">2</pav:versionNumber>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:lineageUri>urn:domeoserver:annotationset:D1715BD2-BD41-46FD-9454-DC7A423A29AC</pav:lineageUri>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:lineageUri>urn:domeoserver:annotation:03869BFC-345D-42FB-85C5-12B65DCAAF90</pav:lineageUri>
    <ao:context rdf:resource="urn:domeoclient:uuid:E3652583-DA12-4711-86A1-59DC39EC9239"/>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <domeo:belongsToSet>urn:domeoserver:annotationset:A5DD001D-C81A-4E2E-B5E0-7A866B35E26B</domeo:belongsToSet>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812eda990003</pav:createdBy>
    <pav:lastSavedOn>2014-09-02 11:46:59 -0400</pav:lastSavedOn>
    <pav:previousVersion>xsd:String</pav:previousVersion>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:7292F6B8-8DF2-4158-91E5-6FA4A069D796">
    <ao:context rdf:resource="urn:domeoclient:uuid:C94B4C4D-E742-4102-A342-E2728F29088D"/>
    <pav:createdOn>2014-09-02 11:53:27 -0400</pav:createdOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#expertstudyAnnotation"/>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812eda990003</pav:createdBy>
    <domeo:belongsToSet>urn:domeoserver:annotationset:A3F0B39A-4249-4B63-BB0D-F24A005066AC</domeo:belongsToSet>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:lastSavedOn>2014-09-02 11:54:50 -0400</pav:lastSavedOn>
    <ao:body rdf:nodeID="N4b5f4fe91a324324b9bc068f74aa3143"/>
    <pav:lineageUri>urn:domeoserver:annotation:C5C09821-2ECD-424B-9FA4-FD278FE901F2</pav:lineageUri>
    <rdfs:label>expertstudy Annotation</rdfs:label>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:previousVersion>xsd:String</pav:previousVersion>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:AD3EF274-2E89-4A1A-9C95-5AE9F608E1E0">
    <ao:context rdf:resource="urn:domeoclient:uuid:CBD1F653-F7E2-49C1-AEF3-0CF16AA17649"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <rdfs:label>Highlight</rdfs:label>
    <pav:lineageUri>urn:domeoserver:annotation:83944842-F662-4A59-B8BB-809D6D8471DC</pav:lineageUri>
    <pav:lastSavedOn>2014-07-21 21:27:51 -0400</pav:lastSavedOn>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812eda990003</pav:createdBy>
    <domeo:belongsToSet>urn:domeoclient:uuid:B6F745E6-5734-4636-A383-683BA4C79E38</domeo:belongsToSet>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:createdOn>2014-07-21 21:27:02 -0400</pav:createdOn>
    <pav:previousVersion>xsd:String</pav:previousVersion>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:8AEAC215-292C-4E6F-9305-D62BECCA32B2">
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <ao:context rdf:resource="urn:domeoclient:uuid:4302BBE9-CEFD-4D9A-8509-E48CACB9AAC3"/>
    <pav:lineageUri>urn:domeoserver:annotation:B0F3FF3D-59BD-4B9F-B0DD-AC814D8A4A0C</pav:lineageUri>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812eda990003</pav:createdBy>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <rdfs:label>Highlight</rdfs:label>
    <pav:lastSavedOn>2014-09-02 12:02:18 -0400</pav:lastSavedOn>
    <domeo:belongsToSet>urn:domeoclient:uuid:4B51141D-C8D2-45DB-8074-74F8D8323E60</domeo:belongsToSet>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:createdOn>2014-09-02 11:56:00 -0400</pav:createdOn>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/1D5C7B20-628D-4819-8BB5-5D5207989917">
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/active-ingredient"/>
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/8787</dailymed:activeMoietyRxCUI>
    <rdfs:label>propranolol</rdfs:label>
    <dct:description>Referred to the drug in the interaction.</dct:description>
    <sio:SIO_000228>dikbD2R:precipitant-drug-of-interaction</sio:SIO_000228>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:44EFF86D-2559-4F65-A1D1-E51A6BDD91CF">
    <ao:suffix>, such as liver enzyme abnormalities and hearing impairment, is warranted (see ADVERSE REACTIONS).</ao:suffix>
    <domeo:uuid>44EFF86D-2559-4F65-A1D1-E51A6BDD91CF</domeo:uuid>
    <ao:exact>azithromycin</ao:exact>
    <pav:createdOn>2014-07-24 20:14:58 -0400</pav:createdOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-161.txt.html</ao:hasSource>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:44EFF86D-2559-4F65-A1D1-E51A6BDD91CF"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:prefix>, close monitoring for known side effects of </ao:prefix>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:29694BD5-41F2-4693-A623-AABDC826F754">
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <domeo:belongsToSet>urn:domeoserver:annotationset:2914A3FD-DF43-4F78-999C-77CE7A028B19</domeo:belongsToSet>
    <pav:createdOn>2014-07-22 19:53:07 -0400</pav:createdOn>
    <ao:context rdf:resource="urn:domeoclient:uuid:62CEF929-8FCC-4F3F-8B23-F0215966A438"/>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812eda990003</pav:createdBy>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <pav:lineageUri>urn:domeoserver:annotation:E618EEC9-CFEC-48EA-A483-0C9F55935BAE</pav:lineageUri>
    <pav:lastSavedOn>2014-07-22 19:54:59 -0400</pav:lastSavedOn>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <rdfs:label>Highlight</rdfs:label>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">7</pav:versionNumber>
    <domeo:belongsToSet>urn:domeoserver:annotationset:F272A789-69D0-47CC-8CC9-F25C55B91261</domeo:belongsToSet>
    <pav:lineageUri>urn:domeoserver:annotationset:AB1741F1-5A5F-4416-AEAC-A544BCBB7D16</pav:lineageUri>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:previousVersion>urn:domeoserver:annotationset:606A5B3F-B6FB-4279-AA42-7893CFC2D20C</pav:previousVersion>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:2CF4DD8F-BE67-4B73-8082-A0A474C61D19">
    <pav:createdOn>2014-07-24 19:39:23 -0400</pav:createdOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:prefix> are increased by 64% and 79%, respectively, by co-administration of </ao:prefix>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:2CF4DD8F-BE67-4B73-8082-A0A474C61D19"/>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-126.txt.html</ao:hasSource>
    <ao:exact>propranolol</ao:exact>
    <domeo:uuid>2CF4DD8F-BE67-4B73-8082-A0A474C61D19</domeo:uuid>
    <ao:suffix>.</ao:suffix>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:EEDA4663-FBED-4C68-848C-30943B88C061">
    <pav:createdOn>2014-07-13 11:10:25 -0400</pav:createdOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <domeo:uuid>EEDA4663-FBED-4C68-848C-30943B88C061</domeo:uuid>
    <ao:prefix> occurred at about 3 hours in extensive metabolizers, and 17 hours in poor metabolizers. Steady-state concentrations of </ao:prefix>
    <ao:suffix> are reached in 1 day in extensive metabolizers and would be expected to reach steady-state in about 5 days in poor metabolizers. Steady-state concentrations of 9-hydroxyrisperidone are reached in 5 to 6 days (measured in extensive metabolizers).</ao:suffix>
    <ao:exact>risperidone</ao:exact>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:EEDA4663-FBED-4C68-848C-30943B88C061"/>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-8.txt.html</ao:hasSource>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:2B951EF5-B48C-4B58-B273-480990730DEA">
    <ao:prefix> in patients receiving </ao:prefix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-8.txt.html</ao:hasSource>
    <domeo:uuid>2B951EF5-B48C-4B58-B273-480990730DEA</domeo:uuid>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:exact>quinidine</ao:exact>
    <pav:createdOn>2014-07-13 11:15:12 -0400</pav:createdOn>
    <ao:suffix> have not been evaluated, but observations in a modest number (N≅70) of poor metabolizers given risperidone do not suggest important differences between poor and extensive metabolizers. Second, co-administration of known enzyme inducers (e.g., carbamazep</ao:suffix>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:2B951EF5-B48C-4B58-B273-480990730DEA"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:DCBFA6B2-22F1-4138-ABA7-CDA3F5A19FC6">
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812eda990003</pav:createdBy>
    <ao:context rdf:resource="urn:domeoclient:uuid:F55B6524-A848-4FBC-99DB-A1B22E5FCA28"/>
    <domeo:belongsToSet>urn:domeoclient:uuid:5D381360-05CD-407C-BAB9-6496A42C73E4</domeo:belongsToSet>
    <rdfs:label>Highlight</rdfs:label>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:lastSavedOn>2014-09-01 16:12:36 -0400</pav:lastSavedOn>
    <pav:createdOn>2014-09-01 16:12:26 -0400</pav:createdOn>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <pav:lineageUri>urn:domeoserver:annotation:AEC461AF-3F72-4CEA-BAB7-FFD36B18B42E</pav:lineageUri>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:E2D1A706-CE7E-4379-97CF-4EE9CA384DB2">
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812eda990003</pav:createdBy>
    <domeo:belongsToSet>urn:domeoserver:annotationset:514BA51B-D734-4003-A7C3-F03C0F95833A</domeo:belongsToSet>
    <pav:previousVersion>urn:domeoserver:annotationset:7E80543E-BF76-4514-92A9-91458DCB802B</pav:previousVersion>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <domeo:belongsToSet>urn:domeoserver:annotationset:2914A3FD-DF43-4F78-999C-77CE7A028B19</domeo:belongsToSet>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">4</pav:versionNumber>
    <rdfs:label>Highlight</rdfs:label>
    <domeo:belongsToSet>urn:domeoserver:annotationset:F272A789-69D0-47CC-8CC9-F25C55B91261</domeo:belongsToSet>
    <domeo:belongsToSet>urn:domeoserver:annotationset:606A5B3F-B6FB-4279-AA42-7893CFC2D20C</domeo:belongsToSet>
    <pav:lineageUri>urn:domeoserver:annotationset:AB1741F1-5A5F-4416-AEAC-A544BCBB7D16</pav:lineageUri>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <ao:context rdf:resource="urn:domeoclient:uuid:04B30485-E368-4D5D-ABB9-17EBA8B817CD"/>
    <domeo:belongsToSet>urn:domeoserver:annotationset:7021B883-FD5C-4083-BD87-DF56D3C87633</domeo:belongsToSet>
    <pav:createdOn>2014-07-22 19:31:11 -0400</pav:createdOn>
    <pav:lineageUri>urn:domeoserver:annotation:3B2F7827-ACE0-41B5-A26D-53FD0A2B7393</pav:lineageUri>
    <pav:lastSavedOn>2014-07-22 19:35:16 -0400</pav:lastSavedOn>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:EAC57EB3-DF7D-46DD-AE24-159494F820F5">
    <pav:lineageUri>urn:domeoserver:annotationset:D1715BD2-BD41-46FD-9454-DC7A423A29AC</pav:lineageUri>
    <domeo:belongsToSet>urn:domeoclient:uuid:BED41F06-565A-4622-9A88-48810E5A28DE</domeo:belongsToSet>
    <pav:createdOn>2014-09-02 11:32:39 -0400</pav:createdOn>
    <ao:context rdf:resource="urn:domeoclient:uuid:5C3FBF61-A16E-4DBB-B539-F88F8B7E60B7"/>
    <rdfs:label>Highlight</rdfs:label>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:lineageUri>urn:domeoserver:annotation:0BD0603B-EBEC-483F-ABFE-8B4B53707918</pav:lineageUri>
    <domeo:belongsToSet>urn:domeoserver:annotationset:3F546823-204F-4F9B-9006-3DC526C56931</domeo:belongsToSet>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <domeo:belongsToSet>urn:domeoserver:annotationset:A5DD001D-C81A-4E2E-B5E0-7A866B35E26B</domeo:belongsToSet>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812eda990003</pav:createdBy>
    <domeo:belongsToSet>urn:domeoserver:annotationset:A3F0B39A-4249-4B63-BB0D-F24A005066AC</domeo:belongsToSet>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:lastSavedOn>2014-09-02 11:35:33 -0400</pav:lastSavedOn>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:87DA7BB9-8F52-460F-B488-90DD6AC36EFF">
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:exact>procyclidine </ao:exact>
    <ao:suffix>should be reduced.</ao:suffix>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-50.txt.html</ao:hasSource>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:87DA7BB9-8F52-460F-B488-90DD6AC36EFF"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:prefix>alone at steady state. If anticholinergic effects are seen, the dose of </ao:prefix>
    <domeo:uuid>87DA7BB9-8F52-460F-B488-90DD6AC36EFF</domeo:uuid>
    <pav:createdOn>2014-07-21 21:42:16 -0400</pav:createdOn>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:160236BC-C839-4CD6-8648-FE98F4F6BC3F">
    <pav:lineageUri>urn:domeoserver:annotation:5EA7658B-D3B7-4DB4-AF90-410FBFB8D0AE</pav:lineageUri>
    <ao:context rdf:resource="urn:domeoclient:uuid:3E22917C-B2E2-46E9-8A17-EDAAF200AA66"/>
    <domeo:belongsToSet>urn:domeoserver:annotationset:D52DFD7B-BDDF-488F-B339-B1BC641E50E9</domeo:belongsToSet>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <domeo:belongsToSet>urn:domeoclient:uuid:379CD8C1-F4B4-42B7-8F87-70776866DB1F</domeo:belongsToSet>
    <pav:createdOn>2014-09-02 12:03:11 -0400</pav:createdOn>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812eda990003</pav:createdBy>
    <rdfs:label>Highlight</rdfs:label>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:lastSavedOn>2014-09-02 12:03:47 -0400</pav:lastSavedOn>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <pav:lineageUri>urn:domeoserver:annotationset:166C20E9-1B4C-47D1-982D-922E2E5ACFF2</pav:lineageUri>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:0A960BCB-9A9F-4998-9418-33D622C35F7C">
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <domeo:belongsToSet>urn:domeoserver:annotationset:7E80543E-BF76-4514-92A9-91458DCB802B</domeo:belongsToSet>
    <pav:lineageUri>urn:domeoserver:annotation:C73C4518-1EEF-4AB7-9853-1AD57B12C083</pav:lineageUri>
    <domeo:belongsToSet>urn:domeoserver:annotationset:514BA51B-D734-4003-A7C3-F03C0F95833A</domeo:belongsToSet>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <rdfs:label>Highlight</rdfs:label>
    <domeo:belongsToSet>urn:domeoserver:annotationset:2914A3FD-DF43-4F78-999C-77CE7A028B19</domeo:belongsToSet>
    <ao:context rdf:resource="urn:domeoclient:uuid:7FB9730F-B82C-4408-87AE-CE704E2BFD12"/>
    <domeo:belongsToSet>urn:domeoserver:annotationset:7021B883-FD5C-4083-BD87-DF56D3C87633</domeo:belongsToSet>
    <pav:lineageUri>urn:domeoserver:annotationset:AB1741F1-5A5F-4416-AEAC-A544BCBB7D16</pav:lineageUri>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:previousVersion>urn:domeoserver:annotationset:467D4F28-D086-4217-9DE0-23E165F30716</pav:previousVersion>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:createdOn>2014-07-22 19:24:47 -0400</pav:createdOn>
    <pav:lastSavedOn>2014-07-22 19:28:02 -0400</pav:lastSavedOn>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812eda990003</pav:createdBy>
    <domeo:belongsToSet>urn:domeoserver:annotationset:606A5B3F-B6FB-4279-AA42-7893CFC2D20C</domeo:belongsToSet>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">3</pav:versionNumber>
    <domeo:belongsToSet>urn:domeoserver:annotationset:F272A789-69D0-47CC-8CC9-F25C55B91261</domeo:belongsToSet>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:270BC940-6C4E-4F0E-91AB-DAC2FC78E847">
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <rdfs:label>Highlight</rdfs:label>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <domeo:belongsToSet>urn:domeoclient:uuid:4B51141D-C8D2-45DB-8074-74F8D8323E60</domeo:belongsToSet>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <ao:context rdf:resource="urn:domeoclient:uuid:C3030391-F9A1-49F9-B8E8-7E56658D5BF2"/>
    <pav:createdOn>2014-09-02 11:57:31 -0400</pav:createdOn>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812eda990003</pav:createdBy>
    <pav:lastSavedOn>2014-09-02 12:02:18 -0400</pav:lastSavedOn>
    <pav:lineageUri>urn:domeoserver:annotation:2C994664-AD86-4E78-8F09-1465E29593D8</pav:lineageUri>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:04AF0456-B803-4275-972A-36BD0F6352B7">
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812eda990003</pav:createdBy>
    <pav:lineageUri>urn:domeoserver:annotationset:D1715BD2-BD41-46FD-9454-DC7A423A29AC</pav:lineageUri>
    <domeo:belongsToSet>urn:domeoserver:annotationset:A3F0B39A-4249-4B63-BB0D-F24A005066AC</domeo:belongsToSet>
    <ao:context rdf:resource="urn:domeoclient:uuid:E17E51AB-6385-4BD7-89B1-ABDDA504EE2C"/>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <rdfs:label>Highlight</rdfs:label>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:createdOn>2014-09-02 11:41:00 -0400</pav:createdOn>
    <domeo:belongsToSet>urn:domeoserver:annotationset:A5DD001D-C81A-4E2E-B5E0-7A866B35E26B</domeo:belongsToSet>
    <pav:previousVersion>urn:domeoclient:uuid:BED41F06-565A-4622-9A88-48810E5A28DE</pav:previousVersion>
    <pav:lastSavedOn>2014-09-02 11:46:58 -0400</pav:lastSavedOn>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">2</pav:versionNumber>
    <pav:lineageUri>urn:domeoserver:annotation:ACF75D4C-9A13-4835-8CAD-691154F85E70</pav:lineageUri>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <domeo:belongsToSet>urn:domeoserver:annotationset:3F546823-204F-4F9B-9006-3DC526C56931</domeo:belongsToSet>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:0DDFAFFA-5DE6-4D3B-BC30-6421E6531AD8">
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:0DDFAFFA-5DE6-4D3B-BC30-6421E6531AD8"/>
    <domeo:uuid>0DDFAFFA-5DE6-4D3B-BC30-6421E6531AD8</domeo:uuid>
    <ao:exact>levonorgestrel</ao:exact>
    <pav:createdOn>2014-07-13 12:41:59 -0400</pav:createdOn>
    <ao:suffix> AUC after the administration of 50 mg of fluconazole. The mean increase in ethinyl estradiol AUC was 6% (range: -47 to 108%) and levonorgestrel AUC increased 17% (range: -33 to 141%).</ao:suffix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-22.txt.html</ao:hasSource>
    <ao:prefix>Oral contraceptives were administered as a single dose both before and after the oral administration of fluconazole 50 mg once daily for 10 days in 10 healthy women. There was no significant difference in ethinyl estradiol or </ao:prefix>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:97D1DB41-3631-4DF4-AC28-E9932F707785">
    <ao:prefix> (3.75 to 10 mg/day) for 7 days did not alter the mean steady-state 24-hour plasma glucose concentrations in diabetic patients stabilized on </ao:prefix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <pav:createdOn>2014-07-22 19:50:12 -0400</pav:createdOn>
    <ao:exact>glyburide </ao:exact>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:97D1DB41-3631-4DF4-AC28-E9932F707785"/>
    <domeo:uuid>97D1DB41-3631-4DF4-AC28-E9932F707785</domeo:uuid>
    <ao:suffix>therapy. Repeat doses of </ao:suffix>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-123.txt.html</ao:hasSource>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:FC139E5E-6513-4B13-9FE1-980FD4117A68">
    <pav:lineageUri>urn:domeoserver:annotation:EB73E2EC-AE38-41D5-9613-FEC43E3BE977</pav:lineageUri>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812eda990003</pav:createdBy>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <domeo:belongsToSet>urn:domeoserver:annotationset:40007BD9-0869-48CF-A8F2-BAD26AE3E6E1</domeo:belongsToSet>
    <pav:lineageUri>urn:domeoserver:annotationset:092451F5-B0C0-430C-8896-07F81D33F9E1</pav:lineageUri>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:createdOn>2014-07-21 21:31:13 -0400</pav:createdOn>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <rdfs:label>Highlight</rdfs:label>
    <ao:context rdf:resource="urn:domeoclient:uuid:B097095F-835A-459A-BD2D-9F8F332DBE40"/>
    <domeo:belongsToSet>urn:domeoclient:uuid:5B3EE83F-83C7-4BA8-A892-C032BE699CFA</domeo:belongsToSet>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:lastSavedOn>2014-07-21 21:31:54 -0400</pav:lastSavedOn>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:2D07F657-485E-493B-84FC-C20CA68F0295">
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:exact>glimepiride</ao:exact>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-123.txt.html</ao:hasSource>
    <ao:suffix> in 14 healthy adult subjects had no clinically significant effect on the steady-state pharmacokinetics of AVANDIA. No clinically significant reductions in glimepiride AUC and Cmax were observed after repeat doses of AVANDIA (8 mg once daily) for 8 days </ao:suffix>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:2D07F657-485E-493B-84FC-C20CA68F0295"/>
    <pav:createdOn>2014-07-22 19:53:12 -0400</pav:createdOn>
    <ao:prefix>Single oral doses of </ao:prefix>
    <domeo:uuid>2D07F657-485E-493B-84FC-C20CA68F0295</domeo:uuid>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:537EDFBD-E119-4A09-B40F-63E4648698FE">
    <domeo:belongsToSet>urn:domeoserver:annotationset:3F546823-204F-4F9B-9006-3DC526C56931</domeo:belongsToSet>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <domeo:belongsToSet>urn:domeoserver:annotationset:A5DD001D-C81A-4E2E-B5E0-7A866B35E26B</domeo:belongsToSet>
    <pav:lineageUri>urn:domeoserver:annotationset:D1715BD2-BD41-46FD-9454-DC7A423A29AC</pav:lineageUri>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">2</pav:versionNumber>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812eda990003</pav:createdBy>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <ao:context rdf:resource="urn:domeoclient:uuid:65F441ED-AF61-4AE3-8365-8ABE9FA557A2"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <rdfs:label>Highlight</rdfs:label>
    <pav:lastSavedOn>2014-09-02 11:46:58 -0400</pav:lastSavedOn>
    <domeo:belongsToSet>urn:domeoserver:annotationset:A3F0B39A-4249-4B63-BB0D-F24A005066AC</domeo:belongsToSet>
    <pav:previousVersion>urn:domeoclient:uuid:BED41F06-565A-4622-9A88-48810E5A28DE</pav:previousVersion>
    <pav:lineageUri>urn:domeoserver:annotation:26E45EE6-8CF5-41E0-9B3A-653B2295B504</pav:lineageUri>
    <pav:createdOn>2014-09-02 11:35:56 -0400</pav:createdOn>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:412C39E0-3B4C-49D9-82A9-AE16507E8B5F">
    <ao:suffix> </ao:suffix>
    <domeo:uuid>412C39E0-3B4C-49D9-82A9-AE16507E8B5F</domeo:uuid>
    <ao:prefix>xsd:String</ao:prefix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <pav:createdOn>2014-07-22 18:36:29 -0400</pav:createdOn>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:412C39E0-3B4C-49D9-82A9-AE16507E8B5F"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-57.txt.html</ao:hasSource>
    <ao:exact>Zonisamide</ao:exact>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:DD06894B-6765-494F-98ED-9B2C217D26FD">
    <ao:prefix>m (about 6% to 8% of Caucasians, and a very low percentage of Asians, have little or no activity and are “poor metabolizers”) and to inhibition by a variety of substrates and some non-substrates, notably quinidine. Extensive CYP 2D6 metabolizers convert </ao:prefix>
    <ao:suffix> rapidly into 9-hydroxyrisperidone, whereas poor CYP 2D6 metabolizers convert it much more slowly. Although extensive metabolizers have lower risperidone and higher 9-hydroxyrisperidone concentrations than poor metabolizers, the pharmacokinetics of rispe</ao:suffix>
    <domeo:uuid>DD06894B-6765-494F-98ED-9B2C217D26FD</domeo:uuid>
    <ao:exact>risperidone</ao:exact>
    <pav:createdOn>2014-07-13 11:13:26 -0400</pav:createdOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-8.txt.html</ao:hasSource>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:DD06894B-6765-494F-98ED-9B2C217D26FD"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:ECB23C3B-E835-480F-B541-EB5CBBAB2855">
    <ao:suffix> 200 mg) did not affect the bioavailability or pharmacokinetics of fluconazole in 24 healthy male volunteers.</ao:suffix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <domeo:uuid>ECB23C3B-E835-480F-B541-EB5CBBAB2855</domeo:uuid>
    <ao:prefix> 600 mg to 900 mg intravenously over a four-hour period (from one hour before to 3 hours after a single oral dose of </ao:prefix>
    <ao:exact>fluconazole</ao:exact>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:ECB23C3B-E835-480F-B541-EB5CBBAB2855"/>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-23.txt.html</ao:hasSource>
    <pav:createdOn>2014-07-13 12:46:33 -0400</pav:createdOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:AFAC33CD-2472-4FC2-BA17-FF7F45039527">
    <ao:exact>oxidase </ao:exact>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-72.txt.html</ao:hasSource>
    <ao:prefix>xsd:String</ao:prefix>
    <pav:createdOn>2014-09-02 19:11:02 -0400</pav:createdOn>
    <domeo:uuid>AFAC33CD-2472-4FC2-BA17-FF7F45039527</domeo:uuid>
    <ao:suffix>inhibitors has been observed, but caution in the use of any opioid in patients taking this class of drugs is appropriate.</ao:suffix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:AFAC33CD-2472-4FC2-BA17-FF7F45039527"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:46890B26-242B-40DA-BF4E-E7B90E54E678">
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <rdfs:label>Highlight</rdfs:label>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <domeo:belongsToSet>urn:domeoclient:uuid:CB83FFC2-EA71-44EA-8F11-DE80E389C84E</domeo:belongsToSet>
    <domeo:belongsToSet>urn:domeoserver:annotationset:392EE0FB-AC4F-4AF2-87A6-2E50A281F434</domeo:belongsToSet>
    <pav:lineageUri>urn:domeoserver:annotationset:C5DEBC9B-77EE-4243-88EB-DBC19737ACD2</pav:lineageUri>
    <pav:createdOn>2014-09-02 19:18:02 -0400</pav:createdOn>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <domeo:belongsToSet>urn:domeoserver:annotationset:E32812A9-205B-4EE1-B488-A1E294EDBFB9</domeo:belongsToSet>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:lastSavedOn>2014-09-02 19:19:47 -0400</pav:lastSavedOn>
    <ao:context rdf:resource="urn:domeoclient:uuid:2B237E79-AEFA-4271-8E72-C8B5A1D78190"/>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812eda990003</pav:createdBy>
    <pav:lineageUri>urn:domeoserver:annotation:5E9F4089-4F01-4BE2-A3B6-E5FE196634C8</pav:lineageUri>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:DBBBE91C-3E2F-469A-9254-58328E372FEA">
    <domeo:uuid>DBBBE91C-3E2F-469A-9254-58328E372FEA</domeo:uuid>
    <ao:exact>sildenafil </ao:exact>
    <ao:prefix>Single oral doses of </ao:prefix>
    <pav:createdOn>2014-07-07 09:37:41 -0400</pav:createdOn>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:DBBBE91C-3E2F-469A-9254-58328E372FEA"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-155.txt.html</ao:hasSource>
    <ao:suffix>100 mg administered to healthy volunteers produced decreases in supine blood pressure (mean maximum decrease in systolic/diastolic blood pressure of 8/5 mmHg). The decrease in blood pressure was most notable approximately 1–2 hours after dosing, and was </ao:suffix>
    <domeo:uuid></domeo:uuid>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:1DA34422-734D-46B1-AB2C-C1CABCA4C26C">
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#AnnotationSet"/>
    <ao:annotatesResource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-40.txt.html</ao:annotatesResource>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <ao:item rdf:resource="urn:domeoclient:uuid:3347F4AE-F668-4910-8729-7775D7697AD7"/>
    <domeo:agents rdf:resource="urn:domeo:software:id:Domeo-2.1alpha-050"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:E854201F-10EB-4992-8353-B60276384931"/>
    <dct:description>The default set is created automatically by Domeo when no other set is existing.</dct:description>
    <pav:createdOn>2014-09-01 16:07:12 -0400</pav:createdOn>
    <rdfs:label>Default Set</rdfs:label>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812eda990003</pav:createdBy>
    <pav:lineageUri>urn:domeoserver:annotationset:3B3D1AF0-4CC7-45F3-88F0-8C987CA69613</pav:lineageUri>
    <domeo:deleted>false</domeo:deleted>
    <ao:item rdf:resource="urn:domeoclient:uuid:75244705-D763-4A47-A23E-5C4CAE8A90B5"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:3B0F0546-41D1-46D1-95BF-CB03118C9BB8"/>
    <domeo:agents rdf:resource="urn:person:uuid:080e143046812afe0146812eda990003"/>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:lastSavedOn>2014-09-01 16:07:52 -0400</pav:lastSavedOn>
    <permissions:permissions rdf:nodeID="Ne729179121c74ba9af7f8549983f96f9"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:74981A52-DA21-4061-9DF7-E2A73DB55601">
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <domeo:uuid>74981A52-DA21-4061-9DF7-E2A73DB55601</domeo:uuid>
    <ao:prefix> oxidation, and direct glucuronidation. It has been estimated that the percentage contributions of these routes to total metabolism are 42%, 41% and 17%, respectively, but with considerable variability between individuals. The four major metabolites are </ao:prefix>
    <ao:suffix>glucuronide, naphthyloxylactic acid and glucuronic acid, and sulfate conjugates of 4-hydroxy propranolol.</ao:suffix>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:74981A52-DA21-4061-9DF7-E2A73DB55601"/>
    <pav:createdOn>2014-07-24 20:00:56 -0400</pav:createdOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:exact>propranolol </ao:exact>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-135.txt.html</ao:hasSource>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:F3C4287B-36A9-48BF-8081-A39BEF5F3C51">
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <domeo:belongsToSet>urn:domeoclient:uuid:FCA2BF23-0BE3-409F-9177-761812F96097</domeo:belongsToSet>
    <pav:lineageUri>urn:domeoserver:annotationset:76FD4BB5-DE2F-4FCA-B93D-302185B1A381</pav:lineageUri>
    <ao:context rdf:resource="urn:domeoclient:uuid:BB359BC3-6C0F-427E-B961-0838B54690D5"/>
    <domeo:belongsToSet>urn:domeoserver:annotationset:131835A3-C655-4F91-97D4-52CAFF7B7CCA</domeo:belongsToSet>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <rdfs:label>Highlight</rdfs:label>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <domeo:belongsToSet>urn:domeoserver:annotationset:8F3CF3D9-AADE-4A86-BD42-2924B3D6A406</domeo:belongsToSet>
    <pav:lastSavedOn>2014-07-07 09:44:19 -0400</pav:lastSavedOn>
    <domeo:belongsToSet>urn:domeoserver:annotationset:22ED7220-C6F6-43C5-9DF9-89F62F0F8E27</domeo:belongsToSet>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812eda990003</pav:createdBy>
    <pav:lineageUri>urn:domeoserver:annotation:2CB15B00-6B57-4B22-8474-DB6365688798</pav:lineageUri>
    <pav:createdOn>2014-07-07 09:38:27 -0400</pav:createdOn>
    <domeo:belongsToSet>urn:domeoserver:annotationset:7AACEF8D-2EBC-4F0B-94B2-190650E562F6</domeo:belongsToSet>
    <domeo:belongsToSet>urn:domeoserver:annotationset:08C0C288-6DF4-43E6-A618-71A8BB9563C3</domeo:belongsToSet>
    <pav:lastSavedOn>2014-07-07 09:44:18 -0400</pav:lastSavedOn>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:C3030391-F9A1-49F9-B8E8-7E56658D5BF2">
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-47.txt.html</ao:hasSource>
    <ao:exact>paroxetine</ao:exact>
    <pav:createdOn>2014-09-02 11:57:31 -0400</pav:createdOn>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:C3030391-F9A1-49F9-B8E8-7E56658D5BF2"/>
    <domeo:uuid>C3030391-F9A1-49F9-B8E8-7E56658D5BF2</domeo:uuid>
    <ao:suffix> 20 mg in patients stabilized on risperidone (4 to 8 mg/day) increased mean plasma concentrations of risperidone approximately 4-fold, decreased 9-hydroxyrisperidone concentrations approximately 10%, and increased concentrations of the active moiety (the</ao:suffix>
    <ao:prefix>, a CYP2D6 substrate has also been evaluated. In 1 study, daily dosing of </ao:prefix>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:85A8E907-AEE7-43A2-A096-5391F5C529CB">
    <ao:exact>valproate</ao:exact>
    <ao:suffix> </ao:suffix>
    <pav:createdOn>2014-07-21 21:53:36 -0400</pav:createdOn>
    <domeo:uuid>85A8E907-AEE7-43A2-A096-5391F5C529CB</domeo:uuid>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-56.txt.html</ao:hasSource>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:85A8E907-AEE7-43A2-A096-5391F5C529CB"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:prefix>xsd:String</ao:prefix>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:59DF3B57-4013-45C3-9A3F-23E01D7020B8">
    <pav:previousVersion>urn:domeoclient:uuid:BED41F06-565A-4622-9A88-48810E5A28DE</pav:previousVersion>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <rdfs:label>Highlight</rdfs:label>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <domeo:belongsToSet>urn:domeoserver:annotationset:A5DD001D-C81A-4E2E-B5E0-7A866B35E26B</domeo:belongsToSet>
    <pav:lineageUri>urn:domeoserver:annotation:2373845D-AAE9-4B15-9AC6-CC32A95859E9</pav:lineageUri>
    <domeo:belongsToSet>urn:domeoserver:annotationset:A3F0B39A-4249-4B63-BB0D-F24A005066AC</domeo:belongsToSet>
    <ao:context rdf:resource="urn:domeoclient:uuid:52224847-1B69-4520-9514-0282DC403A76"/>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">2</pav:versionNumber>
    <pav:lineageUri>urn:domeoserver:annotationset:D1715BD2-BD41-46FD-9454-DC7A423A29AC</pav:lineageUri>
    <pav:lastSavedOn>2014-09-02 11:46:58 -0400</pav:lastSavedOn>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812eda990003</pav:createdBy>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:lastSavedOn>2014-09-02 11:46:59 -0400</pav:lastSavedOn>
    <domeo:belongsToSet>urn:domeoserver:annotationset:3F546823-204F-4F9B-9006-3DC526C56931</domeo:belongsToSet>
    <pav:createdOn>2014-09-02 11:46:37 -0400</pav:createdOn>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:C4558C3C-CC16-4A44-85EC-2AB4969F8A0D">
    <domeo:belongsToSet>urn:domeoserver:annotationset:514BA51B-D734-4003-A7C3-F03C0F95833A</domeo:belongsToSet>
    <pav:previousVersion>urn:domeoserver:annotationset:7E80543E-BF76-4514-92A9-91458DCB802B</pav:previousVersion>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <pav:createdOn>2014-07-22 19:34:31 -0400</pav:createdOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <domeo:belongsToSet>urn:domeoserver:annotationset:2914A3FD-DF43-4F78-999C-77CE7A028B19</domeo:belongsToSet>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">4</pav:versionNumber>
    <rdfs:label>Highlight</rdfs:label>
    <domeo:belongsToSet>urn:domeoserver:annotationset:F272A789-69D0-47CC-8CC9-F25C55B91261</domeo:belongsToSet>
    <pav:lineageUri>urn:domeoserver:annotationset:AB1741F1-5A5F-4416-AEAC-A544BCBB7D16</pav:lineageUri>
    <pav:lineageUri>urn:domeoserver:annotation:EBF8A985-12CA-46F3-B45C-E614FB7F0A10</pav:lineageUri>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812eda990003</pav:createdBy>
    <ao:context rdf:resource="urn:domeoclient:uuid:BD65EDB0-5E4A-430E-B9C2-3D953A7DE94C"/>
    <domeo:belongsToSet>urn:domeoserver:annotationset:7021B883-FD5C-4083-BD87-DF56D3C87633</domeo:belongsToSet>
    <pav:lastSavedOn>2014-07-22 19:35:16 -0400</pav:lastSavedOn>
    <domeo:belongsToSet>urn:domeoserver:annotationset:606A5B3F-B6FB-4279-AA42-7893CFC2D20C</domeo:belongsToSet>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:D5584BFA-AB83-49EE-A2F1-68159AD3AEAC">
    <pav:createdOn>2014-09-02 11:38:45 -0400</pav:createdOn>
    <ao:suffix> did not produce larger mean decrements compared to lorazepam alone.</ao:suffix>
    <ao:exact>lorazepam</ao:exact>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:prefix> and </ao:prefix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:D5584BFA-AB83-49EE-A2F1-68159AD3AEAC"/>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-9.txt.html</ao:hasSource>
    <domeo:uuid>D5584BFA-AB83-49EE-A2F1-68159AD3AEAC</domeo:uuid>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:0772E366-3DDD-4D99-A1E7-B6F12EFF65DC">
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <domeo:belongsToSet>urn:domeoserver:annotationset:392EE0FB-AC4F-4AF2-87A6-2E50A281F434</domeo:belongsToSet>
    <ao:context rdf:resource="urn:domeoclient:uuid:5F9DA591-B9E4-4841-9D52-F5DDC170AE85"/>
    <pav:lastSavedOn>2014-09-02 19:19:47 -0400</pav:lastSavedOn>
    <rdfs:label>Highlight</rdfs:label>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:lineageUri>urn:domeoserver:annotation:70BA4CE9-DC47-406A-BF80-CCF2A6E4CCD6</pav:lineageUri>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812eda990003</pav:createdBy>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <domeo:belongsToSet>urn:domeoclient:uuid:CB83FFC2-EA71-44EA-8F11-DE80E389C84E</domeo:belongsToSet>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <pav:createdOn>2014-09-02 19:16:24 -0400</pav:createdOn>
    <pav:lineageUri>urn:domeoserver:annotationset:C5DEBC9B-77EE-4243-88EB-DBC19737ACD2</pav:lineageUri>
    <domeo:belongsToSet>urn:domeoserver:annotationset:E32812A9-205B-4EE1-B488-A1E294EDBFB9</domeo:belongsToSet>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:8A431E8A-FC95-4652-BD90-CA4F04C5CCB1">
    <sio:SIO_000628 rdf:resource="urn:pddi:uuid:2CAE12EF-8696-41E1-941D-FC8A9A49FCCF"/>
    <dikbD2R:modality>ncit:positive</dikbD2R:modality>
    <sio:SIO_000205>dikbD2R:statement</sio:SIO_000205>
    <sio:SIO_000563>dikbD2R:modality</sio:SIO_000563>
    <dikbD2R:statement>ncit:quantitative</dikbD2R:statement>
    <rdf:type rdf:resource="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#DrugDrugInteractionStatement"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:C6A356B7-0DEE-4744-8B2D-DDF0B281AC9B">
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:prefix>xsd:String</ao:prefix>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:C6A356B7-0DEE-4744-8B2D-DDF0B281AC9B"/>
    <pav:createdOn>2014-07-22 18:46:29 -0400</pav:createdOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <domeo:uuid>C6A356B7-0DEE-4744-8B2D-DDF0B281AC9B</domeo:uuid>
    <ao:suffix>xsd:String</ao:suffix>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-118.txt.html</ao:hasSource>
    <ao:exact>Concomitant administration of Synercid and nifedipine (repeated oral doses) and midazolam (intravenous bolus dose) in healthy volunteers led to elevated plasma concentrations of these drugs. The Cmax increased by 18% and 14% (median values) and the AUC increased by 44% and 33% for nifedipine and midazolam, respectively.</ao:exact>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:ED9A4881-5A44-4C07-BAFB-529340D632F3">
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <domeo:belongsToSet>urn:domeoserver:annotationset:467D4F28-D086-4217-9DE0-23E165F30716</domeo:belongsToSet>
    <domeo:belongsToSet>urn:domeoserver:annotationset:F272A789-69D0-47CC-8CC9-F25C55B91261</domeo:belongsToSet>
    <domeo:belongsToSet>urn:domeoserver:annotationset:606A5B3F-B6FB-4279-AA42-7893CFC2D20C</domeo:belongsToSet>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <ao:context rdf:resource="urn:domeoclient:uuid:47492213-15E8-4498-83DF-D443A77CE0C4"/>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812eda990003</pav:createdBy>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:lineageUri>urn:domeoserver:annotation:9913B537-EFDD-4D38-B47B-E7F08A81901B</pav:lineageUri>
    <pav:lastSavedOn>2014-07-22 19:11:40 -0400</pav:lastSavedOn>
    <pav:createdOn>2014-07-22 19:08:55 -0400</pav:createdOn>
    <pav:lastSavedOn>2014-07-22 19:11:41 -0400</pav:lastSavedOn>
    <pav:lineageUri>urn:domeoserver:annotationset:AB1741F1-5A5F-4416-AEAC-A544BCBB7D16</pav:lineageUri>
    <domeo:belongsToSet>urn:domeoserver:annotationset:7021B883-FD5C-4083-BD87-DF56D3C87633</domeo:belongsToSet>
    <domeo:belongsToSet>urn:domeoserver:annotationset:2914A3FD-DF43-4F78-999C-77CE7A028B19</domeo:belongsToSet>
    <rdfs:label>Highlight</rdfs:label>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <domeo:belongsToSet>urn:domeoserver:annotationset:514BA51B-D734-4003-A7C3-F03C0F95833A</domeo:belongsToSet>
    <domeo:belongsToSet>urn:domeoserver:annotationset:7E80543E-BF76-4514-92A9-91458DCB802B</domeo:belongsToSet>
    <domeo:belongsToSet>urn:domeoclient:uuid:BE4B86AC-FE5F-4543-A713-EC5B852A5A2A</domeo:belongsToSet>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:60E67041-A9C9-414B-A575-799C5BAFAF37">
    <ao:suffix>, cisapride, triazolam, and cyclosporine. Based on the assumption that the relationship between paroxetine’s in vitro Ki and its lack of effect on terfenadine's in vivo clearance predicts its effect on other CYP3A4 substrates, paroxetine’s extent of inhi</ao:suffix>
    <pav:createdOn>2014-09-02 15:04:23 -0400</pav:createdOn>
    <ao:exact>astemizole</ao:exact>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:60E67041-A9C9-414B-A575-799C5BAFAF37"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-48.txt.html</ao:hasSource>
    <domeo:uuid>60E67041-A9C9-414B-A575-799C5BAFAF37</domeo:uuid>
    <ao:prefix>, </ao:prefix>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:190E7AE8-2ACF-42E2-AE00-E433EEA9737C">
    <ao:item rdf:resource="urn:domeoclient:uuid:F2A6F24F-0266-4E33-86F7-71BB9F9CD038"/>
    <domeo:deleted>false</domeo:deleted>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <ao:item rdf:resource="urn:domeoclient:uuid:E69A980E-DFDE-46F6-BAC1-FFD29BDCB6F5"/>
    <permissions:permissions rdf:nodeID="Ndd28f742767f443d8059154f8f353f48"/>
    <dct:description>The default set is created automatically by Domeo when no other set is existing.</dct:description>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#AnnotationSet"/>
    <domeo:agents rdf:resource="urn:person:uuid:080e143046812afe0146812eda990003"/>
    <ao:annotatesResource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-78.txt.html</ao:annotatesResource>
    <ao:item rdf:resource="urn:domeoclient:uuid:EC3A3861-9232-4673-B5DA-6BEA85FD20A7"/>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <ao:item rdf:resource="urn:domeoclient:uuid:5C49E98B-9150-4558-BA6E-8A0528C6D9D6"/>
    <pav:lineageUri>urn:domeoserver:annotationset:D9D9F4B7-9732-49A7-8862-FFF6D70C89DF</pav:lineageUri>
    <rdfs:label>Default Set</rdfs:label>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812eda990003</pav:createdBy>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <domeo:agents rdf:resource="urn:domeo:software:id:Domeo-2.1alpha-050"/>
    <pav:createdOn>2014-09-02 19:38:12 -0400</pav:createdOn>
    <pav:lastSavedOn>2014-09-02 19:38:39 -0400</pav:lastSavedOn>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:97BD942B-FE8A-49D9-A08D-AF25357CEE2D">
    <domeo:belongsToSet>urn:domeoserver:annotationset:F272A789-69D0-47CC-8CC9-F25C55B91261</domeo:belongsToSet>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <rdfs:label>Highlight</rdfs:label>
    <pav:lineageUri>urn:domeoserver:annotation:3B2612E2-2F1F-4406-B35F-844C79D86AEE</pav:lineageUri>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812eda990003</pav:createdBy>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <pav:createdOn>2014-07-22 20:18:44 -0400</pav:createdOn>
    <ao:context rdf:resource="urn:domeoclient:uuid:F1920C60-E3BB-461B-89EC-34061357C4C7"/>
    <pav:lastSavedOn>2014-07-22 20:22:38 -0400</pav:lastSavedOn>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:1E3DB35F-57F6-4253-9254-35A557B0E5C5">
    <sio:SIO_000205>dikbD2R:statement</sio:SIO_000205>
    <sio:SIO_000628 rdf:resource="urn:pddi:uuid:2977EDDB-817D-4A9F-96BE-EAFA109EA9CA"/>
    <sio:SIO_000563>dikbD2R:modality</sio:SIO_000563>
    <dikbD2R:statement>ncit:Qualitative</dikbD2R:statement>
    <dikbD2R:modality>ncit:negative</dikbD2R:modality>
    <rdf:type rdf:resource="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#DrugDrugInteractionStatement"/>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/B7481A86-7883-4807-96C3-AE9B411B847B">
    <dct:description>Referred to the drug in the interaction.</dct:description>
    <rdfs:label>AVANDIA</rdfs:label>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/drug-product"/>
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/261455</dailymed:activeMoietyRxCUI>
    <sio:SIO_000228>dikbD2R:object-drug-of-interaction</sio:SIO_000228>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:41AFFAD3-B330-44BA-91A6-EFE69C07C0A2">
    <domeo:belongsToSet>urn:domeoserver:annotationset:A5DD001D-C81A-4E2E-B5E0-7A866B35E26B</domeo:belongsToSet>
    <domeo:belongsToSet>urn:domeoserver:annotationset:A3F0B39A-4249-4B63-BB0D-F24A005066AC</domeo:belongsToSet>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812eda990003</pav:createdBy>
    <pav:createdOn>2014-09-02 11:40:09 -0400</pav:createdOn>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">2</pav:versionNumber>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:previousVersion>urn:domeoclient:uuid:BED41F06-565A-4622-9A88-48810E5A28DE</pav:previousVersion>
    <ao:context rdf:resource="urn:domeoclient:uuid:8A0FA947-246E-4008-87C0-91C5CA96E875"/>
    <pav:lastSavedOn>2014-09-02 11:46:58 -0400</pav:lastSavedOn>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <pav:lineageUri>urn:domeoserver:annotationset:D1715BD2-BD41-46FD-9454-DC7A423A29AC</pav:lineageUri>
    <domeo:belongsToSet>urn:domeoserver:annotationset:3F546823-204F-4F9B-9006-3DC526C56931</domeo:belongsToSet>
    <rdfs:label>Highlight</rdfs:label>
    <pav:lineageUri>urn:domeoserver:annotation:E48061A6-DCEF-439E-8D26-0CE660E40BFE</pav:lineageUri>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:4B5E4470-CD28-4DCB-9009-8377503D5E57">
    <domeo:belongsToSet>urn:domeoclient:uuid:FCA2BF23-0BE3-409F-9177-761812F96097</domeo:belongsToSet>
    <rdfs:label>Highlight</rdfs:label>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:lastSavedOn>2014-07-07 09:44:19 -0400</pav:lastSavedOn>
    <pav:createdOn>2014-07-07 09:38:19 -0400</pav:createdOn>
    <pav:lineageUri>urn:domeoserver:annotation:E8807F31-F34F-4987-92C4-A2EE297A7A31</pav:lineageUri>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812eda990003</pav:createdBy>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <ao:context rdf:resource="urn:domeoclient:uuid:ACB2EB18-2590-4CF8-9CB3-0EF209C089E0"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:B9517CDA-E201-4D75-90EA-09D040EC5F9E">
    <rdfs:label>Highlight</rdfs:label>
    <pav:createdOn>2014-09-02 19:08:35 -0400</pav:createdOn>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:lastSavedOn>2014-09-02 19:11:13 -0400</pav:lastSavedOn>
    <domeo:belongsToSet>urn:domeoclient:uuid:3966BCFB-CA02-4053-828D-3860558E7BE8</domeo:belongsToSet>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812eda990003</pav:createdBy>
    <pav:lineageUri>urn:domeoserver:annotation:A4CF10B8-6217-4E35-AA5B-2F2FD2C31E87</pav:lineageUri>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <ao:context rdf:resource="urn:domeoclient:uuid:28F0EB50-7D95-4C50-8040-47E337110AC7"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:00672751-8DEF-4963-8AA5-6205618296C1">
    <pav:lastSavedOn>2014-09-02 11:46:59 -0400</pav:lastSavedOn>
    <pav:createdOn>2014-09-02 11:43:54 -0400</pav:createdOn>
    <domeo:belongsToSet>urn:domeoserver:annotationset:A5DD001D-C81A-4E2E-B5E0-7A866B35E26B</domeo:belongsToSet>
    <rdfs:label>Highlight</rdfs:label>
    <pav:previousVersion>urn:domeoclient:uuid:BED41F06-565A-4622-9A88-48810E5A28DE</pav:previousVersion>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812eda990003</pav:createdBy>
    <domeo:belongsToSet>urn:domeoserver:annotationset:A3F0B39A-4249-4B63-BB0D-F24A005066AC</domeo:belongsToSet>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">2</pav:versionNumber>
    <ao:context rdf:resource="urn:domeoclient:uuid:ED5A7142-16C6-4FE6-8733-C955CEF7A376"/>
    <pav:lineageUri>urn:domeoserver:annotationset:D1715BD2-BD41-46FD-9454-DC7A423A29AC</pav:lineageUri>
    <pav:lastSavedOn>2014-09-02 11:46:58 -0400</pav:lastSavedOn>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:lineageUri>urn:domeoserver:annotation:C61971B5-8232-4134-9C4A-B8150C8A359E</pav:lineageUri>
    <domeo:belongsToSet>urn:domeoserver:annotationset:3F546823-204F-4F9B-9006-3DC526C56931</domeo:belongsToSet>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/0FDE0719-4064-4898-AD34-D2D6DF707B50">
    <dct:description>Referred to the drug in the interaction.</dct:description>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/drug-product"/>
    <rdfs:label>Synercid</rdfs:label>
    <sio:SIO_000228>dikbD2R:precipitant-drug-of-interaction</sio:SIO_000228>
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/135097</dailymed:activeMoietyRxCUI>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:85752833-4F1F-4395-A378-9451755A600C">
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <ao:context rdf:resource="urn:domeoclient:uuid:2F0C7C89-516F-4D00-BAAB-BA2950277705"/>
    <pav:lineageUri>urn:domeoserver:annotationset:C5DEBC9B-77EE-4243-88EB-DBC19737ACD2</pav:lineageUri>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <domeo:belongsToSet>urn:domeoclient:uuid:CB83FFC2-EA71-44EA-8F11-DE80E389C84E</domeo:belongsToSet>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812eda990003</pav:createdBy>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <rdfs:label>Highlight</rdfs:label>
    <pav:lastSavedOn>2014-09-02 19:19:47 -0400</pav:lastSavedOn>
    <pav:lineageUri>urn:domeoserver:annotation:1C42E0EF-9031-4DAB-89B1-BE76FD2AA754</pav:lineageUri>
    <domeo:belongsToSet>urn:domeoserver:annotationset:E32812A9-205B-4EE1-B488-A1E294EDBFB9</domeo:belongsToSet>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <domeo:belongsToSet>urn:domeoserver:annotationset:392EE0FB-AC4F-4AF2-87A6-2E50A281F434</domeo:belongsToSet>
    <pav:createdOn>2014-09-02 19:16:07 -0400</pav:createdOn>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:B434A8E1-DA82-459A-AAAF-E55806E0A976">
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:B434A8E1-DA82-459A-AAAF-E55806E0A976"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:suffix>with proton pump inhibitors is expected to substantially decrease atazanavir plasma concentrations and thereby reduce its therapeutic effect.</ao:suffix>
    <ao:exact>atazanavir </ao:exact>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-74.txt.html</ao:hasSource>
    <pav:createdOn>2014-09-02 19:16:55 -0400</pav:createdOn>
    <ao:prefix> and proton pump inhibitors is not recommended. Co-administration of </ao:prefix>
    <domeo:uuid>B434A8E1-DA82-459A-AAAF-E55806E0A976</domeo:uuid>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:918A8BC4-10A8-4ADA-9C87-87BCD441E2ED">
    <domeo:uuid>918A8BC4-10A8-4ADA-9C87-87BCD441E2ED</domeo:uuid>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:exact>cisapride </ao:exact>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:918A8BC4-10A8-4ADA-9C87-87BCD441E2ED"/>
    <pav:createdOn>2014-09-01 15:57:38 -0400</pav:createdOn>
    <ao:prefix>200 mg (q.d.) induces the metabolism of </ao:prefix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:suffix>(cisapride AUC and Cmax were reduced by about 35%).</ao:suffix>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-16.txt.html</ao:hasSource>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:0BD5228B-2C30-4C04-8347-5E28492ED531">
    <pav:createdOn>2014-09-02 19:13:48 -0400</pav:createdOn>
    <ao:exact>e</ao:exact>
    <ao:prefix>Concomitant administration of om</ao:prefix>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-74.txt.html</ao:hasSource>
    <domeo:uuid>0BD5228B-2C30-4C04-8347-5E28492ED531</domeo:uuid>
    <ao:suffix>prazole and voriconazole (a combined inhibitor of CYP2C19 and CYP3A4) resulted in more than doubling of the omeprazole exposure. Dose adjustment of omeprazole is not normally required. However, in patients with Zollinger-Ellison syndrome, who may require</ao:suffix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:0BD5228B-2C30-4C04-8347-5E28492ED531"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:181AEA3C-635D-4DE0-8CD4-D795EB36DD79">
    <pav:createdOn>2014-09-02 11:30:42 -0400</pav:createdOn>
    <ao:suffix>), CYP3A4 (e.g., alprazolam), and CYP2C19 (e.g., omeprazole).</ao:suffix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:exact>warfarin</ao:exact>
    <ao:prefix>), CYP2C9 (e.g., </ao:prefix>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:181AEA3C-635D-4DE0-8CD4-D795EB36DD79"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <domeo:uuid>181AEA3C-635D-4DE0-8CD4-D795EB36DD79</domeo:uuid>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-9.txt.html</ao:hasSource>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:43E08535-8340-472C-92D9-100ECFA2CB93">
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/AFDFD2C0-7545-4E19-ABAA-7E48CFD82223"/>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/PK_DDI"/>
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/CE1B6F16-57BD-40EB-AB83-B1A40576F8C0"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:E74FD429-7BE1-4BBF-BDBE-DA9A73D330DA">
    <pav:lineageUri>urn:domeoserver:annotation:F9E59699-9666-429E-99DF-45A109FF9F5B</pav:lineageUri>
    <domeo:belongsToSet>urn:domeoserver:annotationset:1FC172B8-8AC3-465A-AA69-B73AD9B97CBC</domeo:belongsToSet>
    <rdfs:label>Highlight</rdfs:label>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <domeo:belongsToSet>urn:domeoclient:uuid:8D86A4AC-54BD-4BB3-8B58-AB55DEC01A88</domeo:belongsToSet>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <ao:context rdf:resource="urn:domeoclient:uuid:25B50478-76B9-41F0-8556-A8AEB125E61E"/>
    <pav:lineageUri>urn:domeoserver:annotationset:4A88D0A6-E9B6-4E7F-955F-3692600C178C</pav:lineageUri>
    <pav:createdOn>2014-07-24 20:07:33 -0400</pav:createdOn>
    <pav:lastSavedOn>2014-07-24 20:07:19 -0400</pav:lastSavedOn>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812eda990003</pav:createdBy>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:lastSavedOn>2014-07-24 20:07:20 -0400</pav:lastSavedOn>
    <domeo:belongsToSet>urn:domeoserver:annotationset:37B2514D-1A92-45B1-8A5C-610DA6DC935A</domeo:belongsToSet>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:9BFD55E1-3ADE-4DD6-8289-76C7DC405DE3">
    <ao:prefix>, </ao:prefix>
    <ao:exact>theophylline</ao:exact>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <domeo:uuid>9BFD55E1-3ADE-4DD6-8289-76C7DC405DE3</domeo:uuid>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-9.txt.html</ao:hasSource>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:9BFD55E1-3ADE-4DD6-8289-76C7DC405DE3"/>
    <ao:suffix>, certain benzodiazepines, omeprazole and phenytoin. If fluvoxamine maleate tablets are to be administered together with a drug that is eliminated via oxidative metabolism and has a narrow therapeutic window, plasma levels and/or pharmacodynamic effects </ao:suffix>
    <pav:createdOn>2014-09-02 11:36:10 -0400</pav:createdOn>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:76258D2D-1630-4254-82ED-C3434163EAE3">
    <ao:exact>risperidone</ao:exact>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <domeo:uuid>76258D2D-1630-4254-82ED-C3434163EAE3</domeo:uuid>
    <ao:prefix> pharmacokinetic profile typical of poor metabolizers. The therapeutic benefits and adverse effects of </ao:prefix>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-8.txt.html</ao:hasSource>
    <pav:createdOn>2014-07-13 11:15:09 -0400</pav:createdOn>
    <ao:suffix> in patients receiving quinidine have not been evaluated, but observations in a modest number (N≅70) of poor metabolizers given risperidone do not suggest important differences between poor and extensive metabolizers. Second, co-administration of known e</ao:suffix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:76258D2D-1630-4254-82ED-C3434163EAE3"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:19DF8C99-A2F9-40E1-9BC9-0D4A0531A57A">
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <pav:createdOn>2014-07-22 19:24:53 -0400</pav:createdOn>
    <domeo:uuid>19DF8C99-A2F9-40E1-9BC9-0D4A0531A57A</domeo:uuid>
    <ao:exact>rosiglitazone</ao:exact>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:19DF8C99-A2F9-40E1-9BC9-0D4A0531A57A"/>
    <ao:suffix> with food resulted in no change in overall exposure (AUC), but there was an approximately 28% decrease in Cmax and a delay in Tmax (1.75 hours). These changes are not likely to be clinically significant; therefore, AVANDIA may be administered with or wi</ao:suffix>
    <ao:prefix> is 99%. Peak plasma concentrations are observed about 1 hour after dosing. Administration of </ao:prefix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-123.txt.html</ao:hasSource>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:F64BA1C3-4615-428E-A209-D304847D4A08">
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812eda990003</pav:createdBy>
    <pav:lineageUri>urn:domeoserver:annotation:C7FB4EC1-7B6D-414D-BFAD-AAF1D0DDDA6F</pav:lineageUri>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <domeo:belongsToSet>urn:domeoclient:uuid:CB83FFC2-EA71-44EA-8F11-DE80E389C84E</domeo:belongsToSet>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <ao:context rdf:resource="urn:domeoclient:uuid:C00C0C31-D3ED-43CE-8CB0-398EA275616B"/>
    <pav:lineageUri>urn:domeoserver:annotationset:C5DEBC9B-77EE-4243-88EB-DBC19737ACD2</pav:lineageUri>
    <domeo:belongsToSet>urn:domeoserver:annotationset:392EE0FB-AC4F-4AF2-87A6-2E50A281F434</domeo:belongsToSet>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:lastSavedOn>2014-09-02 19:19:47 -0400</pav:lastSavedOn>
    <pav:createdOn>2014-09-02 19:18:20 -0400</pav:createdOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <rdfs:label>Highlight</rdfs:label>
    <domeo:belongsToSet>urn:domeoserver:annotationset:E32812A9-205B-4EE1-B488-A1E294EDBFB9</domeo:belongsToSet>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:432A7650-30CD-4BF8-8B03-ECC3935769BA">
    <domeo:belongsToSet>urn:domeoserver:annotationset:1FC172B8-8AC3-465A-AA69-B73AD9B97CBC</domeo:belongsToSet>
    <pav:lineageUri>urn:domeoserver:annotation:0236C5C5-A2FF-49E3-889E-80589B392E0C</pav:lineageUri>
    <pav:lastSavedOn>2014-07-24 20:12:49 -0400</pav:lastSavedOn>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812eda990003</pav:createdBy>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <ao:context rdf:resource="urn:domeoclient:uuid:04F1D04C-3FDE-4B85-A97A-D8EA12CEF79C"/>
    <pav:createdOn>2014-07-24 20:12:18 -0400</pav:createdOn>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <rdfs:label>Highlight</rdfs:label>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:previousVersion>xsd:String</pav:previousVersion>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:8C5BA635-EF8B-4165-A2A6-5832D61A15BF">
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812eda990003</pav:createdBy>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <domeo:belongsToSet>urn:domeoserver:annotationset:22ED7220-C6F6-43C5-9DF9-89F62F0F8E27</domeo:belongsToSet>
    <pav:lineageUri>urn:domeoserver:annotationset:76FD4BB5-DE2F-4FCA-B93D-302185B1A381</pav:lineageUri>
    <pav:previousVersion>urn:domeoserver:annotationset:7AACEF8D-2EBC-4F0B-94B2-190650E562F6</pav:previousVersion>
    <pav:lastSavedOn>2014-07-07 11:35:32 -0400</pav:lastSavedOn>
    <ao:body rdf:nodeID="Nbefeb89c55ad42fcaa10ca450e0e6e1a"/>
    <ao:context rdf:resource="urn:domeoclient:uuid:5F97F910-5C88-42D5-BF36-6EFC8C9A3DD1"/>
    <pav:lastSavedOn>2014-07-07 11:35:31 -0400</pav:lastSavedOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#expertstudyAnnotation"/>
    <pav:createdOn>2014-07-07 11:35:30 -0400</pav:createdOn>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <domeo:belongsToSet>urn:domeoserver:annotationset:131835A3-C655-4F91-97D4-52CAFF7B7CCA</domeo:belongsToSet>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <ao:body rdf:nodeID="N43076aac7b814d14b272d7da028a814a"/>
    <domeo:belongsToSet>urn:domeoserver:annotationset:8F3CF3D9-AADE-4A86-BD42-2924B3D6A406</domeo:belongsToSet>
    <ao:body rdf:nodeID="Ncef41bceb86f423ebf6ad633a6670d48"/>
    <pav:lineageUri>urn:domeoserver:annotation:9EA45124-7E00-46A6-9CA4-F4521FB8A397</pav:lineageUri>
    <rdfs:label>expertstudy Annotation</rdfs:label>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">4</pav:versionNumber>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:D5736B17-7DDF-4532-8056-6627EB5A439A">
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:lineageUri>urn:domeoserver:annotation:57129256-B2CA-4B2B-A838-B76DD1C015B3</pav:lineageUri>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <rdfs:label>Highlight</rdfs:label>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812eda990003</pav:createdBy>
    <pav:createdOn>2014-07-07 09:38:21 -0400</pav:createdOn>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <ao:context rdf:resource="urn:domeoclient:uuid:952FDCF1-252C-42FC-BE9F-40622C26F85D"/>
    <pav:lastSavedOn>2014-07-07 09:44:19 -0400</pav:lastSavedOn>
    <domeo:belongsToSet>urn:domeoclient:uuid:FCA2BF23-0BE3-409F-9177-761812F96097</domeo:belongsToSet>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:BE1FD7C4-2F16-4751-88A8-4F0AA6A4450A">
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:exact>fexofenadine</ao:exact>
    <ao:prefix> gastrointestinal absorption. This observed increase in the bioavailability of </ao:prefix>
    <ao:suffix> may be due to transport-related effects, such as p-glycoprotein. In vivo animal studies also suggest that in addition to enhancing absorption, ketoconazole decreases fexofenadine gastrointestinal secretion, while erythromycin may also decrease biliary e</ao:suffix>
    <domeo:uuid>BE1FD7C4-2F16-4751-88A8-4F0AA6A4450A</domeo:uuid>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-139.txt.html</ao:hasSource>
    <pav:createdOn>2014-07-24 20:11:50 -0400</pav:createdOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:BE1FD7C4-2F16-4751-88A8-4F0AA6A4450A"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:3E551BB3-088F-4A07-A523-A094DE08768F">
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:createdOn>2014-09-01 15:57:26 -0400</pav:createdOn>
    <pav:lineageUri>urn:domeoserver:annotation:E8908FB6-439F-4C11-8D19-36DEDFABC4CC</pav:lineageUri>
    <rdfs:label>Highlight</rdfs:label>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812eda990003</pav:createdBy>
    <domeo:belongsToSet>urn:domeoclient:uuid:39B82E57-92E3-4322-A8E6-A3AFF215F02C</domeo:belongsToSet>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <ao:context rdf:resource="urn:domeoclient:uuid:92F50FB9-2DDF-4D9E-B8BE-97306CD17D51"/>
    <pav:lastSavedOn>2014-09-01 15:57:39 -0400</pav:lastSavedOn>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:5841BCC9-42A5-4486-AA8B-635392DB4438">
    <ao:prefix>: Administration of </ao:prefix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:suffix> maleate 100 mg daily for 18 days (N = 8) did not significantly affect the pharmacokinetics of a 1.25 mg single intravenous dose of digoxin.</ao:suffix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <domeo:uuid>5841BCC9-42A5-4486-AA8B-635392DB4438</domeo:uuid>
    <ao:exact>fluvoxamine</ao:exact>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-9.txt.html</ao:hasSource>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:5841BCC9-42A5-4486-AA8B-635392DB4438"/>
    <pav:createdOn>2014-09-02 11:44:39 -0400</pav:createdOn>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:33BB0EA3-00A7-4E9A-8406-1B489BED52FB">
    <ao:prefix>. </ao:prefix>
    <ao:exact>Following multiple doses of nelfinavir (1250 mg, bid) and omeprazole (40 mg, qd), AUC was decreased by 36% and 92%, Cmax by 37% and 89% and Cmin by 39% and 75% respectively for nelfinavir and M8.</ao:exact>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-74.txt.html</ao:hasSource>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:suffix> Following multiple doses of</ao:suffix>
    <domeo:uuid>33BB0EA3-00A7-4E9A-8406-1B489BED52FB</domeo:uuid>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <pav:createdOn>2014-09-02 19:32:05 -0400</pav:createdOn>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:33BB0EA3-00A7-4E9A-8406-1B489BED52FB"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:E6E87B62-FE76-4230-92AF-6FD2DBA966AD">
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:suffix>xsd:String</ao:suffix>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:E6E87B62-FE76-4230-92AF-6FD2DBA966AD"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <pav:createdOn>2014-07-22 19:48:54 -0400</pav:createdOn>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-123.txt.html</ao:hasSource>
    <ao:exact>Glyburide</ao:exact>
    <ao:prefix>xsd:String</ao:prefix>
    <domeo:uuid>E6E87B62-FE76-4230-92AF-6FD2DBA966AD</domeo:uuid>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:302E5EA3-5D0F-4547-B3A1-1B63352BB1A5">
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <pav:createdOn>2014-07-22 18:54:08 -0400</pav:createdOn>
    <ao:exact>Two randomized, open-label, controlled clinical trials of Synercid (7.5 mg/kg q12h intravenously [iv]) in the treatment of complicated skin and skin structure infections were performed. The comparator drug was oxacillin (2g q6h iv) in the first study (JRV 304) and cefazolin (1g q8h iv) in the second study (JRV 305); however, in both studies vancomycin (1g q12h iv) could be substituted for the specified comparator if the causative pathogen was suspected or confirmed methicillin-resistant staphylococcus or if the patient was allergic to penicillins, cephalosporins or carbapenems. Study JRV 304 enrolled 450 patients (n = 229 Synercid; n= 221 Comparator) and Study JRV 305 enrolled 443 patients (n = 221 Synercid; n = 222 Comparator)</ao:exact>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:prefix>xsd:String</ao:prefix>
    <ao:suffix>.</ao:suffix>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-119.txt.html</ao:hasSource>
    <domeo:uuid>302E5EA3-5D0F-4547-B3A1-1B63352BB1A5</domeo:uuid>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:302E5EA3-5D0F-4547-B3A1-1B63352BB1A5"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:735CA4BD-A16D-4729-BFC3-96D72BFE5B0B">
    <pav:lineageUri>urn:domeoserver:annotation:996DAC66-98E7-4BAE-90CA-B2474D43F8E1</pav:lineageUri>
    <pav:createdOn>2014-07-07 11:23:01 -0400</pav:createdOn>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812eda990003</pav:createdBy>
    <pav:lastSavedOn>2014-07-07 11:24:52 -0400</pav:lastSavedOn>
    <domeo:belongsToSet>urn:domeoserver:annotationset:22ED7220-C6F6-43C5-9DF9-89F62F0F8E27</domeo:belongsToSet>
    <ao:context rdf:resource="urn:domeoclient:uuid:007F6835-1CAF-4F0B-8BFD-311D8BFD8926"/>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <domeo:belongsToSet>urn:domeoserver:annotationset:8F3CF3D9-AADE-4A86-BD42-2924B3D6A406</domeo:belongsToSet>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <domeo:belongsToSet>urn:domeoserver:annotationset:7AACEF8D-2EBC-4F0B-94B2-190650E562F6</domeo:belongsToSet>
    <rdfs:label>Highlight</rdfs:label>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <domeo:belongsToSet>urn:domeoserver:annotationset:131835A3-C655-4F91-97D4-52CAFF7B7CCA</domeo:belongsToSet>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:D630E295-F643-4F99-AB1E-8DA3F1178740">
    <ao:prefix>xsd:String</ao:prefix>
    <ao:suffix>xsd:String</ao:suffix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <domeo:uuid>D630E295-F643-4F99-AB1E-8DA3F1178740</domeo:uuid>
    <pav:createdOn>2014-07-24 19:43:26 -0400</pav:createdOn>
    <ao:exact>Propranolol does not affect the pharmacokinetics of verapamil and norverapamil. Verapamil does not affect the pharmacokinetics of propranolol</ao:exact>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:D630E295-F643-4F99-AB1E-8DA3F1178740"/>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-127.txt.html</ao:hasSource>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:F46BEE2C-B82E-4386-96D7-C74221898C04">
    <domeo:belongsToSet>urn:domeoclient:uuid:71191E51-53CB-4FDE-88D0-33C6818E2232</domeo:belongsToSet>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <pav:createdOn>2014-07-13 11:15:12 -0400</pav:createdOn>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812eda990003</pav:createdBy>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:lastSavedOn>2014-07-13 11:32:29 -0400</pav:lastSavedOn>
    <ao:context rdf:resource="urn:domeoclient:uuid:2B951EF5-B48C-4B58-B273-480990730DEA"/>
    <rdfs:label>Highlight</rdfs:label>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:lineageUri>urn:domeoserver:annotation:90D2913F-1AFA-432E-968A-2D879173B288</pav:lineageUri>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/B9F2BCC2-2AB5-46DF-BF40-8E849B5709AB">
    <dct:description>Referred to the drug in the interaction.</dct:description>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/active-ingredient"/>
    <rdfs:label>omeprazole</rdfs:label>
    <sio:SIO_000228>dikbD2R:object-drug-of-interaction</sio:SIO_000228>
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/7646</dailymed:activeMoietyRxCUI>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:7EF07060-EF5D-42BC-87F0-3EFC38B56BAA">
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <pav:lineageUri>urn:domeoserver:annotation:4A688FF7-D55F-411D-A8EF-DDA813F95C96</pav:lineageUri>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:lastSavedOn>2014-07-24 20:02:49 -0400</pav:lastSavedOn>
    <domeo:belongsToSet>urn:domeoclient:uuid:189A8E0E-67D6-4C53-A96E-CB48A3B4B2E9</domeo:belongsToSet>
    <ao:context rdf:resource="urn:domeoclient:uuid:816C98CB-228B-41B9-9F5B-78D35D300142"/>
    <pav:createdOn>2014-07-24 20:01:41 -0400</pav:createdOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812eda990003</pav:createdBy>
    <rdfs:label>Highlight</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:7F9271EC-A8D0-45D0-9412-2C40F45D0D4B">
    <pav:createdOn>2014-07-22 18:47:02 -0400</pav:createdOn>
    <ao:exact>Concomitant administration of Synercid and nifedipine (repeated oral doses) and midazolam (intravenous bolus dose) in healthy volunteers led to elevated plasma concentrations of these drugs. The Cmax increased by 18% and 14% (median values) and the AUC increased by 44% and 33% for nifedipine and midazolam, respectively.</ao:exact>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:7F9271EC-A8D0-45D0-9412-2C40F45D0D4B"/>
    <ao:prefix>xsd:String</ao:prefix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-118.txt.html</ao:hasSource>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:suffix>xsd:String</ao:suffix>
    <domeo:uuid>7F9271EC-A8D0-45D0-9412-2C40F45D0D4B</domeo:uuid>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:26FE0E4C-4C7A-4DDB-B49D-53B765A8B4E3">
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:prefix>tion pharmacokinetic analysis with sparse data from 96 pediatric patients in a single pediatric clinical trial including 33 males and 63 females with ages ranging from 10 to 17 years (weights ranging from 35 to 178.3 kg). Population mean CL/F and V/F of </ao:prefix>
    <pav:createdOn>2014-07-22 19:35:50 -0400</pav:createdOn>
    <domeo:uuid>26FE0E4C-4C7A-4DDB-B49D-53B765A8B4E3</domeo:uuid>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:26FE0E4C-4C7A-4DDB-B49D-53B765A8B4E3"/>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-123.txt.html</ao:hasSource>
    <ao:exact>rosiglitazone</ao:exact>
    <ao:suffix> were 3.15 L/hr and 13.5 L, respectively. These estimates of CL/F and V/F were consistent with the typical parameter estimates from a prior adult population analysis.</ao:suffix>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:EA587655-D235-49D2-9724-0AEBB3E5E13B">
    <rdfs:label>Highlight</rdfs:label>
    <pav:createdOn>2014-09-02 11:39:02 -0400</pav:createdOn>
    <pav:lineageUri>urn:domeoserver:annotation:7538AE68-EE37-48F1-B149-EE3B64F2251B</pav:lineageUri>
    <domeo:belongsToSet>urn:domeoserver:annotationset:A3F0B39A-4249-4B63-BB0D-F24A005066AC</domeo:belongsToSet>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">2</pav:versionNumber>
    <pav:previousVersion>urn:domeoclient:uuid:BED41F06-565A-4622-9A88-48810E5A28DE</pav:previousVersion>
    <pav:lastSavedOn>2014-09-02 11:46:58 -0400</pav:lastSavedOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <domeo:belongsToSet>urn:domeoserver:annotationset:3F546823-204F-4F9B-9006-3DC526C56931</domeo:belongsToSet>
    <domeo:belongsToSet>urn:domeoserver:annotationset:A5DD001D-C81A-4E2E-B5E0-7A866B35E26B</domeo:belongsToSet>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812eda990003</pav:createdBy>
    <pav:lineageUri>urn:domeoserver:annotationset:D1715BD2-BD41-46FD-9454-DC7A423A29AC</pav:lineageUri>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <ao:context rdf:resource="urn:domeoclient:uuid:AC27080F-C738-4176-9E15-7672938F5DF3"/>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoserver:annotationset:392EE0FB-AC4F-4AF2-87A6-2E50A281F434">
    <ao:item rdf:resource="urn:domeoclient:uuid:DC959F62-91AD-411B-AC17-FFBBEE22EAF0"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:D5B6732B-67A7-4A25-9BC2-70185A35217F"/>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">2</pav:versionNumber>
    <pav:lineageUri>urn:domeoserver:annotationset:C5DEBC9B-77EE-4243-88EB-DBC19737ACD2</pav:lineageUri>
    <ao:item rdf:resource="urn:domeoclient:uuid:95404334-796F-4A07-A18A-42601A802CDF"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:F45CCE04-9C17-4AB6-BF4A-23A94A70AB21"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:883BB188-A483-4C32-85F5-63D2C4B33561"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:E63ABC8A-4562-42F9-B5F4-6A27DEE50F44"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:2DE3872D-3935-4824-AF9D-DBFF26D2588F"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:6BD06504-E85C-4ECF-9079-FE0363DD8508"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:42F3EB55-6A92-4EE6-9472-03CDC6E02D69"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:2FAF656F-18DD-448F-84DF-6CC1FD701820"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:E68B19A2-98CC-4D01-88C9-2BCC8709D27A"/>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812eda990003</pav:createdBy>
    <ao:item rdf:resource="urn:domeoclient:uuid:ED46D326-5EE0-47F9-A0D2-97252A43CE9D"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:31C3D8BC-BEE5-4732-B113-5F04341D26EC"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:25474B79-791D-49D5-B5D1-858E90C62BB2"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:70CC18BE-600E-4B98-B2C6-E5920EB63D79"/>
    <domeo:deleted>false</domeo:deleted>
    <ao:item rdf:resource="urn:domeoclient:uuid:812A1777-BC32-4760-9024-CF9758CF804E"/>
    <ao:annotatesResource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-74.txt.html</ao:annotatesResource>
    <ao:item rdf:resource="urn:domeoclient:uuid:B188771E-D938-4A6E-AA65-8D511119CA92"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:820A8921-32D8-4CA7-991C-5585C1088203"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:50CB810E-E5CE-4D21-8703-B10F04053C7D"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:0772E366-3DDD-4D99-A1E7-B6F12EFF65DC"/>
    <pav:createdOn>2014-09-02 19:12:09 -0400</pav:createdOn>
    <domeo:agents rdf:resource="urn:person:uuid:080e143046812afe0146812eda990003"/>
    <rdfs:label>Default Set</rdfs:label>
    <ao:item rdf:resource="urn:domeoclient:uuid:16D91D82-D12B-41E8-A218-F336224CF507"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:56E0618F-C2A8-4B2E-868E-D415AEE3E3EF"/>
    <domeo:agents rdf:resource="urn:domeo:software:id:Domeo-2.1alpha-050"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:DC77541A-190C-4C62-930E-9CF52E6C4A67"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:4B8A305B-D42C-40FD-B384-05FE89B4ACA4"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:85752833-4F1F-4395-A378-9451755A600C"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#AnnotationSet"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:F989B861-2D11-4383-83FA-D6724A4DE400"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:62793798-1CBD-4B4E-97DB-09E6DED152F0"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:F0FFC655-44BB-402B-B7C7-6EB6CD49035C"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:0E2360A5-44FC-4633-8B3E-758DB777C4E6"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:F64BA1C3-4615-428E-A209-D304847D4A08"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:50AA7124-5304-4E5F-8D20-3405C75223FB"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:F1FF7E05-1C80-4A3F-9366-A074CA5EDF15"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:94E71C50-311F-485B-9C5A-D703BD0E29D1"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:939BD222-0159-44F2-9E01-3D674AEF5EFE"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:53200B7D-3B88-4C24-827A-DE552ED1B23F"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:0B3096F2-9B83-424A-BCB8-CF996BA224AC"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:A05ABC03-57B2-463F-8733-BF02DB5FE3A7"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:B1D53EEF-8BCA-4B91-B107-30A073406F41"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:807433B2-EB3F-4CEF-824C-1D71920A4C22"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:00C24F6A-259C-4CD5-BB57-3231935B23AE"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:968E2714-CEBF-4C37-913F-C2DF10947AB8"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:EA6549D1-9142-4B02-863B-C31046392662"/>
    <permissions:permissions rdf:nodeID="N7baac5f2dd6140fe80b95a54dd8eae0d"/>
    <pav:previousVersion>urn:domeoclient:uuid:CB83FFC2-EA71-44EA-8F11-DE80E389C84E</pav:previousVersion>
    <ao:item rdf:resource="urn:domeoclient:uuid:F9653C29-A4D2-424D-A8FE-3DDBAC24C18C"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:F5B0ED12-45EB-48BE-B664-DDC78E05AA4A"/>
    <pav:lastSavedOn>2014-09-02 19:32:13 -0400</pav:lastSavedOn>
    <ao:item rdf:resource="urn:domeoclient:uuid:19626855-8C17-4CB6-BD80-697B52F6ADC9"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:8621DC71-D1C0-4E5B-97BA-B7275B47A413"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:5EA1A12E-999D-4F07-B3EF-67CFE143F274"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:A30DCF7F-AD5F-403E-9FF6-A1CEC51B4252"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:DC13A4FA-8B30-458B-9343-4B48CC945EBF"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:46890B26-242B-40DA-BF4E-E7B90E54E678"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:0A3EAA6A-641B-48C1-A03F-CCA1FF890D64"/>
    <dct:description>The default set is created automatically by Domeo when no other set is existing.</dct:description>
    <ao:item rdf:resource="urn:domeoclient:uuid:FF4B8408-EC34-4E9C-A970-D7F98CF2EEE1"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:CBD1F653-F7E2-49C1-AEF3-0CF16AA17649">
    <ao:suffix>. (See PRECAUTIONS.)</ao:suffix>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-25.txt.html</ao:hasSource>
    <pav:createdOn>2014-07-21 21:27:02 -0400</pav:createdOn>
    <ao:exact>phenytoin</ao:exact>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <domeo:uuid>CBD1F653-F7E2-49C1-AEF3-0CF16AA17649</domeo:uuid>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:prefix>AUC was 88% ± 68% (range: 16 to 247%). The absolute magnitude of this interaction is unknown because of the intrinsically nonlinear disposition of </ao:prefix>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:CBD1F653-F7E2-49C1-AEF3-0CF16AA17649"/>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/161695D1-EF44-45A7-B41B-A52C6CD2F783">
    <sio:SIO_000228>dikbD2R:object-drug-of-interaction</sio:SIO_000228>
    <rdfs:label>midazolam</rdfs:label>
    <dct:description>Referred to the drug in the interaction.</dct:description>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/active-ingredient"/>
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/6960</dailymed:activeMoietyRxCUI>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:5BCF5967-ADD0-4798-B754-B12D230BDBFA">
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <domeo:belongsToSet>urn:domeoclient:uuid:3966BCFB-CA02-4053-828D-3860558E7BE8</domeo:belongsToSet>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812eda990003</pav:createdBy>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <rdfs:label>Highlight</rdfs:label>
    <ao:context rdf:resource="urn:domeoclient:uuid:AFAC33CD-2472-4FC2-BA17-FF7F45039527"/>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:lastSavedOn>2014-09-02 19:11:13 -0400</pav:lastSavedOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:createdOn>2014-09-02 19:11:02 -0400</pav:createdOn>
    <pav:lineageUri>urn:domeoserver:annotation:0498CEC9-6EEB-4566-BE56-E8A1249425AB</pav:lineageUri>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:BC114E92-ED59-4D14-B788-57030FC75EBC">
    <sio:SIO_000205>dikbD2R:statement</sio:SIO_000205>
    <sio:SIO_000563>dikbD2R:modality</sio:SIO_000563>
    <rdf:type rdf:resource="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#DrugDrugInteractionStatement"/>
    <dikbD2R:modality>ncit:negative</dikbD2R:modality>
    <dikbD2R:statement>ncit:Qualitative</dikbD2R:statement>
    <sio:SIO_000628 rdf:resource="urn:pddi:uuid:AB3B0778-C37A-4D38-B2AC-7049DC5E2EE9"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:852CFA91-85F8-4EF7-A64F-D2A63BC3A6B5">
    <pav:lineageUri>urn:domeoserver:annotation:DE440974-EDFE-4A60-BE08-DA4EB981B70C</pav:lineageUri>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812eda990003</pav:createdBy>
    <domeo:belongsToSet>urn:domeoserver:annotationset:D52DFD7B-BDDF-488F-B339-B1BC641E50E9</domeo:belongsToSet>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:createdOn>2014-09-02 12:03:19 -0400</pav:createdOn>
    <ao:context rdf:resource="urn:domeoclient:uuid:BE5B91CD-CF9E-4980-B001-64C0D34FB3CE"/>
    <rdfs:label>Highlight</rdfs:label>
    <domeo:belongsToSet>urn:domeoclient:uuid:379CD8C1-F4B4-42B7-8F87-70776866DB1F</domeo:belongsToSet>
    <pav:lastSavedOn>2014-09-02 12:03:47 -0400</pav:lastSavedOn>
    <pav:lineageUri>urn:domeoserver:annotationset:166C20E9-1B4C-47D1-982D-922E2E5ACFF2</pav:lineageUri>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:previousVersion>xsd:String</pav:previousVersion>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/04F5EE18-51BD-4A42-A9E7-52826EE0EA8B">
    <dct:description>Referred to the drug in the interaction.</dct:description>
    <sio:SIO_000228>dikbD2R:object-drug-of-interaction</sio:SIO_000228>
    <rdfs:label>saquinavir</rdfs:label>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/active-ingredient"/>
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/83395</dailymed:activeMoietyRxCUI>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:0A617D2E-816A-496B-B5FC-091514B75E33">
    <rdfs:label>expertstudy Annotation</rdfs:label>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#expertstudyAnnotation"/>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <domeo:belongsToSet>urn:domeoclient:uuid:4B51141D-C8D2-45DB-8074-74F8D8323E60</domeo:belongsToSet>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <pav:lineageUri>urn:domeoserver:annotation:46C07518-AE09-4026-8E8F-D159078B10AC</pav:lineageUri>
    <pav:lastSavedOn>2014-09-02 12:02:18 -0400</pav:lastSavedOn>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <ao:body rdf:nodeID="N95f881cd66e24b3f8c7b0d9d35a341dd"/>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812eda990003</pav:createdBy>
    <pav:createdOn>2014-09-02 12:00:11 -0400</pav:createdOn>
    <ao:context rdf:resource="urn:domeoclient:uuid:E7AD1296-3138-4E05-ACC3-466E8259339A"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:7C69D717-13B9-4E6F-B20D-24925FA1E992">
    <ao:context rdf:resource="urn:domeoclient:uuid:1FA6545E-180C-46D2-A000-88AB02BD37E4"/>
    <pav:lineageUri>urn:domeoserver:annotation:C250B80E-322B-4526-8087-D8ABAC58D429</pav:lineageUri>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812eda990003</pav:createdBy>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:lastSavedOn>2014-07-22 18:36:37 -0400</pav:lastSavedOn>
    <domeo:belongsToSet>urn:domeoclient:uuid:040380DC-30D6-454D-ACD7-489B2130A9CC</domeo:belongsToSet>
    <pav:createdOn>2014-07-22 18:36:25 -0400</pav:createdOn>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <rdfs:label>Highlight</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:0D6AEBDD-929E-4D65-B956-E7E552F5D014">
    <pav:createdOn>2014-07-21 21:43:18 -0400</pav:createdOn>
    <ao:suffix>with paroxetine significantly decreased plasma levels of paroxetine. Any dose adjustment should be guided by clinical effect (tolerability and efficacy). </ao:suffix>
    <ao:prefix>/</ao:prefix>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-51.txt.html</ao:hasSource>
    <domeo:uuid>0D6AEBDD-929E-4D65-B956-E7E552F5D014</domeo:uuid>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:0D6AEBDD-929E-4D65-B956-E7E552F5D014"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:exact>ritonavir </ao:exact>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:001ECFA6-B086-4B2B-977E-41F4C9DE054B">
    <domeo:uuid>001ECFA6-B086-4B2B-977E-41F4C9DE054B</domeo:uuid>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-132.txt.html</ao:hasSource>
    <ao:suffix>, decreased 18% to 23% the AUC of both, but did not alter their pharmacodynamics. Propranolol did not have an effect on the pharmacokinetics of fluvastatin.</ao:suffix>
    <pav:createdOn>2014-07-24 19:52:46 -0400</pav:createdOn>
    <ao:prefix> or </ao:prefix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:exact>pravastatin</ao:exact>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:001ECFA6-B086-4B2B-977E-41F4C9DE054B"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:3EA9FD84-7972-4F14-ACAC-44E7B91CD0C2">
    <domeo:belongsToSet>urn:domeoserver:annotationset:3F546823-204F-4F9B-9006-3DC526C56931</domeo:belongsToSet>
    <pav:createdOn>2014-09-02 11:43:06 -0400</pav:createdOn>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">2</pav:versionNumber>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812eda990003</pav:createdBy>
    <domeo:belongsToSet>urn:domeoserver:annotationset:A3F0B39A-4249-4B63-BB0D-F24A005066AC</domeo:belongsToSet>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:lineageUri>urn:domeoserver:annotationset:D1715BD2-BD41-46FD-9454-DC7A423A29AC</pav:lineageUri>
    <ao:context rdf:resource="urn:domeoclient:uuid:7E0188B4-6C70-41E7-B903-5A68F972FC55"/>
    <domeo:belongsToSet>urn:domeoserver:annotationset:A5DD001D-C81A-4E2E-B5E0-7A866B35E26B</domeo:belongsToSet>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <rdfs:label>Highlight</rdfs:label>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:previousVersion>urn:domeoclient:uuid:BED41F06-565A-4622-9A88-48810E5A28DE</pav:previousVersion>
    <pav:lineageUri>urn:domeoserver:annotation:02A937CA-8CE4-4CCE-997A-074A77849B59</pav:lineageUri>
    <pav:lastSavedOn>2014-09-02 11:46:58 -0400</pav:lastSavedOn>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:560D7055-0BE0-4AE4-9912-39985A237181">
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <ao:context rdf:resource="urn:domeoclient:uuid:AE73B237-E7E7-49DE-9295-FF17AED8776B"/>
    <rdfs:label>Highlight</rdfs:label>
    <pav:lineageUri>urn:domeoserver:annotation:93131511-B4E7-412F-AB5A-F8722D2FB55B</pav:lineageUri>
    <pav:lastSavedOn>2014-09-01 16:04:28 -0400</pav:lastSavedOn>
    <domeo:belongsToSet>urn:domeoclient:uuid:70BA73C3-70D0-43D1-9E54-82E0AE865E17</domeo:belongsToSet>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812eda990003</pav:createdBy>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:createdOn>2014-09-01 16:04:28 -0400</pav:createdOn>
    <pav:previousVersion>xsd:String</pav:previousVersion>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:AA6CCDE1-25E7-45C1-9526-49B0190E1EC2">
    <pav:createdOn>2014-07-24 19:53:59 -0400</pav:createdOn>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <ao:body rdf:nodeID="N9dfab65a054b47ff9816b750f5427617"/>
    <rdfs:label>expertstudy Annotation</rdfs:label>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812eda990003</pav:createdBy>
    <pav:lineageUri>urn:domeoserver:annotation:72BA026E-14B2-4E60-B7F7-DA440E8ED26F</pav:lineageUri>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#expertstudyAnnotation"/>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <pav:lastSavedOn>2014-07-24 19:53:55 -0400</pav:lastSavedOn>
    <domeo:belongsToSet>urn:domeoclient:uuid:E0863579-8D19-4B30-ADD6-2A5BDBC2F482</domeo:belongsToSet>
    <ao:context rdf:resource="urn:domeoclient:uuid:F8AA6DCD-35A7-4319-9C3D-CFA5C6AE10EE"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:AFC067D9-3DC4-4FB0-B028-1D222EE28907">
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <domeo:uuid>AFC067D9-3DC4-4FB0-B028-1D222EE28907</domeo:uuid>
    <ao:exact>ketoconazole</ao:exact>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-48.txt.html</ao:hasSource>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:AFC067D9-3DC4-4FB0-B028-1D222EE28907"/>
    <ao:suffix>, a potent inhibitor of CYP3A4 activity, to be at least 100 times more potent than paroxetine as an inhibitor of the metabolism of several substrates for this enzyme, including terfenadine, astemizole, cisapride, triazolam, and cyclosporine. Based on the</ao:suffix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:prefix> pharmacokinetics. In addition, in vitro studies have shown </ao:prefix>
    <pav:createdOn>2014-09-02 15:04:18 -0400</pav:createdOn>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:8E89967E-ADD7-495C-B4F3-72B05A30FE8E">
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:prefix>Fruit juices such as grapefruit, orange and apple may reduce the bioavailability and exposure of </ao:prefix>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-139.txt.html</ao:hasSource>
    <pav:createdOn>2014-07-24 20:12:29 -0400</pav:createdOn>
    <ao:exact>fexofenadine</ao:exact>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:8E89967E-ADD7-495C-B4F3-72B05A30FE8E"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <domeo:uuid>8E89967E-ADD7-495C-B4F3-72B05A30FE8E</domeo:uuid>
    <ao:suffix>. This is based on the results from three clinical studies using histamine induced skin wheals and flares coupled with population pharmacokinetic analysis. The size of wheal and flare were significantly larger when fexofenadine hydrochloride was administ</ao:suffix>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:4EA9F290-CB9E-46F8-AF87-B09760F74365">
    <ao:prefix>xsd:String</ao:prefix>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-123.txt.html</ao:hasSource>
    <ao:suffix>xsd:String</ao:suffix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <pav:createdOn>2014-07-22 20:19:49 -0400</pav:createdOn>
    <domeo:uuid>4EA9F290-CB9E-46F8-AF87-B09760F74365</domeo:uuid>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:exact>Concurrent administration of AVANDIA (2 mg twice daily) and metformin (500 mg twice daily) in healthy volunteers for 4 days had no effect on the steady-state pharmacokinetics of either metformin or rosiglitazone</ao:exact>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:4EA9F290-CB9E-46F8-AF87-B09760F74365"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:21C1BD16-9B1B-4BDA-B036-93523B41DFDF">
    <ao:annotatesResource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-130.txt.html</ao:annotatesResource>
    <domeo:agents rdf:resource="urn:person:uuid:080e143046812afe0146812eda990003"/>
    <pav:lineageUri>urn:domeoserver:annotationset:13565436-2280-4488-95B4-68368AB28E9D</pav:lineageUri>
    <permissions:permissions rdf:nodeID="N30366adaa4b14f37a5da84777e35441b"/>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <ao:item rdf:resource="urn:domeoclient:uuid:E9C5B173-AFE1-44E0-A146-6AEBE6A982AB"/>
    <domeo:deleted>false</domeo:deleted>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:createdOn>2014-07-24 19:46:59 -0400</pav:createdOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#AnnotationSet"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:D77CF944-3EF8-45F2-9976-BAD4E451F994"/>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <domeo:agents rdf:resource="urn:domeo:software:id:Domeo-2.1alpha-050"/>
    <pav:lastSavedOn>2014-07-24 19:46:59 -0400</pav:lastSavedOn>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812eda990003</pav:createdBy>
    <ao:item rdf:resource="urn:domeoclient:uuid:2254AD70-D7DF-48C1-827C-280B109CF542"/>
    <rdfs:label>Default Set</rdfs:label>
    <dct:description>The default set is created automatically by Domeo when no other set is existing.</dct:description>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:3B18CF78-48CD-4D32-B4F4-88F8072C8185">
    <pav:createdOn>2014-07-13 11:11:19 -0400</pav:createdOn>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:lineageUri>urn:domeoserver:annotation:A50036CB-D487-48AB-9CE3-45B6CA3540CD</pav:lineageUri>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812eda990003</pav:createdBy>
    <rdfs:label>Highlight</rdfs:label>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <ao:context rdf:resource="urn:domeoclient:uuid:E0ECD29D-DAB1-4D63-85F1-1839E3B04BF6"/>
    <domeo:belongsToSet>urn:domeoclient:uuid:71191E51-53CB-4FDE-88D0-33C6818E2232</domeo:belongsToSet>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:lastSavedOn>2014-07-13 11:32:29 -0400</pav:lastSavedOn>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:93764486-40C1-4D42-A6D0-D1FF47D6EC82">
    <ao:body rdf:nodeID="Nad91449b554f45d0b728c75c9225bce9"/>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <ao:context rdf:resource="urn:domeoclient:uuid:D37AF6F7-4BC0-4394-A3CE-386E408720C1"/>
    <pav:createdOn>2014-07-22 20:19:23 -0400</pav:createdOn>
    <pav:lineageUri>urn:domeoserver:annotation:7F53CC7E-F810-4069-8FD7-156741906E35</pav:lineageUri>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#expertstudyAnnotation"/>
    <rdfs:label>expertstudy Annotation</rdfs:label>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <pav:lastSavedOn>2014-07-22 20:22:38 -0400</pav:lastSavedOn>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812eda990003</pav:createdBy>
    <domeo:belongsToSet>urn:domeoserver:annotationset:F272A789-69D0-47CC-8CC9-F25C55B91261</domeo:belongsToSet>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:5A5707CC-D3AC-4807-9E98-6536CDC7AC55">
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812eda990003</pav:createdBy>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <domeo:belongsToSet>urn:domeoclient:uuid:23567EF7-7482-444A-B1F6-5AAA9D43E54A</domeo:belongsToSet>
    <pav:lastSavedOn>2014-07-13 12:45:54 -0400</pav:lastSavedOn>
    <pav:lineageUri>urn:domeoserver:annotation:645C5A96-70FA-4A0B-86EC-B070C4FE123F</pav:lineageUri>
    <ao:context rdf:resource="urn:domeoclient:uuid:0DDFAFFA-5DE6-4D3B-BC30-6421E6531AD8"/>
    <rdfs:label>Highlight</rdfs:label>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:createdOn>2014-07-13 12:41:59 -0400</pav:createdOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:previousVersion>xsd:String</pav:previousVersion>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:4A624918-A90F-4845-8DFE-C35AFD8B0B68">
    <domeo:belongsToSet>urn:domeoserver:annotationset:3F546823-204F-4F9B-9006-3DC526C56931</domeo:belongsToSet>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <rdfs:label>Highlight</rdfs:label>
    <ao:context rdf:resource="urn:domeoclient:uuid:A16A73F6-04A0-4350-B482-E365FE1CCB81"/>
    <domeo:belongsToSet>urn:domeoserver:annotationset:A3F0B39A-4249-4B63-BB0D-F24A005066AC</domeo:belongsToSet>
    <pav:lastSavedOn>2014-09-02 11:46:58 -0400</pav:lastSavedOn>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">2</pav:versionNumber>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:lineageUri>urn:domeoserver:annotationset:D1715BD2-BD41-46FD-9454-DC7A423A29AC</pav:lineageUri>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:previousVersion>urn:domeoclient:uuid:BED41F06-565A-4622-9A88-48810E5A28DE</pav:previousVersion>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:lineageUri>urn:domeoserver:annotation:71930ED3-9EDD-4DAD-A731-6638648F71C5</pav:lineageUri>
    <domeo:belongsToSet>urn:domeoserver:annotationset:A5DD001D-C81A-4E2E-B5E0-7A866B35E26B</domeo:belongsToSet>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812eda990003</pav:createdBy>
    <pav:createdOn>2014-09-02 11:43:38 -0400</pav:createdOn>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:F9EAA1C1-5B83-488C-8314-2E971233350A">
    <ao:exact>Co-administration of fosamprenavir/ritonavir with paroxetine significantly decreased plasma levels of paroxetine. Any dose adjustment should be guided by clinical effect (tolerability and efficacy). </ao:exact>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-51.txt.html</ao:hasSource>
    <domeo:uuid>F9EAA1C1-5B83-488C-8314-2E971233350A</domeo:uuid>
    <ao:prefix>xsd:String</ao:prefix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:suffix>xsd:String</ao:suffix>
    <pav:createdOn>2014-07-21 21:44:10 -0400</pav:createdOn>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:F9EAA1C1-5B83-488C-8314-2E971233350A"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:F80BB417-0183-4007-8F4C-0705AA0B529E">
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:suffix> 100 mg to 300 mg daily, carbamazepine reduced plasma concentrations of trazodone (as well as mCPP) by 76 and 60%, respectively, compared to pre-carbamazepine values.</ao:suffix>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-137.txt.html</ao:hasSource>
    <domeo:uuid>F80BB417-0183-4007-8F4C-0705AA0B529E</domeo:uuid>
    <ao:prefix> 400 mg/day with </ao:prefix>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:F80BB417-0183-4007-8F4C-0705AA0B529E"/>
    <ao:exact>trazodone</ao:exact>
    <pav:createdOn>2014-07-24 20:03:45 -0400</pav:createdOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:3E22917C-B2E2-46E9-8A17-EDAAF200AA66">
    <pav:createdOn>2014-09-02 12:03:11 -0400</pav:createdOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:exact>paroxetine</ao:exact>
    <domeo:uuid>3E22917C-B2E2-46E9-8A17-EDAAF200AA66</domeo:uuid>
    <ao:prefix>, a CYP2D6 substrate has also been evaluated. In 1 study, daily dosing of </ao:prefix>
    <ao:suffix> 20 mg in patients stabilized on risperidone (4 to 8 mg/day) increased mean plasma concentrations of risperidone approximately 4-fold, decreased 9-hydroxyrisperidone concentrations approximately 10%, and increased concentrations of the active moiety (the</ao:suffix>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-47.txt.html</ao:hasSource>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:3E22917C-B2E2-46E9-8A17-EDAAF200AA66"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:69C094F7-F9EC-4E26-B0BB-5E321AD43538">
    <ao:exact>sertraline </ao:exact>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:prefix>under steady-state conditions. The results of these studies indicated that </ao:prefix>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-16.txt.html</ao:hasSource>
    <pav:createdOn>2014-09-01 15:57:30 -0400</pav:createdOn>
    <domeo:uuid>69C094F7-F9EC-4E26-B0BB-5E321AD43538</domeo:uuid>
    <ao:suffix>did not increase plasma concentrations of terfenadine, carbamazepine, or cisapride. These data indicate that sertraline’s extent of inhibition of P450 3A4 activity is not likely to be of clinical significance. Results of the interaction study with cisapr</ao:suffix>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:69C094F7-F9EC-4E26-B0BB-5E321AD43538"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:3D0D19A7-AA2E-4F5C-86E6-0B171A00A7B1">
    <pav:lastSavedOn>2014-07-22 19:40:32 -0400</pav:lastSavedOn>
    <ao:context rdf:resource="urn:domeoclient:uuid:26FE0E4C-4C7A-4DDB-B49D-53B765A8B4E3"/>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <domeo:belongsToSet>urn:domeoserver:annotationset:2914A3FD-DF43-4F78-999C-77CE7A028B19</domeo:belongsToSet>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">5</pav:versionNumber>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <domeo:belongsToSet>urn:domeoserver:annotationset:514BA51B-D734-4003-A7C3-F03C0F95833A</domeo:belongsToSet>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <rdfs:label>Highlight</rdfs:label>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:lineageUri>urn:domeoserver:annotation:9E463B52-276E-4B05-8088-2962CC1444A2</pav:lineageUri>
    <pav:lastSavedOn>2014-07-22 19:40:31 -0400</pav:lastSavedOn>
    <domeo:belongsToSet>urn:domeoserver:annotationset:606A5B3F-B6FB-4279-AA42-7893CFC2D20C</domeo:belongsToSet>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812eda990003</pav:createdBy>
    <pav:createdOn>2014-07-22 19:35:50 -0400</pav:createdOn>
    <pav:previousVersion>urn:domeoserver:annotationset:7021B883-FD5C-4083-BD87-DF56D3C87633</pav:previousVersion>
    <pav:lineageUri>urn:domeoserver:annotationset:AB1741F1-5A5F-4416-AEAC-A544BCBB7D16</pav:lineageUri>
    <domeo:belongsToSet>urn:domeoserver:annotationset:F272A789-69D0-47CC-8CC9-F25C55B91261</domeo:belongsToSet>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:F7650976-DBE7-4CD9-8158-46355CF2F821">
    <pav:lastSavedOn>2014-07-21 21:35:10 -0400</pav:lastSavedOn>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:lineageUri>urn:domeoserver:annotation:F6DD78C2-91A0-422A-808B-1666B89DB3EF</pav:lineageUri>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812eda990003</pav:createdBy>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <domeo:belongsToSet>urn:domeoclient:uuid:B61F1A9B-4696-4ED0-80AA-4FE2E9016966</domeo:belongsToSet>
    <rdfs:label>Highlight</rdfs:label>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <ao:context rdf:resource="urn:domeoclient:uuid:FAA92561-4F1F-46DE-9C0F-2783EAC09CFA"/>
    <pav:createdOn>2014-07-21 21:34:27 -0400</pav:createdOn>
    <pav:previousVersion>xsd:String</pav:previousVersion>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:B94C34A7-F932-4189-9935-D5DEEC3449E4">
    <ao:prefix>The AUC of </ao:prefix>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-124.txt.html</ao:hasSource>
    <pav:createdOn>2014-07-24 19:36:31 -0400</pav:createdOn>
    <ao:suffix> is increased by more than 200% by co-administration of propranolol.</ao:suffix>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:B94C34A7-F932-4189-9935-D5DEEC3449E4"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <domeo:uuid>B94C34A7-F932-4189-9935-D5DEEC3449E4</domeo:uuid>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:exact>propafenone</ao:exact>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:340175F1-825F-4D60-A67E-F61F27C225F8">
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:lastSavedOn>2014-07-24 19:43:34 -0400</pav:lastSavedOn>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812eda990003</pav:createdBy>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <rdfs:label>Highlight</rdfs:label>
    <pav:createdOn>2014-07-24 19:42:48 -0400</pav:createdOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <ao:context rdf:resource="urn:domeoclient:uuid:015BF3DA-12CC-44A1-9B13-94A006D56307"/>
    <domeo:belongsToSet>urn:domeoclient:uuid:7DEB6848-E3C6-4761-8965-41F19EE5D781</domeo:belongsToSet>
    <pav:lineageUri>urn:domeoserver:annotation:ADF65F0E-08FD-4ECE-88A1-9CD46724D710</pav:lineageUri>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:BD65EDB0-5E4A-430E-B9C2-3D953A7DE94C">
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-123.txt.html</ao:hasSource>
    <ao:suffix> in females. Since therapy should be individualized, no dose adjustments are necessary based on gender alone.</ao:suffix>
    <domeo:uuid>BD65EDB0-5E4A-430E-B9C2-3D953A7DE94C</domeo:uuid>
    <ao:exact> AVANDIA</ao:exact>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <pav:createdOn>2014-07-22 19:34:31 -0400</pav:createdOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:prefix>ident. For a given body mass index (BMI), females tend to have a greater fat mass than males. Since the molecular target PPARγ is expressed in adipose tissues, this differentiating characteristic may account, at least in part, for the greater response to</ao:prefix>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:BD65EDB0-5E4A-430E-B9C2-3D953A7DE94C"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:E2AC08E4-8A5F-4E68-B2F1-20AFB690BAC7">
    <domeo:uuid>E2AC08E4-8A5F-4E68-B2F1-20AFB690BAC7</domeo:uuid>
    <ao:exact>Sildenafil </ao:exact>
    <pav:createdOn>2014-07-07 11:22:40 -0400</pav:createdOn>
    <domeo:uuid></domeo:uuid>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:prefix>clearance when it was co-administered with CYP3A inhibitors. </ao:prefix>
    <ao:suffix>exposure without concomitant medication is shown to be 5-fold higher at a dose of 80 mg TID compared to its exposure at a dose of 20 mg TID. This concentration range covers the same increased sildenafil exposure observed in specifically-designed drug int</ao:suffix>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-155.txt.html</ao:hasSource>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:E2AC08E4-8A5F-4E68-B2F1-20AFB690BAC7"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:42B2FE1C-E6AF-411B-A916-428E36F4B282">
    <ao:prefix> (50 mg) has been studied in 10 healthy subjects. The Cmax of </ao:prefix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:exact>trazodone </ao:exact>
    <pav:createdOn>2014-07-24 20:02:19 -0400</pav:createdOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <domeo:uuid>42B2FE1C-E6AF-411B-A916-428E36F4B282</domeo:uuid>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-136.txt.html</ao:hasSource>
    <ao:suffix> increased by 34%, the AUC increased 2.4 fold, the half-life increased by 2.2 fold, and the clearance decreased by 52%. Adverse effects including nausea, hypotension, and syncope were observed when ritonavir and trazodone were coadministered.</ao:suffix>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:42B2FE1C-E6AF-411B-A916-428E36F4B282"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:1B768EBB-3E7D-4144-B911-6362101E6343">
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812eda990003</pav:createdBy>
    <rdfs:label>Highlight</rdfs:label>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <pav:lineageUri>urn:domeoserver:annotation:7FAAF035-8612-4FF2-9CCE-2560955AB943</pav:lineageUri>
    <ao:context rdf:resource="urn:domeoclient:uuid:9BA34B2D-02C3-4A53-9C4E-833C005A5CBE"/>
    <domeo:belongsToSet>urn:domeoclient:uuid:A84DE8F6-26B7-471D-8309-4E7CC2994FDF</domeo:belongsToSet>
    <pav:lastSavedOn>2014-09-01 16:06:18 -0400</pav:lastSavedOn>
    <pav:createdOn>2014-09-01 16:06:01 -0400</pav:createdOn>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:34472B29-EA4E-45E5-84B2-2EEE556610B6">
    <domeo:belongsToSet>urn:domeoclient:uuid:71191E51-53CB-4FDE-88D0-33C6818E2232</domeo:belongsToSet>
    <rdfs:label>expertstudy Annotation</rdfs:label>
    <ao:context rdf:resource="urn:domeoclient:uuid:B294F73B-169E-4106-90EF-3C87099953E8"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#expertstudyAnnotation"/>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <ao:body rdf:nodeID="N17e8be221f47482c9201f544556a44e1"/>
    <pav:createdOn>2014-07-13 11:29:18 -0400</pav:createdOn>
    <pav:lastSavedOn>2014-07-13 11:32:29 -0400</pav:lastSavedOn>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <pav:lineageUri>urn:domeoserver:annotation:29BBE1A3-B55A-462F-A387-1BC5EE901EF7</pav:lineageUri>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812eda990003</pav:createdBy>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:8C5CCA78-2E90-4B2A-961F-DADE6196F08B">
    <ao:suffix> and oral contraceptives (ethinyl estradiol and norethindrone), which are predominantly metabolized by CYP3A4.</ao:suffix>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-123.txt.html</ao:hasSource>
    <ao:prefix> (4 mg twice daily) was shown to have no clinically relevant effect on the pharmacokinetics of </ao:prefix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:exact>nifedipine</ao:exact>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:8C5CCA78-2E90-4B2A-961F-DADE6196F08B"/>
    <domeo:uuid>8C5CCA78-2E90-4B2A-961F-DADE6196F08B</domeo:uuid>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <pav:createdOn>2014-07-22 19:39:54 -0400</pav:createdOn>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:2BB40EDC-DE0E-4B5E-AEE3-DCE89148115F">
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812eda990003</pav:createdBy>
    <ao:context rdf:resource="urn:domeoclient:uuid:06403BE6-A661-445F-882B-070BE1039BE5"/>
    <domeo:belongsToSet>urn:domeoserver:annotationset:606A5B3F-B6FB-4279-AA42-7893CFC2D20C</domeo:belongsToSet>
    <pav:lineageUri>urn:domeoserver:annotationset:AB1741F1-5A5F-4416-AEAC-A544BCBB7D16</pav:lineageUri>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:previousVersion>urn:domeoserver:annotationset:7021B883-FD5C-4083-BD87-DF56D3C87633</pav:previousVersion>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:lastSavedOn>2014-07-22 19:40:32 -0400</pav:lastSavedOn>
    <domeo:belongsToSet>urn:domeoserver:annotationset:514BA51B-D734-4003-A7C3-F03C0F95833A</domeo:belongsToSet>
    <domeo:belongsToSet>urn:domeoserver:annotationset:2914A3FD-DF43-4F78-999C-77CE7A028B19</domeo:belongsToSet>
    <pav:lineageUri>urn:domeoserver:annotation:4E752687-BD84-49D8-B560-F4B93D173C94</pav:lineageUri>
    <pav:createdOn>2014-07-22 19:37:25 -0400</pav:createdOn>
    <pav:lastSavedOn>2014-07-22 19:40:31 -0400</pav:lastSavedOn>
    <domeo:belongsToSet>urn:domeoserver:annotationset:F272A789-69D0-47CC-8CC9-F25C55B91261</domeo:belongsToSet>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">5</pav:versionNumber>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <rdfs:label>Highlight</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:015BF3DA-12CC-44A1-9B13-94A006D56307">
    <ao:exact>verapamil</ao:exact>
    <ao:prefix> does not affect the pharmacokinetics of </ao:prefix>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-127.txt.html</ao:hasSource>
    <ao:suffix> and norverapamil. Verapamil does not affect the pharmacokinetics of propranolol.</ao:suffix>
    <domeo:uuid>015BF3DA-12CC-44A1-9B13-94A006D56307</domeo:uuid>
    <pav:createdOn>2014-07-24 19:42:48 -0400</pav:createdOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:015BF3DA-12CC-44A1-9B13-94A006D56307"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:093D643B-E7AF-49BD-BBEA-F13CDCDAD6C4">
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <pav:lastSavedOn>2014-09-02 11:54:50 -0400</pav:lastSavedOn>
    <pav:createdOn>2014-09-02 11:53:56 -0400</pav:createdOn>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#expertstudyAnnotation"/>
    <rdfs:label>expertstudy Annotation</rdfs:label>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <domeo:belongsToSet>urn:domeoserver:annotationset:A3F0B39A-4249-4B63-BB0D-F24A005066AC</domeo:belongsToSet>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812eda990003</pav:createdBy>
    <ao:body rdf:nodeID="Na6953118e0ca4281ba05fe0bdd5d5505"/>
    <ao:context rdf:resource="urn:domeoclient:uuid:ACE53139-5B8B-4FB2-8940-338C5989D498"/>
    <pav:lineageUri>urn:domeoserver:annotation:41A41E41-EEC5-49D6-81A5-A1C7FAE7676D</pav:lineageUri>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/D3472C63-0DF1-445A-8D55-A0C2CFC47A4D">
    <sio:SIO_000228>dikbD2R:precipitant-drug-of-interaction</sio:SIO_000228>
    <rdfs:label>glimepiride</rdfs:label>
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/25789</dailymed:activeMoietyRxCUI>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/active-ingredient"/>
    <dct:description>Referred to the drug in the interaction.</dct:description>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:4F81F868-415D-4A79-8A62-6366850D49AA">
    <domeo:uuid>4F81F868-415D-4A79-8A62-6366850D49AA</domeo:uuid>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:4F81F868-415D-4A79-8A62-6366850D49AA"/>
    <ao:exact>digoxin</ao:exact>
    <ao:suffix> (0.375 mg once daily) in healthy volunteers.</ao:suffix>
    <ao:prefix>(8 mg once daily) for 14 days did not alter the steady-state pharmacokinetics of </ao:prefix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <pav:createdOn>2014-07-22 20:20:26 -0400</pav:createdOn>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-123.txt.html</ao:hasSource>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:0D83441D-0916-4D83-A136-CA26588E67D0">
    <pav:createdOn>2014-07-13 11:13:49 -0400</pav:createdOn>
    <ao:exact>9-hydroxyrisperidone</ao:exact>
    <ao:prefix> and </ao:prefix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <domeo:uuid>0D83441D-0916-4D83-A136-CA26588E67D0</domeo:uuid>
    <ao:suffix> combined, after single and multiple doses, are similar in extensive and poor metabolizers.</ao:suffix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:0D83441D-0916-4D83-A136-CA26588E67D0"/>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-8.txt.html</ao:hasSource>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:1554FCFD-7477-413C-879A-913DFFAB5886">
    <ao:suffix>(100 mg single dose) resulted in a 140% increase in sildenafil Cmax and a 210% increase in sildenafil AUC.</ao:suffix>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-155.txt.html</ao:hasSource>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <pav:createdOn>2014-07-07 11:24:07 -0400</pav:createdOn>
    <ao:exact>sildenafil </ao:exact>
    <ao:prefix>, a CYP3A inhibitor, at steady state (1200 mg TID) with </ao:prefix>
    <domeo:uuid>1554FCFD-7477-413C-879A-913DFFAB5886</domeo:uuid>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:1554FCFD-7477-413C-879A-913DFFAB5886"/>
    <domeo:uuid></domeo:uuid>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
  </rdf:Description>
  <rdf:Description rdf:nodeID="N7ab8fdf910c849bea39ab007703bb988">
    <domeo:sets rdf:resource="urn:pddi:uuid:9B027AFC-3BAE-4FDC-889F-813F2AD35C5A"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:D4CA3DCD-82EA-464C-8F9A-1D04DCECE7B6">
    <pav:lineageUri>urn:domeoserver:annotation:A0D327EE-79D7-4122-8DE1-EE7996A255EE</pav:lineageUri>
    <pav:createdOn>2014-09-02 11:45:59 -0400</pav:createdOn>
    <domeo:belongsToSet>urn:domeoserver:annotationset:A5DD001D-C81A-4E2E-B5E0-7A866B35E26B</domeo:belongsToSet>
    <rdfs:label>Highlight</rdfs:label>
    <pav:previousVersion>urn:domeoclient:uuid:BED41F06-565A-4622-9A88-48810E5A28DE</pav:previousVersion>
    <pav:lastSavedOn>2014-09-02 11:46:58 -0400</pav:lastSavedOn>
    <pav:lineageUri>urn:domeoserver:annotationset:D1715BD2-BD41-46FD-9454-DC7A423A29AC</pav:lineageUri>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">2</pav:versionNumber>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <domeo:belongsToSet>urn:domeoserver:annotationset:3F546823-204F-4F9B-9006-3DC526C56931</domeo:belongsToSet>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812eda990003</pav:createdBy>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:lastSavedOn>2014-09-02 11:46:59 -0400</pav:lastSavedOn>
    <ao:context rdf:resource="urn:domeoclient:uuid:3B8303DC-666E-48AC-A169-56BEAEB6610A"/>
    <domeo:belongsToSet>urn:domeoserver:annotationset:A3F0B39A-4249-4B63-BB0D-F24A005066AC</domeo:belongsToSet>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:D37AF6F7-4BC0-4394-A3CE-386E408720C1">
    <ao:prefix>xsd:String</ao:prefix>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-123.txt.html</ao:hasSource>
    <domeo:uuid>D37AF6F7-4BC0-4394-A3CE-386E408720C1</domeo:uuid>
    <ao:suffix>xsd:String</ao:suffix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:exact>Concurrent administration of AVANDIA (2 mg twice daily) and metformin (500 mg twice daily) in healthy volunteers for 4 days had no effect on the steady-state pharmacokinetics of either metformin or rosiglitazone.</ao:exact>
    <pav:createdOn>2014-07-22 20:19:23 -0400</pav:createdOn>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:D37AF6F7-4BC0-4394-A3CE-386E408720C1"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:257F4F5D-CCED-4AAD-9504-4A9F1A855C69">
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:exact>Sumatriptan </ao:exact>
    <ao:prefix>xsd:String</ao:prefix>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:257F4F5D-CCED-4AAD-9504-4A9F1A855C69"/>
    <domeo:uuid>257F4F5D-CCED-4AAD-9504-4A9F1A855C69</domeo:uuid>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-9.txt.html</ao:hasSource>
    <pav:createdOn>2014-09-02 11:43:36 -0400</pav:createdOn>
    <ao:suffix>- There have been rare postmarketing reports describing patients with weakness, hyperreflexia, and incoordination following the use of a selective serotonin reuptake inhibitor (SSRI) and sumatriptan. If concomitant treatment with sumatriptan and an SSRI </ao:suffix>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:A9ACBE0B-1A8C-4271-B63C-7BF4E5B90412">
    <sio:SIO_000205>dikbD2R:statement</sio:SIO_000205>
    <dikbD2R:statement>ncit:Qualitative</dikbD2R:statement>
    <dikbD2R:modality>ncit:negative</dikbD2R:modality>
    <sio:SIO_000563>dikbD2R:modality</sio:SIO_000563>
    <sio:SIO_000628 rdf:resource="urn:pddi:uuid:01299A21-B948-4043-9C23-75E77F3F6D2F"/>
    <rdf:type rdf:resource="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#DrugDrugInteractionStatement"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:56885854-DBBA-451C-B531-1D54B8C98A0B">
    <pav:createdOn>2014-07-24 19:38:56 -0400</pav:createdOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#expertstudyAnnotation"/>
    <pav:lineageUri>urn:domeoserver:annotation:9427347D-3858-453E-8DD2-0BA570A34C9D</pav:lineageUri>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <domeo:belongsToSet>urn:domeoclient:uuid:DBA2FBEC-FB21-4B1E-AFD1-05AF52CBAB09</domeo:belongsToSet>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812eda990003</pav:createdBy>
    <ao:body rdf:nodeID="N2563999c13964c0fb1619be3dbd91060"/>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <ao:context rdf:resource="urn:domeoclient:uuid:67E0B291-7BEC-4E9A-AE3A-91E5111086CD"/>
    <rdfs:label>expertstudy Annotation</rdfs:label>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:lastSavedOn>2014-07-24 19:38:41 -0400</pav:lastSavedOn>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/8FE58707-AFDD-4F32-9EA8-03EC3BF4D67B">
    <rdfs:label>sildenafil</rdfs:label>
    <dct:description>Referred to the drug in the interaction.</dct:description>
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/136411</dailymed:activeMoietyRxCUI>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/active-ingredient"/>
    <sio:SIO_000228>dikbD2R:object-drug-of-interaction</sio:SIO_000228>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:9FA29E53-6B1B-4856-B5BD-22A93164E58E">
    <ao:item rdf:resource="urn:domeoclient:uuid:856332C7-36D0-4788-B89D-FC8E3A9C55D9"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#AnnotationSet"/>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <domeo:agents rdf:resource="urn:domeo:software:id:Domeo-2.1alpha-050"/>
    <pav:lastSavedOn>2014-07-22 18:37:42 -0400</pav:lastSavedOn>
    <dct:description>The default set is created automatically by Domeo when no other set is existing.</dct:description>
    <ao:item rdf:resource="urn:domeoclient:uuid:38CE57C6-582D-4AE5-90CF-F2966A431DF6"/>
    <rdfs:label>Default Set</rdfs:label>
    <ao:annotatesResource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-58.txt.html</ao:annotatesResource>
    <domeo:agents rdf:resource="urn:person:uuid:080e143046812afe0146812eda990003"/>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <permissions:permissions rdf:nodeID="N34c366e42e94442f8030d63cbbf4316c"/>
    <pav:lineageUri>urn:domeoserver:annotationset:B3318C2E-550E-4881-B82E-0796C34E1F98</pav:lineageUri>
    <domeo:deleted>false</domeo:deleted>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <ao:item rdf:resource="urn:domeoclient:uuid:D599C322-4D76-48B0-9A8D-27A82819F5D2"/>
    <pav:createdOn>2014-07-22 18:37:22 -0400</pav:createdOn>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812eda990003</pav:createdBy>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:55A5D871-82BA-4D87-A1EA-62DCA1BF358F">
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-123.txt.html</ao:hasSource>
    <pav:createdOn>2014-07-22 19:28:13 -0400</pav:createdOn>
    <ao:prefix>In vitro data demonstrate that</ao:prefix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:exact> rosiglitazone</ao:exact>
    <ao:suffix> is predominantly metabolized by Cytochrome P450 (CYP) isoenzyme 2C8, with CYP2C9 contributing as a minor pathway.</ao:suffix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <domeo:uuid>55A5D871-82BA-4D87-A1EA-62DCA1BF358F</domeo:uuid>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:55A5D871-82BA-4D87-A1EA-62DCA1BF358F"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:FC76D7A1-BCF3-4AF0-92CC-E5D2F09F6BD7">
    <dikbD2R:modality>ncit:positive</dikbD2R:modality>
    <dikbD2R:statement>ncit:quantitative</dikbD2R:statement>
    <rdf:type rdf:resource="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#DrugDrugInteractionStatement"/>
    <sio:SIO_000205>dikbD2R:statement</sio:SIO_000205>
    <sio:SIO_000563>dikbD2R:modality</sio:SIO_000563>
    <sio:SIO_000628 rdf:resource="urn:pddi:uuid:7FE9AC63-C53E-4EF9-AEF0-CC1F82EDA7C3"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:2AE98FC9-CA39-4A5E-9A97-02182489F1DE">
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:lineageUri>urn:domeoserver:annotation:C674FD8E-5A17-4043-9DFE-245B0F493B69</pav:lineageUri>
    <domeo:belongsToSet>urn:domeoserver:annotationset:F272A789-69D0-47CC-8CC9-F25C55B91261</domeo:belongsToSet>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <ao:context rdf:resource="urn:domeoclient:uuid:2B1C7E3B-0E62-4AAE-9A68-874D098352C2"/>
    <pav:createdOn>2014-07-22 20:18:32 -0400</pav:createdOn>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812eda990003</pav:createdBy>
    <rdfs:label>Highlight</rdfs:label>
    <pav:lastSavedOn>2014-07-22 20:22:38 -0400</pav:lastSavedOn>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:C3BD9C2A-EDB9-42C4-8D62-372034300BF1">
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:createdOn>2014-09-01 16:12:27 -0400</pav:createdOn>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:lineageUri>urn:domeoserver:annotation:A7B6F069-112F-4FDC-9A7B-D22FEB0AF9DB</pav:lineageUri>
    <domeo:belongsToSet>urn:domeoclient:uuid:5D381360-05CD-407C-BAB9-6496A42C73E4</domeo:belongsToSet>
    <ao:context rdf:resource="urn:domeoclient:uuid:E3B6522F-F16C-4872-B4B8-C142D6BC0D2D"/>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <pav:lastSavedOn>2014-09-01 16:12:36 -0400</pav:lastSavedOn>
    <rdfs:label>Highlight</rdfs:label>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812eda990003</pav:createdBy>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:BD1FBEAA-B2D7-405D-8489-BDC578CFEAEB">
    <domeo:uuid>BD1FBEAA-B2D7-405D-8489-BDC578CFEAEB</domeo:uuid>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:prefix> hydroxide should be avoided because it may result in a reduction in Cmax and AUC of 26% and 20%, respectively and consequently in a 25% reduction in the bradycardic effect at rest.</ao:prefix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-70.txt.html</ao:hasSource>
    <ao:exact> Administration of the antacid two hours after sotalol has no effect on the pharmacokinetics or pharmacodynamics of sotalol.</ao:exact>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:BD1FBEAA-B2D7-405D-8489-BDC578CFEAEB"/>
    <pav:createdOn>2014-09-02 15:06:20 -0400</pav:createdOn>
    <ao:suffix>xsd:String</ao:suffix>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:17DEFB36-51D5-4E3A-92CC-91E1F7EEAE4B">
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812eda990003</pav:createdBy>
    <pav:lastSavedOn>2014-07-22 19:54:59 -0400</pav:lastSavedOn>
    <domeo:belongsToSet>urn:domeoserver:annotationset:F272A789-69D0-47CC-8CC9-F25C55B91261</domeo:belongsToSet>
    <pav:lineageUri>urn:domeoserver:annotationset:AB1741F1-5A5F-4416-AEAC-A544BCBB7D16</pav:lineageUri>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:createdOn>2014-07-22 19:51:04 -0400</pav:createdOn>
    <pav:previousVersion>urn:domeoserver:annotationset:606A5B3F-B6FB-4279-AA42-7893CFC2D20C</pav:previousVersion>
    <pav:lineageUri>urn:domeoserver:annotation:A2C407EF-D89B-49CC-91EB-9812D7EFB284</pav:lineageUri>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">7</pav:versionNumber>
    <ao:context rdf:resource="urn:domeoclient:uuid:77415BA5-F65C-46BF-B1E8-F58D8F285BE2"/>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <rdfs:label>Highlight</rdfs:label>
    <domeo:belongsToSet>urn:domeoserver:annotationset:2914A3FD-DF43-4F78-999C-77CE7A028B19</domeo:belongsToSet>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoserver:annotationset:40007BD9-0869-48CF-A8F2-BAD26AE3E6E1">
    <ao:item rdf:resource="urn:domeoclient:uuid:FC139E5E-6513-4B13-9FE1-980FD4117A68"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:01600057-F016-4A5A-AC67-3F30E5F3B4EA"/>
    <pav:previousVersion>urn:domeoclient:uuid:5B3EE83F-83C7-4BA8-A892-C032BE699CFA</pav:previousVersion>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812eda990003</pav:createdBy>
    <pav:lineageUri>urn:domeoserver:annotationset:092451F5-B0C0-430C-8896-07F81D33F9E1</pav:lineageUri>
    <permissions:permissions rdf:nodeID="Nbb3db564e49d48f7bcb16ef6c123e457"/>
    <ao:annotatesResource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-27.txt.html</ao:annotatesResource>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#AnnotationSet"/>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">2</pav:versionNumber>
    <rdfs:label>Default Set</rdfs:label>
    <domeo:deleted>false</domeo:deleted>
    <ao:item rdf:resource="urn:domeoclient:uuid:631B556D-C865-4327-8C15-D735A7315C3D"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:E2932281-71AF-4D8C-BFA1-44627891CD3C"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:C36C5E7A-30AD-4497-9348-913F96DD443E"/>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <domeo:agents rdf:resource="urn:domeo:software:id:Domeo-2.1alpha-050"/>
    <dct:description>The default set is created automatically by Domeo when no other set is existing.</dct:description>
    <ao:item rdf:resource="urn:domeoclient:uuid:8C403ABF-BCD6-4923-946F-4AF2BAAB0800"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:6CB1CEB5-788B-4E3B-9578-C8DF02D212D9"/>
    <pav:createdOn>2014-07-21 21:31:06 -0400</pav:createdOn>
    <pav:lastSavedOn>2014-07-21 21:32:45 -0400</pav:lastSavedOn>
    <domeo:agents rdf:resource="urn:person:uuid:080e143046812afe0146812eda990003"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:1956FA88-0DCF-4091-9E82-114782E551B6">
    <pav:createdOn>2014-07-21 21:26:46 -0400</pav:createdOn>
    <domeo:belongsToSet>urn:domeoclient:uuid:B6F745E6-5734-4636-A383-683BA4C79E38</domeo:belongsToSet>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812eda990003</pav:createdBy>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:lastSavedOn>2014-07-21 21:27:51 -0400</pav:lastSavedOn>
    <rdfs:label>Highlight</rdfs:label>
    <pav:lineageUri>urn:domeoserver:annotation:01711B7F-9102-4563-BBBC-CEC29491356C</pav:lineageUri>
    <ao:context rdf:resource="urn:domeoclient:uuid:819F1E61-50CC-41FC-9596-57CE5DC96A2C"/>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:BFE514C1-B428-49F6-A34E-88C9F7618ABF">
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:lastSavedOn>2014-07-22 20:22:38 -0400</pav:lastSavedOn>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812eda990003</pav:createdBy>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <rdfs:label>Highlight</rdfs:label>
    <ao:context rdf:resource="urn:domeoclient:uuid:C75F6EFB-5E72-4CF2-9017-B3F8CA0EDE1F"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:createdOn>2014-07-22 20:17:52 -0400</pav:createdOn>
    <pav:lineageUri>urn:domeoserver:annotation:12B56AAA-52C8-4D08-9F11-45BACEB9E7C2</pav:lineageUri>
    <domeo:belongsToSet>urn:domeoserver:annotationset:F272A789-69D0-47CC-8CC9-F25C55B91261</domeo:belongsToSet>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:2254AD70-D7DF-48C1-827C-280B109CF542">
    <pav:lineageUri>urn:domeoserver:annotation:C9F9D68A-23F7-4F74-B839-0E2A5A0613D8</pav:lineageUri>
    <domeo:belongsToSet>urn:domeoclient:uuid:21C1BD16-9B1B-4BDA-B036-93523B41DFDF</domeo:belongsToSet>
    <ao:context rdf:resource="urn:domeoclient:uuid:271B21A2-D2A2-4C95-8E2C-A3C373B06A45"/>
    <pav:lastSavedOn>2014-07-24 19:46:59 -0400</pav:lastSavedOn>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812eda990003</pav:createdBy>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <rdfs:label>Highlight</rdfs:label>
    <pav:createdOn>2014-07-24 19:46:59 -0400</pav:createdOn>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:01D05C1E-36FA-4699-B134-4F8E31F1B1CA">
    <pav:createdOn>2014-09-01 16:05:52 -0400</pav:createdOn>
    <rdfs:label>Highlight</rdfs:label>
    <ao:context rdf:resource="urn:domeoclient:uuid:93C83EDE-36D5-4436-B242-D2D391BA499C"/>
    <pav:lineageUri>urn:domeoserver:annotation:11C5CA3C-71F0-4F5E-9925-04242D1BFA4A</pav:lineageUri>
    <domeo:belongsToSet>urn:domeoclient:uuid:A84DE8F6-26B7-471D-8309-4E7CC2994FDF</domeo:belongsToSet>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812eda990003</pav:createdBy>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:lastSavedOn>2014-09-01 16:06:18 -0400</pav:lastSavedOn>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:64792593-BEAB-4B65-88FB-A2254663F469">
    <pav:lastSavedOn>2014-07-13 11:32:29 -0400</pav:lastSavedOn>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <rdfs:label>Highlight</rdfs:label>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <domeo:belongsToSet>urn:domeoclient:uuid:71191E51-53CB-4FDE-88D0-33C6818E2232</domeo:belongsToSet>
    <pav:lineageUri>urn:domeoserver:annotation:C65DDEB0-B97A-4B57-9CA0-73F44448001C</pav:lineageUri>
    <pav:createdOn>2014-07-13 11:12:29 -0400</pav:createdOn>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812eda990003</pav:createdBy>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <ao:context rdf:resource="urn:domeoclient:uuid:DFB0D433-995A-4EB5-B9CC-EAE5A0C16DEA"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:35685454-E730-4B12-A923-46EE9655234C">
    <domeo:belongsToSet>urn:domeoclient:uuid:E89548FF-A4A2-4B87-B1E1-B12E3E255FA1</domeo:belongsToSet>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:lastSavedOn>2014-07-13 12:56:57 -0400</pav:lastSavedOn>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812eda990003</pav:createdBy>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:createdOn>2014-07-13 12:56:13 -0400</pav:createdOn>
    <ao:context rdf:resource="urn:domeoclient:uuid:AB3EAD78-45A5-439B-B26A-FE0BB9EDCBD0"/>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <pav:lineageUri>urn:domeoserver:annotation:2703BC23-B5BF-482E-A701-F416ADF738D1</pav:lineageUri>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <rdfs:label>Highlight</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:09E68084-B057-4315-B5D2-BAB13980BCAE">
    <ao:suffix> metabolism have not been studied.</ao:suffix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:exact>fluvoxamine</ao:exact>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:prefix> has not been fully characterized and the effects of potent cytochrome P450 isoenzyme inhibition, such as the ketoconazole inhibition of CYP3A4, on </ao:prefix>
    <pav:createdOn>2014-09-02 11:35:42 -0400</pav:createdOn>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-9.txt.html</ao:hasSource>
    <domeo:uuid>09E68084-B057-4315-B5D2-BAB13980BCAE</domeo:uuid>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:09E68084-B057-4315-B5D2-BAB13980BCAE"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:4BDD5E48-B9CE-48CF-BD41-105B25B3F7D2">
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812eda990003</pav:createdBy>
    <pav:lineageUri>urn:domeoserver:annotation:2D709EC1-24A5-4D2C-9DB0-06873CF173A6</pav:lineageUri>
    <ao:context rdf:resource="urn:domeoclient:uuid:1827DDD2-0D88-43CF-B4E7-833420181887"/>
    <domeo:belongsToSet>urn:domeoclient:uuid:C9195181-C772-4ED4-ADD8-56970C72AD38</domeo:belongsToSet>
    <pav:lastSavedOn>2014-09-02 19:40:44 -0400</pav:lastSavedOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <rdfs:label>Highlight</rdfs:label>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:createdOn>2014-09-02 19:40:45 -0400</pav:createdOn>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:CE972F8D-C1AD-46A9-B34B-1D883FDAF1EC">
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-155.txt.html</ao:hasSource>
    <domeo:uuid></domeo:uuid>
    <ao:prefix>xsd:String</ao:prefix>
    <domeo:uuid>CE972F8D-C1AD-46A9-B34B-1D883FDAF1EC</domeo:uuid>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:CE972F8D-C1AD-46A9-B34B-1D883FDAF1EC"/>
    <pav:createdOn>2014-07-07 09:40:14 -0400</pav:createdOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:exact>sildenafil </ao:exact>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:suffix>to patients with systemic hypertension, the mean change from baseline in systolic and diastolic blood pressures was a decrease of 9.4 mmHg and 9.1 mmHg, respectively.</ao:suffix>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:8621DC71-D1C0-4E5B-97BA-B7275B47A413">
    <rdfs:label>Highlight</rdfs:label>
    <domeo:belongsToSet>urn:domeoserver:annotationset:E32812A9-205B-4EE1-B488-A1E294EDBFB9</domeo:belongsToSet>
    <domeo:belongsToSet>urn:domeoserver:annotationset:392EE0FB-AC4F-4AF2-87A6-2E50A281F434</domeo:belongsToSet>
    <pav:lineageUri>urn:domeoserver:annotation:8641B576-F2B1-42EF-850A-B4554F18DD13</pav:lineageUri>
    <pav:lastSavedOn>2014-09-02 19:19:47 -0400</pav:lastSavedOn>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:lineageUri>urn:domeoserver:annotationset:C5DEBC9B-77EE-4243-88EB-DBC19737ACD2</pav:lineageUri>
    <pav:createdOn>2014-09-02 19:18:51 -0400</pav:createdOn>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <domeo:belongsToSet>urn:domeoclient:uuid:CB83FFC2-EA71-44EA-8F11-DE80E389C84E</domeo:belongsToSet>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812eda990003</pav:createdBy>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <ao:context rdf:resource="urn:domeoclient:uuid:2025A1F1-3A58-4E3E-A4B7-739A783D52BB"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:5B787EC6-4A3E-44EC-8288-875426F19CB3">
    <ao:exact>propranolol</ao:exact>
    <ao:prefix> </ao:prefix>
    <pav:createdOn>2014-07-24 19:37:23 -0400</pav:createdOn>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:5B787EC6-4A3E-44EC-8288-875426F19CB3"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:suffix>xsd:String</ao:suffix>
    <domeo:uuid>5B787EC6-4A3E-44EC-8288-875426F19CB3</domeo:uuid>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-124.txt.html</ao:hasSource>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:38A0F3BF-9F6A-4A3D-89AB-BD75B2AC4CE8">
    <ao:prefix>There are no clinically relevant differences in the pharmacokinetics of </ao:prefix>
    <ao:exact>rosiglitazone</ao:exact>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <domeo:uuid>38A0F3BF-9F6A-4A3D-89AB-BD75B2AC4CE8</domeo:uuid>
    <pav:createdOn>2014-07-22 19:36:20 -0400</pav:createdOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-123.txt.html</ao:hasSource>
    <ao:suffix> in patients with mild to severe renal impairment or in hemodialysis-dependent patients compared to subjects with normal renal function. No dosage adjustment is therefore required in such patients receiving AVANDIA. Since metformin is contraindicated in </ao:suffix>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:38A0F3BF-9F6A-4A3D-89AB-BD75B2AC4CE8"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:3D9DD245-350D-4E6C-84D1-AA5D144E689A">
    <rdfs:label>Highlight</rdfs:label>
    <ao:context rdf:resource="urn:domeoclient:uuid:D3699069-7DAD-4616-9500-2A16ADBA4010"/>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:lastSavedOn>2014-07-22 18:59:41 -0400</pav:lastSavedOn>
    <domeo:belongsToSet>urn:domeoclient:uuid:F2788742-3226-4BFB-9D85-2FC7211066F7</domeo:belongsToSet>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:createdOn>2014-07-22 18:58:36 -0400</pav:createdOn>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812eda990003</pav:createdBy>
    <pav:lineageUri>urn:domeoserver:annotation:748E0C00-F076-4688-9F44-CC6A5D99FDF4</pav:lineageUri>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:AD975124-2202-48D6-98F2-6042E8AC8DF1">
    <ao:prefix>xsd:String</ao:prefix>
    <domeo:uuid>AD975124-2202-48D6-98F2-6042E8AC8DF1</domeo:uuid>
    <ao:suffix> may enhance the neuromuscular blocking action of skeletal muscle relaxants and produce an increased degree of respiratory depression.</ao:suffix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <pav:createdOn>2014-09-02 19:08:23 -0400</pav:createdOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:exact>Oxycodone hydrochloride</ao:exact>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:AD975124-2202-48D6-98F2-6042E8AC8DF1"/>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-72.txt.html</ao:hasSource>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:BDA75ADA-742A-402B-AE97-4438F99C61FC">
    <rdfs:label>Highlight</rdfs:label>
    <domeo:belongsToSet>urn:domeoserver:annotationset:7AACEF8D-2EBC-4F0B-94B2-190650E562F6</domeo:belongsToSet>
    <domeo:belongsToSet>urn:domeoserver:annotationset:08C0C288-6DF4-43E6-A618-71A8BB9563C3</domeo:belongsToSet>
    <ao:context rdf:resource="urn:domeoclient:uuid:3EBDA2ED-165F-4B57-B4BE-CFA63CD5C5A6"/>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:lineageUri>urn:domeoserver:annotation:3A5ED499-A47F-47B9-8A20-DE5C5355E048</pav:lineageUri>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:createdOn>2014-07-07 09:36:02 -0400</pav:createdOn>
    <domeo:belongsToSet>urn:domeoclient:uuid:FCA2BF23-0BE3-409F-9177-761812F96097</domeo:belongsToSet>
    <pav:lastSavedOn>2014-07-07 09:44:19 -0400</pav:lastSavedOn>
    <domeo:belongsToSet>urn:domeoserver:annotationset:22ED7220-C6F6-43C5-9DF9-89F62F0F8E27</domeo:belongsToSet>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <domeo:belongsToSet>urn:domeoserver:annotationset:8F3CF3D9-AADE-4A86-BD42-2924B3D6A406</domeo:belongsToSet>
    <domeo:belongsToSet>urn:domeoserver:annotationset:131835A3-C655-4F91-97D4-52CAFF7B7CCA</domeo:belongsToSet>
    <pav:lineageUri>urn:domeoserver:annotationset:76FD4BB5-DE2F-4FCA-B93D-302185B1A381</pav:lineageUri>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812eda990003</pav:createdBy>
    <pav:lastSavedOn>2014-07-07 09:44:18 -0400</pav:lastSavedOn>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:183649A8-AEE3-4F6E-9CCA-10E240E419C8">
    <domeo:belongsToSet>urn:domeoserver:annotationset:1FC172B8-8AC3-465A-AA69-B73AD9B97CBC</domeo:belongsToSet>
    <pav:lineageUri>urn:domeoserver:annotation:AAEABA6B-99EF-4FDC-8CA7-2C7B1FCF3FF0</pav:lineageUri>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <ao:context rdf:resource="urn:domeoclient:uuid:8E89967E-ADD7-495C-B4F3-72B05A30FE8E"/>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812eda990003</pav:createdBy>
    <rdfs:label>Highlight</rdfs:label>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:createdOn>2014-07-24 20:12:29 -0400</pav:createdOn>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <pav:lastSavedOn>2014-07-24 20:12:49 -0400</pav:lastSavedOn>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:90498C00-BE72-46BA-94D5-04F8265DDA63">
    <domeo:uuid>90498C00-BE72-46BA-94D5-04F8265DDA63</domeo:uuid>
    <pav:createdOn>2014-07-22 19:22:27 -0400</pav:createdOn>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:90498C00-BE72-46BA-94D5-04F8265DDA63"/>
    <ao:suffix> in combination with other hypoglycemic agents were generally similar to those seen with AVANDIA in monotherapy.</ao:suffix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:exact>AVANDIA</ao:exact>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:prefix>The pattern of LDL and HDL changes following therapy with </ao:prefix>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-123.txt.html</ao:hasSource>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:043FCC7B-7CBD-4BE5-9962-3F6CF2B132DB">
    <domeo:uuid>043FCC7B-7CBD-4BE5-9962-3F6CF2B132DB</domeo:uuid>
    <pav:createdOn>2014-07-13 11:09:21 -0400</pav:createdOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:prefix>Pharmacokinetic studies showed that </ao:prefix>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:043FCC7B-7CBD-4BE5-9962-3F6CF2B132DB"/>
    <ao:exact>risperidone</ao:exact>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:suffix> oral solution is bioequivalent to risperidone tablets.</ao:suffix>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-8.txt.html</ao:hasSource>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:8380B817-2385-42D1-ACFB-89134B65210A">
    <domeo:uuid>8380B817-2385-42D1-ACFB-89134B65210A</domeo:uuid>
    <pav:createdOn>2014-07-07 09:42:37 -0400</pav:createdOn>
    <ao:exact>-</ao:exact>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:8380B817-2385-42D1-ACFB-89134B65210A"/>
    <ao:suffix>xsd:String</ao:suffix>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-155.txt.html</ao:hasSource>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:prefix>xsd:String</ao:prefix>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:D7B822C5-ED4F-4553-B7A4-E4C2A921922B">
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <rdfs:label>Highlight</rdfs:label>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:lineageUri>urn:domeoserver:annotation:C45C4490-8CED-42E2-B469-10CCB87DB2EB</pav:lineageUri>
    <domeo:belongsToSet>urn:domeoserver:annotationset:F272A789-69D0-47CC-8CC9-F25C55B91261</domeo:belongsToSet>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:lastSavedOn>2014-07-22 20:22:38 -0400</pav:lastSavedOn>
    <pav:createdOn>2014-07-22 20:17:59 -0400</pav:createdOn>
    <ao:context rdf:resource="urn:domeoclient:uuid:21ABBCD8-EA84-4836-B499-F6A002CF43B9"/>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812eda990003</pav:createdBy>
    <pav:previousVersion>xsd:String</pav:previousVersion>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:F557214F-193F-480C-8483-C59A8CFCD22E">
    <ao:suffix> from a tablet is 94% (CV=10%) when compared to a solution.</ao:suffix>
    <pav:createdOn>2014-07-13 11:09:17 -0400</pav:createdOn>
    <ao:exact>risperidone</ao:exact>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-8.txt.html</ao:hasSource>
    <domeo:uuid>F557214F-193F-480C-8483-C59A8CFCD22E</domeo:uuid>
    <ao:prefix> is 70% (CV=25%). The relative oral bioavailability of </ao:prefix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:F557214F-193F-480C-8483-C59A8CFCD22E"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:72D01271-A1C0-4012-BD2D-70CB0846FFF5">
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/2E502086-B34B-4ECF-A908-98A7B7EF6EA3"/>
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/90DF0B47-DCBB-4EEC-BC07-A4A1FACD692F"/>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/PK_DDI"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:B0CDA62F-9ACD-470D-B0EC-F331BF018B09">
    <pav:createdOn>2014-07-21 21:28:32 -0400</pav:createdOn>
    <pav:lastSavedOn>2014-07-21 21:30:23 -0400</pav:lastSavedOn>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:lineageUri>urn:domeoserver:annotation:673E0CDF-7F39-4F2D-B468-96E8A768435F</pav:lineageUri>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812eda990003</pav:createdBy>
    <ao:context rdf:resource="urn:domeoclient:uuid:32AF5202-FB01-4507-AD10-D10F0C16E37A"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <rdfs:label>Highlight</rdfs:label>
    <domeo:belongsToSet>urn:domeoclient:uuid:B394B422-1AAF-4ED4-A3BB-3FB13E961EEA</domeo:belongsToSet>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:E804A110-85A5-4650-B960-F11AB9FD25A2">
    <ao:exact>carbamazepine</ao:exact>
    <domeo:uuid>E804A110-85A5-4650-B960-F11AB9FD25A2</domeo:uuid>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-8.txt.html</ao:hasSource>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:suffix> (10 mcg/mL) caused only a slight increase in the free fraction of risperidone at 10 ng/mL and 9-hydroxyrisperidone at 50 ng/mL, changes of unknown clinical significance.</ao:suffix>
    <pav:createdOn>2014-07-13 11:11:36 -0400</pav:createdOn>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:E804A110-85A5-4650-B960-F11AB9FD25A2"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:prefix> (10 mcg/mL), and </ao:prefix>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:ED359A65-2894-4EE7-9430-453B2C8C6D26">
    <domeo:uuid>ED359A65-2894-4EE7-9430-453B2C8C6D26</domeo:uuid>
    <pav:createdOn>2014-07-13 12:40:24 -0400</pav:createdOn>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:ED359A65-2894-4EE7-9430-453B2C8C6D26"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:suffix>xsd:String</ao:suffix>
    <ao:prefix>. </ao:prefix>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-21.txt.html</ao:hasSource>
    <ao:exact>In this placebo-controlled, double-blind, randomized, two-way crossover study carried out over three cycles of oral contraceptive treatment, fluconazole dosing resulted in small increases in the mean AUCs of ethinyl estradiol and norethindrone compared to similar placebo dosing. The mean AUCs of ethinyl estradiol and norethindrone increased by 24% (95% C.I. range 18 to 31%) and 13% (95% C.I. range 8 to 18%), respectively relative to placebo.</ao:exact>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:0991F050-6152-45E8-8D40-DC901E368C9E">
    <pav:createdOn>2014-07-13 11:17:24 -0400</pav:createdOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-8.txt.html</ao:hasSource>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <domeo:uuid>0991F050-6152-45E8-8D40-DC901E368C9E</domeo:uuid>
    <ao:suffix> and its active metabolite decreased by 60% compared to young healthy subjects. Risperidone doses should be reduced in patients with renal disease [see 2 DOSAGE AND ADMINISTRATION and 5 WARNINGS AND PRECAUTIONS].</ao:suffix>
    <ao:prefix>Renal Impairment: In patients with moderate to severe renal disease, clearance of the sum of </ao:prefix>
    <ao:exact>risperidone</ao:exact>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:0991F050-6152-45E8-8D40-DC901E368C9E"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:21A6A401-CC93-4E3D-8008-3C8347574A85">
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <pav:createdOn>2014-09-01 16:19:43 -0400</pav:createdOn>
    <ao:prefix>A compassionate plea trial was conducted from 1977 through 1989 in which 718 evaluable patients with malignancies requiring treatment with cytotoxic chemotherapy, but who were unable to ingest or retain oral medication, received i.v.</ao:prefix>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-43.txt.html</ao:hasSource>
    <ao:suffix> for injection in the U.S. Of these patients, 411 had established hyperuricemia and 307 had normal serum urate levels at the time that treatment was initiated. Normal serum uric acid levels were achieved in 68% (reduction of serum uric acid was documente</ao:suffix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:21A6A401-CC93-4E3D-8008-3C8347574A85"/>
    <domeo:uuid>21A6A401-CC93-4E3D-8008-3C8347574A85</domeo:uuid>
    <ao:exact> allopurinol sodium</ao:exact>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:443354CF-9409-4015-81BA-17601E505BAB">
    <pav:createdOn>2014-09-02 15:05:19 -0400</pav:createdOn>
    <ao:item rdf:resource="urn:domeoclient:uuid:5B5C139F-AE11-4B67-AB76-74B91C6DD60D"/>
    <pav:lastSavedOn>2014-09-02 15:06:18 -0400</pav:lastSavedOn>
    <domeo:agents rdf:resource="urn:person:uuid:080e143046812afe0146812eda990003"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:0A5A79F0-6C01-40CE-B775-CC68C1268935"/>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812eda990003</pav:createdBy>
    <ao:annotatesResource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-70.txt.html</ao:annotatesResource>
    <ao:item rdf:resource="urn:domeoclient:uuid:0F10F658-B658-4FA9-8235-47BB00E1C0A0"/>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <domeo:deleted>false</domeo:deleted>
    <pav:lineageUri>urn:domeoserver:annotationset:E9BC3D72-DC81-43AF-974C-F7283BF4A096</pav:lineageUri>
    <ao:item rdf:resource="urn:domeoclient:uuid:D6A30BCE-90A8-4548-B78C-7949C0F059D0"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#AnnotationSet"/>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <domeo:agents rdf:resource="urn:domeo:software:id:Domeo-2.1alpha-050"/>
    <dct:description>The default set is created automatically by Domeo when no other set is existing.</dct:description>
    <rdfs:label>Default Set</rdfs:label>
    <ao:item rdf:resource="urn:domeoclient:uuid:A2CCEA97-69CF-4E75-83A2-17A2D250C5C4"/>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <permissions:permissions rdf:nodeID="N1a7f3fd57e924addb228258f37fd6173"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:019F3E7A-E338-4B52-B537-D71474689AD1">
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812eda990003</pav:createdBy>
    <pav:lineageUri>urn:domeoserver:annotation:58E427EC-D7E5-4793-B477-C5BA94E35E63</pav:lineageUri>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <pav:lastSavedOn>2014-09-01 16:06:18 -0400</pav:lastSavedOn>
    <domeo:belongsToSet>urn:domeoclient:uuid:A84DE8F6-26B7-471D-8309-4E7CC2994FDF</domeo:belongsToSet>
    <rdfs:label>Highlight</rdfs:label>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:createdOn>2014-09-01 16:06:00 -0400</pav:createdOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <ao:context rdf:resource="urn:domeoclient:uuid:FA7A671D-A8CF-4ED4-9A82-73178DBED757"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:F87926C2-2747-4ED5-93E5-F7C25B2825BF">
    <domeo:uuid>F87926C2-2747-4ED5-93E5-F7C25B2825BF</domeo:uuid>
    <pav:createdOn>2014-09-01 15:57:31 -0400</pav:createdOn>
    <ao:suffix>, or cisapride. These data indicate that sertraline’s extent of inhibition of P450 3A4 activity is not likely to be of clinical significance. Results of the interaction study with cisapride indicate that sertraline 200 mg (q.d.) induces the metabolism of</ao:suffix>
    <ao:exact>carbamazepine</ao:exact>
    <ao:prefix>, </ao:prefix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-16.txt.html</ao:hasSource>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:F87926C2-2747-4ED5-93E5-F7C25B2825BF"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:A1560B5F-D6E1-47EC-A088-C0C90A150994">
    <ao:suffix>xsd:String</ao:suffix>
    <pav:createdOn>2014-07-07 09:42:27 -0400</pav:createdOn>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-155.txt.html</ao:hasSource>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:prefix>xsd:String</ao:prefix>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:A1560B5F-D6E1-47EC-A088-C0C90A150994"/>
    <domeo:uuid>A1560B5F-D6E1-47EC-A088-C0C90A150994</domeo:uuid>
    <ao:exact>-</ao:exact>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:F9653C29-A4D2-424D-A8FE-3DDBAC24C18C">
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812eda990003</pav:createdBy>
    <domeo:belongsToSet>urn:domeoserver:annotationset:E32812A9-205B-4EE1-B488-A1E294EDBFB9</domeo:belongsToSet>
    <pav:lineageUri>urn:domeoserver:annotationset:C5DEBC9B-77EE-4243-88EB-DBC19737ACD2</pav:lineageUri>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:lineageUri>urn:domeoserver:annotation:ACFB0428-0BD1-4B7B-A808-5772DBEDE6CE</pav:lineageUri>
    <domeo:belongsToSet>urn:domeoclient:uuid:CB83FFC2-EA71-44EA-8F11-DE80E389C84E</domeo:belongsToSet>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <domeo:belongsToSet>urn:domeoserver:annotationset:392EE0FB-AC4F-4AF2-87A6-2E50A281F434</domeo:belongsToSet>
    <ao:context rdf:resource="urn:domeoclient:uuid:9FB8A434-B2A7-4CA1-A629-583CC07853C3"/>
    <pav:createdOn>2014-09-02 19:17:54 -0400</pav:createdOn>
    <pav:lastSavedOn>2014-09-02 19:19:47 -0400</pav:lastSavedOn>
    <rdfs:label>Highlight</rdfs:label>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:BC0DA7A3-93CD-44F0-B862-95BDA351400D">
    <pav:lastSavedOn>2014-09-02 12:02:18 -0400</pav:lastSavedOn>
    <ao:context rdf:resource="urn:domeoclient:uuid:702E239E-7D5E-4778-8584-0516BA254DC8"/>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812eda990003</pav:createdBy>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:lineageUri>urn:domeoserver:annotation:67EF776C-169B-4458-8DD4-A843EBC79870</pav:lineageUri>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <domeo:belongsToSet>urn:domeoclient:uuid:4B51141D-C8D2-45DB-8074-74F8D8323E60</domeo:belongsToSet>
    <pav:createdOn>2014-09-02 11:58:42 -0400</pav:createdOn>
    <rdfs:label>Highlight</rdfs:label>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:previousVersion>xsd:String</pav:previousVersion>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:EBDA4EF3-E793-47E4-9F6F-74592DE48307">
    <ao:exact>ethinyl estradiol</ao:exact>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-22.txt.html</ao:hasSource>
    <pav:createdOn>2014-07-13 12:44:29 -0400</pav:createdOn>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:EBDA4EF3-E793-47E4-9F6F-74592DE48307"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:prefix>. The mean increase in </ao:prefix>
    <domeo:uuid>EBDA4EF3-E793-47E4-9F6F-74592DE48307</domeo:uuid>
    <ao:suffix> AUC was 6% (range: -47 to 108%) and levonorgestrel AUC increased 17% (range: -33 to 141%).</ao:suffix>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:3DCB5ACD-9F2E-46B4-98D0-F1D2BD3C8EE7">
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812eda990003</pav:createdBy>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <rdfs:label>Highlight</rdfs:label>
    <ao:context rdf:resource="urn:domeoclient:uuid:DB1EE25E-5302-4609-9598-C6AFBB42CB9A"/>
    <pav:lineageUri>urn:domeoserver:annotation:A3D04FE1-598A-407B-A69E-44B383594D74</pav:lineageUri>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:lastSavedOn>2014-07-24 20:02:49 -0400</pav:lastSavedOn>
    <pav:createdOn>2014-07-24 20:02:33 -0400</pav:createdOn>
    <domeo:belongsToSet>urn:domeoclient:uuid:189A8E0E-67D6-4C53-A96E-CB48A3B4B2E9</domeo:belongsToSet>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:9FB8A434-B2A7-4CA1-A629-583CC07853C3">
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:suffix>and nelfinavir, decreased serum levels have been reported when given together with omeprazole. Following multiple doses of nelfinavir (1250 mg, bid) and omeprazole (40 mg, qd), AUC was decreased by 36% and 92%, Cmax by 37% and 89% and Cmin by 39% and 75%</ao:suffix>
    <ao:prefix> treatment may change the absorption of the antiretroviral drug. Other possible interaction mechanisms are via CYP2C19. For some antiretroviral drugs, such as </ao:prefix>
    <pav:createdOn>2014-09-02 19:17:54 -0400</pav:createdOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:exact>atazanavir </ao:exact>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-74.txt.html</ao:hasSource>
    <domeo:uuid>9FB8A434-B2A7-4CA1-A629-583CC07853C3</domeo:uuid>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:9FB8A434-B2A7-4CA1-A629-583CC07853C3"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:BB14DC78-807E-4A6B-BCB8-D66CC1E0A2E7">
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <ao:context rdf:resource="urn:domeoclient:uuid:D704B671-5676-476E-BB75-84893439C054"/>
    <pav:lastSavedOn>2014-09-02 19:42:49 -0400</pav:lastSavedOn>
    <pav:createdOn>2014-09-02 19:42:42 -0400</pav:createdOn>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:lineageUri>urn:domeoserver:annotation:46D58FBB-E984-4FAD-AA55-BA245F35E096</pav:lineageUri>
    <domeo:belongsToSet>urn:domeoclient:uuid:69C22FA1-8D50-4AA7-ACD8-8F71E69BB8AC</domeo:belongsToSet>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812eda990003</pav:createdBy>
    <rdfs:label>Highlight</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:82628688-78B9-45FB-8BED-8C81D7B2F03E">
    <pav:lineageUri>urn:domeoserver:annotation:56FC3B81-7F1E-47ED-92EA-728261C2666A</pav:lineageUri>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:lineageUri>urn:domeoserver:annotationset:AB1741F1-5A5F-4416-AEAC-A544BCBB7D16</pav:lineageUri>
    <pav:lastSavedOn>2014-07-22 19:44:46 -0400</pav:lastSavedOn>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">6</pav:versionNumber>
    <domeo:belongsToSet>urn:domeoserver:annotationset:2914A3FD-DF43-4F78-999C-77CE7A028B19</domeo:belongsToSet>
    <pav:createdOn>2014-07-22 19:42:20 -0400</pav:createdOn>
    <ao:context rdf:resource="urn:domeoclient:uuid:3778184B-7478-42AC-8128-7363E5970F00"/>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <domeo:belongsToSet>urn:domeoserver:annotationset:606A5B3F-B6FB-4279-AA42-7893CFC2D20C</domeo:belongsToSet>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <pav:previousVersion>urn:domeoserver:annotationset:514BA51B-D734-4003-A7C3-F03C0F95833A</pav:previousVersion>
    <domeo:belongsToSet>urn:domeoserver:annotationset:F272A789-69D0-47CC-8CC9-F25C55B91261</domeo:belongsToSet>
    <rdfs:label>Highlight</rdfs:label>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812eda990003</pav:createdBy>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoserver:annotationset:7021B883-FD5C-4083-BD87-DF56D3C87633">
    <ao:item rdf:resource="urn:domeoclient:uuid:513FF3F1-4FCE-4790-A5C9-F75162D3687B"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:C4558C3C-CC16-4A44-85EC-2AB4969F8A0D"/>
    <rdfs:label>Default Set</rdfs:label>
    <ao:item rdf:resource="urn:domeoclient:uuid:F895E903-9E93-41BD-BED1-2EA2CE628B45"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:37E9FF1C-D06E-42C3-944C-482813D8E38E"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:B1EDC65E-7D2E-4E9E-9D08-0D72BD366C29"/>
    <ao:annotatesResource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-123.txt.html</ao:annotatesResource>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#AnnotationSet"/>
    <domeo:agents rdf:resource="urn:domeo:software:id:Domeo-2.1alpha-050"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:ED9A4881-5A44-4C07-BAFB-529340D632F3"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:E2D1A706-CE7E-4379-97CF-4EE9CA384DB2"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:52B64BE2-7636-4E5D-B162-D84F2D892E3D"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:0A960BCB-9A9F-4998-9418-33D622C35F7C"/>
    <pav:previousVersion>urn:domeoserver:annotationset:7E80543E-BF76-4514-92A9-91458DCB802B</pav:previousVersion>
    <ao:item rdf:resource="urn:domeoclient:uuid:D693BC09-DDB8-454B-A812-E73AB798F6FA"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:78A5F631-80CE-4FB1-974D-F82BE8D8E584"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:2506F4F5-773E-4CCD-8303-CC244D5848D1"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:585BED0D-5182-4D39-912D-F355B5BEA6BA"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:A68BF389-96D4-4F16-BF9D-C1BF35E3CE01"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:AF68257F-3ADB-4BA4-9BD1-247F8428319E"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:9C9FE015-E10A-4124-9250-BA73B7E52470"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:4411E759-9248-468B-B2F6-E5A5A8657C4C"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:D1F55052-16DF-4B25-AC16-7645C8E4AD77"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:FF1FC131-57E9-4A89-8FBF-B786D1543F24"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:8C53D58B-D2A3-4A8C-9924-E26E43A59105"/>
    <pav:createdOn>2014-07-22 19:08:44 -0400</pav:createdOn>
    <pav:lineageUri>urn:domeoserver:annotationset:AB1741F1-5A5F-4416-AEAC-A544BCBB7D16</pav:lineageUri>
    <ao:item rdf:resource="urn:domeoclient:uuid:5CE56B1D-ACF0-4124-B31E-62EF1E11FED8"/>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <domeo:deleted>false</domeo:deleted>
    <dct:description>The default set is created automatically by Domeo when no other set is existing.</dct:description>
    <pav:lastSavedOn>2014-07-22 19:35:16 -0400</pav:lastSavedOn>
    <ao:item rdf:resource="urn:domeoclient:uuid:51F1BD01-1111-4CA2-BC77-65762E0E45AA"/>
    <domeo:agents rdf:resource="urn:person:uuid:080e143046812afe0146812eda990003"/>
    <permissions:permissions rdf:nodeID="N90b6166b32e54466a9e21cdafa8ec1cb"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:15E1712B-2693-4DB6-A2FE-D2F158D3A823"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:796FE422-C147-4AA7-A57F-067429194AA4"/>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">4</pav:versionNumber>
    <ao:item rdf:resource="urn:domeoclient:uuid:B6681C81-EA03-49F0-8187-EF5752C9D126"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:23AC6809-BABB-405A-80DE-630CA211B109"/>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812eda990003</pav:createdBy>
    <ao:item rdf:resource="urn:domeoclient:uuid:15050075-436C-4668-9987-03D689AE2236"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:544614C5-3057-4129-841C-95DBCD1340A4"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:851EB41C-687B-464B-9105-16513BFE3A24"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:D555EE88-9218-4AF9-81CC-40D543746D77"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:3077386C-E136-4431-9DB1-FC99BF18719B"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:5C47D157-D8A4-4053-B2C7-7ECD1B16B721"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:44D9A897-A866-42BB-8DD9-A376BF8D1B3E"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:B28EDC18-743D-4015-956F-B084F96B3589"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:2A2B8454-0B34-43FC-8C83-D2580B9D07B1">
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/0FDE0719-4064-4898-AD34-D2D6DF707B50"/>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/PK_DDI"/>
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/C3802543-BD64-4421-A632-BFDE8408A954"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:6E924DBB-A7DD-4939-9801-279C7188D87E">
    <ao:prefix>xsd:String</ao:prefix>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-123.txt.html</ao:hasSource>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:exact>AVANDIA</ao:exact>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:6E924DBB-A7DD-4939-9801-279C7188D87E"/>
    <ao:suffix> </ao:suffix>
    <domeo:uuid>6E924DBB-A7DD-4939-9801-279C7188D87E</domeo:uuid>
    <pav:createdOn>2014-07-22 20:17:56 -0400</pav:createdOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:DC73A4DB-52A1-428E-A3E7-50DAC49D6A5A">
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <rdfs:label>Highlight</rdfs:label>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:lineageUri>urn:domeoserver:annotation:B9E6F388-F6BA-4A6D-95DF-40A9E25BB859</pav:lineageUri>
    <pav:createdOn>2014-07-24 19:38:18 -0400</pav:createdOn>
    <ao:context rdf:resource="urn:domeoclient:uuid:C9F22978-089A-4215-9421-19B4E3E4358A"/>
    <pav:lastSavedOn>2014-07-24 19:38:41 -0400</pav:lastSavedOn>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <domeo:belongsToSet>urn:domeoclient:uuid:DBA2FBEC-FB21-4B1E-AFD1-05AF52CBAB09</domeo:belongsToSet>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812eda990003</pav:createdBy>
    <pav:previousVersion>xsd:String</pav:previousVersion>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:A676ABAB-01BC-4D19-9DA7-5CF8687711A8">
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <ao:context rdf:resource="urn:domeoclient:uuid:5488F065-12C7-4BC6-B53E-99FE4483B13A"/>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812eda990003</pav:createdBy>
    <pav:lastSavedOn>2014-09-02 12:02:18 -0400</pav:lastSavedOn>
    <domeo:belongsToSet>urn:domeoclient:uuid:4B51141D-C8D2-45DB-8074-74F8D8323E60</domeo:belongsToSet>
    <rdfs:label>Highlight</rdfs:label>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:createdOn>2014-09-02 11:58:39 -0400</pav:createdOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <pav:lineageUri>urn:domeoserver:annotation:F9808DBF-4E74-434F-AD39-3686E0AF3378</pav:lineageUri>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:A0E3203A-2AD3-4045-BAB8-27B340F81B0E">
    <ao:annotatesResource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-166.txt.html</ao:annotatesResource>
    <domeo:deleted>false</domeo:deleted>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812eda990003</pav:createdBy>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <ao:item rdf:resource="urn:domeoclient:uuid:A24D3202-33F3-42B7-9021-4CDA18CA2F7B"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:4F554D87-2148-4927-B2EE-B016ECABC1C6"/>
    <rdfs:label>Default Set</rdfs:label>
    <ao:item rdf:resource="urn:domeoclient:uuid:90D65AEF-2F91-4982-9D2A-D9266BCF827E"/>
    <domeo:agents rdf:resource="urn:domeo:software:id:Domeo-2.1alpha-050"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#AnnotationSet"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:4DAAB121-0E59-4A51-A71B-B8E4DB847D18"/>
    <pav:lineageUri>urn:domeoserver:annotationset:B57AA8FB-9DF0-47AD-B8F5-577E80B7511C</pav:lineageUri>
    <pav:createdOn>2014-07-28 17:02:22 -0400</pav:createdOn>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <dct:description>The default set is created automatically by Domeo when no other set is existing.</dct:description>
    <permissions:permissions rdf:nodeID="N53ff32ea296542c6922f72d3c924712c"/>
    <domeo:agents rdf:resource="urn:person:uuid:080e143046812afe0146812eda990003"/>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:lastSavedOn>2014-07-28 17:02:28 -0400</pav:lastSavedOn>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:05AFE2BC-8117-40BD-BC72-6B1AA0443A12">
    <ao:suffix>:  Coadministration of rosiglitazone (4 mg b.i.d.) was shown to have no clinically relevant effect on the pharmacokinetics of nifedipine.</ao:suffix>
    <ao:prefix>xsd:String</ao:prefix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:exact>Rosiglitazone</ao:exact>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:05AFE2BC-8117-40BD-BC72-6B1AA0443A12"/>
    <domeo:uuid>05AFE2BC-8117-40BD-BC72-6B1AA0443A12</domeo:uuid>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-116.txt.html</ao:hasSource>
    <pav:createdOn>2014-09-02 19:40:40 -0400</pav:createdOn>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:34A4FD4A-1057-41A3-B555-92B00D0BD0D1">
    <ao:exact>fluvoxamin</ao:exact>
    <ao:prefix>The metabolism of </ao:prefix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <pav:createdOn>2014-09-02 11:35:30 -0400</pav:createdOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <domeo:uuid>34A4FD4A-1057-41A3-B555-92B00D0BD0D1</domeo:uuid>
    <ao:suffix>e has not been fully characterized and the effects of potent cytochrome P450 isoenzyme inhibition, such as the ketoconazole inhibition of CYP3A4, on fluvoxamine metabolism have not been studied.</ao:suffix>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-9.txt.html</ao:hasSource>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:34A4FD4A-1057-41A3-B555-92B00D0BD0D1"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:A5711142-9ABC-4A8E-A6A1-D585CB7190C4">
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <domeo:uuid>A5711142-9ABC-4A8E-A6A1-D585CB7190C4</domeo:uuid>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-9.txt.html</ao:hasSource>
    <ao:prefix>7.4 Effects of Smoking on </ao:prefix>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:A5711142-9ABC-4A8E-A6A1-D585CB7190C4"/>
    <ao:exact>Fluvoxamine</ao:exact>
    <ao:suffix> Metabolism</ao:suffix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <pav:createdOn>2014-09-02 11:46:58 -0400</pav:createdOn>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:5C77DFAE-836C-475E-BE78-637BCFAAA992">
    <pav:lineageUri>urn:domeoserver:annotation:75659C5C-DD94-4FAE-AF1C-37389ADEDB74</pav:lineageUri>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <rdfs:label>Highlight</rdfs:label>
    <domeo:belongsToSet>urn:domeoserver:annotationset:F272A789-69D0-47CC-8CC9-F25C55B91261</domeo:belongsToSet>
    <pav:previousVersion>urn:domeoserver:annotationset:606A5B3F-B6FB-4279-AA42-7893CFC2D20C</pav:previousVersion>
    <pav:lineageUri>urn:domeoserver:annotationset:AB1741F1-5A5F-4416-AEAC-A544BCBB7D16</pav:lineageUri>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">7</pav:versionNumber>
    <pav:createdOn>2014-07-22 19:49:16 -0400</pav:createdOn>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812eda990003</pav:createdBy>
    <pav:lastSavedOn>2014-07-22 19:54:59 -0400</pav:lastSavedOn>
    <ao:context rdf:resource="urn:domeoclient:uuid:7A49EC3D-7C54-46A7-831E-A352B5A1B081"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <domeo:belongsToSet>urn:domeoserver:annotationset:2914A3FD-DF43-4F78-999C-77CE7A028B19</domeo:belongsToSet>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:E3B6522F-F16C-4872-B4B8-C142D6BC0D2D">
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <domeo:uuid>E3B6522F-F16C-4872-B4B8-C142D6BC0D2D</domeo:uuid>
    <pav:createdOn>2014-09-01 16:12:27 -0400</pav:createdOn>
    <ao:prefix>or </ao:prefix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:suffix>. Subsequent adjustment of doses of mercaptopurine or azathioprine should be made on the basis of therapeutic response and the appearance of toxic effects (see PRECAUTIONS- Drug Interactions).</ao:suffix>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:E3B6522F-F16C-4872-B4B8-C142D6BC0D2D"/>
    <ao:exact>azathioprine</ao:exact>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-42.txt.html</ao:hasSource>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:B98C3482-C44D-4C61-ACC3-D277890BCE91">
    <ao:exact>REVATIO </ao:exact>
    <ao:prefix>xsd:String</ao:prefix>
    <domeo:uuid></domeo:uuid>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:suffix>Injection: Predictions based on a pharmacokinetic model suggest that drug-drug interactions with CYP3A inhibitors will be less than those observed after oral sildenafil administration.</ao:suffix>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-155.txt.html</ao:hasSource>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <pav:createdOn>2014-07-07 11:23:25 -0400</pav:createdOn>
    <domeo:uuid>B98C3482-C44D-4C61-ACC3-D277890BCE91</domeo:uuid>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:B98C3482-C44D-4C61-ACC3-D277890BCE91"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:AA8809D6-7C92-459E-B3FE-D31BB8203D90">
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-50.txt.html</ao:hasSource>
    <domeo:uuid>AA8809D6-7C92-459E-B3FE-D31BB8203D90</domeo:uuid>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <pav:createdOn>2014-07-21 21:42:13 -0400</pav:createdOn>
    <ao:suffix>alone at steady state. If anticholinergic effects are seen, the dose of procyclidine should be reduced.</ao:suffix>
    <ao:prefix>(5 mg oral once daily) by 35%, 37%, and 67%, respectively, compared to </ao:prefix>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:AA8809D6-7C92-459E-B3FE-D31BB8203D90"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:exact>procyclidine </ao:exact>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:62F3C932-C305-4581-AA4E-BB34C6D0F7D4">
    <ao:exact>TID </ao:exact>
    <pav:createdOn>2014-07-07 11:22:45 -0400</pav:createdOn>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-155.txt.html</ao:hasSource>
    <ao:prefix>exposure without concomitant medication is shown to be 5-fold higher at a dose of 80 mg </ao:prefix>
    <ao:suffix>compared to its exposure at a dose of 20 mg </ao:suffix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <domeo:uuid></domeo:uuid>
    <domeo:uuid>62F3C932-C305-4581-AA4E-BB34C6D0F7D4</domeo:uuid>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:62F3C932-C305-4581-AA4E-BB34C6D0F7D4"/>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/F5B8326E-67BE-4609-AB25-C62EAAC309BC">
    <rdfs:label>gemfibrozil</rdfs:label>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/active-ingredient"/>
    <dct:description>Referred to the drug in the interaction.</dct:description>
    <sio:SIO_000228>dikbD2R:precipitant-drug-of-interaction</sio:SIO_000228>
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/4719</dailymed:activeMoietyRxCUI>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:643EA9F8-ED1A-479B-9B59-6A63D55F43F7">
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <rdfs:label>Highlight</rdfs:label>
    <pav:lastSavedOn>2014-09-02 11:46:58 -0400</pav:lastSavedOn>
    <domeo:belongsToSet>urn:domeoserver:annotationset:A3F0B39A-4249-4B63-BB0D-F24A005066AC</domeo:belongsToSet>
    <ao:context rdf:resource="urn:domeoclient:uuid:5DB19655-BFA0-4BCE-93AA-DD6B932E259B"/>
    <domeo:belongsToSet>urn:domeoserver:annotationset:3F546823-204F-4F9B-9006-3DC526C56931</domeo:belongsToSet>
    <pav:lineageUri>urn:domeoserver:annotation:ACDBC3E9-87F9-4BDE-99AF-6368A537ADB7</pav:lineageUri>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:createdOn>2014-09-02 11:43:51 -0400</pav:createdOn>
    <domeo:belongsToSet>urn:domeoserver:annotationset:A5DD001D-C81A-4E2E-B5E0-7A866B35E26B</domeo:belongsToSet>
    <pav:lineageUri>urn:domeoserver:annotationset:D1715BD2-BD41-46FD-9454-DC7A423A29AC</pav:lineageUri>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">2</pav:versionNumber>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812eda990003</pav:createdBy>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:previousVersion>urn:domeoclient:uuid:BED41F06-565A-4622-9A88-48810E5A28DE</pav:previousVersion>
    <pav:previousVersion>xsd:String</pav:previousVersion>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:E3652583-DA12-4711-86A1-59DC39EC9239">
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-9.txt.html</ao:hasSource>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:E3652583-DA12-4711-86A1-59DC39EC9239"/>
    <domeo:uuid>E3652583-DA12-4711-86A1-59DC39EC9239</domeo:uuid>
    <ao:prefix>xsd:String</ao:prefix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:suffix> and Other Drugs That Interfere With Hemostasis (NSAIDs, Aspirin, etc.): See WARNINGS AND PRECAUTIONS [5.8 and 5.10].</ao:suffix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:exact>Warfarin</ao:exact>
    <pav:createdOn>2014-09-02 11:46:50 -0400</pav:createdOn>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:787692CD-0BB7-4EBC-B1EB-B839CB0674FF">
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <pav:lastSavedOn>2014-07-24 20:14:43 -0400</pav:lastSavedOn>
    <ao:context rdf:resource="urn:domeoclient:uuid:E7B5E0E2-9287-47B6-9135-34CE522BE395"/>
    <domeo:belongsToSet>urn:domeoclient:uuid:2BAA59CB-3862-4A98-8A6C-AA14E82983DC</domeo:belongsToSet>
    <pav:lineageUri>urn:domeoserver:annotation:15178808-6677-451C-9986-6BBD161C3567</pav:lineageUri>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:createdOn>2014-07-24 20:14:43 -0400</pav:createdOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812eda990003</pav:createdBy>
    <rdfs:label>Highlight</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:6DDA4ED5-743F-4C12-93A8-37B2366FF364">
    <pav:createdOn>2014-07-13 11:17:38 -0400</pav:createdOn>
    <domeo:belongsToSet>urn:domeoclient:uuid:71191E51-53CB-4FDE-88D0-33C6818E2232</domeo:belongsToSet>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <ao:context rdf:resource="urn:domeoclient:uuid:135F1FE6-83FC-4E58-95A7-4C08AED291BA"/>
    <pav:lastSavedOn>2014-07-13 11:32:29 -0400</pav:lastSavedOn>
    <rdfs:label>Highlight</rdfs:label>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812eda990003</pav:createdBy>
    <pav:lineageUri>urn:domeoserver:annotation:341C8689-0903-4B8F-836F-B52DFF733FFD</pav:lineageUri>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:95404334-796F-4A07-A18A-42601A802CDF">
    <ao:context rdf:resource="urn:domeoclient:uuid:F5818A7A-2ACD-4500-9EFD-114B559AE626"/>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:createdOn>2014-09-02 19:12:32 -0400</pav:createdOn>
    <pav:lineageUri>urn:domeoserver:annotationset:C5DEBC9B-77EE-4243-88EB-DBC19737ACD2</pav:lineageUri>
    <rdfs:label>Highlight</rdfs:label>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <domeo:belongsToSet>urn:domeoclient:uuid:CB83FFC2-EA71-44EA-8F11-DE80E389C84E</domeo:belongsToSet>
    <pav:lineageUri>urn:domeoserver:annotation:A012450E-F63A-411B-8B55-E089258CBF3E</pav:lineageUri>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812eda990003</pav:createdBy>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:lastSavedOn>2014-09-02 19:19:47 -0400</pav:lastSavedOn>
    <domeo:belongsToSet>urn:domeoserver:annotationset:E32812A9-205B-4EE1-B488-A1E294EDBFB9</domeo:belongsToSet>
    <domeo:belongsToSet>urn:domeoserver:annotationset:392EE0FB-AC4F-4AF2-87A6-2E50A281F434</domeo:belongsToSet>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:60DDCB17-0D44-46B0-8348-C078AAECFF80">
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <rdfs:label>Highlight</rdfs:label>
    <domeo:belongsToSet>urn:domeoserver:annotationset:A5DD001D-C81A-4E2E-B5E0-7A866B35E26B</domeo:belongsToSet>
    <domeo:belongsToSet>urn:domeoserver:annotationset:A3F0B39A-4249-4B63-BB0D-F24A005066AC</domeo:belongsToSet>
    <pav:lineageUri>urn:domeoserver:annotation:3013B639-778D-4865-8A69-0A619BEC1A05</pav:lineageUri>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">2</pav:versionNumber>
    <pav:lineageUri>urn:domeoserver:annotationset:D1715BD2-BD41-46FD-9454-DC7A423A29AC</pav:lineageUri>
    <pav:lastSavedOn>2014-09-02 11:46:58 -0400</pav:lastSavedOn>
    <pav:createdOn>2014-09-02 11:41:14 -0400</pav:createdOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:previousVersion>urn:domeoclient:uuid:BED41F06-565A-4622-9A88-48810E5A28DE</pav:previousVersion>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812eda990003</pav:createdBy>
    <domeo:belongsToSet>urn:domeoserver:annotationset:3F546823-204F-4F9B-9006-3DC526C56931</domeo:belongsToSet>
    <ao:context rdf:resource="urn:domeoclient:uuid:5C335096-224E-43D5-B91F-473E8217B098"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:B6F745E6-5734-4636-A383-683BA4C79E38">
    <ao:item rdf:resource="urn:domeoclient:uuid:AD3EF274-2E89-4A1A-9C95-5AE9F608E1E0"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:D3B6634D-5A1F-4C6F-AF5E-421854DA709D"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:120B172A-5B0A-4411-BB16-2CE6618D971C"/>
    <domeo:agents rdf:resource="urn:person:uuid:080e143046812afe0146812eda990003"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:E4954BA3-FA9C-4983-8CA9-D8BA258D2881"/>
    <pav:lineageUri>urn:domeoserver:annotationset:63218495-2D5D-4BAA-9325-6B514214E40A</pav:lineageUri>
    <rdfs:label>Default Set</rdfs:label>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812eda990003</pav:createdBy>
    <ao:item rdf:resource="urn:domeoclient:uuid:1956FA88-0DCF-4091-9E82-114782E551B6"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:EDAAAA2E-DA5E-4DC5-9EDE-0B4E06286E7C"/>
    <domeo:agents rdf:resource="urn:domeo:software:id:Domeo-2.1alpha-050"/>
    <ao:annotatesResource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-25.txt.html</ao:annotatesResource>
    <ao:item rdf:resource="urn:domeoclient:uuid:405F8748-3E22-452F-AC3B-86C4C931D36A"/>
    <pav:createdOn>2014-07-21 21:26:46 -0400</pav:createdOn>
    <domeo:deleted>false</domeo:deleted>
    <dct:description>The default set is created automatically by Domeo when no other set is existing.</dct:description>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:lastSavedOn>2014-07-21 21:27:51 -0400</pav:lastSavedOn>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <permissions:permissions rdf:nodeID="Nc24d8172d8da436f8c64c9e2b19a133d"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#AnnotationSet"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:3010354C-0396-4F68-8730-35FBE74BAACF">
    <sio:SIO_000205>dikbD2R:statement</sio:SIO_000205>
    <sio:SIO_000628 rdf:resource="urn:pddi:uuid:8D8724AE-D8FE-4EA2-BC2B-883652CC6520"/>
    <rdf:type rdf:resource="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#DrugDrugInteractionStatement"/>
    <dikbD2R:modality>ncit:positive</dikbD2R:modality>
    <sio:SIO_000563>dikbD2R:modality</sio:SIO_000563>
    <dikbD2R:statement>ncit:Qualitative</dikbD2R:statement>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:DB2B2DE0-2BB6-4F47-A9DF-A6326E16D770">
    <domeo:uuid>DB2B2DE0-2BB6-4F47-A9DF-A6326E16D770</domeo:uuid>
    <pav:createdOn>2014-07-22 20:21:10 -0400</pav:createdOn>
    <ao:exact>Repeat oral dosing of AVANDIA (8 mg once daily) for 14 days did not alter the steady-state pharmacokinetics of digoxin (0.375 mg once daily) in healthy volunteers</ao:exact>
    <ao:prefix>xsd:String</ao:prefix>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-123.txt.html</ao:hasSource>
    <ao:suffix>xsd:String</ao:suffix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:DB2B2DE0-2BB6-4F47-A9DF-A6326E16D770"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:F31EE1EC-A22F-4FE9-8763-7C623AD7B0BE">
    <domeo:uuid>F31EE1EC-A22F-4FE9-8763-7C623AD7B0BE</domeo:uuid>
    <ao:prefix> results from the combined concentrations of </ao:prefix>
    <ao:exact>risperidone</ao:exact>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <pav:createdOn>2014-07-13 11:08:54 -0400</pav:createdOn>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-8.txt.html</ao:hasSource>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:suffix> and its major metabolite, 9-hydroxyrisperidone [see 12 CLINICAL PHARMACOLOGY]. Antagonism at receptors other than D2 and 5HT2 [see 12 CLINICAL PHARMACOLOGY] may explain some of the other effects of risperidone.</ao:suffix>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:F31EE1EC-A22F-4FE9-8763-7C623AD7B0BE"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:F0FFC655-44BB-402B-B7C7-6EB6CD49035C">
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <ao:context rdf:resource="urn:domeoclient:uuid:0A177F5C-EB12-4EE0-B135-C40638451C00"/>
    <pav:lastSavedOn>2014-09-02 19:19:47 -0400</pav:lastSavedOn>
    <domeo:belongsToSet>urn:domeoserver:annotationset:392EE0FB-AC4F-4AF2-87A6-2E50A281F434</domeo:belongsToSet>
    <pav:createdOn>2014-09-02 19:18:12 -0400</pav:createdOn>
    <rdfs:label>Highlight</rdfs:label>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812eda990003</pav:createdBy>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <domeo:belongsToSet>urn:domeoclient:uuid:CB83FFC2-EA71-44EA-8F11-DE80E389C84E</domeo:belongsToSet>
    <pav:lineageUri>urn:domeoserver:annotation:CAFB9E90-6C32-4FEC-94C4-560833B750D3</pav:lineageUri>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <pav:lineageUri>urn:domeoserver:annotationset:C5DEBC9B-77EE-4243-88EB-DBC19737ACD2</pav:lineageUri>
    <domeo:belongsToSet>urn:domeoserver:annotationset:E32812A9-205B-4EE1-B488-A1E294EDBFB9</domeo:belongsToSet>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:F5818A7A-2ACD-4500-9EFD-114B559AE626">
    <ao:exact>diazepam</ao:exact>
    <ao:prefix> can prolong the elimination of </ao:prefix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <pav:createdOn>2014-09-02 19:12:32 -0400</pav:createdOn>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:F5818A7A-2ACD-4500-9EFD-114B559AE626"/>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-74.txt.html</ao:hasSource>
    <ao:suffix>, warfarin and phenytoin, drugs that are metabolized by oxidation in the liver. There have been reports of increased INR and prothrombin time in patients receiving proton pump inhibitors, including omeprazole, and warfarin concomitantly. Increases in INR</ao:suffix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <domeo:uuid>F5818A7A-2ACD-4500-9EFD-114B559AE626</domeo:uuid>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:9E45A71F-507C-47A7-A012-D482CF4059D6">
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:createdOn>2014-09-02 11:39:42 -0400</pav:createdOn>
    <pav:lineageUri>urn:domeoserver:annotationset:D1715BD2-BD41-46FD-9454-DC7A423A29AC</pav:lineageUri>
    <domeo:belongsToSet>urn:domeoserver:annotationset:3F546823-204F-4F9B-9006-3DC526C56931</domeo:belongsToSet>
    <pav:lineageUri>urn:domeoserver:annotation:454A44DE-8938-4C4D-A350-4D0834E49786</pav:lineageUri>
    <rdfs:label>Highlight</rdfs:label>
    <ao:context rdf:resource="urn:domeoclient:uuid:15CCD695-F33B-4A85-9FD0-BAFCB7975EAB"/>
    <domeo:belongsToSet>urn:domeoserver:annotationset:A5DD001D-C81A-4E2E-B5E0-7A866B35E26B</domeo:belongsToSet>
    <domeo:belongsToSet>urn:domeoserver:annotationset:A3F0B39A-4249-4B63-BB0D-F24A005066AC</domeo:belongsToSet>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812eda990003</pav:createdBy>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">2</pav:versionNumber>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:previousVersion>urn:domeoclient:uuid:BED41F06-565A-4622-9A88-48810E5A28DE</pav:previousVersion>
    <pav:lastSavedOn>2014-09-02 11:46:58 -0400</pav:lastSavedOn>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoserver:annotationset:467D4F28-D086-4217-9DE0-23E165F30716">
    <permissions:permissions rdf:nodeID="N6a302775c3b24d7c9f997c0789b4078e"/>
    <domeo:agents rdf:resource="urn:domeo:software:id:Domeo-2.1alpha-050"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#AnnotationSet"/>
    <domeo:agents rdf:resource="urn:person:uuid:080e143046812afe0146812eda990003"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:ED9A4881-5A44-4C07-BAFB-529340D632F3"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:51F1BD01-1111-4CA2-BC77-65762E0E45AA"/>
    <dct:description>The default set is created automatically by Domeo when no other set is existing.</dct:description>
    <rdfs:label>Default Set</rdfs:label>
    <ao:item rdf:resource="urn:domeoclient:uuid:513FF3F1-4FCE-4790-A5C9-F75162D3687B"/>
    <pav:lineageUri>urn:domeoserver:annotationset:AB1741F1-5A5F-4416-AEAC-A544BCBB7D16</pav:lineageUri>
    <ao:item rdf:resource="urn:domeoclient:uuid:5C47D157-D8A4-4053-B2C7-7ECD1B16B721"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:D555EE88-9218-4AF9-81CC-40D543746D77"/>
    <ao:annotatesResource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-123.txt.html</ao:annotatesResource>
    <pav:createdOn>2014-07-22 19:08:44 -0400</pav:createdOn>
    <ao:item rdf:resource="urn:domeoclient:uuid:78A5F631-80CE-4FB1-974D-F82BE8D8E584"/>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">2</pav:versionNumber>
    <ao:item rdf:resource="urn:domeoclient:uuid:B6681C81-EA03-49F0-8187-EF5752C9D126"/>
    <pav:previousVersion>urn:domeoclient:uuid:BE4B86AC-FE5F-4543-A713-EC5B852A5A2A</pav:previousVersion>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812eda990003</pav:createdBy>
    <domeo:deleted>false</domeo:deleted>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:lastSavedOn>2014-07-22 19:15:50 -0400</pav:lastSavedOn>
    <ao:item rdf:resource="urn:domeoclient:uuid:585BED0D-5182-4D39-912D-F355B5BEA6BA"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:E960F182-0178-48DA-9F6A-A1F40CDC1A1D">
    <domeo:uuid>E960F182-0178-48DA-9F6A-A1F40CDC1A1D</domeo:uuid>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-74.txt.html</ao:hasSource>
    <ao:exact>warfarin </ao:exact>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <pav:createdOn>2014-09-02 19:12:33 -0400</pav:createdOn>
    <ao:prefix>, </ao:prefix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:suffix>and phenytoin, drugs that are metabolized by oxidation in the liver. There have been reports of increased INR and prothrombin time in patients receiving proton pump inhibitors, including omeprazole, and warfarin concomitantly. Increases in INR and prothr</ao:suffix>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:E960F182-0178-48DA-9F6A-A1F40CDC1A1D"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:2093FF56-689E-4246-AF69-F566860B27BF">
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812eda990003</pav:createdBy>
    <domeo:belongsToSet>urn:domeoserver:annotationset:8F3CF3D9-AADE-4A86-BD42-2924B3D6A406</domeo:belongsToSet>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <domeo:belongsToSet>urn:domeoserver:annotationset:22ED7220-C6F6-43C5-9DF9-89F62F0F8E27</domeo:belongsToSet>
    <pav:createdOn>2014-07-07 09:42:25 -0400</pav:createdOn>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <domeo:belongsToSet>urn:domeoserver:annotationset:08C0C288-6DF4-43E6-A618-71A8BB9563C3</domeo:belongsToSet>
    <pav:lineageUri>urn:domeoserver:annotationset:76FD4BB5-DE2F-4FCA-B93D-302185B1A381</pav:lineageUri>
    <ao:context rdf:resource="urn:domeoclient:uuid:E766D1AC-45BC-4579-89AD-BE0DEC69FC35"/>
    <pav:lastSavedOn>2014-07-07 09:44:18 -0400</pav:lastSavedOn>
    <pav:lastSavedOn>2014-07-07 09:44:19 -0400</pav:lastSavedOn>
    <pav:lineageUri>urn:domeoserver:annotation:187E096B-963B-4ED9-97FB-5E69A71AD4B3</pav:lineageUri>
    <domeo:belongsToSet>urn:domeoserver:annotationset:7AACEF8D-2EBC-4F0B-94B2-190650E562F6</domeo:belongsToSet>
    <domeo:belongsToSet>urn:domeoserver:annotationset:131835A3-C655-4F91-97D4-52CAFF7B7CCA</domeo:belongsToSet>
    <rdfs:label>Highlight</rdfs:label>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <domeo:belongsToSet>urn:domeoclient:uuid:FCA2BF23-0BE3-409F-9177-761812F96097</domeo:belongsToSet>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:02D92735-6D44-4DFA-A2E9-75A5A3D4DCF9">
    <pav:lastSavedOn>2014-07-07 09:44:18 -0400</pav:lastSavedOn>
    <pav:createdOn>2014-07-07 09:42:51 -0400</pav:createdOn>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <domeo:belongsToSet>urn:domeoserver:annotationset:131835A3-C655-4F91-97D4-52CAFF7B7CCA</domeo:belongsToSet>
    <rdfs:label>Highlight</rdfs:label>
    <pav:lineageUri>urn:domeoserver:annotationset:76FD4BB5-DE2F-4FCA-B93D-302185B1A381</pav:lineageUri>
    <domeo:belongsToSet>urn:domeoserver:annotationset:7AACEF8D-2EBC-4F0B-94B2-190650E562F6</domeo:belongsToSet>
    <domeo:belongsToSet>urn:domeoserver:annotationset:22ED7220-C6F6-43C5-9DF9-89F62F0F8E27</domeo:belongsToSet>
    <pav:lastSavedOn>2014-07-07 09:44:19 -0400</pav:lastSavedOn>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812eda990003</pav:createdBy>
    <pav:lineageUri>urn:domeoserver:annotation:21A31B97-1130-4A1C-93A0-70A39037EF29</pav:lineageUri>
    <domeo:belongsToSet>urn:domeoserver:annotationset:08C0C288-6DF4-43E6-A618-71A8BB9563C3</domeo:belongsToSet>
    <ao:context rdf:resource="urn:domeoclient:uuid:DC34C3D8-C58F-483B-80DB-B65FEBB2EC20"/>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <domeo:belongsToSet>urn:domeoserver:annotationset:8F3CF3D9-AADE-4A86-BD42-2924B3D6A406</domeo:belongsToSet>
    <domeo:belongsToSet>urn:domeoclient:uuid:FCA2BF23-0BE3-409F-9177-761812F96097</domeo:belongsToSet>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:805A260D-8C6D-4764-98FF-7A828A5A8A65">
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-54.txt.html</ao:hasSource>
    <ao:suffix>, but quinidine does not alter the kinetics of diltiazem.</ao:suffix>
    <ao:prefix>significantly decreases the clearance and increases the t1/2 of </ao:prefix>
    <pav:createdOn>2014-07-21 21:47:22 -0400</pav:createdOn>
    <domeo:uuid>805A260D-8C6D-4764-98FF-7A828A5A8A65</domeo:uuid>
    <ao:exact>quinidine</ao:exact>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:805A260D-8C6D-4764-98FF-7A828A5A8A65"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:7990829B-F65B-4D7A-B0B9-46A365009737">
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812eda990003</pav:createdBy>
    <ao:context rdf:resource="urn:domeoclient:uuid:3AA77CCF-FE2A-48F6-9346-1114AFD695DA"/>
    <domeo:belongsToSet>urn:domeoclient:uuid:B61F1A9B-4696-4ED0-80AA-4FE2E9016966</domeo:belongsToSet>
    <pav:lineageUri>urn:domeoserver:annotation:B1BFEACD-2C0F-411A-ABC8-BA247A926C11</pav:lineageUri>
    <pav:createdOn>2014-07-21 21:34:02 -0400</pav:createdOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:lastSavedOn>2014-07-21 21:35:10 -0400</pav:lastSavedOn>
    <rdfs:label>Highlight</rdfs:label>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:F1AECF5B-0B80-4F34-AE54-273DA1B3D41A">
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <rdfs:label>Highlight</rdfs:label>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <pav:createdOn>2014-09-02 19:09:15 -0400</pav:createdOn>
    <ao:context rdf:resource="urn:domeoclient:uuid:7E51D112-F22F-4792-B99B-6D615797BAEB"/>
    <pav:lineageUri>urn:domeoserver:annotation:4ADEE51B-1E69-45C2-A11C-A971981D4762</pav:lineageUri>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812eda990003</pav:createdBy>
    <domeo:belongsToSet>urn:domeoclient:uuid:3966BCFB-CA02-4053-828D-3860558E7BE8</domeo:belongsToSet>
    <pav:lastSavedOn>2014-09-02 19:11:13 -0400</pav:lastSavedOn>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:0ED57E86-1291-4DDA-9436-EC8F43B4A452">
    <ao:prefix>. Following multiple doses of </ao:prefix>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-74.txt.html</ao:hasSource>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:exact>nelfinavir</ao:exact>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:0ED57E86-1291-4DDA-9436-EC8F43B4A452"/>
    <domeo:uuid>0ED57E86-1291-4DDA-9436-EC8F43B4A452</domeo:uuid>
    <pav:createdOn>2014-09-02 19:28:25 -0400</pav:createdOn>
    <ao:suffix> (1250 mg, bid) and </ao:suffix>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:8CCC8C43-B443-46E4-8630-042448CA24F6">
    <ao:exact>fluconazole </ao:exact>
    <ao:suffix>(oral fluconazole 200 mg daily for 16 days) in 10 normal male volunteers. There was a significant increase in phenytoin AUC. The mean ± SD increase in phenytoin AUC was 88% ± 68% (range: 16 to 247%). The absolute magnitude of this interaction is unknown </ao:suffix>
    <ao:prefix>dosing (200 mg daily, orally for 3 days followed by 250 mg intravenously for one dose) both with and without the administration of </ao:prefix>
    <domeo:uuid>8CCC8C43-B443-46E4-8630-042448CA24F6</domeo:uuid>
    <pav:createdOn>2014-07-21 21:26:52 -0400</pav:createdOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-25.txt.html</ao:hasSource>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:8CCC8C43-B443-46E4-8630-042448CA24F6"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:095C4B55-33C1-4413-83DF-963BC2158506">
    <pav:createdOn>2014-09-02 19:08:37 -0400</pav:createdOn>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812eda990003</pav:createdBy>
    <rdfs:label>Highlight</rdfs:label>
    <pav:lineageUri>urn:domeoserver:annotation:390EB652-B284-46B4-B184-503F54659708</pav:lineageUri>
    <pav:lastSavedOn>2014-09-02 19:11:13 -0400</pav:lastSavedOn>
    <domeo:belongsToSet>urn:domeoclient:uuid:3966BCFB-CA02-4053-828D-3860558E7BE8</domeo:belongsToSet>
    <ao:context rdf:resource="urn:domeoclient:uuid:3D56C301-550F-4FAE-8357-941B7D128A4B"/>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:7E51D112-F22F-4792-B99B-6D615797BAEB">
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-72.txt.html</ao:hasSource>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:exact>oxycodone</ao:exact>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:7E51D112-F22F-4792-B99B-6D615797BAEB"/>
    <ao:prefix>, a CYP3A4 inhibitor, significantly increased the plasma concentrations of </ao:prefix>
    <domeo:uuid>7E51D112-F22F-4792-B99B-6D615797BAEB</domeo:uuid>
    <ao:suffix>. Inhibition of CYP3A4 activity by its inhibitors, such as macrolide antibiotics (e.g., erythromycin), azole-antifungal agents (e.g., ketoconazole), and protease inhibitors (e.g., ritonavir), may prolong opioid effects. If co-administration is necessary,</ao:suffix>
    <pav:createdOn>2014-09-02 19:09:15 -0400</pav:createdOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:5C47D157-D8A4-4053-B2C7-7ECD1B16B721">
    <ao:context rdf:resource="urn:domeoclient:uuid:709146DB-F43F-4A5F-B3FB-C395469E387B"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <rdfs:label>Highlight</rdfs:label>
    <domeo:belongsToSet>urn:domeoserver:annotationset:2914A3FD-DF43-4F78-999C-77CE7A028B19</domeo:belongsToSet>
    <domeo:belongsToSet>urn:domeoserver:annotationset:514BA51B-D734-4003-A7C3-F03C0F95833A</domeo:belongsToSet>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <pav:lineageUri>urn:domeoserver:annotation:B43BF560-F039-4E65-9579-451511377727</pav:lineageUri>
    <domeo:belongsToSet>urn:domeoserver:annotationset:7E80543E-BF76-4514-92A9-91458DCB802B</domeo:belongsToSet>
    <domeo:belongsToSet>urn:domeoserver:annotationset:606A5B3F-B6FB-4279-AA42-7893CFC2D20C</domeo:belongsToSet>
    <pav:lineageUri>urn:domeoserver:annotationset:AB1741F1-5A5F-4416-AEAC-A544BCBB7D16</pav:lineageUri>
    <domeo:belongsToSet>urn:domeoserver:annotationset:467D4F28-D086-4217-9DE0-23E165F30716</domeo:belongsToSet>
    <pav:createdOn>2014-07-22 19:12:50 -0400</pav:createdOn>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812eda990003</pav:createdBy>
    <domeo:belongsToSet>urn:domeoserver:annotationset:F272A789-69D0-47CC-8CC9-F25C55B91261</domeo:belongsToSet>
    <pav:lastSavedOn>2014-07-22 19:15:50 -0400</pav:lastSavedOn>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">2</pav:versionNumber>
    <pav:previousVersion>urn:domeoclient:uuid:BE4B86AC-FE5F-4543-A713-EC5B852A5A2A</pav:previousVersion>
    <domeo:belongsToSet>urn:domeoserver:annotationset:7021B883-FD5C-4083-BD87-DF56D3C87633</domeo:belongsToSet>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:CB01A892-8D67-4A38-8CA4-2D230875A1F6">
    <pav:createdOn>2014-07-13 11:17:12 -0400</pav:createdOn>
    <ao:exact>risperidone</ao:exact>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:suffix> and 9-hydroxyrisperidone combined, after single and multiple doses, were similar in extensive and poor metabolizers, with an overall mean elimination half-life of about 20 hours.</ao:suffix>
    <ao:prefix> was about 21 hours (CV=20%) in extensive metabolizers and 30 hours (CV=25%) in poor metabolizers. The pharmacokinetics of </ao:prefix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:CB01A892-8D67-4A38-8CA4-2D230875A1F6"/>
    <domeo:uuid>CB01A892-8D67-4A38-8CA4-2D230875A1F6</domeo:uuid>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-8.txt.html</ao:hasSource>
  </rdf:Description>
  <rdf:Description rdf:nodeID="Na8a7bae9105f41b3b7169745044886c2">
    <permissions:isLocked>false</permissions:isLocked>
    <permissions:accessType>urn:domeo:access:public</permissions:accessType>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:DD1327AF-4B75-4BEA-B917-539687934A1F">
    <ao:suffix> may be necessary and it is recommended that atomoxetine be initiated at a reduced dose when given with paroxetine.</ao:suffix>
    <ao:exact>atomoxetine</ao:exact>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:DD1327AF-4B75-4BEA-B917-539687934A1F"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <pav:createdOn>2014-09-02 12:03:40 -0400</pav:createdOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:prefix> 20 mg atomoxetine every 12 hours. This resulted in increases in steady state atomoxetine AUC values that were 6- to 8-fold greater and in atomoxetine Cmax values that were 3- to 4-fold greater than when atomoxetine was given alone. Dosage adjustment of </ao:prefix>
    <domeo:uuid>DD1327AF-4B75-4BEA-B917-539687934A1F</domeo:uuid>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-47.txt.html</ao:hasSource>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:8301C100-8F47-4B2E-A908-FF663A864A1E">
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-139.txt.html</ao:hasSource>
    <ao:prefix> led to increased plasma concentrations of </ao:prefix>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:8301C100-8F47-4B2E-A908-FF663A864A1E"/>
    <ao:suffix> in healthy adult subjects. Fexofenadine had no effect on the pharmacokinetics of either erythromycin or ketoconazole. In two separate studies in healthy adult subjects, fexofenadine hydrochloride 120 mg twice daily (240 mg total daily dose) was coadmini</ao:suffix>
    <domeo:uuid>8301C100-8F47-4B2E-A908-FF663A864A1E</domeo:uuid>
    <ao:exact>fexofenadine</ao:exact>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <pav:createdOn>2014-07-24 20:07:25 -0400</pav:createdOn>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:09CCA90F-F1D9-49A6-A47E-B693A373A03E">
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:lineageUri>urn:domeoserver:annotation:13221C48-455C-448D-963D-B21F34F136A4</pav:lineageUri>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:createdOn>2014-07-24 20:14:49 -0400</pav:createdOn>
    <domeo:belongsToSet>urn:domeoclient:uuid:2BAA59CB-3862-4A98-8A6C-AA14E82983DC</domeo:belongsToSet>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <pav:lastSavedOn>2014-07-24 20:14:43 -0400</pav:lastSavedOn>
    <ao:context rdf:resource="urn:domeoclient:uuid:1A2265F0-B7D6-4A47-834F-F540E39BE257"/>
    <rdfs:label>Highlight</rdfs:label>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812eda990003</pav:createdBy>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:4E6639F4-F4C8-45C0-82E0-34A805D7B468">
    <domeo:uuid>4E6639F4-F4C8-45C0-82E0-34A805D7B468</domeo:uuid>
    <pav:createdOn>2014-07-24 19:55:04 -0400</pav:createdOn>
    <ao:suffix>with </ao:suffix>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:4E6639F4-F4C8-45C0-82E0-34A805D7B468"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:exact>chlorpromazine </ao:exact>
    <ao:prefix>Co-administration of </ao:prefix>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-134.txt.html</ao:hasSource>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:A4B2C542-4FBC-4849-8602-BB3245792CC3">
    <ao:suffix> is approximately 99.8% bound to plasma proteins, primarily albumin.</ao:suffix>
    <domeo:uuid>A4B2C542-4FBC-4849-8602-BB3245792CC3</domeo:uuid>
    <ao:prefix> is approximately 17.6 (30%) liters, based on a population pharmacokinetic analysis. </ao:prefix>
    <pav:createdOn>2014-07-22 19:26:11 -0400</pav:createdOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-123.txt.html</ao:hasSource>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:exact>Rosiglitazone</ao:exact>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:A4B2C542-4FBC-4849-8602-BB3245792CC3"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:5A04C3C3-B677-4732-87D0-83C03497D24C">
    <ao:prefix>In patients receiving </ao:prefix>
    <pav:createdOn>2014-09-01 16:11:59 -0400</pav:createdOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <domeo:uuid>5A04C3C3-B677-4732-87D0-83C03497D24C</domeo:uuid>
    <ao:suffix>or azathioprine, the concomitant administration of 300 to 600 mg of allopurinol sodium for injection per day will require a reduction in dose to approximately one-third to one-fourth of the usual dose of mercaptopurine or azathioprine. Subsequent adjustm</ao:suffix>
    <ao:exact>mercaptopurine </ao:exact>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-42.txt.html</ao:hasSource>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:5A04C3C3-B677-4732-87D0-83C03497D24C"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:2BF9F224-82C0-470E-9645-8A6965E66A04">
    <domeo:uuid>2BF9F224-82C0-470E-9645-8A6965E66A04</domeo:uuid>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:prefix> 50 mg once daily for 10 days in 10 healthy women. </ao:prefix>
    <pav:createdOn>2014-07-13 12:45:35 -0400</pav:createdOn>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-22.txt.html</ao:hasSource>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:suffix> The mean increase in</ao:suffix>
    <ao:exact>There was no significant difference in ethinyl estradiol or levonorgestrel AUC after the administration of 50 mg of fluconazole.</ao:exact>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:2BF9F224-82C0-470E-9645-8A6965E66A04"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:A3654752-C204-49F0-B3F7-87C2EE277992">
    <domeo:uuid>A3654752-C204-49F0-B3F7-87C2EE277992</domeo:uuid>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-8.txt.html</ao:hasSource>
    <ao:prefix> is a selective monoaminergic antagonist with high affinity (Ki of 0.12 to 7.3 nM) for the </ao:prefix>
    <ao:exact>serotonin</ao:exact>
    <pav:createdOn>2014-07-13 11:07:24 -0400</pav:createdOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:suffix> Type 2 (5HT2), dopamine Type 2 (D2), α1 and α2 adrenergic, and H1 histaminergic receptors. Risperidone acts as an antagonist at other receptors, but with lower potency. Risperidone has low to moderate affinity (Ki of 47 to 253 nM) for the serotonin 5HT1</ao:suffix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:A3654752-C204-49F0-B3F7-87C2EE277992"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:AD7D1F18-857F-4502-9621-F93B88E936D2">
    <domeo:agents rdf:resource="urn:domeo:software:id:Domeo-2.1alpha-050"/>
    <dct:description>The default set is created automatically by Domeo when no other set is existing.</dct:description>
    <pav:lastSavedOn>2014-07-28 17:00:02 -0400</pav:lastSavedOn>
    <pav:lineageUri>urn:domeoserver:annotationset:C1303ECA-74F2-4ED6-A92B-92FD35350359</pav:lineageUri>
    <ao:item rdf:resource="urn:domeoclient:uuid:62E1503B-EE9D-40BF-B77B-6779195F8F1F"/>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <rdfs:label>Default Set</rdfs:label>
    <domeo:deleted>false</domeo:deleted>
    <ao:item rdf:resource="urn:domeoclient:uuid:812F20EC-B150-4CC7-8C67-07A45894D904"/>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812eda990003</pav:createdBy>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#AnnotationSet"/>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:createdOn>2014-07-28 17:00:13 -0400</pav:createdOn>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <permissions:permissions rdf:nodeID="Nc9e39d9039b9464f8b8c4f19de24715b"/>
    <domeo:agents rdf:resource="urn:person:uuid:080e143046812afe0146812eda990003"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:F9664F35-3DEE-47BF-95B4-E93F2BBC1965"/>
    <ao:annotatesResource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-163.txt.html</ao:annotatesResource>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:938EFE6C-8A23-4829-AFA7-544CDA08913A">
    <dikbD2R:modality>ncit:positive</dikbD2R:modality>
    <dikbD2R:statement>ncit:Qualitative</dikbD2R:statement>
    <sio:SIO_000628 rdf:resource="urn:pddi:uuid:4BE7A024-EE88-4E7C-BCF8-571E06F8C6B1"/>
    <rdf:type rdf:resource="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#DrugDrugInteractionStatement"/>
    <sio:SIO_000205>dikbD2R:statement</sio:SIO_000205>
    <sio:SIO_000563>dikbD2R:modality</sio:SIO_000563>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:B9805A65-BB53-4315-AF92-EC703ABB5E61">
    <pav:createdOn>2014-07-21 21:52:27 -0400</pav:createdOn>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812eda990003</pav:createdBy>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <domeo:belongsToSet>urn:domeoclient:uuid:C988D053-7CF3-4C50-BDB6-7C2B20B837B9</domeo:belongsToSet>
    <pav:lastSavedOn>2014-07-21 21:55:00 -0400</pav:lastSavedOn>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <rdfs:label>Highlight</rdfs:label>
    <ao:context rdf:resource="urn:domeoclient:uuid:A838F94E-4F5C-413B-9E9E-051199F7FC9F"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <pav:lineageUri>urn:domeoserver:annotation:6F61CF5F-2523-4A70-8E41-8F13894A8AF1</pav:lineageUri>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:3357AB7A-4128-4D9D-8FEF-3908BC9E44F0">
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:suffix> is a registered trademark of Novartis Consumer Healthcare.</ao:suffix>
    <pav:createdOn>2014-07-24 20:07:04 -0400</pav:createdOn>
    <domeo:uuid>3357AB7A-4128-4D9D-8FEF-3908BC9E44F0</domeo:uuid>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-139.txt.html</ao:hasSource>
    <ao:exact>Maalox®</ao:exact>
    <ao:prefix>1 </ao:prefix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:3357AB7A-4128-4D9D-8FEF-3908BC9E44F0"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:0569E8E5-928F-4D8D-93AE-056F350503EF">
    <rdfs:label>Highlight</rdfs:label>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:lineageUri>urn:domeoserver:annotation:FC7F51C8-D140-4695-B609-DCDA64270F6D</pav:lineageUri>
    <domeo:belongsToSet>urn:domeoclient:uuid:EC9B90D7-F9B5-4E51-94E2-878FAA06F611</domeo:belongsToSet>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812eda990003</pav:createdBy>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:createdOn>2014-07-13 12:46:15 -0400</pav:createdOn>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <ao:context rdf:resource="urn:domeoclient:uuid:0C6FF426-D0F6-4DFE-8C13-8BD0EAA98C6F"/>
    <pav:lastSavedOn>2014-07-13 12:48:45 -0400</pav:lastSavedOn>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:2BF35833-2A3B-4AAC-BA24-329D7F891DC5">
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-26.txt.html</ao:hasSource>
    <domeo:uuid>2BF35833-2A3B-4AAC-BA24-329D7F891DC5</domeo:uuid>
    <ao:suffix>. The mean ± SD increase in AUC was 92% ± 43% (range: 18 to 147%). The Cmax increased 60% ± 48% (range: -5 to 133%). The Cmin increased 157% ± 96% (range: 33 to 360%). The apparent oral clearance decreased 45% ± 15% (range: -15 to -60%). (See PRECAUTIONS</ao:suffix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:2BF35833-2A3B-4AAC-BA24-329D7F891DC5"/>
    <ao:prefix>AUC, Cmax, Cmin (24-hour concentration), and a significant reduction in apparent oral clearance following the administration of </ao:prefix>
    <ao:exact>fluconazole</ao:exact>
    <pav:createdOn>2014-07-21 21:28:42 -0400</pav:createdOn>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:E5FE9EFB-83B0-4935-97F9-6C46842B3260">
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/07C054FB-6445-437D-B6D9-477EF937289F"/>
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/58FED583-F7D0-4B0E-913A-6142C90539F0"/>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/PK_DDI"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:0EEDF160-BB48-4F3A-8FC7-D52C908CAECC">
    <pav:createdOn>2014-07-24 20:07:14 -0400</pav:createdOn>
    <rdfs:label>Highlight</rdfs:label>
    <domeo:belongsToSet>urn:domeoclient:uuid:8D86A4AC-54BD-4BB3-8B58-AB55DEC01A88</domeo:belongsToSet>
    <domeo:belongsToSet>urn:domeoserver:annotationset:1FC172B8-8AC3-465A-AA69-B73AD9B97CBC</domeo:belongsToSet>
    <pav:lastSavedOn>2014-07-24 20:07:20 -0400</pav:lastSavedOn>
    <ao:context rdf:resource="urn:domeoclient:uuid:CD89FD03-D99F-41BD-9614-0F760DFF0EFC"/>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:lineageUri>urn:domeoserver:annotation:256E240C-5D82-40E1-8FF3-F2928321333B</pav:lineageUri>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812eda990003</pav:createdBy>
    <domeo:belongsToSet>urn:domeoserver:annotationset:37B2514D-1A92-45B1-8A5C-610DA6DC935A</domeo:belongsToSet>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:lastSavedOn>2014-07-24 20:07:19 -0400</pav:lastSavedOn>
    <pav:lineageUri>urn:domeoserver:annotationset:4A88D0A6-E9B6-4E7F-955F-3692600C178C</pav:lineageUri>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:713FC0EF-F420-4182-BCC3-9D97A1296B91">
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <domeo:uuid>713FC0EF-F420-4182-BCC3-9D97A1296B91</domeo:uuid>
    <ao:suffix> delayed-release capsules USP.</ao:suffix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:713FC0EF-F420-4182-BCC3-9D97A1296B91"/>
    <pav:createdOn>2014-09-02 19:13:24 -0400</pav:createdOn>
    <ao:exact>omeprazole</ao:exact>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-74.txt.html</ao:hasSource>
    <ao:prefix>). Patients should be monitored to determine if it is necessary to adjust the dosage of these drugs when taken concomitantly with </ao:prefix>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:53465311-823E-4CB3-9C24-4241F449E2C3">
    <pav:createdOn>2014-07-21 21:38:52 -0400</pav:createdOn>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-29.txt.html</ao:hasSource>
    <ao:exact>Tolbutamide </ao:exact>
    <ao:suffix>Cmax increased 11% ± 9% (range: -6 to 27%). (See PRECAUTIONS.)</ao:suffix>
    <ao:prefix>AUC of 26% ± 9% (range: 12 to 39%). </ao:prefix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <domeo:uuid>53465311-823E-4CB3-9C24-4241F449E2C3</domeo:uuid>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:53465311-823E-4CB3-9C24-4241F449E2C3"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:7950DCED-7411-4B59-B629-CB1341A53897">
    <ao:suffix>on Blood Pressure</ao:suffix>
    <pav:createdOn>2014-07-07 09:51:17 -0400</pav:createdOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <domeo:uuid></domeo:uuid>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:7950DCED-7411-4B59-B629-CB1341A53897"/>
    <ao:exact>REVATIO </ao:exact>
    <ao:prefix>Effects of </ao:prefix>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-155.txt.html</ao:hasSource>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <domeo:uuid>7950DCED-7411-4B59-B629-CB1341A53897</domeo:uuid>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:E8680340-7715-4656-A160-A6F608AD7CE9">
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <domeo:belongsToSet>urn:domeoclient:uuid:71191E51-53CB-4FDE-88D0-33C6818E2232</domeo:belongsToSet>
    <pav:lastSavedOn>2014-07-13 11:32:29 -0400</pav:lastSavedOn>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <pav:lineageUri>urn:domeoserver:annotation:9F72602C-A51D-443A-8FED-EF0310ADB89F</pav:lineageUri>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:createdOn>2014-07-13 11:08:54 -0400</pav:createdOn>
    <ao:context rdf:resource="urn:domeoclient:uuid:F31EE1EC-A22F-4FE9-8763-7C623AD7B0BE"/>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812eda990003</pav:createdBy>
    <rdfs:label>Highlight</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:EBFA7BB9-378D-445C-9A8F-2DF6D035AC7D">
    <pav:lastSavedOn>2014-07-24 19:53:55 -0400</pav:lastSavedOn>
    <pav:createdOn>2014-07-24 19:53:06 -0400</pav:createdOn>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812eda990003</pav:createdBy>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:lineageUri>urn:domeoserver:annotation:FCB9971B-E34D-4290-8946-8F66C9B4F25A</pav:lineageUri>
    <rdfs:label>Highlight</rdfs:label>
    <domeo:belongsToSet>urn:domeoclient:uuid:E0863579-8D19-4B30-ADD6-2A5BDBC2F482</domeo:belongsToSet>
    <ao:context rdf:resource="urn:domeoclient:uuid:E0BA7513-EC9D-435D-8BE2-617311ADA2D8"/>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:3E13A2A1-DB0E-49CA-8B2D-2D7FD2760FEC">
    <ao:exact>Maalox®1</ao:exact>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <pav:createdOn>2014-07-24 20:06:30 -0400</pav:createdOn>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:3E13A2A1-DB0E-49CA-8B2D-2D7FD2760FEC"/>
    <ao:suffix>) decreased fexofenadine AUC by 41% and Cmax by 43%.</ao:suffix>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-139.txt.html</ao:hasSource>
    <ao:prefix> containing antacid (</ao:prefix>
    <domeo:uuid>3E13A2A1-DB0E-49CA-8B2D-2D7FD2760FEC</domeo:uuid>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:5F95A684-4F34-42D2-8F26-ACB40DD06487">
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <pav:createdOn>2014-07-21 21:26:56 -0400</pav:createdOn>
    <ao:prefix>(oral fluconazole 200 mg daily for 16 days) in 10 normal male volunteers. There was a significant increase in </ao:prefix>
    <domeo:uuid>5F95A684-4F34-42D2-8F26-ACB40DD06487</domeo:uuid>
    <ao:suffix>AUC. The mean ± SD increase in phenytoin AUC was 88% ± 68% (range: 16 to 247%). The absolute magnitude of this interaction is unknown because of the intrinsically nonlinear disposition of phenytoin. (See PRECAUTIONS.)</ao:suffix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-25.txt.html</ao:hasSource>
    <ao:exact>phenytoin </ao:exact>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:5F95A684-4F34-42D2-8F26-ACB40DD06487"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:B7CF0599-4EF7-4EA9-AA71-F3F0B7596EF6">
    <pav:createdOn>2014-07-13 11:26:44 -0400</pav:createdOn>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-8.txt.html</ao:hasSource>
    <ao:suffix>xsd:String</ao:suffix>
    <ao:exact>The mechanism of action of risperidone, as with other drugs used to treat schizophrenia, is unknown. However, it has been proposed that the drug’s therapeutic activity in schizophrenia is mediated through a combination of dopamine Type 2 (D2) and serotonin Type 2 (5HT2) receptor antagonism.</ao:exact>
    <ao:prefix>xsd:String</ao:prefix>
    <domeo:uuid>B7CF0599-4EF7-4EA9-AA71-F3F0B7596EF6</domeo:uuid>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:B7CF0599-4EF7-4EA9-AA71-F3F0B7596EF6"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:FA96F07E-C088-44C7-AC16-D0EBD7DBD41D">
    <domeo:belongsToSet>urn:domeoserver:annotationset:F272A789-69D0-47CC-8CC9-F25C55B91261</domeo:belongsToSet>
    <pav:lineageUri>urn:domeoserver:annotation:15B0865D-E37E-4EE8-A530-A220B9709931</pav:lineageUri>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812eda990003</pav:createdBy>
    <pav:previousVersion>urn:domeoserver:annotationset:7021B883-FD5C-4083-BD87-DF56D3C87633</pav:previousVersion>
    <pav:lastSavedOn>2014-07-22 19:40:32 -0400</pav:lastSavedOn>
    <ao:context rdf:resource="urn:domeoclient:uuid:D23F4554-62F9-4BD8-A750-B7F24EF0C57E"/>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <domeo:belongsToSet>urn:domeoserver:annotationset:606A5B3F-B6FB-4279-AA42-7893CFC2D20C</domeo:belongsToSet>
    <pav:createdOn>2014-07-22 19:38:36 -0400</pav:createdOn>
    <pav:lineageUri>urn:domeoserver:annotationset:AB1741F1-5A5F-4416-AEAC-A544BCBB7D16</pav:lineageUri>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <rdfs:label>Highlight</rdfs:label>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <domeo:belongsToSet>urn:domeoserver:annotationset:2914A3FD-DF43-4F78-999C-77CE7A028B19</domeo:belongsToSet>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">5</pav:versionNumber>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <pav:lastSavedOn>2014-07-22 19:40:31 -0400</pav:lastSavedOn>
    <domeo:belongsToSet>urn:domeoserver:annotationset:514BA51B-D734-4003-A7C3-F03C0F95833A</domeo:belongsToSet>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:454E7688-A4B1-42BF-86B5-6E1A3C88986A">
    <pav:createdOn>2014-07-13 11:10:25 -0400</pav:createdOn>
    <domeo:belongsToSet>urn:domeoclient:uuid:71191E51-53CB-4FDE-88D0-33C6818E2232</domeo:belongsToSet>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <pav:lastSavedOn>2014-07-13 11:32:29 -0400</pav:lastSavedOn>
    <rdfs:label>Highlight</rdfs:label>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812eda990003</pav:createdBy>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <ao:context rdf:resource="urn:domeoclient:uuid:EEDA4663-FBED-4C68-848C-30943B88C061"/>
    <pav:lineageUri>urn:domeoserver:annotation:B5E9E5D3-CEDE-43AC-A6D0-E7513DB65222</pav:lineageUri>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:CBCBF368-3CFC-48BC-94C0-C6E5CA87262D">
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812eda990003</pav:createdBy>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <ao:context rdf:resource="urn:domeoclient:uuid:68293B6C-C124-4A8B-AD38-563F597E9486"/>
    <pav:lineageUri>urn:domeoserver:annotation:56F09161-F30B-4E8B-B945-EBDA08D0D771</pav:lineageUri>
    <pav:createdOn>2014-07-22 18:52:17 -0400</pav:createdOn>
    <rdfs:label>Highlight</rdfs:label>
    <pav:lastSavedOn>2014-07-22 18:54:35 -0400</pav:lastSavedOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <domeo:belongsToSet>urn:domeoclient:uuid:3D195979-3E82-427D-95B8-F50F48DB4AA7</domeo:belongsToSet>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:B9D56D7C-5C37-4BCA-B9C4-0605E9E54998">
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:exact>sildenafil</ao:exact>
    <domeo:uuid></domeo:uuid>
    <ao:suffix>, and is, itself, further metabolized. This metabolite has a phosphodiesterase selectivity profile similar to sildenafil and an in vitro potency for PDE5 approximately 50% of the parent drug. In healthy volunteers, plasma concentrations of this metabolit</ao:suffix>
    <ao:prefix>of </ao:prefix>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-155.txt.html</ao:hasSource>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <domeo:uuid>B9D56D7C-5C37-4BCA-B9C4-0605E9E54998</domeo:uuid>
    <pav:createdOn>2014-07-07 09:43:42 -0400</pav:createdOn>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:B9D56D7C-5C37-4BCA-B9C4-0605E9E54998"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:C624C116-E8F0-4A10-B8B2-BC8AA88D6B11">
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-9.txt.html</ao:hasSource>
    <ao:suffix> syndrome with use of an SSRI and a </ao:suffix>
    <ao:prefix>Triptans: There have been rare postmarketing reports of </ao:prefix>
    <pav:createdOn>2014-09-02 11:43:24 -0400</pav:createdOn>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:C624C116-E8F0-4A10-B8B2-BC8AA88D6B11"/>
    <domeo:uuid>C624C116-E8F0-4A10-B8B2-BC8AA88D6B11</domeo:uuid>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:exact>serotonin</ao:exact>
  </rdf:Description>
  <rdf:Description rdf:nodeID="N2ec233fed53345eaba2278fea73088e8">
    <permissions:accessType>urn:domeo:access:public</permissions:accessType>
    <permissions:isLocked>false</permissions:isLocked>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:5DB19655-BFA0-4BCE-93AA-DD6B932E259B">
    <ao:exact>fluoxetine</ao:exact>
    <ao:prefix> have been rare postmarketing reports describing patients with weakness, hyperreflexia, and incoordination following the use of a selective serotonin reuptake inhibitor (SSRI) and sumatriptan. If concomitant treatment with sumatriptan and an SSRI (e.g., </ao:prefix>
    <domeo:uuid>5DB19655-BFA0-4BCE-93AA-DD6B932E259B</domeo:uuid>
    <pav:createdOn>2014-09-02 11:43:51 -0400</pav:createdOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:suffix>, fluvoxamine, paroxetine, sertraline) is clinically warranted, appropriate observation of the patient is advised.</ao:suffix>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-9.txt.html</ao:hasSource>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:5DB19655-BFA0-4BCE-93AA-DD6B932E259B"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:F0A9334D-2A9F-4B70-AC7A-5A574EACCA65">
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812eda990003</pav:createdBy>
    <domeo:belongsToSet>urn:domeoserver:annotationset:3F546823-204F-4F9B-9006-3DC526C56931</domeo:belongsToSet>
    <domeo:belongsToSet>urn:domeoserver:annotationset:A5DD001D-C81A-4E2E-B5E0-7A866B35E26B</domeo:belongsToSet>
    <domeo:belongsToSet>urn:domeoclient:uuid:BED41F06-565A-4622-9A88-48810E5A28DE</domeo:belongsToSet>
    <pav:createdOn>2014-09-02 11:35:32 -0400</pav:createdOn>
    <pav:lineageUri>urn:domeoserver:annotationset:D1715BD2-BD41-46FD-9454-DC7A423A29AC</pav:lineageUri>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:lineageUri>urn:domeoserver:annotation:41FD3A53-B3A9-473C-A78F-FFA1013DD281</pav:lineageUri>
    <domeo:belongsToSet>urn:domeoserver:annotationset:A3F0B39A-4249-4B63-BB0D-F24A005066AC</domeo:belongsToSet>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <pav:lastSavedOn>2014-09-02 11:35:33 -0400</pav:lastSavedOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <rdfs:label>Highlight</rdfs:label>
    <ao:context rdf:resource="urn:domeoclient:uuid:FC36AAD8-731B-4089-8CD4-237A818B35C9"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:B294F73B-169E-4106-90EF-3C87099953E8">
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:prefix>xsd:String</ao:prefix>
    <domeo:uuid>B294F73B-169E-4106-90EF-3C87099953E8</domeo:uuid>
    <ao:suffix> Antagonism at receptors other than D2 and 5HT2 [see 12 CLINICAL PHARMACOLOGY] may explain some of the other effects of risperidone</ao:suffix>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-8.txt.html</ao:hasSource>
    <ao:exact>The clinical effect from risperidone results from the combined concentrations of risperidone and its major metabolite, 9-hydroxyrisperidone [see 12 CLINICAL PHARMACOLOGY].</ao:exact>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:B294F73B-169E-4106-90EF-3C87099953E8"/>
    <pav:createdOn>2014-07-13 11:29:18 -0400</pav:createdOn>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:A97D0542-D1E0-45E8-A59A-491B0F6B5ABF">
    <ao:exact>lorazepam</ao:exact>
    <pav:createdOn>2014-09-02 11:38:56 -0400</pav:createdOn>
    <ao:suffix> alone.</ao:suffix>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-9.txt.html</ao:hasSource>
    <ao:prefix> did not produce larger mean decrements compared to </ao:prefix>
    <domeo:uuid>A97D0542-D1E0-45E8-A59A-491B0F6B5ABF</domeo:uuid>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:A97D0542-D1E0-45E8-A59A-491B0F6B5ABF"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:1B51833F-74F3-4AB3-A6D0-CD524F9F3140">
    <domeo:uuid>1B51833F-74F3-4AB3-A6D0-CD524F9F3140</domeo:uuid>
    <pav:createdOn>2014-09-02 11:38:06 -0400</pav:createdOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:prefix>Lorazepam: A study of multiple doses of </ao:prefix>
    <ao:exact>fluvoxamine</ao:exact>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:1B51833F-74F3-4AB3-A6D0-CD524F9F3140"/>
    <ao:suffix> maleate (50 mg b.i.d.) in healthy male volunteers (N = 12) and a single dose of lorazepam (4 mg single dose) indicated no significant pharmacokinetic interaction. On average, both lorazepam alone and lorazepam with fluvoxamine produced substantial decre</ao:suffix>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-9.txt.html</ao:hasSource>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:C1836E85-2D43-46EF-848C-F6204E5A50A7">
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <rdfs:label>Highlight</rdfs:label>
    <pav:lastSavedOn>2014-07-13 12:56:57 -0400</pav:lastSavedOn>
    <pav:createdOn>2014-07-13 12:56:03 -0400</pav:createdOn>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <ao:context rdf:resource="urn:domeoclient:uuid:42DD4654-83AE-4111-86D8-574617EB3CAB"/>
    <domeo:belongsToSet>urn:domeoclient:uuid:E89548FF-A4A2-4B87-B1E1-B12E3E255FA1</domeo:belongsToSet>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:lineageUri>urn:domeoserver:annotation:67C91220-39BA-4E36-AF83-B063DCBE7679</pav:lineageUri>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812eda990003</pav:createdBy>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:5D480921-AA61-499B-9C3F-3043269104B4">
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <ao:context rdf:resource="urn:domeoclient:uuid:CFAD9029-E218-4465-9975-0A69DA967891"/>
    <domeo:belongsToSet>urn:domeoserver:annotationset:7AACEF8D-2EBC-4F0B-94B2-190650E562F6</domeo:belongsToSet>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812eda990003</pav:createdBy>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:lineageUri>urn:domeoserver:annotation:AB0B3697-93C5-4EDB-AE47-84A16A407797</pav:lineageUri>
    <pav:lastSavedOn>2014-07-07 09:44:18 -0400</pav:lastSavedOn>
    <domeo:belongsToSet>urn:domeoserver:annotationset:08C0C288-6DF4-43E6-A618-71A8BB9563C3</domeo:belongsToSet>
    <pav:lineageUri>urn:domeoserver:annotationset:76FD4BB5-DE2F-4FCA-B93D-302185B1A381</pav:lineageUri>
    <domeo:belongsToSet>urn:domeoserver:annotationset:22ED7220-C6F6-43C5-9DF9-89F62F0F8E27</domeo:belongsToSet>
    <domeo:belongsToSet>urn:domeoclient:uuid:FCA2BF23-0BE3-409F-9177-761812F96097</domeo:belongsToSet>
    <domeo:belongsToSet>urn:domeoserver:annotationset:131835A3-C655-4F91-97D4-52CAFF7B7CCA</domeo:belongsToSet>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <rdfs:label>Highlight</rdfs:label>
    <pav:createdOn>2014-07-07 09:40:13 -0400</pav:createdOn>
    <pav:lastSavedOn>2014-07-07 09:44:19 -0400</pav:lastSavedOn>
    <domeo:belongsToSet>urn:domeoserver:annotationset:8F3CF3D9-AADE-4A86-BD42-2924B3D6A406</domeo:belongsToSet>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/F83742D9-BF1E-4B6B-9F1C-2CC08800D877">
    <dct:description>Referred to the drug in the interaction.</dct:description>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/active-ingredient"/>
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/4719</dailymed:activeMoietyRxCUI>
    <rdfs:label>gemfibrozil</rdfs:label>
    <sio:SIO_000228>dikbD2R:precipitant-drug-of-interaction</sio:SIO_000228>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:FC36AAD8-731B-4089-8CD4-237A818B35C9">
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-9.txt.html</ao:hasSource>
    <ao:prefix>fluvoxami</ao:prefix>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:FC36AAD8-731B-4089-8CD4-237A818B35C9"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:exact>ne</ao:exact>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <domeo:uuid>FC36AAD8-731B-4089-8CD4-237A818B35C9</domeo:uuid>
    <pav:createdOn>2014-09-02 11:35:32 -0400</pav:createdOn>
    <ao:suffix> has not been fully characterized and the effects of potent cytochrome P450 isoenzyme inhibition, such as the ketoconazole inhibition of CYP3A4, on fluvoxamine metabolism have not been studied</ao:suffix>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/E8F2CA32-13F5-477A-BE7F-DE4F66964CFD">
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/2002</dailymed:activeMoietyRxCUI>
    <rdfs:label>carbamazepine</rdfs:label>
    <sio:SIO_000228>dikbD2R:object-drug-of-interaction</sio:SIO_000228>
    <dct:description>Referred to the drug in the interaction.</dct:description>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/active-ingredient"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:94E71C50-311F-485B-9C5A-D703BD0E29D1">
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <domeo:belongsToSet>urn:domeoserver:annotationset:392EE0FB-AC4F-4AF2-87A6-2E50A281F434</domeo:belongsToSet>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <rdfs:label>Highlight</rdfs:label>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <domeo:belongsToSet>urn:domeoserver:annotationset:E32812A9-205B-4EE1-B488-A1E294EDBFB9</domeo:belongsToSet>
    <pav:createdOn>2014-09-02 19:13:48 -0400</pav:createdOn>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812eda990003</pav:createdBy>
    <pav:lastSavedOn>2014-09-02 19:19:47 -0400</pav:lastSavedOn>
    <ao:context rdf:resource="urn:domeoclient:uuid:0BD5228B-2C30-4C04-8347-5E28492ED531"/>
    <pav:lineageUri>urn:domeoserver:annotationset:C5DEBC9B-77EE-4243-88EB-DBC19737ACD2</pav:lineageUri>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:lineageUri>urn:domeoserver:annotation:FDF5C0E7-F71A-47A0-B17A-A960BD5127A7</pav:lineageUri>
    <domeo:belongsToSet>urn:domeoclient:uuid:CB83FFC2-EA71-44EA-8F11-DE80E389C84E</domeo:belongsToSet>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:7561E693-ED7F-438D-97B3-6718EA0765EF">
    <sio:SIO_000563>dikbD2R:modality</sio:SIO_000563>
    <sio:SIO_000628 rdf:resource="urn:pddi:uuid:BA258499-09C3-45B8-8CA4-4B430E2DB5EB"/>
    <rdf:type rdf:resource="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#DrugDrugInteractionStatement"/>
    <dikbD2R:statement>ncit:quantitative</dikbD2R:statement>
    <dikbD2R:modality>ncit:positive</dikbD2R:modality>
    <sio:SIO_000205>dikbD2R:statement</sio:SIO_000205>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:2CD22D95-BDF9-4FBD-98F2-9CC6023043DD">
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/6AF445DF-7377-4547-8BE8-05F45AE821E0"/>
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/C731F1F0-68ED-49B4-A9BF-768B903AF43C"/>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/PK_DDI"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:9BCE3E38-7FC6-48FE-A2E7-EB618F9B1F7F">
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#expertstudyAnnotation"/>
    <ao:body rdf:nodeID="Nb714f7e20b1244b29340acc8ad3b9f1e"/>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <pav:lineageUri>urn:domeoserver:annotation:E8261332-006B-45FF-A71B-7828DD4D5BE6</pav:lineageUri>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:lastSavedOn>2014-09-02 19:33:40 -0400</pav:lastSavedOn>
    <rdfs:label>expertstudy Annotation</rdfs:label>
    <pav:createdOn>2014-09-02 19:32:23 -0400</pav:createdOn>
    <ao:context rdf:resource="urn:domeoclient:uuid:C988966D-DF06-4093-9B27-77BEB9FDE53C"/>
    <domeo:belongsToSet>urn:domeoserver:annotationset:E32812A9-205B-4EE1-B488-A1E294EDBFB9</domeo:belongsToSet>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812eda990003</pav:createdBy>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:F57938E2-AD63-45EA-B996-C0C893D21182">
    <domeo:uuid>F57938E2-AD63-45EA-B996-C0C893D21182</domeo:uuid>
    <pav:createdOn>2014-09-02 11:58:50 -0400</pav:createdOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-47.txt.html</ao:hasSource>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:prefix> may be necessary and it is recommended that </ao:prefix>
    <ao:suffix> be initiated at a reduced dose when given with paroxetine.</ao:suffix>
    <ao:exact>atomoxetine</ao:exact>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:F57938E2-AD63-45EA-B996-C0C893D21182"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:BD767394-A523-4383-85E2-F42A0A94276D">
    <pav:createdOn>2014-07-21 21:33:43 -0400</pav:createdOn>
    <ao:prefix>were determined from a single intravenous dose of </ao:prefix>
    <domeo:uuid>BD767394-A523-4383-85E2-F42A0A94276D</domeo:uuid>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-28.txt.html</ao:hasSource>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:exact>aminophylline </ao:exact>
    <ao:suffix>(6 mg/kg) before and after the oral administration of fluconazole 200 mg daily for 14 days in 16 normal male volunteers. There were significant increases in theophylline AUC, Cmax, and half-life with a corresponding decrease in clearance. The mean ± SD t</ao:suffix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:BD767394-A523-4383-85E2-F42A0A94276D"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:5139C7C3-ACE5-4F03-BC84-8DD2AF187DDB">
    <ao:suffix>(800 mg), a nonspecific CYP inhibitor, caused a 56% increase in plasma sildenafil concentrations when co-administered with sildenafil (50 mg) to healthy volunteers.</ao:suffix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:exact>Cimetidine </ao:exact>
    <domeo:uuid>5139C7C3-ACE5-4F03-BC84-8DD2AF187DDB</domeo:uuid>
    <pav:createdOn>2014-07-07 11:22:50 -0400</pav:createdOn>
    <domeo:uuid></domeo:uuid>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:5139C7C3-ACE5-4F03-BC84-8DD2AF187DDB"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:prefix>xsd:String</ao:prefix>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-155.txt.html</ao:hasSource>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:EB66F52A-826A-4B19-9DAB-4F305456531E">
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <rdfs:label>Highlight</rdfs:label>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:createdOn>2014-07-13 12:46:18 -0400</pav:createdOn>
    <domeo:belongsToSet>urn:domeoclient:uuid:EC9B90D7-F9B5-4E51-94E2-878FAA06F611</domeo:belongsToSet>
    <pav:lineageUri>urn:domeoserver:annotation:A5C90995-9DDD-408E-A19C-6AA024D77686</pav:lineageUri>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812eda990003</pav:createdBy>
    <pav:lastSavedOn>2014-07-13 12:48:45 -0400</pav:lastSavedOn>
    <ao:context rdf:resource="urn:domeoclient:uuid:40519342-F06B-41D2-A39A-795BA218AF7B"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:B394B422-1AAF-4ED4-A3BB-3FB13E961EEA">
    <domeo:agents rdf:resource="urn:domeo:software:id:Domeo-2.1alpha-050"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:9A057858-10CF-4E79-9283-5F1644D9BB0A"/>
    <domeo:deleted>false</domeo:deleted>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <ao:item rdf:resource="urn:domeoclient:uuid:03276EA7-732F-4344-8706-3960852CCE36"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#AnnotationSet"/>
    <pav:lastSavedOn>2014-07-21 21:30:23 -0400</pav:lastSavedOn>
    <pav:lineageUri>urn:domeoserver:annotationset:DA4FB434-928A-4C10-A856-79B90E224B6F</pav:lineageUri>
    <ao:annotatesResource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-26.txt.html</ao:annotatesResource>
    <pav:createdOn>2014-07-21 21:28:25 -0400</pav:createdOn>
    <domeo:agents rdf:resource="urn:person:uuid:080e143046812afe0146812eda990003"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:FF969EAD-2CD7-4039-AD45-C2D98B79E3B0"/>
    <dct:description>The default set is created automatically by Domeo when no other set is existing.</dct:description>
    <rdfs:label>Default Set</rdfs:label>
    <ao:item rdf:resource="urn:domeoclient:uuid:3123DE1C-E4E4-41E2-8666-474B2051A954"/>
    <permissions:permissions rdf:nodeID="Nb32f510898c745658a4a0e3bf9a57a7e"/>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <ao:item rdf:resource="urn:domeoclient:uuid:4C6E4A21-6D29-4DFC-BCC7-71D10F66BA88"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:B0CDA62F-9ACD-470D-B0EC-F331BF018B09"/>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812eda990003</pav:createdBy>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:0F6275ED-13B1-45BE-8276-90A65C4C4506">
    <pav:createdOn>2014-09-01 15:57:28 -0400</pav:createdOn>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812eda990003</pav:createdBy>
    <pav:lastSavedOn>2014-09-01 15:57:39 -0400</pav:lastSavedOn>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <rdfs:label>Highlight</rdfs:label>
    <domeo:belongsToSet>urn:domeoclient:uuid:39B82E57-92E3-4322-A8E6-A3AFF215F02C</domeo:belongsToSet>
    <pav:lineageUri>urn:domeoserver:annotation:E3D5CDD5-71A5-456B-B855-A9AA17258416</pav:lineageUri>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <ao:context rdf:resource="urn:domeoclient:uuid:4515CD24-4667-47E1-80AE-FBC3F30BFD11"/>
    <pav:previousVersion>xsd:String</pav:previousVersion>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:2BBB51CD-8D17-4DE2-B300-ED38485DEA33">
    <pav:createdOn>2014-09-02 11:35:13 -0400</pav:createdOn>
    <domeo:belongsToSet>urn:domeoserver:annotationset:A5DD001D-C81A-4E2E-B5E0-7A866B35E26B</domeo:belongsToSet>
    <domeo:belongsToSet>urn:domeoserver:annotationset:3F546823-204F-4F9B-9006-3DC526C56931</domeo:belongsToSet>
    <pav:lineageUri>urn:domeoserver:annotation:52F1EA4E-4106-482A-968A-E5CFFFE774D6</pav:lineageUri>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812eda990003</pav:createdBy>
    <rdfs:label>Highlight</rdfs:label>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <ao:context rdf:resource="urn:domeoclient:uuid:18A94768-B77C-45AF-843F-894BD40CD040"/>
    <pav:lastSavedOn>2014-09-02 11:35:33 -0400</pav:lastSavedOn>
    <domeo:belongsToSet>urn:domeoclient:uuid:BED41F06-565A-4622-9A88-48810E5A28DE</domeo:belongsToSet>
    <pav:lineageUri>urn:domeoserver:annotationset:D1715BD2-BD41-46FD-9454-DC7A423A29AC</pav:lineageUri>
    <domeo:belongsToSet>urn:domeoserver:annotationset:A3F0B39A-4249-4B63-BB0D-F24A005066AC</domeo:belongsToSet>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:previousVersion>xsd:String</pav:previousVersion>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:50E47850-992D-44A2-BE5F-681487D5414C">
    <ao:prefix> concomitantly. Increases in INR and </ao:prefix>
    <ao:exact>prothrombin </ao:exact>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-74.txt.html</ao:hasSource>
    <pav:createdOn>2014-09-02 19:12:50 -0400</pav:createdOn>
    <ao:suffix>time may lead to abnormal bleeding and even death. Patients treated with proton pump inhibitors and warfarin may need to be monitored for increases in INR and prothrombin time.</ao:suffix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <domeo:uuid>50E47850-992D-44A2-BE5F-681487D5414C</domeo:uuid>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:50E47850-992D-44A2-BE5F-681487D5414C"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:AB3B0778-C37A-4D38-B2AC-7049DC5E2EE9">
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/D8D922B0-F01D-471E-B5F5-F72185F3B01C"/>
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/F1ACE0D3-FA23-46EC-ACAA-40836B0D32A9"/>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/PK_DDI"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:95BF8C06-515D-4690-B616-64E06F6C0C8D">
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812eda990003</pav:createdBy>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:createdOn>2014-09-02 11:56:15 -0400</pav:createdOn>
    <pav:lineageUri>urn:domeoserver:annotation:B5956029-7918-4124-9821-CDB625D5FA25</pav:lineageUri>
    <pav:lastSavedOn>2014-09-02 12:02:18 -0400</pav:lastSavedOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <rdfs:label>Highlight</rdfs:label>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <domeo:belongsToSet>urn:domeoclient:uuid:4B51141D-C8D2-45DB-8074-74F8D8323E60</domeo:belongsToSet>
    <ao:context rdf:resource="urn:domeoclient:uuid:5DD4A9BB-16CD-4C46-9CE2-E74FD07B5626"/>
  </rdf:Description>
  <rdf:Description rdf:nodeID="Na6953118e0ca4281ba05fe0bdd5d5505">
    <domeo:sets rdf:resource="urn:pddi:uuid:1F1125BC-11EF-427A-9581-C05D50951446"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:7562C75C-08B1-4D26-BA5E-2C77FA08B4F0">
    <ao:prefix>: In a study of 13 healthy, male volunteers, a single 40 mg dose of </ao:prefix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:suffix> added to fluvoxamine 100 mg/day administered at steady-state was associated with five- and eight-fold increases in tacrine Cmax and AUC, respectively, compared to the administration of tacrine alone. Five subjects experienced nausea, vomiting, sweating,</ao:suffix>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-9.txt.html</ao:hasSource>
    <domeo:uuid>7562C75C-08B1-4D26-BA5E-2C77FA08B4F0</domeo:uuid>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:7562C75C-08B1-4D26-BA5E-2C77FA08B4F0"/>
    <pav:createdOn>2014-09-02 11:41:11 -0400</pav:createdOn>
    <ao:exact>tacrine</ao:exact>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:A9F0C45F-A9FD-47B4-BBF0-2D2F2CBAD8B9">
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:lineageUri>urn:domeoserver:annotation:1EB77F23-7DD3-4BA6-88CA-34ABC34C90B4</pav:lineageUri>
    <pav:lastSavedOn>2014-07-24 20:12:49 -0400</pav:lastSavedOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:createdOn>2014-07-24 20:11:50 -0400</pav:createdOn>
    <rdfs:label>Highlight</rdfs:label>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812eda990003</pav:createdBy>
    <ao:context rdf:resource="urn:domeoclient:uuid:BE1FD7C4-2F16-4751-88A8-4F0AA6A4450A"/>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <domeo:belongsToSet>urn:domeoserver:annotationset:1FC172B8-8AC3-465A-AA69-B73AD9B97CBC</domeo:belongsToSet>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:6F9E01FD-BC9F-4B86-8FFF-8A4DC8CD6CB5">
    <ao:suffix> and also the formation of the metabolite, normeperidine, in healthy subjects and thus, caution should be used with concomitant administration.</ao:suffix>
    <ao:prefix> reduced the clearance and volume of distribution of </ao:prefix>
    <domeo:uuid>6F9E01FD-BC9F-4B86-8FFF-8A4DC8CD6CB5</domeo:uuid>
    <ao:exact>meperidine</ao:exact>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <pav:createdOn>2014-07-28 17:00:51 -0400</pav:createdOn>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:6F9E01FD-BC9F-4B86-8FFF-8A4DC8CD6CB5"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-164.txt.html</ao:hasSource>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:F353BFC5-D6B5-4819-8EA8-0A44F2223E3B">
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-155.txt.html</ao:hasSource>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <domeo:uuid>F353BFC5-D6B5-4819-8EA8-0A44F2223E3B</domeo:uuid>
    <ao:prefix>In addition to pulmonary vascular smooth muscle and the corpus cavernosum, PDE5 is also found in other tissues including vascular and visceral smooth muscle and in platelets. The inhibition of PDE5 in these tissues by </ao:prefix>
    <pav:createdOn>2014-07-07 09:37:19 -0400</pav:createdOn>
    <domeo:uuid></domeo:uuid>
    <ao:suffix>may be the basis for the enhanced platelet anti-aggregatory activity of nitric oxide observed in vitro, and the mild peripheral arterial-venous dilatation in vivo.</ao:suffix>
    <ao:exact>sildenafil </ao:exact>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:F353BFC5-D6B5-4819-8EA8-0A44F2223E3B"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:62EE12D9-5314-4E3B-81A5-6CC4F5785F46">
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/5AD16038-68DB-4293-9251-D5A275F9AB73"/>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/PK_DDI"/>
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/4E62726A-262F-4A69-83FB-3965D3CD27BD"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:1D92FA7B-3CB7-4C89-9E21-9980B649BC2E">
    <ao:suffix>clearance when it was co-administered with CYP3A inhibitors. Sildenafil exposure without concomitant medication is shown to be 5-fold higher at a dose of 80 mg TID compared to its exposure at a dose of 20 mg TID. This concentration range covers the same </ao:suffix>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-155.txt.html</ao:hasSource>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:prefix>Population data from patients in clinical trials indicated a reduction in </ao:prefix>
    <ao:exact>sildenafil </ao:exact>
    <domeo:uuid>1D92FA7B-3CB7-4C89-9E21-9980B649BC2E</domeo:uuid>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <domeo:uuid></domeo:uuid>
    <pav:createdOn>2014-07-07 11:22:37 -0400</pav:createdOn>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:1D92FA7B-3CB7-4C89-9E21-9980B649BC2E"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:58C4B9F6-E8BB-4567-9FF2-3D87C6E9284C">
    <pav:createdOn>2014-07-13 12:45:51 -0400</pav:createdOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:suffix>xsd:String</ao:suffix>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-22.txt.html</ao:hasSource>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:58C4B9F6-E8BB-4567-9FF2-3D87C6E9284C"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <domeo:uuid>58C4B9F6-E8BB-4567-9FF2-3D87C6E9284C</domeo:uuid>
    <ao:prefix>xsd:String</ao:prefix>
    <ao:exact>There was no significant difference in ethinyl estradiol or levonorgestrel AUC after the administration of 50 mg of fluconazole.</ao:exact>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/964F2661-87EF-4D00-87C8-D1C5E12C0ECB">
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/4450</dailymed:activeMoietyRxCUI>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/active-ingredient"/>
    <dct:description>Referred to the drug in the interaction.</dct:description>
    <sio:SIO_000228>dikbD2R:object-drug-of-interaction</sio:SIO_000228>
    <rdfs:label>fluconazole</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:nodeID="Nfa6d623468e74423b98469ea146fad76">
    <permissions:accessType>urn:domeo:access:public</permissions:accessType>
    <permissions:isLocked>false</permissions:isLocked>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:B383ED3F-1A7B-49EF-9DAD-049AD0F927DE">
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-126.txt.html</ao:hasSource>
    <pav:createdOn>2014-07-24 19:39:41 -0400</pav:createdOn>
    <ao:prefix>xsd:String</ao:prefix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <domeo:uuid>B383ED3F-1A7B-49EF-9DAD-049AD0F927DE</domeo:uuid>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:B383ED3F-1A7B-49EF-9DAD-049AD0F927DE"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:suffix>xsd:String</ao:suffix>
    <ao:exact>The mean Cmax and AUC of nifedipine are increased by 64% and 79%, respectively, by co-administration of propranolol.</ao:exact>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:ACE53139-5B8B-4FB2-8940-338C5989D498">
    <ao:exact>As with other serotonergic drugs, lithium may enhance the serotonergic effects of fluvoxamine and, therefore, the combination should be used with caution. Seizures have been reported with the coadministration of fluvoxamine maleate and lithium.</ao:exact>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <domeo:uuid>ACE53139-5B8B-4FB2-8940-338C5989D498</domeo:uuid>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:ACE53139-5B8B-4FB2-8940-338C5989D498"/>
    <ao:suffix>xsd:String</ao:suffix>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-9.txt.html</ao:hasSource>
    <pav:createdOn>2014-09-02 11:53:56 -0400</pav:createdOn>
    <ao:prefix>: </ao:prefix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:7BE43707-1914-4E31-AAC1-03F035925C89">
    <sio:SIO_000628 rdf:resource="urn:pddi:uuid:A3AF38F3-51D7-4A66-84B7-21A51A8CE79F"/>
    <dikbD2R:modality>ncit:positive</dikbD2R:modality>
    <sio:SIO_000205>dikbD2R:statement</sio:SIO_000205>
    <sio:SIO_000563>dikbD2R:modality</sio:SIO_000563>
    <dikbD2R:statement>ncit:quantitative</dikbD2R:statement>
    <rdf:type rdf:resource="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#DrugDrugInteractionStatement"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:DB79C29A-687E-46A8-AEEA-C0F67E49EB97">
    <ao:suffix>for 22 days (including 200 mg/day for the final 13 days) caused a statistically significant 16% decrease from baseline in the clearance of tolbutamide following an intravenous 1000 mg dose. Sertraline administration did not noticeably change either the p</ao:suffix>
    <pav:createdOn>2014-09-01 15:59:50 -0400</pav:createdOn>
    <domeo:uuid>DB79C29A-687E-46A8-AEEA-C0F67E49EB97</domeo:uuid>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:prefix>In a placebo-controlled trial in normal volunteers, administration of </ao:prefix>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-17.txt.html</ao:hasSource>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:DB79C29A-687E-46A8-AEEA-C0F67E49EB97"/>
    <ao:exact>sertraline </ao:exact>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:6D3CB53E-CF58-4136-8B4C-980888C68920">
    <sio:SIO_000628 rdf:resource="urn:pddi:uuid:697447CC-E28E-42D6-889F-E4B9D46954FC"/>
    <dikbD2R:modality>ncit:positive</dikbD2R:modality>
    <sio:SIO_000205>dikbD2R:statement</sio:SIO_000205>
    <sio:SIO_000563>dikbD2R:modality</sio:SIO_000563>
    <dikbD2R:statement>ncit:quantitative</dikbD2R:statement>
    <rdf:type rdf:resource="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#DrugDrugInteractionStatement"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:9C9FE015-E10A-4124-9250-BA73B7E52470">
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:lineageUri>urn:domeoserver:annotation:F2C8F31A-E552-425C-90F2-D68EC7FEE632</pav:lineageUri>
    <pav:lastSavedOn>2014-07-22 19:35:16 -0400</pav:lastSavedOn>
    <domeo:belongsToSet>urn:domeoserver:annotationset:F272A789-69D0-47CC-8CC9-F25C55B91261</domeo:belongsToSet>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <ao:context rdf:resource="urn:domeoclient:uuid:6E817E52-FC9C-4090-86D7-ADDBC13CA122"/>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <pav:createdOn>2014-07-22 19:28:50 -0400</pav:createdOn>
    <rdfs:label>Highlight</rdfs:label>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812eda990003</pav:createdBy>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:lineageUri>urn:domeoserver:annotationset:AB1741F1-5A5F-4416-AEAC-A544BCBB7D16</pav:lineageUri>
    <domeo:belongsToSet>urn:domeoserver:annotationset:7021B883-FD5C-4083-BD87-DF56D3C87633</domeo:belongsToSet>
    <domeo:belongsToSet>urn:domeoserver:annotationset:514BA51B-D734-4003-A7C3-F03C0F95833A</domeo:belongsToSet>
    <pav:previousVersion>urn:domeoserver:annotationset:7E80543E-BF76-4514-92A9-91458DCB802B</pav:previousVersion>
    <domeo:belongsToSet>urn:domeoserver:annotationset:2914A3FD-DF43-4F78-999C-77CE7A028B19</domeo:belongsToSet>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">4</pav:versionNumber>
    <domeo:belongsToSet>urn:domeoserver:annotationset:606A5B3F-B6FB-4279-AA42-7893CFC2D20C</domeo:belongsToSet>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:0FC34074-15F7-4C00-87F2-8D4B6F9B8889">
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:lineageUri>urn:domeoserver:annotation:65C4C1CA-156F-4826-A9A8-AA28011A9F9E</pav:lineageUri>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812eda990003</pav:createdBy>
    <pav:lastSavedOn>2014-07-24 20:04:12 -0400</pav:lastSavedOn>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <ao:context rdf:resource="urn:domeoclient:uuid:D2C43BBB-3043-4AE4-89EE-69DCE07C3309"/>
    <pav:createdOn>2014-07-24 20:03:53 -0400</pav:createdOn>
    <rdfs:label>Highlight</rdfs:label>
    <domeo:belongsToSet>urn:domeoclient:uuid:F70AB841-7C14-48D1-B543-A45EA067C642</domeo:belongsToSet>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:98937C65-C245-4875-B071-CCFF5209C083">
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:prefix>Because of its profound and long lasting inhibition of gastric acid secretion, it is theoretically possible that </ao:prefix>
    <ao:exact>omeprazole </ao:exact>
    <domeo:uuid>98937C65-C245-4875-B071-CCFF5209C083</domeo:uuid>
    <pav:createdOn>2014-09-02 19:12:16 -0400</pav:createdOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-74.txt.html</ao:hasSource>
    <ao:suffix>may interfere with absorption of drugs where gastric pH is an important determinant of their bioavailability (e.g., </ao:suffix>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:98937C65-C245-4875-B071-CCFF5209C083"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:7E9300CC-A667-49A8-AD8F-115AE6705100">
    <ao:context rdf:resource="urn:domeoclient:uuid:3B160A10-3999-44C9-A9E0-AB903EF4E9F4"/>
    <rdfs:label>Highlight</rdfs:label>
    <pav:lineageUri>urn:domeoserver:annotation:BA436780-411D-4925-859C-E7850751624C</pav:lineageUri>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:createdOn>2014-07-28 17:01:58 -0400</pav:createdOn>
    <domeo:belongsToSet>urn:domeoclient:uuid:05CE82A3-E1C6-497A-B0B0-31DD508C02A1</domeo:belongsToSet>
    <pav:lastSavedOn>2014-07-28 17:01:39 -0400</pav:lastSavedOn>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812eda990003</pav:createdBy>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:9ED864DE-C2BC-4B14-881F-AFD561FC58D1">
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <domeo:uuid>9ED864DE-C2BC-4B14-881F-AFD561FC58D1</domeo:uuid>
    <ao:exact>rosiglitazone</ao:exact>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:9ED864DE-C2BC-4B14-881F-AFD561FC58D1"/>
    <ao:suffix> was shown to be mediated by increased sensitivity to insulin’s action in the liver, muscle, and adipose tissues. Pharmacological studies in animal models indicate that rosiglitazone inhibits hepatic gluconeogenesis. The expression of the insulin-regulat</ao:suffix>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-123.txt.html</ao:hasSource>
    <pav:createdOn>2014-07-22 19:11:40 -0400</pav:createdOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:prefix>In animal models, the antidiabetic activity of </ao:prefix>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:12ACDF1A-FCDF-42E9-A413-FB39FC095FFC">
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <domeo:belongsToSet>urn:domeoclient:uuid:F70AB841-7C14-48D1-B543-A45EA067C642</domeo:belongsToSet>
    <rdfs:label>Highlight</rdfs:label>
    <ao:context rdf:resource="urn:domeoclient:uuid:8A17CFA1-4C14-4F96-911E-3EB707629E7A"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812eda990003</pav:createdBy>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:lastSavedOn>2014-07-24 20:04:12 -0400</pav:lastSavedOn>
    <pav:lineageUri>urn:domeoserver:annotation:7F6AD967-0ADD-47B3-9A57-B98BAD421735</pav:lineageUri>
    <pav:createdOn>2014-07-24 20:03:50 -0400</pav:createdOn>
    <pav:previousVersion>xsd:String</pav:previousVersion>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:FFD8A436-5516-4F50-8C7E-7512116C24BA">
    <pav:createdOn>2014-07-22 18:44:30 -0400</pav:createdOn>
    <rdfs:label>Highlight</rdfs:label>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:lineageUri>urn:domeoserver:annotation:DA6D10CF-A8C7-4652-89DC-12243324D61B</pav:lineageUri>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812eda990003</pav:createdBy>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <domeo:belongsToSet>urn:domeoclient:uuid:E0054F81-6A9B-4AF0-9DCB-962A6FC1C418</domeo:belongsToSet>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:lastSavedOn>2014-07-22 18:46:52 -0400</pav:lastSavedOn>
    <ao:context rdf:resource="urn:domeoclient:uuid:75348A1F-6A84-4B07-BE23-172E91593A8D"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:87135DB6-D4F3-4808-BE76-D891C704525E">
    <pav:lineageUri>urn:domeoserver:annotation:0DAE67F4-09F0-4193-B783-BC34AA74DD4A</pav:lineageUri>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <domeo:belongsToSet>urn:domeoserver:annotationset:A3F0B39A-4249-4B63-BB0D-F24A005066AC</domeo:belongsToSet>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812eda990003</pav:createdBy>
    <domeo:belongsToSet>urn:domeoclient:uuid:BED41F06-565A-4622-9A88-48810E5A28DE</domeo:belongsToSet>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <pav:lastSavedOn>2014-09-02 11:35:33 -0400</pav:lastSavedOn>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <ao:context rdf:resource="urn:domeoclient:uuid:ABD16F80-DE85-4E62-8A97-6477F60FC07D"/>
    <domeo:belongsToSet>urn:domeoserver:annotationset:A5DD001D-C81A-4E2E-B5E0-7A866B35E26B</domeo:belongsToSet>
    <pav:lineageUri>urn:domeoserver:annotationset:D1715BD2-BD41-46FD-9454-DC7A423A29AC</pav:lineageUri>
    <domeo:belongsToSet>urn:domeoserver:annotationset:3F546823-204F-4F9B-9006-3DC526C56931</domeo:belongsToSet>
    <rdfs:label>Highlight</rdfs:label>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:createdOn>2014-09-02 11:30:22 -0400</pav:createdOn>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:19626855-8C17-4CB6-BD80-697B52F6ADC9">
    <domeo:belongsToSet>urn:domeoserver:annotationset:392EE0FB-AC4F-4AF2-87A6-2E50A281F434</domeo:belongsToSet>
    <domeo:belongsToSet>urn:domeoserver:annotationset:E32812A9-205B-4EE1-B488-A1E294EDBFB9</domeo:belongsToSet>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">2</pav:versionNumber>
    <rdfs:label>Highlight</rdfs:label>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:createdOn>2014-09-02 19:27:52 -0400</pav:createdOn>
    <pav:lineageUri>urn:domeoserver:annotation:D7AD70CE-316B-4807-BC4A-70BC13ACE628</pav:lineageUri>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812eda990003</pav:createdBy>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <pav:previousVersion>urn:domeoclient:uuid:CB83FFC2-EA71-44EA-8F11-DE80E389C84E</pav:previousVersion>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:lastSavedOn>2014-09-02 19:32:13 -0400</pav:lastSavedOn>
    <pav:lineageUri>urn:domeoserver:annotationset:C5DEBC9B-77EE-4243-88EB-DBC19737ACD2</pav:lineageUri>
    <ao:context rdf:resource="urn:domeoclient:uuid:4F5662D1-C03B-40DB-AB83-59D0D62748A6"/>
  </rdf:Description>
  <rdf:Description rdf:nodeID="Ndf26c159fe2a4acebe008a5a61d94409">
    <permissions:isLocked>false</permissions:isLocked>
    <permissions:accessType>urn:domeo:access:public</permissions:accessType>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:28368420-4E42-4D08-91FB-67DAADA661EC">
    <pav:createdOn>2014-09-02 19:18:57 -0400</pav:createdOn>
    <ao:suffix>, elevated serum levels have been reported with an increase in AUC by 82%, in Cmax by 75% and in Cmin by 106% following multiple dosing of saquinavir/ritonavir (1000/100 mg) bid for 15 days with omeprazole 40 mg qd co-administered days 11 to 15. Dose red</ao:suffix>
    <ao:exact>saquinavir</ao:exact>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:prefix> is therefore not recommended. For other antiretroviral drugs, such as </ao:prefix>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:28368420-4E42-4D08-91FB-67DAADA661EC"/>
    <domeo:uuid>28368420-4E42-4D08-91FB-67DAADA661EC</domeo:uuid>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-74.txt.html</ao:hasSource>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:18F9EC5C-6A37-4A41-85DF-87BCEB900110">
    <rdfs:label>Highlight</rdfs:label>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:createdOn>2014-07-24 19:55:04 -0400</pav:createdOn>
    <domeo:belongsToSet>urn:domeoclient:uuid:F87D2273-7E05-4F58-B46E-DA5B9D8816DE</domeo:belongsToSet>
    <pav:lastSavedOn>2014-07-24 19:54:45 -0400</pav:lastSavedOn>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:lineageUri>urn:domeoserver:annotation:EDFB18D2-D8A0-44B9-8E84-FD352C6F84E0</pav:lineageUri>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812eda990003</pav:createdBy>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <ao:context rdf:resource="urn:domeoclient:uuid:4E6639F4-F4C8-45C0-82E0-34A805D7B468"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:76B24ED1-159D-4411-BD4C-8033557FAD2B">
    <sio:SIO_000628 rdf:resource="urn:pddi:uuid:DCA0957A-745E-4232-BE6B-45104AD0FFCD"/>
    <dikbD2R:statement>ncit:quantitative</dikbD2R:statement>
    <sio:SIO_000563>dikbD2R:modality</sio:SIO_000563>
    <dikbD2R:modality>ncit:positive</dikbD2R:modality>
    <sio:SIO_000205>dikbD2R:statement</sio:SIO_000205>
    <rdf:type rdf:resource="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#DrugDrugInteractionStatement"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:2363FCF8-4364-4BDB-BB21-5EDBFD6F753B">
    <pav:createdOn>2014-07-22 19:11:19 -0400</pav:createdOn>
    <ao:suffix> reduces blood glucose concentrations and reduces hyperinsulinemia in the ob/ob obese mouse, db/db diabetic mouse, and fa/fa fatty Zucker rat.</ao:suffix>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-123.txt.html</ao:hasSource>
    <domeo:uuid>2363FCF8-4364-4BDB-BB21-5EDBFD6F753B</domeo:uuid>
    <ao:exact>Rosiglitazone</ao:exact>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:2363FCF8-4364-4BDB-BB21-5EDBFD6F753B"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:prefix> the pathogenesis of type 2 diabetes. The antidiabetic activity of rosiglitazone has been demonstrated in animal models of type 2 diabetes in which hyperglycemia and/or impaired glucose tolerance is a consequence of insulin resistance in target tissues. </ao:prefix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:A31AAC0C-4709-458E-B722-42176D2F7E8D">
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <domeo:uuid>A31AAC0C-4709-458E-B722-42176D2F7E8D</domeo:uuid>
    <pav:createdOn>2014-07-13 11:13:47 -0400</pav:createdOn>
    <ao:suffix> and 9-hydroxyrisperidone combined, after single and multiple doses, are similar in extensive and poor metabolizers.</ao:suffix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:prefix> concentrations than poor metabolizers, the pharmacokinetics of </ao:prefix>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-8.txt.html</ao:hasSource>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:A31AAC0C-4709-458E-B722-42176D2F7E8D"/>
    <ao:exact>risperidone</ao:exact>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:405F8748-3E22-452F-AC3B-86C4C931D36A">
    <rdfs:label>Highlight</rdfs:label>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:createdOn>2014-07-21 21:26:58 -0400</pav:createdOn>
    <ao:context rdf:resource="urn:domeoclient:uuid:1488BDD9-0C63-45D6-A1E6-1AC89EE36E28"/>
    <pav:lineageUri>urn:domeoserver:annotation:BE3E1AB1-3092-4849-B176-18D5F87FBCE0</pav:lineageUri>
    <domeo:belongsToSet>urn:domeoclient:uuid:B6F745E6-5734-4636-A383-683BA4C79E38</domeo:belongsToSet>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812eda990003</pav:createdBy>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:lastSavedOn>2014-07-21 21:27:51 -0400</pav:lastSavedOn>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:E36FB611-A4C3-4DBB-9B86-FD93883853AE">
    <ao:suffix>xsd:String</ao:suffix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-25.txt.html</ao:hasSource>
    <ao:prefix>xsd:String</ao:prefix>
    <pav:createdOn>2014-07-21 21:28:04 -0400</pav:createdOn>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:E36FB611-A4C3-4DBB-9B86-FD93883853AE"/>
    <domeo:uuid>E36FB611-A4C3-4DBB-9B86-FD93883853AE</domeo:uuid>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:exact>Phenytoin AUC was determined after 4 days of phenytoin dosing (200 mg daily, orally for 3 days followed by 250 mg intravenously for one dose) both with and without the administration of fluconazole (oral fluconazole 200 mg daily for 16 days) in 10 normal male volunteers. There was a significant increase in phenytoin AUC. The mean ± SD increase in phenytoin AUC was 88% ± 68% (range: 16 to 247%). The absolute magnitude of this interaction is unknown because of the intrinsically nonlinear disposition of phenytoin. (See PRECAUTIONS.)</ao:exact>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:939BD222-0159-44F2-9E01-3D674AEF5EFE">
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812eda990003</pav:createdBy>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <domeo:belongsToSet>urn:domeoclient:uuid:CB83FFC2-EA71-44EA-8F11-DE80E389C84E</domeo:belongsToSet>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <rdfs:label>Highlight</rdfs:label>
    <ao:context rdf:resource="urn:domeoclient:uuid:5577FA82-F64B-40B7-8542-3CEE5BC9380E"/>
    <pav:lineageUri>urn:domeoserver:annotationset:C5DEBC9B-77EE-4243-88EB-DBC19737ACD2</pav:lineageUri>
    <domeo:belongsToSet>urn:domeoserver:annotationset:392EE0FB-AC4F-4AF2-87A6-2E50A281F434</domeo:belongsToSet>
    <pav:lastSavedOn>2014-09-02 19:19:47 -0400</pav:lastSavedOn>
    <pav:lineageUri>urn:domeoserver:annotation:D84509F9-E5FA-432D-858B-B8B522CE2804</pav:lineageUri>
    <pav:createdOn>2014-09-02 19:19:18 -0400</pav:createdOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <domeo:belongsToSet>urn:domeoserver:annotationset:E32812A9-205B-4EE1-B488-A1E294EDBFB9</domeo:belongsToSet>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:047EE665-B8C6-4153-96F1-5D2C3C08A276">
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <rdfs:label>Highlight</rdfs:label>
    <pav:lastSavedOn>2014-09-02 12:03:47 -0400</pav:lastSavedOn>
    <pav:lineageUri>urn:domeoserver:annotationset:166C20E9-1B4C-47D1-982D-922E2E5ACFF2</pav:lineageUri>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <pav:createdOn>2014-09-02 12:02:48 -0400</pav:createdOn>
    <pav:lineageUri>urn:domeoserver:annotation:C613F9CC-56AC-4A94-AB46-0DAD55BFA6D3</pav:lineageUri>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <ao:context rdf:resource="urn:domeoclient:uuid:8916B040-D309-4348-A145-26FC08137345"/>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812eda990003</pav:createdBy>
    <domeo:belongsToSet>urn:domeoclient:uuid:379CD8C1-F4B4-42B7-8F87-70776866DB1F</domeo:belongsToSet>
    <domeo:belongsToSet>urn:domeoserver:annotationset:D52DFD7B-BDDF-488F-B339-B1BC641E50E9</domeo:belongsToSet>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/BB308B9B-CA39-4247-9128-9D19C4C28A67">
    <dct:description>Referred to the drug in the interaction.</dct:description>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/active-ingredient"/>
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/32937</dailymed:activeMoietyRxCUI>
    <rdfs:label>paroxetine</rdfs:label>
    <sio:SIO_000228>dikbD2R:object-drug-of-interaction</sio:SIO_000228>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:135F1FE6-83FC-4E58-95A7-4C08AED291BA">
    <ao:suffix> in subjects with liver disease were comparable to those in young healthy subjects, the mean free fraction of risperidone in plasma was increased by about 35% because of the diminished concentration of both albumin and α1-acid glycoprotein. Risperidone d</ao:suffix>
    <pav:createdOn>2014-07-13 11:17:38 -0400</pav:createdOn>
    <ao:exact>risperidone</ao:exact>
    <ao:prefix>Hepatic Impairment: While the pharmacokinetics of </ao:prefix>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:135F1FE6-83FC-4E58-95A7-4C08AED291BA"/>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-8.txt.html</ao:hasSource>
    <domeo:uuid>135F1FE6-83FC-4E58-95A7-4C08AED291BA</domeo:uuid>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:194B637B-12E0-40F8-A961-33C50074CD18">
    <pav:createdOn>2014-09-02 19:41:42 -0400</pav:createdOn>
    <rdfs:label>Highlight</rdfs:label>
    <pav:lineageUri>urn:domeoserver:annotation:1F8915F4-D391-48E0-8456-40C2A2D6DC05</pav:lineageUri>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <ao:context rdf:resource="urn:domeoclient:uuid:F0271A3E-BA13-45E3-87AB-B8C1F9BB72CC"/>
    <domeo:belongsToSet>urn:domeoclient:uuid:69C22FA1-8D50-4AA7-ACD8-8F71E69BB8AC</domeo:belongsToSet>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <pav:lastSavedOn>2014-09-02 19:42:49 -0400</pav:lastSavedOn>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812eda990003</pav:createdBy>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:FA208444-D170-43D4-B1EB-ED24016D3210">
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <rdfs:label>Highlight</rdfs:label>
    <pav:createdOn>2014-09-02 19:08:19 -0400</pav:createdOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <pav:lineageUri>urn:domeoserver:annotation:84CCDE46-BE0B-4763-B442-1C17B49D1114</pav:lineageUri>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812eda990003</pav:createdBy>
    <domeo:belongsToSet>urn:domeoclient:uuid:3966BCFB-CA02-4053-828D-3860558E7BE8</domeo:belongsToSet>
    <ao:context rdf:resource="urn:domeoclient:uuid:9019660D-1815-46EC-A26A-41E87A114AA7"/>
    <pav:lastSavedOn>2014-09-02 19:11:13 -0400</pav:lastSavedOn>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:5A5F8C7B-9705-4277-87C9-38037CFFC534">
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/EF2D99E6-548C-4F7E-82EC-A1FF35F17CB0"/>
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/43BF860F-DF76-4336-A687-956DE41661F4"/>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/PK_DDI"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:109B3973-618F-4814-8D01-1C468E7A80F2">
    <ao:exact>risperidone</ao:exact>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-47.txt.html</ao:hasSource>
    <ao:suffix>, a CYP2D6 substrate has also been evaluated. In 1 study, daily dosing of paroxetine 20 mg in patients stabilized on risperidone (4 to 8 mg/day) increased mean plasma concentrations of risperidone approximately 4-fold, decreased 9-hydroxyrisperidone conc</ao:suffix>
    <domeo:uuid>109B3973-618F-4814-8D01-1C468E7A80F2</domeo:uuid>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <pav:createdOn>2014-09-02 12:03:06 -0400</pav:createdOn>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:109B3973-618F-4814-8D01-1C468E7A80F2"/>
    <ao:prefix> with </ao:prefix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:A22D7450-FC77-45A4-B835-3948870AD344">
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:exact>Sertraline</ao:exact>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:prefix>xsd:String</ao:prefix>
    <domeo:uuid>A22D7450-FC77-45A4-B835-3948870AD344</domeo:uuid>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:A22D7450-FC77-45A4-B835-3948870AD344"/>
    <pav:createdOn>2014-07-13 12:34:35 -0400</pav:createdOn>
    <ao:suffix> hydrochloride is supplied for oral administration as scored tablets containing sertraline hydrochloride equivalent to 25, 50, 100, 150 and 200 mg of sertraline and the following inactive ingredients: dibasic calcium phosphate dihydrate, hydroxypropyl ce</ao:suffix>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-20.txt.html</ao:hasSource>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:CE16BF01-AD42-444E-9A68-FEF6AED26815">
    <domeo:belongsToSet>urn:domeoserver:annotationset:08C0C288-6DF4-43E6-A618-71A8BB9563C3</domeo:belongsToSet>
    <domeo:belongsToSet>urn:domeoserver:annotationset:131835A3-C655-4F91-97D4-52CAFF7B7CCA</domeo:belongsToSet>
    <pav:lastSavedOn>2014-07-07 09:44:18 -0400</pav:lastSavedOn>
    <rdfs:label>Highlight</rdfs:label>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <domeo:belongsToSet>urn:domeoserver:annotationset:22ED7220-C6F6-43C5-9DF9-89F62F0F8E27</domeo:belongsToSet>
    <pav:createdOn>2014-07-07 09:39:36 -0400</pav:createdOn>
    <domeo:belongsToSet>urn:domeoserver:annotationset:8F3CF3D9-AADE-4A86-BD42-2924B3D6A406</domeo:belongsToSet>
    <pav:lastSavedOn>2014-07-07 09:44:19 -0400</pav:lastSavedOn>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812eda990003</pav:createdBy>
    <pav:lineageUri>urn:domeoserver:annotationset:76FD4BB5-DE2F-4FCA-B93D-302185B1A381</pav:lineageUri>
    <pav:lineageUri>urn:domeoserver:annotation:09060B7A-6009-499B-A967-F99ED8CDF86B</pav:lineageUri>
    <domeo:belongsToSet>urn:domeoclient:uuid:FCA2BF23-0BE3-409F-9177-761812F96097</domeo:belongsToSet>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <ao:context rdf:resource="urn:domeoclient:uuid:E5D76E00-F5D9-4E93-B3B6-47859812ACDF"/>
    <domeo:belongsToSet>urn:domeoserver:annotationset:7AACEF8D-2EBC-4F0B-94B2-190650E562F6</domeo:belongsToSet>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:D888862A-48F7-478F-BD96-42A7D5B21693">
    <ao:exact>methadone</ao:exact>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:D888862A-48F7-478F-BD96-42A7D5B21693"/>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-201.txt.html</ao:hasSource>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:prefix>, the incidence of withdrawal symptoms decreased and </ao:prefix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <pav:createdOn>2014-07-28 17:04:48 -0400</pav:createdOn>
    <domeo:uuid>D888862A-48F7-478F-BD96-42A7D5B21693</domeo:uuid>
    <ao:suffix> exposure increased to a level comparable to that prior to phenytoin administration.</ao:suffix>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:A2F4B6D6-7CF7-42D6-A019-60A8CCB4F364">
    <pav:createdOn>2014-07-22 19:55:29 -0400</pav:createdOn>
    <ao:suffix> (2 mg twice daily) and metformin (500 mg twice daily) in healthy volunteers for 4 days had no effect on the steady-state pharmacokinetics of either metformin or rosiglitazone.</ao:suffix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:prefix>Concurrent administration of </ao:prefix>
    <domeo:uuid>A2F4B6D6-7CF7-42D6-A019-60A8CCB4F364</domeo:uuid>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:A2F4B6D6-7CF7-42D6-A019-60A8CCB4F364"/>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-123.txt.html</ao:hasSource>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:exact>AVANDIA</ao:exact>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:EC3A3861-9232-4673-B5DA-6BEA85FD20A7">
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:lineageUri>urn:domeoserver:annotation:AD590B0B-4C27-41DB-9A70-638C00DE9BDA</pav:lineageUri>
    <pav:lastSavedOn>2014-09-02 19:38:39 -0400</pav:lastSavedOn>
    <pav:createdOn>2014-09-02 19:38:25 -0400</pav:createdOn>
    <rdfs:label>Highlight</rdfs:label>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812eda990003</pav:createdBy>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <ao:context rdf:resource="urn:domeoclient:uuid:66762812-3E76-4815-AF5C-6E5A2D4739C3"/>
    <domeo:belongsToSet>urn:domeoclient:uuid:190E7AE8-2ACF-42E2-AE00-E433EEA9737C</domeo:belongsToSet>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:EE9876CA-9D21-44C9-A6F5-8C0F13C4447C">
    <rdf:type rdf:resource="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#DrugDrugInteractionStatement"/>
    <dikbD2R:modality>ncit:negative</dikbD2R:modality>
    <sio:SIO_000563>dikbD2R:modality</sio:SIO_000563>
    <sio:SIO_000205>dikbD2R:statement</sio:SIO_000205>
    <sio:SIO_000628 rdf:resource="urn:pddi:uuid:2C22B081-DC6C-4519-BC58-778F31A66BDB"/>
    <dikbD2R:statement>ncit:Qualitative</dikbD2R:statement>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:BB4AA59B-BD34-4506-A617-157D639949C4">
    <rdfs:label>Highlight</rdfs:label>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <domeo:belongsToSet>urn:domeoclient:uuid:23567EF7-7482-444A-B1F6-5AAA9D43E54A</domeo:belongsToSet>
    <ao:context rdf:resource="urn:domeoclient:uuid:EBDA4EF3-E793-47E4-9F6F-74592DE48307"/>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <pav:lastSavedOn>2014-07-13 12:45:54 -0400</pav:lastSavedOn>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:lineageUri>urn:domeoserver:annotation:12FF752F-ABCD-4F14-B2B9-41A0476FEF33</pav:lineageUri>
    <pav:createdOn>2014-07-13 12:44:29 -0400</pav:createdOn>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812eda990003</pav:createdBy>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:702E239E-7D5E-4778-8584-0516BA254DC8">
    <ao:suffix> was given alone. Dosage adjustment of atomoxetine may be necessary and it is recommended that atomoxetine be initiated at a reduced dose when given with paroxetine.</ao:suffix>
    <ao:exact>atomoxetine</ao:exact>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-47.txt.html</ao:hasSource>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:702E239E-7D5E-4778-8584-0516BA254DC8"/>
    <pav:createdOn>2014-09-02 11:58:42 -0400</pav:createdOn>
    <domeo:uuid>702E239E-7D5E-4778-8584-0516BA254DC8</domeo:uuid>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:prefix> Cmax values that were 3- to 4-fold greater than when </ao:prefix>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:5DCEC7D7-75CA-429F-BCD4-2381663B0506">
    <pav:createdOn>2014-07-21 21:49:45 -0400</pav:createdOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:suffix>xsd:String</ao:suffix>
    <ao:prefix>xsd:String</ao:prefix>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:5DCEC7D7-75CA-429F-BCD4-2381663B0506"/>
    <ao:exact>Diltiazem significantly decreases the clearance and increases the t1/2 of quinidine, but quinidine does not alter the kinetics of diltiazem.</ao:exact>
    <domeo:uuid>5DCEC7D7-75CA-429F-BCD4-2381663B0506</domeo:uuid>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-54.txt.html</ao:hasSource>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/200F7C4A-CD90-46C0-8779-AF63E291B5C6">
    <rdfs:label>rosiglitazone</rdfs:label>
    <sio:SIO_000228>dikbD2R:precipitant-drug-of-interaction</sio:SIO_000228>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/active-ingredient"/>
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/84108</dailymed:activeMoietyRxCUI>
    <dct:description>Referred to the drug in the interaction.</dct:description>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:C94B4C4D-E742-4102-A342-E2728F29088D">
    <ao:suffix>xsd:String</ao:suffix>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-9.txt.html</ao:hasSource>
    <ao:exact> Studies involving single 40 g doses of ethanol (oral administration in one study and intravenous in the other) and multiple dosing with fluvoxamine maleate (50 mg b.i.d.) revealed no effect of either drug on the pharmacokinetics or pharmacodynamics of the other. As with other psychotropic medications, patients should be advised to avoid alcohol while taking fluvoxamine maleate tablets.</ao:exact>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <pav:createdOn>2014-09-02 11:53:27 -0400</pav:createdOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:prefix>Alcohol:</ao:prefix>
    <domeo:uuid>C94B4C4D-E742-4102-A342-E2728F29088D</domeo:uuid>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:C94B4C4D-E742-4102-A342-E2728F29088D"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:D94A3BF4-A374-449F-9330-5C3F983FC929">
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812eda990003</pav:createdBy>
    <pav:lastSavedOn>2014-09-01 16:02:33 -0400</pav:lastSavedOn>
    <rdfs:label>Default Set</rdfs:label>
    <permissions:permissions rdf:nodeID="Nb2e79cf51a174e0185de063b4b5f7f72"/>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <ao:annotatesResource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-18.txt.html</ao:annotatesResource>
    <domeo:agents rdf:resource="urn:person:uuid:080e143046812afe0146812eda990003"/>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <domeo:deleted>false</domeo:deleted>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#AnnotationSet"/>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:lineageUri>urn:domeoserver:annotationset:5EC8F086-573B-4106-ABC5-394EC3185A72</pav:lineageUri>
    <pav:createdOn>2014-09-01 16:02:32 -0400</pav:createdOn>
    <domeo:agents rdf:resource="urn:domeo:software:id:Domeo-2.1alpha-050"/>
    <dct:description>The default set is created automatically by Domeo when no other set is existing.</dct:description>
    <ao:item rdf:resource="urn:domeoclient:uuid:704A238F-4D41-41C0-AEE2-EF49045B60D6"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:16393981-08BF-477D-ACB9-8FB804E50D0C">
    <pav:lastSavedOn>2014-07-07 10:02:41 -0400</pav:lastSavedOn>
    <domeo:belongsToSet>urn:domeoserver:annotationset:7AACEF8D-2EBC-4F0B-94B2-190650E562F6</domeo:belongsToSet>
    <pav:lineageUri>urn:domeoserver:annotation:5D5E7705-CD13-417B-BE4C-010E6D19EB36</pav:lineageUri>
    <domeo:belongsToSet>urn:domeoserver:annotationset:131835A3-C655-4F91-97D4-52CAFF7B7CCA</domeo:belongsToSet>
    <pav:createdOn>2014-07-07 09:57:03 -0400</pav:createdOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <domeo:belongsToSet>urn:domeoserver:annotationset:08C0C288-6DF4-43E6-A618-71A8BB9563C3</domeo:belongsToSet>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812eda990003</pav:createdBy>
    <rdfs:label>Highlight</rdfs:label>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <ao:context rdf:resource="urn:domeoclient:uuid:49F8A244-9291-40F9-AE95-B64DDF5E624D"/>
    <domeo:belongsToSet>urn:domeoserver:annotationset:22ED7220-C6F6-43C5-9DF9-89F62F0F8E27</domeo:belongsToSet>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <domeo:belongsToSet>urn:domeoserver:annotationset:8F3CF3D9-AADE-4A86-BD42-2924B3D6A406</domeo:belongsToSet>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/58FED583-F7D0-4B0E-913A-6142C90539F0">
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/136411</dailymed:activeMoietyRxCUI>
    <rdfs:label>sildenafil</rdfs:label>
    <sio:SIO_000228>dikbD2R:object-drug-of-interaction</sio:SIO_000228>
    <dct:description>Referred to the drug in the interaction.</dct:description>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/active-ingredient"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:84AD1907-FCD9-44ED-A2B9-CE7DA4A1A9AA">
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <rdfs:label>Highlight</rdfs:label>
    <pav:lastSavedOn>2014-07-22 20:22:38 -0400</pav:lastSavedOn>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <ao:context rdf:resource="urn:domeoclient:uuid:99D19A33-63BB-4F24-96F1-57FE6B759A48"/>
    <pav:lineageUri>urn:domeoserver:annotation:F59033EF-A957-4A73-82F8-005781304BC2</pav:lineageUri>
    <domeo:belongsToSet>urn:domeoserver:annotationset:F272A789-69D0-47CC-8CC9-F25C55B91261</domeo:belongsToSet>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812eda990003</pav:createdBy>
    <pav:createdOn>2014-07-22 19:55:23 -0400</pav:createdOn>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:E24CDAFA-738D-436F-8EA5-33584022000D">
    <pav:createdOn>2014-09-02 11:54:18 -0400</pav:createdOn>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <ao:context rdf:resource="urn:domeoclient:uuid:F263AADA-7E42-4AA1-B33C-9D0E2B21A723"/>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812eda990003</pav:createdBy>
    <domeo:belongsToSet>urn:domeoserver:annotationset:A3F0B39A-4249-4B63-BB0D-F24A005066AC</domeo:belongsToSet>
    <ao:body rdf:nodeID="Ne6a2939800544018ad3e80871a009edb"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#expertstudyAnnotation"/>
    <pav:lineageUri>urn:domeoserver:annotation:F5584C7B-8E90-4E9E-952C-B4931C5A6238</pav:lineageUri>
    <rdfs:label>expertstudy Annotation</rdfs:label>
    <pav:lastSavedOn>2014-09-02 11:54:50 -0400</pav:lastSavedOn>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:99E97745-423E-4818-BFC6-3F67C8BF2A87">
    <ao:context rdf:resource="urn:domeoclient:uuid:8ED4F58C-10A8-4F3A-8776-FD6D08A25610"/>
    <pav:lineageUri>urn:domeoserver:annotation:EAD485AF-D5DA-435A-B47D-F022CCE0E626</pav:lineageUri>
    <pav:lastSavedOn>2014-07-13 11:32:29 -0400</pav:lastSavedOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <rdfs:label>Highlight</rdfs:label>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <domeo:belongsToSet>urn:domeoclient:uuid:71191E51-53CB-4FDE-88D0-33C6818E2232</domeo:belongsToSet>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812eda990003</pav:createdBy>
    <pav:createdOn>2014-07-13 11:11:00 -0400</pav:createdOn>
    <pav:previousVersion>xsd:String</pav:previousVersion>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:C3E38D47-25A8-4196-B6ED-8D47D85B5D94">
    <ao:prefix> with </ao:prefix>
    <domeo:uuid>C3E38D47-25A8-4196-B6ED-8D47D85B5D94</domeo:uuid>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:suffix> is contraindicated in these patients.</ao:suffix>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:C3E38D47-25A8-4196-B6ED-8D47D85B5D94"/>
    <pav:createdOn>2014-07-22 19:37:28 -0400</pav:createdOn>
    <ao:exact>AVANDIA</ao:exact>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-123.txt.html</ao:hasSource>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:E4954BA3-FA9C-4983-8CA9-D8BA258D2881">
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <rdfs:label>Highlight</rdfs:label>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:lineageUri>urn:domeoserver:annotation:2EE2832E-F77B-407B-AD3C-39A564CB31D3</pav:lineageUri>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <domeo:belongsToSet>urn:domeoclient:uuid:B6F745E6-5734-4636-A383-683BA4C79E38</domeo:belongsToSet>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812eda990003</pav:createdBy>
    <ao:context rdf:resource="urn:domeoclient:uuid:5F95A684-4F34-42D2-8F26-ACB40DD06487"/>
    <pav:createdOn>2014-07-21 21:26:56 -0400</pav:createdOn>
    <pav:lastSavedOn>2014-07-21 21:27:51 -0400</pav:lastSavedOn>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:F70AB841-7C14-48D1-B543-A45EA067C642">
    <ao:item rdf:resource="urn:domeoclient:uuid:74CD19CE-F47D-46AD-8DBC-B02B6A6F0D87"/>
    <permissions:permissions rdf:nodeID="Necbd12bde3994d17bd7db8a39bb1c584"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:B8E504B5-222C-4BAE-88E1-E79A32308174"/>
    <rdfs:label>Default Set</rdfs:label>
    <ao:item rdf:resource="urn:domeoclient:uuid:0FC34074-15F7-4C00-87F2-8D4B6F9B8889"/>
    <pav:createdOn>2014-07-24 20:03:38 -0400</pav:createdOn>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <domeo:deleted>false</domeo:deleted>
    <domeo:agents rdf:resource="urn:person:uuid:080e143046812afe0146812eda990003"/>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <ao:annotatesResource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-137.txt.html</ao:annotatesResource>
    <domeo:agents rdf:resource="urn:domeo:software:id:Domeo-2.1alpha-050"/>
    <dct:description>The default set is created automatically by Domeo when no other set is existing.</dct:description>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#AnnotationSet"/>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812eda990003</pav:createdBy>
    <ao:item rdf:resource="urn:domeoclient:uuid:12ACDF1A-FCDF-42E9-A413-FB39FC095FFC"/>
    <pav:lastSavedOn>2014-07-24 20:04:12 -0400</pav:lastSavedOn>
    <ao:item rdf:resource="urn:domeoclient:uuid:14F32A7A-80E4-454D-A47D-8CEAFB294984"/>
    <pav:lineageUri>urn:domeoserver:annotationset:2CC86AAA-D8FA-4C97-8FBA-1AFD74F6813F</pav:lineageUri>
  </rdf:Description>
  <rdf:Description rdf:nodeID="Nf98d13d8337a44c2b1f1c4c6fe169164">
    <domeo:sets rdf:resource="urn:pddi:uuid:3BA7AB65-2DF7-4BB0-BB24-76AE0AC3003C"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:3D0923EA-66A5-4F6E-A3E6-A3D09E9AA9FA">
    <pav:lastSavedOn>2014-07-28 17:08:37 -0400</pav:lastSavedOn>
    <pav:lineageUri>urn:domeoserver:annotation:A52D638C-2F1C-425C-BFAB-A6120EDEA665</pav:lineageUri>
    <pav:createdOn>2014-07-28 17:07:56 -0400</pav:createdOn>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <domeo:belongsToSet>urn:domeoclient:uuid:48D839E5-6B0A-4EC3-B64A-E3E20E06246A</domeo:belongsToSet>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <ao:context rdf:resource="urn:domeoclient:uuid:874E727F-4FC5-466C-9B3D-C17154D3C2D1"/>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812eda990003</pav:createdBy>
    <ao:body rdf:nodeID="N473080370f864f43a5464ebedb68cdb2"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#expertstudyAnnotation"/>
    <rdfs:label>expertstudy Annotation</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:34C208E6-0FE1-4394-8496-13F4C10CB492">
    <ao:exact>Citalopram</ao:exact>
    <domeo:uuid>34C208E6-0FE1-4394-8496-13F4C10CB492</domeo:uuid>
    <ao:suffix> did not alter the mean AUC or Cmax of pimozide. The mechanism of this pharmacodynamic interaction is not known.</ao:suffix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <pav:createdOn>2014-09-02 19:38:22 -0400</pav:createdOn>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-78.txt.html</ao:hasSource>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:34C208E6-0FE1-4394-8496-13F4C10CB492"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:prefix> 40 mg given once daily for 11 days was associated with a mean increase in QTc values of approximately 10 msec compared to pimozide given alone. </ao:prefix>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:7E0188B4-6C70-41E7-B903-5A68F972FC55">
    <pav:createdOn>2014-09-02 11:43:06 -0400</pav:createdOn>
    <ao:suffix> maleate tablets and TCAs; plasma TCA concentrations may need to be monitored, and the dose of TCA may need to be reduced.</ao:suffix>
    <ao:exact>fluvoxamine</ao:exact>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-9.txt.html</ao:hasSource>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:7E0188B4-6C70-41E7-B903-5A68F972FC55"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <domeo:uuid>7E0188B4-6C70-41E7-B903-5A68F972FC55</domeo:uuid>
    <ao:prefix> maleate and amitriptyline, clomipramine or imipramine. Caution is indicated with the coadministration of </ao:prefix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:EFB91CD1-48E1-4F2E-9E33-D718A3D8D087">
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-139.txt.html</ao:hasSource>
    <pav:createdOn>2014-07-24 20:07:29 -0400</pav:createdOn>
    <domeo:uuid>EFB91CD1-48E1-4F2E-9E33-D718A3D8D087</domeo:uuid>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:EFB91CD1-48E1-4F2E-9E33-D718A3D8D087"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:prefix> in healthy adult subjects. </ao:prefix>
    <ao:exact>Fexofenadine</ao:exact>
    <ao:suffix> had no effect on the pharmacokinetics of either erythromycin or ketoconazole. In two separate studies in healthy adult subjects, fexofenadine hydrochloride 120 mg twice daily (240 mg total daily dose) was coadministered with either erythromycin 500 mg e</ao:suffix>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:2B94664D-D507-4349-822D-1C47F7304469">
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-9.txt.html</ao:hasSource>
    <pav:createdOn>2014-09-02 11:36:31 -0400</pav:createdOn>
    <domeo:uuid>2B94664D-D507-4349-822D-1C47F7304469</domeo:uuid>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:2B94664D-D507-4349-822D-1C47F7304469"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:exact>omeprazole</ao:exact>
    <ao:suffix>xsd:String</ao:suffix>
    <ao:prefix>, certain benzodiazepines, </ao:prefix>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:0323018B-085E-4636-9195-1B6FDC9A582D">
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-123.txt.html</ao:hasSource>
    <ao:exact>Rifampin</ao:exact>
    <ao:prefix>xsd:String</ao:prefix>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:0323018B-085E-4636-9195-1B6FDC9A582D"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <domeo:uuid>0323018B-085E-4636-9195-1B6FDC9A582D</domeo:uuid>
    <ao:suffix>xsd:String</ao:suffix>
    <pav:createdOn>2014-07-22 19:48:57 -0400</pav:createdOn>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:934B866B-AFCB-4F4A-A5CA-1B312B3088E1">
    <pav:createdOn>2014-07-13 11:15:01 -0400</pav:createdOn>
    <ao:context rdf:resource="urn:domeoclient:uuid:A0EE858B-D738-4E79-B01E-E50A3141586B"/>
    <rdfs:label>Highlight</rdfs:label>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:lineageUri>urn:domeoserver:annotation:AD145E05-D965-40D9-8AB9-4C610AF8A665</pav:lineageUri>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812eda990003</pav:createdBy>
    <domeo:belongsToSet>urn:domeoclient:uuid:71191E51-53CB-4FDE-88D0-33C6818E2232</domeo:belongsToSet>
    <pav:lastSavedOn>2014-07-13 11:32:29 -0400</pav:lastSavedOn>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:5B31DBDC-7235-4CB3-937C-37BEC560A1C4">
    <domeo:uuid>5B31DBDC-7235-4CB3-937C-37BEC560A1C4</domeo:uuid>
    <ao:exact>fluconazole </ao:exact>
    <ao:suffix>and glipizide has been demonstrated in a placebo-controlled crossover study in normal volunteers. All subjects received glipizide alone and following treatment with 100 mg of fluconazole as a single daily oral dose for 7 days. The mean percentage increas</ao:suffix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:prefix>and oral hypoglycemic agents leading to severe hypoglycemia has been reported. Whether this interaction also occurs with the intravenous, topical, or vaginal preparations of miconazole is not known. The effect of concomitant administration of </ao:prefix>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:5B31DBDC-7235-4CB3-937C-37BEC560A1C4"/>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-40.txt.html</ao:hasSource>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <pav:createdOn>2014-09-01 16:07:25 -0400</pav:createdOn>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:1230CFBE-6F41-4107-8D50-5F5A730D40C5">
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <domeo:uuid>1230CFBE-6F41-4107-8D50-5F5A730D40C5</domeo:uuid>
    <ao:prefix> acts as an antagonist at other receptors, but with lower potency. </ao:prefix>
    <ao:suffix> has low to moderate affinity (Ki of 47 to 253 nM) for the serotonin 5HT1C, 5HT1D, and 5HT1A receptors, weak affinity (Ki of 620 to 800 nM) for the dopamine D1 and haloperidol-sensitive sigma site, and no affinity (when tested at concentrations &gt;10-5 M) </ao:suffix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <pav:createdOn>2014-07-13 11:07:49 -0400</pav:createdOn>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:1230CFBE-6F41-4107-8D50-5F5A730D40C5"/>
    <ao:exact>Risperidone</ao:exact>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-8.txt.html</ao:hasSource>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:0C7DC9EA-F2B4-4F7F-BD05-8D844F135B91">
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <domeo:belongsToSet>urn:domeoclient:uuid:4519FF07-AE90-4478-8B97-B4B2C84457DC</domeo:belongsToSet>
    <ao:context rdf:resource="urn:domeoclient:uuid:69FB098B-12F9-4F1C-AE30-F8B99226F270"/>
    <pav:lineageUri>urn:domeoserver:annotation:A6C4359D-F4E7-4034-B791-FE7811C43403</pav:lineageUri>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812eda990003</pav:createdBy>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <rdfs:label>Highlight</rdfs:label>
    <pav:createdOn>2014-07-24 19:45:39 -0400</pav:createdOn>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:lastSavedOn>2014-07-24 19:46:05 -0400</pav:lastSavedOn>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/5F10CADF-C9DD-4270-A5C5-81DBB003F49D">
    <rdfs:label>rosiglitazone</rdfs:label>
    <sio:SIO_000228>dikbD2R:object-drug-of-interaction</sio:SIO_000228>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/active-ingredient"/>
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/84108</dailymed:activeMoietyRxCUI>
    <dct:description>Referred to the drug in the interaction.</dct:description>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:56AEEC1F-6F5E-4CAD-A96A-7EC09CB365C8">
    <rdfs:label>Highlight</rdfs:label>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:createdOn>2014-09-01 15:59:54 -0400</pav:createdOn>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812eda990003</pav:createdBy>
    <pav:lastSavedOn>2014-09-01 16:00:14 -0400</pav:lastSavedOn>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <ao:context rdf:resource="urn:domeoclient:uuid:6341241A-9991-4CE8-B771-4A2513B1FF21"/>
    <pav:lineageUri>urn:domeoserver:annotation:0946B8FF-FE7F-4B36-A972-249F2756BCEC</pav:lineageUri>
    <domeo:belongsToSet>urn:domeoclient:uuid:659ED9DF-77DA-41F2-B123-6E455B4F2385</domeo:belongsToSet>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:40519342-F06B-41D2-A39A-795BA218AF7B">
    <ao:prefix> 400 mg to six healthy male volunteers. After the administration of </ao:prefix>
    <ao:suffix>, there was a significant decrease in fluconazole AUC and Cmax. There was a mean ± SD decrease in fluconazole AUC of 13% ± 11% (range: -3.4 to -31%) and Cmax decreased 19% ± 14% (range: -5 to -40%). However, the administration of cimetidine 600 mg to 900</ao:suffix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <domeo:uuid>40519342-F06B-41D2-A39A-795BA218AF7B</domeo:uuid>
    <pav:createdOn>2014-07-13 12:46:18 -0400</pav:createdOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-23.txt.html</ao:hasSource>
    <ao:exact>cimetidine</ao:exact>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:40519342-F06B-41D2-A39A-795BA218AF7B"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:A5DD6E78-70E1-4015-8485-53B5D56072C0">
    <ao:prefix>xsd:String</ao:prefix>
    <pav:createdOn>2014-07-21 21:49:21 -0400</pav:createdOn>
    <ao:suffix>xsd:String</ao:suffix>
    <domeo:uuid>A5DD6E78-70E1-4015-8485-53B5D56072C0</domeo:uuid>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-54.txt.html</ao:hasSource>
    <ao:exact>Diltiazem significantly decreases the clearance and increases the t1/2 of quinidine, but quinidine does not alter the kinetics of diltiazem.</ao:exact>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:A5DD6E78-70E1-4015-8485-53B5D56072C0"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:346B16C2-85FF-42F8-A3AB-6C7DEBB418C7">
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:lineageUri>urn:domeoserver:annotation:27512628-B2FB-4020-B711-A78AA2E6DE2F</pav:lineageUri>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812eda990003</pav:createdBy>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <domeo:belongsToSet>urn:domeoclient:uuid:5D381360-05CD-407C-BAB9-6496A42C73E4</domeo:belongsToSet>
    <rdfs:label>Highlight</rdfs:label>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:lastSavedOn>2014-09-01 16:12:36 -0400</pav:lastSavedOn>
    <pav:createdOn>2014-09-01 16:12:31 -0400</pav:createdOn>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <ao:context rdf:resource="urn:domeoclient:uuid:1459510A-C593-4CF2-959E-F68381AB3C04"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:4A2643B5-4BD1-4161-8CBE-473EFB4DDFC8">
    <domeo:belongsToSet>urn:domeoclient:uuid:B61F1A9B-4696-4ED0-80AA-4FE2E9016966</domeo:belongsToSet>
    <rdfs:label>expertstudy Annotation</rdfs:label>
    <ao:context rdf:resource="urn:domeoclient:uuid:8BB0D7D8-E6FC-43D6-A047-53DA7C4A005E"/>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:lastSavedOn>2014-07-21 21:35:10 -0400</pav:lastSavedOn>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:lineageUri>urn:domeoserver:annotation:06B071FC-227B-4B3A-85BA-6720A021449E</pav:lineageUri>
    <pav:createdOn>2014-07-21 21:34:52 -0400</pav:createdOn>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812eda990003</pav:createdBy>
    <ao:body rdf:nodeID="Nf30b8d8f90f34db298a52bd892a2e53c"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#expertstudyAnnotation"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:6A05795B-B1AB-4DB3-A12F-2765CBCC2FED">
    <ao:item rdf:resource="urn:domeoclient:uuid:92530361-A562-40CE-942A-CC181EBE7AD7"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:489FB94C-2475-4EC7-BE20-CF92749745A7"/>
    <domeo:agents rdf:resource="urn:person:uuid:080e143046812afe0146812eda990003"/>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <domeo:agents rdf:resource="urn:domeo:software:id:Domeo-2.1alpha-050"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:D3F1A48F-9525-4CA3-8022-C7885849CBC2"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#AnnotationSet"/>
    <pav:lastSavedOn>2014-07-13 12:34:42 -0400</pav:lastSavedOn>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <dct:description>The default set is created automatically by Domeo when no other set is existing.</dct:description>
    <rdfs:label>Default Set</rdfs:label>
    <ao:annotatesResource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-20.txt.html</ao:annotatesResource>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812eda990003</pav:createdBy>
    <domeo:deleted>false</domeo:deleted>
    <permissions:permissions rdf:nodeID="N9b7776e7468f4202a5eeeeaf5b975767"/>
    <pav:lineageUri>urn:domeoserver:annotationset:428337F8-4C91-47BA-A4E8-ABD1A86D1498</pav:lineageUri>
    <pav:createdOn>2014-07-13 12:34:35 -0400</pav:createdOn>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:986D80D9-D47C-41ED-95FE-F55B1AE2AC9D">
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:createdOn>2014-07-24 20:11:39 -0400</pav:createdOn>
    <domeo:belongsToSet>urn:domeoserver:annotationset:1FC172B8-8AC3-465A-AA69-B73AD9B97CBC</domeo:belongsToSet>
    <ao:context rdf:resource="urn:domeoclient:uuid:5B7317CD-AFB7-45AB-8141-DD5FD3B899F5"/>
    <rdfs:label>Highlight</rdfs:label>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812eda990003</pav:createdBy>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <pav:lineageUri>urn:domeoserver:annotation:00F781B7-912F-4DC4-ACCE-83BA41B12A3F</pav:lineageUri>
    <pav:lastSavedOn>2014-07-24 20:12:49 -0400</pav:lastSavedOn>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:390CA5FE-7939-4F69-B612-7F5C21A06481">
    <pav:createdOn>2014-07-13 11:02:05 -0400</pav:createdOn>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812eda990003</pav:createdBy>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:lineageUri>urn:domeoserver:annotation:9CBDBE67-2211-4254-BEF8-DDC84C5BB035</pav:lineageUri>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <ao:context rdf:resource="urn:domeoclient:uuid:1085914C-2530-49EB-92B4-1E4BC17AEBAC"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <domeo:belongsToSet>urn:domeoclient:uuid:71CADA90-E1E5-4B50-9394-FDFC0B1512B0</domeo:belongsToSet>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <rdfs:label>Highlight</rdfs:label>
    <pav:lastSavedOn>2014-07-13 11:02:34 -0400</pav:lastSavedOn>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:D909BDC5-468E-434E-B3E5-632F1565E73C">
    <pav:createdOn>2014-07-13 11:11:25 -0400</pav:createdOn>
    <ao:suffix> (100 mcg/mL), warfarin (10 mcg/mL), and carbamazepine (10 mcg/mL) caused only a slight increase in the free fraction of risperidone at 10 ng/mL and 9-hydroxyrisperidone at 50 ng/mL, changes of unknown clinical significance.</ao:suffix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:D909BDC5-468E-434E-B3E5-632F1565E73C"/>
    <ao:exact>ulfamethazine</ao:exact>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-8.txt.html</ao:hasSource>
    <ao:prefix> displaces each other from plasma binding sites. High therapeutic concentrations of s</ao:prefix>
    <domeo:uuid>D909BDC5-468E-434E-B3E5-632F1565E73C</domeo:uuid>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:254E1933-56AE-4110-9A6C-715CC58538B6">
    <pav:createdOn>2014-07-22 19:38:22 -0400</pav:createdOn>
    <ao:prefix>xsd:String</ao:prefix>
    <domeo:uuid>254E1933-56AE-4110-9A6C-715CC58538B6</domeo:uuid>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-123.txt.html</ao:hasSource>
    <ao:exact>rosiglitazone</ao:exact>
    <ao:suffix>xsd:String</ao:suffix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:254E1933-56AE-4110-9A6C-715CC58538B6"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:58F2142F-5F2A-4136-AB4F-944FA95FB01D">
    <pav:lineageUri>urn:domeoserver:annotation:0B49CFF0-97DD-4E4F-B22A-E1301AFF9F67</pav:lineageUri>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812eda990003</pav:createdBy>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <rdfs:label>Highlight</rdfs:label>
    <ao:context rdf:resource="urn:domeoclient:uuid:BF6678E7-2ECF-462C-8BF0-34D8AD9D7A8B"/>
    <domeo:belongsToSet>urn:domeoclient:uuid:1285AF18-3541-4E0D-9BAA-DDBC5E9C152C</domeo:belongsToSet>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:createdOn>2014-09-02 19:46:53 -0400</pav:createdOn>
    <pav:lastSavedOn>2014-09-02 19:46:58 -0400</pav:lastSavedOn>
    <pav:previousVersion>xsd:String</pav:previousVersion>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:88A57962-2A3E-4D94-8F54-0A13BDB6FAD9">
    <pav:createdOn>2014-09-02 15:04:24 -0400</pav:createdOn>
    <ao:context rdf:resource="urn:domeoclient:uuid:631995B6-520A-4B5F-B283-0557077A8B49"/>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:lineageUri>urn:domeoserver:annotation:DEE6A881-BE96-44F5-B16E-077C84D64859</pav:lineageUri>
    <domeo:belongsToSet>urn:domeoclient:uuid:C4B80A95-F569-4ED4-84D1-6796B53A580C</domeo:belongsToSet>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812eda990003</pav:createdBy>
    <pav:lastSavedOn>2014-09-02 15:04:32 -0400</pav:lastSavedOn>
    <rdfs:label>Highlight</rdfs:label>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:previousVersion>xsd:String</pav:previousVersion>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:B63FFC37-B751-48F0-8F6D-DC3232F9B394">
    <ao:exact>colestipol</ao:exact>
    <pav:createdOn>2014-07-24 19:47:46 -0400</pav:createdOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:suffix> with propranolol resulted in up to 50% decrease in propranolol concentrations.</ao:suffix>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-131.txt.html</ao:hasSource>
    <domeo:uuid>B63FFC37-B751-48F0-8F6D-DC3232F9B394</domeo:uuid>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:B63FFC37-B751-48F0-8F6D-DC3232F9B394"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:prefix> or </ao:prefix>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:72584FCC-E5F1-4130-993B-ED469AE3E810">
    <pav:createdOn>2014-07-13 11:15:50 -0400</pav:createdOn>
    <pav:lastSavedOn>2014-07-13 11:32:29 -0400</pav:lastSavedOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <rdfs:label>Highlight</rdfs:label>
    <pav:lineageUri>urn:domeoserver:annotation:4F012046-527A-4412-B5FE-F766182124E4</pav:lineageUri>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <domeo:belongsToSet>urn:domeoclient:uuid:71191E51-53CB-4FDE-88D0-33C6818E2232</domeo:belongsToSet>
    <ao:context rdf:resource="urn:domeoclient:uuid:5B7BF8E5-F410-48B2-AF56-5421E6B7FF0B"/>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812eda990003</pav:createdBy>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:EDF86F62-D99C-4656-9677-171A5B522535">
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <ao:context rdf:resource="urn:domeoclient:uuid:5DCEC7D7-75CA-429F-BCD4-2381663B0506"/>
    <ao:body rdf:nodeID="N9611565c3479448abb5f7f7161535dd7"/>
    <pav:lastSavedOn>2014-07-21 21:49:33 -0400</pav:lastSavedOn>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:lineageUri>urn:domeoserver:annotation:BD2F8285-34FA-4CD1-8607-8FE20DF34F40</pav:lineageUri>
    <domeo:belongsToSet>urn:domeoclient:uuid:B803E851-5AD5-4741-B1B9-1CBAED597E18</domeo:belongsToSet>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812eda990003</pav:createdBy>
    <pav:createdOn>2014-07-21 21:49:45 -0400</pav:createdOn>
    <rdfs:label>expertstudy Annotation</rdfs:label>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#expertstudyAnnotation"/>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:62F73A2A-2D49-4A1C-B836-1F3280DE6ACE">
    <pav:createdOn>2014-07-22 19:48:54 -0400</pav:createdOn>
    <pav:lastSavedOn>2014-07-22 19:54:59 -0400</pav:lastSavedOn>
    <pav:lineageUri>urn:domeoserver:annotationset:AB1741F1-5A5F-4416-AEAC-A544BCBB7D16</pav:lineageUri>
    <domeo:belongsToSet>urn:domeoserver:annotationset:F272A789-69D0-47CC-8CC9-F25C55B91261</domeo:belongsToSet>
    <pav:lineageUri>urn:domeoserver:annotation:A9516CB6-9F44-4BF5-85D8-A6FA39467677</pav:lineageUri>
    <rdfs:label>Highlight</rdfs:label>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">7</pav:versionNumber>
    <domeo:belongsToSet>urn:domeoserver:annotationset:2914A3FD-DF43-4F78-999C-77CE7A028B19</domeo:belongsToSet>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812eda990003</pav:createdBy>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <pav:previousVersion>urn:domeoserver:annotationset:606A5B3F-B6FB-4279-AA42-7893CFC2D20C</pav:previousVersion>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <ao:context rdf:resource="urn:domeoclient:uuid:E6E87B62-FE76-4230-92AF-6FD2DBA966AD"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:1CF0856D-0878-41B0-8A05-7007C19C91DB">
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <ao:context rdf:resource="urn:domeoclient:uuid:2CF4DD8F-BE67-4B73-8082-A0A474C61D19"/>
    <rdfs:label>Highlight</rdfs:label>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <domeo:belongsToSet>urn:domeoclient:uuid:CE5AF44C-D211-4F33-A502-2B4C37E2ACFC</domeo:belongsToSet>
    <pav:lastSavedOn>2014-07-24 19:39:23 -0400</pav:lastSavedOn>
    <pav:createdOn>2014-07-24 19:39:23 -0400</pav:createdOn>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812eda990003</pav:createdBy>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:lineageUri>urn:domeoserver:annotation:3D46B0B0-9486-45F5-8735-D5E5F3EE9D5D</pav:lineageUri>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:30044970-A8CB-42F8-A59C-789340FE24AC">
    <pav:createdOn>2014-07-24 20:01:45 -0400</pav:createdOn>
    <domeo:uuid>30044970-A8CB-42F8-A59C-789340FE24AC</domeo:uuid>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:suffix>xsd:String</ao:suffix>
    <ao:exact> trazodone</ao:exact>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:30044970-A8CB-42F8-A59C-789340FE24AC"/>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-136.txt.html</ao:hasSource>
    <ao:prefix>is a substrate of the cytochrome P450 3A4 (CYP3A4) enzyme and</ao:prefix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:F2F7D256-D331-45B3-9459-089EEB530262">
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">5</pav:versionNumber>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812eda990003</pav:createdBy>
    <pav:createdOn>2014-07-22 19:38:28 -0400</pav:createdOn>
    <pav:lineageUri>urn:domeoserver:annotationset:AB1741F1-5A5F-4416-AEAC-A544BCBB7D16</pav:lineageUri>
    <domeo:belongsToSet>urn:domeoserver:annotationset:F272A789-69D0-47CC-8CC9-F25C55B91261</domeo:belongsToSet>
    <pav:lastSavedOn>2014-07-22 19:40:32 -0400</pav:lastSavedOn>
    <domeo:belongsToSet>urn:domeoserver:annotationset:606A5B3F-B6FB-4279-AA42-7893CFC2D20C</domeo:belongsToSet>
    <domeo:belongsToSet>urn:domeoserver:annotationset:514BA51B-D734-4003-A7C3-F03C0F95833A</domeo:belongsToSet>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:lineageUri>urn:domeoserver:annotation:FC9C9464-1DB3-45F1-B443-77EF12342D91</pav:lineageUri>
    <domeo:belongsToSet>urn:domeoserver:annotationset:2914A3FD-DF43-4F78-999C-77CE7A028B19</domeo:belongsToSet>
    <pav:previousVersion>urn:domeoserver:annotationset:7021B883-FD5C-4083-BD87-DF56D3C87633</pav:previousVersion>
    <pav:lastSavedOn>2014-07-22 19:40:31 -0400</pav:lastSavedOn>
    <ao:context rdf:resource="urn:domeoclient:uuid:56C7D107-DA52-4259-9BBA-41DB4C5FB13D"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <rdfs:label>Highlight</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:167FB68A-5943-4F0E-8CC6-C6BAB7625E4F">
    <rdfs:label>Highlight</rdfs:label>
    <ao:context rdf:resource="urn:domeoclient:uuid:F5A4FF79-C22B-475D-8775-B7CA929DA67C"/>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:lineageUri>urn:domeoserver:annotation:A6AB8619-AAFD-4D65-8839-376407154A96</pav:lineageUri>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:createdOn>2014-07-13 12:38:47 -0400</pav:createdOn>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <domeo:belongsToSet>urn:domeoclient:uuid:4F872953-6D19-4809-9285-FCCF2FF54315</domeo:belongsToSet>
    <pav:lastSavedOn>2014-07-13 12:41:10 -0400</pav:lastSavedOn>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812eda990003</pav:createdBy>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:0D11B975-10D6-42DD-93CA-9D9026AA5279">
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <ao:context rdf:resource="urn:domeoclient:uuid:EC569F9C-8D7B-414A-9059-EDFAE9A86040"/>
    <pav:lineageUri>urn:domeoserver:annotation:6E17111B-43FD-450F-81B0-BB4156153427</pav:lineageUri>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812eda990003</pav:createdBy>
    <domeo:belongsToSet>urn:domeoclient:uuid:1285AF18-3541-4E0D-9BAA-DDBC5E9C152C</domeo:belongsToSet>
    <rdfs:label>Highlight</rdfs:label>
    <pav:lastSavedOn>2014-09-02 19:46:58 -0400</pav:lastSavedOn>
    <pav:createdOn>2014-09-02 19:46:24 -0400</pav:createdOn>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:previousVersion>xsd:String</pav:previousVersion>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:AF657FF8-3529-4A9B-9294-13C604834E0A">
    <rdfs:label>expertstudy Annotation</rdfs:label>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <ao:context rdf:resource="urn:domeoclient:uuid:211F5FD6-FC29-4AC5-96E1-14E088108ABB"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#expertstudyAnnotation"/>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812eda990003</pav:createdBy>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <domeo:belongsToSet>urn:domeoclient:uuid:E89548FF-A4A2-4B87-B1E1-B12E3E255FA1</domeo:belongsToSet>
    <pav:lineageUri>urn:domeoserver:annotation:AB1C3D00-CC4C-4CA3-B347-69BA6BFE0FBF</pav:lineageUri>
    <pav:createdOn>2014-07-13 12:56:54 -0400</pav:createdOn>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <ao:body rdf:nodeID="N8cb546f2298f47b6b06debe187be68f0"/>
    <pav:lastSavedOn>2014-07-13 12:56:57 -0400</pav:lastSavedOn>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:6887274E-F614-42FD-904F-B7E202949297">
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:6887274E-F614-42FD-904F-B7E202949297"/>
    <ao:exact>9-hydroxyrisperidone</ao:exact>
    <domeo:uuid>6887274E-F614-42FD-904F-B7E202949297</domeo:uuid>
    <ao:prefix> is 90%, and that of its major metabolite, </ao:prefix>
    <ao:suffix>, is 77%. Neither risperidone nor 9-hydroxyrisperidone displaces each other from plasma binding sites. High therapeutic concentrations of sulfamethazine (100 mcg/mL), warfarin (10 mcg/mL), and carbamazepine (10 mcg/mL) caused only a slight increase in th</ao:suffix>
    <pav:createdOn>2014-07-13 11:11:10 -0400</pav:createdOn>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-8.txt.html</ao:hasSource>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:DFAAFFAE-4EF6-4FDF-9B79-9C8FCB23829E">
    <ao:prefix>and </ao:prefix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:suffix>(see WARNINGS AND PRECAUTIONS [5.3]).</ao:suffix>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:DFAAFFAE-4EF6-4FDF-9B79-9C8FCB23829E"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <domeo:uuid>DFAAFFAE-4EF6-4FDF-9B79-9C8FCB23829E</domeo:uuid>
    <ao:exact>tryptophan </ao:exact>
    <pav:createdOn>2014-09-02 11:44:27 -0400</pav:createdOn>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-9.txt.html</ao:hasSource>
  </rdf:Description>
  <rdf:Description rdf:nodeID="N4e15a828729e4ee2adbac01643ade321">
    <domeo:sets rdf:resource="urn:pddi:uuid:FC76D7A1-BCF3-4AF0-92CC-E5D2F09F6BD7"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:86692ABC-62BE-4895-A4EF-50FCB21327B2">
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:suffix> to interfere with metabolism of other drugs metabolized by CYP 2D6. Relatively weak binding of risperidone to the enzyme suggests this is unlikely [see 7 DRUG INTERACTIONS].</ao:suffix>
    <pav:createdOn>2014-07-13 11:16:08 -0400</pav:createdOn>
    <domeo:uuid>86692ABC-62BE-4895-A4EF-50FCB21327B2</domeo:uuid>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-8.txt.html</ao:hasSource>
    <ao:exact>risperidone</ao:exact>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:86692ABC-62BE-4895-A4EF-50FCB21327B2"/>
    <ao:prefix> [see 7 DRUG INTERACTIONS]. It would also be possible for </ao:prefix>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:8164F866-D42E-492E-9290-5B0170C62867">
    <domeo:belongsToSet>urn:domeoclient:uuid:C4B80A95-F569-4ED4-84D1-6796B53A580C</domeo:belongsToSet>
    <pav:createdOn>2014-09-02 15:04:06 -0400</pav:createdOn>
    <rdfs:label>Highlight</rdfs:label>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:lastSavedOn>2014-09-02 15:04:32 -0400</pav:lastSavedOn>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812eda990003</pav:createdBy>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <ao:context rdf:resource="urn:domeoclient:uuid:60F0E01C-50AF-48FD-82F1-C840D5A8FDDD"/>
    <pav:lineageUri>urn:domeoserver:annotation:CB9D594C-4469-45CF-B5C6-3B8FFA5E53B2</pav:lineageUri>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:CDDC5F6F-E40F-4F4A-BB7A-C77A3A968B0B">
    <ao:suffix>xsd:String</ao:suffix>
    <ao:prefix>xsd:String</ao:prefix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <domeo:uuid>CDDC5F6F-E40F-4F4A-BB7A-C77A3A968B0B</domeo:uuid>
    <ao:exact>Zonisamide single dose pharmacokinetic parameters were not affected by cimetidine (300 mg four times a day for 12 days).</ao:exact>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:CDDC5F6F-E40F-4F4A-BB7A-C77A3A968B0B"/>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-57.txt.html</ao:hasSource>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <pav:createdOn>2014-07-22 18:36:48 -0400</pav:createdOn>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/B9254794-2257-403D-AD8D-D269CBB2679F">
    <sio:SIO_000228>dikbD2R:object-drug-of-interaction</sio:SIO_000228>
    <rdfs:label>Zonisamide</rdfs:label>
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/39998</dailymed:activeMoietyRxCUI>
    <dct:description>Referred to the drug in the interaction.</dct:description>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/active-ingredient"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:9E2FD166-718B-4FDB-8465-F19A84DE1BB4">
    <domeo:belongsToSet>urn:domeoserver:annotationset:D52DFD7B-BDDF-488F-B339-B1BC641E50E9</domeo:belongsToSet>
    <pav:createdOn>2014-09-02 12:02:51 -0400</pav:createdOn>
    <domeo:belongsToSet>urn:domeoclient:uuid:379CD8C1-F4B4-42B7-8F87-70776866DB1F</domeo:belongsToSet>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812eda990003</pav:createdBy>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <ao:context rdf:resource="urn:domeoclient:uuid:5A444D2E-FB37-4D42-8D22-19CAC1F671D0"/>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:lineageUri>urn:domeoserver:annotationset:166C20E9-1B4C-47D1-982D-922E2E5ACFF2</pav:lineageUri>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <rdfs:label>Highlight</rdfs:label>
    <pav:lineageUri>urn:domeoserver:annotation:4EF8730E-F19C-439C-A869-FD0A2268343B</pav:lineageUri>
    <pav:lastSavedOn>2014-09-02 12:03:47 -0400</pav:lastSavedOn>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:1C538CF6-5CD8-48ED-96FC-B9B3546A66F8">
    <pav:previousVersion>urn:domeoclient:uuid:8D86A4AC-54BD-4BB3-8B58-AB55DEC01A88</pav:previousVersion>
    <domeo:belongsToSet>urn:domeoserver:annotationset:37B2514D-1A92-45B1-8A5C-610DA6DC935A</domeo:belongsToSet>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <domeo:belongsToSet>urn:domeoserver:annotationset:1FC172B8-8AC3-465A-AA69-B73AD9B97CBC</domeo:belongsToSet>
    <rdfs:label>Highlight</rdfs:label>
    <pav:lastSavedOn>2014-07-24 20:10:49 -0400</pav:lastSavedOn>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:lineageUri>urn:domeoserver:annotation:C47BB336-1CC3-4FE1-8E3B-B4BFCAEC4CB6</pav:lineageUri>
    <pav:createdOn>2014-07-24 20:08:18 -0400</pav:createdOn>
    <ao:context rdf:resource="urn:domeoclient:uuid:E80C09FF-4092-4C04-9821-CFC8593DEFD7"/>
    <pav:lastSavedOn>2014-07-24 20:10:48 -0400</pav:lastSavedOn>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">2</pav:versionNumber>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812eda990003</pav:createdBy>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:lineageUri>urn:domeoserver:annotationset:4A88D0A6-E9B6-4E7F-955F-3692600C178C</pav:lineageUri>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:EA1C9791-9797-4F15-A767-767B900E9B87">
    <ao:exact>-</ao:exact>
    <pav:createdOn>2014-07-07 09:58:58 -0400</pav:createdOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <domeo:uuid>EA1C9791-9797-4F15-A767-767B900E9B87</domeo:uuid>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:EA1C9791-9797-4F15-A767-767B900E9B87"/>
    <ao:suffix>xsd:String</ao:suffix>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-155.txt.html</ao:hasSource>
    <domeo:uuid></domeo:uuid>
    <ao:prefix>xsd:String</ao:prefix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/94DFD21D-D749-4F5E-AE57-CF5CE30BA0D9">
    <dct:description>Referred to the drug in the interaction.</dct:description>
    <sio:SIO_000228>dikbD2R:object-drug-of-interaction</sio:SIO_000228>
    <rdfs:label>fluconazole</rdfs:label>
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/4450</dailymed:activeMoietyRxCUI>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/active-ingredient"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:57242808-9748-4ED3-908E-E0054E0C8BBE">
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-23.txt.html</ao:hasSource>
    <domeo:uuid>57242808-9748-4ED3-908E-E0054E0C8BBE</domeo:uuid>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:prefix> 200 mg) did not affect the bioavailability or pharmacokinetics of </ao:prefix>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:57242808-9748-4ED3-908E-E0054E0C8BBE"/>
    <ao:exact>fluconazole</ao:exact>
    <ao:suffix> in 24 healthy male volunteers.</ao:suffix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <pav:createdOn>2014-07-13 12:46:37 -0400</pav:createdOn>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:8C89B51C-E5B9-4048-B277-4FA66AA36C16">
    <pav:createdOn>2014-07-22 18:44:33 -0400</pav:createdOn>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:8C89B51C-E5B9-4048-B277-4FA66AA36C16"/>
    <ao:suffix> (repeated oral doses) and midazolam (intravenous bolus dose) in healthy volunteers led to elevated plasma concentrations of these drugs. The Cmax increased by 18% and 14% (median values) and the AUC increased by 44% and 33% for nifedipine and midazolam,</ao:suffix>
    <domeo:uuid>8C89B51C-E5B9-4048-B277-4FA66AA36C16</domeo:uuid>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:prefix> and </ao:prefix>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-118.txt.html</ao:hasSource>
    <ao:exact>nifedipine</ao:exact>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:2F71B86E-3B80-4813-9F00-A9E3E6B30C9E">
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <domeo:belongsToSet>urn:domeoclient:uuid:FCA2BF23-0BE3-409F-9177-761812F96097</domeo:belongsToSet>
    <pav:lineageUri>urn:domeoserver:annotationset:76FD4BB5-DE2F-4FCA-B93D-302185B1A381</pav:lineageUri>
    <domeo:belongsToSet>urn:domeoserver:annotationset:131835A3-C655-4F91-97D4-52CAFF7B7CCA</domeo:belongsToSet>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <rdfs:label>Highlight</rdfs:label>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <domeo:belongsToSet>urn:domeoserver:annotationset:8F3CF3D9-AADE-4A86-BD42-2924B3D6A406</domeo:belongsToSet>
    <ao:context rdf:resource="urn:domeoclient:uuid:EAE26632-A8D8-4E80-ADE1-8902853460F6"/>
    <pav:lastSavedOn>2014-07-07 09:44:19 -0400</pav:lastSavedOn>
    <domeo:belongsToSet>urn:domeoserver:annotationset:22ED7220-C6F6-43C5-9DF9-89F62F0F8E27</domeo:belongsToSet>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812eda990003</pav:createdBy>
    <pav:createdOn>2014-07-07 09:39:26 -0400</pav:createdOn>
    <domeo:belongsToSet>urn:domeoserver:annotationset:7AACEF8D-2EBC-4F0B-94B2-190650E562F6</domeo:belongsToSet>
    <domeo:belongsToSet>urn:domeoserver:annotationset:08C0C288-6DF4-43E6-A618-71A8BB9563C3</domeo:belongsToSet>
    <pav:lineageUri>urn:domeoserver:annotation:630D3E24-BEE4-405B-B4BF-F8D5BE2929A7</pav:lineageUri>
    <pav:lastSavedOn>2014-07-07 09:44:18 -0400</pav:lastSavedOn>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:4E71470A-E5FA-4B06-9981-E64925A42B90">
    <pav:createdOn>2014-07-22 20:18:40 -0400</pav:createdOn>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812eda990003</pav:createdBy>
    <ao:context rdf:resource="urn:domeoclient:uuid:CF43541C-6D0C-436D-805F-CCE8AF9ED52C"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <rdfs:label>Highlight</rdfs:label>
    <pav:lastSavedOn>2014-07-22 20:22:38 -0400</pav:lastSavedOn>
    <domeo:belongsToSet>urn:domeoserver:annotationset:F272A789-69D0-47CC-8CC9-F25C55B91261</domeo:belongsToSet>
    <pav:lineageUri>urn:domeoserver:annotation:EEDCBBC3-C811-4145-B325-0617B41561BD</pav:lineageUri>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:C4441B5B-C18F-4F66-90A8-3A3306CD1C90">
    <ao:exact>desmethyl </ao:exact>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-155.txt.html</ao:hasSource>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:prefix>and its major circulating N-</ao:prefix>
    <domeo:uuid>C4441B5B-C18F-4F66-90A8-3A3306CD1C90</domeo:uuid>
    <domeo:uuid></domeo:uuid>
    <ao:suffix>metabolite are both approximately 96% bound to plasma proteins. Protein binding is independent of total drug concentrations.</ao:suffix>
    <pav:createdOn>2014-07-07 09:42:24 -0400</pav:createdOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:C4441B5B-C18F-4F66-90A8-3A3306CD1C90"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:76ADDE4C-05F0-4C9D-B547-37B2AA813054">
    <domeo:belongsToSet>urn:domeoclient:uuid:3966BCFB-CA02-4053-828D-3860558E7BE8</domeo:belongsToSet>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812eda990003</pav:createdBy>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <pav:createdOn>2014-09-02 19:10:32 -0400</pav:createdOn>
    <ao:context rdf:resource="urn:domeoclient:uuid:0129AA9B-FCF1-4926-ABF4-20D80C13A55D"/>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <rdfs:label>Highlight</rdfs:label>
    <pav:lineageUri>urn:domeoserver:annotation:93675D22-5FCD-4C8A-8A2D-BB6E7CF53E25</pav:lineageUri>
    <pav:lastSavedOn>2014-09-02 19:11:13 -0400</pav:lastSavedOn>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:D390D1C1-F946-4B8E-A2EB-3CBC7637D30E">
    <ao:suffix>xsd:String</ao:suffix>
    <ao:prefix> has been evaluated when both drugs were at steady state. </ao:prefix>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-47.txt.html</ao:hasSource>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <domeo:uuid>D390D1C1-F946-4B8E-A2EB-3CBC7637D30E</domeo:uuid>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:exact>In healthy volunteers who were extensive metabolizers of CYP2D6, paroxetine 20 mg daily was given in combination with 20 mg atomoxetine every 12 hours. This resulted in increases in steady state atomoxetine AUC values that were 6- to 8-fold greater and in atomoxetine Cmax values that were 3- to 4-fold greater than when atomoxetine was given alone. Dosage adjustment of atomoxetine may be necessary and it is recommended that atomoxetine be initiated at a reduced dose when given with paroxetine.</ao:exact>
    <pav:createdOn>2014-09-02 12:01:08 -0400</pav:createdOn>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:D390D1C1-F946-4B8E-A2EB-3CBC7637D30E"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:F8AA6DCD-35A7-4319-9C3D-CFA5C6AE10EE">
    <ao:prefix>xsd:String</ao:prefix>
    <domeo:uuid>F8AA6DCD-35A7-4319-9C3D-CFA5C6AE10EE</domeo:uuid>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-132.txt.html</ao:hasSource>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:suffix>xsd:String</ao:suffix>
    <ao:exact>Co-administration of propranolol with lovastatin or pravastatin, decreased 18% to 23% the AUC of both, but did not alter their pharmacodynamics. Propranolol did not have an effect on the pharmacokinetics of fluvastatin.</ao:exact>
    <pav:createdOn>2014-07-24 19:53:59 -0400</pav:createdOn>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:F8AA6DCD-35A7-4319-9C3D-CFA5C6AE10EE"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:E76D782E-ADBF-42D0-9CCA-8944F07D22DA">
    <domeo:belongsToSet>urn:domeoserver:annotationset:22ED7220-C6F6-43C5-9DF9-89F62F0F8E27</domeo:belongsToSet>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <ao:context rdf:resource="urn:domeoclient:uuid:B98C3482-C44D-4C61-ACC3-D277890BCE91"/>
    <pav:lineageUri>urn:domeoserver:annotation:D0DD21B4-2DEA-49DA-B4BC-07501CC0DD24</pav:lineageUri>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812eda990003</pav:createdBy>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <domeo:belongsToSet>urn:domeoserver:annotationset:131835A3-C655-4F91-97D4-52CAFF7B7CCA</domeo:belongsToSet>
    <pav:createdOn>2014-07-07 11:23:25 -0400</pav:createdOn>
    <rdfs:label>Highlight</rdfs:label>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <domeo:belongsToSet>urn:domeoserver:annotationset:8F3CF3D9-AADE-4A86-BD42-2924B3D6A406</domeo:belongsToSet>
    <pav:lastSavedOn>2014-07-07 11:24:52 -0400</pav:lastSavedOn>
    <domeo:belongsToSet>urn:domeoserver:annotationset:7AACEF8D-2EBC-4F0B-94B2-190650E562F6</domeo:belongsToSet>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:1B38A7F0-853F-46CF-9666-915C8032692B">
    <sio:SIO_000628 rdf:resource="urn:pddi:uuid:096D1A71-9692-49E7-AB6D-F82889C71621"/>
    <rdf:type rdf:resource="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#DrugDrugInteractionStatement"/>
    <sio:SIO_000205>dikbD2R:statement</sio:SIO_000205>
    <sio:SIO_000563>dikbD2R:modality</sio:SIO_000563>
    <dikbD2R:statement>ncit:quantitative</dikbD2R:statement>
    <dikbD2R:modality>ncit:positive</dikbD2R:modality>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:2C5969D2-1348-44AF-8DA9-7B96D70B4770">
    <domeo:belongsToSet>urn:domeoserver:annotationset:A5DD001D-C81A-4E2E-B5E0-7A866B35E26B</domeo:belongsToSet>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:createdOn>2014-09-02 11:44:24 -0400</pav:createdOn>
    <rdfs:label>Highlight</rdfs:label>
    <pav:previousVersion>urn:domeoclient:uuid:BED41F06-565A-4622-9A88-48810E5A28DE</pav:previousVersion>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <ao:context rdf:resource="urn:domeoclient:uuid:464E41DE-27DF-4413-A7E6-C191985E633B"/>
    <pav:lastSavedOn>2014-09-02 11:46:58 -0400</pav:lastSavedOn>
    <pav:lastSavedOn>2014-09-02 11:46:59 -0400</pav:lastSavedOn>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:lineageUri>urn:domeoserver:annotation:BBBB507D-9A64-40EA-9AE6-9463FB0FF8D6</pav:lineageUri>
    <domeo:belongsToSet>urn:domeoserver:annotationset:3F546823-204F-4F9B-9006-3DC526C56931</domeo:belongsToSet>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812eda990003</pav:createdBy>
    <domeo:belongsToSet>urn:domeoserver:annotationset:A3F0B39A-4249-4B63-BB0D-F24A005066AC</domeo:belongsToSet>
    <pav:lineageUri>urn:domeoserver:annotationset:D1715BD2-BD41-46FD-9454-DC7A423A29AC</pav:lineageUri>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">2</pav:versionNumber>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:1A79F27D-249B-477A-8F23-ED3A357054B9">
    <dikbD2R:modality>ncit:positive</dikbD2R:modality>
    <dikbD2R:statement>ncit:quantitative</dikbD2R:statement>
    <sio:SIO_000205>dikbD2R:statement</sio:SIO_000205>
    <rdf:type rdf:resource="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#DrugDrugInteractionStatement"/>
    <sio:SIO_000563>dikbD2R:modality</sio:SIO_000563>
    <sio:SIO_000628 rdf:resource="urn:pddi:uuid:8EEB8C5F-684D-4C78-B063-32431C5FE74A"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:5EA1A12E-999D-4F07-B3EF-67CFE143F274">
    <domeo:belongsToSet>urn:domeoserver:annotationset:E32812A9-205B-4EE1-B488-A1E294EDBFB9</domeo:belongsToSet>
    <ao:context rdf:resource="urn:domeoclient:uuid:57427A36-AF04-4B9A-A5C2-85D0AE5CA845"/>
    <pav:createdOn>2014-09-02 19:12:09 -0400</pav:createdOn>
    <rdfs:label>Highlight</rdfs:label>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <domeo:belongsToSet>urn:domeoclient:uuid:CB83FFC2-EA71-44EA-8F11-DE80E389C84E</domeo:belongsToSet>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812eda990003</pav:createdBy>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:lastSavedOn>2014-09-02 19:19:47 -0400</pav:lastSavedOn>
    <pav:lineageUri>urn:domeoserver:annotation:3E013E33-FDEC-4071-87D0-687541B9A133</pav:lineageUri>
    <pav:lineageUri>urn:domeoserver:annotationset:C5DEBC9B-77EE-4243-88EB-DBC19737ACD2</pav:lineageUri>
    <domeo:belongsToSet>urn:domeoserver:annotationset:392EE0FB-AC4F-4AF2-87A6-2E50A281F434</domeo:belongsToSet>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:04DF851F-404D-44D4-A74D-22017210AF9A">
    <pav:lineageUri>urn:domeoserver:annotationset:166C20E9-1B4C-47D1-982D-922E2E5ACFF2</pav:lineageUri>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <domeo:belongsToSet>urn:domeoclient:uuid:379CD8C1-F4B4-42B7-8F87-70776866DB1F</domeo:belongsToSet>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <rdfs:label>Highlight</rdfs:label>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812eda990003</pav:createdBy>
    <pav:lastSavedOn>2014-09-02 12:03:47 -0400</pav:lastSavedOn>
    <ao:context rdf:resource="urn:domeoclient:uuid:23EBC507-A336-4506-9D28-78F1ECDFDF8B"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:lineageUri>urn:domeoserver:annotation:DF31D05D-09BF-4AD0-964C-6A07A274F994</pav:lineageUri>
    <domeo:belongsToSet>urn:domeoserver:annotationset:D52DFD7B-BDDF-488F-B339-B1BC641E50E9</domeo:belongsToSet>
    <pav:createdOn>2014-09-02 12:03:29 -0400</pav:createdOn>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:6C2517B0-E801-41F8-8917-AC00583F30D9">
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/PK_DDI"/>
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/D31FCC9E-EA25-4856-B3C1-1712E7892B63"/>
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/F044222C-AB83-4B62-B72A-FD9B65C89DD6"/>
  </rdf:Description>
  <rdf:Description rdf:nodeID="Ne8aaca3863a84ef5965d29d88f1e8ead">
    <permissions:isLocked>false</permissions:isLocked>
    <permissions:accessType>urn:domeo:access:public</permissions:accessType>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:16C89EA1-7173-40AF-99E3-B5CF422C3FBB">
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <domeo:belongsToSet>urn:domeoclient:uuid:4B51141D-C8D2-45DB-8074-74F8D8323E60</domeo:belongsToSet>
    <rdfs:label>Highlight</rdfs:label>
    <pav:lineageUri>urn:domeoserver:annotation:5183CA14-21F4-45E0-840D-A1DC67564C1F</pav:lineageUri>
    <ao:context rdf:resource="urn:domeoclient:uuid:7EB0AC81-B2FD-4D6F-8BAC-50662A16D4C6"/>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:lastSavedOn>2014-09-02 12:02:18 -0400</pav:lastSavedOn>
    <pav:createdOn>2014-09-02 11:57:18 -0400</pav:createdOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812eda990003</pav:createdBy>
    <pav:previousVersion>xsd:String</pav:previousVersion>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:39262D74-39DF-473E-A61D-3DBC89E74ACA">
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <pav:createdOn>2014-07-24 19:39:19 -0400</pav:createdOn>
    <rdfs:label>Highlight</rdfs:label>
    <pav:lastSavedOn>2014-07-24 19:39:23 -0400</pav:lastSavedOn>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812eda990003</pav:createdBy>
    <ao:context rdf:resource="urn:domeoclient:uuid:8067DF3E-2917-42D8-A222-AC1982EBCC5F"/>
    <pav:lineageUri>urn:domeoserver:annotation:EF749290-86B8-450E-A199-18D1E647CA0B</pav:lineageUri>
    <domeo:belongsToSet>urn:domeoclient:uuid:CE5AF44C-D211-4F33-A502-2B4C37E2ACFC</domeo:belongsToSet>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/7BF23512-3FBF-4262-B453-848863F44618">
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/active-ingredient"/>
    <dct:description>Referred to the drug in the interaction.</dct:description>
    <sio:SIO_000228>dikbD2R:precipitant-drug-of-interaction</sio:SIO_000228>
    <rdfs:label>Rifampin</rdfs:label>
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/9384</dailymed:activeMoietyRxCUI>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:76579336-5224-465A-A966-852EF8B65F10">
    <ao:suffix>: See CONTRAINDICATIONS (4) and WARNINGS AND PRECAUTIONS (5.5).</ao:suffix>
    <domeo:uuid>76579336-5224-465A-A966-852EF8B65F10</domeo:uuid>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-9.txt.html</ao:hasSource>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:76579336-5224-465A-A966-852EF8B65F10"/>
    <ao:prefix>xsd:String</ao:prefix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:exact>Tizanidine</ao:exact>
    <pav:createdOn>2014-09-02 11:42:13 -0400</pav:createdOn>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:5B3EE83F-83C7-4BA8-A892-C032BE699CFA">
    <ao:item rdf:resource="urn:domeoclient:uuid:C36C5E7A-30AD-4497-9348-913F96DD443E"/>
    <permissions:permissions rdf:nodeID="Nfa6d623468e74423b98469ea146fad76"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#AnnotationSet"/>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <domeo:agents rdf:resource="urn:domeo:software:id:Domeo-2.1alpha-050"/>
    <dct:description>The default set is created automatically by Domeo when no other set is existing.</dct:description>
    <ao:item rdf:resource="urn:domeoclient:uuid:631B556D-C865-4327-8C15-D735A7315C3D"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:E2932281-71AF-4D8C-BFA1-44627891CD3C"/>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <pav:lastSavedOn>2014-07-21 21:31:54 -0400</pav:lastSavedOn>
    <pav:createdOn>2014-07-21 21:31:06 -0400</pav:createdOn>
    <ao:item rdf:resource="urn:domeoclient:uuid:FC139E5E-6513-4B13-9FE1-980FD4117A68"/>
    <domeo:agents rdf:resource="urn:person:uuid:080e143046812afe0146812eda990003"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:8C403ABF-BCD6-4923-946F-4AF2BAAB0800"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:01600057-F016-4A5A-AC67-3F30E5F3B4EA"/>
    <ao:annotatesResource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-27.txt.html</ao:annotatesResource>
    <pav:lineageUri>urn:domeoserver:annotationset:092451F5-B0C0-430C-8896-07F81D33F9E1</pav:lineageUri>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812eda990003</pav:createdBy>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <domeo:deleted>false</domeo:deleted>
    <rdfs:label>Default Set</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:0E2ABCCE-5CA9-4636-B0AA-BA504DC9879E">
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <pav:createdOn>2014-07-21 21:33:56 -0400</pav:createdOn>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-28.txt.html</ao:hasSource>
    <ao:exact>theophylline </ao:exact>
    <ao:prefix>AUC, Cmax, and half-life with a corresponding decrease in clearance. The mean ± SD </ao:prefix>
    <domeo:uuid>0E2ABCCE-5CA9-4636-B0AA-BA504DC9879E</domeo:uuid>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:0E2ABCCE-5CA9-4636-B0AA-BA504DC9879E"/>
    <ao:suffix>AUC increased 21% ± 16% (range: -5 to 48%). The Cmax increased 13% ± 17% (range: -13 to 40%). Theophylline clearance decreased 16% ± 11 % (range: -32 to 5%). The half-life of theophylline increased from 6.6 ± 1.7 hours to 7.9 ± 1.5 hours. (See PRECAUTION</ao:suffix>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/804CF934-20BE-47B7-9B48-D1203ED27B8A">
    <sio:SIO_000228>dikbD2R:precipitant-drug-of-interaction</sio:SIO_000228>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/active-ingredient"/>
    <rdfs:label>rosiglitazone</rdfs:label>
    <dct:description>Referred to the drug in the interaction.</dct:description>
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/84108</dailymed:activeMoietyRxCUI>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:F2788742-3226-4BFB-9D85-2FC7211066F7">
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <ao:item rdf:resource="urn:domeoclient:uuid:F47F11AD-A4E0-4F3C-B00C-4BAD618B41C3"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#AnnotationSet"/>
    <dct:description>The default set is created automatically by Domeo when no other set is existing.</dct:description>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812eda990003</pav:createdBy>
    <pav:lastSavedOn>2014-07-22 18:59:40 -0400</pav:lastSavedOn>
    <domeo:agents rdf:resource="urn:domeo:software:id:Domeo-2.1alpha-050"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:3D9DD245-350D-4E6C-84D1-AA5D144E689A"/>
    <domeo:agents rdf:resource="urn:person:uuid:080e143046812afe0146812eda990003"/>
    <pav:createdOn>2014-07-22 18:58:19 -0400</pav:createdOn>
    <rdfs:label>Default Set</rdfs:label>
    <permissions:permissions rdf:nodeID="Nd59c409ee09449d7bbc830d00cbae38d"/>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <ao:item rdf:resource="urn:domeoclient:uuid:59E51D24-193D-4075-8FE6-4129F350FD59"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:C86F61CA-C8B8-45D2-86FA-DC4DB976D43B"/>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:lineageUri>urn:domeoserver:annotationset:C838220C-7EBC-4E05-B48B-8211CA4F259C</pav:lineageUri>
    <ao:annotatesResource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-120.txt.html</ao:annotatesResource>
    <domeo:deleted>false</domeo:deleted>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:24143967-8568-40EB-838F-056E2F0B075C">
    <pav:createdOn>2014-07-24 20:12:42 -0400</pav:createdOn>
    <pav:lineageUri>urn:domeoserver:annotation:16F6FA5F-D1BC-4840-A4C5-5F4443E7706A</pav:lineageUri>
    <rdfs:label>Highlight</rdfs:label>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <domeo:belongsToSet>urn:domeoserver:annotationset:1FC172B8-8AC3-465A-AA69-B73AD9B97CBC</domeo:belongsToSet>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:lastSavedOn>2014-07-24 20:12:49 -0400</pav:lastSavedOn>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812eda990003</pav:createdBy>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <ao:context rdf:resource="urn:domeoclient:uuid:03FCDCDD-B854-48FC-9FD5-39AD4A15667C"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:B9C5564E-F653-404D-B333-299E63141AF5">
    <domeo:belongsToSet>urn:domeoclient:uuid:71191E51-53CB-4FDE-88D0-33C6818E2232</domeo:belongsToSet>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <pav:createdOn>2014-07-13 11:15:52 -0400</pav:createdOn>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812eda990003</pav:createdBy>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <ao:context rdf:resource="urn:domeoclient:uuid:D78CEABF-EE24-4AFF-81A9-B148050EFE16"/>
    <pav:lastSavedOn>2014-07-13 11:32:29 -0400</pav:lastSavedOn>
    <rdfs:label>Highlight</rdfs:label>
    <pav:lineageUri>urn:domeoserver:annotation:228452B8-64FE-4746-AB80-952A986140F5</pav:lineageUri>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:1E61DE2D-66C2-4CB4-9D74-6D8DC468ABA3">
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-42.txt.html</ao:hasSource>
    <pav:createdOn>2014-09-01 16:12:00 -0400</pav:createdOn>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:1E61DE2D-66C2-4CB4-9D74-6D8DC468ABA3"/>
    <ao:exact>azathioprine</ao:exact>
    <ao:suffix>, the concomitant administration of 300 to 600 mg of allopurinol sodium for injection per day will require a reduction in dose to approximately one-third to one-fourth of the usual dose of mercaptopurine or azathioprine. Subsequent adjustment of doses of</ao:suffix>
    <domeo:uuid>1E61DE2D-66C2-4CB4-9D74-6D8DC468ABA3</domeo:uuid>
    <ao:prefix>or </ao:prefix>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:697C8F03-1543-4427-9D85-7967FCEA3100">
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:createdOn>2014-07-07 09:41:30 -0400</pav:createdOn>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812eda990003</pav:createdBy>
    <pav:lineageUri>urn:domeoserver:annotation:E365599C-3650-4894-A315-9AFC760442EA</pav:lineageUri>
    <pav:lineageUri>urn:domeoserver:annotationset:76FD4BB5-DE2F-4FCA-B93D-302185B1A381</pav:lineageUri>
    <domeo:belongsToSet>urn:domeoserver:annotationset:8F3CF3D9-AADE-4A86-BD42-2924B3D6A406</domeo:belongsToSet>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <domeo:belongsToSet>urn:domeoserver:annotationset:22ED7220-C6F6-43C5-9DF9-89F62F0F8E27</domeo:belongsToSet>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <pav:lastSavedOn>2014-07-07 09:44:18 -0400</pav:lastSavedOn>
    <rdfs:label>Highlight</rdfs:label>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <domeo:belongsToSet>urn:domeoserver:annotationset:131835A3-C655-4F91-97D4-52CAFF7B7CCA</domeo:belongsToSet>
    <pav:lastSavedOn>2014-07-07 09:44:19 -0400</pav:lastSavedOn>
    <ao:context rdf:resource="urn:domeoclient:uuid:D346F3FB-2896-495E-BF67-B2BC6E8F5714"/>
    <domeo:belongsToSet>urn:domeoclient:uuid:FCA2BF23-0BE3-409F-9177-761812F96097</domeo:belongsToSet>
    <domeo:belongsToSet>urn:domeoserver:annotationset:08C0C288-6DF4-43E6-A618-71A8BB9563C3</domeo:belongsToSet>
    <domeo:belongsToSet>urn:domeoserver:annotationset:7AACEF8D-2EBC-4F0B-94B2-190650E562F6</domeo:belongsToSet>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:0124DF91-B793-47E7-9547-2BF080146FA7">
    <domeo:uuid>0124DF91-B793-47E7-9547-2BF080146FA7</domeo:uuid>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <pav:createdOn>2014-07-13 11:12:20 -0400</pav:createdOn>
    <ao:prefix> by the enzyme, CYP 2D6. A minor metabolic pathway is through N-dealkylation. The main metabolite, </ao:prefix>
    <ao:suffix>, has similar pharmacological activity as risperidone. Consequently, the clinical effect of the drug results from the combined concentrations of risperidone plus 9-hydroxyrisperidone.</ao:suffix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:0124DF91-B793-47E7-9547-2BF080146FA7"/>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-8.txt.html</ao:hasSource>
    <ao:exact>9-hydroxyrisperidone</ao:exact>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:DFB0D433-995A-4EB5-B9CC-EAE5A0C16DEA">
    <ao:prefix>. Consequently, the clinical effect of the drug results from the combined concentrations of </ao:prefix>
    <pav:createdOn>2014-07-13 11:12:29 -0400</pav:createdOn>
    <ao:suffix> plus 9-hydroxyrisperidone.</ao:suffix>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:DFB0D433-995A-4EB5-B9CC-EAE5A0C16DEA"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:exact>risperidone</ao:exact>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-8.txt.html</ao:hasSource>
    <domeo:uuid>DFB0D433-995A-4EB5-B9CC-EAE5A0C16DEA</domeo:uuid>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:DDB0C59F-0568-4D74-A9AA-D0E0750F758C">
    <sio:SIO_000563>dikbD2R:modality</sio:SIO_000563>
    <dikbD2R:statement>ncit:Qualitative</dikbD2R:statement>
    <dikbD2R:modality>ncit:negative</dikbD2R:modality>
    <sio:SIO_000628 rdf:resource="urn:pddi:uuid:29E9C9FA-0648-4564-86E4-3E4F28AF69B7"/>
    <rdf:type rdf:resource="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#DrugDrugInteractionStatement"/>
    <sio:SIO_000205>dikbD2R:statement</sio:SIO_000205>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:4C303406-873F-442A-82D7-9FA28371D696">
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:lineageUri>urn:domeoserver:annotation:7CE724FC-6C82-4813-B4E1-392FDE649F66</pav:lineageUri>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:createdOn>2014-07-24 19:52:52 -0400</pav:createdOn>
    <domeo:belongsToSet>urn:domeoclient:uuid:E0863579-8D19-4B30-ADD6-2A5BDBC2F482</domeo:belongsToSet>
    <pav:lastSavedOn>2014-07-24 19:53:55 -0400</pav:lastSavedOn>
    <ao:context rdf:resource="urn:domeoclient:uuid:B748A453-816C-4DEF-91A1-F20E7FC12F1A"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812eda990003</pav:createdBy>
    <rdfs:label>Highlight</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:08D219B2-A0EC-49C7-A943-47EE7CE4B542">
    <domeo:belongsToSet>urn:domeoclient:uuid:94DCE217-B72B-4727-9783-98D7EFCB02E6</domeo:belongsToSet>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <ao:context rdf:resource="urn:domeoclient:uuid:21A6A401-CC93-4E3D-8008-3C8347574A85"/>
    <rdfs:label>Highlight</rdfs:label>
    <pav:lastSavedOn>2014-09-01 16:20:01 -0400</pav:lastSavedOn>
    <pav:createdOn>2014-09-01 16:19:43 -0400</pav:createdOn>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812eda990003</pav:createdBy>
    <pav:lineageUri>urn:domeoserver:annotation:F08B1EA8-F65C-40FB-B1FA-F3BC3C80E89D</pav:lineageUri>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:584B0A9B-8106-4A13-BCCB-4DD9957E0EF1">
    <domeo:uuid>584B0A9B-8106-4A13-BCCB-4DD9957E0EF1</domeo:uuid>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-123.txt.html</ao:hasSource>
    <ao:exact>rosiglitazone</ao:exact>
    <ao:suffix> maleate, approximately 64% and 23% of the dose was eliminated in the urine and in the feces, respectively. The plasma half-life of [14C]related material ranged from 103 to 158 hours.</ao:suffix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:584B0A9B-8106-4A13-BCCB-4DD9957E0EF1"/>
    <ao:prefix>Following oral or intravenous administration of [14C]</ao:prefix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <pav:createdOn>2014-07-22 19:28:27 -0400</pav:createdOn>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/D356370B-E2E4-45FD-AA2A-DBBBC15D7668">
    <dct:description>Referred to the drug in the interaction.</dct:description>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/active-ingredient"/>
    <rdfs:label>gemfibrozil</rdfs:label>
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/4719</dailymed:activeMoietyRxCUI>
    <sio:SIO_000228>dikbD2R:precipitant-drug-of-interaction</sio:SIO_000228>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:F0E54D90-28C4-48FD-B72C-21011511DD58">
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#expertstudyAnnotation"/>
    <pav:lineageUri>urn:domeoserver:annotation:CC36BBDD-6E14-44E8-9E21-FE419782FE72</pav:lineageUri>
    <pav:createdOn>2014-07-13 12:45:51 -0400</pav:createdOn>
    <rdfs:label>expertstudy Annotation</rdfs:label>
    <ao:context rdf:resource="urn:domeoclient:uuid:58C4B9F6-E8BB-4567-9FF2-3D87C6E9284C"/>
    <ao:body rdf:nodeID="N35ade76377e24dacbfd3cf3c3ab19dec"/>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812eda990003</pav:createdBy>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <domeo:belongsToSet>urn:domeoclient:uuid:23567EF7-7482-444A-B1F6-5AAA9D43E54A</domeo:belongsToSet>
    <pav:lastSavedOn>2014-07-13 12:45:54 -0400</pav:lastSavedOn>
    <pav:previousVersion>xsd:String</pav:previousVersion>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:BEED566B-9689-4906-8331-FFFE92EBBEEE">
    <pav:lastSavedOn>2014-09-01 15:57:39 -0400</pav:lastSavedOn>
    <domeo:belongsToSet>urn:domeoclient:uuid:39B82E57-92E3-4322-A8E6-A3AFF215F02C</domeo:belongsToSet>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812eda990003</pav:createdBy>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:lineageUri>urn:domeoserver:annotation:B28E83A5-C85B-4EA5-8EDD-9A0A637268F6</pav:lineageUri>
    <ao:context rdf:resource="urn:domeoclient:uuid:AD70C5DB-2834-4A85-B530-F776A208FB2C"/>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <rdfs:label>Highlight</rdfs:label>
    <pav:createdOn>2014-09-01 15:57:33 -0400</pav:createdOn>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/BD00EF21-094C-47ED-9DFE-B32774923CD1">
    <sio:SIO_000228>dikbD2R:precipitant-drug-of-interaction</sio:SIO_000228>
    <rdfs:label>phenytoin</rdfs:label>
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/8183</dailymed:activeMoietyRxCUI>
    <dct:description>Referred to the drug in the interaction.</dct:description>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/active-ingredient"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:72BE2161-391C-488C-B44D-F6CF16588EAC">
    <domeo:uuid>72BE2161-391C-488C-B44D-F6CF16588EAC</domeo:uuid>
    <ao:suffix> and glyburide at week 52 were statistically significant.</ao:suffix>
    <ao:exact>AVANDIA</ao:exact>
    <ao:prefix> effects on lipids. At baseline, week 26, and week 52, mean LDL/HDL ratios were 3.1, 3.2, and 3.0, respectively, for AVANDIA 4 mg twice daily. The corresponding values for glyburide were 3.2, 3.1, and 2.9. The differences in change from baseline between </ao:prefix>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-123.txt.html</ao:hasSource>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <pav:createdOn>2014-07-22 19:22:07 -0400</pav:createdOn>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:72BE2161-391C-488C-B44D-F6CF16588EAC"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:56F428F6-CAF7-4343-B57C-103B1BA935EB">
    <domeo:belongsToSet>urn:domeoclient:uuid:71191E51-53CB-4FDE-88D0-33C6818E2232</domeo:belongsToSet>
    <pav:lineageUri>urn:domeoserver:annotation:679C48F0-BCFA-4F3B-93B6-03B171A529E1</pav:lineageUri>
    <rdfs:label>Highlight</rdfs:label>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:createdOn>2014-07-13 11:10:06 -0400</pav:createdOn>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812eda990003</pav:createdBy>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <ao:context rdf:resource="urn:domeoclient:uuid:532294F2-A52D-4732-85C4-0F955156A615"/>
    <pav:lastSavedOn>2014-07-13 11:32:29 -0400</pav:lastSavedOn>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:CC1D209A-F362-4FEA-ABD5-96B660CE4A7A">
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-138.txt.html</ao:hasSource>
    <ao:prefix>e should be initiated at a low level and increased gradually, noting the clinical response and any evidence of intolerance. Occurrence of drowsiness may require the administration of a major portion of the daily dose at bedtime or a reduction of dosage. </ao:prefix>
    <domeo:uuid>CC1D209A-F362-4FEA-ABD5-96B660CE4A7A</domeo:uuid>
    <ao:exact>Trazodone</ao:exact>
    <pav:createdOn>2014-07-24 20:05:02 -0400</pav:createdOn>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:CC1D209A-F362-4FEA-ABD5-96B660CE4A7A"/>
    <ao:suffix> hydrochloride tablets should be taken shortly after a meal or light snack. Symptomatic relief may be seen during the first week, with optimal antidepressant effects typically evident within two weeks. Twenty-five percent of those who respond to trazodon</ao:suffix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:E7B5E0E2-9287-47B6-9135-34CE522BE395">
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:prefix> resulted in increased </ao:prefix>
    <pav:createdOn>2014-07-24 20:14:43 -0400</pav:createdOn>
    <ao:exact>azithromycin</ao:exact>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:E7B5E0E2-9287-47B6-9135-34CE522BE395"/>
    <domeo:uuid>E7B5E0E2-9287-47B6-9135-34CE522BE395</domeo:uuid>
    <ao:suffix> serum concentrations. Although a dose adjustment of azithromycin is not recommended when administered in combination with nelfinavir, close monitoring for known side effects of azithromycin, such as liver enzyme abnormalities and hearing impairment, is </ao:suffix>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-161.txt.html</ao:hasSource>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:BCC3E44B-0E96-41D5-AB03-A4CC9A1EB653">
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:suffix>may need to be monitored for increases in INR and prothrombin time.</ao:suffix>
    <ao:prefix>time may lead to abnormal bleeding and even death. Patients treated with proton pump inhibitors and </ao:prefix>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:BCC3E44B-0E96-41D5-AB03-A4CC9A1EB653"/>
    <domeo:uuid>BCC3E44B-0E96-41D5-AB03-A4CC9A1EB653</domeo:uuid>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-74.txt.html</ao:hasSource>
    <ao:exact>warfarin </ao:exact>
    <pav:createdOn>2014-09-02 19:12:54 -0400</pav:createdOn>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:631995B6-520A-4B5F-B283-0557077A8B49">
    <pav:createdOn>2014-09-02 15:04:24 -0400</pav:createdOn>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-48.txt.html</ao:hasSource>
    <ao:suffix>, triazolam, and cyclosporine. Based on the assumption that the relationship between paroxetine’s in vitro Ki and its lack of effect on terfenadine's in vivo clearance predicts its effect on other CYP3A4 substrates, paroxetine’s extent of inhibition of C</ao:suffix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:631995B6-520A-4B5F-B283-0557077A8B49"/>
    <ao:exact>cisapride</ao:exact>
    <domeo:uuid>631995B6-520A-4B5F-B283-0557077A8B49</domeo:uuid>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:prefix>, </ao:prefix>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:7F0238CB-D573-4236-AA09-42BC8251946C">
    <ao:body rdf:nodeID="N453d8d1d1a654fd9a5a165618e7b45fa"/>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812eda990003</pav:createdBy>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#expertstudyAnnotation"/>
    <rdfs:label>expertstudy Annotation</rdfs:label>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:createdOn>2014-07-24 19:39:41 -0400</pav:createdOn>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <ao:context rdf:resource="urn:domeoclient:uuid:B383ED3F-1A7B-49EF-9DAD-049AD0F927DE"/>
    <pav:lineageUri>urn:domeoserver:annotation:AFB9CA92-A9E3-4B4C-83E2-8651E1485BD5</pav:lineageUri>
    <pav:lastSavedOn>2014-07-24 19:39:23 -0400</pav:lastSavedOn>
    <domeo:belongsToSet>urn:domeoclient:uuid:CE5AF44C-D211-4F33-A502-2B4C37E2ACFC</domeo:belongsToSet>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:EC416A29-1315-42C5-90FA-652412A6AD12">
    <pav:lastSavedOn>2014-07-07 09:44:18 -0400</pav:lastSavedOn>
    <domeo:belongsToSet>urn:domeoserver:annotationset:08C0C288-6DF4-43E6-A618-71A8BB9563C3</domeo:belongsToSet>
    <pav:createdOn>2014-07-07 09:40:48 -0400</pav:createdOn>
    <rdfs:label>Highlight</rdfs:label>
    <domeo:belongsToSet>urn:domeoclient:uuid:FCA2BF23-0BE3-409F-9177-761812F96097</domeo:belongsToSet>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <domeo:belongsToSet>urn:domeoserver:annotationset:131835A3-C655-4F91-97D4-52CAFF7B7CCA</domeo:belongsToSet>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <ao:context rdf:resource="urn:domeoclient:uuid:8EA1563F-47E7-4983-918E-643A5D2021DC"/>
    <pav:lastSavedOn>2014-07-07 09:44:19 -0400</pav:lastSavedOn>
    <domeo:belongsToSet>urn:domeoserver:annotationset:22ED7220-C6F6-43C5-9DF9-89F62F0F8E27</domeo:belongsToSet>
    <domeo:belongsToSet>urn:domeoserver:annotationset:8F3CF3D9-AADE-4A86-BD42-2924B3D6A406</domeo:belongsToSet>
    <pav:lineageUri>urn:domeoserver:annotationset:76FD4BB5-DE2F-4FCA-B93D-302185B1A381</pav:lineageUri>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:lineageUri>urn:domeoserver:annotation:5921BA7A-A507-4387-9FEF-14A8A1423763</pav:lineageUri>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812eda990003</pav:createdBy>
    <domeo:belongsToSet>urn:domeoserver:annotationset:7AACEF8D-2EBC-4F0B-94B2-190650E562F6</domeo:belongsToSet>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:796FE422-C147-4AA7-A57F-067429194AA4">
    <ao:context rdf:resource="urn:domeoclient:uuid:584B0A9B-8106-4A13-BCCB-4DD9957E0EF1"/>
    <domeo:belongsToSet>urn:domeoserver:annotationset:606A5B3F-B6FB-4279-AA42-7893CFC2D20C</domeo:belongsToSet>
    <domeo:belongsToSet>urn:domeoserver:annotationset:F272A789-69D0-47CC-8CC9-F25C55B91261</domeo:belongsToSet>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812eda990003</pav:createdBy>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:lineageUri>urn:domeoserver:annotation:4AD913EF-8CF2-47AA-9070-2F775E8AF0BA</pav:lineageUri>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:lastSavedOn>2014-07-22 19:35:16 -0400</pav:lastSavedOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">4</pav:versionNumber>
    <pav:lineageUri>urn:domeoserver:annotationset:AB1741F1-5A5F-4416-AEAC-A544BCBB7D16</pav:lineageUri>
    <domeo:belongsToSet>urn:domeoserver:annotationset:7021B883-FD5C-4083-BD87-DF56D3C87633</domeo:belongsToSet>
    <pav:previousVersion>urn:domeoserver:annotationset:7E80543E-BF76-4514-92A9-91458DCB802B</pav:previousVersion>
    <domeo:belongsToSet>urn:domeoserver:annotationset:2914A3FD-DF43-4F78-999C-77CE7A028B19</domeo:belongsToSet>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <domeo:belongsToSet>urn:domeoserver:annotationset:514BA51B-D734-4003-A7C3-F03C0F95833A</domeo:belongsToSet>
    <rdfs:label>Highlight</rdfs:label>
    <pav:createdOn>2014-07-22 19:28:27 -0400</pav:createdOn>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:6F243BA5-FCEC-4956-AF25-0E751A006E5C">
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:6F243BA5-FCEC-4956-AF25-0E751A006E5C"/>
    <ao:exact>Sertraline</ao:exact>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-17.txt.html</ao:hasSource>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:prefix>following an intravenous 1000 mg dose. </ao:prefix>
    <domeo:uuid>6F243BA5-FCEC-4956-AF25-0E751A006E5C</domeo:uuid>
    <ao:suffix> administration did not noticeably change either the plasma protein binding or the apparent volume of distribution of tolbutamide, suggesting that the decreased clearance was due to a change in the metabolism of the drug. The clinical significance of thi</ao:suffix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <pav:createdOn>2014-09-01 15:59:56 -0400</pav:createdOn>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:2DBC33BA-B5CF-487A-BE2E-5C3FB9F71111">
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:createdOn>2014-07-22 19:55:20 -0400</pav:createdOn>
    <pav:lastSavedOn>2014-07-22 20:22:38 -0400</pav:lastSavedOn>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812eda990003</pav:createdBy>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <rdfs:label>Highlight</rdfs:label>
    <ao:context rdf:resource="urn:domeoclient:uuid:7B342FF2-047C-4302-8F5E-8EED89D8C32D"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:lineageUri>urn:domeoserver:annotation:E742E839-0D02-426E-A4C3-7F1867EC092E</pav:lineageUri>
    <domeo:belongsToSet>urn:domeoserver:annotationset:F272A789-69D0-47CC-8CC9-F25C55B91261</domeo:belongsToSet>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:B8E504B5-222C-4BAE-88E1-E79A32308174">
    <ao:context rdf:resource="urn:domeoclient:uuid:7EEF7294-F55C-48E2-8A50-69D9A3726172"/>
    <domeo:belongsToSet>urn:domeoclient:uuid:F70AB841-7C14-48D1-B543-A45EA067C642</domeo:belongsToSet>
    <rdfs:label>Highlight</rdfs:label>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:lineageUri>urn:domeoserver:annotation:16C3044F-D627-4305-8565-E4F15BE17B40</pav:lineageUri>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812eda990003</pav:createdBy>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <pav:lastSavedOn>2014-07-24 20:04:12 -0400</pav:lastSavedOn>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:createdOn>2014-07-24 20:03:38 -0400</pav:createdOn>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:51F1BD01-1111-4CA2-BC77-65762E0E45AA">
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812eda990003</pav:createdBy>
    <pav:lineageUri>urn:domeoserver:annotation:44057811-D9E4-4C92-A654-908AD51CF0A0</pav:lineageUri>
    <pav:createdOn>2014-07-22 19:11:53 -0400</pav:createdOn>
    <pav:lastSavedOn>2014-07-22 19:11:40 -0400</pav:lastSavedOn>
    <pav:lineageUri>urn:domeoserver:annotationset:AB1741F1-5A5F-4416-AEAC-A544BCBB7D16</pav:lineageUri>
    <domeo:belongsToSet>urn:domeoserver:annotationset:467D4F28-D086-4217-9DE0-23E165F30716</domeo:belongsToSet>
    <domeo:belongsToSet>urn:domeoserver:annotationset:7021B883-FD5C-4083-BD87-DF56D3C87633</domeo:belongsToSet>
    <domeo:belongsToSet>urn:domeoserver:annotationset:606A5B3F-B6FB-4279-AA42-7893CFC2D20C</domeo:belongsToSet>
    <domeo:belongsToSet>urn:domeoserver:annotationset:514BA51B-D734-4003-A7C3-F03C0F95833A</domeo:belongsToSet>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:lastSavedOn>2014-07-22 19:11:41 -0400</pav:lastSavedOn>
    <ao:context rdf:resource="urn:domeoclient:uuid:B94B65A7-B52E-41EB-9E72-C3F942808AFB"/>
    <domeo:belongsToSet>urn:domeoclient:uuid:BE4B86AC-FE5F-4543-A713-EC5B852A5A2A</domeo:belongsToSet>
    <domeo:belongsToSet>urn:domeoserver:annotationset:2914A3FD-DF43-4F78-999C-77CE7A028B19</domeo:belongsToSet>
    <domeo:belongsToSet>urn:domeoserver:annotationset:7E80543E-BF76-4514-92A9-91458DCB802B</domeo:belongsToSet>
    <domeo:belongsToSet>urn:domeoserver:annotationset:F272A789-69D0-47CC-8CC9-F25C55B91261</domeo:belongsToSet>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <rdfs:label>Highlight</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:C48F039A-1F94-471B-9DF9-0D4E6B99DA14">
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-129.txt.html</ao:hasSource>
    <ao:prefix>Co-administration of propranolol with </ao:prefix>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:C48F039A-1F94-471B-9DF9-0D4E6B99DA14"/>
    <domeo:uuid>C48F039A-1F94-471B-9DF9-0D4E6B99DA14</domeo:uuid>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:suffix>, a non-specific CYP450 inhibitor, increased propranolol AUC and Cmax by 46% and 35%, respectively. Co-administration with aluminum hydroxide gel (1200 mg) may result in a decrease in propranolol concentrations.</ao:suffix>
    <ao:exact>cimetidine</ao:exact>
    <pav:createdOn>2014-07-24 19:45:35 -0400</pav:createdOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:BA8C16C4-EEEA-4E22-BEA7-98D738176A08">
    <ao:context rdf:resource="urn:domeoclient:uuid:BF575835-131F-4DD9-876A-6D2B6D7A7744"/>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812eda990003</pav:createdBy>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <domeo:belongsToSet>urn:domeoclient:uuid:4B51141D-C8D2-45DB-8074-74F8D8323E60</domeo:belongsToSet>
    <rdfs:label>Highlight</rdfs:label>
    <pav:createdOn>2014-09-02 11:58:31 -0400</pav:createdOn>
    <pav:lineageUri>urn:domeoserver:annotation:D87F2CD3-CBAA-4935-84B1-F85E0D5E7632</pav:lineageUri>
    <pav:lastSavedOn>2014-09-02 12:02:18 -0400</pav:lastSavedOn>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:D704B671-5676-476E-BB75-84893439C054">
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <domeo:uuid>D704B671-5676-476E-BB75-84893439C054</domeo:uuid>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:D704B671-5676-476E-BB75-84893439C054"/>
    <ao:prefix>lts in an inhibition of calcium influx through these channels. Stores of intracellular calcium in vascular smooth muscle are limited and thus dependent upon the influx of extracellular calcium for contraction to occur. The reduction in calcium influx by </ao:prefix>
    <ao:exact>nifedipine</ao:exact>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-117.txt.html</ao:hasSource>
    <pav:createdOn>2014-09-02 19:42:42 -0400</pav:createdOn>
    <ao:suffix> causes arterial vasodilation and decreased peripheral vascular resistance which results in reduced arterial blood pressure.</ao:suffix>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:F55B6524-A848-4FBC-99DB-A1B22E5FCA28">
    <ao:suffix>or azathioprine. Subsequent adjustment of doses of mercaptopurine or azathioprine should be made on the basis of therapeutic response and the appearance of toxic effects (see PRECAUTIONS- Drug Interactions).</ao:suffix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:prefix> for injection per day will require a reduction in dose to approximately one-third to one-fourth of the usual dose of </ao:prefix>
    <domeo:uuid>F55B6524-A848-4FBC-99DB-A1B22E5FCA28</domeo:uuid>
    <ao:exact>mercaptopurine </ao:exact>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <pav:createdOn>2014-09-01 16:12:26 -0400</pav:createdOn>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:F55B6524-A848-4FBC-99DB-A1B22E5FCA28"/>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-42.txt.html</ao:hasSource>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:8543469A-E725-45C1-A0A3-93FAB55D1DD5">
    <ao:exact>9-hydroxyrisperidone</ao:exact>
    <ao:prefix> and higher </ao:prefix>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-8.txt.html</ao:hasSource>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:8543469A-E725-45C1-A0A3-93FAB55D1DD5"/>
    <ao:suffix> concentrations than poor metabolizers, the pharmacokinetics of risperidone and 9-hydroxyrisperidone combined, after single and multiple doses, are similar in extensive and poor metabolizers.</ao:suffix>
    <pav:createdOn>2014-07-13 11:13:40 -0400</pav:createdOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <domeo:uuid>8543469A-E725-45C1-A0A3-93FAB55D1DD5</domeo:uuid>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:ED46D326-5EE0-47F9-A0D2-97252A43CE9D">
    <pav:lineageUri>urn:domeoserver:annotation:555083DC-A2BB-4A1E-8C0C-5EA8764C9BD6</pav:lineageUri>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <domeo:belongsToSet>urn:domeoserver:annotationset:392EE0FB-AC4F-4AF2-87A6-2E50A281F434</domeo:belongsToSet>
    <ao:context rdf:resource="urn:domeoclient:uuid:ACDCB5F4-8A15-444E-AB50-018A46C6500F"/>
    <rdfs:label>Highlight</rdfs:label>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:createdOn>2014-09-02 19:12:11 -0400</pav:createdOn>
    <domeo:belongsToSet>urn:domeoserver:annotationset:E32812A9-205B-4EE1-B488-A1E294EDBFB9</domeo:belongsToSet>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812eda990003</pav:createdBy>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:lastSavedOn>2014-09-02 19:19:47 -0400</pav:lastSavedOn>
    <pav:lineageUri>urn:domeoserver:annotationset:C5DEBC9B-77EE-4243-88EB-DBC19737ACD2</pav:lineageUri>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <domeo:belongsToSet>urn:domeoclient:uuid:CB83FFC2-EA71-44EA-8F11-DE80E389C84E</domeo:belongsToSet>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:539264FC-F626-408A-BB71-03BC387083CB">
    <pav:lineageUri>urn:domeoserver:annotation:88B8196E-4906-4695-9420-CEEF74F91F98</pav:lineageUri>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812eda990003</pav:createdBy>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <ao:context rdf:resource="urn:domeoclient:uuid:AB311B8D-11CB-4B44-BDC1-9641D482BE0D"/>
    <pav:createdOn>2014-07-13 11:18:02 -0400</pav:createdOn>
    <pav:lastSavedOn>2014-07-13 11:32:29 -0400</pav:lastSavedOn>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <domeo:belongsToSet>urn:domeoclient:uuid:71191E51-53CB-4FDE-88D0-33C6818E2232</domeo:belongsToSet>
    <rdfs:label>Highlight</rdfs:label>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:previousVersion>xsd:String</pav:previousVersion>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:D7A544C2-F82A-49C9-83A0-D19D9DDF7E00">
    <pav:createdOn>2014-07-22 20:20:12 -0400</pav:createdOn>
    <domeo:uuid>D7A544C2-F82A-49C9-83A0-D19D9DDF7E00</domeo:uuid>
    <ao:suffix>xsd:String</ao:suffix>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-123.txt.html</ao:hasSource>
    <ao:prefix>xsd:String</ao:prefix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:D7A544C2-F82A-49C9-83A0-D19D9DDF7E00"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:exact>Coadministration of acarbose (100 mg three times daily) for 7 days in healthy volunteers had no clinically relevant effect on the pharmacokinetics of a single oral dose of AVANDIA.</ao:exact>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:8A0FA947-246E-4008-87C0-91C5CA96E875">
    <pav:createdOn>2014-09-02 11:40:09 -0400</pav:createdOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-9.txt.html</ao:hasSource>
    <ao:exact>fluvoxamine</ao:exact>
    <ao:prefix> and, therefore, the combination should be used with caution. Seizures have been reported with the coadministration of </ao:prefix>
    <domeo:uuid>8A0FA947-246E-4008-87C0-91C5CA96E875</domeo:uuid>
    <ao:suffix> maleate and lithium.</ao:suffix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:8A0FA947-246E-4008-87C0-91C5CA96E875"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:D555A94C-D1DE-4B5C-B227-8172F8605613">
    <ao:exact>erythromycin</ao:exact>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-72.txt.html</ao:hasSource>
    <ao:prefix>. Inhibition of CYP3A4 activity by its inhibitors, such as macrolide antibiotics (e.g., </ao:prefix>
    <ao:suffix>), azole-antifungal agents (e.g., ketoconazole), and protease inhibitors (e.g., ritonavir), may prolong opioid effects. If co-administration is necessary, caution is advised when initiating therapy with, currently taking, or discontinuing CYP3A4 inhibito</ao:suffix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <pav:createdOn>2014-09-02 19:09:20 -0400</pav:createdOn>
    <domeo:uuid>D555A94C-D1DE-4B5C-B227-8172F8605613</domeo:uuid>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:D555A94C-D1DE-4B5C-B227-8172F8605613"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:84B56A7B-030D-4746-A4B2-C5097E07099C">
    <ao:context rdf:resource="urn:domeoclient:uuid:30044970-A8CB-42F8-A59C-789340FE24AC"/>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:createdOn>2014-07-24 20:01:45 -0400</pav:createdOn>
    <rdfs:label>Highlight</rdfs:label>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812eda990003</pav:createdBy>
    <pav:lineageUri>urn:domeoserver:annotation:28CDC6CA-725A-4228-B269-418A74B1E75D</pav:lineageUri>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:lastSavedOn>2014-07-24 20:02:49 -0400</pav:lastSavedOn>
    <domeo:belongsToSet>urn:domeoclient:uuid:189A8E0E-67D6-4C53-A96E-CB48A3B4B2E9</domeo:belongsToSet>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:2C00A54D-2DAC-4CE9-9A86-5591EF7E3323">
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:suffix>) may increase the AUC of </ao:suffix>
    <ao:prefix>An inhibitor of CYP2C8 (e.g., </ao:prefix>
    <domeo:uuid>2C00A54D-2DAC-4CE9-9A86-5591EF7E3323</domeo:uuid>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:2C00A54D-2DAC-4CE9-9A86-5591EF7E3323"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <pav:createdOn>2014-07-22 19:07:10 -0400</pav:createdOn>
    <ao:exact>gemfibrozil</ao:exact>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-122.txt.html</ao:hasSource>
  </rdf:Description>
  <rdf:Description rdf:nodeID="Nb193dcf35a6a452d98488c4ed0e0f508">
    <permissions:accessType>urn:domeo:access:public</permissions:accessType>
    <permissions:isLocked>false</permissions:isLocked>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:2DE3872D-3935-4824-AF9D-DBFF26D2588F">
    <pav:createdOn>2014-09-02 19:12:33 -0400</pav:createdOn>
    <pav:lineageUri>urn:domeoserver:annotationset:C5DEBC9B-77EE-4243-88EB-DBC19737ACD2</pav:lineageUri>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812eda990003</pav:createdBy>
    <ao:context rdf:resource="urn:domeoclient:uuid:E960F182-0178-48DA-9F6A-A1F40CDC1A1D"/>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <domeo:belongsToSet>urn:domeoclient:uuid:CB83FFC2-EA71-44EA-8F11-DE80E389C84E</domeo:belongsToSet>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <domeo:belongsToSet>urn:domeoserver:annotationset:E32812A9-205B-4EE1-B488-A1E294EDBFB9</domeo:belongsToSet>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <rdfs:label>Highlight</rdfs:label>
    <domeo:belongsToSet>urn:domeoserver:annotationset:392EE0FB-AC4F-4AF2-87A6-2E50A281F434</domeo:belongsToSet>
    <pav:lineageUri>urn:domeoserver:annotation:16EDFA83-F2AD-438C-800C-F86D057E4933</pav:lineageUri>
    <pav:lastSavedOn>2014-09-02 19:19:47 -0400</pav:lastSavedOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:EE0F6228-C669-47FF-9D22-04B7A608D69E">
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:EE0F6228-C669-47FF-9D22-04B7A608D69E"/>
    <ao:exact>orazepam</ao:exact>
    <ao:prefix> maleate (50 mg b.i.d.) in healthy male volunteers (N = 12) and a single dose of l</ao:prefix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:suffix> (4 mg single dose) indicated no significant pharmacokinetic interaction. On average, both lorazepam alone and lorazepam with fluvoxamine produced substantial decrements in cognitive functioning; however, the coadministration of fluvoxamine and lorazepam</ao:suffix>
    <domeo:uuid>EE0F6228-C669-47FF-9D22-04B7A608D69E</domeo:uuid>
    <pav:createdOn>2014-09-02 11:38:12 -0400</pav:createdOn>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-9.txt.html</ao:hasSource>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/5EC1436F-02A8-4F09-BB9E-972F4E3E26CE">
    <dct:description>Referred to the drug in the interaction.</dct:description>
    <sio:SIO_000228>dikbD2R:precipitant-drug-of-interaction</sio:SIO_000228>
    <rdfs:label>Rifampin</rdfs:label>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/active-ingredient"/>
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/9384</dailymed:activeMoietyRxCUI>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:BE7787BA-2717-4D64-BE0B-A188784B75CE">
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:exact>miconazole </ao:exact>
    <domeo:uuid>BE7787BA-2717-4D64-BE0B-A188784B75CE</domeo:uuid>
    <pav:createdOn>2014-09-01 16:07:12 -0400</pav:createdOn>
    <ao:prefix>A potential interaction between oral </ao:prefix>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-40.txt.html</ao:hasSource>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:BE7787BA-2717-4D64-BE0B-A188784B75CE"/>
    <ao:suffix>and oral hypoglycemic agents leading to severe hypoglycemia has been reported. Whether this interaction also occurs with the intravenous, topical, or vaginal preparations of miconazole is not known. The effect of concomitant administration of fluconazole</ao:suffix>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:BE4B86AC-FE5F-4543-A713-EC5B852A5A2A">
    <domeo:agents rdf:resource="urn:person:uuid:080e143046812afe0146812eda990003"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:ED9A4881-5A44-4C07-BAFB-529340D632F3"/>
    <pav:lineageUri>urn:domeoserver:annotationset:AB1741F1-5A5F-4416-AEAC-A544BCBB7D16</pav:lineageUri>
    <ao:annotatesResource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-123.txt.html</ao:annotatesResource>
    <ao:item rdf:resource="urn:domeoclient:uuid:51F1BD01-1111-4CA2-BC77-65762E0E45AA"/>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <ao:item rdf:resource="urn:domeoclient:uuid:513FF3F1-4FCE-4790-A5C9-F75162D3687B"/>
    <domeo:deleted>false</domeo:deleted>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <ao:item rdf:resource="urn:domeoclient:uuid:78A5F631-80CE-4FB1-974D-F82BE8D8E584"/>
    <pav:createdOn>2014-07-22 19:08:44 -0400</pav:createdOn>
    <ao:item rdf:resource="urn:domeoclient:uuid:585BED0D-5182-4D39-912D-F355B5BEA6BA"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#AnnotationSet"/>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <permissions:permissions rdf:nodeID="Ndb4a6d99843b4577b479f75d45f8e399"/>
    <domeo:agents rdf:resource="urn:domeo:software:id:Domeo-2.1alpha-050"/>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812eda990003</pav:createdBy>
    <ao:item rdf:resource="urn:domeoclient:uuid:B6681C81-EA03-49F0-8187-EF5752C9D126"/>
    <pav:lastSavedOn>2014-07-22 19:11:40 -0400</pav:lastSavedOn>
    <rdfs:label>Default Set</rdfs:label>
    <dct:description>The default set is created automatically by Domeo when no other set is existing.</dct:description>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:B837C05B-2090-4797-A3CF-E78BA29EF167">
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <ao:context rdf:resource="urn:domeoclient:uuid:C914763B-B8F8-41B8-8D18-F2B33883EA27"/>
    <rdfs:label>Highlight</rdfs:label>
    <pav:lineageUri>urn:domeoserver:annotation:7813F6C5-4FF9-4AE9-9A46-848C3D9E4D3F</pav:lineageUri>
    <pav:lastSavedOn>2014-09-02 11:46:58 -0400</pav:lastSavedOn>
    <domeo:belongsToSet>urn:domeoserver:annotationset:A3F0B39A-4249-4B63-BB0D-F24A005066AC</domeo:belongsToSet>
    <pav:previousVersion>urn:domeoclient:uuid:BED41F06-565A-4622-9A88-48810E5A28DE</pav:previousVersion>
    <domeo:belongsToSet>urn:domeoserver:annotationset:3F546823-204F-4F9B-9006-3DC526C56931</domeo:belongsToSet>
    <pav:createdOn>2014-09-02 11:46:02 -0400</pav:createdOn>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <domeo:belongsToSet>urn:domeoserver:annotationset:A5DD001D-C81A-4E2E-B5E0-7A866B35E26B</domeo:belongsToSet>
    <pav:lineageUri>urn:domeoserver:annotationset:D1715BD2-BD41-46FD-9454-DC7A423A29AC</pav:lineageUri>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">2</pav:versionNumber>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812eda990003</pav:createdBy>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <pav:lastSavedOn>2014-09-02 11:46:59 -0400</pav:lastSavedOn>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:EDE878E4-C5E0-46C3-B925-8B3825F4CA93">
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <pav:createdOn>2014-07-24 20:07:21 -0400</pav:createdOn>
    <ao:prefix> or </ao:prefix>
    <ao:suffix> led to increased plasma concentrations of fexofenadine in healthy adult subjects. Fexofenadine had no effect on the pharmacokinetics of either erythromycin or ketoconazole. In two separate studies in healthy adult subjects, fexofenadine hydrochloride 12</ao:suffix>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-139.txt.html</ao:hasSource>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:EDE878E4-C5E0-46C3-B925-8B3825F4CA93"/>
    <domeo:uuid>EDE878E4-C5E0-46C3-B925-8B3825F4CA93</domeo:uuid>
    <ao:exact>erythromycin</ao:exact>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:5B9978DD-BF7E-4B48-BA74-826CB1EA9750">
    <domeo:belongsToSet>urn:domeoclient:uuid:8AA46BC0-EA66-4E73-81A9-6463BB4DE15B</domeo:belongsToSet>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <ao:context rdf:resource="urn:domeoclient:uuid:A3802033-7DB0-4AE2-833F-5EF306928ABF"/>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812eda990003</pav:createdBy>
    <pav:createdOn>2014-07-24 19:54:37 -0400</pav:createdOn>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <rdfs:label>Highlight</rdfs:label>
    <pav:lastSavedOn>2014-07-24 19:54:28 -0400</pav:lastSavedOn>
    <pav:lineageUri>urn:domeoserver:annotation:924923B4-F032-417D-AA15-AA656F363BB9</pav:lineageUri>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:1085914C-2530-49EB-92B4-1E4BC17AEBAC">
    <domeo:uuid>1085914C-2530-49EB-92B4-1E4BC17AEBAC</domeo:uuid>
    <ao:exact>acebutolol</ao:exact>
    <pav:createdOn>2014-07-13 11:02:05 -0400</pav:createdOn>
    <ao:suffix> is 400 mg daily given as 200 mg b.i.d. Dosage should be increased gradually until an optimal clinical response is obtained, generally at 600 to 1200 mg per day. If treatment is to be discontinued, the dosage should be reduced gradually over a period of </ao:suffix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:prefix>The usual initial dosage of </ao:prefix>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-4.txt.html</ao:hasSource>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:1085914C-2530-49EB-92B4-1E4BC17AEBAC"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:16D91D82-D12B-41E8-A218-F336224CF507">
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812eda990003</pav:createdBy>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <domeo:belongsToSet>urn:domeoclient:uuid:CB83FFC2-EA71-44EA-8F11-DE80E389C84E</domeo:belongsToSet>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <pav:lineageUri>urn:domeoserver:annotation:5AA23555-488A-4835-88D7-23C4B45B7BB9</pav:lineageUri>
    <ao:context rdf:resource="urn:domeoclient:uuid:689B7657-F3FC-48C0-A564-2904140C7D29"/>
    <pav:lineageUri>urn:domeoserver:annotationset:C5DEBC9B-77EE-4243-88EB-DBC19737ACD2</pav:lineageUri>
    <domeo:belongsToSet>urn:domeoserver:annotationset:392EE0FB-AC4F-4AF2-87A6-2E50A281F434</domeo:belongsToSet>
    <rdfs:label>Highlight</rdfs:label>
    <pav:lastSavedOn>2014-09-02 19:19:47 -0400</pav:lastSavedOn>
    <pav:createdOn>2014-09-02 19:16:36 -0400</pav:createdOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <domeo:belongsToSet>urn:domeoserver:annotationset:E32812A9-205B-4EE1-B488-A1E294EDBFB9</domeo:belongsToSet>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:503397EF-2F88-4CC5-9295-97542C30A8DC">
    <pav:lineageUri>urn:domeoserver:annotation:4C7C4F50-7592-47DB-940D-41FEFF9DF638</pav:lineageUri>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812eda990003</pav:createdBy>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:lastSavedOn>2014-07-22 20:22:38 -0400</pav:lastSavedOn>
    <pav:createdOn>2014-07-22 19:55:18 -0400</pav:createdOn>
    <ao:context rdf:resource="urn:domeoclient:uuid:3A0236F4-5119-432D-9B94-B00A5EEC35E7"/>
    <domeo:belongsToSet>urn:domeoserver:annotationset:F272A789-69D0-47CC-8CC9-F25C55B91261</domeo:belongsToSet>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <rdfs:label>Highlight</rdfs:label>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:previousVersion>xsd:String</pav:previousVersion>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:143E0873-3AEC-4273-B2E8-23467A7C6978">
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:143E0873-3AEC-4273-B2E8-23467A7C6978"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:prefix>, </ao:prefix>
    <ao:suffix>, sertraline) is clinically warranted, appropriate observation of the patient is advised.</ao:suffix>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-9.txt.html</ao:hasSource>
    <ao:exact>paroxetine</ao:exact>
    <domeo:uuid>143E0873-3AEC-4273-B2E8-23467A7C6978</domeo:uuid>
    <pav:createdOn>2014-09-02 11:43:53 -0400</pav:createdOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:4DAAB121-0E59-4A51-A71B-B8E4DB847D18">
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:lastSavedOn>2014-07-28 17:02:28 -0400</pav:lastSavedOn>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <ao:context rdf:resource="urn:domeoclient:uuid:36443C46-71EF-4792-ADF2-D6E6E248EFAA"/>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812eda990003</pav:createdBy>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <rdfs:label>Highlight</rdfs:label>
    <pav:lineageUri>urn:domeoserver:annotation:C503BECC-F67A-4BAE-BF4C-6F8F7B0511DA</pav:lineageUri>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <domeo:belongsToSet>urn:domeoclient:uuid:A0E3203A-2AD3-4045-BAB8-27B340F81B0E</domeo:belongsToSet>
    <pav:createdOn>2014-07-28 17:02:33 -0400</pav:createdOn>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:20F62F72-784B-45A3-91FF-645FE13940A8">
    <ao:exact>zidovudine </ao:exact>
    <ao:suffix>concentrations were determined on two occasions (before and following fluconazole 200 mg daily for 15 days) in 13 volunteers with AIDS or ARC who were on a stable zidovudine dose for at least two weeks. There was a significant increase in zidovudine AUC </ao:suffix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <domeo:uuid>20F62F72-784B-45A3-91FF-645FE13940A8</domeo:uuid>
    <pav:createdOn>2014-07-21 21:31:06 -0400</pav:createdOn>
    <ao:prefix>Plasma </ao:prefix>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-27.txt.html</ao:hasSource>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:20F62F72-784B-45A3-91FF-645FE13940A8"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:1BD555DB-DE08-478A-98FE-8A631606CA83">
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:exact>Gemfibrozil</ao:exact>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-123.txt.html</ao:hasSource>
    <ao:prefix>xsd:String</ao:prefix>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:1BD555DB-DE08-478A-98FE-8A631606CA83"/>
    <domeo:uuid>1BD555DB-DE08-478A-98FE-8A631606CA83</domeo:uuid>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <pav:createdOn>2014-07-22 19:49:08 -0400</pav:createdOn>
    <ao:suffix>xsd:String</ao:suffix>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:62E1503B-EE9D-40BF-B77B-6779195F8F1F">
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812eda990003</pav:createdBy>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <domeo:belongsToSet>urn:domeoclient:uuid:AD7D1F18-857F-4502-9621-F93B88E936D2</domeo:belongsToSet>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <ao:context rdf:resource="urn:domeoclient:uuid:AC6949EC-26AB-43DC-8B1B-1401086A35B0"/>
    <pav:lastSavedOn>2014-07-28 17:00:03 -0400</pav:lastSavedOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:lineageUri>urn:domeoserver:annotation:6A93619D-217A-4394-B947-CAB50B0721D6</pav:lineageUri>
    <pav:createdOn>2014-07-28 17:00:22 -0400</pav:createdOn>
    <rdfs:label>Highlight</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:3B160A10-3999-44C9-A9E0-AB903EF4E9F4">
    <ao:suffix>. If a narcotic is needed in such patients, a sensitivity test should be performed in which repeated, small, incremental doses of morphine are administered over the course of several hours while the patient's condition and vital signs are under careful o</ao:suffix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <pav:createdOn>2014-07-28 17:01:58 -0400</pav:createdOn>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-165.txt.html</ao:hasSource>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:exact>meperidine</ao:exact>
    <domeo:uuid>3B160A10-3999-44C9-A9E0-AB903EF4E9F4</domeo:uuid>
    <ao:prefix>inant manifestations have been hyper-excitability, convulsions, tachycardia, hyperpyrexia, and hypertension. Although it is not known that other narcotics are free of the risk of such reactions, virtually all of the reported reactions have occurred with </ao:prefix>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:3B160A10-3999-44C9-A9E0-AB903EF4E9F4"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:6BC9135A-65A9-4BB2-A462-DD73D14C286B">
    <ao:body rdf:nodeID="Ne21ada11b56e470b8c1782ed43501aea"/>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <domeo:belongsToSet>urn:domeoclient:uuid:876DAFB7-BB08-4119-BA16-59187031D7BB</domeo:belongsToSet>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812eda990003</pav:createdBy>
    <rdfs:label>expertstudy Annotation</rdfs:label>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#expertstudyAnnotation"/>
    <ao:context rdf:resource="urn:domeoclient:uuid:54953EDA-07BE-4F30-8DE9-32B9DFDAC13D"/>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:lineageUri>urn:domeoserver:annotation:DDF78D61-DEA7-475E-A81F-CC94BAF10D7B</pav:lineageUri>
    <pav:createdOn>2014-07-21 21:47:00 -0400</pav:createdOn>
    <pav:lastSavedOn>2014-07-21 21:46:47 -0400</pav:lastSavedOn>
    <pav:previousVersion>xsd:String</pav:previousVersion>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:1B6E9A08-C112-4656-8901-F8802CD64317">
    <pav:lastSavedOn>2014-07-13 12:45:54 -0400</pav:lastSavedOn>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <rdfs:label>expertstudy Annotation</rdfs:label>
    <domeo:belongsToSet>urn:domeoclient:uuid:23567EF7-7482-444A-B1F6-5AAA9D43E54A</domeo:belongsToSet>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812eda990003</pav:createdBy>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:lineageUri>urn:domeoserver:annotation:B0DBD770-879A-4A78-90BD-890A235DEC8D</pav:lineageUri>
    <pav:createdOn>2014-07-13 12:45:35 -0400</pav:createdOn>
    <ao:context rdf:resource="urn:domeoclient:uuid:2BF9F224-82C0-470E-9645-8A6965E66A04"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#expertstudyAnnotation"/>
    <ao:body rdf:nodeID="Nb30e482b535a4cbfa38da60936fb469b"/>
    <pav:previousVersion>xsd:String</pav:previousVersion>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/46FB1ED5-40B7-4788-9A91-7689FC73A793">
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/85762</dailymed:activeMoietyRxCUI>
    <rdfs:label>ritonavir</rdfs:label>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/active-ingredient"/>
    <dct:description>Referred to the drug in the interaction.</dct:description>
    <sio:SIO_000228>dikbD2R:precipitant-drug-of-interaction</sio:SIO_000228>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:E80C09FF-4092-4C04-9821-CFC8593DEFD7">
    <pav:createdOn>2014-07-24 20:08:18 -0400</pav:createdOn>
    <ao:exact>ketoconazole</ao:exact>
    <ao:prefix> or </ao:prefix>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-139.txt.html</ao:hasSource>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <domeo:uuid>E80C09FF-4092-4C04-9821-CFC8593DEFD7</domeo:uuid>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:E80C09FF-4092-4C04-9821-CFC8593DEFD7"/>
    <ao:suffix>. The findings of these studies are summarized in the following table:</ao:suffix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:29E9C9FA-0648-4564-86E4-3E4F28AF69B7">
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/PK_DDI"/>
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/D3472C63-0DF1-445A-8D55-A0C2CFC47A4D"/>
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/F68E59B2-9C61-4DC7-A6E2-B96F04B0D293"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:87659984-6B68-48C3-9D52-19757F705CEB">
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:prefix> 2 mg coadministered with </ao:prefix>
    <domeo:uuid>87659984-6B68-48C3-9D52-19757F705CEB</domeo:uuid>
    <pav:createdOn>2014-09-02 19:38:16 -0400</pav:createdOn>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:87659984-6B68-48C3-9D52-19757F705CEB"/>
    <ao:suffix> 40 mg given once daily for 11 days was associated with a mean increase in QTc values of approximately 10 msec compared to pimozide given alone. Citalopram did not alter the mean AUC or Cmax of pimozide. The mechanism of this pharmacodynamic interaction </ao:suffix>
    <ao:exact>citalopram</ao:exact>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-78.txt.html</ao:hasSource>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/C9B2FC03-3B32-472D-B469-B9F86400F4C6">
    <rdfs:label>risperidone</rdfs:label>
    <sio:SIO_000228>dikbD2R:object-drug-of-interaction</sio:SIO_000228>
    <dct:description>Referred to the drug in the interaction.</dct:description>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/active-ingredient"/>
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/35636</dailymed:activeMoietyRxCUI>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:58576832-5E8D-41C1-98BF-9612C4FEA54D">
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-9.txt.html</ao:hasSource>
    <domeo:uuid>58576832-5E8D-41C1-98BF-9612C4FEA54D</domeo:uuid>
    <pav:createdOn>2014-09-02 11:40:59 -0400</pav:createdOn>
    <ao:prefix>xsd:String</ao:prefix>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:58576832-5E8D-41C1-98BF-9612C4FEA54D"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:exact>Pimozide</ao:exact>
    <ao:suffix>: See CONTRAINDICATIONS (4) and WARNINGS AND PRECAUTIONS (5.6).</ao:suffix>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:1083CE4D-6393-4589-AC36-1DEC7BFE570A">
    <pav:createdOn>2014-07-22 18:54:08 -0400</pav:createdOn>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812eda990003</pav:createdBy>
    <ao:context rdf:resource="urn:domeoclient:uuid:302E5EA3-5D0F-4547-B3A1-1B63352BB1A5"/>
    <pav:lineageUri>urn:domeoserver:annotation:30E22C75-24AF-4589-9D91-F93CB0D6E229</pav:lineageUri>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#expertstudyAnnotation"/>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <pav:lastSavedOn>2014-07-22 18:54:35 -0400</pav:lastSavedOn>
    <domeo:belongsToSet>urn:domeoclient:uuid:3D195979-3E82-427D-95B8-F50F48DB4AA7</domeo:belongsToSet>
    <ao:body rdf:nodeID="N0d07a984c63446faa00323759a8d8cd3"/>
    <rdfs:label>expertstudy Annotation</rdfs:label>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:8786A121-1479-4E39-A0A4-280F6167DD01">
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <domeo:belongsToSet>urn:domeoserver:annotationset:3F546823-204F-4F9B-9006-3DC526C56931</domeo:belongsToSet>
    <ao:context rdf:resource="urn:domeoclient:uuid:7E65733E-5455-4115-AFE9-BA2E1EB6BB2F"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:previousVersion>urn:domeoclient:uuid:BED41F06-565A-4622-9A88-48810E5A28DE</pav:previousVersion>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812eda990003</pav:createdBy>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <domeo:belongsToSet>urn:domeoserver:annotationset:A3F0B39A-4249-4B63-BB0D-F24A005066AC</domeo:belongsToSet>
    <domeo:belongsToSet>urn:domeoserver:annotationset:A5DD001D-C81A-4E2E-B5E0-7A866B35E26B</domeo:belongsToSet>
    <pav:lineageUri>urn:domeoserver:annotation:3AB5063F-8492-4F48-9330-36CA6685903E</pav:lineageUri>
    <rdfs:label>Highlight</rdfs:label>
    <pav:createdOn>2014-09-02 11:43:18 -0400</pav:createdOn>
    <pav:lastSavedOn>2014-09-02 11:46:58 -0400</pav:lastSavedOn>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">2</pav:versionNumber>
    <pav:lineageUri>urn:domeoserver:annotationset:D1715BD2-BD41-46FD-9454-DC7A423A29AC</pav:lineageUri>
    <pav:previousVersion>xsd:String</pav:previousVersion>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:8A17CFA1-4C14-4F96-911E-3EB707629E7A">
    <ao:prefix> 100 mg to 300 mg daily, </ao:prefix>
    <domeo:uuid>8A17CFA1-4C14-4F96-911E-3EB707629E7A</domeo:uuid>
    <ao:suffix> reduced plasma concentrations of trazodone (as well as mCPP) by 76 and 60%, respectively, compared to pre-carbamazepine values.</ao:suffix>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-137.txt.html</ao:hasSource>
    <ao:exact>carbamazepine</ao:exact>
    <pav:createdOn>2014-07-24 20:03:50 -0400</pav:createdOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:8A17CFA1-4C14-4F96-911E-3EB707629E7A"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:FAD17173-A1D3-4A24-A29E-5999F0DFA8F4">
    <ao:exact>REVATIO </ao:exact>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-155.txt.html</ao:hasSource>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:FAD17173-A1D3-4A24-A29E-5999F0DFA8F4"/>
    <domeo:uuid></domeo:uuid>
    <domeo:uuid>FAD17173-A1D3-4A24-A29E-5999F0DFA8F4</domeo:uuid>
    <ao:suffix>Injection: The pharmacokinetic profile of REVATIO has been characterized following intravenous administration. A 10 mg dose of REVATIO Injection is predicted to provide a pharmacological effect of sildenafil and its N-desmethyl metabolite equivalent to t</ao:suffix>
    <pav:createdOn>2014-07-07 09:58:43 -0400</pav:createdOn>
    <ao:prefix>xsd:String</ao:prefix>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:034AD896-FB93-4F64-9796-CB98DF23644B">
    <domeo:uuid>034AD896-FB93-4F64-9796-CB98DF23644B</domeo:uuid>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:exact>paroxetine</ao:exact>
    <pav:createdOn>2014-09-01 16:22:02 -0400</pav:createdOn>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-45.txt.html</ao:hasSource>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:034AD896-FB93-4F64-9796-CB98DF23644B"/>
    <ao:prefix>xidative) enzymes. When a single oral 30-mg dose of immediate-release paroxetine  was administered at phenobarbital steady state (100 mg once daily for 14 days), paroxetine AUC and T½ were reduced (by an average of 25% and 38%, respectively) compared to </ao:prefix>
    <ao:suffix> administered alone. The effect of </ao:suffix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:3B664870-D5A4-43DD-8990-228B68AA60AA">
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:createdOn>2014-09-02 11:43:36 -0400</pav:createdOn>
    <pav:lineageUri>urn:domeoserver:annotationset:D1715BD2-BD41-46FD-9454-DC7A423A29AC</pav:lineageUri>
    <domeo:belongsToSet>urn:domeoserver:annotationset:3F546823-204F-4F9B-9006-3DC526C56931</domeo:belongsToSet>
    <domeo:belongsToSet>urn:domeoserver:annotationset:A3F0B39A-4249-4B63-BB0D-F24A005066AC</domeo:belongsToSet>
    <rdfs:label>Highlight</rdfs:label>
    <pav:lastSavedOn>2014-09-02 11:46:58 -0400</pav:lastSavedOn>
    <domeo:belongsToSet>urn:domeoserver:annotationset:A5DD001D-C81A-4E2E-B5E0-7A866B35E26B</domeo:belongsToSet>
    <ao:context rdf:resource="urn:domeoclient:uuid:257F4F5D-CCED-4AAD-9504-4A9F1A855C69"/>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812eda990003</pav:createdBy>
    <pav:lineageUri>urn:domeoserver:annotation:0B1B9FDD-C8D2-4D84-862A-3A5294041467</pav:lineageUri>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">2</pav:versionNumber>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:previousVersion>urn:domeoclient:uuid:BED41F06-565A-4622-9A88-48810E5A28DE</pav:previousVersion>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:F34547B1-36EF-43A2-81A9-922401A6E906">
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:suffix> 120 mg twice daily (240 mg total daily dose) was coadministered with either erythromycin 500 mg every 8 hours or ketoconazole 400 mg once daily under steady-state conditions to healthy adult subjects (n = 24, each study). No differences in adverse event</ao:suffix>
    <pav:createdOn>2014-07-24 20:07:44 -0400</pav:createdOn>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:F34547B1-36EF-43A2-81A9-922401A6E906"/>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-139.txt.html</ao:hasSource>
    <ao:exact>fexofenadine hydrochloride</ao:exact>
    <domeo:uuid>F34547B1-36EF-43A2-81A9-922401A6E906</domeo:uuid>
    <ao:prefix>. In two separate studies in healthy adult subjects, </ao:prefix>
  </rdf:Description>
  <rdf:Description rdf:nodeID="Nc242a3240d214e07aeb4e0d80b8d4d15">
    <permissions:accessType>urn:domeo:access:public</permissions:accessType>
    <permissions:isLocked>false</permissions:isLocked>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:89F35E49-064B-44B8-B2CE-6FDE26A34AC7">
    <pav:createdOn>2014-09-02 11:44:17 -0400</pav:createdOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-9.txt.html</ao:hasSource>
    <ao:suffix>xsd:String</ao:suffix>
    <ao:exact> Tryptophan</ao:exact>
    <ao:prefix>:</ao:prefix>
    <domeo:uuid>89F35E49-064B-44B8-B2CE-6FDE26A34AC7</domeo:uuid>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:89F35E49-064B-44B8-B2CE-6FDE26A34AC7"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:807433B2-EB3F-4CEF-824C-1D71920A4C22">
    <ao:context rdf:resource="urn:domeoclient:uuid:08F7FCFD-3C5E-46FE-8EDA-8ED22CA77882"/>
    <pav:lineageUri>urn:domeoserver:annotationset:C5DEBC9B-77EE-4243-88EB-DBC19737ACD2</pav:lineageUri>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812eda990003</pav:createdBy>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:lastSavedOn>2014-09-02 19:19:47 -0400</pav:lastSavedOn>
    <pav:createdOn>2014-09-02 19:13:55 -0400</pav:createdOn>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <domeo:belongsToSet>urn:domeoserver:annotationset:E32812A9-205B-4EE1-B488-A1E294EDBFB9</domeo:belongsToSet>
    <rdfs:label>Highlight</rdfs:label>
    <domeo:belongsToSet>urn:domeoserver:annotationset:392EE0FB-AC4F-4AF2-87A6-2E50A281F434</domeo:belongsToSet>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <domeo:belongsToSet>urn:domeoclient:uuid:CB83FFC2-EA71-44EA-8F11-DE80E389C84E</domeo:belongsToSet>
    <pav:lineageUri>urn:domeoserver:annotation:17FAD1B5-177A-476D-82F0-5D1C028F7238</pav:lineageUri>
    <pav:previousVersion>xsd:String</pav:previousVersion>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/F9A7B706-7816-4689-A106-0C28124DEA2F">
    <sio:SIO_000228>dikbD2R:precipitant-drug-of-interaction</sio:SIO_000228>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/active-ingredient"/>
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/38400</dailymed:activeMoietyRxCUI>
    <dct:description>Referred to the drug in the interaction.</dct:description>
    <rdfs:label>atomoxetine</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:39C2E9DA-729E-466D-9F16-3F254B23A03C">
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-9.txt.html</ao:hasSource>
    <ao:exact>fluvoxamine</ao:exact>
    <pav:createdOn>2014-09-02 11:44:56 -0400</pav:createdOn>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:39C2E9DA-729E-466D-9F16-3F254B23A03C"/>
    <ao:suffix> maleate 100 mg per day and propranolol 160 mg per day in normal volunteers resulted in a mean five-fold increase (range 2 to 17) in minimum propranolol plasma concentrations. In this study, there was a slight potentiation of the propranolol-induced redu</ao:suffix>
    <domeo:uuid>39C2E9DA-729E-466D-9F16-3F254B23A03C</domeo:uuid>
    <ao:prefix>Propranolol and Other Beta-Blockers: Coadministration of </ao:prefix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:E0863579-8D19-4B30-ADD6-2A5BDBC2F482">
    <pav:createdOn>2014-07-24 19:52:41 -0400</pav:createdOn>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812eda990003</pav:createdBy>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <ao:item rdf:resource="urn:domeoclient:uuid:4C303406-873F-442A-82D7-9FA28371D696"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:84794CD6-2D7E-423B-92EC-B0CDCB2CF050"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:4BBBCCF7-77AF-4B32-B246-8C1032EB3DF0"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:CE82B7F1-A555-4EA6-BB43-259D94DCEA76"/>
    <domeo:deleted>false</domeo:deleted>
    <ao:item rdf:resource="urn:domeoclient:uuid:9207210A-6F7A-4F79-BDF9-A1A2BE0D055E"/>
    <domeo:agents rdf:resource="urn:person:uuid:080e143046812afe0146812eda990003"/>
    <pav:lastSavedOn>2014-07-24 19:53:55 -0400</pav:lastSavedOn>
    <permissions:permissions rdf:nodeID="N4aa7752b812f42fa852dea95761e1caa"/>
    <dct:description>The default set is created automatically by Domeo when no other set is existing.</dct:description>
    <ao:annotatesResource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-132.txt.html</ao:annotatesResource>
    <ao:item rdf:resource="urn:domeoclient:uuid:EBFA7BB9-378D-445C-9A8F-2DF6D035AC7D"/>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <rdfs:label>Default Set</rdfs:label>
    <domeo:agents rdf:resource="urn:domeo:software:id:Domeo-2.1alpha-050"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#AnnotationSet"/>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <ao:item rdf:resource="urn:domeoclient:uuid:AA6CCDE1-25E7-45C1-9526-49B0190E1EC2"/>
    <pav:lineageUri>urn:domeoserver:annotationset:0498601E-1695-4042-B282-36B6420F06B7</pav:lineageUri>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:553A6608-733A-477E-BDCB-F0D16F1054E3">
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/093D1F2A-587E-4B3C-AAF4-10347561D8A9"/>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/PK_DDI"/>
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/E4072F00-AC18-479B-BBF5-FE87E12CA45B"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:446F532B-903F-4B10-9F56-9CC000DF6BDF">
    <pav:previousVersion>urn:domeoserver:annotationset:606A5B3F-B6FB-4279-AA42-7893CFC2D20C</pav:previousVersion>
    <pav:createdOn>2014-07-22 19:54:40 -0400</pav:createdOn>
    <ao:body rdf:nodeID="N4157df53fe474d3596fa22356da6afeb"/>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">7</pav:versionNumber>
    <ao:body rdf:nodeID="N4874a069bde348c7a432f6baacb57bfb"/>
    <domeo:belongsToSet>urn:domeoserver:annotationset:2914A3FD-DF43-4F78-999C-77CE7A028B19</domeo:belongsToSet>
    <ao:context rdf:resource="urn:domeoclient:uuid:4C7B2841-F48B-46C2-A7DF-E954EDF0385C"/>
    <rdfs:label>expertstudy Annotation</rdfs:label>
    <domeo:belongsToSet>urn:domeoserver:annotationset:F272A789-69D0-47CC-8CC9-F25C55B91261</domeo:belongsToSet>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#expertstudyAnnotation"/>
    <pav:lineageUri>urn:domeoserver:annotationset:AB1741F1-5A5F-4416-AEAC-A544BCBB7D16</pav:lineageUri>
    <pav:lineageUri>urn:domeoserver:annotation:8DAA615E-72AA-4E5E-A420-87A7A585A18C</pav:lineageUri>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812eda990003</pav:createdBy>
    <pav:lastSavedOn>2014-07-22 19:54:59 -0400</pav:lastSavedOn>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:0FDB999F-470E-431C-829C-F231318245D8">
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812eda990003</pav:createdBy>
    <pav:lineageUri>urn:domeoserver:annotationset:AB1741F1-5A5F-4416-AEAC-A544BCBB7D16</pav:lineageUri>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:createdOn>2014-07-22 19:53:20 -0400</pav:createdOn>
    <domeo:belongsToSet>urn:domeoserver:annotationset:2914A3FD-DF43-4F78-999C-77CE7A028B19</domeo:belongsToSet>
    <pav:previousVersion>urn:domeoserver:annotationset:606A5B3F-B6FB-4279-AA42-7893CFC2D20C</pav:previousVersion>
    <pav:lastSavedOn>2014-07-22 19:54:59 -0400</pav:lastSavedOn>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">7</pav:versionNumber>
    <domeo:belongsToSet>urn:domeoserver:annotationset:F272A789-69D0-47CC-8CC9-F25C55B91261</domeo:belongsToSet>
    <rdfs:label>Highlight</rdfs:label>
    <ao:context rdf:resource="urn:domeoclient:uuid:7C414A6F-D97C-4DE2-83B7-8EA499CCDE11"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:lineageUri>urn:domeoserver:annotation:7BB3B5AF-153C-498B-BAC0-0A2AC177A6E9</pav:lineageUri>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:9B609E45-9C17-43F3-B813-24BD2E69F02B">
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/558D6A02-4F09-4F64-900B-5C61E2E8EC45"/>
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/2EC6AEAC-5E19-484C-A69E-7511B32043B8"/>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/PK_DDI"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:DE5C582E-1F4C-478C-9DDC-DAB4C0C1ABFF">
    <domeo:belongsToSet>urn:domeoserver:annotationset:22ED7220-C6F6-43C5-9DF9-89F62F0F8E27</domeo:belongsToSet>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812eda990003</pav:createdBy>
    <pav:createdOn>2014-07-07 09:58:57 -0400</pav:createdOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <domeo:belongsToSet>urn:domeoserver:annotationset:8F3CF3D9-AADE-4A86-BD42-2924B3D6A406</domeo:belongsToSet>
    <rdfs:label>Highlight</rdfs:label>
    <domeo:belongsToSet>urn:domeoserver:annotationset:08C0C288-6DF4-43E6-A618-71A8BB9563C3</domeo:belongsToSet>
    <ao:context rdf:resource="urn:domeoclient:uuid:AA9BE1F2-854A-4E7D-8C64-DCE1158C5D96"/>
    <pav:lastSavedOn>2014-07-07 10:02:41 -0400</pav:lastSavedOn>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <domeo:belongsToSet>urn:domeoserver:annotationset:131835A3-C655-4F91-97D4-52CAFF7B7CCA</domeo:belongsToSet>
    <pav:lineageUri>urn:domeoserver:annotation:FFE74587-6133-48F1-B1FA-716CCC2AA2F3</pav:lineageUri>
    <domeo:belongsToSet>urn:domeoserver:annotationset:7AACEF8D-2EBC-4F0B-94B2-190650E562F6</domeo:belongsToSet>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:8C807E9A-52F6-4F5A-9553-5D4EB47525AC">
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:exact>diazepam</ao:exact>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:8C807E9A-52F6-4F5A-9553-5D4EB47525AC"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:prefix> can inhibit the metabolism of </ao:prefix>
    <ao:suffix>, resulting in increased concentrations of diazepam and its metabolites. Diazepam does not alter the pharmacokinetics of propranolol.</ao:suffix>
    <pav:createdOn>2014-07-24 19:44:10 -0400</pav:createdOn>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-128.txt.html</ao:hasSource>
    <domeo:uuid>8C807E9A-52F6-4F5A-9553-5D4EB47525AC</domeo:uuid>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:631B556D-C865-4327-8C15-D735A7315C3D">
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <ao:context rdf:resource="urn:domeoclient:uuid:20F62F72-784B-45A3-91FF-645FE13940A8"/>
    <pav:lineageUri>urn:domeoserver:annotationset:092451F5-B0C0-430C-8896-07F81D33F9E1</pav:lineageUri>
    <pav:lineageUri>urn:domeoserver:annotation:BF1A04AE-D42D-4325-8FB7-71A006594780</pav:lineageUri>
    <rdfs:label>Highlight</rdfs:label>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812eda990003</pav:createdBy>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <domeo:belongsToSet>urn:domeoserver:annotationset:40007BD9-0869-48CF-A8F2-BAD26AE3E6E1</domeo:belongsToSet>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <domeo:belongsToSet>urn:domeoclient:uuid:5B3EE83F-83C7-4BA8-A892-C032BE699CFA</domeo:belongsToSet>
    <pav:createdOn>2014-07-21 21:31:06 -0400</pav:createdOn>
    <pav:lastSavedOn>2014-07-21 21:31:54 -0400</pav:lastSavedOn>
  </rdf:Description>
  <rdf:Description rdf:nodeID="Nf33676a225644d7f86722ec2a00d93d4">
    <permissions:accessType>urn:domeo:access:public</permissions:accessType>
    <permissions:isLocked>false</permissions:isLocked>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/B9045C9A-4D72-42C8-90B8-EFC09CB8C259">
    <dct:description>Referred to the drug in the interaction.</dct:description>
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/2541</dailymed:activeMoietyRxCUI>
    <sio:SIO_000228>dikbD2R:object-drug-of-interaction</sio:SIO_000228>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/active-ingredient"/>
    <rdfs:label>cimetidine</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:0A2D6969-9724-41E9-BCD8-E35100958761">
    <ao:context rdf:resource="urn:domeoclient:uuid:55590627-6DCB-46F4-B196-1032E6ECA077"/>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:lineageUri>urn:domeoserver:annotation:1D52E1DA-96E5-4844-867C-9D6C0FB89EA8</pav:lineageUri>
    <domeo:belongsToSet>urn:domeoclient:uuid:A84DE8F6-26B7-471D-8309-4E7CC2994FDF</domeo:belongsToSet>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <pav:lastSavedOn>2014-09-01 16:06:18 -0400</pav:lastSavedOn>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812eda990003</pav:createdBy>
    <pav:createdOn>2014-09-01 16:06:05 -0400</pav:createdOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <rdfs:label>Highlight</rdfs:label>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:D555EE88-9218-4AF9-81CC-40D543746D77">
    <domeo:belongsToSet>urn:domeoserver:annotationset:7E80543E-BF76-4514-92A9-91458DCB802B</domeo:belongsToSet>
    <domeo:belongsToSet>urn:domeoserver:annotationset:606A5B3F-B6FB-4279-AA42-7893CFC2D20C</domeo:belongsToSet>
    <domeo:belongsToSet>urn:domeoserver:annotationset:467D4F28-D086-4217-9DE0-23E165F30716</domeo:belongsToSet>
    <domeo:belongsToSet>urn:domeoserver:annotationset:F272A789-69D0-47CC-8CC9-F25C55B91261</domeo:belongsToSet>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">2</pav:versionNumber>
    <pav:previousVersion>urn:domeoclient:uuid:BE4B86AC-FE5F-4543-A713-EC5B852A5A2A</pav:previousVersion>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812eda990003</pav:createdBy>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:lastSavedOn>2014-07-22 19:15:50 -0400</pav:lastSavedOn>
    <pav:createdOn>2014-07-22 19:12:55 -0400</pav:createdOn>
    <domeo:belongsToSet>urn:domeoserver:annotationset:7021B883-FD5C-4083-BD87-DF56D3C87633</domeo:belongsToSet>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <rdfs:label>Highlight</rdfs:label>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <domeo:belongsToSet>urn:domeoserver:annotationset:514BA51B-D734-4003-A7C3-F03C0F95833A</domeo:belongsToSet>
    <ao:context rdf:resource="urn:domeoclient:uuid:097BBD64-4910-4F32-9440-9A37CCEA09F8"/>
    <domeo:belongsToSet>urn:domeoserver:annotationset:2914A3FD-DF43-4F78-999C-77CE7A028B19</domeo:belongsToSet>
    <pav:lineageUri>urn:domeoserver:annotation:0B425084-EF72-47B8-8ACC-ADFFEBDC9B0A</pav:lineageUri>
    <pav:lineageUri>urn:domeoserver:annotationset:AB1741F1-5A5F-4416-AEAC-A544BCBB7D16</pav:lineageUri>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:3152AF8A-AAEB-4E0D-8A47-3405FA95E483">
    <ao:context rdf:resource="urn:domeoclient:uuid:36B5198A-3542-4C86-BF30-6375D3BC2CDB"/>
    <rdfs:label>Highlight</rdfs:label>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <domeo:belongsToSet>urn:domeoclient:uuid:39B82E57-92E3-4322-A8E6-A3AFF215F02C</domeo:belongsToSet>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812eda990003</pav:createdBy>
    <pav:lineageUri>urn:domeoserver:annotation:8E2AFF27-C876-4683-AE00-8DBC41A95E70</pav:lineageUri>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:createdOn>2014-09-01 15:57:27 -0400</pav:createdOn>
    <pav:lastSavedOn>2014-09-01 15:57:39 -0400</pav:lastSavedOn>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/F66BC8F5-49B9-4B6B-9972-D0A9AFB6AF18">
    <sio:SIO_000228>dikbD2R:object-drug-of-interaction</sio:SIO_000228>
    <dct:description>Referred to the drug in the interaction.</dct:description>
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/9068</dailymed:activeMoietyRxCUI>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/active-ingredient"/>
    <rdfs:label>quinidine</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:8739072C-5D47-4302-BD43-4756B65DFB2B">
    <ao:suffix>), and protease inhibitors (e.g., ritonavir), may prolong opioid effects. If co-administration is necessary, caution is advised when initiating therapy with, currently taking, or discontinuing CYP3A4 inhibitors. Evaluate these patients at frequent interv</ao:suffix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:prefix>), azole-antifungal agents (e.g., </ao:prefix>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-72.txt.html</ao:hasSource>
    <ao:exact>ketoconazole</ao:exact>
    <pav:createdOn>2014-09-02 19:09:23 -0400</pav:createdOn>
    <domeo:uuid>8739072C-5D47-4302-BD43-4756B65DFB2B</domeo:uuid>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:8739072C-5D47-4302-BD43-4756B65DFB2B"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:9C474000-EB80-4F4E-8C99-0066BDF22196">
    <ao:prefix> (intravenous bolus dose) in healthy volunteers led to elevated plasma concentrations of these drugs. The Cmax increased by 18% and 14% (median values) and the AUC increased by 44% and 33% for </ao:prefix>
    <pav:createdOn>2014-07-22 18:44:50 -0400</pav:createdOn>
    <ao:suffix> and midazolam, respectively.</ao:suffix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-118.txt.html</ao:hasSource>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:9C474000-EB80-4F4E-8C99-0066BDF22196"/>
    <ao:exact>nifedipine</ao:exact>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <domeo:uuid>9C474000-EB80-4F4E-8C99-0066BDF22196</domeo:uuid>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:5C3FBF61-A16E-4DBB-B539-F88F8B7E60B7">
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:exact>debrisoquin</ao:exact>
    <ao:prefix>Approximately 7% of the normal population has a genetic code that leads to reduced levels of activity of CYP2D6. Such individuals have been referred to as "poor metabolizers" (PM) of drugs such as </ao:prefix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:5C3FBF61-A16E-4DBB-B539-F88F8B7E60B7"/>
    <ao:suffix>, dextromethorphan, and tricyclic antidepressants. While none of the drugs studied for drug interactions significantly affected the pharmacokinetics of fluvoxamine, an in vivo study of fluvoxamine single-dose pharmacokinetics in 13 PM subjects demonstrat</ao:suffix>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-9.txt.html</ao:hasSource>
    <pav:createdOn>2014-09-02 11:32:39 -0400</pav:createdOn>
    <domeo:uuid>5C3FBF61-A16E-4DBB-B539-F88F8B7E60B7</domeo:uuid>
  </rdf:Description>
  <rdf:Description rdf:nodeID="Nb391a10f8b6443949f426d7d2805e116">
    <permissions:isLocked>false</permissions:isLocked>
    <permissions:accessType>urn:domeo:access:public</permissions:accessType>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:AFC27E91-AC15-4700-A2C7-343191A7F13A">
    <ao:exact>normeperidine</ao:exact>
    <domeo:uuid>AFC27E91-AC15-4700-A2C7-343191A7F13A</domeo:uuid>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <pav:createdOn>2014-07-28 17:00:54 -0400</pav:createdOn>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:AFC27E91-AC15-4700-A2C7-343191A7F13A"/>
    <ao:prefix> and also the formation of the metabolite, </ao:prefix>
    <ao:suffix>, in healthy subjects and thus, caution should be used with concomitant administration.</ao:suffix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-164.txt.html</ao:hasSource>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:D98E97B5-BA28-4298-8921-05B56B7A1166">
    <ao:exact>oxacillin </ao:exact>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:prefix> (7.5 mg/kg q12h intravenously [iv]) in the treatment of complicated skin and skin structure infections were performed. The comparator drug was </ao:prefix>
    <ao:suffix> (2g q6h iv) in the first study (JRV 304) and cefazolin (1g q8h iv) in the second study (JRV 305); however, in both studies vancomycin (1g q12h iv) could be substituted for the specified comparator if the causative pathogen was suspected or confirmed met</ao:suffix>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:D98E97B5-BA28-4298-8921-05B56B7A1166"/>
    <domeo:uuid>D98E97B5-BA28-4298-8921-05B56B7A1166</domeo:uuid>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-119.txt.html</ao:hasSource>
    <pav:createdOn>2014-07-22 18:51:31 -0400</pav:createdOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:14E49F07-F26F-4932-B80D-AB20FFEFDB12">
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:suffix>xsd:String</ao:suffix>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-137.txt.html</ao:hasSource>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:14E49F07-F26F-4932-B80D-AB20FFEFDB12"/>
    <ao:exact>Carbamazepine induces CYP3A4. Following coadministration of carbamazepine 400 mg/day with trazodone 100 mg to 300 mg daily, carbamazepine reduced plasma concentrations of trazodone (as well as mCPP) by 76 and 60%, respectively, compared to pre-carbamazepine values.</ao:exact>
    <domeo:uuid>14E49F07-F26F-4932-B80D-AB20FFEFDB12</domeo:uuid>
    <pav:createdOn>2014-07-24 20:04:30 -0400</pav:createdOn>
    <ao:prefix>xsd:String</ao:prefix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:EB06C7B2-447E-44A6-9D7B-F5BB28ED6AB3">
    <domeo:uuid>EB06C7B2-447E-44A6-9D7B-F5BB28ED6AB3</domeo:uuid>
    <pav:createdOn>2014-07-22 19:36:30 -0400</pav:createdOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:EB06C7B2-447E-44A6-9D7B-F5BB28ED6AB3"/>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-123.txt.html</ao:hasSource>
    <ao:suffix>. Since metformin is contraindicated in patients with renal impairment, coadministration of metformin with AVANDIA is contraindicated in these patients.</ao:suffix>
    <ao:prefix> in patients with mild to severe renal impairment or in hemodialysis-dependent patients compared to subjects with normal renal function. No dosage adjustment is therefore required in such patients receiving </ao:prefix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:exact>AVANDIA</ao:exact>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:64F7664B-0B75-443E-8A3F-3A145064071E">
    <pav:createdOn>2014-07-21 21:53:36 -0400</pav:createdOn>
    <pav:lineageUri>urn:domeoserver:annotation:E18BAA97-6DC8-4523-A6ED-EC1EB1A1FA99</pav:lineageUri>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <domeo:belongsToSet>urn:domeoclient:uuid:C988D053-7CF3-4C50-BDB6-7C2B20B837B9</domeo:belongsToSet>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812eda990003</pav:createdBy>
    <rdfs:label>Highlight</rdfs:label>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <ao:context rdf:resource="urn:domeoclient:uuid:85A8E907-AEE7-43A2-A096-5391F5C529CB"/>
    <pav:lastSavedOn>2014-07-21 21:55:00 -0400</pav:lastSavedOn>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:4989A785-0867-4672-982C-3FCFF8AB4F7A">
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <domeo:uuid>4989A785-0867-4672-982C-3FCFF8AB4F7A</domeo:uuid>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:4989A785-0867-4672-982C-3FCFF8AB4F7A"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:prefix>xsd:String</ao:prefix>
    <ao:suffix> should not be taken closely in time with aluminum and magnesium containing antacids. In healthy adult subjects, administration of 120 mg of fexofenadine hydrochloride (2 × 60 mg capsule) within 15 minutes of an aluminum and magnesium containing antacid </ao:suffix>
    <ao:exact>Fexofenadine hydrochloride</ao:exact>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-139.txt.html</ao:hasSource>
    <pav:createdOn>2014-07-24 20:05:33 -0400</pav:createdOn>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:F47F11AD-A4E0-4F3C-B00C-4BAD618B41C3">
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#expertstudyAnnotation"/>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812eda990003</pav:createdBy>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <pav:lastSavedOn>2014-07-22 18:59:41 -0400</pav:lastSavedOn>
    <pav:createdOn>2014-07-22 18:59:42 -0400</pav:createdOn>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <ao:body rdf:nodeID="Nd4fdabd8780947e8a84af7d5d132c858"/>
    <pav:lineageUri>urn:domeoserver:annotation:8117623B-4BF0-4517-82B6-2304B430DF21</pav:lineageUri>
    <ao:context rdf:resource="urn:domeoclient:uuid:E8525C10-3E49-4039-8E81-69ACBAC8A16F"/>
    <domeo:belongsToSet>urn:domeoclient:uuid:F2788742-3226-4BFB-9D85-2FC7211066F7</domeo:belongsToSet>
    <rdfs:label>expertstudy Annotation</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/60257C53-72AE-476E-AFC6-21B1AA00F626">
    <rdfs:label>sildenafil</rdfs:label>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/active-ingredient"/>
    <dct:description>Referred to the drug in the interaction.</dct:description>
    <sio:SIO_000228>dikbD2R:object-drug-of-interaction</sio:SIO_000228>
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/136411</dailymed:activeMoietyRxCUI>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:724EC70E-AD36-444C-A1EB-23C9873CB536">
    <ao:context rdf:resource="urn:domeoclient:uuid:DE725ECB-6E8C-4D1C-9EE0-A969014D8035"/>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:createdOn>2014-09-02 19:09:57 -0400</pav:createdOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <rdfs:label>Highlight</rdfs:label>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812eda990003</pav:createdBy>
    <domeo:belongsToSet>urn:domeoclient:uuid:3966BCFB-CA02-4053-828D-3860558E7BE8</domeo:belongsToSet>
    <pav:lastSavedOn>2014-09-02 19:11:13 -0400</pav:lastSavedOn>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:lineageUri>urn:domeoserver:annotation:84923C44-9D21-46C3-9B14-82EC8E46C8A7</pav:lineageUri>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:48D839E5-6B0A-4EC3-B64A-E3E20E06246A">
    <ao:item rdf:resource="urn:domeoclient:uuid:C889EF0F-E8A2-4563-BA94-C8364D653756"/>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:lineageUri>urn:domeoserver:annotationset:034D46EE-44D2-4CA1-8E4F-58992C64123C</pav:lineageUri>
    <rdfs:label>Default Set</rdfs:label>
    <domeo:deleted>false</domeo:deleted>
    <pav:lastSavedOn>2014-07-28 17:08:37 -0400</pav:lastSavedOn>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <pav:createdOn>2014-07-28 17:04:15 -0400</pav:createdOn>
    <ao:item rdf:resource="urn:domeoclient:uuid:B8794C27-AB48-4247-A5DC-F99E0DB48B2D"/>
    <ao:annotatesResource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-201.txt.html</ao:annotatesResource>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812eda990003</pav:createdBy>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#AnnotationSet"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:3D0923EA-66A5-4F6E-A3E6-A3D09E9AA9FA"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:70E66A8A-36A7-4A61-AFC4-4E0A6DF9B0BC"/>
    <permissions:permissions rdf:nodeID="N92420773eb5944839f49fd7e66841af1"/>
    <domeo:agents rdf:resource="urn:person:uuid:080e143046812afe0146812eda990003"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:06A101E3-2794-4554-92A9-5297495C183D"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:2551E950-6EBC-471F-B165-F68320BB8C62"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:D6A80456-C24A-4B51-9FF1-54B2442E9245"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:4FEA5923-D748-4E87-8041-D8BE9DFF7EAA"/>
    <domeo:agents rdf:resource="urn:domeo:software:id:Domeo-2.1alpha-050"/>
    <dct:description>The default set is created automatically by Domeo when no other set is existing.</dct:description>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:EF32B76C-C252-4DA7-9AC6-7FCD32EE9F83">
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <rdfs:label>Highlight</rdfs:label>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <domeo:belongsToSet>urn:domeoserver:annotationset:F272A789-69D0-47CC-8CC9-F25C55B91261</domeo:belongsToSet>
    <pav:lastSavedOn>2014-07-22 19:40:32 -0400</pav:lastSavedOn>
    <domeo:belongsToSet>urn:domeoserver:annotationset:2914A3FD-DF43-4F78-999C-77CE7A028B19</domeo:belongsToSet>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">5</pav:versionNumber>
    <pav:lineageUri>urn:domeoserver:annotation:B254E525-F518-4064-82D8-787D381BFF25</pav:lineageUri>
    <domeo:belongsToSet>urn:domeoserver:annotationset:606A5B3F-B6FB-4279-AA42-7893CFC2D20C</domeo:belongsToSet>
    <domeo:belongsToSet>urn:domeoserver:annotationset:514BA51B-D734-4003-A7C3-F03C0F95833A</domeo:belongsToSet>
    <ao:context rdf:resource="urn:domeoclient:uuid:254E1933-56AE-4110-9A6C-715CC58538B6"/>
    <pav:lineageUri>urn:domeoserver:annotationset:AB1741F1-5A5F-4416-AEAC-A544BCBB7D16</pav:lineageUri>
    <pav:previousVersion>urn:domeoserver:annotationset:7021B883-FD5C-4083-BD87-DF56D3C87633</pav:previousVersion>
    <pav:createdOn>2014-07-22 19:38:22 -0400</pav:createdOn>
    <pav:lastSavedOn>2014-07-22 19:40:31 -0400</pav:lastSavedOn>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812eda990003</pav:createdBy>
    <pav:previousVersion>xsd:String</pav:previousVersion>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:9A057858-10CF-4E79-9283-5F1644D9BB0A">
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <rdfs:label>Highlight</rdfs:label>
    <pav:lineageUri>urn:domeoserver:annotation:3CBAF7C7-97EE-4740-8EC9-BC03D8839AB8</pav:lineageUri>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812eda990003</pav:createdBy>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <ao:context rdf:resource="urn:domeoclient:uuid:82CD11C4-7E04-4E14-81A6-7D8B8CBC98F0"/>
    <pav:lastSavedOn>2014-07-21 21:30:23 -0400</pav:lastSavedOn>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:createdOn>2014-07-21 21:28:29 -0400</pav:createdOn>
    <domeo:belongsToSet>urn:domeoclient:uuid:B394B422-1AAF-4ED4-A3BB-3FB13E961EEA</domeo:belongsToSet>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:0DEE6C6F-A6F1-480F-B422-0E55E610EAAB">
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">2</pav:versionNumber>
    <pav:lineageUri>urn:domeoserver:annotationset:D1715BD2-BD41-46FD-9454-DC7A423A29AC</pav:lineageUri>
    <pav:lastSavedOn>2014-09-02 11:46:58 -0400</pav:lastSavedOn>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812eda990003</pav:createdBy>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <domeo:belongsToSet>urn:domeoserver:annotationset:3F546823-204F-4F9B-9006-3DC526C56931</domeo:belongsToSet>
    <ao:context rdf:resource="urn:domeoclient:uuid:BFF92609-A328-4612-927E-6F35023B6FC8"/>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <rdfs:label>Highlight</rdfs:label>
    <pav:createdOn>2014-09-02 11:43:30 -0400</pav:createdOn>
    <domeo:belongsToSet>urn:domeoserver:annotationset:A5DD001D-C81A-4E2E-B5E0-7A866B35E26B</domeo:belongsToSet>
    <pav:lineageUri>urn:domeoserver:annotation:620974B5-9925-4823-BA9E-A7212DE13FA7</pav:lineageUri>
    <pav:previousVersion>urn:domeoclient:uuid:BED41F06-565A-4622-9A88-48810E5A28DE</pav:previousVersion>
    <domeo:belongsToSet>urn:domeoserver:annotationset:A3F0B39A-4249-4B63-BB0D-F24A005066AC</domeo:belongsToSet>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:1B6D964C-5C7B-4A8B-91D1-71E48BED6297">
    <domeo:belongsToSet>urn:domeoclient:uuid:EC9B90D7-F9B5-4E51-94E2-878FAA06F611</domeo:belongsToSet>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:lineageUri>urn:domeoserver:annotation:A5674909-9644-497C-B284-D55E831FC413</pav:lineageUri>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812eda990003</pav:createdBy>
    <pav:lastSavedOn>2014-07-13 12:48:45 -0400</pav:lastSavedOn>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <ao:context rdf:resource="urn:domeoclient:uuid:D16208CB-7392-415A-8487-52928A419F00"/>
    <rdfs:label>Highlight</rdfs:label>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:createdOn>2014-07-13 12:46:12 -0400</pav:createdOn>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:96E66F0D-E214-4562-BC8C-77A59132E471">
    <ao:prefix>xsd:String</ao:prefix>
    <ao:suffix>produced no genotoxic effects in a battery of 5 in vitro and 2 in vivo assays that included the following: Bacterial mutation assay, mouse lymphoma mutation assay, unscheduled DNA synthesis assay, and tests for cytogenetic aberrations in vivo in mouse bo</ao:suffix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <domeo:uuid>96E66F0D-E214-4562-BC8C-77A59132E471</domeo:uuid>
    <ao:exact>Paroxetine </ao:exact>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:96E66F0D-E214-4562-BC8C-77A59132E471"/>
    <pav:createdOn>2014-07-21 21:44:28 -0400</pav:createdOn>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-52.txt.html</ao:hasSource>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/E5F7CCC2-0F44-40A0-87D9-225E3A4EAC91">
    <dct:description>Referred to the drug in the interaction.</dct:description>
    <rdfs:label>paroxetine</rdfs:label>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/active-ingredient"/>
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/32937</dailymed:activeMoietyRxCUI>
    <sio:SIO_000228>dikbD2R:object-drug-of-interaction</sio:SIO_000228>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:77F990A5-C7A6-4873-A32F-AD9607EFDE51">
    <pav:createdOn>2014-07-13 11:10:19 -0400</pav:createdOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-8.txt.html</ao:hasSource>
    <ao:suffix> occurred at about 3 hours in extensive metabolizers, and 17 hours in poor metabolizers. Steady-state concentrations of risperidone are reached in 1 day in extensive metabolizers and would be expected to reach steady-state in about 5 days in poor metabol</ao:suffix>
    <domeo:uuid>77F990A5-C7A6-4873-A32F-AD9607EFDE51</domeo:uuid>
    <ao:exact>9-hydroxyrisperidone</ao:exact>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:prefix> occurred at about 1 hour. Peak concentrations of </ao:prefix>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:77F990A5-C7A6-4873-A32F-AD9607EFDE51"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:E89548FF-A4A2-4B87-B1E1-B12E3E255FA1">
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <ao:item rdf:resource="urn:domeoclient:uuid:962DC691-3D08-4224-8D22-C0DD8D9F24CA"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:70919722-5B5F-4E86-A52F-8A64A1EFDA72"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:B4E5EBBF-965D-41F8-B54E-0CF48653C43C"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:C1836E85-2D43-46EF-848C-F6204E5A50A7"/>
    <rdfs:label>Default Set</rdfs:label>
    <pav:lineageUri>urn:domeoserver:annotationset:66EBA4F6-77AF-4AB4-A3E8-E0D406200FF6</pav:lineageUri>
    <permissions:permissions rdf:nodeID="Nd3ada4e9318c4f7ea2045d513a051a84"/>
    <domeo:agents rdf:resource="urn:person:uuid:080e143046812afe0146812eda990003"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:AF657FF8-3529-4A9B-9294-13C604834E0A"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:11E26B74-9DE2-4B10-A8C9-A250D2747B3E"/>
    <domeo:agents rdf:resource="urn:domeo:software:id:Domeo-2.1alpha-050"/>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812eda990003</pav:createdBy>
    <pav:createdOn>2014-07-13 12:55:59 -0400</pav:createdOn>
    <pav:lastSavedOn>2014-07-13 12:56:57 -0400</pav:lastSavedOn>
    <dct:description>The default set is created automatically by Domeo when no other set is existing.</dct:description>
    <domeo:deleted>false</domeo:deleted>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#AnnotationSet"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:A5A1F4E1-991C-4D93-AC6A-4DEDDF392601"/>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <ao:annotatesResource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-24.txt.html</ao:annotatesResource>
    <ao:item rdf:resource="urn:domeoclient:uuid:35685454-E730-4B12-A923-46EE9655234C"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:C0ABFAEB-5A08-4B49-A2D0-716AA915DFF2">
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <domeo:uuid>C0ABFAEB-5A08-4B49-A2D0-716AA915DFF2</domeo:uuid>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <pav:createdOn>2014-09-02 11:36:07 -0400</pav:createdOn>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:C0ABFAEB-5A08-4B49-A2D0-716AA915DFF2"/>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-9.txt.html</ao:hasSource>
    <ao:suffix>, theophylline, certain benzodiazepines, omeprazole and phenytoin. If fluvoxamine maleate tablets are to be administered together with a drug that is eliminated via oxidative metabolism and has a narrow therapeutic window, plasma levels and/or pharmacody</ao:suffix>
    <ao:prefix>, </ao:prefix>
    <ao:exact>warfarin</ao:exact>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:D5D8B7FB-8F69-439A-B1F3-0DC084AEDE1E">
    <domeo:uuid>D5D8B7FB-8F69-439A-B1F3-0DC084AEDE1E</domeo:uuid>
    <ao:prefix>Many drugs, including most drugs effective in the treatment of major depressive disorder (</ao:prefix>
    <ao:suffix>, other SSRIs, and many tricyclics), are metabolized by the cytochrome P450 isozyme CYP2D6. Like other agents that are metabolized by CYP2D6, paroxetine may significantly inhibit the activity of this isozyme. In most patients (&gt;90%), this CYP2D6 isozyme </ao:suffix>
    <ao:exact>paroxetine</ao:exact>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:D5D8B7FB-8F69-439A-B1F3-0DC084AEDE1E"/>
    <pav:createdOn>2014-09-02 11:55:53 -0400</pav:createdOn>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-47.txt.html</ao:hasSource>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:3805F006-2423-4B51-87AB-CAE85C6B4E21">
    <domeo:belongsToSet>urn:domeoclient:uuid:71191E51-53CB-4FDE-88D0-33C6818E2232</domeo:belongsToSet>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812eda990003</pav:createdBy>
    <pav:createdOn>2014-07-13 11:10:15 -0400</pav:createdOn>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <pav:lastSavedOn>2014-07-13 11:32:29 -0400</pav:lastSavedOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <rdfs:label>Highlight</rdfs:label>
    <ao:context rdf:resource="urn:domeoclient:uuid:A95EA236-59E2-47FB-878A-81116D82930F"/>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:lineageUri>urn:domeoserver:annotation:4E13C50F-B8D6-4676-A219-AD5C04FF7CDB</pav:lineageUri>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:4515CD24-4667-47E1-80AE-FBC3F30BFD11">
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-16.txt.html</ao:hasSource>
    <domeo:uuid>4515CD24-4667-47E1-80AE-FBC3F30BFD11</domeo:uuid>
    <ao:suffix>under steady-state conditions. The results of these studies indicated that sertraline did not increase plasma concentrations of terfenadine, carbamazepine, or cisapride. These data indicate that sertraline’s extent of inhibition of P450 3A4 activity is n</ao:suffix>
    <ao:prefix>, or </ao:prefix>
    <ao:exact>cisapride </ao:exact>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:4515CD24-4667-47E1-80AE-FBC3F30BFD11"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <pav:createdOn>2014-09-01 15:57:28 -0400</pav:createdOn>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:883BB188-A483-4C32-85F5-63D2C4B33561">
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812eda990003</pav:createdBy>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <domeo:belongsToSet>urn:domeoclient:uuid:CB83FFC2-EA71-44EA-8F11-DE80E389C84E</domeo:belongsToSet>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <pav:createdOn>2014-09-02 19:18:57 -0400</pav:createdOn>
    <rdfs:label>Highlight</rdfs:label>
    <pav:lineageUri>urn:domeoserver:annotationset:C5DEBC9B-77EE-4243-88EB-DBC19737ACD2</pav:lineageUri>
    <domeo:belongsToSet>urn:domeoserver:annotationset:392EE0FB-AC4F-4AF2-87A6-2E50A281F434</domeo:belongsToSet>
    <pav:lineageUri>urn:domeoserver:annotation:0A5D3CA1-51AE-4AC7-9B93-34964A3B7D58</pav:lineageUri>
    <pav:lastSavedOn>2014-09-02 19:19:47 -0400</pav:lastSavedOn>
    <ao:context rdf:resource="urn:domeoclient:uuid:28368420-4E42-4D08-91FB-67DAADA661EC"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <domeo:belongsToSet>urn:domeoserver:annotationset:E32812A9-205B-4EE1-B488-A1E294EDBFB9</domeo:belongsToSet>
  </rdf:Description>
  <rdf:Description rdf:nodeID="N0fcd4616fad649c2bfdaa906ac45fc4d">
    <permissions:accessType>urn:domeo:access:public</permissions:accessType>
    <permissions:isLocked>false</permissions:isLocked>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:F9FE917E-CAFF-4C8B-B16B-BB0606212145">
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812eda990003</pav:createdBy>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:lineageUri>urn:domeoserver:annotationset:76FD4BB5-DE2F-4FCA-B93D-302185B1A381</pav:lineageUri>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <domeo:belongsToSet>urn:domeoserver:annotationset:131835A3-C655-4F91-97D4-52CAFF7B7CCA</domeo:belongsToSet>
    <domeo:belongsToSet>urn:domeoserver:annotationset:8F3CF3D9-AADE-4A86-BD42-2924B3D6A406</domeo:belongsToSet>
    <pav:lastSavedOn>2014-07-07 09:44:18 -0400</pav:lastSavedOn>
    <domeo:belongsToSet>urn:domeoserver:annotationset:22ED7220-C6F6-43C5-9DF9-89F62F0F8E27</domeo:belongsToSet>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <ao:context rdf:resource="urn:domeoclient:uuid:C29885C9-C34F-446F-88D0-5C6DE9D91033"/>
    <domeo:belongsToSet>urn:domeoclient:uuid:FCA2BF23-0BE3-409F-9177-761812F96097</domeo:belongsToSet>
    <rdfs:label>Highlight</rdfs:label>
    <pav:lineageUri>urn:domeoserver:annotation:B87E8C78-2AB2-4100-9E1E-BE2714EEBB4B</pav:lineageUri>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <domeo:belongsToSet>urn:domeoserver:annotationset:7AACEF8D-2EBC-4F0B-94B2-190650E562F6</domeo:belongsToSet>
    <domeo:belongsToSet>urn:domeoserver:annotationset:08C0C288-6DF4-43E6-A618-71A8BB9563C3</domeo:belongsToSet>
    <pav:lastSavedOn>2014-07-07 09:44:19 -0400</pav:lastSavedOn>
    <pav:createdOn>2014-07-07 09:43:59 -0400</pav:createdOn>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:4C7B2841-F48B-46C2-A7DF-E954EDF0385C">
    <ao:exact>Glimepiride\n\nSingle oral doses of glimepiride in 14 healthy adult subjects had no clinically significant effect on the steady-state pharmacokinetics of AVANDIA. No clinically significant reductions in glimepiride AUC and Cmax were observed after repeat doses of AVANDIA (8 mg once daily) for 8 days in healthy adult subjects</ao:exact>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-123.txt.html</ao:hasSource>
    <domeo:uuid>4C7B2841-F48B-46C2-A7DF-E954EDF0385C</domeo:uuid>
    <ao:suffix>xsd:String</ao:suffix>
    <pav:createdOn>2014-07-22 19:54:59 -0400</pav:createdOn>
    <ao:prefix>xsd:String</ao:prefix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:4C7B2841-F48B-46C2-A7DF-E954EDF0385C"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:3778184B-7478-42AC-8128-7363E5970F00">
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <domeo:uuid>3778184B-7478-42AC-8128-7363E5970F00</domeo:uuid>
    <pav:createdOn>2014-07-22 19:42:20 -0400</pav:createdOn>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:3778184B-7478-42AC-8128-7363E5970F00"/>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-123.txt.html</ao:hasSource>
    <ao:exact>rosiglitazone</ao:exact>
    <ao:suffix> may be needed when </ao:suffix>
    <ao:prefix> (4 mg once daily) alone. Given the potential for dose-related adverse events with rosiglitazone, a decrease in the dose of </ao:prefix>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/558D6A02-4F09-4F64-900B-5C61E2E8EC45">
    <sio:SIO_000228>dikbD2R:object-drug-of-interaction</sio:SIO_000228>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/active-ingredient"/>
    <rdfs:label>rosiglitazone</rdfs:label>
    <dct:description>Referred to the drug in the interaction.</dct:description>
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/84108</dailymed:activeMoietyRxCUI>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:465EEACA-9FFE-4F82-9410-36A29C720187">
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <pav:createdOn>2014-09-02 11:45:38 -0400</pav:createdOn>
    <ao:prefix>If </ao:prefix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:suffix> or metoprolol is coadministered with fluvoxamine maleate tablets, a reduction in the initial beta-blocker dose and more cautious dose titration are recommended. No dosage adjustment is required for fluvoxamine maleate tablets.</ao:suffix>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:465EEACA-9FFE-4F82-9410-36A29C720187"/>
    <domeo:uuid>465EEACA-9FFE-4F82-9410-36A29C720187</domeo:uuid>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-9.txt.html</ao:hasSource>
    <ao:exact>propranolol</ao:exact>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:FA7A671D-A8CF-4ED4-9A82-73178DBED757">
    <pav:createdOn>2014-09-01 16:06:00 -0400</pav:createdOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:suffix>did not increase plasma concentrations of terfenadine, carbamazepine, or cisapride. These data indicate that sertraline’s extent of inhibition of P450 3A4 activity is not likely to be of clinical significance. Results of the interaction study with cisapr</ao:suffix>
    <ao:prefix>under steady-state conditions. The results of these studies indicated that </ao:prefix>
    <domeo:uuid>FA7A671D-A8CF-4ED4-9A82-73178DBED757</domeo:uuid>
    <ao:exact>sertraline </ao:exact>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-16.txt.html</ao:hasSource>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:FA7A671D-A8CF-4ED4-9A82-73178DBED757"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoserver:annotationset:2B18F6B1-59F7-4EA0-9386-55A934108055">
    <ao:item rdf:resource="urn:domeoclient:uuid:2FC7CD9D-9CBA-4723-8996-9E721AB52D4A"/>
    <domeo:agents rdf:resource="urn:domeo:software:id:Domeo-2.1alpha-050"/>
    <permissions:permissions rdf:nodeID="Nff3a983272534733a7f39d693c6021a9"/>
    <pav:previousVersion>urn:domeoclient:uuid:0819E6B8-B8E8-4EB2-9248-CA54623D1BB2</pav:previousVersion>
    <ao:item rdf:resource="urn:domeoclient:uuid:525D9A2A-57D7-4B82-AAC2-92BA3D298032"/>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812eda990003</pav:createdBy>
    <pav:createdOn>2014-07-22 19:06:46 -0400</pav:createdOn>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">2</pav:versionNumber>
    <ao:item rdf:resource="urn:domeoclient:uuid:E5B69523-748D-4576-8C13-43546FFB2F5E"/>
    <rdfs:label>Default Set</rdfs:label>
    <pav:lineageUri>urn:domeoserver:annotationset:32C325B9-09DD-4A0B-A270-BAA0C42956A1</pav:lineageUri>
    <domeo:deleted>false</domeo:deleted>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#AnnotationSet"/>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <ao:annotatesResource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-122.txt.html</ao:annotatesResource>
    <dct:description>The default set is created automatically by Domeo when no other set is existing.</dct:description>
    <pav:lastSavedOn>2014-07-22 19:08:05 -0400</pav:lastSavedOn>
    <ao:item rdf:resource="urn:domeoclient:uuid:605A1706-1C67-4FBD-9A42-21DF312E4339"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:ACA8DFD4-1166-4984-97D0-E4E251EA94F3"/>
    <domeo:agents rdf:resource="urn:person:uuid:080e143046812afe0146812eda990003"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:CF873305-5222-4D37-9C71-925D3C390B7A">
    <domeo:uuid>CF873305-5222-4D37-9C71-925D3C390B7A</domeo:uuid>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-8.txt.html</ao:hasSource>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:CF873305-5222-4D37-9C71-925D3C390B7A"/>
    <ao:suffix>, and </ao:suffix>
    <ao:prefix>, its major metabolite, 9-</ao:prefix>
    <pav:createdOn>2014-07-13 11:09:51 -0400</pav:createdOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:exact>hydroxyrisperidone</ao:exact>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:9AF0B949-C133-4703-9F65-362D4B5B4494">
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:lineageUri>urn:domeoserver:annotation:C0DB2807-8137-4A89-A166-930A58544F71</pav:lineageUri>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <domeo:belongsToSet>urn:domeoclient:uuid:71191E51-53CB-4FDE-88D0-33C6818E2232</domeo:belongsToSet>
    <pav:lastSavedOn>2014-07-13 11:32:29 -0400</pav:lastSavedOn>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <ao:context rdf:resource="urn:domeoclient:uuid:6887274E-F614-42FD-904F-B7E202949297"/>
    <pav:createdOn>2014-07-13 11:11:10 -0400</pav:createdOn>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812eda990003</pav:createdBy>
    <rdfs:label>Highlight</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:B6E0548D-97C5-4C24-A078-F69D2D16D9FE">
    <ao:prefix>xsd:String</ao:prefix>
    <pav:createdOn>2014-07-21 21:54:13 -0400</pav:createdOn>
    <ao:suffix>xsd:String</ao:suffix>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-56.txt.html</ao:hasSource>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:exact>Zonisamide had no appreciable effect on the steady-state plasma concentrations of phenytoin, carbamazepine, or valproate during clinical trials. Zonisamide did not inhibit mixed-function liver oxidase enzymes (cytochrome P450), as measured in human liver microsomal preparations, in vitro. Zonisamide is not expected to interfere with the metabolism of other drugs that are metabolized by cytochrome P450 isozymes.</ao:exact>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <domeo:uuid>B6E0548D-97C5-4C24-A078-F69D2D16D9FE</domeo:uuid>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:B6E0548D-97C5-4C24-A078-F69D2D16D9FE"/>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/5E9DF383-ABD6-4F64-BB57-8EF69FDE4C64">
    <rdfs:label>ketoconazole</rdfs:label>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/active-ingredient"/>
    <dct:description>Referred to the drug in the interaction.</dct:description>
    <sio:SIO_000228>dikbD2R:precipitant-drug-of-interaction</sio:SIO_000228>
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/6135</dailymed:activeMoietyRxCUI>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:C36C5E7A-30AD-4497-9348-913F96DD443E">
    <pav:lineageUri>urn:domeoserver:annotationset:092451F5-B0C0-430C-8896-07F81D33F9E1</pav:lineageUri>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812eda990003</pav:createdBy>
    <pav:createdOn>2014-07-21 21:31:17 -0400</pav:createdOn>
    <domeo:belongsToSet>urn:domeoserver:annotationset:40007BD9-0869-48CF-A8F2-BAD26AE3E6E1</domeo:belongsToSet>
    <pav:lastSavedOn>2014-07-21 21:31:54 -0400</pav:lastSavedOn>
    <ao:context rdf:resource="urn:domeoclient:uuid:F41B0D87-B434-42EF-90F7-E87825A6741D"/>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:lineageUri>urn:domeoserver:annotation:E219770E-35B6-4564-8781-1C5F77703F11</pav:lineageUri>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <domeo:belongsToSet>urn:domeoclient:uuid:5B3EE83F-83C7-4BA8-A892-C032BE699CFA</domeo:belongsToSet>
    <rdfs:label>Highlight</rdfs:label>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:C9195181-C772-4ED4-ADD8-56970C72AD38">
    <domeo:deleted>false</domeo:deleted>
    <pav:lastSavedOn>2014-09-02 19:40:44 -0400</pav:lastSavedOn>
    <pav:createdOn>2014-09-02 19:40:30 -0400</pav:createdOn>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <ao:item rdf:resource="urn:domeoclient:uuid:BD57075E-3889-44CB-8FF4-EC5663C33AC0"/>
    <dct:description>The default set is created automatically by Domeo when no other set is existing.</dct:description>
    <domeo:agents rdf:resource="urn:domeo:software:id:Domeo-2.1alpha-050"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#AnnotationSet"/>
    <rdfs:label>Default Set</rdfs:label>
    <ao:annotatesResource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-116.txt.html</ao:annotatesResource>
    <pav:lineageUri>urn:domeoserver:annotationset:0B03E269-DEFB-43D7-8E21-1473D883F9E1</pav:lineageUri>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812eda990003</pav:createdBy>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <ao:item rdf:resource="urn:domeoclient:uuid:4BDD5E48-B9CE-48CF-BD41-105B25B3F7D2"/>
    <permissions:permissions rdf:nodeID="N4e5d7e81389f4f418aae49bd889e8a92"/>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <domeo:agents rdf:resource="urn:person:uuid:080e143046812afe0146812eda990003"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:EAE26632-A8D8-4E80-ADE1-8902853460F6">
    <ao:suffix>xsd:String</ao:suffix>
    <domeo:uuid></domeo:uuid>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <domeo:uuid>EAE26632-A8D8-4E80-ADE1-8902853460F6</domeo:uuid>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:exact>TID </ao:exact>
    <pav:createdOn>2014-07-07 09:39:26 -0400</pav:createdOn>
    <ao:prefix>After chronic dosing of 80 mg </ao:prefix>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:EAE26632-A8D8-4E80-ADE1-8902853460F6"/>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-155.txt.html</ao:hasSource>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:6981279A-8AEC-4DEB-BDFB-296A4FDF471C">
    <pav:lastSavedOn>2014-07-22 19:40:32 -0400</pav:lastSavedOn>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <domeo:belongsToSet>urn:domeoserver:annotationset:514BA51B-D734-4003-A7C3-F03C0F95833A</domeo:belongsToSet>
    <domeo:belongsToSet>urn:domeoserver:annotationset:2914A3FD-DF43-4F78-999C-77CE7A028B19</domeo:belongsToSet>
    <rdfs:label>Highlight</rdfs:label>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:lineageUri>urn:domeoserver:annotation:0D416627-F21F-4C5D-A4E6-EB6DAE0DC720</pav:lineageUri>
    <pav:lineageUri>urn:domeoserver:annotationset:AB1741F1-5A5F-4416-AEAC-A544BCBB7D16</pav:lineageUri>
    <domeo:belongsToSet>urn:domeoserver:annotationset:F272A789-69D0-47CC-8CC9-F25C55B91261</domeo:belongsToSet>
    <domeo:belongsToSet>urn:domeoserver:annotationset:606A5B3F-B6FB-4279-AA42-7893CFC2D20C</domeo:belongsToSet>
    <ao:context rdf:resource="urn:domeoclient:uuid:954496DB-A54A-496F-92B2-F690C8B1E299"/>
    <pav:lastSavedOn>2014-07-22 19:40:31 -0400</pav:lastSavedOn>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">5</pav:versionNumber>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812eda990003</pav:createdBy>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:createdOn>2014-07-22 19:38:52 -0400</pav:createdOn>
    <pav:previousVersion>urn:domeoserver:annotationset:7021B883-FD5C-4083-BD87-DF56D3C87633</pav:previousVersion>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:A838F94E-4F5C-413B-9E9E-051199F7FC9F">
    <ao:exact>carbamazepine</ao:exact>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <pav:createdOn>2014-07-21 21:52:27 -0400</pav:createdOn>
    <ao:prefix>, </ao:prefix>
    <ao:suffix>, or valproate during clinical trials. Zonisamide did not inhibit mixed-function liver oxidase enzymes (cytochrome P450), as measured in human liver microsomal preparations, in vitro. Zonisamide is not expected to interfere with the metabolism of other d</ao:suffix>
    <domeo:uuid>A838F94E-4F5C-413B-9E9E-051199F7FC9F</domeo:uuid>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-56.txt.html</ao:hasSource>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:A838F94E-4F5C-413B-9E9E-051199F7FC9F"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:8ED4F58C-10A8-4F3A-8776-FD6D08A25610">
    <ao:suffix> is 90%, and that of its major metabolite, 9-hydroxyrisperidone, is 77%. Neither risperidone nor 9-hydroxyrisperidone displaces each other from plasma binding sites. High therapeutic concentrations of sulfamethazine (100 mcg/mL), warfarin (10 mcg/mL), an</ao:suffix>
    <pav:createdOn>2014-07-13 11:11:00 -0400</pav:createdOn>
    <ao:prefix> and α1-acid glycoprotein. The plasma protein binding of </ao:prefix>
    <domeo:uuid>8ED4F58C-10A8-4F3A-8776-FD6D08A25610</domeo:uuid>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:exact>risperidone</ao:exact>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:8ED4F58C-10A8-4F3A-8776-FD6D08A25610"/>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-8.txt.html</ao:hasSource>
  </rdf:Description>
  <rdf:Description rdf:nodeID="N9395dc1455f943798fdcef107cb3fea6">
    <domeo:sets rdf:resource="urn:pddi:uuid:9074A799-2AB0-4D0E-81F8-6BBEA5AAB884"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:A2B398FC-383E-4A71-A215-EA4AD0E5C9DA">
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-74.txt.html</ao:hasSource>
    <ao:prefix>Although in normal subjects no interaction with </ao:prefix>
    <ao:suffix> or propranolol was found, there have been clinical reports of interaction with other drugs metabolized via the cytochrome P450 system (e.g., cyclosporine, disulfiram, benzodiazepines). Patients should be monitored to determine if it is necessary to adju</ao:suffix>
    <pav:createdOn>2014-09-02 19:13:05 -0400</pav:createdOn>
    <ao:exact>theophylline</ao:exact>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:A2B398FC-383E-4A71-A215-EA4AD0E5C9DA"/>
    <domeo:uuid>A2B398FC-383E-4A71-A215-EA4AD0E5C9DA</domeo:uuid>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:18E928D8-1D25-4E2F-BBD0-E7B1E4E45799">
    <rdfs:label>Highlight</rdfs:label>
    <pav:lineageUri>urn:domeoserver:annotation:44433A89-79F3-4B05-802D-4636E2FBCB70</pav:lineageUri>
    <pav:lastSavedOn>2014-09-02 19:11:13 -0400</pav:lastSavedOn>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:createdOn>2014-09-02 19:10:00 -0400</pav:createdOn>
    <domeo:belongsToSet>urn:domeoclient:uuid:3966BCFB-CA02-4053-828D-3860558E7BE8</domeo:belongsToSet>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <ao:context rdf:resource="urn:domeoclient:uuid:808DC7C6-B4BD-432C-A6A2-0F47B3206319"/>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812eda990003</pav:createdBy>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:6A67B256-CA48-48CA-B584-DB13E0D52B58">
    <pav:lineageUri>urn:domeoserver:annotation:DDD5170B-BD72-4902-BBC4-DBDD4CE44BB5</pav:lineageUri>
    <pav:createdOn>2014-07-22 19:37:28 -0400</pav:createdOn>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812eda990003</pav:createdBy>
    <pav:previousVersion>urn:domeoserver:annotationset:7021B883-FD5C-4083-BD87-DF56D3C87633</pav:previousVersion>
    <pav:lastSavedOn>2014-07-22 19:40:32 -0400</pav:lastSavedOn>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <domeo:belongsToSet>urn:domeoserver:annotationset:606A5B3F-B6FB-4279-AA42-7893CFC2D20C</domeo:belongsToSet>
    <pav:lineageUri>urn:domeoserver:annotationset:AB1741F1-5A5F-4416-AEAC-A544BCBB7D16</pav:lineageUri>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <rdfs:label>Highlight</rdfs:label>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <domeo:belongsToSet>urn:domeoserver:annotationset:2914A3FD-DF43-4F78-999C-77CE7A028B19</domeo:belongsToSet>
    <domeo:belongsToSet>urn:domeoserver:annotationset:514BA51B-D734-4003-A7C3-F03C0F95833A</domeo:belongsToSet>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <ao:context rdf:resource="urn:domeoclient:uuid:C3E38D47-25A8-4196-B6ED-8D47D85B5D94"/>
    <pav:lastSavedOn>2014-07-22 19:40:31 -0400</pav:lastSavedOn>
    <domeo:belongsToSet>urn:domeoserver:annotationset:F272A789-69D0-47CC-8CC9-F25C55B91261</domeo:belongsToSet>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">5</pav:versionNumber>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:7D867112-B5D9-4FEA-A8A5-D8FC72239EAE">
    <ao:prefix> dosing. In 1 study, daily dosing of immediate-release </ao:prefix>
    <pav:createdOn>2014-09-02 11:57:13 -0400</pav:createdOn>
    <ao:suffix>  (20 mg once daily) under steady-state conditions increased single-dose desipramine (100 mg) Cmax, AUC, and T½ by an average of approximately 2-, 5-, and 3-fold, respectively. Concomitant use of paroxetine with risperidone, a CYP2D6 substrate has also b</ao:suffix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:exact>paroxetine</ao:exact>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:7D867112-B5D9-4FEA-A8A5-D8FC72239EAE"/>
    <domeo:uuid>7D867112-B5D9-4FEA-A8A5-D8FC72239EAE</domeo:uuid>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-47.txt.html</ao:hasSource>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:EC569F9C-8D7B-414A-9059-EDFAE9A86040">
    <domeo:uuid>EC569F9C-8D7B-414A-9059-EDFAE9A86040</domeo:uuid>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:suffix> is a peripheral arterial vasodilator which acts directly on vascular smooth muscle. The binding of nifedipine to voltage-dependent and possibly receptor-operated channels in vascular smooth muscle results in an inhibition of calcium influx through these</ao:suffix>
    <pav:createdOn>2014-09-02 19:46:24 -0400</pav:createdOn>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-117.txt.html</ao:hasSource>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:EC569F9C-8D7B-414A-9059-EDFAE9A86040"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:exact>Nifedipine</ao:exact>
    <ao:prefix>xsd:String</ao:prefix>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:CFD62BB2-11C8-4215-B304-C5A0146A8A66">
    <ao:exact>Synercid</ao:exact>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <pav:createdOn>2014-07-22 18:52:22 -0400</pav:createdOn>
    <ao:prefix>substituted for the specified comparator if the causative pathogen was suspected or confirmed methicillin-resistant staphylococcus or if the patient was allergic to penicillins, cephalosporins or carbapenems. Study JRV 304 enrolled 450 patients (n = 229 </ao:prefix>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:CFD62BB2-11C8-4215-B304-C5A0146A8A66"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:suffix>; n= 221 Comparator) and Study JRV 305 enrolled 443 patients (n = 221 </ao:suffix>
    <domeo:uuid>CFD62BB2-11C8-4215-B304-C5A0146A8A66</domeo:uuid>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-119.txt.html</ao:hasSource>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:60F0E01C-50AF-48FD-82F1-C840D5A8FDDD">
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-48.txt.html</ao:hasSource>
    <domeo:uuid>60F0E01C-50AF-48FD-82F1-C840D5A8FDDD</domeo:uuid>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:60F0E01C-50AF-48FD-82F1-C840D5A8FDDD"/>
    <ao:prefix>, a substrate for  CYP3A4, revealed no effect of </ao:prefix>
    <ao:suffix> on terfenadine pharmacokinetics. In addition, in vitro studies have shown ketoconazole, a potent inhibitor of CYP3A4 activity, to be at least 100 times more potent than paroxetine as an inhibitor of the metabolism of several substrates for this enzyme, </ao:suffix>
    <ao:exact>paroxetine</ao:exact>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <pav:createdOn>2014-09-02 15:04:06 -0400</pav:createdOn>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:C5594C9A-8B88-4CF6-B5AA-3F081580D92D">
    <ao:context rdf:resource="urn:domeoclient:uuid:8543469A-E725-45C1-A0A3-93FAB55D1DD5"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:createdOn>2014-07-13 11:13:40 -0400</pav:createdOn>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <rdfs:label>Highlight</rdfs:label>
    <pav:lastSavedOn>2014-07-13 11:32:29 -0400</pav:lastSavedOn>
    <pav:lineageUri>urn:domeoserver:annotation:3F11C6A1-A35B-4B78-8E4B-F4E54C9EB08B</pav:lineageUri>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812eda990003</pav:createdBy>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <domeo:belongsToSet>urn:domeoclient:uuid:71191E51-53CB-4FDE-88D0-33C6818E2232</domeo:belongsToSet>
    <pav:previousVersion>xsd:String</pav:previousVersion>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/07C054FB-6445-437D-B6D9-477EF937289F">
    <rdfs:label>erythromycin</rdfs:label>
    <dct:description>Referred to the drug in the interaction.</dct:description>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/active-ingredient"/>
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/4053</dailymed:activeMoietyRxCUI>
    <sio:SIO_000228>dikbD2R:precipitant-drug-of-interaction</sio:SIO_000228>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:CEF578D1-19C2-4C11-9689-C713DB6D19A6">
    <pav:lastSavedOn>2014-07-24 19:44:56 -0400</pav:lastSavedOn>
    <ao:body rdf:nodeID="N58e27bae606b403e88e9a3d990f41269"/>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <domeo:belongsToSet>urn:domeoclient:uuid:511EDFA9-5A42-4340-9D4A-CBF6EDD9185C</domeo:belongsToSet>
    <pav:lineageUri>urn:domeoserver:annotation:F859E2F6-DC05-424F-ACDA-CB07A73C778A</pav:lineageUri>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812eda990003</pav:createdBy>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#expertstudyAnnotation"/>
    <pav:createdOn>2014-07-24 19:45:14 -0400</pav:createdOn>
    <ao:context rdf:resource="urn:domeoclient:uuid:BAF53035-A41C-4F81-96B6-41B0D9633025"/>
    <rdfs:label>expertstudy Annotation</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:ABD16F80-DE85-4E62-8A97-6477F60FC07D">
    <domeo:uuid>ABD16F80-DE85-4E62-8A97-6477F60FC07D</domeo:uuid>
    <ao:exact>fluvoxamine</ao:exact>
    <ao:suffix> inhibits several cytochrome P450 isoenzymes that are known to be involved in the metabolism of other drugs such as: CYP1A2 (e.g., warfarin, theophylline, propranolol, tizanidine), CYP2C9 (e.g., warfarin), CYP3A4 (e.g., alprazolam), and CYP2C19 (e.g., om</ao:suffix>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-9.txt.html</ao:hasSource>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:ABD16F80-DE85-4E62-8A97-6477F60FC07D"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <pav:createdOn>2014-09-02 11:30:22 -0400</pav:createdOn>
    <ao:prefix> with certain of these drugs (see later parts of this section and also WARNINGS AND PRECAUTIONS [5]) and limited in vitro data for CYP3A4, it appears that </ao:prefix>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:58BF67B8-BDBC-4A81-816F-832DAD1FC0F8">
    <ao:prefix>had no appreciable effect on the steady-state plasma concentrations of </ao:prefix>
    <ao:suffix>, carbamazepine, or valproate during clinical trials. Zonisamide did not inhibit mixed-function liver oxidase enzymes (cytochrome P450), as measured in human liver microsomal preparations, in vitro. Zonisamide is not expected to interfere with the metabo</ao:suffix>
    <pav:createdOn>2014-07-21 21:52:26 -0400</pav:createdOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-56.txt.html</ao:hasSource>
    <ao:exact>phenytoin</ao:exact>
    <domeo:uuid>58BF67B8-BDBC-4A81-816F-832DAD1FC0F8</domeo:uuid>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:58BF67B8-BDBC-4A81-816F-832DAD1FC0F8"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:7EA46EFB-1A94-409D-B432-24203EA5400F">
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812eda990003</pav:createdBy>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <domeo:belongsToSet>urn:domeoclient:uuid:4F872953-6D19-4809-9285-FCCF2FF54315</domeo:belongsToSet>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:lineageUri>urn:domeoserver:annotation:0DE5D981-90C9-4EFB-8436-D8AEB6978507</pav:lineageUri>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <ao:context rdf:resource="urn:domeoclient:uuid:8A7AE105-ADC2-416B-AD5B-0B0B1DB2A2E2"/>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <pav:createdOn>2014-07-13 12:38:56 -0400</pav:createdOn>
    <rdfs:label>Highlight</rdfs:label>
    <pav:lastSavedOn>2014-07-13 12:41:10 -0400</pav:lastSavedOn>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:464DEB11-7E78-4A1A-BC27-EFBA56EDF6A6">
    <ao:suffix> to voltage-dependent and possibly receptor-operated channels in vascular smooth muscle results in an inhibition of calcium influx through these channels. Stores of intracellular calcium in vascular smooth muscle are limited and thus dependent upon the i</ao:suffix>
    <pav:createdOn>2014-09-02 19:46:36 -0400</pav:createdOn>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-117.txt.html</ao:hasSource>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:464DEB11-7E78-4A1A-BC27-EFBA56EDF6A6"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:prefix> is a peripheral arterial vasodilator which acts directly on vascular smooth muscle. The binding of </ao:prefix>
    <domeo:uuid>464DEB11-7E78-4A1A-BC27-EFBA56EDF6A6</domeo:uuid>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:exact>nifedipine</ao:exact>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:CFAD9029-E218-4465-9975-0A69DA967891">
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:CFAD9029-E218-4465-9975-0A69DA967891"/>
    <ao:prefix>After chronic dosing of 80 mg </ao:prefix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-155.txt.html</ao:hasSource>
    <pav:createdOn>2014-07-07 09:40:13 -0400</pav:createdOn>
    <domeo:uuid></domeo:uuid>
    <ao:suffix>sildenafil to patients with systemic hypertension, the mean change from baseline in systolic and diastolic blood pressures was a decrease of 9.4 mmHg and 9.1 mmHg, respectively.</ao:suffix>
    <domeo:uuid>CFAD9029-E218-4465-9975-0A69DA967891</domeo:uuid>
    <ao:exact>TID </ao:exact>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/D17A3686-1703-468A-9054-837449C245F1">
    <rdfs:label>cimetidine</rdfs:label>
    <sio:SIO_000228>dikbD2R:precipitant-drug-of-interaction</sio:SIO_000228>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/active-ingredient"/>
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/2541</dailymed:activeMoietyRxCUI>
    <dct:description>Referred to the drug in the interaction.</dct:description>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:985C3233-0D87-48CA-9DDA-A1D83B9FCA6D">
    <pav:createdOn>2014-09-02 15:03:58 -0400</pav:createdOn>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:985C3233-0D87-48CA-9DDA-A1D83B9FCA6D"/>
    <domeo:uuid>985C3233-0D87-48CA-9DDA-A1D83B9FCA6D</domeo:uuid>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:suffix> and terfenadine, a substrate for  CYP3A4, revealed no effect of paroxetine on terfenadine pharmacokinetics. In addition, in vitro studies have shown ketoconazole, a potent inhibitor of CYP3A4 activity, to be at least 100 times more potent than paroxetin</ao:suffix>
    <ao:prefix>An in vivo interaction study involving the coadministration under steady-state conditions of </ao:prefix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-48.txt.html</ao:hasSource>
    <ao:exact>paroxetine</ao:exact>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/830A06B9-325D-4AF2-8757-EF2CC57EB2F9">
    <sio:SIO_000228>dikbD2R:object-drug-of-interaction</sio:SIO_000228>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/active-ingredient"/>
    <rdfs:label>desipramine</rdfs:label>
    <dct:description>Referred to the drug in the interaction.</dct:description>
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/3247</dailymed:activeMoietyRxCUI>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:38A85164-B87B-441D-87CB-0E3B5B67551D">
    <ao:exact>phenytoin</ao:exact>
    <ao:suffix>. If fluvoxamine maleate tablets are to be administered together with a drug that is eliminated via oxidative metabolism and has a narrow therapeutic window, plasma levels and/or pharmacodynamic effects of the latter drug should be monitored closely, at </ao:suffix>
    <domeo:uuid>38A85164-B87B-441D-87CB-0E3B5B67551D</domeo:uuid>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-9.txt.html</ao:hasSource>
    <ao:prefix> and </ao:prefix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <pav:createdOn>2014-09-02 11:36:19 -0400</pav:createdOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:38A85164-B87B-441D-87CB-0E3B5B67551D"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:F0BD5D38-FA1E-4B14-9F0A-76765ADF5FEE">
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812eda990003</pav:createdBy>
    <pav:createdOn>2014-07-21 21:42:10 -0400</pav:createdOn>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <rdfs:label>Highlight</rdfs:label>
    <pav:lineageUri>urn:domeoserver:annotation:C02BB3CE-597B-4042-8BE4-2FEACC94E100</pav:lineageUri>
    <ao:context rdf:resource="urn:domeoclient:uuid:D09BF05F-7BD7-4E57-A285-8CF1F5BA4395"/>
    <pav:lastSavedOn>2014-07-21 21:42:43 -0400</pav:lastSavedOn>
    <domeo:belongsToSet>urn:domeoclient:uuid:BD4B7475-BD13-46C4-932F-139564A0063D</domeo:belongsToSet>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:73B577C5-182A-4914-B557-9A6594045898">
    <rdfs:label>Highlight</rdfs:label>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:lineageUri>urn:domeoserver:annotation:85C9C895-421F-49CC-9306-FD55486F21E9</pav:lineageUri>
    <pav:createdOn>2014-07-22 19:55:24 -0400</pav:createdOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812eda990003</pav:createdBy>
    <pav:lastSavedOn>2014-07-22 20:22:38 -0400</pav:lastSavedOn>
    <domeo:belongsToSet>urn:domeoserver:annotationset:F272A789-69D0-47CC-8CC9-F25C55B91261</domeo:belongsToSet>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <ao:context rdf:resource="urn:domeoclient:uuid:28F8F8B3-4AAE-49BF-945F-3B91F3DE3958"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:3D2E5F5D-2D44-4EC9-93CD-D558EE6CAD75">
    <domeo:uuid></domeo:uuid>
    <ao:prefix>xsd:String</ao:prefix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:exact>sildenafil </ao:exact>
    <ao:suffix>to patients with pulmonary arterial hypertension, lesser reductions than above in systolic and diastolic blood pressures were observed (a decrease in both of 2 mmHg).</ao:suffix>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:3D2E5F5D-2D44-4EC9-93CD-D558EE6CAD75"/>
    <domeo:uuid>3D2E5F5D-2D44-4EC9-93CD-D558EE6CAD75</domeo:uuid>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-155.txt.html</ao:hasSource>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <pav:createdOn>2014-07-07 09:40:26 -0400</pav:createdOn>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:49838230-189C-4414-9619-31B8A0459B9E">
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <pav:createdOn>2014-07-24 20:08:15 -0400</pav:createdOn>
    <domeo:uuid>49838230-189C-4414-9619-31B8A0459B9E</domeo:uuid>
    <ao:exact>erythromycin</ao:exact>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-139.txt.html</ao:hasSource>
    <ao:prefix> alone or in combination with either </ao:prefix>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:49838230-189C-4414-9619-31B8A0459B9E"/>
    <ao:suffix> or ketoconazole. The findings of these studies are summarized in the following table:</ao:suffix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/3C01338E-7E0D-4BD8-B48B-5D14379A445C">
    <dct:description>Referred to the drug in the interaction.</dct:description>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/active-ingredient"/>
    <rdfs:label>propranolol</rdfs:label>
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/8787</dailymed:activeMoietyRxCUI>
    <sio:SIO_000228>dikbD2R:precipitant-drug-of-interaction</sio:SIO_000228>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/ED3BCC98-B0FE-4421-B54B-7B2414CF4328">
    <sio:SIO_000228>dikbD2R:precipitant-drug-of-interaction</sio:SIO_000228>
    <rdfs:label>norethindrone</rdfs:label>
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/7514</dailymed:activeMoietyRxCUI>
    <dct:description>Referred to the drug in the interaction.</dct:description>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/active-ingredient"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:1F12731E-6D41-4E27-83E3-C87822424FCA">
    <domeo:belongsToSet>urn:domeoserver:annotationset:08C0C288-6DF4-43E6-A618-71A8BB9563C3</domeo:belongsToSet>
    <pav:lastSavedOn>2014-07-07 10:02:41 -0400</pav:lastSavedOn>
    <rdfs:label>Highlight</rdfs:label>
    <domeo:belongsToSet>urn:domeoserver:annotationset:7AACEF8D-2EBC-4F0B-94B2-190650E562F6</domeo:belongsToSet>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:lineageUri>urn:domeoserver:annotation:35639159-ED9C-4B53-8BA3-5D1C355CF374</pav:lineageUri>
    <pav:createdOn>2014-07-07 09:59:05 -0400</pav:createdOn>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <domeo:belongsToSet>urn:domeoserver:annotationset:8F3CF3D9-AADE-4A86-BD42-2924B3D6A406</domeo:belongsToSet>
    <domeo:belongsToSet>urn:domeoserver:annotationset:131835A3-C655-4F91-97D4-52CAFF7B7CCA</domeo:belongsToSet>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812eda990003</pav:createdBy>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <domeo:belongsToSet>urn:domeoserver:annotationset:22ED7220-C6F6-43C5-9DF9-89F62F0F8E27</domeo:belongsToSet>
    <ao:context rdf:resource="urn:domeoclient:uuid:F14E8BB4-85EC-49A7-B9E5-8976B448D19D"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:098AA784-6695-4935-9450-C87D502EDBCD">
    <ao:prefix>was co-administered with </ao:prefix>
    <ao:suffix>, a CYP3A inhibitor, at steady state (500 mg BID for 5 days), there was a 182% increase in sildenafil systemic exposure (AUC).</ao:suffix>
    <pav:createdOn>2014-07-07 11:23:07 -0400</pav:createdOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <domeo:uuid>098AA784-6695-4935-9450-C87D502EDBCD</domeo:uuid>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:098AA784-6695-4935-9450-C87D502EDBCD"/>
    <domeo:uuid></domeo:uuid>
    <ao:exact>erythromycin</ao:exact>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-155.txt.html</ao:hasSource>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:AAC67B06-289C-4EF8-9E7D-46A9BC438F20">
    <domeo:uuid>AAC67B06-289C-4EF8-9E7D-46A9BC438F20</domeo:uuid>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:AAC67B06-289C-4EF8-9E7D-46A9BC438F20"/>
    <pav:createdOn>2014-07-21 21:47:27 -0400</pav:createdOn>
    <ao:exact>quinidine </ao:exact>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-54.txt.html</ao:hasSource>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:prefix>, but </ao:prefix>
    <ao:suffix>does not alter the kinetics of diltiazem.</ao:suffix>
  </rdf:Description>
  <rdf:Description rdf:nodeID="N191340f154f546248363868794a22928">
    <permissions:isLocked>false</permissions:isLocked>
    <permissions:accessType>urn:domeo:access:public</permissions:accessType>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:DE4A37C3-330E-406A-8B07-E596729011D4">
    <pav:lineageUri>urn:domeoserver:annotation:8631DCC5-B27D-47B4-B621-CA41E8FF2E7A</pav:lineageUri>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812eda990003</pav:createdBy>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:createdOn>2014-07-13 12:46:33 -0400</pav:createdOn>
    <ao:context rdf:resource="urn:domeoclient:uuid:ECB23C3B-E835-480F-B541-EB5CBBAB2855"/>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <rdfs:label>Highlight</rdfs:label>
    <pav:lastSavedOn>2014-07-13 12:48:45 -0400</pav:lastSavedOn>
    <domeo:belongsToSet>urn:domeoclient:uuid:EC9B90D7-F9B5-4E51-94E2-878FAA06F611</domeo:belongsToSet>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:3A0236F4-5119-432D-9B94-B00A5EEC35E7">
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:suffix>xsd:String</ao:suffix>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:3A0236F4-5119-432D-9B94-B00A5EEC35E7"/>
    <ao:exact>Metformin</ao:exact>
    <pav:createdOn>2014-07-22 19:55:18 -0400</pav:createdOn>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-123.txt.html</ao:hasSource>
    <ao:prefix>xsd:String</ao:prefix>
    <domeo:uuid>3A0236F4-5119-432D-9B94-B00A5EEC35E7</domeo:uuid>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:40918124-C290-4DAB-B23D-F9B3E387A308">
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:suffix> were used concomitantly with the administration of omeprazole delayed-release capsules USP.</ao:suffix>
    <ao:exact>antacids</ao:exact>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-74.txt.html</ao:hasSource>
    <domeo:uuid>40918124-C290-4DAB-B23D-F9B3E387A308</domeo:uuid>
    <ao:prefix>). In the clinical trials, </ao:prefix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:40918124-C290-4DAB-B23D-F9B3E387A308"/>
    <pav:createdOn>2014-09-02 19:12:24 -0400</pav:createdOn>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:E2D0AAC2-1961-4E4C-93E0-B707D321E662">
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <domeo:uuid>E2D0AAC2-1961-4E4C-93E0-B707D321E662</domeo:uuid>
    <ao:exact>nifedipine</ao:exact>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:E2D0AAC2-1961-4E4C-93E0-B707D321E662"/>
    <ao:suffix> to voltage-dependent and possibly receptor-operated channels in vascular smooth muscle results in an inhibition of calcium influx through these channels. Stores of intracellular calcium in vascular smooth muscle are limited and thus dependent upon the i</ao:suffix>
    <pav:createdOn>2014-09-02 19:42:27 -0400</pav:createdOn>
    <ao:prefix> which acts directly on vascular smooth muscle. The binding of </ao:prefix>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-117.txt.html</ao:hasSource>
  </rdf:Description>
  <rdf:Description rdf:nodeID="Nea72ce4021ff4644963864ea46bae207">
    <permissions:isLocked>false</permissions:isLocked>
    <permissions:accessType>urn:domeo:access:public</permissions:accessType>
  </rdf:Description>
  <rdf:Description rdf:nodeID="Ne5e0ceaa5c9f4dce916c24355e0ac8af">
    <permissions:isLocked>false</permissions:isLocked>
    <permissions:accessType>urn:domeo:access:public</permissions:accessType>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:0025BED1-B4CA-4D8F-9C43-B2F10841CCF4">
    <domeo:belongsToSet>urn:domeoclient:uuid:71191E51-53CB-4FDE-88D0-33C6818E2232</domeo:belongsToSet>
    <rdfs:label>Highlight</rdfs:label>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:createdOn>2014-07-13 11:15:56 -0400</pav:createdOn>
    <pav:lineageUri>urn:domeoserver:annotation:0A047BE5-CEF6-494B-A811-C7F89C6D2A1B</pav:lineageUri>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812eda990003</pav:createdBy>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <ao:context rdf:resource="urn:domeoclient:uuid:F6864EB3-C97B-4F46-976B-E976F8C03348"/>
    <pav:lastSavedOn>2014-07-13 11:32:29 -0400</pav:lastSavedOn>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:15F23356-1BF5-4C1D-B511-6EA6E4D8AC0E">
    <pav:lastSavedOn>2014-09-01 16:06:18 -0400</pav:lastSavedOn>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812eda990003</pav:createdBy>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <pav:createdOn>2014-09-01 16:05:58 -0400</pav:createdOn>
    <domeo:belongsToSet>urn:domeoclient:uuid:A84DE8F6-26B7-471D-8309-4E7CC2994FDF</domeo:belongsToSet>
    <rdfs:label>Highlight</rdfs:label>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <ao:context rdf:resource="urn:domeoclient:uuid:D4EA61C9-E628-4806-856F-9D86959C5B20"/>
    <pav:lineageUri>urn:domeoserver:annotation:E80212C3-3917-4EEB-A788-72AC214F830F</pav:lineageUri>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:812F20EC-B150-4CC7-8C67-07A45894D904">
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:createdOn>2014-07-28 17:00:25 -0400</pav:createdOn>
    <pav:lineageUri>urn:domeoserver:annotation:B4AAADEA-D177-4862-AE55-20365549BFDE</pav:lineageUri>
    <rdfs:label>Highlight</rdfs:label>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812eda990003</pav:createdBy>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <domeo:belongsToSet>urn:domeoclient:uuid:AD7D1F18-857F-4502-9621-F93B88E936D2</domeo:belongsToSet>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <ao:context rdf:resource="urn:domeoclient:uuid:CB40975A-75D0-432E-9BC4-38AE8661FBF6"/>
    <pav:lastSavedOn>2014-07-28 17:00:03 -0400</pav:lastSavedOn>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:3C076A6A-DF94-4E44-AAAE-9F07C1FE0946">
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812eda990003</pav:createdBy>
    <domeo:belongsToSet>urn:domeoclient:uuid:379CD8C1-F4B4-42B7-8F87-70776866DB1F</domeo:belongsToSet>
    <pav:lineageUri>urn:domeoserver:annotation:0DBC6AFB-FB55-4640-8BF8-04A348698292</pav:lineageUri>
    <domeo:belongsToSet>urn:domeoserver:annotationset:D52DFD7B-BDDF-488F-B339-B1BC641E50E9</domeo:belongsToSet>
    <pav:createdOn>2014-09-02 12:03:50 -0400</pav:createdOn>
    <pav:lineageUri>urn:domeoserver:annotationset:166C20E9-1B4C-47D1-982D-922E2E5ACFF2</pav:lineageUri>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <ao:context rdf:resource="urn:domeoclient:uuid:78651239-7677-4E29-8D57-C04613A83C19"/>
    <rdfs:label>Highlight</rdfs:label>
    <pav:lastSavedOn>2014-09-02 12:03:47 -0400</pav:lastSavedOn>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:590B6F13-4CF1-42FD-BA01-FB622D059EBD">
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:lastSavedOn>2014-07-24 19:51:13 -0400</pav:lastSavedOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812eda990003</pav:createdBy>
    <rdfs:label>Highlight</rdfs:label>
    <ao:context rdf:resource="urn:domeoclient:uuid:AF3F948A-978C-448B-972C-FC7423B8770D"/>
    <pav:lineageUri>urn:domeoserver:annotation:8CAB1CDF-9254-4D75-B7E1-3EC7187FF089</pav:lineageUri>
    <domeo:belongsToSet>urn:domeoclient:uuid:6C727003-BB8F-45A8-BBAC-ACBE1D4D132E</domeo:belongsToSet>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <pav:createdOn>2014-07-24 19:51:25 -0400</pav:createdOn>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:659ED9DF-77DA-41F2-B123-6E455B4F2385">
    <ao:item rdf:resource="urn:domeoclient:uuid:56AEEC1F-6F5E-4CAD-A96A-7EC09CB365C8"/>
    <rdfs:label>Default Set</rdfs:label>
    <pav:lineageUri>urn:domeoserver:annotationset:767CBD9B-B530-4930-AF7E-16533AEFF50A</pav:lineageUri>
    <dct:description>The default set is created automatically by Domeo when no other set is existing.</dct:description>
    <domeo:agents rdf:resource="urn:domeo:software:id:Domeo-2.1alpha-050"/>
    <ao:annotatesResource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-17.txt.html</ao:annotatesResource>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <ao:item rdf:resource="urn:domeoclient:uuid:6586910C-89D6-48D4-A5C5-1E4D8CB29677"/>
    <permissions:permissions rdf:nodeID="Na31b253049884fadb73cd8664c9880cc"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:3469EEA4-696B-455B-896A-1006CE93364D"/>
    <pav:createdOn>2014-09-01 15:59:50 -0400</pav:createdOn>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:lastSavedOn>2014-09-01 16:00:14 -0400</pav:lastSavedOn>
    <domeo:agents rdf:resource="urn:person:uuid:080e143046812afe0146812eda990003"/>
    <domeo:deleted>false</domeo:deleted>
    <ao:item rdf:resource="urn:domeoclient:uuid:7D618B8B-0DAF-414B-911B-81ED1815FD8C"/>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#AnnotationSet"/>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812eda990003</pav:createdBy>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:DBA99B4F-F7DB-4460-981A-81817F4BFE98">
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <domeo:belongsToSet>urn:domeoserver:annotationset:3F546823-204F-4F9B-9006-3DC526C56931</domeo:belongsToSet>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <ao:context rdf:resource="urn:domeoclient:uuid:62667796-1E15-449B-8175-6954CB53F6DF"/>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812eda990003</pav:createdBy>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:createdOn>2014-09-02 11:38:20 -0400</pav:createdOn>
    <domeo:belongsToSet>urn:domeoserver:annotationset:A3F0B39A-4249-4B63-BB0D-F24A005066AC</domeo:belongsToSet>
    <domeo:belongsToSet>urn:domeoserver:annotationset:A5DD001D-C81A-4E2E-B5E0-7A866B35E26B</domeo:belongsToSet>
    <rdfs:label>Highlight</rdfs:label>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <pav:lastSavedOn>2014-09-02 11:46:58 -0400</pav:lastSavedOn>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">2</pav:versionNumber>
    <pav:lineageUri>urn:domeoserver:annotation:9D60D8C7-16D0-48D9-AE22-0B38935D1689</pav:lineageUri>
    <pav:lineageUri>urn:domeoserver:annotationset:D1715BD2-BD41-46FD-9454-DC7A423A29AC</pav:lineageUri>
    <pav:previousVersion>urn:domeoclient:uuid:BED41F06-565A-4622-9A88-48810E5A28DE</pav:previousVersion>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:AE31FB45-DE35-4E4D-B623-72AA865505E0">
    <ao:prefix>xsd:String</ao:prefix>
    <ao:suffix>xsd:String</ao:suffix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-164.txt.html</ao:hasSource>
    <domeo:uuid>AE31FB45-DE35-4E4D-B623-72AA865505E0</domeo:uuid>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <pav:createdOn>2014-07-28 17:00:46 -0400</pav:createdOn>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:AE31FB45-DE35-4E4D-B623-72AA865505E0"/>
    <ao:exact>Cimetidine</ao:exact>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:A6F0B480-ABD4-436B-8A6F-A4BD34827F73">
    <ao:context rdf:resource="urn:domeoclient:uuid:30818391-5098-4A86-BF01-5AB0C0597335"/>
    <rdfs:label>Highlight</rdfs:label>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:createdOn>2014-07-13 11:11:27 -0400</pav:createdOn>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <domeo:belongsToSet>urn:domeoclient:uuid:71191E51-53CB-4FDE-88D0-33C6818E2232</domeo:belongsToSet>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812eda990003</pav:createdBy>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:lineageUri>urn:domeoserver:annotation:945BD1E4-DE7D-4DBC-804B-A4E048F20780</pav:lineageUri>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:lastSavedOn>2014-07-13 11:32:29 -0400</pav:lastSavedOn>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:B9174469-54E0-4FAB-8165-210C50F1F809">
    <pav:lineageUri>urn:domeoserver:annotation:2051B080-40BC-4A2C-B53F-A08613EB9C84</pav:lineageUri>
    <pav:createdOn>2014-07-13 12:37:33 -0400</pav:createdOn>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <ao:context rdf:resource="urn:domeoclient:uuid:2CE66065-C68D-4E90-911C-F8B5E04B3813"/>
    <pav:lastSavedOn>2014-07-13 12:41:10 -0400</pav:lastSavedOn>
    <rdfs:label>Highlight</rdfs:label>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812eda990003</pav:createdBy>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <domeo:belongsToSet>urn:domeoclient:uuid:4F872953-6D19-4809-9285-FCCF2FF54315</domeo:belongsToSet>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:FF8F1249-3CE1-41AF-B118-1647BE5597AF">
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:suffix> maleate and metoprolol.</ao:suffix>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:FF8F1249-3CE1-41AF-B118-1647BE5597AF"/>
    <domeo:uuid>FF8F1249-3CE1-41AF-B118-1647BE5597AF</domeo:uuid>
    <ao:exact>fluvoxamine</ao:exact>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-9.txt.html</ao:hasSource>
    <ao:prefix>One case of bradycardia and hypotension and a second case of orthostatic hypotension have been reported with the coadministration of </ao:prefix>
    <pav:createdOn>2014-09-02 11:45:26 -0400</pav:createdOn>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:D4EC67EE-50D3-4156-87D9-A45D936232F9">
    <ao:context rdf:resource="urn:domeoclient:uuid:3E595AA2-A52D-41DE-BC69-4125AE10A552"/>
    <pav:lineageUri>urn:domeoserver:annotation:513F1D38-9F2A-48A2-A22D-9F19EE14C73C</pav:lineageUri>
    <domeo:belongsToSet>urn:domeoclient:uuid:C4B80A95-F569-4ED4-84D1-6796B53A580C</domeo:belongsToSet>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812eda990003</pav:createdBy>
    <rdfs:label>Highlight</rdfs:label>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:lastSavedOn>2014-09-02 15:04:32 -0400</pav:lastSavedOn>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <pav:createdOn>2014-09-02 15:04:34 -0400</pav:createdOn>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
  </rdf:Description>
  <rdf:Description rdf:nodeID="Ne0c3e53a72ed4027892719db68739fa5">
    <permissions:isLocked>false</permissions:isLocked>
    <permissions:accessType>urn:domeo:access:public</permissions:accessType>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:1E2204BD-B487-4C13-BC7C-E1E0D6A4C4AC">
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/80A8FD32-5EAE-4A18-B02F-5B0F1D34F3C9"/>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/PK_DDI"/>
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/5EC1436F-02A8-4F09-BB9E-972F4E3E26CE"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:97C1D6A3-E462-4C1F-8DD6-513D5AD2268A">
    <domeo:belongsToSet>urn:domeoclient:uuid:71191E51-53CB-4FDE-88D0-33C6818E2232</domeo:belongsToSet>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <ao:context rdf:resource="urn:domeoclient:uuid:F63AE259-E4D8-48C8-9143-FADBBFAD548B"/>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812eda990003</pav:createdBy>
    <pav:createdOn>2014-07-13 11:07:54 -0400</pav:createdOn>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:lastSavedOn>2014-07-13 11:32:29 -0400</pav:lastSavedOn>
    <rdfs:label>Highlight</rdfs:label>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:lineageUri>urn:domeoserver:annotation:693FA6F8-074D-41A3-9AF3-2256D761F345</pav:lineageUri>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:6BF6E19B-3833-4401-A589-B16E9522C485">
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <pav:createdOn>2014-07-07 09:58:53 -0400</pav:createdOn>
    <domeo:uuid>6BF6E19B-3833-4401-A589-B16E9522C485</domeo:uuid>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-155.txt.html</ao:hasSource>
    <ao:prefix>Injection: The pharmacokinetic profile of REVATIO has been characterized following intravenous administration. A 10 mg dose of </ao:prefix>
    <ao:suffix>Injection is predicted to provide a pharmacological effect of sildenafil and its N-desmethyl metabolite equivalent to that of a 20 mg oral dose.</ao:suffix>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:6BF6E19B-3833-4401-A589-B16E9522C485"/>
    <ao:exact>REVATIO </ao:exact>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <domeo:uuid></domeo:uuid>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:7CE3802C-582C-4A21-83B9-9CF98F3D327C">
    <sio:SIO_000205>dikbD2R:statement</sio:SIO_000205>
    <sio:SIO_000563>dikbD2R:modality</sio:SIO_000563>
    <rdf:type rdf:resource="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#DrugDrugInteractionStatement"/>
    <dikbD2R:modality>ncit:negative</dikbD2R:modality>
    <dikbD2R:statement>ncit:Qualitative</dikbD2R:statement>
    <sio:SIO_000628 rdf:resource="urn:pddi:uuid:30AC56DD-1608-4DFA-90FC-CCBC462BCAEF"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:DC9FB0B5-1564-4BF2-A4E4-4D05B0A1AB86">
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <domeo:belongsToSet>urn:domeoserver:annotationset:7AACEF8D-2EBC-4F0B-94B2-190650E562F6</domeo:belongsToSet>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <pav:lastSavedOn>2014-07-07 09:44:19 -0400</pav:lastSavedOn>
    <pav:lastSavedOn>2014-07-07 09:44:18 -0400</pav:lastSavedOn>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <domeo:belongsToSet>urn:domeoserver:annotationset:08C0C288-6DF4-43E6-A618-71A8BB9563C3</domeo:belongsToSet>
    <pav:lineageUri>urn:domeoserver:annotationset:76FD4BB5-DE2F-4FCA-B93D-302185B1A381</pav:lineageUri>
    <domeo:belongsToSet>urn:domeoserver:annotationset:22ED7220-C6F6-43C5-9DF9-89F62F0F8E27</domeo:belongsToSet>
    <rdfs:label>Highlight</rdfs:label>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812eda990003</pav:createdBy>
    <pav:lineageUri>urn:domeoserver:annotation:4E623F19-61D3-4432-BDDE-28C77FBDA1C0</pav:lineageUri>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <domeo:belongsToSet>urn:domeoserver:annotationset:131835A3-C655-4F91-97D4-52CAFF7B7CCA</domeo:belongsToSet>
    <ao:context rdf:resource="urn:domeoclient:uuid:F353BFC5-D6B5-4819-8EA8-0A44F2223E3B"/>
    <domeo:belongsToSet>urn:domeoclient:uuid:FCA2BF23-0BE3-409F-9177-761812F96097</domeo:belongsToSet>
    <domeo:belongsToSet>urn:domeoserver:annotationset:8F3CF3D9-AADE-4A86-BD42-2924B3D6A406</domeo:belongsToSet>
    <pav:createdOn>2014-07-07 09:37:19 -0400</pav:createdOn>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:B549CAF8-BA63-4493-B342-27702B9FC841">
    <rdfs:label>Highlight</rdfs:label>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:lastSavedOn>2014-07-21 21:44:00 -0400</pav:lastSavedOn>
    <pav:createdOn>2014-07-21 21:43:17 -0400</pav:createdOn>
    <pav:lineageUri>urn:domeoserver:annotation:CCF2824F-F8E6-41C2-9BA5-3EB9D1CDDB8A</pav:lineageUri>
    <domeo:belongsToSet>urn:domeoclient:uuid:42248733-4719-42F4-8132-866191F8E708</domeo:belongsToSet>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812eda990003</pav:createdBy>
    <ao:context rdf:resource="urn:domeoclient:uuid:1C4D4CDE-899A-4154-909A-B83F015F7989"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:1DBDA3FA-5F1C-4CC1-9712-91AF1D9421C6">
    <ao:context rdf:resource="urn:domeoclient:uuid:8C89B51C-E5B9-4048-B277-4FA66AA36C16"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <domeo:belongsToSet>urn:domeoclient:uuid:E0054F81-6A9B-4AF0-9DCB-962A6FC1C418</domeo:belongsToSet>
    <pav:lineageUri>urn:domeoserver:annotation:B268E8D2-7CCD-4C59-B9AD-152E8C225A69</pav:lineageUri>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <rdfs:label>Highlight</rdfs:label>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812eda990003</pav:createdBy>
    <pav:createdOn>2014-07-22 18:44:33 -0400</pav:createdOn>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <pav:lastSavedOn>2014-07-22 18:46:52 -0400</pav:lastSavedOn>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:95D28FFB-FF92-495E-92BC-C2E25FBE02B1">
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <domeo:belongsToSet>urn:domeoserver:annotationset:3F546823-204F-4F9B-9006-3DC526C56931</domeo:belongsToSet>
    <ao:context rdf:resource="urn:domeoclient:uuid:39C2E9DA-729E-466D-9F16-3F254B23A03C"/>
    <pav:lineageUri>urn:domeoserver:annotationset:D1715BD2-BD41-46FD-9454-DC7A423A29AC</pav:lineageUri>
    <pav:lastSavedOn>2014-09-02 11:46:59 -0400</pav:lastSavedOn>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812eda990003</pav:createdBy>
    <rdfs:label>Highlight</rdfs:label>
    <pav:lineageUri>urn:domeoserver:annotation:A32F0C53-EA2D-4DB2-AE52-425165351535</pav:lineageUri>
    <pav:previousVersion>urn:domeoclient:uuid:BED41F06-565A-4622-9A88-48810E5A28DE</pav:previousVersion>
    <pav:createdOn>2014-09-02 11:44:56 -0400</pav:createdOn>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">2</pav:versionNumber>
    <domeo:belongsToSet>urn:domeoserver:annotationset:A3F0B39A-4249-4B63-BB0D-F24A005066AC</domeo:belongsToSet>
    <domeo:belongsToSet>urn:domeoserver:annotationset:A5DD001D-C81A-4E2E-B5E0-7A866B35E26B</domeo:belongsToSet>
    <pav:lastSavedOn>2014-09-02 11:46:58 -0400</pav:lastSavedOn>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:93550871-2475-42C7-82BF-66ECE7117537">
    <ao:prefix>xsd:String</ao:prefix>
    <ao:exact>Zonisamide had no appreciable effect on the steady-state plasma concentrations of phenytoin, carbamazepine, or valproate during clinical trials. Zonisamide did not inhibit mixed-function liver oxidase enzymes (cytochrome P450), as measured in human liver microsomal preparations, in vitro. Zonisamide is not expected to interfere with the metabolism of other drugs that are metabolized by cytochrome P450 isozymes.</ao:exact>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <pav:createdOn>2014-07-21 21:55:12 -0400</pav:createdOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:93550871-2475-42C7-82BF-66ECE7117537"/>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-56.txt.html</ao:hasSource>
    <domeo:uuid>93550871-2475-42C7-82BF-66ECE7117537</domeo:uuid>
    <ao:suffix>xsd:String</ao:suffix>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/BB75F5EA-3BE0-4FC8-9344-269517A2A6EE">
    <rdfs:label>diazepam</rdfs:label>
    <dct:description>Referred to the drug in the interaction.</dct:description>
    <sio:SIO_000228>dikbD2R:precipitant-drug-of-interaction</sio:SIO_000228>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/active-ingredient"/>
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/3322</dailymed:activeMoietyRxCUI>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:98363801-880A-4060-8919-70CE42916B17">
    <domeo:uuid>98363801-880A-4060-8919-70CE42916B17</domeo:uuid>
    <ao:exact>rosiglitazone</ao:exact>
    <ao:prefix> (4 mg once daily) for 7 days increased </ao:prefix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <pav:createdOn>2014-07-22 19:42:09 -0400</pav:createdOn>
    <ao:suffix> AUC by 127%, compared to the administration of </ao:suffix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-123.txt.html</ao:hasSource>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:98363801-880A-4060-8919-70CE42916B17"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:8916B040-D309-4348-A145-26FC08137345">
    <ao:suffix>  (20 mg once daily) under steady-state conditions increased single-dose desipramine (100 mg) Cmax, AUC, and T½ by an average of approximately 2-, 5-, and 3-fold, respectively. Concomitant use of paroxetine with risperidone, a CYP2D6 substrate has also b</ao:suffix>
    <domeo:uuid>8916B040-D309-4348-A145-26FC08137345</domeo:uuid>
    <pav:createdOn>2014-09-02 12:02:48 -0400</pav:createdOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-47.txt.html</ao:hasSource>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:8916B040-D309-4348-A145-26FC08137345"/>
    <ao:exact>paroxetine</ao:exact>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:prefix>may significantly inhibit the activity of this isozyme. In most patients (&gt;90%), this CYP2D6 isozyme is saturated early during paroxetine dosing. In 1 study, daily dosing of immediate-release </ao:prefix>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:ACB2EB18-2590-4CF8-9CB3-0EF209C089E0">
    <ao:prefix>, therefore the effects are not related to dose or plasma levels within this dosage range. Larger effects were recorded among patients receiving </ao:prefix>
    <pav:createdOn>2014-07-07 09:38:19 -0400</pav:createdOn>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:ACB2EB18-2590-4CF8-9CB3-0EF209C089E0"/>
    <domeo:uuid>ACB2EB18-2590-4CF8-9CB3-0EF209C089E0</domeo:uuid>
    <ao:exact>concomitant </ao:exact>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:suffix>nitrates [see Contraindications (4)].</ao:suffix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-155.txt.html</ao:hasSource>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:F6864EB3-C97B-4F46-976B-E976F8C03348">
    <pav:createdOn>2014-07-13 11:15:56 -0400</pav:createdOn>
    <domeo:uuid>F6864EB3-C97B-4F46-976B-E976F8C03348</domeo:uuid>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:suffix> may cause a decrease in the combined plasma concentrations of risperidone and 9-hydroxyrisperidone [see 7 DRUG INTERACTIONS]. It would also be possible for risperidone to interfere with metabolism of other drugs metabolized by CYP 2D6. Relatively weak b</ao:suffix>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:F6864EB3-C97B-4F46-976B-E976F8C03348"/>
    <ao:exact>risperidone</ao:exact>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-8.txt.html</ao:hasSource>
    <ao:prefix>) with </ao:prefix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:EDAAAA2E-DA5E-4DC5-9EDE-0B4E06286E7C">
    <pav:lastSavedOn>2014-07-21 21:27:51 -0400</pav:lastSavedOn>
    <domeo:belongsToSet>urn:domeoclient:uuid:B6F745E6-5734-4636-A383-683BA4C79E38</domeo:belongsToSet>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#expertstudyAnnotation"/>
    <pav:lineageUri>urn:domeoserver:annotation:6C5335E0-4F46-4772-AFE2-0838AAA48FEB</pav:lineageUri>
    <pav:createdOn>2014-07-21 21:28:04 -0400</pav:createdOn>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <ao:body rdf:nodeID="N4b500e29673242eaab2b681a1a2e65bc"/>
    <ao:context rdf:resource="urn:domeoclient:uuid:E36FB611-A4C3-4DBB-9B86-FD93883853AE"/>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812eda990003</pav:createdBy>
    <rdfs:label>expertstudy Annotation</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/AA628DF4-FFD3-40B4-AF7F-28CD7B682042">
    <sio:SIO_000228>dikbD2R:precipitant-drug-of-interaction</sio:SIO_000228>
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/3407</dailymed:activeMoietyRxCUI>
    <rdfs:label>digoxin</rdfs:label>
    <dct:description>Referred to the drug in the interaction.</dct:description>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/active-ingredient"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:58271A45-7CE7-4B20-8F9F-82D4B6DD0D74">
    <domeo:belongsToSet>urn:domeoserver:annotationset:A3F0B39A-4249-4B63-BB0D-F24A005066AC</domeo:belongsToSet>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:lastSavedOn>2014-09-02 11:46:58 -0400</pav:lastSavedOn>
    <ao:context rdf:resource="urn:domeoclient:uuid:62E0CEDC-0C94-4CC8-83F4-85DD741C49B6"/>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812eda990003</pav:createdBy>
    <domeo:belongsToSet>urn:domeoserver:annotationset:3F546823-204F-4F9B-9006-3DC526C56931</domeo:belongsToSet>
    <pav:previousVersion>urn:domeoclient:uuid:BED41F06-565A-4622-9A88-48810E5A28DE</pav:previousVersion>
    <pav:lineageUri>urn:domeoserver:annotationset:D1715BD2-BD41-46FD-9454-DC7A423A29AC</pav:lineageUri>
    <pav:lastSavedOn>2014-09-02 11:46:59 -0400</pav:lastSavedOn>
    <pav:createdOn>2014-09-02 11:44:35 -0400</pav:createdOn>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <rdfs:label>Highlight</rdfs:label>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <domeo:belongsToSet>urn:domeoserver:annotationset:A5DD001D-C81A-4E2E-B5E0-7A866B35E26B</domeo:belongsToSet>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">2</pav:versionNumber>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <pav:lineageUri>urn:domeoserver:annotation:047D493C-2615-4DD1-9452-952F94AD0DA4</pav:lineageUri>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:70CC18BE-600E-4B98-B2C6-E5920EB63D79">
    <ao:context rdf:resource="urn:domeoclient:uuid:40918124-C290-4DAB-B23D-F9B3E387A308"/>
    <pav:lineageUri>urn:domeoserver:annotationset:C5DEBC9B-77EE-4243-88EB-DBC19737ACD2</pav:lineageUri>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <domeo:belongsToSet>urn:domeoclient:uuid:CB83FFC2-EA71-44EA-8F11-DE80E389C84E</domeo:belongsToSet>
    <domeo:belongsToSet>urn:domeoserver:annotationset:392EE0FB-AC4F-4AF2-87A6-2E50A281F434</domeo:belongsToSet>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <rdfs:label>Highlight</rdfs:label>
    <pav:lineageUri>urn:domeoserver:annotation:B085DF26-3EDE-4EC1-B42A-0BA26F95D0B9</pav:lineageUri>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812eda990003</pav:createdBy>
    <domeo:belongsToSet>urn:domeoserver:annotationset:E32812A9-205B-4EE1-B488-A1E294EDBFB9</domeo:belongsToSet>
    <pav:lastSavedOn>2014-09-02 19:19:47 -0400</pav:lastSavedOn>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <pav:createdOn>2014-09-02 19:12:24 -0400</pav:createdOn>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:AEC296E5-554D-42F1-BF6A-CA09B038958F">
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:suffix>to healthy volunteers, the largest mean change from baseline in supine systolic and supine diastolic blood pressures was a decrease of 9.0 mmHg and 8.4 mmHg, respectively.</ao:suffix>
    <domeo:uuid>AEC296E5-554D-42F1-BF6A-CA09B038958F</domeo:uuid>
    <pav:createdOn>2014-07-07 09:39:24 -0400</pav:createdOn>
    <ao:prefix>After chronic dosing of 80 mg TID </ao:prefix>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-155.txt.html</ao:hasSource>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:exact>sildenafil </ao:exact>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:AEC296E5-554D-42F1-BF6A-CA09B038958F"/>
    <domeo:uuid></domeo:uuid>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:98C6E110-7293-43BC-967C-E828D967CC54">
    <ao:suffix>.</ao:suffix>
    <ao:exact>carbamazepine</ao:exact>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-9.txt.html</ao:hasSource>
    <domeo:uuid>98C6E110-7293-43BC-967C-E828D967CC54</domeo:uuid>
    <ao:prefix> maleate and </ao:prefix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <pav:createdOn>2014-09-02 11:39:37 -0400</pav:createdOn>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:98C6E110-7293-43BC-967C-E828D967CC54"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:968E2714-CEBF-4C37-913F-C2DF10947AB8">
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812eda990003</pav:createdBy>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:createdOn>2014-09-02 19:18:40 -0400</pav:createdOn>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <rdfs:label>Highlight</rdfs:label>
    <ao:context rdf:resource="urn:domeoclient:uuid:F2CEE4B1-2371-4B8E-B2D2-F9EED99532CB"/>
    <pav:lineageUri>urn:domeoserver:annotationset:C5DEBC9B-77EE-4243-88EB-DBC19737ACD2</pav:lineageUri>
    <domeo:belongsToSet>urn:domeoserver:annotationset:392EE0FB-AC4F-4AF2-87A6-2E50A281F434</domeo:belongsToSet>
    <domeo:belongsToSet>urn:domeoclient:uuid:CB83FFC2-EA71-44EA-8F11-DE80E389C84E</domeo:belongsToSet>
    <pav:lastSavedOn>2014-09-02 19:19:47 -0400</pav:lastSavedOn>
    <pav:lineageUri>urn:domeoserver:annotation:7EF761A8-1E5F-4B19-8440-47FFFBD20025</pav:lineageUri>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <domeo:belongsToSet>urn:domeoserver:annotationset:E32812A9-205B-4EE1-B488-A1E294EDBFB9</domeo:belongsToSet>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:366925ED-C6A8-41CA-97EB-602399B8DB72">
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:366925ED-C6A8-41CA-97EB-602399B8DB72"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:exact>Risperidone</ao:exact>
    <ao:prefix>Excretion: </ao:prefix>
    <pav:createdOn>2014-07-13 11:16:30 -0400</pav:createdOn>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-8.txt.html</ao:hasSource>
    <domeo:uuid>366925ED-C6A8-41CA-97EB-602399B8DB72</domeo:uuid>
    <ao:suffix> and its metabolites are eliminated via the urine and, to a much lesser extent, via the feces. As illustrated by a mass balance study of a single 1 mg oral dose of 14C-risperidone administered as solution to three healthy male volunteers, total recovery </ao:suffix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:404B1852-88F6-45BB-8C18-358B3A408485">
    <pav:createdOn>2014-07-21 21:50:34 -0400</pav:createdOn>
    <rdfs:label>Default Set</rdfs:label>
    <ao:item rdf:resource="urn:domeoclient:uuid:A1184FE6-5357-43C5-BB6C-87EC586C8468"/>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812eda990003</pav:createdBy>
    <ao:item rdf:resource="urn:domeoclient:uuid:3CA31561-312B-4AE9-A654-27502AE41947"/>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:lineageUri>urn:domeoserver:annotationset:43084B54-D615-43F5-8037-82E9AB110383</pav:lineageUri>
    <domeo:deleted>false</domeo:deleted>
    <domeo:agents rdf:resource="urn:domeo:software:id:Domeo-2.1alpha-050"/>
    <permissions:permissions rdf:nodeID="N081e68e058754f909437b54af38fdce1"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#AnnotationSet"/>
    <ao:annotatesResource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-55.txt.html</ao:annotatesResource>
    <pav:lastSavedOn>2014-07-21 21:50:30 -0400</pav:lastSavedOn>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <dct:description>The default set is created automatically by Domeo when no other set is existing.</dct:description>
    <domeo:agents rdf:resource="urn:person:uuid:080e143046812afe0146812eda990003"/>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:346C2F84-FCE8-40ED-8A94-975E020C4F44">
    <rdfs:label>Highlight</rdfs:label>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:lastSavedOn>2014-07-28 17:01:39 -0400</pav:lastSavedOn>
    <pav:lineageUri>urn:domeoserver:annotation:30A1784E-C043-4F5D-A6AA-4EA335E7F589</pav:lineageUri>
    <ao:context rdf:resource="urn:domeoclient:uuid:7956E8A3-C5E3-47AD-A166-8DD4306EBB1D"/>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <pav:createdOn>2014-07-28 17:01:27 -0400</pav:createdOn>
    <domeo:belongsToSet>urn:domeoclient:uuid:05CE82A3-E1C6-497A-B0B0-31DD508C02A1</domeo:belongsToSet>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812eda990003</pav:createdBy>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:76D2A20E-E18E-4676-958D-12D182D20430">
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <ao:context rdf:resource="urn:domeoclient:uuid:575F0CD0-2CEC-4594-9019-B1A6C8BA5D55"/>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:createdOn>2014-07-13 12:37:40 -0400</pav:createdOn>
    <domeo:belongsToSet>urn:domeoclient:uuid:4F872953-6D19-4809-9285-FCCF2FF54315</domeo:belongsToSet>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:lastSavedOn>2014-07-13 12:41:10 -0400</pav:lastSavedOn>
    <pav:lineageUri>urn:domeoserver:annotation:B2317F54-7476-4D82-9C44-76D503E6DA71</pav:lineageUri>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812eda990003</pav:createdBy>
    <rdfs:label>Highlight</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:FA839309-7C8B-4446-A5C1-08694E7B8482">
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-8.txt.html</ao:hasSource>
    <pav:createdOn>2014-07-13 11:09:57 -0400</pav:createdOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:prefix>, its major metabolite, </ao:prefix>
    <ao:suffix>xsd:String</ao:suffix>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:FA839309-7C8B-4446-A5C1-08694E7B8482"/>
    <ao:exact>9-</ao:exact>
    <domeo:uuid>FA839309-7C8B-4446-A5C1-08694E7B8482</domeo:uuid>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:A8053299-E5E9-402F-B927-AC23DB68E0B9">
    <rdfs:label>Highlight</rdfs:label>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:lastSavedOn>2014-09-01 16:22:41 -0400</pav:lastSavedOn>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <pav:lineageUri>urn:domeoserver:annotation:6245E059-3512-4EE8-B021-453F0EC2955B</pav:lineageUri>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <domeo:belongsToSet>urn:domeoclient:uuid:215CE713-9F50-45C2-808D-0725CC11DF6D</domeo:belongsToSet>
    <pav:createdOn>2014-09-01 16:22:12 -0400</pav:createdOn>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812eda990003</pav:createdBy>
    <ao:context rdf:resource="urn:domeoclient:uuid:A2D6105B-A1D5-4610-94EC-C0CB40BB9E6D"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
  </rdf:Description>
  <rdf:Description rdf:nodeID="N7f7756a59f0c415186455e5e0044522a">
    <domeo:sets rdf:resource="urn:pddi:uuid:31A6A7B0-3980-4B84-A4E6-68B8A08EC05D"/>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/7C1B3FD3-CA8D-4D2F-B094-F0DB74BF2108">
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/active-ingredient"/>
    <rdfs:label>ethinyl estradiol</rdfs:label>
    <dct:description>Referred to the drug in the interaction.</dct:description>
    <sio:SIO_000228>dikbD2R:precipitant-drug-of-interaction</sio:SIO_000228>
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/4124</dailymed:activeMoietyRxCUI>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:137CD66C-79A5-4DE2-BF83-E1E083B1F26F">
    <ao:context rdf:resource="urn:domeoclient:uuid:6E924DBB-A7DD-4939-9801-279C7188D87E"/>
    <rdfs:label>Highlight</rdfs:label>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:lineageUri>urn:domeoserver:annotation:65F0E5B5-1315-4738-B18A-166E4145A2DF</pav:lineageUri>
    <pav:createdOn>2014-07-22 20:17:56 -0400</pav:createdOn>
    <domeo:belongsToSet>urn:domeoserver:annotationset:F272A789-69D0-47CC-8CC9-F25C55B91261</domeo:belongsToSet>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <pav:lastSavedOn>2014-07-22 20:22:38 -0400</pav:lastSavedOn>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812eda990003</pav:createdBy>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/5AD16038-68DB-4293-9251-D5A275F9AB73">
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/drug-product"/>
    <dct:description>Referred to the drug in the interaction.</dct:description>
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/</dailymed:activeMoietyRxCUI>
    <sio:SIO_000228>dikbD2R:precipitant-drug-of-interaction</sio:SIO_000228>
    <rdfs:label>oxacillin</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:D3D401FD-5D13-4E47-A4E2-A367B34A8F2B">
    <domeo:uuid>D3D401FD-5D13-4E47-A4E2-A367B34A8F2B</domeo:uuid>
    <ao:suffix>, warfarin, theophylline, certain benzodiazepines, omeprazole and phenytoin. If fluvoxamine maleate tablets are to be administered together with a drug that is eliminated via oxidative metabolism and has a narrow therapeutic window, plasma levels and/or </ao:suffix>
    <ao:prefix> interaction is possible with drugs having a narrow therapeutic ratio such as </ao:prefix>
    <ao:exact>pimozide</ao:exact>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-9.txt.html</ao:hasSource>
    <pav:createdOn>2014-09-02 11:36:01 -0400</pav:createdOn>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:D3D401FD-5D13-4E47-A4E2-A367B34A8F2B"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:3E420EBD-D4BF-4705-A9AE-EDDA116820D1">
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <domeo:uuid>3E420EBD-D4BF-4705-A9AE-EDDA116820D1</domeo:uuid>
    <ao:suffix>. In these patients, mixed agonist/antagonist analgesics may reduce the analgesic effect and/or may precipitate withdrawal symptoms.</ao:suffix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:prefix>) to patients who have received or are receiving a course of therapy with a pure opioid agonist analgesic such as </ao:prefix>
    <ao:exact>oxycodone hydrochloride</ao:exact>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-72.txt.html</ao:hasSource>
    <pav:createdOn>2014-09-02 19:08:48 -0400</pav:createdOn>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:3E420EBD-D4BF-4705-A9AE-EDDA116820D1"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:2F209001-62CD-42DB-94B6-8505E0EB8F2E">
    <domeo:uuid>2F209001-62CD-42DB-94B6-8505E0EB8F2E</domeo:uuid>
    <ao:prefix>Daily oral dosing of immediate-release </ao:prefix>
    <pav:createdOn>2014-07-21 21:42:03 -0400</pav:createdOn>
    <ao:exact>paroxetine </ao:exact>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:suffix>(30 mg once daily) increased steady-state AUC0-24, Cmax, and Cmin values of procyclidine (5 mg oral once daily) by 35%, 37%, and 67%, respectively, compared to procyclidine alone at steady state. If anticholinergic effects are seen, the dose of procyclid</ao:suffix>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-50.txt.html</ao:hasSource>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:2F209001-62CD-42DB-94B6-8505E0EB8F2E"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:F9664F35-3DEE-47BF-95B4-E93F2BBC1965">
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <ao:context rdf:resource="urn:domeoclient:uuid:544DD6BF-DAEB-4EEF-86D9-2AD7760B51C5"/>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:lineageUri>urn:domeoserver:annotation:B79DF7F1-8FF8-4B3E-A461-BBAFAD29A77F</pav:lineageUri>
    <domeo:belongsToSet>urn:domeoclient:uuid:AD7D1F18-857F-4502-9621-F93B88E936D2</domeo:belongsToSet>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <pav:createdOn>2014-07-28 17:00:13 -0400</pav:createdOn>
    <pav:lastSavedOn>2014-07-28 17:00:03 -0400</pav:lastSavedOn>
    <rdfs:label>Highlight</rdfs:label>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812eda990003</pav:createdBy>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:A810EBBA-9C6C-4A0D-9FD2-AFA2874096F5">
    <ao:prefix> and </ao:prefix>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-21.txt.html</ao:hasSource>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:A810EBBA-9C6C-4A0D-9FD2-AFA2874096F5"/>
    <ao:exact>norethindrone</ao:exact>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <pav:createdOn>2014-07-13 12:38:23 -0400</pav:createdOn>
    <domeo:uuid>A810EBBA-9C6C-4A0D-9FD2-AFA2874096F5</domeo:uuid>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:suffix> compared to similar placebo dosing. The mean AUCs of ethinyl estradiol and norethindrone increased by 24% (95% C.I. range 18 to 31%) and 13% (95% C.I. range 8 to 18%), respectively relative to placebo. Fluconazole treatment did not cause a decrease in t</ao:suffix>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:3E4DD9DD-ACD7-4BE1-99C4-C10C579DD83A">
    <pav:lastSavedOn>2014-07-21 21:42:43 -0400</pav:lastSavedOn>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812eda990003</pav:createdBy>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <pav:createdOn>2014-07-21 21:42:13 -0400</pav:createdOn>
    <ao:context rdf:resource="urn:domeoclient:uuid:AA8809D6-7C92-459E-B3FE-D31BB8203D90"/>
    <rdfs:label>Highlight</rdfs:label>
    <pav:lineageUri>urn:domeoserver:annotation:5DCE6B18-109F-4776-930D-EF11FAF93A80</pav:lineageUri>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <domeo:belongsToSet>urn:domeoclient:uuid:BD4B7475-BD13-46C4-932F-139564A0063D</domeo:belongsToSet>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:15CCD695-F33B-4A85-9FD0-BAFCB7975EAB">
    <domeo:uuid>15CCD695-F33B-4A85-9FD0-BAFCB7975EAB</domeo:uuid>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-9.txt.html</ao:hasSource>
    <ao:prefix>xsd:String</ao:prefix>
    <ao:exact>Carbamazepine</ao:exact>
    <ao:suffix>: Elevated carbamazepine levels and symptoms of toxicity have been reported with the coadministration of </ao:suffix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:15CCD695-F33B-4A85-9FD0-BAFCB7975EAB"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <pav:createdOn>2014-09-02 11:39:42 -0400</pav:createdOn>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:17E64297-0A57-4C9B-94C4-18ED1956FCF7">
    <rdfs:label>Highlight</rdfs:label>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812eda990003</pav:createdBy>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:lineageUri>urn:domeoserver:annotation:2F1405B4-F41E-4809-AC54-DA4B296E83DB</pav:lineageUri>
    <pav:createdOn>2014-07-07 09:51:17 -0400</pav:createdOn>
    <domeo:belongsToSet>urn:domeoserver:annotationset:22ED7220-C6F6-43C5-9DF9-89F62F0F8E27</domeo:belongsToSet>
    <domeo:belongsToSet>urn:domeoserver:annotationset:8F3CF3D9-AADE-4A86-BD42-2924B3D6A406</domeo:belongsToSet>
    <domeo:belongsToSet>urn:domeoserver:annotationset:08C0C288-6DF4-43E6-A618-71A8BB9563C3</domeo:belongsToSet>
    <domeo:belongsToSet>urn:domeoserver:annotationset:7AACEF8D-2EBC-4F0B-94B2-190650E562F6</domeo:belongsToSet>
    <ao:context rdf:resource="urn:domeoclient:uuid:7950DCED-7411-4B59-B629-CB1341A53897"/>
    <pav:lastSavedOn>2014-07-07 10:02:41 -0400</pav:lastSavedOn>
    <domeo:belongsToSet>urn:domeoserver:annotationset:131835A3-C655-4F91-97D4-52CAFF7B7CCA</domeo:belongsToSet>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:previousVersion>xsd:String</pav:previousVersion>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:97DC09C5-358C-425D-918D-34D9317DC89F">
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <domeo:uuid>97DC09C5-358C-425D-918D-34D9317DC89F</domeo:uuid>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:97DC09C5-358C-425D-918D-34D9317DC89F"/>
    <ao:exact>propranolol</ao:exact>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-131.txt.html</ao:hasSource>
    <ao:prefix> resulted in up to 50% decrease in </ao:prefix>
    <ao:suffix> concentrations.</ao:suffix>
    <pav:createdOn>2014-07-24 19:51:31 -0400</pav:createdOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/6156849A-B0E2-444B-9C14-2B19DFE9DB2F">
    <sio:SIO_000228>dikbD2R:precipitant-drug-of-interaction</sio:SIO_000228>
    <rdfs:label>nelfinavir</rdfs:label>
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/134527</dailymed:activeMoietyRxCUI>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/active-ingredient"/>
    <dct:description>Referred to the drug in the interaction.</dct:description>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:71E5047C-5690-4D45-9A6E-FB1384C14928">
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812eda990003</pav:createdBy>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:lineageUri>urn:domeoserver:annotation:DFC21707-69A6-4E64-9438-1D6C69F0352F</pav:lineageUri>
    <pav:createdOn>2014-07-13 11:16:15 -0400</pav:createdOn>
    <ao:context rdf:resource="urn:domeoclient:uuid:4A268B82-4B69-4D00-A6E9-95F225012877"/>
    <pav:lastSavedOn>2014-07-13 11:32:29 -0400</pav:lastSavedOn>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <domeo:belongsToSet>urn:domeoclient:uuid:71191E51-53CB-4FDE-88D0-33C6818E2232</domeo:belongsToSet>
    <rdfs:label>Highlight</rdfs:label>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:previousVersion>xsd:String</pav:previousVersion>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:C8AD4F27-4001-4A0B-9D27-50063C65337E">
    <pav:lastSavedOn>2014-09-02 11:46:59 -0400</pav:lastSavedOn>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <pav:createdOn>2014-09-02 11:46:58 -0400</pav:createdOn>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">2</pav:versionNumber>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <rdfs:label>Highlight</rdfs:label>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <domeo:belongsToSet>urn:domeoserver:annotationset:A5DD001D-C81A-4E2E-B5E0-7A866B35E26B</domeo:belongsToSet>
    <pav:lastSavedOn>2014-09-02 11:46:58 -0400</pav:lastSavedOn>
    <pav:lineageUri>urn:domeoserver:annotationset:D1715BD2-BD41-46FD-9454-DC7A423A29AC</pav:lineageUri>
    <domeo:belongsToSet>urn:domeoserver:annotationset:A3F0B39A-4249-4B63-BB0D-F24A005066AC</domeo:belongsToSet>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812eda990003</pav:createdBy>
    <domeo:belongsToSet>urn:domeoserver:annotationset:3F546823-204F-4F9B-9006-3DC526C56931</domeo:belongsToSet>
    <pav:previousVersion>urn:domeoclient:uuid:BED41F06-565A-4622-9A88-48810E5A28DE</pav:previousVersion>
    <ao:context rdf:resource="urn:domeoclient:uuid:A5711142-9ABC-4A8E-A6A1-D585CB7190C4"/>
    <pav:lineageUri>urn:domeoserver:annotation:83169EBA-DCC9-4591-9086-E98217F7D066</pav:lineageUri>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:4B7476C3-D9FB-4C21-AF95-2B4CD2143061">
    <pav:createdOn>2014-09-02 19:10:44 -0400</pav:createdOn>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-72.txt.html</ao:hasSource>
    <ao:suffix> via the cytochrome p450 isoenzyme CYP2D6. While this pathway may be blocked by a variety of drugs (e.g., certain cardiovascular drugs and antidepressants), such blockade has not yet been shown to be of clinical significance with this agent. However, cli</ao:suffix>
    <ao:prefix> is metabolized in part to </ao:prefix>
    <ao:exact>oxymorphone</ao:exact>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:4B7476C3-D9FB-4C21-AF95-2B4CD2143061"/>
    <domeo:uuid>4B7476C3-D9FB-4C21-AF95-2B4CD2143061</domeo:uuid>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:6ECE2E9A-54C4-4507-95A6-2F4053719529">
    <pav:lastSavedOn>2014-07-13 11:32:29 -0400</pav:lastSavedOn>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <rdfs:label>Highlight</rdfs:label>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <domeo:belongsToSet>urn:domeoclient:uuid:71191E51-53CB-4FDE-88D0-33C6818E2232</domeo:belongsToSet>
    <ao:context rdf:resource="urn:domeoclient:uuid:CF873305-5222-4D37-9C71-925D3C390B7A"/>
    <pav:lineageUri>urn:domeoserver:annotation:D829A856-ADE0-4E82-B940-6DE74589EFC8</pav:lineageUri>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812eda990003</pav:createdBy>
    <pav:createdOn>2014-07-13 11:09:51 -0400</pav:createdOn>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:489FB94C-2475-4EC7-BE20-CF92749745A7">
    <rdfs:label>Highlight</rdfs:label>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <ao:context rdf:resource="urn:domeoclient:uuid:B0AC894E-27E2-43D9-BFEB-167E8117247A"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:lineageUri>urn:domeoserver:annotation:88C1F1C9-E75C-4A69-9BFF-84FAF6F2C2ED</pav:lineageUri>
    <pav:createdOn>2014-07-13 12:34:38 -0400</pav:createdOn>
    <domeo:belongsToSet>urn:domeoclient:uuid:6A05795B-B1AB-4DB3-A12F-2765CBCC2FED</domeo:belongsToSet>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <pav:lastSavedOn>2014-07-13 12:34:42 -0400</pav:lastSavedOn>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812eda990003</pav:createdBy>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:F0271A3E-BA13-45E3-87AB-B8C1F9BB72CC">
    <ao:prefix>xsd:String</ao:prefix>
    <ao:suffix> is a peripheral arterial </ao:suffix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <domeo:uuid>F0271A3E-BA13-45E3-87AB-B8C1F9BB72CC</domeo:uuid>
    <pav:createdOn>2014-09-02 19:41:42 -0400</pav:createdOn>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:F0271A3E-BA13-45E3-87AB-B8C1F9BB72CC"/>
    <ao:exact>Nifedipine</ao:exact>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-117.txt.html</ao:hasSource>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/4BCB725A-6FD9-45A7-A5BE-7BB7C488437E">
    <sio:SIO_000228>dikbD2R:precipitant-drug-of-interaction</sio:SIO_000228>
    <rdfs:label>quinidine</rdfs:label>
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/9068</dailymed:activeMoietyRxCUI>
    <dct:description>Referred to the drug in the interaction.</dct:description>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/active-ingredient"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:72C81315-5D14-41CA-AEB9-E23AC335F4C3">
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:exact>ethinyl estradiol</ao:exact>
    <pav:createdOn>2014-07-13 12:38:31 -0400</pav:createdOn>
    <domeo:uuid>72C81315-5D14-41CA-AEB9-E23AC335F4C3</domeo:uuid>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:72C81315-5D14-41CA-AEB9-E23AC335F4C3"/>
    <ao:suffix> and norethindrone increased by 24% (95% C.I. range 18 to 31%) and 13% (95% C.I. range 8 to 18%), respectively relative to placebo. Fluconazole treatment did not cause a decrease in the ethinyl estradiol AUC of any individual subject in this study compar</ao:suffix>
    <ao:prefix> compared to similar placebo dosing. The mean AUCs of </ao:prefix>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-21.txt.html</ao:hasSource>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/D860A1B6-8D5E-4FE4-9EDB-4E1397B29BBD">
    <dct:description>Referred to the drug in the interaction.</dct:description>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/active-ingredient"/>
    <sio:SIO_000228>dikbD2R:precipitant-drug-of-interaction</sio:SIO_000228>
    <rdfs:label>sildenafil</rdfs:label>
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/136411</dailymed:activeMoietyRxCUI>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:15050075-436C-4668-9987-03D689AE2236">
    <pav:createdOn>2014-07-22 19:28:40 -0400</pav:createdOn>
    <domeo:belongsToSet>urn:domeoserver:annotationset:514BA51B-D734-4003-A7C3-F03C0F95833A</domeo:belongsToSet>
    <pav:previousVersion>urn:domeoserver:annotationset:7E80543E-BF76-4514-92A9-91458DCB802B</pav:previousVersion>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <domeo:belongsToSet>urn:domeoserver:annotationset:2914A3FD-DF43-4F78-999C-77CE7A028B19</domeo:belongsToSet>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">4</pav:versionNumber>
    <pav:lineageUri>urn:domeoserver:annotationset:AB1741F1-5A5F-4416-AEAC-A544BCBB7D16</pav:lineageUri>
    <rdfs:label>Highlight</rdfs:label>
    <domeo:belongsToSet>urn:domeoserver:annotationset:F272A789-69D0-47CC-8CC9-F25C55B91261</domeo:belongsToSet>
    <domeo:belongsToSet>urn:domeoserver:annotationset:606A5B3F-B6FB-4279-AA42-7893CFC2D20C</domeo:belongsToSet>
    <pav:lineageUri>urn:domeoserver:annotation:060D7E76-977D-4EAA-ABAE-E4B669D9F652</pav:lineageUri>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812eda990003</pav:createdBy>
    <ao:context rdf:resource="urn:domeoclient:uuid:62CFF353-D9DB-4975-A77C-87D5AE3C0CCA"/>
    <domeo:belongsToSet>urn:domeoserver:annotationset:7021B883-FD5C-4083-BD87-DF56D3C87633</domeo:belongsToSet>
    <pav:lastSavedOn>2014-07-22 19:35:16 -0400</pav:lastSavedOn>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/15A5B0E0-F6E2-41DD-B290-4DFF5706433B">
    <sio:SIO_000228>dikbD2R:object-drug-of-interaction</sio:SIO_000228>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/active-ingredient"/>
    <dct:description>Referred to the drug in the interaction.</dct:description>
    <rdfs:label>propranolol</rdfs:label>
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/8787</dailymed:activeMoietyRxCUI>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:7DC48B58-6464-4FBE-B643-CA178DD552DB">
    <ao:context rdf:resource="urn:domeoclient:uuid:6279850D-A32F-4EDB-A281-0BC6CBECE7F7"/>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">2</pav:versionNumber>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <rdfs:label>Highlight</rdfs:label>
    <pav:previousVersion>urn:domeoclient:uuid:BED41F06-565A-4622-9A88-48810E5A28DE</pav:previousVersion>
    <domeo:belongsToSet>urn:domeoserver:annotationset:A5DD001D-C81A-4E2E-B5E0-7A866B35E26B</domeo:belongsToSet>
    <pav:lastSavedOn>2014-09-02 11:46:58 -0400</pav:lastSavedOn>
    <pav:lineageUri>urn:domeoserver:annotationset:D1715BD2-BD41-46FD-9454-DC7A423A29AC</pav:lineageUri>
    <domeo:belongsToSet>urn:domeoserver:annotationset:A3F0B39A-4249-4B63-BB0D-F24A005066AC</domeo:belongsToSet>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812eda990003</pav:createdBy>
    <pav:createdOn>2014-09-02 11:39:16 -0400</pav:createdOn>
    <domeo:belongsToSet>urn:domeoserver:annotationset:3F546823-204F-4F9B-9006-3DC526C56931</domeo:belongsToSet>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:lineageUri>urn:domeoserver:annotation:79D44731-1CF1-4827-A659-C53C7235418D</pav:lineageUri>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:CC8C2FEA-C8BE-4A4F-98E3-3E4C44B65C83">
    <ao:suffix> to 9-hydroxyrisperidone [see 7 DRUG INTERACTIONS]. This occurs with quinidine, giving essentially all recipients a risperidone pharmacokinetic profile typical of poor metabolizers. The therapeutic benefits and adverse effects of risperidone in patients </ao:suffix>
    <domeo:uuid>CC8C2FEA-C8BE-4A4F-98E3-3E4C44B65C83</domeo:uuid>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-8.txt.html</ao:hasSource>
    <ao:prefix> could be subject to two kinds of drug-drug interactions. First, inhibitors of CYP 2D6 interfere with conversion of </ao:prefix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <pav:createdOn>2014-07-13 11:14:00 -0400</pav:createdOn>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:CC8C2FEA-C8BE-4A4F-98E3-3E4C44B65C83"/>
    <ao:exact>risperidone</ao:exact>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:26C8F2D4-9063-4B38-ABF2-AC4FA32AD27F">
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:createdOn>2014-09-02 11:44:17 -0400</pav:createdOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812eda990003</pav:createdBy>
    <pav:lastSavedOn>2014-09-02 11:46:58 -0400</pav:lastSavedOn>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <ao:context rdf:resource="urn:domeoclient:uuid:89F35E49-064B-44B8-B2CE-6FDE26A34AC7"/>
    <pav:lastSavedOn>2014-09-02 11:46:59 -0400</pav:lastSavedOn>
    <domeo:belongsToSet>urn:domeoserver:annotationset:A3F0B39A-4249-4B63-BB0D-F24A005066AC</domeo:belongsToSet>
    <domeo:belongsToSet>urn:domeoserver:annotationset:A5DD001D-C81A-4E2E-B5E0-7A866B35E26B</domeo:belongsToSet>
    <pav:lineageUri>urn:domeoserver:annotation:88CCE394-5D90-44DC-A612-D06944854C83</pav:lineageUri>
    <rdfs:label>Highlight</rdfs:label>
    <pav:previousVersion>urn:domeoclient:uuid:BED41F06-565A-4622-9A88-48810E5A28DE</pav:previousVersion>
    <domeo:belongsToSet>urn:domeoserver:annotationset:3F546823-204F-4F9B-9006-3DC526C56931</domeo:belongsToSet>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">2</pav:versionNumber>
    <pav:lineageUri>urn:domeoserver:annotationset:D1715BD2-BD41-46FD-9454-DC7A423A29AC</pav:lineageUri>
    <pav:previousVersion>xsd:String</pav:previousVersion>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:29043652-5144-43F9-865A-114AECF87D36">
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <rdfs:label>Highlight</rdfs:label>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:lastSavedOn>2014-09-02 19:11:13 -0400</pav:lastSavedOn>
    <pav:createdOn>2014-09-02 19:09:27 -0400</pav:createdOn>
    <domeo:belongsToSet>urn:domeoclient:uuid:3966BCFB-CA02-4053-828D-3860558E7BE8</domeo:belongsToSet>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812eda990003</pav:createdBy>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <pav:lineageUri>urn:domeoserver:annotation:76A6D4E8-CFC0-4AA9-B614-87128EB7486B</pav:lineageUri>
    <ao:context rdf:resource="urn:domeoclient:uuid:C072F602-C93D-48EA-B6A2-EEDE4C49DC48"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:4BE7A024-EE88-4E7C-BCF8-571E06F8C6B1">
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/BB75F5EA-3BE0-4FC8-9344-269517A2A6EE"/>
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/D10C9054-F924-40A5-9EDB-304BEF56C148"/>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/PK_DDI"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:914E70FC-7296-4025-B9C4-BDAD1F572CC6">
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <domeo:belongsToSet>urn:domeoclient:uuid:39B82E57-92E3-4322-A8E6-A3AFF215F02C</domeo:belongsToSet>
    <rdfs:label>Highlight</rdfs:label>
    <ao:context rdf:resource="urn:domeoclient:uuid:F87926C2-2747-4ED5-93E5-F7C25B2825BF"/>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:createdOn>2014-09-01 15:57:31 -0400</pav:createdOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812eda990003</pav:createdBy>
    <pav:lastSavedOn>2014-09-01 15:57:39 -0400</pav:lastSavedOn>
    <pav:lineageUri>urn:domeoserver:annotation:60449E8A-52B3-4A22-B766-56A345187A81</pav:lineageUri>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:6016855A-FC6C-4F50-BBD3-3126439782E9">
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <ao:context rdf:resource="urn:domeoclient:uuid:C8BC97FA-A136-4744-ADD4-4988FBBA6CCB"/>
    <pav:previousVersion>urn:domeoserver:annotationset:514BA51B-D734-4003-A7C3-F03C0F95833A</pav:previousVersion>
    <pav:lineageUri>urn:domeoserver:annotation:3D45AC52-674B-4183-A125-A270C205A7E2</pav:lineageUri>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812eda990003</pav:createdBy>
    <domeo:belongsToSet>urn:domeoserver:annotationset:F272A789-69D0-47CC-8CC9-F25C55B91261</domeo:belongsToSet>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">6</pav:versionNumber>
    <pav:createdOn>2014-07-22 19:41:41 -0400</pav:createdOn>
    <rdfs:label>Highlight</rdfs:label>
    <domeo:belongsToSet>urn:domeoserver:annotationset:606A5B3F-B6FB-4279-AA42-7893CFC2D20C</domeo:belongsToSet>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <pav:lineageUri>urn:domeoserver:annotationset:AB1741F1-5A5F-4416-AEAC-A544BCBB7D16</pav:lineageUri>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <domeo:belongsToSet>urn:domeoserver:annotationset:2914A3FD-DF43-4F78-999C-77CE7A028B19</domeo:belongsToSet>
    <pav:lastSavedOn>2014-07-22 19:44:46 -0400</pav:lastSavedOn>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:85EED099-46E9-43C2-A412-DB4141880448">
    <ao:context rdf:resource="urn:domeoclient:uuid:9BFD55E1-3ADE-4DD6-8289-76C7DC405DE3"/>
    <domeo:belongsToSet>urn:domeoserver:annotationset:3F546823-204F-4F9B-9006-3DC526C56931</domeo:belongsToSet>
    <domeo:belongsToSet>urn:domeoserver:annotationset:A3F0B39A-4249-4B63-BB0D-F24A005066AC</domeo:belongsToSet>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">2</pav:versionNumber>
    <pav:previousVersion>urn:domeoclient:uuid:BED41F06-565A-4622-9A88-48810E5A28DE</pav:previousVersion>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812eda990003</pav:createdBy>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <rdfs:label>Highlight</rdfs:label>
    <domeo:belongsToSet>urn:domeoserver:annotationset:A5DD001D-C81A-4E2E-B5E0-7A866B35E26B</domeo:belongsToSet>
    <pav:lineageUri>urn:domeoserver:annotationset:D1715BD2-BD41-46FD-9454-DC7A423A29AC</pav:lineageUri>
    <pav:lineageUri>urn:domeoserver:annotation:407DF9F4-9D55-43EA-B5C9-252A0331E872</pav:lineageUri>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:lastSavedOn>2014-09-02 11:46:58 -0400</pav:lastSavedOn>
    <pav:createdOn>2014-09-02 11:36:10 -0400</pav:createdOn>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:137A1951-AA86-4074-9581-B011801B955F">
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <domeo:belongsToSet>urn:domeoclient:uuid:FCA2BF23-0BE3-409F-9177-761812F96097</domeo:belongsToSet>
    <pav:lineageUri>urn:domeoserver:annotationset:76FD4BB5-DE2F-4FCA-B93D-302185B1A381</pav:lineageUri>
    <domeo:belongsToSet>urn:domeoserver:annotationset:8F3CF3D9-AADE-4A86-BD42-2924B3D6A406</domeo:belongsToSet>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <rdfs:label>Highlight</rdfs:label>
    <pav:lineageUri>urn:domeoserver:annotation:00BCB920-F72B-4D37-B5EA-82E77099F0EE</pav:lineageUri>
    <ao:context rdf:resource="urn:domeoclient:uuid:5FD113AB-8FB6-4F29-B1BE-0A776992E0B0"/>
    <domeo:belongsToSet>urn:domeoserver:annotationset:131835A3-C655-4F91-97D4-52CAFF7B7CCA</domeo:belongsToSet>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:lastSavedOn>2014-07-07 09:44:19 -0400</pav:lastSavedOn>
    <domeo:belongsToSet>urn:domeoserver:annotationset:22ED7220-C6F6-43C5-9DF9-89F62F0F8E27</domeo:belongsToSet>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812eda990003</pav:createdBy>
    <pav:createdOn>2014-07-07 09:39:42 -0400</pav:createdOn>
    <domeo:belongsToSet>urn:domeoserver:annotationset:7AACEF8D-2EBC-4F0B-94B2-190650E562F6</domeo:belongsToSet>
    <domeo:belongsToSet>urn:domeoserver:annotationset:08C0C288-6DF4-43E6-A618-71A8BB9563C3</domeo:belongsToSet>
    <pav:lastSavedOn>2014-07-07 09:44:18 -0400</pav:lastSavedOn>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:5E8A53CD-1A4A-4A56-ABAA-82D073884595">
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:lineageUri>urn:domeoserver:annotationset:AB1741F1-5A5F-4416-AEAC-A544BCBB7D16</pav:lineageUri>
    <pav:lastSavedOn>2014-07-22 19:40:32 -0400</pav:lastSavedOn>
    <ao:context rdf:resource="urn:domeoclient:uuid:EB06C7B2-447E-44A6-9D7B-F5BB28ED6AB3"/>
    <domeo:belongsToSet>urn:domeoserver:annotationset:514BA51B-D734-4003-A7C3-F03C0F95833A</domeo:belongsToSet>
    <domeo:belongsToSet>urn:domeoserver:annotationset:2914A3FD-DF43-4F78-999C-77CE7A028B19</domeo:belongsToSet>
    <pav:createdOn>2014-07-22 19:36:30 -0400</pav:createdOn>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <domeo:belongsToSet>urn:domeoserver:annotationset:606A5B3F-B6FB-4279-AA42-7893CFC2D20C</domeo:belongsToSet>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:lastSavedOn>2014-07-22 19:40:31 -0400</pav:lastSavedOn>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">5</pav:versionNumber>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <pav:lineageUri>urn:domeoserver:annotation:B6A9A3FA-8C2C-40BA-B4B1-1C3E42225FB5</pav:lineageUri>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812eda990003</pav:createdBy>
    <domeo:belongsToSet>urn:domeoserver:annotationset:F272A789-69D0-47CC-8CC9-F25C55B91261</domeo:belongsToSet>
    <rdfs:label>Highlight</rdfs:label>
    <pav:previousVersion>urn:domeoserver:annotationset:7021B883-FD5C-4083-BD87-DF56D3C87633</pav:previousVersion>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:2FF3133B-3C6A-4B14-A744-B8F141C65349">
    <ao:context rdf:resource="urn:domeoclient:uuid:6EF1F67B-32D0-48C5-BEB7-6F545D96A5AA"/>
    <pav:lineageUri>urn:domeoserver:annotation:2D15DC95-96C2-4349-A95D-53D48B48C4C8</pav:lineageUri>
    <pav:createdOn>2014-07-24 20:02:30 -0400</pav:createdOn>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812eda990003</pav:createdBy>
    <pav:lastSavedOn>2014-07-24 20:02:49 -0400</pav:lastSavedOn>
    <domeo:belongsToSet>urn:domeoclient:uuid:189A8E0E-67D6-4C53-A96E-CB48A3B4B2E9</domeo:belongsToSet>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <rdfs:label>Highlight</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:3DFC0290-B79C-492E-A5DB-32EF23C9B433">
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-127.txt.html</ao:hasSource>
    <ao:suffix>.</ao:suffix>
    <ao:exact>propranolol</ao:exact>
    <ao:prefix> does not affect the pharmacokinetics of </ao:prefix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:3DFC0290-B79C-492E-A5DB-32EF23C9B433"/>
    <domeo:uuid>3DFC0290-B79C-492E-A5DB-32EF23C9B433</domeo:uuid>
    <pav:createdOn>2014-07-24 19:43:03 -0400</pav:createdOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:90D65AEF-2F91-4982-9D2A-D9266BCF827E">
    <domeo:belongsToSet>urn:domeoclient:uuid:A0E3203A-2AD3-4045-BAB8-27B340F81B0E</domeo:belongsToSet>
    <rdfs:label>Highlight</rdfs:label>
    <pav:lastSavedOn>2014-07-28 17:02:28 -0400</pav:lastSavedOn>
    <pav:lineageUri>urn:domeoserver:annotation:0934A57A-D0F5-437D-812B-5E7C1D8E703E</pav:lineageUri>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <ao:context rdf:resource="urn:domeoclient:uuid:5F53CA93-4A9A-47DB-B928-A643C66C9223"/>
    <pav:createdOn>2014-07-28 17:02:45 -0400</pav:createdOn>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812eda990003</pav:createdBy>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:B4B8ACAF-EC72-42B7-8537-72C0706EA026">
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:suffix> containing antacid (Maalox®1) decreased fexofenadine AUC by 41% and Cmax by 43%.</ao:suffix>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-139.txt.html</ao:hasSource>
    <domeo:uuid>B4B8ACAF-EC72-42B7-8537-72C0706EA026</domeo:uuid>
    <pav:createdOn>2014-07-24 20:05:50 -0400</pav:createdOn>
    <ao:prefix> and </ao:prefix>
    <ao:exact>magnesium</ao:exact>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:B4B8ACAF-EC72-42B7-8537-72C0706EA026"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:962DC691-3D08-4224-8D22-C0DD8D9F24CA">
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <rdfs:label>Highlight</rdfs:label>
    <ao:context rdf:resource="urn:domeoclient:uuid:0F95BD67-87EE-4AA9-A33E-A0BCF7921FF0"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:createdOn>2014-07-13 12:56:00 -0400</pav:createdOn>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812eda990003</pav:createdBy>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <domeo:belongsToSet>urn:domeoclient:uuid:E89548FF-A4A2-4B87-B1E1-B12E3E255FA1</domeo:belongsToSet>
    <pav:lineageUri>urn:domeoserver:annotation:4EAFAB1D-1E62-4401-9065-8F44961694A1</pav:lineageUri>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:lastSavedOn>2014-07-13 12:56:57 -0400</pav:lastSavedOn>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:96647834-C481-4294-B866-A481E00D4F42">
    <rdf:type rdf:resource="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#DrugDrugInteractionStatement"/>
    <sio:SIO_000205>dikbD2R:statement</sio:SIO_000205>
    <sio:SIO_000563>dikbD2R:modality</sio:SIO_000563>
    <dikbD2R:statement>ncit:Qualitative</dikbD2R:statement>
    <sio:SIO_000628 rdf:resource="urn:pddi:uuid:C20ADD05-5DFA-4D15-B8F8-1DD1BE6A5E76"/>
    <dikbD2R:modality>ncit:negative</dikbD2R:modality>
  </rdf:Description>
  <rdf:Description rdf:nodeID="N2a3050d2d2594b3d86b5f5fbdea7e9f1">
    <domeo:sets rdf:resource="urn:pddi:uuid:7561E693-ED7F-438D-97B3-6718EA0765EF"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:DD921AA0-5FC8-4BE9-AAB8-13B1D92E1958">
    <ao:context rdf:resource="urn:domeoclient:uuid:83CCA675-BEDD-43C9-AB17-7E503848F851"/>
    <domeo:belongsToSet>urn:domeoserver:annotationset:3F546823-204F-4F9B-9006-3DC526C56931</domeo:belongsToSet>
    <domeo:belongsToSet>urn:domeoserver:annotationset:A3F0B39A-4249-4B63-BB0D-F24A005066AC</domeo:belongsToSet>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">2</pav:versionNumber>
    <pav:previousVersion>urn:domeoclient:uuid:BED41F06-565A-4622-9A88-48810E5A28DE</pav:previousVersion>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812eda990003</pav:createdBy>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <rdfs:label>Highlight</rdfs:label>
    <pav:lineageUri>urn:domeoserver:annotation:D0A83273-3F3F-41A3-8EC5-1E9E1DFBA2BB</pav:lineageUri>
    <domeo:belongsToSet>urn:domeoserver:annotationset:A5DD001D-C81A-4E2E-B5E0-7A866B35E26B</domeo:belongsToSet>
    <pav:lineageUri>urn:domeoserver:annotationset:D1715BD2-BD41-46FD-9454-DC7A423A29AC</pav:lineageUri>
    <pav:createdOn>2014-09-02 11:39:08 -0400</pav:createdOn>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:lastSavedOn>2014-09-02 11:46:58 -0400</pav:lastSavedOn>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/E3B94EBF-C4D0-4821-A9AB-263797FD795D">
    <sio:SIO_000228>dikbD2R:object-drug-of-interaction</sio:SIO_000228>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/active-ingredient"/>
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/87636</dailymed:activeMoietyRxCUI>
    <dct:description>Referred to the drug in the interaction.</dct:description>
    <rdfs:label>Fexofenadine</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:4F8ED859-2391-4F15-8FA4-EA14374BCE11">
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-47.txt.html</ao:hasSource>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:exact>atomoxetine</ao:exact>
    <ao:suffix> be initiated at a reduced dose when given with paroxetine.</ao:suffix>
    <domeo:uuid>4F8ED859-2391-4F15-8FA4-EA14374BCE11</domeo:uuid>
    <pav:createdOn>2014-09-02 12:03:45 -0400</pav:createdOn>
    <ao:prefix> may be necessary and it is recommended that </ao:prefix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:4F8ED859-2391-4F15-8FA4-EA14374BCE11"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:7A327F1B-E170-41D6-BEC1-65E5D1CB43B8">
    <rdf:type rdf:resource="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#DrugDrugInteractionStatement"/>
    <sio:SIO_000628 rdf:resource="urn:pddi:uuid:62EE12D9-5314-4E3B-81A5-6CC4F5785F46"/>
    <sio:SIO_000205>dikbD2R:statement</sio:SIO_000205>
    <sio:SIO_000563>dikbD2R:modality</sio:SIO_000563>
    <dikbD2R:statement>ncit:quantitative</dikbD2R:statement>
    <dikbD2R:modality>ncit:positive</dikbD2R:modality>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:F8DD977A-C7DF-4C3A-9290-F79622C98E04">
    <sio:SIO_000563>dikbD2R:modality</sio:SIO_000563>
    <dikbD2R:statement>ncit:Qualitative</dikbD2R:statement>
    <dikbD2R:modality>ncit:negative</dikbD2R:modality>
    <rdf:type rdf:resource="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#DrugDrugInteractionStatement"/>
    <sio:SIO_000628 rdf:resource="urn:pddi:uuid:72A9F07A-1698-493D-9547-2E7E44A97B40"/>
    <sio:SIO_000205>dikbD2R:statement</sio:SIO_000205>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:35CDD6FE-B2DA-45B7-836A-B05452D0DAB8">
    <ao:exact>voriconazole </ao:exact>
    <ao:prefix>and </ao:prefix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:35CDD6FE-B2DA-45B7-836A-B05452D0DAB8"/>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-74.txt.html</ao:hasSource>
    <domeo:uuid>35CDD6FE-B2DA-45B7-836A-B05452D0DAB8</domeo:uuid>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <pav:createdOn>2014-09-02 19:13:49 -0400</pav:createdOn>
    <ao:suffix>(a combined inhibitor of CYP2C19 and CYP3A4) resulted in more than doubling of the omeprazole exposure. Dose adjustment of omeprazole is not normally required. However, in patients with Zollinger-Ellison syndrome, who may require higher doses up to 240 m</ao:suffix>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:164A1C02-147C-4620-8927-26251560C2C2">
    <pav:createdOn>2014-07-24 20:02:13 -0400</pav:createdOn>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:lastSavedOn>2014-07-24 20:02:49 -0400</pav:lastSavedOn>
    <domeo:belongsToSet>urn:domeoclient:uuid:189A8E0E-67D6-4C53-A96E-CB48A3B4B2E9</domeo:belongsToSet>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:lineageUri>urn:domeoserver:annotation:56C2F38D-C848-4229-BC11-951066231DC2</pav:lineageUri>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <ao:context rdf:resource="urn:domeoclient:uuid:F4BA9A75-9ED6-4A34-AD9F-D5874AACDFF0"/>
    <rdfs:label>Highlight</rdfs:label>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812eda990003</pav:createdBy>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:BD57075E-3889-44CB-8FF4-EC5663C33AC0">
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <rdfs:label>Highlight</rdfs:label>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812eda990003</pav:createdBy>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <domeo:belongsToSet>urn:domeoclient:uuid:C9195181-C772-4ED4-ADD8-56970C72AD38</domeo:belongsToSet>
    <pav:createdOn>2014-09-02 19:40:40 -0400</pav:createdOn>
    <pav:lineageUri>urn:domeoserver:annotation:148E4096-0199-4C34-98AB-FB1EA8CD9625</pav:lineageUri>
    <pav:lastSavedOn>2014-09-02 19:40:44 -0400</pav:lastSavedOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <ao:context rdf:resource="urn:domeoclient:uuid:05AFE2BC-8117-40BD-BC72-6B1AA0443A12"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:0DCFB2B8-8A03-443E-AC2D-8FA3EBDA0087">
    <rdfs:label>expertstudy Annotation</rdfs:label>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:lastSavedOn>2014-07-22 20:22:38 -0400</pav:lastSavedOn>
    <pav:lineageUri>urn:domeoserver:annotation:BA098515-4096-4EFB-BF90-5970404842E1</pav:lineageUri>
    <pav:createdOn>2014-07-22 20:19:49 -0400</pav:createdOn>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812eda990003</pav:createdBy>
    <ao:body rdf:nodeID="Ncae526887c204b68a2b7d826aaa1be04"/>
    <domeo:belongsToSet>urn:domeoserver:annotationset:F272A789-69D0-47CC-8CC9-F25C55B91261</domeo:belongsToSet>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#expertstudyAnnotation"/>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <ao:context rdf:resource="urn:domeoclient:uuid:4EA9F290-CB9E-46F8-AF87-B09760F74365"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:03FCDCDD-B854-48FC-9FD5-39AD4A15667C">
    <domeo:uuid>03FCDCDD-B854-48FC-9FD5-39AD4A15667C</domeo:uuid>
    <ao:exact>fexofenadine hydrochloride</ao:exact>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-139.txt.html</ao:hasSource>
    <ao:suffix> was administered with either grapefruit or orange juices compared to water. Based on the literature reports, the same effects may be extrapolated to other fruit juices such as apple juice. The clinical significance of these observations is unknown. In a</ao:suffix>
    <ao:prefix>. This is based on the results from three clinical studies using histamine induced skin wheals and flares coupled with population pharmacokinetic analysis. The size of wheal and flare were significantly larger when </ao:prefix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:03FCDCDD-B854-48FC-9FD5-39AD4A15667C"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <pav:createdOn>2014-07-24 20:12:42 -0400</pav:createdOn>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:A250DA9B-BB28-425B-B634-A002C82007BD">
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/7C9742EE-BA6E-4470-AF96-757C3B8CF332"/>
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/2B0C5D0C-3721-4FB9-8865-41008B332960"/>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/PK_DDI"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:7AF3A49F-90C3-4D03-97CB-74AE03BF7C86">
    <rdfs:label>Highlight</rdfs:label>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <ao:context rdf:resource="urn:domeoclient:uuid:F557214F-193F-480C-8483-C59A8CFCD22E"/>
    <domeo:belongsToSet>urn:domeoclient:uuid:71191E51-53CB-4FDE-88D0-33C6818E2232</domeo:belongsToSet>
    <pav:lastSavedOn>2014-07-13 11:32:29 -0400</pav:lastSavedOn>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812eda990003</pav:createdBy>
    <pav:lineageUri>urn:domeoserver:annotation:0C24008F-78E2-49EE-9161-71EEB60D2ECD</pav:lineageUri>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:createdOn>2014-07-13 11:09:17 -0400</pav:createdOn>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:47CAE4AD-FEB1-437D-9ADB-758C9BEBE377">
    <pav:createdOn>2014-07-24 20:07:48 -0400</pav:createdOn>
    <ao:exact>erythromycin</ao:exact>
    <ao:suffix> 500 mg every 8 hours or ketoconazole 400 mg once daily under steady-state conditions to healthy adult subjects (n = 24, each study). No differences in adverse events or QTc interval were observed when subjects were administered fexofenadine hydrochlorid</ao:suffix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:47CAE4AD-FEB1-437D-9ADB-758C9BEBE377"/>
    <ao:prefix> 120 mg twice daily (240 mg total daily dose) was coadministered with either </ao:prefix>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-139.txt.html</ao:hasSource>
    <domeo:uuid>47CAE4AD-FEB1-437D-9ADB-758C9BEBE377</domeo:uuid>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:8FCF78FA-4364-4E1D-8DBE-DAD0065AD4F4">
    <pav:createdOn>2014-07-22 19:34:53 -0400</pav:createdOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:exact>rosiglitazone</ao:exact>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:8FCF78FA-4364-4E1D-8DBE-DAD0065AD4F4"/>
    <ao:prefix>Unbound oral clearance of </ao:prefix>
    <ao:suffix> was significantly lower in patients with moderate to severe liver disease (Child-Pugh Class B/C) compared to healthy subjects. As a result, unbound Cmax and AUC0-inf were increased 2- and 3-fold, respectively. Elimination half-life for rosiglitazone was</ao:suffix>
    <domeo:uuid>8FCF78FA-4364-4E1D-8DBE-DAD0065AD4F4</domeo:uuid>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-123.txt.html</ao:hasSource>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:FF3A4E4B-56B2-47CF-B174-C006C3954623">
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812eda990003</pav:createdBy>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:createdOn>2014-09-01 16:19:52 -0400</pav:createdOn>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <rdfs:label>Highlight</rdfs:label>
    <domeo:belongsToSet>urn:domeoclient:uuid:94DCE217-B72B-4727-9783-98D7EFCB02E6</domeo:belongsToSet>
    <ao:context rdf:resource="urn:domeoclient:uuid:082BC34B-E2CB-4EAD-908C-433213A92A0D"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:lineageUri>urn:domeoserver:annotation:B604BC28-04F3-406B-BA4D-891CD1698D81</pav:lineageUri>
    <pav:lastSavedOn>2014-09-01 16:20:01 -0400</pav:lastSavedOn>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:EFB9988E-CEA1-4326-AC04-4DC5F728B495">
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <pav:createdOn>2014-07-22 19:38:33 -0400</pav:createdOn>
    <domeo:uuid>EFB9988E-CEA1-4326-AC04-4DC5F728B495</domeo:uuid>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-123.txt.html</ao:hasSource>
    <ao:prefix>xsd:String</ao:prefix>
    <ao:exact>rosiglitazone</ao:exact>
    <ao:suffix>xsd:String</ao:suffix>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:EFB9988E-CEA1-4326-AC04-4DC5F728B495"/>
  </rdf:Description>
  <rdf:Description rdf:nodeID="N6b4960fe8ade40debecf6a621b26c4a4">
    <permissions:isLocked>false</permissions:isLocked>
    <permissions:accessType>urn:domeo:access:public</permissions:accessType>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:97C469A7-A5FD-4636-8744-4240B805D2D0">
    <pav:lineageUri>urn:domeoserver:annotationset:4A88D0A6-E9B6-4E7F-955F-3692600C178C</pav:lineageUri>
    <pav:createdOn>2014-07-24 20:07:48 -0400</pav:createdOn>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812eda990003</pav:createdBy>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <domeo:belongsToSet>urn:domeoserver:annotationset:1FC172B8-8AC3-465A-AA69-B73AD9B97CBC</domeo:belongsToSet>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">2</pav:versionNumber>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <rdfs:label>Highlight</rdfs:label>
    <pav:lastSavedOn>2014-07-24 20:10:49 -0400</pav:lastSavedOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <ao:context rdf:resource="urn:domeoclient:uuid:47CAE4AD-FEB1-437D-9ADB-758C9BEBE377"/>
    <domeo:belongsToSet>urn:domeoserver:annotationset:37B2514D-1A92-45B1-8A5C-610DA6DC935A</domeo:belongsToSet>
    <pav:lastSavedOn>2014-07-24 20:10:48 -0400</pav:lastSavedOn>
    <pav:lineageUri>urn:domeoserver:annotation:19DB9C4A-1EA6-47E6-B4EC-00F3327FBEC4</pav:lineageUri>
    <pav:previousVersion>urn:domeoclient:uuid:8D86A4AC-54BD-4BB3-8B58-AB55DEC01A88</pav:previousVersion>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:2E73BB40-870E-4E49-B189-491A7CC6CA08">
    <pav:createdOn>2014-09-02 15:04:25 -0400</pav:createdOn>
    <ao:exact>cyclosporine</ao:exact>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-48.txt.html</ao:hasSource>
    <ao:prefix>, and </ao:prefix>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:2E73BB40-870E-4E49-B189-491A7CC6CA08"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:suffix>. Based on the assumption that the relationship between paroxetine’s in vitro Ki and its lack of effect on terfenadine's in vivo clearance predicts its effect on other CYP3A4 substrates, paroxetine’s extent of inhibition of CYP3A4 activity is not likely </ao:suffix>
    <domeo:uuid>2E73BB40-870E-4E49-B189-491A7CC6CA08</domeo:uuid>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:A5437FEA-0356-41EE-AA7B-C75739F23B59">
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <rdfs:label>Highlight</rdfs:label>
    <pav:lineageUri>urn:domeoserver:annotation:E8F4B9CE-115D-4AE7-A348-FFA1CBDB2315</pav:lineageUri>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812eda990003</pav:createdBy>
    <pav:createdOn>2014-09-01 16:12:30 -0400</pav:createdOn>
    <ao:context rdf:resource="urn:domeoclient:uuid:8DA59D18-94D7-4239-958E-D00E6CCD30E7"/>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <domeo:belongsToSet>urn:domeoclient:uuid:5D381360-05CD-407C-BAB9-6496A42C73E4</domeo:belongsToSet>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:lastSavedOn>2014-09-01 16:12:36 -0400</pav:lastSavedOn>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:3E595AA2-A52D-41DE-BC69-4125AE10A552">
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <domeo:uuid>3E595AA2-A52D-41DE-BC69-4125AE10A552</domeo:uuid>
    <ao:exact>paroxetine</ao:exact>
    <pav:createdOn>2014-09-02 15:04:34 -0400</pav:createdOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:3E595AA2-A52D-41DE-BC69-4125AE10A552"/>
    <ao:prefix>’s in vitro Ki and its lack of effect on terfenadine's in vivo clearance predicts its effect on other CYP3A4 substrates, </ao:prefix>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-48.txt.html</ao:hasSource>
    <ao:suffix>’s extent of inhibition of CYP3A4 activity is not likely to be of clinical significance.</ao:suffix>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:D693BC09-DDB8-454B-A812-E73AB798F6FA">
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:lineageUri>urn:domeoserver:annotation:6B49FA47-1F50-493D-8BC1-8FE334B2397B</pav:lineageUri>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <domeo:belongsToSet>urn:domeoserver:annotationset:606A5B3F-B6FB-4279-AA42-7893CFC2D20C</domeo:belongsToSet>
    <pav:lineageUri>urn:domeoserver:annotationset:AB1741F1-5A5F-4416-AEAC-A544BCBB7D16</pav:lineageUri>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">4</pav:versionNumber>
    <pav:createdOn>2014-07-22 19:34:53 -0400</pav:createdOn>
    <domeo:belongsToSet>urn:domeoserver:annotationset:F272A789-69D0-47CC-8CC9-F25C55B91261</domeo:belongsToSet>
    <domeo:belongsToSet>urn:domeoserver:annotationset:514BA51B-D734-4003-A7C3-F03C0F95833A</domeo:belongsToSet>
    <domeo:belongsToSet>urn:domeoserver:annotationset:2914A3FD-DF43-4F78-999C-77CE7A028B19</domeo:belongsToSet>
    <pav:previousVersion>urn:domeoserver:annotationset:7E80543E-BF76-4514-92A9-91458DCB802B</pav:previousVersion>
    <domeo:belongsToSet>urn:domeoserver:annotationset:7021B883-FD5C-4083-BD87-DF56D3C87633</domeo:belongsToSet>
    <rdfs:label>Highlight</rdfs:label>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812eda990003</pav:createdBy>
    <pav:lastSavedOn>2014-07-22 19:35:16 -0400</pav:lastSavedOn>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <ao:context rdf:resource="urn:domeoclient:uuid:8FCF78FA-4364-4E1D-8DBE-DAD0065AD4F4"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:C7A86B1F-FEF9-4500-AC47-4A4949A51ABD">
    <pav:createdOn>2014-07-13 12:38:35 -0400</pav:createdOn>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812eda990003</pav:createdBy>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <rdfs:label>Highlight</rdfs:label>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <domeo:belongsToSet>urn:domeoclient:uuid:4F872953-6D19-4809-9285-FCCF2FF54315</domeo:belongsToSet>
    <pav:lineageUri>urn:domeoserver:annotation:47D86654-5774-44C8-91EF-5162D998152D</pav:lineageUri>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:lastSavedOn>2014-07-13 12:41:10 -0400</pav:lastSavedOn>
    <ao:context rdf:resource="urn:domeoclient:uuid:A54DB360-9E9B-4E55-AC79-A80E321825D3"/>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/2EC6AEAC-5E19-484C-A69E-7511B32043B8">
    <dct:description>Referred to the drug in the interaction.</dct:description>
    <sio:SIO_000228>dikbD2R:precipitant-drug-of-interaction</sio:SIO_000228>
    <rdfs:label>Rifampin</rdfs:label>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/active-ingredient"/>
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/9384</dailymed:activeMoietyRxCUI>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:4FEA5923-D748-4E87-8041-D8BE9DFF7EAA">
    <pav:lineageUri>urn:domeoserver:annotation:D2F7CB67-D160-465A-9A39-FCF7F38FFD34</pav:lineageUri>
    <rdfs:label>Highlight</rdfs:label>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:lastSavedOn>2014-07-28 17:08:37 -0400</pav:lastSavedOn>
    <domeo:belongsToSet>urn:domeoclient:uuid:48D839E5-6B0A-4EC3-B64A-E3E20E06246A</domeo:belongsToSet>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <ao:context rdf:resource="urn:domeoclient:uuid:D39A9499-CCA7-4666-A0EC-BE7D45405E91"/>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812eda990003</pav:createdBy>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:createdOn>2014-07-28 17:04:35 -0400</pav:createdOn>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:C3190341-7099-485B-A4E9-E9FFAB0E8032">
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-165.txt.html</ao:hasSource>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <domeo:uuid>C3190341-7099-485B-A4E9-E9FFAB0E8032</domeo:uuid>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:C3190341-7099-485B-A4E9-E9FFAB0E8032"/>
    <ao:exact>Meperidine</ao:exact>
    <pav:createdOn>2014-07-28 17:01:19 -0400</pav:createdOn>
    <ao:suffix> is contraindicated in patients who are receiving monoamine oxidase (MAO) inhibitors or those who have recently received such agents. Therapeutic doses of meperidine have occasionally precipitated unpredictable, severe, and occasionally fatal reactions i</ao:suffix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:prefix>xsd:String</ao:prefix>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:A1184FE6-5357-43C5-BB6C-87EC586C8468">
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <pav:createdOn>2014-07-21 21:50:34 -0400</pav:createdOn>
    <rdfs:label>Highlight</rdfs:label>
    <ao:context rdf:resource="urn:domeoclient:uuid:35FBCEB9-D10F-4DB4-8F8D-DB121D785B9B"/>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812eda990003</pav:createdBy>
    <pav:lastSavedOn>2014-07-21 21:50:30 -0400</pav:lastSavedOn>
    <domeo:belongsToSet>urn:domeoclient:uuid:404B1852-88F6-45BB-8C18-358B3A408485</domeo:belongsToSet>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:lineageUri>urn:domeoserver:annotation:2ABACF29-D8D4-48D6-8FEC-7F26497385EC</pav:lineageUri>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:292BF8EC-0E65-4E33-A331-3D217DD6B134">
    <domeo:belongsToSet>urn:domeoserver:annotationset:514BA51B-D734-4003-A7C3-F03C0F95833A</domeo:belongsToSet>
    <pav:lineageUri>urn:domeoserver:annotation:19C62095-BAAB-4536-A42D-007C74348003</pav:lineageUri>
    <ao:context rdf:resource="urn:domeoclient:uuid:B2987A9F-B765-4C33-B2FF-1E55869E162F"/>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:lastSavedOn>2014-07-22 19:40:31 -0400</pav:lastSavedOn>
    <pav:lastSavedOn>2014-07-22 19:40:32 -0400</pav:lastSavedOn>
    <pav:previousVersion>urn:domeoserver:annotationset:7021B883-FD5C-4083-BD87-DF56D3C87633</pav:previousVersion>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <domeo:belongsToSet>urn:domeoserver:annotationset:606A5B3F-B6FB-4279-AA42-7893CFC2D20C</domeo:belongsToSet>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">5</pav:versionNumber>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <rdfs:label>Highlight</rdfs:label>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812eda990003</pav:createdBy>
    <pav:lineageUri>urn:domeoserver:annotationset:AB1741F1-5A5F-4416-AEAC-A544BCBB7D16</pav:lineageUri>
    <domeo:belongsToSet>urn:domeoserver:annotationset:F272A789-69D0-47CC-8CC9-F25C55B91261</domeo:belongsToSet>
    <domeo:belongsToSet>urn:domeoserver:annotationset:2914A3FD-DF43-4F78-999C-77CE7A028B19</domeo:belongsToSet>
    <pav:createdOn>2014-07-22 19:37:19 -0400</pav:createdOn>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:FC8952F2-7F31-41D0-BEDA-AC57C009870A">
    <domeo:uuid>FC8952F2-7F31-41D0-BEDA-AC57C009870A</domeo:uuid>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-47.txt.html</ao:hasSource>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:FC8952F2-7F31-41D0-BEDA-AC57C009870A"/>
    <ao:exact> In 1 study, daily dosing of immediate-release paroxetine (20 mg once daily) under steady-state conditions increased single-dose desipramine (100 mg) Cmax, AUC, and T½ by an average of approximately 2-, 5-, and 3-fold, respectively. </ao:exact>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:prefix>may significantly inhibit the activity of this isozyme. In most patients (&gt;90%), this CYP2D6 isozyme is saturated early during paroxetine dosing.</ao:prefix>
    <ao:suffix> Concomitant use of</ao:suffix>
    <pav:createdOn>2014-09-02 12:04:40 -0400</pav:createdOn>
  </rdf:Description>
  <rdf:Description rdf:nodeID="Nf76a020971ca4e628b60dbd5707e083d">
    <permissions:accessType>urn:domeo:access:public</permissions:accessType>
    <permissions:isLocked>false</permissions:isLocked>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:3CDFB7B3-F366-4F19-B27E-4B00DC64BA96">
    <domeo:uuid>3CDFB7B3-F366-4F19-B27E-4B00DC64BA96</domeo:uuid>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <pav:createdOn>2014-09-02 19:19:31 -0400</pav:createdOn>
    <ao:prefix>Concomitant administration of </ao:prefix>
    <ao:suffix> and tacrolimus may increase the serum levels of tacrolimus. </ao:suffix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:3CDFB7B3-F366-4F19-B27E-4B00DC64BA96"/>
    <ao:exact>omeprazole</ao:exact>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-74.txt.html</ao:hasSource>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:2B1C7E3B-0E62-4AAE-9A68-874D098352C2">
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:suffix> (150 mg twice daily for 4 days) did not alter the pharmacokinetics of either single oral or intravenous doses of rosiglitazone in healthy volunteers. These results suggest that the absorption of oral rosiglitazone is not altered in conditions accompanie</ao:suffix>
    <ao:exact>ranitidine</ao:exact>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:2B1C7E3B-0E62-4AAE-9A68-874D098352C2"/>
    <pav:createdOn>2014-07-22 20:18:32 -0400</pav:createdOn>
    <ao:prefix>Pretreatment with </ao:prefix>
    <domeo:uuid>2B1C7E3B-0E62-4AAE-9A68-874D098352C2</domeo:uuid>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-123.txt.html</ao:hasSource>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:CE03C8BC-514A-4589-B370-5BBCAFD1AFE7">
    <ao:context rdf:resource="urn:domeoclient:uuid:0B56F971-EB28-4859-ADD4-58040927A5DF"/>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">3</pav:versionNumber>
    <domeo:belongsToSet>urn:domeoserver:annotationset:A5DD001D-C81A-4E2E-B5E0-7A866B35E26B</domeo:belongsToSet>
    <pav:previousVersion>urn:domeoserver:annotationset:3F546823-204F-4F9B-9006-3DC526C56931</pav:previousVersion>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812eda990003</pav:createdBy>
    <rdfs:label>Highlight</rdfs:label>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:lineageUri>urn:domeoserver:annotation:D8CC0B5B-6A6C-49F5-844C-4C4FFD6FF292</pav:lineageUri>
    <pav:lastSavedOn>2014-09-02 11:49:28 -0400</pav:lastSavedOn>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <pav:createdOn>2014-09-02 11:49:22 -0400</pav:createdOn>
    <pav:lineageUri>urn:domeoserver:annotationset:D1715BD2-BD41-46FD-9454-DC7A423A29AC</pav:lineageUri>
    <domeo:belongsToSet>urn:domeoserver:annotationset:A3F0B39A-4249-4B63-BB0D-F24A005066AC</domeo:belongsToSet>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/4BCAA30A-4939-4A50-A548-16A452EDFC69">
    <dct:description>Referred to the drug in the interaction.</dct:description>
    <rdfs:label>fluvoxamine</rdfs:label>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/active-ingredient"/>
    <sio:SIO_000228>dikbD2R:precipitant-drug-of-interaction</sio:SIO_000228>
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/42355</dailymed:activeMoietyRxCUI>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:95AEC430-A2F4-4B0D-B623-70050D7B891E">
    <pav:lastSavedOn>2014-07-13 11:32:29 -0400</pav:lastSavedOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <ao:context rdf:resource="urn:domeoclient:uuid:CC861D6D-4076-4F69-B134-B404C685F91A"/>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <rdfs:label>Highlight</rdfs:label>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812eda990003</pav:createdBy>
    <domeo:belongsToSet>urn:domeoclient:uuid:71191E51-53CB-4FDE-88D0-33C6818E2232</domeo:belongsToSet>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <pav:createdOn>2014-07-13 11:18:24 -0400</pav:createdOn>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:lineageUri>urn:domeoserver:annotation:EB8C6594-359A-42D0-A03E-A9374296DDDA</pav:lineageUri>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/60D19F56-D600-4248-96B6-A68AD83F290A">
    <rdfs:label>diltiazem</rdfs:label>
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/3443</dailymed:activeMoietyRxCUI>
    <sio:SIO_000228>dikbD2R:object-drug-of-interaction</sio:SIO_000228>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/active-ingredient"/>
    <dct:description>Referred to the drug in the interaction.</dct:description>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:E65F5A7D-A02D-468C-B1BF-DA59E8B655C9">
    <ao:prefix>In post-marketing experience, there have been isolated, spontaneous reports of pulmonary changes including pulmonary infiltration and pulmonary fibrosis during </ao:prefix>
    <ao:suffix> therapy with or without other drugs or diseases that are known to produce pulmonary toxicity. A causal relationship to </ao:suffix>
    <ao:exact>mexiletine</ao:exact>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-160.txt.html</ao:hasSource>
    <domeo:uuid>E65F5A7D-A02D-468C-B1BF-DA59E8B655C9</domeo:uuid>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <pav:createdOn>2014-07-24 20:14:15 -0400</pav:createdOn>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:E65F5A7D-A02D-468C-B1BF-DA59E8B655C9"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:4E7D289E-0E68-4A95-9CAF-BA6B4026295E">
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812eda990003</pav:createdBy>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <domeo:belongsToSet>urn:domeoclient:uuid:379CD8C1-F4B4-42B7-8F87-70776866DB1F</domeo:belongsToSet>
    <pav:lineageUri>urn:domeoserver:annotationset:166C20E9-1B4C-47D1-982D-922E2E5ACFF2</pav:lineageUri>
    <rdfs:label>Highlight</rdfs:label>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <domeo:belongsToSet>urn:domeoserver:annotationset:D52DFD7B-BDDF-488F-B339-B1BC641E50E9</domeo:belongsToSet>
    <pav:lineageUri>urn:domeoserver:annotation:FA6E79F7-840B-4AC3-9280-D7221B60BBFF</pav:lineageUri>
    <ao:context rdf:resource="urn:domeoclient:uuid:DB9F8CF3-932C-4B62-8B9D-7E4C3E1A4FF6"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:createdOn>2014-09-02 12:03:00 -0400</pav:createdOn>
    <pav:lastSavedOn>2014-09-02 12:03:47 -0400</pav:lastSavedOn>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:55F0E65E-65B9-4FEF-9D48-18521D03D3DC">
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <pav:lineageUri>urn:domeoserver:annotation:0B3AC343-21C5-41C7-88CD-1F70840866D0</pav:lineageUri>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <ao:context rdf:resource="urn:domeoclient:uuid:3E420EBD-D4BF-4705-A9AE-EDDA116820D1"/>
    <pav:createdOn>2014-09-02 19:08:48 -0400</pav:createdOn>
    <rdfs:label>Highlight</rdfs:label>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <domeo:belongsToSet>urn:domeoclient:uuid:3966BCFB-CA02-4053-828D-3860558E7BE8</domeo:belongsToSet>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812eda990003</pav:createdBy>
    <pav:lastSavedOn>2014-09-02 19:11:13 -0400</pav:lastSavedOn>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:762110B9-8FE2-4631-8D47-86C30D8D9102">
    <domeo:uuid>762110B9-8FE2-4631-8D47-86C30D8D9102</domeo:uuid>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:exact>Propranolol</ao:exact>
    <pav:createdOn>2014-07-24 20:00:44 -0400</pav:createdOn>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-135.txt.html</ao:hasSource>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:762110B9-8FE2-4631-8D47-86C30D8D9102"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:prefix> is extensively metabolized with most metabolites appearing in the urine. </ao:prefix>
    <ao:suffix> is metabolized through three primary routes: aromatic hydroxylation (mainly 4-hydroxylation), N-dealkylation followed by further side-chain oxidation, and direct glucuronidation. It has been estimated that the percentage contributions of these routes to</ao:suffix>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:0A177F5C-EB12-4EE0-B135-C40638451C00">
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <domeo:uuid>0A177F5C-EB12-4EE0-B135-C40638451C00</domeo:uuid>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-74.txt.html</ao:hasSource>
    <ao:prefix>. Following multiple doses of nelfinavir (1250 mg, bid) and </ao:prefix>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:0A177F5C-EB12-4EE0-B135-C40638451C00"/>
    <pav:createdOn>2014-09-02 19:18:12 -0400</pav:createdOn>
    <ao:suffix> (40 mg, qd), AUC was decreased by 36% and 92%, Cmax by 37% and 89% and Cmin by 39% and 75% respectively for nelfinavir and M8. Following multiple doses of atazanavir (400 mg, qd) and omeprazole (40 mg, qd, 2 hr before atazanavir), AUC was decreased by 9</ao:suffix>
    <ao:exact>omeprazole</ao:exact>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:B866F0DD-7DF3-4E04-804F-9A346D40E738">
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <pav:createdOn>2014-07-24 20:14:10 -0400</pav:createdOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:exact>mexiletine</ao:exact>
    <domeo:uuid>B866F0DD-7DF3-4E04-804F-9A346D40E738</domeo:uuid>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:B866F0DD-7DF3-4E04-804F-9A346D40E738"/>
    <ao:suffix> treatment.</ao:suffix>
    <ao:prefix>ted reports of drowsiness, nystagmus, ataxia, dyspepsia, hypersensitivity reaction, and exacerbation of congestive heart failure in patients with pre-existing compromised ventricular function. There have been rare reports of pancreatitis associated with </ao:prefix>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-160.txt.html</ao:hasSource>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:45E3AE96-A235-4D7F-BF78-51E479E847A6">
    <sio:SIO_000628 rdf:resource="urn:pddi:uuid:5073B1CB-26F2-4345-8573-7827801E8DD6"/>
    <sio:SIO_000205>dikbD2R:statement</sio:SIO_000205>
    <sio:SIO_000563>dikbD2R:modality</sio:SIO_000563>
    <dikbD2R:statement>ncit:quantitative</dikbD2R:statement>
    <dikbD2R:modality>ncit:positive</dikbD2R:modality>
    <rdf:type rdf:resource="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#DrugDrugInteractionStatement"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:7E65733E-5455-4115-AFE9-BA2E1EB6BB2F">
    <ao:suffix>. If concomitant treatment of fluvoxamine with a triptan is clinically warranted, careful observation of the patient is advised, particularly during treatment initiation and dose increases (see WARNINGS AND PRECAUTIONS [5.3]).</ao:suffix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:prefix>Triptans: There have been rare postmarketing reports of serotonin syndrome with use of an SSRI and a </ao:prefix>
    <ao:exact>triptan</ao:exact>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <domeo:uuid>7E65733E-5455-4115-AFE9-BA2E1EB6BB2F</domeo:uuid>
    <pav:createdOn>2014-09-02 11:43:18 -0400</pav:createdOn>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-9.txt.html</ao:hasSource>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:7E65733E-5455-4115-AFE9-BA2E1EB6BB2F"/>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/EAC1688B-D768-4B56-8D0E-B9D5F8FC7164">
    <rdfs:label>Diazepam</rdfs:label>
    <sio:SIO_000228>dikbD2R:object-drug-of-interaction</sio:SIO_000228>
    <dct:description>Referred to the drug in the interaction.</dct:description>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/active-ingredient"/>
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/3322</dailymed:activeMoietyRxCUI>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:CEE8C6E7-92B6-4611-A8A6-213D50A907B1">
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:exact>An inhibitor of CYP2C8 (e.g., gemfibrozil) may increase the AUC of rosiglitazone and an inducer of CYP2C8 (e.g., rifampin) may decrease the AUC of rosiglitazone. Therefore, if an inhibitor or an inducer of CYP2C8 is started or stopped during treatment with rosiglitazone, changes in diabetes treatment may be needed based upon clinical response.</ao:exact>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:CEE8C6E7-92B6-4611-A8A6-213D50A907B1"/>
    <ao:suffix> [See Clinical Pharmacology (12.4).]</ao:suffix>
    <domeo:uuid>CEE8C6E7-92B6-4611-A8A6-213D50A907B1</domeo:uuid>
    <pav:createdOn>2014-07-22 19:08:18 -0400</pav:createdOn>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-122.txt.html</ao:hasSource>
    <ao:prefix>xsd:String</ao:prefix>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:58965DB7-A15D-49D8-BC77-60DF512B6132">
    <sio:SIO_000563>dikbD2R:modality</sio:SIO_000563>
    <rdf:type rdf:resource="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#DrugDrugInteractionStatement"/>
    <sio:SIO_000205>dikbD2R:statement</sio:SIO_000205>
    <dikbD2R:modality>ncit:positive</dikbD2R:modality>
    <sio:SIO_000628 rdf:resource="urn:pddi:uuid:72D01271-A1C0-4012-BD2D-70CB0846FFF5"/>
    <dikbD2R:statement>ncit:quantitative</dikbD2R:statement>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:28F0EB50-7D95-4C50-8040-47E337110AC7">
    <pav:createdOn>2014-09-02 19:08:35 -0400</pav:createdOn>
    <domeo:uuid>28F0EB50-7D95-4C50-8040-47E337110AC7</domeo:uuid>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:28F0EB50-7D95-4C50-8040-47E337110AC7"/>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-72.txt.html</ao:hasSource>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:exact>pentazocine</ao:exact>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:suffix>, nalbuphine, butorphanol and buprenorphine) to patients who have received or are receiving a course of therapy with a pure opioid agonist analgesic such as oxycodone hydrochloride. In these patients, mixed agonist/antagonist analgesics may reduce the an</ao:suffix>
    <ao:prefix>Do not administer mixed agonist/antagonist analgesics (i.e., </ao:prefix>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:16FE2F0D-3BF4-4708-9147-BD5159B47059">
    <domeo:uuid>16FE2F0D-3BF4-4708-9147-BD5159B47059</domeo:uuid>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:exact>quinidine</ao:exact>
    <pav:createdOn>2014-07-13 11:14:31 -0400</pav:createdOn>
    <ao:suffix>. Extensive CYP 2D6 metabolizers convert </ao:suffix>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-8.txt.html</ao:hasSource>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:16FE2F0D-3BF4-4708-9147-BD5159B47059"/>
    <ao:prefix>r drugs. CYP 2D6 is subject to genetic polymorphism (about 6% to 8% of Caucasians, and a very low percentage of Asians, have little or no activity and are “poor metabolizers”) and to inhibition by a variety of substrates and some non-substrates, notably </ao:prefix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:024DA998-8A48-48B5-83FB-3E3328F234D5">
    <ao:prefix>. These data indicate that sertraline’s extent of inhibition of P450 3A4 activity is not likely to be of clinical significance. Results of the interaction study with cisapride indicate that </ao:prefix>
    <pav:createdOn>2014-09-01 15:57:37 -0400</pav:createdOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:suffix>200 mg (q.d.) induces the metabolism of cisapride (cisapride AUC and Cmax were reduced by about 35%).</ao:suffix>
    <ao:exact>sertraline </ao:exact>
    <domeo:uuid>024DA998-8A48-48B5-83FB-3E3328F234D5</domeo:uuid>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:024DA998-8A48-48B5-83FB-3E3328F234D5"/>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-16.txt.html</ao:hasSource>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:F4BA9A75-9ED6-4A34-AD9F-D5874AACDFF0">
    <ao:prefix> (200 mg twice daily, 4 doses) on the pharmacokinetics of a single dose of </ao:prefix>
    <ao:exact>trazodone</ao:exact>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:F4BA9A75-9ED6-4A34-AD9F-D5874AACDFF0"/>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-136.txt.html</ao:hasSource>
    <ao:suffix> (50 mg) has been studied in 10 healthy subjects. The Cmax of trazodone increased by 34%, the AUC increased 2.4 fold, the half-life increased by 2.2 fold, and the clearance decreased by 52%. Adverse effects including nausea, hypotension, and syncope were</ao:suffix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <domeo:uuid>F4BA9A75-9ED6-4A34-AD9F-D5874AACDFF0</domeo:uuid>
    <pav:createdOn>2014-07-24 20:02:13 -0400</pav:createdOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:68293B6C-C124-4A8B-AD38-563F597E9486">
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-119.txt.html</ao:hasSource>
    <domeo:uuid>68293B6C-C124-4A8B-AD38-563F597E9486</domeo:uuid>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:prefix>ed or confirmed methicillin-resistant staphylococcus or if the patient was allergic to penicillins, cephalosporins or carbapenems. Study JRV 304 enrolled 450 patients (n = 229 Synercid; n= 221 Comparator) and Study JRV 305 enrolled 443 patients (n = 221 </ao:prefix>
    <ao:suffix>; n = 222 Comparator). </ao:suffix>
    <pav:createdOn>2014-07-22 18:52:17 -0400</pav:createdOn>
    <ao:exact>Synercid</ao:exact>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:68293B6C-C124-4A8B-AD38-563F597E9486"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:806597EC-5BAB-46E0-96D6-B25563A80A8C">
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-8.txt.html</ao:hasSource>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:exact>risperidone</ao:exact>
    <pav:createdOn>2014-07-13 11:14:57 -0400</pav:createdOn>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:806597EC-5BAB-46E0-96D6-B25563A80A8C"/>
    <ao:prefix> [see 7 DRUG INTERACTIONS]. This occurs with quinidine, giving essentially all recipients a </ao:prefix>
    <domeo:uuid>806597EC-5BAB-46E0-96D6-B25563A80A8C</domeo:uuid>
    <ao:suffix> pharmacokinetic profile typical of poor metabolizers. The therapeutic benefits and adverse effects of risperidone in patients receiving quinidine have not been evaluated, but observations in a modest number (N≅70) of poor metabolizers given risperidone </ao:suffix>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:326CE5A9-3567-4645-9375-940B32F01216">
    <domeo:belongsToSet>urn:domeoserver:annotationset:1FC172B8-8AC3-465A-AA69-B73AD9B97CBC</domeo:belongsToSet>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <rdfs:label>Highlight</rdfs:label>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:createdOn>2014-07-24 20:12:55 -0400</pav:createdOn>
    <ao:context rdf:resource="urn:domeoclient:uuid:4EED7C96-E04B-4187-8077-DF5C7020A789"/>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:lastSavedOn>2014-07-24 20:12:49 -0400</pav:lastSavedOn>
    <pav:lineageUri>urn:domeoserver:annotation:64586693-F5DB-44D2-AF71-39671402DBA2</pav:lineageUri>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812eda990003</pav:createdBy>
    <pav:previousVersion>xsd:String</pav:previousVersion>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:657DCEFF-DA71-40A0-8E23-F90A79E8F3B2">
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812eda990003</pav:createdBy>
    <pav:lastSavedOn>2014-09-02 12:02:18 -0400</pav:lastSavedOn>
    <pav:createdOn>2014-09-02 11:58:26 -0400</pav:createdOn>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <ao:context rdf:resource="urn:domeoclient:uuid:5B60DE0C-DAD3-497E-B767-27CC4F4AA306"/>
    <domeo:belongsToSet>urn:domeoclient:uuid:4B51141D-C8D2-45DB-8074-74F8D8323E60</domeo:belongsToSet>
    <pav:lineageUri>urn:domeoserver:annotation:23A6B85A-8C04-4B54-AC49-8D72F071AD15</pav:lineageUri>
    <rdfs:label>Highlight</rdfs:label>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:E5D76E00-F5D9-4E93-B3B6-47859812ACDF">
    <domeo:uuid></domeo:uuid>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <pav:createdOn>2014-07-07 09:39:36 -0400</pav:createdOn>
    <ao:exact>TID s</ao:exact>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-155.txt.html</ao:hasSource>
    <ao:suffix>ildenafil</ao:suffix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <domeo:uuid>E5D76E00-F5D9-4E93-B3B6-47859812ACDF</domeo:uuid>
    <ao:prefix>After chronic dosing of 80 mg </ao:prefix>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:E5D76E00-F5D9-4E93-B3B6-47859812ACDF"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:E4C91349-DA7A-412B-B58B-E0D1EEF83781">
    <sio:SIO_000628 rdf:resource="urn:pddi:uuid:346407F0-F265-40E8-A6A0-BB0525152D4E"/>
    <sio:SIO_000563>dikbD2R:modality</sio:SIO_000563>
    <rdf:type rdf:resource="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#DrugDrugInteractionStatement"/>
    <dikbD2R:modality>ncit:negative</dikbD2R:modality>
    <dikbD2R:statement>ncit:Qualitative</dikbD2R:statement>
    <sio:SIO_000205>dikbD2R:statement</sio:SIO_000205>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:A03AB529-B51D-495B-88D7-404C443338CF">
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-155.txt.html</ao:hasSource>
    <ao:exact>-</ao:exact>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <pav:createdOn>2014-07-07 09:42:34 -0400</pav:createdOn>
    <domeo:uuid>A03AB529-B51D-495B-88D7-404C443338CF</domeo:uuid>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:prefix>xsd:String</ao:prefix>
    <ao:suffix>xsd:String</ao:suffix>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:A03AB529-B51D-495B-88D7-404C443338CF"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:35B88B08-A82B-4D65-B565-57DA9528E578">
    <ao:body rdf:nodeID="N34fa5344f2f446109603fb6d2855ae08"/>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:createdOn>2014-07-24 19:37:50 -0400</pav:createdOn>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <rdfs:label>expertstudy Annotation</rdfs:label>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:lineageUri>urn:domeoserver:annotation:F409994B-1EBD-49AA-BBB6-E27FBBC16767</pav:lineageUri>
    <domeo:belongsToSet>urn:domeoclient:uuid:079AA7B9-9BE4-4706-A20A-5848B50272B5</domeo:belongsToSet>
    <ao:context rdf:resource="urn:domeoclient:uuid:285AE4B3-9649-4D7B-A540-9B1BE0CD0CDA"/>
    <pav:lastSavedOn>2014-07-24 19:37:34 -0400</pav:lastSavedOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#expertstudyAnnotation"/>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812eda990003</pav:createdBy>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:0129AA9B-FCF1-4926-ABF4-20D80C13A55D">
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:suffix> is metabolized in part to oxymorphone via the cytochrome p450 isoenzyme CYP2D6. While this pathway may be blocked by a variety of drugs (e.g., certain cardiovascular drugs and antidepressants), such blockade has not yet been shown to be of clinical sign</ao:suffix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-72.txt.html</ao:hasSource>
    <domeo:uuid>0129AA9B-FCF1-4926-ABF4-20D80C13A55D</domeo:uuid>
    <pav:createdOn>2014-09-02 19:10:32 -0400</pav:createdOn>
    <ao:prefix>xsd:String</ao:prefix>
    <ao:exact>Oxycodone</ao:exact>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:0129AA9B-FCF1-4926-ABF4-20D80C13A55D"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:0E2360A5-44FC-4633-8B3E-758DB777C4E6">
    <pav:createdOn>2014-09-02 19:12:16 -0400</pav:createdOn>
    <ao:context rdf:resource="urn:domeoclient:uuid:98937C65-C245-4875-B071-CCFF5209C083"/>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812eda990003</pav:createdBy>
    <pav:lastSavedOn>2014-09-02 19:19:47 -0400</pav:lastSavedOn>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <domeo:belongsToSet>urn:domeoserver:annotationset:392EE0FB-AC4F-4AF2-87A6-2E50A281F434</domeo:belongsToSet>
    <pav:lineageUri>urn:domeoserver:annotationset:C5DEBC9B-77EE-4243-88EB-DBC19737ACD2</pav:lineageUri>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <domeo:belongsToSet>urn:domeoclient:uuid:CB83FFC2-EA71-44EA-8F11-DE80E389C84E</domeo:belongsToSet>
    <pav:lineageUri>urn:domeoserver:annotation:57D74E8D-2C63-45AB-B060-363407584125</pav:lineageUri>
    <domeo:belongsToSet>urn:domeoserver:annotationset:E32812A9-205B-4EE1-B488-A1E294EDBFB9</domeo:belongsToSet>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <rdfs:label>Highlight</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:AE5EBB85-C1D9-438F-B2E8-17B61D972F3D">
    <ao:prefix> </ao:prefix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:suffix> volunteers</ao:suffix>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-23.txt.html</ao:hasSource>
    <ao:exact>However, the administration of cimetidine 600 mg to 900 mg intravenously over a four-hour period (from one hour before to 3 hours after a single oral dose of fluconazole 200 mg) did not affect the bioavailability or pharmacokinetics of fluconazole in 24 healthy male</ao:exact>
    <pav:createdOn>2014-07-13 12:48:08 -0400</pav:createdOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <domeo:uuid>AE5EBB85-C1D9-438F-B2E8-17B61D972F3D</domeo:uuid>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:AE5EBB85-C1D9-438F-B2E8-17B61D972F3D"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:79293219-D172-4E27-A045-D16B4F539C60">
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:createdOn>2014-07-07 11:22:40 -0400</pav:createdOn>
    <domeo:belongsToSet>urn:domeoserver:annotationset:22ED7220-C6F6-43C5-9DF9-89F62F0F8E27</domeo:belongsToSet>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <domeo:belongsToSet>urn:domeoserver:annotationset:8F3CF3D9-AADE-4A86-BD42-2924B3D6A406</domeo:belongsToSet>
    <ao:context rdf:resource="urn:domeoclient:uuid:E2AC08E4-8A5F-4E68-B2F1-20AFB690BAC7"/>
    <domeo:belongsToSet>urn:domeoserver:annotationset:131835A3-C655-4F91-97D4-52CAFF7B7CCA</domeo:belongsToSet>
    <pav:lineageUri>urn:domeoserver:annotation:A98BA61A-C2C5-4182-B0E9-6095CE94E0D1</pav:lineageUri>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <domeo:belongsToSet>urn:domeoserver:annotationset:7AACEF8D-2EBC-4F0B-94B2-190650E562F6</domeo:belongsToSet>
    <pav:lastSavedOn>2014-07-07 11:24:52 -0400</pav:lastSavedOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812eda990003</pav:createdBy>
    <rdfs:label>Highlight</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:E3238558-AF7F-4E81-BA1F-62B0266A4DDE">
    <pav:createdOn>2014-07-07 09:34:24 -0400</pav:createdOn>
    <domeo:uuid>E3238558-AF7F-4E81-BA1F-62B0266A4DDE</domeo:uuid>
    <ao:prefix>xsd:String</ao:prefix>
    <ao:suffix>(PDE5) in the smooth muscle of the pulmonary vasculature, where PDE5 is responsible for degradation of cGMP. Sildenafil, therefore, increases cGMP within pulmonary vascular smooth muscle cells resulting in relaxation. In patients with pulmonary hypertens</ao:suffix>
    <ao:exact>5 </ao:exact>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-155.txt.html</ao:hasSource>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:E3238558-AF7F-4E81-BA1F-62B0266A4DDE"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:7FB9730F-B82C-4408-87AE-CE704E2BFD12">
    <domeo:uuid>7FB9730F-B82C-4408-87AE-CE704E2BFD12</domeo:uuid>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-123.txt.html</ao:hasSource>
    <ao:prefix>The absolute bioavailability of </ao:prefix>
    <pav:createdOn>2014-07-22 19:24:47 -0400</pav:createdOn>
    <ao:suffix> is 99%. Peak plasma concentrations are observed about 1 hour after dosing. Administration of rosiglitazone with food resulted in no change in overall exposure (AUC), but there was an approximately 28% decrease in Cmax and a delay in Tmax (1.75 hours). T</ao:suffix>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:7FB9730F-B82C-4408-87AE-CE704E2BFD12"/>
    <ao:exact>rosiglitazone</ao:exact>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:0CD4EB6E-420B-4F8E-802C-4BC8BDD384E4">
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812eda990003</pav:createdBy>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:lastSavedOn>2014-07-24 19:43:34 -0400</pav:lastSavedOn>
    <pav:lineageUri>urn:domeoserver:annotation:20733A72-ADFB-4446-B449-BD9E22203676</pav:lineageUri>
    <ao:context rdf:resource="urn:domeoclient:uuid:6E7448AD-8A84-4C38-A84C-AA12E07DD681"/>
    <domeo:belongsToSet>urn:domeoclient:uuid:7DEB6848-E3C6-4761-8965-41F19EE5D781</domeo:belongsToSet>
    <pav:createdOn>2014-07-24 19:42:58 -0400</pav:createdOn>
    <rdfs:label>Highlight</rdfs:label>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:373141E1-A5DA-4819-A876-BCB2CCE1144A">
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <domeo:belongsToSet>urn:domeoclient:uuid:511EDFA9-5A42-4340-9D4A-CBF6EDD9185C</domeo:belongsToSet>
    <ao:context rdf:resource="urn:domeoclient:uuid:9C2BE5C7-01F4-4E29-A201-893A98F5268A"/>
    <pav:createdOn>2014-07-24 19:44:20 -0400</pav:createdOn>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:lineageUri>urn:domeoserver:annotation:341AD40F-1D77-4D32-94CA-1FAF53B56288</pav:lineageUri>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <pav:lastSavedOn>2014-07-24 19:44:56 -0400</pav:lastSavedOn>
    <rdfs:label>Highlight</rdfs:label>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812eda990003</pav:createdBy>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:AC27080F-C738-4176-9E15-7672938F5DF3">
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:prefix>Alcohol: Studies involving single 40 g doses of </ao:prefix>
    <domeo:uuid>AC27080F-C738-4176-9E15-7672938F5DF3</domeo:uuid>
    <ao:suffix> (oral administration in one study and intravenous in the other) and multiple dosing with fluvoxamine maleate (50 mg b.i.d.) revealed no effect of either drug on the pharmacokinetics or pharmacodynamics of the other. As with other psychotropic medication</ao:suffix>
    <ao:exact>ethanol</ao:exact>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:AC27080F-C738-4176-9E15-7672938F5DF3"/>
    <pav:createdOn>2014-09-02 11:39:02 -0400</pav:createdOn>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-9.txt.html</ao:hasSource>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:83CCA675-BEDD-43C9-AB17-7E503848F851">
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:prefix> (oral administration in one study and intravenous in the other) and multiple dosing with </ao:prefix>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-9.txt.html</ao:hasSource>
    <ao:exact>fluvoxamine</ao:exact>
    <ao:suffix> maleate (50 mg b.i.d.) revealed no effect of either drug on the pharmacokinetics or pharmacodynamics of the other. As with other psychotropic medications, patients should be advised to avoid alcohol while taking fluvoxamine maleate tablets.</ao:suffix>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:83CCA675-BEDD-43C9-AB17-7E503848F851"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <pav:createdOn>2014-09-02 11:39:08 -0400</pav:createdOn>
    <domeo:uuid>83CCA675-BEDD-43C9-AB17-7E503848F851</domeo:uuid>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:0B3096F2-9B83-424A-BCB8-CF996BA224AC">
    <pav:lineageUri>urn:domeoserver:annotation:E8A2AD10-0881-4D58-B7E5-6299431547C0</pav:lineageUri>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812eda990003</pav:createdBy>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <rdfs:label>Highlight</rdfs:label>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <domeo:belongsToSet>urn:domeoserver:annotationset:E32812A9-205B-4EE1-B488-A1E294EDBFB9</domeo:belongsToSet>
    <pav:lastSavedOn>2014-09-02 19:19:47 -0400</pav:lastSavedOn>
    <domeo:belongsToSet>urn:domeoserver:annotationset:392EE0FB-AC4F-4AF2-87A6-2E50A281F434</domeo:belongsToSet>
    <pav:lineageUri>urn:domeoserver:annotationset:C5DEBC9B-77EE-4243-88EB-DBC19737ACD2</pav:lineageUri>
    <ao:context rdf:resource="urn:domeoclient:uuid:B434A8E1-DA82-459A-AAAF-E55806E0A976"/>
    <pav:createdOn>2014-09-02 19:16:55 -0400</pav:createdOn>
    <domeo:belongsToSet>urn:domeoclient:uuid:CB83FFC2-EA71-44EA-8F11-DE80E389C84E</domeo:belongsToSet>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:6EAB4BAE-C8C3-48B7-AC36-EFE4C7088448">
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">2</pav:versionNumber>
    <pav:lineageUri>urn:domeoserver:annotationset:D1715BD2-BD41-46FD-9454-DC7A423A29AC</pav:lineageUri>
    <pav:lastSavedOn>2014-09-02 11:46:58 -0400</pav:lastSavedOn>
    <pav:createdOn>2014-09-02 11:38:17 -0400</pav:createdOn>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812eda990003</pav:createdBy>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:lineageUri>urn:domeoserver:annotation:2EF12625-E2B3-4205-91A4-76E1E1522E22</pav:lineageUri>
    <domeo:belongsToSet>urn:domeoserver:annotationset:3F546823-204F-4F9B-9006-3DC526C56931</domeo:belongsToSet>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <rdfs:label>Highlight</rdfs:label>
    <pav:previousVersion>urn:domeoclient:uuid:BED41F06-565A-4622-9A88-48810E5A28DE</pav:previousVersion>
    <ao:context rdf:resource="urn:domeoclient:uuid:C72F4C30-BFCD-4714-88DE-DBF33CE067AD"/>
    <domeo:belongsToSet>urn:domeoserver:annotationset:A5DD001D-C81A-4E2E-B5E0-7A866B35E26B</domeo:belongsToSet>
    <domeo:belongsToSet>urn:domeoserver:annotationset:A3F0B39A-4249-4B63-BB0D-F24A005066AC</domeo:belongsToSet>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:70919722-5B5F-4E86-A52F-8A64A1EFDA72">
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812eda990003</pav:createdBy>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:lastSavedOn>2014-07-13 12:56:57 -0400</pav:lastSavedOn>
    <ao:context rdf:resource="urn:domeoclient:uuid:C1C706B9-7F27-4C22-8F0D-E46B96B35A86"/>
    <domeo:belongsToSet>urn:domeoclient:uuid:E89548FF-A4A2-4B87-B1E1-B12E3E255FA1</domeo:belongsToSet>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <pav:lineageUri>urn:domeoserver:annotation:34E978B5-2DD2-44FE-B1ED-248C51C20EC2</pav:lineageUri>
    <pav:createdOn>2014-07-13 12:56:11 -0400</pav:createdOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <rdfs:label>Highlight</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:2B237E79-AEFA-4271-8E72-C8B5A1D78190">
    <domeo:uuid>2B237E79-AEFA-4271-8E72-C8B5A1D78190</domeo:uuid>
    <ao:exact>omeprazole</ao:exact>
    <ao:suffix>. Following multiple doses of nelfinavir (1250 mg, bid) and omeprazole (40 mg, qd), AUC was decreased by 36% and 92%, Cmax by 37% and 89% and Cmin by 39% and 75% respectively for nelfinavir and M8. Following multiple doses of atazanavir (400 mg, qd) and </ao:suffix>
    <ao:prefix>, decreased serum levels have been reported when given together with </ao:prefix>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-74.txt.html</ao:hasSource>
    <pav:createdOn>2014-09-02 19:18:02 -0400</pav:createdOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:2B237E79-AEFA-4271-8E72-C8B5A1D78190"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:C1C706B9-7F27-4C22-8F0D-E46B96B35A86">
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <domeo:uuid>C1C706B9-7F27-4C22-8F0D-E46B96B35A86</domeo:uuid>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-24.txt.html</ao:hasSource>
    <ao:suffix> increased 32% ± 17% (range: 16 to 72%). Fluconazole half-life decreased from 33.4 ± 4.4 hours to 26.8 ± 3.9 hours. (See PRECAUTIONS.)</ao:suffix>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:C1C706B9-7F27-4C22-8F0D-E46B96B35A86"/>
    <ao:exact>fluconazole</ao:exact>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <pav:createdOn>2014-07-13 12:56:11 -0400</pav:createdOn>
    <ao:prefix> AUC of 23% ± 9% (range: -13 to -42%). Apparent oral clearance of </ao:prefix>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:42814771-C705-49EC-A4A8-3257DD3ADB49">
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <domeo:uuid>42814771-C705-49EC-A4A8-3257DD3ADB49</domeo:uuid>
    <ao:prefix>Lorazepam: </ao:prefix>
    <pav:createdOn>2014-09-02 11:53:02 -0400</pav:createdOn>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-9.txt.html</ao:hasSource>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:42814771-C705-49EC-A4A8-3257DD3ADB49"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:suffix>. On average, bot</ao:suffix>
    <ao:exact>A study of multiple doses of fluvoxamine maleate (50 mg b.i.d.) in healthy male volunteers (N = 12) and a single dose of lorazepam (4 mg single dose) indicated no significant pharmacokinetic interaction</ao:exact>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:8F1DD8EF-72E2-425B-B98B-233F1591A13F">
    <domeo:uuid>8F1DD8EF-72E2-425B-B98B-233F1591A13F</domeo:uuid>
    <pav:createdOn>2014-07-07 09:42:06 -0400</pav:createdOn>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-155.txt.html</ao:hasSource>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:suffix>is 105 L, indicating distribution into the tissues. Sildenafil and its major circulating N-desmethyl metabolite are both approximately 96% bound to plasma proteins. Protein binding is independent of total drug concentrations.</ao:suffix>
    <domeo:uuid></domeo:uuid>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:8F1DD8EF-72E2-425B-B98B-233F1591A13F"/>
    <ao:prefix>is taken with a high-fat meal, the rate of absorption is reduced, with a mean delay in Tmax of 60 minutes and a mean reduction in Cmax of 29%. The mean steady state volume of distribution (Vss) for </ao:prefix>
    <ao:exact>sildenafil </ao:exact>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:26DA75B4-1584-4219-A170-BBFBF5DAB037">
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-9.txt.html</ao:hasSource>
    <ao:suffix> and lithium.</ao:suffix>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:26DA75B4-1584-4219-A170-BBFBF5DAB037"/>
    <ao:prefix> </ao:prefix>
    <pav:createdOn>2014-09-02 11:40:12 -0400</pav:createdOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:exact>maleate</ao:exact>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <domeo:uuid>26DA75B4-1584-4219-A170-BBFBF5DAB037</domeo:uuid>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:04B30485-E368-4D5D-ABB9-17EBA8B817CD">
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:prefix>Results of the population pharmacokinetic analysis (n = 716 &lt;65 years; n = 331 ≥65 years) showed that age does not significantly affect the pharmacokinetics of </ao:prefix>
    <ao:suffix>.</ao:suffix>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:04B30485-E368-4D5D-ABB9-17EBA8B817CD"/>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-123.txt.html</ao:hasSource>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <domeo:uuid>04B30485-E368-4D5D-ABB9-17EBA8B817CD</domeo:uuid>
    <ao:exact>rosiglitazone</ao:exact>
    <pav:createdOn>2014-07-22 19:31:11 -0400</pav:createdOn>
  </rdf:Description>
  <rdf:Description rdf:nodeID="N64fcf5e4115d4b7ba4cdf2b5e3e63044">
    <permissions:isLocked>false</permissions:isLocked>
    <permissions:accessType>urn:domeo:access:public</permissions:accessType>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:70E66A8A-36A7-4A61-AFC4-4E0A6DF9B0BC">
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <rdfs:label>Highlight</rdfs:label>
    <pav:lastSavedOn>2014-07-28 17:08:37 -0400</pav:lastSavedOn>
    <ao:context rdf:resource="urn:domeoclient:uuid:74C12A9B-7A11-44EB-A829-30F93AA6ADCF"/>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <domeo:belongsToSet>urn:domeoclient:uuid:48D839E5-6B0A-4EC3-B64A-E3E20E06246A</domeo:belongsToSet>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812eda990003</pav:createdBy>
    <pav:lineageUri>urn:domeoserver:annotation:8A1382BC-E89F-4716-8CE8-1B58C9B713DC</pav:lineageUri>
    <pav:createdOn>2014-07-28 17:04:24 -0400</pav:createdOn>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:5C901133-925A-4BA8-947F-0FE9FB6D60DB">
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-21.txt.html</ao:hasSource>
    <domeo:uuid>5C901133-925A-4BA8-947F-0FE9FB6D60DB</domeo:uuid>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:suffix>xsd:String</ao:suffix>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:5C901133-925A-4BA8-947F-0FE9FB6D60DB"/>
    <pav:createdOn>2014-07-13 12:38:04 -0400</pav:createdOn>
    <ao:prefix>xsd:String</ao:prefix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:exact>ethinyl estradiol</ao:exact>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:FB7CDA28-9814-4B6E-95D0-E4733B2DD0B9">
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-119.txt.html</ao:hasSource>
    <pav:createdOn>2014-07-22 18:51:35 -0400</pav:createdOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:suffix> (1g q8h iv) in the second study (JRV 305); however, in both studies vancomycin (1g q12h iv) could be substituted for the specified comparator if the causative pathogen was suspected or confirmed methicillin-resistant staphylococcus or if the patient was</ao:suffix>
    <domeo:uuid>FB7CDA28-9814-4B6E-95D0-E4733B2DD0B9</domeo:uuid>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:prefix>(2g q6h iv) in the first study (JRV 304) and </ao:prefix>
    <ao:exact>cefazolin</ao:exact>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:FB7CDA28-9814-4B6E-95D0-E4733B2DD0B9"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:4019A76A-1D16-4F04-8CBF-FF855DD2A7A2">
    <ao:context rdf:resource="urn:domeoclient:uuid:636BB7C2-294D-452D-967D-461DEF7A510A"/>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812eda990003</pav:createdBy>
    <pav:lineageUri>urn:domeoserver:annotation:09B51181-CF5C-416F-839B-FE6DF66105EA</pav:lineageUri>
    <rdfs:label>Highlight</rdfs:label>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <domeo:belongsToSet>urn:domeoclient:uuid:71191E51-53CB-4FDE-88D0-33C6818E2232</domeo:belongsToSet>
    <pav:createdOn>2014-07-13 11:07:17 -0400</pav:createdOn>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <pav:lastSavedOn>2014-07-13 11:32:29 -0400</pav:lastSavedOn>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:ABF527C0-D635-49E4-BC45-911EBB72D2E8">
    <domeo:uuid>ABF527C0-D635-49E4-BC45-911EBB72D2E8</domeo:uuid>
    <ao:suffix> is rapidly distributed. The volume of distribution is 1 to 2 L/kg. In plasma, risperidone is bound to albumin and α1-acid glycoprotein. The plasma protein binding of risperidone is 90%, and that of its major metabolite, 9-hydroxyrisperidone, is 77%. Nei</ao:suffix>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-8.txt.html</ao:hasSource>
    <ao:prefix>Distribution: </ao:prefix>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:ABF527C0-D635-49E4-BC45-911EBB72D2E8"/>
    <pav:createdOn>2014-07-13 11:10:47 -0400</pav:createdOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:exact>Risperidone</ao:exact>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:D7F3CF4B-F577-4BF7-B88B-B5D04D01A04A">
    <sio:SIO_000205>dikbD2R:statement</sio:SIO_000205>
    <sio:SIO_000628 rdf:resource="urn:pddi:uuid:9A220CC1-B0E4-46E3-92ED-BA102CB9A99F"/>
    <dikbD2R:statement>ncit:Qualitative</dikbD2R:statement>
    <sio:SIO_000563>dikbD2R:modality</sio:SIO_000563>
    <dikbD2R:modality>ncit:negative</dikbD2R:modality>
    <rdf:type rdf:resource="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#DrugDrugInteractionStatement"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:6198583A-79DD-481E-925D-CD236EDFDC7D">
    <dikbD2R:statement>ncit:Qualitative</dikbD2R:statement>
    <dikbD2R:modality>ncit:negative</dikbD2R:modality>
    <sio:SIO_000563>dikbD2R:modality</sio:SIO_000563>
    <sio:SIO_000205>dikbD2R:statement</sio:SIO_000205>
    <rdf:type rdf:resource="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#DrugDrugInteractionStatement"/>
    <sio:SIO_000628 rdf:resource="urn:pddi:uuid:5FD51EEB-1F14-4FFB-92BE-098757E4ED58"/>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/6AF445DF-7377-4547-8BE8-05F45AE821E0">
    <sio:SIO_000228>dikbD2R:object-drug-of-interaction</sio:SIO_000228>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/active-ingredient"/>
    <rdfs:label>metoclopramide</rdfs:label>
    <dct:description>Referred to the drug in the interaction.</dct:description>
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/6915</dailymed:activeMoietyRxCUI>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:36B5198A-3542-4C86-BF30-6375D3BC2CDB">
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <pav:createdOn>2014-09-01 15:57:27 -0400</pav:createdOn>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:36B5198A-3542-4C86-BF30-6375D3BC2CDB"/>
    <domeo:uuid>36B5198A-3542-4C86-BF30-6375D3BC2CDB</domeo:uuid>
    <ao:exact>carbamazepine</ao:exact>
    <ao:suffix>, or cisapride under steady-state conditions. The results of these studies indicated that sertraline did not increase plasma concentrations of terfenadine, carbamazepine, or cisapride. These data indicate that sertraline’s extent of inhibition of P450 3A</ao:suffix>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-16.txt.html</ao:hasSource>
    <ao:prefix>, </ao:prefix>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:6F412DAA-5D4B-4581-AA6A-DB01672CE4BB">
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-120.txt.html</ao:hasSource>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:suffix> and other oral coumarin anticoagulants, resulting in a prolongation of prothrombin time. This possible drug interaction should be considered when FLAGYL (metronidazole) is prescribed for patients on this type of anticoagulant therapy.</ao:suffix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <pav:createdOn>2014-07-22 18:58:24 -0400</pav:createdOn>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:6F412DAA-5D4B-4581-AA6A-DB01672CE4BB"/>
    <ao:prefix> has been reported to potentiate the anticoagulant effect of </ao:prefix>
    <domeo:uuid>6F412DAA-5D4B-4581-AA6A-DB01672CE4BB</domeo:uuid>
    <ao:exact>warfarin</ao:exact>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:D4EA61C9-E628-4806-856F-9D86959C5B20">
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:prefix>, or </ao:prefix>
    <pav:createdOn>2014-09-01 16:05:58 -0400</pav:createdOn>
    <ao:exact>cisapride </ao:exact>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:suffix>under steady-state conditions. The results of these studies indicated that sertraline did not increase plasma concentrations of terfenadine, carbamazepine, or cisapride. These data indicate that sertraline’s extent of inhibition of P450 3A4 activity is n</ao:suffix>
    <domeo:uuid>D4EA61C9-E628-4806-856F-9D86959C5B20</domeo:uuid>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:D4EA61C9-E628-4806-856F-9D86959C5B20"/>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-16.txt.html</ao:hasSource>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:6C37E9D5-F4A3-4CDB-AE4B-E46CCA6F2A60">
    <domeo:uuid>6C37E9D5-F4A3-4CDB-AE4B-E46CCA6F2A60</domeo:uuid>
    <ao:prefix>Increases in LDL occurred primarily during the first 1 to 2 months of therapy with </ao:prefix>
    <ao:suffix> and LDL levels remained elevated above baseline throughout the trials. In contrast, HDL continued to rise over time. As a result, the LDL/HDL ratio peaked after 2 months of therapy and then appeared to decrease over time. Because of the temporal nature </ao:suffix>
    <ao:exact>AVANDIA</ao:exact>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-123.txt.html</ao:hasSource>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <pav:createdOn>2014-07-22 19:16:20 -0400</pav:createdOn>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:6C37E9D5-F4A3-4CDB-AE4B-E46CCA6F2A60"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:E61B11CA-1C13-4025-B813-17930363237F">
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <pav:createdOn>2014-07-28 17:04:20 -0400</pav:createdOn>
    <domeo:uuid>E61B11CA-1C13-4025-B813-17930363237F</domeo:uuid>
    <ao:suffix> maintenance therapy, phenytoin administration (250 mg b.i.d. initially for 1 day followed by 300 mg QD for 3 to 4 days) resulted in an approximately 50% reduction in methadone exposure and withdrawal symptoms occurred concurrently. Upon discontinuation </ao:suffix>
    <ao:prefix>In a pharmacokinetic study with patients on </ao:prefix>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:E61B11CA-1C13-4025-B813-17930363237F"/>
    <ao:exact>methadone</ao:exact>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-201.txt.html</ao:hasSource>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:8041B2EF-1040-472F-A3E7-DC65F8159B41">
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:createdOn>2014-09-02 11:36:31 -0400</pav:createdOn>
    <domeo:belongsToSet>urn:domeoserver:annotationset:A3F0B39A-4249-4B63-BB0D-F24A005066AC</domeo:belongsToSet>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812eda990003</pav:createdBy>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <pav:lineageUri>urn:domeoserver:annotation:EC05B4DD-4AAA-45AA-A061-63446FAB7445</pav:lineageUri>
    <rdfs:label>Highlight</rdfs:label>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <domeo:belongsToSet>urn:domeoserver:annotationset:A5DD001D-C81A-4E2E-B5E0-7A866B35E26B</domeo:belongsToSet>
    <pav:previousVersion>urn:domeoclient:uuid:BED41F06-565A-4622-9A88-48810E5A28DE</pav:previousVersion>
    <pav:lastSavedOn>2014-09-02 11:46:58 -0400</pav:lastSavedOn>
    <ao:context rdf:resource="urn:domeoclient:uuid:2B94664D-D507-4349-822D-1C47F7304469"/>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">2</pav:versionNumber>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <domeo:belongsToSet>urn:domeoserver:annotationset:3F546823-204F-4F9B-9006-3DC526C56931</domeo:belongsToSet>
    <pav:lineageUri>urn:domeoserver:annotationset:D1715BD2-BD41-46FD-9454-DC7A423A29AC</pav:lineageUri>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:B0AC894E-27E2-43D9-BFEB-167E8117247A">
    <ao:exact>sertraline</ao:exact>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:suffix> hydrochloride equivalent to 25, 50, 100, 150 and 200 mg of sertraline and the following inactive ingredients: dibasic calcium phosphate dihydrate, hydroxypropyl cellulose, hypromellose, magnesium stearate, microcrystalline cellulose, polyethylene glycol</ao:suffix>
    <ao:prefix> hydrochloride is supplied for oral administration as scored tablets containing </ao:prefix>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:B0AC894E-27E2-43D9-BFEB-167E8117247A"/>
    <pav:createdOn>2014-07-13 12:34:38 -0400</pav:createdOn>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-20.txt.html</ao:hasSource>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <domeo:uuid>B0AC894E-27E2-43D9-BFEB-167E8117247A</domeo:uuid>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:0415BFC3-92B0-4B40-B23A-DCE512A51F26">
    <ao:suffix>, carbamazepine, or cisapride under steady-state conditions. The results of these studies indicated that sertraline did not increase plasma concentrations of terfenadine, carbamazepine, or cisapride. These data indicate that sertraline’s extent of inhibi</ao:suffix>
    <ao:exact>terfenadine</ao:exact>
    <pav:createdOn>2014-09-01 16:05:56 -0400</pav:createdOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <domeo:uuid>0415BFC3-92B0-4B40-B23A-DCE512A51F26</domeo:uuid>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:0415BFC3-92B0-4B40-B23A-DCE512A51F26"/>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-16.txt.html</ao:hasSource>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:prefix>was co-administered with cytochrome P450 3A4 substrates, </ao:prefix>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:954496DB-A54A-496F-92B2-F690C8B1E299">
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:954496DB-A54A-496F-92B2-F690C8B1E299"/>
    <ao:exact> rosiglitazone.</ao:exact>
    <ao:suffix>xsd:String</ao:suffix>
    <domeo:uuid>954496DB-A54A-496F-92B2-F690C8B1E299</domeo:uuid>
    <pav:createdOn>2014-07-22 19:38:52 -0400</pav:createdOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:prefix>Results of a population pharmacokinetic analysis including subjects of Caucasian, black, and other ethnic origins indicate that race has no influence on the pharmacokinetics of</ao:prefix>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-123.txt.html</ao:hasSource>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:420B9B73-0394-4975-8634-61202EA8F217">
    <pav:lineageUri>urn:domeoserver:annotation:F0B97FA3-5873-4BED-A500-3F99EF51951C</pav:lineageUri>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:createdOn>2014-07-13 11:12:03 -0400</pav:createdOn>
    <rdfs:label>Highlight</rdfs:label>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <ao:context rdf:resource="urn:domeoclient:uuid:83D060E5-70B4-4270-94D2-6FF812E77E78"/>
    <domeo:belongsToSet>urn:domeoclient:uuid:71191E51-53CB-4FDE-88D0-33C6818E2232</domeo:belongsToSet>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812eda990003</pav:createdBy>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <pav:lastSavedOn>2014-07-13 11:32:29 -0400</pav:lastSavedOn>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:4C207F47-3585-4A4F-A5A4-245A1F19DF8E">
    <rdfs:label>Default Set</rdfs:label>
    <ao:item rdf:resource="urn:domeoclient:uuid:23CAE79F-92D8-407B-BE7A-4BCA038E20F4"/>
    <dct:description>The default set is created automatically by Domeo when no other set is existing.</dct:description>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <domeo:deleted>false</domeo:deleted>
    <domeo:agents rdf:resource="urn:domeo:software:id:Domeo-2.1alpha-050"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#AnnotationSet"/>
    <pav:createdOn>2014-07-22 19:00:38 -0400</pav:createdOn>
    <permissions:permissions rdf:nodeID="N3e0ef8d7f89047be92e80a915b90b0dc"/>
    <pav:lastSavedOn>2014-07-22 19:00:28 -0400</pav:lastSavedOn>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812eda990003</pav:createdBy>
    <pav:lineageUri>urn:domeoserver:annotationset:7672655E-EB53-498B-A4E1-8C8EF326B3C0</pav:lineageUri>
    <domeo:agents rdf:resource="urn:person:uuid:080e143046812afe0146812eda990003"/>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <ao:annotatesResource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-121.txt.html</ao:annotatesResource>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:A3612760-5AFD-415B-8269-F1483D859C5D">
    <ao:exact>sildenafil</ao:exact>
    <domeo:uuid></domeo:uuid>
    <pav:createdOn>2014-07-07 09:37:58 -0400</pav:createdOn>
    <domeo:uuid>A3612760-5AFD-415B-8269-F1483D859C5D</domeo:uuid>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-155.txt.html</ao:hasSource>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:suffix>, therefore the effects are not related to dose or plasma levels within this dosage range. Larger effects were recorded among patients receiving concomitant nitrates [see Contraindications (4)].</ao:suffix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:prefix>iastolic blood pressure of 8/5 mmHg). The decrease in blood pressure was most notable approximately 1–2 hours after dosing, and was not different from placebo at 8 hours. Similar effects on blood pressure were noted with 25 mg, 50 mg and 100 mg doses of </ao:prefix>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:A3612760-5AFD-415B-8269-F1483D859C5D"/>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/A6BB2E0B-6C79-40DE-987D-E28594E02093">
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/active-ingredient"/>
    <rdfs:label>ketoconazole</rdfs:label>
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/6135</dailymed:activeMoietyRxCUI>
    <dct:description>Referred to the drug in the interaction.</dct:description>
    <sio:SIO_000228>dikbD2R:precipitant-drug-of-interaction</sio:SIO_000228>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:A3D1E36E-124A-4042-BB9B-6A358D1F3E3B">
    <rdfs:label>Highlight</rdfs:label>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <pav:lastSavedOn>2014-09-02 11:46:58 -0400</pav:lastSavedOn>
    <pav:lineageUri>urn:domeoserver:annotation:0C7538CE-438C-42F7-A22B-A9CAEE1AE984</pav:lineageUri>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">2</pav:versionNumber>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <domeo:belongsToSet>urn:domeoserver:annotationset:A5DD001D-C81A-4E2E-B5E0-7A866B35E26B</domeo:belongsToSet>
    <domeo:belongsToSet>urn:domeoserver:annotationset:3F546823-204F-4F9B-9006-3DC526C56931</domeo:belongsToSet>
    <pav:createdOn>2014-09-02 11:39:46 -0400</pav:createdOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <domeo:belongsToSet>urn:domeoserver:annotationset:A3F0B39A-4249-4B63-BB0D-F24A005066AC</domeo:belongsToSet>
    <pav:previousVersion>urn:domeoclient:uuid:BED41F06-565A-4622-9A88-48810E5A28DE</pav:previousVersion>
    <pav:lineageUri>urn:domeoserver:annotationset:D1715BD2-BD41-46FD-9454-DC7A423A29AC</pav:lineageUri>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812eda990003</pav:createdBy>
    <ao:context rdf:resource="urn:domeoclient:uuid:E8A5F802-A216-476E-AB1E-621B048A27EA"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:97FF727B-70F7-4A8F-9355-6D53C2602A7E">
    <pav:lastSavedOn>2014-07-13 11:32:29 -0400</pav:lastSavedOn>
    <ao:context rdf:resource="urn:domeoclient:uuid:A31AAC0C-4709-458E-B722-42176D2F7E8D"/>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812eda990003</pav:createdBy>
    <pav:lineageUri>urn:domeoserver:annotation:7226510B-6369-4D4F-859D-276E6199315C</pav:lineageUri>
    <domeo:belongsToSet>urn:domeoclient:uuid:71191E51-53CB-4FDE-88D0-33C6818E2232</domeo:belongsToSet>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <rdfs:label>Highlight</rdfs:label>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:createdOn>2014-07-13 11:13:47 -0400</pav:createdOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:864B2878-F3F7-49DF-B591-E0E101E10F02">
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:lastSavedOn>2014-07-24 19:44:56 -0400</pav:lastSavedOn>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <rdfs:label>Highlight</rdfs:label>
    <pav:lineageUri>urn:domeoserver:annotation:B86683B0-8443-4B4B-BB6E-3E9A3F377B8E</pav:lineageUri>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812eda990003</pav:createdBy>
    <pav:createdOn>2014-07-24 19:44:17 -0400</pav:createdOn>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <domeo:belongsToSet>urn:domeoclient:uuid:511EDFA9-5A42-4340-9D4A-CBF6EDD9185C</domeo:belongsToSet>
    <ao:context rdf:resource="urn:domeoclient:uuid:4779D2E6-DE3C-43C7-BA5C-2FB2261F8E92"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:93DAC455-F057-464E-B0F5-494B00341776">
    <pav:createdOn>2014-07-21 21:33:59 -0400</pav:createdOn>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <rdfs:label>Highlight</rdfs:label>
    <domeo:belongsToSet>urn:domeoclient:uuid:B61F1A9B-4696-4ED0-80AA-4FE2E9016966</domeo:belongsToSet>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812eda990003</pav:createdBy>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <ao:context rdf:resource="urn:domeoclient:uuid:0F9E744D-C586-43FA-AB0E-FF3294D6D12E"/>
    <pav:lastSavedOn>2014-07-21 21:35:10 -0400</pav:lastSavedOn>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:lineageUri>urn:domeoserver:annotation:6034386E-A439-4FD9-A50D-3EFD1BBB961F</pav:lineageUri>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:EFBA3663-4C52-45BA-895B-7EB3C0A4DA3A">
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812eda990003</pav:createdBy>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <domeo:belongsToSet>urn:domeoclient:uuid:71191E51-53CB-4FDE-88D0-33C6818E2232</domeo:belongsToSet>
    <pav:lastSavedOn>2014-07-13 11:32:29 -0400</pav:lastSavedOn>
    <rdfs:label>Highlight</rdfs:label>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:lineageUri>urn:domeoserver:annotation:03C6457D-A506-405A-9290-D5818D79A053</pav:lineageUri>
    <ao:context rdf:resource="urn:domeoclient:uuid:1B4D9B85-636E-45EE-9796-1A7AE7E45DCF"/>
    <pav:createdOn>2014-07-13 11:11:43 -0400</pav:createdOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:previousVersion>xsd:String</pav:previousVersion>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:5C335096-224E-43D5-B91F-473E8217B098">
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <domeo:uuid>5C335096-224E-43D5-B91F-473E8217B098</domeo:uuid>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:5C335096-224E-43D5-B91F-473E8217B098"/>
    <ao:suffix> 100 mg/day administered at steady-state was associated with five- and eight-fold increases in tacrine Cmax and AUC, respectively, compared to the administration of tacrine alone. Five subjects experienced nausea, vomiting, sweating, and diarrhea followi</ao:suffix>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-9.txt.html</ao:hasSource>
    <ao:prefix> added to </ao:prefix>
    <ao:exact>fluvoxamine</ao:exact>
    <pav:createdOn>2014-09-02 11:41:14 -0400</pav:createdOn>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:42F3EB55-6A92-4EE6-9472-03CDC6E02D69">
    <domeo:belongsToSet>urn:domeoserver:annotationset:E32812A9-205B-4EE1-B488-A1E294EDBFB9</domeo:belongsToSet>
    <pav:lineageUri>urn:domeoserver:annotation:1C0BAB34-1E8A-4DEF-9B8D-D1F458183923</pav:lineageUri>
    <domeo:belongsToSet>urn:domeoserver:annotationset:392EE0FB-AC4F-4AF2-87A6-2E50A281F434</domeo:belongsToSet>
    <ao:context rdf:resource="urn:domeoclient:uuid:D2CDE5DF-B4CC-4374-8C21-8821B6582DB8"/>
    <rdfs:label>Highlight</rdfs:label>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <domeo:belongsToSet>urn:domeoclient:uuid:CB83FFC2-EA71-44EA-8F11-DE80E389C84E</domeo:belongsToSet>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812eda990003</pav:createdBy>
    <pav:createdOn>2014-09-02 19:16:52 -0400</pav:createdOn>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:lastSavedOn>2014-09-02 19:19:47 -0400</pav:lastSavedOn>
    <pav:lineageUri>urn:domeoserver:annotationset:C5DEBC9B-77EE-4243-88EB-DBC19737ACD2</pav:lineageUri>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:23AC6809-BABB-405A-80DE-630CA211B109">
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812eda990003</pav:createdBy>
    <pav:lineageUri>urn:domeoserver:annotationset:AB1741F1-5A5F-4416-AEAC-A544BCBB7D16</pav:lineageUri>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <domeo:belongsToSet>urn:domeoserver:annotationset:F272A789-69D0-47CC-8CC9-F25C55B91261</domeo:belongsToSet>
    <domeo:belongsToSet>urn:domeoserver:annotationset:7E80543E-BF76-4514-92A9-91458DCB802B</domeo:belongsToSet>
    <domeo:belongsToSet>urn:domeoserver:annotationset:606A5B3F-B6FB-4279-AA42-7893CFC2D20C</domeo:belongsToSet>
    <pav:createdOn>2014-07-22 19:26:11 -0400</pav:createdOn>
    <pav:previousVersion>urn:domeoserver:annotationset:467D4F28-D086-4217-9DE0-23E165F30716</pav:previousVersion>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <ao:context rdf:resource="urn:domeoclient:uuid:A4B2C542-4FBC-4849-8602-BB3245792CC3"/>
    <domeo:belongsToSet>urn:domeoserver:annotationset:514BA51B-D734-4003-A7C3-F03C0F95833A</domeo:belongsToSet>
    <pav:lastSavedOn>2014-07-22 19:28:02 -0400</pav:lastSavedOn>
    <pav:lineageUri>urn:domeoserver:annotation:0231800C-2324-4C45-A7BE-0AC6CEB6966F</pav:lineageUri>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">3</pav:versionNumber>
    <domeo:belongsToSet>urn:domeoserver:annotationset:7021B883-FD5C-4083-BD87-DF56D3C87633</domeo:belongsToSet>
    <domeo:belongsToSet>urn:domeoserver:annotationset:2914A3FD-DF43-4F78-999C-77CE7A028B19</domeo:belongsToSet>
    <rdfs:label>Highlight</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:6522F182-C5C2-4066-893C-355B3A906EBE">
    <domeo:belongsToSet>urn:domeoclient:uuid:4B51141D-C8D2-45DB-8074-74F8D8323E60</domeo:belongsToSet>
    <rdfs:label>Highlight</rdfs:label>
    <ao:context rdf:resource="urn:domeoclient:uuid:BE2369F6-B30D-45B8-9655-5079A35C9D6D"/>
    <pav:lineageUri>urn:domeoserver:annotation:D374971E-30F6-426D-8ED6-7C54E217A624</pav:lineageUri>
    <pav:lastSavedOn>2014-09-02 12:02:18 -0400</pav:lastSavedOn>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812eda990003</pav:createdBy>
    <pav:createdOn>2014-09-02 11:58:19 -0400</pav:createdOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:23D9C242-E097-43FB-88F0-20E20588FBFC">
    <ao:body rdf:nodeID="Nda86cc713b9949f2afef135ffe7a910e"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#expertstudyAnnotation"/>
    <rdfs:label>expertstudy Annotation</rdfs:label>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <ao:context rdf:resource="urn:domeoclient:uuid:D7A544C2-F82A-49C9-83A0-D19D9DDF7E00"/>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812eda990003</pav:createdBy>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <pav:lastSavedOn>2014-07-22 20:22:38 -0400</pav:lastSavedOn>
    <domeo:belongsToSet>urn:domeoserver:annotationset:F272A789-69D0-47CC-8CC9-F25C55B91261</domeo:belongsToSet>
    <pav:createdOn>2014-07-22 20:20:12 -0400</pav:createdOn>
    <pav:lineageUri>urn:domeoserver:annotation:7186BD4F-BACE-424E-B322-19883E2F77B1</pav:lineageUri>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:1DCA5297-1C05-4654-AADE-90A7C81DD992">
    <ao:body rdf:nodeID="N0694a5f7f1bf4644b362b9d9d13b8f0a"/>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812eda990003</pav:createdBy>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <pav:createdOn>2014-09-02 12:01:08 -0400</pav:createdOn>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:lastSavedOn>2014-09-02 12:02:18 -0400</pav:lastSavedOn>
    <ao:context rdf:resource="urn:domeoclient:uuid:D390D1C1-F946-4B8E-A2EB-3CBC7637D30E"/>
    <pav:lineageUri>urn:domeoserver:annotation:A7BFA862-67B8-4B4D-A2A5-B578E891D1E6</pav:lineageUri>
    <rdfs:label>expertstudy Annotation</rdfs:label>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <domeo:belongsToSet>urn:domeoclient:uuid:4B51141D-C8D2-45DB-8074-74F8D8323E60</domeo:belongsToSet>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#expertstudyAnnotation"/>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/9C6B1447-979C-42A2-8477-0513E82FA0CC">
    <dct:description>Referred to the drug in the interaction.</dct:description>
    <sio:SIO_000228>dikbD2R:object-drug-of-interaction</sio:SIO_000228>
    <rdfs:label>Synercid</rdfs:label>
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/135097</dailymed:activeMoietyRxCUI>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/drug-product"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:B8794C27-AB48-4247-A5DC-F99E0DB48B2D">
    <pav:lineageUri>urn:domeoserver:annotation:88D4AAD7-575C-4C65-A82F-5671A64A4763</pav:lineageUri>
    <pav:createdOn>2014-07-28 17:04:52 -0400</pav:createdOn>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812eda990003</pav:createdBy>
    <domeo:belongsToSet>urn:domeoclient:uuid:48D839E5-6B0A-4EC3-B64A-E3E20E06246A</domeo:belongsToSet>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <ao:context rdf:resource="urn:domeoclient:uuid:EE9D00B3-F511-4E8E-BFBF-A30D7A5C5F82"/>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <rdfs:label>Highlight</rdfs:label>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:lastSavedOn>2014-07-28 17:08:37 -0400</pav:lastSavedOn>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:9074A799-2AB0-4D0E-81F8-6BBEA5AAB884">
    <sio:SIO_000563>dikbD2R:modality</sio:SIO_000563>
    <sio:SIO_000628 rdf:resource="urn:pddi:uuid:46D1DA7B-A66C-4B0D-A948-C7A31C7B7FFF"/>
    <rdf:type rdf:resource="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#DrugDrugInteractionStatement"/>
    <dikbD2R:modality>ncit:negative</dikbD2R:modality>
    <dikbD2R:statement>ncit:Qualitative</dikbD2R:statement>
    <sio:SIO_000205>dikbD2R:statement</sio:SIO_000205>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/FD1343BF-2E5B-4241-8B0E-0B7BDDB60C21">
    <rdfs:label>pravastatin</rdfs:label>
    <sio:SIO_000228>dikbD2R:precipitant-drug-of-interaction</sio:SIO_000228>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/active-ingredient"/>
    <dct:description>Referred to the drug in the interaction.</dct:description>
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/42463</dailymed:activeMoietyRxCUI>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:B206386D-9F43-45A3-96CA-50B346B26C4D">
    <pav:previousVersion>urn:domeoclient:uuid:BED41F06-565A-4622-9A88-48810E5A28DE</pav:previousVersion>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <domeo:belongsToSet>urn:domeoserver:annotationset:3F546823-204F-4F9B-9006-3DC526C56931</domeo:belongsToSet>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">2</pav:versionNumber>
    <domeo:belongsToSet>urn:domeoserver:annotationset:A3F0B39A-4249-4B63-BB0D-F24A005066AC</domeo:belongsToSet>
    <ao:context rdf:resource="urn:domeoclient:uuid:FC9F95A3-1FEE-4EEA-8C1A-39DFE96EBAB8"/>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <pav:lineageUri>urn:domeoserver:annotation:CB90294A-E61C-423D-B06B-9492A5597887</pav:lineageUri>
    <rdfs:label>Highlight</rdfs:label>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812eda990003</pav:createdBy>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <domeo:belongsToSet>urn:domeoserver:annotationset:A5DD001D-C81A-4E2E-B5E0-7A866B35E26B</domeo:belongsToSet>
    <pav:createdOn>2014-09-02 11:42:53 -0400</pav:createdOn>
    <pav:lineageUri>urn:domeoserver:annotationset:D1715BD2-BD41-46FD-9454-DC7A423A29AC</pav:lineageUri>
    <pav:lastSavedOn>2014-09-02 11:46:58 -0400</pav:lastSavedOn>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:CA9B3930-3D00-45F4-81DF-D789FB3565E3">
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <rdfs:label>Highlight</rdfs:label>
    <pav:lastSavedOn>2014-07-22 20:22:38 -0400</pav:lastSavedOn>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:createdOn>2014-07-22 20:19:56 -0400</pav:createdOn>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812eda990003</pav:createdBy>
    <pav:lineageUri>urn:domeoserver:annotation:B613A799-0F9A-4FAC-813B-1B0F1A11F614</pav:lineageUri>
    <domeo:belongsToSet>urn:domeoserver:annotationset:F272A789-69D0-47CC-8CC9-F25C55B91261</domeo:belongsToSet>
    <ao:context rdf:resource="urn:domeoclient:uuid:0ACECEC3-3253-49CC-B7BF-D586E8F2D7A4"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:94239CD6-2883-459B-A125-FF55B9791833">
    <rdfs:label>Highlight</rdfs:label>
    <pav:createdOn>2014-07-13 11:11:25 -0400</pav:createdOn>
    <pav:lineageUri>urn:domeoserver:annotation:4B9E6D9B-AF88-4692-9DEF-8B6FA5D8F2B7</pav:lineageUri>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <domeo:belongsToSet>urn:domeoclient:uuid:71191E51-53CB-4FDE-88D0-33C6818E2232</domeo:belongsToSet>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812eda990003</pav:createdBy>
    <ao:context rdf:resource="urn:domeoclient:uuid:D909BDC5-468E-434E-B3E5-632F1565E73C"/>
    <pav:lastSavedOn>2014-07-13 11:32:29 -0400</pav:lastSavedOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:AF177109-0D4D-4DEA-BD5C-F29B10621C02">
    <pav:createdOn>2014-07-22 20:18:04 -0400</pav:createdOn>
    <ao:context rdf:resource="urn:domeoclient:uuid:6DEBCD8F-80B7-4229-A275-28C4CFF1B5A0"/>
    <domeo:belongsToSet>urn:domeoserver:annotationset:F272A789-69D0-47CC-8CC9-F25C55B91261</domeo:belongsToSet>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812eda990003</pav:createdBy>
    <rdfs:label>Highlight</rdfs:label>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:lastSavedOn>2014-07-22 20:22:38 -0400</pav:lastSavedOn>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <pav:lineageUri>urn:domeoserver:annotation:55B9C1C9-DA6A-4528-A411-28F4318BAEDF</pav:lineageUri>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:371BCC12-3242-4854-9882-2DB2B2EE1A70">
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:suffix> decreased very slightly (&lt;5%) in 3 of the 21 subjects after fluconazole treatment.</ao:suffix>
    <ao:exact>norethindrone</ao:exact>
    <domeo:uuid>371BCC12-3242-4854-9882-2DB2B2EE1A70</domeo:uuid>
    <ao:prefix> AUC of any individual subject in this study compared to placebo dosing. The individual AUC values of </ao:prefix>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-21.txt.html</ao:hasSource>
    <pav:createdOn>2014-07-13 12:38:53 -0400</pav:createdOn>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:371BCC12-3242-4854-9882-2DB2B2EE1A70"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:FC9F95A3-1FEE-4EEA-8C1A-39DFE96EBAB8">
    <ao:prefix>Tricyclic Antidepressants (TCAs): Significantly increased plasma TCA levels have been reported with the coadministration of </ao:prefix>
    <pav:createdOn>2014-09-02 11:42:53 -0400</pav:createdOn>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:FC9F95A3-1FEE-4EEA-8C1A-39DFE96EBAB8"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:exact>fluvoxamine</ao:exact>
    <domeo:uuid>FC9F95A3-1FEE-4EEA-8C1A-39DFE96EBAB8</domeo:uuid>
    <ao:suffix> maleate and amitriptyline, clomipramine or imipramine. Caution is indicated with the coadministration of fluvoxamine maleate tablets and TCAs; plasma TCA concentrations may need to be monitored, and the dose of TCA may need to be reduced.</ao:suffix>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-9.txt.html</ao:hasSource>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:1AD84D60-1A25-43EF-A981-A873C4F1D40E">
    <pav:createdOn>2014-09-02 11:44:48 -0400</pav:createdOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:suffix> maleate and diltiazem.</ao:suffix>
    <ao:prefix>: Bradycardia has been reported with the coadministration of </ao:prefix>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:1AD84D60-1A25-43EF-A981-A873C4F1D40E"/>
    <ao:exact>fluvoxamine</ao:exact>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-9.txt.html</ao:hasSource>
    <domeo:uuid>1AD84D60-1A25-43EF-A981-A873C4F1D40E</domeo:uuid>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:C914763B-B8F8-41B8-8D18-F2B33883EA27">
    <pav:createdOn>2014-09-02 11:46:02 -0400</pav:createdOn>
    <ao:suffix> maleate tablets, a reduction in the initial beta-blocker dose and more cautious dose titration are recommended. No dosage adjustment is required for fluvoxamine maleate tablets.</ao:suffix>
    <ao:prefix> is coadministered with </ao:prefix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:C914763B-B8F8-41B8-8D18-F2B33883EA27"/>
    <domeo:uuid>C914763B-B8F8-41B8-8D18-F2B33883EA27</domeo:uuid>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-9.txt.html</ao:hasSource>
    <ao:exact>fluvoxamine</ao:exact>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:6EB0C05E-6581-4241-B07F-CF48B6405DC1">
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <pav:createdOn>2014-07-21 21:31:10 -0400</pav:createdOn>
    <domeo:uuid>6EB0C05E-6581-4241-B07F-CF48B6405DC1</domeo:uuid>
    <ao:prefix>concentrations were determined on two occasions (before and following </ao:prefix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:6EB0C05E-6581-4241-B07F-CF48B6405DC1"/>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-27.txt.html</ao:hasSource>
    <ao:suffix>200 mg daily for 15 days) in 13 volunteers with AIDS or ARC who were on a stable zidovudine dose for at least two weeks. There was a significant increase in zidovudine AUC following the administration of fluconazole. The mean ± SD increase in AUC was 20%</ao:suffix>
    <ao:exact>fluconazole </ao:exact>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:AE2B15F2-9CA8-49EC-B61F-0A38DD22AF0C">
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <domeo:uuid>AE2B15F2-9CA8-49EC-B61F-0A38DD22AF0C</domeo:uuid>
    <pav:createdOn>2014-07-22 20:17:49 -0400</pav:createdOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:exact>AVANDIA</ao:exact>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-123.txt.html</ao:hasSource>
    <ao:prefix>xsd:String</ao:prefix>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:AE2B15F2-9CA8-49EC-B61F-0A38DD22AF0C"/>
    <ao:suffix> </ao:suffix>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:436A0572-7B45-4903-B1A7-9FA513872756">
    <ao:context rdf:resource="urn:domeoclient:uuid:C48F039A-1F94-471B-9DF9-0D4E6B99DA14"/>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812eda990003</pav:createdBy>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <pav:createdOn>2014-07-24 19:45:35 -0400</pav:createdOn>
    <domeo:belongsToSet>urn:domeoclient:uuid:4519FF07-AE90-4478-8B97-B4B2C84457DC</domeo:belongsToSet>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <rdfs:label>Highlight</rdfs:label>
    <pav:lineageUri>urn:domeoserver:annotation:0E6FAD46-DBE8-4B45-9895-373A8D9E0281</pav:lineageUri>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:lastSavedOn>2014-07-24 19:46:05 -0400</pav:lastSavedOn>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:CA65F737-1E98-4A37-A7F1-220396E99856">
    <dikbD2R:modality>ncit:positive</dikbD2R:modality>
    <sio:SIO_000205>dikbD2R:statement</sio:SIO_000205>
    <sio:SIO_000628 rdf:resource="urn:pddi:uuid:1BC59DC6-C39B-4F32-9DCC-98000370046A"/>
    <rdf:type rdf:resource="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#DrugDrugInteractionStatement"/>
    <sio:SIO_000563>dikbD2R:modality</sio:SIO_000563>
    <dikbD2R:statement>ncit:Qualitative</dikbD2R:statement>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:40692CE2-57E3-4181-873F-BF7EE5E8B25B">
    <pav:lastSavedOn>2014-07-24 20:02:49 -0400</pav:lastSavedOn>
    <rdfs:label>Highlight</rdfs:label>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <domeo:belongsToSet>urn:domeoclient:uuid:189A8E0E-67D6-4C53-A96E-CB48A3B4B2E9</domeo:belongsToSet>
    <pav:lineageUri>urn:domeoserver:annotation:F54F1F42-E29B-4BF2-B251-F0FD34444115</pav:lineageUri>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812eda990003</pav:createdBy>
    <ao:context rdf:resource="urn:domeoclient:uuid:060B4AD5-C06D-4579-9AB3-F6932ED1425B"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:createdOn>2014-07-24 20:01:38 -0400</pav:createdOn>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:A512929D-5410-4D52-AEA7-F2E68A62A9E8">
    <pav:previousVersion>urn:domeoclient:uuid:BED41F06-565A-4622-9A88-48810E5A28DE</pav:previousVersion>
    <domeo:belongsToSet>urn:domeoserver:annotationset:A5DD001D-C81A-4E2E-B5E0-7A866B35E26B</domeo:belongsToSet>
    <rdfs:label>Highlight</rdfs:label>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <pav:lineageUri>urn:domeoserver:annotation:783B0C18-A3F1-42D9-8024-138C2EC044CF</pav:lineageUri>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:lineageUri>urn:domeoserver:annotationset:D1715BD2-BD41-46FD-9454-DC7A423A29AC</pav:lineageUri>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">2</pav:versionNumber>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812eda990003</pav:createdBy>
    <domeo:belongsToSet>urn:domeoserver:annotationset:A3F0B39A-4249-4B63-BB0D-F24A005066AC</domeo:belongsToSet>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:lastSavedOn>2014-09-02 11:46:58 -0400</pav:lastSavedOn>
    <ao:context rdf:resource="urn:domeoclient:uuid:0DC4E7B3-91DD-45B9-9175-1936730AC49F"/>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:createdOn>2014-09-02 11:43:26 -0400</pav:createdOn>
    <domeo:belongsToSet>urn:domeoserver:annotationset:3F546823-204F-4F9B-9006-3DC526C56931</domeo:belongsToSet>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:DFF0F114-795C-4A7F-B8CF-1A970C7B1D1A">
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-70.txt.html</ao:hasSource>
    <ao:prefix>Administration of </ao:prefix>
    <pav:createdOn>2014-09-02 15:05:19 -0400</pav:createdOn>
    <domeo:uuid>DFF0F114-795C-4A7F-B8CF-1A970C7B1D1A</domeo:uuid>
    <ao:suffix> within 2 hours of antacids containing aluminum oxide and magnesium hydroxide should be avoided because it may result in a reduction in Cmax and AUC of 26% and 20%, respectively and consequently in a 25% reduction in the bradycardic effect at rest. Admin</ao:suffix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:exact>sotalol</ao:exact>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:DFF0F114-795C-4A7F-B8CF-1A970C7B1D1A"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:D346F3FB-2896-495E-BF67-B2BC6E8F5714">
    <domeo:uuid></domeo:uuid>
    <ao:suffix>is rapidly absorbed after oral administration, with a mean absolute bioavailability of 41% (25–63%). Maximum observed plasma concentrations are reached within 30 to 120 minutes (median 60 minutes) of oral dosing in the fasted state. When REVATIO is taken</ao:suffix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <domeo:uuid>D346F3FB-2896-495E-BF67-B2BC6E8F5714</domeo:uuid>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:D346F3FB-2896-495E-BF67-B2BC6E8F5714"/>
    <ao:exact>REVATIO </ao:exact>
    <ao:prefix>xsd:String</ao:prefix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-155.txt.html</ao:hasSource>
    <pav:createdOn>2014-07-07 09:41:30 -0400</pav:createdOn>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:6A119113-824F-4EAE-B66E-B060687F0A7E">
    <ao:prefix>does not alter the kinetics of </ao:prefix>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-54.txt.html</ao:hasSource>
    <ao:exact>diltiazem</ao:exact>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:6A119113-824F-4EAE-B66E-B060687F0A7E"/>
    <domeo:uuid>6A119113-824F-4EAE-B66E-B060687F0A7E</domeo:uuid>
    <ao:suffix>.</ao:suffix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <pav:createdOn>2014-07-21 21:47:28 -0400</pav:createdOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:5F55A562-8BC3-4202-8F0A-0D9AD00722CD">
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-123.txt.html</ao:hasSource>
    <ao:prefix>xsd:String</ao:prefix>
    <ao:suffix>xsd:String</ao:suffix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <pav:createdOn>2014-07-22 19:44:10 -0400</pav:createdOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:exact>Rifampin administration (600 mg once a day), an inducer of CYP2C8, for 6 days is reported to decrease rosiglitazone AUC by 66%, compared to the administration of rosiglitazone (8 mg) alone [see Drug Interactions (7.1)].4</ao:exact>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:5F55A562-8BC3-4202-8F0A-0D9AD00722CD"/>
    <domeo:uuid>5F55A562-8BC3-4202-8F0A-0D9AD00722CD</domeo:uuid>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:9F07EC2D-B722-4E66-94F2-FC8B5EEAC608">
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-132.txt.html</ao:hasSource>
    <domeo:uuid>9F07EC2D-B722-4E66-94F2-FC8B5EEAC608</domeo:uuid>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:prefix>xsd:String</ao:prefix>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:9F07EC2D-B722-4E66-94F2-FC8B5EEAC608"/>
    <pav:createdOn>2014-07-24 19:53:38 -0400</pav:createdOn>
    <ao:suffix>xsd:String</ao:suffix>
    <ao:exact>Co-administration of propranolol with lovastatin or pravastatin, decreased 18% to 23% the AUC of both, but did not alter their pharmacodynamics. Propranolol did not have an effect on the pharmacokinetics of fluvastatin.</ao:exact>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:D47C4E1D-3FAD-4BB4-842A-3B71726A722C">
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-9.txt.html</ao:hasSource>
    <pav:createdOn>2014-09-02 11:30:03 -0400</pav:createdOn>
    <ao:prefix>Multiple hepatic cytochrome P450 isoenzymes are involved in the oxidative biotransformation of a large number of structurally different drugs and endogenous compounds. The available knowledge concerning the relationship of </ao:prefix>
    <domeo:uuid>D47C4E1D-3FAD-4BB4-842A-3B71726A722C</domeo:uuid>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:suffix> and the cytochrome P450 isoenzyme system has been obtained mostly from pharmacokinetic interaction studies conducted in healthy volunteers, but some preliminary in vitro data are also available. Based on a finding of substantial interactions of fluvoxam</ao:suffix>
    <ao:exact>fluvoxamine</ao:exact>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:D47C4E1D-3FAD-4BB4-842A-3B71726A722C"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:9A355239-7CF3-43F5-B979-1B59EE6C6121">
    <rdfs:label>Highlight</rdfs:label>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <ao:context rdf:resource="urn:domeoclient:uuid:465EEACA-9FFE-4F82-9410-36A29C720187"/>
    <domeo:belongsToSet>urn:domeoserver:annotationset:A5DD001D-C81A-4E2E-B5E0-7A866B35E26B</domeo:belongsToSet>
    <pav:createdOn>2014-09-02 11:45:38 -0400</pav:createdOn>
    <pav:lastSavedOn>2014-09-02 11:46:58 -0400</pav:lastSavedOn>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">2</pav:versionNumber>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <domeo:belongsToSet>urn:domeoserver:annotationset:3F546823-204F-4F9B-9006-3DC526C56931</domeo:belongsToSet>
    <pav:lastSavedOn>2014-09-02 11:46:59 -0400</pav:lastSavedOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:previousVersion>urn:domeoclient:uuid:BED41F06-565A-4622-9A88-48810E5A28DE</pav:previousVersion>
    <pav:lineageUri>urn:domeoserver:annotation:2B103281-CAE1-4073-93B6-904DBD3F593D</pav:lineageUri>
    <pav:lineageUri>urn:domeoserver:annotationset:D1715BD2-BD41-46FD-9454-DC7A423A29AC</pav:lineageUri>
    <domeo:belongsToSet>urn:domeoserver:annotationset:A3F0B39A-4249-4B63-BB0D-F24A005066AC</domeo:belongsToSet>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812eda990003</pav:createdBy>
    <pav:previousVersion>xsd:String</pav:previousVersion>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:CE82B7F1-A555-4EA6-BB43-259D94DCEA76">
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:createdOn>2014-07-24 19:53:38 -0400</pav:createdOn>
    <rdfs:label>expertstudy Annotation</rdfs:label>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:lastSavedOn>2014-07-24 19:53:55 -0400</pav:lastSavedOn>
    <ao:context rdf:resource="urn:domeoclient:uuid:9F07EC2D-B722-4E66-94F2-FC8B5EEAC608"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#expertstudyAnnotation"/>
    <ao:body rdf:nodeID="N5aa0f1f7ed364c4fa6de5a60877475fc"/>
    <pav:lineageUri>urn:domeoserver:annotation:207A3707-CA29-4402-95C8-5CD7687B2868</pav:lineageUri>
    <domeo:belongsToSet>urn:domeoclient:uuid:E0863579-8D19-4B30-ADD6-2A5BDBC2F482</domeo:belongsToSet>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812eda990003</pav:createdBy>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:20B4F69C-E14E-46A0-8FCE-6AAC4D5EF0B0">
    <domeo:uuid></domeo:uuid>
    <pav:createdOn>2014-07-07 09:40:23 -0400</pav:createdOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:exact>TID </ao:exact>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:20B4F69C-E14E-46A0-8FCE-6AAC4D5EF0B0"/>
    <domeo:uuid>20B4F69C-E14E-46A0-8FCE-6AAC4D5EF0B0</domeo:uuid>
    <ao:suffix>sildenafil to patients with pulmonary arterial hypertension, lesser reductions than above in systolic and diastolic blood pressures were observed (a decrease in both of 2 mmHg).</ao:suffix>
    <ao:prefix>After chronic dosing of 80 mg </ao:prefix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-155.txt.html</ao:hasSource>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:E71F7227-79D2-4BF7-AAF2-F7F5CA5F1555">
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-139.txt.html</ao:hasSource>
    <ao:exact>fexofenadine</ao:exact>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <pav:createdOn>2014-07-24 20:11:46 -0400</pav:createdOn>
    <ao:prefix> coadministration enhances </ao:prefix>
    <ao:suffix> gastrointestinal absorption. This observed increase in the bioavailability of fexofenadine may be due to transport-related effects, such as p-glycoprotein. In vivo animal studies also suggest that in addition to enhancing absorption, ketoconazole decrea</ao:suffix>
    <domeo:uuid>E71F7227-79D2-4BF7-AAF2-F7F5CA5F1555</domeo:uuid>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:E71F7227-79D2-4BF7-AAF2-F7F5CA5F1555"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:1F561698-D9D5-496E-A7E9-97BDA5059FED">
    <domeo:belongsToSet>urn:domeoclient:uuid:BED41F06-565A-4622-9A88-48810E5A28DE</domeo:belongsToSet>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812eda990003</pav:createdBy>
    <domeo:belongsToSet>urn:domeoserver:annotationset:A3F0B39A-4249-4B63-BB0D-F24A005066AC</domeo:belongsToSet>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:lineageUri>urn:domeoserver:annotation:3FB37094-4AA7-46AF-BFA8-56624D31C404</pav:lineageUri>
    <pav:lastSavedOn>2014-09-02 11:35:33 -0400</pav:lastSavedOn>
    <domeo:belongsToSet>urn:domeoserver:annotationset:A5DD001D-C81A-4E2E-B5E0-7A866B35E26B</domeo:belongsToSet>
    <rdfs:label>Highlight</rdfs:label>
    <pav:createdOn>2014-09-02 11:30:45 -0400</pav:createdOn>
    <pav:lineageUri>urn:domeoserver:annotationset:D1715BD2-BD41-46FD-9454-DC7A423A29AC</pav:lineageUri>
    <ao:context rdf:resource="urn:domeoclient:uuid:BA2A0666-709F-4D11-B84E-C64B1709D0F9"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <domeo:belongsToSet>urn:domeoserver:annotationset:3F546823-204F-4F9B-9006-3DC526C56931</domeo:belongsToSet>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:A9F3E7CF-7FCB-472F-9AC5-B1BE53CD842F">
    <domeo:uuid>A9F3E7CF-7FCB-472F-9AC5-B1BE53CD842F</domeo:uuid>
    <pav:createdOn>2014-07-22 19:26:02 -0400</pav:createdOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:exact>rosiglitazone</ao:exact>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:A9F3E7CF-7FCB-472F-9AC5-B1BE53CD842F"/>
    <ao:suffix> is approximately 17.6 (30%) liters, based on a population pharmacokinetic analysis. Rosiglitazone is approximately 99.8% bound to plasma proteins, primarily albumin.</ao:suffix>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-123.txt.html</ao:hasSource>
    <ao:prefix>The mean (CV%) oral volume of distribution (Vss/F) of </ao:prefix>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:42DD4654-83AE-4111-86D8-574617EB3CAB">
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <domeo:uuid>42DD4654-83AE-4111-86D8-574617EB3CAB</domeo:uuid>
    <ao:exact>fluconazole</ao:exact>
    <ao:prefix> administered as 600 mg daily in eight healthy male volunteers resulted in a significant decrease in </ao:prefix>
    <pav:createdOn>2014-07-13 12:56:03 -0400</pav:createdOn>
    <ao:suffix> AUC and a significant increase in apparent oral clearance of fluconazole. There was a mean ± SD reduction in fluconazole AUC of 23% ± 9% (range: -13 to -42%). Apparent oral clearance of fluconazole increased 32% ± 17% (range: 16 to 72%). Fluconazole hal</ao:suffix>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:42DD4654-83AE-4111-86D8-574617EB3CAB"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-24.txt.html</ao:hasSource>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/B6FF0814-E04F-4FA2-8963-BC913DC8898E">
    <rdfs:label>antacid</rdfs:label>
    <sio:SIO_000228>dikbD2R:object-drug-of-interaction</sio:SIO_000228>
    <dct:description>Referred to the drug in the interaction.</dct:description>
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/</dailymed:activeMoietyRxCUI>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/active-ingredient"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:41C681E8-1D19-42FD-B50F-1189BEEA2B54">
    <ao:exact>Sotalol </ao:exact>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-71.txt.html</ao:hasSource>
    <domeo:uuid>41C681E8-1D19-42FD-B50F-1189BEEA2B54</domeo:uuid>
    <ao:suffix>hydrochloride tablets USP, 80 mg are available as light blue, oval-shaped tablets that are scored on one side and debossed with the numbers “93” and “61” on each side of the score, and plain on the other side. They are available in bottles of 100.</ao:suffix>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:41C681E8-1D19-42FD-B50F-1189BEEA2B54"/>
    <pav:createdOn>2014-09-02 15:08:17 -0400</pav:createdOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:prefix>xsd:String</ao:prefix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:CAEF4002-AC71-41B3-AB37-783C0F6D54AB">
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:suffix>xsd:String</ao:suffix>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-118.txt.html</ao:hasSource>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:CAEF4002-AC71-41B3-AB37-783C0F6D54AB"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <domeo:uuid>CAEF4002-AC71-41B3-AB37-783C0F6D54AB</domeo:uuid>
    <ao:prefix>xsd:String</ao:prefix>
    <pav:createdOn>2014-07-22 18:46:46 -0400</pav:createdOn>
    <ao:exact>Concomitant administration of Synercid and nifedipine (repeated oral doses) and midazolam (intravenous bolus dose) in healthy volunteers led to elevated plasma concentrations of these drugs. The Cmax increased by 18% and 14% (median values) and the AUC increased by 44% and 33% for nifedipine and midazolam, respectively.</ao:exact>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:37E9FF1C-D06E-42C3-944C-482813D8E38E">
    <pav:lastSavedOn>2014-07-22 19:28:02 -0400</pav:lastSavedOn>
    <pav:lineageUri>urn:domeoserver:annotation:E53B783B-E812-41F2-BEEB-A3B59F998028</pav:lineageUri>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812eda990003</pav:createdBy>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">3</pav:versionNumber>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <domeo:belongsToSet>urn:domeoserver:annotationset:7021B883-FD5C-4083-BD87-DF56D3C87633</domeo:belongsToSet>
    <pav:lineageUri>urn:domeoserver:annotationset:AB1741F1-5A5F-4416-AEAC-A544BCBB7D16</pav:lineageUri>
    <ao:context rdf:resource="urn:domeoclient:uuid:55A5D871-82BA-4D87-A1EA-62DCA1BF358F"/>
    <pav:createdOn>2014-07-22 19:28:13 -0400</pav:createdOn>
    <domeo:belongsToSet>urn:domeoserver:annotationset:514BA51B-D734-4003-A7C3-F03C0F95833A</domeo:belongsToSet>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <domeo:belongsToSet>urn:domeoserver:annotationset:2914A3FD-DF43-4F78-999C-77CE7A028B19</domeo:belongsToSet>
    <domeo:belongsToSet>urn:domeoserver:annotationset:7E80543E-BF76-4514-92A9-91458DCB802B</domeo:belongsToSet>
    <domeo:belongsToSet>urn:domeoserver:annotationset:F272A789-69D0-47CC-8CC9-F25C55B91261</domeo:belongsToSet>
    <pav:previousVersion>urn:domeoserver:annotationset:467D4F28-D086-4217-9DE0-23E165F30716</pav:previousVersion>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <domeo:belongsToSet>urn:domeoserver:annotationset:606A5B3F-B6FB-4279-AA42-7893CFC2D20C</domeo:belongsToSet>
    <rdfs:label>Highlight</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:F1920C60-E3BB-461B-89EC-34061357C4C7">
    <pav:createdOn>2014-07-22 20:18:44 -0400</pav:createdOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:suffix> is not altered in conditions accompanied by increases in gastrointestinal pH.</ao:suffix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-123.txt.html</ao:hasSource>
    <ao:exact>rosiglitazone</ao:exact>
    <domeo:uuid>F1920C60-E3BB-461B-89EC-34061357C4C7</domeo:uuid>
    <ao:prefix> in healthy volunteers. These results suggest that the absorption of oral </ao:prefix>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:F1920C60-E3BB-461B-89EC-34061357C4C7"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:6C727003-BB8F-45A8-BBAC-ACBE1D4D132E">
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <ao:item rdf:resource="urn:domeoclient:uuid:1584C65E-C32D-42F5-A725-32DCDF671F11"/>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812eda990003</pav:createdBy>
    <permissions:permissions rdf:nodeID="N3592ee25bcc24f299b939c17e35a9553"/>
    <pav:lineageUri>urn:domeoserver:annotationset:6E55DAE1-1B74-4DEB-88DF-468C3C50E4E0</pav:lineageUri>
    <ao:item rdf:resource="urn:domeoclient:uuid:E2EC2236-F4B5-4F35-8112-88B3BB4A33EA"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:590B6F13-4CF1-42FD-BA01-FB622D059EBD"/>
    <ao:annotatesResource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-131.txt.html</ao:annotatesResource>
    <domeo:agents rdf:resource="urn:person:uuid:080e143046812afe0146812eda990003"/>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <domeo:agents rdf:resource="urn:domeo:software:id:Domeo-2.1alpha-050"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#AnnotationSet"/>
    <pav:createdOn>2014-07-24 19:47:39 -0400</pav:createdOn>
    <ao:item rdf:resource="urn:domeoclient:uuid:BCA04010-E0E5-4D69-A2B7-6AB2C8D2081F"/>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <dct:description>The default set is created automatically by Domeo when no other set is existing.</dct:description>
    <rdfs:label>Default Set</rdfs:label>
    <domeo:deleted>false</domeo:deleted>
    <pav:lastSavedOn>2014-07-24 19:51:12 -0400</pav:lastSavedOn>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:F5B0ED12-45EB-48BE-B664-DDC78E05AA4A">
    <pav:lineageUri>urn:domeoserver:annotationset:C5DEBC9B-77EE-4243-88EB-DBC19737ACD2</pav:lineageUri>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812eda990003</pav:createdBy>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:lastSavedOn>2014-09-02 19:19:47 -0400</pav:lastSavedOn>
    <ao:context rdf:resource="urn:domeoclient:uuid:7F7832F9-F40E-4E9B-917C-25342C417D3F"/>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:lineageUri>urn:domeoserver:annotation:FEFB6F6A-2307-4B9F-B71D-233D49DC1C4A</pav:lineageUri>
    <domeo:belongsToSet>urn:domeoserver:annotationset:E32812A9-205B-4EE1-B488-A1E294EDBFB9</domeo:belongsToSet>
    <rdfs:label>Highlight</rdfs:label>
    <domeo:belongsToSet>urn:domeoserver:annotationset:392EE0FB-AC4F-4AF2-87A6-2E50A281F434</domeo:belongsToSet>
    <pav:createdOn>2014-09-02 19:17:02 -0400</pav:createdOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <domeo:belongsToSet>urn:domeoclient:uuid:CB83FFC2-EA71-44EA-8F11-DE80E389C84E</domeo:belongsToSet>
    <pav:previousVersion>xsd:String</pav:previousVersion>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:2977EDDB-817D-4A9F-96BE-EAFA109EA9CA">
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/PK_DDI"/>
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/EA31E970-6539-4E1A-AF71-DC79346D30C3"/>
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/990B9FF4-1B11-4306-B335-B576A2DE3124"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:C0B517A8-DCD4-4740-A77D-8490A77113AE">
    <rdfs:label>expertstudy Annotation</rdfs:label>
    <ao:context rdf:resource="urn:domeoclient:uuid:CAB91F57-2F70-4DDB-9BF8-A50167C8BBCE"/>
    <pav:lastSavedOn>2014-07-13 12:41:10 -0400</pav:lastSavedOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#expertstudyAnnotation"/>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:createdOn>2014-07-13 12:40:40 -0400</pav:createdOn>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812eda990003</pav:createdBy>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:lineageUri>urn:domeoserver:annotation:8D387F71-D7EF-42BB-8B40-0EBCAFF64A75</pav:lineageUri>
    <domeo:belongsToSet>urn:domeoclient:uuid:4F872953-6D19-4809-9285-FCCF2FF54315</domeo:belongsToSet>
    <ao:body rdf:nodeID="N4915c989454d42718ef582c99ebdffdb"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:ED5A7142-16C6-4FE6-8733-C955CEF7A376">
    <ao:exact>sertraline</ao:exact>
    <ao:prefix>, </ao:prefix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <domeo:uuid>ED5A7142-16C6-4FE6-8733-C955CEF7A376</domeo:uuid>
    <ao:suffix>) is clinically warranted, appropriate observation of the patient is advised.</ao:suffix>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:ED5A7142-16C6-4FE6-8733-C955CEF7A376"/>
    <pav:createdOn>2014-09-02 11:43:54 -0400</pav:createdOn>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-9.txt.html</ao:hasSource>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
  </rdf:Description>
  <rdf:Description rdf:nodeID="N90b6166b32e54466a9e21cdafa8ec1cb">
    <permissions:isLocked>false</permissions:isLocked>
    <permissions:accessType>urn:domeo:access:public</permissions:accessType>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:C0F812BF-119E-4BE1-AAA3-BF2DAE39B76F">
    <ao:prefix>Studies in vitro have shown that </ao:prefix>
    <pav:createdOn>2014-07-07 09:36:31 -0400</pav:createdOn>
    <ao:exact>sildenafil </ao:exact>
    <ao:suffix>is selective for PDE5. Its effect is more potent on PDE5 than on other known phosphodiesterases (10-fold for PDE6, &gt; 80-fold for PDE1, &gt; 700-fold for PDE2, PDE3, PDE4, PDE7, PDE8, PDE9, PDE10, and PDE11). The approximately 4,000-fold selectivity for PDE5</ao:suffix>
    <domeo:uuid>C0F812BF-119E-4BE1-AAA3-BF2DAE39B76F</domeo:uuid>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-155.txt.html</ao:hasSource>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:C0F812BF-119E-4BE1-AAA3-BF2DAE39B76F"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <domeo:uuid></domeo:uuid>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:0F8D75BE-6E65-4B3E-AA75-B1FF492AC889">
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <ao:context rdf:resource="urn:domeoclient:uuid:05DDDFF9-6ACB-4806-8A4D-37A221046E18"/>
    <pav:createdOn>2014-09-02 11:40:15 -0400</pav:createdOn>
    <pav:lineageUri>urn:domeoserver:annotationset:D1715BD2-BD41-46FD-9454-DC7A423A29AC</pav:lineageUri>
    <domeo:belongsToSet>urn:domeoserver:annotationset:A3F0B39A-4249-4B63-BB0D-F24A005066AC</domeo:belongsToSet>
    <rdfs:label>Highlight</rdfs:label>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812eda990003</pav:createdBy>
    <pav:previousVersion>urn:domeoclient:uuid:BED41F06-565A-4622-9A88-48810E5A28DE</pav:previousVersion>
    <pav:lastSavedOn>2014-09-02 11:46:58 -0400</pav:lastSavedOn>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">2</pav:versionNumber>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <domeo:belongsToSet>urn:domeoserver:annotationset:A5DD001D-C81A-4E2E-B5E0-7A866B35E26B</domeo:belongsToSet>
    <domeo:belongsToSet>urn:domeoserver:annotationset:3F546823-204F-4F9B-9006-3DC526C56931</domeo:belongsToSet>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:lineageUri>urn:domeoserver:annotation:7A299BD5-3215-49A0-B7D5-FAA7ABC39E23</pav:lineageUri>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:79F49E5C-6D04-4116-8E54-1C6470AEB616">
    <ao:suffix> may increase the serum levels of tacrolimus. </ao:suffix>
    <ao:prefix> and </ao:prefix>
    <domeo:uuid>79F49E5C-6D04-4116-8E54-1C6470AEB616</domeo:uuid>
    <pav:createdOn>2014-09-02 19:19:41 -0400</pav:createdOn>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:79F49E5C-6D04-4116-8E54-1C6470AEB616"/>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-74.txt.html</ao:hasSource>
    <ao:exact>tacrolimus</ao:exact>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:2CE66065-C68D-4E90-911C-F8B5E04B3813">
    <pav:createdOn>2014-07-13 12:37:33 -0400</pav:createdOn>
    <ao:prefix> and </ao:prefix>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:2CE66065-C68D-4E90-911C-F8B5E04B3813"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-21.txt.html</ao:hasSource>
    <domeo:uuid>2CE66065-C68D-4E90-911C-F8B5E04B3813</domeo:uuid>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:exact>norethindrone</ao:exact>
    <ao:suffix>. In this placebo-controlled, double-blind, randomized, two-way crossover study carried out over three cycles of oral contraceptive treatment, fluconazole dosing resulted in small increases in the mean AUCs of ethinyl estradiol and norethindrone compared</ao:suffix>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:E5B69523-748D-4576-8C13-43546FFB2F5E">
    <pav:createdOn>2014-07-22 19:08:18 -0400</pav:createdOn>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <ao:context rdf:resource="urn:domeoclient:uuid:CEE8C6E7-92B6-4611-A8A6-213D50A907B1"/>
    <pav:lastSavedOn>2014-07-22 19:08:05 -0400</pav:lastSavedOn>
    <ao:body rdf:nodeID="N483102e238f746379c32ec3b79d6fb3e"/>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <domeo:belongsToSet>urn:domeoserver:annotationset:2B18F6B1-59F7-4EA0-9386-55A934108055</domeo:belongsToSet>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812eda990003</pav:createdBy>
    <pav:lineageUri>urn:domeoserver:annotation:B5EDCB4C-88FB-4DBE-B359-830C5B6FE5A7</pav:lineageUri>
    <rdfs:label>expertstudy Annotation</rdfs:label>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#expertstudyAnnotation"/>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:A95F4FE2-696A-4769-8ED1-FC8F49B83876">
    <ao:suffix>.</ao:suffix>
    <pav:createdOn>2014-07-24 19:44:25 -0400</pav:createdOn>
    <ao:prefix> does not alter the pharmacokinetics of </ao:prefix>
    <ao:exact>propranolol</ao:exact>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <domeo:uuid>A95F4FE2-696A-4769-8ED1-FC8F49B83876</domeo:uuid>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:A95F4FE2-696A-4769-8ED1-FC8F49B83876"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-128.txt.html</ao:hasSource>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:FE17741D-F10F-4662-94F4-BB9A69F3D7F4">
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:lastSavedOn>2014-07-21 21:49:33 -0400</pav:lastSavedOn>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <pav:lineageUri>urn:domeoserver:annotation:8EFE25C9-2600-4A54-BE26-4485EA6A3DFC</pav:lineageUri>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812eda990003</pav:createdBy>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <domeo:belongsToSet>urn:domeoclient:uuid:B803E851-5AD5-4741-B1B9-1CBAED597E18</domeo:belongsToSet>
    <ao:context rdf:resource="urn:domeoclient:uuid:6A119113-824F-4EAE-B66E-B060687F0A7E"/>
    <pav:createdOn>2014-07-21 21:47:28 -0400</pav:createdOn>
    <rdfs:label>Highlight</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:BBA25E8B-C9EC-4761-85B9-71DE456EB881">
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <rdfs:label>Highlight</rdfs:label>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812eda990003</pav:createdBy>
    <domeo:belongsToSet>urn:domeoclient:uuid:A52F0287-AD68-4755-8E11-75217CD4FED8</domeo:belongsToSet>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:lastSavedOn>2014-07-21 21:38:46 -0400</pav:lastSavedOn>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <ao:context rdf:resource="urn:domeoclient:uuid:53465311-823E-4CB3-9C24-4241F449E2C3"/>
    <pav:createdOn>2014-07-21 21:38:52 -0400</pav:createdOn>
    <pav:lineageUri>urn:domeoserver:annotation:1F0337A4-2EFA-48BC-A824-5EE6C6368FED</pav:lineageUri>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:6B93EB2B-A516-48C4-A750-602CF9462A88">
    <sio:SIO_000563>dikbD2R:modality</sio:SIO_000563>
    <rdf:type rdf:resource="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#DrugDrugInteractionStatement"/>
    <sio:SIO_000205>dikbD2R:statement</sio:SIO_000205>
    <sio:SIO_000628 rdf:resource="urn:pddi:uuid:8AF7E41C-63B6-4042-8707-4622E9BC98AA"/>
    <dikbD2R:statement>ncit:Qualitative</dikbD2R:statement>
    <dikbD2R:modality>ncit:negative</dikbD2R:modality>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:9802981C-E3CC-427F-9464-29E20B17C0CD">
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:suffix>, and warfarin concomitantly. Increases in INR and prothrombin time may lead to abnormal bleeding and even death. Patients treated with proton pump inhibitors and warfarin may need to be monitored for increases in INR and prothrombin time.</ao:suffix>
    <ao:exact>omeprazole</ao:exact>
    <domeo:uuid>9802981C-E3CC-427F-9464-29E20B17C0CD</domeo:uuid>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:9802981C-E3CC-427F-9464-29E20B17C0CD"/>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-74.txt.html</ao:hasSource>
    <pav:createdOn>2014-09-02 19:12:43 -0400</pav:createdOn>
    <ao:prefix>, drugs that are metabolized by oxidation in the liver. There have been reports of increased INR and prothrombin time in patients receiving proton pump inhibitors, including </ao:prefix>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:AC6949EC-26AB-43DC-8B1B-1401086A35B0">
    <domeo:uuid>AC6949EC-26AB-43DC-8B1B-1401086A35B0</domeo:uuid>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:suffix>, may be increased by acyclovir, thus caution should be used with concomitant administration.</ao:suffix>
    <pav:createdOn>2014-07-28 17:00:22 -0400</pav:createdOn>
    <ao:exact>normeperidine</ao:exact>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:AC6949EC-26AB-43DC-8B1B-1401086A35B0"/>
    <ao:prefix> and its metabolite, </ao:prefix>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-163.txt.html</ao:hasSource>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:65044E3B-BE66-455E-B576-1B8DF996B6B4">
    <pav:createdOn>2014-07-13 11:13:36 -0400</pav:createdOn>
    <ao:suffix> and higher 9-hydroxyrisperidone concentrations than poor metabolizers, the pharmacokinetics of risperidone and 9-hydroxyrisperidone combined, after single and multiple doses, are similar in extensive and poor metabolizers.</ao:suffix>
    <ao:prefix>, whereas poor CYP 2D6 metabolizers convert it much more slowly. Although extensive metabolizers have lower </ao:prefix>
    <ao:exact>risperidone</ao:exact>
    <domeo:uuid>65044E3B-BE66-455E-B576-1B8DF996B6B4</domeo:uuid>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:65044E3B-BE66-455E-B576-1B8DF996B6B4"/>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-8.txt.html</ao:hasSource>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:E0DCF362-11F8-4FF3-8C3C-EDB9DD3D53A7">
    <domeo:belongsToSet>urn:domeoserver:annotationset:22ED7220-C6F6-43C5-9DF9-89F62F0F8E27</domeo:belongsToSet>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812eda990003</pav:createdBy>
    <ao:context rdf:resource="urn:domeoclient:uuid:3A07EF3E-A1DF-4E0E-952B-5422EC6E9B3D"/>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <pav:lastSavedOn>2014-07-07 11:24:52 -0400</pav:lastSavedOn>
    <domeo:belongsToSet>urn:domeoserver:annotationset:7AACEF8D-2EBC-4F0B-94B2-190650E562F6</domeo:belongsToSet>
    <rdfs:label>Highlight</rdfs:label>
    <pav:lineageUri>urn:domeoserver:annotation:206422C6-3F3C-47E8-AC4D-3CADF0982F38</pav:lineageUri>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:createdOn>2014-07-07 11:22:54 -0400</pav:createdOn>
    <domeo:belongsToSet>urn:domeoserver:annotationset:8F3CF3D9-AADE-4A86-BD42-2924B3D6A406</domeo:belongsToSet>
    <domeo:belongsToSet>urn:domeoserver:annotationset:131835A3-C655-4F91-97D4-52CAFF7B7CCA</domeo:belongsToSet>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:AB1F4800-7A8C-48DD-A103-ADE54191154D">
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <pav:lineageUri>urn:domeoserver:annotationset:166C20E9-1B4C-47D1-982D-922E2E5ACFF2</pav:lineageUri>
    <ao:context rdf:resource="urn:domeoclient:uuid:4F8ED859-2391-4F15-8FA4-EA14374BCE11"/>
    <rdfs:label>Highlight</rdfs:label>
    <pav:lastSavedOn>2014-09-02 12:03:47 -0400</pav:lastSavedOn>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <domeo:belongsToSet>urn:domeoserver:annotationset:D52DFD7B-BDDF-488F-B339-B1BC641E50E9</domeo:belongsToSet>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:createdOn>2014-09-02 12:03:45 -0400</pav:createdOn>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812eda990003</pav:createdBy>
    <domeo:belongsToSet>urn:domeoclient:uuid:379CD8C1-F4B4-42B7-8F87-70776866DB1F</domeo:belongsToSet>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:lineageUri>urn:domeoserver:annotation:1A2AF76B-24DA-4F88-B959-8F700A36D988</pav:lineageUri>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/1FCFC8E7-95A0-4188-9582-891391C2CFE6">
    <sio:SIO_000228>dikbD2R:object-drug-of-interaction</sio:SIO_000228>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/active-ingredient"/>
    <rdfs:label>fluconazole</rdfs:label>
    <dct:description>Referred to the drug in the interaction.</dct:description>
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/4450</dailymed:activeMoietyRxCUI>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:414AB21B-E61F-45BC-90CC-D10C8E784BF6">
    <domeo:belongsToSet>urn:domeoserver:annotationset:514BA51B-D734-4003-A7C3-F03C0F95833A</domeo:belongsToSet>
    <domeo:belongsToSet>urn:domeoserver:annotationset:F272A789-69D0-47CC-8CC9-F25C55B91261</domeo:belongsToSet>
    <pav:lastSavedOn>2014-07-22 19:40:31 -0400</pav:lastSavedOn>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <domeo:belongsToSet>urn:domeoserver:annotationset:2914A3FD-DF43-4F78-999C-77CE7A028B19</domeo:belongsToSet>
    <rdfs:label>Highlight</rdfs:label>
    <ao:context rdf:resource="urn:domeoclient:uuid:8C5CCA78-2E90-4B2A-961F-DADE6196F08B"/>
    <pav:previousVersion>urn:domeoserver:annotationset:7021B883-FD5C-4083-BD87-DF56D3C87633</pav:previousVersion>
    <pav:lineageUri>urn:domeoserver:annotationset:AB1741F1-5A5F-4416-AEAC-A544BCBB7D16</pav:lineageUri>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">5</pav:versionNumber>
    <pav:createdOn>2014-07-22 19:39:54 -0400</pav:createdOn>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812eda990003</pav:createdBy>
    <domeo:belongsToSet>urn:domeoserver:annotationset:606A5B3F-B6FB-4279-AA42-7893CFC2D20C</domeo:belongsToSet>
    <pav:lastSavedOn>2014-07-22 19:40:32 -0400</pav:lastSavedOn>
    <pav:lineageUri>urn:domeoserver:annotation:E42333E1-DEB6-4A8E-9953-245C9148C4A9</pav:lineageUri>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:031F5AE1-D155-403C-AE7F-01A1DD9F84AC">
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:prefix>xsd:String</ao:prefix>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-26.txt.html</ao:hasSource>
    <ao:suffix>AUC and Cmax were determined before and after the administration of fluconazole 200 mg daily for 14 days in eight renal transplant patients who had been on cyclosporine therapy for at least 6 months and on a stable cyclosporine dose for at least 6 weeks.</ao:suffix>
    <pav:createdOn>2014-07-21 21:28:25 -0400</pav:createdOn>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:031F5AE1-D155-403C-AE7F-01A1DD9F84AC"/>
    <domeo:uuid>031F5AE1-D155-403C-AE7F-01A1DD9F84AC</domeo:uuid>
    <ao:exact>Cyclosporine </ao:exact>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:46461303-C78E-4E52-94D7-0AB13BC2A0A5">
    <domeo:belongsToSet>urn:domeoclient:uuid:05CE82A3-E1C6-497A-B0B0-31DD508C02A1</domeo:belongsToSet>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812eda990003</pav:createdBy>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <ao:context rdf:resource="urn:domeoclient:uuid:C3190341-7099-485B-A4E9-E9FFAB0E8032"/>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:lastSavedOn>2014-07-28 17:01:39 -0400</pav:lastSavedOn>
    <pav:lineageUri>urn:domeoserver:annotation:5F16508C-3D93-4DE2-A5F1-292B959915AB</pav:lineageUri>
    <pav:createdOn>2014-07-28 17:01:19 -0400</pav:createdOn>
    <rdfs:label>Highlight</rdfs:label>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:3C500E90-E946-4B1B-B3D2-27B11967A625">
    <rdfs:label>Highlight</rdfs:label>
    <pav:lastSavedOn>2014-07-07 09:44:19 -0400</pav:lastSavedOn>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:lineageUri>urn:domeoserver:annotation:62EDA0C1-785C-4EA5-8DB3-7CC59013D2D5</pav:lineageUri>
    <ao:context rdf:resource="urn:domeoclient:uuid:441651E7-B4B0-4FA2-BDD8-3B5B7B207EE2"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:createdOn>2014-07-07 09:34:22 -0400</pav:createdOn>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812eda990003</pav:createdBy>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <domeo:belongsToSet>urn:domeoclient:uuid:FCA2BF23-0BE3-409F-9177-761812F96097</domeo:belongsToSet>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:A2D6105B-A1D5-4610-94EC-C0CB40BB9E6D">
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:exact>paroxetine</ao:exact>
    <ao:prefix>Phenobarbital induces many cytochrome P450 (oxidative) enzymes. When a single oral 30-mg dose of immediate-release paroxetine  was administered at phenobarbital steady state (100 mg once daily for 14 days), </ao:prefix>
    <ao:suffix> AUC and T½ were reduced (by an average of 25% and 38%, respectively) compared to </ao:suffix>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-45.txt.html</ao:hasSource>
    <pav:createdOn>2014-09-01 16:22:12 -0400</pav:createdOn>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:A2D6105B-A1D5-4610-94EC-C0CB40BB9E6D"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <domeo:uuid>A2D6105B-A1D5-4610-94EC-C0CB40BB9E6D</domeo:uuid>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:B7059CDB-FD5F-4D07-9802-7905CA2F92BA">
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:createdOn>2014-07-22 18:51:35 -0400</pav:createdOn>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <rdfs:label>Highlight</rdfs:label>
    <ao:context rdf:resource="urn:domeoclient:uuid:FB7CDA28-9814-4B6E-95D0-E4733B2DD0B9"/>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812eda990003</pav:createdBy>
    <domeo:belongsToSet>urn:domeoclient:uuid:3D195979-3E82-427D-95B8-F50F48DB4AA7</domeo:belongsToSet>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <pav:lineageUri>urn:domeoserver:annotation:B12DFBA5-C6D2-4173-89F1-D7B5DBF95B30</pav:lineageUri>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:lastSavedOn>2014-07-22 18:54:35 -0400</pav:lastSavedOn>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:F94384BA-7A08-4E0D-A89C-A73959BAA203">
    <domeo:belongsToSet>urn:domeoclient:uuid:71191E51-53CB-4FDE-88D0-33C6818E2232</domeo:belongsToSet>
    <rdfs:label>Highlight</rdfs:label>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:createdOn>2014-07-13 11:09:28 -0400</pav:createdOn>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812eda990003</pav:createdBy>
    <pav:lineageUri>urn:domeoserver:annotation:2D596385-5BFD-4D31-8E3A-AF1CD1B646BB</pav:lineageUri>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <ao:context rdf:resource="urn:domeoclient:uuid:55C36B4E-CDCE-4B16-94D5-178014A48A7F"/>
    <pav:lastSavedOn>2014-07-13 11:32:29 -0400</pav:lastSavedOn>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:30CD6C3F-1B6D-4C66-B96F-A460B56D3480">
    <ao:prefix> (2 mg twice daily) and </ao:prefix>
    <ao:exact>metformin</ao:exact>
    <domeo:uuid>30CD6C3F-1B6D-4C66-B96F-A460B56D3480</domeo:uuid>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:30CD6C3F-1B6D-4C66-B96F-A460B56D3480"/>
    <pav:createdOn>2014-07-22 19:55:33 -0400</pav:createdOn>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-123.txt.html</ao:hasSource>
    <ao:suffix> (500 mg twice daily) in healthy volunteers for 4 days had no effect on the steady-state pharmacokinetics of either metformin or rosiglitazone.</ao:suffix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:01600057-F016-4A5A-AC67-3F30E5F3B4EA">
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:createdOn>2014-07-21 21:31:10 -0400</pav:createdOn>
    <pav:lineageUri>urn:domeoserver:annotationset:092451F5-B0C0-430C-8896-07F81D33F9E1</pav:lineageUri>
    <rdfs:label>Highlight</rdfs:label>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812eda990003</pav:createdBy>
    <pav:lastSavedOn>2014-07-21 21:31:54 -0400</pav:lastSavedOn>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <domeo:belongsToSet>urn:domeoserver:annotationset:40007BD9-0869-48CF-A8F2-BAD26AE3E6E1</domeo:belongsToSet>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <domeo:belongsToSet>urn:domeoclient:uuid:5B3EE83F-83C7-4BA8-A892-C032BE699CFA</domeo:belongsToSet>
    <ao:context rdf:resource="urn:domeoclient:uuid:6EB0C05E-6581-4241-B07F-CF48B6405DC1"/>
    <pav:lineageUri>urn:domeoserver:annotation:EC92E4A8-6EFF-48B4-B2EB-9246CAEB8CEA</pav:lineageUri>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:2D0A6C88-E510-4AF5-8DFB-C35B1F919461">
    <pav:lineageUri>urn:domeoserver:annotation:FC41D6EB-7A15-4E29-A065-BBD07F30DA83</pav:lineageUri>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:lastSavedOn>2014-07-22 19:40:32 -0400</pav:lastSavedOn>
    <ao:context rdf:resource="urn:domeoclient:uuid:9E86ADEB-E76E-4255-8364-3D0CF7C52E24"/>
    <rdfs:label>Highlight</rdfs:label>
    <domeo:belongsToSet>urn:domeoserver:annotationset:2914A3FD-DF43-4F78-999C-77CE7A028B19</domeo:belongsToSet>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <domeo:belongsToSet>urn:domeoserver:annotationset:514BA51B-D734-4003-A7C3-F03C0F95833A</domeo:belongsToSet>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <domeo:belongsToSet>urn:domeoserver:annotationset:F272A789-69D0-47CC-8CC9-F25C55B91261</domeo:belongsToSet>
    <pav:createdOn>2014-07-22 19:39:44 -0400</pav:createdOn>
    <pav:lineageUri>urn:domeoserver:annotationset:AB1741F1-5A5F-4416-AEAC-A544BCBB7D16</pav:lineageUri>
    <pav:previousVersion>urn:domeoserver:annotationset:7021B883-FD5C-4083-BD87-DF56D3C87633</pav:previousVersion>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812eda990003</pav:createdBy>
    <pav:lastSavedOn>2014-07-22 19:40:31 -0400</pav:lastSavedOn>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">5</pav:versionNumber>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <domeo:belongsToSet>urn:domeoserver:annotationset:606A5B3F-B6FB-4279-AA42-7893CFC2D20C</domeo:belongsToSet>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/BB10D5C0-6D53-40A0-8A2D-D31E8D5FA6E1">
    <sio:SIO_000228>dikbD2R:object-drug-of-interaction</sio:SIO_000228>
    <rdfs:label>Zonisamide</rdfs:label>
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/39998</dailymed:activeMoietyRxCUI>
    <dct:description>Referred to the drug in the interaction.</dct:description>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/active-ingredient"/>
  </rdf:Description>
  <rdf:Description rdf:nodeID="Na92c96060fbd4d65b78ad9bc3db29319">
    <permissions:accessType>urn:domeo:access:public</permissions:accessType>
    <permissions:isLocked>false</permissions:isLocked>
  </rdf:Description>
  <rdf:Description rdf:nodeID="N7baac5f2dd6140fe80b95a54dd8eae0d">
    <permissions:isLocked>false</permissions:isLocked>
    <permissions:accessType>urn:domeo:access:public</permissions:accessType>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/C4007BE1-F417-40F4-9849-29EA38C247C5">
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/6472</dailymed:activeMoietyRxCUI>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/active-ingredient"/>
    <rdfs:label>lovastatin</rdfs:label>
    <dct:description>Referred to the drug in the interaction.</dct:description>
    <sio:SIO_000228>dikbD2R:precipitant-drug-of-interaction</sio:SIO_000228>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:4FCA7E7B-CC82-4455-94C0-73C09ED070C1">
    <ao:exact>sertraline</ao:exact>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <pav:createdOn>2014-07-13 12:34:41 -0400</pav:createdOn>
    <domeo:uuid>4FCA7E7B-CC82-4455-94C0-73C09ED070C1</domeo:uuid>
    <ao:suffix> and the following inactive ingredients: dibasic calcium phosphate dihydrate, hydroxypropyl cellulose, hypromellose, magnesium stearate, microcrystalline cellulose, polyethylene glycol, sodium starch glycolate, talc, and titanium dioxide.</ao:suffix>
    <ao:prefix> hydrochloride equivalent to 25, 50, 100, 150 and 200 mg of </ao:prefix>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-20.txt.html</ao:hasSource>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:4FCA7E7B-CC82-4455-94C0-73C09ED070C1"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:44D9A897-A866-42BB-8DD9-A376BF8D1B3E">
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812eda990003</pav:createdBy>
    <pav:lastSavedOn>2014-07-22 19:35:16 -0400</pav:lastSavedOn>
    <domeo:belongsToSet>urn:domeoserver:annotationset:606A5B3F-B6FB-4279-AA42-7893CFC2D20C</domeo:belongsToSet>
    <ao:context rdf:resource="urn:domeoclient:uuid:74381157-1392-49DE-BD6B-8C71824715BF"/>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <domeo:belongsToSet>urn:domeoserver:annotationset:514BA51B-D734-4003-A7C3-F03C0F95833A</domeo:belongsToSet>
    <domeo:belongsToSet>urn:domeoserver:annotationset:2914A3FD-DF43-4F78-999C-77CE7A028B19</domeo:belongsToSet>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">4</pav:versionNumber>
    <pav:createdOn>2014-07-22 19:31:30 -0400</pav:createdOn>
    <domeo:belongsToSet>urn:domeoserver:annotationset:7021B883-FD5C-4083-BD87-DF56D3C87633</domeo:belongsToSet>
    <domeo:belongsToSet>urn:domeoserver:annotationset:F272A789-69D0-47CC-8CC9-F25C55B91261</domeo:belongsToSet>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <pav:previousVersion>urn:domeoserver:annotationset:7E80543E-BF76-4514-92A9-91458DCB802B</pav:previousVersion>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <rdfs:label>Highlight</rdfs:label>
    <pav:lineageUri>urn:domeoserver:annotationset:AB1741F1-5A5F-4416-AEAC-A544BCBB7D16</pav:lineageUri>
    <pav:lineageUri>urn:domeoserver:annotation:963ADA84-C049-4738-A8B7-9609750F76B8</pav:lineageUri>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:53FAB419-4FF7-440E-89DD-64411826800A">
    <rdfs:label>Highlight</rdfs:label>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:createdOn>2014-09-02 11:30:35 -0400</pav:createdOn>
    <domeo:belongsToSet>urn:domeoserver:annotationset:A5DD001D-C81A-4E2E-B5E0-7A866B35E26B</domeo:belongsToSet>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <domeo:belongsToSet>urn:domeoserver:annotationset:A3F0B39A-4249-4B63-BB0D-F24A005066AC</domeo:belongsToSet>
    <ao:context rdf:resource="urn:domeoclient:uuid:F3B66F49-9D04-482E-BF7F-722441E81595"/>
    <pav:lastSavedOn>2014-09-02 11:35:33 -0400</pav:lastSavedOn>
    <pav:lineageUri>urn:domeoserver:annotationset:D1715BD2-BD41-46FD-9454-DC7A423A29AC</pav:lineageUri>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:lineageUri>urn:domeoserver:annotation:7ED1D395-B673-4CE7-A3BE-62608DA17DA3</pav:lineageUri>
    <domeo:belongsToSet>urn:domeoserver:annotationset:3F546823-204F-4F9B-9006-3DC526C56931</domeo:belongsToSet>
    <domeo:belongsToSet>urn:domeoclient:uuid:BED41F06-565A-4622-9A88-48810E5A28DE</domeo:belongsToSet>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812eda990003</pav:createdBy>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:612855C1-32AF-48C7-A341-A649DD897808">
    <ao:prefix> and </ao:prefix>
    <ao:exact>9-hydroxyrisperidone</ao:exact>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:612855C1-32AF-48C7-A341-A649DD897808"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-8.txt.html</ao:hasSource>
    <pav:createdOn>2014-07-13 11:16:05 -0400</pav:createdOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:suffix> [see 7 DRUG INTERACTIONS]. It would also be possible for risperidone to interfere with metabolism of other drugs metabolized by CYP 2D6. Relatively weak binding of risperidone to the enzyme suggests this is unlikely [see 7 DRUG INTERACTIONS].</ao:suffix>
    <domeo:uuid>612855C1-32AF-48C7-A341-A649DD897808</domeo:uuid>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:F888C6E8-7F16-450A-A3B5-0E20C026DA2A">
    <pav:lineageUri>urn:domeoserver:annotation:15C3232E-943A-416F-90D9-C0872C8EC1AA</pav:lineageUri>
    <domeo:belongsToSet>urn:domeoclient:uuid:A84DE8F6-26B7-471D-8309-4E7CC2994FDF</domeo:belongsToSet>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <ao:context rdf:resource="urn:domeoclient:uuid:C13FD629-159C-4DA7-9B01-A5B3536DF254"/>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812eda990003</pav:createdBy>
    <rdfs:label>Highlight</rdfs:label>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <pav:createdOn>2014-09-01 16:06:11 -0400</pav:createdOn>
    <pav:lastSavedOn>2014-09-01 16:06:18 -0400</pav:lastSavedOn>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:8067DF3E-2917-42D8-A222-AC1982EBCC5F">
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:suffix> are increased by 64% and 79%, respectively, by co-administration of propranolol.</ao:suffix>
    <ao:prefix>The mean Cmax and AUC of </ao:prefix>
    <domeo:uuid>8067DF3E-2917-42D8-A222-AC1982EBCC5F</domeo:uuid>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:8067DF3E-2917-42D8-A222-AC1982EBCC5F"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-126.txt.html</ao:hasSource>
    <pav:createdOn>2014-07-24 19:39:19 -0400</pav:createdOn>
    <ao:exact>nifedipine</ao:exact>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:7CC41192-004E-44F9-8E3D-0FF7CECF1DC2">
    <rdfs:label>Highlight</rdfs:label>
    <ao:context rdf:resource="urn:domeoclient:uuid:F3F94F7A-3299-4ECD-8A0C-54D9B0E17A6D"/>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:lineageUri>urn:domeoserver:annotation:2E085178-1D00-47D7-8B18-1A094C6C93A7</pav:lineageUri>
    <domeo:belongsToSet>urn:domeoclient:uuid:71191E51-53CB-4FDE-88D0-33C6818E2232</domeo:belongsToSet>
    <pav:lastSavedOn>2014-07-13 11:32:29 -0400</pav:lastSavedOn>
    <pav:createdOn>2014-07-13 11:13:30 -0400</pav:createdOn>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812eda990003</pav:createdBy>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:AA680547-50B2-43E1-8768-6007654CDEF9">
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">5</pav:versionNumber>
    <pav:lineageUri>urn:domeoserver:annotationset:AB1741F1-5A5F-4416-AEAC-A544BCBB7D16</pav:lineageUri>
    <ao:context rdf:resource="urn:domeoclient:uuid:EFB9988E-CEA1-4326-AC04-4DC5F728B495"/>
    <pav:lastSavedOn>2014-07-22 19:40:31 -0400</pav:lastSavedOn>
    <pav:previousVersion>urn:domeoserver:annotationset:7021B883-FD5C-4083-BD87-DF56D3C87633</pav:previousVersion>
    <domeo:belongsToSet>urn:domeoserver:annotationset:F272A789-69D0-47CC-8CC9-F25C55B91261</domeo:belongsToSet>
    <pav:createdOn>2014-07-22 19:38:33 -0400</pav:createdOn>
    <domeo:belongsToSet>urn:domeoserver:annotationset:606A5B3F-B6FB-4279-AA42-7893CFC2D20C</domeo:belongsToSet>
    <rdfs:label>Highlight</rdfs:label>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812eda990003</pav:createdBy>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <pav:lastSavedOn>2014-07-22 19:40:32 -0400</pav:lastSavedOn>
    <domeo:belongsToSet>urn:domeoserver:annotationset:514BA51B-D734-4003-A7C3-F03C0F95833A</domeo:belongsToSet>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:lineageUri>urn:domeoserver:annotation:8FDD5145-3125-4DFB-B7B1-3F6F7B8F17B2</pav:lineageUri>
    <domeo:belongsToSet>urn:domeoserver:annotationset:2914A3FD-DF43-4F78-999C-77CE7A028B19</domeo:belongsToSet>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:6189C7ED-8284-4BC1-8C1D-995A1B9E9199">
    <sio:SIO_000628 rdf:resource="urn:pddi:uuid:991B1A28-CCE6-4672-8304-2C2413DEA09C"/>
    <dikbD2R:statement>ncit:quantitative</dikbD2R:statement>
    <dikbD2R:modality>ncit:positive</dikbD2R:modality>
    <sio:SIO_000205>dikbD2R:statement</sio:SIO_000205>
    <sio:SIO_000563>dikbD2R:modality</sio:SIO_000563>
    <rdf:type rdf:resource="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#DrugDrugInteractionStatement"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:4B8A305B-D42C-40FD-B384-05FE89B4ACA4">
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:lineageUri>urn:domeoserver:annotation:F7A02D27-BE7F-4E28-9113-F2A4EE1E7CBA</pav:lineageUri>
    <rdfs:label>Highlight</rdfs:label>
    <domeo:belongsToSet>urn:domeoserver:annotationset:392EE0FB-AC4F-4AF2-87A6-2E50A281F434</domeo:belongsToSet>
    <domeo:belongsToSet>urn:domeoclient:uuid:CB83FFC2-EA71-44EA-8F11-DE80E389C84E</domeo:belongsToSet>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <ao:context rdf:resource="urn:domeoclient:uuid:7882D277-8513-479D-B463-EFE36E633410"/>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <pav:lineageUri>urn:domeoserver:annotationset:C5DEBC9B-77EE-4243-88EB-DBC19737ACD2</pav:lineageUri>
    <pav:lastSavedOn>2014-09-02 19:19:47 -0400</pav:lastSavedOn>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812eda990003</pav:createdBy>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:createdOn>2014-09-02 19:13:48 -0400</pav:createdOn>
    <domeo:belongsToSet>urn:domeoserver:annotationset:E32812A9-205B-4EE1-B488-A1E294EDBFB9</domeo:belongsToSet>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:3CB57EB2-8A93-411F-AFE4-75EE6C88177B">
    <domeo:uuid>3CB57EB2-8A93-411F-AFE4-75EE6C88177B</domeo:uuid>
    <ao:suffix>and buprenorphine) to patients who have received or are receiving a course of therapy with a pure opioid agonist analgesic such as oxycodone hydrochloride. In these patients, mixed agonist/antagonist analgesics may reduce the analgesic effect and/or may </ao:suffix>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:3CB57EB2-8A93-411F-AFE4-75EE6C88177B"/>
    <ao:prefix>, </ao:prefix>
    <pav:createdOn>2014-09-02 19:08:36 -0400</pav:createdOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-72.txt.html</ao:hasSource>
    <ao:exact>butorphanol </ao:exact>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:B6024659-1A02-4A19-8ED3-F29F4A70681F">
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">2</pav:versionNumber>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <rdfs:label>Highlight</rdfs:label>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:lastSavedOn>2014-09-02 11:46:58 -0400</pav:lastSavedOn>
    <domeo:belongsToSet>urn:domeoserver:annotationset:A3F0B39A-4249-4B63-BB0D-F24A005066AC</domeo:belongsToSet>
    <pav:previousVersion>urn:domeoclient:uuid:BED41F06-565A-4622-9A88-48810E5A28DE</pav:previousVersion>
    <domeo:belongsToSet>urn:domeoserver:annotationset:3F546823-204F-4F9B-9006-3DC526C56931</domeo:belongsToSet>
    <pav:lastSavedOn>2014-09-02 11:46:59 -0400</pav:lastSavedOn>
    <domeo:belongsToSet>urn:domeoserver:annotationset:A5DD001D-C81A-4E2E-B5E0-7A866B35E26B</domeo:belongsToSet>
    <pav:createdOn>2014-09-02 11:44:27 -0400</pav:createdOn>
    <pav:lineageUri>urn:domeoserver:annotation:1A46D070-65FA-4490-A098-645F1A3D1284</pav:lineageUri>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:lineageUri>urn:domeoserver:annotationset:D1715BD2-BD41-46FD-9454-DC7A423A29AC</pav:lineageUri>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812eda990003</pav:createdBy>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <ao:context rdf:resource="urn:domeoclient:uuid:DFAAFFAE-4EF6-4FDF-9B79-9C8FCB23829E"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:4E77E45D-0BB8-4168-8CAF-9D1591E37A36">
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812eda990003</pav:createdBy>
    <pav:lastSavedOn>2014-07-13 11:32:29 -0400</pav:lastSavedOn>
    <domeo:belongsToSet>urn:domeoclient:uuid:71191E51-53CB-4FDE-88D0-33C6818E2232</domeo:belongsToSet>
    <pav:lineageUri>urn:domeoserver:annotation:A1D65D6C-6A4B-478F-8140-AA87C27DB44D</pav:lineageUri>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <pav:createdOn>2014-07-13 11:11:50 -0400</pav:createdOn>
    <ao:context rdf:resource="urn:domeoclient:uuid:A29DA787-54E3-4422-B166-2BA6676BC91D"/>
    <rdfs:label>Highlight</rdfs:label>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:2CE98409-9106-46BC-A9DE-155A92568532">
    <rdf:type rdf:resource="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#DrugDrugInteractionStatement"/>
    <sio:SIO_000628 rdf:resource="urn:pddi:uuid:71B67447-4B56-4869-AE20-875B5CD8C070"/>
    <sio:SIO_000563>dikbD2R:modality</sio:SIO_000563>
    <dikbD2R:statement>ncit:Qualitative</dikbD2R:statement>
    <dikbD2R:modality>ncit:negative</dikbD2R:modality>
    <sio:SIO_000205>dikbD2R:statement</sio:SIO_000205>
  </rdf:Description>
  <rdf:Description rdf:nodeID="N729b963d2af14b1a915b36f442e42634">
    <domeo:sets rdf:resource="urn:pddi:uuid:E8B9127A-D513-4699-BEA0-07E095BADF5D"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:6E3CCB3A-24FB-48E1-AC28-838B1ACF54A3">
    <sio:SIO_000563>dikbD2R:modality</sio:SIO_000563>
    <sio:SIO_000628 rdf:resource="urn:pddi:uuid:2F9FC4A6-CD86-434B-9237-24FD478F9ECA"/>
    <rdf:type rdf:resource="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#DrugDrugInteractionStatement"/>
    <dikbD2R:statement>ncit:quantitative</dikbD2R:statement>
    <dikbD2R:modality>ncit:positive</dikbD2R:modality>
    <sio:SIO_000205>dikbD2R:statement</sio:SIO_000205>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:905FFDFF-C273-410A-BE8E-A56C8BC94629">
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <pav:lineageUri>urn:domeoserver:annotation:FDD961B0-A5E5-4FCF-A847-3D4424A756CF</pav:lineageUri>
    <pav:createdOn>2014-07-21 21:47:18 -0400</pav:createdOn>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <domeo:belongsToSet>urn:domeoclient:uuid:B803E851-5AD5-4741-B1B9-1CBAED597E18</domeo:belongsToSet>
    <ao:context rdf:resource="urn:domeoclient:uuid:8F01E73F-19F5-4FA0-A47A-6EC3310E264C"/>
    <rdfs:label>Highlight</rdfs:label>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:lastSavedOn>2014-07-21 21:49:33 -0400</pav:lastSavedOn>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812eda990003</pav:createdBy>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:0F69928C-A74C-43BB-99CF-5CCE1F577586">
    <rdfs:label>expertstudy Annotation</rdfs:label>
    <ao:body rdf:nodeID="Neb8c1cca5997411dbeeab956bd4d48f4"/>
    <pav:createdOn>2014-07-24 19:46:23 -0400</pav:createdOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#expertstudyAnnotation"/>
    <ao:context rdf:resource="urn:domeoclient:uuid:78B644A0-98B2-496A-9F5D-B3073007740E"/>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <domeo:belongsToSet>urn:domeoclient:uuid:4519FF07-AE90-4478-8B97-B4B2C84457DC</domeo:belongsToSet>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <pav:lastSavedOn>2014-07-24 19:46:05 -0400</pav:lastSavedOn>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812eda990003</pav:createdBy>
    <pav:lineageUri>urn:domeoserver:annotation:91F0A093-3132-4A59-B89C-FC9E8195C30F</pav:lineageUri>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:4A9B35D2-1697-453D-A110-43EEC635AE7B">
    <ao:prefix> was reduced by 36%. Therefore, to maximize the effects of </ao:prefix>
    <ao:exact>fexofenadine</ao:exact>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:4A9B35D2-1697-453D-A110-43EEC635AE7B"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <pav:createdOn>2014-07-24 20:13:00 -0400</pav:createdOn>
    <domeo:uuid>4A9B35D2-1697-453D-A110-43EEC635AE7B</domeo:uuid>
    <ao:suffix>, it is recommended that fexofenadine hydrochloride tablets should be taken with water [see Clinical Pharmacology (12.3) and Dosage and Administration (2.1)].</ao:suffix>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-139.txt.html</ao:hasSource>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:3D195979-3E82-427D-95B8-F50F48DB4AA7">
    <pav:lastSavedOn>2014-07-22 18:54:34 -0400</pav:lastSavedOn>
    <ao:item rdf:resource="urn:domeoclient:uuid:1083CE4D-6393-4589-AC36-1DEC7BFE570A"/>
    <pav:lineageUri>urn:domeoserver:annotationset:264C22B2-F825-4CBC-9FA7-11B3154B2F50</pav:lineageUri>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812eda990003</pav:createdBy>
    <pav:createdOn>2014-07-22 18:51:22 -0400</pav:createdOn>
    <ao:item rdf:resource="urn:domeoclient:uuid:EAE18A28-D547-4A0F-951B-598FF59A2D26"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:86DB27B2-C2AF-49CE-BCD7-E158388CE52E"/>
    <domeo:agents rdf:resource="urn:person:uuid:080e143046812afe0146812eda990003"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:86768360-42DE-4CD0-A167-0F5E6C6CAE55"/>
    <ao:annotatesResource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-119.txt.html</ao:annotatesResource>
    <permissions:permissions rdf:nodeID="N8f1ddde4db10450aaa41d832154812bb"/>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <rdfs:label>Default Set</rdfs:label>
    <ao:item rdf:resource="urn:domeoclient:uuid:CBCBF368-3CFC-48BC-94C0-C6E5CA87262D"/>
    <dct:description>The default set is created automatically by Domeo when no other set is existing.</dct:description>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <domeo:deleted>false</domeo:deleted>
    <ao:item rdf:resource="urn:domeoclient:uuid:996C494E-48A6-41DB-B582-CC68851B64C1"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:B7059CDB-FD5F-4D07-9802-7905CA2F92BA"/>
    <domeo:agents rdf:resource="urn:domeo:software:id:Domeo-2.1alpha-050"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#AnnotationSet"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:9AD8A1AA-8615-46DA-AE55-BBCBAC221CBF"/>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:3FDC3F96-3CFF-46A2-ABE6-20195EB336B0">
    <pav:createdOn>2014-07-24 19:43:48 -0400</pav:createdOn>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812eda990003</pav:createdBy>
    <ao:context rdf:resource="urn:domeoclient:uuid:9BDFA0ED-9096-4328-B514-6A94D7426FE7"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#expertstudyAnnotation"/>
    <pav:lastSavedOn>2014-07-24 19:43:34 -0400</pav:lastSavedOn>
    <pav:lineageUri>urn:domeoserver:annotation:D828BA61-D00D-4D81-84AD-C53D822CACC1</pav:lineageUri>
    <rdfs:label>expertstudy Annotation</rdfs:label>
    <domeo:belongsToSet>urn:domeoclient:uuid:7DEB6848-E3C6-4761-8965-41F19EE5D781</domeo:belongsToSet>
    <ao:body rdf:nodeID="N8d26281194d14f66893d604676dfd791"/>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:D2C43BBB-3043-4AE4-89EE-69DCE07C3309">
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-137.txt.html</ao:hasSource>
    <ao:exact>trazodone</ao:exact>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:D2C43BBB-3043-4AE4-89EE-69DCE07C3309"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <domeo:uuid>D2C43BBB-3043-4AE4-89EE-69DCE07C3309</domeo:uuid>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:prefix> reduced plasma concentrations of </ao:prefix>
    <pav:createdOn>2014-07-24 20:03:53 -0400</pav:createdOn>
    <ao:suffix> (as well as mCPP) by 76 and 60%, respectively, compared to pre-carbamazepine values.</ao:suffix>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:6A0AE7AB-260B-4296-BC83-DB443FEE5161">
    <pav:createdOn>2014-07-13 12:46:24 -0400</pav:createdOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-23.txt.html</ao:hasSource>
    <ao:exact>fluconazole</ao:exact>
    <ao:suffix> AUC of 13% ± 11% (range: -3.4 to -31%) and Cmax decreased 19% ± 14% (range: -5 to -40%). However, the administration of cimetidine 600 mg to 900 mg intravenously over a four-hour period (from one hour before to 3 hours after a single oral dose of flucon</ao:suffix>
    <domeo:uuid>6A0AE7AB-260B-4296-BC83-DB443FEE5161</domeo:uuid>
    <ao:prefix> AUC and Cmax. There was a mean ± SD decrease in </ao:prefix>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:6A0AE7AB-260B-4296-BC83-DB443FEE5161"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:86DB27B2-C2AF-49CE-BCD7-E158388CE52E">
    <rdfs:label>Highlight</rdfs:label>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:lastSavedOn>2014-07-22 18:54:35 -0400</pav:lastSavedOn>
    <pav:createdOn>2014-07-22 18:51:31 -0400</pav:createdOn>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <pav:lineageUri>urn:domeoserver:annotation:A27E2049-1CFB-4276-BEE2-19C4F918601D</pav:lineageUri>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812eda990003</pav:createdBy>
    <domeo:belongsToSet>urn:domeoclient:uuid:3D195979-3E82-427D-95B8-F50F48DB4AA7</domeo:belongsToSet>
    <ao:context rdf:resource="urn:domeoclient:uuid:D98E97B5-BA28-4298-8921-05B56B7A1166"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
  </rdf:Description>
  <rdf:Description rdf:nodeID="N483102e238f746379c32ec3b79d6fb3e">
    <domeo:sets rdf:resource="urn:pddi:uuid:9C2359BE-4DCE-4088-A5EE-19EA356FF32D"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:689B7657-F3FC-48C0-A564-2904140C7D29">
    <ao:prefix> was given without </ao:prefix>
    <ao:exact>voriconazole</ao:exact>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-74.txt.html</ao:hasSource>
    <ao:suffix>.</ao:suffix>
    <domeo:uuid>689B7657-F3FC-48C0-A564-2904140C7D29</domeo:uuid>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:689B7657-F3FC-48C0-A564-2904140C7D29"/>
    <pav:createdOn>2014-09-02 19:16:36 -0400</pav:createdOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/6FA2E5AB-9D75-44CD-B064-73797C92A684">
    <rdfs:label>aminophylline</rdfs:label>
    <dct:description>Referred to the drug in the interaction.</dct:description>
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/689</dailymed:activeMoietyRxCUI>
    <sio:SIO_000228>dikbD2R:precipitant-drug-of-interaction</sio:SIO_000228>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/active-ingredient"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:00D416DF-EC2B-4E10-8956-D09B3C52D5E6">
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">2</pav:versionNumber>
    <pav:lineageUri>urn:domeoserver:annotationset:D1715BD2-BD41-46FD-9454-DC7A423A29AC</pav:lineageUri>
    <pav:lastSavedOn>2014-09-02 11:46:58 -0400</pav:lastSavedOn>
    <pav:lineageUri>urn:domeoserver:annotation:AF228A2A-B4E5-4ECB-9698-DA84D9B8B4C9</pav:lineageUri>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812eda990003</pav:createdBy>
    <ao:context rdf:resource="urn:domeoclient:uuid:58576832-5E8D-41C1-98BF-9612C4FEA54D"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <domeo:belongsToSet>urn:domeoserver:annotationset:3F546823-204F-4F9B-9006-3DC526C56931</domeo:belongsToSet>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <pav:createdOn>2014-09-02 11:40:59 -0400</pav:createdOn>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <rdfs:label>Highlight</rdfs:label>
    <pav:previousVersion>urn:domeoclient:uuid:BED41F06-565A-4622-9A88-48810E5A28DE</pav:previousVersion>
    <domeo:belongsToSet>urn:domeoserver:annotationset:A5DD001D-C81A-4E2E-B5E0-7A866B35E26B</domeo:belongsToSet>
    <domeo:belongsToSet>urn:domeoserver:annotationset:A3F0B39A-4249-4B63-BB0D-F24A005066AC</domeo:belongsToSet>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:C00C0C31-D3ED-43CE-8CB0-398EA275616B">
    <pav:createdOn>2014-09-02 19:18:20 -0400</pav:createdOn>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:C00C0C31-D3ED-43CE-8CB0-398EA275616B"/>
    <domeo:uuid>C00C0C31-D3ED-43CE-8CB0-398EA275616B</domeo:uuid>
    <ao:exact>atazanavir</ao:exact>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:prefix> (40 mg, qd), AUC was decreased by 36% and 92%, Cmax by 37% and 89% and Cmin by 39% and 75% respectively for nelfinavir and M8. Following multiple doses of </ao:prefix>
    <ao:suffix> (400 mg, qd) and omeprazole (40 mg, qd, 2 hr before atazanavir), AUC was decreased by 94%, Cmax by 96%, and Cmin by 95%. Concomitant administration with omeprazole and drugs such as atazanavir and nelfinavir is therefore not recommended. For other antir</ao:suffix>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-74.txt.html</ao:hasSource>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:B60D6EE8-97E8-426E-9A95-B877100EC48A">
    <ao:context rdf:resource="urn:domeoclient:uuid:06311B02-CE01-4B2E-9D8E-7EAC3FBB8602"/>
    <domeo:belongsToSet>urn:domeoserver:annotationset:1FC172B8-8AC3-465A-AA69-B73AD9B97CBC</domeo:belongsToSet>
    <domeo:belongsToSet>urn:domeoclient:uuid:8D86A4AC-54BD-4BB3-8B58-AB55DEC01A88</domeo:belongsToSet>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812eda990003</pav:createdBy>
    <pav:lastSavedOn>2014-07-24 20:07:19 -0400</pav:lastSavedOn>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:createdOn>2014-07-24 20:05:48 -0400</pav:createdOn>
    <pav:lineageUri>urn:domeoserver:annotationset:4A88D0A6-E9B6-4E7F-955F-3692600C178C</pav:lineageUri>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <rdfs:label>Highlight</rdfs:label>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:lastSavedOn>2014-07-24 20:07:20 -0400</pav:lastSavedOn>
    <pav:lineageUri>urn:domeoserver:annotation:B4C8F4AA-8294-43AA-9EBD-DA37B0A7277D</pav:lineageUri>
    <domeo:belongsToSet>urn:domeoserver:annotationset:37B2514D-1A92-45B1-8A5C-610DA6DC935A</domeo:belongsToSet>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:FDA6AE08-3F60-49BF-A915-AF6F8F16E6C0">
    <sio:SIO_000205>dikbD2R:statement</sio:SIO_000205>
    <sio:SIO_000563>dikbD2R:modality</sio:SIO_000563>
    <rdf:type rdf:resource="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#DrugDrugInteractionStatement"/>
    <sio:SIO_000628 rdf:resource="urn:pddi:uuid:A48F9E31-BBA4-4315-8056-D4A8A7BA3369"/>
    <dikbD2R:modality>ncit:negative</dikbD2R:modality>
    <dikbD2R:statement>ncit:Qualitative</dikbD2R:statement>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:CDF62581-CF1E-49F8-8077-2328677F5CAD">
    <dikbD2R:modality>ncit:positive</dikbD2R:modality>
    <dikbD2R:statement>ncit:quantitative</dikbD2R:statement>
    <rdf:type rdf:resource="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#DrugDrugInteractionStatement"/>
    <sio:SIO_000205>dikbD2R:statement</sio:SIO_000205>
    <sio:SIO_000563>dikbD2R:modality</sio:SIO_000563>
    <sio:SIO_000628 rdf:resource="urn:pddi:uuid:DFEFC5E6-CD9E-430A-AB17-673B60C626A3"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:5039F6DC-F654-4E38-8762-0E1BD92F058C">
    <ao:exact>After the administration of cimetidine, there was a significant decrease in fluconazole AUC and Cmax. There was a mean ± SD decrease in fluconazole AUC of 13% ± 11% (range: -3.4 to -31%) and Cmax decreased 19% ± 14% (range: -5 to -40%).</ao:exact>
    <ao:prefix> 400 mg to six healthy male volunteers. </ao:prefix>
    <pav:createdOn>2014-07-13 12:47:19 -0400</pav:createdOn>
    <ao:suffix> However, the administration of</ao:suffix>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-23.txt.html</ao:hasSource>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <domeo:uuid>5039F6DC-F654-4E38-8762-0E1BD92F058C</domeo:uuid>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:5039F6DC-F654-4E38-8762-0E1BD92F058C"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:5F97F910-5C88-42D5-BF36-6EFC8C9A3DD1">
    <domeo:uuid>5F97F910-5C88-42D5-BF36-6EFC8C9A3DD1</domeo:uuid>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-155.txt.html</ao:hasSource>
    <ao:suffix>xsd:String</ao:suffix>
    <pav:createdOn>2014-07-07 11:35:30 -0400</pav:createdOn>
    <ao:prefix>xsd:String</ao:prefix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:5F97F910-5C88-42D5-BF36-6EFC8C9A3DD1"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:exact>When a single 100 mg dose of sildenafil was co-administered with erythromycin, a CYP3A inhibitor, at steady state (500 mg BID for 5 days), there was a 182% increase in sildenafil systemic exposure (AUC)</ao:exact>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:59E51D24-193D-4075-8FE6-4129F350FD59">
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:lineageUri>urn:domeoserver:annotation:481FD8E2-4FE1-48EC-822F-EBE0190A2F47</pav:lineageUri>
    <rdfs:label>Highlight</rdfs:label>
    <pav:createdOn>2014-07-22 18:58:24 -0400</pav:createdOn>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812eda990003</pav:createdBy>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <domeo:belongsToSet>urn:domeoclient:uuid:F2788742-3226-4BFB-9D85-2FC7211066F7</domeo:belongsToSet>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <ao:context rdf:resource="urn:domeoclient:uuid:6F412DAA-5D4B-4581-AA6A-DB01672CE4BB"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:lastSavedOn>2014-07-22 18:59:41 -0400</pav:lastSavedOn>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:CC861D6D-4076-4F69-B134-B404C685F91A">
    <ao:prefix> and </ao:prefix>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-8.txt.html</ao:hasSource>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:suffix> was decreased, and elimination half-lives were prolonged compared to young healthy subjects. Dosing should be modified accordingly in the elderly patients [see 2 DOSAGE AND ADMINISTRATION].</ao:suffix>
    <pav:createdOn>2014-07-13 11:18:24 -0400</pav:createdOn>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:CC861D6D-4076-4F69-B134-B404C685F91A"/>
    <domeo:uuid>CC861D6D-4076-4F69-B134-B404C685F91A</domeo:uuid>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:exact>9-hydroxyrisperidone</ao:exact>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:6DF7A5F7-A5AA-4B80-A495-D1E04A24A471">
    <pav:lastSavedOn>2014-07-24 20:12:49 -0400</pav:lastSavedOn>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812eda990003</pav:createdBy>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <pav:createdOn>2014-07-24 20:11:46 -0400</pav:createdOn>
    <ao:context rdf:resource="urn:domeoclient:uuid:E71F7227-79D2-4BF7-AAF2-F7F5CA5F1555"/>
    <domeo:belongsToSet>urn:domeoserver:annotationset:1FC172B8-8AC3-465A-AA69-B73AD9B97CBC</domeo:belongsToSet>
    <rdfs:label>Highlight</rdfs:label>
    <pav:lineageUri>urn:domeoserver:annotation:7F45168A-D602-4AE9-97E4-CBD63E9FE38D</pav:lineageUri>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:7EB0AC81-B2FD-4D6F-8BAC-50662A16D4C6">
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <domeo:uuid>7EB0AC81-B2FD-4D6F-8BAC-50662A16D4C6</domeo:uuid>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-47.txt.html</ao:hasSource>
    <ao:suffix> (100 mg) Cmax, AUC, and T½ by an average of approximately 2-, 5-, and 3-fold, respectively. Concomitant use of paroxetine with risperidone, a CYP2D6 substrate has also been evaluated. In 1 study, daily dosing of paroxetine 20 mg in patients stabilized o</ao:suffix>
    <pav:createdOn>2014-09-02 11:57:18 -0400</pav:createdOn>
    <ao:exact>desipramine</ao:exact>
    <ao:prefix>  (20 mg once daily) under steady-state conditions increased single-dose </ao:prefix>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:7EB0AC81-B2FD-4D6F-8BAC-50662A16D4C6"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:11E26B74-9DE2-4B10-A8C9-A250D2747B3E">
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <domeo:belongsToSet>urn:domeoclient:uuid:E89548FF-A4A2-4B87-B1E1-B12E3E255FA1</domeo:belongsToSet>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812eda990003</pav:createdBy>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <pav:createdOn>2014-07-13 12:55:59 -0400</pav:createdOn>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:lineageUri>urn:domeoserver:annotation:74A8BD59-3770-4E00-8C04-C4D9A82E8F47</pav:lineageUri>
    <pav:lastSavedOn>2014-07-13 12:56:57 -0400</pav:lastSavedOn>
    <ao:context rdf:resource="urn:domeoclient:uuid:EBCFB082-4C3F-4C27-B1B4-7DE7E01178ED"/>
    <rdfs:label>Highlight</rdfs:label>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:651C0626-4BF6-4B96-A66A-7385C6456D51">
    <pav:createdOn>2014-07-13 11:13:26 -0400</pav:createdOn>
    <domeo:belongsToSet>urn:domeoclient:uuid:71191E51-53CB-4FDE-88D0-33C6818E2232</domeo:belongsToSet>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <pav:lastSavedOn>2014-07-13 11:32:29 -0400</pav:lastSavedOn>
    <rdfs:label>Highlight</rdfs:label>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812eda990003</pav:createdBy>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:lineageUri>urn:domeoserver:annotation:298F93DA-79DF-482C-B367-9A29F14FB3D6</pav:lineageUri>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <ao:context rdf:resource="urn:domeoclient:uuid:DD06894B-6765-494F-98ED-9B2C217D26FD"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:1BF82CCC-CD60-4AB5-8C1B-4176DC1A85F3">
    <domeo:uuid>1BF82CCC-CD60-4AB5-8C1B-4176DC1A85F3</domeo:uuid>
    <ao:suffix> was 3 hours (CV=30%) in extensive metabolizers and 20 hours (CV=40%) in poor metabolizers. The apparent half-life of 9-hydroxyrisperidone was about 21 hours (CV=20%) in extensive metabolizers and 30 hours (CV=25%) in poor metabolizers. The pharmacokinet</ao:suffix>
    <ao:exact>risperidone</ao:exact>
    <ao:prefix>The apparent half-life of </ao:prefix>
    <pav:createdOn>2014-07-13 11:16:53 -0400</pav:createdOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-8.txt.html</ao:hasSource>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:1BF82CCC-CD60-4AB5-8C1B-4176DC1A85F3"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
  </rdf:Description>
  <rdf:Description rdf:nodeID="Neb8c1cca5997411dbeeab956bd4d48f4">
    <domeo:sets rdf:resource="urn:pddi:uuid:F3D5E3DD-A431-4A01-92CB-C01ED4EF9988"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:7FE9AC63-C53E-4EF9-AEF0-CC1F82EDA7C3">
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/PK_DDI"/>
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/04F5EE18-51BD-4A42-A9E7-52826EE0EA8B"/>
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/D860A1B6-8D5E-4FE4-9EDB-4E1397B29BBD"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:F3FEE8D2-9817-490A-AF14-CC53E5ADFBF2">
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:prefix>A third study evaluated the potential interaction of once weekly dosing of </ao:prefix>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-21.txt.html</ao:hasSource>
    <ao:exact>fluconazole</ao:exact>
    <pav:createdOn>2014-07-13 12:35:54 -0400</pav:createdOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <domeo:uuid>F3FEE8D2-9817-490A-AF14-CC53E5ADFBF2</domeo:uuid>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:F3FEE8D2-9817-490A-AF14-CC53E5ADFBF2"/>
    <ao:suffix> 300 mg to 21 normal females taking an oral contraceptive containing ethinyl estradiol and norethindrone. In this placebo-controlled, double-blind, randomized, two-way crossover study carried out over three cycles of oral contraceptive treatment, flucona</ao:suffix>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:E68B19A2-98CC-4D01-88C9-2BCC8709D27A">
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:lineageUri>urn:domeoserver:annotationset:C5DEBC9B-77EE-4243-88EB-DBC19737ACD2</pav:lineageUri>
    <ao:context rdf:resource="urn:domeoclient:uuid:79F49E5C-6D04-4116-8E54-1C6470AEB616"/>
    <pav:lineageUri>urn:domeoserver:annotation:B703F9E8-33A5-4B55-B912-4818BA21BE54</pav:lineageUri>
    <domeo:belongsToSet>urn:domeoclient:uuid:CB83FFC2-EA71-44EA-8F11-DE80E389C84E</domeo:belongsToSet>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812eda990003</pav:createdBy>
    <domeo:belongsToSet>urn:domeoserver:annotationset:E32812A9-205B-4EE1-B488-A1E294EDBFB9</domeo:belongsToSet>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <pav:lastSavedOn>2014-09-02 19:19:47 -0400</pav:lastSavedOn>
    <rdfs:label>Highlight</rdfs:label>
    <pav:createdOn>2014-09-02 19:19:41 -0400</pav:createdOn>
    <domeo:belongsToSet>urn:domeoserver:annotationset:392EE0FB-AC4F-4AF2-87A6-2E50A281F434</domeo:belongsToSet>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:0C6D1C88-D003-4F29-8AF2-F22A03983530">
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <domeo:belongsToSet>urn:domeoserver:annotationset:A5DD001D-C81A-4E2E-B5E0-7A866B35E26B</domeo:belongsToSet>
    <ao:context rdf:resource="urn:domeoclient:uuid:907AD9A7-E55A-480A-BC73-7429BC2CE1DE"/>
    <pav:createdOn>2014-09-02 11:30:39 -0400</pav:createdOn>
    <rdfs:label>Highlight</rdfs:label>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812eda990003</pav:createdBy>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <domeo:belongsToSet>urn:domeoserver:annotationset:3F546823-204F-4F9B-9006-3DC526C56931</domeo:belongsToSet>
    <pav:lastSavedOn>2014-09-02 11:35:33 -0400</pav:lastSavedOn>
    <pav:lineageUri>urn:domeoserver:annotation:7B37962D-0B41-4074-B8FC-A40DE69B5437</pav:lineageUri>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <domeo:belongsToSet>urn:domeoserver:annotationset:A3F0B39A-4249-4B63-BB0D-F24A005066AC</domeo:belongsToSet>
    <pav:lineageUri>urn:domeoserver:annotationset:D1715BD2-BD41-46FD-9454-DC7A423A29AC</pav:lineageUri>
    <domeo:belongsToSet>urn:domeoclient:uuid:BED41F06-565A-4622-9A88-48810E5A28DE</domeo:belongsToSet>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:F33CE913-7DCE-473E-810F-A9B07CED9081">
    <ao:prefix>xsd:String</ao:prefix>
    <pav:createdOn>2014-07-24 19:47:18 -0400</pav:createdOn>
    <domeo:uuid>F33CE913-7DCE-473E-810F-A9B07CED9081</domeo:uuid>
    <ao:suffix>xsd:String</ao:suffix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-130.txt.html</ao:hasSource>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:F33CE913-7DCE-473E-810F-A9B07CED9081"/>
    <ao:exact>Co-administration of metoclopramide with the long-acting propranolol did not have a significant effect on propranolol’s pharmacokinetics</ao:exact>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:DA838F12-E2BB-4B13-B633-B6F4480341B7">
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <domeo:uuid>DA838F12-E2BB-4B13-B633-B6F4480341B7</domeo:uuid>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-74.txt.html</ao:hasSource>
    <ao:exact>Omeprazole</ao:exact>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:DA838F12-E2BB-4B13-B633-B6F4480341B7"/>
    <pav:createdOn>2014-09-02 19:12:29 -0400</pav:createdOn>
    <ao:suffix> can prolong the elimination of diazepam, warfarin and phenytoin, drugs that are metabolized by oxidation in the liver. There have been reports of increased INR and prothrombin time in patients receiving proton pump inhibitors, including omeprazole, and </ao:suffix>
    <ao:prefix>xsd:String</ao:prefix>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:FA4C8A6E-17D4-47F8-A369-67AF061E9037">
    <domeo:belongsToSet>urn:domeoserver:annotationset:131835A3-C655-4F91-97D4-52CAFF7B7CCA</domeo:belongsToSet>
    <domeo:belongsToSet>urn:domeoserver:annotationset:8F3CF3D9-AADE-4A86-BD42-2924B3D6A406</domeo:belongsToSet>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <domeo:belongsToSet>urn:domeoserver:annotationset:7AACEF8D-2EBC-4F0B-94B2-190650E562F6</domeo:belongsToSet>
    <pav:lastSavedOn>2014-07-07 09:44:19 -0400</pav:lastSavedOn>
    <pav:lineageUri>urn:domeoserver:annotation:544A607C-AF7D-4602-81E2-A48B9FFC5466</pav:lineageUri>
    <pav:lastSavedOn>2014-07-07 09:44:18 -0400</pav:lastSavedOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812eda990003</pav:createdBy>
    <rdfs:label>Highlight</rdfs:label>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <ao:context rdf:resource="urn:domeoclient:uuid:A412DBFC-2FE0-43FA-A538-B84D822A5BFD"/>
    <domeo:belongsToSet>urn:domeoserver:annotationset:22ED7220-C6F6-43C5-9DF9-89F62F0F8E27</domeo:belongsToSet>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <pav:lineageUri>urn:domeoserver:annotationset:76FD4BB5-DE2F-4FCA-B93D-302185B1A381</pav:lineageUri>
    <domeo:belongsToSet>urn:domeoserver:annotationset:08C0C288-6DF4-43E6-A618-71A8BB9563C3</domeo:belongsToSet>
    <domeo:belongsToSet>urn:domeoclient:uuid:FCA2BF23-0BE3-409F-9177-761812F96097</domeo:belongsToSet>
    <pav:createdOn>2014-07-07 09:44:07 -0400</pav:createdOn>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:1EB12059-BBA2-4D0D-8E36-2569CD51DC88">
    <ao:prefix>A published study showed that the co-administration of </ao:prefix>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-72.txt.html</ao:hasSource>
    <ao:exact>rifampin</ao:exact>
    <pav:createdOn>2014-09-02 19:09:38 -0400</pav:createdOn>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:1EB12059-BBA2-4D0D-8E36-2569CD51DC88"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:suffix>, a drug metabolizing enzyme inducer, significantly decreased plasma oxycodone concentrations. Induction of CYP3A4 activity by its inducers, such as rifampin, carbamazepine, and phenytoin, may lead to a lack of efficacy or, possibly, development of an ab</ao:suffix>
    <domeo:uuid>1EB12059-BBA2-4D0D-8E36-2569CD51DC88</domeo:uuid>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:A3DCC3AB-4469-4227-B682-6E7F65CD2A7A">
    <rdf:type rdf:resource="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#DrugDrugInteractionStatement"/>
    <sio:SIO_000628 rdf:resource="urn:pddi:uuid:9D2EDEBD-1223-4650-A96C-6AA36F00C854"/>
    <sio:SIO_000205>dikbD2R:statement</sio:SIO_000205>
    <sio:SIO_000563>dikbD2R:modality</sio:SIO_000563>
    <dikbD2R:statement>ncit:quantitative</dikbD2R:statement>
    <dikbD2R:modality>ncit:positive</dikbD2R:modality>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:FB0C633B-9063-4FD0-91E9-2810CF1C157A">
    <pav:lastSavedOn>2014-07-07 09:44:18 -0400</pav:lastSavedOn>
    <domeo:belongsToSet>urn:domeoserver:annotationset:08C0C288-6DF4-43E6-A618-71A8BB9563C3</domeo:belongsToSet>
    <rdfs:label>Highlight</rdfs:label>
    <domeo:belongsToSet>urn:domeoserver:annotationset:22ED7220-C6F6-43C5-9DF9-89F62F0F8E27</domeo:belongsToSet>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:lineageUri>urn:domeoserver:annotation:B5AC23C4-D57A-4FA8-9939-152CD7533DC3</pav:lineageUri>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <domeo:belongsToSet>urn:domeoserver:annotationset:131835A3-C655-4F91-97D4-52CAFF7B7CCA</domeo:belongsToSet>
    <domeo:belongsToSet>urn:domeoserver:annotationset:8F3CF3D9-AADE-4A86-BD42-2924B3D6A406</domeo:belongsToSet>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <domeo:belongsToSet>urn:domeoclient:uuid:FCA2BF23-0BE3-409F-9177-761812F96097</domeo:belongsToSet>
    <pav:lastSavedOn>2014-07-07 09:44:19 -0400</pav:lastSavedOn>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <ao:context rdf:resource="urn:domeoclient:uuid:3D2E5F5D-2D44-4EC9-93CD-D558EE6CAD75"/>
    <domeo:belongsToSet>urn:domeoserver:annotationset:7AACEF8D-2EBC-4F0B-94B2-190650E562F6</domeo:belongsToSet>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812eda990003</pav:createdBy>
    <pav:lineageUri>urn:domeoserver:annotationset:76FD4BB5-DE2F-4FCA-B93D-302185B1A381</pav:lineageUri>
    <pav:createdOn>2014-07-07 09:40:26 -0400</pav:createdOn>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:1A7382E8-45D1-4872-98EA-20455089A06B">
    <pav:createdOn>2014-07-07 11:23:45 -0400</pav:createdOn>
    <ao:suffix>, a CYP3A inhibitor, at steady state (1200 mg TID) with sildenafil (100 mg single dose) resulted in a 140% increase in sildenafil Cmax and a 210% increase in sildenafil AUC.</ao:suffix>
    <ao:prefix>In a study performed in healthy volunteers, co-administration of the HIV protease inhibitor </ao:prefix>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-155.txt.html</ao:hasSource>
    <domeo:uuid></domeo:uuid>
    <ao:exact>saquinavir</ao:exact>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:1A7382E8-45D1-4872-98EA-20455089A06B"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <domeo:uuid>1A7382E8-45D1-4872-98EA-20455089A06B</domeo:uuid>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:2FF47DA5-4366-4BC2-AA71-7E8F63D7F2AA">
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:suffix> pharmacokinetics. In addition, in vitro studies have shown ketoconazole, a potent inhibitor of CYP3A4 activity, to be at least 100 times more potent than paroxetine as an inhibitor of the metabolism of several substrates for this enzyme, including terfe</ao:suffix>
    <domeo:uuid>2FF47DA5-4366-4BC2-AA71-7E8F63D7F2AA</domeo:uuid>
    <ao:exact>terfenadine</ao:exact>
    <pav:createdOn>2014-09-02 15:04:10 -0400</pav:createdOn>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:2FF47DA5-4366-4BC2-AA71-7E8F63D7F2AA"/>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-48.txt.html</ao:hasSource>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:prefix> on </ao:prefix>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:00CDF4D6-2271-4B2A-9836-98BD00E7E952">
    <domeo:uuid>00CDF4D6-2271-4B2A-9836-98BD00E7E952</domeo:uuid>
    <pav:createdOn>2014-07-13 12:42:05 -0400</pav:createdOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:suffix> or </ao:suffix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:exact>ethinyl estradiol</ao:exact>
    <ao:prefix> 50 mg once daily for 10 days in 10 healthy women. There was no significant difference in </ao:prefix>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:00CDF4D6-2271-4B2A-9836-98BD00E7E952"/>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-22.txt.html</ao:hasSource>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:5F4EA581-2F5C-4FF1-8DA3-D5101E760F69">
    <pav:createdOn>2014-07-13 11:28:14 -0400</pav:createdOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:prefix> and its major metabolite, </ao:prefix>
    <ao:suffix> [see 12 CLINICAL PHARMACOLOGY]. Antagonism at receptors other than D2 and 5HT2 [see 12 CLINICAL PHARMACOLOGY] may explain some of the other effects of risperidone.</ao:suffix>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:5F4EA581-2F5C-4FF1-8DA3-D5101E760F69"/>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-8.txt.html</ao:hasSource>
    <domeo:uuid>5F4EA581-2F5C-4FF1-8DA3-D5101E760F69</domeo:uuid>
    <ao:exact>9-hydroxyrisperidone</ao:exact>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:F2A6F24F-0266-4E33-86F7-71BB9F9CD038">
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <ao:context rdf:resource="urn:domeoclient:uuid:D0733D8F-AF43-42E3-B473-28271029CCA5"/>
    <pav:lineageUri>urn:domeoserver:annotation:0DDAC282-2A1A-42BF-8975-6A46E40E4033</pav:lineageUri>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812eda990003</pav:createdBy>
    <domeo:belongsToSet>urn:domeoclient:uuid:190E7AE8-2ACF-42E2-AE00-E433EEA9737C</domeo:belongsToSet>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <rdfs:label>Highlight</rdfs:label>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:createdOn>2014-09-02 19:38:12 -0400</pav:createdOn>
    <pav:lastSavedOn>2014-09-02 19:38:39 -0400</pav:lastSavedOn>
  </rdf:Description>
  <rdf:Description rdf:nodeID="N3e0ef8d7f89047be92e80a915b90b0dc">
    <permissions:accessType>urn:domeo:access:public</permissions:accessType>
    <permissions:isLocked>false</permissions:isLocked>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:B57AEEF2-0F0B-4E76-9F59-DBC483D6322C">
    <pav:createdOn>2014-07-24 20:14:32 -0400</pav:createdOn>
    <ao:exact>nelfinavir</ao:exact>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:suffix> at steady-state with a single oral dose of azithromycin resulted in increased azithromycin serum concentrations. Although a dose adjustment of azithromycin is not recommended when administered in combination with nelfinavir, close monitoring for known s</ao:suffix>
    <ao:prefix>Coadministration of </ao:prefix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:B57AEEF2-0F0B-4E76-9F59-DBC483D6322C"/>
    <domeo:uuid>B57AEEF2-0F0B-4E76-9F59-DBC483D6322C</domeo:uuid>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-161.txt.html</ao:hasSource>
  </rdf:Description>
  <rdf:Description rdf:nodeID="N4d79055f10be45ae940dfb257d1b015f">
    <permissions:accessType>urn:domeo:access:public</permissions:accessType>
    <permissions:isLocked>false</permissions:isLocked>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:86BC1F50-DBC2-4291-BD23-23F4890101B8">
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812eda990003</pav:createdBy>
    <ao:context rdf:resource="urn:domeoclient:uuid:918A8BC4-10A8-4ADA-9C87-87BCD441E2ED"/>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:createdOn>2014-09-01 15:57:38 -0400</pav:createdOn>
    <pav:lineageUri>urn:domeoserver:annotation:A6BDBF68-2B8A-4549-9B4E-E673438B46D8</pav:lineageUri>
    <pav:lastSavedOn>2014-09-01 15:57:39 -0400</pav:lastSavedOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <rdfs:label>Highlight</rdfs:label>
    <domeo:belongsToSet>urn:domeoclient:uuid:39B82E57-92E3-4322-A8E6-A3AFF215F02C</domeo:belongsToSet>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:AD70C5DB-2834-4A85-B530-F776A208FB2C">
    <ao:prefix>, or </ao:prefix>
    <pav:createdOn>2014-09-01 15:57:33 -0400</pav:createdOn>
    <ao:suffix>. These data indicate that sertraline’s extent of inhibition of P450 3A4 activity is not likely to be of clinical significance. Results of the interaction study with cisapride indicate that sertraline 200 mg (q.d.) induces the metabolism of cisapride (ci</ao:suffix>
    <ao:exact>cisapride</ao:exact>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:AD70C5DB-2834-4A85-B530-F776A208FB2C"/>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-16.txt.html</ao:hasSource>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <domeo:uuid>AD70C5DB-2834-4A85-B530-F776A208FB2C</domeo:uuid>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:D4866C08-5431-4BCB-8D02-35C7E6408B74">
    <ao:prefix>, </ao:prefix>
    <domeo:uuid>D4866C08-5431-4BCB-8D02-35C7E6408B74</domeo:uuid>
    <pav:createdOn>2014-09-01 16:06:02 -0400</pav:createdOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:exact>carbamazepine</ao:exact>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:D4866C08-5431-4BCB-8D02-35C7E6408B74"/>
    <ao:suffix>, or cisapride. These data indicate that sertraline’s extent of inhibition of P450 3A4 activity is not likely to be of clinical significance. Results of the interaction study with cisapride indicate that sertraline 200 mg (q.d.) induces the metabolism of</ao:suffix>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-16.txt.html</ao:hasSource>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:E76B5D64-7248-4EBD-A023-3820BFDEFD26">
    <pav:lineageUri>urn:domeoserver:annotationset:76FD4BB5-DE2F-4FCA-B93D-302185B1A381</pav:lineageUri>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <domeo:belongsToSet>urn:domeoserver:annotationset:08C0C288-6DF4-43E6-A618-71A8BB9563C3</domeo:belongsToSet>
    <pav:lastSavedOn>2014-07-07 09:44:19 -0400</pav:lastSavedOn>
    <pav:lastSavedOn>2014-07-07 09:44:18 -0400</pav:lastSavedOn>
    <domeo:belongsToSet>urn:domeoserver:annotationset:22ED7220-C6F6-43C5-9DF9-89F62F0F8E27</domeo:belongsToSet>
    <pav:lineageUri>urn:domeoserver:annotation:812DC48C-1B54-46F9-A56A-190D7D91EE6E</pav:lineageUri>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812eda990003</pav:createdBy>
    <domeo:belongsToSet>urn:domeoserver:annotationset:7AACEF8D-2EBC-4F0B-94B2-190650E562F6</domeo:belongsToSet>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <domeo:belongsToSet>urn:domeoclient:uuid:FCA2BF23-0BE3-409F-9177-761812F96097</domeo:belongsToSet>
    <rdfs:label>Highlight</rdfs:label>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <domeo:belongsToSet>urn:domeoserver:annotationset:131835A3-C655-4F91-97D4-52CAFF7B7CCA</domeo:belongsToSet>
    <pav:createdOn>2014-07-07 09:36:31 -0400</pav:createdOn>
    <ao:context rdf:resource="urn:domeoclient:uuid:C0F812BF-119E-4BE1-AAA3-BF2DAE39B76F"/>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <domeo:belongsToSet>urn:domeoserver:annotationset:8F3CF3D9-AADE-4A86-BD42-2924B3D6A406</domeo:belongsToSet>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:B097095F-835A-459A-BD2D-9F8F332DBE40">
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:exact>zidovudine </ao:exact>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-27.txt.html</ao:hasSource>
    <ao:prefix>200 mg daily for 15 days) in 13 volunteers with AIDS or ARC who were on a stable </ao:prefix>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:B097095F-835A-459A-BD2D-9F8F332DBE40"/>
    <ao:suffix>dose for at least two weeks. There was a significant increase in zidovudine AUC following the administration of fluconazole. The mean ± SD increase in AUC was 20% ± 32% (range: -27 to 104%). The metabolite, GZDV, to parent drug ratio significantly decrea</ao:suffix>
    <domeo:uuid>B097095F-835A-459A-BD2D-9F8F332DBE40</domeo:uuid>
    <pav:createdOn>2014-07-21 21:31:13 -0400</pav:createdOn>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:907AD9A7-E55A-480A-BC73-7429BC2CE1DE">
    <ao:suffix>), CYP2C9 (e.g., warfarin), CYP3A4 (e.g., alprazolam), and CYP2C19 (e.g., omeprazole).</ao:suffix>
    <ao:prefix>, </ao:prefix>
    <domeo:uuid>907AD9A7-E55A-480A-BC73-7429BC2CE1DE</domeo:uuid>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:907AD9A7-E55A-480A-BC73-7429BC2CE1DE"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-9.txt.html</ao:hasSource>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <pav:createdOn>2014-09-02 11:30:39 -0400</pav:createdOn>
    <ao:exact>tizanidine</ao:exact>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:7E52164F-6FEF-4A1A-A55B-01314BCEB19B">
    <domeo:uuid>7E52164F-6FEF-4A1A-A55B-01314BCEB19B</domeo:uuid>
    <pav:createdOn>2014-07-13 11:12:23 -0400</pav:createdOn>
    <ao:suffix>. Consequently, the clinical effect of the drug results from the combined concentrations of risperidone plus 9-hydroxyrisperidone.</ao:suffix>
    <ao:prefix>, has similar pharmacological activity as </ao:prefix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:exact>risperidone</ao:exact>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:7E52164F-6FEF-4A1A-A55B-01314BCEB19B"/>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-8.txt.html</ao:hasSource>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:74C12A9B-7A11-44EB-A829-30F93AA6ADCF">
    <ao:suffix> administration (250 mg b.i.d. initially for 1 day followed by 300 mg QD for 3 to 4 days) resulted in an approximately 50% reduction in methadone exposure and withdrawal symptoms occurred concurrently. Upon discontinuation of phenytoin, the incidence of </ao:suffix>
    <domeo:uuid>74C12A9B-7A11-44EB-A829-30F93AA6ADCF</domeo:uuid>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-201.txt.html</ao:hasSource>
    <ao:prefix> maintenance therapy,</ao:prefix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:exact> phenytoin</ao:exact>
    <pav:createdOn>2014-07-28 17:04:24 -0400</pav:createdOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:74C12A9B-7A11-44EB-A829-30F93AA6ADCF"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:52224847-1B69-4520-9514-0282DC403A76">
    <ao:prefix>xsd:String</ao:prefix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:exact>Theophylline</ao:exact>
    <pav:createdOn>2014-09-02 11:46:37 -0400</pav:createdOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:52224847-1B69-4520-9514-0282DC403A76"/>
    <ao:suffix>: See WARNINGS AND PRECAUTIONS (5.8).</ao:suffix>
    <domeo:uuid>52224847-1B69-4520-9514-0282DC403A76</domeo:uuid>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-9.txt.html</ao:hasSource>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:4F872953-6D19-4809-9285-FCCF2FF54315">
    <rdfs:label>Default Set</rdfs:label>
    <ao:item rdf:resource="urn:domeoclient:uuid:3CE3E7D7-79CE-4BA9-8CA0-7B7A05D77AFC"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:6BF180C6-926E-4F67-84B0-1DC9E664C663"/>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812eda990003</pav:createdBy>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <permissions:permissions rdf:nodeID="N5571c0d101ee402383c012bbf1147a53"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:76D2A20E-E18E-4676-958D-12D182D20430"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:12FA04F1-54A6-4C48-9FDA-8E372C8A648A"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:3BEBBBC1-7503-4FA0-9B16-ED708F2AE108"/>
    <pav:lineageUri>urn:domeoserver:annotationset:7698170F-5CE1-49C4-9F55-5ED355B5BEA7</pav:lineageUri>
    <ao:item rdf:resource="urn:domeoclient:uuid:C0B517A8-DCD4-4740-A77D-8490A77113AE"/>
    <pav:lastSavedOn>2014-07-13 12:41:09 -0400</pav:lastSavedOn>
    <ao:item rdf:resource="urn:domeoclient:uuid:167FB68A-5943-4F0E-8CC6-C6BAB7625E4F"/>
    <domeo:agents rdf:resource="urn:person:uuid:080e143046812afe0146812eda990003"/>
    <domeo:deleted>false</domeo:deleted>
    <ao:item rdf:resource="urn:domeoclient:uuid:72594949-CA92-4CEF-8CB6-0072661759A0"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:C7A86B1F-FEF9-4500-AC47-4A4949A51ABD"/>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <ao:item rdf:resource="urn:domeoclient:uuid:B9174469-54E0-4FAB-8165-210C50F1F809"/>
    <pav:createdOn>2014-07-13 12:35:54 -0400</pav:createdOn>
    <ao:item rdf:resource="urn:domeoclient:uuid:7EA46EFB-1A94-409D-B432-24203EA5400F"/>
    <dct:description>The default set is created automatically by Domeo when no other set is existing.</dct:description>
    <domeo:agents rdf:resource="urn:domeo:software:id:Domeo-2.1alpha-050"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:DA8337B7-4497-4F34-93E8-291B9ED278CB"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#AnnotationSet"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:5E38DB7B-2B38-491B-8686-9C2D434ACD79"/>
    <ao:annotatesResource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-21.txt.html</ao:annotatesResource>
    <ao:item rdf:resource="urn:domeoclient:uuid:4EEAF739-3D04-465D-8AC0-35EAE4B00AE0"/>
    <pav:previousVersion>xsd:String</pav:previousVersion>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:E60C908C-8168-4614-80BA-973B0DEE03B0">
    <rdfs:label>Highlight</rdfs:label>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:lineageUri>urn:domeoserver:annotation:5862629C-B55B-45E0-8352-762AC58DBF16</pav:lineageUri>
    <domeo:belongsToSet>urn:domeoclient:uuid:B803E851-5AD5-4741-B1B9-1CBAED597E18</domeo:belongsToSet>
    <pav:createdOn>2014-07-21 21:47:27 -0400</pav:createdOn>
    <ao:context rdf:resource="urn:domeoclient:uuid:AAC67B06-289C-4EF8-9E7D-46A9BC438F20"/>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:lastSavedOn>2014-07-21 21:49:33 -0400</pav:lastSavedOn>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812eda990003</pav:createdBy>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:9D275C93-4567-4FDB-902A-6385CDBFA809">
    <pav:lineageUri>urn:domeoserver:annotation:58A85B09-BFE3-4349-8AAB-C9D3F4CFA818</pav:lineageUri>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:lastSavedOn>2014-09-02 12:02:18 -0400</pav:lastSavedOn>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <domeo:belongsToSet>urn:domeoclient:uuid:4B51141D-C8D2-45DB-8074-74F8D8323E60</domeo:belongsToSet>
    <rdfs:label>Highlight</rdfs:label>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812eda990003</pav:createdBy>
    <ao:context rdf:resource="urn:domeoclient:uuid:0461B0A0-7D13-480F-A86F-F2496AAA8BE6"/>
    <pav:createdOn>2014-09-02 11:58:47 -0400</pav:createdOn>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:3BEBBBC1-7503-4FA0-9B16-ED708F2AE108">
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <domeo:belongsToSet>urn:domeoclient:uuid:4F872953-6D19-4809-9285-FCCF2FF54315</domeo:belongsToSet>
    <rdfs:label>Highlight</rdfs:label>
    <pav:lastSavedOn>2014-07-13 12:41:10 -0400</pav:lastSavedOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812eda990003</pav:createdBy>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:lineageUri>urn:domeoserver:annotation:2A576179-7248-4360-B213-E95632A0489F</pav:lineageUri>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <pav:createdOn>2014-07-13 12:38:53 -0400</pav:createdOn>
    <ao:context rdf:resource="urn:domeoclient:uuid:371BCC12-3242-4854-9882-2DB2B2EE1A70"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:0EA544B7-9EBE-419C-A57B-B74B8AC3FB29">
    <rdfs:label>expertstudy Annotation</rdfs:label>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:lastSavedOn>2014-07-21 21:44:00 -0400</pav:lastSavedOn>
    <pav:createdOn>2014-07-21 21:44:10 -0400</pav:createdOn>
    <ao:body rdf:nodeID="Na32a2b76569940d5a8755e340acf74ca"/>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <ao:context rdf:resource="urn:domeoclient:uuid:F9EAA1C1-5B83-488C-8314-2E971233350A"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#expertstudyAnnotation"/>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812eda990003</pav:createdBy>
    <domeo:belongsToSet>urn:domeoclient:uuid:42248733-4719-42F4-8132-866191F8E708</domeo:belongsToSet>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:lineageUri>urn:domeoserver:annotation:7873FB6D-C7A1-42FA-A154-13822B5AA213</pav:lineageUri>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:8156B623-1ED5-4672-8474-3E892FC84DF5">
    <domeo:uuid>8156B623-1ED5-4672-8474-3E892FC84DF5</domeo:uuid>
    <ao:prefix>xsd:String</ao:prefix>
    <ao:exact>Zonisamide</ao:exact>
    <pav:createdOn>2014-07-22 18:37:22 -0400</pav:createdOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-58.txt.html</ao:hasSource>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:8156B623-1ED5-4672-8474-3E892FC84DF5"/>
    <ao:suffix> has been administered to 1,598 individuals during all clinical trials, only some of which were placebo-controlled. During these trials, all events were recorded by the investigators using their own terms. To provide a useful estimate of the proportion o</ao:suffix>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:E2A93D3C-935C-417F-BE1B-282EDBEB8D85">
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812eda990003</pav:createdBy>
    <domeo:belongsToSet>urn:domeoclient:uuid:71191E51-53CB-4FDE-88D0-33C6818E2232</domeo:belongsToSet>
    <pav:lastSavedOn>2014-07-13 11:32:29 -0400</pav:lastSavedOn>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <rdfs:label>Highlight</rdfs:label>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <pav:lineageUri>urn:domeoserver:annotation:12676179-27AE-44BF-86DE-5AE7A37D1457</pav:lineageUri>
    <pav:createdOn>2014-07-13 11:14:04 -0400</pav:createdOn>
    <ao:context rdf:resource="urn:domeoclient:uuid:56FE6B9A-96B3-43BC-A4E1-A9AFE78680CE"/>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:5442793D-CF1E-40C2-8779-648AB7BD1967">
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <pav:lastSavedOn>2014-09-01 16:06:18 -0400</pav:lastSavedOn>
    <pav:createdOn>2014-09-01 16:05:56 -0400</pav:createdOn>
    <domeo:belongsToSet>urn:domeoclient:uuid:A84DE8F6-26B7-471D-8309-4E7CC2994FDF</domeo:belongsToSet>
    <ao:context rdf:resource="urn:domeoclient:uuid:0415BFC3-92B0-4B40-B23A-DCE512A51F26"/>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:lineageUri>urn:domeoserver:annotation:C512B0A7-104C-4F2C-A89E-7F1B583CDB00</pav:lineageUri>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812eda990003</pav:createdBy>
    <rdfs:label>Highlight</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:06403BE6-A661-445F-882B-070BE1039BE5">
    <pav:createdOn>2014-07-22 19:37:25 -0400</pav:createdOn>
    <domeo:uuid>06403BE6-A661-445F-882B-070BE1039BE5</domeo:uuid>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-123.txt.html</ao:hasSource>
    <ao:prefix> is contraindicated in patients with renal impairment, coadministration of </ao:prefix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:exact>metformin</ao:exact>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:06403BE6-A661-445F-882B-070BE1039BE5"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:suffix> with AVANDIA is contraindicated in these patients.</ao:suffix>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:9FAFF1D3-9F76-4586-93FE-52B6168FFC14">
    <pav:lineageUri>urn:domeoserver:annotation:D0A27279-F905-4F2D-9872-52DD6349DF41</pav:lineageUri>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812eda990003</pav:createdBy>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <pav:createdOn>2014-07-21 21:33:50 -0400</pav:createdOn>
    <pav:lastSavedOn>2014-07-21 21:35:10 -0400</pav:lastSavedOn>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <ao:context rdf:resource="urn:domeoclient:uuid:40F97AE4-1A18-4FD3-B30C-9226F8465F7B"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <domeo:belongsToSet>urn:domeoclient:uuid:B61F1A9B-4696-4ED0-80AA-4FE2E9016966</domeo:belongsToSet>
    <rdfs:label>Highlight</rdfs:label>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:B748A453-816C-4DEF-91A1-F20E7FC12F1A">
    <pav:createdOn>2014-07-24 19:52:52 -0400</pav:createdOn>
    <ao:prefix>, decreased 18% to 23% the AUC of both, but did not alter their pharmacodynamics. </ao:prefix>
    <domeo:uuid>B748A453-816C-4DEF-91A1-F20E7FC12F1A</domeo:uuid>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:suffix> did not have an effect on the pharmacokinetics of fluvastatin.</ao:suffix>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:B748A453-816C-4DEF-91A1-F20E7FC12F1A"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:exact>Propranolol</ao:exact>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-132.txt.html</ao:hasSource>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:511EDFA9-5A42-4340-9D4A-CBF6EDD9185C">
    <pav:lineageUri>urn:domeoserver:annotationset:33F0F3E1-6662-4AD7-B2E4-3F73AF120086</pav:lineageUri>
    <domeo:deleted>false</domeo:deleted>
    <ao:annotatesResource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-128.txt.html</ao:annotatesResource>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <ao:item rdf:resource="urn:domeoclient:uuid:E456854E-5580-4BC4-A878-DCBA76DC28FA"/>
    <domeo:agents rdf:resource="urn:domeo:software:id:Domeo-2.1alpha-050"/>
    <pav:lastSavedOn>2014-07-24 19:44:56 -0400</pav:lastSavedOn>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812eda990003</pav:createdBy>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <rdfs:label>Default Set</rdfs:label>
    <ao:item rdf:resource="urn:domeoclient:uuid:87027A0D-796C-443F-ADD9-9F9890FD40ED"/>
    <dct:description>The default set is created automatically by Domeo when no other set is existing.</dct:description>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <pav:createdOn>2014-07-24 19:44:04 -0400</pav:createdOn>
    <permissions:permissions rdf:nodeID="Na92c96060fbd4d65b78ad9bc3db29319"/>
    <domeo:agents rdf:resource="urn:person:uuid:080e143046812afe0146812eda990003"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#AnnotationSet"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:B16948AC-DC5A-471F-B39F-849EE793A353"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:CEF578D1-19C2-4C11-9689-C713DB6D19A6"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:864B2878-F3F7-49DF-B591-E0E101E10F02"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:3F0937C0-5C7C-49F4-A929-655D47825AE9"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:373141E1-A5DA-4819-A876-BCB2CCE1144A"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:B49DFB13-7D38-41A6-989C-F0F22BFBCA7D">
    <domeo:uuid>B49DFB13-7D38-41A6-989C-F0F22BFBCA7D</domeo:uuid>
    <pav:createdOn>2014-07-13 11:15:18 -0400</pav:createdOn>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-8.txt.html</ao:hasSource>
    <ao:suffix> do not suggest important differences between poor and extensive metabolizers. Second, co-administration of known enzyme inducers (e.g., carbamazepine, phenytoin, rifampin, and phenobarbital) with risperidone may cause a decrease in the combined plasma c</ao:suffix>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:B49DFB13-7D38-41A6-989C-F0F22BFBCA7D"/>
    <ao:prefix> have not been evaluated, but observations in a modest number (N≅70) of poor metabolizers given </ao:prefix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:exact>risperidone</ao:exact>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:31A6BF79-BBAC-479E-B954-4B14FED74D2E">
    <ao:exact>ketoconazole</ao:exact>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <domeo:uuid>31A6BF79-BBAC-479E-B954-4B14FED74D2E</domeo:uuid>
    <ao:suffix>. In two separate studies in healthy adult subjects, fexofenadine hydrochloride 120 mg twice daily (240 mg total daily dose) was coadministered with either erythromycin 500 mg every 8 hours or ketoconazole 400 mg once daily under steady-state conditions </ao:suffix>
    <pav:createdOn>2014-07-24 20:07:37 -0400</pav:createdOn>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-139.txt.html</ao:hasSource>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:prefix> or </ao:prefix>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:31A6BF79-BBAC-479E-B954-4B14FED74D2E"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:B9E21C61-063D-4F80-8E08-85865B387669">
    <ao:context rdf:resource="urn:domeoclient:uuid:8232EB8B-B7ED-4583-BE33-F0AD71DA4D1C"/>
    <domeo:belongsToSet>urn:domeoserver:annotationset:22ED7220-C6F6-43C5-9DF9-89F62F0F8E27</domeo:belongsToSet>
    <pav:createdOn>2014-07-07 09:36:49 -0400</pav:createdOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:lastSavedOn>2014-07-07 09:44:18 -0400</pav:lastSavedOn>
    <domeo:belongsToSet>urn:domeoserver:annotationset:08C0C288-6DF4-43E6-A618-71A8BB9563C3</domeo:belongsToSet>
    <pav:lastSavedOn>2014-07-07 09:44:19 -0400</pav:lastSavedOn>
    <domeo:belongsToSet>urn:domeoserver:annotationset:8F3CF3D9-AADE-4A86-BD42-2924B3D6A406</domeo:belongsToSet>
    <domeo:belongsToSet>urn:domeoserver:annotationset:7AACEF8D-2EBC-4F0B-94B2-190650E562F6</domeo:belongsToSet>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812eda990003</pav:createdBy>
    <rdfs:label>Highlight</rdfs:label>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <domeo:belongsToSet>urn:domeoserver:annotationset:131835A3-C655-4F91-97D4-52CAFF7B7CCA</domeo:belongsToSet>
    <domeo:belongsToSet>urn:domeoclient:uuid:FCA2BF23-0BE3-409F-9177-761812F96097</domeo:belongsToSet>
    <pav:lineageUri>urn:domeoserver:annotation:7BCC1444-4E3C-4804-B95F-68D13D651A9A</pav:lineageUri>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:lineageUri>urn:domeoserver:annotationset:76FD4BB5-DE2F-4FCA-B93D-302185B1A381</pav:lineageUri>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:32B4AA19-CBBE-4BDC-AB2F-037EBB0AE5EB">
    <dikbD2R:statement>ncit:quantitative</dikbD2R:statement>
    <rdf:type rdf:resource="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#DrugDrugInteractionStatement"/>
    <sio:SIO_000628 rdf:resource="urn:pddi:uuid:032977FB-2362-4162-8691-DC921A41219C"/>
    <sio:SIO_000205>dikbD2R:statement</sio:SIO_000205>
    <sio:SIO_000563>dikbD2R:modality</sio:SIO_000563>
    <dikbD2R:modality>ncit:positive</dikbD2R:modality>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:CA1AC920-C96A-453E-A808-BB6D8038B11E">
    <pav:createdOn>2014-09-02 11:30:30 -0400</pav:createdOn>
    <ao:exact>warfarin</ao:exact>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-9.txt.html</ao:hasSource>
    <ao:suffix>, theophylline, propranolol, tizanidine), CYP2C9 (e.g., warfarin), CYP3A4 (e.g., alprazolam), and CYP2C19 (e.g., omeprazole).</ao:suffix>
    <domeo:uuid>CA1AC920-C96A-453E-A808-BB6D8038B11E</domeo:uuid>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:CA1AC920-C96A-453E-A808-BB6D8038B11E"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:prefix> inhibits several cytochrome P450 isoenzymes that are known to be involved in the metabolism of other drugs such as: CYP1A2 (e.g., </ao:prefix>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:E2932281-71AF-4D8C-BFA1-44627891CD3C">
    <pav:lineageUri>urn:domeoserver:annotation:303682DC-7850-49A3-B738-19CD7BD73212</pav:lineageUri>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812eda990003</pav:createdBy>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <domeo:belongsToSet>urn:domeoserver:annotationset:40007BD9-0869-48CF-A8F2-BAD26AE3E6E1</domeo:belongsToSet>
    <pav:createdOn>2014-07-21 21:31:15 -0400</pav:createdOn>
    <pav:lineageUri>urn:domeoserver:annotationset:092451F5-B0C0-430C-8896-07F81D33F9E1</pav:lineageUri>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <ao:context rdf:resource="urn:domeoclient:uuid:02D77FC0-6DA3-45AA-9C58-66539927EF97"/>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <rdfs:label>Highlight</rdfs:label>
    <domeo:belongsToSet>urn:domeoclient:uuid:5B3EE83F-83C7-4BA8-A892-C032BE699CFA</domeo:belongsToSet>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:lastSavedOn>2014-07-21 21:31:54 -0400</pav:lastSavedOn>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:2C536245-38D8-4238-BA9C-5A2C84CD1E14">
    <pav:lineageUri>urn:domeoserver:annotation:87D7D751-E4FB-4247-993D-C93391BD1998</pav:lineageUri>
    <pav:createdOn>2014-07-22 18:36:29 -0400</pav:createdOn>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812eda990003</pav:createdBy>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:lastSavedOn>2014-07-22 18:36:37 -0400</pav:lastSavedOn>
    <domeo:belongsToSet>urn:domeoclient:uuid:040380DC-30D6-454D-ACD7-489B2130A9CC</domeo:belongsToSet>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <ao:context rdf:resource="urn:domeoclient:uuid:412C39E0-3B4C-49D9-82A9-AE16507E8B5F"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <rdfs:label>Highlight</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:E07974BC-9D8F-4D5E-A1B2-C28141CD86ED">
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:lastSavedOn>2014-09-02 12:03:47 -0400</pav:lastSavedOn>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <pav:lineageUri>urn:domeoserver:annotationset:166C20E9-1B4C-47D1-982D-922E2E5ACFF2</pav:lineageUri>
    <pav:createdOn>2014-09-02 12:03:40 -0400</pav:createdOn>
    <pav:lineageUri>urn:domeoserver:annotation:4DCE2D04-E864-43B4-9C0B-751FB56A1A76</pav:lineageUri>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <ao:context rdf:resource="urn:domeoclient:uuid:DD1327AF-4B75-4BEA-B917-539687934A1F"/>
    <domeo:belongsToSet>urn:domeoserver:annotationset:D52DFD7B-BDDF-488F-B339-B1BC641E50E9</domeo:belongsToSet>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <domeo:belongsToSet>urn:domeoclient:uuid:379CD8C1-F4B4-42B7-8F87-70776866DB1F</domeo:belongsToSet>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812eda990003</pav:createdBy>
    <rdfs:label>Highlight</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:4588D04A-4EE6-4AEB-8E31-47ECEB3BF1E4">
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <pav:createdOn>2014-07-22 19:35:38 -0400</pav:createdOn>
    <ao:prefix>Pharmacokinetic parameters of </ao:prefix>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-123.txt.html</ao:hasSource>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:4588D04A-4EE6-4AEB-8E31-47ECEB3BF1E4"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:exact>rosiglitazone</ao:exact>
    <ao:suffix> in pediatric patients were established using a population pharmacokinetic analysis with sparse data from 96 pediatric patients in a single pediatric clinical trial including 33 males and 63 females with ages ranging from 10 to 17 years (weights ranging </ao:suffix>
    <domeo:uuid>4588D04A-4EE6-4AEB-8E31-47ECEB3BF1E4</domeo:uuid>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:15E1712B-2693-4DB6-A2FE-D2F158D3A823">
    <pav:createdOn>2014-07-22 19:22:31 -0400</pav:createdOn>
    <pav:lastSavedOn>2014-07-22 19:28:02 -0400</pav:lastSavedOn>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812eda990003</pav:createdBy>
    <domeo:belongsToSet>urn:domeoserver:annotationset:7021B883-FD5C-4083-BD87-DF56D3C87633</domeo:belongsToSet>
    <domeo:belongsToSet>urn:domeoserver:annotationset:7E80543E-BF76-4514-92A9-91458DCB802B</domeo:belongsToSet>
    <domeo:belongsToSet>urn:domeoserver:annotationset:F272A789-69D0-47CC-8CC9-F25C55B91261</domeo:belongsToSet>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <domeo:belongsToSet>urn:domeoserver:annotationset:606A5B3F-B6FB-4279-AA42-7893CFC2D20C</domeo:belongsToSet>
    <pav:lineageUri>urn:domeoserver:annotation:6F180D4A-1B05-42AB-912B-DD2B4509C6CB</pav:lineageUri>
    <pav:lineageUri>urn:domeoserver:annotationset:AB1741F1-5A5F-4416-AEAC-A544BCBB7D16</pav:lineageUri>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <rdfs:label>Highlight</rdfs:label>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <domeo:belongsToSet>urn:domeoserver:annotationset:2914A3FD-DF43-4F78-999C-77CE7A028B19</domeo:belongsToSet>
    <domeo:belongsToSet>urn:domeoserver:annotationset:514BA51B-D734-4003-A7C3-F03C0F95833A</domeo:belongsToSet>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <ao:context rdf:resource="urn:domeoclient:uuid:C45EB527-9AC4-4005-86AF-8EEB1D4B88FA"/>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">3</pav:versionNumber>
    <pav:previousVersion>urn:domeoserver:annotationset:467D4F28-D086-4217-9DE0-23E165F30716</pav:previousVersion>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:9AE25ABB-CFC2-479D-B1B0-184576D49108">
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:createdOn>2014-07-21 21:43:20 -0400</pav:createdOn>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812eda990003</pav:createdBy>
    <domeo:belongsToSet>urn:domeoclient:uuid:42248733-4719-42F4-8132-866191F8E708</domeo:belongsToSet>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:lastSavedOn>2014-07-21 21:44:00 -0400</pav:lastSavedOn>
    <pav:lineageUri>urn:domeoserver:annotation:8834E508-3DB6-40D4-997D-4BC1EFD12E61</pav:lineageUri>
    <rdfs:label>Highlight</rdfs:label>
    <ao:context rdf:resource="urn:domeoclient:uuid:846B6C02-30BD-4750-BAD3-4CC242462EE4"/>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:F0919B6C-E254-4D92-89B8-6C9E487C9A1E">
    <domeo:uuid>F0919B6C-E254-4D92-89B8-6C9E487C9A1E</domeo:uuid>
    <ao:suffix>).</ao:suffix>
    <ao:exact>omeprazole</ao:exact>
    <pav:createdOn>2014-09-02 11:30:48 -0400</pav:createdOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:F0919B6C-E254-4D92-89B8-6C9E487C9A1E"/>
    <ao:prefix>), and CYP2C19 (e.g., </ao:prefix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-9.txt.html</ao:hasSource>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:EE072CDD-1278-4505-A3C0-39DABDD38987">
    <pav:lastSavedOn>2014-07-24 19:46:05 -0400</pav:lastSavedOn>
    <pav:createdOn>2014-07-24 19:45:44 -0400</pav:createdOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <rdfs:label>Highlight</rdfs:label>
    <pav:lineageUri>urn:domeoserver:annotation:B21366EB-B88D-4F1E-AD23-59BC46AC5171</pav:lineageUri>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <ao:context rdf:resource="urn:domeoclient:uuid:205F8706-B144-4ED0-9F00-551E6481AD6D"/>
    <domeo:belongsToSet>urn:domeoclient:uuid:4519FF07-AE90-4478-8B97-B4B2C84457DC</domeo:belongsToSet>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812eda990003</pav:createdBy>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:F6BB6E4E-BC80-4ACC-A7B5-88D5847926E4">
    <pav:createdOn>2014-07-22 19:55:19 -0400</pav:createdOn>
    <ao:exact>Acarbose</ao:exact>
    <domeo:uuid>F6BB6E4E-BC80-4ACC-A7B5-88D5847926E4</domeo:uuid>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:F6BB6E4E-BC80-4ACC-A7B5-88D5847926E4"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:suffix>xsd:String</ao:suffix>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-123.txt.html</ao:hasSource>
    <ao:prefix>xsd:String</ao:prefix>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:C86F61CA-C8B8-45D2-86FA-DC4DB976D43B">
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812eda990003</pav:createdBy>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:createdOn>2014-07-22 18:58:19 -0400</pav:createdOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <domeo:belongsToSet>urn:domeoclient:uuid:F2788742-3226-4BFB-9D85-2FC7211066F7</domeo:belongsToSet>
    <ao:context rdf:resource="urn:domeoclient:uuid:1FEAE882-CD22-4693-8DC0-495CC155160B"/>
    <pav:lastSavedOn>2014-07-22 18:59:41 -0400</pav:lastSavedOn>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <rdfs:label>Highlight</rdfs:label>
    <pav:lineageUri>urn:domeoserver:annotation:CF02237F-C859-48FC-9C3F-9401B806E6E6</pav:lineageUri>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:9BDFA0ED-9096-4328-B514-6A94D7426FE7">
    <ao:exact>Propranolol does not affect the pharmacokinetics of verapamil and norverapamil. Verapamil does not affect the pharmacokinetics of propranolol.</ao:exact>
    <ao:suffix>xsd:String</ao:suffix>
    <ao:prefix>xsd:String</ao:prefix>
    <domeo:uuid>9BDFA0ED-9096-4328-B514-6A94D7426FE7</domeo:uuid>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:9BDFA0ED-9096-4328-B514-6A94D7426FE7"/>
    <pav:createdOn>2014-07-24 19:43:48 -0400</pav:createdOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-127.txt.html</ao:hasSource>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:285AE4B3-9649-4D7B-A540-9B1BE0CD0CDA">
    <pav:createdOn>2014-07-24 19:37:50 -0400</pav:createdOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-124.txt.html</ao:hasSource>
    <domeo:uuid>285AE4B3-9649-4D7B-A540-9B1BE0CD0CDA</domeo:uuid>
    <ao:exact>The AUC of propafenone is increased by more than 200% by co-administration of propranolol.</ao:exact>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:prefix>xsd:String</ao:prefix>
    <ao:suffix>xsd:String</ao:suffix>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:285AE4B3-9649-4D7B-A540-9B1BE0CD0CDA"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:0ABA0AC7-182A-406C-840C-4443E197D138">
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <rdfs:label>Highlight</rdfs:label>
    <pav:lineageUri>urn:domeoserver:annotation:1CE9469B-7304-476E-AA93-EA94C2D2AB7C</pav:lineageUri>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:lastSavedOn>2014-07-24 19:38:41 -0400</pav:lastSavedOn>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <domeo:belongsToSet>urn:domeoclient:uuid:DBA2FBEC-FB21-4B1E-AFD1-05AF52CBAB09</domeo:belongsToSet>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812eda990003</pav:createdBy>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <ao:context rdf:resource="urn:domeoclient:uuid:8B0374C4-A360-43F1-A6B7-10442B0A8905"/>
    <pav:createdOn>2014-07-24 19:38:25 -0400</pav:createdOn>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:AA479503-5E2B-4688-851D-61C9DCC47907">
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-134.txt.html</ao:hasSource>
    <ao:exact>propranolol </ao:exact>
    <ao:suffix>resulted in a 70% increase in propranolol plasma level.</ao:suffix>
    <ao:prefix>Co-administration of chlorpromazine with </ao:prefix>
    <domeo:uuid>AA479503-5E2B-4688-851D-61C9DCC47907</domeo:uuid>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <pav:createdOn>2014-07-24 19:55:03 -0400</pav:createdOn>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:AA479503-5E2B-4688-851D-61C9DCC47907"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:A05276D6-1557-4F87-90F3-A0B48D17A341">
    <ao:exact>fluvoxamine</ao:exact>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:prefix>, and tricyclic antidepressants. While none of the drugs studied for drug interactions significantly affected the pharmacokinetics of </ao:prefix>
    <ao:suffix>, an in vivo study of fluvoxamine single-dose pharmacokinetics in 13 PM subjects demonstrated altered pharmacokinetic properties compared to 16 "extensive metabolizers" (EM): mean Cmax, AUC, and half-life were increased by 52%, 200%, and 62%, respectivel</ao:suffix>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:A05276D6-1557-4F87-90F3-A0B48D17A341"/>
    <domeo:uuid>A05276D6-1557-4F87-90F3-A0B48D17A341</domeo:uuid>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-9.txt.html</ao:hasSource>
    <pav:createdOn>2014-09-02 11:34:59 -0400</pav:createdOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:1C02BE13-5688-4657-A7A7-6A459283AEB2">
    <domeo:belongsToSet>urn:domeoserver:annotationset:22ED7220-C6F6-43C5-9DF9-89F62F0F8E27</domeo:belongsToSet>
    <domeo:belongsToSet>urn:domeoserver:annotationset:8F3CF3D9-AADE-4A86-BD42-2924B3D6A406</domeo:belongsToSet>
    <pav:createdOn>2014-07-07 11:24:07 -0400</pav:createdOn>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812eda990003</pav:createdBy>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <pav:lastSavedOn>2014-07-07 11:24:52 -0400</pav:lastSavedOn>
    <domeo:belongsToSet>urn:domeoserver:annotationset:7AACEF8D-2EBC-4F0B-94B2-190650E562F6</domeo:belongsToSet>
    <rdfs:label>Highlight</rdfs:label>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <domeo:belongsToSet>urn:domeoserver:annotationset:131835A3-C655-4F91-97D4-52CAFF7B7CCA</domeo:belongsToSet>
    <pav:lineageUri>urn:domeoserver:annotation:A431D5CB-5994-440B-99C7-32C2F2EC8DE9</pav:lineageUri>
    <ao:context rdf:resource="urn:domeoclient:uuid:1554FCFD-7477-413C-879A-913DFFAB5886"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/8F36BE9D-F662-4788-A209-5115C542C5AE">
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/active-ingredient"/>
    <rdfs:label>tacrine</rdfs:label>
    <dct:description>Referred to the drug in the interaction.</dct:description>
    <sio:SIO_000228>dikbD2R:object-drug-of-interaction</sio:SIO_000228>
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/10318</dailymed:activeMoietyRxCUI>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:57427A36-AF04-4B9A-A5C2-85D0AE5CA845">
    <ao:exact>ketoconazole</ao:exact>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <domeo:uuid>57427A36-AF04-4B9A-A5C2-85D0AE5CA845</domeo:uuid>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:57427A36-AF04-4B9A-A5C2-85D0AE5CA845"/>
    <ao:suffix>, ampicillin esters, and iron salts). In the clinical trials, antacids were used concomitantly with the administration of omeprazole delayed-release capsules USP.</ao:suffix>
    <pav:createdOn>2014-09-02 19:12:09 -0400</pav:createdOn>
    <ao:prefix>Because of its profound and long lasting inhibition of gastric acid secretion, it is theoretically possible that omeprazole may interfere with absorption of drugs where gastric pH is an important determinant of their bioavailability (e.g., </ao:prefix>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-74.txt.html</ao:hasSource>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:0072DC69-60A4-45F2-9EA7-C1B1D9B53CA2">
    <ao:exact>Tacrine</ao:exact>
    <domeo:uuid>0072DC69-60A4-45F2-9EA7-C1B1D9B53CA2</domeo:uuid>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:0072DC69-60A4-45F2-9EA7-C1B1D9B53CA2"/>
    <ao:prefix>xsd:String</ao:prefix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <pav:createdOn>2014-09-02 11:41:05 -0400</pav:createdOn>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-9.txt.html</ao:hasSource>
    <ao:suffix>: In a study of 13 healthy, male volunteers, a single 40 mg dose of tacrine added to fluvoxamine 100 mg/day administered at steady-state was associated with five- and eight-fold increases in tacrine Cmax and AUC, respectively, compared to the administrat</ao:suffix>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:7086D655-845E-4135-B24F-75B4FFD47BD0">
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812eda990003</pav:createdBy>
    <domeo:belongsToSet>urn:domeoserver:annotationset:606A5B3F-B6FB-4279-AA42-7893CFC2D20C</domeo:belongsToSet>
    <pav:lineageUri>urn:domeoserver:annotationset:AB1741F1-5A5F-4416-AEAC-A544BCBB7D16</pav:lineageUri>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:lastSavedOn>2014-07-22 19:44:46 -0400</pav:lastSavedOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <domeo:belongsToSet>urn:domeoserver:annotationset:2914A3FD-DF43-4F78-999C-77CE7A028B19</domeo:belongsToSet>
    <pav:lineageUri>urn:domeoserver:annotation:0428880A-A8A5-4385-9AFD-D6B0811EEBA4</pav:lineageUri>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">6</pav:versionNumber>
    <ao:context rdf:resource="urn:domeoclient:uuid:69C6BE85-B8AD-457C-8581-67B0BD3C4802"/>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <pav:createdOn>2014-07-22 19:41:37 -0400</pav:createdOn>
    <domeo:belongsToSet>urn:domeoserver:annotationset:F272A789-69D0-47CC-8CC9-F25C55B91261</domeo:belongsToSet>
    <pav:previousVersion>urn:domeoserver:annotationset:514BA51B-D734-4003-A7C3-F03C0F95833A</pav:previousVersion>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <rdfs:label>Highlight</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:984E4D2D-A998-4068-9BF7-F709348DD1B2">
    <ao:suffix> and 9-hydroxyrisperidone was decreased, and elimination half-lives were prolonged compared to young healthy subjects. Dosing should be modified accordingly in the elderly patients [see 2 DOSAGE AND ADMINISTRATION].</ao:suffix>
    <pav:createdOn>2014-07-13 11:18:21 -0400</pav:createdOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:984E4D2D-A998-4068-9BF7-F709348DD1B2"/>
    <ao:exact>risperidone</ao:exact>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-8.txt.html</ao:hasSource>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:prefix>Elderly: In healthy elderly subjects, renal clearance of both </ao:prefix>
    <domeo:uuid>984E4D2D-A998-4068-9BF7-F709348DD1B2</domeo:uuid>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:0AE7742B-EF74-477D-95CF-44A73986D022">
    <domeo:uuid>0AE7742B-EF74-477D-95CF-44A73986D022</domeo:uuid>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:prefix>. Therefore, if an inhibitor or an inducer of CYP2C8 is started or stopped during treatment with </ao:prefix>
    <ao:suffix>, changes in diabetes treatment may be needed based upon clinical response. [See Clinical Pharmacology (12.4).] </ao:suffix>
    <ao:exact>rosiglitazone</ao:exact>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <pav:createdOn>2014-07-22 19:06:58 -0400</pav:createdOn>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-122.txt.html</ao:hasSource>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:0AE7742B-EF74-477D-95CF-44A73986D022"/>
  </rdf:Description>
  <rdf:Description rdf:nodeID="Ncf3ed7da0a38468dba031c79b0406f46">
    <permissions:isLocked>false</permissions:isLocked>
    <permissions:accessType>urn:domeo:access:public</permissions:accessType>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:545EC8BB-0B95-4E21-B88B-BE07F31247CE">
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:lastSavedOn>2014-07-22 20:22:38 -0400</pav:lastSavedOn>
    <pav:createdOn>2014-07-22 19:55:19 -0400</pav:createdOn>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <domeo:belongsToSet>urn:domeoserver:annotationset:F272A789-69D0-47CC-8CC9-F25C55B91261</domeo:belongsToSet>
    <ao:context rdf:resource="urn:domeoclient:uuid:F6BB6E4E-BC80-4ACC-A7B5-88D5847926E4"/>
    <pav:lineageUri>urn:domeoserver:annotation:0C65C382-D747-4535-B13B-98E69E9D4718</pav:lineageUri>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812eda990003</pav:createdBy>
    <rdfs:label>Highlight</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/A11930F7-6D95-4B60-BEDF-64A102BE527C">
    <rdfs:label>fluconazole</rdfs:label>
    <sio:SIO_000228>dikbD2R:precipitant-drug-of-interaction</sio:SIO_000228>
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/4450</dailymed:activeMoietyRxCUI>
    <dct:description>Referred to the drug in the interaction.</dct:description>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/active-ingredient"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:2C22B081-DC6C-4519-BC58-778F31A66BDB">
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/089280DB-9E3B-46D1-9448-CA64307E1CBF"/>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/PK_DDI"/>
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/B959D351-8EA8-4A27-AEBB-7E2C63519031"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:62667796-1E15-449B-8175-6954CB53F6DF">
    <ao:suffix> with fluvoxamine produced substantial decrements in cognitive functioning; however, the coadministration of fluvoxamine and lorazepam did not produce larger mean decrements compared to lorazepam alone.</ao:suffix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:exact>lorazepam</ao:exact>
    <ao:prefix> alone and </ao:prefix>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-9.txt.html</ao:hasSource>
    <domeo:uuid>62667796-1E15-449B-8175-6954CB53F6DF</domeo:uuid>
    <pav:createdOn>2014-09-02 11:38:20 -0400</pav:createdOn>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:62667796-1E15-449B-8175-6954CB53F6DF"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:5FF2B43E-5E15-4C21-BFDD-C97D4C18B3B1">
    <rdfs:label>Highlight</rdfs:label>
    <pav:createdOn>2014-07-13 11:08:45 -0400</pav:createdOn>
    <pav:lineageUri>urn:domeoserver:annotation:28D6D7F6-0FFB-41F2-BC7C-A9F0E4ED53AC</pav:lineageUri>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <ao:context rdf:resource="urn:domeoclient:uuid:C2EEFE36-AE7E-4BF4-943E-03D2760C673E"/>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812eda990003</pav:createdBy>
    <pav:lastSavedOn>2014-07-13 11:32:29 -0400</pav:lastSavedOn>
    <domeo:belongsToSet>urn:domeoclient:uuid:71191E51-53CB-4FDE-88D0-33C6818E2232</domeo:belongsToSet>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:E2C79BAB-965C-479E-824A-F2884B348419">
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <pav:createdOn>2014-07-13 12:38:39 -0400</pav:createdOn>
    <ao:suffix> treatment did not cause a decrease in the ethinyl estradiol AUC of any individual subject in this study compared to placebo dosing. The individual AUC values of norethindrone decreased very slightly (&lt;5%) in 3 of the 21 subjects after fluconazole treatm</ao:suffix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:E2C79BAB-965C-479E-824A-F2884B348419"/>
    <domeo:uuid>E2C79BAB-965C-479E-824A-F2884B348419</domeo:uuid>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-21.txt.html</ao:hasSource>
    <ao:prefix> increased by 24% (95% C.I. range 18 to 31%) and 13% (95% C.I. range 8 to 18%), respectively relative to placebo. </ao:prefix>
    <ao:exact>Fluconazole</ao:exact>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:C44A8620-423F-46B3-A5AA-096744C9A1FF">
    <rdfs:label>Highlight</rdfs:label>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:lineageUri>urn:domeoserver:annotation:E6595957-5AB4-48D0-BA7E-DA2D008F36BF</pav:lineageUri>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:lastSavedOn>2014-09-01 15:57:39 -0400</pav:lastSavedOn>
    <pav:createdOn>2014-09-01 15:57:37 -0400</pav:createdOn>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812eda990003</pav:createdBy>
    <domeo:belongsToSet>urn:domeoclient:uuid:39B82E57-92E3-4322-A8E6-A3AFF215F02C</domeo:belongsToSet>
    <ao:context rdf:resource="urn:domeoclient:uuid:024DA998-8A48-48B5-83FB-3E3328F234D5"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:87027A0D-796C-443F-ADD9-9F9890FD40ED">
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <ao:context rdf:resource="urn:domeoclient:uuid:48081C9F-3CDC-436C-888F-B763536ACD92"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#expertstudyAnnotation"/>
    <pav:createdOn>2014-07-24 19:44:48 -0400</pav:createdOn>
    <pav:lineageUri>urn:domeoserver:annotation:67F5D7F3-4C61-454A-8DC4-5AF1F8E00A9D</pav:lineageUri>
    <rdfs:label>expertstudy Annotation</rdfs:label>
    <ao:body rdf:nodeID="Nc4707fb6856b4f709a369bba42059710"/>
    <pav:lastSavedOn>2014-07-24 19:44:56 -0400</pav:lastSavedOn>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812eda990003</pav:createdBy>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <domeo:belongsToSet>urn:domeoclient:uuid:511EDFA9-5A42-4340-9D4A-CBF6EDD9185C</domeo:belongsToSet>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:3B40A6C2-C532-4FE1-9D1E-96A1576E7CC1">
    <rdfs:label>Highlight</rdfs:label>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:createdOn>2014-09-02 19:11:00 -0400</pav:createdOn>
    <domeo:belongsToSet>urn:domeoclient:uuid:3966BCFB-CA02-4053-828D-3860558E7BE8</domeo:belongsToSet>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812eda990003</pav:createdBy>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <ao:context rdf:resource="urn:domeoclient:uuid:BB9A9C70-7859-46AE-887F-B9F2CBDE39DB"/>
    <pav:lastSavedOn>2014-09-02 19:11:13 -0400</pav:lastSavedOn>
    <pav:lineageUri>urn:domeoserver:annotation:C437B730-34CD-4CA8-A3D5-EEB1FCE27C9A</pav:lineageUri>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:8ABD9FDA-0F08-474A-A9C8-437A5346F2AC">
    <domeo:belongsToSet>urn:domeoserver:annotationset:22ED7220-C6F6-43C5-9DF9-89F62F0F8E27</domeo:belongsToSet>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:lastSavedOn>2014-07-07 09:44:18 -0400</pav:lastSavedOn>
    <domeo:belongsToSet>urn:domeoserver:annotationset:08C0C288-6DF4-43E6-A618-71A8BB9563C3</domeo:belongsToSet>
    <pav:lastSavedOn>2014-07-07 09:44:19 -0400</pav:lastSavedOn>
    <domeo:belongsToSet>urn:domeoserver:annotationset:8F3CF3D9-AADE-4A86-BD42-2924B3D6A406</domeo:belongsToSet>
    <domeo:belongsToSet>urn:domeoserver:annotationset:7AACEF8D-2EBC-4F0B-94B2-190650E562F6</domeo:belongsToSet>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812eda990003</pav:createdBy>
    <ao:context rdf:resource="urn:domeoclient:uuid:20B4F69C-E14E-46A0-8FCE-6AAC4D5EF0B0"/>
    <rdfs:label>Highlight</rdfs:label>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:lineageUri>urn:domeoserver:annotation:880929CF-0105-4579-A800-E42B40197857</pav:lineageUri>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <domeo:belongsToSet>urn:domeoserver:annotationset:131835A3-C655-4F91-97D4-52CAFF7B7CCA</domeo:belongsToSet>
    <domeo:belongsToSet>urn:domeoclient:uuid:FCA2BF23-0BE3-409F-9177-761812F96097</domeo:belongsToSet>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:createdOn>2014-07-07 09:40:23 -0400</pav:createdOn>
    <pav:lineageUri>urn:domeoserver:annotationset:76FD4BB5-DE2F-4FCA-B93D-302185B1A381</pav:lineageUri>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:A98AC7AB-8326-46FF-A484-D9D3774E511A">
    <rdfs:label>expertstudy Annotation</rdfs:label>
    <pav:lineageUri>urn:domeoserver:annotation:F1F5B076-CA43-4BBF-AD5E-46855A01FCB5</pav:lineageUri>
    <domeo:belongsToSet>urn:domeoclient:uuid:BD4B7475-BD13-46C4-932F-139564A0063D</domeo:belongsToSet>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#expertstudyAnnotation"/>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <ao:context rdf:resource="urn:domeoclient:uuid:AE4E1848-BBFA-4DA4-8738-800749B0AAF2"/>
    <pav:lastSavedOn>2014-07-21 21:42:43 -0400</pav:lastSavedOn>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812eda990003</pav:createdBy>
    <pav:createdOn>2014-07-21 21:42:56 -0400</pav:createdOn>
    <ao:body rdf:nodeID="N8c96dfabf826491e86ec0b0142045ff9"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:C3406496-29A1-41A2-B195-BAD281E72E4B">
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:suffix> and, therefore, the combination should be used with caution. Seizures have been reported with the coadministration of fluvoxamine maleate and lithium.</ao:suffix>
    <ao:prefix> may enhance the serotonergic effects of </ao:prefix>
    <domeo:uuid>C3406496-29A1-41A2-B195-BAD281E72E4B</domeo:uuid>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:C3406496-29A1-41A2-B195-BAD281E72E4B"/>
    <pav:createdOn>2014-09-02 11:40:04 -0400</pav:createdOn>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-9.txt.html</ao:hasSource>
    <ao:exact>fluvoxamine</ao:exact>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:513FF3F1-4FCE-4790-A5C9-F75162D3687B">
    <pav:lineageUri>urn:domeoserver:annotation:6E3D26C2-5916-4D24-B1BA-C28DDEEBE93D</pav:lineageUri>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <domeo:belongsToSet>urn:domeoserver:annotationset:467D4F28-D086-4217-9DE0-23E165F30716</domeo:belongsToSet>
    <ao:context rdf:resource="urn:domeoclient:uuid:DAB2122F-CA41-44C2-9EB5-3469E45FCF04"/>
    <domeo:belongsToSet>urn:domeoserver:annotationset:7021B883-FD5C-4083-BD87-DF56D3C87633</domeo:belongsToSet>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <domeo:belongsToSet>urn:domeoserver:annotationset:606A5B3F-B6FB-4279-AA42-7893CFC2D20C</domeo:belongsToSet>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812eda990003</pav:createdBy>
    <pav:createdOn>2014-07-22 19:08:44 -0400</pav:createdOn>
    <domeo:belongsToSet>urn:domeoserver:annotationset:2914A3FD-DF43-4F78-999C-77CE7A028B19</domeo:belongsToSet>
    <domeo:belongsToSet>urn:domeoserver:annotationset:514BA51B-D734-4003-A7C3-F03C0F95833A</domeo:belongsToSet>
    <pav:lastSavedOn>2014-07-22 19:11:40 -0400</pav:lastSavedOn>
    <pav:lineageUri>urn:domeoserver:annotationset:AB1741F1-5A5F-4416-AEAC-A544BCBB7D16</pav:lineageUri>
    <pav:lastSavedOn>2014-07-22 19:11:41 -0400</pav:lastSavedOn>
    <rdfs:label>Highlight</rdfs:label>
    <domeo:belongsToSet>urn:domeoserver:annotationset:F272A789-69D0-47CC-8CC9-F25C55B91261</domeo:belongsToSet>
    <domeo:belongsToSet>urn:domeoserver:annotationset:7E80543E-BF76-4514-92A9-91458DCB802B</domeo:belongsToSet>
    <domeo:belongsToSet>urn:domeoclient:uuid:BE4B86AC-FE5F-4543-A713-EC5B852A5A2A</domeo:belongsToSet>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:4683A379-9BF3-47AD-B269-BF50998FE88B">
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <rdfs:label>Highlight</rdfs:label>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812eda990003</pav:createdBy>
    <pav:lastSavedOn>2014-09-02 19:11:13 -0400</pav:lastSavedOn>
    <domeo:belongsToSet>urn:domeoclient:uuid:3966BCFB-CA02-4053-828D-3860558E7BE8</domeo:belongsToSet>
    <pav:lineageUri>urn:domeoserver:annotation:B8091647-B5DD-4576-A186-2BCF2E1FA6BF</pav:lineageUri>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:createdOn>2014-09-02 19:08:35 -0400</pav:createdOn>
    <ao:context rdf:resource="urn:domeoclient:uuid:52AE2649-A143-4E37-A21D-82019096A697"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:8186AE14-85DE-4E1A-B5F4-BC58233DC47B">
    <rdf:type rdf:resource="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#DrugDrugInteractionStatement"/>
    <sio:SIO_000628 rdf:resource="urn:pddi:uuid:43E08535-8340-472C-92D9-100ECFA2CB93"/>
    <sio:SIO_000563>dikbD2R:modality</sio:SIO_000563>
    <sio:SIO_000205>dikbD2R:statement</sio:SIO_000205>
    <dikbD2R:modality>ncit:positive</dikbD2R:modality>
    <dikbD2R:statement>ncit:quantitative</dikbD2R:statement>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:1C14E39F-8619-4318-B524-D5D59AE2A868">
    <ao:exact>AVANDIA</ao:exact>
    <ao:suffix> </ao:suffix>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:1C14E39F-8619-4318-B524-D5D59AE2A868"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <domeo:uuid>1C14E39F-8619-4318-B524-D5D59AE2A868</domeo:uuid>
    <pav:createdOn>2014-07-22 20:17:43 -0400</pav:createdOn>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-123.txt.html</ao:hasSource>
    <ao:prefix>xsd:String</ao:prefix>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:FF394C23-B19D-4287-8ACE-54167C17E2D1">
    <sio:SIO_000205>dikbD2R:statement</sio:SIO_000205>
    <sio:SIO_000563>dikbD2R:modality</sio:SIO_000563>
    <sio:SIO_000628 rdf:resource="urn:pddi:uuid:AB5CE3C5-4CFD-489B-9021-04685E6B310D"/>
    <dikbD2R:modality>ncit:positive</dikbD2R:modality>
    <rdf:type rdf:resource="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#DrugDrugInteractionStatement"/>
    <dikbD2R:statement>ncit:Qualitative</dikbD2R:statement>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/DBD9B114-1A26-42A6-8975-25C258D84F84">
    <sio:SIO_000228>dikbD2R:object-drug-of-interaction</sio:SIO_000228>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/active-ingredient"/>
    <dct:description>Referred to the drug in the interaction.</dct:description>
    <rdfs:label>propranolol</rdfs:label>
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/8787</dailymed:activeMoietyRxCUI>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:A48F9E31-BBA4-4315-8056-D4A8A7BA3369">
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/9CBD9468-F0C7-47D4-9BAC-C2AA3E99A206"/>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/PK_DDI"/>
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/7CA3AC53-AB27-4372-8466-89F72F2E0674"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:D6A80456-C24A-4B51-9FF1-54B2442E9245">
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812eda990003</pav:createdBy>
    <domeo:belongsToSet>urn:domeoclient:uuid:48D839E5-6B0A-4EC3-B64A-E3E20E06246A</domeo:belongsToSet>
    <ao:context rdf:resource="urn:domeoclient:uuid:E61B11CA-1C13-4025-B813-17930363237F"/>
    <pav:lastSavedOn>2014-07-28 17:08:37 -0400</pav:lastSavedOn>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <rdfs:label>Highlight</rdfs:label>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:lineageUri>urn:domeoserver:annotation:5FB651AA-4C9C-42E4-94BA-0C38AC19F913</pav:lineageUri>
    <pav:createdOn>2014-07-28 17:04:20 -0400</pav:createdOn>
  </rdf:Description>
  <rdf:Description rdf:nodeID="N4915c989454d42718ef582c99ebdffdb">
    <domeo:sets rdf:resource="urn:pddi:uuid:A3DCC3AB-4469-4227-B682-6E7F65CD2A7A"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:00F93F74-A2F5-4F4F-869B-19496B9D0B0C">
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812eda990003</pav:createdBy>
    <domeo:belongsToSet>urn:domeoclient:uuid:B61F1A9B-4696-4ED0-80AA-4FE2E9016966</domeo:belongsToSet>
    <pav:lineageUri>urn:domeoserver:annotation:44426881-7EDB-4E11-9DB3-EB4EEC0315EF</pav:lineageUri>
    <pav:createdOn>2014-07-21 21:33:43 -0400</pav:createdOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:lastSavedOn>2014-07-21 21:35:10 -0400</pav:lastSavedOn>
    <rdfs:label>Highlight</rdfs:label>
    <ao:context rdf:resource="urn:domeoclient:uuid:BD767394-A523-4383-85E2-F42A0A94276D"/>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:F7ED86B3-B970-41BF-B468-D38526646742">
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:suffix>, carbamazepine, and phenytoin, may lead to a lack of efficacy or, possibly, development of an abstinence syndrome in a patient who had developed physical dependence to oxycodone. If co-administration is necessary, caution is advised when initiating ther</ao:suffix>
    <pav:createdOn>2014-09-02 19:09:50 -0400</pav:createdOn>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-72.txt.html</ao:hasSource>
    <domeo:uuid>F7ED86B3-B970-41BF-B468-D38526646742</domeo:uuid>
    <ao:prefix> concentrations. Induction of CYP3A4 activity by its inducers, such as </ao:prefix>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:F7ED86B3-B970-41BF-B468-D38526646742"/>
    <ao:exact>rifampin</ao:exact>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:95E14AD2-785D-44CE-B25D-C8A915ADD717">
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <ao:context rdf:resource="urn:domeoclient:uuid:AFC27E91-AC15-4700-A2C7-343191A7F13A"/>
    <rdfs:label>Highlight</rdfs:label>
    <domeo:belongsToSet>urn:domeoclient:uuid:4FC315CC-8F6D-4166-AEB6-FBF9CF2FA510</domeo:belongsToSet>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812eda990003</pav:createdBy>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:createdOn>2014-07-28 17:00:54 -0400</pav:createdOn>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <pav:lineageUri>urn:domeoserver:annotation:88CAF2D5-BF6B-4F50-8663-F233B152EA66</pav:lineageUri>
    <pav:lastSavedOn>2014-07-28 17:00:29 -0400</pav:lastSavedOn>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:31A6A7B0-3980-4B84-A4E6-68B8A08EC05D">
    <sio:SIO_000205>dikbD2R:statement</sio:SIO_000205>
    <dikbD2R:statement>ncit:Qualitative</dikbD2R:statement>
    <dikbD2R:modality>ncit:negative</dikbD2R:modality>
    <sio:SIO_000628 rdf:resource="urn:pddi:uuid:A250DA9B-BB28-425B-B634-A002C82007BD"/>
    <sio:SIO_000563>dikbD2R:modality</sio:SIO_000563>
    <rdf:type rdf:resource="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#DrugDrugInteractionStatement"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:5CE56B1D-ACF0-4124-B31E-62EF1E11FED8">
    <domeo:belongsToSet>urn:domeoserver:annotationset:514BA51B-D734-4003-A7C3-F03C0F95833A</domeo:belongsToSet>
    <domeo:belongsToSet>urn:domeoserver:annotationset:2914A3FD-DF43-4F78-999C-77CE7A028B19</domeo:belongsToSet>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">3</pav:versionNumber>
    <pav:lastSavedOn>2014-07-22 19:28:02 -0400</pav:lastSavedOn>
    <domeo:belongsToSet>urn:domeoserver:annotationset:7021B883-FD5C-4083-BD87-DF56D3C87633</domeo:belongsToSet>
    <rdfs:label>Highlight</rdfs:label>
    <ao:context rdf:resource="urn:domeoclient:uuid:5A221420-4081-46A9-839D-6DA46028DA4B"/>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <domeo:belongsToSet>urn:domeoserver:annotationset:F272A789-69D0-47CC-8CC9-F25C55B91261</domeo:belongsToSet>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812eda990003</pav:createdBy>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:lineageUri>urn:domeoserver:annotation:270C58C1-1821-41CC-A95B-3F4D2C0372FF</pav:lineageUri>
    <domeo:belongsToSet>urn:domeoserver:annotationset:7E80543E-BF76-4514-92A9-91458DCB802B</domeo:belongsToSet>
    <domeo:belongsToSet>urn:domeoserver:annotationset:606A5B3F-B6FB-4279-AA42-7893CFC2D20C</domeo:belongsToSet>
    <pav:lineageUri>urn:domeoserver:annotationset:AB1741F1-5A5F-4416-AEAC-A544BCBB7D16</pav:lineageUri>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:createdOn>2014-07-22 19:25:31 -0400</pav:createdOn>
    <pav:previousVersion>urn:domeoserver:annotationset:467D4F28-D086-4217-9DE0-23E165F30716</pav:previousVersion>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:1F1125BC-11EF-427A-9581-C05D50951446">
    <dikbD2R:statement>ncit:Qualitative</dikbD2R:statement>
    <dikbD2R:modality>ncit:positive</dikbD2R:modality>
    <rdf:type rdf:resource="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#DrugDrugInteractionStatement"/>
    <sio:SIO_000205>dikbD2R:statement</sio:SIO_000205>
    <sio:SIO_000628 rdf:resource="urn:pddi:uuid:4ABC712B-B1B6-46E9-80C3-428EA00FAEEF"/>
    <sio:SIO_000563>dikbD2R:modality</sio:SIO_000563>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:78B644A0-98B2-496A-9F5D-B3073007740E">
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:prefix>xsd:String</ao:prefix>
    <ao:suffix> Co-administration with aluminum hydroxide gel (1200 mg) may result in a decrease in propranolol concentrations</ao:suffix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <domeo:uuid>78B644A0-98B2-496A-9F5D-B3073007740E</domeo:uuid>
    <ao:exact>Co-administration of propranolol with cimetidine, a non-specific CYP450 inhibitor, increased propranolol AUC and Cmax by 46% and 35%, respectively.</ao:exact>
    <pav:createdOn>2014-07-24 19:46:23 -0400</pav:createdOn>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-129.txt.html</ao:hasSource>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:78B644A0-98B2-496A-9F5D-B3073007740E"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:6A4B6F3D-5923-4FB1-A369-D9FE1BF7FD5C">
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">2</pav:versionNumber>
    <pav:lineageUri>urn:domeoserver:annotation:BF0E28A6-4835-4EB5-B5C2-DDA4BC49144B</pav:lineageUri>
    <ao:context rdf:resource="urn:domeoclient:uuid:F941BEEC-394B-4F88-B13F-E8C0361B2C8D"/>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812eda990003</pav:createdBy>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:lastSavedOn>2014-07-24 20:10:49 -0400</pav:lastSavedOn>
    <pav:lineageUri>urn:domeoserver:annotationset:4A88D0A6-E9B6-4E7F-955F-3692600C178C</pav:lineageUri>
    <pav:createdOn>2014-07-24 20:08:12 -0400</pav:createdOn>
    <domeo:belongsToSet>urn:domeoserver:annotationset:37B2514D-1A92-45B1-8A5C-610DA6DC935A</domeo:belongsToSet>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <rdfs:label>Highlight</rdfs:label>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <domeo:belongsToSet>urn:domeoserver:annotationset:1FC172B8-8AC3-465A-AA69-B73AD9B97CBC</domeo:belongsToSet>
    <pav:previousVersion>urn:domeoclient:uuid:8D86A4AC-54BD-4BB3-8B58-AB55DEC01A88</pav:previousVersion>
    <pav:lastSavedOn>2014-07-24 20:10:48 -0400</pav:lastSavedOn>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:06416843-5F84-4886-A5D4-559FA1082541">
    <ao:suffix>xsd:String</ao:suffix>
    <ao:prefix>xsd:String</ao:prefix>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-123.txt.html</ao:hasSource>
    <ao:exact>Warfarin</ao:exact>
    <pav:createdOn>2014-07-22 19:55:21 -0400</pav:createdOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <domeo:uuid>06416843-5F84-4886-A5D4-559FA1082541</domeo:uuid>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:06416843-5F84-4886-A5D4-559FA1082541"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:7ACE5CBD-6F8F-4F53-8756-2657011A4A35">
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812eda990003</pav:createdBy>
    <ao:context rdf:resource="urn:domeoclient:uuid:60E67041-A9C9-414B-A575-799C5BAFAF37"/>
    <domeo:belongsToSet>urn:domeoclient:uuid:C4B80A95-F569-4ED4-84D1-6796B53A580C</domeo:belongsToSet>
    <pav:createdOn>2014-09-02 15:04:23 -0400</pav:createdOn>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <pav:lineageUri>urn:domeoserver:annotation:290AF144-A2E1-407F-983D-E11E6DCD09ED</pav:lineageUri>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:lastSavedOn>2014-09-02 15:04:32 -0400</pav:lastSavedOn>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <rdfs:label>Highlight</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:150123D0-F340-48A6-8FF1-AE43891B6007">
    <ao:prefix>xsd:String</ao:prefix>
    <ao:suffix> for injection per day will require a reduction in dose to approximately one-third to one-fourth of the usual dose of mercaptopurine or azathioprine. Subsequent adjustment of doses of mercaptopurine or azathioprine should be made on the basis of therapeu</ao:suffix>
    <ao:exact>allopurinol sodium</ao:exact>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-42.txt.html</ao:hasSource>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <domeo:uuid>150123D0-F340-48A6-8FF1-AE43891B6007</domeo:uuid>
    <pav:createdOn>2014-09-01 16:12:22 -0400</pav:createdOn>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:150123D0-F340-48A6-8FF1-AE43891B6007"/>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/FA86A8F3-C1E5-4301-8EE4-2F312AEF69D5">
    <sio:SIO_000228>dikbD2R:precipitant-drug-of-interaction</sio:SIO_000228>
    <rdfs:label>atazanavir</rdfs:label>
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/343047</dailymed:activeMoietyRxCUI>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/active-ingredient"/>
    <dct:description>Referred to the drug in the interaction.</dct:description>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:9B027AFC-3BAE-4FDC-889F-813F2AD35C5A">
    <sio:SIO_000205>dikbD2R:statement</sio:SIO_000205>
    <sio:SIO_000563>dikbD2R:modality</sio:SIO_000563>
    <dikbD2R:statement>ncit:quantitative</dikbD2R:statement>
    <rdf:type rdf:resource="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#DrugDrugInteractionStatement"/>
    <dikbD2R:modality>ncit:positive</dikbD2R:modality>
    <sio:SIO_000628 rdf:resource="urn:pddi:uuid:D318A30A-F708-43F6-AB5B-A9D659E063BF"/>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/3891574B-5AAE-4384-9ECD-390CFAD0C78D">
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/</dailymed:activeMoietyRxCUI>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/drug-product"/>
    <rdfs:label>Maalox®1</rdfs:label>
    <dct:description>Referred to the drug in the interaction.</dct:description>
    <sio:SIO_000228>dikbD2R:precipitant-drug-of-interaction</sio:SIO_000228>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:3E692274-1B14-40DE-8BD6-F464FE52CF01">
    <pav:createdOn>2014-07-22 20:22:47 -0400</pav:createdOn>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812eda990003</pav:createdBy>
    <ao:body rdf:nodeID="N5ce44c0b9d3247d28eb3cb9274509065"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#expertstudyAnnotation"/>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <ao:context rdf:resource="urn:domeoclient:uuid:6F5EB55C-E7E1-447C-B54E-5F02D52FA3AE"/>
    <pav:lineageUri>urn:domeoserver:annotation:92352C6B-D275-4DA3-A8EC-F2963768C84F</pav:lineageUri>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <rdfs:label>expertstudy Annotation</rdfs:label>
    <pav:lastSavedOn>2014-07-22 20:22:38 -0400</pav:lastSavedOn>
    <domeo:belongsToSet>urn:domeoserver:annotationset:F272A789-69D0-47CC-8CC9-F25C55B91261</domeo:belongsToSet>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:669918DD-5E01-4F63-9C3C-FB4172F004FB">
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:lineageUri>urn:domeoserver:annotation:24463F87-390E-4A86-AC9D-79822B2C93D8</pav:lineageUri>
    <pav:lastSavedOn>2014-07-22 19:54:59 -0400</pav:lastSavedOn>
    <domeo:belongsToSet>urn:domeoserver:annotationset:F272A789-69D0-47CC-8CC9-F25C55B91261</domeo:belongsToSet>
    <pav:lineageUri>urn:domeoserver:annotationset:AB1741F1-5A5F-4416-AEAC-A544BCBB7D16</pav:lineageUri>
    <domeo:belongsToSet>urn:domeoserver:annotationset:2914A3FD-DF43-4F78-999C-77CE7A028B19</domeo:belongsToSet>
    <rdfs:label>Highlight</rdfs:label>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812eda990003</pav:createdBy>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:createdOn>2014-07-22 19:48:57 -0400</pav:createdOn>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <pav:previousVersion>urn:domeoserver:annotationset:606A5B3F-B6FB-4279-AA42-7893CFC2D20C</pav:previousVersion>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">7</pav:versionNumber>
    <ao:context rdf:resource="urn:domeoclient:uuid:0323018B-085E-4636-9195-1B6FDC9A582D"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:55590627-6DCB-46F4-B196-1032E6ECA077">
    <ao:prefix>. These data indicate that </ao:prefix>
    <domeo:uuid>55590627-6DCB-46F4-B196-1032E6ECA077</domeo:uuid>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:exact>sertraline’s </ao:exact>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:55590627-6DCB-46F4-B196-1032E6ECA077"/>
    <ao:suffix>extent of inhibition of P450 3A4 activity is not likely to be of clinical significance. Results of the interaction study with cisapride indicate that sertraline 200 mg (q.d.) induces the metabolism of cisapride (cisapride AUC and Cmax were reduced by abo</ao:suffix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <pav:createdOn>2014-09-01 16:06:05 -0400</pav:createdOn>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-16.txt.html</ao:hasSource>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:CC6345F2-574E-4300-B936-8ED1CC3E2DBC">
    <ao:prefix> (4 mg once daily) alone. Given the potential for dose-related adverse events with rosiglitazone, a decrease in the dose of rosiglitazone may be needed when </ao:prefix>
    <pav:createdOn>2014-07-22 19:42:13 -0400</pav:createdOn>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-123.txt.html</ao:hasSource>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:exact>gemfibrozil</ao:exact>
    <ao:suffix> is introduced [see Drug Interactions (7.1)].</ao:suffix>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:CC6345F2-574E-4300-B936-8ED1CC3E2DBC"/>
    <domeo:uuid>CC6345F2-574E-4300-B936-8ED1CC3E2DBC</domeo:uuid>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:0605CFD4-BB68-443D-9ABF-C97A7A0563B0">
    <sio:SIO_000628 rdf:resource="urn:pddi:uuid:E5FE9EFB-83B0-4935-97F9-6C46842B3260"/>
    <dikbD2R:modality>ncit:positive</dikbD2R:modality>
    <rdf:type rdf:resource="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#DrugDrugInteractionStatement"/>
    <sio:SIO_000205>dikbD2R:statement</sio:SIO_000205>
    <sio:SIO_000563>dikbD2R:modality</sio:SIO_000563>
    <dikbD2R:statement>ncit:quantitative</dikbD2R:statement>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:35B0C843-6298-4494-92B8-CA2A60C766FB">
    <pav:createdOn>2014-09-02 19:09:38 -0400</pav:createdOn>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812eda990003</pav:createdBy>
    <domeo:belongsToSet>urn:domeoclient:uuid:3966BCFB-CA02-4053-828D-3860558E7BE8</domeo:belongsToSet>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <rdfs:label>Highlight</rdfs:label>
    <pav:lineageUri>urn:domeoserver:annotation:FED7A6FE-8A79-472C-8B1D-4F49432D005D</pav:lineageUri>
    <pav:lastSavedOn>2014-09-02 19:11:13 -0400</pav:lastSavedOn>
    <ao:context rdf:resource="urn:domeoclient:uuid:1EB12059-BBA2-4D0D-8E36-2569CD51DC88"/>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:2EC3D9EC-E1A7-4DD1-A006-50B08564335E">
    <pav:lineageUri>urn:domeoserver:annotation:01F5BBDB-E20A-4996-9E0A-81199182C6B7</pav:lineageUri>
    <domeo:belongsToSet>urn:domeoclient:uuid:23567EF7-7482-444A-B1F6-5AAA9D43E54A</domeo:belongsToSet>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <ao:context rdf:resource="urn:domeoclient:uuid:E17F3ACA-8486-4702-886B-6FA2562FDEFF"/>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812eda990003</pav:createdBy>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <pav:lastSavedOn>2014-07-13 12:45:54 -0400</pav:lastSavedOn>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <rdfs:label>Highlight</rdfs:label>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:createdOn>2014-07-13 12:44:35 -0400</pav:createdOn>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:1380C3AE-72EA-44B5-B7B6-5D990055E8E2">
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/BB10D5C0-6D53-40A0-8A2D-D31E8D5FA6E1"/>
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/BD00EF21-094C-47ED-9DFE-B32774923CD1"/>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/PK_DDI"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:8EA1563F-47E7-4983-918E-643A5D2021DC">
    <ao:exact>REVATIO </ao:exact>
    <ao:suffix>on Vision</ao:suffix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-155.txt.html</ao:hasSource>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <pav:createdOn>2014-07-07 09:40:48 -0400</pav:createdOn>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:8EA1563F-47E7-4983-918E-643A5D2021DC"/>
    <domeo:uuid></domeo:uuid>
    <ao:prefix>Effects of </ao:prefix>
    <domeo:uuid>8EA1563F-47E7-4983-918E-643A5D2021DC</domeo:uuid>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/903A96DD-5D24-4703-BA4D-F99711E452A7">
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/active-ingredient"/>
    <rdfs:label>metformin</rdfs:label>
    <dct:description>Referred to the drug in the interaction.</dct:description>
    <sio:SIO_000228>dikbD2R:object-drug-of-interaction</sio:SIO_000228>
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/6809</dailymed:activeMoietyRxCUI>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:30818391-5098-4A86-BF01-5AB0C0597335">
    <ao:prefix> displaces each other from plasma binding sites. High therapeutic concentrations of </ao:prefix>
    <domeo:uuid>30818391-5098-4A86-BF01-5AB0C0597335</domeo:uuid>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-8.txt.html</ao:hasSource>
    <ao:exact>s</ao:exact>
    <ao:suffix>xsd:String</ao:suffix>
    <pav:createdOn>2014-07-13 11:11:27 -0400</pav:createdOn>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:30818391-5098-4A86-BF01-5AB0C0597335"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:ACDCB5F4-8A15-444E-AB50-018A46C6500F">
    <ao:suffix>, and iron salts). In the clinical trials, antacids were used concomitantly with the administration of omeprazole delayed-release capsules USP.</ao:suffix>
    <domeo:uuid>ACDCB5F4-8A15-444E-AB50-018A46C6500F</domeo:uuid>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:ACDCB5F4-8A15-444E-AB50-018A46C6500F"/>
    <ao:prefix>xsd:String</ao:prefix>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-74.txt.html</ao:hasSource>
    <ao:exact>esters</ao:exact>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <pav:createdOn>2014-09-02 19:12:11 -0400</pav:createdOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:92AF00E3-613A-4E27-ACAC-A744AA15CCB8">
    <ao:prefix>Two randomized, open-label, controlled clinical trials of </ao:prefix>
    <pav:createdOn>2014-07-22 18:51:22 -0400</pav:createdOn>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:92AF00E3-613A-4E27-ACAC-A744AA15CCB8"/>
    <domeo:uuid>92AF00E3-613A-4E27-ACAC-A744AA15CCB8</domeo:uuid>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:exact>Synercid</ao:exact>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-119.txt.html</ao:hasSource>
    <ao:suffix> (7.5 mg/kg q12h intravenously [iv]) in the treatment of complicated skin and skin structure infections were performed. The comparator drug was oxacillin (2g q6h iv) in the first study (JRV 304) and cefazolin (1g q8h iv) in the second study (JRV 305); ho</ao:suffix>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:5CFC30D6-1C24-402D-845E-93F7BF5F0922">
    <pav:lastSavedOn>2014-09-02 12:03:47 -0400</pav:lastSavedOn>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <domeo:belongsToSet>urn:domeoserver:annotationset:D52DFD7B-BDDF-488F-B339-B1BC641E50E9</domeo:belongsToSet>
    <domeo:belongsToSet>urn:domeoclient:uuid:379CD8C1-F4B4-42B7-8F87-70776866DB1F</domeo:belongsToSet>
    <pav:createdOn>2014-09-02 12:02:37 -0400</pav:createdOn>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:lineageUri>urn:domeoserver:annotationset:166C20E9-1B4C-47D1-982D-922E2E5ACFF2</pav:lineageUri>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <ao:context rdf:resource="urn:domeoclient:uuid:BFB51383-F8CA-4B7D-AF51-8BC2302A8276"/>
    <pav:lineageUri>urn:domeoserver:annotation:55AB2674-BD5D-469D-9D21-DFA57BF50CC3</pav:lineageUri>
    <rdfs:label>Highlight</rdfs:label>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812eda990003</pav:createdBy>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:35CE9A7F-F23D-4EBE-B09F-02A153717FBA">
    <ao:prefix>. Thus, </ao:prefix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <pav:createdOn>2014-07-13 11:10:38 -0400</pav:createdOn>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:35CE9A7F-F23D-4EBE-B09F-02A153717FBA"/>
    <ao:suffix> can be given with or without meals.</ao:suffix>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-8.txt.html</ao:hasSource>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <domeo:uuid>35CE9A7F-F23D-4EBE-B09F-02A153717FBA</domeo:uuid>
    <ao:exact>risperidone</ao:exact>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:364EB4BF-76FF-46DE-8F92-5E5F5D0222E7">
    <rdfs:label>Highlight</rdfs:label>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <ao:context rdf:resource="urn:domeoclient:uuid:D96F23AA-C203-4EA6-BA78-F8249D904C85"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <domeo:belongsToSet>urn:domeoclient:uuid:4FC315CC-8F6D-4166-AEB6-FBF9CF2FA510</domeo:belongsToSet>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812eda990003</pav:createdBy>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <pav:lineageUri>urn:domeoserver:annotation:1DEA14EB-D88E-4D43-BAE8-FC44C4169F4A</pav:lineageUri>
    <pav:lastSavedOn>2014-07-28 17:00:29 -0400</pav:lastSavedOn>
    <pav:createdOn>2014-07-28 17:00:48 -0400</pav:createdOn>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:6BF180C6-926E-4F67-84B0-1DC9E664C663">
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <pav:lineageUri>urn:domeoserver:annotation:B86B4616-9A36-459A-BD9A-3E75A70DBB8E</pav:lineageUri>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <rdfs:label>Highlight</rdfs:label>
    <pav:createdOn>2014-07-13 12:38:39 -0400</pav:createdOn>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <domeo:belongsToSet>urn:domeoclient:uuid:4F872953-6D19-4809-9285-FCCF2FF54315</domeo:belongsToSet>
    <pav:lastSavedOn>2014-07-13 12:41:10 -0400</pav:lastSavedOn>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812eda990003</pav:createdBy>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <ao:context rdf:resource="urn:domeoclient:uuid:E2C79BAB-965C-479E-824A-F2884B348419"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:125C14DB-1F35-4667-846F-F789D6D0AFCF">
    <sio:SIO_000628 rdf:resource="urn:pddi:uuid:E72D7D03-AAE5-42A5-A83A-3C68C2C2BCB6"/>
    <dikbD2R:modality>ncit:positive</dikbD2R:modality>
    <sio:SIO_000205>dikbD2R:statement</sio:SIO_000205>
    <rdf:type rdf:resource="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#DrugDrugInteractionStatement"/>
    <sio:SIO_000563>dikbD2R:modality</sio:SIO_000563>
    <dikbD2R:statement>ncit:Qualitative</dikbD2R:statement>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:BAF53035-A41C-4F81-96B6-41B0D9633025">
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <domeo:uuid>BAF53035-A41C-4F81-96B6-41B0D9633025</domeo:uuid>
    <ao:suffix>xsd:String</ao:suffix>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:BAF53035-A41C-4F81-96B6-41B0D9633025"/>
    <ao:exact>Propranolol can inhibit the metabolism of diazepam, resulting in increased concentrations of diazepam and its metabolites. Diazepam does not alter the pharmacokinetics of propranolol</ao:exact>
    <pav:createdOn>2014-07-24 19:45:14 -0400</pav:createdOn>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-128.txt.html</ao:hasSource>
    <ao:prefix>xsd:String</ao:prefix>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:46780EA4-462F-4B55-AB22-23CB7FC82C80">
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:exact>risperidone</ao:exact>
    <ao:suffix> tablets.</ao:suffix>
    <pav:createdOn>2014-07-13 11:09:25 -0400</pav:createdOn>
    <domeo:uuid>46780EA4-462F-4B55-AB22-23CB7FC82C80</domeo:uuid>
    <ao:prefix> oral solution is bioequivalent to </ao:prefix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:46780EA4-462F-4B55-AB22-23CB7FC82C80"/>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-8.txt.html</ao:hasSource>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:0CE6C620-40B4-4E55-8185-8A319ECD6D71">
    <dikbD2R:statement>ncit:quantitative</dikbD2R:statement>
    <rdf:type rdf:resource="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#DrugDrugInteractionStatement"/>
    <sio:SIO_000563>dikbD2R:modality</sio:SIO_000563>
    <sio:SIO_000205>dikbD2R:statement</sio:SIO_000205>
    <sio:SIO_000628 rdf:resource="urn:pddi:uuid:553A6608-733A-477E-BDCB-F0D16F1054E3"/>
    <dikbD2R:modality>ncit:positive</dikbD2R:modality>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:3AA77CCF-FE2A-48F6-9346-1114AFD695DA">
    <pav:createdOn>2014-07-21 21:34:02 -0400</pav:createdOn>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-28.txt.html</ao:hasSource>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:3AA77CCF-FE2A-48F6-9346-1114AFD695DA"/>
    <ao:prefix>clearance decreased 16% ± 11 % (range: -32 to 5%). The half-life of </ao:prefix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:suffix>increased from 6.6 ± 1.7 hours to 7.9 ± 1.5 hours. (See PRECAUTIONS.)</ao:suffix>
    <domeo:uuid>3AA77CCF-FE2A-48F6-9346-1114AFD695DA</domeo:uuid>
    <ao:exact>theophylline </ao:exact>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:5B60DE0C-DAD3-497E-B767-27CC4F4AA306">
    <ao:suffix> 20 mg daily was given in combination with 20 mg atomoxetine every 12 hours. This resulted in increases in steady state atomoxetine AUC values that were 6- to 8-fold greater and in atomoxetine Cmax values that were 3- to 4-fold greater than when atomoxet</ao:suffix>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-47.txt.html</ao:hasSource>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <pav:createdOn>2014-09-02 11:58:26 -0400</pav:createdOn>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:5B60DE0C-DAD3-497E-B767-27CC4F4AA306"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:prefix> has been evaluated when both drugs were at steady state. In healthy volunteers who were extensive metabolizers of CYP2D6, </ao:prefix>
    <ao:exact>paroxetine</ao:exact>
    <domeo:uuid>5B60DE0C-DAD3-497E-B767-27CC4F4AA306</domeo:uuid>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:C72F4C30-BFCD-4714-88DE-DBF33CE067AD">
    <pav:createdOn>2014-09-02 11:38:17 -0400</pav:createdOn>
    <domeo:uuid>C72F4C30-BFCD-4714-88DE-DBF33CE067AD</domeo:uuid>
    <ao:prefix> (4 mg single dose) indicated no significant pharmacokinetic interaction. On average, both</ao:prefix>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-9.txt.html</ao:hasSource>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:suffix> alone and lorazepam with fluvoxamine produced substantial decrements in cognitive functioning; however, the coadministration of fluvoxamine and lorazepam did not produce larger mean decrements compared to lorazepam alone.</ao:suffix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:exact> lorazepam</ao:exact>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:C72F4C30-BFCD-4714-88DE-DBF33CE067AD"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:9C4009FB-5A17-4B3C-B5E0-D9CC8275A5D7">
    <ao:context rdf:resource="urn:domeoclient:uuid:FF9C19C8-A145-4276-833C-C3641196A24F"/>
    <pav:createdOn>2014-07-21 21:35:21 -0400</pav:createdOn>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <pav:lastSavedOn>2014-07-21 21:35:10 -0400</pav:lastSavedOn>
    <domeo:belongsToSet>urn:domeoclient:uuid:B61F1A9B-4696-4ED0-80AA-4FE2E9016966</domeo:belongsToSet>
    <pav:lineageUri>urn:domeoserver:annotation:2849471A-11C0-4F9B-B7D7-4D948F848B33</pav:lineageUri>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812eda990003</pav:createdBy>
    <ao:body rdf:nodeID="Nc4eb2a673aa04d6a8dd11f1386c5f0c0"/>
    <rdfs:label>expertstudy Annotation</rdfs:label>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#expertstudyAnnotation"/>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:36129C88-CE12-4AF2-ABDA-B2DC6006FD29">
    <ao:suffix> and 9-hydroxyrisperidone [see 7 DRUG INTERACTIONS]. It would also be possible for risperidone to interfere with metabolism of other drugs metabolized by CYP 2D6. Relatively weak binding of risperidone to the enzyme suggests this is unlikely [see 7 DRUG </ao:suffix>
    <pav:createdOn>2014-07-13 11:16:01 -0400</pav:createdOn>
    <ao:exact>risperidone</ao:exact>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-8.txt.html</ao:hasSource>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:36129C88-CE12-4AF2-ABDA-B2DC6006FD29"/>
    <ao:prefix> may cause a decrease in the combined plasma concentrations of </ao:prefix>
    <domeo:uuid>36129C88-CE12-4AF2-ABDA-B2DC6006FD29</domeo:uuid>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/DBA1F413-B42A-40DE-B1F5-8527CD8BE365">
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/0</dailymed:activeMoietyRxCUI>
    <rdfs:label>norverapamil</rdfs:label>
    <sio:SIO_000228>dikbD2R:precipitant-drug-of-interaction</sio:SIO_000228>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/drug-product"/>
    <dct:description>Referred to the drug in the interaction.</dct:description>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:4AF93FFE-AF2A-4091-98AF-CE5D00B15BB0">
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:4AF93FFE-AF2A-4091-98AF-CE5D00B15BB0"/>
    <domeo:uuid>4AF93FFE-AF2A-4091-98AF-CE5D00B15BB0</domeo:uuid>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:exact>triazolam</ao:exact>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-48.txt.html</ao:hasSource>
    <pav:createdOn>2014-09-02 15:04:25 -0400</pav:createdOn>
    <ao:suffix>, and cyclosporine. Based on the assumption that the relationship between paroxetine’s in vitro Ki and its lack of effect on terfenadine's in vivo clearance predicts its effect on other CYP3A4 substrates, paroxetine’s extent of inhibition of CYP3A4 activ</ao:suffix>
    <ao:prefix>, </ao:prefix>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:70B9E8E9-06ED-4420-9CDE-4E0F36F57CC9">
    <ao:suffix> combined, after single and multiple doses, were similar in extensive and poor metabolizers, with an overall mean elimination half-life of about 20 hours.</ao:suffix>
    <ao:exact>9-hydroxyrisperidone</ao:exact>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <domeo:uuid>70B9E8E9-06ED-4420-9CDE-4E0F36F57CC9</domeo:uuid>
    <ao:prefix> and </ao:prefix>
    <pav:createdOn>2014-07-13 11:17:15 -0400</pav:createdOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:70B9E8E9-06ED-4420-9CDE-4E0F36F57CC9"/>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-8.txt.html</ao:hasSource>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/2B0C5D0C-3721-4FB9-8865-41008B332960">
    <dct:description>Referred to the drug in the interaction.</dct:description>
    <rdfs:label>ketoconazole</rdfs:label>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/active-ingredient"/>
    <sio:SIO_000228>dikbD2R:precipitant-drug-of-interaction</sio:SIO_000228>
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/6135</dailymed:activeMoietyRxCUI>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:5FD113AB-8FB6-4F29-B1BE-0A776992E0B0">
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-155.txt.html</ao:hasSource>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <domeo:uuid>5FD113AB-8FB6-4F29-B1BE-0A776992E0B0</domeo:uuid>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:prefix>xsd:String</ao:prefix>
    <pav:createdOn>2014-07-07 09:39:42 -0400</pav:createdOn>
    <ao:exact>TID sildenafil</ao:exact>
    <ao:suffix>xsd:String</ao:suffix>
    <domeo:uuid></domeo:uuid>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:5FD113AB-8FB6-4F29-B1BE-0A776992E0B0"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:A533EC0D-DA36-41E1-8BF3-3650517EB300">
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:lineageUri>urn:domeoserver:annotation:0D02D3C9-3B10-4061-87CA-3B4D5940C940</pav:lineageUri>
    <ao:context rdf:resource="urn:domeoclient:uuid:4A9B35D2-1697-453D-A110-43EEC635AE7B"/>
    <pav:createdOn>2014-07-24 20:13:00 -0400</pav:createdOn>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812eda990003</pav:createdBy>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <domeo:belongsToSet>urn:domeoserver:annotationset:1FC172B8-8AC3-465A-AA69-B73AD9B97CBC</domeo:belongsToSet>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <rdfs:label>Highlight</rdfs:label>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:lastSavedOn>2014-07-24 20:12:49 -0400</pav:lastSavedOn>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:07FAC59A-4DB3-40BE-8ADC-7231ECC711EF">
    <pav:createdOn>2014-09-02 11:30:33 -0400</pav:createdOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:suffix>, propranolol, tizanidine), CYP2C9 (e.g., warfarin), CYP3A4 (e.g., alprazolam), and CYP2C19 (e.g., omeprazole).</ao:suffix>
    <domeo:uuid>07FAC59A-4DB3-40BE-8ADC-7231ECC711EF</domeo:uuid>
    <ao:prefix>,</ao:prefix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:07FAC59A-4DB3-40BE-8ADC-7231ECC711EF"/>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-9.txt.html</ao:hasSource>
    <ao:exact> theophylline</ao:exact>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:16E9C8A9-8DAA-4EB9-8859-7C353FD7C273">
    <domeo:uuid>16E9C8A9-8DAA-4EB9-8859-7C353FD7C273</domeo:uuid>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:suffix> </ao:suffix>
    <pav:createdOn>2014-07-21 21:53:44 -0400</pav:createdOn>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-56.txt.html</ao:hasSource>
    <ao:exact>Zonisamide</ao:exact>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:16E9C8A9-8DAA-4EB9-8859-7C353FD7C273"/>
    <ao:prefix>xsd:String</ao:prefix>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:B4ADFA01-70C2-42CC-87CC-869B81E3104E">
    <pav:lineageUri>urn:domeoserver:annotation:56FD27A9-9A20-480B-9750-E65B79E50EDB</pav:lineageUri>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <rdfs:label>Highlight</rdfs:label>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812eda990003</pav:createdBy>
    <domeo:belongsToSet>urn:domeoclient:uuid:EC9B90D7-F9B5-4E51-94E2-878FAA06F611</domeo:belongsToSet>
    <pav:createdOn>2014-07-13 12:46:24 -0400</pav:createdOn>
    <ao:context rdf:resource="urn:domeoclient:uuid:6A0AE7AB-260B-4296-BC83-DB443FEE5161"/>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:lastSavedOn>2014-07-13 12:48:45 -0400</pav:lastSavedOn>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:E766D1AC-45BC-4579-89AD-BE0DEC69FC35">
    <ao:suffix>-</ao:suffix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <domeo:uuid>E766D1AC-45BC-4579-89AD-BE0DEC69FC35</domeo:uuid>
    <pav:createdOn>2014-07-07 09:42:25 -0400</pav:createdOn>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-155.txt.html</ao:hasSource>
    <ao:prefix>and its major circulating </ao:prefix>
    <ao:exact>N</ao:exact>
    <domeo:uuid></domeo:uuid>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:E766D1AC-45BC-4579-89AD-BE0DEC69FC35"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:06311B02-CE01-4B2E-9D8E-7EAC3FBB8602">
    <ao:prefix> (2 × 60 mg capsule) within 15 minutes of an </ao:prefix>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-139.txt.html</ao:hasSource>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <domeo:uuid>06311B02-CE01-4B2E-9D8E-7EAC3FBB8602</domeo:uuid>
    <ao:exact>aluminum</ao:exact>
    <ao:suffix> and magnesium containing antacid (Maalox®1) decreased fexofenadine AUC by 41% and Cmax by 43%.</ao:suffix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <pav:createdOn>2014-07-24 20:05:48 -0400</pav:createdOn>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:06311B02-CE01-4B2E-9D8E-7EAC3FBB8602"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:AB3EAD78-45A5-439B-B26A-FE0BB9EDCBD0">
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <pav:createdOn>2014-07-13 12:56:13 -0400</pav:createdOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <domeo:uuid>AB3EAD78-45A5-439B-B26A-FE0BB9EDCBD0</domeo:uuid>
    <ao:suffix> half-life decreased from 33.4 ± 4.4 hours to 26.8 ± 3.9 hours. (See PRECAUTIONS.)</ao:suffix>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:AB3EAD78-45A5-439B-B26A-FE0BB9EDCBD0"/>
    <ao:prefix> increased 32% ± 17% (range: 16 to 72%). </ao:prefix>
    <ao:exact>Fluconazole</ao:exact>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-24.txt.html</ao:hasSource>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:3B332456-24D5-452E-8A10-14D40375ED79">
    <rdfs:label>Highlight</rdfs:label>
    <pav:createdOn>2014-09-01 16:11:59 -0400</pav:createdOn>
    <pav:lastSavedOn>2014-09-01 16:12:36 -0400</pav:lastSavedOn>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <domeo:belongsToSet>urn:domeoclient:uuid:5D381360-05CD-407C-BAB9-6496A42C73E4</domeo:belongsToSet>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <ao:context rdf:resource="urn:domeoclient:uuid:5A04C3C3-B677-4732-87D0-83C03497D24C"/>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812eda990003</pav:createdBy>
    <pav:lineageUri>urn:domeoserver:annotation:5FD35D8D-0021-4DC8-9F96-6883D484A470</pav:lineageUri>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:2EB7D7E2-B15C-4936-A208-A041FD22D74F">
    <pav:createdOn>2014-07-21 21:31:24 -0400</pav:createdOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:prefix>. The mean ± SD increase in AUC was 20% ± 32% (range: -27 to 104%). The metabolite, GZDV, to parent drug ratio significantly decreased after the administration of </ao:prefix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:2EB7D7E2-B15C-4936-A208-A041FD22D74F"/>
    <ao:exact>fluconazole</ao:exact>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-27.txt.html</ao:hasSource>
    <ao:suffix>, from 7.6 ± 3.6 to 5.7 ± 2.2.</ao:suffix>
    <domeo:uuid>2EB7D7E2-B15C-4936-A208-A041FD22D74F</domeo:uuid>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:F9B083BB-350D-424C-ABD3-5F63B771A9A9">
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:createdOn>2014-07-28 17:00:46 -0400</pav:createdOn>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812eda990003</pav:createdBy>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:lineageUri>urn:domeoserver:annotation:3571BBB6-88DC-455D-8449-2369BE0EA051</pav:lineageUri>
    <rdfs:label>Highlight</rdfs:label>
    <domeo:belongsToSet>urn:domeoclient:uuid:4FC315CC-8F6D-4166-AEB6-FBF9CF2FA510</domeo:belongsToSet>
    <ao:context rdf:resource="urn:domeoclient:uuid:AE31FB45-DE35-4E4D-B623-72AA865505E0"/>
    <pav:lastSavedOn>2014-07-28 17:00:29 -0400</pav:lastSavedOn>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:CAB91F57-2F70-4DDB-9BF8-A50167C8BBCE">
    <domeo:uuid>CAB91F57-2F70-4DDB-9BF8-A50167C8BBCE</domeo:uuid>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-21.txt.html</ao:hasSource>
    <ao:prefix>xsd:String</ao:prefix>
    <pav:createdOn>2014-07-13 12:40:40 -0400</pav:createdOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:exact>In this placebo-controlled, double-blind, randomized, two-way crossover study carried out over three cycles of oral contraceptive treatment, fluconazole dosing resulted in small increases in the mean AUCs of ethinyl estradiol and norethindrone compared to similar placebo dosing. The mean AUCs of ethinyl estradiol and norethindrone increased by 24% (95% C.I. range 18 to 31%) and 13% (95% C.I. range 8 to 18%), respectively relative to placebo.</ao:exact>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:CAB91F57-2F70-4DDB-9BF8-A50167C8BBCE"/>
    <ao:suffix>xsd:String</ao:suffix>
  </rdf:Description>
  <rdf:Description rdf:nodeID="Na31b253049884fadb73cd8664c9880cc">
    <permissions:accessType>urn:domeo:access:public</permissions:accessType>
    <permissions:isLocked>false</permissions:isLocked>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/EF2D99E6-548C-4F7E-82EC-A1FF35F17CB0">
    <dct:description>Referred to the drug in the interaction.</dct:description>
    <rdfs:label>procyclidine</rdfs:label>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/active-ingredient"/>
    <sio:SIO_000228>dikbD2R:object-drug-of-interaction</sio:SIO_000228>
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/</dailymed:activeMoietyRxCUI>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/7194CD60-DB00-4648-AB1D-C4A22CFC0FBE">
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/active-ingredient"/>
    <dct:description>Referred to the drug in the interaction.</dct:description>
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/4719</dailymed:activeMoietyRxCUI>
    <rdfs:label>gemfibrozil</rdfs:label>
    <sio:SIO_000228>dikbD2R:precipitant-drug-of-interaction</sio:SIO_000228>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:BB9A9C70-7859-46AE-887F-B9F2CBDE39DB">
    <pav:createdOn>2014-09-02 19:11:00 -0400</pav:createdOn>
    <ao:prefix>and </ao:prefix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:suffix>oxidase inhibitors has been observed, but caution in the use of any opioid in patients taking this class of drugs is appropriate.</ao:suffix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:BB9A9C70-7859-46AE-887F-B9F2CBDE39DB"/>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-72.txt.html</ao:hasSource>
    <ao:exact>monoamine </ao:exact>
    <domeo:uuid>BB9A9C70-7859-46AE-887F-B9F2CBDE39DB</domeo:uuid>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:50CB810E-E5CE-4D21-8703-B10F04053C7D">
    <rdfs:label>Highlight</rdfs:label>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:lineageUri>urn:domeoserver:annotation:D177BA51-294C-4325-9184-EB6F0577CAE8</pav:lineageUri>
    <domeo:belongsToSet>urn:domeoclient:uuid:CB83FFC2-EA71-44EA-8F11-DE80E389C84E</domeo:belongsToSet>
    <ao:context rdf:resource="urn:domeoclient:uuid:19AF6A28-5E1F-4E38-963D-A9F4633CDDE9"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <domeo:belongsToSet>urn:domeoserver:annotationset:392EE0FB-AC4F-4AF2-87A6-2E50A281F434</domeo:belongsToSet>
    <pav:lastSavedOn>2014-09-02 19:19:47 -0400</pav:lastSavedOn>
    <pav:lineageUri>urn:domeoserver:annotationset:C5DEBC9B-77EE-4243-88EB-DBC19737ACD2</pav:lineageUri>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <domeo:belongsToSet>urn:domeoserver:annotationset:E32812A9-205B-4EE1-B488-A1E294EDBFB9</domeo:belongsToSet>
    <pav:createdOn>2014-09-02 19:19:04 -0400</pav:createdOn>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812eda990003</pav:createdBy>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:67B51F20-AA33-44F4-AC6E-1115C0BA7889">
    <ao:exact>trazodone</ao:exact>
    <ao:prefix> hydrochloride tablets should be taken shortly after a meal or light snack. Symptomatic relief may be seen during the first week, with optimal antidepressant effects typically evident within two weeks. Twenty-five percent of those who respond to </ao:prefix>
    <ao:suffix> require more than two weeks (up to four weeks) of drug administration.</ao:suffix>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-138.txt.html</ao:hasSource>
    <domeo:uuid>67B51F20-AA33-44F4-AC6E-1115C0BA7889</domeo:uuid>
    <pav:createdOn>2014-07-24 20:05:09 -0400</pav:createdOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:67B51F20-AA33-44F4-AC6E-1115C0BA7889"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:53C71D4E-A625-4012-ABC4-932105C30699">
    <rdfs:label>Highlight</rdfs:label>
    <domeo:belongsToSet>urn:domeoserver:annotationset:A5DD001D-C81A-4E2E-B5E0-7A866B35E26B</domeo:belongsToSet>
    <pav:lineageUri>urn:domeoserver:annotationset:D1715BD2-BD41-46FD-9454-DC7A423A29AC</pav:lineageUri>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:lastSavedOn>2014-09-02 11:46:58 -0400</pav:lastSavedOn>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <domeo:belongsToSet>urn:domeoserver:annotationset:3F546823-204F-4F9B-9006-3DC526C56931</domeo:belongsToSet>
    <domeo:belongsToSet>urn:domeoserver:annotationset:A3F0B39A-4249-4B63-BB0D-F24A005066AC</domeo:belongsToSet>
    <pav:createdOn>2014-09-02 11:38:27 -0400</pav:createdOn>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">2</pav:versionNumber>
    <ao:context rdf:resource="urn:domeoclient:uuid:9E6E80C9-FE56-4016-839A-ADB4FEFC8C55"/>
    <pav:lineageUri>urn:domeoserver:annotation:4AB2AE3D-EC25-488E-9C10-959BB4B1BD08</pav:lineageUri>
    <pav:previousVersion>urn:domeoclient:uuid:BED41F06-565A-4622-9A88-48810E5A28DE</pav:previousVersion>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812eda990003</pav:createdBy>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:E7176E11-44D4-4336-A0B0-21D16F8910C5">
    <ao:suffix> metabolite (mesoridazine) concentrations ranging from 33% to 209%.</ao:suffix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-133.txt.html</ao:hasSource>
    <pav:createdOn>2014-07-24 19:54:46 -0400</pav:createdOn>
    <ao:exact>thioridazine</ao:exact>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:E7176E11-44D4-4336-A0B0-21D16F8910C5"/>
    <domeo:uuid>E7176E11-44D4-4336-A0B0-21D16F8910C5</domeo:uuid>
    <ao:prefix> at doses greater than or equal to 160 mg/day resulted in increased thioridazine plasma concentrations ranging from 55% to 369% and increased </ao:prefix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:CA230F0A-406C-43AE-88DE-A7FD67CF4D61">
    <pav:lineageUri>urn:domeoserver:annotation:814003AB-50EC-489D-967C-53D890293957</pav:lineageUri>
    <pav:createdOn>2014-07-13 11:12:34 -0400</pav:createdOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812eda990003</pav:createdBy>
    <rdfs:label>Highlight</rdfs:label>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <ao:context rdf:resource="urn:domeoclient:uuid:EEA0DB9F-24A6-4283-B426-FDECA24BE603"/>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <pav:lastSavedOn>2014-07-13 11:32:29 -0400</pav:lastSavedOn>
    <domeo:belongsToSet>urn:domeoclient:uuid:71191E51-53CB-4FDE-88D0-33C6818E2232</domeo:belongsToSet>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:236BB8FF-931E-44E4-8D12-9F1FB83D8082">
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">2</pav:versionNumber>
    <domeo:belongsToSet>urn:domeoserver:annotationset:37B2514D-1A92-45B1-8A5C-610DA6DC935A</domeo:belongsToSet>
    <pav:createdOn>2014-07-24 20:08:15 -0400</pav:createdOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <rdfs:label>Highlight</rdfs:label>
    <domeo:belongsToSet>urn:domeoserver:annotationset:1FC172B8-8AC3-465A-AA69-B73AD9B97CBC</domeo:belongsToSet>
    <pav:previousVersion>urn:domeoclient:uuid:8D86A4AC-54BD-4BB3-8B58-AB55DEC01A88</pav:previousVersion>
    <pav:lineageUri>urn:domeoserver:annotation:A3E072F1-176B-4B1A-A6D6-0EC42D5BAB22</pav:lineageUri>
    <pav:lineageUri>urn:domeoserver:annotationset:4A88D0A6-E9B6-4E7F-955F-3692600C178C</pav:lineageUri>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:lastSavedOn>2014-07-24 20:10:48 -0400</pav:lastSavedOn>
    <ao:context rdf:resource="urn:domeoclient:uuid:49838230-189C-4414-9619-31B8A0459B9E"/>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812eda990003</pav:createdBy>
    <pav:lastSavedOn>2014-07-24 20:10:49 -0400</pav:lastSavedOn>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:A75B59C8-60A9-4317-B506-9477A97901ED">
    <domeo:belongsToSet>urn:domeoserver:annotationset:606A5B3F-B6FB-4279-AA42-7893CFC2D20C</domeo:belongsToSet>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812eda990003</pav:createdBy>
    <pav:previousVersion>urn:domeoserver:annotationset:514BA51B-D734-4003-A7C3-F03C0F95833A</pav:previousVersion>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">6</pav:versionNumber>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:lineageUri>urn:domeoserver:annotationset:AB1741F1-5A5F-4416-AEAC-A544BCBB7D16</pav:lineageUri>
    <domeo:belongsToSet>urn:domeoserver:annotationset:F272A789-69D0-47CC-8CC9-F25C55B91261</domeo:belongsToSet>
    <pav:lastSavedOn>2014-07-22 19:44:46 -0400</pav:lastSavedOn>
    <pav:lineageUri>urn:domeoserver:annotation:9CD69FA7-1C01-40C5-A3FD-9FA5A3D368B1</pav:lineageUri>
    <domeo:belongsToSet>urn:domeoserver:annotationset:2914A3FD-DF43-4F78-999C-77CE7A028B19</domeo:belongsToSet>
    <rdfs:label>Highlight</rdfs:label>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:createdOn>2014-07-22 19:42:13 -0400</pav:createdOn>
    <ao:context rdf:resource="urn:domeoclient:uuid:CC6345F2-574E-4300-B936-8ED1CC3E2DBC"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:C75F6EFB-5E72-4CF2-9017-B3F8CA0EDE1F">
    <ao:exact> AVANDIA</ao:exact>
    <ao:prefix>Repeat oral dosing of</ao:prefix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <domeo:uuid>C75F6EFB-5E72-4CF2-9017-B3F8CA0EDE1F</domeo:uuid>
    <ao:suffix>xsd:String</ao:suffix>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:C75F6EFB-5E72-4CF2-9017-B3F8CA0EDE1F"/>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-123.txt.html</ao:hasSource>
    <pav:createdOn>2014-07-22 20:17:52 -0400</pav:createdOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:6586910C-89D6-48D4-A5C5-1E4D8CB29677">
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:lineageUri>urn:domeoserver:annotation:B1FC7631-66BC-44DC-8003-1595B584F6D2</pav:lineageUri>
    <ao:context rdf:resource="urn:domeoclient:uuid:F05ECB2E-0877-466E-936C-3A60595FD6B9"/>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812eda990003</pav:createdBy>
    <pav:createdOn>2014-09-01 16:00:05 -0400</pav:createdOn>
    <rdfs:label>Highlight</rdfs:label>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <domeo:belongsToSet>urn:domeoclient:uuid:659ED9DF-77DA-41F2-B123-6E455B4F2385</domeo:belongsToSet>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <pav:lastSavedOn>2014-09-01 16:00:14 -0400</pav:lastSavedOn>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:1C446162-FA92-4715-9095-A116DC12F4C8">
    <domeo:belongsToSet>urn:domeoclient:uuid:71191E51-53CB-4FDE-88D0-33C6818E2232</domeo:belongsToSet>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812eda990003</pav:createdBy>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:createdOn>2014-07-13 11:15:18 -0400</pav:createdOn>
    <pav:lineageUri>urn:domeoserver:annotation:22154A78-8E19-4B3A-8326-6AAAB8A19F14</pav:lineageUri>
    <pav:lastSavedOn>2014-07-13 11:32:29 -0400</pav:lastSavedOn>
    <rdfs:label>Highlight</rdfs:label>
    <ao:context rdf:resource="urn:domeoclient:uuid:B49DFB13-7D38-41A6-989C-F0F22BFBCA7D"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:92436D94-1FB4-49B2-B20D-385CA961A940">
    <pav:lineageUri>urn:domeoserver:annotation:19D86C58-A255-44F5-87D8-8E8795312D29</pav:lineageUri>
    <domeo:belongsToSet>urn:domeoclient:uuid:71191E51-53CB-4FDE-88D0-33C6818E2232</domeo:belongsToSet>
    <ao:context rdf:resource="urn:domeoclient:uuid:1E6C968E-32AF-45A2-96F3-10B3A640C99F"/>
    <rdfs:label>Highlight</rdfs:label>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812eda990003</pav:createdBy>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:createdOn>2014-07-13 11:13:53 -0400</pav:createdOn>
    <pav:lastSavedOn>2014-07-13 11:32:29 -0400</pav:lastSavedOn>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:06A101E3-2794-4554-92A9-5297495C183D">
    <domeo:belongsToSet>urn:domeoclient:uuid:48D839E5-6B0A-4EC3-B64A-E3E20E06246A</domeo:belongsToSet>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812eda990003</pav:createdBy>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <pav:createdOn>2014-07-28 17:04:15 -0400</pav:createdOn>
    <pav:lastSavedOn>2014-07-28 17:08:37 -0400</pav:lastSavedOn>
    <ao:context rdf:resource="urn:domeoclient:uuid:25C05DA7-D004-4C59-A96C-F35D5BEB9B3F"/>
    <pav:lineageUri>urn:domeoserver:annotation:D66FE462-CC41-4C42-83B4-1BDD6C8E54A7</pav:lineageUri>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <rdfs:label>Highlight</rdfs:label>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:6A9F403B-F60E-4954-9EEE-BB0C7DAD583B">
    <ao:suffix> </ao:suffix>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-56.txt.html</ao:hasSource>
    <ao:exact>Zonisamide</ao:exact>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:prefix>xsd:String</ao:prefix>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:6A9F403B-F60E-4954-9EEE-BB0C7DAD583B"/>
    <domeo:uuid>6A9F403B-F60E-4954-9EEE-BB0C7DAD583B</domeo:uuid>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <pav:createdOn>2014-07-21 21:53:39 -0400</pav:createdOn>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:C3024DC6-4D5D-4ED8-8896-E6A281746675">
    <pav:createdOn>2014-09-02 19:19:06 -0400</pav:createdOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <domeo:uuid>C3024DC6-4D5D-4ED8-8896-E6A281746675</domeo:uuid>
    <ao:prefix>/</ao:prefix>
    <ao:exact>ritonavir</ao:exact>
    <ao:suffix> (1000/100 mg) bid for 15 days with omeprazole 40 mg qd co-administered days 11 to 15. Dose reduction of saquinavir should be considered from the safety perspective for individual patients. There are also some antiretroviral drugs of which unchanged seru</ao:suffix>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-74.txt.html</ao:hasSource>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:C3024DC6-4D5D-4ED8-8896-E6A281746675"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:84F2753B-0F8B-4975-8EFA-3A99E0B82A50">
    <ao:suffix> </ao:suffix>
    <domeo:uuid>84F2753B-0F8B-4975-8EFA-3A99E0B82A50</domeo:uuid>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <pav:createdOn>2014-09-02 11:44:14 -0400</pav:createdOn>
    <ao:prefix>xsd:String</ao:prefix>
    <ao:exact>Tryptophan</ao:exact>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-9.txt.html</ao:hasSource>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:84F2753B-0F8B-4975-8EFA-3A99E0B82A50"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:1E16FBF3-81EA-402D-80A2-67FDDDC020EA">
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/3B9DE0DC-8223-4138-A13C-06DB166E9DEF"/>
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/5F00796E-B959-488F-969F-87505727DC32"/>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/PK_DDI"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:A08092E7-4D52-4833-B9FF-4EFA3BA6D2E4">
    <pav:createdOn>2014-09-01 16:07:44 -0400</pav:createdOn>
    <ao:suffix> as a single daily oral dose for 7 days. The mean percentage increase in the glipizide AUC after fluconazole administration was 56.9% (range: 35 to 81).</ao:suffix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-40.txt.html</ao:hasSource>
    <ao:prefix>and glipizide has been demonstrated in a placebo-controlled crossover study in normal volunteers. All subjects received glipizide alone and following treatment with 100 mg of </ao:prefix>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:A08092E7-4D52-4833-B9FF-4EFA3BA6D2E4"/>
    <ao:exact>fluconazole</ao:exact>
    <domeo:uuid>A08092E7-4D52-4833-B9FF-4EFA3BA6D2E4</domeo:uuid>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:96A8BD35-396A-4A08-9E1C-55EB39E4B7D4">
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:suffix> (4 to 8 mg/day) increased mean plasma concentrations of risperidone approximately 4-fold, decreased 9-hydroxyrisperidone concentrations approximately 10%, and increased concentrations of the active moiety (the sum of risperidone plus 9-hydroxyrisperidon</ao:suffix>
    <ao:prefix> 20 mg in patients stabilized on</ao:prefix>
    <pav:createdOn>2014-09-02 12:03:14 -0400</pav:createdOn>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:96A8BD35-396A-4A08-9E1C-55EB39E4B7D4"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-47.txt.html</ao:hasSource>
    <domeo:uuid>96A8BD35-396A-4A08-9E1C-55EB39E4B7D4</domeo:uuid>
    <ao:exact> risperidone</ao:exact>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:15DA0901-8237-4923-B2A0-A784328F0684">
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <pav:createdOn>2014-09-01 16:07:51 -0400</pav:createdOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:prefix> as a single daily oral dose for 7 days. The mean percentage increase in the glipizide AUC after </ao:prefix>
    <ao:suffix> administration was 56.9% (range: 35 to 81).</ao:suffix>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:15DA0901-8237-4923-B2A0-A784328F0684"/>
    <ao:exact>fluconazole</ao:exact>
    <domeo:uuid>15DA0901-8237-4923-B2A0-A784328F0684</domeo:uuid>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-40.txt.html</ao:hasSource>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/021311B6-82A4-4AA1-97CE-B7A322F4EE50">
    <dct:description>Referred to the drug in the interaction.</dct:description>
    <rdfs:label>erythromycin</rdfs:label>
    <sio:SIO_000228>dikbD2R:precipitant-drug-of-interaction</sio:SIO_000228>
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/4053</dailymed:activeMoietyRxCUI>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/active-ingredient"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:1295B95D-9BC5-45F6-8E74-F4D1E052F64C">
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <pav:lineageUri>urn:domeoserver:annotation:F820B19A-BB67-4E1D-8DEC-25DCF826ED55</pav:lineageUri>
    <domeo:belongsToSet>urn:domeoserver:annotationset:A3F0B39A-4249-4B63-BB0D-F24A005066AC</domeo:belongsToSet>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812eda990003</pav:createdBy>
    <domeo:belongsToSet>urn:domeoclient:uuid:BED41F06-565A-4622-9A88-48810E5A28DE</domeo:belongsToSet>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:lastSavedOn>2014-09-02 11:35:33 -0400</pav:lastSavedOn>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:lineageUri>urn:domeoserver:annotationset:D1715BD2-BD41-46FD-9454-DC7A423A29AC</pav:lineageUri>
    <domeo:belongsToSet>urn:domeoserver:annotationset:3F546823-204F-4F9B-9006-3DC526C56931</domeo:belongsToSet>
    <domeo:belongsToSet>urn:domeoserver:annotationset:A5DD001D-C81A-4E2E-B5E0-7A866B35E26B</domeo:belongsToSet>
    <rdfs:label>Highlight</rdfs:label>
    <ao:context rdf:resource="urn:domeoclient:uuid:E3A608F7-C1CD-4106-B1C6-F80BB86494C0"/>
    <pav:createdOn>2014-09-02 11:30:53 -0400</pav:createdOn>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:856332C7-36D0-4788-B89D-FC8E3A9C55D9">
    <pav:lineageUri>urn:domeoserver:annotation:7323A4E6-9262-4C31-906F-6A9D2369FE37</pav:lineageUri>
    <ao:context rdf:resource="urn:domeoclient:uuid:2B12E6D2-E83F-42E5-821A-DFDAD994F783"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812eda990003</pav:createdBy>
    <rdfs:label>Highlight</rdfs:label>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:createdOn>2014-07-22 18:37:56 -0400</pav:createdOn>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <pav:lastSavedOn>2014-07-22 18:37:42 -0400</pav:lastSavedOn>
    <domeo:belongsToSet>urn:domeoclient:uuid:9FA29E53-6B1B-4856-B5BD-22A93164E58E</domeo:belongsToSet>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/A52FAC94-0446-462D-9EE8-53E67CFDFC2E">
    <rdfs:label>Metronidazole</rdfs:label>
    <sio:SIO_000228>dikbD2R:object-drug-of-interaction</sio:SIO_000228>
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/6922</dailymed:activeMoietyRxCUI>
    <dct:description>Referred to the drug in the interaction.</dct:description>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/active-ingredient"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:DE707944-9AAF-45E4-85A6-2EA10D365226">
    <pav:lastSavedOn>2014-07-24 20:10:48 -0400</pav:lastSavedOn>
    <rdfs:label>expertstudy Annotation</rdfs:label>
    <ao:context rdf:resource="urn:domeoclient:uuid:D87DBE9A-311B-4697-A944-4490E16F4680"/>
    <pav:lastSavedOn>2014-07-24 20:10:49 -0400</pav:lastSavedOn>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812eda990003</pav:createdBy>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:lineageUri>urn:domeoserver:annotationset:4A88D0A6-E9B6-4E7F-955F-3692600C178C</pav:lineageUri>
    <pav:createdOn>2014-07-24 20:11:05 -0400</pav:createdOn>
    <pav:previousVersion>urn:domeoclient:uuid:8D86A4AC-54BD-4BB3-8B58-AB55DEC01A88</pav:previousVersion>
    <domeo:belongsToSet>urn:domeoserver:annotationset:1FC172B8-8AC3-465A-AA69-B73AD9B97CBC</domeo:belongsToSet>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">2</pav:versionNumber>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#expertstudyAnnotation"/>
    <pav:lineageUri>urn:domeoserver:annotation:8B0B159B-E896-497E-AB95-09460FC2D9A8</pav:lineageUri>
    <domeo:belongsToSet>urn:domeoserver:annotationset:37B2514D-1A92-45B1-8A5C-610DA6DC935A</domeo:belongsToSet>
    <ao:body rdf:nodeID="Nb93889a977264765ba140c50cf08c496"/>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <ao:body rdf:nodeID="N6e48ab40e9d04219afa770451338b941"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:76A2A466-4D5D-4AA1-8114-FAD1FF0E6FC0">
    <ao:suffix>Cmax and a 210% increase in sildenafil AUC.</ao:suffix>
    <domeo:uuid></domeo:uuid>
    <pav:createdOn>2014-07-07 11:24:12 -0400</pav:createdOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:prefix>(100 mg single dose) resulted in a 140% increase in </ao:prefix>
    <ao:exact>sildenafil </ao:exact>
    <domeo:uuid>76A2A466-4D5D-4AA1-8114-FAD1FF0E6FC0</domeo:uuid>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:76A2A466-4D5D-4AA1-8114-FAD1FF0E6FC0"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-155.txt.html</ao:hasSource>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:0A3EAA6A-641B-48C1-A03F-CCA1FF890D64">
    <pav:createdOn>2014-09-02 19:12:29 -0400</pav:createdOn>
    <ao:context rdf:resource="urn:domeoclient:uuid:DA838F12-E2BB-4B13-B633-B6F4480341B7"/>
    <rdfs:label>Highlight</rdfs:label>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:lineageUri>urn:domeoserver:annotation:F40E9557-724E-4C41-8669-D9A97367DB56</pav:lineageUri>
    <pav:lastSavedOn>2014-09-02 19:19:47 -0400</pav:lastSavedOn>
    <domeo:belongsToSet>urn:domeoserver:annotationset:E32812A9-205B-4EE1-B488-A1E294EDBFB9</domeo:belongsToSet>
    <domeo:belongsToSet>urn:domeoserver:annotationset:392EE0FB-AC4F-4AF2-87A6-2E50A281F434</domeo:belongsToSet>
    <pav:lineageUri>urn:domeoserver:annotationset:C5DEBC9B-77EE-4243-88EB-DBC19737ACD2</pav:lineageUri>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812eda990003</pav:createdBy>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <domeo:belongsToSet>urn:domeoclient:uuid:CB83FFC2-EA71-44EA-8F11-DE80E389C84E</domeo:belongsToSet>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:159DCA30-3727-4241-9440-301E40381956">
    <ao:exact>warfarin</ao:exact>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <pav:createdOn>2014-07-13 11:11:31 -0400</pav:createdOn>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:159DCA30-3727-4241-9440-301E40381956"/>
    <domeo:uuid>159DCA30-3727-4241-9440-301E40381956</domeo:uuid>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-8.txt.html</ao:hasSource>
    <ao:prefix> (100 mcg/mL), </ao:prefix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:suffix> (10 mcg/mL), and carbamazepine (10 mcg/mL) caused only a slight increase in the free fraction of risperidone at 10 ng/mL and 9-hydroxyrisperidone at 50 ng/mL, changes of unknown clinical significance.</ao:suffix>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:D0733D8F-AF43-42E3-B473-28271029CCA5">
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <domeo:uuid>D0733D8F-AF43-42E3-B473-28271029CCA5</domeo:uuid>
    <ao:prefix>In a controlled study, a single dose of </ao:prefix>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-78.txt.html</ao:hasSource>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:exact>pimozide</ao:exact>
    <pav:createdOn>2014-09-02 19:38:12 -0400</pav:createdOn>
    <ao:suffix> 2 mg coadministered with citalopram 40 mg given once daily for 11 days was associated with a mean increase in QTc values of approximately 10 msec compared to pimozide given alone. Citalopram did not alter the mean AUC or Cmax of pimozide. The mechanism </ao:suffix>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:D0733D8F-AF43-42E3-B473-28271029CCA5"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:9E1B668B-C744-4EDA-8C35-67ED2D2886D7">
    <pav:createdOn>2014-07-22 19:43:36 -0400</pav:createdOn>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:9E1B668B-C744-4EDA-8C35-67ED2D2886D7"/>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-123.txt.html</ao:hasSource>
    <ao:suffix> administration (600 mg once a day), an inducer of CYP2C8, for 6 days is reported to decrease rosiglitazone AUC by 66%, compared to the administration of rosiglitazone (8 mg) alone [see Drug Interactions (7.1)].4</ao:suffix>
    <ao:prefix>xsd:String</ao:prefix>
    <domeo:uuid>9E1B668B-C744-4EDA-8C35-67ED2D2886D7</domeo:uuid>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:exact>Rifampin</ao:exact>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/D0EF2EA1-1BE2-4B9B-8114-37709CA5774E">
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/active-ingredient"/>
    <rdfs:label>sotalol</rdfs:label>
    <dct:description>Referred to the drug in the interaction.</dct:description>
    <sio:SIO_000228>dikbD2R:precipitant-drug-of-interaction</sio:SIO_000228>
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/</dailymed:activeMoietyRxCUI>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:6DEBCD8F-80B7-4229-A275-28C4CFF1B5A0">
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-123.txt.html</ao:hasSource>
    <pav:createdOn>2014-07-22 20:18:04 -0400</pav:createdOn>
    <ao:suffix> enantiomers.</ao:suffix>
    <domeo:uuid>6DEBCD8F-80B7-4229-A275-28C4CFF1B5A0</domeo:uuid>
    <ao:prefix>had no clinically relevant effect on the steady-state pharmacokinetics of </ao:prefix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:exact>warfarin</ao:exact>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:6DEBCD8F-80B7-4229-A275-28C4CFF1B5A0"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:52AE2649-A143-4E37-A21D-82019096A697">
    <ao:prefix>, </ao:prefix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-72.txt.html</ao:hasSource>
    <ao:suffix>, butorphanol and buprenorphine) to patients who have received or are receiving a course of therapy with a pure opioid agonist analgesic such as oxycodone hydrochloride. In these patients, mixed agonist/antagonist analgesics may reduce the analgesic effe</ao:suffix>
    <pav:createdOn>2014-09-02 19:08:35 -0400</pav:createdOn>
    <ao:exact>nalbuphine</ao:exact>
    <domeo:uuid>52AE2649-A143-4E37-A21D-82019096A697</domeo:uuid>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:52AE2649-A143-4E37-A21D-82019096A697"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:1488BDD9-0C63-45D6-A1E6-1AC89EE36E28">
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <domeo:uuid>1488BDD9-0C63-45D6-A1E6-1AC89EE36E28</domeo:uuid>
    <ao:prefix>AUC. The mean ± SD increase in </ao:prefix>
    <pav:createdOn>2014-07-21 21:26:58 -0400</pav:createdOn>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-25.txt.html</ao:hasSource>
    <ao:suffix>AUC was 88% ± 68% (range: 16 to 247%). The absolute magnitude of this interaction is unknown because of the intrinsically nonlinear disposition of phenytoin. (See PRECAUTIONS.)</ao:suffix>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:1488BDD9-0C63-45D6-A1E6-1AC89EE36E28"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:exact>phenytoin </ao:exact>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:1FE8E158-755A-4E57-81FB-928873E93B12">
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:lastSavedOn>2014-07-21 21:49:33 -0400</pav:lastSavedOn>
    <ao:body rdf:nodeID="N68a4d20630fd486c8391ab65c44a1cc9"/>
    <pav:lineageUri>urn:domeoserver:annotation:9D336A52-427C-4D16-B0EB-4A52D6237761</pav:lineageUri>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#expertstudyAnnotation"/>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812eda990003</pav:createdBy>
    <domeo:belongsToSet>urn:domeoclient:uuid:B803E851-5AD5-4741-B1B9-1CBAED597E18</domeo:belongsToSet>
    <ao:context rdf:resource="urn:domeoclient:uuid:A5DD6E78-70E1-4015-8485-53B5D56072C0"/>
    <rdfs:label>expertstudy Annotation</rdfs:label>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:createdOn>2014-07-21 21:49:21 -0400</pav:createdOn>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:D5BCCF61-F8EE-41B5-8F8E-D5A8F239ED7F">
    <ao:prefix>, and</ao:prefix>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-74.txt.html</ao:hasSource>
    <ao:suffix>). In the clinical trials, antacids were used concomitantly with the administration of omeprazole delayed-release capsules USP.</ao:suffix>
    <ao:exact> iron salts</ao:exact>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <pav:createdOn>2014-09-02 19:12:13 -0400</pav:createdOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <domeo:uuid>D5BCCF61-F8EE-41B5-8F8E-D5A8F239ED7F</domeo:uuid>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:D5BCCF61-F8EE-41B5-8F8E-D5A8F239ED7F"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:5C2CFA62-3DF2-413F-9AE0-376E0D06DC3C">
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <pav:createdOn>2014-09-02 11:49:17 -0400</pav:createdOn>
    <domeo:uuid>5C2CFA62-3DF2-413F-9AE0-376E0D06DC3C</domeo:uuid>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-9.txt.html</ao:hasSource>
    <ao:suffix> compared to nonsmokers.</ao:suffix>
    <ao:exact>fluvoxamine</ao:exact>
    <ao:prefix>Smokers had a 25% increase in the metabolism of </ao:prefix>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:5C2CFA62-3DF2-413F-9AE0-376E0D06DC3C"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:06439E07-6402-42CF-99AD-58333426FE52">
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <domeo:belongsToSet>urn:domeoclient:uuid:4B51141D-C8D2-45DB-8074-74F8D8323E60</domeo:belongsToSet>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:createdOn>2014-09-02 11:55:53 -0400</pav:createdOn>
    <ao:context rdf:resource="urn:domeoclient:uuid:D5D8B7FB-8F69-439A-B1F3-0DC084AEDE1E"/>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <pav:lastSavedOn>2014-09-02 12:02:18 -0400</pav:lastSavedOn>
    <pav:lineageUri>urn:domeoserver:annotation:9784302E-E2D0-4C10-91A7-37F0E9D1996B</pav:lineageUri>
    <rdfs:label>Highlight</rdfs:label>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812eda990003</pav:createdBy>
  </rdf:Description>
  <rdf:Description rdf:nodeID="Nc4eb2a673aa04d6a8dd11f1386c5f0c0">
    <domeo:sets rdf:resource="urn:pddi:uuid:6E3CCB3A-24FB-48E1-AC28-838B1ACF54A3"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:70094340-3BB3-42EB-8579-D2FEE274AB33">
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/C8697DBE-189E-49C7-A34D-563280FA497C"/>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/PK_DDI"/>
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/027E2EA7-BD8C-4E55-AE53-75289D2AB62C"/>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/A3E00879-812C-4400-97F2-AF59166DF8BB">
    <rdfs:label>phenytoin</rdfs:label>
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/8183</dailymed:activeMoietyRxCUI>
    <dct:description>Referred to the drug in the interaction.</dct:description>
    <sio:SIO_000228>dikbD2R:precipitant-drug-of-interaction</sio:SIO_000228>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/active-ingredient"/>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/5F00796E-B959-488F-969F-87505727DC32">
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/active-ingredient"/>
    <dct:description>Referred to the drug in the interaction.</dct:description>
    <sio:SIO_000228>dikbD2R:precipitant-drug-of-interaction</sio:SIO_000228>
    <rdfs:label>cimetidine</rdfs:label>
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/2541</dailymed:activeMoietyRxCUI>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:05003F42-3401-4DB3-B275-544005230F77">
    <pav:createdOn>2014-09-02 15:04:30 -0400</pav:createdOn>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-48.txt.html</ao:hasSource>
    <ao:prefix>. Based on the assumption that the relationship between </ao:prefix>
    <ao:suffix>’s in vitro Ki and its lack of effect on terfenadine's in vivo clearance predicts its effect on other CYP3A4 substrates, paroxetine’s extent of inhibition of CYP3A4 activity is not likely to be of clinical significance.</ao:suffix>
    <ao:exact>paroxetine</ao:exact>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <domeo:uuid>05003F42-3401-4DB3-B275-544005230F77</domeo:uuid>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:05003F42-3401-4DB3-B275-544005230F77"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:1584C65E-C32D-42F5-A725-32DCDF671F11">
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <domeo:belongsToSet>urn:domeoclient:uuid:6C727003-BB8F-45A8-BBAC-ACBE1D4D132E</domeo:belongsToSet>
    <pav:lastSavedOn>2014-07-24 19:51:13 -0400</pav:lastSavedOn>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:createdOn>2014-07-24 19:47:46 -0400</pav:createdOn>
    <ao:context rdf:resource="urn:domeoclient:uuid:B63FFC37-B751-48F0-8F6D-DC3232F9B394"/>
    <pav:lineageUri>urn:domeoserver:annotation:17F7A9E9-6742-46E5-B13E-47EE41D9F8C1</pav:lineageUri>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812eda990003</pav:createdBy>
    <rdfs:label>Highlight</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:190DDFDA-8456-4B27-972C-5E815FA29EBD">
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:createdOn>2014-07-13 12:47:19 -0400</pav:createdOn>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#expertstudyAnnotation"/>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:lastSavedOn>2014-07-13 12:48:45 -0400</pav:lastSavedOn>
    <ao:context rdf:resource="urn:domeoclient:uuid:5039F6DC-F654-4E38-8762-0E1BD92F058C"/>
    <ao:body rdf:nodeID="N729b963d2af14b1a915b36f442e42634"/>
    <rdfs:label>expertstudy Annotation</rdfs:label>
    <pav:lineageUri>urn:domeoserver:annotation:6778C161-ADEE-4D2A-83DD-90876C90F77A</pav:lineageUri>
    <domeo:belongsToSet>urn:domeoclient:uuid:EC9B90D7-F9B5-4E51-94E2-878FAA06F611</domeo:belongsToSet>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812eda990003</pav:createdBy>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:15AF1994-00EF-4BF7-9C44-C16149A1F769">
    <sio:SIO_000628 rdf:resource="urn:pddi:uuid:A87B61D2-D72C-42FD-B166-A4440E8574B1"/>
    <sio:SIO_000563>dikbD2R:modality</sio:SIO_000563>
    <dikbD2R:statement>ncit:quantitative</dikbD2R:statement>
    <rdf:type rdf:resource="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#DrugDrugInteractionStatement"/>
    <sio:SIO_000205>dikbD2R:statement</sio:SIO_000205>
    <dikbD2R:modality>ncit:positive</dikbD2R:modality>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:A3A7600E-EE05-47D1-8823-CA504866B3BD">
    <pav:createdOn>2014-09-02 11:36:37 -0400</pav:createdOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:prefix>. If </ao:prefix>
    <ao:exact>fluvoxamine </ao:exact>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:A3A7600E-EE05-47D1-8823-CA504866B3BD"/>
    <ao:suffix> maleate tablets are to be administered together with a drug that is eliminated via oxidative metabolism and has a narrow therapeutic window, plasma levels and/or pharmacodynamic effects of the latter drug should be monitored closely, at least until stea</ao:suffix>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-9.txt.html</ao:hasSource>
    <domeo:uuid>A3A7600E-EE05-47D1-8823-CA504866B3BD</domeo:uuid>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:CF3DBDD7-1816-4E91-BF27-7D21BEF67A06">
    <pav:createdOn>2014-07-07 11:37:21 -0400</pav:createdOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:suffix>xsd:String</ao:suffix>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:CF3DBDD7-1816-4E91-BF27-7D21BEF67A06"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:exact>In a study performed in healthy volunteers, co-administration of the HIV protease inhibitor saquinavir, a CYP3A inhibitor, at steady state (1200 mg TID) with sildenafil (100 mg single dose) resulted in a 140% increase in sildenafil Cmax and a 210% increase in sildenafil AUC</ao:exact>
    <domeo:uuid>CF3DBDD7-1816-4E91-BF27-7D21BEF67A06</domeo:uuid>
    <ao:prefix>xsd:String</ao:prefix>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-155.txt.html</ao:hasSource>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:BFE9EAEF-FFFF-446F-B84E-D50E1FB72CA0">
    <pav:createdOn>2014-07-22 19:22:42 -0400</pav:createdOn>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-123.txt.html</ao:hasSource>
    <ao:suffix> were variable and were generally not statistically different from placebo or glyburide controls.</ao:suffix>
    <domeo:uuid>BFE9EAEF-FFFF-446F-B84E-D50E1FB72CA0</domeo:uuid>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:prefix>The changes in triglycerides during therapy with </ao:prefix>
    <ao:exact>AVANDIA</ao:exact>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:BFE9EAEF-FFFF-446F-B84E-D50E1FB72CA0"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:E1974882-EFE7-48A1-A145-232BC76F5E40">
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/506F49B8-922C-4813-A6D3-3A7CFAA9C474"/>
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/8E677686-F1A8-4E2D-A503-156B748361AB"/>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/PK_DDI"/>
  </rdf:Description>
  <rdf:Description rdf:nodeID="N4e5d7e81389f4f418aae49bd889e8a92">
    <permissions:isLocked>false</permissions:isLocked>
    <permissions:accessType>urn:domeo:access:public</permissions:accessType>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:222C9B55-A770-41C7-AF04-566E7C7A1DBC">
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <domeo:belongsToSet>urn:domeoserver:annotationset:7AACEF8D-2EBC-4F0B-94B2-190650E562F6</domeo:belongsToSet>
    <pav:lineageUri>urn:domeoserver:annotationset:76FD4BB5-DE2F-4FCA-B93D-302185B1A381</pav:lineageUri>
    <pav:lastSavedOn>2014-07-07 09:44:19 -0400</pav:lastSavedOn>
    <pav:createdOn>2014-07-07 09:43:42 -0400</pav:createdOn>
    <pav:lastSavedOn>2014-07-07 09:44:18 -0400</pav:lastSavedOn>
    <pav:lineageUri>urn:domeoserver:annotation:0B532474-916D-40A3-BDAD-D06FF3A01947</pav:lineageUri>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <domeo:belongsToSet>urn:domeoserver:annotationset:08C0C288-6DF4-43E6-A618-71A8BB9563C3</domeo:belongsToSet>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <domeo:belongsToSet>urn:domeoserver:annotationset:22ED7220-C6F6-43C5-9DF9-89F62F0F8E27</domeo:belongsToSet>
    <rdfs:label>Highlight</rdfs:label>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812eda990003</pav:createdBy>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <ao:context rdf:resource="urn:domeoclient:uuid:B9D56D7C-5C37-4BCA-B9C4-0605E9E54998"/>
    <domeo:belongsToSet>urn:domeoserver:annotationset:131835A3-C655-4F91-97D4-52CAFF7B7CCA</domeo:belongsToSet>
    <domeo:belongsToSet>urn:domeoclient:uuid:FCA2BF23-0BE3-409F-9177-761812F96097</domeo:belongsToSet>
    <domeo:belongsToSet>urn:domeoserver:annotationset:8F3CF3D9-AADE-4A86-BD42-2924B3D6A406</domeo:belongsToSet>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/4E62726A-262F-4A69-83FB-3965D3CD27BD">
    <sio:SIO_000228>dikbD2R:object-drug-of-interaction</sio:SIO_000228>
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/135097</dailymed:activeMoietyRxCUI>
    <rdfs:label>Synercid</rdfs:label>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/drug-product"/>
    <dct:description>Referred to the drug in the interaction.</dct:description>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:9E6E80C9-FE56-4016-839A-ADB4FEFC8C55">
    <domeo:uuid>9E6E80C9-FE56-4016-839A-ADB4FEFC8C55</domeo:uuid>
    <ao:prefix> with </ao:prefix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:suffix> produced substantial decrements in cognitive functioning; however, the coadministration of fluvoxamine and lorazepam did not produce larger mean decrements compared to lorazepam alone.</ao:suffix>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-9.txt.html</ao:hasSource>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:9E6E80C9-FE56-4016-839A-ADB4FEFC8C55"/>
    <pav:createdOn>2014-09-02 11:38:27 -0400</pav:createdOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:exact>fluvoxamine</ao:exact>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:3D56C301-550F-4FAE-8357-941B7D128A4B">
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:prefix>and </ao:prefix>
    <pav:createdOn>2014-09-02 19:08:37 -0400</pav:createdOn>
    <ao:suffix>) to patients who have received or are receiving a course of therapy with a pure opioid agonist analgesic such as oxycodone hydrochloride. In these patients, mixed agonist/antagonist analgesics may reduce the analgesic effect and/or may precipitate withd</ao:suffix>
    <domeo:uuid>3D56C301-550F-4FAE-8357-941B7D128A4B</domeo:uuid>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-72.txt.html</ao:hasSource>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:3D56C301-550F-4FAE-8357-941B7D128A4B"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:exact>buprenorphine</ao:exact>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:25B50478-76B9-41F0-8556-A8AEB125E61E">
    <pav:createdOn>2014-07-24 20:07:33 -0400</pav:createdOn>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-139.txt.html</ao:hasSource>
    <ao:suffix> or ketoconazole. In two separate studies in healthy adult subjects, fexofenadine hydrochloride 120 mg twice daily (240 mg total daily dose) was coadministered with either erythromycin 500 mg every 8 hours or ketoconazole 400 mg once daily under steady-s</ao:suffix>
    <domeo:uuid>25B50478-76B9-41F0-8556-A8AEB125E61E</domeo:uuid>
    <ao:prefix> had no effect on the pharmacokinetics of either </ao:prefix>
    <ao:exact>erythromycin</ao:exact>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:25B50478-76B9-41F0-8556-A8AEB125E61E"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:35718176-8B1F-491A-BA1E-B0A7887FDD76">
    <ao:prefix> and </ao:prefix>
    <domeo:uuid>35718176-8B1F-491A-BA1E-B0A7887FDD76</domeo:uuid>
    <ao:exact>norverapamil</ao:exact>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-127.txt.html</ao:hasSource>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:35718176-8B1F-491A-BA1E-B0A7887FDD76"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <pav:createdOn>2014-07-24 19:42:53 -0400</pav:createdOn>
    <ao:suffix>. Verapamil does not affect the pharmacokinetics of propranolol.</ao:suffix>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:7210ECAE-0079-4C21-98CB-EDA94264D7DA">
    <sio:SIO_000628 rdf:resource="urn:pddi:uuid:BC898759-CCCD-4E6C-9FBB-4E76A3E8F0BE"/>
    <dikbD2R:statement>ncit:quantitative</dikbD2R:statement>
    <rdf:type rdf:resource="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#DrugDrugInteractionStatement"/>
    <sio:SIO_000563>dikbD2R:modality</sio:SIO_000563>
    <sio:SIO_000205>dikbD2R:statement</sio:SIO_000205>
    <dikbD2R:modality>ncit:positive</dikbD2R:modality>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:5FBE9544-4653-482C-B065-70CA3AA07309">
    <ao:exact>rifampin</ao:exact>
    <domeo:uuid>5FBE9544-4653-482C-B065-70CA3AA07309</domeo:uuid>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:prefix>, </ao:prefix>
    <ao:suffix>, and phenobarbital) with risperidone may cause a decrease in the combined plasma concentrations of risperidone and 9-hydroxyrisperidone [see 7 DRUG INTERACTIONS]. It would also be possible for risperidone to interfere with metabolism of other drugs meta</ao:suffix>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:5FBE9544-4653-482C-B065-70CA3AA07309"/>
    <pav:createdOn>2014-07-13 11:15:53 -0400</pav:createdOn>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-8.txt.html</ao:hasSource>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:7F63A36F-F819-4E40-9C8A-C518B5519787">
    <domeo:uuid>7F63A36F-F819-4E40-9C8A-C518B5519787</domeo:uuid>
    <ao:suffix> and α1-acid glycoprotein. Risperidone doses should be reduced in patients with liver disease [see 2 DOSAGE AND ADMINISTRATION and 5 WARNINGS AND PRECAUTIONS].</ao:suffix>
    <pav:createdOn>2014-07-13 11:17:56 -0400</pav:createdOn>
    <ao:exact>albumin</ao:exact>
    <ao:prefix> in plasma was increased by about 35% because of the diminished concentration of both </ao:prefix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-8.txt.html</ao:hasSource>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:7F63A36F-F819-4E40-9C8A-C518B5519787"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:D526C276-CAAE-4E9B-8038-08BB2FB8FBBD">
    <ao:suffix>) with risperidone may cause a decrease in the combined plasma concentrations of risperidone and 9-hydroxyrisperidone [see 7 DRUG INTERACTIONS]. It would also be possible for risperidone to interfere with metabolism of other drugs metabolized by CYP 2D6.</ao:suffix>
    <ao:prefix>, and </ao:prefix>
    <pav:createdOn>2014-07-13 11:15:55 -0400</pav:createdOn>
    <domeo:uuid>D526C276-CAAE-4E9B-8038-08BB2FB8FBBD</domeo:uuid>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-8.txt.html</ao:hasSource>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:D526C276-CAAE-4E9B-8038-08BB2FB8FBBD"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:exact>phenobarbital</ao:exact>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:1827DDD2-0D88-43CF-B4E7-833420181887">
    <pav:createdOn>2014-09-02 19:40:45 -0400</pav:createdOn>
    <ao:prefix>:  Coadministration of</ao:prefix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-116.txt.html</ao:hasSource>
    <ao:exact> rosiglitazone</ao:exact>
    <ao:suffix> (4 mg b.i.d.) was shown to have no clinically relevant effect on the pharmacokinetics of nifedipine.</ao:suffix>
    <domeo:uuid>1827DDD2-0D88-43CF-B4E7-833420181887</domeo:uuid>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:1827DDD2-0D88-43CF-B4E7-833420181887"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:B188771E-D938-4A6E-AA65-8D511119CA92">
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <domeo:belongsToSet>urn:domeoclient:uuid:CB83FFC2-EA71-44EA-8F11-DE80E389C84E</domeo:belongsToSet>
    <pav:createdOn>2014-09-02 19:19:06 -0400</pav:createdOn>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812eda990003</pav:createdBy>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:lastSavedOn>2014-09-02 19:19:47 -0400</pav:lastSavedOn>
    <ao:context rdf:resource="urn:domeoclient:uuid:C3024DC6-4D5D-4ED8-8896-E6A281746675"/>
    <domeo:belongsToSet>urn:domeoserver:annotationset:E32812A9-205B-4EE1-B488-A1E294EDBFB9</domeo:belongsToSet>
    <rdfs:label>Highlight</rdfs:label>
    <pav:lineageUri>urn:domeoserver:annotationset:C5DEBC9B-77EE-4243-88EB-DBC19737ACD2</pav:lineageUri>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:lineageUri>urn:domeoserver:annotation:A33A5270-A8F8-4373-A7CC-760818D96917</pav:lineageUri>
    <domeo:belongsToSet>urn:domeoserver:annotationset:392EE0FB-AC4F-4AF2-87A6-2E50A281F434</domeo:belongsToSet>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:C42C067D-4201-4F47-96EA-FFFFA5B4C4AB">
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:exact>risperidone</ao:exact>
    <pav:createdOn>2014-09-02 11:57:27 -0400</pav:createdOn>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-47.txt.html</ao:hasSource>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <domeo:uuid>C42C067D-4201-4F47-96EA-FFFFA5B4C4AB</domeo:uuid>
    <ao:suffix>, a CYP2D6 substrate has also been evaluated. In 1 study, daily dosing of paroxetine 20 mg in patients stabilized on risperidone (4 to 8 mg/day) increased mean plasma concentrations of risperidone approximately 4-fold, decreased 9-hydroxyrisperidone conc</ao:suffix>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:C42C067D-4201-4F47-96EA-FFFFA5B4C4AB"/>
    <ao:prefix> with </ao:prefix>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:DB1EE25E-5302-4609-9598-C6AFBB42CB9A">
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:exact>trazodone</ao:exact>
    <ao:suffix> were coadministered.</ao:suffix>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-136.txt.html</ao:hasSource>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:DB1EE25E-5302-4609-9598-C6AFBB42CB9A"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <pav:createdOn>2014-07-24 20:02:33 -0400</pav:createdOn>
    <domeo:uuid>DB1EE25E-5302-4609-9598-C6AFBB42CB9A</domeo:uuid>
    <ao:prefix> and </ao:prefix>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:3BA7AB65-2DF7-4BB0-BB24-76AE0AC3003C">
    <sio:SIO_000205>dikbD2R:statement</sio:SIO_000205>
    <sio:SIO_000563>dikbD2R:modality</sio:SIO_000563>
    <dikbD2R:statement>ncit:Qualitative</dikbD2R:statement>
    <dikbD2R:modality>ncit:negative</dikbD2R:modality>
    <rdf:type rdf:resource="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#DrugDrugInteractionStatement"/>
    <sio:SIO_000628 rdf:resource="urn:pddi:uuid:1380C3AE-72EA-44B5-B7B6-5D990055E8E2"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:D6A30BCE-90A8-4548-B78C-7949C0F059D0">
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:lastSavedOn>2014-09-02 15:06:18 -0400</pav:lastSavedOn>
    <pav:lineageUri>urn:domeoserver:annotation:16F3A6F5-5770-4762-81FE-B45C6811904F</pav:lineageUri>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <ao:context rdf:resource="urn:domeoclient:uuid:D0CD8B93-AF6F-43D3-99AB-2252325772E9"/>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812eda990003</pav:createdBy>
    <rdfs:label>Highlight</rdfs:label>
    <domeo:belongsToSet>urn:domeoclient:uuid:443354CF-9409-4015-81BA-17601E505BAB</domeo:belongsToSet>
    <pav:createdOn>2014-09-02 15:05:52 -0400</pav:createdOn>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:532294F2-A52D-4732-85C4-0F955156A615">
    <ao:prefix> plus </ao:prefix>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-8.txt.html</ao:hasSource>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:532294F2-A52D-4732-85C4-0F955156A615"/>
    <ao:suffix> are dose proportional over the dosing range of 1 to 16 mg daily (0.5 to 8 mg twice daily). Following oral administration of solution or tablet, mean peak plasma concentrations of risperidone occurred at about 1 hour. Peak concentrations of 9-hydroxyrisp</ao:suffix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <pav:createdOn>2014-07-13 11:10:06 -0400</pav:createdOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <domeo:uuid>532294F2-A52D-4732-85C4-0F955156A615</domeo:uuid>
    <ao:exact>9-hydroxyrisperidone</ao:exact>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:2479E0A1-BF58-4BD9-9AB9-45B56AC1BD6A">
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/7D37C82A-2E31-4FCE-8C21-50B73E96FF3E"/>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/PK_DDI"/>
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/5224D32E-E4DE-4A9C-B197-4A0F7E4F982D"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:E202AAE6-7DCA-486D-9C29-8CB3B82CFECF">
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <rdfs:label>Highlight</rdfs:label>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:lineageUri>urn:domeoserver:annotation:70E60126-522D-4A50-BCBB-D49738745AFC</pav:lineageUri>
    <pav:lastSavedOn>2014-07-13 11:32:29 -0400</pav:lastSavedOn>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <domeo:belongsToSet>urn:domeoclient:uuid:71191E51-53CB-4FDE-88D0-33C6818E2232</domeo:belongsToSet>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812eda990003</pav:createdBy>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <ao:context rdf:resource="urn:domeoclient:uuid:30903A1B-437C-4ABA-B24D-6148F07F178D"/>
    <pav:createdOn>2014-07-13 11:09:35 -0400</pav:createdOn>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:14556CC1-0C55-47A6-8175-973C292639CC">
    <rdfs:label>Highlight</rdfs:label>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <domeo:belongsToSet>urn:domeoclient:uuid:71191E51-53CB-4FDE-88D0-33C6818E2232</domeo:belongsToSet>
    <ao:context rdf:resource="urn:domeoclient:uuid:86692ABC-62BE-4895-A4EF-50FCB21327B2"/>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:createdOn>2014-07-13 11:16:08 -0400</pav:createdOn>
    <pav:lineageUri>urn:domeoserver:annotation:71D2AAB3-67A2-451B-BC9A-B33DCA934E67</pav:lineageUri>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812eda990003</pav:createdBy>
    <pav:lastSavedOn>2014-07-13 11:32:29 -0400</pav:lastSavedOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:9019660D-1815-46EC-A26A-41E87A114AA7">
    <pav:createdOn>2014-09-02 19:08:19 -0400</pav:createdOn>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-72.txt.html</ao:hasSource>
    <ao:exact>oxycodone hydrochloride</ao:exact>
    <domeo:uuid>9019660D-1815-46EC-A26A-41E87A114AA7</domeo:uuid>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:9019660D-1815-46EC-A26A-41E87A114AA7"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:suffix> with caution and in reduced dosages in patients taking these agents.</ao:suffix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:prefix>Other central nervous system (CNS) depressants including sedatives, hypnotics, general anesthetics, antiemetics, phenothiazines, or other tranquilizers or alcohol increases the risk of respiratory depression, hypotension, profound sedation, or coma. Use </ao:prefix>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:097BBD64-4910-4F32-9440-9A37CCEA09F8">
    <ao:suffix> as monotherapy was associated with increases in total cholesterol, LDL, and HDL and decreases in free fatty acids. These changes were statistically significantly different from placebo or glyburide controls (Table 7).</ao:suffix>
    <ao:prefix>. In all 26-week controlled trials, across the recommended dose range, </ao:prefix>
    <pav:createdOn>2014-07-22 19:12:55 -0400</pav:createdOn>
    <domeo:uuid>097BBD64-4910-4F32-9440-9A37CCEA09F8</domeo:uuid>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:exact>AVANDIA</ao:exact>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-123.txt.html</ao:hasSource>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:097BBD64-4910-4F32-9440-9A37CCEA09F8"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:AC96215A-123C-49AB-9A1D-9FE75BE48E10">
    <rdfs:label>Highlight</rdfs:label>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <pav:lastSavedOn>2014-07-21 21:44:21 -0400</pav:lastSavedOn>
    <pav:createdOn>2014-07-21 21:44:28 -0400</pav:createdOn>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <ao:context rdf:resource="urn:domeoclient:uuid:96E66F0D-E214-4562-BC8C-77A59132E471"/>
    <pav:lineageUri>urn:domeoserver:annotation:38876558-6B16-4ACF-B7B6-2CCFB80241BA</pav:lineageUri>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812eda990003</pav:createdBy>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <domeo:belongsToSet>urn:domeoclient:uuid:BF2D2BC3-6C22-44A4-8021-D0C2308687B9</domeo:belongsToSet>
  </rdf:Description>
  <rdf:Description rdf:nodeID="Nef5cd4ad855b4351b1ae1fe0205cfa0c">
    <permissions:isLocked>false</permissions:isLocked>
    <permissions:accessType>urn:domeo:access:public</permissions:accessType>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:1B4D9B85-636E-45EE-9796-1A7AE7E45DCF">
    <domeo:uuid>1B4D9B85-636E-45EE-9796-1A7AE7E45DCF</domeo:uuid>
    <pav:createdOn>2014-07-13 11:11:43 -0400</pav:createdOn>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:1B4D9B85-636E-45EE-9796-1A7AE7E45DCF"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-8.txt.html</ao:hasSource>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:exact>risperidone</ao:exact>
    <ao:prefix> (10 mcg/mL) caused only a slight increase in the free fraction of </ao:prefix>
    <ao:suffix> at 10 ng/mL and 9-hydroxyrisperidone at 50 ng/mL, changes of unknown clinical significance.</ao:suffix>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:1FA6545E-180C-46D2-A000-88AB02BD37E4">
    <pav:createdOn>2014-07-22 18:36:25 -0400</pav:createdOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:prefix>xsd:String</ao:prefix>
    <ao:suffix> </ao:suffix>
    <ao:exact>cimetidine</ao:exact>
    <domeo:uuid>1FA6545E-180C-46D2-A000-88AB02BD37E4</domeo:uuid>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:1FA6545E-180C-46D2-A000-88AB02BD37E4"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-57.txt.html</ao:hasSource>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/692FB180-95F1-4EAA-88D0-82BF4B541921">
    <dct:description>Referred to the drug in the interaction.</dct:description>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/active-ingredient"/>
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/6960</dailymed:activeMoietyRxCUI>
    <sio:SIO_000228>dikbD2R:precipitant-drug-of-interaction</sio:SIO_000228>
    <rdfs:label>midazolam</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/EA31E970-6539-4E1A-AF71-DC79346D30C3">
    <sio:SIO_000228>dikbD2R:precipitant-drug-of-interaction</sio:SIO_000228>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/active-ingredient"/>
    <rdfs:label>rosiglitazone</rdfs:label>
    <dct:description>Referred to the drug in the interaction.</dct:description>
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/84108</dailymed:activeMoietyRxCUI>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:DCEF4B50-19DE-4DDE-ADB0-22E897CE8FC1">
    <pav:createdOn>2014-07-22 19:31:27 -0400</pav:createdOn>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-123.txt.html</ao:hasSource>
    <ao:suffix>, AVANDIA improved glycemic control in both males and females. In metformin combination studies, efficacy was demonstrated with no gender differences in glycemic response.</ao:suffix>
    <domeo:uuid>DCEF4B50-19DE-4DDE-ADB0-22E897CE8FC1</domeo:uuid>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:prefix>As monotherapy and in combination with </ao:prefix>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:DCEF4B50-19DE-4DDE-ADB0-22E897CE8FC1"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:exact>metformin</ao:exact>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:3DC39945-7562-466B-9B45-B860249B5C62">
    <pav:lastSavedOn>2014-07-24 20:10:48 -0400</pav:lastSavedOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <rdfs:label>Highlight</rdfs:label>
    <pav:lineageUri>urn:domeoserver:annotationset:4A88D0A6-E9B6-4E7F-955F-3692600C178C</pav:lineageUri>
    <domeo:belongsToSet>urn:domeoserver:annotationset:37B2514D-1A92-45B1-8A5C-610DA6DC935A</domeo:belongsToSet>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <ao:context rdf:resource="urn:domeoclient:uuid:F34547B1-36EF-43A2-81A9-922401A6E906"/>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812eda990003</pav:createdBy>
    <pav:lineageUri>urn:domeoserver:annotation:8D65FDE1-6D43-4AF8-BD4C-72B524476197</pav:lineageUri>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">2</pav:versionNumber>
    <pav:createdOn>2014-07-24 20:07:44 -0400</pav:createdOn>
    <domeo:belongsToSet>urn:domeoserver:annotationset:1FC172B8-8AC3-465A-AA69-B73AD9B97CBC</domeo:belongsToSet>
    <pav:previousVersion>urn:domeoclient:uuid:8D86A4AC-54BD-4BB3-8B58-AB55DEC01A88</pav:previousVersion>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:7BB31731-2995-4E32-A961-91EF24F0EEE7">
    <pav:createdOn>2014-07-22 18:47:02 -0400</pav:createdOn>
    <rdfs:label>expertstudy Annotation</rdfs:label>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:lineageUri>urn:domeoserver:annotation:033DECA4-8588-431F-BA99-F93BE3AFFA0D</pav:lineageUri>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <ao:context rdf:resource="urn:domeoclient:uuid:7F9271EC-A8D0-45D0-9412-2C40F45D0D4B"/>
    <ao:body rdf:nodeID="Nd9e83c1d95e64582bf0d86c1725a629b"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#expertstudyAnnotation"/>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812eda990003</pav:createdBy>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:lastSavedOn>2014-07-22 18:46:52 -0400</pav:lastSavedOn>
    <domeo:belongsToSet>urn:domeoclient:uuid:E0054F81-6A9B-4AF0-9DCB-962A6FC1C418</domeo:belongsToSet>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:816C98CB-228B-41B9-9F5B-78D35D300142">
    <domeo:uuid>816C98CB-228B-41B9-9F5B-78D35D300142</domeo:uuid>
    <ao:suffix> </ao:suffix>
    <ao:exact>trazodone</ao:exact>
    <pav:createdOn>2014-07-24 20:01:41 -0400</pav:createdOn>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:816C98CB-228B-41B9-9F5B-78D35D300142"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-136.txt.html</ao:hasSource>
    <ao:prefix>xsd:String</ao:prefix>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:56E0618F-C2A8-4B2E-868E-D415AEE3E3EF">
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <domeo:belongsToSet>urn:domeoserver:annotationset:392EE0FB-AC4F-4AF2-87A6-2E50A281F434</domeo:belongsToSet>
    <pav:lineageUri>urn:domeoserver:annotation:DF32FDB7-BBF0-4A3E-8804-613E06C8CB86</pav:lineageUri>
    <pav:lastSavedOn>2014-09-02 19:19:47 -0400</pav:lastSavedOn>
    <ao:context rdf:resource="urn:domeoclient:uuid:43D69C84-CE2E-4308-B875-6976981E58BC"/>
    <rdfs:label>Highlight</rdfs:label>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812eda990003</pav:createdBy>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <domeo:belongsToSet>urn:domeoclient:uuid:CB83FFC2-EA71-44EA-8F11-DE80E389C84E</domeo:belongsToSet>
    <pav:createdOn>2014-09-02 19:19:11 -0400</pav:createdOn>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <pav:lineageUri>urn:domeoserver:annotationset:C5DEBC9B-77EE-4243-88EB-DBC19737ACD2</pav:lineageUri>
    <domeo:belongsToSet>urn:domeoserver:annotationset:E32812A9-205B-4EE1-B488-A1E294EDBFB9</domeo:belongsToSet>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:4C6E4A21-6D29-4DFC-BCC7-71D10F66BA88">
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <ao:context rdf:resource="urn:domeoclient:uuid:E67991C8-7BD1-474A-98AE-6F58A72C0A35"/>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:lastSavedOn>2014-07-21 21:30:24 -0400</pav:lastSavedOn>
    <pav:lineageUri>urn:domeoserver:annotation:D9B4B7F7-2711-4353-9C2F-C940C1013315</pav:lineageUri>
    <domeo:belongsToSet>urn:domeoclient:uuid:B394B422-1AAF-4ED4-A3BB-3FB13E961EEA</domeo:belongsToSet>
    <pav:createdOn>2014-07-21 21:28:38 -0400</pav:createdOn>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812eda990003</pav:createdBy>
    <rdfs:label>Highlight</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:55C36B4E-CDCE-4B16-94D5-178014A48A7F">
    <domeo:uuid>55C36B4E-CDCE-4B16-94D5-178014A48A7F</domeo:uuid>
    <ao:suffix>, its major metabolite, 9-hydroxyrisperidone, and risperidone plus 9-hydroxyrisperidone are dose proportional over the dosing range of 1 to 16 mg daily (0.5 to 8 mg twice daily). Following oral administration of solution or tablet, mean peak plasma conce</ao:suffix>
    <ao:prefix>Plasma concentrations of </ao:prefix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:exact>risperidone</ao:exact>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:55C36B4E-CDCE-4B16-94D5-178014A48A7F"/>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-8.txt.html</ao:hasSource>
    <pav:createdOn>2014-07-13 11:09:28 -0400</pav:createdOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:9BB046B1-5949-4043-9525-70D01EC3816C">
    <ao:exact>risperidone</ao:exact>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:prefix> is rapidly distributed. The volume of distribution is 1 to 2 L/kg. In plasma, </ao:prefix>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-8.txt.html</ao:hasSource>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:9BB046B1-5949-4043-9525-70D01EC3816C"/>
    <domeo:uuid>9BB046B1-5949-4043-9525-70D01EC3816C</domeo:uuid>
    <ao:suffix> is bound to albumin and α1-acid glycoprotein. The plasma protein binding of risperidone is 90%, and that of its major metabolite, 9-hydroxyrisperidone, is 77%. Neither risperidone nor 9-hydroxyrisperidone displaces each other from plasma binding sites. </ao:suffix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <pav:createdOn>2014-07-13 11:10:51 -0400</pav:createdOn>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/990B9FF4-1B11-4306-B335-B576A2DE3124">
    <rdfs:label>AVANDIA</rdfs:label>
    <sio:SIO_000228>dikbD2R:object-drug-of-interaction</sio:SIO_000228>
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/261455</dailymed:activeMoietyRxCUI>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/drug-product"/>
    <dct:description>Referred to the drug in the interaction.</dct:description>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:CCA3540C-4A74-4782-9325-18A999F61C75">
    <ao:prefix> was shown to be mediated by increased sensitivity to insulin’s action in the liver, muscle, and adipose tissues. Pharmacological studies in animal models indicate that </ao:prefix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:CCA3540C-4A74-4782-9325-18A999F61C75"/>
    <ao:exact>rosiglitazone</ao:exact>
    <ao:suffix> inhibits hepatic gluconeogenesis. The expression of the insulin-regulated glucose transporter GLUT-4 was increased in adipose tissue. Rosiglitazone did not induce hypoglycemia in animal models of type 2 diabetes and/or impaired glucose tolerance.</ao:suffix>
    <pav:createdOn>2014-07-22 19:11:48 -0400</pav:createdOn>
    <domeo:uuid>CCA3540C-4A74-4782-9325-18A999F61C75</domeo:uuid>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-123.txt.html</ao:hasSource>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/FE6B22BB-D261-488B-A15D-2B75123912F4">
    <rdfs:label>carbamazepine</rdfs:label>
    <sio:SIO_000228>dikbD2R:precipitant-drug-of-interaction</sio:SIO_000228>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/active-ingredient"/>
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/2002</dailymed:activeMoietyRxCUI>
    <dct:description>Referred to the drug in the interaction.</dct:description>
  </rdf:Description>
  <rdf:Description rdf:nodeID="N8fe5ef43f5504515b80ec3dc6104d9b9">
    <permissions:accessType>urn:domeo:access:public</permissions:accessType>
    <permissions:isLocked>false</permissions:isLocked>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:7F7832F9-F40E-4E9B-917C-25342C417D3F">
    <ao:exact>Omeprazole</ao:exact>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:suffix> has been reported to interact with some antiretroviral drugs. The clinical importance and the mechanisms behind these interactions are not always known. Increased gastric pH during omeprazole treatment may change the absorption of the antiretroviral dru</ao:suffix>
    <domeo:uuid>7F7832F9-F40E-4E9B-917C-25342C417D3F</domeo:uuid>
    <ao:prefix>xsd:String</ao:prefix>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-74.txt.html</ao:hasSource>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <pav:createdOn>2014-09-02 19:17:02 -0400</pav:createdOn>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:7F7832F9-F40E-4E9B-917C-25342C417D3F"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:3558088E-2467-4C3A-87EA-D9EA80C217D1">
    <domeo:uuid>3558088E-2467-4C3A-87EA-D9EA80C217D1</domeo:uuid>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-72.txt.html</ao:hasSource>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:suffix> concentrations. Induction of CYP3A4 activity by its inducers, such as rifampin, carbamazepine, and phenytoin, may lead to a lack of efficacy or, possibly, development of an abstinence syndrome in a patient who had developed physical dependence to oxycod</ao:suffix>
    <pav:createdOn>2014-09-02 19:09:44 -0400</pav:createdOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:3558088E-2467-4C3A-87EA-D9EA80C217D1"/>
    <ao:prefix>, a drug metabolizing enzyme inducer, significantly decreased </ao:prefix>
    <ao:exact>plasma oxycodone</ao:exact>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:8214D15C-5AF1-47D0-A63C-30543353403D">
    <ao:prefix> dosing resulted in small increases in the mean AUCs of </ao:prefix>
    <domeo:uuid>8214D15C-5AF1-47D0-A63C-30543353403D</domeo:uuid>
    <ao:exact>ethinyl estradiol</ao:exact>
    <ao:suffix> and norethindrone compared to similar placebo dosing. The mean AUCs of ethinyl estradiol and norethindrone increased by 24% (95% C.I. range 18 to 31%) and 13% (95% C.I. range 8 to 18%), respectively relative to placebo. Fluconazole treatment did not cau</ao:suffix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:8214D15C-5AF1-47D0-A63C-30543353403D"/>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-21.txt.html</ao:hasSource>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <pav:createdOn>2014-07-13 12:37:44 -0400</pav:createdOn>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:F3D2A83E-9B62-495D-A7E7-A17FEF5E2561">
    <ao:suffix>, as with other drugs used to treat schizophrenia, is unknown. However, it has been proposed that the drug’s therapeutic activity in schizophrenia is mediated through a combination of dopamine Type 2 (D2) and serotonin Type 2 (5HT2) receptor antagonism.</ao:suffix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:prefix>The mechanism of action of </ao:prefix>
    <domeo:uuid>F3D2A83E-9B62-495D-A7E7-A17FEF5E2561</domeo:uuid>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:F3D2A83E-9B62-495D-A7E7-A17FEF5E2561"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-8.txt.html</ao:hasSource>
    <pav:createdOn>2014-07-13 11:04:07 -0400</pav:createdOn>
    <ao:exact>risperidone</ao:exact>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:9F788EEC-77F0-4E60-8480-F71299529EB7">
    <pav:createdOn>2014-07-22 20:21:31 -0400</pav:createdOn>
    <rdfs:label>expertstudy Annotation</rdfs:label>
    <domeo:belongsToSet>urn:domeoserver:annotationset:F272A789-69D0-47CC-8CC9-F25C55B91261</domeo:belongsToSet>
    <ao:context rdf:resource="urn:domeoclient:uuid:176AA3EF-BFBB-48D5-8C72-B5138286D455"/>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:lastSavedOn>2014-07-22 20:22:38 -0400</pav:lastSavedOn>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#expertstudyAnnotation"/>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812eda990003</pav:createdBy>
    <ao:body rdf:nodeID="N76aaf2fc3a3749a691604463a91f34cb"/>
    <pav:lineageUri>urn:domeoserver:annotation:F77DAE8C-2F42-4FBF-A88C-549AE7ECC4C0</pav:lineageUri>
  </rdf:Description>
  <rdf:Description rdf:nodeID="Nff3a983272534733a7f39d693c6021a9">
    <permissions:accessType>urn:domeo:access:public</permissions:accessType>
    <permissions:isLocked>false</permissions:isLocked>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:2632D1DD-2AAF-40EA-9A99-DCA6352518F5">
    <pav:lastSavedOn>2014-09-02 19:46:58 -0400</pav:lastSavedOn>
    <pav:createdOn>2014-09-02 19:46:36 -0400</pav:createdOn>
    <rdfs:label>Highlight</rdfs:label>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812eda990003</pav:createdBy>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <domeo:belongsToSet>urn:domeoclient:uuid:1285AF18-3541-4E0D-9BAA-DDBC5E9C152C</domeo:belongsToSet>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <ao:context rdf:resource="urn:domeoclient:uuid:464DEB11-7E78-4A1A-BC27-EFBA56EDF6A6"/>
    <pav:lineageUri>urn:domeoserver:annotation:35B3106D-87ED-421E-904D-19B280409F61</pav:lineageUri>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:53D686B6-4D2E-4EA7-922E-FFE9A54F0AFC">
    <ao:context rdf:resource="urn:domeoclient:uuid:EC4F7D99-8435-471D-98FA-12D2364884E1"/>
    <ao:body rdf:nodeID="N592bb7bb66a84d5da9b77ac2d8bb9e22"/>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <domeo:belongsToSet>urn:domeoclient:uuid:E0054F81-6A9B-4AF0-9DCB-962A6FC1C418</domeo:belongsToSet>
    <rdfs:label>expertstudy Annotation</rdfs:label>
    <pav:lineageUri>urn:domeoserver:annotation:6619A95A-D5DA-440A-ACEE-7F01BBD64327</pav:lineageUri>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#expertstudyAnnotation"/>
    <pav:lastSavedOn>2014-07-22 18:46:52 -0400</pav:lastSavedOn>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <pav:createdOn>2014-07-22 18:46:07 -0400</pav:createdOn>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812eda990003</pav:createdBy>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:A3DAB1A6-C48D-422B-A0D0-776352B4CC3F">
    <domeo:belongsToSet>urn:domeoserver:annotationset:A3F0B39A-4249-4B63-BB0D-F24A005066AC</domeo:belongsToSet>
    <pav:lineageUri>urn:domeoserver:annotationset:D1715BD2-BD41-46FD-9454-DC7A423A29AC</pav:lineageUri>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <rdfs:label>Highlight</rdfs:label>
    <pav:createdOn>2014-09-02 11:36:19 -0400</pav:createdOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812eda990003</pav:createdBy>
    <pav:previousVersion>urn:domeoclient:uuid:BED41F06-565A-4622-9A88-48810E5A28DE</pav:previousVersion>
    <pav:lastSavedOn>2014-09-02 11:46:58 -0400</pav:lastSavedOn>
    <ao:context rdf:resource="urn:domeoclient:uuid:38A85164-B87B-441D-87CB-0E3B5B67551D"/>
    <pav:lineageUri>urn:domeoserver:annotation:C52F9D13-A47B-4CB6-85D6-84237822D148</pav:lineageUri>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <domeo:belongsToSet>urn:domeoserver:annotationset:3F546823-204F-4F9B-9006-3DC526C56931</domeo:belongsToSet>
    <domeo:belongsToSet>urn:domeoserver:annotationset:A5DD001D-C81A-4E2E-B5E0-7A866B35E26B</domeo:belongsToSet>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">2</pav:versionNumber>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:704A238F-4D41-41C0-AEE2-EF49045B60D6">
    <domeo:belongsToSet>urn:domeoclient:uuid:D94A3BF4-A374-449F-9330-5C3F983FC929</domeo:belongsToSet>
    <pav:lastSavedOn>2014-09-01 16:02:34 -0400</pav:lastSavedOn>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:lineageUri>urn:domeoserver:annotation:A7D6B2F9-CA80-489F-A2EE-AF66905E962F</pav:lineageUri>
    <ao:context rdf:resource="urn:domeoclient:uuid:5034993F-95BA-483B-9B77-F3B8E9E3CFC5"/>
    <pav:createdOn>2014-09-01 16:02:32 -0400</pav:createdOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812eda990003</pav:createdBy>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <rdfs:label>Highlight</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:463EFB94-13AD-4945-B3D3-4B953F099775">
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812eda990003</pav:createdBy>
    <pav:lineageUri>urn:domeoserver:annotation:BDB7A5F6-354B-467E-8723-23AEC5C9C146</pav:lineageUri>
    <domeo:belongsToSet>urn:domeoserver:annotationset:F272A789-69D0-47CC-8CC9-F25C55B91261</domeo:belongsToSet>
    <ao:context rdf:resource="urn:domeoclient:uuid:AE2B15F2-9CA8-49EC-B61F-0A38DD22AF0C"/>
    <rdfs:label>Highlight</rdfs:label>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:lastSavedOn>2014-07-22 20:22:38 -0400</pav:lastSavedOn>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <pav:createdOn>2014-07-22 20:17:49 -0400</pav:createdOn>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:3A07EF3E-A1DF-4E0E-952B-5422EC6E9B3D">
    <ao:exact>sildenafil </ao:exact>
    <domeo:uuid>3A07EF3E-A1DF-4E0E-952B-5422EC6E9B3D</domeo:uuid>
    <ao:prefix>(800 mg), a nonspecific CYP inhibitor, caused a 56% increase in plasma </ao:prefix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:3A07EF3E-A1DF-4E0E-952B-5422EC6E9B3D"/>
    <domeo:uuid></domeo:uuid>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-155.txt.html</ao:hasSource>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:suffix>concentrations when co-administered with sildenafil (50 mg) to healthy volunteers.</ao:suffix>
    <pav:createdOn>2014-07-07 11:22:54 -0400</pav:createdOn>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/61AE2D64-FCA3-4A33-91AF-196E90750A35">
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/8787</dailymed:activeMoietyRxCUI>
    <rdfs:label>Propranolol</rdfs:label>
    <sio:SIO_000228>dikbD2R:object-drug-of-interaction</sio:SIO_000228>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/active-ingredient"/>
    <dct:description>Referred to the drug in the interaction.</dct:description>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:CE8D9855-AB1B-4B9E-97B4-6A441B8254E8">
    <pav:lineageUri>urn:domeoserver:annotation:6845B377-D6ED-489F-AEA2-ACDD60E3B922</pav:lineageUri>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812eda990003</pav:createdBy>
    <pav:createdOn>2014-09-02 19:08:23 -0400</pav:createdOn>
    <domeo:belongsToSet>urn:domeoclient:uuid:3966BCFB-CA02-4053-828D-3860558E7BE8</domeo:belongsToSet>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <rdfs:label>Highlight</rdfs:label>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:lastSavedOn>2014-09-02 19:11:13 -0400</pav:lastSavedOn>
    <ao:context rdf:resource="urn:domeoclient:uuid:AD975124-2202-48D6-98F2-6042E8AC8DF1"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:C0DCB0F4-61CC-48CE-8688-567F2327B321">
    <ao:exact>cimetidine</ao:exact>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:suffix> 600 mg to 900 mg intravenously over a four-hour period (from one hour before to 3 hours after a single oral dose of fluconazole 200 mg) did not affect the bioavailability or pharmacokinetics of fluconazole in 24 healthy male volunteers.</ao:suffix>
    <pav:createdOn>2014-07-13 12:46:27 -0400</pav:createdOn>
    <ao:prefix> AUC of 13% ± 11% (range: -3.4 to -31%) and Cmax decreased 19% ± 14% (range: -5 to -40%). However, the administration of </ao:prefix>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:C0DCB0F4-61CC-48CE-8688-567F2327B321"/>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-23.txt.html</ao:hasSource>
    <domeo:uuid>C0DCB0F4-61CC-48CE-8688-567F2327B321</domeo:uuid>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:776765AF-5295-4800-809B-C7978354CB7E">
    <sio:SIO_000563>dikbD2R:modality</sio:SIO_000563>
    <sio:SIO_000628 rdf:resource="urn:pddi:uuid:370F2AF6-A399-4830-9318-16C2CC56C4E5"/>
    <dikbD2R:statement>ncit:quantitative</dikbD2R:statement>
    <dikbD2R:modality>ncit:positive</dikbD2R:modality>
    <sio:SIO_000205>dikbD2R:statement</sio:SIO_000205>
    <rdf:type rdf:resource="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#DrugDrugInteractionStatement"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:693EEFEC-7BCC-4823-A86C-533B31687EFA">
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-123.txt.html</ao:hasSource>
    <pav:createdOn>2014-07-22 19:49:22 -0400</pav:createdOn>
    <ao:suffix> (8 mg once daily) for 8 days in healthy adult Caucasian subjects caused a decrease in glyburide AUC and Cmax of approximately 30%. In Japanese subjects, glyburide AUC and Cmax slightly increased following coadministration of AVANDIA.</ao:suffix>
    <ao:prefix> (3.75 to 10 mg/day) for 7 days did not alter the mean steady-state 24-hour plasma glucose concentrations in diabetic patients stabilized on glyburide therapy. Repeat doses of </ao:prefix>
    <domeo:uuid>693EEFEC-7BCC-4823-A86C-533B31687EFA</domeo:uuid>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:exact>AVANDIA</ao:exact>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:693EEFEC-7BCC-4823-A86C-533B31687EFA"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:FE7EF264-FC22-45A9-853D-E8804BE9EF1B">
    <ao:context rdf:resource="urn:domeoclient:uuid:78619284-035D-4B46-89AF-54BD7FF23461"/>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#expertstudyAnnotation"/>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812eda990003</pav:createdBy>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <pav:lineageUri>urn:domeoserver:annotation:0F617270-F9F7-43F7-B46E-93AD726CB6E6</pav:lineageUri>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <ao:body rdf:nodeID="Nc71143847f9f4013b76facbad12ba057"/>
    <rdfs:label>expertstudy Annotation</rdfs:label>
    <pav:lastSavedOn>2014-07-21 21:55:00 -0400</pav:lastSavedOn>
    <domeo:belongsToSet>urn:domeoclient:uuid:C988D053-7CF3-4C50-BDB6-7C2B20B837B9</domeo:belongsToSet>
    <pav:createdOn>2014-07-21 21:54:37 -0400</pav:createdOn>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:7FD7602A-D05F-4BEA-AC56-67DE4BF0AB32">
    <ao:prefix> may be due to transport-related effects, such as p-glycoprotein. In vivo animal studies also suggest that in addition to enhancing absorption, </ao:prefix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <domeo:uuid>7FD7602A-D05F-4BEA-AC56-67DE4BF0AB32</domeo:uuid>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:7FD7602A-D05F-4BEA-AC56-67DE4BF0AB32"/>
    <ao:suffix> decreases fexofenadine gastrointestinal secretion, while erythromycin may also decrease biliary excretion.</ao:suffix>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-139.txt.html</ao:hasSource>
    <ao:exact>ketoconazole</ao:exact>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <pav:createdOn>2014-07-24 20:11:57 -0400</pav:createdOn>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:78619284-035D-4B46-89AF-54BD7FF23461">
    <ao:exact>Zonisamide had no appreciable effect on the steady-state plasma concentrations of phenytoin, carbamazepine, or valproate during clinical trials. Zonisamide did not inhibit mixed-function liver oxidase enzymes (cytochrome P450), as measured in human liver microsomal preparations, in vitro. Zonisamide is not expected to interfere with the metabolism of other drugs that are metabolized by cytochrome P450 isozymes</ao:exact>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <domeo:uuid>78619284-035D-4B46-89AF-54BD7FF23461</domeo:uuid>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:78619284-035D-4B46-89AF-54BD7FF23461"/>
    <ao:suffix>xsd:String</ao:suffix>
    <pav:createdOn>2014-07-21 21:54:37 -0400</pav:createdOn>
    <ao:prefix>xsd:String</ao:prefix>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-56.txt.html</ao:hasSource>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:7359157D-6F7C-43D2-9127-08D4CCFA7E1A">
    <ao:context rdf:resource="urn:domeoclient:uuid:31A6BF79-BBAC-479E-B954-4B14FED74D2E"/>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <rdfs:label>Highlight</rdfs:label>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:lineageUri>urn:domeoserver:annotation:CB678F6C-1A52-472F-B483-C669D0703E1B</pav:lineageUri>
    <domeo:belongsToSet>urn:domeoserver:annotationset:1FC172B8-8AC3-465A-AA69-B73AD9B97CBC</domeo:belongsToSet>
    <pav:lastSavedOn>2014-07-24 20:07:20 -0400</pav:lastSavedOn>
    <domeo:belongsToSet>urn:domeoserver:annotationset:37B2514D-1A92-45B1-8A5C-610DA6DC935A</domeo:belongsToSet>
    <domeo:belongsToSet>urn:domeoclient:uuid:8D86A4AC-54BD-4BB3-8B58-AB55DEC01A88</domeo:belongsToSet>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812eda990003</pav:createdBy>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:lastSavedOn>2014-07-24 20:07:19 -0400</pav:lastSavedOn>
    <pav:createdOn>2014-07-24 20:07:37 -0400</pav:createdOn>
    <pav:lineageUri>urn:domeoserver:annotationset:4A88D0A6-E9B6-4E7F-955F-3692600C178C</pav:lineageUri>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/DF818BD4-17A0-4731-84D5-207257326816">
    <rdfs:label>propranolol</rdfs:label>
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/8787</dailymed:activeMoietyRxCUI>
    <sio:SIO_000228>dikbD2R:precipitant-drug-of-interaction</sio:SIO_000228>
    <dct:description>Referred to the drug in the interaction.</dct:description>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/active-ingredient"/>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/089280DB-9E3B-46D1-9448-CA64307E1CBF">
    <sio:SIO_000228>dikbD2R:precipitant-drug-of-interaction</sio:SIO_000228>
    <rdfs:label>fluvoxamine</rdfs:label>
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/42355</dailymed:activeMoietyRxCUI>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/active-ingredient"/>
    <dct:description>Referred to the drug in the interaction.</dct:description>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:D16208CB-7392-415A-8487-52928A419F00">
    <domeo:uuid>D16208CB-7392-415A-8487-52928A419F00</domeo:uuid>
    <pav:createdOn>2014-07-13 12:46:12 -0400</pav:createdOn>
    <ao:exact>Fluconazole</ao:exact>
    <ao:prefix>xsd:String</ao:prefix>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-23.txt.html</ao:hasSource>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:D16208CB-7392-415A-8487-52928A419F00"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:suffix> 100 mg was administered as a single oral dose alone and two hours after a single dose of cimetidine 400 mg to six healthy male volunteers. After the administration of cimetidine, there was a significant decrease in fluconazole AUC and Cmax. There was a </ao:suffix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:DFCBEAF2-DEEA-4C46-A167-B2B6F5C56C00">
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <rdfs:label>Highlight</rdfs:label>
    <pav:lastSavedOn>2014-07-13 11:32:29 -0400</pav:lastSavedOn>
    <pav:lineageUri>urn:domeoserver:annotation:AB8C215A-FA3F-4A34-A334-0F1287CE0DA8</pav:lineageUri>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812eda990003</pav:createdBy>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <ao:context rdf:resource="urn:domeoclient:uuid:49F82F74-6EDD-4994-8052-10CB1FCA4BA0"/>
    <domeo:belongsToSet>urn:domeoclient:uuid:71191E51-53CB-4FDE-88D0-33C6818E2232</domeo:belongsToSet>
    <pav:createdOn>2014-07-13 11:09:11 -0400</pav:createdOn>
    <pav:previousVersion>xsd:String</pav:previousVersion>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:C9DB2D07-ABDB-402C-AA6C-8EB7046415D4">
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <rdfs:label>Highlight</rdfs:label>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <pav:lineageUri>urn:domeoserver:annotation:7206074C-7221-4AA1-8796-9AD7DCD6C411</pav:lineageUri>
    <domeo:belongsToSet>urn:domeoclient:uuid:3966BCFB-CA02-4053-828D-3860558E7BE8</domeo:belongsToSet>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812eda990003</pav:createdBy>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:lastSavedOn>2014-09-02 19:11:13 -0400</pav:lastSavedOn>
    <pav:createdOn>2014-09-02 19:10:13 -0400</pav:createdOn>
    <ao:context rdf:resource="urn:domeoclient:uuid:B30D95E2-6A9C-41B9-A6BC-823FD4639E01"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
  </rdf:Description>
  <rdf:Description rdf:nodeID="N8d9f93872ec744fdb315e073c71343eb">
    <domeo:sets rdf:resource="urn:pddi:uuid:A4653C46-2FC4-4FCC-9060-201662C0BAB0"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:BFB51383-F8CA-4B7D-AF51-8BC2302A8276">
    <domeo:uuid>BFB51383-F8CA-4B7D-AF51-8BC2302A8276</domeo:uuid>
    <pav:createdOn>2014-09-02 12:02:37 -0400</pav:createdOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:suffix>, other SSRIs, and many tricyclics), are metabolized by the cytochrome P450 isozyme CYP2D6. Like other agents that are metabolized by CYP2D6, paroxetine may significantly inhibit the activity of this isozyme. In most patients (&gt;90%), this CYP2D6 isozyme </ao:suffix>
    <ao:exact>paroxetine</ao:exact>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:BFB51383-F8CA-4B7D-AF51-8BC2302A8276"/>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-47.txt.html</ao:hasSource>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:prefix>Many drugs, including most drugs effective in the treatment of major depressive disorder (</ao:prefix>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:A71C73E7-BDEF-430C-BE2B-73E35D00A542">
    <domeo:uuid>A71C73E7-BDEF-430C-BE2B-73E35D00A542</domeo:uuid>
    <ao:suffix> has been shown to exhibit minimal (ca. 5%) metabolism. However, coadministration of fexofenadine hydrochloride with either ketoconazole or erythromycin led to increased plasma concentrations of fexofenadine in healthy adult subjects. Fexofenadine had no</ao:suffix>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-139.txt.html</ao:hasSource>
    <pav:createdOn>2014-07-24 20:07:07 -0400</pav:createdOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:A71C73E7-BDEF-430C-BE2B-73E35D00A542"/>
    <ao:exact>Fexofenadine</ao:exact>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:prefix>xsd:String</ao:prefix>
  </rdf:Description>
  <rdf:Description rdf:nodeID="Nb2e79cf51a174e0185de063b4b5f7f72">
    <permissions:isLocked>false</permissions:isLocked>
    <permissions:accessType>urn:domeo:access:public</permissions:accessType>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:AE73B237-E7E7-49DE-9295-FF17AED8776B">
    <ao:suffix>for 17 days (including 200 mg/day for the last 10 days) did not change serum digoxin levels or digoxin renal clearance.</ao:suffix>
    <ao:prefix>In a placebo-controlled trial in normal volunteers, administration of </ao:prefix>
    <ao:exact>sertraline </ao:exact>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:AE73B237-E7E7-49DE-9295-FF17AED8776B"/>
    <pav:createdOn>2014-09-01 16:04:28 -0400</pav:createdOn>
    <domeo:uuid>AE73B237-E7E7-49DE-9295-FF17AED8776B</domeo:uuid>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-19.txt.html</ao:hasSource>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:D41F6EB4-7428-411F-9159-905789D6B7B0">
    <domeo:belongsToSet>urn:domeoclient:uuid:C988D053-7CF3-4C50-BDB6-7C2B20B837B9</domeo:belongsToSet>
    <ao:context rdf:resource="urn:domeoclient:uuid:6A9F403B-F60E-4954-9EEE-BB0C7DAD583B"/>
    <rdfs:label>Highlight</rdfs:label>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812eda990003</pav:createdBy>
    <pav:lineageUri>urn:domeoserver:annotation:36367788-6B4F-48D5-ACBF-69147D22E350</pav:lineageUri>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <pav:lastSavedOn>2014-07-21 21:55:00 -0400</pav:lastSavedOn>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:createdOn>2014-07-21 21:53:39 -0400</pav:createdOn>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:62E3DBD7-F876-4CE9-8CED-6955F6A66F76">
    <sio:SIO_000205>dikbD2R:statement</sio:SIO_000205>
    <sio:SIO_000563>dikbD2R:modality</sio:SIO_000563>
    <rdf:type rdf:resource="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#DrugDrugInteractionStatement"/>
    <dikbD2R:statement>ncit:Qualitative</dikbD2R:statement>
    <dikbD2R:modality>ncit:negative</dikbD2R:modality>
    <sio:SIO_000628 rdf:resource="urn:pddi:uuid:D11B175A-9529-45D5-B5B7-A6B7917B6593"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:A59202ED-7ABE-4A45-97C0-8272FAD7DF90">
    <pav:createdOn>2014-07-24 20:14:54 -0400</pav:createdOn>
    <rdfs:label>Highlight</rdfs:label>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:lineageUri>urn:domeoserver:annotation:C8BC9320-3D21-4D57-81E6-481EA29CFBC0</pav:lineageUri>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812eda990003</pav:createdBy>
    <domeo:belongsToSet>urn:domeoclient:uuid:2BAA59CB-3862-4A98-8A6C-AA14E82983DC</domeo:belongsToSet>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <ao:context rdf:resource="urn:domeoclient:uuid:E6FE6875-950C-46F9-801E-FB47AB83A2ED"/>
    <pav:lastSavedOn>2014-07-24 20:14:43 -0400</pav:lastSavedOn>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/F0EB30BB-0A91-4488-BC91-DB2E42B74BC6">
    <sio:SIO_000228>dikbD2R:object-drug-of-interaction</sio:SIO_000228>
    <dct:description>Referred to the drug in the interaction.</dct:description>
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/</dailymed:activeMoietyRxCUI>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/active-ingredient"/>
    <rdfs:label>lithium</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:F442DD1F-67E3-41D3-92CB-9048022BDFCC">
    <ao:suffix> is not normally required. However, in patients with Zollinger-Ellison syndrome, who may require higher doses up to 240 mg/day, dose adjustment may be considered. When voriconazole (400 mg Q12h x 1 day, then 200 mg x 6 days) was given with omeprazole (40</ao:suffix>
    <ao:exact>omeprazole</ao:exact>
    <pav:createdOn>2014-09-02 19:15:59 -0400</pav:createdOn>
    <ao:prefix> exposure. Dose adjustment of </ao:prefix>
    <domeo:uuid>F442DD1F-67E3-41D3-92CB-9048022BDFCC</domeo:uuid>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-74.txt.html</ao:hasSource>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:F442DD1F-67E3-41D3-92CB-9048022BDFCC"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:B1D53EEF-8BCA-4B91-B107-30A073406F41">
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812eda990003</pav:createdBy>
    <ao:context rdf:resource="urn:domeoclient:uuid:50E47850-992D-44A2-BE5F-681487D5414C"/>
    <pav:createdOn>2014-09-02 19:12:50 -0400</pav:createdOn>
    <pav:lineageUri>urn:domeoserver:annotationset:C5DEBC9B-77EE-4243-88EB-DBC19737ACD2</pav:lineageUri>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <domeo:belongsToSet>urn:domeoclient:uuid:CB83FFC2-EA71-44EA-8F11-DE80E389C84E</domeo:belongsToSet>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <domeo:belongsToSet>urn:domeoserver:annotationset:392EE0FB-AC4F-4AF2-87A6-2E50A281F434</domeo:belongsToSet>
    <domeo:belongsToSet>urn:domeoserver:annotationset:E32812A9-205B-4EE1-B488-A1E294EDBFB9</domeo:belongsToSet>
    <rdfs:label>Highlight</rdfs:label>
    <pav:lastSavedOn>2014-09-02 19:19:47 -0400</pav:lastSavedOn>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:lineageUri>urn:domeoserver:annotation:CF2C9880-1697-4D82-B0BF-386A44B06512</pav:lineageUri>
  </rdf:Description>
  <rdf:Description rdf:nodeID="N7f50465193fa40bb98a3df058c623458">
    <domeo:sets rdf:resource="urn:pddi:uuid:B3F6AB4E-3B37-4465-8CFC-119F30A661AA"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:50649F2A-1F77-4AC3-AA05-9C465AAF3D79">
    <ao:exact>sildenafil </ao:exact>
    <ao:suffix> pharmacokinetics in patients with PAH.</ao:suffix>
    <domeo:uuid>50649F2A-1F77-4AC3-AA05-9C465AAF3D79</domeo:uuid>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:50649F2A-1F77-4AC3-AA05-9C465AAF3D79"/>
    <domeo:uuid></domeo:uuid>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <pav:createdOn>2014-07-07 09:59:10 -0400</pav:createdOn>
    <ao:prefix> in patients with PAH. The dataset available for the population pharmacokinetic evaluation contained a wide range of demographic data and laboratory parameters associated with hepatic and renal function. None of these factors had a significant impact on </ao:prefix>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-155.txt.html</ao:hasSource>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:ABB70710-CA87-4445-8EB3-1BFDDC4636FE">
    <domeo:uuid>ABB70710-CA87-4445-8EB3-1BFDDC4636FE</domeo:uuid>
    <ao:suffix> doses should be reduced in patients with renal disease [see 2 DOSAGE AND ADMINISTRATION and 5 WARNINGS AND PRECAUTIONS].</ao:suffix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <pav:createdOn>2014-07-13 11:17:32 -0400</pav:createdOn>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-8.txt.html</ao:hasSource>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:ABB70710-CA87-4445-8EB3-1BFDDC4636FE"/>
    <ao:exact>Risperidone</ao:exact>
    <ao:prefix> and its active metabolite decreased by 60% compared to young healthy subjects. </ao:prefix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:35C90981-123B-4326-86DF-489A6FE9CBFD">
    <ao:prefix> did not have an effect on the pharmacokinetics of </ao:prefix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:exact>fluvastatin</ao:exact>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:35C90981-123B-4326-86DF-489A6FE9CBFD"/>
    <ao:suffix>.</ao:suffix>
    <domeo:uuid>35C90981-123B-4326-86DF-489A6FE9CBFD</domeo:uuid>
    <pav:createdOn>2014-07-24 19:52:56 -0400</pav:createdOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-132.txt.html</ao:hasSource>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:E6FE6875-950C-46F9-801E-FB47AB83A2ED">
    <ao:suffix>, close monitoring for known side effects of azithromycin, such as liver enzyme abnormalities and hearing impairment, is warranted (see ADVERSE REACTIONS).</ao:suffix>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-161.txt.html</ao:hasSource>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:E6FE6875-950C-46F9-801E-FB47AB83A2ED"/>
    <pav:createdOn>2014-07-24 20:14:54 -0400</pav:createdOn>
    <domeo:uuid>E6FE6875-950C-46F9-801E-FB47AB83A2ED</domeo:uuid>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:exact>nelfinavir</ao:exact>
    <ao:prefix> is not recommended when administered in combination with </ao:prefix>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:697447CC-E28E-42D6-889F-E4B9D46954FC">
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/F66BC8F5-49B9-4B6B-9972-D0A9AFB6AF18"/>
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/C17461FE-A35A-4C0A-940B-01CB796E4877"/>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/PK_DDI"/>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/EA8D118F-5115-426B-8423-6A5269AC5A4A">
    <rdfs:label>phenytoin</rdfs:label>
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/8183</dailymed:activeMoietyRxCUI>
    <dct:description>Referred to the drug in the interaction.</dct:description>
    <sio:SIO_000228>dikbD2R:object-drug-of-interaction</sio:SIO_000228>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/active-ingredient"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:217FEFFB-6BFC-422A-B88B-75EE70185C1C">
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/4BCB725A-6FD9-45A7-A5BE-7BB7C488437E"/>
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/60D19F56-D600-4248-96B6-A68AD83F290A"/>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/PK_DDI"/>
  </rdf:Description>
  <rdf:Description rdf:nodeID="Nbb9efdfbe41245aebe2673a73a96d42f">
    <permissions:accessType>urn:domeo:access:public</permissions:accessType>
    <permissions:isLocked>false</permissions:isLocked>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:A361190A-A611-4162-AA47-4014AAEBA0B2">
    <domeo:belongsToSet>urn:domeoclient:uuid:71191E51-53CB-4FDE-88D0-33C6818E2232</domeo:belongsToSet>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:createdOn>2014-07-13 11:12:23 -0400</pav:createdOn>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812eda990003</pav:createdBy>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <pav:lineageUri>urn:domeoserver:annotation:19172135-E2AA-4088-BCFD-164180C591A3</pav:lineageUri>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <rdfs:label>Highlight</rdfs:label>
    <ao:context rdf:resource="urn:domeoclient:uuid:7E52164F-6FEF-4A1A-A55B-01314BCEB19B"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:lastSavedOn>2014-07-13 11:32:29 -0400</pav:lastSavedOn>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/8E677686-F1A8-4E2D-A503-156B748361AB">
    <sio:SIO_000228>dikbD2R:object-drug-of-interaction</sio:SIO_000228>
    <dct:description>Referred to the drug in the interaction.</dct:description>
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/39998</dailymed:activeMoietyRxCUI>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/active-ingredient"/>
    <rdfs:label>Zonisamide</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:FA48E451-6066-4222-B6F6-48D1739BF14F">
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/19778C35-B5B2-4C65-9F2A-49A170F2C3CF"/>
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/AA628DF4-FFD3-40B4-AF7F-28CD7B682042"/>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/PK_DDI"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:4302BBE9-CEFD-4D9A-8509-E48CACB9AAC3">
    <ao:prefix>, other SSRIs, and many tricyclics), are metabolized by the cytochrome P450 isozyme CYP2D6. Like other agents that are metabolized by CYP2D6, </ao:prefix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:suffix> may significantly inhibit the activity of this isozyme. In most patients (&gt;90%), this CYP2D6 isozyme is saturated early during paroxetine dosing. In 1 study, daily dosing of immediate-release paroxetine  (20 mg once daily) under steady-state conditions </ao:suffix>
    <pav:createdOn>2014-09-02 11:56:00 -0400</pav:createdOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-47.txt.html</ao:hasSource>
    <ao:exact>paroxetine</ao:exact>
    <domeo:uuid>4302BBE9-CEFD-4D9A-8509-E48CACB9AAC3</domeo:uuid>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:4302BBE9-CEFD-4D9A-8509-E48CACB9AAC3"/>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/A36E11B0-6726-4AD1-ACC7-4E8E59A350EB">
    <dct:description>Referred to the drug in the interaction.</dct:description>
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/6373</dailymed:activeMoietyRxCUI>
    <sio:SIO_000228>dikbD2R:precipitant-drug-of-interaction</sio:SIO_000228>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/active-ingredient"/>
    <rdfs:label>levonorgestrel</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:nodeID="Nd9e83c1d95e64582bf0d86c1725a629b">
    <domeo:sets rdf:resource="urn:pddi:uuid:B77653C9-A978-4DDF-BFD4-9627754056FA"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:C5023B49-22AF-4880-9F9A-B1FCB16EAE71">
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-22.txt.html</ao:hasSource>
    <domeo:uuid>C5023B49-22AF-4880-9F9A-B1FCB16EAE71</domeo:uuid>
    <ao:exact>fluconazole</ao:exact>
    <ao:prefix>Oral contraceptives were administered as a single dose both before and after the oral administration of </ao:prefix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <pav:createdOn>2014-07-13 12:42:01 -0400</pav:createdOn>
    <ao:suffix> 50 mg once daily for 10 days in 10 healthy women. There was no significant difference in ethinyl estradiol or </ao:suffix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:C5023B49-22AF-4880-9F9A-B1FCB16EAE71"/>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/04BE103D-A7ED-4289-9B72-CCC97FDE114E">
    <rdfs:label>warfarin</rdfs:label>
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/11289</dailymed:activeMoietyRxCUI>
    <dct:description>Referred to the drug in the interaction.</dct:description>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/active-ingredient"/>
    <sio:SIO_000228>dikbD2R:precipitant-drug-of-interaction</sio:SIO_000228>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/4B3161A8-052C-446A-A771-EB9186F64AD8">
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/active-ingredient"/>
    <rdfs:label>omeprazole</rdfs:label>
    <dct:description>Referred to the drug in the interaction.</dct:description>
    <sio:SIO_000228>dikbD2R:object-drug-of-interaction</sio:SIO_000228>
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/7646</dailymed:activeMoietyRxCUI>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:F05ECB2E-0877-466E-936C-3A60595FD6B9">
    <pav:createdOn>2014-09-01 16:00:05 -0400</pav:createdOn>
    <ao:suffix>, suggesting that the decreased clearance was due to a change in the metabolism of the drug. The clinical significance of this decrease in tolbutamide clearance is unknown.</ao:suffix>
    <domeo:uuid>F05ECB2E-0877-466E-936C-3A60595FD6B9</domeo:uuid>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:F05ECB2E-0877-466E-936C-3A60595FD6B9"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:prefix> administration did not noticeably change either the plasma protein binding or the apparent volume of distribution of </ao:prefix>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-17.txt.html</ao:hasSource>
    <ao:exact>tolbutamide</ao:exact>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:8D8724AE-D8FE-4EA2-BC2B-883652CC6520">
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/PK_DDI"/>
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/3FCE39BA-811B-456A-83F4-652EA5B4F4FC"/>
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/E8F2CA32-13F5-477A-BE7F-DE4F66964CFD"/>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/C3802543-BD64-4421-A632-BFDE8408A954">
    <sio:SIO_000228>dikbD2R:object-drug-of-interaction</sio:SIO_000228>
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/7417</dailymed:activeMoietyRxCUI>
    <rdfs:label>nifedipine</rdfs:label>
    <dct:description>Referred to the drug in the interaction.</dct:description>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/active-ingredient"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:87FEE025-38F8-476B-BB04-19AD3D10B07C">
    <pav:createdOn>2014-09-02 19:33:36 -0400</pav:createdOn>
    <ao:exact>For other antiretroviral drugs, such as saquinavir, elevated serum levels have been reported with an increase in AUC by 82%, in Cmax by 75% and in Cmin by 106% following multiple dosing of saquinavir/ritonavir (1000/100 mg) bid for 15 days with omeprazole 40 mg qd co-administered days 11 to 15.</ao:exact>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-74.txt.html</ao:hasSource>
    <ao:suffix> Dose reduction of</ao:suffix>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:87FEE025-38F8-476B-BB04-19AD3D10B07C"/>
    <ao:prefix> is therefore not recommended. </ao:prefix>
    <domeo:uuid>87FEE025-38F8-476B-BB04-19AD3D10B07C</domeo:uuid>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:84BD0311-11DD-4CCD-B082-CEE1C8BAAD37">
    <pav:previousVersion>urn:domeoclient:uuid:8D86A4AC-54BD-4BB3-8B58-AB55DEC01A88</pav:previousVersion>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:lineageUri>urn:domeoserver:annotationset:4A88D0A6-E9B6-4E7F-955F-3692600C178C</pav:lineageUri>
    <ao:context rdf:resource="urn:domeoclient:uuid:CB138E02-5A43-4D20-A598-828A1F13AC26"/>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">2</pav:versionNumber>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812eda990003</pav:createdBy>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <domeo:belongsToSet>urn:domeoserver:annotationset:1FC172B8-8AC3-465A-AA69-B73AD9B97CBC</domeo:belongsToSet>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <rdfs:label>Highlight</rdfs:label>
    <pav:lastSavedOn>2014-07-24 20:10:49 -0400</pav:lastSavedOn>
    <pav:createdOn>2014-07-24 20:07:52 -0400</pav:createdOn>
    <pav:lastSavedOn>2014-07-24 20:10:48 -0400</pav:lastSavedOn>
    <pav:lineageUri>urn:domeoserver:annotation:1B44FE80-C865-4A7F-ACDE-3C53995F7B9A</pav:lineageUri>
    <domeo:belongsToSet>urn:domeoserver:annotationset:37B2514D-1A92-45B1-8A5C-610DA6DC935A</domeo:belongsToSet>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:4BC86345-8DEB-4D78-A90E-121B217F37B6">
    <pav:lineageUri>urn:domeoserver:annotation:077DB5A5-02CD-411D-9AA7-244E43FF395E</pav:lineageUri>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812eda990003</pav:createdBy>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:createdOn>2014-09-02 12:03:26 -0400</pav:createdOn>
    <domeo:belongsToSet>urn:domeoserver:annotationset:D52DFD7B-BDDF-488F-B339-B1BC641E50E9</domeo:belongsToSet>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <rdfs:label>Highlight</rdfs:label>
    <domeo:belongsToSet>urn:domeoclient:uuid:379CD8C1-F4B4-42B7-8F87-70776866DB1F</domeo:belongsToSet>
    <pav:lastSavedOn>2014-09-02 12:03:47 -0400</pav:lastSavedOn>
    <pav:lineageUri>urn:domeoserver:annotationset:166C20E9-1B4C-47D1-982D-922E2E5ACFF2</pav:lineageUri>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <ao:context rdf:resource="urn:domeoclient:uuid:46345058-661B-476F-9809-F885E60E0311"/>
    <pav:previousVersion>xsd:String</pav:previousVersion>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/F4851EA8-C391-4F16-B8F8-81A3F2688015">
    <rdfs:label>fluconazole</rdfs:label>
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/4450</dailymed:activeMoietyRxCUI>
    <sio:SIO_000228>dikbD2R:object-drug-of-interaction</sio:SIO_000228>
    <dct:description>Referred to the drug in the interaction.</dct:description>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/active-ingredient"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:4599F40B-EE74-4C90-A4C8-716EBE52CAA7">
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <rdfs:label>Highlight</rdfs:label>
    <domeo:belongsToSet>urn:domeoclient:uuid:4B51141D-C8D2-45DB-8074-74F8D8323E60</domeo:belongsToSet>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <ao:context rdf:resource="urn:domeoclient:uuid:977500EC-B7B9-4889-A108-85D25AA19BE0"/>
    <pav:createdOn>2014-09-02 11:58:35 -0400</pav:createdOn>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:lineageUri>urn:domeoserver:annotation:9CD077F0-DA16-4E30-8E10-EF64E4D50B64</pav:lineageUri>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812eda990003</pav:createdBy>
    <pav:lastSavedOn>2014-09-02 12:02:18 -0400</pav:lastSavedOn>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:47492213-15E8-4498-83DF-D443A77CE0C4">
    <pav:createdOn>2014-07-22 19:08:55 -0400</pav:createdOn>
    <ao:suffix> is a highly selective and potent agonist for the peroxisome proliferator-activated receptor-gamma (PPARγ). In humans, PPAR receptors are found in key target tissues for insulin action such as adipose tissue, skeletal muscle, and liver. Activation of PPA</ao:suffix>
    <ao:exact>Rosiglitazone</ao:exact>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:47492213-15E8-4498-83DF-D443A77CE0C4"/>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-123.txt.html</ao:hasSource>
    <domeo:uuid>47492213-15E8-4498-83DF-D443A77CE0C4</domeo:uuid>
    <ao:prefix>, a member of the thiazolidinedione class of antidiabetic agents, improves glycemic control by improving insulin sensitivity. </ao:prefix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:CDCD9DD7-A54D-402A-8BEE-9FE5E515E7D4">
    <rdfs:label>Highlight</rdfs:label>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812eda990003</pav:createdBy>
    <pav:createdOn>2014-07-24 19:36:31 -0400</pav:createdOn>
    <pav:lineageUri>urn:domeoserver:annotation:7B905D92-17B4-4D52-AA01-D27CB223394F</pav:lineageUri>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <domeo:belongsToSet>urn:domeoclient:uuid:079AA7B9-9BE4-4706-A20A-5848B50272B5</domeo:belongsToSet>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <pav:lastSavedOn>2014-07-24 19:37:34 -0400</pav:lastSavedOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <ao:context rdf:resource="urn:domeoclient:uuid:B94C34A7-F932-4189-9935-D5DEEC3449E4"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:9AD8A1AA-8615-46DA-AE55-BBCBAC221CBF">
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:lineageUri>urn:domeoserver:annotation:46500A6E-E71E-4137-BEB6-043CBB4397F1</pav:lineageUri>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812eda990003</pav:createdBy>
    <rdfs:label>Highlight</rdfs:label>
    <pav:createdOn>2014-07-22 18:52:22 -0400</pav:createdOn>
    <ao:context rdf:resource="urn:domeoclient:uuid:CFD62BB2-11C8-4215-B304-C5A0146A8A66"/>
    <domeo:belongsToSet>urn:domeoclient:uuid:3D195979-3E82-427D-95B8-F50F48DB4AA7</domeo:belongsToSet>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <pav:lastSavedOn>2014-07-22 18:54:35 -0400</pav:lastSavedOn>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:1459510A-C593-4CF2-959E-F68381AB3C04">
    <ao:exact>azathioprine </ao:exact>
    <domeo:uuid>1459510A-C593-4CF2-959E-F68381AB3C04</domeo:uuid>
    <ao:suffix>should be made on the basis of therapeutic response and the appearance of toxic effects (see PRECAUTIONS- Drug Interactions).</ao:suffix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:prefix>or </ao:prefix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <pav:createdOn>2014-09-01 16:12:31 -0400</pav:createdOn>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-42.txt.html</ao:hasSource>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:1459510A-C593-4CF2-959E-F68381AB3C04"/>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/80A8FD32-5EAE-4A18-B02F-5B0F1D34F3C9">
    <rdfs:label>rosiglitazone</rdfs:label>
    <dct:description>Referred to the drug in the interaction.</dct:description>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/active-ingredient"/>
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/84108</dailymed:activeMoietyRxCUI>
    <sio:SIO_000228>dikbD2R:object-drug-of-interaction</sio:SIO_000228>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:D0643518-055A-42DE-BA98-B5C01760828C">
    <ao:prefix>xsd:String</ao:prefix>
    <domeo:uuid>D0643518-055A-42DE-BA98-B5C01760828C</domeo:uuid>
    <pav:createdOn>2014-07-24 19:42:43 -0400</pav:createdOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:suffix> does not affect the pharmacokinetics of verapamil and norverapamil. Verapamil does not affect the pharmacokinetics of propranolol.</ao:suffix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:exact>Propranolol</ao:exact>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-127.txt.html</ao:hasSource>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:D0643518-055A-42DE-BA98-B5C01760828C"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:BA2A0666-709F-4D11-B84E-C64B1709D0F9">
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-9.txt.html</ao:hasSource>
    <ao:suffix>), and CYP2C19 (e.g., omeprazole).</ao:suffix>
    <pav:createdOn>2014-09-02 11:30:45 -0400</pav:createdOn>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:BA2A0666-709F-4D11-B84E-C64B1709D0F9"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:prefix>), CYP3A4 (e.g., </ao:prefix>
    <domeo:uuid>BA2A0666-709F-4D11-B84E-C64B1709D0F9</domeo:uuid>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:exact>alprazolam</ao:exact>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:7A374628-9340-4980-A329-4E957642EBA7">
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-74.txt.html</ao:hasSource>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:exact>tacrolimus</ao:exact>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:7A374628-9340-4980-A329-4E957642EBA7"/>
    <domeo:uuid>7A374628-9340-4980-A329-4E957642EBA7</domeo:uuid>
    <ao:prefix> may increase the serum levels of </ao:prefix>
    <pav:createdOn>2014-09-02 19:19:46 -0400</pav:createdOn>
    <ao:suffix>. </ao:suffix>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:271B21A2-D2A2-4C95-8E2C-A3C373B06A45">
    <domeo:uuid>271B21A2-D2A2-4C95-8E2C-A3C373B06A45</domeo:uuid>
    <ao:suffix> with the long-acting propranolol did not have a significant effect on propranolol’s pharmacokinetics.</ao:suffix>
    <ao:exact>metoclopramide</ao:exact>
    <ao:prefix>Co-administration of </ao:prefix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:271B21A2-D2A2-4C95-8E2C-A3C373B06A45"/>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-130.txt.html</ao:hasSource>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <pav:createdOn>2014-07-24 19:46:59 -0400</pav:createdOn>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:7DEB6848-E3C6-4761-8965-41F19EE5D781">
    <ao:item rdf:resource="urn:domeoclient:uuid:D41626C4-D21B-4872-9F5F-C3F819ACF1BB"/>
    <domeo:agents rdf:resource="urn:person:uuid:080e143046812afe0146812eda990003"/>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <domeo:agents rdf:resource="urn:domeo:software:id:Domeo-2.1alpha-050"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#AnnotationSet"/>
    <pav:lineageUri>urn:domeoserver:annotationset:E72B2B0D-2578-4768-AC75-E12D6E7F84A9</pav:lineageUri>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <dct:description>The default set is created automatically by Domeo when no other set is existing.</dct:description>
    <rdfs:label>Default Set</rdfs:label>
    <pav:createdOn>2014-07-24 19:42:43 -0400</pav:createdOn>
    <permissions:permissions rdf:nodeID="N8e22aea97ed04b759f7621219d206999"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:3FDC3F96-3CFF-46A2-ABE6-20195EB336B0"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:340175F1-825F-4D60-A67E-F61F27C225F8"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:A6BFB4F6-55F6-4660-A8CF-B7A01D2650C1"/>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <ao:annotatesResource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-127.txt.html</ao:annotatesResource>
    <ao:item rdf:resource="urn:domeoclient:uuid:224F94C2-6E6D-4C8D-9B6C-9E8B442425A3"/>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812eda990003</pav:createdBy>
    <domeo:deleted>false</domeo:deleted>
    <ao:item rdf:resource="urn:domeoclient:uuid:0CD4EB6E-420B-4F8E-802C-4BC8BDD384E4"/>
    <pav:lastSavedOn>2014-07-24 19:43:34 -0400</pav:lastSavedOn>
    <ao:item rdf:resource="urn:domeoclient:uuid:9904E394-CEF0-416A-8F6B-42179BE2B9C6"/>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/9CBD9468-F0C7-47D4-9BAC-C2AA3E99A206">
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/261455</dailymed:activeMoietyRxCUI>
    <rdfs:label>AVANDIA</rdfs:label>
    <dct:description>Referred to the drug in the interaction.</dct:description>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/drug-product"/>
    <sio:SIO_000228>dikbD2R:object-drug-of-interaction</sio:SIO_000228>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:62E0CEDC-0C94-4CC8-83F4-85DD741C49B6">
    <pav:createdOn>2014-09-02 11:44:35 -0400</pav:createdOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:suffix>: Administration of fluvoxamine maleate 100 mg daily for 18 days (N = 8) did not significantly affect the pharmacokinetics of a 1.25 mg single intravenous dose of digoxin.</ao:suffix>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-9.txt.html</ao:hasSource>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:62E0CEDC-0C94-4CC8-83F4-85DD741C49B6"/>
    <ao:prefix>xsd:String</ao:prefix>
    <ao:exact>Digoxin</ao:exact>
    <domeo:uuid>62E0CEDC-0C94-4CC8-83F4-85DD741C49B6</domeo:uuid>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:EE5A4249-D765-40E0-B39A-F0725082F558">
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:lineageUri>urn:domeoserver:annotation:9B9C1209-F5B5-4C60-96C7-DD33A9BFB63C</pav:lineageUri>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <rdfs:label>Highlight</rdfs:label>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:createdOn>2014-07-07 09:34:23 -0400</pav:createdOn>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812eda990003</pav:createdBy>
    <pav:lastSavedOn>2014-07-07 09:44:19 -0400</pav:lastSavedOn>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <domeo:belongsToSet>urn:domeoclient:uuid:FCA2BF23-0BE3-409F-9177-761812F96097</domeo:belongsToSet>
    <ao:context rdf:resource="urn:domeoclient:uuid:AA5EEC38-13CE-4D77-8996-A3CFF229A32F"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:50AA7124-5304-4E5F-8D20-3405C75223FB">
    <rdfs:label>Highlight</rdfs:label>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:createdOn>2014-09-02 19:17:45 -0400</pav:createdOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <domeo:belongsToSet>urn:domeoclient:uuid:CB83FFC2-EA71-44EA-8F11-DE80E389C84E</domeo:belongsToSet>
    <domeo:belongsToSet>urn:domeoserver:annotationset:392EE0FB-AC4F-4AF2-87A6-2E50A281F434</domeo:belongsToSet>
    <pav:lastSavedOn>2014-09-02 19:19:47 -0400</pav:lastSavedOn>
    <ao:context rdf:resource="urn:domeoclient:uuid:207BC1EC-ACF7-457D-B193-939C1AE9DD4B"/>
    <pav:lineageUri>urn:domeoserver:annotationset:C5DEBC9B-77EE-4243-88EB-DBC19737ACD2</pav:lineageUri>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <domeo:belongsToSet>urn:domeoserver:annotationset:E32812A9-205B-4EE1-B488-A1E294EDBFB9</domeo:belongsToSet>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812eda990003</pav:createdBy>
    <pav:lineageUri>urn:domeoserver:annotation:ED73E5A7-93E4-483F-8C38-B3D34550E19E</pav:lineageUri>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:E8A5F802-A216-476E-AB1E-621B048A27EA">
    <ao:suffix> levels and symptoms of toxicity have been reported with the coadministration of </ao:suffix>
    <ao:prefix>: Elevated </ao:prefix>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-9.txt.html</ao:hasSource>
    <ao:exact>carbamazepine</ao:exact>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <domeo:uuid>E8A5F802-A216-476E-AB1E-621B048A27EA</domeo:uuid>
    <pav:createdOn>2014-09-02 11:39:46 -0400</pav:createdOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:E8A5F802-A216-476E-AB1E-621B048A27EA"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:7B017829-D9F5-484A-8F49-2CBAD935419D">
    <pav:lineageUri>urn:domeoserver:annotation:801D52C5-A4A0-4C8E-873C-878BAB088D1F</pav:lineageUri>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <domeo:belongsToSet>urn:domeoclient:uuid:C4B80A95-F569-4ED4-84D1-6796B53A580C</domeo:belongsToSet>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812eda990003</pav:createdBy>
    <ao:context rdf:resource="urn:domeoclient:uuid:338E8B18-C7D9-423A-ACA5-3E11D88F42E9"/>
    <pav:lastSavedOn>2014-09-02 15:04:32 -0400</pav:lastSavedOn>
    <pav:createdOn>2014-09-02 15:04:01 -0400</pav:createdOn>
    <rdfs:label>Highlight</rdfs:label>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:previousVersion>xsd:String</pav:previousVersion>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:C988966D-DF06-4093-9B27-77BEB9FDE53C">
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:C988966D-DF06-4093-9B27-77BEB9FDE53C"/>
    <domeo:uuid>C988966D-DF06-4093-9B27-77BEB9FDE53C</domeo:uuid>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <pav:createdOn>2014-09-02 19:32:23 -0400</pav:createdOn>
    <ao:prefix> </ao:prefix>
    <ao:suffix> Concomitant administration with omeprazole and drugs such as</ao:suffix>
    <ao:exact>Following multiple doses of atazanavir (400 mg, qd) and omeprazole (40 mg, qd, 2 hr before atazanavir), AUC was decreased by 94%, Cmax by 96%, and Cmin by 95%.</ao:exact>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-74.txt.html</ao:hasSource>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:84794CD6-2D7E-423B-92EC-B0CDCB2CF050">
    <pav:createdOn>2014-07-24 19:52:56 -0400</pav:createdOn>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <rdfs:label>Highlight</rdfs:label>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812eda990003</pav:createdBy>
    <pav:lineageUri>urn:domeoserver:annotation:C5E7457A-F5FC-4FE3-8A92-FB8C37909455</pav:lineageUri>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <ao:context rdf:resource="urn:domeoclient:uuid:35C90981-123B-4326-86DF-489A6FE9CBFD"/>
    <domeo:belongsToSet>urn:domeoclient:uuid:E0863579-8D19-4B30-ADD6-2A5BDBC2F482</domeo:belongsToSet>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:lastSavedOn>2014-07-24 19:53:55 -0400</pav:lastSavedOn>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:07EE36EA-171A-4057-95BE-E666C69DD2C3">
    <domeo:uuid>07EE36EA-171A-4057-95BE-E666C69DD2C3</domeo:uuid>
    <ao:exact>methotrexate</ao:exact>
    <ao:suffix>. Use of methotrexate with penicillins should be carefully monitored.</ao:suffix>
    <pav:createdOn>2014-07-28 17:02:39 -0400</pav:createdOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:prefix> with concomitant hematologic and gastrointestinal toxicity have been observed with </ao:prefix>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:07EE36EA-171A-4057-95BE-E666C69DD2C3"/>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-166.txt.html</ao:hasSource>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/E4072F00-AC18-479B-BBF5-FE87E12CA45B">
    <sio:SIO_000228>dikbD2R:precipitant-drug-of-interaction</sio:SIO_000228>
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/2541</dailymed:activeMoietyRxCUI>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/active-ingredient"/>
    <rdfs:label>cimetidine</rdfs:label>
    <dct:description>Referred to the drug in the interaction.</dct:description>
  </rdf:Description>
  <rdf:Description rdf:nodeID="N3592ee25bcc24f299b939c17e35a9553">
    <permissions:isLocked>false</permissions:isLocked>
    <permissions:accessType>urn:domeo:access:public</permissions:accessType>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:FCB07677-3685-4C25-935B-67786B32E56B">
    <domeo:uuid>FCB07677-3685-4C25-935B-67786B32E56B</domeo:uuid>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <pav:createdOn>2014-07-21 21:33:53 -0400</pav:createdOn>
    <ao:exact>theophylline </ao:exact>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:FCB07677-3685-4C25-935B-67786B32E56B"/>
    <ao:prefix>200 mg daily for 14 days in 16 normal male volunteers. There were significant increases in </ao:prefix>
    <ao:suffix>AUC, Cmax, and half-life with a corresponding decrease in clearance. The mean ± SD theophylline AUC increased 21% ± 16% (range: -5 to 48%). The Cmax increased 13% ± 17% (range: -13 to 40%). Theophylline clearance decreased 16% ± 11 % (range: -32 to 5%). </ao:suffix>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-28.txt.html</ao:hasSource>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:11BCB02F-AC6F-47D4-98D8-4B72C6ED08A2">
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/PK_DDI"/>
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/8AB4378A-0391-4B0C-86C1-A8941D0249CB"/>
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/830A06B9-325D-4AF2-8757-EF2CC57EB2F9"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:6EC654F2-7C5C-4C0B-9973-518245983B18">
    <pav:lineageUri>urn:domeoserver:annotation:2B0A8F16-94F6-4911-8E78-98C4225AC672</pav:lineageUri>
    <domeo:belongsToSet>urn:domeoclient:uuid:71191E51-53CB-4FDE-88D0-33C6818E2232</domeo:belongsToSet>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <pav:lastSavedOn>2014-07-13 11:32:29 -0400</pav:lastSavedOn>
    <rdfs:label>Highlight</rdfs:label>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812eda990003</pav:createdBy>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <ao:context rdf:resource="urn:domeoclient:uuid:36129C88-CE12-4AF2-ABDA-B2DC6006FD29"/>
    <pav:createdOn>2014-07-13 11:16:01 -0400</pav:createdOn>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:23E5F3F5-E089-460E-A736-58E2FC44ADC6">
    <pav:lineageUri>urn:domeoserver:annotation:8FDCFCF8-1579-4EA3-B0D9-73159007B108</pav:lineageUri>
    <domeo:belongsToSet>urn:domeoclient:uuid:71191E51-53CB-4FDE-88D0-33C6818E2232</domeo:belongsToSet>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <pav:createdOn>2014-07-13 11:11:55 -0400</pav:createdOn>
    <ao:context rdf:resource="urn:domeoclient:uuid:C84DD53D-5B64-47C5-92EE-E2D0E78BD754"/>
    <rdfs:label>Highlight</rdfs:label>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812eda990003</pav:createdBy>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:lastSavedOn>2014-07-13 11:32:29 -0400</pav:lastSavedOn>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:5D96071F-E598-4A67-BE46-D1F8D7E04E18">
    <ao:suffix> approximately 4-fold, decreased 9-hydroxyrisperidone concentrations approximately 10%, and increased concentrations of the active moiety (the sum of risperidone plus 9-hydroxyrisperidone) approximately 1.4-fold. The effect of paroxetine on the pharmacok</ao:suffix>
    <domeo:uuid>5D96071F-E598-4A67-BE46-D1F8D7E04E18</domeo:uuid>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:5D96071F-E598-4A67-BE46-D1F8D7E04E18"/>
    <ao:prefix> (4 to 8 mg/day) increased mean plasma concentrations of </ao:prefix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:exact>risperidone</ao:exact>
    <pav:createdOn>2014-09-02 11:57:44 -0400</pav:createdOn>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-47.txt.html</ao:hasSource>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:4746991B-1E22-4518-B0DA-6C25E8605F5D">
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:createdOn>2014-09-02 12:02:39 -0400</pav:createdOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <ao:context rdf:resource="urn:domeoclient:uuid:40158315-C4E3-4EA7-89A6-6D4031E7590C"/>
    <pav:lineageUri>urn:domeoserver:annotationset:166C20E9-1B4C-47D1-982D-922E2E5ACFF2</pav:lineageUri>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:lastSavedOn>2014-09-02 12:03:47 -0400</pav:lastSavedOn>
    <domeo:belongsToSet>urn:domeoserver:annotationset:D52DFD7B-BDDF-488F-B339-B1BC641E50E9</domeo:belongsToSet>
    <pav:lineageUri>urn:domeoserver:annotation:4BEFBB05-BFD6-44D1-9EE6-DDE54A448F7B</pav:lineageUri>
    <domeo:belongsToSet>urn:domeoclient:uuid:379CD8C1-F4B4-42B7-8F87-70776866DB1F</domeo:belongsToSet>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812eda990003</pav:createdBy>
    <rdfs:label>Highlight</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/D8D922B0-F01D-471E-B5F5-F72185F3B01C">
    <rdfs:label>metformin</rdfs:label>
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/6809</dailymed:activeMoietyRxCUI>
    <sio:SIO_000228>dikbD2R:precipitant-drug-of-interaction</sio:SIO_000228>
    <dct:description>Referred to the drug in the interaction.</dct:description>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/active-ingredient"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:01E43715-3610-4176-8FB9-E2D7C94F6C63">
    <sio:SIO_000205>dikbD2R:statement</sio:SIO_000205>
    <dikbD2R:modality>ncit:positive</dikbD2R:modality>
    <sio:SIO_000628 rdf:resource="urn:pddi:uuid:181381FE-800A-4970-81D8-2B14B7735770"/>
    <sio:SIO_000563>dikbD2R:modality</sio:SIO_000563>
    <dikbD2R:statement>ncit:quantitative</dikbD2R:statement>
    <rdf:type rdf:resource="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#DrugDrugInteractionStatement"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:1338CA36-AF29-4D2A-AAA6-13857E4D14F2">
    <domeo:belongsToSet>urn:domeoclient:uuid:4B51141D-C8D2-45DB-8074-74F8D8323E60</domeo:belongsToSet>
    <rdfs:label>Highlight</rdfs:label>
    <pav:lastSavedOn>2014-09-02 12:02:18 -0400</pav:lastSavedOn>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:lineageUri>urn:domeoserver:annotation:5D62F542-8672-4D61-9EF9-E4202E2BA8EB</pav:lineageUri>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <ao:context rdf:resource="urn:domeoclient:uuid:E415356D-7B99-400C-A966-58BF2ADC3FC9"/>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812eda990003</pav:createdBy>
    <pav:createdOn>2014-09-02 11:57:35 -0400</pav:createdOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:A2CCEA97-69CF-4E75-83A2-17A2D250C5C4">
    <domeo:belongsToSet>urn:domeoclient:uuid:443354CF-9409-4015-81BA-17601E505BAB</domeo:belongsToSet>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812eda990003</pav:createdBy>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <ao:context rdf:resource="urn:domeoclient:uuid:DCC80BE8-931B-476D-BAB4-F949DB49D489"/>
    <pav:createdOn>2014-09-02 15:05:39 -0400</pav:createdOn>
    <pav:lastSavedOn>2014-09-02 15:06:18 -0400</pav:lastSavedOn>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <rdfs:label>Highlight</rdfs:label>
    <pav:lineageUri>urn:domeoserver:annotation:2D276657-76B1-4CE2-91A8-A5540BFC39D1</pav:lineageUri>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:previousVersion>xsd:String</pav:previousVersion>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:5C49E98B-9150-4558-BA6E-8A0528C6D9D6">
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <rdfs:label>Highlight</rdfs:label>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:lineageUri>urn:domeoserver:annotation:E3F63B46-8EC1-4286-BFE3-5437DCC1DD99</pav:lineageUri>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <domeo:belongsToSet>urn:domeoclient:uuid:190E7AE8-2ACF-42E2-AE00-E433EEA9737C</domeo:belongsToSet>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812eda990003</pav:createdBy>
    <pav:createdOn>2014-09-02 19:38:16 -0400</pav:createdOn>
    <pav:lastSavedOn>2014-09-02 19:38:39 -0400</pav:lastSavedOn>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <ao:context rdf:resource="urn:domeoclient:uuid:87659984-6B68-48C3-9D52-19757F705CEB"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:5DC04223-08C0-4FC9-9E10-75D588673E2D">
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <domeo:uuid>5DC04223-08C0-4FC9-9E10-75D588673E2D</domeo:uuid>
    <ao:exact>sotalol</ao:exact>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:5DC04223-08C0-4FC9-9E10-75D588673E2D"/>
    <pav:createdOn>2014-09-02 15:05:47 -0400</pav:createdOn>
    <ao:suffix>.</ao:suffix>
    <ao:prefix> result in a reduction in Cmax and AUC of 26% and 20%, respectively and consequently in a 25% reduction in the bradycardic effect at rest. Administration of the antacid two hours after sotalol has no effect on the pharmacokinetics or pharmacodynamics of </ao:prefix>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-70.txt.html</ao:hasSource>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:326B6DC1-778C-4951-9B8A-4B76A407BA1D">
    <rdf:type rdf:resource="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#DrugDrugInteractionStatement"/>
    <dikbD2R:statement>ncit:Qualitative</dikbD2R:statement>
    <dikbD2R:modality>ncit:negative</dikbD2R:modality>
    <sio:SIO_000628 rdf:resource="urn:pddi:uuid:2CD22D95-BDF9-4FBD-98F2-9CC6023043DD"/>
    <sio:SIO_000563>dikbD2R:modality</sio:SIO_000563>
    <sio:SIO_000205>dikbD2R:statement</sio:SIO_000205>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:176AA3EF-BFBB-48D5-8C72-B5138286D455">
    <domeo:uuid>176AA3EF-BFBB-48D5-8C72-B5138286D455</domeo:uuid>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-123.txt.html</ao:hasSource>
    <ao:exact>Repeat dosing with AVANDIA had no clinically relevant effect on the steady-state pharmacokinetics of warfarin enantiomers.</ao:exact>
    <ao:suffix>xsd:String</ao:suffix>
    <ao:prefix>xsd:String</ao:prefix>
    <pav:createdOn>2014-07-22 20:21:31 -0400</pav:createdOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:176AA3EF-BFBB-48D5-8C72-B5138286D455"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:54E3B0B5-2096-41BF-BC0D-256928923869">
    <ao:exact>dextromethorphan</ao:exact>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <domeo:uuid>54E3B0B5-2096-41BF-BC0D-256928923869</domeo:uuid>
    <ao:prefix>, </ao:prefix>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:54E3B0B5-2096-41BF-BC0D-256928923869"/>
    <ao:suffix>, and tricyclic antidepressants. While none of the drugs studied for drug interactions significantly affected the pharmacokinetics of fluvoxamine, an in vivo study of fluvoxamine single-dose pharmacokinetics in 13 PM subjects demonstrated altered pharmac</ao:suffix>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-9.txt.html</ao:hasSource>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <pav:createdOn>2014-09-02 11:32:43 -0400</pav:createdOn>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:A4653C46-2FC4-4FCC-9060-201662C0BAB0">
    <dikbD2R:modality>ncit:negative</dikbD2R:modality>
    <sio:SIO_000628 rdf:resource="urn:pddi:uuid:3580D7AB-C344-4344-96C6-6C6FF5BA9B3D"/>
    <sio:SIO_000563>dikbD2R:modality</sio:SIO_000563>
    <sio:SIO_000205>dikbD2R:statement</sio:SIO_000205>
    <rdf:type rdf:resource="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#DrugDrugInteractionStatement"/>
    <dikbD2R:statement>ncit:Qualitative</dikbD2R:statement>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:370F2AF6-A399-4830-9318-16C2CC56C4E5">
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/F9A7B706-7816-4689-A106-0C28124DEA2F"/>
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/BB308B9B-CA39-4247-9128-9D19C4C28A67"/>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/PK_DDI"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:3123DE1C-E4E4-41E2-8666-474B2051A954">
    <pav:lastSavedOn>2014-07-21 21:30:24 -0400</pav:lastSavedOn>
    <pav:lineageUri>urn:domeoserver:annotation:53F885E2-F0AA-488B-A5A9-317542EA1C11</pav:lineageUri>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <pav:createdOn>2014-07-21 21:28:42 -0400</pav:createdOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <rdfs:label>Highlight</rdfs:label>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812eda990003</pav:createdBy>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <domeo:belongsToSet>urn:domeoclient:uuid:B394B422-1AAF-4ED4-A3BB-3FB13E961EEA</domeo:belongsToSet>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <ao:context rdf:resource="urn:domeoclient:uuid:2BF35833-2A3B-4AAC-BA24-329D7F891DC5"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:6791DC23-BC40-4E62-815B-0DA5CCA7BD4F">
    <ao:suffix>is taken with a high-fat meal, the rate of absorption is reduced, with a mean delay in Tmax of 60 minutes and a mean reduction in Cmax of 29%. The mean steady state volume of distribution (Vss) for sildenafil is 105 L, indicating distribution into the ti</ao:suffix>
    <ao:exact>REVATIO </ao:exact>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:6791DC23-BC40-4E62-815B-0DA5CCA7BD4F"/>
    <domeo:uuid></domeo:uuid>
    <domeo:uuid>6791DC23-BC40-4E62-815B-0DA5CCA7BD4F</domeo:uuid>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-155.txt.html</ao:hasSource>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <pav:createdOn>2014-07-07 09:41:41 -0400</pav:createdOn>
    <ao:prefix>is rapidly absorbed after oral administration, with a mean absolute bioavailability of 41% (25–63%). Maximum observed plasma concentrations are reached within 30 to 120 minutes (median 60 minutes) of oral dosing in the fasted state. When </ao:prefix>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:B088F7FA-8870-4336-965B-4A558E3F08B0">
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:lineageUri>urn:domeoserver:annotation:0D1F3FB5-E327-4ED5-A129-940CBC83C151</pav:lineageUri>
    <pav:lastSavedOn>2014-07-13 11:32:29 -0400</pav:lastSavedOn>
    <domeo:belongsToSet>urn:domeoclient:uuid:71191E51-53CB-4FDE-88D0-33C6818E2232</domeo:belongsToSet>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812eda990003</pav:createdBy>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <pav:createdOn>2014-07-13 11:17:32 -0400</pav:createdOn>
    <rdfs:label>Highlight</rdfs:label>
    <ao:context rdf:resource="urn:domeoclient:uuid:ABB70710-CA87-4445-8EB3-1BFDDC4636FE"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:5DD4A9BB-16CD-4C46-9CE2-E74FD07B5626">
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-47.txt.html</ao:hasSource>
    <pav:createdOn>2014-09-02 11:56:15 -0400</pav:createdOn>
    <ao:exact>paroxetine</ao:exact>
    <ao:prefix> may significantly inhibit the activity of this isozyme. In most patients (&gt;90%), this CYP2D6 isozyme is saturated early during </ao:prefix>
    <domeo:uuid>5DD4A9BB-16CD-4C46-9CE2-E74FD07B5626</domeo:uuid>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:suffix> dosing. In 1 study, daily dosing of immediate-release paroxetine  (20 mg once daily) under steady-state conditions increased single-dose desipramine (100 mg) Cmax, AUC, and T½ by an average of approximately 2-, 5-, and 3-fold, respectively. Concomitant </ao:suffix>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:5DD4A9BB-16CD-4C46-9CE2-E74FD07B5626"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:30AC56DD-1608-4DFA-90FC-CCBC462BCAEF">
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/EAC1688B-D768-4B56-8D0E-B9D5F8FC7164"/>
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/DF818BD4-17A0-4731-84D5-207257326816"/>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/PK_DDI"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:99D19A33-63BB-4F24-96F1-57FE6B759A48">
    <ao:exact>Ethanol</ao:exact>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:99D19A33-63BB-4F24-96F1-57FE6B759A48"/>
    <pav:createdOn>2014-07-22 19:55:23 -0400</pav:createdOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:suffix>xsd:String</ao:suffix>
    <domeo:uuid>99D19A33-63BB-4F24-96F1-57FE6B759A48</domeo:uuid>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-123.txt.html</ao:hasSource>
    <ao:prefix>xsd:String</ao:prefix>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:4A268B82-4B69-4D00-A6E9-95F225012877">
    <ao:suffix> to the enzyme suggests this is unlikely [see 7 DRUG INTERACTIONS].</ao:suffix>
    <domeo:uuid>4A268B82-4B69-4D00-A6E9-95F225012877</domeo:uuid>
    <ao:prefix> to interfere with metabolism of other drugs metabolized by CYP 2D6. Relatively weak binding of </ao:prefix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:exact>risperidone</ao:exact>
    <pav:createdOn>2014-07-13 11:16:15 -0400</pav:createdOn>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:4A268B82-4B69-4D00-A6E9-95F225012877"/>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-8.txt.html</ao:hasSource>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:636BB7C2-294D-452D-967D-461DEF7A510A">
    <ao:exact>Risperidone</ao:exact>
    <pav:createdOn>2014-07-13 11:07:17 -0400</pav:createdOn>
    <ao:suffix> is a selective monoaminergic antagonist with high affinity (Ki of 0.12 to 7.3 nM) for the serotonin Type 2 (5HT2), dopamine Type 2 (D2), α1 and α2 adrenergic, and H1 histaminergic receptors. Risperidone acts as an antagonist at other receptors, but with</ao:suffix>
    <domeo:uuid>636BB7C2-294D-452D-967D-461DEF7A510A</domeo:uuid>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:636BB7C2-294D-452D-967D-461DEF7A510A"/>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-8.txt.html</ao:hasSource>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:prefix>xsd:String</ao:prefix>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:2B12E6D2-E83F-42E5-821A-DFDAD994F783">
    <ao:prefix>perienced an event on at least one occasion. All events are included except those already listed in the previous table or discussed in WARNINGS or PRECAUTIONS, trivial events, those too general to be informative, and those not reasonably associated with </ao:prefix>
    <ao:exact>zonisamide</ao:exact>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <domeo:uuid>2B12E6D2-E83F-42E5-821A-DFDAD994F783</domeo:uuid>
    <pav:createdOn>2014-07-22 18:37:56 -0400</pav:createdOn>
    <ao:suffix>.</ao:suffix>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-58.txt.html</ao:hasSource>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:2B12E6D2-E83F-42E5-821A-DFDAD994F783"/>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/066DE754-7246-47EA-9F6B-DB99A3097E26">
    <rdfs:label>AVANDIA</rdfs:label>
    <dct:description>Referred to the drug in the interaction.</dct:description>
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/261455</dailymed:activeMoietyRxCUI>
    <sio:SIO_000228>dikbD2R:object-drug-of-interaction</sio:SIO_000228>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/drug-product"/>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/513340A0-A222-4865-9DAF-1EDDCCCA86A0">
    <dct:description>Referred to the drug in the interaction.</dct:description>
    <rdfs:label>omeprazole</rdfs:label>
    <sio:SIO_000228>dikbD2R:object-drug-of-interaction</sio:SIO_000228>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/active-ingredient"/>
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/7646</dailymed:activeMoietyRxCUI>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:FA428F64-D782-46F5-B866-2FBC24D3F4F8">
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812eda990003</pav:createdBy>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:createdOn>2014-07-07 09:58:58 -0400</pav:createdOn>
    <domeo:belongsToSet>urn:domeoserver:annotationset:131835A3-C655-4F91-97D4-52CAFF7B7CCA</domeo:belongsToSet>
    <domeo:belongsToSet>urn:domeoserver:annotationset:08C0C288-6DF4-43E6-A618-71A8BB9563C3</domeo:belongsToSet>
    <domeo:belongsToSet>urn:domeoserver:annotationset:22ED7220-C6F6-43C5-9DF9-89F62F0F8E27</domeo:belongsToSet>
    <pav:lineageUri>urn:domeoserver:annotation:9F3CAE5F-12DF-463B-A0AD-4F223784EC31</pav:lineageUri>
    <rdfs:label>Highlight</rdfs:label>
    <domeo:belongsToSet>urn:domeoserver:annotationset:8F3CF3D9-AADE-4A86-BD42-2924B3D6A406</domeo:belongsToSet>
    <pav:lastSavedOn>2014-07-07 10:02:41 -0400</pav:lastSavedOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <ao:context rdf:resource="urn:domeoclient:uuid:EA1C9791-9797-4F15-A767-767B900E9B87"/>
    <domeo:belongsToSet>urn:domeoserver:annotationset:7AACEF8D-2EBC-4F0B-94B2-190650E562F6</domeo:belongsToSet>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:D62F417A-98ED-4008-ADC4-F7EBC73F9F68">
    <ao:context rdf:resource="urn:domeoclient:uuid:A332788B-8D94-435B-A2BD-5419224AC500"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812eda990003</pav:createdBy>
    <pav:lineageUri>urn:domeoserver:annotation:1C9ED6F4-C4B6-48C2-A50E-4B01D040C1EC</pav:lineageUri>
    <domeo:belongsToSet>urn:domeoserver:annotationset:2914A3FD-DF43-4F78-999C-77CE7A028B19</domeo:belongsToSet>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <domeo:belongsToSet>urn:domeoserver:annotationset:F272A789-69D0-47CC-8CC9-F25C55B91261</domeo:belongsToSet>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <pav:lineageUri>urn:domeoserver:annotationset:AB1741F1-5A5F-4416-AEAC-A544BCBB7D16</pav:lineageUri>
    <pav:lastSavedOn>2014-07-22 19:54:59 -0400</pav:lastSavedOn>
    <rdfs:label>Highlight</rdfs:label>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">7</pav:versionNumber>
    <pav:previousVersion>urn:domeoserver:annotationset:606A5B3F-B6FB-4279-AA42-7893CFC2D20C</pav:previousVersion>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:createdOn>2014-07-22 19:48:47 -0400</pav:createdOn>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/0A6A30F9-53A5-47E7-B0BA-25617EEE3E7A">
    <dct:description>Referred to the drug in the interaction.</dct:description>
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/8754</dailymed:activeMoietyRxCUI>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/active-ingredient"/>
    <rdfs:label>propafenone</rdfs:label>
    <sio:SIO_000228>dikbD2R:object-drug-of-interaction</sio:SIO_000228>
  </rdf:Description>
  <rdf:Description rdf:nodeID="Ne21ada11b56e470b8c1782ed43501aea">
    <domeo:sets rdf:resource="urn:pddi:uuid:8BAAA01E-8AC9-466E-B388-3972354A4BAB"/>
  </rdf:Description>
  <rdf:Description rdf:nodeID="N4b500e29673242eaab2b681a1a2e65bc">
    <domeo:sets rdf:resource="urn:pddi:uuid:11C59DB6-9144-4BAA-B630-BA9A001B4C4A"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:AD57239D-3225-4F0C-8054-FBD32976EE0C">
    <ao:exact>risperidone</ao:exact>
    <pav:createdOn>2014-07-13 11:17:48 -0400</pav:createdOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:prefix> in subjects with liver disease were comparable to those in young healthy subjects, the mean free fraction of </ao:prefix>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-8.txt.html</ao:hasSource>
    <domeo:uuid>AD57239D-3225-4F0C-8054-FBD32976EE0C</domeo:uuid>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:AD57239D-3225-4F0C-8054-FBD32976EE0C"/>
    <ao:suffix> in plasma was increased by about 35% because of the diminished concentration of both albumin and α1-acid glycoprotein. Risperidone doses should be reduced in patients with liver disease [see 2 DOSAGE AND ADMINISTRATION and 5 WARNINGS AND PRECAUTIONS].</ao:suffix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:C241BBD6-7DDD-4B8E-BA29-A9A307595892">
    <pav:createdOn>2014-09-02 19:09:23 -0400</pav:createdOn>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812eda990003</pav:createdBy>
    <pav:lineageUri>urn:domeoserver:annotation:A64B7936-C650-42B0-B7E7-C6585052410D</pav:lineageUri>
    <ao:context rdf:resource="urn:domeoclient:uuid:8739072C-5D47-4302-BD43-4756B65DFB2B"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <rdfs:label>Highlight</rdfs:label>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:lastSavedOn>2014-09-02 19:11:13 -0400</pav:lastSavedOn>
    <domeo:belongsToSet>urn:domeoclient:uuid:3966BCFB-CA02-4053-828D-3860558E7BE8</domeo:belongsToSet>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/7C90A079-6EB4-494B-B58B-CC7428475342">
    <rdfs:label>quinidine</rdfs:label>
    <dct:description>Referred to the drug in the interaction.</dct:description>
    <sio:SIO_000228>dikbD2R:precipitant-drug-of-interaction</sio:SIO_000228>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/active-ingredient"/>
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/9068</dailymed:activeMoietyRxCUI>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/25CF5D55-E18C-41A3-8548-34F37BD2A10A">
    <rdfs:label>fosamprenavir</rdfs:label>
    <dct:description>Referred to the drug in the interaction.</dct:description>
    <sio:SIO_000228>dikbD2R:precipitant-drug-of-interaction</sio:SIO_000228>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/active-ingredient"/>
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/358262</dailymed:activeMoietyRxCUI>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:2D04CBBE-379A-4D9F-BDD4-AA3663CD4669">
    <domeo:uuid>2D04CBBE-379A-4D9F-BDD4-AA3663CD4669</domeo:uuid>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:2D04CBBE-379A-4D9F-BDD4-AA3663CD4669"/>
    <ao:exact>Cimetidine (800 mg), a nonspecific CYP inhibitor, caused a 56% increase in plasma sildenafil concentrations when co-administered with sildenafil (50 mg) to healthy volunteers</ao:exact>
    <ao:suffix>xsd:String</ao:suffix>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-155.txt.html</ao:hasSource>
    <ao:prefix>xsd:String</ao:prefix>
    <pav:createdOn>2014-07-07 11:36:13 -0400</pav:createdOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:03ABEF2C-055A-4C30-91E7-3717F41B4C84">
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:lineageUri>urn:domeoserver:annotation:97CCDA9F-F14E-48A6-A583-AA3AB41BA52E</pav:lineageUri>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <pav:lastSavedOn>2014-09-01 16:06:18 -0400</pav:lastSavedOn>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <domeo:belongsToSet>urn:domeoclient:uuid:A84DE8F6-26B7-471D-8309-4E7CC2994FDF</domeo:belongsToSet>
    <ao:context rdf:resource="urn:domeoclient:uuid:D6854021-6829-4D54-8ADE-ADC84C0AF5B8"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:createdOn>2014-09-01 16:05:57 -0400</pav:createdOn>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812eda990003</pav:createdBy>
    <rdfs:label>Highlight</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:7015192E-CCA2-475B-8C8B-10870378056A">
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812eda990003</pav:createdBy>
    <pav:lastSavedOn>2014-07-22 19:54:59 -0400</pav:lastSavedOn>
    <domeo:belongsToSet>urn:domeoserver:annotationset:2914A3FD-DF43-4F78-999C-77CE7A028B19</domeo:belongsToSet>
    <domeo:belongsToSet>urn:domeoserver:annotationset:F272A789-69D0-47CC-8CC9-F25C55B91261</domeo:belongsToSet>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">7</pav:versionNumber>
    <pav:lineageUri>urn:domeoserver:annotationset:AB1741F1-5A5F-4416-AEAC-A544BCBB7D16</pav:lineageUri>
    <pav:previousVersion>urn:domeoserver:annotationset:606A5B3F-B6FB-4279-AA42-7893CFC2D20C</pav:previousVersion>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <ao:context rdf:resource="urn:domeoclient:uuid:693EEFEC-7BCC-4823-A86C-533B31687EFA"/>
    <pav:createdOn>2014-07-22 19:49:22 -0400</pav:createdOn>
    <rdfs:label>Highlight</rdfs:label>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:lineageUri>urn:domeoserver:annotation:6D14BD77-D3D3-41F7-854C-287414970BB9</pav:lineageUri>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:032977FB-2362-4162-8691-DC921A41219C">
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/F83742D9-BF1E-4B6B-9F1C-2CC08800D877"/>
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/77D06206-6695-47A2-961A-30BA8D501FA5"/>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/PK_DDI"/>
  </rdf:Description>
  <rdf:Description rdf:nodeID="N92420773eb5944839f49fd7e66841af1">
    <permissions:isLocked>false</permissions:isLocked>
    <permissions:accessType>urn:domeo:access:public</permissions:accessType>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:056787DE-BFEB-4038-A418-CB53FF7030DC">
    <ao:suffix>. Any dose adjustment should be guided by clinical effect (tolerability and efficacy). </ao:suffix>
    <ao:prefix>significantly decreased plasma levels of </ao:prefix>
    <domeo:uuid>056787DE-BFEB-4038-A418-CB53FF7030DC</domeo:uuid>
    <pav:createdOn>2014-07-21 21:43:22 -0400</pav:createdOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:exact>paroxetine</ao:exact>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:056787DE-BFEB-4038-A418-CB53FF7030DC"/>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-51.txt.html</ao:hasSource>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:0BE2F54A-5A28-4297-82E1-2B83EE8D882C">
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <rdfs:label>Highlight</rdfs:label>
    <domeo:belongsToSet>urn:domeoserver:annotationset:A5DD001D-C81A-4E2E-B5E0-7A866B35E26B</domeo:belongsToSet>
    <ao:context rdf:resource="urn:domeoclient:uuid:143E0873-3AEC-4273-B2E8-23467A7C6978"/>
    <pav:previousVersion>urn:domeoclient:uuid:BED41F06-565A-4622-9A88-48810E5A28DE</pav:previousVersion>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">2</pav:versionNumber>
    <domeo:belongsToSet>urn:domeoserver:annotationset:A3F0B39A-4249-4B63-BB0D-F24A005066AC</domeo:belongsToSet>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:lastSavedOn>2014-09-02 11:46:58 -0400</pav:lastSavedOn>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812eda990003</pav:createdBy>
    <domeo:belongsToSet>urn:domeoserver:annotationset:3F546823-204F-4F9B-9006-3DC526C56931</domeo:belongsToSet>
    <pav:lineageUri>urn:domeoserver:annotation:0845F123-F76C-4211-B1E9-207282D7887D</pav:lineageUri>
    <pav:createdOn>2014-09-02 11:43:53 -0400</pav:createdOn>
    <pav:lineageUri>urn:domeoserver:annotationset:D1715BD2-BD41-46FD-9454-DC7A423A29AC</pav:lineageUri>
    <pav:lastSavedOn>2014-09-02 11:46:59 -0400</pav:lastSavedOn>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:D87DBE9A-311B-4697-A944-4490E16F4680">
    <ao:exact>Fexofenadine had no effect on the pharmacokinetics of either erythromycin or ketoconazole</ao:exact>
    <pav:createdOn>2014-07-24 20:11:05 -0400</pav:createdOn>
    <domeo:uuid>D87DBE9A-311B-4697-A944-4490E16F4680</domeo:uuid>
    <ao:prefix>xsd:String</ao:prefix>
    <ao:suffix>xsd:String</ao:suffix>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-139.txt.html</ao:hasSource>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:D87DBE9A-311B-4697-A944-4490E16F4680"/>
  </rdf:Description>
  <rdf:Description rdf:nodeID="N3b4342baa5b040bbb0d1c39149bc5a02">
    <domeo:sets rdf:resource="urn:pddi:uuid:1E635F35-7B6C-49A8-AD29-C3853F8DC576"/>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/376B1F96-6FA6-4A71-9966-1F46E0D854C7">
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/active-ingredient"/>
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/16681</dailymed:activeMoietyRxCUI>
    <rdfs:label>acarbose</rdfs:label>
    <dct:description>Referred to the drug in the interaction.</dct:description>
    <sio:SIO_000228>dikbD2R:precipitant-drug-of-interaction</sio:SIO_000228>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:4779D2E6-DE3C-43C7-BA5C-2FB2261F8E92">
    <pav:createdOn>2014-07-24 19:44:17 -0400</pav:createdOn>
    <ao:suffix> and its metabolites. Diazepam does not alter the pharmacokinetics of propranolol.</ao:suffix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:prefix>, resulting in increased concentrations of </ao:prefix>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-128.txt.html</ao:hasSource>
    <domeo:uuid>4779D2E6-DE3C-43C7-BA5C-2FB2261F8E92</domeo:uuid>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:exact>diazepam</ao:exact>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:4779D2E6-DE3C-43C7-BA5C-2FB2261F8E92"/>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/E02048B2-A2E1-475E-9345-1FE9194336FD">
    <rdfs:label>ranitidine</rdfs:label>
    <dct:description>Referred to the drug in the interaction.</dct:description>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/active-ingredient"/>
    <sio:SIO_000228>dikbD2R:precipitant-drug-of-interaction</sio:SIO_000228>
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/9143</dailymed:activeMoietyRxCUI>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/E74D3AEA-33B5-4A50-A977-87798E92D401">
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/8787</dailymed:activeMoietyRxCUI>
    <rdfs:label>propranolol</rdfs:label>
    <sio:SIO_000228>dikbD2R:object-drug-of-interaction</sio:SIO_000228>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/active-ingredient"/>
    <dct:description>Referred to the drug in the interaction.</dct:description>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:2FB03C2F-1973-4F66-AF66-7DEAA97D5719">
    <sio:SIO_000205>dikbD2R:statement</sio:SIO_000205>
    <sio:SIO_000563>dikbD2R:modality</sio:SIO_000563>
    <dikbD2R:statement>ncit:Qualitative</dikbD2R:statement>
    <sio:SIO_000628 rdf:resource="urn:pddi:uuid:9C7097E9-595B-4F6E-9745-CA4FB4156079"/>
    <dikbD2R:modality>ncit:positive</dikbD2R:modality>
    <rdf:type rdf:resource="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#DrugDrugInteractionStatement"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:3B743E18-8323-4761-B0A4-3B200C16F9BE">
    <domeo:belongsToSet>urn:domeoclient:uuid:71191E51-53CB-4FDE-88D0-33C6818E2232</domeo:belongsToSet>
    <pav:createdOn>2014-07-13 11:14:31 -0400</pav:createdOn>
    <rdfs:label>Highlight</rdfs:label>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812eda990003</pav:createdBy>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:lineageUri>urn:domeoserver:annotation:9644563B-1E1E-4AF0-871E-E395B93BB653</pav:lineageUri>
    <ao:context rdf:resource="urn:domeoclient:uuid:16FE2F0D-3BF4-4708-9147-BD5159B47059"/>
    <pav:lastSavedOn>2014-07-13 11:32:29 -0400</pav:lastSavedOn>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:D96F23AA-C203-4EA6-BA78-F8249D904C85">
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <pav:createdOn>2014-07-28 17:00:48 -0400</pav:createdOn>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-164.txt.html</ao:hasSource>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:D96F23AA-C203-4EA6-BA78-F8249D904C85"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:exact>Cimetidine</ao:exact>
    <ao:suffix> reduced the clearance and volume of distribution of meperidine and also the formation of the metabolite, normeperidine, in healthy subjects and thus, caution should be used with concomitant administration.</ao:suffix>
    <ao:prefix>xsd:String</ao:prefix>
    <domeo:uuid>D96F23AA-C203-4EA6-BA78-F8249D904C85</domeo:uuid>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:9C71E884-F7BA-41EE-A3DD-8DAE2AB3D4C0">
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/692FB180-95F1-4EAA-88D0-82BF4B541921"/>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/PK_DDI"/>
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/20398182-F09D-4166-8536-A74DA8BDB5D5"/>
  </rdf:Description>
  <rdf:Description rdf:nodeID="N68a4d20630fd486c8391ab65c44a1cc9">
    <domeo:sets rdf:resource="urn:pddi:uuid:6D3CB53E-CF58-4136-8B4C-980888C68920"/>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/027E2EA7-BD8C-4E55-AE53-75289D2AB62C">
    <dct:description>Referred to the drug in the interaction.</dct:description>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/drug-product"/>
    <rdfs:label>Maalox®1</rdfs:label>
    <sio:SIO_000228>dikbD2R:precipitant-drug-of-interaction</sio:SIO_000228>
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/</dailymed:activeMoietyRxCUI>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/AFDFD2C0-7545-4E19-ABAA-7E48CFD82223">
    <sio:SIO_000228>dikbD2R:object-drug-of-interaction</sio:SIO_000228>
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/4450</dailymed:activeMoietyRxCUI>
    <rdfs:label>fluconazole</rdfs:label>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/active-ingredient"/>
    <dct:description>Referred to the drug in the interaction.</dct:description>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:DCC80BE8-931B-476D-BAB4-F949DB49D489">
    <ao:suffix> hydroxide should be avoided because it may result in a reduction in Cmax and AUC of 26% and 20%, respectively and consequently in a 25% reduction in the bradycardic effect at rest. Administration of the antacid two hours after sotalol has no effect on t</ao:suffix>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-70.txt.html</ao:hasSource>
    <ao:exact>magnesium</ao:exact>
    <pav:createdOn>2014-09-02 15:05:39 -0400</pav:createdOn>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:DCC80BE8-931B-476D-BAB4-F949DB49D489"/>
    <ao:prefix> within 2 hours of antacids containing aluminum oxide and </ao:prefix>
    <domeo:uuid>DCC80BE8-931B-476D-BAB4-F949DB49D489</domeo:uuid>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:B94B65A7-B52E-41EB-9E72-C3F942808AFB">
    <pav:createdOn>2014-07-22 19:11:53 -0400</pav:createdOn>
    <ao:exact>Rosiglitazone</ao:exact>
    <domeo:uuid>B94B65A7-B52E-41EB-9E72-C3F942808AFB</domeo:uuid>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:prefix> inhibits hepatic gluconeogenesis. The expression of the insulin-regulated glucose transporter GLUT-4 was increased in adipose tissue. </ao:prefix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:suffix> did not induce hypoglycemia in animal models of type 2 diabetes and/or impaired glucose tolerance.</ao:suffix>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-123.txt.html</ao:hasSource>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:B94B65A7-B52E-41EB-9E72-C3F942808AFB"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:67967D27-75AF-4745-A665-F0AE8B4677A2">
    <dikbD2R:statement>ncit:quantitative</dikbD2R:statement>
    <dikbD2R:modality>ncit:positive</dikbD2R:modality>
    <sio:SIO_000205>dikbD2R:statement</sio:SIO_000205>
    <sio:SIO_000628 rdf:resource="urn:pddi:uuid:311508D9-4E16-476A-B489-8598869EEF79"/>
    <rdf:type rdf:resource="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#DrugDrugInteractionStatement"/>
    <sio:SIO_000563>dikbD2R:modality</sio:SIO_000563>
  </rdf:Description>
  <rdf:Description rdf:nodeID="N17e8be221f47482c9201f544556a44e1">
    <domeo:sets rdf:resource="urn:pddi:uuid:C2471146-B114-47FF-BB78-F58B6158FB99"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:A332788B-8D94-435B-A2BD-5419224AC500">
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <pav:createdOn>2014-07-22 19:48:47 -0400</pav:createdOn>
    <ao:exact>AVANDIA</ao:exact>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:prefix>xsd:String</ao:prefix>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-123.txt.html</ao:hasSource>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:A332788B-8D94-435B-A2BD-5419224AC500"/>
    <domeo:uuid>A332788B-8D94-435B-A2BD-5419224AC500</domeo:uuid>
    <ao:suffix> (2 mg twice daily) taken concomitantly with glyburide (3.75 to 10 mg/day) for 7 days did not alter the mean steady-state 24-hour plasma glucose concentrations in diabetic patients stabilized on glyburide therapy. Repeat doses of AVANDIA (8 mg once daily</ao:suffix>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:46ACA9D3-9DB9-4318-BFF9-15A57F3153D1">
    <ao:suffix>; increased serum concentrations of methotrexate with concomitant hematologic and gastrointestinal toxicity have been observed with methotrexate. Use of methotrexate with penicillins should be carefully monitored.</ao:suffix>
    <domeo:uuid>46ACA9D3-9DB9-4318-BFF9-15A57F3153D1</domeo:uuid>
    <ao:exact>methotrexate</ao:exact>
    <ao:prefix> may reduce the renal clearance of </ao:prefix>
    <pav:createdOn>2014-07-28 17:02:30 -0400</pav:createdOn>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-166.txt.html</ao:hasSource>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:46ACA9D3-9DB9-4318-BFF9-15A57F3153D1"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:99838144-4399-4843-860D-C565071F0347">
    <ao:prefix>Carbamazepine: Elevated carbamazepine levels and symptoms of toxicity have been reported with the coadministration of </ao:prefix>
    <domeo:uuid>99838144-4399-4843-860D-C565071F0347</domeo:uuid>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:exact>fluvoxamine</ao:exact>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:99838144-4399-4843-860D-C565071F0347"/>
    <pav:createdOn>2014-09-02 11:39:30 -0400</pav:createdOn>
    <ao:suffix> maleate and carbamazepine.</ao:suffix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-9.txt.html</ao:hasSource>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:04931205-C053-487C-8E10-4A1A8F38120C">
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-48.txt.html</ao:hasSource>
    <ao:prefix>, a potent inhibitor of CYP3A4 activity, to be at least 100 times more potent than paroxetine as an inhibitor of the metabolism of several substrates for this enzyme, including </ao:prefix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <domeo:uuid>04931205-C053-487C-8E10-4A1A8F38120C</domeo:uuid>
    <ao:exact>terfenadine</ao:exact>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:suffix>, astemizole, cisapride, triazolam, and cyclosporine. Based on the assumption that the relationship between paroxetine’s in vitro Ki and its lack of effect on terfenadine's in vivo clearance predicts its effect on other CYP3A4 substrates, paroxetine’s ex</ao:suffix>
    <pav:createdOn>2014-09-02 15:04:22 -0400</pav:createdOn>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:04931205-C053-487C-8E10-4A1A8F38120C"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:F3967C16-EC04-423B-908A-CF2BC1EC4011">
    <ao:suffix> Type 2 (5HT2) receptor antagonism.</ao:suffix>
    <ao:exact>serotonin</ao:exact>
    <domeo:uuid>F3967C16-EC04-423B-908A-CF2BC1EC4011</domeo:uuid>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <pav:createdOn>2014-07-13 11:04:27 -0400</pav:createdOn>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-8.txt.html</ao:hasSource>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:prefix> Type 2 (D2) and </ao:prefix>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:F3967C16-EC04-423B-908A-CF2BC1EC4011"/>
  </rdf:Description>
  <rdf:Description rdf:nodeID="Na7bed5b05e634d2a9cf00a98762765c8">
    <permissions:isLocked>false</permissions:isLocked>
    <permissions:accessType>urn:domeo:access:public</permissions:accessType>
  </rdf:Description>
  <rdf:Description rdf:nodeID="N2d513254c3ed46bdb906d08dec2b8d5c">
    <domeo:sets rdf:resource="urn:pddi:uuid:32B4AA19-CBBE-4BDC-AB2F-037EBB0AE5EB"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:639E5CAD-4CBF-4CC5-8D9F-6103AC373BA4">
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/A11930F7-6D95-4B60-BEDF-64A102BE527C"/>
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/EA8D118F-5115-426B-8423-6A5269AC5A4A"/>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/PK_DDI"/>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/2E8E0C08-A9A5-4122-9C0E-4594641FBED5">
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/134527</dailymed:activeMoietyRxCUI>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/active-ingredient"/>
    <dct:description>Referred to the drug in the interaction.</dct:description>
    <sio:SIO_000228>dikbD2R:precipitant-drug-of-interaction</sio:SIO_000228>
    <rdfs:label>nelfinavir</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:5F53CA93-4A9A-47DB-B928-A643C66C9223">
    <ao:exact>methotrexate</ao:exact>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <pav:createdOn>2014-07-28 17:02:45 -0400</pav:createdOn>
    <ao:prefix>. Use of </ao:prefix>
    <ao:suffix> with penicillins should be carefully monitored.</ao:suffix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-166.txt.html</ao:hasSource>
    <domeo:uuid>5F53CA93-4A9A-47DB-B928-A643C66C9223</domeo:uuid>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:5F53CA93-4A9A-47DB-B928-A643C66C9223"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:0C6FF426-D0F6-4DFE-8C13-8BD0EAA98C6F">
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:exact>cimetidine</ao:exact>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-23.txt.html</ao:hasSource>
    <ao:suffix> 400 mg to six healthy male volunteers. After the administration of cimetidine, there was a significant decrease in fluconazole AUC and Cmax. There was a mean ± SD decrease in fluconazole AUC of 13% ± 11% (range: -3.4 to -31%) and Cmax decreased 19% ± 14</ao:suffix>
    <domeo:uuid>0C6FF426-D0F6-4DFE-8C13-8BD0EAA98C6F</domeo:uuid>
    <pav:createdOn>2014-07-13 12:46:15 -0400</pav:createdOn>
    <ao:prefix> 100 mg was administered as a single oral dose alone and two hours after a single dose of </ao:prefix>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:0C6FF426-D0F6-4DFE-8C13-8BD0EAA98C6F"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:21ABBCD8-EA84-4836-B499-F6A002CF43B9">
    <domeo:uuid>21ABBCD8-EA84-4836-B499-F6A002CF43B9</domeo:uuid>
    <ao:exact> AVANDIA</ao:exact>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-123.txt.html</ao:hasSource>
    <ao:prefix>Repeat dosing with</ao:prefix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <pav:createdOn>2014-07-22 20:17:59 -0400</pav:createdOn>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:21ABBCD8-EA84-4836-B499-F6A002CF43B9"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:suffix>xsd:String</ao:suffix>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:2F750407-05DE-4618-A170-8A67EDC3FDCE">
    <sio:SIO_000628 rdf:resource="urn:pddi:uuid:74DA3155-03D5-4087-B352-391D15BBC016"/>
    <dikbD2R:modality>ncit:positive</dikbD2R:modality>
    <dikbD2R:statement>ncit:quantitative</dikbD2R:statement>
    <sio:SIO_000205>dikbD2R:statement</sio:SIO_000205>
    <sio:SIO_000563>dikbD2R:modality</sio:SIO_000563>
    <rdf:type rdf:resource="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#DrugDrugInteractionStatement"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:08F7FCFD-3C5E-46FE-8EDA-8ED22CA77882">
    <ao:prefix>(a combined inhibitor of CYP2C19 and CYP3A4) resulted in more than doubling of the </ao:prefix>
    <ao:suffix> exposure. Dose adjustment of omeprazole is not normally required. However, in patients with Zollinger-Ellison syndrome, who may require higher doses up to 240 mg/day, dose adjustment may be considered. When voriconazole (400 mg Q12h x 1 day, then 200 mg</ao:suffix>
    <pav:createdOn>2014-09-02 19:13:55 -0400</pav:createdOn>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-74.txt.html</ao:hasSource>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <domeo:uuid>08F7FCFD-3C5E-46FE-8EDA-8ED22CA77882</domeo:uuid>
    <ao:exact>omeprazole</ao:exact>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:08F7FCFD-3C5E-46FE-8EDA-8ED22CA77882"/>
  </rdf:Description>
  <rdf:Description rdf:nodeID="Ncef41bceb86f423ebf6ad633a6670d48">
    <domeo:sets rdf:resource="urn:pddi:uuid:01E43715-3610-4176-8FB9-E2D7C94F6C63"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:1BB855FB-FD90-4495-85CA-4D3634124298">
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812eda990003</pav:createdBy>
    <pav:lastSavedOn>2014-07-24 20:02:49 -0400</pav:lastSavedOn>
    <pav:createdOn>2014-07-24 20:02:19 -0400</pav:createdOn>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:lineageUri>urn:domeoserver:annotation:2A35646F-1DFD-4CD6-9FB4-83DC9A5AE3D6</pav:lineageUri>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <rdfs:label>Highlight</rdfs:label>
    <domeo:belongsToSet>urn:domeoclient:uuid:189A8E0E-67D6-4C53-A96E-CB48A3B4B2E9</domeo:belongsToSet>
    <ao:context rdf:resource="urn:domeoclient:uuid:42B2FE1C-E6AF-411B-A916-428E36F4B282"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:0A1E742B-4ABE-40BF-84E5-2A5F57F232F2">
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:exact>risperidone</ao:exact>
    <ao:suffix> is 70% (CV=25%). The relative oral bioavailability of risperidone from a tablet is 94% (CV=10%) when compared to a solution.</ao:suffix>
    <ao:prefix> is well absorbed. The absolute oral bioavailability of </ao:prefix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <domeo:uuid>0A1E742B-4ABE-40BF-84E5-2A5F57F232F2</domeo:uuid>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:0A1E742B-4ABE-40BF-84E5-2A5F57F232F2"/>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-8.txt.html</ao:hasSource>
    <pav:createdOn>2014-07-13 11:09:15 -0400</pav:createdOn>
  </rdf:Description>
  <rdf:Description rdf:nodeID="Ncbea3f977c6a49b084d5c6f125159da8">
    <permissions:accessType>urn:domeo:access:public</permissions:accessType>
    <permissions:isLocked>false</permissions:isLocked>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/DABEA160-744E-4F3F-99D1-342761D8E356">
    <rdfs:label>verapamil</rdfs:label>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/active-ingredient"/>
    <dct:description>Referred to the drug in the interaction.</dct:description>
    <sio:SIO_000228>dikbD2R:precipitant-drug-of-interaction</sio:SIO_000228>
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/11170</dailymed:activeMoietyRxCUI>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:8F192869-CBB9-4ECB-A4F1-F621F322E7E6">
    <domeo:uuid>8F192869-CBB9-4ECB-A4F1-F621F322E7E6</domeo:uuid>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-53.txt.html</ao:hasSource>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:8F192869-CBB9-4ECB-A4F1-F621F322E7E6"/>
    <ao:prefix>xsd:String</ao:prefix>
    <ao:exact>quinidine</ao:exact>
    <ao:suffix> </ao:suffix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <pav:createdOn>2014-07-21 21:46:36 -0400</pav:createdOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:2B0ED6AC-8154-4067-8180-F00F0B22BE08">
    <sio:SIO_000563>dikbD2R:modality</sio:SIO_000563>
    <dikbD2R:statement>ncit:quantitative</dikbD2R:statement>
    <sio:SIO_000628 rdf:resource="urn:pddi:uuid:1E2204BD-B487-4C13-BC7C-E1E0D6A4C4AC"/>
    <dikbD2R:modality>ncit:positive</dikbD2R:modality>
    <sio:SIO_000205>dikbD2R:statement</sio:SIO_000205>
    <rdf:type rdf:resource="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#DrugDrugInteractionStatement"/>
  </rdf:Description>
  <rdf:Description rdf:nodeID="Nb806b78da4d0430c85637054820d1a2a">
    <permissions:isLocked>false</permissions:isLocked>
    <permissions:accessType>urn:domeo:access:public</permissions:accessType>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:464E41DE-27DF-4413-A7E6-C191985E633B">
    <ao:exact>fluvoxamine </ao:exact>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:prefix>, and the combination should, therefore, be used with caution. Severe vomiting has been reported with the coadministration of </ao:prefix>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-9.txt.html</ao:hasSource>
    <domeo:uuid>464E41DE-27DF-4413-A7E6-C191985E633B</domeo:uuid>
    <pav:createdOn>2014-09-02 11:44:24 -0400</pav:createdOn>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:464E41DE-27DF-4413-A7E6-C191985E633B"/>
    <ao:suffix> maleate and tryptophan (see WARNINGS AND PRECAUTIONS [5.3]).</ao:suffix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:F3D5E3DD-A431-4A01-92CB-C01ED4EF9988">
    <sio:SIO_000205>dikbD2R:statement</sio:SIO_000205>
    <sio:SIO_000563>dikbD2R:modality</sio:SIO_000563>
    <dikbD2R:statement>ncit:quantitative</dikbD2R:statement>
    <rdf:type rdf:resource="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#DrugDrugInteractionStatement"/>
    <sio:SIO_000628 rdf:resource="urn:pddi:uuid:4A35ABC4-4C04-40DD-A14B-E710CC4288AE"/>
    <dikbD2R:modality>ncit:positive</dikbD2R:modality>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:FA692151-6A7E-43FA-8077-22E490457CAD">
    <ao:prefix>ose of immediate-release paroxetine  was administered at phenobarbital steady state (100 mg once daily for 14 days), paroxetine AUC and T½ were reduced (by an average of 25% and 38%, respectively) compared to paroxetine administered alone. The effect of </ao:prefix>
    <ao:exact>paroxetine</ao:exact>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:FA692151-6A7E-43FA-8077-22E490457CAD"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <pav:createdOn>2014-09-01 16:21:59 -0400</pav:createdOn>
    <ao:suffix> on phenobarbital pharmacokinetics was not studied. Since paroxetine exhibits nonlinear pharmacokinetics, the results of this study may not address the case where the 2 drugs are both being chronically dosed. No initial dosage adjustment with Paroxetine </ao:suffix>
    <domeo:uuid>FA692151-6A7E-43FA-8077-22E490457CAD</domeo:uuid>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-45.txt.html</ao:hasSource>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:23EBC507-A336-4506-9D28-78F1ECDFDF8B">
    <ao:exact>tomoxetine</ao:exact>
    <pav:createdOn>2014-09-02 12:03:29 -0400</pav:createdOn>
    <domeo:uuid>23EBC507-A336-4506-9D28-78F1ECDFDF8B</domeo:uuid>
    <ao:prefix> on the pharmacokinetics of a</ao:prefix>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-47.txt.html</ao:hasSource>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:23EBC507-A336-4506-9D28-78F1ECDFDF8B"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:suffix> has been evaluated when both drugs were at steady state. In healthy volunteers who were extensive metabolizers of CYP2D6, paroxetine 20 mg daily was given in combination with 20 mg atomoxetine every 12 hours. This resulted in increases in steady state a</ao:suffix>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:4ABC712B-B1B6-46E9-80C3-428EA00FAEEF">
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/PK_DDI"/>
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/B92741C4-FB91-4395-8B40-7C9F2438DDA0"/>
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/F0EB30BB-0A91-4488-BC91-DB2E42B74BC6"/>
  </rdf:Description>
  <rdf:Description rdf:nodeID="Ndd28f742767f443d8059154f8f353f48">
    <permissions:isLocked>false</permissions:isLocked>
    <permissions:accessType>urn:domeo:access:public</permissions:accessType>
  </rdf:Description>
  <rdf:Description rdf:nodeID="N8d5d337888f54793a3bf9be12fa2ed6c">
    <permissions:accessType>urn:domeo:access:public</permissions:accessType>
    <permissions:isLocked>false</permissions:isLocked>
  </rdf:Description>
  <rdf:Description rdf:nodeID="N53ff32ea296542c6922f72d3c924712c">
    <permissions:accessType>urn:domeo:access:public</permissions:accessType>
    <permissions:isLocked>false</permissions:isLocked>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/7CA3AC53-AB27-4372-8466-89F72F2E0674">
    <rdfs:label>rosiglitazone</rdfs:label>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/active-ingredient"/>
    <dct:description>Referred to the drug in the interaction.</dct:description>
    <sio:SIO_000228>dikbD2R:precipitant-drug-of-interaction</sio:SIO_000228>
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/84108</dailymed:activeMoietyRxCUI>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:25C05DA7-D004-4C59-A96C-F35D5BEB9B3F">
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:exact>Phenytoin</ao:exact>
    <ao:prefix>xsd:String</ao:prefix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:25C05DA7-D004-4C59-A96C-F35D5BEB9B3F"/>
    <domeo:uuid>25C05DA7-D004-4C59-A96C-F35D5BEB9B3F</domeo:uuid>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-201.txt.html</ao:hasSource>
    <ao:suffix>xsd:String</ao:suffix>
    <pav:createdOn>2014-07-28 17:04:15 -0400</pav:createdOn>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:4F5662D1-C03B-40DB-AB83-59D0D62748A6">
    <ao:prefix> (40 mg, qd), AUC was decreased by 36% and 92%, Cmax by 37% and 89% and Cmin by 39% and 75% respectively for </ao:prefix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:4F5662D1-C03B-40DB-AB83-59D0D62748A6"/>
    <domeo:uuid>4F5662D1-C03B-40DB-AB83-59D0D62748A6</domeo:uuid>
    <pav:createdOn>2014-09-02 19:27:52 -0400</pav:createdOn>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-74.txt.html</ao:hasSource>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:exact>nelfinavir</ao:exact>
    <ao:suffix> and M8. Following multiple doses of </ao:suffix>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:3CE3E7D7-79CE-4BA9-8CA0-7B7A05D77AFC">
    <rdfs:label>Highlight</rdfs:label>
    <pav:createdOn>2014-07-13 12:38:04 -0400</pav:createdOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <domeo:belongsToSet>urn:domeoclient:uuid:4F872953-6D19-4809-9285-FCCF2FF54315</domeo:belongsToSet>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:lineageUri>urn:domeoserver:annotation:746D73EB-609F-4ABC-8FAC-F496DCDBACDA</pav:lineageUri>
    <ao:context rdf:resource="urn:domeoclient:uuid:5C901133-925A-4BA8-947F-0FE9FB6D60DB"/>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <pav:lastSavedOn>2014-07-13 12:41:10 -0400</pav:lastSavedOn>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812eda990003</pav:createdBy>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/F04829AF-C604-411D-8F92-B9DB45D4050E">
    <dct:description>Referred to the drug in the interaction.</dct:description>
    <sio:SIO_000228>dikbD2R:object-drug-of-interaction</sio:SIO_000228>
    <rdfs:label>Synercid</rdfs:label>
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/135097</dailymed:activeMoietyRxCUI>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/drug-product"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:5F9DA591-B9E4-4841-9D52-F5DDC170AE85">
    <ao:suffix> (40 mg once daily x 7 days) to healthy subjects, it significantly increased the steady-state Cmax and AUC0-24 of omeprazole, an average of 2 times (90% CI: 1.8, 2.6) and 4 times (90% CI: 3.3, 4.4) respectively as compared to when omeprazole was given wi</ao:suffix>
    <pav:createdOn>2014-09-02 19:16:24 -0400</pav:createdOn>
    <domeo:uuid>5F9DA591-B9E4-4841-9D52-F5DDC170AE85</domeo:uuid>
    <ao:prefix> (400 mg Q12h x 1 day, then 200 mg x 6 days) was given with </ao:prefix>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-74.txt.html</ao:hasSource>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:exact>omeprazole</ao:exact>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:5F9DA591-B9E4-4841-9D52-F5DDC170AE85"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:EE9D00B3-F511-4E8E-BFBF-A30D7A5C5F82">
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <domeo:uuid>EE9D00B3-F511-4E8E-BFBF-A30D7A5C5F82</domeo:uuid>
    <ao:exact>phenytoin</ao:exact>
    <pav:createdOn>2014-07-28 17:04:52 -0400</pav:createdOn>
    <ao:prefix> exposure increased to a level comparable to that prior to </ao:prefix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:EE9D00B3-F511-4E8E-BFBF-A30D7A5C5F82"/>
    <ao:suffix> administration.</ao:suffix>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-201.txt.html</ao:hasSource>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:04F1D04C-3FDE-4B85-A97A-D8EA12CEF79C">
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <domeo:uuid>04F1D04C-3FDE-4B85-A97A-D8EA12CEF79C</domeo:uuid>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-139.txt.html</ao:hasSource>
    <ao:prefix> decreases </ao:prefix>
    <ao:exact>fexofenadine</ao:exact>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <pav:createdOn>2014-07-24 20:12:18 -0400</pav:createdOn>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:04F1D04C-3FDE-4B85-A97A-D8EA12CEF79C"/>
    <ao:suffix>xsd:String</ao:suffix>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:8844F882-4F5A-460C-9215-039DEB9CB5A2">
    <sio:SIO_000205>dikbD2R:statement</sio:SIO_000205>
    <dikbD2R:statement>ncit:Qualitative</dikbD2R:statement>
    <dikbD2R:modality>ncit:negative</dikbD2R:modality>
    <sio:SIO_000563>dikbD2R:modality</sio:SIO_000563>
    <sio:SIO_000628 rdf:resource="urn:pddi:uuid:1E16FBF3-81EA-402D-80A2-67FDDDC020EA"/>
    <rdf:type rdf:resource="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#DrugDrugInteractionStatement"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:83D060E5-70B4-4270-94D2-6FF812E77E78">
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <domeo:uuid>83D060E5-70B4-4270-94D2-6FF812E77E78</domeo:uuid>
    <pav:createdOn>2014-07-13 11:12:03 -0400</pav:createdOn>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-8.txt.html</ao:hasSource>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:exact>risperidone</ao:exact>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:83D060E5-70B4-4270-94D2-6FF812E77E78"/>
    <ao:prefix> is extensively metabolized in the liver. The main metabolic pathway is through hydroxylation of </ao:prefix>
    <ao:suffix> to 9-hydroxyrisperidone by the enzyme, CYP 2D6. A minor metabolic pathway is through N-dealkylation. The main metabolite, 9-hydroxyrisperidone, has similar pharmacological activity as risperidone. Consequently, the clinical effect of the drug results fr</ao:suffix>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:ED1540C5-0D63-4D37-A891-4B8F18792981">
    <pav:createdOn>2014-07-22 19:56:13 -0400</pav:createdOn>
    <pav:lastSavedOn>2014-07-22 20:22:38 -0400</pav:lastSavedOn>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812eda990003</pav:createdBy>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <ao:context rdf:resource="urn:domeoclient:uuid:AA4737DB-0EF5-4431-A3C1-AB7A8F5E730A"/>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <rdfs:label>Highlight</rdfs:label>
    <pav:lineageUri>urn:domeoserver:annotation:A84907A8-B9AD-4919-822F-3903218E78F8</pav:lineageUri>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <domeo:belongsToSet>urn:domeoserver:annotationset:F272A789-69D0-47CC-8CC9-F25C55B91261</domeo:belongsToSet>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/EBBEEEE3-DF09-427E-A3A1-75B1DB0D82D6">
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/261455</dailymed:activeMoietyRxCUI>
    <rdfs:label>AVANDIA</rdfs:label>
    <sio:SIO_000228>dikbD2R:object-drug-of-interaction</sio:SIO_000228>
    <dct:description>Referred to the drug in the interaction.</dct:description>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/drug-product"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:40158315-C4E3-4EA7-89A6-6D4031E7590C">
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:suffix>may significantly inhibit the activity of this isozyme. In most patients (&gt;90%), this CYP2D6 isozyme is saturated early during paroxetine dosing. In 1 study, daily dosing of immediate-release paroxetine  (20 mg once daily) under steady-state conditions i</ao:suffix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:prefix>, other SSRIs, and many tricyclics), are metabolized by the cytochrome P450 isozyme CYP2D6. Like other agents that are metabolized by CYP2D6, </ao:prefix>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:40158315-C4E3-4EA7-89A6-6D4031E7590C"/>
    <domeo:uuid>40158315-C4E3-4EA7-89A6-6D4031E7590C</domeo:uuid>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-47.txt.html</ao:hasSource>
    <ao:exact>paroxetine </ao:exact>
    <pav:createdOn>2014-09-02 12:02:39 -0400</pav:createdOn>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:096D1A71-9692-49E7-AB6D-F82889C71621">
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/6156849A-B0E2-444B-9C14-2B19DFE9DB2F"/>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/PK_DDI"/>
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/B9F2BCC2-2AB5-46DF-BF40-8E849B5709AB"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:C4DA9FCE-B7DB-4AB2-8187-C60945E96A8D">
    <pav:createdOn>2014-07-24 20:07:18 -0400</pav:createdOn>
    <domeo:uuid>C4DA9FCE-B7DB-4AB2-8187-C60945E96A8D</domeo:uuid>
    <ao:prefix> with either </ao:prefix>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-139.txt.html</ao:hasSource>
    <ao:suffix> or erythromycin led to increased plasma concentrations of fexofenadine in healthy adult subjects. Fexofenadine had no effect on the pharmacokinetics of either erythromycin or ketoconazole. In two separate studies in healthy adult subjects, fexofenadine </ao:suffix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:exact>ketoconazole</ao:exact>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:C4DA9FCE-B7DB-4AB2-8187-C60945E96A8D"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:F2BC4367-94B2-4BA7-AAA4-DA34C58B02C3">
    <ao:exact>cyclosporine </ao:exact>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <domeo:uuid>F2BC4367-94B2-4BA7-AAA4-DA34C58B02C3</domeo:uuid>
    <pav:createdOn>2014-07-21 21:28:35 -0400</pav:createdOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:F2BC4367-94B2-4BA7-AAA4-DA34C58B02C3"/>
    <ao:prefix>therapy for at least 6 months and on a stable </ao:prefix>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-26.txt.html</ao:hasSource>
    <ao:suffix>dose for at least 6 weeks. There was a significant increase in cyclosporine AUC, Cmax, Cmin (24-hour concentration), and a significant reduction in apparent oral clearance following the administration of fluconazole. The mean ± SD increase in AUC was 92%</ao:suffix>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:808DC7C6-B4BD-432C-A6A2-0F47B3206319">
    <ao:prefix>, and </ao:prefix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-72.txt.html</ao:hasSource>
    <ao:suffix>, may lead to a lack of efficacy or, possibly, development of an abstinence syndrome in a patient who had developed physical dependence to oxycodone. If co-administration is necessary, caution is advised when initiating therapy with, currently taking, or</ao:suffix>
    <domeo:uuid>808DC7C6-B4BD-432C-A6A2-0F47B3206319</domeo:uuid>
    <ao:exact>phenytoin</ao:exact>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <pav:createdOn>2014-09-02 19:10:00 -0400</pav:createdOn>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:808DC7C6-B4BD-432C-A6A2-0F47B3206319"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:8B0374C4-A360-43F1-A6B7-10442B0A8905">
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:suffix>, leading to a two-three fold increased blood concentration and greater degrees of clinical beta-blockade.</ao:suffix>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-125.txt.html</ao:hasSource>
    <ao:exact>quinidine</ao:exact>
    <pav:createdOn>2014-07-24 19:38:25 -0400</pav:createdOn>
    <ao:prefix> is reduced by co-administration of </ao:prefix>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:8B0374C4-A360-43F1-A6B7-10442B0A8905"/>
    <domeo:uuid>8B0374C4-A360-43F1-A6B7-10442B0A8905</domeo:uuid>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:398266C6-18B2-479E-8C00-4B3F67E7DB6D">
    <rdfs:label>Highlight</rdfs:label>
    <domeo:belongsToSet>urn:domeoserver:annotationset:F272A789-69D0-47CC-8CC9-F25C55B91261</domeo:belongsToSet>
    <pav:previousVersion>urn:domeoserver:annotationset:606A5B3F-B6FB-4279-AA42-7893CFC2D20C</pav:previousVersion>
    <pav:lineageUri>urn:domeoserver:annotationset:AB1741F1-5A5F-4416-AEAC-A544BCBB7D16</pav:lineageUri>
    <ao:context rdf:resource="urn:domeoclient:uuid:82B114B4-DF8C-4358-AB9B-8EBA4957BC3F"/>
    <pav:lineageUri>urn:domeoserver:annotation:EEBC9DD8-BC57-4856-AA73-E8F9290225BB</pav:lineageUri>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:createdOn>2014-07-22 19:50:53 -0400</pav:createdOn>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">7</pav:versionNumber>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812eda990003</pav:createdBy>
    <pav:lastSavedOn>2014-07-22 19:54:59 -0400</pav:lastSavedOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <domeo:belongsToSet>urn:domeoserver:annotationset:2914A3FD-DF43-4F78-999C-77CE7A028B19</domeo:belongsToSet>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:7EEF7294-F55C-48E2-8A50-69D9A3726172">
    <domeo:uuid>7EEF7294-F55C-48E2-8A50-69D9A3726172</domeo:uuid>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-137.txt.html</ao:hasSource>
    <ao:suffix> 400 mg/day with trazodone 100 mg to 300 mg daily, carbamazepine reduced plasma concentrations of trazodone (as well as mCPP) by 76 and 60%, respectively, compared to pre-carbamazepine values.</ao:suffix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:7EEF7294-F55C-48E2-8A50-69D9A3726172"/>
    <pav:createdOn>2014-07-24 20:03:38 -0400</pav:createdOn>
    <ao:prefix>Carbamazepine induces CYP3A4. Following coadministration of </ao:prefix>
    <ao:exact>carbamazepine</ao:exact>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:01299A21-B948-4043-9C23-75E77F3F6D2F">
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/BD0AC8FF-8734-4C34-ADDF-43EE98A0C2CD"/>
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/73BF06A9-0D2D-46D8-916E-0EC7FC22E2F7"/>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/PK_DDI"/>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/56DDE847-8CB1-4471-8B16-A24584A6647C">
    <dct:description>Referred to the drug in the interaction.</dct:description>
    <sio:SIO_000228>dikbD2R:object-drug-of-interaction</sio:SIO_000228>
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/10737</dailymed:activeMoietyRxCUI>
    <rdfs:label>trazodone</rdfs:label>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/active-ingredient"/>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/CE20B5C0-36BB-4878-B0C9-3069561D06F7">
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/6470</dailymed:activeMoietyRxCUI>
    <rdfs:label>lorazepam</rdfs:label>
    <sio:SIO_000228>dikbD2R:object-drug-of-interaction</sio:SIO_000228>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/active-ingredient"/>
    <dct:description>Referred to the drug in the interaction.</dct:description>
  </rdf:Description>
  <rdf:Description rdf:nodeID="N6dbf83d8109d4a67af6bca7b2afbbf85">
    <permissions:accessType>urn:domeo:access:public</permissions:accessType>
    <permissions:isLocked>false</permissions:isLocked>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:9639DF56-3E53-4998-9064-63357AB54862">
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/PK_DDI"/>
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/10A838C4-49F6-43A9-A4D2-77899C57569E"/>
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/376B1F96-6FA6-4A71-9966-1F46E0D854C7"/>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/3FCE39BA-811B-456A-83F4-652EA5B4F4FC">
    <dct:description>Referred to the drug in the interaction.</dct:description>
    <sio:SIO_000228>dikbD2R:precipitant-drug-of-interaction</sio:SIO_000228>
    <rdfs:label>trazodone</rdfs:label>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/active-ingredient"/>
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/10737</dailymed:activeMoietyRxCUI>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:0461B0A0-7D13-480F-A86F-F2496AAA8BE6">
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:0461B0A0-7D13-480F-A86F-F2496AAA8BE6"/>
    <domeo:uuid>0461B0A0-7D13-480F-A86F-F2496AAA8BE6</domeo:uuid>
    <ao:suffix> may be necessary and it is recommended that atomoxetine be initiated at a reduced dose when given with paroxetine.</ao:suffix>
    <ao:exact>atomoxetine</ao:exact>
    <ao:prefix> was given alone. Dosage adjustment of </ao:prefix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-47.txt.html</ao:hasSource>
    <pav:createdOn>2014-09-02 11:58:47 -0400</pav:createdOn>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:584394EB-71B4-485C-B5DE-CECED70A1339">
    <domeo:belongsToSet>urn:domeoclient:uuid:FCA2BF23-0BE3-409F-9177-761812F96097</domeo:belongsToSet>
    <pav:lastSavedOn>2014-07-07 09:44:19 -0400</pav:lastSavedOn>
    <pav:lineageUri>urn:domeoserver:annotation:8CAC7CC1-905D-4DEF-889B-C73183EBC16C</pav:lineageUri>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <ao:context rdf:resource="urn:domeoclient:uuid:E3238558-AF7F-4E81-BA1F-62B0266A4DDE"/>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812eda990003</pav:createdBy>
    <rdfs:label>Highlight</rdfs:label>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:createdOn>2014-07-07 09:34:24 -0400</pav:createdOn>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:A54DB360-9E9B-4E55-AC79-A80E321825D3">
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-21.txt.html</ao:hasSource>
    <ao:suffix> increased by 24% (95% C.I. range 18 to 31%) and 13% (95% C.I. range 8 to 18%), respectively relative to placebo. Fluconazole treatment did not cause a decrease in the ethinyl estradiol AUC of any individual subject in this study compared to placebo dosi</ao:suffix>
    <ao:prefix> and </ao:prefix>
    <ao:exact>norethindrone</ao:exact>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <pav:createdOn>2014-07-13 12:38:35 -0400</pav:createdOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <domeo:uuid>A54DB360-9E9B-4E55-AC79-A80E321825D3</domeo:uuid>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:A54DB360-9E9B-4E55-AC79-A80E321825D3"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:12AC269E-4947-4540-A483-BE43615F8E88">
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:12AC269E-4947-4540-A483-BE43615F8E88"/>
    <ao:exact>fexofenadine</ao:exact>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <domeo:uuid>12AC269E-4947-4540-A483-BE43615F8E88</domeo:uuid>
    <ao:prefix>, it is recommended that </ao:prefix>
    <ao:suffix> hydrochloride tablets should be taken with water [see Clinical Pharmacology (12.3) and Dosage and Administration (2.1)].</ao:suffix>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-139.txt.html</ao:hasSource>
    <pav:createdOn>2014-07-24 20:13:04 -0400</pav:createdOn>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:DFEFC5E6-CD9E-430A-AB17-673B60C626A3">
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/PK_DDI"/>
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/6C885934-8872-486F-BCF1-97D398581817"/>
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/F04829AF-C604-411D-8F92-B9DB45D4050E"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeo:software:id:Domeo-2.1alpha-050">
    <foafx:homepage></foafx:homepage>
    <foafx:name>Domeo Annotation Toolkit</foafx:name>
    <foafx:version>2.1alpha</foafx:version>
    <rdfs:label>Domeo Annotation Toolkit</rdfs:label>
    <rdf:type rdf:resource="http://xmlns.com/foaf/0.1/Software"/>
    <foafx:build>050</foafx:build>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:B4E5EBBF-965D-41F8-B54E-0CF48653C43C">
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <pav:lineageUri>urn:domeoserver:annotation:F61FAB34-A2B1-45CE-B6A6-123A03AAD69D</pav:lineageUri>
    <pav:lastSavedOn>2014-07-13 12:56:57 -0400</pav:lastSavedOn>
    <rdfs:label>Highlight</rdfs:label>
    <pav:createdOn>2014-07-13 12:56:09 -0400</pav:createdOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <domeo:belongsToSet>urn:domeoclient:uuid:E89548FF-A4A2-4B87-B1E1-B12E3E255FA1</domeo:belongsToSet>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812eda990003</pav:createdBy>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <ao:context rdf:resource="urn:domeoclient:uuid:76B68D47-1D9C-4B2A-B9A6-CFE359C93E64"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:D41626C4-D21B-4872-9F5F-C3F819ACF1BB">
    <pav:lastSavedOn>2014-07-24 19:43:34 -0400</pav:lastSavedOn>
    <pav:lineageUri>urn:domeoserver:annotation:A8A2A505-B5C3-4980-A24B-C5D9EBD9B482</pav:lineageUri>
    <ao:context rdf:resource="urn:domeoclient:uuid:35718176-8B1F-491A-BA1E-B0A7887FDD76"/>
    <pav:createdOn>2014-07-24 19:42:53 -0400</pav:createdOn>
    <domeo:belongsToSet>urn:domeoclient:uuid:7DEB6848-E3C6-4761-8965-41F19EE5D781</domeo:belongsToSet>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812eda990003</pav:createdBy>
    <rdfs:label>Highlight</rdfs:label>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:B4B52B26-239D-47C5-8E82-702E109CC247">
    <domeo:uuid>B4B52B26-239D-47C5-8E82-702E109CC247</domeo:uuid>
    <ao:prefix>(500 mg single dose) AUC and Cmax following the administration of fluconazole. There was a mean ± SD increase in </ao:prefix>
    <ao:exact>tolbutamide </ao:exact>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <pav:createdOn>2014-07-21 21:38:46 -0400</pav:createdOn>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:B4B52B26-239D-47C5-8E82-702E109CC247"/>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-29.txt.html</ao:hasSource>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:suffix>AUC of 26% ± 9% (range: 12 to 39%). Tolbutamide Cmax increased 11% ± 9% (range: -6 to 27%). (See PRECAUTIONS.)</ao:suffix>
  </rdf:Description>
  <rdf:Description rdf:nodeID="Nbddbe61709044c32874ac9cdf7b7d2df">
    <domeo:sets rdf:resource="urn:pddi:uuid:125C14DB-1F35-4667-846F-F789D6D0AFCF"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:74DA3155-03D5-4087-B352-391D15BBC016">
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/PK_DDI"/>
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/880C51AF-841B-4199-8CE7-148DD94269D0"/>
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/3891574B-5AAE-4384-9ECD-390CFAD0C78D"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:D6809060-E4EB-4D01-8BD0-6671105C2ACF">
    <rdf:type rdf:resource="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#DrugDrugInteractionStatement"/>
    <sio:SIO_000205>dikbD2R:statement</sio:SIO_000205>
    <sio:SIO_000563>dikbD2R:modality</sio:SIO_000563>
    <dikbD2R:statement>ncit:Qualitative</dikbD2R:statement>
    <sio:SIO_000628 rdf:resource="urn:pddi:uuid:217FEFFB-6BFC-422A-B88B-75EE70185C1C"/>
    <dikbD2R:modality>ncit:negative</dikbD2R:modality>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:55E300CE-2A8F-42F4-9877-A49DDE4F3360">
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <domeo:belongsToSet>urn:domeoserver:annotationset:8F3CF3D9-AADE-4A86-BD42-2924B3D6A406</domeo:belongsToSet>
    <domeo:belongsToSet>urn:domeoserver:annotationset:22ED7220-C6F6-43C5-9DF9-89F62F0F8E27</domeo:belongsToSet>
    <domeo:belongsToSet>urn:domeoserver:annotationset:7AACEF8D-2EBC-4F0B-94B2-190650E562F6</domeo:belongsToSet>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812eda990003</pav:createdBy>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:lineageUri>urn:domeoserver:annotation:7897E8BB-DD46-4B51-BE6D-8D92A1B57431</pav:lineageUri>
    <ao:context rdf:resource="urn:domeoclient:uuid:76A2A466-4D5D-4AA1-8114-FAD1FF0E6FC0"/>
    <pav:lastSavedOn>2014-07-07 11:24:52 -0400</pav:lastSavedOn>
    <rdfs:label>Highlight</rdfs:label>
    <domeo:belongsToSet>urn:domeoserver:annotationset:131835A3-C655-4F91-97D4-52CAFF7B7CCA</domeo:belongsToSet>
    <pav:createdOn>2014-07-07 11:24:12 -0400</pav:createdOn>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:060B4AD5-C06D-4579-9AB3-F6932ED1425B">
    <pav:createdOn>2014-07-24 20:01:38 -0400</pav:createdOn>
    <domeo:uuid>060B4AD5-C06D-4579-9AB3-F6932ED1425B</domeo:uuid>
    <ao:suffix> </ao:suffix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:060B4AD5-C06D-4579-9AB3-F6932ED1425B"/>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-136.txt.html</ao:hasSource>
    <ao:prefix>xsd:String</ao:prefix>
    <ao:exact>trazodone</ao:exact>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/EF32B31F-C41A-4F94-8E6E-65DFB595B9F0">
    <sio:SIO_000228>dikbD2R:object-drug-of-interaction</sio:SIO_000228>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/active-ingredient"/>
    <rdfs:label>rosiglitazone</rdfs:label>
    <dct:description>Referred to the drug in the interaction.</dct:description>
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/84108</dailymed:activeMoietyRxCUI>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/314A940A-9CA5-4B7A-B433-2AECFF25EFA4">
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/8787</dailymed:activeMoietyRxCUI>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/active-ingredient"/>
    <rdfs:label>propranolol</rdfs:label>
    <dct:description>Referred to the drug in the interaction.</dct:description>
    <sio:SIO_000228>dikbD2R:precipitant-drug-of-interaction</sio:SIO_000228>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:5073B1CB-26F2-4345-8573-7827801E8DD6">
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/EF32B31F-C41A-4F94-8E6E-65DFB595B9F0"/>
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/7194CD60-DB00-4648-AB1D-C4A22CFC0FBE"/>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/PK_DDI"/>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/BAE41BF7-CAA3-4865-832D-24EB9699E14C">
    <sio:SIO_000228>dikbD2R:precipitant-drug-of-interaction</sio:SIO_000228>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/active-ingredient"/>
    <rdfs:label>erythromycin</rdfs:label>
    <dct:description>Referred to the drug in the interaction.</dct:description>
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/4053</dailymed:activeMoietyRxCUI>
  </rdf:Description>
  <rdf:Description rdf:nodeID="N291410c6a5af42dfab7129b7962092a6">
    <permissions:isLocked>false</permissions:isLocked>
    <permissions:accessType>urn:domeo:access:public</permissions:accessType>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:3469EEA4-696B-455B-896A-1006CE93364D">
    <pav:lineageUri>urn:domeoserver:annotation:2307DB07-8B9A-4D0C-B0D0-0E14E0095777</pav:lineageUri>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812eda990003</pav:createdBy>
    <rdfs:label>Highlight</rdfs:label>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <domeo:belongsToSet>urn:domeoclient:uuid:659ED9DF-77DA-41F2-B123-6E455B4F2385</domeo:belongsToSet>
    <pav:createdOn>2014-09-01 15:59:56 -0400</pav:createdOn>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <ao:context rdf:resource="urn:domeoclient:uuid:6F243BA5-FCEC-4956-AF25-0E751A006E5C"/>
    <pav:lastSavedOn>2014-09-01 16:00:14 -0400</pav:lastSavedOn>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:E69A980E-DFDE-46F6-BAC1-FFD29BDCB6F5">
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812eda990003</pav:createdBy>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <rdfs:label>Highlight</rdfs:label>
    <pav:createdOn>2014-09-02 19:38:22 -0400</pav:createdOn>
    <domeo:belongsToSet>urn:domeoclient:uuid:190E7AE8-2ACF-42E2-AE00-E433EEA9737C</domeo:belongsToSet>
    <pav:lineageUri>urn:domeoserver:annotation:10225704-623F-4ACB-82E2-8720FFAEF850</pav:lineageUri>
    <ao:context rdf:resource="urn:domeoclient:uuid:34C208E6-0FE1-4394-8496-13F4C10CB492"/>
    <pav:lastSavedOn>2014-09-02 19:38:39 -0400</pav:lastSavedOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:BAFAC6A6-4A37-498B-BA86-449A697DAA80">
    <sio:SIO_000628 rdf:resource="urn:pddi:uuid:70094340-3BB3-42EB-8579-D2FEE274AB33"/>
    <dikbD2R:statement>ncit:quantitative</dikbD2R:statement>
    <dikbD2R:modality>ncit:positive</dikbD2R:modality>
    <sio:SIO_000205>dikbD2R:statement</sio:SIO_000205>
    <rdf:type rdf:resource="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#DrugDrugInteractionStatement"/>
    <sio:SIO_000563>dikbD2R:modality</sio:SIO_000563>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:5B5C139F-AE11-4B67-AB76-74B91C6DD60D">
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <ao:context rdf:resource="urn:domeoclient:uuid:5DC04223-08C0-4FC9-9E10-75D588673E2D"/>
    <pav:createdOn>2014-09-02 15:05:47 -0400</pav:createdOn>
    <domeo:belongsToSet>urn:domeoclient:uuid:443354CF-9409-4015-81BA-17601E505BAB</domeo:belongsToSet>
    <rdfs:label>Highlight</rdfs:label>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812eda990003</pav:createdBy>
    <pav:lastSavedOn>2014-09-02 15:06:18 -0400</pav:lastSavedOn>
    <pav:lineageUri>urn:domeoserver:annotation:E9D6FD85-CFBF-4435-A027-4008AB18DB92</pav:lineageUri>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
  </rdf:Description>
  <rdf:Description rdf:nodeID="N9611565c3479448abb5f7f7161535dd7">
    <domeo:sets rdf:resource="urn:pddi:uuid:D6809060-E4EB-4D01-8BD0-6671105C2ACF"/>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/851B37FE-C029-42CD-9AFE-2CD0906FA393">
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/4450</dailymed:activeMoietyRxCUI>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/active-ingredient"/>
    <dct:description>Referred to the drug in the interaction.</dct:description>
    <sio:SIO_000228>dikbD2R:object-drug-of-interaction</sio:SIO_000228>
    <rdfs:label>fluconazole</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:nodeID="Nec6db731a7ae4f9985354696d1c120cd">
    <permissions:accessType>urn:domeo:access:public</permissions:accessType>
    <permissions:isLocked>false</permissions:isLocked>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:69C6BE85-B8AD-457C-8581-67B0BD3C4802">
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:exact>gemfibrozi</ao:exact>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:69C6BE85-B8AD-457C-8581-67B0BD3C4802"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:prefix>Concomitant administration of </ao:prefix>
    <domeo:uuid>69C6BE85-B8AD-457C-8581-67B0BD3C4802</domeo:uuid>
    <pav:createdOn>2014-07-22 19:41:37 -0400</pav:createdOn>
    <ao:suffix>l (600 mg twice daily), an inhibitor of CYP2C8, and rosiglitazone (4 mg once daily) for 7 days increased rosiglitazone AUC by 127%, compared to the administration of rosiglitazone (4 mg once daily) alone. Given the potential for dose-related adverse even</ao:suffix>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-123.txt.html</ao:hasSource>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:2C30455C-E476-4155-9E8E-67570BFAB396">
    <ao:context rdf:resource="urn:domeoclient:uuid:0E2ABCCE-5CA9-4636-B0AA-BA504DC9879E"/>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:lastSavedOn>2014-07-21 21:35:10 -0400</pav:lastSavedOn>
    <domeo:belongsToSet>urn:domeoclient:uuid:B61F1A9B-4696-4ED0-80AA-4FE2E9016966</domeo:belongsToSet>
    <rdfs:label>Highlight</rdfs:label>
    <pav:createdOn>2014-07-21 21:33:56 -0400</pav:createdOn>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812eda990003</pav:createdBy>
    <pav:lineageUri>urn:domeoserver:annotation:171FCBF8-8AC9-4B78-9E1B-9B6E17C3BC2E</pav:lineageUri>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:207BC1EC-ACF7-457D-B193-939C1AE9DD4B">
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:exact>omeprazole</ao:exact>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:207BC1EC-ACF7-457D-B193-939C1AE9DD4B"/>
    <pav:createdOn>2014-09-02 19:17:45 -0400</pav:createdOn>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-74.txt.html</ao:hasSource>
    <domeo:uuid>207BC1EC-ACF7-457D-B193-939C1AE9DD4B</domeo:uuid>
    <ao:suffix> treatment may change the absorption of the antiretroviral drug. Other possible interaction mechanisms are via CYP2C19. For some antiretroviral drugs, such as atazanavir and nelfinavir, decreased serum levels have been reported when given together with o</ao:suffix>
    <ao:prefix> has been reported to interact with some antiretroviral drugs. The clinical importance and the mechanisms behind these interactions are not always known. Increased gastric pH during </ao:prefix>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/31951605-3312-425D-ABB9-1EF6CB9A6AA5">
    <sio:SIO_000228>dikbD2R:precipitant-drug-of-interaction</sio:SIO_000228>
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/4450</dailymed:activeMoietyRxCUI>
    <rdfs:label>fluconazole</rdfs:label>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/active-ingredient"/>
    <dct:description>Referred to the drug in the interaction.</dct:description>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/B7CB635F-4EBF-434B-9159-71DC46A33588">
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/active-ingredient"/>
    <rdfs:label>ethinyl estradiol</rdfs:label>
    <dct:description>Referred to the drug in the interaction.</dct:description>
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/4124</dailymed:activeMoietyRxCUI>
    <sio:SIO_000228>dikbD2R:precipitant-drug-of-interaction</sio:SIO_000228>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:0F9E744D-C586-43FA-AB0E-FF3294D6D12E">
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:0F9E744D-C586-43FA-AB0E-FF3294D6D12E"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-28.txt.html</ao:hasSource>
    <ao:suffix>clearance decreased 16% ± 11 % (range: -32 to 5%). The half-life of theophylline increased from 6.6 ± 1.7 hours to 7.9 ± 1.5 hours. (See PRECAUTIONS.)</ao:suffix>
    <pav:createdOn>2014-07-21 21:33:59 -0400</pav:createdOn>
    <ao:prefix>AUC increased 21% ± 16% (range: -5 to 48%). The Cmax increased 13% ± 17% (range: -13 to 40%). </ao:prefix>
    <domeo:uuid>0F9E744D-C586-43FA-AB0E-FF3294D6D12E</domeo:uuid>
    <ao:exact>Theophylline </ao:exact>
  </rdf:Description>
  <rdf:Description rdf:nodeID="N338d4b4b54f1412b8351fede6a9e0c18">
    <permissions:isLocked>false</permissions:isLocked>
    <permissions:accessType>urn:domeo:access:public</permissions:accessType>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:8F01E73F-19F5-4FA0-A47A-6EC3310E264C">
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-54.txt.html</ao:hasSource>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:8F01E73F-19F5-4FA0-A47A-6EC3310E264C"/>
    <ao:suffix>significantly decreases the clearance and increases the t1/2 of quinidine, but quinidine does not alter the kinetics of diltiazem.</ao:suffix>
    <domeo:uuid>8F01E73F-19F5-4FA0-A47A-6EC3310E264C</domeo:uuid>
    <ao:exact>Diltiazem </ao:exact>
    <pav:createdOn>2014-07-21 21:47:18 -0400</pav:createdOn>
    <ao:prefix>xsd:String</ao:prefix>
  </rdf:Description>
  <rdf:Description rdf:nodeID="Nda86cc713b9949f2afef135ffe7a910e">
    <domeo:sets rdf:resource="urn:pddi:uuid:3A2D166B-BD0B-4C2A-9E40-D07C3CE85DBC"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:F63AE259-E4D8-48C8-9143-FADBBFAD548B">
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-8.txt.html</ao:hasSource>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:exact>serotonin</ao:exact>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:F63AE259-E4D8-48C8-9143-FADBBFAD548B"/>
    <domeo:uuid>F63AE259-E4D8-48C8-9143-FADBBFAD548B</domeo:uuid>
    <ao:suffix> 5HT1C, 5HT1D, and 5HT1A receptors, weak affinity (Ki of 620 to 800 nM) for the dopamine D1 and haloperidol-sensitive sigma site, and no affinity (when tested at concentrations &gt;10-5 M) for cholinergic muscarinic or β1 and β2 adrenergic receptors.</ao:suffix>
    <ao:prefix> has low to moderate affinity (Ki of 47 to 253 nM) for the </ao:prefix>
    <pav:createdOn>2014-07-13 11:07:54 -0400</pav:createdOn>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/5AC4FDB3-99BB-4CC2-9A03-87893DB04756">
    <sio:SIO_000228>dikbD2R:precipitant-drug-of-interaction</sio:SIO_000228>
    <dct:description>Referred to the drug in the interaction.</dct:description>
    <rdfs:label>cimetidine</rdfs:label>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/active-ingredient"/>
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/2541</dailymed:activeMoietyRxCUI>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:4D592D1B-7B6F-448B-9149-4BBF0B36A730">
    <pav:lastSavedOn>2014-07-24 20:14:43 -0400</pav:lastSavedOn>
    <domeo:belongsToSet>urn:domeoclient:uuid:2BAA59CB-3862-4A98-8A6C-AA14E82983DC</domeo:belongsToSet>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812eda990003</pav:createdBy>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:createdOn>2014-07-24 20:14:58 -0400</pav:createdOn>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <ao:context rdf:resource="urn:domeoclient:uuid:44EFF86D-2559-4F65-A1D1-E51A6BDD91CF"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <rdfs:label>Highlight</rdfs:label>
    <pav:lineageUri>urn:domeoserver:annotation:A96839AB-F43F-41B5-BAE4-0A2BE8F8A144</pav:lineageUri>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:977500EC-B7B9-4889-A108-85D25AA19BE0">
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-47.txt.html</ao:hasSource>
    <ao:prefix> every 12 hours. This resulted in increases in steady state </ao:prefix>
    <pav:createdOn>2014-09-02 11:58:35 -0400</pav:createdOn>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:977500EC-B7B9-4889-A108-85D25AA19BE0"/>
    <ao:suffix> AUC values that were 6- to 8-fold greater and in atomoxetine Cmax values that were 3- to 4-fold greater than when atomoxetine was given alone. Dosage adjustment of atomoxetine may be necessary and it is recommended that atomoxetine be initiated at a red</ao:suffix>
    <ao:exact>atomoxetine</ao:exact>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <domeo:uuid>977500EC-B7B9-4889-A108-85D25AA19BE0</domeo:uuid>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:7EDEC592-2359-4661-BE34-B3BD50D59548">
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <rdfs:label>Highlight</rdfs:label>
    <pav:lineageUri>urn:domeoserver:annotation:60C5D726-2ED7-4694-AF41-71FA9512BAFC</pav:lineageUri>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <domeo:belongsToSet>urn:domeoclient:uuid:4FC315CC-8F6D-4166-AEB6-FBF9CF2FA510</domeo:belongsToSet>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812eda990003</pav:createdBy>
    <pav:lastSavedOn>2014-07-28 17:00:29 -0400</pav:lastSavedOn>
    <ao:context rdf:resource="urn:domeoclient:uuid:6F9E01FD-BC9F-4B86-8FFF-8A4DC8CD6CB5"/>
    <pav:createdOn>2014-07-28 17:00:51 -0400</pav:createdOn>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:79016A6C-CD48-4680-8D24-28567975EAC5">
    <ao:suffix>, the incidence of withdrawal symptoms decreased and methadone exposure increased to a level comparable to that prior to phenytoin administration.</ao:suffix>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-201.txt.html</ao:hasSource>
    <pav:createdOn>2014-07-28 17:04:42 -0400</pav:createdOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:79016A6C-CD48-4680-8D24-28567975EAC5"/>
    <domeo:uuid>79016A6C-CD48-4680-8D24-28567975EAC5</domeo:uuid>
    <ao:prefix> exposure and withdrawal symptoms occurred concurrently. Upon discontinuation of </ao:prefix>
    <ao:exact>phenytoin</ao:exact>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:E32C0683-393F-4141-AB8D-7863405CC923">
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/AB6125AD-8476-408C-A170-B40BE6A511E4"/>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/PK_DDI"/>
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/FD1E05D2-DBCD-40D9-A3EB-92B46960D6B9"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:04DB6C49-D431-40EA-98E8-D720E8A6787D">
    <dikbD2R:modality>ncit:positive</dikbD2R:modality>
    <sio:SIO_000628 rdf:resource="urn:pddi:uuid:11BCB02F-AC6F-47D4-98D8-4B72C6ED08A2"/>
    <rdf:type rdf:resource="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#DrugDrugInteractionStatement"/>
    <sio:SIO_000205>dikbD2R:statement</sio:SIO_000205>
    <sio:SIO_000563>dikbD2R:modality</sio:SIO_000563>
    <dikbD2R:statement>ncit:quantitative</dikbD2R:statement>
  </rdf:Description>
  <rdf:Description rdf:nodeID="Na1b73923fdf94353bfac4a63980fb1ba">
    <domeo:sets rdf:resource="urn:pddi:uuid:2EF11BBD-DFCE-4A86-A72C-0BCC80E7E152"/>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/6C885934-8872-486F-BCF1-97D398581817">
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/drug-product"/>
    <rdfs:label>cefazolin</rdfs:label>
    <dct:description>Referred to the drug in the interaction.</dct:description>
    <sio:SIO_000228>dikbD2R:precipitant-drug-of-interaction</sio:SIO_000228>
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/</dailymed:activeMoietyRxCUI>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:1E635F35-7B6C-49A8-AD29-C3853F8DC576">
    <sio:SIO_000628 rdf:resource="urn:pddi:uuid:2479E0A1-BF58-4BD9-9AB9-45B56AC1BD6A"/>
    <sio:SIO_000205>dikbD2R:statement</sio:SIO_000205>
    <sio:SIO_000563>dikbD2R:modality</sio:SIO_000563>
    <dikbD2R:statement>ncit:quantitative</dikbD2R:statement>
    <dikbD2R:modality>ncit:positive</dikbD2R:modality>
    <rdf:type rdf:resource="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#DrugDrugInteractionStatement"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:3580D7AB-C344-4344-96C6-6C6FF5BA9B3D">
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/PK_DDI"/>
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/066DE754-7246-47EA-9F6B-DB99A3097E26"/>
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/200F7C4A-CD90-46C0-8779-AF63E291B5C6"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:E17F3ACA-8486-4702-886B-6FA2562FDEFF">
    <pav:createdOn>2014-07-13 12:44:35 -0400</pav:createdOn>
    <ao:exact>levonorgestrel</ao:exact>
    <ao:prefix> AUC was 6% (range: -47 to 108%) and </ao:prefix>
    <ao:suffix> AUC increased 17% (range: -33 to 141%).</ao:suffix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <domeo:uuid>E17F3ACA-8486-4702-886B-6FA2562FDEFF</domeo:uuid>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-22.txt.html</ao:hasSource>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:E17F3ACA-8486-4702-886B-6FA2562FDEFF"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
  </rdf:Description>
  <rdf:Description rdf:nodeID="N0aa099019b724c3ca0bff1a233f95591">
    <permissions:isLocked>false</permissions:isLocked>
    <permissions:accessType>urn:domeo:access:public</permissions:accessType>
  </rdf:Description>
  <rdf:Description rdf:nodeID="Nc4707fb6856b4f709a369bba42059710">
    <domeo:sets rdf:resource="urn:pddi:uuid:938EFE6C-8A23-4829-AFA7-544CDA08913A"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:AB5CE3C5-4CFD-489B-9021-04685E6B310D">
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/F027CB1D-7D5A-4ADC-8E54-303492562FCA"/>
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/A52FAC94-0446-462D-9EE8-53E67CFDFC2E"/>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/PK_DDI"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:D78CEABF-EE24-4AFF-81A9-B148050EFE16">
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-8.txt.html</ao:hasSource>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:D78CEABF-EE24-4AFF-81A9-B148050EFE16"/>
    <ao:exact>phenytoin</ao:exact>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:suffix>, rifampin, and phenobarbital) with risperidone may cause a decrease in the combined plasma concentrations of risperidone and 9-hydroxyrisperidone [see 7 DRUG INTERACTIONS]. It would also be possible for risperidone to interfere with metabolism of other </ao:suffix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:prefix>, </ao:prefix>
    <domeo:uuid>D78CEABF-EE24-4AFF-81A9-B148050EFE16</domeo:uuid>
    <pav:createdOn>2014-07-13 11:15:52 -0400</pav:createdOn>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:C2EEFE36-AE7E-4BF4-943E-03D2760C673E">
    <ao:prefix>The clinical effect from </ao:prefix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <domeo:uuid>C2EEFE36-AE7E-4BF4-943E-03D2760C673E</domeo:uuid>
    <ao:exact>risperidone</ao:exact>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-8.txt.html</ao:hasSource>
    <ao:suffix> results from the combined concentrations of risperidone and its major metabolite, 9-hydroxyrisperidone [see 12 CLINICAL PHARMACOLOGY]. Antagonism at receptors other than D2 and 5HT2 [see 12 CLINICAL PHARMACOLOGY] may explain some of the other effects of</ao:suffix>
    <pav:createdOn>2014-07-13 11:08:45 -0400</pav:createdOn>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:C2EEFE36-AE7E-4BF4-943E-03D2760C673E"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:DFE53F7D-4938-4208-8BAE-E74CAD65CFE9">
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/B9254794-2257-403D-AD8D-D269CBB2679F"/>
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/FE6B22BB-D261-488B-A15D-2B75123912F4"/>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/PK_DDI"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:5058C561-7B00-4413-BD99-D40414B31D77">
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/CEF2E7CC-61D6-42FF-A861-DCF099AE1E0C"/>
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/DA01DC4D-57B2-4142-A8DB-72DB578A27AD"/>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/PK_DDI"/>
  </rdf:Description>
  <rdf:Description rdf:nodeID="Ndb4a6d99843b4577b479f75d45f8e399">
    <permissions:isLocked>false</permissions:isLocked>
    <permissions:accessType>urn:domeo:access:public</permissions:accessType>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:BE2369F6-B30D-45B8-9655-5079A35C9D6D">
    <ao:suffix> has been evaluated when both drugs were at steady state. In healthy volunteers who were extensive metabolizers of CYP2D6, paroxetine 20 mg daily was given in combination with 20 mg atomoxetine every 12 hours. This resulted in increases in steady state a</ao:suffix>
    <domeo:uuid>BE2369F6-B30D-45B8-9655-5079A35C9D6D</domeo:uuid>
    <pav:createdOn>2014-09-02 11:58:19 -0400</pav:createdOn>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-47.txt.html</ao:hasSource>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:exact>atomoxetine</ao:exact>
    <ao:prefix>ely 4-fold, decreased 9-hydroxyrisperidone concentrations approximately 10%, and increased concentrations of the active moiety (the sum of risperidone plus 9-hydroxyrisperidone) approximately 1.4-fold. The effect of paroxetine on the pharmacokinetics of </ao:prefix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:BE2369F6-B30D-45B8-9655-5079A35C9D6D"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:DC75BC49-9657-4DDD-BA6E-E382607C98F8">
    <pav:createdOn>2014-07-22 19:22:19 -0400</pav:createdOn>
    <ao:suffix> 4 mg twice daily. The corresponding values for glyburide were 3.2, 3.1, and 2.9. The differences in change from baseline between </ao:suffix>
    <ao:exact>AVANDIA</ao:exact>
    <ao:prefix> over time. Because of the temporal nature of lipid changes, the 52-week glyburide-controlled study is most pertinent to assess long-term effects on lipids. At baseline, week 26, and week 52, mean LDL/HDL ratios were 3.1, 3.2, and 3.0, respectively, for </ao:prefix>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-123.txt.html</ao:hasSource>
    <domeo:uuid>DC75BC49-9657-4DDD-BA6E-E382607C98F8</domeo:uuid>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:DC75BC49-9657-4DDD-BA6E-E382607C98F8"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:9207210A-6F7A-4F79-BDF9-A1A2BE0D055E">
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812eda990003</pav:createdBy>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <pav:lineageUri>urn:domeoserver:annotation:06D43679-56C3-4F36-AF63-D6FFEE09CD2D</pav:lineageUri>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:createdOn>2014-07-24 19:52:46 -0400</pav:createdOn>
    <ao:context rdf:resource="urn:domeoclient:uuid:001ECFA6-B086-4B2B-977E-41F4C9DE054B"/>
    <domeo:belongsToSet>urn:domeoclient:uuid:E0863579-8D19-4B30-ADD6-2A5BDBC2F482</domeo:belongsToSet>
    <pav:lastSavedOn>2014-07-24 19:53:55 -0400</pav:lastSavedOn>
    <rdfs:label>Highlight</rdfs:label>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:0FEC326D-6B98-40B2-8D49-7B4318AEB3B8">
    <ao:suffix>, and the combination should, therefore, be used with caution. Severe vomiting has been reported with the coadministration of fluvoxamine maleate and tryptophan (see WARNINGS AND PRECAUTIONS [5.3]).</ao:suffix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:exact>fluvoxamine</ao:exact>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <domeo:uuid>0FEC326D-6B98-40B2-8D49-7B4318AEB3B8</domeo:uuid>
    <pav:createdOn>2014-09-02 11:44:20 -0400</pav:createdOn>
    <ao:prefix>may enhance the serotonergic effects of </ao:prefix>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-9.txt.html</ao:hasSource>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:0FEC326D-6B98-40B2-8D49-7B4318AEB3B8"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:6E8F08BA-7079-4216-9618-95A54B886D84">
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812eda990003</pav:createdBy>
    <domeo:belongsToSet>urn:domeoclient:uuid:876DAFB7-BB08-4119-BA16-59187031D7BB</domeo:belongsToSet>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:createdOn>2014-07-21 21:46:36 -0400</pav:createdOn>
    <pav:lastSavedOn>2014-07-21 21:46:47 -0400</pav:lastSavedOn>
    <ao:context rdf:resource="urn:domeoclient:uuid:8F192869-CBB9-4ECB-A4F1-F621F322E7E6"/>
    <rdfs:label>Highlight</rdfs:label>
    <pav:lineageUri>urn:domeoserver:annotation:B81F177E-80FA-4C7E-AD7A-4FA9D5D95A8B</pav:lineageUri>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:181381FE-800A-4970-81D8-2B14B7735770">
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/BAE41BF7-CAA3-4865-832D-24EB9699E14C"/>
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/8FE58707-AFDD-4F32-9EA8-03EC3BF4D67B"/>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/PK_DDI"/>
  </rdf:Description>
  <rdf:Description rdf:nodeID="N1fc69d89f9db4e15b51906db9cc8ed0b">
    <permissions:isLocked>false</permissions:isLocked>
    <permissions:accessType>urn:domeo:access:public</permissions:accessType>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:7956E8A3-C5E3-47AD-A166-8DD4306EBB1D">
    <ao:exact>meperidine</ao:exact>
    <ao:prefix> is contraindicated in patients who are receiving monoamine oxidase (MAO) inhibitors or those who have recently received such agents. Therapeutic doses of </ao:prefix>
    <pav:createdOn>2014-07-28 17:01:27 -0400</pav:createdOn>
    <ao:suffix> have occasionally precipitated unpredictable, severe, and occasionally fatal reactions in patients who have received such agents within 14 days. The mechanism of these reactions is unclear, but may be related to a preexisting hyperphenylalaninemia. Some</ao:suffix>
    <domeo:uuid>7956E8A3-C5E3-47AD-A166-8DD4306EBB1D</domeo:uuid>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-165.txt.html</ao:hasSource>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:7956E8A3-C5E3-47AD-A166-8DD4306EBB1D"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:F8116D96-F5B7-4381-AFCF-C48903001E05">
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <pav:createdOn>2014-07-24 19:44:04 -0400</pav:createdOn>
    <ao:prefix>xsd:String</ao:prefix>
    <ao:suffix> can inhibit the metabolism of diazepam, resulting in increased concentrations of diazepam and its metabolites. Diazepam does not alter the pharmacokinetics of propranolol.</ao:suffix>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-128.txt.html</ao:hasSource>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:exact>Propranolol</ao:exact>
    <domeo:uuid>F8116D96-F5B7-4381-AFCF-C48903001E05</domeo:uuid>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:F8116D96-F5B7-4381-AFCF-C48903001E05"/>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/C17461FE-A35A-4C0A-940B-01CB796E4877">
    <sio:SIO_000228>dikbD2R:precipitant-drug-of-interaction</sio:SIO_000228>
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/3443</dailymed:activeMoietyRxCUI>
    <rdfs:label>diltiazem</rdfs:label>
    <dct:description>Referred to the drug in the interaction.</dct:description>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/active-ingredient"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:0D94D28F-90BB-4AF1-9CBD-EC4DB10359AA">
    <dikbD2R:statement>ncit:quantitative</dikbD2R:statement>
    <dikbD2R:modality>ncit:positive</dikbD2R:modality>
    <sio:SIO_000205>dikbD2R:statement</sio:SIO_000205>
    <sio:SIO_000563>dikbD2R:modality</sio:SIO_000563>
    <rdf:type rdf:resource="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#DrugDrugInteractionStatement"/>
    <sio:SIO_000628 rdf:resource="urn:pddi:uuid:E3F718F3-CFE3-42BB-856E-B673538F448A"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:B6DF21E9-E88D-43B6-BC67-2BA93CF4CFEF">
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/PK_DDI"/>
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/161695D1-EF44-45A7-B41B-A52C6CD2F783"/>
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/C5B717C7-A880-452E-91DB-A2F2F96090B8"/>
  </rdf:Description>
  <rdf:Description rdf:nodeID="Na03f780a531743b3a9322c7223f7d56b">
    <domeo:sets rdf:resource="urn:pddi:uuid:1A9D1840-CE0D-486B-A233-984C10D2DFDC"/>
  </rdf:Description>
  <rdf:Description rdf:nodeID="Nc332bcd7d43c4208845b6dd3ed9bf9a2">
    <permissions:accessType>urn:domeo:access:public</permissions:accessType>
    <permissions:isLocked>false</permissions:isLocked>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:8AF7E41C-63B6-4042-8707-4622E9BC98AA">
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/PK_DDI"/>
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/5F10CADF-C9DD-4270-A5C5-81DBB003F49D"/>
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/E02048B2-A2E1-475E-9345-1FE9194336FD"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:F941BEEC-394B-4F88-B13F-E8C0361B2C8D">
    <pav:createdOn>2014-07-24 20:08:12 -0400</pav:createdOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:exact>fexofenadine hydrochloride</ao:exact>
    <ao:suffix> alone or in combination with either erythromycin or ketoconazole. The findings of these studies are summarized in the following table</ao:suffix>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:F941BEEC-394B-4F88-B13F-E8C0361B2C8D"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <domeo:uuid>F941BEEC-394B-4F88-B13F-E8C0361B2C8D</domeo:uuid>
    <ao:prefix>xsd:String</ao:prefix>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-139.txt.html</ao:hasSource>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:0F10F658-B658-4FA9-8235-47BB00E1C0A0">
    <rdfs:label>expertstudy Annotation</rdfs:label>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#expertstudyAnnotation"/>
    <pav:lineageUri>urn:domeoserver:annotation:A3482164-6D7D-4B99-A855-EA0193119654</pav:lineageUri>
    <pav:createdOn>2014-09-02 15:06:20 -0400</pav:createdOn>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <ao:body rdf:nodeID="N8218b8284bbb47cb8f57a18ee2681d5c"/>
    <pav:lastSavedOn>2014-09-02 15:06:18 -0400</pav:lastSavedOn>
    <ao:context rdf:resource="urn:domeoclient:uuid:BD1FBEAA-B2D7-405D-8489-BDC578CFEAEB"/>
    <domeo:belongsToSet>urn:domeoclient:uuid:443354CF-9409-4015-81BA-17601E505BAB</domeo:belongsToSet>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812eda990003</pav:createdBy>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:previousVersion>xsd:String</pav:previousVersion>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/D31FCC9E-EA25-4856-B3C1-1712E7892B63">
    <dct:description>Referred to the drug in the interaction.</dct:description>
    <sio:SIO_000228>dikbD2R:precipitant-drug-of-interaction</sio:SIO_000228>
    <rdfs:label>glyburide</rdfs:label>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/active-ingredient"/>
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/4815</dailymed:activeMoietyRxCUI>
  </rdf:Description>
  <rdf:Description rdf:nodeID="Ne5c97be6b2a0427582efb6162e81fd0c">
    <permissions:isLocked>false</permissions:isLocked>
    <permissions:accessType>urn:domeo:access:public</permissions:accessType>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:789A1E1D-CA44-4410-B654-F6392AB94EDC">
    <pav:createdOn>2014-07-13 11:10:54 -0400</pav:createdOn>
    <ao:prefix> is bound to </ao:prefix>
    <domeo:uuid>789A1E1D-CA44-4410-B654-F6392AB94EDC</domeo:uuid>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:suffix> and α1-acid glycoprotein. The plasma protein binding of risperidone is 90%, and that of its major metabolite, 9-hydroxyrisperidone, is 77%. Neither risperidone nor 9-hydroxyrisperidone displaces each other from plasma binding sites. High therapeutic con</ao:suffix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:exact>albumin</ao:exact>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:789A1E1D-CA44-4410-B654-F6392AB94EDC"/>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-8.txt.html</ao:hasSource>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:18BE6999-E03C-4FFF-8400-81AB658469AB">
    <rdf:type rdf:resource="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#DrugDrugInteractionStatement"/>
    <dikbD2R:modality>ncit:negative</dikbD2R:modality>
    <sio:SIO_000563>dikbD2R:modality</sio:SIO_000563>
    <sio:SIO_000205>dikbD2R:statement</sio:SIO_000205>
    <dikbD2R:statement>ncit:Qualitative</dikbD2R:statement>
    <sio:SIO_000628 rdf:resource="urn:pddi:uuid:4B76211E-8EB7-4844-9558-2AE555B3F201"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:AB311B8D-11CB-4B44-BDC1-9641D482BE0D">
    <ao:prefix> and α1-acid glycoprotein. </ao:prefix>
    <pav:createdOn>2014-07-13 11:18:02 -0400</pav:createdOn>
    <ao:exact>Risperidone</ao:exact>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-8.txt.html</ao:hasSource>
    <domeo:uuid>AB311B8D-11CB-4B44-BDC1-9641D482BE0D</domeo:uuid>
    <ao:suffix> doses should be reduced in patients with liver disease [see 2 DOSAGE AND ADMINISTRATION and 5 WARNINGS AND PRECAUTIONS].</ao:suffix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:AB311B8D-11CB-4B44-BDC1-9641D482BE0D"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:29BA1C64-71E4-4437-B3E3-C16FF494B3CA">
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/F4851EA8-C391-4F16-B8F8-81A3F2688015"/>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/PK_DDI"/>
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/5AC4FDB3-99BB-4CC2-9A03-87893DB04756"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:C970223A-AA7A-4283-8B0C-B1F7B0A1261F">
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <pav:createdOn>2014-09-02 11:44:36 -0400</pav:createdOn>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:C970223A-AA7A-4283-8B0C-B1F7B0A1261F"/>
    <ao:suffix>: Bradycardia has been reported with the coadministration of fluvoxamine maleate and diltiazem.</ao:suffix>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-9.txt.html</ao:hasSource>
    <ao:exact>Diltiazem</ao:exact>
    <domeo:uuid>C970223A-AA7A-4283-8B0C-B1F7B0A1261F</domeo:uuid>
    <ao:prefix>xsd:String</ao:prefix>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:082BC34B-E2CB-4EAD-908C-433213A92A0D">
    <pav:createdOn>2014-09-01 16:19:52 -0400</pav:createdOn>
    <ao:prefix> for injection in the U.S. Of these patients, 411 had established </ao:prefix>
    <ao:suffix> and 307 had normal serum urate levels at the time that treatment was initiated. Normal serum uric acid levels were achieved in 68% (reduction of serum uric acid was documented in 93%) of the former, and were maintained throughout chemotherapy in 97% of </ao:suffix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:exact>hyperuricemia</ao:exact>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-43.txt.html</ao:hasSource>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:082BC34B-E2CB-4EAD-908C-433213A92A0D"/>
    <domeo:uuid>082BC34B-E2CB-4EAD-908C-433213A92A0D</domeo:uuid>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:72A9F07A-1698-493D-9547-2E7E44A97B40">
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/CFDD7235-9837-4F98-AB73-620E6FE98023"/>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/PK_DDI"/>
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/EBBEEEE3-DF09-427E-A3A1-75B1DB0D82D6"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:BB5170BC-470C-4927-94E9-76D8F5299B74">
    <pav:lineageUri>urn:domeoserver:annotation:85A49C92-4B0E-4688-B7A9-F420702DEF48</pav:lineageUri>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812eda990003</pav:createdBy>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:createdOn>2014-07-24 19:55:03 -0400</pav:createdOn>
    <rdfs:label>Highlight</rdfs:label>
    <ao:context rdf:resource="urn:domeoclient:uuid:AA479503-5E2B-4688-851D-61C9DCC47907"/>
    <domeo:belongsToSet>urn:domeoclient:uuid:F87D2273-7E05-4F58-B46E-DA5B9D8816DE</domeo:belongsToSet>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:lastSavedOn>2014-07-24 19:54:45 -0400</pav:lastSavedOn>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:D11B175A-9529-45D5-B5B7-A6B7917B6593">
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/CE20B5C0-36BB-4878-B0C9-3069561D06F7"/>
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/B4FD0768-DC29-42AD-9E32-079005955FF6"/>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/PK_DDI"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:EF55F74E-B5B2-4F66-9B6B-11C22CD3DDC4">
    <sio:SIO_000563>dikbD2R:modality</sio:SIO_000563>
    <sio:SIO_000628 rdf:resource="urn:pddi:uuid:30C6EC33-90D7-4C2C-8AF0-1C1F9C9F0DFD"/>
    <dikbD2R:statement>ncit:quantitative</dikbD2R:statement>
    <dikbD2R:modality>ncit:positive</dikbD2R:modality>
    <rdf:type rdf:resource="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#DrugDrugInteractionStatement"/>
    <sio:SIO_000205>dikbD2R:statement</sio:SIO_000205>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/6C80031B-9390-46A4-B67F-9430DCF128A9">
    <sio:SIO_000228>dikbD2R:object-drug-of-interaction</sio:SIO_000228>
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/4450</dailymed:activeMoietyRxCUI>
    <rdfs:label>fluconazole</rdfs:label>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/active-ingredient"/>
    <dct:description>Referred to the drug in the interaction.</dct:description>
  </rdf:Description>
  <rdf:Description rdf:nodeID="N9dfab65a054b47ff9816b750f5427617">
    <domeo:sets rdf:resource="urn:pddi:uuid:6189C7ED-8284-4BC1-8C1D-995A1B9E9199"/>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/880C51AF-841B-4199-8CE7-148DD94269D0">
    <rdfs:label>fexofenadine hydrochloride</rdfs:label>
    <dct:description>Referred to the drug in the interaction.</dct:description>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/active-ingredient"/>
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/236474</dailymed:activeMoietyRxCUI>
    <sio:SIO_000228>dikbD2R:object-drug-of-interaction</sio:SIO_000228>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:F1D81A6A-D89D-4D44-96EB-35FB50C7D732">
    <dikbD2R:modality>ncit:negative</dikbD2R:modality>
    <rdf:type rdf:resource="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#DrugDrugInteractionStatement"/>
    <sio:SIO_000628 rdf:resource="urn:pddi:uuid:2E7AB2E6-7FEA-4A78-80FB-CE3FA7ABBCCB"/>
    <sio:SIO_000205>dikbD2R:statement</sio:SIO_000205>
    <sio:SIO_000563>dikbD2R:modality</sio:SIO_000563>
    <dikbD2R:statement>ncit:Qualitative</dikbD2R:statement>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:5D477356-49DE-4F65-97BE-07989E4A1B92">
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812eda990003</pav:createdBy>
    <pav:lineageUri>urn:domeoserver:annotation:7E943426-6E66-4EE6-89C5-B45CC35BD194</pav:lineageUri>
    <pav:lastSavedOn>2014-07-22 18:46:52 -0400</pav:lastSavedOn>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <domeo:belongsToSet>urn:domeoclient:uuid:E0054F81-6A9B-4AF0-9DCB-962A6FC1C418</domeo:belongsToSet>
    <ao:context rdf:resource="urn:domeoclient:uuid:E19B0AE6-FB85-4E0D-AC07-7E22C589DC36"/>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <pav:createdOn>2014-07-22 18:44:54 -0400</pav:createdOn>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <rdfs:label>Highlight</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:8EEB8C5F-684D-4C78-B063-32431C5FE74A">
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/PK_DDI"/>
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/504D9B65-0BA3-47AC-BD1D-5D353F912A60"/>
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/1D5C7B20-628D-4819-8BB5-5D5207989917"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:36209E50-DEE4-4172-A9EA-98FA4D4477D3">
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/D356370B-E2E4-45FD-AA2A-DBBBC15D7668"/>
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/FE87FAA2-1979-46D4-90FE-4C8F260790F0"/>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/PK_DDI"/>
  </rdf:Description>
  <rdf:Description rdf:nodeID="N34c366e42e94442f8030d63cbbf4316c">
    <permissions:accessType>urn:domeo:access:public</permissions:accessType>
    <permissions:isLocked>false</permissions:isLocked>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:C2471146-B114-47FF-BB78-F58B6158FB99">
    <sio:SIO_000205>dikbD2R:statement</sio:SIO_000205>
    <sio:SIO_000563>dikbD2R:modality</sio:SIO_000563>
    <rdf:type rdf:resource="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#DrugDrugInteractionStatement"/>
    <dikbD2R:statement>ncit:Qualitative</dikbD2R:statement>
    <dikbD2R:modality>ncit:positive</dikbD2R:modality>
    <sio:SIO_000628 rdf:resource="urn:pddi:uuid:DC200567-4E8F-495B-9D13-A2A04A7A47EC"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:1C4D4CDE-899A-4154-909A-B83F015F7989">
    <ao:exact>fosamprenavir</ao:exact>
    <pav:createdOn>2014-07-21 21:43:17 -0400</pav:createdOn>
    <ao:prefix>Co-administration of </ao:prefix>
    <ao:suffix>/ritonavir with paroxetine significantly decreased plasma levels of paroxetine. Any dose adjustment should be guided by clinical effect (tolerability and efficacy). </ao:suffix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <domeo:uuid>1C4D4CDE-899A-4154-909A-B83F015F7989</domeo:uuid>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-51.txt.html</ao:hasSource>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:1C4D4CDE-899A-4154-909A-B83F015F7989"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/CFDD7235-9837-4F98-AB73-620E6FE98023">
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/active-ingredient"/>
    <rdfs:label>glimepiride</rdfs:label>
    <dct:description>Referred to the drug in the interaction.</dct:description>
    <sio:SIO_000228>dikbD2R:precipitant-drug-of-interaction</sio:SIO_000228>
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/25789</dailymed:activeMoietyRxCUI>
  </rdf:Description>
  <rdf:Description rdf:nodeID="Ncc463923d5f548f5820845eea9f80a6b">
    <permissions:accessType>urn:domeo:access:public</permissions:accessType>
    <permissions:isLocked>false</permissions:isLocked>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:D2CDE5DF-B4CC-4374-8C21-8821B6582DB8">
    <ao:suffix> and proton pump inhibitors is not recommended. Co-administration of atazanavir with proton pump inhibitors is expected to substantially decrease atazanavir plasma concentrations and thereby reduce its therapeutic effect.</ao:suffix>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-74.txt.html</ao:hasSource>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <pav:createdOn>2014-09-02 19:16:52 -0400</pav:createdOn>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:D2CDE5DF-B4CC-4374-8C21-8821B6582DB8"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <domeo:uuid>D2CDE5DF-B4CC-4374-8C21-8821B6582DB8</domeo:uuid>
    <ao:exact>atazanavir</ao:exact>
    <ao:prefix>Concomitant use of </ao:prefix>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:CBE541BF-AED9-48E5-ACA0-9309C45B20F5">
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <rdfs:label>Highlight</rdfs:label>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:lastSavedOn>2014-07-13 11:32:29 -0400</pav:lastSavedOn>
    <ao:context rdf:resource="urn:domeoclient:uuid:78BBB6BD-543C-42F3-B5F5-431ADE5F4D72"/>
    <domeo:belongsToSet>urn:domeoclient:uuid:71191E51-53CB-4FDE-88D0-33C6818E2232</domeo:belongsToSet>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:lineageUri>urn:domeoserver:annotation:133A11F3-97FE-4A36-97AB-CF474CA6CAA0</pav:lineageUri>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812eda990003</pav:createdBy>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <pav:createdOn>2014-07-13 11:12:09 -0400</pav:createdOn>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:71B67447-4B56-4869-AE20-875B5CD8C070">
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/C197B5FB-D5F4-4BAD-8C29-F575B4DDF092"/>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/PK_DDI"/>
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/804CF934-20BE-47B7-9B48-D1203ED27B8A"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:5672F5D0-071A-4DE9-9A98-BD20431A00C2">
    <ao:exact>Sildenafil </ao:exact>
    <pav:createdOn>2014-07-07 09:34:12 -0400</pav:createdOn>
    <ao:prefix>xsd:String</ao:prefix>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:5672F5D0-071A-4DE9-9A98-BD20431A00C2"/>
    <domeo:uuid></domeo:uuid>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:suffix>is an inhibitor of cGMP specific phosphodiesterase type-5 (PDE5) in the smooth muscle of the pulmonary vasculature, where PDE5 is responsible for degradation of cGMP. Sildenafil, therefore, increases cGMP within pulmonary vascular smooth muscle cells res</ao:suffix>
    <domeo:uuid>5672F5D0-071A-4DE9-9A98-BD20431A00C2</domeo:uuid>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-155.txt.html</ao:hasSource>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/C731F1F0-68ED-49B4-A9BF-768B903AF43C">
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/8787</dailymed:activeMoietyRxCUI>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/active-ingredient"/>
    <rdfs:label>propranolol</rdfs:label>
    <dct:description>Referred to the drug in the interaction.</dct:description>
    <sio:SIO_000228>dikbD2R:precipitant-drug-of-interaction</sio:SIO_000228>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:E8450D63-C063-4E83-BCD1-4BE5A8F6FF5C">
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <domeo:uuid>E8450D63-C063-4E83-BCD1-4BE5A8F6FF5C</domeo:uuid>
    <pav:createdOn>2014-07-21 21:50:40 -0400</pav:createdOn>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:E8450D63-C063-4E83-BCD1-4BE5A8F6FF5C"/>
    <ao:prefix> Extended-release Tablet contains 300 mg of </ao:prefix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:suffix> (249 mg of quinidine base) in a formulation to provide extended release; the inactive ingredients are: fumaric acid, hypromellose, lactose monohydrate, magnesium stearate, polydextrose, polyethylene glycol, povidone, triacetin and titanium dioxide.</ao:suffix>
    <ao:exact>quinidine sulfate</ao:exact>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-55.txt.html</ao:hasSource>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/F027CB1D-7D5A-4ADC-8E54-303492562FCA">
    <sio:SIO_000228>dikbD2R:precipitant-drug-of-interaction</sio:SIO_000228>
    <rdfs:label>warfarin</rdfs:label>
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/11289</dailymed:activeMoietyRxCUI>
    <dct:description>Referred to the drug in the interaction.</dct:description>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/active-ingredient"/>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/C98F4F9C-3452-4547-9D59-858A821616E1">
    <dct:description>Referred to the drug in the interaction.</dct:description>
    <sio:SIO_000228>dikbD2R:object-drug-of-interaction</sio:SIO_000228>
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/6813</dailymed:activeMoietyRxCUI>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/active-ingredient"/>
    <rdfs:label>methadone</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:9D2EDEBD-1223-4650-A96C-6AA36F00C854">
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/7C1B3FD3-CA8D-4D2F-B094-F0DB74BF2108"/>
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/964F2661-87EF-4D00-87C8-D1C5E12C0ECB"/>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/PK_DDI"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:8AA02101-5E16-4D28-B719-8FAC66F7E101">
    <domeo:uuid>8AA02101-5E16-4D28-B719-8FAC66F7E101</domeo:uuid>
    <pav:createdOn>2014-09-02 19:13:15 -0400</pav:createdOn>
    <ao:prefix> was found, there have been clinical reports of interaction with other drugs metabolized via the cytochrome P450 system (e.g., cyclosporine, </ao:prefix>
    <ao:suffix>, </ao:suffix>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-74.txt.html</ao:hasSource>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:8AA02101-5E16-4D28-B719-8FAC66F7E101"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:exact>disulfiram</ao:exact>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:5FD51EEB-1F14-4FFB-92BE-098757E4ED58">
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/04BE103D-A7ED-4289-9B72-CCC97FDE114E"/>
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/B7481A86-7883-4807-96C3-AE9B411B847B"/>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/PK_DDI"/>
  </rdf:Description>
  <rdf:Description rdf:nodeID="N8e07f133bf774d7397e9bf67b9759e19">
    <domeo:sets rdf:resource="urn:pddi:uuid:2CE98409-9106-46BC-A9DE-155A92568532"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:6D31780D-83B2-4F04-8282-BA0D62D2F386">
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/46FB1ED5-40B7-4788-9A91-7689FC73A793"/>
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/56DDE847-8CB1-4471-8B16-A24584A6647C"/>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/PK_DDI"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:39EB4A47-EAC7-4A2A-9B4F-05E57C8A10E3">
    <ao:prefix> 100 mg/day administered at steady-state was associated with five- and eight-fold increases in tacrine Cmax and AUC, respectively, compared to the administration of </ao:prefix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <domeo:uuid>39EB4A47-EAC7-4A2A-9B4F-05E57C8A10E3</domeo:uuid>
    <pav:createdOn>2014-09-02 11:42:08 -0400</pav:createdOn>
    <ao:exact>tacrine</ao:exact>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-9.txt.html</ao:hasSource>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:39EB4A47-EAC7-4A2A-9B4F-05E57C8A10E3"/>
    <ao:suffix> alone. Five subjects experienced nausea, vomiting, sweating, and diarrhea following coadministration, consistent with the cholinergic effects of </ao:suffix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:E3F718F3-CFE3-42BB-856E-B673538F448A">
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/9C6B1447-979C-42A2-8477-0513E82FA0CC"/>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/PK_DDI"/>
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/AEA0CF77-C0B7-4D4A-ABBA-4F3F58A6C3CA"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:BC898759-CCCD-4E6C-9FBB-4E76A3E8F0BE">
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/6C80031B-9390-46A4-B67F-9430DCF128A9"/>
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/31951605-3312-425D-ABB9-1EF6CB9A6AA5"/>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/PK_DDI"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:23B46B7B-627E-4D42-A5FF-1DBE8AB466EF">
    <sio:SIO_000205>dikbD2R:statement</sio:SIO_000205>
    <sio:SIO_000628 rdf:resource="urn:pddi:uuid:5A32BB60-7D2B-448B-A3EB-21F28A75BB33"/>
    <sio:SIO_000563>dikbD2R:modality</sio:SIO_000563>
    <dikbD2R:statement>ncit:Qualitative</dikbD2R:statement>
    <dikbD2R:modality>ncit:negative</dikbD2R:modality>
    <rdf:type rdf:resource="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#DrugDrugInteractionStatement"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:D318A30A-F708-43F6-AB5B-A9D659E063BF">
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/ED3BCC98-B0FE-4421-B54B-7B2414CF4328"/>
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/851B37FE-C029-42CD-9AFE-2CD0906FA393"/>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/PK_DDI"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:DCA0957A-745E-4232-BE6B-45104AD0FFCD">
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/021311B6-82A4-4AA1-97CE-B7A322F4EE50"/>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/PK_DDI"/>
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/CA0AE675-8281-46D4-AD74-54B4F3150E52"/>
  </rdf:Description>
  <rdf:Description rdf:nodeID="Nba115080b5364b22ab22abf0490e9926">
    <permissions:accessType>urn:domeo:access:public</permissions:accessType>
    <permissions:isLocked>false</permissions:isLocked>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/FE87FAA2-1979-46D4-90FE-4C8F260790F0">
    <sio:SIO_000228>dikbD2R:object-drug-of-interaction</sio:SIO_000228>
    <dct:description>Referred to the drug in the interaction.</dct:description>
    <rdfs:label>rosiglitazone</rdfs:label>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/active-ingredient"/>
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/84108</dailymed:activeMoietyRxCUI>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/7D37C82A-2E31-4FCE-8C21-50B73E96FF3E">
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/active-ingredient"/>
    <rdfs:label>saquinavir</rdfs:label>
    <dct:description>Referred to the drug in the interaction.</dct:description>
    <sio:SIO_000228>dikbD2R:object-drug-of-interaction</sio:SIO_000228>
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/83395</dailymed:activeMoietyRxCUI>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:19EC0F23-10DE-4B34-BA59-B2E33CFE1030">
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/E5F7CCC2-0F44-40A0-87D9-225E3A4EAC91"/>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/PK_DDI"/>
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/25CF5D55-E18C-41A3-8548-34F37BD2A10A"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:9A7BCFA2-0D97-4701-B6BB-99407F80BF4B">
    <sio:SIO_000563>dikbD2R:modality</sio:SIO_000563>
    <rdf:type rdf:resource="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#DrugDrugInteractionStatement"/>
    <sio:SIO_000628 rdf:resource="urn:pddi:uuid:41533E80-E3DB-4B1A-BC74-31DB2EDCBDFA"/>
    <dikbD2R:statement>ncit:quantitative</dikbD2R:statement>
    <dikbD2R:modality>ncit:positive</dikbD2R:modality>
    <sio:SIO_000205>dikbD2R:statement</sio:SIO_000205>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/C5B717C7-A880-452E-91DB-A2F2F96090B8">
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/7417</dailymed:activeMoietyRxCUI>
    <rdfs:label>nifedipine</rdfs:label>
    <dct:description>Referred to the drug in the interaction.</dct:description>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/active-ingredient"/>
    <sio:SIO_000228>dikbD2R:precipitant-drug-of-interaction</sio:SIO_000228>
  </rdf:Description>
  <rdf:Description rdf:nodeID="N8d26281194d14f66893d604676dfd791">
    <domeo:sets rdf:resource="urn:pddi:uuid:18BE6999-E03C-4FFF-8400-81AB658469AB"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:5A32BB60-7D2B-448B-A3EB-21F28A75BB33">
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/D0EF2EA1-1BE2-4B9B-8114-37709CA5774E"/>
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/B6FF0814-E04F-4FA2-8963-BC913DC8898E"/>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/PK_DDI"/>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/90DF0B47-DCBB-4EEC-BC07-A4A1FACD692F">
    <sio:SIO_000228>dikbD2R:precipitant-drug-of-interaction</sio:SIO_000228>
    <rdfs:label>paroxetine</rdfs:label>
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/32937</dailymed:activeMoietyRxCUI>
    <dct:description>Referred to the drug in the interaction.</dct:description>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/active-ingredient"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:991B1A28-CCE6-4672-8304-2C2413DEA09C">
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/C4007BE1-F417-40F4-9849-29EA38C247C5"/>
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/DBD9B114-1A26-42A6-8975-25C258D84F84"/>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/PK_DDI"/>
  </rdf:Description>
  <rdf:Description rdf:nodeID="N34fa5344f2f446109603fb6d2855ae08">
    <domeo:sets rdf:resource="urn:pddi:uuid:67967D27-75AF-4745-A665-F0AE8B4677A2"/>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/AEA0CF77-C0B7-4D4A-ABBA-4F3F58A6C3CA">
    <dct:description>Referred to the drug in the interaction.</dct:description>
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/7417</dailymed:activeMoietyRxCUI>
    <sio:SIO_000228>dikbD2R:precipitant-drug-of-interaction</sio:SIO_000228>
    <rdfs:label>nifedipine</rdfs:label>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/active-ingredient"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:7A7954C3-5D7A-42B7-A218-ECC19277FC3A">
    <rdf:type rdf:resource="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#DrugDrugInteractionStatement"/>
    <sio:SIO_000628 rdf:resource="urn:pddi:uuid:5058C561-7B00-4413-BD99-D40414B31D77"/>
    <sio:SIO_000205>dikbD2R:statement</sio:SIO_000205>
    <sio:SIO_000563>dikbD2R:modality</sio:SIO_000563>
    <dikbD2R:statement>ncit:quantitative</dikbD2R:statement>
    <dikbD2R:modality>ncit:positive</dikbD2R:modality>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:AE1A087B-7CF8-4549-978E-17FEC965A2FF">
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:lineageUri>urn:domeoserver:annotation:B266BF7D-76BD-461F-B348-21B59090D7D3</pav:lineageUri>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <domeo:belongsToSet>urn:domeoclient:uuid:FCA2BF23-0BE3-409F-9177-761812F96097</domeo:belongsToSet>
    <pav:lastSavedOn>2014-07-07 09:44:19 -0400</pav:lastSavedOn>
    <pav:createdOn>2014-07-07 09:42:27 -0400</pav:createdOn>
    <ao:context rdf:resource="urn:domeoclient:uuid:A1560B5F-D6E1-47EC-A088-C0C90A150994"/>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812eda990003</pav:createdBy>
    <rdfs:label>Highlight</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:C20ADD05-5DFA-4D15-B8F8-1DD1BE6A5E76">
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/903A96DD-5D24-4703-BA4D-F99711E452A7"/>
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/39638090-D8E9-46BA-A5C4-A4210E7F0DCB"/>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/PK_DDI"/>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/19778C35-B5B2-4C65-9F2A-49A170F2C3CF">
    <sio:SIO_000228>dikbD2R:object-drug-of-interaction</sio:SIO_000228>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/drug-product"/>
    <rdfs:label>AVANDIA</rdfs:label>
    <dct:description>Referred to the drug in the interaction.</dct:description>
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/261455</dailymed:activeMoietyRxCUI>
  </rdf:Description>
  <rdf:Description rdf:nodeID="Nf34060c5ea7740afa9db91c1b9ddec16">
    <permissions:accessType>urn:domeo:access:public</permissions:accessType>
    <permissions:isLocked>false</permissions:isLocked>
  </rdf:Description>
  <rdf:Description rdf:nodeID="N58e27bae606b403e88e9a3d990f41269">
    <domeo:sets rdf:resource="urn:pddi:uuid:7CE3802C-582C-4A21-83B9-9CF98F3D327C"/>
  </rdf:Description>
  <rdf:Description rdf:nodeID="N35ade76377e24dacbfd3cf3c3ab19dec">
    <domeo:sets rdf:resource="urn:pddi:uuid:114406CD-55D0-459D-A4F0-CEDB09E201C6"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:7CBD8092-1453-4994-9F29-22622E743A15">
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/94DFD21D-D749-4F5E-AE57-CF5CE30BA0D9"/>
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/B7CB635F-4EBF-434B-9159-71DC46A33588"/>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/PK_DDI"/>
  </rdf:Description>
  <rdf:Description rdf:nodeID="N1b3b231d098047199ffc450ddab36bb2">
    <domeo:sets rdf:resource="urn:pddi:uuid:45E3AE96-A235-4D7F-BF78-51E479E847A6"/>
  </rdf:Description>
  <rdf:Description rdf:nodeID="N915e02fd95714098aba133476f1afce3">
    <permissions:accessType>urn:domeo:access:public</permissions:accessType>
    <permissions:isLocked>false</permissions:isLocked>
  </rdf:Description>
  <rdf:Description rdf:nodeID="Nd3ada4e9318c4f7ea2045d513a051a84">
    <permissions:accessType>urn:domeo:access:public</permissions:accessType>
    <permissions:isLocked>false</permissions:isLocked>
  </rdf:Description>
  <rdf:Description rdf:nodeID="Na443844cba664ce7bec9cb7102024110">
    <domeo:sets rdf:resource="urn:pddi:uuid:FDA6AE08-3F60-49BF-A915-AF6F8F16E6C0"/>
  </rdf:Description>
  <rdf:Description rdf:nodeID="N4aa7752b812f42fa852dea95761e1caa">
    <permissions:isLocked>false</permissions:isLocked>
    <permissions:accessType>urn:domeo:access:public</permissions:accessType>
  </rdf:Description>
  <rdf:Description rdf:nodeID="Nacfb48ddb4644f188db24def45011806">
    <permissions:isLocked>false</permissions:isLocked>
    <permissions:accessType>urn:domeo:access:public</permissions:accessType>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/506F49B8-922C-4813-A6D3-3A7CFAA9C474">
    <sio:SIO_000228>dikbD2R:precipitant-drug-of-interaction</sio:SIO_000228>
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/40254</dailymed:activeMoietyRxCUI>
    <rdfs:label>valproate</rdfs:label>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/active-ingredient"/>
    <dct:description>Referred to the drug in the interaction.</dct:description>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:3B709C4D-773B-4209-8440-63FF184B3636">
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/PK_DDI"/>
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/FA86A8F3-C1E5-4301-8EE4-2F312AEF69D5"/>
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/4B3161A8-052C-446A-A771-EB9186F64AD8"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:3CF71FFB-73DC-483D-B743-8D191F63D01D">
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/D907D608-9F35-4208-BA27-EE0CA65B1AE3"/>
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/5E9DF383-ABD6-4F64-BB57-8EF69FDE4C64"/>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/PK_DDI"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:B3435A02-DBAF-4D33-9A80-3B78037721AE">
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-8.txt.html</ao:hasSource>
    <domeo:uuid>B3435A02-DBAF-4D33-9A80-3B78037721AE</domeo:uuid>
    <ao:suffix> acts as an antagonist at other receptors, but with lower potency. Risperidone has low to moderate affinity (Ki of 47 to 253 nM) for the serotonin 5HT1C, 5HT1D, and 5HT1A receptors, weak affinity (Ki of 620 to 800 nM) for the dopamine D1 and haloperidol-</ao:suffix>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:B3435A02-DBAF-4D33-9A80-3B78037721AE"/>
    <ao:exact>Risperidone</ao:exact>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <pav:createdOn>2014-07-13 11:07:46 -0400</pav:createdOn>
    <ao:prefix> Type 2 (D2), α1 and α2 adrenergic, and H1 histaminergic receptors. </ao:prefix>
  </rdf:Description>
  <rdf:Description rdf:nodeID="Nb32f510898c745658a4a0e3bf9a57a7e">
    <permissions:isLocked>false</permissions:isLocked>
    <permissions:accessType>urn:domeo:access:public</permissions:accessType>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:C97B59CB-4DC7-442A-BF74-3C9020F4F7FA">
    <dikbD2R:modality>ncit:positive</dikbD2R:modality>
    <sio:SIO_000628 rdf:resource="urn:pddi:uuid:3B709C4D-773B-4209-8440-63FF184B3636"/>
    <dikbD2R:statement>ncit:quantitative</dikbD2R:statement>
    <rdf:type rdf:resource="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#DrugDrugInteractionStatement"/>
    <sio:SIO_000205>dikbD2R:statement</sio:SIO_000205>
    <sio:SIO_000563>dikbD2R:modality</sio:SIO_000563>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:C13FD629-159C-4DA7-9B01-A5B3536DF254">
    <ao:suffix>200 mg (q.d.) induces the metabolism of cisapride (cisapride AUC and Cmax were reduced by about 35%).</ao:suffix>
    <ao:exact>sertraline </ao:exact>
    <ao:prefix>extent of inhibition of P450 3A4 activity is not likely to be of clinical significance. Results of the interaction study with cisapride indicate that </ao:prefix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-16.txt.html</ao:hasSource>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:C13FD629-159C-4DA7-9B01-A5B3536DF254"/>
    <pav:createdOn>2014-09-01 16:06:11 -0400</pav:createdOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <domeo:uuid>C13FD629-159C-4DA7-9B01-A5B3536DF254</domeo:uuid>
  </rdf:Description>
  <rdf:Description rdf:nodeID="N8b00472424fb4f43b0f1dd36140a81fa">
    <permissions:accessType>urn:domeo:access:public</permissions:accessType>
    <permissions:isLocked>false</permissions:isLocked>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:22A46207-521A-4D8F-8D17-31F7E25F3B95">
    <sio:SIO_000205>dikbD2R:statement</sio:SIO_000205>
    <dikbD2R:statement>ncit:Qualitative</dikbD2R:statement>
    <dikbD2R:modality>ncit:negative</dikbD2R:modality>
    <sio:SIO_000628 rdf:resource="urn:pddi:uuid:DFE53F7D-4938-4208-8BAE-E74CAD65CFE9"/>
    <sio:SIO_000563>dikbD2R:modality</sio:SIO_000563>
    <rdf:type rdf:resource="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#DrugDrugInteractionStatement"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:A87B61D2-D72C-42FD-B166-A4440E8574B1">
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/8F36BE9D-F662-4788-A209-5115C542C5AE"/>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/PK_DDI"/>
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/4BCAA30A-4939-4A50-A548-16A452EDFC69"/>
  </rdf:Description>
  <rdf:Description rdf:nodeID="N0b4a8c0f60a84910a71e5620b4c61c1a">
    <permissions:isLocked>false</permissions:isLocked>
    <permissions:accessType>urn:domeo:access:public</permissions:accessType>
  </rdf:Description>
  <rdf:Description rdf:nodeID="Nf740a826859f4224933964a512ae3b72">
    <domeo:sets rdf:resource="urn:pddi:uuid:FD421B20-B74E-481A-8077-F6D9C42943B8"/>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/D907D608-9F35-4208-BA27-EE0CA65B1AE3">
    <sio:SIO_000228>dikbD2R:object-drug-of-interaction</sio:SIO_000228>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/active-ingredient"/>
    <rdfs:label>quinidine</rdfs:label>
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/9068</dailymed:activeMoietyRxCUI>
    <dct:description>Referred to the drug in the interaction.</dct:description>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:BA258499-09C3-45B8-8CA4-4B430E2DB5EB">
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/PK_DDI"/>
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/60257C53-72AE-476E-AFC6-21B1AA00F626"/>
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/E529663E-F098-4A61-A526-168945DFC957"/>
  </rdf:Description>
  <rdf:Description rdf:nodeID="N8e22aea97ed04b759f7621219d206999">
    <permissions:accessType>urn:domeo:access:public</permissions:accessType>
    <permissions:isLocked>false</permissions:isLocked>
  </rdf:Description>
  <rdf:Description rdf:nodeID="N8fb4f1f2fd2e4c6b98aa7794dd80f966">
    <permissions:accessType>urn:domeo:access:public</permissions:accessType>
    <permissions:isLocked>false</permissions:isLocked>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:788F9802-1A2C-4B8B-958F-27977AB9BE1B">
    <dikbD2R:statement>ncit:quantitative</dikbD2R:statement>
    <sio:SIO_000628 rdf:resource="urn:pddi:uuid:9C71E884-F7BA-41EE-A3DD-8DAE2AB3D4C0"/>
    <dikbD2R:modality>ncit:positive</dikbD2R:modality>
    <sio:SIO_000205>dikbD2R:statement</sio:SIO_000205>
    <rdf:type rdf:resource="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#DrugDrugInteractionStatement"/>
    <sio:SIO_000563>dikbD2R:modality</sio:SIO_000563>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/8CED9A21-7623-4055-94D4-793400BC8FD1">
    <sio:SIO_000228>dikbD2R:object-drug-of-interaction</sio:SIO_000228>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/active-ingredient"/>
    <rdfs:label>rosiglitazone</rdfs:label>
    <dct:description>Referred to the drug in the interaction.</dct:description>
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/84108</dailymed:activeMoietyRxCUI>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:46D1DA7B-A66C-4B0D-A948-C7A31C7B7FFF">
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/PK_DDI"/>
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/A6BB2E0B-6C79-40DE-987D-E28594E02093"/>
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/E3B94EBF-C4D0-4821-A9AB-263797FD795D"/>
  </rdf:Description>
  <rdf:Description rdf:nodeID="N6374cce4c5da4eb7bc6dcaac29aa8f8a">
    <permissions:isLocked>false</permissions:isLocked>
    <permissions:accessType>urn:domeo:access:public</permissions:accessType>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/C197B5FB-D5F4-4BAD-8C29-F575B4DDF092">
    <dct:description>Referred to the drug in the interaction.</dct:description>
    <rdfs:label>AVANDIA</rdfs:label>
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/261455</dailymed:activeMoietyRxCUI>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/drug-product"/>
    <sio:SIO_000228>dikbD2R:object-drug-of-interaction</sio:SIO_000228>
  </rdf:Description>
  <rdf:Description rdf:nodeID="Nc80e187ccaaa40b6b607c8ebc34e55a5">
    <permissions:isLocked>false</permissions:isLocked>
    <permissions:accessType>urn:domeo:access:public</permissions:accessType>
  </rdf:Description>
  <rdf:Description rdf:nodeID="N37626d7c9c104850ba69b8f6d816e599">
    <permissions:accessType>urn:domeo:access:public</permissions:accessType>
    <permissions:isLocked>false</permissions:isLocked>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:11C59DB6-9144-4BAA-B630-BA9A001B4C4A">
    <sio:SIO_000205>dikbD2R:statement</sio:SIO_000205>
    <sio:SIO_000563>dikbD2R:modality</sio:SIO_000563>
    <dikbD2R:statement>ncit:quantitative</dikbD2R:statement>
    <rdf:type rdf:resource="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#DrugDrugInteractionStatement"/>
    <sio:SIO_000628 rdf:resource="urn:pddi:uuid:639E5CAD-4CBF-4CC5-8D9F-6103AC373BA4"/>
    <dikbD2R:modality>ncit:positive</dikbD2R:modality>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:30C6EC33-90D7-4C2C-8AF0-1C1F9C9F0DFD">
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/FD1343BF-2E5B-4241-8B0E-0B7BDDB60C21"/>
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/15A5B0E0-F6E2-41DD-B290-4DFF5706433B"/>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/PK_DDI"/>
  </rdf:Description>
  <rdf:Description rdf:nodeID="Ne83f7a588a36426087d7dce3cf6c689d">
    <permissions:accessType>urn:domeo:access:public</permissions:accessType>
    <permissions:isLocked>false</permissions:isLocked>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/691C5E88-8E4D-4153-997E-9AC3F9C35064">
    <dct:description>Referred to the drug in the interaction.</dct:description>
    <sio:SIO_000228>dikbD2R:object-drug-of-interaction</sio:SIO_000228>
    <rdfs:label>rosiglitazone</rdfs:label>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/active-ingredient"/>
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/84108</dailymed:activeMoietyRxCUI>
  </rdf:Description>
  <rdf:Description rdf:nodeID="N30366adaa4b14f37a5da84777e35441b">
    <permissions:isLocked>false</permissions:isLocked>
    <permissions:accessType>urn:domeo:access:public</permissions:accessType>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:5C74E3FF-0F23-47DF-BFE0-C6FFA3577DFE">
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <domeo:uuid>5C74E3FF-0F23-47DF-BFE0-C6FFA3577DFE</domeo:uuid>
    <pav:createdOn>2014-07-22 19:35:05 -0400</pav:createdOn>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-123.txt.html</ao:hasSource>
    <ao:prefix> was significantly lower in patients with moderate to severe liver disease (Child-Pugh Class B/C) compared to healthy subjects. As a result, unbound Cmax and AUC0-inf were increased 2- and 3-fold, respectively. Elimination half-life for </ao:prefix>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:5C74E3FF-0F23-47DF-BFE0-C6FFA3577DFE"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:exact>rosiglitazone</ao:exact>
    <ao:suffix> was about 2 hours longer in patients with liver disease, compared to healthy subjects.</ao:suffix>
  </rdf:Description>
  <rdf:Description rdf:nodeID="N672f966abc88436087a9cc1f6f77d772">
    <permissions:accessType>urn:domeo:access:public</permissions:accessType>
    <permissions:isLocked>false</permissions:isLocked>
  </rdf:Description>
  <rdf:Description rdf:nodeID="Nd59c409ee09449d7bbc830d00cbae38d">
    <permissions:isLocked>false</permissions:isLocked>
    <permissions:accessType>urn:domeo:access:public</permissions:accessType>
  </rdf:Description>
  <rdf:Description rdf:nodeID="N5aa0f1f7ed364c4fa6de5a60877475fc">
    <domeo:sets rdf:resource="urn:pddi:uuid:EF55F74E-B5B2-4F66-9B6B-11C22CD3DDC4"/>
  </rdf:Description>
  <rdf:Description rdf:nodeID="Nad91449b554f45d0b728c75c9225bce9">
    <domeo:sets rdf:resource="urn:pddi:uuid:96647834-C481-4294-B866-A481E00D4F42"/>
  </rdf:Description>
  <rdf:Description rdf:nodeID="N8218b8284bbb47cb8f57a18ee2681d5c">
    <domeo:sets rdf:resource="urn:pddi:uuid:23B46B7B-627E-4D42-A5FF-1DBE8AB466EF"/>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/CE1B6F16-57BD-40EB-AB83-B1A40576F8C0">
    <rdfs:label>rifampin</rdfs:label>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/active-ingredient"/>
    <dct:description>Referred to the drug in the interaction.</dct:description>
    <sio:SIO_000228>dikbD2R:precipitant-drug-of-interaction</sio:SIO_000228>
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/9384</dailymed:activeMoietyRxCUI>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:B3F6AB4E-3B37-4465-8CFC-119F30A661AA">
    <sio:SIO_000563>dikbD2R:modality</sio:SIO_000563>
    <dikbD2R:statement>ncit:Qualitative</dikbD2R:statement>
    <dikbD2R:modality>ncit:negative</dikbD2R:modality>
    <rdf:type rdf:resource="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#DrugDrugInteractionStatement"/>
    <sio:SIO_000205>dikbD2R:statement</sio:SIO_000205>
    <sio:SIO_000628 rdf:resource="urn:pddi:uuid:FA48E451-6066-4222-B6F6-48D1739BF14F"/>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/F68E59B2-9C61-4DC7-A6E2-B96F04B0D293">
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/261455</dailymed:activeMoietyRxCUI>
    <sio:SIO_000228>dikbD2R:object-drug-of-interaction</sio:SIO_000228>
    <rdfs:label>AVANDIA</rdfs:label>
    <dct:description>Referred to the drug in the interaction.</dct:description>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/drug-product"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:EB533813-9EA9-4387-A0AA-5E6F4443AB02">
    <domeo:belongsToSet>urn:domeoclient:uuid:69C22FA1-8D50-4AA7-ACD8-8F71E69BB8AC</domeo:belongsToSet>
    <pav:createdOn>2014-09-02 19:42:27 -0400</pav:createdOn>
    <ao:context rdf:resource="urn:domeoclient:uuid:E2D0AAC2-1961-4E4C-93E0-B707D321E662"/>
    <rdfs:label>Highlight</rdfs:label>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:lineageUri>urn:domeoserver:annotation:1C30AA73-C5EE-49D8-89F7-9E1BF28A2C37</pav:lineageUri>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812eda990003</pav:createdBy>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <pav:lastSavedOn>2014-09-02 19:42:49 -0400</pav:lastSavedOn>
  </rdf:Description>
  <rdf:Description rdf:nodeID="N5571c0d101ee402383c012bbf1147a53">
    <permissions:accessType>urn:domeo:access:public</permissions:accessType>
    <permissions:isLocked>false</permissions:isLocked>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:ECBE6688-F3FC-4F3A-AB24-57398C040B44">
    <rdf:type rdf:resource="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#DrugDrugInteractionStatement"/>
    <sio:SIO_000205>dikbD2R:statement</sio:SIO_000205>
    <sio:SIO_000563>dikbD2R:modality</sio:SIO_000563>
    <dikbD2R:statement>ncit:quantitative</dikbD2R:statement>
    <dikbD2R:modality>ncit:positive</dikbD2R:modality>
    <sio:SIO_000628 rdf:resource="urn:pddi:uuid:2A2B8454-0B34-43FC-8C83-D2580B9D07B1"/>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/27D0B4AA-F7F1-4B7F-ADC9-3414612394E8">
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/87636</dailymed:activeMoietyRxCUI>
    <sio:SIO_000228>dikbD2R:object-drug-of-interaction</sio:SIO_000228>
    <rdfs:label>Fexofenadine</rdfs:label>
    <dct:description>Referred to the drug in the interaction.</dct:description>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/active-ingredient"/>
  </rdf:Description>
  <rdf:Description rdf:nodeID="Nc7bf281fc5664d4cb1298129cce93627">
    <domeo:sets rdf:resource="urn:pddi:uuid:1E3DB35F-57F6-4253-9254-35A557B0E5C5"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:49F82F74-6EDD-4994-8052-10CB1FCA4BA0">
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <domeo:uuid>49F82F74-6EDD-4994-8052-10CB1FCA4BA0</domeo:uuid>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-8.txt.html</ao:hasSource>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <pav:createdOn>2014-07-13 11:09:11 -0400</pav:createdOn>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:49F82F74-6EDD-4994-8052-10CB1FCA4BA0"/>
    <ao:exact>Risperidone</ao:exact>
    <ao:prefix>Absorption: </ao:prefix>
    <ao:suffix> is well absorbed. The absolute oral bioavailability of risperidone is 70% (CV=25%). The relative oral bioavailability of risperidone from a tablet is 94% (CV=10%) when compared to a solution.</ao:suffix>
  </rdf:Description>
  <rdf:Description rdf:nodeID="Nf30b8d8f90f34db298a52bd892a2e53c">
    <domeo:sets rdf:resource="urn:pddi:uuid:7BE43707-1914-4E31-AAC1-03F035925C89"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:2CAE12EF-8696-41E1-941D-FC8A9A49FCCF">
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/PK_DDI"/>
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/F5B8326E-67BE-4609-AB25-C62EAAC309BC"/>
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/691C5E88-8E4D-4153-997E-9AC3F9C35064"/>
  </rdf:Description>
  <rdf:Description rdf:nodeID="N4d885807613045c1b8c2bf4351085fa7">
    <domeo:sets rdf:resource="urn:pddi:uuid:8844F882-4F5A-460C-9215-039DEB9CB5A2"/>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/73BF06A9-0D2D-46D8-916E-0EC7FC22E2F7">
    <rdfs:label>erythromycin</rdfs:label>
    <sio:SIO_000228>dikbD2R:precipitant-drug-of-interaction</sio:SIO_000228>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/active-ingredient"/>
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/4053</dailymed:activeMoietyRxCUI>
    <dct:description>Referred to the drug in the interaction.</dct:description>
  </rdf:Description>
  <rdf:Description rdf:nodeID="Nb714f7e20b1244b29340acc8ad3b9f1e">
    <domeo:sets rdf:resource="urn:pddi:uuid:C97B59CB-4DC7-442A-BF74-3C9020F4F7FA"/>
  </rdf:Description>
  <rdf:Description rdf:nodeID="N43076aac7b814d14b272d7da028a814a">
    <domeo:sets rdf:resource="urn:pddi:uuid:0605CFD4-BB68-443D-9ABF-C97A7A0563B0"/>
  </rdf:Description>
  <rdf:Description rdf:nodeID="Ne6a2939800544018ad3e80871a009edb">
    <domeo:sets rdf:resource="urn:pddi:uuid:15AF1994-00EF-4BF7-9C44-C16149A1F769"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:EACE427F-1066-4C2C-B450-F3CF99633404">
    <pav:createdOn>2014-07-24 20:02:07 -0400</pav:createdOn>
    <ao:prefix>metabolism can be inhibited by the CYP3A4 inhibitors ketoconazole, ritonavir, and indinavir. The effect of short-term administration of </ao:prefix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:suffix> (200 mg twice daily, 4 doses) on the pharmacokinetics of a single dose of trazodone (50 mg) has been studied in 10 healthy subjects. The Cmax of trazodone increased by 34%, the AUC increased 2.4 fold, the half-life increased by 2.2 fold, and the clearan</ao:suffix>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-136.txt.html</ao:hasSource>
    <domeo:uuid>EACE427F-1066-4C2C-B450-F3CF99633404</domeo:uuid>
    <ao:exact>ritonavir</ao:exact>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:EACE427F-1066-4C2C-B450-F3CF99633404"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:5F397631-58CE-4AAD-85E7-C4D90E5C8F78">
    <ao:exact>phenytoin</ao:exact>
    <domeo:uuid>5F397631-58CE-4AAD-85E7-C4D90E5C8F78</domeo:uuid>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-74.txt.html</ao:hasSource>
    <ao:prefix>and </ao:prefix>
    <ao:suffix>, drugs that are metabolized by oxidation in the liver. There have been reports of increased INR and prothrombin time in patients receiving proton pump inhibitors, including omeprazole, and warfarin concomitantly. Increases in INR and prothrombin time ma</ao:suffix>
    <pav:createdOn>2014-09-02 19:12:34 -0400</pav:createdOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:5F397631-58CE-4AAD-85E7-C4D90E5C8F78"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
  </rdf:Description>
  <rdf:Description rdf:nodeID="N671a11f55a4f4168ae4ffe27f5d6b14b">
    <permissions:isLocked>false</permissions:isLocked>
    <permissions:accessType>urn:domeo:access:public</permissions:accessType>
  </rdf:Description>
  <rdf:Description rdf:nodeID="Neb407c1162d0489cbadf4aa85f4d56d6">
    <domeo:sets rdf:resource="urn:pddi:uuid:58965DB7-A15D-49D8-BC77-60DF512B6132"/>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/D10C9054-F924-40A5-9EDB-304BEF56C148">
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/8787</dailymed:activeMoietyRxCUI>
    <rdfs:label>Propranolol</rdfs:label>
    <sio:SIO_000228>dikbD2R:object-drug-of-interaction</sio:SIO_000228>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/active-ingredient"/>
    <dct:description>Referred to the drug in the interaction.</dct:description>
  </rdf:Description>
  <rdf:Description rdf:nodeID="Nbb3db564e49d48f7bcb16ef6c123e457">
    <permissions:isLocked>false</permissions:isLocked>
    <permissions:accessType>urn:domeo:access:public</permissions:accessType>
  </rdf:Description>
  <rdf:Description rdf:nodeID="Nd4fdabd8780947e8a84af7d5d132c858">
    <domeo:sets rdf:resource="urn:pddi:uuid:FF394C23-B19D-4287-8ACE-54167C17E2D1"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:861C11A2-8AEA-4CD2-AC61-355B6002E25D">
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/8CED9A21-7623-4055-94D4-793400BC8FD1"/>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/PK_DDI"/>
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/7BF23512-3FBF-4262-B453-848863F44618"/>
  </rdf:Description>
  <rdf:Description rdf:nodeID="Nc9e39d9039b9464f8b8c4f19de24715b">
    <permissions:accessType>urn:domeo:access:public</permissions:accessType>
    <permissions:isLocked>false</permissions:isLocked>
  </rdf:Description>
  <rdf:Description rdf:nodeID="N18967e1edbe24429a8e76b4f205a3993">
    <permissions:isLocked>false</permissions:isLocked>
    <permissions:accessType>urn:domeo:access:public</permissions:accessType>
  </rdf:Description>
  <rdf:Description rdf:nodeID="Nf4e755f2a5f848cea2dfc20df09619d1">
    <domeo:sets rdf:resource="urn:pddi:uuid:3010354C-0396-4F68-8730-35FBE74BAACF"/>
  </rdf:Description>
  <rdf:Description rdf:nodeID="Nc71143847f9f4013b76facbad12ba057">
    <domeo:sets rdf:resource="urn:pddi:uuid:22A46207-521A-4D8F-8D17-31F7E25F3B95"/>
  </rdf:Description>
  <rdf:Description rdf:nodeID="N4157df53fe474d3596fa22356da6afeb">
    <domeo:sets rdf:resource="urn:pddi:uuid:DDB0C59F-0568-4D74-A9AA-D0E0750F758C"/>
  </rdf:Description>
  <rdf:Description rdf:nodeID="N842258e05292469bb2edfeff6dbf1e5e">
    <permissions:accessType>urn:domeo:access:public</permissions:accessType>
    <permissions:isLocked>false</permissions:isLocked>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:346407F0-F265-40E8-A6A0-BB0525152D4E">
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/PK_DDI"/>
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/60730FAE-AD66-492F-8E58-7FE659B7159F"/>
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/DABEA160-744E-4F3F-99D1-342761D8E356"/>
  </rdf:Description>
  <rdf:Description rdf:nodeID="N773370ee26bd463b9ae13d34c157680f">
    <permissions:isLocked>false</permissions:isLocked>
    <permissions:accessType>urn:domeo:access:public</permissions:accessType>
  </rdf:Description>
  <rdf:Description rdf:nodeID="N5e591169c55e4fee81fc72353a06ce87">
    <permissions:accessType>urn:domeo:access:public</permissions:accessType>
    <permissions:isLocked>false</permissions:isLocked>
  </rdf:Description>
  <rdf:Description rdf:nodeID="Ncc0591e02c1845af940211aab3b5baae">
    <domeo:sets rdf:resource="urn:pddi:uuid:BAFAC6A6-4A37-498B-BA86-449A697DAA80"/>
  </rdf:Description>
  <rdf:Description rdf:nodeID="Nb0ce8ef3d8e3495baf70e3f4f30f0fb1">
    <permissions:accessType>urn:domeo:access:public</permissions:accessType>
    <permissions:isLocked>false</permissions:isLocked>
  </rdf:Description>
  <rdf:Description rdf:nodeID="Nd3e5f90c8929405ab99d16af856698a7">
    <domeo:sets rdf:resource="urn:pddi:uuid:788F9802-1A2C-4B8B-958F-27977AB9BE1B"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:41533E80-E3DB-4B1A-BC74-31DB2EDCBDFA">
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/2E8E0C08-A9A5-4122-9C0E-4594641FBED5"/>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/PK_DDI"/>
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/513340A0-A222-4865-9DAF-1EDDCCCA86A0"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:311508D9-4E16-476A-B489-8598869EEF79">
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/314A940A-9CA5-4B7A-B433-2AECFF25EFA4"/>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/PK_DDI"/>
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/0A6A30F9-53A5-47E7-B0BA-25617EEE3E7A"/>
  </rdf:Description>
  <rdf:Description rdf:nodeID="N6d7109c3144743b0b145f59b9b892212">
    <permissions:isLocked>false</permissions:isLocked>
    <permissions:accessType>urn:domeo:access:public</permissions:accessType>
  </rdf:Description>
  <rdf:Description rdf:nodeID="N9b7776e7468f4202a5eeeeaf5b975767">
    <permissions:accessType>urn:domeo:access:public</permissions:accessType>
    <permissions:isLocked>false</permissions:isLocked>
  </rdf:Description>
  <rdf:Description rdf:nodeID="Ne729179121c74ba9af7f8549983f96f9">
    <permissions:isLocked>false</permissions:isLocked>
    <permissions:accessType>urn:domeo:access:public</permissions:accessType>
  </rdf:Description>
  <rdf:Description rdf:nodeID="N95f881cd66e24b3f8c7b0d9d35a341dd">
    <domeo:sets rdf:resource="urn:pddi:uuid:04DB6C49-D431-40EA-98E8-D720E8A6787D"/>
  </rdf:Description>
  <rdf:Description rdf:nodeID="N80f08c6ada294f36974b6afcb7c03d3f">
    <domeo:sets rdf:resource="urn:pddi:uuid:7210ECAE-0079-4C21-98CB-EDA94264D7DA"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:1A9D1840-CE0D-486B-A233-984C10D2DFDC">
    <sio:SIO_000563>dikbD2R:modality</sio:SIO_000563>
    <rdf:type rdf:resource="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#DrugDrugInteractionStatement"/>
    <dikbD2R:statement>ncit:quantitative</dikbD2R:statement>
    <dikbD2R:modality>ncit:positive</dikbD2R:modality>
    <sio:SIO_000205>dikbD2R:statement</sio:SIO_000205>
    <sio:SIO_000628 rdf:resource="urn:pddi:uuid:6C2517B0-E801-41F8-8917-AC00583F30D9"/>
  </rdf:Description>
  <rdf:Description rdf:nodeID="N499cfe574e01485b98190f0d8c354a4d">
    <domeo:sets rdf:resource="urn:pddi:uuid:8A431E8A-FC95-4652-BD90-CA4F04C5CCB1"/>
  </rdf:Description>
  <rdf:Description rdf:nodeID="Neca3071258a94b6eb31ff51e56358b36">
    <permissions:accessType>urn:domeo:access:public</permissions:accessType>
    <permissions:isLocked>false</permissions:isLocked>
  </rdf:Description>
  <rdf:Description rdf:nodeID="N1a7f3fd57e924addb228258f37fd6173">
    <permissions:isLocked>false</permissions:isLocked>
    <permissions:accessType>urn:domeo:access:public</permissions:accessType>
  </rdf:Description>
  <rdf:Description rdf:nodeID="Ne8c75e56ecff40c8bb7a31fda7cad1e4">
    <domeo:sets rdf:resource="urn:pddi:uuid:CDF62581-CF1E-49F8-8077-2328677F5CAD"/>
  </rdf:Description>
  <rdf:Description rdf:nodeID="Nb594beb684ad4f3485d5101e3633fb63">
    <permissions:isLocked>false</permissions:isLocked>
    <permissions:accessType>urn:domeo:access:public</permissions:accessType>
  </rdf:Description>
  <rdf:Description rdf:nodeID="Nfa1448e0e5c74a8185feb4e1e0cfccc6">
    <domeo:sets rdf:resource="urn:pddi:uuid:2B0ED6AC-8154-4067-8180-F00F0B22BE08"/>
  </rdf:Description>
  <rdf:Description rdf:nodeID="Na32a2b76569940d5a8755e340acf74ca">
    <domeo:sets rdf:resource="urn:pddi:uuid:7650C658-240A-439A-9275-FFBCC1902F40"/>
  </rdf:Description>
  <rdf:Description rdf:nodeID="N20e49fc8c1d14b46bba22f77b4068d67">
    <domeo:sets rdf:resource="urn:pddi:uuid:62E3DBD7-F876-4CE9-8CED-6955F6A66F76"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:F049BA4A-8DAF-49C1-ABA1-6E76A2F6DA6B">
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/A36E11B0-6726-4AD1-ACC7-4E8E59A350EB"/>
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/1FCFC8E7-95A0-4188-9582-891391C2CFE6"/>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/PK_DDI"/>
  </rdf:Description>
  <rdf:Description rdf:nodeID="N081e68e058754f909437b54af38fdce1">
    <permissions:accessType>urn:domeo:access:public</permissions:accessType>
    <permissions:isLocked>false</permissions:isLocked>
  </rdf:Description>
  <rdf:Description rdf:nodeID="N0694a5f7f1bf4644b362b9d9d13b8f0a">
    <domeo:sets rdf:resource="urn:pddi:uuid:776765AF-5295-4800-809B-C7978354CB7E"/>
  </rdf:Description>
  <rdf:Description rdf:nodeID="N75f00f9999f84ff3afc8788435c7f8c2">
    <domeo:sets rdf:resource="urn:pddi:uuid:9A7BCFA2-0D97-4701-B6BB-99407F80BF4B"/>
  </rdf:Description>
  <rdf:Description rdf:nodeID="N4874a069bde348c7a432f6baacb57bfb">
    <domeo:sets rdf:resource="urn:pddi:uuid:F8DD977A-C7DF-4C3A-9290-F79622C98E04"/>
  </rdf:Description>
  <rdf:Description rdf:nodeID="N2563999c13964c0fb1619be3dbd91060">
    <domeo:sets rdf:resource="urn:pddi:uuid:CA65F737-1E98-4A37-A7F1-220396E99856"/>
  </rdf:Description>
  <rdf:Description rdf:nodeID="N2e09856b11054fd1938ac7e4e4ccd332">
    <domeo:sets rdf:resource="urn:pddi:uuid:1B38A7F0-853F-46CF-9666-915C8032692B"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:4B76211E-8EB7-4844-9558-2AE555B3F201">
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/DBA1F413-B42A-40DE-B1F5-8527CD8BE365"/>
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/61AE2D64-FCA3-4A33-91AF-196E90750A35"/>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/PK_DDI"/>
  </rdf:Description>
  <rdf:Description rdf:nodeID="N729962a69d5e4d598616d395d5a64342">
    <permissions:isLocked>false</permissions:isLocked>
    <permissions:accessType>urn:domeo:access:public</permissions:accessType>
  </rdf:Description>
  <rdf:Description rdf:nodeID="Nc24d8172d8da436f8c64c9e2b19a133d">
    <permissions:accessType>urn:domeo:access:public</permissions:accessType>
    <permissions:isLocked>false</permissions:isLocked>
  </rdf:Description>
  <rdf:Description rdf:nodeID="N473080370f864f43a5464ebedb68cdb2">
    <domeo:sets rdf:resource="urn:pddi:uuid:2FB03C2F-1973-4F66-AF66-7DEAA97D5719"/>
  </rdf:Description>
  <rdf:Description rdf:nodeID="Nc51dd627f9534301bba7d2b069ae1357">
    <domeo:sets rdf:resource="urn:pddi:uuid:2F750407-05DE-4618-A170-8A67EDC3FDCE"/>
  </rdf:Description>
  <rdf:Description rdf:nodeID="N7ffc8cb50878452ba52294e3ede3067e">
    <permissions:accessType>urn:domeo:access:public</permissions:accessType>
    <permissions:isLocked>false</permissions:isLocked>
  </rdf:Description>
  <rdf:Description rdf:nodeID="N76aaf2fc3a3749a691604463a91f34cb">
    <domeo:sets rdf:resource="urn:pddi:uuid:6198583A-79DD-481E-925D-CD236EDFDC7D"/>
  </rdf:Description>
  <rdf:Description rdf:nodeID="Nc8427479039e45d6959dd84aa7121215">
    <domeo:sets rdf:resource="urn:pddi:uuid:D7F3CF4B-F577-4BF7-B88B-B5D04D01A04A"/>
  </rdf:Description>
  <rdf:Description rdf:nodeID="N5ce44c0b9d3247d28eb3cb9274509065">
    <domeo:sets rdf:resource="urn:pddi:uuid:6B93EB2B-A516-48C4-A750-602CF9462A88"/>
  </rdf:Description>
  <rdf:Description rdf:nodeID="Nbfc121d4b53846209962b13800c070cd">
    <domeo:sets rdf:resource="urn:pddi:uuid:ECBE6688-F3FC-4F3A-AB24-57398C040B44"/>
  </rdf:Description>
  <rdf:Description rdf:nodeID="N8f1ddde4db10450aaa41d832154812bb">
    <permissions:accessType>urn:domeo:access:public</permissions:accessType>
    <permissions:isLocked>false</permissions:isLocked>
  </rdf:Description>
  <rdf:Description rdf:nodeID="Nf2408aefedbd436294109f70281787da">
    <permissions:isLocked>false</permissions:isLocked>
    <permissions:accessType>urn:domeo:access:public</permissions:accessType>
  </rdf:Description>
  <rdf:Description rdf:nodeID="N777b976cbd3f4c92a82e132e0b0fd8f0">
    <domeo:sets rdf:resource="urn:pddi:uuid:0CE6C620-40B4-4E55-8185-8A319ECD6D71"/>
  </rdf:Description>
  <rdf:Description rdf:nodeID="N8cb546f2298f47b6b06debe187be68f0">
    <domeo:sets rdf:resource="urn:pddi:uuid:8186AE14-85DE-4E1A-B5F4-BC58233DC47B"/>
  </rdf:Description>
  <rdf:Description rdf:nodeID="N0d07a984c63446faa00323759a8d8cd3">
    <domeo:sets rdf:resource="urn:pddi:uuid:7A327F1B-E170-41D6-BEC1-65E5D1CB43B8"/>
  </rdf:Description>
  <rdf:Description rdf:nodeID="Nd50e98fc4cd04367ba07408a8e7e411a">
    <domeo:sets rdf:resource="urn:pddi:uuid:326B6DC1-778C-4951-9B8A-4B76A407BA1D"/>
  </rdf:Description>
  <rdf:Description rdf:nodeID="N6e48ab40e9d04219afa770451338b941">
    <domeo:sets rdf:resource="urn:pddi:uuid:F1D81A6A-D89D-4D44-96EB-35FB50C7D732"/>
  </rdf:Description>
  <rdf:Description rdf:nodeID="Nb93889a977264765ba140c50cf08c496">
    <domeo:sets rdf:resource="urn:pddi:uuid:A9ACBE0B-1A8C-4271-B63C-7BF4E5B90412"/>
  </rdf:Description>
  <rdf:Description rdf:nodeID="N0c077dafa1b34d60ae091274c58d4cf4">
    <domeo:sets rdf:resource="urn:pddi:uuid:CF243312-0709-454B-9D42-8D2FEDA95D55"/>
  </rdf:Description>
  <rdf:Description rdf:nodeID="Ncae526887c204b68a2b7d826aaa1be04">
    <domeo:sets rdf:resource="urn:pddi:uuid:BC114E92-ED59-4D14-B788-57030FC75EBC"/>
  </rdf:Description>
  <rdf:Description rdf:nodeID="Nd63715d19f2242479033a24abc4bc590">
    <domeo:sets rdf:resource="urn:pddi:uuid:171C7925-6F8E-4017-8743-473B0DE0C8C1"/>
  </rdf:Description>
  <rdf:Description rdf:nodeID="N4b5f4fe91a324324b9bc068f74aa3143">
    <domeo:sets rdf:resource="urn:pddi:uuid:EE9876CA-9D21-44C9-A6F5-8C0F13C4447C"/>
  </rdf:Description>
  <rdf:Description rdf:nodeID="N8c96dfabf826491e86ec0b0142045ff9">
    <domeo:sets rdf:resource="urn:pddi:uuid:C8D072B3-4844-4132-96FD-1E44EFE7C281"/>
  </rdf:Description>
  <rdf:Description rdf:nodeID="N592bb7bb66a84d5da9b77ac2d8bb9e22">
    <domeo:sets rdf:resource="urn:pddi:uuid:0D94D28F-90BB-4AF1-9CBD-EC4DB10359AA"/>
  </rdf:Description>
  <rdf:Description rdf:nodeID="N453d8d1d1a654fd9a5a165618e7b45fa">
    <domeo:sets rdf:resource="urn:pddi:uuid:1A79F27D-249B-477A-8F23-ED3A357054B9"/>
  </rdf:Description>
</rdf:RDF>
